71 FR 231 pgs. 69624-70251 - Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance Inflation Factor Update for CY 2007

Type: RULEVolume: 71Number: 231Pages: 69624 - 70251
Docket number: [CMS-1321-FC and CMS-1317-F]
FR document: [FR Doc. 06-9086 Filed 11-1-06; 5:00 pm]
Agency: Health and Human Services Department
Sub Agency: Centers for Medicare Medicaid Services
Official PDF Version:  PDF Version

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare Medicaid Services

42 CFR Parts 405, 410, 411, 414, 415, and 424

[CMS-1321-FC and CMS-1317-F]

RINs 0938-AO24 and 0938-AO11

Medicare Program; Revisions to Payment Policies, Five-Year Review of Work Relative Value Units, Changes to the Practice Expense Methodology Under the Physician Fee Schedule, and Other Changes to Payment Under Part B; Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services; and Ambulance Inflation Factor Update for CY 2007

AGENCY:

Centers for Medicare Medicaid Services (CMS), HHS.

ACTION:

Final rule with comment period.

SUMMARY:

This final rule with comment period addresses certain provisions of the Deficit Reduction Act of 2005, as well as making other changes to Medicare Part B payment policy. These changes are intended to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. This final rule with comment period also discusses geographic practice cost indices (GPCI) changes; requests for additions to the list of telehealth services; payment for covered outpatient drugs and biologicals; payment for renal dialysis services; policies related to private contracts and opt-out; policies related to bone mass measurement (BMM) services, independent diagnostic testing facilities (IDTFs), the physician self-referral prohibition; laboratory billing for the technical component (TC) of physician pathology services; the clinical laboratory fee schedule; certification of advanced practice nurses; health information technology, the health care information transparency initiative; updates the list of certain services subject to the physician self-referral prohibitions, finalizes ASP reporting requirements, and codifies Medicare's longstanding policy that payment of bad debts associated with services paid under a fee schedule/charge-based system are not allowable.

We are also finalizing the calendar year (CY) 2006 interim RVUs and are issuing interim RVUs for new and revised procedure codes for CY 2007.

In addition, this rule includes revisions to payment policies under the fee schedule for ambulance services and the ambulance inflation factor update for CY 2007.

As required by the statute, we are announcing that the physician fee schedule update for CY 2007 is -5.0 percent, the initial estimate for the sustainable growth rate for CY 2007 is 2.0 percent and the CF for CY 2007 is $35.9848.

DATES:

Effective Date: These regulations are effective on January 1, 2007.

Comment Date: Comments will be considered if we receive them at one of the addresses provided below, no later than 5 p.m. on January 2, 2007.

ADDRESSES:

In commenting, please refer to file code CMS-1321-FC. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission.

You may submit comments in one of three ways (no duplicates, please):

1. Electronically. You may submit electronic comments on specific issues in this regulation to http://www.cms.hhs.gov/eRulemaking. Click on the link "Submit electronic comments on CMS regulations with an open comment period." (Attachments should be in Microsoft Word, WordPerfect, or Excel; however, we prefer Microsoft Word.)

2. By mail. You may mail written comments (one original and two copies) to the following address ONLY: Centers for Medicare Medicaid Services, Department of Health and Human Services, Attention: CMS-1321-FC, P.O. Box 8014, Baltimore, MD 21244-8014.

Please allow sufficient time for mailed comments to be received before the close of the comment period.

3. By express or overnight mail. You may send written comments (one original and two copies) to the following address only: Centers for Medicare Medicaid Services, Department of Health and Human Services,Attention: CMS-1321-FC, Mail Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.

4. By hand or courier. If you prefer, you may deliver (by hand or courier) your written comments (one original and two copies) before the close of the comment period to one of the following addresses. If you intend to deliver your comments to the Baltimore address, please call telephone number (410) 786-7197 in advance to schedule your arrival with one of our staff members.

Room 445-G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; or 7500 Security Boulevard, Baltimore, MD 21244-1850.

(Because access to the interior of the HHH Building is not readily available to persons without Federal Government identification, commenters are encouraged to leave their comments in the CMS drop slots located in the main lobby of the building. A stamp-in clock is available for persons wishing to retain a proof of filing by stamping in and retaining an extra copy of the comments being filed.)

Comments mailed to the addresses indicated as appropriate for hand or courier delivery may be delayed and received after the comment period.

Submission of comments on paperwork requirements. You may submit comments on this document's paperwork requirements by mailing your comments to the addresses provided at the end of the "Collection of Information Requirements" section in this document.

For information on viewing public comments, see the beginning of the SUPPLEMENTARY INFORMATION section.

FOR FURTHER INFORMATION CONTACT:

Pam West, (410) 786-2302 (for issues related to practice expense).

Stephanie Monroe, (410) 786-6864 (for issues related to the geographic practice cost index).

Craig Dobyski, (410) 786-4584 (for issues related to list of telehealth services).

Roberta Epps, (410) 786-4503 (for issues related to diagnostic imaging services).

Bill Larson, (410) 786-4639 (for issues related to coverage of bone mass measurement and addition of ultrasound screening for abdominal aortic aneurysm to the "Welcome to Medicare" benefit).

Dorothy Shannon, (410) 786-3396 (for issues related to the outpatient therapy cap).

Catherine Jansto, (410) 786-7762 (for issues related to payment for covered outpatient drugs and biologicals).

Henry Richter, (410) 786-4562 (for issues related to payments for end-stage renal disease facilities).

Fred Grabau, (410) 786-0206 (for issues related to private contracts and opt-out provision).

David Walczak, (410) 786-4475 (for issues related to reassignment provisions).

August Nemec, (410) 786-0612 (for issues related to independent diagnostic testing facilities).

Anita Greenberg, (410) 786-4601 (for issues related to the clinical laboratory fee schedule).

James Menas, (410) 786-4507 (for issues related to payment for physician pathology services).

Anne Tayloe, (410) 786-4546; or

Glenn McGuirk, (410) 786-5723 (for issues related to the ambulance fee schedule.

Diane Milstead, (410) 786-3355 or Gaysha Brooks, (410) 786-9649 (for all other issues).

SUPPLEMENTARY INFORMATION:

Submitting Comments: We welcome comments from the public on the following issues: interim Relative Value Units (RVUs) for selected procedure codes identified in Addendum C and the physician self-referral designated health services (DHS) listed in Tables 18 and 19. You can assist us by referencing the file code CMS-1321-FC and the specific "issue identifier" that precedes the section on which you choose to comment.

Inspection of Public Comments: All comments received before the close of the comment period are available for viewing by the public, including any personally identifiable or confidential business information that is included in a comment. We post all comments received before the close of the comment period on the following Web site as soon as possible after they have been received: http://www.cms.hhs.gov/eRulemaking. Click on the link "Electronic Comments on CMS Regulations" on that Web site to view public comments.

Comments received timely will also be available for public inspection as they are received, generally beginning approximately 3 weeks after publication of a document, at the headquarters of the Centers for Medicare Medicaid Services, 7500 Security Boulevard, Baltimore, Maryland 21244, Monday through Friday of each week from 8:30 a.m. to 4 p.m. To schedule an appointment to view public comments, phone 1-800-743-3951.

This Federal Register document is also available from the Federal Register online database through Government Printing Office Access, a service of the U.S. Government Printing Office. The Web site address is: http://www.access.gpo.gov/nara/index.html.

Information on the physician fee schedule can also be found on the CMS homepage. You can access this data by using the following directions:

1. Go to the following Web site: http://www.cms.hhs.gov/PhysicianFeeSched/.

2. Select "PFS Federal Regulation Notices."

To assist readers in referencing sections contained in this preamble, we are providing the following table of contents. Some of the issues discussed in this preamble affect the payment policies, but do not require changes to the regulations in the Code of Federal Regulations. Information on the regulation's impact appears throughout the preamble and is not exclusively in section VI.

Table of Contents

I. Background

A. Development of the Relative Value System

B. Components of the Fee Schedule Payment Amounts

C. Most Recent Changes to the Fee Schedule

II. Provisions of the Final Rule

A. Resource-Based Practice Expense Relative Value Units

1. Current Methodology

2. Proposals for Revising the PE Methodology

3. Specific Changes to the Indirect PE Methodology for Calendar Year 2007

4. Additional PE Issues for CY 2007

a. RUC Recommendations for Direct PE Inputs and Other PE Input Issues

b. Payment for Splint and Cast Supplies

c. Medical Nutrition Therapy Services

d. Surgical Pathology Codes

e. PE Issues from Rulemaking for CY 2006

f. Other PE Issues for CY 2007

g. Specific PE Concerns Raised by Commenters

h. Concerns About Decreases in PE RVUs

i. Equipment Utilization and Interest Rate Assumptions

j. Further Review of PE Direct Inputs

k. Supply and Equipment Items Needing Specialty Input

B. Geographic Practice Cost Indices (GPCIs)

C. Medicare Telehealth Services

D. Miscellaneous Coding Issues

1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

2. Assignment of RVUS for Proton Beam Treatment Delivery Services

E. Deficit Reduction Act (DRA)

1. Section 5102-Adjustments for Payments to Imaging Services

a. Payment for Multiple Imaging Procedures for 2007

b. Reduction in TC for Imaging Services Under the PFS to OPD Payment Amount

c. Interaction of the Multiple Imaging Payment Reduction and the OPPS Cap

2. Section 5107-Revisions to Payments for Therapy Services

3. Section 5112-Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA)

a. Coverage

b. Payment

4. Section 5113-Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests

5. Section 5114-Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

F. Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

1. ASP Issues

2. Intravenous Immune Globulin (IVIG)

3. Clotting Factor Furnishing Fee

4. Widely Available Market Prices (WAMP) and Average Manufacturer Price (AMP) Threshold

5. Payment for Drugs Furnished During CY 2006 and Subsequent Years in Connection With the Furnishing of Renal Dialysis Services if Separately Billed by Renal Dialysis Facilities

6. Other Issues

G. Revisions Related to Payment for Renal Dialysis Services Furnished by End Stage Renal Disease (ESRD) Facilities

1. Growth Update to the Drug Add-on Adjustment to the Composite Rate

2. Update to the Geographic Adjustments to the Composite Rates

H. Private Contracts and Opt-Out Provision-Practitioner Definition

I. Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests

J. Supplier Access to Claims Billed on Reassignment

K. Coverage of Bone Mass Measurement

1. Provisions of the June 24, 1998 IFC

2. Additional Scientific Evidence

3. Changes to the June 24, 1998 IFC

4. Analysis of and Response to Comments on the June 24, 1998 IFC and the CY 2007 PFS Proposed Rule

L. Independent Diagnostic Testing Facility (IDTF) Issues

1. IDTF Changes

2. Performance Standards for IDTFs

3. Supervision

4. Place of Service

5. Analysis of and Response to Public Comments

6. Provisions of the Final Rule

M. Independent Laboratory Billing for the TC of Physician Pathology Services to Hospital Patients

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

1. Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 (BIPA)

2. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA)

3. Other Laboratory Issues

a. Quality

b. Blood Glucose Monitoring in SNFs

c. Other Lab Issues-Clinical Diagnostic Laboratory Date of Service (DOS) for Stored Specimens

O. Criteria for National Certifying Bodies that Certify Advanced Practice Nurses

P. Chiropractic Services Demonstration

Q. Promoting Effective Use of Health Information Technology (HIT)

R. Health Care Information Transparency Initiative

S. Bad Debt Payment for Services Associated with Reasonable Charge/Fee Schedules

III. Revisions to the Payment Policies of Ambulance Services Under the Fee Schedule for Ambulance Services and the Ambulance Inflation Factor Update for CY 2007

A. History of Medicare Ambulance Services

B. Provisions of the Final Regulation

C. Analysis of and Responses to Public Comments

D. Ambulance Inflation Factor (AIF) for 2007

IV. Five-Year Refinement of Relative Value Units Under the Physician Fee Schedule: Responses to Public Comments on the Five-Year Review of Work Relative Value Units

A. Scope of Five-Year Review

B. Review of Comments (Includes Table entitled "Work RVU Revisions in Response to the June 29, 2006 proposed notice")

C. Discussion of Comments by Clinical Area

1. Dermatology and Plastic Surgery

2. Orthopedic Surgery

3. Gynecology, Urology, Pain Medicine, and Neurosurgery

4. Radiology, Pathology, and Other Miscellaneous Services

5. Evaluation and Management Services

6. Cardiothoracic Surgery

7. General, Colorectal and Vascular Surgery

8. Otolaryngology and Ophthalmology

9. HCPAC codes

D. Other Issues Under the 5-Year Review

1. Anesthesia Services

2. Discussion of Post-Operative Visits included in the Global Surgical Packages

3. Budget Neutrality

4. Review Process

V. Refinement of Relative Value Units for Calendar Year 2007 and Response to Public Comments on Interim Relative Value Units for 2006

A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units

B. Process for Establishing Work Relative Value Units for the 2006 Physician Fee Schedule

C. Work Relative Value Unit Refinements of Interim Relative Value Units

1. Methodology (Includes table entitled "2006 Interim Work Relative Value Units for Codes Reviewed Under the Refinement Panel Process")

2. Interim 2006 Codes

D. Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2007 (Includes Table titled "American Medical Association Specialty Relative Value Update Committee and Health Care Professionals Advisory Committee Recommendations and CMS' Decisions for New and Revised 2007 CPT Codes")

E. Discussion of Codes for Which There Were No RUC Recommendations or for Which the RUC Recommendations Were Not Accepted

F. Additional Pricing Issue

G. Establishment of Interim PE RVUs for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System (HCPCS) Codes for 2007

VI. Physician Self-Referral Prohibition: Annual Update to the List of CPT/HCPCS Codes

A. General

B. Nuclear Medicine

C. Annual Update to the Code List

VII. Physician Fee Schedule Update for CY 2007

A. Physician Fee Schedule Update

B. The Percentage Change in the Medicare Economic Index (MEI)

C. The Update Adjustment Factor (UAF)

VIII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate

A. Medicare Sustainable Growth Rate

B. Physicians' Services

C. Preliminary Estimate of the SGR for 2007

D. Revised Sustainable Growth Rate for 2006

E. Final Sustainable Growth Rate for 2005

F. Calculation of 2007, 2006, and 2005 Sustainable Growth Rates

IX. Anesthesia and Physician Fee Schedule Conversion Factors for CY 2007

A. Physician Fee Schedule Conversion Factor

B. Anesthesia Fee Schedule Conversion Factor

X. Telehealth Originating Site Facility Fee Payment Amount Update

XI. Provisions of the Final Rule

XII. Waiver of Proposed Rulemaking and Delay in Effective Date

XIII. Collection of Information Requirements

XIV. Response to Comments

XV. Regulatory Impact Analysis

A. RVU Impacts

1. Resource-Based Work and PE RVUs

2. Section 5102 of the DRA Adjustments for Payments for Imaging Services

3. Combined Impacts

B. Geographic Practice Cost Indices (GPCI) Payment Localities

C. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

D. DRA 5112: Addition of Ultrasound Screening for Abdominal Aortic Aneurysm to "Welcome to Medicare" Benefit

E. DRA 5113: Colorectal Screening Exemption from Part B Deductible

F. Section 5114: Addition of Diabetes Outpatient Self-management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

G. Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

H. Provisions Related to Payment for Renal Dialysis Services Furnished by End State Renal Disease (ESRD) Facilities

I. Private Contracts and Opt-out Provision

J. Supplier Access to Claims Billed on Reassignment

K. Coverage of Bone Mass Measurement

L. IDTF Changes

M. Independent Lab Billing for TC Component of Physician Pathology Services for Hospital Patients

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

O. Bad Debt Payment for Services Associated with Reasonable Charge/Fee Schedules

P. Revisions to Payment Policies under the Ambulance Fee Schedule and the Ambulance Inflation Factor Update for CY 2007

Q. Alternatives Considered

R. Impact on Beneficiaries

S. Accounting Statement

Addendum A-Explanation and Use of Addendum B.

Addendum B-2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2006.

Addendum C-Codes with Interim RVUs

Addendum D-2007 Geographic Practice Cost Indices by Medicare Carrier and Locality

Addendum E-GAF Addenda

Addendum F-Addendum F: CPT/HCPCS Imaging Codes Defined by DRA 5102(b)

Addendum G-CY 2007 Wage Index For Urban Areas Based On CBSA Labor Market Areas

Addendum H-CY 2007 ESRD Wage Index for Rural Areas Based on CBSA Labor Market Areas

Addendum I-RUCA Rurality Level by State and Zip Code

Addendum J-Updated List of CPT/HCPCS Codes Used to Describe Certain Designated Health Services Under the Physician Self-Referral Provision

In addition, because of the many organizations and terms to which we refer by acronym in this final rule with comment period, we are listing these acronyms and their corresponding terms in alphabetical order below:

AAAAbdominal aortic aneurysm

AADAmerican Academy of Dermatology

AAFPAmerican Academy of Family Physicians

AANSAmerican Association of Neurological Surgeons

AAOAmerican Academy of Ophthalmology

AAOSAmerican Academy of Orthopaedic Surgeons

AATSAmerican Association for Thoracic Surgery

ACCAmerican College of Cardiology

ACGAmerican College of Gastroenterology

ACHPNAdvanced Certified Hospice and Palliative Nurse

ACOGAmerican College of Obstetrics and Gynecology

ACRAmerican College of Radiology

ACSAmerican College of Surgeons

ADAAmerican Dietetic Association

AFROCAssociation of Freestanding Radiation Oncology Centers

AGAAmerican Gastroenterological Association

AMAAmerican Medical Association

AMPAverage manufacturer price

APCAmbulatory payment classification

ASAAmerican Society of Anesthesiologists

ASCAmbulatory surgical center

ASCRSAmerican Society of Colon and Rectal Surgeons

ASGEAmerican Society of Gastrointestinal Endoscopy

ASPAverage sales price

ASSHAmerican Society for Surgery of the Hand

ASTROAmerican Society for Therapeutic Radiology and Oncology

AUAAmerican Urological Association

BBABalanced Budget Act of 1997 (Pub. L. 105-33)

BBRA[Medicare, Medicaid and State Child Health Insurance Program] Balanced Budget Refinement Act of 1999 (Pub. L. 106-113)

BIPAMedicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000

BLSBureau of Labor Statistics

BMDBone mineral density

BMMBone mass measurement

BNBudget neutrality

BNFBudget neutrality factor

BPBest price

CADComputer-aided detection

CAHCritical access hospital

CAPCompetitive acquisition program

CBSACore-Based Statistical Area

CCICorrect Coding Initiative

CEOChief executive officer

CFConversion factor

CFOChief financial officer

CFRCode of Federal Regulations

CMPCompetitive medical plan

CMSCenters for Medicare Medicaid Services

CNSClinical nurse specialist

CPIConsumer Price Index

CPT(Physicians') Current Procedural Terminology (4th Edition, 2002, copyrighted by the American Medical Association)

CTComputed tomography

CTAComputed tomographic angiography

CYCalendar year

DHSDesignated health services

DMEDurable medical equipment

DMEPOSDurable medical equipment, prosthetics, orthotics, and supplies

DRADeficit Reduction Act

DSMTDiabetes outpatient self-management training services

DXADual energy x-ray absorptiometry

E/MEvaluation and management

EPOErythopoeitin

ESRDEnd stage renal disease

FAXFacsimile

FDAFood and Drug Administration (HHS)

FQHCFederally qualified health center

FR Federal Register

GAFGeographic adjustment factor

GAOGovernment Accountability Office

GDPGross domestic product

GPOGroup purchasing organization

GPCIGeographic practice cost index

HCPACHealth Care Professional Advisory Committee

HCPCSHealthcare Common Procedure Coding System

HCRISHealthcare Cost Report Information System

HSAHealth Savings Account

HHAHome health agency

HHS[Department of] Health and Human Services

HITHealth information technology

HMOHealth maintenance organization

HOCMHigh osmolar contrast media

HPSAHealth Professional Shortage Area

HRSAHealth Resources Services Administration (HHS)

HUD[Department of] Housing and Urban Development

ICFIntermediate care facilities

IDTFIndependent diagnostic testing facility

IFCInterim final rule with comment period

IPPEInitial preventive physical examination

IPPSInpatient prospective payment system

IVIGIntravenous immune globulin

IWPUTIntra-service work per unit of time

JCAAIJoint Council of Allergy, Asthma, and Immunology

LCDLocal coverage determination

LOCMLow osmolar contrast media

LOINCLogical Observation Identifiers Names and Codes

MAMedicare Advantage

MCPMonthly capitation payment

MedPACMedicare Payment Advisory Commission

MEIMedicare Economic Index

MLNMedicare Learning Network

MMAMedicare Prescription Drug, Improvement, and Modernization Act of 2003 (Pub. L. 108-173)

MNTMedical nutrition therapy

MRAMagnetic resonance angiography

MRIMagnetic resonance imaging

MSAMetropolitan statistical area

MSVP Multi-specialty visit package

NCDNational coverage determination

NCQDISNational Coalition of Quality Diagnostic Imaging Services

NDCNational drug code

NEMANational Electrical Manufacturers Association

NHENational health expenditures

NOPNational Osteoporosis Foundation

NPNurse practitioner

NPPNonphysician practitioners

NPWPNonphysician Work Pool

NSQIPNational Surgical Quality Improvement Program

OBRAOmnibus Budget Reconciliation Act

OIGOffice of Inspector General

OMBOffice of Management and Budget

OPDOutpatient Department

OPPSOutpatient prospective payment system

OSCAROnline Survey and Certification and Reporting

PAPhysician assistant

PBMPharmacy benefit managers

PCProfessional component

PEPractice Expense

PE/HRPractice expense per hour

PEACPractice Expense Advisory Committee

PERCPractice Expense Review Committee

PETPositron emission tomography

PFSPhysician Fee Schedule

PLIProfessional liability insurance

PPIProducer price index

PPOPreferred provider organization

PPSProspective payment system

PRAPaperwork Reduction Act

PRMProvider Reimbursement Manual

PTPhysical therapy

QCTQuantitative computerized tomography

RFARegulatory Flexibility Act

RHCRural health clinic

RIARegulatory impact analysis

RNRegistered nurse

RUC[AMA's Specialty Society] Relative (Value) Update Committee

RVURelative value unit

SGRSustainable growth rate

SMS[AMA's] Socioeconomic Monitoring System

SNFSkilled nursing facility

SNMSociety for Nuclear Medicine

SPASingle photon absorptiometry

STSSociety of Thoracic Surgeons

SVSSociety for Vascular Surgery

SXASingle energy x-ray absorptiometry

TATechnology Assessment

TCTechnical Component

UAFUpdate adjustment factor

UPINUnique Physician Identification Number

USPSTFUnited States Preventive Services Task Force

VA[Department of] Veteran Affairs

WACWholesale acquisition cost

WAMPWidely available market price

WHOWorld Health Organization

I. Background

Since January 1, 1992, Medicare has paid for physicians' services under section 1848 of the Social Security Act (the Act), "Payment for Physicians' Services." The Act requires that payments under the physician fee schedule (PFS) be based on national uniform relative value units (RVUs) based on the resources used in furnishing a service. Section 1848(c) of the Act requires that national RVUs be established for physician work, practice expense (PE), and malpractice expense. Before the establishment of the resource-based relative value system, Medicare payment for physicians' services was based on reasonable charges.

A. Development of the Relative Value System

1. Work RVUs

The concepts and methodology underlying the PFS were enacted as part of the Omnibus Budget Reconciliation Act (OBRA) of 1989 (Pub. L. 101-239), and OBRA 1990 (Pub. L. 101-508). The final rule, published November 25, 1991 (56 FR 59502), set forth the fee schedule for payment for physicians' services beginning January 1, 1992. Initially, only the physician work RVUs were resource-based, and the PE and malpractice RVUs were based on average allowable charges.

The physician work RVUs established for the implementation of the fee schedule in January 1992 were developed with extensive input from the physician community. A research team at the Harvard School of Public Health developed the original physician work RVUs for most codes in a cooperative agreement with the Department of Health and Human Services (HHS). In constructing the code-specific vignettes for the original physician work RVUs, Harvard worked with panels of experts, both inside and outside the Federal government, and obtained input from numerous physician specialty groups.

Section 1848(b)(2)(A) of the Act specifies that the RVUs for radiology services are based on relative value scale we adopted under section 1834(b)(1)(A) of the Act, (the American College of Radiology (ACR) relative value scale), which we integrated into the overall PFS. Section 1848(b)(2)(B) of the Act specifies that the RVUs for anesthesia services are based on RVUs from a uniform relative value guide. We established a separate conversion factor (CF) for anesthesia services, and we continue to utilize time units as a factor in determining payment for these services. As a result, there is a separate payment methodology for anesthesia services.

We establish physician work RVUs for new and revised codes based on recommendations received from the American Medical Association's (AMA) Specialty Society Relative Value Update Committee (RUC).

2. Practice Expense Relative Value Units (PE RVUs)

Section 121 of the Social Security Act Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, amended section 1848(c)(2)(C)(ii) of the Act and required us to develop resource-based PE RVUs for each physician's service beginning in 1998. We were to consider general categories of expenses (such as office rent and wages of personnel, but excluding malpractice expenses) comprising PEs.

Section 4505(a) of the Balanced Budget Act of 1997 (BBA) (Pub. L. 105-33), amended section 1848(c)(2)(C)(ii) of the Act to delay implementation of the resource-based PE RVU system until January 1, 1999. In addition, section 4505(b) of the BBA provided for a 4-year transition period from charge-based PE RVUs to resource-based RVUs.

We established the resource-based PE RVUs for each physician's service in a final rule, published November 2, 1998 (63 FR 58814), effective for services furnished in 1999. Based on the requirement to transition to a resource-based system for PE over a 4-year period, resource-based PE RVUs did not become fully effective until 2002.

This resource-based system was based on two significant sources of actual PE data: The Clinical Practice Expert Panel (CPEP) data and the AMA's Socioeconomic Monitoring System (SMS) data. The CPEP data were collected from panels of physicians, practice administrators, and nonphysicians (for example, registered nurses) nominated by physician specialty societies and other groups. The CPEP panels identified the direct inputs required for each physician's service in both the office setting and out-of-office setting. The AMA's SMS data provided aggregate specialty-specific information on hours worked and PEs.

Separate PE RVUs are established for procedures that can be performed in both a nonfacility setting, such as a physician's office, and a facility setting, such as a hospital outpatient department (OPD). The difference between the facility and nonfacility RVUs reflects the fact that a facility receives separate payment from Medicare for its costs of providing the service, apart from payment under the PFS. The nonfacility RVUs reflect all of the direct and indirect PEs of providing a particular service.

Section 212 of the Balanced Budget Refinement Act of 1999 (BBRA) (Pub. L. 106-113) directed the Secretary of Health and Human Services (the Secretary) to establish a process under which we accept and use, to the maximum extent practicable and consistent with sound data practices, data collected or developed by entities and organizations to supplement the data we normally collect in determining the PE component. On May 3, 2000, we published the interim final rule (65 FR 25664) that set forth the criteria for the submission of these supplemental PE survey data. The criteria were modified in response to comments received, and published in the Federal Register (65 FR 65376) as part of a November 1, 2000 final rule. The PFS final rules published in 2001 and 2003, respectively, (66 FR 55246 and 68 FR 63196) extended the period during which we would accept these supplemental data.

3. Resource-Based Malpractice RVUs

Section 4505(f) of the BBA amended section 1848(c) of the Act to require us to implement resource-based malpractice RVUs for services furnished on or after 2000. The resource-based malpractice RVUs were implemented in the PFS final rule published November 2, 1999 (64 FR 59380) (hereinafter referred to as the CY 2000 PFS final rule). The malpractice RVUs were based on malpractice insurance premium data collected from commercial and physician-owned insurers from all the States, the District of Columbia, and Puerto Rico.

4. Refinements to the RVUs

Section 1848(c)(2)(B)(i) of the Act requires that we review all RVUs no less often than every 5 years. The first 5-year review of the physician work RVUs went into effect in 1997, published on November 22, 1996 (61 FR 59489). The second 5-year review of work RVUs went into effect in 2002, published on November 1, 2001 (66 FR 55246). The third 5-year review is being finalized in this rule for CY 2007.

In 1999, the AMA's RUC established the Practice Expense Advisory Committee (PEAC) for the purpose of refining the direct PE inputs. Through March 2004, the PEAC provided recommendations to CMS for over 7,600 codes (all but a few hundred of the codes currently listed in the AMA's Current Procedural Terminology (CPT) codes).

In the November 15, 2004, PFS final rule (69 FR 66236) (hereinafter referred to as the CY 2005 PFS final rule), we implemented the first 5-year review of the malpractice RVUs (69 FR 66263).

5. Adjustments to RVUS Are Budget Neutral

Section 1848(c)(2)(B)(ii)(II) of the Act provides that adjustments in RVUs for a year may not cause total PFS payments to differ by more than $20 million from what they would have been if the adjustments were not made. In accordance with section 1848(c)(2)(B)(ii)(II) of the Act, if adjustments to RVUs cause expenditures to change by more than $20 million, we make adjustments to ensure that expenditures do not increase or decrease by more than $20 million.

B. Components of the Fee Schedule Payment Amounts

To calculate the payment for every physician service, the components of the fee schedule (physician work, PE, and malpractice RVUs) are adjusted by a geographic practice cost index (GPCI). The GPCIs reflect the relative costs of physician work, PEs, and malpractice insurance in an area compared to the national average costs for each component.

Payments are converted to dollar amounts through the application of a CF, which is calculated by the Office of the Actuary and is updated annually for inflation.

The general formula for calculating the Medicare fee schedule amount for a given service and fee schedule area can be expressed as:

Payment = [(RVU work × GPCI work) + (RVU PE × GPCI PE) + (RVU malpractice × GPCI malpractice)] × CF.

However, as discussed in section IV.D of this final rule with comment period, due to the need to meet the budget neutrality (BN) provisions of 1848(c)(2)(B)(ii), we are applying a BN adjustor to the work RVUs in order to calculate payment for a service. Therefore, payment for services will now be calculated as follows:

Payment = [(RVU work × BN adjustor × GPCI work) + (RVU PE × GPCI PE) + (RVU malpractice × GPCI malpractice)] × CF.)

C. Most Recent Changes to the Fee Schedule

The final rule with comment period that appeared in the Federal Register on November 21, 2005 (70 FR 70116) (hereinafter referred to as the CY 2006 PFS final rule with comment period) addressed Medicare Part B payment policy including the PFS that is applicable for CY 2006; and finalized certain provisions of the interim final rule to implement the Competitive Acquisition Program (CAP) for Part B Drugs.

It also revised Medicare Part B payment and related policies regarding: physician work, PE and malpractice RVUs; Medicare telehealth services; multiple diagnostic imaging procedures; covered outpatient drugs and biologicals; supplemental payments to Federally Qualified Health Centers (FQHCs); renal dialysis services; coverage for glaucoma screening services; National Coverage Determination (NCD) timeframes; and physician referrals for nuclear medicine services and supplies to health care entities with which physicians have financial relationships.

In addition, the rule finalized the interim RVUs for CY 2005 and issued interim RVUs for new and revised procedure codes for CY 2006. The rule also updated the codes subject to the physician self-referral prohibition and discussed payment policies relating to teaching anesthesia services, therapy caps, private contracts and opt-out, and chiropractic and oncology demonstrations.

In accordance with section 1848(d)(1)(E)(i) of the Act, we also announced that the PFS update for CY 2006 would be -4.4 percent; the initial estimate for the sustainable growth rate for CY 2006 would be 1.7 percent; and the CF for CY 2006 would be $36.1770. However, subsequent to publication of the CY 2006 PFS final rule with comment period, section 5104 of the Deficit Reduction Act (DRA) of 2005 (Pub. L. 109-171, February 8, 2006), was enacted which amended section 1848(d) of the statute. As a result of this statutory change we maintained the CY 2005 CF of $37.8975 for CY 2006.

We also note that the Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology proposed notice appeared in the Federal Register on June 29, 2006 (71 FR 37170). In that notice, we proposed revisions to work RVUs affecting payment for physicians' services. The revisions reflect changes in medical practice, coding changes, and new data on relative value components that affect the relative amount of physician work required to perform each service, as required by the statute. We also proposed revisions to our methodology for calculating PE RVUs, including changes based on supplemental survey data for PE. This revised methodology would be used to establish payment for services beginning January 1, 2007.

In this final rule with comment period, we are responding to the comments received on that notice. To the extent that comments received were outside the scope of the proposed notice, they are not addressed in this rule.

Work RVU revisions will be fully implemented for services furnished to Medicare beneficiaries on or after January 1, 2007. The changes in PE methodology will be phased-in over a 4-year period; although, as we gain experience with the new methodology, we will reexamine this policy beginning next year and propose necessary revisions through future rulemaking.

II. Provisions of the Proposed Rule

A. Resource-Based Practice Expense (PE) Relative Value Units (RVUs)

Practice expense (PE) is the portion of the resources used in furnishing the service that reflects the general categories of physician and practitioner expenses, such as office rent and personnel wages but excluding malpractice expenses, as specified in section 1848(c)(1)(B) of the Act.

Section 121 of the Social Security Amendments of 1994 (Pub. L. 103-432), enacted on October 31, 1994, required CMS to develop a methodology for a resource-based system for determining PE RVUs for each physician's service. Until that time, PEs were based on historical allowed charges. This legislation stated that the revised PE methodology must consider the staff, equipment, and supplies used in the provision of various medical and surgical services in various settings beginning in 1998. The Secretary has interpreted this to mean that Medicare payments for each service would be based on the relative PE resources typically involved with furnishing the service.

The initial implementation of resource-based PE RVUs was delayed from January 1, 1998, until January 1, 1999, by section 4505(a) of the BBA. In addition, section 4505(b) of the BBA required that the new payment methodology be phased-in over 4 years, effective for services furnished in CY 1999, and fully effective in CY 2002. The first step toward implementation of the statute was to adjust the PE values for certain services for CY 1998. Section 4505(d) of the BBA required that, in developing the resource-based PE RVUs, the Secretary must:

• Use, to the maximum extent possible, generally accepted cost accounting principles that recognize all staff, equipment, supplies, and expenses, not solely those that can be linked to specific procedures.

• Develop a refinement method to be used during the transition.

• Consider, in the course of notice and comment rulemaking, impact projections that compare new proposed payment amounts to data on actual physician PE.

Beginning in CY 1999, we began the 4-year transition to resource-based PE RVUs. In CY 2002, the resource-based PE RVUs were fully transitioned.

1. Current Methodology

The following sections discuss the current PE methodology.

a. Data Sources

There are two primary data sources used to calculate PE. The AMA's Socioeconomic Monitoring System (SMS) survey data are used to develop the PE per hour (PE/HR) for each specialty. The second source of data used to calculate PE was originally developed by the Clinical Practice Expert Panels (CPEP). The CPEP data include the supplies, equipment and staff times specific to each procedure.

The AMA developed the SMS survey in 1981 and discontinued it in 1999. Beginning in 2002, we incorporated the 1999 SMS survey data into our calculation of the PE RVUs, using a 5-year average of SMS survey data. (See Revisions to Payment Policies and Five-Year Review of and Adjustments to the Relative Value Units Under the Physician Fee Schedule for CY 2002 final rule, published November 1, 2001 (66 FR 55246) (hereinafter referred to as CY 2002 PFS final rule).) The SMS PE survey data are adjusted to a common year, 1995. The SMS data provide the following six categories of PE costs:

• Clinical payroll expenses, which are payroll expenses (including fringe benefits) for nonphysician personnel.

• Administrative payroll expenses, which are payroll expenses (including fringe benefits) for nonphysician personnel involved in administrative, secretarial or clerical activities.

• Office expenses, which include expenses for rent, mortgage interest, depreciation on medical buildings, utilities and telephones.

• Medical material and supply expenses, which include expenses for drugs, x-ray films, and disposable medical products.

• Medical equipment expenses, which include expenses depreciation, leases, and rent of medical equipment used in the diagnosis or treatment of patients.

• All other expenses, which include expenses for legal services, accounting, office management, professional association memberships, and any professional expenses not previously mentioned in this section.

In accordance with section 212 of the BBRA, we established a process to supplement the SMS data for a specialty with data collected by entities and organizations other than the AMA (that is, the specialty itself). (See the Criteria for Submitting Supplemental Practice Expense Survey Data interim final rule with comment period, (May 3, 2000, 65 FR 25664).) Originally, the deadline to submit supplementary survey data was through August 1, 2001. In the CY 2002 PFS final rule (66 FR 55246), the deadline was extended through August 1, 2003. To ensure maximum opportunity for specialties to submit supplementary survey data, we extended the deadline to submit surveys until March 1, 2005 in the Revisions to Payment Policies Under the Physician Fee Schedule for CY 2004 final rule, (November 7, 2003; 68 FR 63196) (hereinafter referred to as CY 2004 PFS final rule).

The CPEPs consisted of panels of physicians, practice administrators, and nonphysicians (registered nurses (RNs), for example) who were nominated by physician specialty societies and other groups. There were 15 CPEPs consisting of 180 members from more than 61 specialties and subspecialties. Approximately 50 percent of the panelists were physicians.

The CPEPs identified specific inputs involved in each physician's service provided in an office or facility setting. The inputs identified were the quantity and type of nonphysician labor, medical supplies, and medical equipment.

In 1999, the AMA's RUC established the Practice Expense Advisory Committee (PEAC). From 1999 to March 2004, the PEAC, a multi-specialty committee, reviewed the original CPEP inputs and provided us with recommendations for refining these direct PE inputs for existing CPT codes. Through its last meeting in March 2004, the PEAC provided recommendations for over 7,600 codes which we have reviewed and accepted. As a result, the current PE inputs differ markedly from those originally recommended by the CPEPs. The PEAC has now been replaced by the Practice Expense Review Committee (PERC), which acts to assist the RUC in recommending PE inputs.

b. Allocation of PE to Services

To establish PE RVUs for specific services, it is necessary to establish the direct and indirect PE associated with each service. Our current approach allocates aggregate specialty practice costs to specific procedures and, thus, is often referred to as a "top-down" approach. The specialty PEs are derived from the AMA's SMS survey and supplementary survey data. The PEs for a given specialty are allocated to the services furnished by that specialty on the basis of the direct input data and work RVUs assigned to each CPT code. The specific process is outlined in the June 29, 2006 proposed notice (71 FR 37242).

c. Other Methodological Issues: Nonphysician Work Pool (NPWP)

As an interim measure, until we could further analyze the effect of the top-down methodology on the Medicare payment for services with no physician work (including the technical components (TCs) of radiation oncology, radiology and other diagnostic tests), we created a separate PE pool for these services. However, any specialty society could request that its services be removed from the nonphysician work pool (NPWP). The specific steps for the NPWP calculation are detailed in the June 29, 2006 proposed notice (71 FR 37243).

d. Facility/Non-facility Costs

Procedures that can be furnished in a physician's office, as well as in a hospital, have two PE RVUs: facility and non-facility. The non-facility setting includes physicians' offices, patients' homes, freestanding imaging centers, and independent pathology labs. Facility settings include hospitals, ambulatory surgical centers (ASCs), and skilled nursing facilities (SNFs). The methodology for calculating the PE RVU is the same for both facility and non-facility RVUs, but is applied independently to yield two separate PE RVUs. Because the PEs for services provided in a facility setting are generally included in the payment to the facility (rather than the payment to the physician under the fee schedule), the PE RVUs are generally lower for services provided in the facility setting.

2. Proposals for Revising the PE Methodology

We have three major goals for our resource-based PE methodology:

• To ensure that the PE portion of PFS payments reflect, to the greatest extent possible, the relative resources required for each of the services on the PFS. This could only be accomplished by using the best available data to calculate the PE RVUs.

• To develop a payment system for PE that is understandable and at least somewhat intuitive, so that specialties could better predict the impacts of changes in the PE data.

• To stabilize the PE portion of PFS payments so that changes in PE RVUs do not produce large fluctuations in the payment for given procedures from year-to-year.

In the CY 2006 PFS proposed rule (70 FR 45764), we proposed the following changes to the PE methodology that we believed would help in achieving these three major goals:

• Using the PE/HR data from seven specialty-specific supplementary surveys.

• Calculating the direct PE using a bottom-up methodology.

• Eliminating the NPWP.

We also proposed an indirect PE methodology that was to assign to each service the higher of the current indirect PE RVUs or the indirect PE RVUs calculated using the supplementary survey data.

In the CY 2006 PFS final rule with comment period (70 FR 70116), we withdrew these proposals primarily because a programming error for the indirect PE RVU calculation had led to the publication of inaccurate proposed PE RVUs. On February 15, 2006, we sponsored a PE Town Hall Meeting and invited the public, including all specialty representatives to attend. At this meeting, we supplied a detailed description of the bottom-up approach to the calculation of resource-based PE RVUs. Three examples were examined in detail that illustrated the impact of the various assumptions that could be used under a bottom-up approach. We specifically requested input from all interested parties on possible changes to our PE methodology, including the move to a bottom-up approach and the various methods of calculating indirect PE.

We reviewed the approximately 35 comments that we received in response to our solicitation. Many of the comments were combined efforts from related specialty organizations. Additionally, the AMA RUC also supplied a letter that captured the comments of nearly 30 specialty organizations. The following is a summary of the comments received as a result of the February 15, 2006 PE Town Hall meeting.

• Delaying Implementation of Changes to the Current PE Methodology: There were mixed opinions from commenters on whether we should proceed with a proposal to use a bottom-up approach. Some commenters emphasized that the CPEP data has been refined and is now the best available source of data, and asserted that it should be used for the calculation of resource-based PE RVUs. Other comments suggested a delay in changing to a bottom-up approach because of the other issues that are affecting PFS payments this year (such as, the effect of imaging payment provisions in the DRA, the impact of the negative update, and the uncertainty regarding the impact of the 5-Year Review of work RVUs).

• Transition to a Bottom-Up Approach: The majority of commenters requested a minimum 1-year transition to a maximum 3-year transition period to fully implement any change to a bottom-up approach. All of the commenters supported a transition period whether or not they supported the implementation of a bottom-up approach.

• Use of Supplemental Survey Data: Many commenters stated that, irrespective of what we proposed for CY 2007, the supplemental survey data that has already been accepted should be used. Other commenters believed that the supplemental survey data grossly overstated PEs and should not be utilized in the development of resource-based PE RVUs.

• Multi-Specialty PE Survey: The majority of commenters supported the construction and use of a multi-specialty survey to collect PE data. Commenters believed that the supplemental survey data is inflated and that the SMS survey data are outdated.

• Review Equipment Utilization Assumptions and Interest Rates: Many commenters supported the review and revision of both the current utilization assumptions and the interest rates associated with high cost equipment. Commenters had mixed reactions as to whether the utilization rates should be higher or lower, and some suggested that we review the possibility of equipment-specific utilization assumptions for the future. Most commenters believed that the current 11 percent interest rate is significantly higher then the actual interest rates and many commenters suggested a rate of approximately prime plus 2 percent.

• Proxy Work RVUs for No Physician Work Services: Commenters were divided on the assignment of a proxy work RVU to services that contain no physician work. Some commenters believed that no physician work services are unfairly penalized under any bottom-up approach, while other comments stated that the inclusion of a proxy work RVU would double count the clinical labor associated with the no physician work services.

After considering these comments, we made the following proposals for direct PEs in the June 29, 2006 proposed notice (71 FR 37245).

a. Use a Bottom-up Method to Calculate the Direct PEs

We believe that we have consistently made a good faith effort to ensure fairness in our PE RVU-setting system by using the best data available at any one time. The reason we did not adopt the bottom-up methodology originally proposed in 1997 and instead adopted the top-down methodology finalized in 1998 was because we recognized the concerns among the physician community that the resource input data developed in 1995 by the CPEP were less reliable than the aggregate specialty cost data derived from the SMS process.

However, the situation has now changed. The PEAC/PERC/RUC has completed the refinement of the original CPEP data and we believe that the refined PE inputs now, in general, accurately capture the relative direct costs of PFS services. Conversely, although we have now accepted supplementary survey data from 13 specialties, we have not received updated aggregate cost data from most specialties. Thus, we believe that, in the aggregate, the refined direct input data represent more reliably the relative direct cost PE inputs for physicians' services.

Therefore, instead of using the top-down approach to calculate the direct PE RVUs, where the aggregate CPEP/RUC costs for each specialty are scaled to match the aggregate SMS costs, we proposed to adopt a bottom-up method of determining the relative direct costs for each service. Under this method, the direct costs would be determined by adding the costs of the resources (that is, the clinical staff, equipment and supplies) typically required to provide the service. The costs of the resources, in turn, would be calculated from the refined direct PE inputs in our PE database.

We believe that this proposed change, which was welcomed by most commenters in the CY 2006 PFS proposed rule, will lead to greater stability and accuracy in the PE portion of our payment system. Currently, under the top-down methodology, the need to scale the CPEP costs to equal the SMS costs has meant that any changes in the direct PE inputs for one service often leads to unexpected results for other services where the inputs have not been altered. In addition, the current PE RVUs for a procedure do not necessarily change proportionately with changes in the direct inputs, creating possible anomalous values. We believe that our proposed bottom-up methodology would resolve these issues, so that changes in the PE RVUs would be more intuitive and would result in fewer surprises.

b. Use the PE/HR Data from the 7 Surveys We Have Previously Accepted and, in addition, Use the PE/HR Data from the Survey Submitted by the National Coalition of Quality Diagnostic Imaging Services (NCQDIS)

As explained in the CY 2005 PFS final rule with comment period (69 FR 66242), we received surveys from the American College of Cardiology (ACC), the American College of Radiology (ACR), and the American Society for Therapeutic Radiology and Oncology (ASTRO) by March 1, 2004. The data submitted by the ACC and the ACR met our criteria. However, as requested by the ACC and the ACR, we deferred using their data until issues related to the NPWP could be addressed. (The survey data from ASTRO did not meet the precision criteria established for supplemental surveys; therefore, we did not accept or use it in the calculation of PE RVUs for 2005.)

In March 2005, we also received surveys from the Association of Freestanding Radiation Oncology Centers (AFROC), the American Urological Association (AUA), the American Academy of Dermatology (AAD), the Joint Council of Allergy, Asthma, and Immunology (JCAAI), the NCQDIS, and a joint survey from the American Gastroenterological Association (AGA), the American Society of Gastrointestinal Endoscopy (ASGE) and the American College of Gastroenterology (ACG).

All the surveys, with the exception of the survey from NCQDIS, met our criteria. Therefore, we proposed in the CY 2006 PFS proposed rule (70 FR 45775) to use the survey data from all the surveys meeting our criteria in the calculation of PE RVUs for 2006; but, as discussed in the CY 2006 PFS final rule with comment period (70 FR 70116) and above in this section, this proposal was not finalized.

We contracted with the Lewin Group (Lewin) to evaluate whether the supplemental survey data that were submitted met our criteria and to make recommendations to us regarding their suitability for use in calculating PE RVUs. As described in the CY 2006 PFS proposed rule (70 FR 45775), Lewin recommended blending the radiation oncology data from the AFROC survey data with the ASTRO survey data submitted in 2004 to calculate the PE/HR. According to Lewin, the goal of the AFROC survey was to represent the population of freestanding radiation oncology centers only. To develop an overall average for the radiation oncology PE pool, Lewin recommended we use the AFROC survey for freestanding radiation oncology centers, and the hospital-based subset of last year's ASTRO survey. We agreed that this blending of the AFROC and ASTRO data was a reasonable way to calculate an average PE/HR that fully reflects the practice of radiation oncology in all settings. Blending the survey data overcame the initial problem that the ASTRO data do not meet the precision criteria as discussed in the CY 2005 PFS final rule (69 FR 66242). In addition, as discussed in the CY 2006 PFS proposed rule (70 FR 45776), blending of the data allowed for a broader base of radiation oncology providers to be represented.

Also, as discussed in the CY 2006 PFS proposed rule (70 FR 45764), Lewin indicated that the survey data submitted by the NCQDIS on independent diagnostic testing facilities (IDTFs) did not meet our precision criterion. However, upon further analysis, Lewin agreed with NCQDIS' determination that the inclusion of one inaccurate record skewed the findings outside the acceptable precision range. Lewin recalculated the precision level at 8.1 percent of the mean PE/HR (weighted by the number of physicians in the practice). Lewin indicated that the level of precision for the total PE/HR satisfies the level of precision requirement, and recommended acceptance of the survey.

We proposed to use the PE/HR data from all of these surveys, including the NCQDIS survey, in the calculation of the PE RVUs for 2007. For radiation oncology, we proposed to use the new PE/HR derived from combining the AFROC and ASTRO survey data, as recommended by Lewin. The proposed figures for PE per physician hour were listed in Table 52 in the June 29, 2006 proposed notice (71 FR 37246).

Section 303(a)(1)(B) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108-173) added section 1848(c)(2)(I) of the Act to require CMS to use survey data submitted by a specialty group where at least 40 percent of the specialty's payments for Part B services are attributable to the administration of drugs in 2002 to adjust PE RVUs for drug administration services. The statute applies to surveys that include expenses for the administration of drugs and biologicals, and were received by March 1, 2005 for determining the CY 2006 PE RVUs. Section 303(a)(1)(A)(ii) of the MMA also added section 1848(c)(2)(B)(iv)(II) of the Act to provide an exemption from budget neutrality (BN) in 2005 and 2006 for any additional expenditures resulting from the use of these surveys. In the Changes to Medicare Payment for Drugs and Physician Fee Schedule Payments for CY 2004 interim final rule published January 7, 2004 (69 FR 1084), we stated that the specialties of urology, gynecology, and rheumatology meet this criteria. As described in the CY 2006 PFS final rule with comment period (70 FR 70116), we accepted for the purposes of calculating the 2006 PE RVUs for drug administration services the new survey data from the AUA and exempted from the BN adjustment any impacts of accepting these data for purposes of calculating PE RVUs for drug administration services.

( Note: Rheumatology and gynecology did not submit supplemental survey data.)

c. Eliminate the NPWP and Calculate the PE RVUs for all Services Using the Same Methodology

Primarily because of the lack of representative SMS data or accurate direct cost inputs for specialties such as radiology and radiation oncology, the adoption of the top-down approach necessitated the creation of the NPWP. This separate work pool was created to allocate PE RVUs for TC codes and codes that are not furnished by physicians and, thus, have no work RVUs. In the CY 2000 Physician Fee Schedule; Payment Policies and Relative Value Unit Adjustment final rule, we indicated that "the purpose of this pool was only to protect the (TC) services from the substantial decreases" caused by inaccurate CPEP data and the lack of physician work RVU in the allocation of the indirect costs (64 FR 59406). Unfortunately, the services priced by the NPWP methodology have proven to be especially vulnerable to any change in the work pool's composition. This has led to significant fluctuations from year-to-year in the PE RVUs calculated for these services.

The major specialties comprising the NPWP (radiology, radiation oncology and cardiology) have now submitted supplemental survey data that we have accepted and proposed to use in their PE calculations. (See the discussion on supplementary surveys above in this section.) Now that we have representative aggregate PE data for these specialties, and with the completion of the refinement of the direct cost inputs, the continued necessity and equity of treating these technical services outside the PE methodology applied to other services is questionable.

Therefore, we proposed to eliminate the NPWP and to calculate the PE RVUs for the services currently in the work pool by the same methodology used for all other services. This would also allow the use of the refined CPEP/RUC data to price the direct costs of individual services, rather than utilizing the pre-1998 charge-based PE RVUs. In addition, the revised methodology would lead to greater stability for the PE RVUs for these services and would lead to more intuitive results than have occurred with the NPWP methodology.

d. Modify the Current Indirect PE RVUs Methodology

As described previously, the SMS and supplementary survey data are the source for the specialty-specific aggregate indirect costs used in our PE calculations. We then allocate the indirect costs to particular codes on the basis of the direct costs allocated to a code and the work RVUs. In the CY 2006 PFS proposed rule (70 FR 45764), we stated that we had no information that would indicate that the current indirect PE methodology is inaccurate. At that time, we also were not aware of any alternative approaches or data sources that we could use to calculate more appropriately the indirect PE, other than the new supplementary survey data, which we proposed to incorporate into our PE calculations. Therefore, in the CY 2006 PFS proposed rule, we proposed to use the current indirect PEs in our calculation, incorporating the new survey data into the codes furnished by the specialties submitting the surveys (71 FR 45764). We also indicated in that same proposed rule that we would welcome any suggestions that would assist us in further refinement of this indirect PE methodology. For example, we were considering whether we should continue to accept supplementary survey data or whether it would be preferable and feasible to have an SMS-type survey of only indirect costs for all specialties, or whether a more formula- based methodology independent of the SMS should be adopted, perhaps using the specialty-specific indirect-to-total cost percentage as a basis of the calculation. For a prior discussion of many of the issues associated with allocating indirect costs, please refer to the CY 2000 Physician Fee Schedule; Payment Policies and Relative Value Unit Adjustment proposed rule (63 FR 30823).

3. Specific Changes to the Indirect PE Methodology for CY 2007

a. Summary of the PE Proposals From the June 29, 2006 Proposed Notice

As a result of collaboration with the PFS community and public comments on this issue, in the June 29, 2006 proposed notice, we proposed the following modifications to the indirect PE methodology.

(1) Indirect Percentage Factor: Use of the Specialty-Specific Percentage that Indirect PEs Represent of Total PEs Based on the Survey Data

We currently allocate indirect expenses on the sum of the direct expenses and the work RVUs (converted to dollars by multiplying by the CF). We proposed to allocate indirect expenses by applying a specialty-specific indirect percentage factor to the direct expenses to recognize the varying proportion that indirect costs represent of total costs by specialty. This will have the effect of relatively increasing the indirect expense allocation for services that are on average furnished by specialties with higher indirect PE percentages, and relatively decreasing the indirect expense allocation for services that are furnished by specialties with lower indirect PE percentages. For a given service, the specific indirect percentage factor to apply to the direct costs for the purpose of the indirect allocation will be calculated as the weighted average of the ratio of the indirect to direct costs (based on the survey data) for the specialties that furnish the service. For example, if a service is furnished by a single specialty with indirect PEs that were 75 percent of total PEs, the indirect percentage factor to apply to the direct costs for the purposes of the indirect allocation would be (0.75/0.25) = 3.0.

(2) Continued Use of the Specialty-Specific Indirect Scaling Factors

As described earlier in this section, we incorporate the indirect PE/HR surveys into the methodology through the use of specialty-specific indirect scaling factors. We would continue to use the specialty-specific indirect scaling factors; however, to apply them in a simpler manner we proposed to create an index. This index would reflect the relationship between each specialty's indirect scaling factor and the overall indirect scaling factor for the entire PFS. For example, if a specialty had an indirect practice cost index of 2.00, this specialty would have an indirect scaling factor that was twice the overall average indirect scaling factor. If a specialty had an indirect practice cost index of 0.50, this specialty would have an indirect scaling factor that was half the overall average indirect scaling factor. The calculation and application of the indirect practice cost index is described in more detail below in this section.

(3) Use of the Clinical Labor Costs in the Indirect Allocation for a Service When the Clinical Labor Costs are Greater than the Physician Work RVU

We have received numerous comments that services with little or no physician work RVUs are disadvantaged under our current indirect allocation methodology based on the direct costs and the work RVUs. In response to these comments, when the clinical labor portion of the direct PE RVU is greater than the physician work RVU for a particular service, we proposed to allocate on the direct costs and the clinical labor costs. For example, if a service has no physician work, if the direct PE RVU is 1.10 and if the clinical labor portion of the direct PE RVU is 0.65 RVUs, we would use the 1.10 direct PE RVUs and the 0.65 clinical labor portion of the direct PE RVUs for the indirect PE allocation for that service. As another example, if the physician work RVUs for a service are 0.25, if the direct PE RVU is 1.10 and if the clinical labor portion of the direct PE RVU is 0.65 RVUs, we would use the 1.10 direct PE RVUs and the 0.65 clinical labor RVUs for the indirect allocation for that service. We would not use the 0.25 physician work RVUs for the indirect PE allocation since the 0.65 clinical labor RVUs are greater than the 0.25 physician work RVUs.

(4) Use of 2005 Utilization Data in the Indirect PE RVU Calculation

Under the current PE methodology, we predominately use the 1997-2000 utilization data in the calculation of the indirect PE RVUs when the service existed during 1997-2000 or the first year of utilization data if the service did not exist during that time period. We used those years of utilization data primarily to increase the year-to-year stability of the PE RVUs. With the changes we proposed to PE RVUs, in particular the elimination of the NPWP, we will increase the year-to-year stability of the PE RVUs. We believe it is now appropriate to use updated utilization data in the calculation of the indirect PEs. We believe the other proposed changes in the PE methodology would help obtain the year-to-year stability we were attempting to achieve by continuing to use the older utilization data. Additionally, the use of more current utilization data would reflect the more current practice patterns. We proposed to use the 2005 utilization data in the calculation of the 2007 indirect PE RVUs. We also sought comments on whether the utilization data should be updated yearly, which would increase the accuracy of the PE calculations, or less often, which would increase the stability of the PE RVUs.

(5) Elimination of the Special Methodologies for Services with Technical Components (TCs) and Professional Components (PCs)

Under the PFS, when services have TC, PC, and global components that can be billed separately, the payment for the global component equals the sum of the payment for the TC and PCs. Under the current PE methodology, the different mix of specialties that furnish the global, TC and PCs can cause the PE RVUs, otherwise created by the methodology, to fail to add together properly; that is, the global component does not equal the sum of the PC and TCs. The global component might exceed the sum of the TC and PCs or it might be less than the sum of the TC and PCs. We ensure that the TC and PCs add to the global component in one of two ways. For services in the NPWP, we set the PE RVUs for the global component equal to the sum of the PC PE RVU and the TC PE RVU. For services outside the NPWP, we set the PE RVUs for the TC equal to the difference between the global PE RVUs and the PC RVUs.

With our proposed change to a bottom-up methodology for the direct PEs, there will be no weighted averaging of the direct cost inputs necessary to create the direct PE RVUs and, therefore, the direct PE RVUs for the PC and TCs would sum to the global component. Under the current methodology, as a result of the process used to ensure the PC and TCs sum to the global, RVUs for a service with a global component can be either more or less than the RVUs that would have been calculated for the service if the PC and TCs did not have to sum to the global.

Given the proposed change to bottom-up methodology and the elimination of the NPWP, we believe it is inappropriate to have codes for which the global, and the TC and PCs are assigned RVUs that are either less than or greater than the methodology would otherwise produce, and thus, are paid at a rate that is either less than or greater than the methodology would otherwise specify. ( See section II.A.1. of this final rule with comment period for the discussion of the current methodology.) Therefore, we proposed that in the calculation of the indirect percentage factor described earlier in section II.A.3.a.(1), we would use a weighted average of the ratio of indirect to direct costs across all the specialties that furnish the global components, TCs, and PCs; that is, we would apply the same weighted average indirect percentage factor to allocate indirect expenses to the global components, PC, and TCs for a service. We also proposed to utilize a similar weighted averaging approach across all the specialties that furnish the components when calculating the indirect PE scaling factor. Because the direct PE RVUs for the TC and PCs sum to the global under the bottom-up methodology, and we proposed to calculate the indirect percentage factor and the indirect scaling factor so that they do not vary between the TCs, PCs, and global components, our proposed methodology would create TCs and PCs that sum to the global, and no other special methodology would need to be employed.

(a) PE RVU Methodology

The following is a description of the proposed PE RVU methodology.

(i) Setup File

First, we create a setup file for the PE methodology. The setup file contains the direct cost inputs, the utilization for each procedure code at the specialty and facility/nonfacility place of service level, and the specialty-specific survey PE per physician hour data.

(ii) Calculate the Direct Cost PE RVUs

Sum the costs of each direct input.

Step 1: Sum the direct costs of the inputs for each service. The direct costs consist of the costs of the direct inputs for clinical labor, medical supplies, and medical equipment. The clinical labor cost is the sum of the cost of all the staff types associated with the service; it is the product of the time for each staff type and the wage rate for that staff type. The medical supplies cost is the sum of the supplies associated with the service; it is the product of the quantity of each supply and the cost of the supply. The medical equipment cost is the sum of the cost of the equipment associated with the service; it is the product of the number of minutes each piece of equipment is used in the service and the equipment cost per minute. The equipment cost per minute is calculated as described at the end of this section.

Apply a BN adjustment to the direct inputs.

Step 2: Calculate the current aggregate pool of direct PE costs. To do this, multiply the current aggregate pool of total direct and indirect PE costs (that is, the current aggregate PE RVUs multiplied by the CF) by the average direct PE percentage from the SMS and supplementary specialty survey data.

Step 3: Calculate the aggregate pool of direct costs. To do this, for all PFS services, sum the product of the direct costs for each service from Step 1 and the utilization data for that service.

Step 4: Using the results of Step 2 and Step 3 calculate a direct PE BN adjustment so that the proposed aggregate direct cost pool does not exceed the current aggregate direct cost pool and apply it to the direct costs from Step 1 for each service.

Step 5: Convert the results of Step 4 to an RVU scale for each service. To do this, divide the results of Step 4 by the Medicare PFS CF.

(iii) Create the Indirect PE RVUs

Create indirect allocators.

Step 6: Based on the SMS and supplementary specialty survey data, calculate direct and indirect PE percentages for each physician specialty.

Step 7: Calculate direct and indirect PE percentages at the service level by taking a weighted average of the results of Step 6 for the specialties that furnish the service. Note that for services with TC and PCs we are calculating the direct and indirect percentages across the global components, PCs and TCs. That is, the direct and indirect percentages for a given service (for example, echocardiogram) do not vary by the PC, TC and global components.

Step 8: Calculate the service level allocators for the indirect PEs based on the percentages calculated in Step 7. The indirect PEs are allocated based on the three components: The direct PE RVU, the clinical PE RVU and the work RVU. (Note that the work RVU used in the calculation included the separate work BN adjustment from the 5-Year Review of the work RVUs discussed in the June 29, 2006 proposed notice. In this final rule, unadjusted work RVUs are used.)

For most services the indirect allocator is:

indirect percentage * (direct PE RVU/direct percentage) + work RVU.

There are two situations where this formula is modified:

• If the service is a global service (that is, a service with global, professional and technical components), then the indirect allocator is:

indirect percentage * (direct PERVU/direct percentage) + clinical PE RVU + work RVU.

• If the clinical labor PE RVU exceeds the work RVU (and the service is not a global service), then the indirect allocator is:

indirect percentage * (direct PERVU/direct percentage) + clinical PE RVU.

( Note that for global services the indirect allocator is based on both the work RVU and the clinical labor PE RVU. We do this to recognize that, for the professional service, indirect PEs will be allocated using the work RVUs, and for the TC service, indirect PEs will be allocated using the direct PE RVU and the clinical labor PE RVU. This also allows the global component RVUs to equal the sum of the PC and TC RVUs.)

For presentation purposes in the examples in the Table 1, the formulas were divided into two parts for each service. The first part does not vary by service and is

the indirect percentage * (direct PE RVU/direct percentage).

The second part is either the work RVU, clinical PE RVU, or both depending on whether the service is a global service and whether the clinical PE RVU exceeds the work RVU (as described earlier in this step.)

Apply a BN adjustment to the indirect allocators.

Step 9: Calculate the current aggregate pool of indirect PE RVUs by multiplying the current aggregate pool of PE RVUs by the average indirect PE percentage from the physician specialty survey data. This is similar to the Step 2 calculation for the direct PE RVUs.

Step 10: Calculate an aggregate pool of proposed indirect PE RVUs for all PFS services by adding the product of the indirect PE allocators for a service from Step 8 and the utilization data for that service. This is similar to the Step 3 calculation for the direct PE RVUs.

Step 11: Using the results of Step 9 and Step 10, calculate an indirect PE adjustment so that the aggregate indirect allocation does not exceed the available aggregate indirect PE RVUs and apply it to indirect allocators calculated in Step 8. This is similar to the Step 4 calculation for the direct PE RVUs.

Calculate the Indirect Practice Cost Index.

Step 12: Using the results of Step 11, calculate aggregate pools of specialty-specific adjusted indirect PE allocators for all PFS services for a specialty by adding the product of the adjusted indirect PE allocator for each service and the utilization data for that service.

Step 13: Using the specialty-specific indirect PE/HR data, calculate specialty-specific aggregate pools of indirect PE for all PFS services for that specialty by adding the product of the indirect PE/HR for the specialty, the physician time for the service, and the specialty's utilization for the service.

Step 14: Using the results of Step 12 and Step 13, calculate the specialty-specific indirect PE scaling factors as under the current methodology.

Step 15: Using the results of Step 14, calculate an indirect practice cost index at the specialty level by dividing each specialty-specific indirect scaling factor by the average indirect scaling factor for the entire PFS.

Step 16: Calculate the indirect practice cost index at the service level to ensure the capture of all indirect costs. Calculate a weighted average of the practice cost index values for the specialties that furnish the service. Note that for services with TC and PCs, we calculate the indirect practice cost index across the global components, PCs and TCs. Under this method, the indirect practice cost index for a given service (for example, echocardiogram) does not vary by the PC, TC and global components.

Step 17: Apply the service level indirect practice cost index calculated in Step 16 to the service level adjusted indirect allocators calculated in Step 11 to get the indirect PE RVU.

(iv) Calculate the Final PE RVUs.

Step 18: Add the direct PE RVUs from Step 6 to the indirect PE RVUs from Step 17.

Step 19: Calculate and apply the final PE BN adjustment by comparing the results of Step 18 to the current pool of PE RVUs. This final BN adjustment is primarily required because certain specialties are excluded from the PE RVU calculation for rate-setting purposes, but all specialties are included for purposes of calculating the final BN adjustment. ( See "Specialties excluded from rate-setting calculation" below in this section.)

(v) Setup File Information

• Specialties excluded from rate-setting calculation: For the purposes of calculating the PE RVUs, we exclude certain specialties such as midlevel practitioners paid at a percentage of the PFS, audiology, and low volume specialties from the calculation. This is the same approach used under the current methodology. These specialties are included for the purposes of calculating the BN adjustment.

• Crosswalk certain low volume physician specialties: Crosswalk the utilization of certain specialties with relatively low PFS utilization to the associated specialties. This is the same approach used under the current methodology.

• Physical therapy utilization: Crosswalk physical therapy utilization to the specialty of physical therapy. This is the same approach used under the current methodology.

• Identify professional and technical services not identified under the usual TC and 26 modifier: Flag the services that are PC and TC services, but do not use TC and 26 modifiers (for example, electrocardiograms). This flag associates the PC and TC with the associated global code for use in creating the indirect PE RVU. For example, the professional service code 93010 is associated with the global code 93000.

• Payment modifiers: Payment modifiers are accounted for in the creation of the file. For example, services billed with the assistant at surgery modifier are paid 16 percent of the PFS amount for that service; therefore, the utilization file is modified to only account for 16 percent of any service that contains the assistant at surgery modifier.

• Work RVUs from the 5-Year Review: The setup file contains the proposed work RVUs from the 5-Year Review published in the June 29, 2006 proposed notice (71 FR 37174).

(vi) Equipment Cost Per Minute =

The equipment cost per minute is calculated as:

(1/(minutes per year * usage)) * price * ((interest rate/(1-(1/((1 + interest rate) * life of equipment)))) + maintenance)

Where:

minutes per year = maximum minutes per year if usage were continuous (that is, usage = 1); 150,000 minutes.

usage = equipment utilization assumption; 0.5.

price = price of the particular piece of equipment.

interest rate = 0.11.

life of equipment = useful life of the particular piece of equipment.

maintenance = factor for maintenance; 0.05.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.002" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.003" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

(b) Transition the Resulting Revised PE RVUs Over a 4-Year Period

As explained in the June 29, 2006 proposed notice, we had concerns that, when combined with a negative update factor for CY 2007 and the changes to the work RVUs under the 5-Year Review, the shifts in some of the PE RVUs resulting from the immediate implementation of our proposals could potentially cause some disruption for medical practices (71 FR 37252). Therefore, we proposed to transition the PE changes over a 4-year period. This would also give ample opportunity for us, as well as the medical specialties and the RUC, to identify any anomalies in the PE data, to make any further appropriate revisions, and to collect additional data as needed prior to the full implementation of the PE changes.

During the transition period, the PE RVUs would be calculated on the basis of a blend of RVUs calculated using our methodology described above in this section (weighted by 25 percent during CY 2007, 50 percent during CY 2008, 75 percent during CY 2009, and 100 percent thereinafter), and the current CY 2006 PE RVUs for each existing code. PE RVUs for codes that are new during this period would be calculated using only the methodology, and paid at the fully transitioned rate.

We also believe the methodology is less confusing and more intuitive than the current approach. First, the NPWP would be eliminated and all services would be priced using one methodology, eliminating the complicated calculations needed to price NPWP services. Second, any revisions made to the direct inputs for one or more services would now have predictable results. Changes in the direct practice inputs for a service would proportionately change the PE RVUs for that service without significantly affecting the PE RVUs for unrelated services (except, of course, to the extent that a BN adjustment is required to be applied by the statute).

The methodology will also create a system that would be significantly more stable from year-to-year than the current approach. Specialties should no longer experience the wide fluctuations in payment for a given service due to an aberrant direct cost scaling factor. Direct PEs should only change for a service if the service is further refined or when prices are updated, while indirect PEs should change only when there are changes in the mix of specialties furnishing the service or if any future new survey data for indirect costs are utilized.

b. Comments and Responses From the June 29, 2006 Proposed Notice

The following is a summary of the comments we received on the June 29, 2006 proposed notice (71 FR 37170).

(1) Bottom-Up Methodology

Comment: The majority of commenters expressed support for the proposed bottom-up approach to calculating resource-based PE RVUs. Many of these commenters stated that the bottom-up approach, which bases the direct portion of the PE RVUs on the actual direct cost inputs, produces more accurate, intuitive, and stable PE RVUs.

A few commenters expressed concern about the proposed bottom-up approach. These commenters were not critical of the merits of the proposed bottom-up methodology itself, but were instead critical of the data sources used in the calculation of resource-based PE RVUs. The commenters suggested that the proposal should be delayed until the direct cost data, aggregate specialty cost data, and indirect specialty cost data derived from the aggregate specialty cost data could be verified.

Response: We are appreciative of the support for the proposed bottom-up approach to calculating resource-based PE. We also appreciate the comments that expressed concern about our data sources, since we also believe that it is important that we use the best available data to develop the PE RVUs. As discussed in greater detail in subsequent responses, we do believe that the data sources used to calculate the proposed PE RVUs are the best available at this time. This is particularly true of the direct cost input data that forms the basis of the bottom-up methodology, and that has been thoroughly analyzed and discussed by the RUC, PEAC, HCPAC and the PERC and then has been reviewed by us. Therefore, we will implement the bottom-up methodology as proposed.

(2) Supplemental Survey Data

Comment: Several commenters expressed concern about the significant increase in PE values for specialty groups that submitted supplemental survey data. They stated their belief that the data has created serious inequities in the relativity of PE RVUs across the PFS. The commenters recommended that the supplemental survey data not be used; but, rather, that we wait until a new multi-specialty survey can be completed before using this revised data. One commenter questioned the validity of supplemental survey data, noting that the response rates were fairly low. The commenter also indicated that it was inequitable to accept more recent data from only a few specialties. Another commenter did not agree that individual specialty groups should be allowed to provide survey data. Conversely, several commenters strongly supported our acceptance and use of the supplementary survey data.

Response: The BBRA requires us to establish a process for specialty groups to submit supplemental survey data. The statute mandated that we establish criteria for surveys, but required that we accept such data for only two years. However, to give all specialty groups an opportunity to submit data, we twice extended the period for submitting data. Therefore, we accepted data over a 6-year period, instead of the 2-year period mandated by the Congress. In addition, our contractor, Lewin, was available to provide assistance to any group interested in submitting a survey by helping to ensure that the proper protocols were met in order to maximize the survey's chance of meeting our survey criteria.

We recognize the limitations of the supplemental survey process. However, we were obligated by statute to establish and use such a process, all specialty groups had an equal opportunity to submit data, and groups that conducted surveys did so at great expense. If the submitted survey data met the criteria we established by notice and comment rulemaking, we were obligated to accept and use the supplemental survey data to the maximum extent practicable and consistent with sound data practices. Additionally, we previously accepted most of the surveys we proposed to use in the CY 2007 PFS proposed rule in either the CY 2005 or the CY 2006 PFS final rules with comment. Although we delayed the use of these surveys for various reasons, as explained fully in the CY 2005 and CY 2006 rules, there is no reason to continue to delay implementation of these surveys.

We note that we support the AMA's efforts to field a multi-specialty survey. However, the earliest this data would be available to incorporate into the PFS would be for CY 2009. We will consider any such data as soon as it becomes available.

Comment: The majority of commenters expressed support for the design and use of a multi-specialty practice cost survey. Several commenters further recommended that any multi-specialty practice cost survey adhere to the same standards as the supplemental surveys accepted by CMS. Two commenters were concerned that a multi-specialty practice costs survey would not capture the practice costs associated with specialties whose practices focus on technical services.

Response: We support the design of an AMA-sponsored multi-specialty survey and we understand that over 40 physician and nonphysician specialties have agreed to participate. The AMA has designed this survey tool and the process has been open for comment to all interested parties. We have also offered comments on the survey design to ensure that both the appropriate practice cost data is collected and the highest standards are met in the collection of this data.

Comment: A few commenters recommended that we commit to including the costs associated with uncompensated care in the PE RVUs. One commenter suggested that the costs of uncompensated care should be included in the AMA-sponsored multi-specialty practice cost survey.

Response: Many specialties must deal with the issue of uncompensated care, though we believe that the number of patient care hours spent on uncompensated care is significantly higher for emergency medicine. We currently make an adjustment to the patient care hours for emergency medicine to account for the hours of uncompensated care included in the SMS survey because the calculated PE/hour should only reflect reimbursable hours. We agree that it would be beneficial if the AMA-sponsored multi-specialty survey includes a question on this issue.

Comment: ACR expressed concern that we did not fully utilize its supplementary survey data by excluding data on part-time physicians.

Response: The precedent for applying average full-time practice hours to all doctors in the practice when analyzing practice hours was set by the AMA's Socioeconomic Monitoring System (SMS) and was also discussed in the September 23, 2003 Lewin report, "Recommendations Regarding Supplemental Practice Expense Data Submitted for 2004." As described in this report, independent laboratory organizations were surveyed at the practice level because most independent labs are owned by an organization, not physicians; this is also the case with many free-standing radiology practices.

Lewin applied a comparable methodology to the radiology practice level supplemental survey data for its May 26, 2004 recommendation to CMS. The radiology supplemental survey reported that less than 10 percent of radiologists in the practice were part-time doctors. The average of the practice hours for the 2,250 full-time doctors was 38.9 hours and for the 237 part-time doctors 22.2 hours. Using the supplemental survey data results in less than a 5 percent increase in the total practice hours over the number of hours derived from using the SMS methodology.

We have determined that the original Lewin calculation is consistent with historical practice hour calculations used in the SMS, and with subsequent recommendations submitted by Lewin to CMS.

Comment: Lewin recommended accepting supplemental survey data from ASTRO and AFROC by blending the data in the proportion of 75 percent hospital-based radiation oncology and 25 percent freestanding radiation oncology, resulting in a PE/HR of $161.08. AFROC engaged the services of an independent claims analyst who found that a 62/38 proportion is more appropriate, resulting in a PE/HR of $213. AFROC supplied this information as part of its comments on the proposed notice.

Response: Lewin calculated a PE/HR for radiation oncology of $161.08, which is the weighted average based on the percentage of Medicare claims for hospital-based (75 percent) versus freestanding (25 percent) radiation oncologists. In our standard outpatient claims data file for 2003, a radiation oncologist was deemed to be hospital-based if 50 percent or more of his claims, based on the Unique Physician Identification Number (UPIN), were for services furnished at a hospital-based radiation oncology center. The rationale for weighting the PE/HR by Medicare claims was discussed by Lewin in its "2005 Recommendations to CMS" regarding the American Society for Therapeutic Radiation and Oncology (ASTRO) supplemental survey data.

In its comments, AFROC offered two alternative calculations. The first proposed to recount the Medicare claims after removing TC only claims. This method results in a reweighting of hospital-based versus freestanding radiation oncologists of 64 percent hospital based and 36 percent freestanding. The second method used time-weighting to determine the mix of hospital based versus freestanding practitioners. AFROC used physician time data for FY 2004 by radiation oncology CPT code and removed the TCs, resulting in a reweighting of hospital-based versus freestanding proportion of physician time of 62 percent to 38 percent, yielding a combined average PE/HR of $213.07.

Lewin reviewed AFROC's analysis and believes that AFROC presented two reasonable alternatives to weighting hospital-based and freestanding radiation oncologists, with both methods resulting in essentially the same answer. However, Lewin has determined that the time-weighting method is more consistent with the SMS and Lewin analysis of practice hours per physician. Lewin conducted the physician time-weighting analysis using our time and utilization data for FY 2005, resulting in a hospital-based to freestanding weight of 63 percent to 37 percent, respectively. The combined average using this weighting results in a PE/HR for radiation oncologist of $209.19, as shown in Table 2.

ASTRO survey Hospital-based physicians Freestanding practices Weighted average AFROC survey Freestanding practices Combined average ASTRO's hospital-based and AFROC's freestanding (by share of Medicare claims) ASTRO's hospital-based and AFROC's freestanding (by share of physician time)
Number in Sample 67 23
Percent of Medicare Claims 75.2% 24.8% 24.8%
Percent of Physician Time (Facility vs. Non-Facility) 63.0% 37.0% 37.0%
Direct PE per hour:
Clinical Payroll $9.93 $104.80 $33.46 $153.24 $45.47 $62.98
Medical Equipment 3.64 80.92 22.81 91.04 25.32 35.99
Medical Supplies 1.56 31.56 9.00 13.11 4.42 5.84
Indirect PE per hour:
Office Expense 19.31 69.40 31.73 87.88 36.32 44.69
Clerical Payroll 12.04 39.42 18.83 59.56 23.82 29.63
Other Expense 16.92 20.17 17.73 52.43 25.73 30.06
Total PE per hour 63.40 346.27 133.55 457.26 161.08 209.19

Lewin agrees with AFROC that weighting by hours of patient care is most consistent with our underlying methodology for calculating physician practice hours. Lewin has recommended that the time-weighting methodology for determining the percentage of hospital-based to freestanding radiation oncologist PE be adopted, which would result in a PE/HR of $213/HR based on 2004 data or $209/HR based on 2005 data. We accept Lewin's recommendation and will implement a PE/HR of $209 for radiation oncology.

(3) Nonphysician Workpool

Comment: With the exception of those comments that requested that we delay the entire revision to the PE methodology, the majority of commenters expressed support for the elimination of the NPWP.

Response: The development of the NPWP was necessitated by our lack of accurate aggregate cost data for specialties such as radiology and radiation oncology necessitated the development of the NPWP. The major specialties comprising the NPWP have now submitted supplemental survey data that we have accepted. Now that we have reliable aggregate PE data for these specialties, as well as and refined direct input data at the code level, we will finalize our proposal to eliminate the NPWP.

(4) Indirect PE RVUs Methodology

Comment: Many commenters recommended that we not use the budget-neutralized work RVUs in the indirect PE allocation, but rather use the unadjusted work RVUs.

Response: As discussed in section III.D.3. of this final rule with comment period , the BN adjustment necessitated by the 5-Year Review of work RVUs will be accomplished through the use of a separate, BN adjustor applied to the work RVUs. However, as recommended by the commenters, we will not use the budget-neutralized work RVUs to calculate indirect PE.

Comment: Many commenters disagreed with the use of the physician work RVUs in allocating indirect PE. Some commenters further contended that the intensity portion of physician work has no correlation to indirect PEs. A few commenters contended that physician time would be a more appropriate allocation tool than physician work RVUs.

Response: There is no perfect method of allocating indirect expenses down to individual services. We believe the work RVUs are the most constant of the available allocation tools, and this characteristic coincides best with our goal of stability for the PE RVUs. In this final rule with comment, we will continue to use the work RVUs as one of the indirect PE allocators.

Comment: Many commenters supported the proposal to use clinical labor costs as an indirect allocator when either the clinical labor RVU exceeds the work RVU or when the service does not contain physician work. Two commenters disagreed with the use of clinical labor costs in allocating indirect PE and stated that this is a "fudge factor" that inappropriately allocates costs to services with very low or no physician work.

Response: Because work RVUs reflect the time required to perform the service in addition to the intensity of the physician work involved, services with low or no work RVUs could be valued inappropriately unless we use a proxy for the work RVUs in allocating indirect PE to them. To bring these services onto the same scale as services that do contain physician work, we believe it is appropriate to utilize clinical labor costs as a proxy for physician work in the indirect allocation. We agree with the majority of commenters and will finalize our proposal to use clinical labor costs in allocating indirect PE where the physician work RVU is zero or less than the clinical labor RVU.

Comment: Several commenters recommended that the methodology be modified to include clinical labor time in the calculation of specialty-specific aggregate indirect PE pools.

Response: We do not agree with the commenters because the PE/HR for each specialty is calculated using physician time as the denominator; clinical staff time is not included in that calculation. It would be inconsistent to then use clinical labor time in the creation of the specialty-specific indirect PE pools.

Comment: Many commenters recommend the use of unscaled direct inputs in the allocation of the indirect PE.

Response: It would be inconsistent to base the direct PE RVUs on budget neutral scaled direct inputs, and then use unscaled direct inputs that are not budget neutral in creation of the indirect PE RVUs. We also disagree with the commenters' suggestion that we should use unscaled inputs for the direct PE RVUs. Direct costs represent, on average, approximately one-third of PEs based on the SMS survey data. Therefore, we believe it is appropriate to scale the direct inputs so that approximately one-third of the aggregate PE RVUs are for direct PEs.

Comment: Several commenters contended that the approach of basing PE calculations on the weighted average of all specialties performing a service is flawed and should be replaced with an approach that bases the specialty-weighted factors upon specialties that represent 95 percent of the utilization for a CPT code and modifier. A commenter stated that utilizing the service counts associated with lower cost specialties, such as optometry, that would perform only the postoperative portion of a service, as opposed to the full service, inappropriately deflates the total PEs of a service when the practice costs of these specialties are weight averaged.

Response: With regards to the general question of including all specialties performing a service in the weight-averaging of the practice costs of the service, this is an issue that has been raised since we first proposed a resource-based PE methodology. We still believe, as we have previously stated, that the inclusion of specialties that perform a very small proportion of a service has no discernible impact on the PE calculation.

We agree that it would be inappropriate to assign full service counts to a specialty that only performs the postoperative work of a given surgical procedure. For this reason, we have always adjusted the per specialty utilization for a service using the appropriate payment modifier (modifier -55) before the service is used to weight the practice costs of the various specialties performing a given service. For example, if a specialty performs 100,000 postoperative-only services for a specific procedure (that is, uses modifier -55), those services would be counted based upon the code-specific postoperative percentage multiplied by the 100,000 services. If the postoperative percentage was 10 percent, the specialty performing 100,000 postoperative-only services will be weighted with only 10,000 services. Therefore, we do not believe that any further adjustments are needed.

Comment: One commenter recommended that the indirect PE allocation be distributed from the global services to the professional and technical services based upon the share of billings for each service.

Response: Although we are unsure of what, exactly, the commenter is suggesting, it is not clear to us how this recommendation could result in an appropriate resource-based PE RVU (for example, if the majority of services furnished were for the PC of a procedure, we believe the commenter is suggesting that it would then be necessary for the PC to have a higher PE RVU then the TC). Therefore, we will retain our current methodology for the allocation of indirect PE for services with TC and PCs, but we welcome further clarification regarding this suggestion.

(5) Transition Period

Comment: The majority of commenters expressed support for the proposal to transition the PE methodology changes over a 4-year period. One commenter recommended that if the work RVU changes associated with the 5-Year Review are not transitioned, then the PE RVUs should also not be transitioned.

Response: We are concerned that, when combined with the negative update adjustment factor (UAF) for CY 2007 and the impact of changes to the work RVUs under the 5-Year Review, the shifts associated with the PE methodology changes could potentially cause some disruption for medical practices. For this reason, we will finalize the proposed 4-year transition to the PE methodology.

Comment: One comment supported the use of supplemental survey data, but requested that this supplemental survey data be implemented with no transition, since this data was originally accepted 1-2 years ago.

Response: The supplemental survey data is not independently transitioned in the proposed PE methodology. Rather, the RVUs resulting from all the changes to the methodology, which are to some degree interdependent, would be transitioned over 4 years. It would be very difficult to isolate one aspect of our proposed methodology and exempt it from the transition. In addition, we are concerned that such an approach could lead to inequities whereby, for a given specialty, a PE methodology change that has a positive impact would be transitioned over 4 years, while a change with a negative impact would not. For these reasons, we will finalize the 4-year transition as proposed.

(6) Other Comments on the PE Methodology

Comment: Several commenters requested that one budget neutrality factor (BNF) be applied for PE as opposed to applying a direct adjuster, an indirect adjuster, and a final BN adjustment.

Response: The separate adjusters for the direct and indirect pools of RVUs are not pure BN adjustments but are more appropriately viewed as scaling factors. The purpose of the separate direct and indirect adjustments is to scale the pool of direct input RVUs and the pool of indirect RVUs to the direct and indirect RVUs that are available, as determined by the total direct and indirect dollars from the SMS and supplemental surveys. For this reason, the adjustments should be viewed as direct and indirect scaling factors, as opposed to BN adjustments. If we only applied one BN/scaling factor to the final PE RVUs, there would not be the appropriate balance between the direct and indirect PE RVUs and services with more direct RVUs would be paying for those services with less direct RVUs, since the indirect scaler is greater then the direct scaler.

Since the direct and indirect RVU pools are scaled and made "budget neutral" in these initial steps, the final BN adjustment is very small. The only reason the final adjustment is needed is because the RVUs associated with specialties that are not used in the rate setting process need to be incorporated back into the system. This introduction of additional RVUs causes a very small adjustment in the final step. For these reasons, we will finalize the proposal to utilize three separate adjustments in the calculation of resource-based PE RVUs.

Comment: Several commenters applauded our proposals relating to the PE methodology for being more intuitive and transparent, but requested that we go one step further toward pure transparency by publishing the PE/HR figures and the specialty indirect practice cost indices.

Response: We appreciate the support for the intuitive and transparent nature of the revised methodology. Following our original intention of making this methodology resource-based, intuitive, and transparent, we will publish both the PE/HR figures and the indirect practice cost indices on the homepage of the CMS Web site.

Comment: A few commenters requested that either their services be "frozen" at the current 2006 PE RVUs or that a floor be placed on the percent reduction associated with any given service due to the revised methodology.

Response: We do not believe it would be equitable to maintain current values for certain codes or to place a floor on the percentage reduction associated with a given service in a resource-based system. However, in order to minimize any potential disruptive effects that could be caused by sudden shifts in RVUs, we will be finalizing our proposal to transition to the bottom-up methodology over a 4-year period. This transition period will allow interested parties an opportunity to review the data elements associated with their services. For these reasons, we will not institute a floor on the reduction in PE RVUs for a service, nor will we freeze any services at their CY 2006 PE RVUs.

Comment: Several commenters have requested that, for purposes of calculating resource-based PE RVUs, certain services should be assigned to specialties with higher PEs then those that are reported in the Medicare claims data.

Response: Unless there is evidence that the Medicare claims data is incorrect, or that there is something unique about the services in question, we do not believe it would be appropriate to override our existing utilization data. The Medicare claims data identifies what specialties are furnishing what services and this is an essential component in the development of our resource-based system. If interested specialties contend that persons within their specialty are reporting their specialty designation incorrectly, we urge those specialties to work with their respective organizations to educate their membership about the importance of correct reporting of their specialty designation when billing Medicare.

Comment: Several commenters contended that the independent diagnostic testing facility (IDTF) survey data does not reflect the costs of cardiac event monitoring services, because issues such as hours of operation, intense staffing needs and equipment usage are not taken into account.

Response: We agree with the commenters that cardiac event monitoring services are unique and are not appropriately represented by the IDTF survey data. For this reason, we will use the PE data associated with cardiology to value these services. Additionally, as discussed in more detail in the section on direct cost inputs (section II.A.4.f. of this final rule with comment period), we are revising the direct inputs for these services to reflect that the PEs are not limited to direct patient encounters.

Comment: Some commenters recommended that we review the crosswalk used for both interventional pain management and pain medicine in the CY 2007 PFS proposed rule. The commenters suggested that the appropriate crosswalk for these specialties is the "all physician" PE/HR.

Response: We agree with this comment and will crosswalk both interventional pain management and pain medicine to the "all physician" PE/HR.

Comment: Several commenters supported the use of revised 2005 utilization data. A few commenters expressed concerns that the use of this revised single year data might cause problems with the stability of the PE RVUs and requested that we delay using this data until the impact on the stability of PE RVUs can be determined.

Response: We will finalize our proposal to incorporate the most current Medicare utilization data into the calculation of resource-based PE RVUs. We have always attempted to use the most current data available in rate-setting. Although we understand the concerns conveyed by the few comments that requested a delay in the use of the 2005 utilization data, we do not believe that the use of this data will destabilize the PE RVUs to the extent that a delay would be warranted.

Comment: Some commenters contended that we are in violation of the MMA when reducing the PE RVUs of drug administration services by adopting a new methodology. The commenters stated that, because the oncology supplemental survey is not being used for the same purpose as it was when MMA directed us to use the survey, all drug administration services must be exempt from any impact associated with the revised PE methodology.

Response: We disagree with this comment. Although the MMA was enacted prior to these changes in our PE methodology, the MMA did not prescribe the use of any particular resource-based PE RVU methodology or constrain our rulemaking authority. The MMA directed us to use the oncology survey data in determining PE RVUs. We have, in fact, used the survey data (in exactly the way the Congress envisioned when it passed MMA) to establish PE RVUs for services furnished during CYs 2004, 2005 and 2006. In addition, under the revised PE methodology, we are utilizing the survey data in the calculation of the indirect PE RVUs. Thus, we do not believe that the use of the survey data within our revised methodology violates the provisions of MMA.

Comment: Several commenters contended that the proposed indirect practice costs may not be appropriate for cardiology practices that operate free-standing cardiac catheterization labs. The commenters further stated that the nonfacility technical billings for cardiac catheterization are dominated by IDTFs, but the IDTF supplemental survey data was primarily based on imaging centers. The commenters recommended that the cardiac catheterization services be based solely upon the PE data for cardiology.

Response: We agree with these comments. We currently do not have direct cost input data for the nonfacility setting for these services. Until we are able to obtain such data, we will carrier-price the cardiac catheterization codes. We urge interested parties to continue to work with the RUC to develop direct cost inputs for these services in the future.

Comment: One commenter recommended that we reinstate the clinical labor costs associated with physicians bringing their own staff to the hospital and contended that not counting these costs is in violation of the statute.

Response: We have indicated that we will not pay for clinical staff brought by physicians to the hospital for the following reasons: (1) These costs are already paid to the hospital and would thus be a double payment; (2) we already pay for physician extender staff through the physician work RVUs; and (3) we pay physician assistants (PAs) directly when they serve as assistants at surgery. In response to this decision, the thoracic surgeons contended that hospitals are no longer providing the staff to furnish adequate care. We asked the Office of Inspector General (OIG) to conduct an independent assessment of the staffing arrangements between hospitals and thoracic surgeons. In response to our request, in an April 2002 report, the OIG clearly supported our position to exclude the costs of clinical staff brought to the hospital from the PE calculations. For these reasons we will continue to exclude the clinical labor costs associated with physicians bringing their own staff to the hospital from the calculation of resource-based PE RVUs.

Comment: One commenter recommended that the practice costs associated with the handling of pharmaceuticals should be incorporated into the cost categories associated with the calculation of resource-based PE RVUs.

Response: The commenter did not offer any recommended inputs or strategies on how to incorporate these costs into the methodology. For this reason we will not incorporate any additional costs related to the handling of pharmaceuticals into the methodology at this time.

Comment: One commenter recommended that administrative staff time should be counted as a direct cost.

Response: Administrative staff time was included in the original CPEP data as direct PE. However, because of the difficulty in accurately assigning the administrative time to individual procedures, we then converted this expense to an indirect cost. We agree that, in principle, it could be helpful to treat as many of the practice costs as possible as direct, rather than indirect PE, and we would be willing to consider such recommendations if the PERC or RUC would agree to undertake the task of assigning administrative staff times to each code.

Comment: One commenter recommended that special resource considerations for screening services should be factored into the calculation of the PE RVUs.

Response: We have attempted to account for all resource cost in the calculation of the PE RVUS for all services. Unfortunately, the commenter did not supply any documentation regarding additional resources that the commenter believes should be included for screening services. Therefore, we will not add additional resources as requested at this time.

Comment: Many specialty societies expressed concern that the Medicare database currently does not permit the collection of nurse practitioner (NP) specialty-specific data. The commenters contended that this limitation unfairly excludes NPs from participating in certain demonstration projects and other programs. The commenters also state that they are ready to work with us on this and any related issues.

Response: It is not clear from the comment exactly what specialty-specific data is at issue. However, we would certainly be willing to work with the commenters to address their concerns.

4. Additional PE Issues for CY 2007

a. RUC Recommendations for Direct PE Inputs and Other PE Input Issues

In the CY 2007 PFS proposed rule (71 FR 48982), we proposed the following concerning direct PE inputs.

(i) RUC PE Recommendations

The AMA's Relative Value Update Committee (RUC) established a new subcommittee, the Practice Expense Review Committee (PERC), to assist the RUC in recommending direct PE inputs (clinical staff, supplies, and equipment) for new and existing CPT codes. The RUC reviews and gives final approval for all PERC recommendations.

The PERC reviewed the PE inputs for over 2000 existing codes, some of which were unresolved PE issues from the CY 2006 PFS final rule with comment period, at their meetings held in September 2005, February 2006 and April 2006.

We reviewed the PERC recommendations that were forwarded by the RUC and proposed to adopt all of them. We have worked with the AMA staff to correct any typographical errors and to ensure that previously PEAC-accepted standards are incorporated in the recommendations.

The complete PERC recommendations and the revised PE database can be found on our Web site. ( See the SUPPLEMENTARY INFORMATION section of this final rule with comment period for directions on accessing our Web site.)

Comment: We received comments from many of the specialty societies thanking us for our acceptance of the PERC recommendations.

Response: We thank the specialty societies for their positive remarks and we look forward to our continuing relationship with the PERC and the societies.

(ii) Standard Supplies and Equipment for 90-Day Global Codes

In our proposed rule of August 22, 2006, we proposed to revise the CPEP supply and equipment inputs for those 90-day global procedures for which the RUC had only refined the clinical labor direct PE inputs. We proposed to apply the standard supply and equipment inputs for the facility setting for 90-day global services to these remaining unrefined 90-day global procedure codes. As recommended by the PERC at its April 2006 meeting, for supplies, we proposed to include one minimum supply visit package for each postoperative visit assigned to each code and a postsurgical incision care kit (suture, staple, or both) where appropriate, along with additional items reviewed and recommended by the PERC for certain procedures. For equipment, we proposed to include an exam table and light as the standard equipment, as well as other equipment items recommended by the PERC that were identified by the specialty societies as necessary during the postoperative visit period. However, there are several issues on which we requested input from the PERC or the specialty before we finalized the recommended standards. For example, for many of the 90-day codes in question, the current supply input data contain supplies in far larger quantities than are contained in either the visit package or incision care kit. For other codes, the current data include items that are not contained in the package or kit. In other cases, the PERC recommendations contain additional items in quantities that appear excessive. We plan to work with all the concerned specialties to ensure that the finalized inputs do represent the typical supplies needed to perform each procedure.

Because the application of the 90-day global standard supplies and equipment would result in the deletion of some original CPEP inputs, we requested that all the medical specialties examine the direct PE inputs on our Web site and inform us if there are additional items from the original CPEP data that are a necessary part of the postoperative care and if the PERC-recommended PE inputs were listed correctly.

Comment: Several commenters expressed concern regarding the accuracy of our PE database for the specialty-specific PERC recommendations and the application of the standard supplies and equipment that we proposed to include in the 90-day global codes. One commenter representing urologists noted that several supply items approved by the PERC were missing in the PE database and provided us with specific supply inputs for CPT codes 57310, 57311, 57320, and 57330. Another commenter representing prosthetic urologists recommended that the standard supplies used for infection control or patient comfort be included for each postoperative visit, such as gloves for the physician and clinical staff, table paper, patient drapes and gowns, and also questioned the accuracy of the number of "multi-specialty visit package" (MSVP) associated with their services. They believe that their services entail more postoperative visits than the current number of MSVPs reflected in the PE database. A society representing gynecologic oncologists also recommended that the standard supplies for their procedures should be modified to include additional supplies that are associated with their procedures, such as a pelvic exam kit and a patient drape. Lastly, a medical society representing ophthalmologists urged us to incorporate the PERC-recommended supply and equipment direct inputs for the 90-day global ophthalmologic codes.

Response: We thank the urology specialty for reviewing the PE database and providing us with the specific supply items missing from their four CPT codes. These PERC-approved supplies have been added as requested. We have addressed the prosthetic urologists' concerns regarding the inclusion of supplies for infection control and patient comfort by ensuring that one MSVP was included in the PE database for each postoperative visit for these services. The MSVP contains, among other things, 2 pairs of gloves, table paper, and a patient gown. We also note that the inclusion of a patient drape is a standard for the codes identified by the specialty for gynecology and obstetrics. To the extent that prosthetic urologists believe a patient drape is needed in their 90-day global codes, we encourage them to work through the RUC process to correct possible discrepancies. In regard to the request for additional MSVPs for each procedure performed by the urologic prosthetists, we believe the commenter is mistaken, as there is one MSVP for each of the RUC-recommended postoperative visits entered in the PE database. With respect to the comments about the absence of specific supplies in gynecologic oncology procedures, we would note that the 90-day CPT codes identified by the specialty for gynecology and obstetrics all contain these specific items as part of the standard packages, as approved by the RUC and accepted by CMS. We would again suggest that the commenter work through the RUC process to assure that the necessary inputs are included in these services. In response to the request from the society representing ophthalmologists to implement the PERC-recommended supply and equipment changes for ophthalmology services, we have already incorporated these changes into the PE database and they are reflected in the PE RVUs. However, we would note that further equipment adjustments were not made for the ophthalmology CPT codes, as the PERC recommendations did not include any changes to the current equipment or ophthalmology lane assignments.

b. Payment for Splint and Cast Supplies

In the CY 2000 and CY 2001 PFS final rules (64 FR 59380 and 65 FR 65376, respectively), we removed splint and cast supplies from the PE database for the CPT codes for fracture management and cast/strapping application procedures. Because splint and cast supplies could be separately billed using Healthcare Common Procedure Coding System (HCPCS) codes (Q4001 through Q4051) that were established for payment of these supplies under section 1861(s)(5) of the Act, we did not want to make duplicate payment under the PFS for these items.

In the CY 2006 PFS proposed rule (70 FR 45764), we proposed to reinstate payment for all splints and cast supplies through the PE component of the PFS because we believed we may have unintentionally prohibited remuneration for these supplies when they are not used for reduction of a fracture or dislocation (covered under section 1861(s)(5) of the Act), but rather are provided (and covered) as "incident to" a physician's service under section 1861(s)(2)(A) of the Act. This proposal was not finalized; however, in our CY 2006 final rule with comment period (70 FR 70116) we asked the medical specialties and the PERC to determine the typical supplies for splints and casts necessary for each of the fracture management codes and the cast/strapping application codes because we wanted to make certain that the supply inputs were correct before we proceeded with rulemaking for the CY 2007 PFS. At its February 2006 meeting, the PERC reviewed and approved the supply inputs submitted by the American Academy of Orthopaedic Surgeons (AAOS) for each CPT code for fracture management and cast/strapping application and these were forwarded to us as PERC recommendations. During this interim period we also reassessed the options for payment of materials for splints and casts.

We believe that the majority of the splint and cast supplies that are currently paid through the Q-codes are furnished in relationship to cast/strapping procedures for the management of fractures and dislocations. However, we did not intend for the medically necessary splint and cast supplies used for other reasons (for example, serial casting, wound care, or protection) not to be paid. Because it may be difficult for the contractors to identify the purpose for the cast/strapping application procedure on a claim form, we believe that contractors may have been paying for the splint and cast supply Q-codes when the service is performed for other purposes than treatment of fractures and dislocations.

Since these splint and cast supplies can be covered under both sections 1861(s)(5) and 1861(s)(2)(A) of the Act, we proposed to include payment for both statutory benefits using the separate HCPCS Q-codes. This would allow for payment for these medically necessary supplies whether based on sections 1861(s)(5) or 1861(s)(2)(A) of the Act, while ensuring that no duplicate payments are made. Physicians will continue to bill the HCPCS Q-codes, in addition to the cast/strapping application procedure codes, to be paid for these materials.

The following supplies will continue to be paid separately using the HCPCS Q-codes and would not be included in the PE database:

• Fiberglass roll.

• Cast padding.

• Cast shoe.

• Stockingnet/stockinette.

• Plaster bandage.

• Denver splint.

• Dome paste bandage.

• Cast sole.

• Elastoplast roll.

• Fiberglass splint.

• Ace wrap.

• Kerlix.

• Webril.

• Malleable arch bars and elastics.

The splint and cast supplies will not be included in the PEs for the following CPT codes:

• 24500 through 24685.

• 25500 through 25695.

• 26600 through 26785.

• 27500 through 27566.

• 27750 through 27848.

• 28400 through 28675.

• 29000 through 29750.

We specifically requested input, from medical specialties and contractors on our proposal.

Comment: Commenters offered their appreciation and support of our proposal to pay for medically necessary splint and cast supplies using HCPCS Q-codes for both statutory benefits, that is, sections 1861(s)(5) and 1861(s)(2)(A) of the Act. However, one commenter requested that we clarify "whether this separation applied to the rehabilitation non-physician service codes." In addition, a few commenters noted that the supplies for the Unna-boot have been excluded from payment under the Q-codes, because they are assigned HCPCS A-codes, and asked that we clarify if the Unna-boot supplies will now be included in the Q-codes. One commenter suggested that we omit the cast shoe from the list of supplies that are covered under either benefit. Another commenter asked us to temporarily include the A-HCPCS codes, A-6441 though A-6457, as billable HCPCS codes in conjunction with the strapping and casting CPT procedures codes.

Response: We will proceed with our proposal to pay for the splint and cast supplies using the existing HCPCS Q-codes for all medically necessary splints and casts, as appropriate. While we appreciate the comments received, we have questions about and do not understand the request concerning whether this applied to the "rehabilitation nonphysician service codes." We apologize that our listing of the applicable CPT code ranges in the proposal caused confusion about whether the Unna-boot supplies that currently are identified with HCPCS A-codes would change and be paid using the Q-codes. For clarification purposes, we would like to note that our proposal does not change the existing Q-code descriptors or their pairing with certain CPT codes for payment purposes. For CPT code 29580, (Strapping; Unna boot) physicians and other qualified providers will continue to use the A-codes designed for the Unna-boot supplies. We appreciate the comments from the commenter asking us to remove the cast shoe from the PE database since shoes are statutorily noncovered items, except for certain diabetic shoes and those that are attached to braces. The cast shoe was erroneously identified as a supply item separately paid using the Q-codes in the listing in our proposed rule. We now realize that the listing in the proposed rule, in reality, merely identifies the supply inputs to be removed from the PE database rather than those that are separately billable. We agree with the commenter, and will remove the cast shoe item from our PE database (27 codes). While we appreciate a commenter's request to include certain A-codes as separately billable under our proposal, these items were never included in the PE database and it would not be appropriate to include them in the existing Q-codes.

c. Medical Nutrition Therapy Services

In 2000, the Health Care Professional Advisory Committee (HCPAC) recommended that we assign work RVUs to three new medical nutrition therapy (MNT) CPT codes: 97802, Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes at 0.45 RVUs; 97803, Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes at 0.37 RVUs; and 97804, Medical nutrition therapy; group (two or more individuals), each 30 minutes at 0.25 RVUs. However, during rulemaking for the CY 2001 PFS final rule, we indicated that MNT was not covered because there was no statutory benefit category that would allow medical nutritionists to bill these services. We also did not accept the HCPAC recommendations for work RVUs for these MNT services because the codes were designed for use only by nonphysicians. The following year, section 105(c) of the Medicare, Medicaid, and State Child Health Insurance Program Benefits Improvement Protection Act of 2000 (BIPA) (Pub. L. 106-554) provided for the coverage of MNT services when furnished by registered dietitians or nutritional professionals at 85 percent of the amount that a physician would be paid for the same services. As a result, we established values for these MNT services for the CY 2002 PFS. In keeping with our earlier decision, we did not assign the HCPAC-recommended work values. However, the associated work value for each code was utilized in the conversion of work to clinical labor time for MNTs as part of the PE component. At that time we received several comments, including one from the American Dietetic Association (ADA), urging us to adopt the work values recommended by the HCPAC.

More recently, the ADA has requested us to reconsider our decision not to accept the HCPAC recommended work RVUs. The ADA contends that the payment rate established by section 105(c) of BIPA, 85 percent of the PFS amount that would be paid for the same service if furnished by a physician, is based on the premise that work values are inherent to these MNT services. The ADA believes that without work RVUs, the payment for these services does not reflect 85 percent of what a physician would be paid for performing the same service. Because these MNT codes were created specifically for MNT professionals, the ADA compared the work associated with their services to physician E/M services of CPT codes 99203 and 99213, which have respective work RVUs of 1.34 and 0.67.

After reviewing the issues and relevant arguments raised by the ADA, we are persuaded that it would be appropriate to include work RVUs for the MNT services. Consequently, we proposed to establish work RVUs for each code at the level previously recommended by the HCPAC, as follows:

• CPT code 97802 = 0.45 RVUs.

• CPT code 97803 = 0.37 RVUs.

• CPT code 97804 = 0.25 RVUs.

Because we proposed to add the work RVUs to these services, the MNT clinical labor time in the direct input database will be removed. Additionally, two HCPCS codes, G0270, MNT subs tx for change dx and G0271, Group MNT 2 or more 30 mins were created to track MNT services following the second referral in the same year and these HCPCS codes correspond to CPT codes 97803 and 97804, respectively. Therefore, we also proposed to add the same work RVUs to these HCPCS codes and to delete the MNT clinical labor inputs from the PE database upon adoption of this policy. We encouraged specialty societies and other professional groups to comment on this proposal.

Comment: We received comments from the ADA, several MNT providers, one drug company, the National Kidney Foundation and one Congressional member all supporting our decision to establish work RVUs for the MNT services. Further, several commenters joined the ADA in requesting an increase in the proposed work RVUs. In justification of their request, the ADA and other commenters compared these services to CPT codes 99213 (mid-level E/M service) and 90804 (individual psychotherapy service). These commenters also requested that the total work RVUs for 97802, 97803, and G0270 be equal and the total work RVUs for CPT code 97804 and HCPCS code G0271 also be equal. In addition, the ADA provided specific supplies and equipment to be added to the PE database in order to facilitate correct PE calculations for these codes.

Response: We appreciate that the commenters acknowledge and support our decision to establish work RVUs for the 5 MNT services. However, we do not believe it would be appropriate to accommodate the request to increase these work RVUs. We believe that the HCPAC work recommendations best represent the MNT services and encourage the ADA to utilize the established RUC or HCPAC processes to further assess valuation of their services. For this reason, we will maintain the proposed work values for all MNT CPT/HCPCS codes. However, we have added the supplies and equipment to the PE database as requested.

d. Surgical Pathology Codes

The College of American Pathologists commented on the equipment times assigned to CPT codes 88304 and 88305 in the basic surgical pathology family of codes. While all six codes in this family have been refined by the PEAC, this refinement occurred at four separate PEAC meetings. CPT codes 88304 and 88305 were refined at the first PEAC meeting in April 1999 before time standards were established for the equipment at subsequent PEAC meetings when the other four CPT codes 88300, 88302, 88307, and 88309 were reviewed. Using our proposed bottom-up PE methodology to value these codes, the lack of the equipment time standards for CPT codes 88304 and 88305 create a rank-order anomaly in this family. Consequently, the College of American Pathologists, after reviewing and applying current standards for the equipment times, submitted suggested revised equipment times to us. We proposed to accept these times and the times will be reflected in the PE database on our Web site (See the SUPPLEMENTARY INFORMATION section of this final rule with comment period for directions on accessing our Web site.)

Comment: The College of American Pathologists expressed appreciation for these revisions to the equipment time to the surgical pathology CPT codes.

Response: We appreciate the College of American Pathologists's review of the PE direct inputs, which led to our proposal. We are finalizing our proposal for these changes in the equipment times in the PE database.

e. PE Issues from Rulemaking for CY 2006

In the CY 2006 PFS final rule with comment period (70 FR 70116), we explained that we were not implementing the PERC or other proposed PE changes for CY 2006 due to issues with the PE methodology. In the CY 2007 PFS proposed rule, we proposed that the PERC and other PE changes originally proposed for CY 2006 would be implemented and effective with the CY 2007 PFS (71 FR 48987). The following subsections, (i) through (x), summarize the PE proposals from the CY 2006 PFS final rule with comment period.

(i) PE Recommendations on CPEP Inputs for CY 2006

We proposed to use a clinical labor time of 167 minutes for the service period for CPT code 36522, Extracorporeal Photopheresis ; maintain the nonfacility setting PE RVUs for CPT code 78350, single photon bone densitometry ; and remove the PE inputs for the nonfacility setting for CPT codes 76975, GI endoscopic ultrasound , and 15852, Dressing change not for burn. (70 FR 70136 through 70137)

(ii) Supply Items for CPT Code 95015 (Which is Used for Intradermal Allergy Tests with Drugs, Biologicals, or Venoms)

We proposed to implement the allergy and immunology specialty's recommendation to change the test substance in CPT code 95015 to venom, at $10.70 (from single antigen, at $5.18) and the quantity to 0.3 ml (from 0.1 ml) (70 FR 70138).

(iii) Flow Cytometry Services

Based on information from the society representing independent laboratories, we proposed to implement the following direct PE inputs:

• Clinical Labor: We proposed to change the staff type in the service (intra) period in both CPT codes 88184 and 88185 to cytotechnologist, at $0.45 per minute (currently lab technician, at $0.33 per minute).

• Supplies: We proposed to change the antibody cost for both CPT codes 88184 and 88185 to $8.50 (from $3.544).

• Equipment: We proposed to add the following equipment to CPT code 88184:

• Computer.

• Printer.

• Slide strainer.

• Biohazard hood.

• Wash assistant.

• FAC loader.

We proposed to add a computer and printer to the equipment for CPT code 88185 (70 FR 70138).

(iv) Low Osmolar Contrast Media (LOCM) and High Osmolar Contrast Media (HOCM)

Because separate payment is available for both types of contrast media, we proposed to delete LOCM and HOCM from the PE database in this final rule with comment period (70 FR 70138).

Comment : Several specialty organizations expressed their appreciation for implementing the recommendations for the PE changes in section (i) of this section to CPT codes 36522, 78350, 76975 and 15852; in section (ii) of this section for changing the amount and test substance inputs in CPT 95015; in section (iii) of this section for implementing the PE changes to the flow cytometry CPT codes 88184 and 88185; and in section (iv) of this section for removing the LOCM and HOCM from the PE database because they are separately reimbursed.

Response: We will implement these changes for CY 2007.

(v) Imaging Rooms

We proposed to implement the updates for the contents and prices of 5 "rooms" used in imaging procedures including-

• Basic radiology room;

• Radiographic-fluoroscopic room;

• Mammography room;

• Computed tomography (CT) room; and

• Magnetic resonance imaging (MRI) room (70 FR 70139).

Comment: Two commenters questioned why the contents and prices for ultrasound "rooms" were not being updated in CY 2007 proposed rule.

Response: The imaging rooms proposals that appeared in this year's proposed rule were deferred from the previous year. These imaging rooms all contained equipment without updated pricing information. The two ultrasound rooms, general and vascular, were valued during the repricing of the equipment for the PE database that occurred during rulemaking for CY 2005.

(vi) Equipment Pricing for Select Services and Procedures

We proposed to accept the following equipment pricing information provided by various specialty societies for select services and procedures as discussed in the CY 2006 PFS final rule with comment period (70 FR 70139).

• Equipment pricing for certain radiology services received from the ACR as presented in Table 15 of the CY 2006 PFS proposed rule.

• Equipment pricing on the ultrasound color doppler transducers and vaginal probe received from the American College of Obstetrics and Gynecology (ACOG).

• Equipment pricing for CPT code 36522, extracorporeal photopheresis .

• Pricing of the EMG botox machine used in CPT code 92265 as presented by the American Academy of Ophthalmology (AAO).

(vii) Supply Item for In Situ Hybridization Codes (CPT Codes 88365, 88367, and 88368)

We proposed to implement the Society for Clinical Pathologists' request to change the probe quantity to 1.5 for CPT code 88367, In situ hybridization, auto, which is equal to the quantity in the other two codes in the family.

(viii) Supply Item for Percutaneous Vertebroplasty Procedures (CPT codes 22520 and 22525)

Based on documentation provided by the Society for Interventional Radiology, we proposed to implement a new price of $696.00 for the vertebroplasty kit, to replace a temporary price of $660.50 that was a placeholder price from the CY 2006 PFS final rule with comment period (70 FR 70139).

(ix) Clinical Labor for G-Codes Related to Home Health and Hospice Physician Supervision, Certification and Recertification

We proposed to apply the refinements made to the PE inputs to CPT codes 99375 and 99378 for home health and hospice supervision to four G-codes that are related to home health and hospice physician supervision, certification and recertification, G0179, GO180, GO181, and GO182. These G-codes are incorrectly valued for clinical labor. These G-codes are crosswalked from CPT codes 99375 and 99378, which underwent PEAC refinement in January 2003 for the CY 2004 PFS. However, at that time we inadvertently did not apply the new refinements to these specific G-codes (70 FR 70139 through 70140).

(x) Programmers for Implantable Neurostimulators and Intrathecal Drug Infusion Pumps

Although we had initially proposed in the CY 2006 PFS proposed rule to remove two programmers from the PE database (EQ208 for medication pump from two codes (CPT codes 62367 and 62368) and EQ209 for the neurostimulator from 8 codes (CPT codes 95970 through 97979)), based on comments received as discussed in the CY 2006 PFS final rule with comment period (70 FR 70140), we determined that we will retain these programmers in the database. In addition, we added "with printer" to the description of EQ208, based on comments received. We proposed to implement these decisions for CY 2007.

Comment: Commenters expressed appreciation for the implementation of these changes that had been deferred from the previous year.

Response: We will implement the PE changes noted in sections (vi) through (x) of this section for CY 2007.

f. Other PE Issues for CY 2007

(i) Clarification With Respect to Non-Facility PE RVUs

In the CY 2006 PFS final rule with comment period (70 FR 70335), we provided a clarification in Addendum A concerning use of "NA" in the PE RVU columns for Addendum B. Commenters requested that further clarification be made concerning the payment amount for procedures performed in the non-facility setting if there is an "NA" in the non-facility PE RVU column. In the CY 2007 PFS proposed rule, we clarified that our policy is that the service will be paid at the facility PE RVU rate if the Medicare carrier pays for the service in the non-facility setting. In the CY 2007 PFS proposed rule (71 FR 48982), we proposed revisions to Addendum A to include this clarification.

Comment: Commenters expressed appreciation for this clarification.

Response: We have modified Addendum A to include this clarification.

(ii) Supply for CPT Code 50384, Removal (Via Snare/Capture) of Internally Dwelling Ureteral Stent Via Percutaneous Approach, Including Radiological Supervision and Interpretation

Upon review of the RUC-recommended direct PE inputs for CPT code 50384, a new procedure for the 2006 CPT codes, we identified the inappropriate inclusion of a ureteral stent that we proposed to delete for CY 2007. We believe that the addition of the ureteral stent, valued by the specialty at $162, to CPT code 50384, which is the procedure for the removal of a stent, was an inadvertent error by the specialty during the April 2005 RUC meeting.

Comment: The commenters agreed with the deletion of the ureteral stent from this service.

Response: This stent will be removed from CPT code 50384 in the PE database.

(iii) Cardiac Monitoring Services

We requested more specific PE information on remote cardiac event monitoring services in the CY 2007 PFS proposed rule as a result of a comment and response discussion in last year's final rule related to these services and an inappropriate fit with the direct PE model used for typical physicians' services. These services are overwhelmingly performed by specialized IDTFs that are paid under the PFS, but frequently maintain more extensive operating hours than the typical physician office due to the characteristics of cardiac monitoring services. Specifically, we requested data to indicate the typical number and type of transmissions or other encounters per day between the beneficiary and the IDTF for each of the remote monitoring services. We also requested the number and type of clinical staff, as well as the corresponding times, that are necessary to ensure that appropriate services are available for each patient. Additionally, we requested assistance in identifying any other direct PE inputs for typical supplies and equipment relating to these services, and any data that would reflect indirect PE, such as overhead and non-clinical payroll expenses. Because we believe that the following codes, predominately performed by specialized IDTFs, represent atypical PE scenarios, we requested PE information for these services:

• Cardiac event monitoring (CPT codes 93271, 93012 and 93270).

• Pacemaker monitoring (CPT codes 93733 and 93736).

• Holter monitoring (CPT codes 93232, 93226, 93231 and 93225).

• INR monitoring (HCPCS codes G0248 and G0249).

Comment: Several commenters voiced concern about the dramatic decrease in the PE RVUs for these services and most agreed that the remote cardiac monitoring services do not fit the PE model for physicians' services and believed that the information that we requested could be useful to value these technical services. One commenter submitted the requested information after conducting a survey of 7 large IDTFs specializing in these remote cardiac monitoring services. For each of the 11 CPT/HCPCS codes referenced above in this section, the commenter provided recommendations for the direct PE inputs, including the type of clinical labor and the related minutes for their service, the needed disposable supplies and the equipment costs, the number of minutes in use, and the respective life of each piece of equipment. In addition, two commenters suggested that CPT code 92326 (remote, real-time, wireless cardiac monitoring) be added to the above list of services:

Response: We appreciate that the provider group conducted such a detailed survey to capture the costs of these services. We have reviewed the direct inputs that were forwarded by the commenter and have accepted many of their recommendations, some with modifications, for all these codes. For example, we used the "discounted" purchase prices for the equipment which is our standard policy rather than the additional list prices that were also included. The specific direct inputs for the following CPT/HCPCS codes: 93012, 93271, 93270, 93733, 93736, 93232, 93226, 93231, 93225, G0248 and G0249 are included in the PE database that is posted with this rule on the CMS Web site. We will consider these inputs interim, for CY 2007, and will continue to work with the provider group to appropriately value these services. For the request to include CPT code 93236 in this list of codes, we would note that this procedure is not valued in the nonfacility setting and has no direct inputs. CPT code 93236 is discussed in the following comment and response.

g. Specific PE Concerns Raised by Commenters

(i) Wireless Cardiac Monitoring

Comment: One commenter expressed concern about the impact of the PE methodology proposal and stated that there is not a CPT code that accurately represents "remote, real-time cardiac monitoring through wireless communications and computerized arrhythmia detection technology" service. The commenter requested that a HCPCS code be created specifically for this service and provided direct input recommendations that could be used to price this new code. In the event that we could not create a HCPCS code, the commenter requested that the direct inputs be applied to the CPT code 93236 which is currently being used to bill for this service.

Response: We are reluctant to create a HCPCS code at this time because the commenter has not demonstrated a compelling need for a distinct code for this service. Because this code is currently not valued in the nonfacility setting, we proposed to carrier price this service for CY 2007. We suggest that if the commenter believes a distinct code is necessary to describe this service, the provider should work with the specialty and contact the CPT Editorial Panel to pursue this matter. We will maintain our proposal to carrier price this service for CY 2007.

(ii) Endovenous Ablation Services, CPT Codes 36475, 36476, 36478, and 36479

Comment: We received numerous comments with concerns about the decrease in PE RVUs proposed for CY 2007. In addition, a few commenters noted a disparity between the cost of supplies for the RF and the laser ablation procedures, CPT codes 36475 and 36478, respectively. One commenter supplied documentation to support that the price of the endovascular laser kit, at $677, in the PE database is not typical. This commenter presented a range of prices from $275 to $315 as typical. The commenter also demonstrated that 3 other supplies listed for CPT code 36478 were duplicated as they are part of the kit. Another commenter noted a price of $360 for the laser kit.

Response: We reviewed the supplies in the laser kit and the other supplies for this endovenous service and believe that the hydrophilic guide wire, the vascular sheath and the vessel dilator are duplicated. These items were removed from the database for CPT code 36478. In addition, based on the information and documentation supplied, we used the $360 laser kit to average with the existing price of $677 to obtain the new price of $519. We have also made this change to the PE database. While we realize that the PE RVUs were negatively impacted by the change in the PE methodology, it is also important to ensure that the direct inputs accurately reflect the typical resources used to provide each service.

(iii) Development of Nonfacility PE for Arthroscopic Procedures

Comment: We received comments requesting that we establish direct PE inputs for five arthroscopy codes for the nonfacility setting, including CPT codes 29870, 29805, 29830, 29840 and 29900.

Response: The RUC discussed this request at its October 2006 meeting and determined that the procedures are not safe to perform in the physician's office. We support the RUC's decision not to value these arthroscopy procedures in the nonfacility setting and will continue to use the "NA" indicator in the PE RVU column for the nonfacility setting in Addendum B.

(iv) Audiologist Wage Rate

Comment: One commenter requested that we add 25 percent to the professional audiologists wage rate per minute which is now $0.52. The commenter contended that the fringe benefits factor was not applied at the time we established the clinical labor rates for CY 2002.

Response: We used data from the Bureau of Labor Statistics (BLS) to establish the base wage rate for audiologists when we repriced the clinical staff wage rates for CY 2002. We also applied a 33.6 percent fringe benefit factor to all wage rates, including the wage rate for audiology. Therefore, we will maintain the wage rate for audiologists until the time that all clinical labor wages are updated in future rulemaking.

(v) Medical Physicists Wage Rate

Comment: Several commenters recommended that we accept the 2005 survey data on hourly wages, inflated to 2006, that was presented by the association representing medical physicists. They contend that we inappropriately used the wage rate for health physicists, instead of medical physicists, when we updated the clinical labor wage rates for CY 2002.

Response: In the PFS final rule for CY 2002, we finalized our proposal to price the physicist staff type on the average salary data for all certified health physicists from the 1999 survey conducted by the American Academy of Health Physics and the American Board of Health Physics. At the time we were revising the wage rates, this was the best information available. Further, the source of the majority of wage rates in the CY 2002 PFS final rule was the BLS. In the case of medical physicists, we were unable to obtain salary data from BLS. We agree with the commenters that this revised 2005 salary data is more appropriate than our current salary data. We will utilize this revised data, deflated to 2002, to keep all salary data on the same scale. As a result of this information, we will change the wage rate per minute for the two following clinical staff types: (a) Medical physicists from $1.21 to $1.523; and (b) medical dosimetrists/medical physicists from $0.92 to $1.075.

(vi) Home Visit E/M Services

Comment: We received a comment that stated that the home care clinical labor times are incorrectly reported in our PE database with each lacking 6 minutes in the pre-service period. In addition, the commenter stated that a supply item, specula tips, is missing in one service. Another commenter voiced support for the efforts of the home care physician group.

Response: We have verified that our PE database is correct. For the CPT codes 99341, 99342, and 99343, there is a total 12 minutes labor for each code, with 6 minutes assigned to the pre-service period and 6 minutes assigned to the postservice period. Also, the supply item the commenters reported as missing is included in the PE database.

(vii) Supply Inputs for CPT 31730

Comment: Prior to the publication of the CY 2007 PFS proposed rule, we received documentation from the association representing pulmonary physicians that specified the contents of the fast track supply tray for CPT code 31730. The specialty was complying with our request for information on supply items needing specialty input in last year's final rule.

Response: We thank the specialty group for its submission of the fast track supply tray contents and note that we accepted this documentation and the $750 price in our proposed rule. However, we regret that we did not remove the duplicated supply items from the PE database at that time. The following supplies will be removed from the inputs for CPT 31730 because they are already contained in the fast track tray: alcohol pads, 6 cc syringe with needle, 27G needle and 4x4 gauze pads. The PE RVUs that appear in this rule reflect the removal of these supply items.

(viii) Supply Costs for CPT Code 58565

Comment: One commenter noted that the cost of the kit used for hysteroscopic tubal implant for sterilization (supply code SA076) has increased in price from $980 to $1245. The specialty society representing gynecology and obstetrics services did not supply supporting documentation.

Response: We appreciate that this commenter has reviewed the direct inputs for accuracy. However, lacking any documentation to substantiate this request for a higher price, we will maintain the $980 price for the kit in the PE database for CY 2007. We will add this supply to the table requiring specialty input and will review any documentation provided by the specialty as part of a future rulemaking.

(ix) Bone Density Testing Services

Comment: Many commenters requested that we review the costs related to bone density testing (DXA) services, particularly related to CPT codes 76075 and 76076 used for detection and quantification of osteoporosis. These commenters state that the current direct inputs in the PE database identify the low cost pencil beam technology ($41,000) as the equipment utilized in performing these DXA services in place of the higher cost fan beam technology ($85,000). Commenters contended that the majority of densitometers sold are of the higher cost fan beam variety. Another commenter noted that the DXA services using the fan beam technology should also contain "phantom" equipment to be used to perform the daily quality check on this equipment.

Response: We have changed the PE database to reflect the fan beam DXA technology for CPT codes 76075 and 76076. In addition, we have added, on an interim basis, the "solid water calibration check phantom" to the equipment file in the PE database for the family of codes using the fan beam technology for 15 minutes each, based on the survey information presented by one commenter noting that these DXA services are performed, on average, twice daily. We ask the medical specialty to provide us with the correct information on the specific "phantom" used for the fan beam DXA technology, including pricing verification. While reviewing the PE database for these services, we discovered a rank order anomaly between CPT code 76075 and 76076 that apparently is due to a change in the clinical labor from the April 2006 PERC meeting where CPT code 76075 was used as a reference code. We have added back the 5 minutes of labor time in the PE database to CPT code 76075 to correct this rank order anomaly.

(x) PE Missing for CPT Code 28890

Comment: One commenter stated that the non-facility inputs for CPT code 28890, Extracorporeal shock wave, high energy, performed by a physician, requiring anesthesia other than local, including ultrasound guidance, involving the plantar fascia, lacked enough clinical staff to assist the physician with applying the regional (anesthetic) block and that the ultrasound equipment was not included in the PE database for this "shock-wave" service.

Response: In the CY 2006 PFS final rule with comment, we assigned nonfacility PE inputs for CPT code 28890, because we believed these services were being performed in the office. (This assignment of PE for CPT 28890 is discussed in a subsequent section of this rule.) Since the "shock-wave" machine was the only equipment listed in the PE database, we added the ultrasound equipment for 36 minutes, to the PE database, but we question whether additional staff is needed to assist the physician during the procedure since one nurse "blend" (RN/LPN/MTA) staff type is currently assigned for this procedure. We would entertain future discussions on this issue with interested parties, including the specialty organization involved in performing this procedure in the office. For CY 2007, we have maintained the current clinical labor assignment in the PE database.

h. Concerns About Decreases in PE RVUs for Women's Health and Other Services

Many commenters raised concerns regarding payment for services that affect women's health:

Comment: We received many comments regarding the proposed decrease in PE RVUs for either specific services or for given specialties. Many commenters raised concerns regarding payment for services that affect women's health.

Commenters opposed the proposed decrease in payment for the axial bone density testing (DXA) service, CPT code 76075, which is used for detection and quantification of osteoporosis, and CPT code 76077, which is used for vertebral fracture assessment. The commenters raised the concern that the proposed decrease in payment for these services would severely restrict patient access to bone density testing, thereby undermining our effort to effectively screen Medicare beneficiaries for osteoporosis and vertebral fractures. These commenters identified what they believed to be flaws in the direct input data and with the utilization rate applied to the DXA machine. The commenters also requested that we keep the payment for these services at the current level.

We received several comments that expressed concern about the decrease in payment for computer-aided detection (CAD) services, CPT codes 76082 and 76083, both add-on procedures that are billed in combination with an appropriate mammography service. The commenters stressed that CAD systems for mammography are diagnostic tools that can increase breast cancer detection rates, especially in the early stages. One commenter contended that the decrease in payment for this service could cripple the ability of physicians to offer this highest quality screening service to the broadest patient population.

Several commenters expressed concern about the proposed RVUs for the various radiation therapy codes involved in breast brachytherapy, as well as brachytherapy for ovarian and cervical cancer. A society representing brachytherapy stated that the proposed reductions may force providers to resort to other less beneficial cancer treatments. One commenter contended that the proposals could deny a greater number of African American women access to an important, patient friendly and proven breast cancer treatment. The above concerns were echoed in comments from a society representing NPs and a society concerned with research on women's health.

We also received several comments regarding a related service, CPT code 19296, Placement of a radiotherapy afterloading balloon catheter into the breast for interstitial radioelement application. Commenters expressed concern regarding the proposed decrease in payment for this service and predicted that this decrease from 129.74 RVUs in 2006 to 89.31 RVUs in 2010 would cause the service not to be offered in a physician's office to Medicare patients.

We received comments that expressed concern regarding the proposed decrease in payments for a number of other services. These include: The surgical hysteroscopy service, CPT code 58565; the chemodenervation procedures, CPT codes 64612, 64613 and 64614; the EMG-guided Botox therapy, CPT 92265; and endovenous ablation procedures, CPT codes 36475, 36476, 36478 and 36479.

We also received comments regarding the effect on certain specialties of our proposed payments. One commenter stated that the proposed cuts could diminish Medicare patients' access to cardiac care. Many commenters requested that we reconsider the cuts for interventional radiology, and others requested that we reverse any decrease for anesthesiology. Another commenter expressed concern regarding the decreases for this specialty. Commenters opposed the changes to the RVUs that would cause a total 14 percent decrease in payment for clinical social workers. In addition, other commenters expressed concern regarding our proposed payments for gastroenterology, neonatology, pain management, radiosurgery and phlebology.

Response: We understand the concern expressed by all of these commenters. However, payments made for services on the PFS can only reflect, in a budget neutral manner, the relative resources required to perform each service. With the exception of the requested changes to the equipment direct inputs for the DXA service, the commenters have not provided specific information regarding the relative resources required for the services in question that would support the requested changes in payment. We also do not believe it would be equitable to keep the payment for any specific service at the current rate when there are many other services that will see decreases in payment. We would note that one of the main reasons for the proposed 4-year transition of our new PE methodology was to give specialties and practitioners the opportunity to work with us to determine whether any changes in our payment calculation for such services is warranted and we are open to further discussion on this issue.

We also applaud the commenters who have stressed the importance of women's health issues. We certainly share their commitment to ensuring that those services that meet the health care needs of women remain accessible to our beneficiaries. In addition, we appreciate the important role that all of the preventive screening services play in helping to maintain the health of these beneficiaries. In response to comments, we have revised our equipment database to reflect the correct DXA equipment. It should also be noted that, although payment for the CAD service itself is decreasing, payment for most mammography services is increasing, which could potentially offset any reductions to the providers of CAD. However, we will request that the RUC review again the PE inputs for the DXA and CAD services to ensure that the direct inputs associated with these services are accurately reflected in our PE database.

i. Equipment Utilization and Interest Rate Assumptions

Comment: Many specialty societies, MedPAC, and the RUC all offered comments about the 11 percent interest rate and the 50 percent utilization rate used to calculate the price per minute for each piece of equipment. MedPAC stressed the importance of obtaining a reliable source for updating the yearly interest rate that physicians would pay when borrowing money to buy equipment. They believe that we should select the Federal Reserve Board because of the frequent updating, issued quarterly. MedPAC notes that interest rates, of more than one year, ranged from 5.3 percent to 6.0 percent over the past 5 years. Other commenters suggested that we adopt the prime interest rate plus 2 percent, while the RUC and several specialty societies noted that we should select a competitive market rate. One commenter suggested using caution in our selection process and requested that the interest rate be examined before future changes are made.

For updating the current 50 percent utilization rate, many commenters, including the MedPAC and the RUC, suggested that this rate should be higher. These comments stressed that by using the assumption that equipment is in use 50 percent of the time when the utilization is actually higher, our price per minute would be too high. The RUC recommended we use a rate higher than 50 percent and permit individual specialty societies to present support for lower rates for specific equipment items. While the overall comments contained a broad array of suggested revisions to the utilization rate, a few specialty organizations believed that the utilization rate should be lower than 50 percent. Several comments, specific to equipment for bone density testing (DXA), believe the utilization rate to be closer to 20 percent for these services performed in primary care physicians' offices and requested that we review this utilization to more appropriately measure the actual utilization of this equipment. MedPAC suggested that we begin our updating process by looking at the higher-priced equipment, and noted a study it conducted of imaging providers in six markets that indicated 70 percent and 90 percent utilization rates for CT and MRI, respectively. A few commenters noted that they would like for us to assign code-specific equipment utilization rates, although they did not forward possible avenues for us to follow in making the determinations of these assignments.

Response: We agree with commenters that the proposed interest rate of 11 percent and the proposed 50 percent utilization rate should be examined for accuracy. We are committed to working with all interested parties to define the most accurate utilization and interest rate information for equipment used in the performance of physicians' services. We do not believe that we have sufficient empirical evidence to justify a change in this final rule, but we will continue to work with the physician community to examine, and potentially revise, these estimates in future rulemaking. We have used the 11 percent interest rate and the 50 percent utilization rate to determine the valuation for equipment reflected in the PE RVUs in Addendum B.

j. Further Review of PE Direct Inputs

Comment: Several commenters, including the RUC and MedPAC, recommended that we establish an update process to ensure that the direct PE inputs-wage rates of clinical staff, purchase price of supplies, and purchase price of equipment-are updated for completeness and accuracy. MedPAC requested that we establish a timeline, recurring at least every 5 years, for the comprehensive review of the PE database direct inputs. Both MedPAC and the RUC made suggestions that the new, higher-priced supplies and equipment may need to be updated more frequently because their prices may decrease over time as other companies manufacture them.

Response: We appreciate the commenters' remarks regarding the establishment of a regular update process for the direct inputs utilized in the calculation of resource-based PE RVUs. We plan to examine this issue with both the RUC and interested specialty organizations, as well as with the medical community to determine the most useful approach to updating our direct PE inputs. Additionally, we encourage interested parties to continue working with the RUC to develop direct inputs for those services absent inputs and to correct any errors contained in our direct input database.

k. Supply and Equipment Items Needing Specialty Input

We have identified certain supply and equipment items for which we were unable to verify the pricing information in Table 3: Supply Items Needing Specialty Input for Pricing and Table 4: Equipment Items Needing Specialty Input for Pricing. In our CY 2007 PFS proposed rule, we listed both supply and equipment items for which pricing documentation was needed from the medical specialty societies and, for many of these items, we received sufficient documentation in the form of catalog listings, vendor Web sites, invoices, and manufacturer quotes. We have accepted the documented prices for many of these items and these prices are reflected in the PE RVUs in Addendum B of this final rule with comment period. For the items listed in Tables 3 and 4, we are requesting that commenters provide pricing information on items in these tables along with acceptable documentation, as noted in the footnote to each table, to support recommended prices.

In Tables 5 and 6, we have listed new supplies and equipment from the new CPT codes for CY 2007 that are discussed elsewhere in this final rule with comment period. These items have been added to the PE database and, where priced, are reflected in the PE RVUs in Addendum B.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.004" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.005" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.006" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

Equip code Supply description Unit Unit price *CPT code(s) associated with item Supply category
NA Agent, embolic1 Vial 37210 Accessory, Procedure.
NA Bolster covers, disposable Item 0.06 96904 Gown, drape.
NA Filter, mouthpiece Unit 4.6 95012 Infection control.
NA Gas, argon Cu ft 0.25 19105 Accessory, Procedure.
NA Kit, capsule, ESO, endoscopy w-application Kit 450 91111 Kit, Pack, Tray.
NA Kit, gold markers, fiducial, 3 per kit Kit 119 55876 Kit, Pack, Tray.
NA Probe, cryoablation, (Viscia ICE 30 or 40) Item 1589 19105 Accessory, Procedure.
*CPT codes and descriptions only are copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS77373y.
1. Price verification needed. Item(s) added to table of equipment requiring specialty input.

Equip code Equipment description Life Unit price *CPT code(s) associated with item Equipment category
NA AV projection system (integrated headphone, video goggles, transducer, control unit w-remote-Cinema Vision) 5 3800 70554 IMAGING EQUIP.
NA camera mount-floor2 15 1 2300 96904 OTHER EQUIPMENT.
NA cross slide attachment2 10 1 500 96904 OTHER EQUIPMENT .
NA cryoablation system, fibroadenoma 3 24950 19105 OTHER EQUIPMENT.
NA dermal imaging software2 5 1 4500 96904 OTHER EQUIPMENT.
NA dermoscopy attachments2 5 1 650 96904 OTHER EQUIPMENT.
NA Gammaknife 7 3870000 77371 IMAGING EQUIP.
NA generator, spine, IDET, w-extension 5 28299 22526 22527 OTHER EQUIPMENT.
NA genetic counseling, pedigree, software2 5 96040 DOCUMENTATION.
NA image-acquisition software and hardware (Brainwave RealTime, PA, Hardware) 3 108807 70554 IMAGING EQUIP.
NA lens, macro, 35-70 mm2 5 96904 OTHER EQUIPMENT.
NA monitoring system, nitric oxide w-computer (Acerine, NIOX) 5 39200 95012 OTHER EQUIPMENT.
NA radioactive source3 77371 IMAGING EQUIP.
NA speakers, sound field (brainstem implant) 5 1775 92640 OTHER EQUIPMENT.
NA SRS system, Lincac 7 4350000 77372 IMAGING EQUIP.
NA SRS system, SBRT, six-systems, average 7 4000000 77373 IMAGING EQUIP.
NA strobe, 400 watts (Studio)(2)2 10 1 1500 96904 OTHER EQUIPMENT.
*CPT codes and descriptions only are copyright 2007 American Medical Association. All Rights Reserved. Applicable FARS/DFARS77373y.
1. Prices interim for CY 2007-Acceptable documentation required for price verification.
2. Price verification needed. Item(s) added to table of equipment requiring specialty input.
3. Discussion with CMS necessary to establish appropriate value.

B. Geographic Practice Cost Indices (GPCIs)

Section 1848(e)(1)(A) of the Act requires us to develop separate GPCIs to measure resource cost differences among localities compared to the national average for each of the three fee schedule components. While requiring that the PE and malpractice GPCIs reflect the full relative cost differences, section 1848(e)(1)(A)(iii) of the Act requires that the physician work GPCIs reflect only one-quarter of the relative cost differences compared to the national average.

Section 1848(e)(1)(C) of the Act requires us, in consultation with appropriate physician representatives, to review the GPCIs at least every 3 years and allows us to make adjustments based on our review. This section of the Act also requires us to phase-in the adjustment over 2 years, implementing only one-half of any adjustment in the first year if more than 1 year has elapsed since the last GPCI revision. CMS is currently working with Acumen, LLC to review and revise the GPCIs in accordance with the requirement that GPCIs be revised at least every 3 years. We expect to implement any revisions based on our review in January 2008.

In addition, section 412 of the MMA amended section 1848(e)(1) of the Act to establish a floor of 1.0 for the work GPCI for any locality where the GPCI would otherwise fall below 1.0 for purposes of payment for services furnished on or after January 1, 2004 and before January 1, 2007. Beginning on January 1, 2007, the 1.00 floor will be removed and the work GPCI will revert to the fully implemented value. The values for the work GPCI and subsequent changes to the geographic adjustment factor (GAF) published in the CY 2007 PFS proposed rule reflect the removal of the 1.0 floor. For many payment localities, this change had no impact on the GAF; however, the GAFs for a number of payment localities were reduced due to this change. The impact of this change on the GAFs for those payment localities was shown in Table 3 of the CY 2007 PFS proposed rule (71 FR 48993).

In the CY 2007 PFS proposed rule, we also published the proposed GPCIs for 2007 in Addendum D and the proposed GAFs for 2007 in Addendum E (71 FR 49246 through 49249). The GPCIs shown in Addendum D represent the fully implemented value and reflect 2007 BN scaling coefficients provided by our Office of the Actuary.

In the CY 2005 PFS proposed rule, we discussed issues relating to changes to the GPCI payment localities (69 FR 47504). In that proposed rule, we noted that we look for the support of a State medical society as the impetus for changes to existing payment localities. Because the GPCIs for each locality are calculated using the average of the county-specific data from all of the counties in the locality, removing high cost counties from a locality will result in lower GPCIs for the remaining counties. Therefore, because of this redistributive impact, we have refrained, in the past, from making changes to payment localities unless the State medical association provides evidence that any proposed change has statewide support.

We requested suggestions on alternative ways that we could administratively reconfigure payment localities that could be developed and proposed in future rulemaking. In addition, MEDPAC and the General Accounting Office (GAO) have both expressed interest in studying the physician payment localities. We intend to work with both groups to study our current methodology and develop alternative options.

We received the following comments in response to our GPCI proposals.

Comment: During the comment period, commenters advised us of two errors in Table 3 (there were two entries for Kansas and there was a mistake in the equation for calculating the GAF). We were also advised of typographical errors in Addendum D.

Response: We appreciate that these were brought to our attention. Table 7 contains the corrected information and we have corrected Addendum D in this final rule.

Locality name 2006 GAF 2007 GAF Percent change
Fort Worth, TX 0.998 0.996 -0.17
Rest of Michigan 0.986 0.984 -0.20
Rest of New York 0.952 0.950 -0.21
Rest of Maryland 0.982 0.978 -0.36
Metropolitan St. Louis, MO 0.978 0.974 -0.41
Rest of Pennsylvania 0.950 0.946 -0.44
Ohio 0.970 0.966 -0.44
Austin, TX 1.020 1.015 -0.47
New Hampshire 1.010 1.005 -0.50
Minnesota 0.980 0.975 -0.53
Galveston, TX 0.991 0.986 -0.54
Metropolitan Kansas City, MO 0.987 0.981 -0.56
Fort Lauderdale, FL 1.022 1.016 -0.59
Arizona 0.999 0.993 -0.65
Wisconsin 0.956 0.950 -0.65
Colorado 0.998 0.991 -0.67
East St. Louis, IL 1.003 0.996 -0.68
New Orleans, LA 0.984 0.977 -0.73
Rest of Washington 0.984 0.976 -0.77
Indiana 0.937 0.930 -0.79
Beaumont, TX 0.951 0.942 -0.96
Alabama 0.923 0.914 -0.99
Virginia 0.958 0.948 -1.06
Southern Maine 0.992 0.981 -1.09
Rest of Georgia 0.943 0.932 -1.14
Tennessee 0.933 0.921 -1.27
Utah 0.960 0.948 -1.30
South Carolina 0.930 0.917 -1.41
Rest of Illinois 0.952 0.938 -1.43
Rest of Florida 0.982 0.968 -1.45
West Virginia 0.942 0.928 -1.47
North Carolina 0.951 0.936 -1.55
New Mexico 0.947 0.932 -1.57
Rest of Louisiana 0.936 0.919 -1.78
Kentucky 0.932 0.915 -1.80
Kansas* 0.936 0.919 -1.81
Rest of Oregon 0.946 0.929 -1.81
Vermont 0.968 0.950 -1.82
Virgin Islands 1.007 0.989 -1.83
Rest of Texas 0.947 0.929 -1.87
Idaho 0.922 0.904 -1.91
Iowa 0.927 0.909 -1.97
Rest of Maine 0.936 0.916 -2.14
Oklahoma 0.913 0.893 -2.14
Mississippi 0.919 0.898 -2.31
Arkansas 0.905 0.884 -2.34
Puerto Rico 0.905 0.883 -2.44
Nebraska 0.925 0.902 -2.44
Wyoming 0.934 0.910 -2.55
Montana 0.928 0.902 -2.83
Rest of Missouri* 0.910 0.883 -2.97
North Dakota 0.924 0.895 -3.16
South Dakota 0.922 0.891 -3.35
1 Calculation for the GAF: (0.52466*work gpci) + (0.03865*mp gpci) + (0.43669*pe gpci)

Comment: We received several comments indicating that the GPCIs for Puerto Rico are inadequate because they do not take into consideration the higher costs of living in Puerto Rico. Commenters are concerned that physicians in Puerto Rico will relocate to areas with higher GPCIs. Their comments focused on suggested revisions to the data used in calculating the GPCIs for Puerto Rico with the intent of raising the GPCI for Puerto Rico.

Response: We want to ensure that beneficiaries have access to high quality care in all parts of the United States; however, we do not use relative costs of living in the calculation of the GPCIs as the commenters are requesting. Relative costs of living among payment localities are already accounted for within other measures of relative resource cost that we use in calculating GPCIs, and we do not believe it would be appropriate to use different measures of resource cost for some localities than are used for others.

Comment: We received numerous comments reflecting concerns about the negative impact on physician payments resulting from removal of the MMA-mandated floor of 1.0 on the physician work GPCI. Comments also stated that GPCIs should not be applied to physician work as a general policy.

Response: The 1.000 floor is being removed for services furnished after December 31, 2006, because the MMA provision established the floor only for services furnished on or after January 1, 2004, and before January 1, 2007. We do not have the legal authority to extend application of the floor beyond the statutory timeframe. In addition, application of GPCIs to the work RVUs is required by the statute.

Comment: We received numerous comments requesting that we administratively change the relative values for codes that have a TC and a PC. The focus of the comments was that for many codes the TC has a higher malpractice relative value than the PC. A suggestion was made that we administratively change the TC RVU to equal the PC RVU.

Response: The commenters are suggesting a change in methodology for calculating the malpractice RVUs. We did not make any proposals relating to this methodology; therefore, comments relating to malpractice RVU policy are outside the scope of this rule. We appreciate the commenters' suggestions, and if we were to propose changes to malpractice RVU policy, we would consider the commenters' suggestions in future rulemaking.

Comment: Commenters indicated that they were troubled about the data used in developing the GPCIs. Specifically, the proxy categories used in the wage determination and the real estate data used in the rent portion of the PE GPCI are of the greatest concern. They stated that our data do not reflect true costs and, therefore, put many practitioners in rural areas at a disadvantage and create inequities between payment localities.

Response: We have previously addressed the issue of rental data in the CY 2005 PFS final rule (69 FR 66261). We stated that the Department of Housing and Urban Development (HUD) rental data may be the subject of concern, but we believe it remains the best data source to fulfill our requirements that the data be available for all areas, be updated annually, and retain consistency area-to-area and year-to-year. In that same rule, we discussed our belief that the wage proxies we use are the best tools available for the development of the GPCIs. However, we will consider the possibility of using different wage proxies or wage data sources for some future update of the GPCIs.

C. Medicare Telehealth Services

As discussed in the CY 2007 PFS proposed rule (71 FR 48994), section 1834(m)(4)(F) of the Act defines telehealth services as professional consultations, office visits, and office psychiatry services (identified as of July 1, 2000 by CPT codes 99241 through 99275, 99201 through 99215, 90804 through 90809, and 90862) and any additional service specified by the Secretary. In addition, the statute requires us to establish a process for adding services to or deleting services from the list of telehealth services on an annual basis.

In the December 31, 2002 Federal Register (67 FR 79988), we established a process for adding services to or deleting services from the list of Medicare telehealth services. This process provides the public an ongoing opportunity to submit requests for adding services. We assign any request to make additions to the list of Medicare telehealth services to one of the following categories:

Category #1: Services that are similar to office and other outpatient visits, consultation, and office psychiatry services. In reviewing these requests, we look for similarities between the proposed and existing telehealth services for the roles of, and interactions among, the beneficiary, the physician (or other practitioner) at the distant site and, if necessary, the telepresenter. We also look for similarities in the telecommunications system used to deliver the proposed service, for example, the use of interactive audio and video equipment.

Category #2: Services that are not similar to the current list of telehealth services. Our review of these requests includes an assessment of whether the use of a telecommunications system to deliver the service produces similar diagnostic findings or therapeutic interventions as compared with the face-to-face "hands on" delivery of the same service. Requestors should submit evidence showing that the use of a telecommunications system does not affect the diagnosis or treatment plan as compared to a face-to-face delivery of the requested service.

Since establishing the process, we have added the following to the list of Medicare telehealth services: Psychiatric diagnostic interview examination; ESRD services with two to three visits per month and four or more visits per month (although we require at least one visit a month by a physician, CNS, NP, or PA to examine the vascular access site); and individual medical nutritional therapy.

Requests to add services to the list of Medicare telehealth services must be submitted and received no later than December 31 of each CY to be considered for the next proposed rule. For example, requests submitted before the end of CY 2005 are considered for the CY 2007 proposed rule. For more information on submitting a request for an addition to the list of Medicare telehealth services, visit our Web site at http://www.cms.hhs.gov/telehealth.

We received the following requests for additional approved services in CY 2005: Nursing facility care; speech language pathology; audiology; and physical therapy services.

After reviewing the public requests, we explained that section 1834(m)(4)(C)(ii) of the Act defines a telehealth originating site as a physician's or practitioner's office; or a hospital, critical access hospital (CAH), rural health clinic, or Federally qualified health center (FQHC). SNFs are not defined in the statute as originating sites. The authority to allow SNFs to serve as telehealth originating sites is dependent upon HHS submitting the Report to Congress on permitting a SNF to be an originating site (as required by the section 418 of the MMA) and the Secretary concluding in the Report that it is advisable to include a SNF as a Medicare telehealth originating site and that mechanisms could be established to ensure that use of a telecommunications system does not serve as a substitute for the required in-person physician or practitioner visits to SNF residents.

As discussed in the CY 2007 PFS proposed rule, given that SNFs are not defined in the statute as a telehealth originating site and HHS is currently reviewing the Report to Congress, it would not be appropriate to approve nursing facility care for telehealth at this time.

In addition, we explained that the statute permits only a physician, as defined by section 1861(r) of the Act or a practitioner as described in section 1842(b)(18)(C) of the Act (CNS, NP, PA, nurse midwife, clinical psychologist, clinical social worker, registered dietitian or other nutrition professional), to furnish Medicare telehealth services. Since speech language pathologists, audiologists and physical therapists are not permitted under the statute to provide and receive payment for Medicare telehealth services at the distant site, we could not fully consider the request to add speech therapy, audiology services and physical therapy to the list of Medicare telehealth services (71 FR 48994).

We received the following comments on the Medicare telehealth services.

Comment: Some commenters stated that the process for adding services to the list of Medicare telehealth services does not require an originating site to be approved prior to the approval of a service for telehealth (and mentioned that we previously approved ESRD-related visits furnished under the monthly capitation payment (MCP) for telehealth without the approval of a dialysis center as an originating site). The commenters believe that approving nursing facility services for telehealth is mutually exclusive from the Report to Congress on permitting a SNF to be a Medicare telehealth originating site and that the findings of the report are not necessary to approve services for telehealth. Moreover, the commenters requested that we approve nursing facility care for telehealth (initial nursing facility care, subsequent nursing facility care, nursing facility discharge services and other nursing facility services) prior to the completion of the Report to Congress on permitting a SNF to be an originating site.

Response: As previously discussed in this section, the MMA specifically requires an evaluation of SNFs as potential originating sites for the furnishing of telehealth services, and a Report to Congress on such evaluation. The law provides the authority to add SNFs as an originating site if the Secretary concludes in the report that it is advisable to do so, and that mechanisms could be established to ensure that the use of telehealth does not substitute for the required in-person physician or practitioner visits to SNF residents (which could have significant implications for the type of services we would approve for telehealth). As such, we believe that a decision to add (or not add) nursing facility care to the list of Medicare telehealth services is related to the conclusions reached in the Report to Congress on permitting a SNF to serve as an originating site. Given that the conclusions of the Report to Congress are not final, we do not believe that it would be appropriate to consider the request to add nursing facility care to the list of Medicare telehealth services at this time. We intend to review and consider the recommendations of the Report to Congress once it is issued and would address the request to approve nursing facility care for telehealth in future rulemaking.

Comment: One commenter expressed support for expanding telehealth services and for allowing SNFs to serve as a telehealth originating site.

Response: We appreciate the comment on the use of SNFs as telehealth originating sites. As discussed earlier in this section, the Report to Congress that could permit an SNF to serve as an originating site is currently under review within HHS. We expect to address this issue in future rulemaking after the Report to Congress is issued.

Comment: Two commenters requested clarification on whether the public would need to resubmit a request to approve nursing facility care for telehealth if it is determined that SNFs could be added as an originating site.

Response: After the Report to Congress is issued regarding SNFs as a telehealth originating site, we will address the requests to approve nursing facility care for telehealth and discuss our review through future rulemaking. It would not be necessary to resubmit a request to approve nursing facility care for telehealth.

Comment: Commenters stated that we added medical nutritional therapy (MNT) to the list of telehealth services in the CY 2006 PFS rule without nutrition professionals being authorized to furnish telehealth services. The commenters note that physical therapists, audiologists, and speech language pathologists currently cannot furnish Medicare telehealth services and requested an explanation as to why we cannot also consider approving audiology, speech language pathology, and physical therapy services for telehealth.

Response: The statute permits a physician, as defined by section 1861(r) of the Act or a practitioner as described in section 1842(b)(18)(C) of the Act (that is, CNS, NP, PA, nurse midwife, clinical psychologist, clinical social worker, registered dietitian or other nutrition professional), to furnish Medicare telehealth services. Registered dietitians or nutrition professionals are included in the statutory definition of practitioner under section 1842(c)(18)(C)(vi), and thus, are permitted under the statute to furnish telehealth services (and are the only practitioners permitted by the statute to furnish MNT). As such, when approving individual MNT for telehealth, registered dietitians and nutrition professionals as defined in § 410.134 were added to the list of practitioners that may furnish and receive payment for a telehealth service in the CY 2006 PFS final rule with comment period (70 FR 70160).

In contrast, speech language pathologists, audiologists and physical therapists are not permitted under the statute to provide and receive payment for Medicare telehealth services at the distant site. Therefore, we do not believe it would be appropriate to consider adding audiology, speech language pathology, and physical therapy services for telehealth.

Comment: Two commenters requested that we provide clarification on when the telehealth Report to Congress, as required by section 223(d) of the BIPA, would be completed and submitted to Congress. Another commenter urged us to expedite the completion of the telehealth report (as required by the BIPA).

Response: The Report to Congress on additional sites and settings, practitioners, and geographic areas that may be appropriate for Medicare telehealth payment, as required by section 223(d) of the BIPA, is under development. We will work to expedite the completion of this report.

D. Miscellaneous Coding Issues

The following sections address specific coding issues related to payment for services under the PFS.

1. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

CPT code 77783, Remote afterloading high intensity brachytherapy; 9-12 source positions or catheters, resides in a family of codes with varying numbers of source positions. All of the codes in the family, CPT codes 77781 through 77784, are currently designated as 90-day global services. CPT codes 77781 through 77784 are used to treat many clinical conditions, but primarily patients with prostate cancer, breast cancer and sarcoma. Patients with any of these conditions usually receive several treatments (2 through 10) over a 2 to 10-day period of time. Due to the increasing variability in treatment regimens, it is difficult to assign RVUs for a "typical" patient based on a global period of 90 days.

Therefore, we proposed that this family of codes (CPT codes 77781, 77782, 77783 and 77784) be assigned a global period of "XXX", which will permit separate payment each time the services are provided and allow payment to be based on the actual service(s) provided. We will request that the RUC revalue the work RVUs and the PE inputs for these services if a change in the global period is finalized. However we proposed, on an interim basis, to revise the work RVUs and PE inputs to reflect the removal of the postoperative visit, CPT code 99212 that is currently assigned to these services. The interim work RVUs for these services are as follows:

• CPT code 77781 = 1.21

• CPT code 77782 = 2.04

• CPT code 77783 = 3.27

• CPT code 77784 = 5.15

We proposed to delete the registered nurse (RN) time in the postservice period, as well as the patient gowns for the postservice visit. We also noted that, to the extent that these services are performed as staged procedures, providers may make use of applicable modifiers.

We received the following comments on these coding issues.

Comment: Many commenters concurred with our proposal. However, some commenters wanted either a reconsideration of the proposed work RVU reduction, or if needed, a reduction in the CF. One commenter agreed with the global period revision but recommended establishment of a threshold for brachytherapy codes at a maximum of 10 percent per year. Another commenter concurred with the change in the global period; however, the commenter recommended no change in the work RVUs or a reduction to the 1992 levels, and prior to any work RVU changes it was recommended that such changes be reviewed by the RUC. In addition, the RUC, in its comments, agreed to include a review of the brachytherapy codes on its April 2007 meeting agenda and several commenters expressed an interest in working with the RUC on the work RVUs and PE inputs.

Response: We believe that the commenters misunderstood the intent of the proposed work RVU reductions. They are designed to allow the billing of the brachytherapy physician service codes on a more frequent basis than is currently permitted, and are reflective of the present course of treatment regimens. The current codes have a 90-day global period and are to be billed only once for the entirety of physician services provided during the specified time period.

Comment: Some commenters expressed concern that the PE inputs for the brachytherapy codes should not be reduced to reflect the removal of a post-operative visit because there is no visit.

Response: A post-operative visit is included within the current PE inputs for the current 90-day global period brachytherapy codes. The change to a global period of "XXX" necessitates the removal of this visit from the PE inputs because the codes could be billed several times during a course of treatment, and each occurrence would not include a post-operative visit.

The brachytherapy family of codes (CPT codes 77781, 77782, 77783 and 77784) will be assigned a global period of "XXX", which will permit separate payment each time the services are provided and allow payment to be based on the actual service(s) provided. Because of the change in the global period a request will be made to the RUC for a revaluation of the work RVUs and the PE inputs for these services. On an interim basis the work RVUs and the PE inputs will be revised as delineated in the proposed rule. In addition, the RN time in the postservice period, as well as the patient gowns for the postservice visit will be deleted from the PE database as proposed.

Separate payment will be made for medically necessary post-therapy visits based on the documented level of E/M service for the post procedure encounter(s).

We also note that appropriate modifiers are to be used when these services are performed as staged procedures.

2. Assignment of RVUs for Proton Beam Treatment Delivery Services

As discussed in the CY 2006 PFS proposed rule, we have received a request to assign PE inputs for the non-facility setting to Proton Beam treatment delivery services represented by CPT codes 77520 through 77525. These services are currently carrier-priced; therefore, payment in the facility or non-facility setting is established by each carrier. To the extent that physicians and suppliers wish to have national RVUs assigned for these services, we encourage them to use the established process at the AMA-RUC.

Comment: We received several comments in response to this discussion. Two commenters stated that due to the relatively limited availability of these services in freestanding environments given the small number of proton therapy centers at this point in time, these services should remain carrier priced. However, one commenter indicated that allowances established by carriers do not appear to account for capital and operating costs. This commenter referenced payment amounts proposed for hospital OPDs under the Outpatient Prospective Payment System (OPPS), and urged us to provide guidance to carriers in establishing appropriate payment for these services under the PFS.

Other commenters suggested that RVUs should be established for these services. Many of these commenters expressed agreement with the payment rate for these services under OPPS. These commenters were concerned that since each State has its own CMS-contracted carrier, variations exist in proton therapy coverage and reimbursement under the PFS. These commenters requested that we provide payment rates for carriers to use when these services are furnished in freestanding centers so that payments are consistent with payment rates under OPPS.

We also received comments from the AMA-RUC and ASTRO regarding this discussion. The RUC reiterated the process that is used to develop RVUs and ASTRO indicated it would be willing to participate in the development of RVUs for these services.

Response: As discussed in the CY 2006 PFS proposed rule, at the present time payment for these services is established at the carrier level. The carriers have discretion to establish payment using available information about these services. Should providers wish to have RVUs established for these services, we would request that they use the AMA-RUC process that has been established for recommending RVUs and direct PE inputs used to compute national RVUs for PFS services to CMS.

E. Deficit Reduction Act (DRA)

The Deficit Reduction Act of 2005 (DRA) (Pub. L. 109-171), was enacted February 8, 2006 and included provisions that affect the Medicare program. The following section addresses the specific DRA provisions that were addressed in the CY 2007 PFS proposed rule (71 FR 48996).

1. Section 5102-Adjustments for Payments to Imaging Services

Section 5102 of the DRA includes two provisions that affect payments of imaging services under the Medicare PFS. The first provision addresses payment for certain multiple imaging procedures for CY 2007 and application of BN while the second provision addresses limiting the payment amount under PFS to the OPD payment amount for the TC of certain imaging services.

a. Payment for Multiple Imaging Procedures for 2007

In general, Medicare prices diagnostic imaging procedures in the following three ways:

• The PC represents the physician's interpretation (PC-only services are billed with the 26 modifier).

• The TC represents PE and includes clinical staff, supplies, and equipment (TC-only services are billed with the TC modifier).

• The global service represents both PC and TC.

As discussed in the CY 2006 PFS final rule with comment period (70 FR 70261), in the CY 2006 PFS proposed rule (70 FR 45764 through 46064), we had proposed to reduce payment for the TC of selected diagnostic imaging procedures belonging to one of eleven imaging families when the procedures are performed on contiguous body areas by 50 percent for CY 2006. However, in the final rule with comment period, we stated that we would phase-in the 50 percent reduction over 2 years beginning with a 25 percent reduction in 2006. We also sought additional data and comments on the appropriateness of 50 percent as the final level of reduction. The reduction applies to the TC and the technical portion of the global service, but does not apply to the PC of the service. Currently, we make full payment for the highest priced procedure and reduce payment for each additional procedure by 25 percent, when more than one procedure from the same imaging family is performed during the same session on the same day.

As described in the CY 2006 PFS final rule with comment period, at the time, the statute required us to make changes such as this in a budget neutral manner, meaning that the estimated savings generated by the application of the multiple imaging procedure payment reduction were used to increase payment for other physician fee schedule services. We increased the CY 2006 PE RVUs by 0.3 percent to offset the estimated savings generated by the multiple imaging payment reduction policy.

Subsequent to the publication of the CY 2006 PFS final rule with comment period, section 5102(a) of the DRA (Multiple Procedure Payment Reduction for Imaging Exempted From Budget Neutrality), required that "effective for fee schedules established beginning with 2007, reduced expenditures attributable to the multiple procedure payment reduction for imaging under the CY 2006 PFS final rule with comment period (42 CFR 405, et al.) insofar as it relates to the PFSs for 2006 and 2007" are exempted from the BN provision. As a result, we proposed to remove the 0.3 percent increase to the CY 2006 PE RVUs from the CY 2007 PE RVUs in accordance with the statute.

In addition, in response to our request for data on the appropriateness of the 50 percent reduction in the CY 2006 PFS final rule with comment period (70 FR 70261), the ACR provided information for 25 code combinations supporting a reduction of between 21 and 44 percent. Given the expected interaction between the multiple procedure imaging policy and the further imaging payment reductions mandated by section 5102(b) of the DRA, along with the new information we have received from the ACR on the multiple imaging procedure policy as it applies to common combinations of imaging services, we believe it would be prudent to maintain the multiple imaging payment reduction at its current 25 percent level while we continue to examine the appropriate payment levels. Therefore, we proposed to continue the multiple imaging payment reduction for CY 2007 at the 25 percent level. We would proceed through future rulemaking in the event we determine that revisions to the policy are warranted.

b. Reduction in TC for Imaging Services Under the PFS to OPD Payment Amount

Section 5102(b)(1) of the DRA amended section 1848 of the Act and requires that, for imaging services, if-

"(i) The technical component (including the technical component portion of a global fee) of the service established for a year under the fee schedule * * * without application of the geographic adjustment factor * * *, exceeds

(ii) The Medicare OPD fee schedule amount established under the prospective payment system for hospital outpatient department services * * * for such service for such year, determined without regard to geographic adjustment * * *,the Secretary shall substitute the amount described in clause (ii), adjusted by the geographic adjustment factor [under the PFS] * * *, for the fee schedule amount for such technical component for such year."

As required by the statute, for imaging services (described below in this section) furnished on or after January 1, 2007, we will cap the TC of the PFS payment amount for the year (prior to geographic adjustment) by the CY 2007 OPPS payment amount (prior to geographic adjustment). We will then apply the PFS geographic adjustment to the capped payment amount.

Section 5102(b)(2) of the DRA exempts the estimated savings from this provision from the PFS BN requirement. Section 5102(b)(1) of the DRA defines imaging services as "* * * imaging and computer-assisted imaging services, including X-ray, ultrasound (including echocardiography), nuclear medicine (including positron emission tomography), MRI, CT, and fluoroscopy, but excluding diagnostic and screening mammography."

To apply section 5102(b) of the DRA, we needed to determine the CPT and alpha-numeric HCPCS codes that fall within the scope of "imaging services" defined by the DRA provision. In general, we believe that imaging services provide visual information regarding areas of the body that are not normally visible, thereby assisting in the diagnosis or treatment of illness or injury. We began by considering the CPT 7XXXX series codes for radiology services and then adding in other CPT codes and alpha-numeric HCPCS codes that describe imaging services. We then excluded nuclear medicine services that were either non-imaging diagnostic or treatment services. We also excluded all codes for unlisted procedures, since we would not know in advance of any specific clinical scenario whether or not the unlisted procedure was an imaging service. We excluded all mammography services, consistent with the statute. We excluded radiation oncology services that were not imaging or computer-assisted imaging services. We also excluded all HCPCS codes for imaging services that are not separately paid under the OPPS since there would be no corresponding OPPS payment to serve as a TC cap. We excluded any service where the CPT code describes a procedure for which fluoroscopy, ultrasound, or another imaging modality is either included in the code whether or not it is used or is employed peripherally in the performance of the main procedure, for example, CPT code 31622 for bronchoscopy with or without fluoroscopic guidance and CPT code 43242 for upper gastrointestinal endoscopy with transendoscopic ultrasound-guided intramural or transmural fine needle aspiration/biopsy(s). In these cases, we are unable to clearly distinguish imaging from non-imaging services because, for example, a specific procedure may or may not utilize an imaging modality, or the use of an imaging technology cannot be segregated from the performance of the main procedure. Note that we included carrier priced services since these services are within the statutory definition of imaging services and are also within the statutory definition of PFS services (that is, carrier-priced TCs of PET scans).

A list of proposed codes that identify imaging services defined by the DRA OPPS cap provision was found in Addendum F of the proposed rule.

To the extent changes are made to codes for services already on the list, we proposed to update the list through program instructions to our contractors. To the extent that the same imaging service is coded differently under the PFS and the OPPS, we proposed to crosswalk the code under the PFS to the appropriate code under the OPPS that could be reported for the same service provided in the hospital outpatient setting. These crosswalks are listed in Table 8.

MFS Code Descriptor OPPS Code Desc
74185 Mri angio, abdom w or w/o dye C8900 MRA w/cont, abd.
76093 * Magnetic image, breast C8905 MRI w/o fol w/cont, brst, un.
76094 * Magnetic image, both breasts C8908 MRI w/o fol w/cont, breast.
71555 Mri angio chest w or w/o dye C8909 MRA w/cont, chest.
73725 Mr ang lwr ext w or w/o dye C8912 MRA w/cont, lwr ext.
72198 Mr angio pelvis w/o w/dye C8918 MRA w/cont, pelvis.
* Note: These codes have been renumbered for CY 2007. New code number is reflected in Addendum F.

c. Interaction of the Multiple Imaging Payment Reduction and the OPPS Cap

For CY 2007 imaging services potentially subject to both the multiple imaging reduction and the OPPS cap, we proposed to first apply the multiple imaging payment reduction and then apply the OPPS cap to the reduced amount as illustrated in Table 9.

HCPCS Pre-OPPS cap MPFS rate 25% Multiple imaging reduction OPPS cap rate Final MPFS payment
7XXX1 $341.89 $256.42 $316.55 $256.42
7XXX2 552.86 414.65 391.83 391.83

We considered first applying the OPPS cap and then applying the multiple procedure reduction. However, as indicated in the CY 2006 OPPS final rule, we received public comments suggesting that the OPPS payment rates may implicitly include at least some multiple imaging discount. While we continue to examine this issue, we believe the most appropriate policy is to apply the multiple imaging payment reduction prior to the application of the OPPS cap.

i. OPPS Cap

Comment: Many commenters criticized the OPPS cap, maintaining that OPPS rate was never intended to reflect the cost of providing individual physicians' services. They indicated that it is methodologically unjustifiable, and that it undermines the resource-based system.

One commenter noted that physician costs are determined on a per procedure basis, whereas hospital costs are not determined on a per procedure basis because expensive capital equipment is allocated over other procedures within a revenue center. Given this methodological difference, the commenter indicated that it is not surprising that the cost of a procedure under the PFS is greater than under OPPS. Another commenter noted that we need to recognize that the delivery of care has shifted from the hospital to physicians' offices; that there is an increased complexity of care; and the need to practice defensive medicine due to the threat of malpractice lawsuits. One commenter noted that hospital and IDTF payments should not be the same.

Various commenters indicated that the cap will have a devastating impact and threatens the future viability of outpatient imaging. Commenters predicted that the consequences will include:

• Reduced patient access to diagnostic technologies capable of preventing the onset of more serious conditions, requiring more complex and expensive treatment later.

• Shifting of procedures back to hospitals.

• Increased volume to offset the affects of the payment cuts.

• Conversion of IDTFs ownership and legal structure to allow billing under OPPS, negating any savings from the cap.

A few commenters requested a delay in implementing the cap and requested that we consider co-sponsoring H.R.5704 that calls for a 2-year moratorium on imaging cuts.

Response: We acknowledge the commenters concerns and appreciate their comments. However, we are obligated to implement the statutory provision. We will continue to work with the Congress and specialty societies to ensure equitable payments and proper access to care.

Comment: Several commenters requested that the following procedure codes be excluded from the OPPS cap:

• Non-invasive vascular diagnostic study codes (CPT codes 93875-93990 and G0365) because they either contain no imaging or are predominately non-imaging in nature. Particularly noted were transcranial Doppler procedures and duplex scans.

• Imaging guidance procedures that are integral to the performance of interventional treatment or diagnostic procedures. CPT codes cited were: 75894, 75896, 75901-75945, 75952, 75954, 75962, 75966, 75970, 75989-75996, 76940-76948 and 76965.

• Nuclear medicine codes 78020, 78135, 78140, 78190, and 78282, based on the fact that other nuclear medicine codes, such as radioisotope lab codes were excluded.

• Codes performed in conjunction with radiation therapy (CPT codes 76370, 76950, 76965, 77417, and 77421) because they are never performed for diagnostic purposes. The commenters were pleased that we excluded radiation oncology codes.

• Positron Emission Tomography (PET), PET/ CT, and CT/Computed Tomographic Angiography (CTA) and Category III codes used to report emerging technologies because they are carrier-priced codes and, therefore, not paid under the PFS.

• Codes for imaging service that are not separately paid under OPPS since there is no corresponding OPPS payment to serve as a TC cap. Codes cited were cardiac catheterization codes 93555 and 93556 and code 0152T.

Additionally, several commenters proposed the following definition of medical imaging procedures for the purpose of the DRA provision: "Medical imaging uses noninvasive techniques to view all parts of the body and thereby diagnose an array of medical conditions. These techniques include the use of ionizing radiation (X-rays and CT scans), MRI, ultrasound and scans obtained after the injection of radio nucleotides (such as bone scans and PET)."

Response: The DRA defines imaging service subject to the OPPS cap as "imaging and computer-assisted imaging services, including x-ray, ultrasound (including echocardiography), nuclear medicine, (including positron emission tomography [PET], magnetic resonance imaging [MRI], computed tomography [CT], and fluoroscopy, but excluding diagnostic and screening mammography." The DRA does not distinguish between diagnostic and therapeutic imaging. We have no authority to modify the statutory definition of imaging services. Therefore, we cannot exclude certain non-invasive diagnostic study procedures, imaging guidance procedures, nuclear medicine procedures, and radiation oncology imaging procedures. However, in our review of the codes in response to comments, we determined that there are certain non-invasive vascular diagnostic study codes that do not involve the generation of an image, (that is, codes 93875, 93922, 93923, 93924 and 93965.) Therefore, we are removing these codes from the list of codes subject to the OPPS cap.

Additionally, we note that imaging guidance procedures that are separately billed, are appropriately included on the list of codes subject to the cap. However, codes 75952, 75954, and 75993-75996 were inadvertently included on the list. These codes do not have a TC and we are removing them from the list.

Regarding carrier-priced services, all physicians' services (as defined by the statute under section 1848(j)(3) of the Act) are paid under the PFS, regardless of how they are priced. Carrier-priced services are services for which an alternative methodology is used to arrive at TC payment under the PFS, and, therefore, they are subject to the DRA provision. The same is true of Category III codes to the extent that they are carrier-priced (and to the extent they are not carrier-priced, there is no basis to exempt these codes from application of the cap).

Regarding codes that are not separately paid under the OPPS, we agree that there is no corresponding OPPS payment to serve as a TC cap. Because these codes meet the statutory definition of procedures subject to the OPPS cap, we will retain these codes on the list of procedures subject to the cap, but payments for the procedures will not be affected by the cap.

Comment: One commenter noted that the Ambulatory Payment Classification (APC) groups are intended to set an average payment, where some lower cost procedures are paid at a higher average rate, and some higher cost procedures are paid at a lower average rate. In crosswalking from the PFS to the OPPS payment, the commenter noted that it would be more equitable to crosswalk to the median cost by CPT code, rather than using the median cost per the APC grouping payment.

One commenter requested exclusion of codes bundled under OPPS having no additional APC payment, but having a TC amount under PFS. The commenter noted that the list of bundled services under the APC payments will vary from year-to-year and it is inappropriate to not make a payment under PFS as there is no packaging of the service into another procedure. Another commenter noted that drugs and radiopharmaceuticals are bundled into some OPPS procedures. They indicated that these should be unbundled to achieve more parity in the payment systems.

Response: The DRA is specific in its requirements to compare the TC of a service for a year to the Medicare OPD fee schedule amount. Therefore, we will crosswalk the TC to the corresponding OPD fee schedule service and use that rate as a cap. For the same reason, we must use the OPD payment amount even if there are drugs or radiopharmaceuticals bundled into a particular OPD payment amount.

In regard to the concern that bundled services vary year to year, we intend to review the relevant OPD and PFS codes to determine the appropriate crosswalk for a given year. We recognize that there will be changes and we believe our process will help to ensure that TC codes are being crosswalked to the most appropriate OPD codes.

ii. Multiple Procedure Payment Reduction

Comment: Many commenters expressed appreciation for our decision to apply the multiple procedure payment reduction prior to application of the OPPS cap, and for maintaining the reduction at 25 percent. However, the commenters also indicated that the multiple procedure payment reduction is duplicative, inappropriate and excessive in light of the OPPS cap, and requested its elimination. Other commenters requested continued evaluation, indicating a 25 percent reduction is greater than what is justified by any efficiencies achieved in, performing multiple procedures. One commenter noted we had previously stated that our multiple procedure analysis does not disprove earlier assertions by physician and industry representatives that some portion of multiple procedure efficiencies may be already reflected in OPPS payment rates. Conversely, MedPAC indicated that it is unclear why the DRA OPPS cap justifies maintaining the 25 percent reduction since the DRA policy applies only to those services where the TC exceeds the OPPS rate. In addition, MedPAC requested more information on the ACR data cited in the CY 2007 PFS proposed rule (71 FR 48996).

Response: When we proposed the multiple procedure payment reduction last year, as recommended by MedPAC, our data supported a 50 percent payment reduction. However, we agreed to phase-in the reduction over two years to allow for a transition of the changes in payment for these services attributable to the reduction policy and to provide further opportunity for public comment. Subsequently, the Congress passed the DRA provision capping imaging procedures at the OPPS payment rate. In view of the DRA provision, and additional data received from ACR, we determined that it is more appropriate to retain the multiple procedure payment reduction at 25 percent, rather than to increase it to 50 percent as previously proposed. We share the concerns of the providers of imaging services that excessive reductions could be harmful to both physicians and patients. Therefore, we believe it is more appropriate to maintain the 25 percent reduction level while we continue to examine this issue.

The list of codes that identify imaging services defined by the DRA OPPS cap provision can be found in Addendum F to this final rule with comment period. Note that the list in the proposed rule was affected by the renumbering of CPT codes that is effective January 1, 2007. Addendum F in this final rule with comment period reflects the renumbering of CPT codes that is effective January 1, 2007, and also reflects the removal of certain codes in response to comments, as discussed previously in this section. Payment for an individual service on this list will only be capped if the PFS TC payment amount exceeds the OPPS payment amount.

2. Section 5107-Revisions to Payments for Therapy Services

Section 1833(g) of the Act applies an annual per beneficiary combined cap beginning January 1, 1999 on outpatient physical therapy and speech-language pathology services and a similar separate cap on outpatient occupational therapy services. These caps apply to expenses incurred for the respective therapy services under Medicare Part B, with the exception of outpatient hospital services. The caps were in effect from January 1, 1999 through December 31, 1999, from September 1, 2003 through December 7, 2003, and beginning January 1, 2006. In 2000 through 2002, and from December 8, 2003 through December 31, 2005, the Congress placed moratoria on implementation of the caps. Section 1833(g)(2) of the Act provides that, for 1999 through 2001, the caps were $1500, and for years after 2001, the caps are equal to the preceding year's cap increased by the percentage increase in the Medicare Economic Index (MEI) (except that if an increase for a year is not a multiple of $10, it is rounded to the nearest multiple of $10).

As discussed in the CY 2006 PFS proposed rule, we implemented the separate statutory limits of $1740 for outpatient physical therapy and speech-language pathology services and $1740 for occupational therapy on January 1, 2006. The DRA was enacted on February 8, 2006. Section 5107(a) of the DRA required the Secretary to develop an exceptions process for the therapy caps effective January 1, 2006. The exceptions process applies only to expenses incurred in 2006. Details of the exceptions process were published in a manual change on February 13, 2006 (CR 4364). The change request consists of three transmittals with current numbers of-

• Transmittal 855, CR 4364, Pub. L. 100-04;

• Transmittal 47, CR 4365, Pub. L. 100-02; and

• Transmittal 140, CR 4364, Pub. L. 100-08.

The transmittals are available on the CMS Web site at http://www.cms.hhs.gov/Transmittals/ .

In accordance with the statute, the therapy caps will remain in effect, but without the exceptions process, for expenses incurred beginning on January 1, 2007. The dollar amount of each therapy cap in CY 2007 will be $1780 (which is the CY 2006 rate ($1740) increased by the percentage increase in the MEI), rounded to the nearest multiple of $10. As noted previously in this section, under the statute, the exceptions process will not apply to therapy services after December 31, 2006, but the therapy caps will remain inapplicable to therapy services provided in the outpatient hospital setting as provided under section 1833(g) of the Act.

Comment: We received six comments about therapy caps. All indicated that the cap exception process was working well to assure provision of needed therapy services. Some commenters acknowledged that we do not have the authority to extend therapy cap exceptions, but they requested that we be aggressive in urging the Congress to intervene to extend the exceptions or remove the caps.

Several commenters urged us to place a high priority in resources and funding on continuing to conduct research that could be used to identify alternatives to the cap that would ensure that patients receive medically necessary therapy services. Some commenters cited the Medicare Payment Advisory Commission (MedPAC) recommendations of June 2006 regarding continued research into measuring patient condition and treatment outcomes as a basis for reforming the payment system. Commenters also mentioned the Government Accountability Office publication issued in November 2005 (GAO-06-59) recommending that DHHS "expedite development of a process for ensuring that these services were considered in its efforts to standardize existing patient assessment instruments." Specifically, the one commenter, while recognizing important priorities in allocating limited funds, strongly urged us to conduct research and pilot studies leading to alternatives to therapy caps that ensure the needs of patients are met through high quality care. Another commenter agreed and also noted strong support for development of a condition-based payment as a viable alternative to caps. We received no negative comments concerning the exception process or our efforts to develop alternative payment systems based on the patient's need for services.

Response: As commenters noted, we do not have the authority to extend the exceptions process beyond the December 31, 2006, statutory expiration date. We will continue, to the extent that resources allow, pursuing a payment policy that encourages provision of high quality, covered services to all beneficiaries who need them.

Section 5107(b) of the DRA requires the Secretary to implement edits for clinically illogical combinations of procedure codes and other edits to limit inappropriate payment for therapy services by July 1, 2006. As explained in the CY 2006 PFS proposed rule, in January 2006, we implemented Correct Coding Initiative (CCI) edits for the therapy providers that bill the fiscal intermediaries, thus, addressing the section 5107 of the DRA requirement for edits for clinically illogical combinations of procedure codes. Adoption of these code edits ensures that these providers of outpatient Part B therapy services, including SNFs, comprehensive outpatient rehabilitation facilities, certain outpatient physical therapy and speech-language therapy providers (rehabilitation agencies) and home health agencies (HHAs) (where beneficiary is not under a Part A plan of care) meet the same CCI edit requirements as those that have been in place for physicians, private practice therapists, and OPPS hospitals. We also noted that we are considering the implementation of other edits in the future to further address concerns about inappropriate payment for therapy services.

Comment: MedPAC indicated that the CCI code-pair edits we have implemented are a good start in controlling inappropriate billing, but encouraged further work and consultation with experts to develop other clinically appropriate edits for therapy services.

Response: We appreciate the MedPAC's remarks and will consider its suggestions in the implementation of future edits.

3. Section 5112-Addition of Ultrasound Screening for Abdominal Aortic Aneurysm (AAA)

a. Coverage

Section 5112 of the DRA amended section 1861 of the Act to provide for coverage under Part B of ultrasound screening for AAAs, effective for services furnished on or after January 1, 2007, subject to certain eligibility and other limitations. This screening test will be available even if the qualifying patient does not present signs or symptoms of disease or illness.

To conform the regulations to the statutory requirements of section 5112 of the DRA, we proposed to include an exception in § 411.15(a)(1) to permit coverage for ultrasound screening for AAAs that meet the conditions for coverage that we proposed to specify under new § 410.19(b) (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms). We also proposed to add a new § 411.15(k)(12).

As provided in the DRA, this new coverage allows payment for a one-time only screening examination. We proposed new § 410.19(b) to provide for the coverage of the screening examinations for AAAs as specified in section 5112 of the DRA. We also proposed to add new § 410.19(c) (Limitation on coverage of ultrasound screening for abdominal aortic aneurysms.) to provide the limitation on coverage for an individual who is not an eligible beneficiary as defined in new § 410.19(a).

We proposed the definitions set forth in new § 410.19(a) to implement the statutory provisions and to help the reader in understanding the provisions of this regulation. The definitions include the following terms:

• Eligible beneficiary.

• Ultrasound screening for abdominal aortic aneurysms.

Specifically, section 5112(a)(1) of the DRA amended section 1861 of the Act to provide that coverage of ultrasound screening for AAAs will be available for an individual: (1) Who receives a referral for such as ultrasound screening as a result of an initial preventive physical examination (IPPE) (as defined in section 1861(ww)(1) of the Act); (2) who has not been previously furnished such as ultrasound screening under this title; and (3) who has a family history of AAA or manifests risk factors included in a beneficiary category recommended for screening by the United States Preventive Services Task Force (USPSTF) regarding AAAs.

Section 5112(a)(2) of the DRA also adds a definition of the term "ultrasound screening for an Abdominal Aortic Aneurysm" to mean, "(1) a procedure using sound waves (or other procedures using alternative technologies, of commensurate accuracy and cost, that the Secretary may specify) provided for the early detection of abdominal aortic aneurysm; and (2) includes a physician's interpretation of the results of the procedure."

Based on this provision, we reviewed the 2005 USPSTF recommendations and related material on ultrasound screening for AAAs which includes-

• A recommendation for a one-time ultrasound screening for men aged 65 to 75 who have smoked at least 100 cigarettes in their lifetime;

• No recommendation for, or against, ultrasound screening for AAAs for men who have not smoked at least 100 cigarettes in their lifetime; and

• A recommendation against routine screening for AAAs in women.

Based on the statutory language and the USPSTF recommendations outlined in this section, we proposed to define the term "eligible beneficiary" for coverage of ultrasound screening examinations for AAA to mean an individual who-

• Has received a referral for an ultrasound screening as a result of an IPPE (as defined in section 1861(ww)(1) of the Act);

• Has not been previously furnished such a covered ultrasound screening examination under the Medicare program; and

• Is included in at least one of the following risk categories:

+ Has a family history of an AAA.

+ Is a man age 65 to 75 years who smoked at least 100 cigarettes in his lifetime.

+ Is an individual who manifests other risk factors that are described in a benefit category recommended by the USPSTF regarding an AAA that has been determined by the Secretary through the NCD process.

To facilitate our consideration of possible expansions of coverage in the future for identifying other risk factors in a benefit category recommended for screening for the early detection of AAAs by the USPSTF, and alternative screening technologies to ultrasound screening for AAAs of commensurate accuracy and cost, we proposed to add language to our regulations that would allow us to make determinations through the NCD process. The NCD process would allow the Secretary to expand coverage more quickly following an assessment of those subjects than is possible under the standard rulemaking process. We intend to use the NCD process, which includes an opportunity for public comments, for evaluating the medical and scientific issues relating to the coverage of alternative screening technologies and the identification of other risk factors for AAAs recommended by the USPSTF that may be brought to our attention in the future. Use of an NCD to establish a change in the scope of benefits is authorized by section 1871(a)(2) of the Act. An aggrieved party can challenge an NCD under the procedures established by section 1869(f) of the Act. We proposed to add these coverage provisions in new § 410.19 (a)(1)(i) and § 410.19(a)(2)(iii)(C).

Section 5112(b) of DRA also amended section 1861(ww)(2) of the Act (the IPPE benefit) by adding the new ultrasound screening benefit to the list of preventive services for which physicians and other qualified nonphysician practitioners (NPPs) must provide "education, counseling and referral" to new beneficiaries who take advantage of the IPPE benefit within the first 6 months after the effective date of their first Part B coverage period. Therefore, we also proposed to amend § 410.16(a)(7) of the regulations so that it reflects the additional responsibilities that physicians and qualified NPPs will have under the IPPE benefit for the new ultrasound screening benefit.

We received 14 comments that generally supported the proposal to implement section 5112 of the DRA that provides for Medicare coverage of ultrasound screening for AAAs. Several commenters had suggestions for revising certain specific coverage provisions of the proposal.

Comment: Several commenters addressed the issue of the need for certification of qualification requirements for the Medicare providers or suppliers who furnish beneficiaries with the new ultrasound screening for AAAs. A commenter referenced the USPSTF recommendations that state, "There is good evidence that abdominal ultrasonography, performed in a setting with adequate quality assurance (that is, in an accredited facility with credentialed technologists), is an accurate screening test for AAA." The commenter noted that the proposed rule did not mention the qualifications of the people performing the screening and strongly recommended that quality standards be applied to any laboratories performing this testing.

Response: Section 5112 of the DRA provides for coverage of a one-time ultrasound screening for AAAs for beneficiaries, subject to certain eligibility and other limitations. However, section 5112 does not expressly address the subject of quality standards for the providers or suppliers of these services and, therefore, in the absence of a clearly demonstrated need for quality or qualification standards that are specifically targeted to ultrasound screenings for AAAs, we do not believe it is appropriate to establish at this time such detailed standards for these services. We believe that any Medicare provider or supplier that is authorized to provide covered diagnostic ultrasound services is qualified to provide covered ultrasound screening services for AAAs. The ultrasound test is conducted in a similar manner whether the test is for a screening or diagnostic purpose. We are adding language at § 410.19(b) to reflect this condition.

Comment: Two commenters expressed concern that many beneficiaries who became entitled to Medicare Part B coverage for the first time before the IPPE benefit became effective (January 2005) will not be able to qualify for coverage of the ultrasound screenings for AAAs because of the IPPE referral requirement for the exam.

Response: The commenters are correct that the IPPE referral requirement for coverage of the ultrasound screening for AAAs will preclude many older beneficiaries from qualifying for coverage of the exam, but that requirement is specified in section 5112 of the DRA. It would require a change in the statute to permit us to expand the scope of the benefit to older beneficiaries who do not satisfy this requirement.

Comment: Several commenters suggested that we should implement safeguards against providers billing for duplicative testing for the AAA screening and an abdominal or retroperitoneal ultrasound exam (with a diagnosis such as abdominal pain) later the same or the next day.

Response: We agree that the potential for duplicative billing for the screening and the diagnostic ultrasound test of the same type does exist. Therefore, we will work with our contractors to implement the necessary safeguards to insure that this type of billing does not occur.

Comment: Several commenters are concerned that the proposed rule does not provide any guidance on the meaning of the statutory IPPE referral requirement for coverage of the AAA screening service. The commenter suggests that the term "referral" should be interpreted to include a practitioner's "direction to receive care from a qualified provider" that may be provided orally or in written form during or after the eligible beneficiary receives his or her IPPE service.

Response: Section 410.16(a)(7) (as modified in this final rule) provides that each eligible beneficiary who takes advantage of that benefit is entitled (among other things) to education, counseling, and referral, including a brief written plan such as a checklist provided to the beneficiary for obtaining appropriate screening and other preventive services that are covered as separate Medicare benefits, such as the ultrasound screening for AAAs. Based on this referral provision for the IPPE benefit, we believe there is considerable flexibility that is allowed the IPPE provider in making referrals to qualified Medicare providers of screening and other preventive services, such as the AAA screening service. However, at a minimum, we believe § 410.16(a)(7)of the IPPE regulation requires that the referral include a brief written plan provided the beneficiary for obtaining, if appropriate, the AAA screening service from a qualified Medicare provider.

Comment: Several commenters recommended that we monitor the utilization of the new AAA screening benefit over the next couple of years to determine if beneficiary access to this service is a concern that requires our efforts to ensure appropriate beneficiary awareness and utilization of the benefit.

Response: We agree that we should monitor use of this benefit to ensure that there is appropriate beneficiary awareness and use of the service.

Comment: A commenter urged us to implement a targeted campaign to educate beneficiaries and physicians about the new screening benefit and to encourage their use of it.

Response: We will release the appropriate manual and transmittal instructions and other information, including a "Medicare Learning Network (MLN) Matters" provider education article, an updated new "Medicare Preventive Services Guide," and other information. We would encourage the medical community to contribute to this effort by distributing their own communications, bulletins, or other publications to physicians, qualified NPPs, and beneficiaries.

Except for the additional language added at § 410.19(b) relating to the ability of a provider or supplier to furnish ultrasound diagnostic services, we are finalizing this section as proposed to provide for coverage of the AAA screening service for beneficiaries under the statute, subject to the statutory eligibility and other limitations.

b. Payment

Beginning January 1, 2007, we proposed to pay for ultrasound screening for AAAs through the use of a new HCPCS code G0389, Ultrasound, B-scan and/or real time with image documentation; for abdominal aortic aneurysm (AAA) screening . We proposed that payment for this service be made at the same level as CPT code 76775, Ultrasound, retroperitoneal (eg, renal, aorta, nodes), B-scan and/or real time with image documentation; limited . CPT code 76775 is used to bill for the service when it is provided as a diagnostic test, and we believe the service associated with the HCPCS codereflects equivalent resources and work intensity to those contained in CPT code 76775.

In addition, since the DRA provides that the Medicare Part B deductible will not apply for ultrasound screening for AAA (as defined in section 1861(bbb) of the Act), we proposed to revise § 410.160 to include an exception from the Medicare Part B deductible for the ultrasound screening for AAA as described in § 410.19 (Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms).

Comment: Commenters were in agreement with the proposed payment amount for this service.

Response: We will adopt the proposed values for this new HCPCS code (that is, make it equivalent to CPT code 76775). This service will be identified by the following code number and descriptor G0389, Ultrasound, B-scan and/or real time with image documentation; for abdominal aortic aneurysm (AAA) screening .

We will also finalize the proposed revisions to § 410.160 to include an exception from the Medicare Part B deductible for the ultrasound screening for AAA as described in § 410.19.

4. Section 5113-Non-Application of the Part B Deductible for Colorectal Cancer Screening Tests

Current Medicare policy requires that, with limited exceptions, incurred expenses for covered part B services are subject to, and count toward meeting the Part B annual deductible. Section 5113 of the DRA amended section 1833(b) of the Act to provide for an exception to the application of the Part B deductible for colorectal cancer screening tests. Beginning January 1, 2007, colorectal cancer screening services, as described in section 1861(pp)(1) of the Act, are no longer subject to the Part B deductible. The conditions for and limitations on coverage for colorectal cancer screening tests under Medicare Part B are described in § 410.37.

To conform our regulations to this statutory change, we proposed to revise § 410.160 to include an exception from the Part B annual deductible for the colorectal cancer screening services described in § 410.37.

Comment: Commenters were supportive of this conforming change. However, it was pointed out that we had failed to address the situation where a colorectal cancer screening service actually results in a beneficiary having a biopsy or a growth removed, requiring the service to be coded as a diagnostic procedure. Clarification was requested as to whether in such situations, the deductible would still be waived.

Response: Section 1834(d)(3)(D) of the Act states "if during the course of such screening colonoscopy, a lesion or growth is detected which results in a biopsy or removal of the lesion or growth, payment under this part shall not be made for the screening colonoscopy but shall be made for the procedure classified as a colonoscopy with such biopsy or removal." Based on this statutory language, in such instances the test or procedure is no longer classified as a "screening test." Thus, the deductible would not be waived in such situations.

After reviewing the public comments, we are finalizing § 410.160 as proposed.

5. Section 5114-Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

Section 5114 of the DRA amended section 1861(aa)(3) the Act to add DSMT and MNT services to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we proposed to conform the regulations to the new statutory requirement.

FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. That is, if all relevant program requirements are met, these services are included under the Medicare FQHC benefit as billable visits.

In public response to the proposed rule, we received a small number of comments expressing support for our proposal. Therefore, we will finalize the changes as proposed.

To conform the regulations, we are amending § 405.2446(b) to expand the scope of FQHC services to include certified providers of DSMT and MNT services by adding a new paragraph (b)(10). We are also revising § 405.2463 by-

• Revising paragraph (a) to expand the definition of an FQHC visit to include certified providers of DSMT and MNT services under new paragraph (a)(1)(ii)(B). We are also revising the definition of an rural health clinic (RHC) visit in new paragraph (a)(1)(i) to include a face-to-face encounter between a patient and a clinical psychologist or clinical social worker to conform to statutory language at section 1861(aa)(1)(B) of the Act. We also proposed to redesignate and revise paragraphs (b) and (c) as new paragraphs (a)(2) and (a)(3), respectively.

• We are incorporating paragraph (a)(2) into (a)(1), and redesignating and revising current paragraph (a)(3) as new paragraph (b). We also clarify that it is generally permissible for both FQHCs and RHCs to furnish, when necessary, most types of medical and other health visits on the same day to the same patient. We also amend this paragraph to permit a separate additional FQHC visit for DSMT and MNT services (which may occur on the same date of service when the beneficiary receives care from their FQHC physician or NPP) when reasonable and necessary, consistent with the Congressional mandate under section 5114 of the DRA to provide coverage and adequate access to these services in the FQHC setting.

• Finally, we are redesignating and revising current paragraph (a)(4) as new paragraph (c).

F. Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

Medicare Part B covers a limited number of prescription drugs and biologicals. For the purposes of this final rule with comment period, the term "drugs" will hereinafter refer to both drugs and biologicals. Medicare Part B covered drugs not paid on a cost or prospective payment basis generally fall into the following three categories:

• Drugs furnished incident to a physician's service.

• Durable medical equipment (DME) drugs.

• Drugs specifically covered by statute (for example, certain immunosuppressive drugs).

Beginning in CY 2005, the vast majority of Medicare Part B drugs not paid on a cost or prospective payment basis are paid under the average sales price (ASP) methodology. The ASP methodology is based on data submitted to us quarterly by manufacturers. In addition to the payment for the drug, Medicare currently pays a furnishing fee for blood clotting factors, a dispensing fee for inhalation drugs, and a supplying fee to pharmacies for certain Part B drugs.

In January 2006, the drug coverage available to Medicare beneficiaries expanded with the implementation of the Medicare Part D benefit. The Medicare Part D benefit does not change Medicare Part B drug coverage.

This section of the preamble discusses changes and issues related to the determination of the payment amounts for covered Part B drugs and furnishing blood clotting factor. This section also discusses changes to how manufacturers calculate and report ASP data to us.

1. ASP Issues

Section 303(c) of the MMA amended title XVIII of the Act by adding new section 1847A. This new section revised the payment methodology for the vast majority of drugs and biologicals not paid on a cost or prospective payment basis furnished on or after January 1, 2005. The ASP reporting requirements are set forth in section 1927(b) of the Act. Manufacturers must submit ASP data for each 11-digit NDC to us quarterly. The manufacturers' submissions are due to CMS no later than 30 days after the last day of each calendar quarter. The methodology for developing Medicare drug payment allowances based on the manufacturers' submitted ASP data is described in the regulations in part 414, subpart K. We update the Part B drug payment amounts quarterly based on the data we receive.

On April 6, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) interim final rule with comment period (IFC) (69 FR 17935) to implement the ASP calculation and reporting requirements. Manufacturers were required to submit their initial quarterly ASP data to us shortly thereafter, by April 30, 2004. We received comments on the April 6, 2004 IFC from drug manufacturers, pharmacies, physicians, national associations of the pharmaceutical industry, national associations of physicians, and consultants. These comments addressed a variety of aspects of calculating and reporting ASPs. On September 16, 2004, we published the Manufacturer's Submission of Average Sales Price Data for Medicare Part B Drugs and Biologicals (ASP) final rule (69 FR 55763) addressing only the comments pertaining to the methodology for estimating lagged price concessions. We have also addressed ASP calculation and reporting requirements in other proposed and final rules and information collection notices, including rulemaking to implement the Competitive Acquisition Program for Part B Drugs and Biologicals (CAP) (70 FR 39069, 70 FR 45842, 70 FR 70215, 70 FR 70477, and 71 FR 48130). In addition, we have posted official agency guidance, including responses to frequently asked questions, on our Web site to implement the ASP provisions in accordance with section 1847A(c)(5)(C) of the Act.

In the CY 2007 PFS proposed rule, we stated that we intended to finalize the April 6, 2004 IFC in the near future and that we may publish the final rule as part of this rulemaking, or as a separate final rule. We also stated that because the comments received during the comment period in response to the April 6, 2004 IFC were made during the initial months of manufacturers' experience with calculating and reporting ASPs and prior to publication of payment amounts based on the ASP methodology, we believed there was good reason to give the public an opportunity to provide additional comments. Therefore, we sought comments on the ASP reporting provisions in the April 6, 2004 IFC, as well as several topics specifically discussed in the CY 2007 PFS proposed rule. These topics included: Fees not considered price concessions, excluded sales known on a lagged basis, nominal sales, and other price concession issues. In this final rule with comment period, we are responding to comments received on the April 6, 2004 IFC and the CY 2007 PFS proposed rule and revising provisions related to the estimation methodology for price concessions known on a lagged basis, which were finalized in the September 16, 2004 final rule. Except as otherwise specified in this final rule with comment, we are finalizing the provisions of part 414, subpart J as presented in the April 6, 2004 IFC.

a. Comments Not Related to ASP Reporting

As stated in the CY 2007 PFS proposed rule, we received numerous comments on the use and potential impacts of the ASP payment methodology. The April 6, 2004 IFC implemented provisions of the MMA related to how manufacturers calculate ASP and report their ASP data. Thus, comments about the appropriateness and use of 106 percent of the ASP as a basis for Medicare Part B drug payment rates are outside the scope of the final ASP reporting rule. Implementation of the ASP payment methodology as the basis for establishing payment amounts for the vast majority of Part B drugs was discussed in notice and comment rulemaking in the CY 2005 PFS proposed and final rules (69 FR 47520 and 69 FR 66299). Comments about the ASP payment methodology that address issues other than how manufacturers calculate and report their ASPs are outside the scope of this rulemaking. Other topics for which we received comments that are not within the scope of this rulemaking and are not otherwise addressed are as follows:

• How the ASP-based payment rates are calculated;

• How NDCs are assigned to billing codes;

• Requests for billing codes for specific products;

• Whether alternative payment methodologies or exceptions to the ASP-based payment should be considered;

• Billing and claims processing and adjudication issues;

• Variation in local coverage policies:

• Whether Part B policies apply to Medicaid and/or Part D;

• Issues related to Competitive Acquisition of Outpatient Drugs and Biologicals Under Part B (CAP); and

• Issues pertaining to the content and format of the quarterly Part B drug pricing files.

b. Fees Not Considered Price Concessions

Section 1847A(c)(5)(A) of the Act states that the ASP is to be calculated by the manufacturer on a quarterly basis. As a part of that calculation, manufacturers must take into account price concessions such as-

• Volume discounts;

• Prompt pay discounts;

• Cash discounts;

• Free goods that are contingent on any purchase requirement;

• Chargebacks; and

• Rebates (other than rebates under the Medicaid drug rebate programs).

If the data on these price concessions are lagged, then the manufacturer is required to estimate costs attributable to these price concessions using the required ratio methodology as specified in § 414.804(a)(3). This methodology was finalized in the September 16, 2004 final rule based on comments submitted in response to the April 6, 2004 IFC. In the CY 2007 PFS proposed rule, we proposed modifications to the requirements for estimating lagged price concessions specified § 414.804(a)(3) to conform with other proposals put forth in the proposed rule. Comments received in response to the proposed rule related to potential impacts on the estimation of lagged price concessions are discussed in the appropriate subsections in this section.

In response to the April 6, 2004 IFC, commenters representing drug manufacturers, national associations of wholesalers and distributors, and physicians and other health care providers requested clarification and detailed guidance on the treatment of administrative fees, service fees and fees paid to pharmacy benefit managers (PBMs) in the ASP calculation. We posted guidance on our Web site ( http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg ) to clarify that in the absence of specific guidance in the Act or Federal regulations, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and intent of the Act, Federal regulations, and its customary business practices. These assumptions should be submitted along with the ASP data. In December 2004, we posted further guidance on our Web site addressing service fees and administrative fees paid to buyers ( http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg ).

On July 6, 2005, we restated our guidance on service fees in the preamble of the Competitive Acquisition of Outpatient Drugs and Biologicals Under Part B (CAP) interim final rule with comment (70 FR 39069). Subsequently, we received requests for clarification on how fees paid to entities such as group purchasing organizations (GPOs) or PBMs must be treated for purposes of the ASP calculation.

Therefore, we proposed to further clarify in the final ASP reporting rule that, beginning with the ASP reporting for sales during the first quarter of CY 2007, bona fide service fees that are paid by a manufacturer to an entity, whether or not the entity takes title to the drug, are not considered price concessions under § 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we proposed at § 414.802. In § 414.802, we proposed to define bona fide service fees as fees paid by a manufacturer to an entity that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on, in whole or in part, to a client or customer of an entity, whether or not the entity takes title to the drug. We further proposed that our current guidance, which provides that bona fide service fees means expenses that would have generally been paid for by the manufacturer at the same rate had these services been performed by other entities, would remain in effect unless we adopted an alternative approach. Further, we proposed to clarify in the final ASP reporting rule that fees, including service fees, administrative fees and other fees, paid to GPOs or PBMs are not considered price concessions under § 414.804(a)(2) insofar as, and to the extent that, they satisfy the definition of a bona fide service fee that we proposed at § 414.802.

In the CY 2007 PFS proposed rule, we discussed comments to the April 6, 2004 IFC that provided some insight into the types of activities that are performed in the distribution of drugs. We noted that these comments did not provide detailed information about whether and how one would determine the extent to which these activities are bona fide services actually performed on behalf of the manufacturer. To better understand the scope of appropriate bona fide services and how they may vary across categories of drugs, we sought comment on the specific types of services entities performed on behalf of the manufacturer and the necessity of those services in the efficient distribution of drugs. We also stated that we were considering providing further guidance on the types of services that may qualify as bona fide services for purposes of the ASP calculation. We also indicated that we were considering providing further guidance on or revising the approach or methodology manufacturers must use to determine the fair market value of bona fide services performed on their behalf and whether the service fee paid was passed on in whole or in part, as well as activities that should not be considered bona fide services performed on behalf of manufacturers, and bona fide services that may be appropriate for all or specific types of products or circumstances. We also sought comments on the costs and relative costs of services performed on behalf of manufacturers. Specifically related to the determination of whether or not a fee represents fair market value for ASP purposes, we solicited comments on the potential appropriateness of fees tied to performance of a service, fixed fee, revenue generated by product sales, or other basis. In addition, we requested comments on the appropriate methods for determining whether a fee is passed on in whole or in part and on how Medicare's guidance on the treatment of service fees for ASP calculation purposes may differ with the treatment of service fees for financial accounting or other purposes, and any implications that this may have for manufacturers.

Comment: We received numerous comments on the topic of service fees. Among the commenters there was general agreement with our clarification that the treatment of bona fide service fees in the ASP calculation should not be conditioned on whether or not the entity takes title to the drug. However, many commenters objected to a definition of bona fide service fee that would limit in any way the services or amount of fee that a manufacturer would establish in a contract with any partner in the distribution of drugs or that otherwise would limit flexibility and evolution in the industry. Many of the commenters on this issue were opposed to establishing a list of bona fide services; while a few commenters requested that certain services such as "pick, pack and ship," chargeback administration, data services, and patient care programs be specifically included in a list of bona fide services. A few commenters stated that such a list, even if the list were illustrative, would be helpful in standardizing the treatment of service fees across manufacturers' ASP calculations. Other commenters cautioned that establishing a list of bona fide services would require ongoing refinement in order for manufacturers to accurately calculate ASPs as service fee arrangements evolved.

Several commenters recommended that we adopt a more general standard for evaluating whether an arrangement represents a bona fide service fee arrangement. However, very few suggestions for modifying the wording of the proposed definition of bona fide service fee were offered. One commenter recommended changing "itemized" to "supply chain" to address concerns regarding how fair market value may be determined, and several commenters recommended that we delete the requirement that the fees not be passed on; these comments are discussed in more detail below in this section.

In discussing how a more general standard might be applied, several commenters suggested allowing the marketplace to decide the appropriate scope of services and fair market value. These commenters stated that this approach would result in a satisfactory means of determining fees that are not price concessions (that is, are bona fide and not passed on) by virtue of the competitiveness of the market for drug distribution service. Under this approach, any service and price agreed to in an arm's-length contract with the manufacturer would be sufficient for determining that the services were bona fide and at fair market value for ASP purposes.

Other commenters, who support a general standard, suggest that so long as a service is "reasonably necessary" or "necessary and useful" in meeting a manufacturer's business needs, it should be considered to be both bona fide and a service performed on behalf of the manufacturer. These commenters emphasize that the purpose of the service should determine whether it was performed on behalf of the manufacturer. As a result, in the opinion of these commenters, all activities related to distributing drugs are services a manufacturer would either have to perform or contract for if it did not have the capacity to perform the activity or chose not to perform the activity.

Some of the comments in support of a general standard pointed to the personal services safe harbor from anti-kickback penalties as specified in 42 CFR 1001.952(d)(7) as a potential benchmark for purposes of identifying services and fees that would be excluded from the ASP calculation. Other commenters recommended that any reasonable method of determining fair market value should be acceptable. However, several commenters requested that we specify the acceptable methods for determining fair market value. A small number of commenters requested that we specifically address whether the income method, market method or cost method could be used to estimate the range for fair market value of the bona fide service fee arrangement for ASP purposes. These commenters did not provide details on the applicability of these three methods for estimating fair market value for commonly performed drug distribution services. Many commenters stated that, regardless of the method used to determine fair market value, manufacturers should be permitted to calculate fair market value across a set of services (in lieu of determining fair market value for each itemized service specified in an arrangement), and that it would be impossible to calculate fair market value adequately for certain low-volume or value-added services or certain services that can only be performed by the purchaser (for example, in the case of wholesalers, compiling, and sharing retail customer data). Some commenters noted that service fee contracts may be broadly constructed for a set of services across a number of drugs without itemizing each service or activity. To reflect market practices and trends, as noted above in this section, one commenter recommended that we revise the proposed definition of bona fide service fees to remove the word "itemized" and, in its place, insert "supply chain."

Several commenters supported our proposed definition of bona fide service fees in general, while also suggesting that we refine or eliminate the "not passed on" requirement because it is not needed if the services included in an arrangement are bona fide and the fee represents fair market value. A number of commenters offered that including "itemized" in the definition was unnecessary for the same reason. While a few commenters stated that specific requirements not to pass on fees and terms requiring disclosure of any fees passed on could be written in the bona fide service fee contracts. In contrast, several commenters stated that for a variety of reasons, manufacturers may not know or be able to accurately certify that a fee is not passed on in whole or in part. These commenters identified anti-trust constraints as one such reason.

Commenters asked that: (1) We clarify that services that can only be performed by the party that takes possession of the drug from the manufacturer may be considered to be bona fide services; and (2) we remove the limitation in our current guidance that bona fide service fees must be at the same rate had these services been performed by other entities.

We did not receive comments on services that should not be considered bona fide services, or on the costs or relative costs of services performed on behalf of manufacturers.

Response: After consideration of the comments received, we are finalizing our proposed definition of bona fide service fees at § 414.802 which specifies that in order for a fee to be determined not to be a price concession, and thus to be excluded from the calculation of the ASP, the following conditions must be met:

• The fee paid must be for a bona fide , itemized service that is actually performed on behalf of the manufacturer;

• The manufacturer would otherwise perform or contract for the service in the absence of the service arrangement;

• The fee represents fair market value; and

• The fee is not passed on in whole or in part to a client or customer of any entity.

We believe that if a fee satisfies the definition of bona fide services fees it can be excluded from the calculation of the ASP. We believe the specificity and scope of this definition provides an appropriate safeguard against the potential risk for inappropriately higher ASPs, while adopting a more general standard, a more limited definition or relying solely on market forces, as some commenters suggested, would not. This is because, taken together, this four elements describe those situations in which we believe a fee paid is compensation for services rather than a price concession for drugs. We disagree with the comments that recommended alternative standards because a definition with greater breadth or less specificity or both would not as clearly distinguish bona fide services fees from price concessions and could result in inappropriately high ASPs and insconsistent treatment of services fees (for example, if we were to permit a fee for any services at any price to be excluded from the calculation of ASP or to eliminate the "not passed on" or "itemized" requirements.) However, we found many of the comments informative with respect to how our definition of a bona fide service fee is met and we discuss below in this section how these comments have been incorporated into our guidance. In codifying the definition of bona fide service fees, we seek to clarify a framework for differentiating between those price concessions that must be included in the calculation of ASP and bona fide service fees,which are not included in the calculation of ASP. Beginning with the effective date of this final rule with comment, the definition of bona fide service fees will apply to the ASP reporting for sales during the first calendar quarter of 2007. Additional guidance is discussed below.

(1) Bona fide , Itemized, Actually Performed on Behalf of the Manufacturer and "Otherwise Performed"

The first and second elements of the definition of bona fide service fees relate to the scope of bona fide services for which a fee paid does not represent a price concession for ASP purposes. To be considered a bona fide service fee, the fee must be for services that are: Bona fide , itemized, actually performed on behalf of the manufacturer, and those the manufacturer would otherwise perform or contract for in the absence of the service arrangement. Some commenters requested further guidance on these elements. We were persuaded by comments that referenced the necessity or usefulness of services. Therefore, we interpret these elements of the definition to encompass any reasonably necessary or useful services of value to the manufacturer that are associated with the efficient distribution of drugs. In response to commenters' concerns, we are clarifying that services "on behalf of" the manufacturer include both those the manufacturer has the capacity to perform, and those that can only be performed by another entity.

Although some commenters provided us with general information on what they would view to be bona fide services, to avoid inadverently limiting the scope of what could constitute a bona fide service, we will not establish a list of "bona fide services" at this time.

(2) Fair Market Value

The third element of the definition of bona fide service fees specifies that the fees must represent fair market value. In response to comments, we are refining our current guidance to address concerns that it may not permit exclusion from ASP of fees for services that can only be performed by the entity to which the fee is paid. Therefore, our guidance is that bona fide service fees means expenses that generally would have been paid for by the manufacturer at the same rate had these services been performed by other or similarly situated entities.

In addition, we tend to agree with the commenters that, in certain circumstances, it may be appropriate to calculate fair market value for a set of itemized bona fide services, rather than fair market value for each individual itemized service, when the nature of the itemized services warrants such treatment. We also tend to agree that the appropriate method or methods for determining whether a fee represents fair market value may depend upon the specifics of the contracting terms, such as the activities the entity will perform and the agreed-upon mechanism for establishing the payment (for example, percentage of goods purchased). We believe manufacturers are well-equipped to determine the most appropriate, industry-accepted method for determining fair market value of drug distribution services for which they contract. Therefore, we are not mandating the specific method manufacturers must use to determine whether a fee represents fair market value for purposes of excluding bona fide service fees from the calculation of ASP.

(3) "Not Passed On"

We appreciate the commenter views on the fourth element of the definition of bona fide service fees, which specifies that the bona fide service fee must not be passed on, in whole or in part, to a client or customer of an entity. At this time, we understand that there may be significant barriers that limit a manufacturer's ability to determine whether a fee that otherwise meets the definition of "bona fide service fee" described in this rule is passed on, in whole or in part, to a client or customer of any entity. Nevertheless, we believe that it is essential to retain the "not passed on" element in the definition of bona fide service fees. The "not passed on" element is, in our view, a key factor in distinguishing a price concession from a bona fide service fee because, if a fee that is passed on is excluded from the ASP calculation, then there is a greater risk of the ASP being inappropriately higher.

However, we recognize that, in some instances, manufacturers may have no effective way of knowing whether a fee paid that meets the other elements of the definition of "bona fide service fee" is passed on. Although we decided to retain the "not passed on" requirement in the definition of bona fide service fees because of its importance in distinguishing bona fide service fees from price concessions, we believe it is appropriate to seek to balance our goal of ensuring appropriate Medicare payments are made with the level of burden a manufacturer would have to undertake to validate that a fee was not passed on. Therefore, with respect to certifying to the accuracy of their ASP calculations when it is unknown to the manufacturer whether the fee paid was passed on in whole or in part to a client or customer of any entity, we are clarifying, in this preamble, how manufacturers may address this concern. If a manufacturer has determined that a fee paid meets the other elements of the definition of "bona fide service fee," then the manufacturer may presume, in the absence of any evidence or notice to the contrary, that the fee paid is not passed on to a client or customer of any entity.

Comment: Several commenters indicated that some of the fees that they believe would meet our definition of bona fide services fees for ASP purposes would be treated as a reduction to revenues for financial accounting purposes. Commenters asked us to clarify that the treatment of service fees for ASP purposes and financial accounting purposes may be different, and that if a fee meets our definition of a bona fide service fee it can be excluded from the ASP regardless of its treatment for financial accounting purposes.

Response: Fees that meet our definition of bona fide service fees are not considered price concessions for purposes of the ASP calculation, regardless of how they are treated for financial accounting purposes.

Comment: Many commenters asserted that all fees and other payments to GPOs and PBMs should be excluded from ASP because the statute requires only that sales to purchasers be included in ASP, and, they argue, GPOs and PBMs are not purchasers, do not take title to and possession of products, and the fees paid to GPOs and PBMs are not passed on to physicians (or other providers) in a manner that can be attributable to a particular purchase or drug. Commenters asked that, if we consider fees paid to GPOs and PBMs to be price concessions (except to the extent that the fees are bona fide service fees for purposes of the ASP calculation), we allow fees paid to the GPOs and PBMs under arrangements that meet the anti-kickback safe harbor for purchasing arrangements to be excluded from the ASP calculation without having to meet our definition of bona fide service fees. Other commenters expressed concern that considering GPO and PBM fees to be price concessions could artificially deflate ASP such that it would not accurately reflect the costs incurred by physicians and other providers. Another commenter suggested that we provide additional guidance on payments to managed care organizations.

Response: We note that we did not make a specific proposal with respect to how PBM and GPO fees must be treated for ASP purposes other than to say that to the extent that such fees meet the definition of "bona fide service fee," they are excluded from the calculation of ASP. We are continuing to develop our understanding of the variety of agreements made with entities such as PBMs and GPOs and the possible effects of these arrangements on the calculation of ASP and provider acquisition costs. For this reason, at this time we believe it is premature for us to provide specific guidance with respect to treatment of fees paid by manufacturers to PBMs and GPOs in the ASP calculation (other than to specify, as we proposed, that PBM and GPO fees that meet the definition of "bona fide service fees" are excluded from the calculation of ASP). Instead, we will continue to consider the comments received and to study the matter further. In addition, we may take into consideration how fees paid to these entities are addressed in the context of the Medicaid drug rebate program. We also note that the MedPAC commented that in the upcoming year it would be continuing to examine the issue of the average prices physicians pay and the effect of price concessions that might not be passed on to physicians.

In the absence of specific guidance, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Act, Federal regulations, and its customary business practices. These assumptions should be submitted along with the ASP data.

Recognizing that the treatment of fees to PBMs and GPOs in the ASP calculation may have implications for the integrity of the ASP payment methodology, we will be paying close attention to this issue and may provide more specific guidance in the future through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act).

Comment: Many commenters noted that the Congress excluded wholesaler prompt pay discounts from the calculation of average manufacturer price (AMP) under the DRA. Commenters asserted that we have the authority to extend this provision to ASP reporting and thus could exclude wholesaler prompt pay discounts from ASP reporting.

Response: We do not agree that extending the DRA provision to ASP reporting would be consistent with Congressional intent. Section 1847A(c)(3) does not specify a carve-out for prompt pay discounts extended to wholesalers. Therefore, along with all other prompt pay discounts, prompt payment discounts extended to wholesalers must be included in the calculation of ASP.

c. Estimation Methodology for Lagged Exempted Sales

Section 1847A(c)(2) of the Act requires manufacturers to exclude from the calculation of ASP those sales that are exempt from inclusion in the determination of Medicaid best price (BP). In the comments on the April 6, 2004 IFC, commenters requested more guidance on the method manufacturers should use to exclude exempted sales that are known on a lagged basis. Manufacturers identify exempted sales based on direct sales and through chargeback and rebate data that may not be sufficiently available at the time the ASP is calculated. In the absence of specific guidance on how to account for lagged exempted sales (that is, exempted sales identified through chargeback or rebate processes), manufacturers have relied upon assumptions in accordance with their customary business practices to develop their approach for excluding these sales from the ASP calculation. In our work with manufacturers that submit ASP data, we understand that some manufacturers have used a ratio methodology for estimating exempted sales known on a lagged basis that is similar to the ratio methodology manufacturers must use to estimate price concessions known on a lagged basis.

To establish a uniform approach, we proposed to require, in the final ASP reporting rule, that all manufacturers use a 12-month (or less, if applicable) rolling average ratio methodology to estimate exempted sales known on a lagged basis (through chargebacks or rebates) to more accurately exclude these sales from the ASP calculation. Specifically, for exempted sales known on a lagged basis, the manufacturer would sum the lagged exempted sales for the most recent 12-month period available (or the number of months the NDC has been sold for NDCs with less than 12 months of sales, except for redesignated NDCs as described in section II.F.1.e.). The manufacturer then calculates a percentage using this summed amount as the numerator and the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the same period (12 months or less, if applicable) as the denominator. The result would be a rolling average percentage estimate for lagged exempted sales that is applied to the sales (the number of units after non-lagged exempted sales have been subtracted from total sales) for the quarter being reported. The product that results from multiplying the rolling average percentage estimate of lagged exempted sales and sales (the number of units after non-lagged exempted sales have been subtracted from total sales) would determine the number of lagged exempted sales (in units) to be excluded from the denominator of the ASP calculation. Manufacturers would be required to make a corresponding adjustment to the numerator of the ASP calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged, exempted sales excluded from the denominator using the proposed estimation methodology. Further, manufacturers would be required to remove the dollar value of lagged exempted sales from their estimates of lagged price concessions by subtracting the dollar value of estimated lagged exempted sales from the denominator as specified in § 414.804(a)(3)(i).

Our proposed methodology for excluding lagged, exempted sales is similar to the methodology manufacturers are required to use to estimate price concessions known on a lagged basis, and was recommended by manufacturers. We believe requiring similar methods to estimate both lagged exempted sales and lagged price concessions would be reasonable and reduces potential errors in the manufacturers' ASP calculations, while ensuring that exempted sales are appropriately removed from the ASP calculation. In addition, using an estimation methodology to remove lagged exempted sales would reduce the likelihood of quarter-to-quarter variations in the ASP.

We sought comments on the proposed methodology for excluding exempted sales known on a lagged basis from the ASP calculation and estimate of lagged price concessions. We also solicited suggestions on appropriate alternative methodologies that may be less complex.

Comment: We received comments that were supportive of our approach. However, some commenters stated that the proposed methodology would be overly complex and inappropriate for certain types of exempted sales known on a lagged basis. Several commenters stated that the proposed methodology would be helpful and useful for accurately excluding from the ASP calculation sales excluded based on the type of entity to which the sale is made and known on a lagged basis (for example, sales relating to subclauses (I), (II), and (IV) of section 1927(c)(1)(C)(i) of the Act). However, most of these commenters cautioned that use of the proposed methodology to estimate and exclude from the ASP calculation sales which are excluded on the basis of rebates paid to State pharmacy assistance programs and Part D plans or qualified retiree prescription drug plans (for example, prices under clauses (III) and (VI) of section 1927(c)(1)(C)(i) of the Act) and known on a lagged basis would be: (1) Inadequate to fully and accurately account and adjust for other price concessions applicable to these sales; and (2) may lead to an inappropriately low ASP if a manufacturer is unable to identify and remove all price concessions associated with an exempted sale. Some commenters supported an alternative, two-pronged approach. Lagged sales excluded based on the type of entity to which the sale is made would be removed from the ASP using the proposed methodology if the manufacturer determined that a 12-month rolling average estimation methodology was necessary to accurately exclude these lagged exempted sales from the ASP calculation. On the other hand, the manufacturer would either not make any adjustment for or use reasonable assumptions to determine the best method for excluding any prices under a State pharmaceutical assistance program, and any prices charged which are negotiated by a prescription drug plan under Part D of title XVIII, by an MA-PD plan under Part C of title XVIII or by a qualified retiree prescription drug plan as defined in section 1860D-22(a)(2) of the Act. Several commenters suggested we adopt an approach that would permit manufacturers not to exclude certain exempted sales because: (1) Current information sources may not distinguish all exempted sales; (2) certain sales may satisfy more than one of the exemptions from the determination of BP so there would be a potential for over counting excluded sales (for example, a sale to a 340B hospital that is also reimbursed by Medicare Part D); and (3) in some instances the manufacturer may be unable to fully identify and adjust for the price concessions granted along the distribution chain associated with certain exempted sales (for example, the portion of volume discounts granted to distributors and pharmacies that were based on excluded sales). In addition, a few commenters noted that we did not specify a standard method for making the necessary corresponding adjustment to the numerator of the ASP calculation to ensure that the total in dollars for the reporting quarter does not include revenue related to lagged, exempted sales excluded from the denominator using the proposed estimation methodology. These commenters suggested that the excluded sales be valued at the manufacturer's wholesale acquisition cost (less customary prompt pay discounts) for purposes of making the necessary adjustment.

A few manufacturers supported our proposal for calculating excluded sales known on a lagged basis; however, one manufacturer requested that we consider requiring use of a revenue-based ratio instead of or as an alternative to the proposed units-based ratio. This commenter recommended that manufacturers be given a choice between a revenue-based or a units-based method to fit their data systems. Another manufacturer noted that a revenue-based ratio would result in unintended results if the price of the drug changed during the 12-month period used to establish the estimation ratio; therefore, a ratio methodology based on units such as the one we proposed should be required.

Response: Section 1847A(c)(2) of the Act requires that manufacturers exclude certain sales from their ASP calculations. The statute does not make the exclusion of these sales from the ASP calculation optional. Therefore, we do not have the discretion to permit manufacturers not to exclude sales from ASP that are exempt from the determination of BP. Manufacturers must comply with the requirements in § 414.804(a)(4)(i). In this final rule with comment period we are revising § 414.804(a)(4)(i) by adding a reference to nominal prices, as well as sales exempt from inclusion in the determination of BP. We believe that this revision conforms the regulatory text to the language of the statute.

To establish a uniform approach for excluding exempted sales known on a lagged basis, we proposed to amend § 414.804(a)(4) to require that all manufacturers use a 12-month (or less, if applicable) rolling average ratio methodology to more accurately estimate and exclude these sales from the ASP calculation. Our proposal was based on comments we received in response to the April 6, 2004 IFC and subsequent feedback from a few manufacturers. The comments received in response to the proposed rule reflect a broader set of manufacturers' perspectives. Some commenters indicated that for certain types of exempted sales the proposed methodology for excluding lagged exempted sales from the ASP calculation might lead to inaccuracies in the ASP calculation in their particular circumstances. At the same time, a number of commenters supported the proposed methodology. We recognize these commenters' concerns regarding the difficulties in tracking both the exempted sale and its associated price concessions. Given the range of comments, we do not believe it is not advisable to mandate the use of the methodology, which we proposed at § 414.804(a)(4)(iii), for excluding lagged exempted sales. We recognize the proposed ratio methodology may not be the most accurate method for identifying and excluding certain types of exempted sales known on a lagged basis. However we also believe that our proposed ratio methodology may be appropriate for identifying and excluding lagged exempted sales in some instances. For this reason, we are not including the methodology in our regulations, but are allowing the manufacturers to use the methodology where applicable. We did not receive specific comments on our proposed modifications to § 414.804(a)(1) and (3) clarifying further that exempted sales are excluded from the ASP calculation. We are finalizing those clarifications as proposed.

d. Nominal Sales

Section 1847A(c)(2)(B) of the Act requires manufacturers to exclude from the ASP calculation sales that are merely nominal in amount, as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, except as the Secretary may otherwise provide. In the preamble to the April 6, 2004 IFC, we stated that, for ASP purposes, sales to an entity that are nominal in amount are defined in the Medicaid drug rebate agreement (see sample agreement at http://www.cms.hhs.gov/MedicaidDrugRebateProgram/downloads/rebateagreement.pdf ). That is, for ASP purposes, a sale at a nominal price is a sale at a price less than 10 percent of the AMP in the same quarter for which the AMP is computed.

Effective January 1, 2007, the DRA revises the AMP calculation (to omit customary prompt pay discounts extended to wholesalers), adds a monthly AMP reporting requirement, and establishes limitations on nominal sales (only sales to certain entities may qualify as nominal sales). Section 1927(c)(1)(D) of the Act limits the nominal sales exclusion to sales at a nominal price made to the following entities:

• Covered entities as described in section 340B(a)(4) of the Public Health Services Act.

• Intermediate care facilities for the mentally retarded (ICFs/MR).

• State-owned or operated nursing facilities.

• Any other facility or entity that the Secretary determines is a safety net provider to which sales of such drugs at a nominal price would be appropriate based on the factors described in section 1927(c)(1)(D)(ii) of the Act.

In light of the DRA changes affecting which sales may be considered sales at a nominal price or merely nominal in amount, for purposes of section 1927(c)(1)(C)(ii)(III), the CY 2007 PFS proposed rule sought to clarify the method manufacturers must follow in 2007 to identify such sales for ASP reporting purposes and to exclude sales at a nominal price from the calculation of ASP. For 2007 and beyond, we proposed to continue to rely on the Medicaid threshold (less than 10 percent of AMP) to determine whether a sale is at a nominal price and to apply the limitations in section 1927(c)(1)(D) of the Act for determining the types of sales that can be considered to be sales at a nominal price for purposes of the ASP calculation. We made this proposal for several reasons.

As we indicated in the CY 2007 PFS proposed rule, we believe this approach helps maintain continuity in the ASP calculation and minimizes manufacturers' reporting burden, as Medicare continues to follow the Medicaid approach for identifying sales at a nominal price and manufacturers can use a single method for identifying nominal sales for both ASP and AMP purposes.

In addition, we believe the DRA modifications to section 1927 of the Act will have minimal effect on reported ASPs. We expect that the exclusion of customary prompt pay discounts extended to wholesalers from AMP would lead to a modest increase in AMP, and as a result a modest increase in the nominal price threshold for purposes of ASP reporting. At the same time, we anticipate that the limitation on the types of entities to which the nominal sales exclusion may apply, as specified in section 1927(c)(1)(D) of the Act, will result in a modest reduction in the number of sales that qualify for the nominal sales exclusion for purposes of ASP reporting because we believe that the entities outlined in section 1927(c)(1)(D) of the Act generally represent the types of entities to which manufacturers sell at a nominal price. Consequently, we expect these two countervailing changes would have a minimal overall impact on nominal sales that would be excluded from the ASP calculation. For these reasons, we proposed to continue to rely on the application of section 1927(c)(1)(C)(ii)(III) of the Act (as limited by section 1927(c)(1)(D) of the Act) for identifying sales to an entity at a nominal price for purposes of excluding such sales from the manufacturer's calculation of the ASP.

We solicited comments on our proposal to continue use of the AMP as the basis for identifying the threshold for sales at a nominal price for purposes of the exclusion from the ASP calculation and on whether an alternative threshold is necessary or desirable to ensure the accuracy of the ASP payment methodology. Specifically, we sought comments on whether sales at less than 10 percent of the ASP (instead of the AMP) should be used as the threshold for determining whether a sale to an entity identified in section 1927(c)(1)(D) of the Act is at a nominal price. We also sought comments on our belief that the new limitations in section 1927(c)(1)(D) of the Act, if applied for ASP purposes, will have minimal impact on reported ASPs.

Comment: We received comments supporting our proposals to continue to rely on the application of section 1927(c)(1)(C)(ii)(III) of the Act, as modified by section 1927(c)(1)(D) of the Act, to identify and exclude sales at a nominal price from the ASP calculation. These commenters agreed that using the same standard for Medicare and Medicaid purposes would reduce reporting burden.

Response: We appreciate the comments in support of our proposal. We are adopting our proposal to continue to rely on the Medicaid threshold (less than 10 percent of AMP) to determine whether a sale is at a nominal price, and to apply the limitations in section 1927(c)(1)(D) of the Act for purposes of identifying sales at a nominal price in determining the ASP.

Comment: We received a few comments suggesting that the Secretary provide a list of additional types of safety net providers that would qualify for the nominal sales exclusion.

Response: The issue of whether the Secretary should designate additional types of entities that would qualify as safety net providers for purposes of section 1927(c)(1)(D) of the Act is outside of the scope of this rulemaking.

Comment: We received a comment suggesting that because of the short timeframe for performing the ASP calculation, manufacturers should be allowed to identify sales at a nominal price for ASP purposes using the AMP for the previous quarter provided that the manufacturer does this consistently across all of its products.

Response: We are concerned that the commenter's suggestion that we allow use of last quarter's AMP to identify sales at a nominal price in the current quarter could have an adverse impact on the accuracy of the ASP calculation. It is possible for the AMP to change substantially from one quarter to the next (for example, when generic products first become available). In such situations, using the current quarter's AMP, as opposed to last quarter's AMP, would generally result in a more accurate identification of sales at a nominal price. Consequently, we are continuing to require that for ASP calculation purposes nominal sales in a reporting quarter be identified based on the AMP for the same quarter.

In the CY 2007 PFS proposed rule, we also responded to requests for clarification on a technical aspect related to the identification of nominal sales. Specifically, some manufacturers have asked whether sales at a nominal price are identified by performing a series of calculations once or whether the manufacturer repeats the series of calculations until no remaining ASP eligible sales are below the nominal threshold. Manufacturers must identify sales at a nominal price by performing the following steps once-

• The manufacturer calculates the AMP for the reporting quarter to identify the dollar amount that represents 10 percent of the AMP for that reporting period.

• The manufacturer then identifies sales at prices below this amount and excludes these sales from the ASP calculation.

• Beginning in 2007, only those sales that meet the criteria discussed previously and are to an entity identified in section 1927(c)(1)(D) of the Act shall be excluded from the calculation of ASP.

We received no comments concerning this clarification; therefore we are finalizing the clarification as proposed.

e. Other Price Concession Issues

In our ongoing work with manufacturers that submit ASP data, some manufacturers have posed questions or raised concerns about how the estimate of lagged price concessions is done prior to having 12 months of data for a NDC and, when a product is redesignated with a new NDC, whether price concessions from the prior NDC must be included in calculating the ASP for the new NDC. Manufacturers and other stakeholders have also asked us about how Medicare's ASP guidance concerning price concessions is to be applied when drugs are sold under bundling arrangements.

In response, we proposed clarifications and solicited comment on these issues.

(1) Price Concessions for NDCs With Less Than 12 Months of Sales

To address situations when a NDC with price concessions known on a lagged basis has not been sold for a full 12 months, we proposed to revise § 414.804(a)(3) to specify that the period used to estimate lagged price concessions is the total number of months the NDC has been sold. We proposed to require that manufacturers use less than 12 months of data in the estimation methodology for lagged price concessions for NDCs with less than 12 months of sales (except when the manufacturer has redesignated the product's NDC, as discussed in this section). We also clarified in the preamble of the proposed rule that manufacturers may include the current ASP reporting quarter in the most recent 12-month period (or less for NDCs with less than 12 months of sales) so long as the manufacturer follows this approach in calculating the ASP for all of its reported NDCs.

Comment: We received a number of comments supporting our proposal.

Response: We are finalizing our proposal. We will require that manufacturers use less than 12 months of data in the estimation methodology for lagged price concessions for NDCs with less than 12 months of sales (except when the manufacturer has redesignated the product's NDC, as discussed in this section).

(2) Redesignated NDCs

From time to time, a manufacturer may change the NDC assigned to a specific product and package size while continuing or offering price concessions that span across sales of the product under its prior and redesignated NDCs. For example, an NDC may be changed to reflect a change in the labeler code while lagged price concessions in place under the prior NDC remain in effect and carry over to the redesignated NDC. Another example would be a manufacturer that modifies its package design or other non-drug feature of the NDC and assigns a new NDC to reflect the revised packaging.

We proposed to clarify in the final ASP reporting rule that, when an NDC is changed (except when a product is repackaged or relabeled by a different manufacturer or relabeler or is privately labeled) and lagged price concessions offered for the prior NDC remain in effect, the manufacturer must use 12 months (or the total number of months of sales of the prior and redesignated NDCs if the total number of months of sales is less than 12 months) of sales and price concession data from the prior and redesignated NDCs to estimate lagged price concessions applicable to the redesignated NDC. In establishing this methodology, we are relying on our authority under section 1847A(c)(5)(A) of the Act.

We sought comments on our proposed refinements to the estimation of lagged price concessions for NDCs with less than 12 months of sales and when a manufacturer redesignates the NDC assigned to a product. We also solicited suggestions for potentially clarifying these policies further.

Comment: We received a number of comments supporting our proposal. In addition, some commenters asked for more guidance concerning what circumstances the policy regarding redesignated NDCs would or would not apply to. In particular, some commenters suggested the policy should not apply when there is a change in the 9-digit NDC (that is, a change in the product code). We also received comments asking for clarification on how manufacturers should combine price concessions in situations where the NDC is redesignated and both products are sold for a time concurrently. Some commenters asked whether the lagged price concessions for the prior and redesignated NDCs should be combined to create a single lagged price concession ratio to be used to estimate lagged price concessions for the prior and redesignated NDC, and if so, how long this practice should occur. In addition, some commenters noted that the Food and Drug Administration (FDA) has issued a proposed rule concerning the assignment of NDC codes, and that the issue of redesignated NDCs and the ASP calculation may need to be revisited when the FDA finalizes its regulation.

Response: In making our proposal, we intended our proposal to apply in instances when a manufacturer redesignates an NDC meaning the manufacturer establishes a new NDC as a replacement for a prior NDC for the same product and package size. After reviewing the comments, we are finalizing our proposal. When a manufacturer redesignates an NDC (except when a product is repackaged or relabeled by a different manufacturer or relabeler or is privately labeled) for a specific drug product and package size and lagged price concessions offered for the prior NDC remain in effect, the manufacturer must use 12 months (or the total number of months of sales of the prior and redesignated NDCs if the total number of months of sales is less than 12 months) of sales and price concession data from the prior and redesignated NDCs to estimate lagged price concessions applicable to the redesignated NDC. Several commenters recommended that we clarify that this policy would never apply to a change in the product code for an NDC. We disagree and believe the policy could apply to a change in the product code depending on the circumstances. When an NDC is redesignated as a replacement for a prior NDC for a specific drug product and package size and lagged price concessions for the prior NDC remain in effect, we believe the policy described previously should apply regardless of which segment of the NDC code is changed.

Several commenters asked for guidance concerning how to handle situations where the redesignated NDC and prior NDC are for a time sold concurrently. If the redesignated NDC is a replacement for the prior NDC and if the two NDCs are sold for only a limited time concurrently, then we agree with commenters' suggestion that lagged price concessions that are based on sales of the prior NDC and redesignated NDC should be combined to calculate a single lagged price concessions ratio (for the applicable price concessions) that would be applied to the ASP calculation for the prior NDC and for the redesignated NDC. In this situation, the manufacturer should combine the lagged price concession data that are based on sales of the prior NDC and redesignated NDC as described previously until the last lot sold of the prior NDC expires. Finally, we agree that the FDA's proposed regulations concerning the assignment of NDC codes, once they are finalized, may have implications for our policy concerning redesignated NDCs, and we may revisit this issue in the future, if we believe it is warranted.

(3) Bundled Price Concessions

The statute requires that the ASP include volume discounts, prompt pay discounts, cash discounts, free goods that are contingent on any purchase requirement, chargebacks, and rebates (other than rebates under section 1927 of the Act). Thus far, we have not provided specific guidance in the ASP context on the issue of how to allocate price concessions across drugs that are sold under bundling arrangements. In the absence of specific guidance, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Act, Federal regulations, and its customary business practices. Manufacturers should include these assumptions in their ASP submissions.

As we indicated in the CY 2007 PFS proposed rule, we expect manufacturers of drugs reimbursed by Medicare Part B to comply with all applicable laws, regulations, and legal decisions including, but not limited to the Stark law, other relevant anti-kickback laws, antitrust laws, and laws governing fair trade practices (71 FR 49003). Our discussion of this issue in the proposed rule or in this final rule with comment period should not be construed as an endorsement or authorization of any pricing practices that contravene any laws, legal decisions, or regulations.

In the CY 2007 PFS proposed rule, we indicated that we would like to better understand howbundling affects sales of Part B drugs and the ASP calculation, and any concerns stakeholders may have on this issue (71 FR 49003). Furthermore, we indicated that we are considering providing guidance, through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847A(c)(5)(C) of the Act) on the methodology manufacturers must use for apportioning price concessions across Part B drugs sold under bundling arrangements for purposes of the calculation of ASP. We also noted that in considering this issue our goal is to ensure that the ASP is an accurate reflection of market prices for Part B drugs and that the treatment of bundled price concessions in the ASP calculation does not create inappropriate financial incentives.

In the CY 2007 PFS proposed rule, we solicited comments on a number of issues related to bundled price concessions, including how frequently Part B drugs are sold under bundling arrangements, the different structures of bundling arrangements that may exist (for example, the number of products included in a bundling arrangement; whether the price concessions are contingent on the purchase of only one product, the purchase of multiple products, or the inclusion of one or more products on a formulary; and the timing of the price concessions), and the extent to which sales of Part B drugs are bundled with sales of non-Part B drugs or non-drug products. We also sought comments on what effect bundling arrangements may have on the ASP calculation, on beneficiary access to high quality, appropriate care (including access to drugs that may not have clinical alternatives), and on costs to the Medicare program and beneficiaries. In addition, we solicited comments on whether additional guidance on apportioning bundled price concessions for purposes of the calculation of ASP is needed and potential methodologies that Medicare could consider requiring. Furthermore, we solicited comments on how variation in the structure of bundling arrangements may affect the impact of potential apportionment methodologies on the ASP calculation.

Comment: Some commenters recommended that we provide guidance on the treatment of bundled price concessions in the ASP calculation. A number of these commenters stated that having specific guidance on this issue would promote consistency in ASP reporting across manufacturers. In addition, many commenters believed that we should issue another proposed rule with a specific proposal and offer an opportunity for public comment before finalizing any policy. Many of these commenters were also concerned about how the treatment of bundled price concessions in the ASP calculation would affect providers who do not purchase the drug as part of a bundling arrangement.

Some commenters did not take a position on whether specific guidance was needed on the treatment of bundled price concessions in the ASP calculation, citing both the general desirability of having guidance on various ASP reporting issues and concerns that a specific methodology with regard to bundled price concessions and ASP might be inflexible and hinder beneficial arrangements.

While most commenters did not offer a specific suggestion on a potential methodology for the treatment of bundled price concessions in the ASP calculation, a few commenters did. One commenter suggested that Medicare adopt for ASP purposes the apportionment methodology that the Medicaid rebate program requires manufacturers to use in the calculation of AMP and BP. The current Medicaid National Drug Rebate Agreement states that "for Bundled Sales, the allocation of the discount is made proportionately to the dollar value of the units of each drug sold under the bundled arrangement."

Another commenter suggested that we adopt the current Medicaid rebate program methodology for apportioning bundled price concessions described above, but create an exception for dominant drugs without significant clinical alternatives. This commenter stated that drug manufacturers do not have an incentive to provide discounts on dominant drugs that do not have significant clinical alternatives. As a result, the commenter believes that in situations where a "dominant" drug is bundled with non-dominant drugs, none of the bundled price concessions should be apportioned to the "dominant" drug. Furthermore, the commenter stated that if the Medicaid methodology were employed without an exception for dominant drugs, there would be the potential to lower the ASP for a dominant drug in a bundle while increasing the ASP for the other, non-dominant drugs in that bundle. The commenter believes such a policy would result in an unfair competitive advantage and would impose additional costs on the public health system and the Medicare program. The commenter stated that determining whether a bundling arrangement contained a dominant drug would be relatively easy for manufacturers, and suggested a number of criteria such as a drug's indication and risk profile, whether it is a single source product, its patent-protected status, the drug's market share, the relative magnitude of incentives provided on the drug both before and after it is inclusion in the bundle, the effect of the introduction of the drug into the bundle on the sales volume of other products in the bundle, and Medicare expenditures on the drug relative to potential alternatives.

In contrast, another commenter urged us not to adopt a methodology where price concessions offered on drugs sold under bundling arrangements are allocated across those drugs based on specified criteria. The commenter stated that the ASP is intended to reflect the prices available in the market for each product, and they believe reallocating discounts across drugs is unnecessary and could result in inaccurate ASPs, impaired beneficiary access, and inappropriate financial incentives. Another commenter stated that manufacturers should be allowed to make reasonable assumptions concerning the treatment of bundled price concessions in the ASP calculation, and that any bundled price concessions that meet a safe harbor to the OIG anti-kickback statute should be handled like nonbundled price concessions for ASP calculation purposes.

We also received some comments expressing satisfaction with current contracts with drug manufacturers, and raising concerns that the establishment of guidelines concerning the treatment of bundled price concessions in the ASP calculation may require them to renegotiate those contracts. In addition, we received some comments expressing concern about the affect of bundling arrangements on physician and health care provider's choice of products.

A number of commenters also raised the issue of Part B drugs being bundled with non-Part B drugs or other products. Some stated that when Part B drugs are bundled with other products, the bundled price concessions should not be apportioned from other products to Part B drugs, citing concerns that the Part B drug payment rates would be inappropriately low. However, another commenter believes that bundled price concessions should be allocated from non-Part B drug products to Part B drugs, stating that it otherwise results in government overpayments. A number of other commenters offered suggestions on how a bundle should be defined, with several commenters suggesting that discounts contingent on the placement of one or more products on a formulary should not constitute a bundle. We also received comments recommending that for the purposes of the ASP calculation we only consider bundling arrangements to exist in situations where several different products are sold for a single price, and the individual products do not have separately identifiable prices.

Finally, we note that the MedPAC commented that it would be examining the issue of bundled price concessions and the ASP in the upcoming year.

Response: In considering the issue of bundled price concessions, our goal is to ensure the accuracy of the ASP calculation and to prevent the treatment of bundled price concessions in the ASP calculation from creating inappropriate financial incentives. A number of comments suggested, that potential bundling arrangements may be complex and vary widely in terms of the structure and types of performance requirements upon which a bundled discount may be conditioned, the magnitude of price concessions, and the characteristics of the drugs or other products included in the bundle (for example, whether the bundle includes Part B drugs only or other products, the market position of products in the bundle, the relative sales volume of products in the bundle, and how commonly a particular product is sold under a bundling arrangement). Given the potentially wide range of bundling arrangements that might exist, based on the information we currently have about such arrangements, we are not in a position to determine, at this time, whether there is a universal approach for treating bundled price concessions in the ASP calculation that would address all potential structures of bundling arrangements in a manner that would achieve our goal of ensuring the accuracy of the ASP payment methodology and preventing inappropriate financial incentives.

Furthermore, we note that we received a comment suggesting that Medicare adopt a special policy concerning the treatment of bundled price concessions in the ASP calculation for bundling arrangements that include dominant drugs without significant clinical alternatives. We do not believe it would be feasible for the Medicare program to establish a definition of a dominant drug without significant clinical alternatives that would be precise enough to clearly delineate when a product was or was not dominant, especially given the potential for great variation in the structure of bundling arrangements and the characteristics of drugs included in those arrangements.

Since we do not yet fully understand the variety of bundling arrangements that exist in the marketplace and how they are likely to evolve over time, we believe it is important to be cautious in establishing a specific methodology that all manufacturers must follow for ASP purposes. Consequently, we are not establishing a specific methodology that manufacturers must use for the treatment of bundled price concessions for purposes of the ASP calculation at this time. In the absence of specific guidance, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Act, Federal regulations, and its customary business practices. Our intent in not being prescriptive in this area at this time is to allow manufacturers the flexibility to adopt a methodology with regard to the treatment of bundled price concessions in the ASP calculation that, based on their particular circumstances, will best ensure the accuracy of the ASP calculation and not create inappropriate financial incentives.

Recognizing that the treatment of bundled price concessions in the ASP calculation has implications for the integrity of the ASP payment methodology, we will be paying close attention to this issue and may provide more specific guidance in the future through rulemaking or through program instruction or other guidance (consistent with our authority under section 1847(c)(5)(C) of the Act) if we determine it is warranted. Furthermore, as we continue to monitor this issue, we want to be sure we are aware of concerns from all stakeholders, and thus we encourage the public to relay additional information or concerns to us on this issue as they may arise. In addition, we note that MedPAC has indicated it will be studying this issue in the upcoming year, and we look forward to its work in this area.

Finally, we emphasize that we expect manufacturers of drugs reimbursed by Medicare Part B to comply with all applicable laws, regulations, and legal decisions including, but not limited to the Stark law, other relevant anti-kickback laws, antitrust laws, and laws governing fair trade practices. Our discussion of this issue should not be construed as an endorsement or authorization of any pricing practices that contravene any laws, legal decisions, or regulations.

f. Other ASP Reporting Issues

Comment: Several commenters stated that it can be difficult for manufacturers to determine which drugs are subject to the ASP reporting requirements, considering that section 1927(b)(3)(A)(iii) of the statute states that ASP data must be reported for drugs that are described in subparagraph (C), (D), (E), or (G) of section 1842(o)(1), or 1881(b)(13)(A)(ii) of the Act.

Response: In general, these subparagraphs refer to broad categories of drugs covered by Medicare Part B such as drugs that are administered incident to a physician's service in physician offices; certain immunosuppressive, oral anticancer, and oral anti-emetic drugs supplied by pharmacies; infusion drugs furnished through an item of DME; intravenous immune globulin (IVIG), inhalation drugs furnished through an item of DME, and separately payable drugs furnished by ESRD providers. Because Medicare Part B drugs are subject to local coverage determinations (LCDs) by the local claims processing contractors and the scope of Part B drug coverage varies among contractors, we do not maintain a list of all drugs covered under Part B at any given time in all contractor jurisdictions. However, the following resources may be helpful and can be retrieved at http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/02_aspfiles.asp#TopOfPage.

The NDC to HCPCS crosswalk is posted quarterly on our Web site and lists a majority of billing codes used by providers to submit claims for drugs. We welcome ongoing feedback on the accuracy of the crosswalk. We also publish a list of many of the frequently administered drugs that are billed using the not otherwise classified billing codes.

Comment: Several commenters suggested that we develop a formal process for requesting a determination of whether for a particular NDC the ASP reporting requirements apply. These commenters contend such a process is necessary particularly for drugs that may be typically self-administered, may be used for prevention or cosmetic purposes, are available in potentially noncovered forms, and new drugs for which LCDs have not yet been made.

Response: Medicare Part B drug coverage under title XVIII is generally limited to certain drugs within specific benefit categories as described at the beginning of this section. For the most part, we believe manufacturers have identified the drugs for which they have an ASP reporting obligation. Medicare has established processes for issuing national, as well as local, coverage determinations for Part B drugs and other services. Therefore, we are not persuaded by the commenters that an entirely separate process is necessary for assisting manufacturers in determining whether a drug qualifies for coverage under Part B as a means of determining whether it is subject to the ASP reporting requirements. We encourage manufacturers to contact us directly to discuss the specifics of their ASP reporting concerns.

Comment: One commenter asked us to clarify whether manufacturers have to include in their calculation of the ASP for a given NDC sales of that NDC that are used for purposes not covered by Medicare Part B. The commenter also wanted to know if NDCs that are labeled for Medicare noncovered indications are subject to the ASP reporting provisions.

Response: With respect to whether a manufacturer may exclude sales for noncovered uses from its calculation of the ASP for an NDC and whether NDCs that are labeled for cosmetic or other typically noncovered use (for example, contraception) are exempt from the ASP reporting requirements, we believe the statute provides no such exclusion.

Comment: Another commenter suggested that we clarify whether manufacturers are required to report ASP data for infusion drugs administered via DME and for a drug that is usually self-administered and not covered by Medicare Part B (even if Medicare utilization data suggests that there are small levels of utilization which a manufacturer believes are contractor mistakes).

Response: Section 1927(b)(3)(A)(iii) of the Act specifies the drugs for which manufacturers have to report ASP data, and it includes infusion drugs furnished through an item of DME (by reference to section 1842(o)(1)(D) of the Act). Manufacturers must report ASP data for these drugs quarterly.

With respect to drugs that a manufacturer believes are noncovered by Medicare despite a local claims processing contractor's payments for the drug, we are aware of one such situation and have been working closely with the manufacturer to resolve the matter. We encourage manufacturers to contact us directly so that we can consider these issues on a case-by-case basis.

Comment: One manufacturer expressed concern that submitting ASP data for a noncovered drug may be viewed as a claim for coverage.

Response: We do not believe that reporting ASP data for a drug, in the absence of other actions, would be a claim of coverage for the drug.

Comment: A few commenters requested clarification regarding when a manufacturer's reporting obligation for an NDC ends. One commenter noted that ASP will not be a positive number unless there is product sold in a quarter, and suggest there is no need to report the ASP after the last lot is sold.

Response: In the March 3, 2006 Federal Register (71 FR 10975), we clarified that manufacturers would no longer report ASP data for an NDC beginning the reporting period after they report the ASP data for the quarter during which the expiration date of the last lot sold occurs. We are aware that a manufacturer's ASP will not be a positive value unless a reportable sale occurs in the reporting period. However, for single source drugs, manufacturers not only have a requirement to report ASP but also wholesale acquisition cost (WAC).

Comment: Several commenters requested that we clarify whether the manufacturer that holds title to the NDC is always responsible for reporting the ASP data, and whether certain exceptions are permissible such as when manufacturers establish licensing agreements or a manufacturer divests a product but the NDC's labeler code is not changed. Some commenters stated that the title-holding manufacturer should determine which entity has the ASP reporting obligation. In addition, a commenter requested that manufacturers not be required to certify ASP data that they did not have access to or did not generate. One commenter suggested that a manufacturer's ASP reporting obligation would cease upon the transfer of the product to another manufacturer with control over its pricing.

Response: For ASP purposes, the definition of manufacturer has the same definition set forth in section 1927(k)(5) of the Act, which is the definition included in the Medicaid drug rebate statute. We believe that likewise the ASP reporting obligation should follow the process established under the Medicaid drug rebate program, and we see no reason to establish separate guidance at this time. Further, we believe that manufacturers have means of dealing with these issues within their business arrangements.

Comment: One commenter recommended that we provide guidance that sales between wholly-owned subsidiaries of a common parent company would not constitute a sale for ASP reporting and calculation purposes.

Response: We will consider the issue and any broader implications it may have for the ASP calculation, and may issue additional guidance if we determine it is appropriate.

Comment: Some manufacturers supported maintaining the same definition of manufacturer for ASP purposes and for Medicaid AMP and BP purposes. Several commenters requested that we formally state that wholesalers and distributors do not have to report ASP data. A retail pharmacy chain requested that retail pharmacies be excluded from the definition of manufacturer in so far as they repackage drugs for purposes of dispensing drugs to customers under state law. Similarly, a mail order pharmacy requested that we clarify that mail order pharmacies are not considered manufacturers. One commenter suggested that only the holders of the product's New Drug Approval, Abbreviated New Drug Approval, or Biologic License Application should be considered manufacturers or repackagers for the purposes of reporting ASP.

Response: Under section 1847A of the Act, entities that fall under the definition of manufacturers in section 1927(k)(5) of the Act must report ASP data. This definition is separate from the FDA process for drug applications. We interpret manufacturer for ASP purposes to have the same meaning as under the Medicaid Rebate Agreement. Therefore, wholesalers that relabel or repackage NDCs and pharmacies must report ASP data to the extent that they qualify as manufacturers for Medicaid drug rebate purposes.

Comment: A few commenters requested that we formalize our guidance on whether sales in the United States include sales to purchasers in the territories.

Response: We are not addressing this issue in the regulations text.

Comment: A few commenters requested that we incorporate into the regulation our current guidance on the treatment of returned units.

Response: We issued guidance on our Web site in September 2004 instructing manufacturers not to make adjustments to the ASP calculation to account for returns. We stated in that guidance beginning with the data submission for sales during the third quarter of 2004 and thereafter, manufacturers should not subtract the value of the returns from the numerator of the ASP calculation and should not subtract the number of units returned from the denominator. In other words, the value of returns should not be included in the numerator and the number of returned units should not be included in the denominator when calculating the ASP for a reporting quarter. This continues be our guidance as we study the issue further, but we have decided not to place this guidance into the regulation text at this time.

Comment: Some of the commenters noted that, at this time, manufacturers' reasonable assumptions continue to be an important principle in ensuring that the calculation of ASP is appropriate. Several commenters suggested we include in the final rule guidance we have previously provided through QA that in the absence of guidance manufacturers may make reasonable assumptions and should provide those assumptions in their ASP submission.

Response: We agree with these commenters; manufacturers' reasonable assumptions remain an important aspect of ASP reporting. The complexities of each calculation can differ across manufacturers. Therefore, it is essential that each manufacturer examine the facts and complexities of its business practices and products to determine how it will comply with the ASP reporting requirements. We posted a frequently asked question on our Web site to inform manufacturers of the importance of reasonable assumptions. In that guidance we state, "In the absence of specific guidance in the Act or Federal regulations, the manufacturer may make reasonable assumptions in its calculations of ASP, consistent with the general requirements and the intent of the Act, Federal regulations, and its customary business practices. These assumptions should be submitted along with the ASP data and the signed certification form."

Comment: Some commenters wanted to know whether data on nominal sales must be reported at this time as required under section 1927(b)(3)(A)(iii)(III) of the Act.

Response: We currently consider the requirements of section 1927(b)(3)(A)(iii)(III) of the Act for the reporting of nominal prices for purposes of ASP to be met when the manufacturer reports its ASPs, to the extent that the ASPs accurately account for nominal prices that are excluded from the ASP calculation. Thus, we are not currently requiring this information to be separately reported from the ASP. As we gain more experience with the ASP system, we may require this information to be separately reported in the future. We note that our interpretation of the reporting requirement for nominal prices for purposes of ASP has no effect on any Medicaid reporting requirement.

Comment: Several commenters stated that the statute does not require certification of the ASP by the manufacturer's chief financial officer (CFO), chief executive officer (CEO) or individual who has delegated authority to sign for and reports directly to either the CFO or CEO. A large international manufacturer commented that it was impractical to have ASP reports certified by international executives. Another manufacturer commented that its organizational structure did not have executives matching the specified titles, and therefore, it was impossible to comply with this requirement. Further, many commenters stated that it was inappropriate to require certification of the ASP data until sufficient guidance on how to calculate the ASP has been established. A few commenters suggested that the certification language should be revised to acknowledge that reasonable assumptions had been made and to reflect the limited ability of manufacturers to accurately estimate lagged price concessions and determine whether fees were passed on in whole or in part. Another commenter stated that the penalties for failing to report accurate ASP data are a sufficient deterrent to abuse, and the certification is unnecessary and should be eliminated.

Response: Because of the consequences for failing to submit accurate and timely ASP data, we continue to believe there is good reason to require that each ASP report be certified by the manufacturer at this time. With the ASP data being the basis of Medicare payment rates for the vast majority of Part B covered drugs and biologicals, we believe that certification requirement is an important program safeguard. We acknowledge the operational constraints some manufacturers may experience in obtaining certain senior executive level signatures to coincide with the quarterly ASP reporting deadlines, although our experience is that nearly all manufacturers are able to do so without causing a delay in reporting their ASP data timely.

Comment: Several commenters noted that the Medicaid AMP and BP can be restated within the specified time period. These commenters requested that we establish procedures to identify potentially errant ASP data and to allow for corrections of ASP data.

Response: If a manufacturer has good cause for resubmitting its quarterly ASP data, it may do so following the submission instructions available at http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg. Resubmission of ASP data does not constitute a release from liability for failure to submit timely and accurate ASP data.

Comment: Several manufacturers suggested that the reasonable assumptions submitted along with the ASP data be afforded the same confidential protections as specified for the ASP data.

Response: We provided guidance on our Web site addressing this issue. That guidance states, "As indicated in section 1927(b)(3)(D) of the Act, as amended by MMA section 303(i)(4)(D), information disclosed by the manufacturer in connection with the requirement for ASP data submission is confidential and, not withstanding other laws, shall not be disclosed by the Secretary (or contractor therewith) in a form which discloses the identity of a specific manufacturer or wholesaler, prices charged for drugs by such manufacturer or wholesaler, except as necessary by the Secretary to carry out the provisions of section 1847A or 1847B of the Act, and to permit the OIG, the Comptroller General, and the Director of the Congressional Budget Office to review the information provided. http://questions.cms.hhs.gov/cgi-bin/cmshhs.cfg. As is good practice with any sensitive material, manufacturers should clearly mark their reported ASP data, if applicable, to indicate that the information contained therein is confidential, proprietary, or contains trade secrets, for example, as appropriate.

Comment: One commenter asked that we clarify that the number units to be reported are the number of units sold excluding exempted sales.

Response: The commenter is correct. Effective with the publication of the FY 2007 IPPS final rule (August 18, 2006, 71 FR 47870), we revised the definition of unit in § 414.802. "Unit" means the product represented by the 11-digit NDC. During the first 3 years of the CAP (as defined in § 414.902), the method of counting units excludes units of CAP drugs (as defined in § 414.902) for use under the CAP (as defined in § 414.902). The CAP is the Competitive Acquisition for Outpatient Part B Drug and Biologicals which began in July 2006. Units of drugs sold to an approved CAP vendor for use under the CAP are excluded from the ASP calculation. Manufacturers must report the number of units sold after adjusting for exempted sales, including exempted sales known on a lagged basis.

Comment: In response to the April 6, 2006 IFC, a commenter stated that some manufacturers submit AMP and then restate it in subsequent periods to take into account rebates. The commenter requested that we provide assurance that they will not be liable for misrepresentation of nominal sales, if the manufacturer bases its nominal sales on AMP for the reporting quarter and then the manufacturer modifies AMP subsequently to take into account rebates.

Response: Nominal sales for ASP purposes are calculated based on the AMP for the reporting quarter. We have not provided guidance on how a manufacturer should handle identification of nominal sales if current reporting quarter AMP is subsequently restated for Medicaid purposes. We did not receive comments on this issue in response to our request in the proposed rule regarding the method manufacturers must use to identify nominal sales. We believe that maunfacturers may have considered this issue in making their comments in support of continued use of the AMP as the basis for determining nominal sales excluded from the calculation of ASP. We will continue to work with manufacturers to determine if further guidance on this issue is warranted. With regard to the comment concerning liability, if the Secretary determines that a manufacturer has made a misrepresentation in the reporting of its ASP for a drug, the Secretary may apply a civil money penalty as specified in section 1847A(d)(4) of the Act.

Comment: One commenter suggests we explore methods of receiving ASP data by e-mail. This commenter also recommends we include information in the final rule on where and how to submit ASP data.

Response: At this time, we do not permit electronic mail submission of ASP data because the confidentiality of the ASP data would not be assured. However, we continue to explore opportunities for enhancing the efficiency of the ASP submission process. Procedural information on how and where to submit ASP data is provided in a QA on our Web site. We believe it is best to provide information on the logistics of how and where to submit the ASP data through our Web site, which can be updated more quickly than a regulation.

Comment: We received comments recommending we provide guidance in the final regulation on requirements related to the reporting of WAC and urged Addendum A to be revised to include this information.

Response: In the CY 2006 PFS final rule, we clarified that manufacturers must report WAC for all single source drugs (including new drugs) each reporting period in addition to reporting ASP. Manufacturers must report the WAC in effect on the last day of the reporting period. Effective July 2006, we revised the reporting template, Addendum A, to include a specific column for reporting WAC. Addendum A can be found on our Web site at- http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/.

Comment: We received comments suggesting that we publicize the NDC-HCPCS crosswalk and have a process for informing manufacturers of where changes have occurred, and a process for soliciting and responding to input on the crosswalk. Also, they suggest establishing procedures so manufacturers can determine whether we are defining package codes correctly.

Response: Every quarter, we publish on the CMS Web site a crosswalk of NDCs to HCPCS codes. Included in the crosswalk is information on the package size and package quantity that we believe is reflected by each NDC. The crosswalk file provides an e-mail address ( sec303aspdata@cms.hhs.gov ) to which individuals can send comments. Furthermore, as of July 2006, manufacturers are now required to report with their ASP submission specific information on the package size of each NDC as specified in more detail in the Appendix A data elements guide on our Web site.

Comment: We received comments requesting clarification of how and when civil monetary penalties would apply in certain situations where ASP was misreported.

Response: If the Secretary determines that manufacturer has made a misrepresentation in the reporting of its ASP for a drug, the Secretary may apply a civil money penalty in section 1847A(d)(4) of the Act.

Comment: One commenter suggested that we consider requiring manufacturers to report ASP data monthly.

Response: Section 1927(b)(3) of the Act sets forth the quarterly reporting requirement. We believe changes to the frequency of ASP reporting would require a statutory change.

Comment: One commenter noted that for Medicaid BP determinations manufacturers may not exempt prices given to State pharmacy assistance programs that we have not identified as a State Pharmaceutical Assistance Program excluded from the Medicaid BP and may not exclude Medicaid supplemental rebates that are not under an approved supplemental rebate agreement. This commenter asked whether the same rule applies to excluding exempt sales from the ASP calculation.

Response: To be excluded from the ASP calculation, the Medicaid supplemental rebates must be under an approved supplemental rebate agreement authorized by us through a Medicaid State plan, and the State pharmacy assistance programs must be identified by us as State Pharmaceutical Assistance Program excluded from the Medicaid BP.

Comment: We received a comment in response to the April 6, 2004 IFC, asking us to provide more clarification on a methodology that we indicated manufacturers should use in situations where a manufacturer is unable to associate price concessions with individual 11-digit NDCs. The commenter requested information on several technical aspects of the formula, including one scenario involving bundled price concessions.

Response: In the April 6, 2004 IFC with comment, we indicated that if a manufacturer is unable to associate price concessions to the individual NDC level, the manufacturer should associate those price concessions within the group of NDCs for which it can associate the price concessions based on the percentage of sales (in dollars) for the group of NDCs that is attributable to each individual NDC. This guidance was issued in the early stages of ASP implementation, and was intended to address situations where manufacturers are unable to associate price concessions to the 11-digit NDC level such as when a manufacturer reporting maintains data on rebates at the drug level rather than at the 11-digit NDC level.

In response to the commenter's request for clarification on a technical aspect of the methodology described above in a situation involving bundled price concessions, we are clarifying in this final rule with comment that this policy was not intended to be guidance on the treatment of bundled price concessions (for example, when price concessions on one drug are contingent on the purchase of one or more other drugs) in the ASP calculation. As discussed in more detail elsewhere in this preamble, we have not provided specific guidance on the methodology manufacturers should use for the treatment of bundled price concessions in the ASP calculation. In terms of the commenter's request for additional clarification on other technical aspects of the calculation described above, we believe the level of detail prescribed on the technical aspects of the calculation is sufficient, given the variation in price concession offerings across manufacturers.

After consideration of the public comments, we are finalizing subpart J (§§ 414.800 through 414.806) by-(1) revising § 414.802 and § 414.804 as specified in this section of the preamble to this final rule with comment; and (2) incorporating the provisions of § 414.800 and § 414.806 as specified in the April 6, 2004 IFC without change.

2. Intravenous Immune Globulin (IVIG)

Comment: We received several comments urging the continuation of the 1-year temporary preadministration-related services fee for IVIG that we established for 2006. Commenters stated that there continue to be concerns with IVIG access and availability and that eliminating the fee will have an adverse impact on beneficiary access to care. Furthermore, some indicated that we did not provide any rationale in the proposed rule for why the fee was no longer needed.

A number of commenters expressed concerns about the adequacy of Medicare's drug and drug administration payment rates for IVIG, and made some suggestions for changes to these payment rates that they have previously expressed to us. For example, some urged us to take actions such as establishing separate HCPCS codes for each IVIG product, increasing payment for IVIG administration in physicians' offices, and instituting a payment adjustment to the ASP-based payment rates for IVIG.

One commenter provided information from a survey conducted of 800 patients with primary immune deficiency syndrome. The commenter stated that since the beginning of 2005, Medicare patients receiving IVIG have been more likely than patients with other types of insurance to report a shift in site of care, increased intervals between infusions, reduced IVIG dosages, and adverse health effects, and they believe that this is the result of Medicare reimbursement issues.

Response: We recognize the importance of IVIG to patients who need it and we are concerned about reports of problems with IVIG access and availability. Since 2005, we have taken several specific actions that are within our statutory authority in response to the IVIG concerns that have been raised, including creating separate billing codes for lyophilized and non-lyophilized IVIG in April 2005, having discussions with manufacturers about their ASP data to confirm that their ASPs have been developed in accordance with applicable guidance, and for 2006 establishing a temporary additional payment for IVIG preadministration-related services to compensate physicians and hospital OPDs for extra resources expended on locating and obtaining appropriate IVIG products and on scheduling patients infusions during a period where there may be temporary market instability. In addition, we continue to work with manufacturers, patient groups, and stakeholders to understand the present situation and to assess potential actions that could help ensure an adequate supply of IVIG and patients receiving appropriate, high quality care.

Furthermore, there are currently two studies underway in HHS concerning IVIG. The HHS Assistant Secretary for Planning and Evaluation has commissioned a study to better understand the market for IVIG and evaluate the demand, supply, and access to IVIG. The HHS OIG is also conducting a study on availability and pricing of IVIG. We anticipate that these studies will provide more information on IVIG supply, demand, and pricing.

With several studies on IVIG not yet completed and with comments from stakeholders suggesting that some beneficiaries are experiencing IVIG access issues such as delayed treatments and site of service shifts, we believe it is appropriate to continue the temporary IVIG preadministration-related services payment into CY 2007 to help ensure continued patient access to IVIG. We will continue to review IVIG access during CY 2007 as additional information becomes available, and we will discontinue this temporary preadministration-related service payment during CY 2007 through rulemaking if we determine it is no longer warranted. Consequently, in 2007, we will temporarily allow a separate payment for each day of IVIG administration to physicians and hospital OPDs that administer IVIG to Medicare beneficiaries. This payment is for the extra resources expended on locating and obtaining appropriate IVIG products and on scheduling patients' infusions during this time when there may continue to be transient disruptions in the marketplace. In 2007, the preadministration-related service payment will continue to be billed under the same HCPCS code as 2006: G0332, preadministration-related services for intravenous infusion of immunoglobulin, per infusion encounter (This service is to be billed in conjunction with administration of immunoglobulin ). This payment will on average be about $71 per day of IVIG administration in physicians' offices. The payment for preadministration-related services is in addition to the separate payments Medicare makes for the IVIG product itself and its administration.

We note that for 2007 we reviewed and revised the resource based relative value units crosswalk for G0332. We continue to believe the administrative resources associated with IVIG preadministration-related services are similar to the clinical staff resources associated with ESRD management services, where both types of services are typically conducted over the course of a month, without requiring face-to-face visits with clinical staff for this ongoing preparation for treatment of these patients. Considering the expected staff resources required to prepare for IVIG infusions for patients who require them, we believe those resources are greater than the lowest level ESRD-related service described by HCPCS code G0319, End stage renal disease (ESRD) related services during the course of treatment, for patients 20 years of age and over; with one face-to-face physician visit per month, but we do not believe they are as great as those required by the mid-level ESRD-related code G0318, End stage renal disease (ESRD) related services during the course of treatment, for patients 20 years of age and over; with 2 or 3 face-to-face physician visits per month. Therefore, for 2007, we have crosswalked G0332 to a 50 percent blend of the 2007 transitional PE RVUs for G0318 and G0319. As we did for 2006, we have not allocated physician work RVUs to G0332 since we do not believe there is physician work associated with G0332.

We believe that continuation of this temporary separate payment provided through G0332 in CY 2007 for the physician office and hospital outpatient resources associated with additional IVIG preadministration-related services will help facilitate beneficiary access to care in this current period where there may be continuing market fluctuations for IVIG products. At the same time, we will continue to work with the IVIG community, manufacturers, providers, and other stakeholders, and will be monitoring IVIG market developments and access to care closely.

Commenters made several suggestions for changes to Medicare IVIG-related payments. Regarding comments requesting the establishment of brand-specific HCPCS codes for IVIG products, while HCPCS coding is outside the scope of this rulemaking, we note that HCPCS coding procedures do not provide for brand-specific coding. For further discussion of HCPCS coding procedures, see http://www.cms.hhs.gov/medicare/hcpcs/codpayproc.asp.

Commenters also expressed concern regarding Medicare ASP+6 percent payment rates for IVIG, suggesting we make an adjustment to the payment rate. Section 1847(o)(1)(E) of the Act specifies that the payment amount for IVIG furnished in physicians' offices and the home will be the amount provided under section 1847A of the Act. With limited exceptions not applicable here, section 1847A of the Act specifies that the payment amount is 106 percent of a drug's ASP. We do not have the discretion to adjust the payment rate upward by adjusting the percentage that is added on to the ASP to arrive at the payment rate. While some commenters suggested we use inherent reasonableness authority to increase the IVIG payment rate, we do not believe that we have the data to support a determination concerning inherent reasonableness. Finally, we received several comments requesting that we classify IVIG therapy as a biological response modifier. We note that the term "biological response modifier" is used in the text preceding CY 2006 CPT codes, and as such, we refer commenters to the AMA CPT Editorial Panel, as they are the creators and maintainers of CPT codes and CPT code instructions.

3. Clotting Factor Furnishing Fee

Section 303(e)(1) of the MMA added section 1842(o)(5) of the Act which requires the Secretary, beginning in CY 2005, to pay a furnishing fee, in an amount the Secretary determines to be appropriate, to hemophilia treatment centers and homecare companies for the items and services associated with the furnishing of blood clotting factor. Section 1842(o)(5)(C) of the Act specifies that the furnishing fee for clotting factor for years after CY 2006 and subsequent years will be equal to the fee for the previous year increased by the percentage increase in the consumer price index (CPI) for medical care for the 12-month period ending with June of the previous year.

The 2006 furnishing fee for clotting factor is $0.146. The percent increase in the CPI for medical care for the 12-month period ending with June 2006 is 4.1 percent. Consequently, the furnishing fee will be $0.152 per unit clotting factor for CY 2007. While the furnishing fee payment rate is calculated at 3 digits, the actual amount paid to providers and suppliers is rounded to 2 digits.

4. Widely Available Market Prices (WAMP) and Average Manufacturer Price (AMP) Threshold

Section 1847A(d)(1) of the Act states that "the Inspector General of HHS shall conduct studies, which may include surveys to determine the widely available market prices (WAMP) of drugs and biologicals to which this section applies, as the Inspector General, in consultation with the Secretary, determines to be appropriate." Section 1847A(d)(2) of the Act states that, "based upon such studies and other data for drugs and biologicals, the Inspector General shall compare the ASP under this section for drugs and biologicals with-

• The WAMP for these drugs and biologicals (if any); and

• The AMP (as determined under section 1927(k)(1) of the Act) for such drugs and biologicals."

Section 1847A(d)(3)(A) of the Act states that, "the Secretary may disregard the ASP for a drug or biological that exceeds the WAMP or the AMP for such drug or biological by the applicable threshold percentage (as defined in paragraph 1847A(d)(3)(B))." The applicable threshold is specified as 5 percent for CY 2005. For CY 2006 and subsequent years, section 1847A(d)(3)(B) of the Act establishes that the applicable threshold is the percentage applied thereafter, subject to such adjustment as the Secretary may specify for the WAMP or the AMP, or both. In CY 2006, we specified an applicable threshold percentage of 5 percent for both the WAMP and AMP. We based this decision on the limited data available to support a change in the current threshold percentage.

For CY 2007, we proposed to specify an applicable threshold percentage of 5 percent for the WAMP and the AMP. At present, the OIG is continuing its comparison of both the WAMP and the AMP. Currently, we do not have data that suggests that another level is more appropriate. Therefore, we believe that continuing the 5 percent applicable threshold percentage for both the WAMP and AMP is appropriate.

We received numerous comments regarding our decision to maintain the WAMP and AMP threshold at 5 percent, as well as our request for comments regarding operational issues surrounding implementation of the 5 percent threshold.

Comment: Several comments supported our decision to continue using 5 percent as the threshold and commended us for requesting comments on the important operational issues associated with price comparisons. Other commenters acknowledged that that there are many operational issues involved with implementation of the 5 percent threshold and advised us to proceed cautiously before adjusting payment amounts. These commenters stated that the AMP and the ASP use different methodologies when accounting for price concessions and such differences could result in varied ASP and AMP values. They also indicated that we have never issued a final rule describing how the AMP is calculated. The commenters indicated that such differences must be accounted for prior to substituting the WAMP or the AMP for the ASP. Commenters also encouraged us to provide stakeholders with an opportunity to comment through rulemaking prior to proceeding with the substitutions of payment allowances. Commenters were particularly interested in the methodology utilized by the OIG in conducting its surveys.

Response: We understand that there are complicated operational issues associated with potential payment rate substitutions. Therefore we will proceed cautiously and provide stakeholders, particularly manufacturers of drugs impacted by potential price substitutions, with adequate notice of our intentions regarding such, including the opportunity to provide input with regard to the processes for substituting the WAMP or the AMP for the ASP. As required by statute, we are finalizing our proposal to establish the WAMP and AMP threshold at 5 percent for CY 2007.

5. Payment for Drugs Furnished During CY 2006 and Subsequent Years in Connection With the Furnishing of Renal Dialysis Services if Separately Billed by Renal Dialysis Facilities

In the CY 2006 PFS final rule (70 FR 70116), we stated that payment for a drug furnished during CY 2006 in connection with renal dialysis services and separately billed by freestanding renal dialysis facilities and hospital-based facilities would be based on section 1847A of the Act. For CY 2007, we clarified that the policy would extend for CY 2006 and subsequent years until otherwise specified. We received comments regarding our policy clarification of the policy, as well as our intention to extend the policy beyond CY 2006 until otherwise specified.

Comment: Several commenters supported our decision to clarify that the payment policy for separately-billed ESRD drugs applied to CY 2006 and subsequent years until otherwise specified. These commenters viewed the current payment policy as the best option available under the statute, citing consistency with the methodology used to pay for other Part B drugs. Commenters indicated that the current methodology was more accurate and easier to administer than attempting to update a prior year's acquisition cost data. Other commenters, while applauding our decision to clarify the policy, explicitly encouraged us to be more direct and expressly state that the payment for drugs furnished in connection with renal dialysis services and separately billed by freestanding renal dialysis facilities and hospital-based facilities will be based on ASP+6 percent. They indicated that stating that payment would be based on ASP+6 percent rather than stating that payment will be based on section 1847A of the Act would avoid confusion, provide clarity for the provider community, and ensure consistency with current regulatory language.

Response: We appreciate the commenters who acknowledge that the current payment methodology is the most appropriate option available. We also thank the commenters who noted the discrepancy between the preamble language and regulatory text. We acknowledge that we inadvertently made reference to ASP+6 percent in our regulatory text instead of referring to section 1847A of the Act. In accordance with section 1881(b)(13)(A)(iii), payment for drugs furnished in 2006 and subsequent years will be based on the acquisition costs or the amount determined under section 1847A of the Act, as the Secretary may specify. The amount determined under section 1847A of the Act, except in limited circumstances, is ASP+6 percent. Therefore, we are revising the regulatory text to state that payment for a drug furnished during CY 2006 and subsequent years, until otherwise specified, in connection with renal dialysis services and separately billed by freestanding renal dialysis facilities and hospital-based facilities is based on section 1847A of the Act.

Comment: MedPAC expressed concern that there is no recent evidence that ASP+6 percent reflects the variation in the acquisition of costs of physicians and dialysis providers and thus, the current payment rate should not be set indefinitely. They also recommended that in the future we periodically collect acquisition cost data from providers to gauge the appropriate percentage of ASP for the payment amount, acknowledging that an analysis of this data could lead to a different percentage amount for the payment rate.

Response: We acknowledge MedPAC's recommendations. We will continue to monitor the payment methodology in relation to the acquisition costs of physician and dialysis providers for future analysis.

6. Other Issues

Comment: We have received several comments requesting the creation or revision of billing codes for certain drug products.

Response: Requests for the creation of new or revised billing codes for drug products is outside the scope of this rulemaking. There is a separate, well-established, process for the public to make requests for new or revised billing codes for drug products through the HCPCS panel. More information on the HCPCS coding process can be obtained at the following Web site: http://www.cms.hhs.gov/MedHCPCSGenInfo/.

Comment: We received a few comments recommending that Medicare increase the pharmacy supplying fee it pays for immunosuppressive, oral anti-cancer, and oral-antiemetic drugs for 2007. We also received a comment suggesting that we have a process in place to increase the supplying fee over time so that it remains adequate. In addition, we received a comment asking that we make clear in the final rule that we will continue to reimburse the supplying fee in 2007 at the 2006 rates.

Response: We pay a supplying fee for Medicare Part B drugs and biologicals eligible for a supplying fee are immunosuppressive drugs described in section 1861(s)(2)(J) of the Act, oral anticancer chemotherapeutic drugs described in section 1861(s)(2)(Q) of the Act, and oral anti-emetic drugs used as part of an anticancer chemotherapeutic regimen described in section 1861(s)(2)(T) of the Act. For 2006, we pay a supplying fee of $24 per prescription for the first prescription in a 30-day period, and $16 per prescription for all subsequent prescriptions in a 30-day period. Medicare also pays a special supplying fee rate of $50 for the first immunosuppressive prescription after a Medicare covered transplant. Since we did not propose a change to these rates for 2007, they will continue to be in effect in 2007.

Comment: We received a comment asking that we clarify how infusion drugs administered through DME will be paid in 2007, in light of the competitive bidding program that is authorized to be phased-in beginning in 2007.

Response: Beginning in 2004, infusion drugs furnished through an item of DME covered under section 1861(n) of the Act are paid at 95 percent of the AWP in effect as of October 1, 2003. These payment rates continue until such time as the Secretary establishes a competitive acquisition program for these drugs in specific competitive acquisition areas, in which case the payment rates in the competitive acquisition areas will be determined under the CAP. Beginning in 2007, the Secretary has the authority, under section 1847 of the Act, to phase-in implementation of the competitive acquisition program, which will be the subject of separate rulemaking.

G. Revisions Related to Payment for Renal Dialysis Services Furnished by End Stage Renal Disease (ESRD) Facilities

In the CY 2007 PFS proposed rule (71 FR 48982), we outlined the proposed updates to the case-mix adjusted composite rate payment system established under section 1881(b)(12) of the Act, added by section 623 of the MMA. These included updates to the drug add-on component of the composite rate system, as well as the wage index values used to adjust the labor component of the composite payment rate.

Specifically, we proposed the following provisions which are described in more detail below in this section.

• A method to annually calculate the growth update to the drug add-on adjustment required by section 1881(b)(12) of the Act, as well as an estimated growth update adjustment to the add-on amount for CY 2007.

• An update to the wage index adjustments to reflect the latest hospital wage data, including a BN adjustment to the wage index for CY 2007.

We received a total of 10 comments from the ESRD community that represented major organizations and concerned individuals. The comments and responses are summarized in the following sections.

Comment: Several comments focused on the need to specify that payment for separately billable ESRD drugs in CY 2007 will continue at ASP +6 percent. The comments cross referenced a section in the CY 2007 PFS proposed rule (71 FR 49004) that discussed proposals for establishing the ASP rate for WAMPs and AMP. This proposal preceded the section outlining the proposed payment changes for ESRD facilities, and thus led to some confusion regarding the use of the ASP-based payment methodology for separately billable ESRD drug payments in CY 2007.

Response: As noted in section II.E.5., entitled, "Payment for Drugs Furnished during CY 2006 and Subsequent Years in Connection with the Furnishing of Renal Dialysis Services if Separately Billed by Renal Dialysis Facilities," we proposed no policy changes to the approach that we currently use to pay for separately billed ESRD drugs. Therefore, for CY 2007, payment for separately billable drugs furnished by ESRD facilities will continue at ASP+6 percent in accordance with section 1847A of the Act.

Comment: We received a comment recommending that we implement the MedPAC's recommendation that the composite rate be equalized between hospital-based and independent dialysis facilities. The commenter stated that, notwithstanding the language under 1881(b)(7) of the Act, we had the statutory authority to administratively revise the current hospital-based/independent facility rate structure to provide the same rate to both facility types.

Response: While section 1881(b)(7) of the Act provided some discretion in establishing the initial composite payment rates, it did specify the need to differentiate between hospital-based and other renal dialysis facilities. Therefore, based on our analysis of cost differences, we established separate composite rates for hospital-based facilities and independent facilities. Section 1881(b)(12) of the Act, added by section 623(d) of MMA, established a new basic case-mix adjusted payment system. The statute instructed us to use, as one of the elements of the new system, the services comprising the composite rate established under section 1881(b)(7) of the Act. We believe that the statute requires that we carry forward the composite rate structure established in accordance with section 1881(b)(7) of the Act prior to enactment of MMA. The statute directed us to substitute, in place of a payment system based solely on the composite rate established under section 1881(b)(7) of the Act, a payment system comprised of the original composite rate, incorporating the services included under that composite rate, plus a drug add-on component. Moreover, the 1.6 percent update established under section 623(a) of MMA clearly contemplated that the update would be applied to "such composite rate payment amounts * * *" in effect in the prior year. Therefore, in accordance with section 1881(b)(12) of the Act, we will continue to maintain the separate composite rates for hospital-based and freestanding facilities that were established under section 1881(b)(7) of the Act.

1. Growth Update to the Drug Add-On Adjustment to the Composite Rates

Section 623(d) of the MMA added section 1881(b)(12)(B)(ii) of the Act which required the establishment of an add-on to the composite rate to account for changes in the drug payment methodology stemming from enactment of the MMA. Section 1881(b)(12)(C) of the Act provides that the drug add-on must reflect the difference in aggregate payments between the revised drug payment methodology for separately billable ESRD drugs (acquisition costs in CY 2005; ASP+6 percent in CY 2006) and the AWP payment methodology in effect in CY 2004.

In addition, section 1881(b)(12)(F) of the Act requires that, beginning in CY 2006, we establish an annual update to the drug add-on to reflect the estimated growth in expenditures for separately billable drugs and biologicals furnished by ESRD facilities. This growth update applies only to the drug add-on portion of the case-mix adjusted payment system.

The CY 2006 drug add-on adjustment to the composite rate is 14.5 percent. The drug add-on adjustment for CY 2006 incorporates an inflation adjustment of 1.4 percent. This computation is explained in detail in the CY 2006 PFS final rule with comment period (70 FR 70162). We note that the drug add-on adjustment of 14.7 percent that was published in the CY 2006 PFS final rule with comment period did not account for the 1.6 percent update to the composite rate portion of the basic case-mix adjusted payment system that was subsequently enacted by the DRA, effective January 1, 2006. Since we compute the drug add-on adjustment as a percentage of the weighted average base composite rate, the drug add-on percentage was decreased to account for the higher composite payment rate resulting in a 14.5 percent add-on adjustment for CY 2006. This adjustment was necessary to ensure that the total drug add-on dollars remained constant.

a. Estimating Growth in Expenditures for Drugs and Biologicals for CY 2007

In developing the growth update to the drug add-on for CY 2006, we conducted a trend analysis of prior years' ESRD drug expenditure data (2001 through 2004). All 4 years of data used for the trend analysis reflected expenditures associated with payment for separately billed drugs and biologicals under the AWP methodology. Therefore, we could develop growth estimates for CY 2006 using comparable historical expenditure data. To extend the trend analysis for CY 2007, we would need to include drug expenditure data from CY 2005. However, in CY 2005, section 1881(b)(13)(A)(ii) of the Act required that we use a different drug payment methodology, based on average acquisition costs, rather than the AWP methodology used in prior years. Therefore, ESRD drug expenditure data for CY 2005 are not comparable to expenditure data for CY 2001 through CY 2004 for trend analysis purposes. This data issue will extend to subsequent years' data as well since we are now paying for separately billable drugs using ASP+6 percent. Because we do not have comparable data on which to base continuing trend analysis, we decided to re-evaluate our methodology for updating the drug add-on adjustment.

Section 1881(b)(12)(F) of the Act specifies that the drug update must reflect "the estimated growth in expenditures for drugs and biologicals that are separately billable * * *" By referring to "expenditures", we believe the statute contemplates that the update would account for both increases in drug prices, as well as increases in utilization of those drugs.

In order to meet this requirement, we proposed an update methodology that uses the producer price index (PPI) for prescription drugs as a proxy measure of drug pricing growth, in conjunction with an estimate of per patient growth in drug utilization. We proposed to estimate growth in per patient utilization of drugs by using historical data from 2004 and 2005.

In addition, we indicated that we would reconsider our methodology for updating the drug add-on component of the payment system when we have sufficient historical data reflecting the revised drug payment methodology using ASP pricing.

Comment: Commenters were generally favorable toward using a standard index to update the drug add-on adjustment, but were concerned about the calculation of the utilization factor. They suggested that we use our National Health Expenditures (NHE) projection that uses only the Medicare Part B component of the projection to estimate prescription drug expenditures.

Response: We do not believe that the Part B drug projections included in the NHE projections would be the best proxy for the growth in ESRD drug expenditures. The NHE projections are based on the economic, demographic and Medicare spending projections contained in the Medicare Trustees Report, as opposed to an independent forecast of economic assumptions, such as the Global Insights projections of the PPI for prescription drugs that are used in our Medicare market basket forecasts to update many of our payment systems. The NHE projection modeling approach is at an aggregate level. It does not capture the nuances of both labor and economic markets as accurately as does the specific PPI forecast from Global Insights, Inc. We believe that using the PPI is a more accurate predictor of ESRD drug pricing growth. In addition, we believe that estimating utilization from reported ESRD claims data, as discussed below in this section, is superior to using NHE's Part B projections.

b. Estimating Growth in Per Patient Drug Utilization

To isolate and project the growth in per patient utilization of ESRD drugs for CY 2007, we needed to remove the enrollment and price growth components from the latest historical drug expenditure data and consider the residual utilization growth. We proposed to use total drug expenditure data from CYs 2004 and 2005 to estimate per patient utilization growth for CY 2007.

We first estimated total drug expenditures. For the CY 2007 PFS proposed rule (71 FR 49007), we used the final CY 2004 ESRD facility claims data and the latest available CY 2005 ESRD facility claims data, updated through December 31, 2005. That is, for CY 2005 we used claims that were received, processed, paid, and passed to the National Claims History File as of December 31, 2005. For this final rule with comment period, we are using more updated CY 2005 claims with dates of service for the same time period. This updated CY 2005 data file includes claims that were received, processed, paid, and passed to the National Claims History File as of June 30, 2006.

For the proposed rule, we adjusted the December 2005 file to reflect our estimate of what the total drug expenditures would be using the final June 30, 2006 bill file for CY 2005. The net adjustment we applied to the CY 2005 claims data was an increase of 13 percent to the December 2005 expenditure data. For this final rule, we are using the CY 2005 claims file as of June 30, 2006, which represents the final claims file for that year. Next, we removed the enrollment and price growth components from total estimated drug expenditures for CYs 2004 and 2005.

To calculate the per patient utilization growth, we removed the enrollment component by using the growth in enrollment data between 2004 and 2005. This was approximately 3 percent. To remove the price effect, we used a two-step process. For the proposed rule, we first calculated a weighted average between erythopoeitin (EPO) and non-EPO price growth factors to account for the growth in pre-MMA pricing between 2004 and 2005. Since EPO was priced at $10 per thousand units prior to the implementation of the MMA, there was no growth for EPO between 2004 and 2005. For the non-EPO drugs, we used the PPI as a proxy for the growth between the 2 years to maintain consistency with the established methodology for calculating the drug add-on adjustment for CY 2005 which used the PPI to estimate the price growth in separately billable drugs (69 FR 66321). For the proposed rule, we next incorporated the estimated negative 13 percent weighted price difference between 2005 AWP and 2005 AAP pricing as was published in the CY 2005 PFS final rule with comment period (69 FR 66319 through 66334). This two-step process accounts for the price effect from 2004 to 2005, that is, an overall 12 percent reduction in price between 2004 and 2005.

For the proposed rule, following the removal of the enrollment and price effects from the expenditure data, we expected the residual growth to reflect the per patient utilization growth. To remove the enrollment and price effects, we divided the product of the enrollment growth of 3 percent (1.03) and the price reduction of 12 percent (1.00 - 0.12 = 0.88) into the total drug expenditure decrease between 2004 and 2005 of 9 percent (1.00 - 0.09 = 0.91). The result was a proposed utilization factor equal to 1.00 ((0.91/1.03)/0.88) = 1.0).

We observed no growth in per patient utilization of drugs between 2004 and 2005. Therefore, we projected no growth in per patient utilization for CY 2007.

Comment: On commenter suggested that we should use the drug expenditure weights we developed in computing the drug add-on adjustment related to ASP pricing for 2006, rather than the weights developed by the OIG with respect to acquisition costs for 2005. This would have resulted in an overall price reduction of 13.2 percent rather than the overall reduction of 12 percent we used in our calculation.

Response: We believe it would be more appropriate to use the published OIG weights as they represent the weights that were used to develop the 2005 drug add-on adjustment. If we were to use updated weights, it would be more appropriate to use actual 2005 weights. Preliminary analysis suggests that if we were to develop weights based on the most recent 2005 expenditure data, the resulting price reduction factor would be well under 13.2 percent. However, as discussed above in this section, we believe the price reduction calculation should be consistent with the calculation used to develop the 2005 drug add-on adjustment. Therefore, for this final rule with comment we are using the same 12 percent price reduction factor calculated in the proposed rule.

Comment: One commenter indicated that their analysis resulted in a slightly different value for the reduction in total drug expenditures than we calculated between 2004 and 2005. Rather than the 9 percent reduction we calculated for the proposed rule, this commenter computed a 9.198 percent reduction using the 2004 5 percent sample file compared to the 2005 ESRD file.

Response: Although the 2004 5 percent file may have contained a significant number of ESRD claims, our analysis uses 100 percent of the 2004 ESRD facility claims. As such, we believe the results calculated by the commenter are consistent with our results, but that slight differences would be expected when an incomplete file is used. For the final rule, using the latest, complete ESRD claims file for CY 2005 (June 30, 2006), we computed a 9.5 percent reduction in total ESRD facility drug expenditures between CY 2004 and CY 2005.

Comment: We received one comment that the source of the 3 percent enrollment growth we projected for CY 2007 was unclear, and did not match the Part B enrollment growth included in the 2006 Trustees Report.

Response: The 3 percent enrollment growth projection represents the estimated growth factor specific to dialysis patients between CY 2004 and CY 2005.

Comment: One comment expressed concern that we were basing payment policy on the assumption that the new EPO monitoring policy would decrease utilization of drugs.

Response: The determination of the CY 2007 update was not based on an assumption that the new EPO monitoring policy would decrease utilization. The discussion of the EPO monitoring policy was only intended to illustrate the need to use the latest data available to determine utilization, especially since new policies such as the EPO monitoring could affect utilization growth in the future. The potential effect of the monitoring policy was not incorporated into the computation of the CY 2007 adjustment factor.

i. Applying the Growth Update to the Drug Add-On Adjustment

For CY 2006, we estimated the growth update by trending drug expenditures forward based on four years of AWP payment data (CY 2001 through CY 2004). We then applied the estimated growth update percentage to the total amount of drug add-on dollars established for CY 2005 to come up with a dollar amount for the CY 2006 growth update. In addition, we projected the growth in dialysis treatments for CY 2006 based on the projected growth in ESRD enrollment. We divided the projected total dialysis treatments for CY 2006 into the projected dollar amount of the CY 2006 growth to develop the per treatment growth update amount. This growth update amount, combined with the CY 2005 per treatment drug add-on amount, resulted in an average drug add-on amount per treatment of $18.88 (or a 14.5 percent adjustment to the composite rate) for CY 2006.

Beginning in CY 2007, we proposed to annually update the per treatment drug add-on amount of $18.88 established in CY 2006 and convert the update to an adjustment factor as stipulated in section 1881(b)(12)(F) of the Act. By proposing to apply the update to the CY 2006 per treatment add-on amount, the need to estimate growth in dialysis treatments is eliminated for CY 2007 and future years.

We received no comments on this proposed change and are therefore adopting this provision in this final rule.

ii. Update to the Drug Add-On Adjustment

In the proposed rule, we estimated no growth in per patient utilization of ESRD drugs for CY 2007. Using the projected growth of the CY 2007 PPI for prescription drugs of 4.9 percent, we projected that the combined growth in per patient utilization and pricing for CY 2007 would result in an update equal to the PPI growth or 4.9 percent (1.0 × 1.049 = 1.049). This proposed update factor was applied to the CY 2006 average per treatment drug add-on amount of $18.88 (reflecting a 14.5 percent adjustment in CY 2006), resulting in a proposed weighted average increase to the composite rate of $0.93 for CY 2007 or a 0.6 percent increase in the CY 2006 drug add-on percentage. Thus, the total proposed drug add-on adjustment to the composite rate for CY 2007, including the growth update, was 15.2 percent (1.145 × 1.006 = 1.152).

In addition, we proposed to continue to use this method to estimate the growth update to the drug add-on component of the case-mix adjusted payment system until we have at least 3 years worth of ASP-based historical drug expenditure data that could be used to conduct a trend analysis to estimate the growth in drug expenditures. Given the time lag in the availability of ASP drug expenditure data, we expect that the earliest we could consider using trend analysis to update the drug add-on adjustment would be 2010. We proposed to reevaluate our methodology for estimating the growth update at that time.

Comment: We received comments requesting clarification concerning the PPI projections we use in calculating the growth update to the drug add-on adjustment.

Response: We use the PPI for prescription drugs developed by Global Insight for the fourth quarter of 2007, which represents a four quarter average percent change projection between 2006 and 2007. For the final rule we are using the latest projection for 2007 which is 4.03 percent.

Comment: A number of comments recommended that a mechanism be established to provide for forecasting error adjustment of prior estimates. This adjustment would be applied only for the years covered by the proposed interim methodology for updating the drug add-on adjustment. The comments suggest that once stable expenditure data is available to use historical trend analysis for updating the drug add-on adjustment, the forecast error adjustment would no longer be necessary.

Response: We have not accepted this recommendation. While we appreciate the concern related to accuracy of an update based on proxy measures for price and the proposed utilization computations, the very nature of estimating future expenditures under a prospective payment system requires that those estimates are based on the best historical data available. As such, we believe we have met our obligation under the statue in estimating the growth in ESRD drug expenditures for CY 2007. Moreover forecast error adjustments are rarely made in any of CMS' prospective payment systems.

We also note that even after ASP expenditure data become available for purposes of using trend analysis to estimate future expenditures, those estimates may not be the same as actual expenditures. That could also be the case for the 2006 update currently in effect. While the commenters are not suggesting that we revisit the 2006 update, we believe that once we set the policy of adjusting any year's estimated update, we would need to do so for all years, not just those covered by the proposed interim update methodology.

Comment: One commenter wanted an update on the steps we were taking to obtain drug utilization data from hospital-based ESRD facilities for purposes of refining the drug add-on adjustment related to those providers. In last year's final rule we indicated that we would pursue options for obtaining that data (70 FR 70163).

Response: We have determined that a separate data collection of historical drug dosing data for hospital based facilities would be both burdensome and costly. Therefore, we decided not to pursue that avenue for estimating the drug add-on amount related to those facilities. However, once we have 2006 ASP data, we will evaluate the difference in payments to hospital-based ESRD facilities under cost reimbursement compared to ASP-based payments to determine if our drug add-on estimate was reasonable.

iii. Final Growth Update to the Drug Add-On Adjustment for 2007

Similar to the proposed rule, we estimated no growth in per patient utilization of ESRD drugs for CY 2007. We removed the enrollment and price effects from the expenditure data to determine the per patient utilization growth. To do this, we divided the product of the enrollment growth of 3 percent (1.03) and the price reduction of 12 percent (1.00-0.12 = 0.88) into the total drug expenditure decrease between 2004 and 2005 of 9.5 percent (1.0-0.095 = 0.0905). The result is a utilization factor equal to 1.0 ((0.905/1.03)/0.88) = 1.0).

Using the projected growth of the CY 2007 PPI for prescription drugs of 4.03 percent, we projected that the combined growth in per patient utilization and pricing for CY 2007 would result in an update equal to the PPI growth or 4.03 percent (1.0 × 1.0403 = 1.0403). This update factor was applied to the CY 2006 average per treatment drug add-on amount of $18.88 (reflecting a 14.5 percent adjustment in CY 2006), resulting in a weighted average increase to the composite rate of $0.76 for CY 2007 or a 0.5 percent increase in the CY 2006 drug add-on percentage. Thus, the total drug add-on adjustment to the composite rate for CY 2007, including the growth update, is 15.1 percent (1.145 × 1.005 = 1.151).

c. OIG Report on New Drug Codes

Section 623(c)(1) of the MMA mandated that the OIG conduct two studies to determine the difference between the Medicare payment amount for separately billable ESRD drugs and the facilities' acquisition costs for these drugs, as well as estimating the growth rate of expenditures for these drugs. The initial study, "Medicare Reimbursement for Existing End Stage Renal Disease Drugs" (OEI-03-04-00120), was completed in May 2004, and reported on existing ESRD drugs. This report was used to set the CY 2005 payment rates for ESRD drugs billed by independent dialysis facilities (69 FR 66322). The second study ("Medicare Reimbursement for New ESRD Drugs" (OEI-03-06-00200)) focused on new drugs. New drugs for the purpose of this study were defined as an ESRD drug that did not have a billing code prior to January 1, 2004.

One drug, darbepoetin alfa (Aranesp) accounted for the majority of all payments for new drugs. Therefore, this was the only new ESRD drug studied. The OIG report found that use of this drug was limited to a small number of facilities (only 157 facilities reported using this drug with concentrated use in approximately 55 of these facilities). Because of the recent changes we made to the drug payment methodology and the lack of comparable historical data, the OIG report made no estimate of an expenditure growth rate for this drug.

Darbepoetin alfa (Aranesp) is currently paid as a separately billable drug at ASP+6 percent. Because of the recent (CY 2006) implementation of the ASP+6 percent drug payment methodology, the small number of facilities using this drug for ESRD patients, and the lack of historical data for trending purposes, we have no data to indicate that any difference in payment methods for Aranesp (between CY 2004 and CY 2006) would affect our calculation of the drug add-on or of the growth update. Moreover, since Aranesp was approved in 2001 for use in ESRD patients, we believe that expenditures for Aranesp were reflected in the historical data used to establish the CY 2005 drug add-on under a generic drug code. Therefore, we proposed to make no additional changes to the drug add-on adjustment for CY 2007. We received no comments on this issue.

2. Update to the Geographic Adjustments to the Composite Rates

Section 1881(b)(12)(D) of the Act, added by section 623(d) of the MMA, gave the Secretary the authority to revise the wage indexes previously applied to the ESRD composite rates. The wage indexes are calculated for each urban and rural area. The purpose of the wage index is to adjust the composite rates for differing wage levels covering the areas in which ESRD facilities are located.

a. Updates to the CBSA Definitions

In the CY 2007 proposed rule (71 FR 49008), we published revised CBSA-based geographic areas which reflected all of the changes announced by OMB in Bulletins 05-02 and 06-01 issued February 22, 2005 and December 5, 2005, respectively. Those bulletins changed the titles of several of the MSAs and Metropolitan Divisions used in connection with the urban wage index.

b. Updated Wage Index Values

In the CY 2006 PFS final rule with comment period, we stated that we intended to update the wage index values annually (70 FR 70167). Current ESRD wage index values for CY 2006 were developed from FY 2002 wage and employment data obtained from the Medicare hospital cost reports. The values are calculated without regard to geographic reclassifications authorized under sections 1886(d)(8) and (d)(10) of the Act and utilize pre-floor hospital data that is unadjusted for occupational mix.

The methodology for calculating the CY 2006 wage index values was described in the CY 2006 PFS final rule with comment period (70 FR 70168). We proposed to use the same methodology for CY 2007, with the exception that FY 2003 hospital data will be used to develop the CY 2007 ESRD wage index values. For a detailed description of the development of the CY 2007 ESRD wage index values based on FY 2003 hospital data see the FY 2007 IPPS final rule entitled, "Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2007 Rates," (71 FR 48016). Section F of the preamble to that final rule describes the cost report schedules, line items, data elements, adjustments, and wage index computations. The wage index data affecting ESRD composite rates for each urban and rural locale may also be accessed on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp. The wage data are located in the section entitled, "FY 2007 Final Rule Occupational Mix Adjusted and Unadjusted Average Hourly Wage and Pre-Reclassified Wage Index by CBSA".

Comment: One commenter criticized our use of hospital wage and employment data to develop the ESRD wage index. The commenter maintained that the use of hospital data presumed that wage levels in hospitals and freestanding ESRD facilities are similar, a conclusion which has not been substantiated. The commenter urged us to locate an alternative data source that reflects information directly tied to ESRD facilities.

Response: Although the mix of occupations in hospitals is broader and more diverse, ESRD facilities compete with hospitals for labor. While the use of wage and employment data from freestanding ESRD facility cost reports would result in the development of a wage index which reflected ESRD wage levels among independent facilities, the administrative burden posed by the need for the Medicare fiscal intermediaries to engage in a separate data collection to compile, edit, and validate ESRD wage and employment data would be considerable. Given the similarity of the labor market for professional, technical, and nursing staff between hospitals and ESRD facilities, we believe our use of hospital wage and employment data obtained from the Medicare cost reports to develop the ESRD wage index is appropriate.

(i) Wage Index Values for Areas With No Hospital Data

In CY 2006, while adopting the CBSA designations, we identified a small number of ESRD facilities in both urban and rural geographic areas where there is no hospital wage data on which to base the calculations of the CY 2006 ESRD wage index values.

The first situation was rural Massachusetts. Because there were no reasonable proxies for rural data within Massachusetts, we used the prior year's acute care hospital wage index value for rural Massachusetts. For CY 2007, we proposed to continue to use this value and requested public input on an alternative methodology.

Since there may be additional rural areas in the future similarly impacted by a lack of hospital wage data on which to derive a hospital wage index, we stated that we were considering alternative methodologies for imputing a rural wage index for areas in States where no hospital wage data are available. We also described an alternative methodology whereby we would impute a rural wage index value by using a simple average CBSA-based rural wage index value at the Census Division level. For CY 2007, hospital wage data are not available to compute a rural wage index for ESRD facilities in rural Massachusetts, and this proposed alternative methodology could be applied in this case. Massachusetts is located in Census Division I (New England).

Under this proposed alternative methodology, the States in Census Division I for which rural wage index values are available would be used; this would result in a simple average proposed rural wage index value of 1.0227 (1.0770 after applying BNF).

Rural Puerto Rico is similar to rural Massachusetts in that there are ESRD facilities where there are no acute care hospitals and, therefore, no hospital data. However, the situation for facilities in rural Puerto Rico is different in that the floor would be applied to rural Puerto Rico ESRD facilities. All areas in Puerto Rico that have an index are eligible for the floor because they have wage-index values that are less than 0.8000. For CY 2007, we proposed to apply the floor to rural Puerto Rico.

The third situation involves an urban area in Hinesville, GA (CBSA 25980). For CY 2006, we used a wage index value based on the average of the wage index values in all of the other urban areas within the same State to serve as a reasonable proxy for the urban areas without hospital wage index data. Specifically, we used the average wage index value for all urban areas within the State of Georgia as the urban wage index for purposes of calculating the value for Hinesville for CY 2006. For CY 2007, we proposed to continue using this method for Hinesville, GA (CBSA 25980).

We solicited comments on maintaining our current policy for establishing wage index values for rural and urban areas without hospitals or adopting an alternative approach. We also indicated that we would continue to evaluate existing hospital wage data and, possibly, wage data from other sources, such as the Bureau of Labor Statistics, to determine if other methodologies of imputing a wage index value where hospital wage data are not available may be feasible.

We received no comments on maintaining our current policy for establishing wage index values for rural and urban areas without hospitals, or an alternative approach for developing wage index values for rural areas without hospitals for CY 2007 and subsequent years. Therefore, for CY 2007, we will maintain our current policies for establishing wage index values for rural and urban areas:

• For rural Massachusetts, we will continue to use the prior year's acute care hospital wage index value for rural Massachusetts.

• For rural Puerto Rico, we will apply the CY 2007 ESRD wage index floor.

• For Hinesville, GA (CBSA 25980), we will use the average wage index value for all urban areas within the State of Georgia as the urban wage index for purposes of calculating the value for Hinesville for CY 2007.

(ii) Second Year of the Transition

For each transition year, the share of the blended wage-adjusted base payment rate that is derived from the MSA-based and CBSA-based wage index values is shown in Table 10. In the CY 2007 PFS proposed rule, we proposed no changes to the transition. CY 2007 is the second year of the 4-year transition period. Consistent with the transition blends, we are implementing a 50/50 blend between an ESRD facility's MSA-based composite rate, and its CY 2007 CBSA-based rate reflecting its revised wage index values.

For CY 2007, we are reducing the wage index floor to 0.80. As we stated in the CY 2006 PFS final rule with comment period, we intend to reassess the continuing need for a wage index floor in CY 2008 and CY 2009 (70 FR 70169 through 70170). The wage index floors, caps, and blended shares of the composite rates applicable to all ESRD facilities during CYs 2007 through 2009 are shown in Table 10. They are identical to the values shown in Table 20 of the CY 2006 PFS final rule with comment period (70 FR 70170) for the applicable years.

CY payment Floor Ceiling Old MSA (percent) New CBSA (percent)
2007 0.80* None 50 50
2008 Reassess None 25 75
2009 Reassess None 0 100
*Each wage index floor is multiplied by a BN adjustment factor. For CY 2007 the BN adjustment is 1.052818 resulting in an actual wage index floor of 0.8423.

The following is an example of how the wage-adjusted composite rates would be blended during CY 2007 and the 2 subsequent transition years.

Example: An ESRD facility has a wage-adjusted composite rate (without regard to any case-mix adjustments) of $135.00 per treatment in CY 2006. Using CBSA-based geographic area designations, the facility's CY 2007 wage-adjusted composite rate, reflecting its wage index value as shown in Addendum H, would be $145.00. During the remaining 3 years of the 4-year transition period to the new CBSA-based wage index values, this facility's blended rate through CY 2009 would be calculated as follows:

CY 2007 = (0.50 $135.00) + (0.50 × $145.00) = $140.00

CY 2008 = (0.25 × $135.00) + (0.75 × $145.00) = $142.50

CY 2009 = (0.00 × $135.00) + (1.00 × $145.00) = $145.00

We note that this hypothetical example assumes that the calculated wage-adjusted composite rate of $145.00 for CY 2007 does not change in CYs 2008 and 2009. In actuality, the wage-adjusted composite rate would change because of annual revisions to the wage index. However, the example serves only to demonstrate the effect on the composite rate of the CBSA-based wage index values which will be phased-in during the remaining 3 years of the transition period.

Comment: One commenter representing a number of dialysis facilities in Puerto Rico disagreed with our proposal to reduce the wage index floor to 0.80, pointing out that wage index values have not been realistically updated in quite some time. The commenter was concerned with further reductions in composite payments and recommended that the reduction in the wage index floor for CY 2007 be suspended. Another commenter also recommended that the impact of any further planned proposed reductions in the wage index floor be thoroughly considered before implementation because of potential impact on the ability of dialysis facilities to recruit and retain qualified personnel.

Response: We believe that the ESRD wage index should not be artificially constrained by the application of floors and ceilings. We eliminated the cap of 1.30 because of the effect it had on restricting payments in high wage areas. While we would like to eliminate the floor as well, we recognized that its immediate elimination could substantially reduce composite payments in locales where prevailing labor costs are lower. Accordingly, in CY 2006 we implemented a reduction in the wage index floor to 0.85, and proposed a further reduction to 0.80 in CY 2007. We plan to reassess the continuing application of the wage index floor in connection with the CY 2008 and CY 2009 updates to the composite payment rates.

The actual wage index values for urban locales in Puerto Rico, without application of any floor and prior to the application of the CY 2007 the BN adjustment, are shown in Table 11.

CBSA code Urban area Wage index
10380 Aguadilla-Isabela-San Sebastian 0.3922
21940 Fajardo 0.4044
25020 Guayama 0.3241
32420 Mayaguez 0.3857
38660 Ponce 0.4851
41900 San German-Cabo Rojo 0.4893
41980 San Juan-Caguas-Guaynabo 0.4397
49500 Yauco 0.3861

The proposed CY 2007 wage index floor of 0.80 is substantially higher than each of the above wage index values. After application of the BN adjustment to the wage index floor of 0.80, each area in Puerto Rico has a wage index of 0.8423 reflected in its composite rate. Therefore, we believe that the CY 2007 wage index floor of 0.80 compared to actual wage levels will not adversely affect access to care for dialysis patients in Puerto Rico.

With respect to the commenter's concern that the wage index values have not been updated in quite some time, we point out that the CY 2007 wage index values were developed from the latest available FY 2003 hospital wage and employment data obtained from the Medicare cost reports. While we will not suspend application of the proposed 0.80 wage index floor in CY 2007, we intend to carefully assess the potential impact of any further proposed reductions in the wage index floor for CY 2008 and following years.

c. Budget Neutrality (BN) Adjustment

Section 1881 (b)(12)(E)(i) of the Act, as added by section 623(d) of the MMA, requires that any revisions to the ESRD composite rate payment system as a result of the MMA provision (including the geographic adjustment) be made in a budget neutral manner. This means that aggregate payments to ESRD facilities in CY 2007 should be the same as aggregate payments that would have been made if we had not made any changes to the geographic adjusters. We note that the BN adjustment discussed in this final rule only addresses the impact of changes in the geographic adjustments. A separate BN adjustment was developed for the case-mix adjustments, currently in effect. Since we did not propose any changes to the case-mix measures for CY 2007, the current case-mix BN will remain in effect for CY 2007. For CY 2007, we again proposed to apply a BNF directly to the ESRD wage index values, as we did in CY 2006. As we explained in the CY 2006 PFS final rule with comment period (70 FR 70170 through 70171), we believe this is the simplest approach because it allows us to maintain our base composite rates during the transition from the current wage adjustments to the revised wage adjustments described earlier in this section. Because the ESRD wage index is only applied to the labor-related portion of the composite rate, we computed the proposed BNF adjustment based on that proportion (53.711 percent).

To compute the proposed CY 2007 wage index BNF, we used the proposed wage index values, 2005 outpatient claims (paid and processed as of December 31, 2005), and geographic location information for each facility.

Using treatment counts from the 2005 claims and facility-specific CY 2006 composite rates, we computed the estimated total dollar amount each ESRD provider would have received in CY 2006 (the first year of the 4-year transition). The total of these payments became the target amount of expenditures for all ESRD facilities for CY 2007. Next, we computed the estimated dollar amount that would have been paid to the same ESRD facilities using the ESRD wage index for CY 2007 (the second year of the 4-year transition). The total of these payments became the second year new amount of wage-adjusted composite rate expenditures for all ESRD facilities.

After comparing these dollar amounts (target amount divided by second year new amount), we calculated an adjustment factor that, when multiplied by the applicable CY 2007 ESRD wage index, would result in aggregate payments within the target amount of composite rate expenditures. The proposed BN adjustment factor for the CY 2007 wage index was 1.053069.

To ensure BN we also must apply the BNF to the wage index floor of 0.8000 which resulted in a proposed adjusted wage index floor of 0.8425 for CY 2007.

Comment: We received comments asking that we clarify the calculation of the wage index BNF so that commenters could understand that the BNF is being calculated correctly. One commenter asked that we provide both the data and the methodology so that they could assess the accuracy of our computations.

Response: During the comment period on the CY 2007 PFS proposed rule, we made available an ESRD Composite Payment System File. This file contained select claim level data from the 2005 ESRD facility outpatient claims, updated through December 31, 2005. For more information on this file, see the following link: http://www.cms.hhs.gov/IdentifiableDataFiles/05.asp#TopOfPage.

After the publication of this final rule with comment period, we intend to make available the updated version of the CY 2005 outpatient claims (paid and processed as of June 30, 2006) that were used to compute the BNF.

To compute the final CY 2007 ESRD wage index BNF, we used FY 2003 pre-floor, pre-reclassified, non-occupational mix-adjusted hospital wage data to compute the wage index values, 2005 outpatient claims (paid and processed as of June 30, 2006), and geographic location information for each ESRD facility which may be found through Dialysis Facility Compare. The FY 2003 hospital wage index data for each urban and rural locale by CBSA may also be accessed on the CMS Web site at: http://www.cms.hhs.gov/AcuteInpatientPPS/WIFN/list.asp. The wage index data are located in the section entitled, "FY 2007 Final Rule Occupational Mix Adjusted and Unadjusted Average Hourly Wage and Pre-Reclassified Wage Indexes by CBSA".

Dialysis Facility Compare can be found by going to the following CMS Web site: http://www.cms.hhs.gov/DialysisFacilityCompare/.

Using treatment counts from the latest 2005 claims file and facility-specific CY 2006 composite rates, we computed the estimated total dollar amount each ESRD provider would have received in CY 2006 (the first year of the 4-year transition). The total of these payments became the target amount of expenditures for all ESRD facilities for CY 2007. Next, we computed the estimated dollar amount that would have been paid to the same ESRD facilities using the ESRD wage index for CY 2007 (the second year of the 4-year transition). The total of these payments became the second year new amount of wage-adjusted composite rate expenditures for all ESRD facilities.

After comparing these dollar amounts (target amount divided by second year new amount), we calculated an adjustment factor that, when multiplied by the applicable FY 2007 wage index value, will result in aggregate payments to ESRD facilities that will remain within the target amount of composite rate expenditures. When making this calculation, the ESRD wage index floor value of 0.8000 is used whenever appropriate.

The final BN adjustment factor for the CY 2007 wage index is 1.052818.

To ensure BN we also must apply the BNF to all index values, including the wage index floor of 0.8000, which results in an adjusted wage index floor of 0.8423 for CY 2007.

d. ESRD Wage Index Tables

Addenda F and G show the CY 2007 ESRD wage index, including the BNF adjustment, for urban areas (Addendum F) and rural areas (Addendum G).

H. Private Contracts and Opt-Out Provision-Practitioner Definition

Section 4507 of the BBA amended section 1802 of the Act to permit certain physicians and practitioners to opt-out of Medicare if certain conditions were met, and to provide through private contracts services that would otherwise be covered by Medicare. Before enactment of the BIPA (Pub. L. 106-554), section 1802(b)(5)(C) of the Act, which refers to the definition of "practitioner" at section 1842(b)(18)(C) of the Act, did not include registered dietitians or nutrition professionals among the practitioners who may choose to opt-out of Medicare. Section 105(d) of the BIPA amended the definition of practitioner located at section 1842(b)(18)(c) of the Act to include registered dietitians or nutrition professionals. Because section 1802(b)(5)(C) of the Act references section 1842(b)(18)(c) of the Act in order to define the term practitioner for purposes of opting out of Medicare, current law permits registered dietitians or nutrition professionals to opt-out of Medicare. Because the definition of practitioner located at § 405.400 does not include registered dietitians or nutrition professionals, we proposed to amend that section so that it is consistent with section 1802(b)(5)(C) of the Act.

Commenters were very supportive of our proposals. Therefore, we are finalizing the changes to § 405.400 as proposed.

I. Changes to Reassignment and Physician Self-Referral Rules Relating to Diagnostic Tests

In the CY 2007 PFS proposed rule, we stated that recent changes to our rules on reassignment of the right to receive Medicare payment may have led to some confusion as to whether the anti-markup and purchased interpretation requirements apply to certain situations where a reassignment has occurred under a contractual arrangement. We also stated that we were concerned about the existence of certain arrangements that are not within the intended purpose of our physician self-referral rules, which allow physician group practices to bill for services furnished by a contractor physician in a "centralized building" as defined at § 411.351. We are concerned that allowing physician group practices or other suppliers to purchase or otherwise contract for the provision of diagnostic tests and then to realize a profit when billing Medicare may lead to patient and program abuse in the form of over utilization of services and result in higher costs to the Medicare program.

We proposed to amend our reassignment regulations to clarify how the purchased test and purchased interpretation rules apply in the case of a reassignment made under the contractual arrangement exception set forth at § 424.80(d)(2). In addition, we proposed to change the definition of "centralized building" at § 411.351 of the physician self-referral regulations to place certain restrictions on what types of space ownership or leasing arrangements will qualify for purposes of the physician self-referral in-office ancillary services exception and physician services exception. We received numerous comments on our proposals. Instead of issuing final regulations at this time, we are studying the issues further and plan to issue final regulations in the near future. We remain committed to addressing revenue-driven arrangements that may be facilitating over utilization of diagnostic services, but do not wish to unduly impact legitimate group practice arrangements that enable Medicare beneficiaries to have the convenience of receiving medical services at one location.

J. Supplier Access to Claims Billed on Reassignment

Section 1842(b)(6) of the Act generally provides that Medicare may pay Part B benefits only to the physician or other supplier who performed the service, or to the beneficiary. This provision, known as the prohibition on reassignment, contains several exceptions. Section 952 of the MMA amended section 1842(b)(6)(A)(ii) of the Act to allow a physician or other person who was in a contractual arrangement rather than in an employee-employer relationship to reassign his or her right to bill and receive payment, irrespective of whether the services were performed on the premises of the entity. In implementing section 952 of the MMA, we amended § 424.80(d) to provide that a supplier, who reassigns his or her right to bill Medicare to an entity with which he or she is employed as an independent contractor, has the right to access the entity's billing information concerning the services the supplier is alleged to have performed and for which the entity billed Medicare. We extended such a right in order to give added assurance that the services for which such an entity billed Medicare were in fact performed and were performed as billed. In the CY 2007 PFS proposed rule, we stated that we believe that employees, in addition to independent contractors, should have access to records on billings for services furnished by them (71 FR 49057 through 49058). We proposed changing the title of § 424.80(d) and amending § 424.80(d)(2) of our regulations to state that the individual supplier who reassigns his or her right to bill and receive Medicare payment to an entity has unrestricted access to claims information submitted by that entity for services furnished by the individual supplier, irrespective of whether the supplier is an employee or an independent contractor of the entity receiving payment. Under our proposal, if an entity receiving the reassigned benefits were to refuse to provide the billing information to the employee supplier requesting the information, the entity's right to receive reassigned benefits could be revoked under § 424.82(c)(3) (which is currently the case with respect to an entity's refusal to provide billing information to an independent contractor supplier).

We are adopting the proposal without modification.

Comment: Two commenters who support the proposal stated they are unsure how having unrestricted access to submitted claims data will correspond to improved program integrity. They believe that a more practical approach to ensure Medicare program integrity would be to incorporate physician involvement in compliance programs that are structured to address risk areas particular to their operations. These commenters are also concerned that providing unrestricted access to submitted claims data is not a clear requirement for a billing entity to meet.

Response: We believe that by allowing a physician or other supplier access to billing information concerning services allegedly performed by that physician or other supplier, we gain more assurance that entities that are billing on reassignment are billing for services actually performed and are otherwise billing accurately for such services. With respect to the commenters' suggestion that physician involvement in compliance programs offers a more practical approach to ensure Medicare program integrity, we believe that physicians should be engaged already in compliance programs, and that such involvement should include the physician regularly requesting access to billing records for services that he or she allegedly performed and that are being billed to Medicare, through a reassignment, by the entity that employs the physician as an independent contractor or employee. We disagree that our proposal would pose an unclear requirement for entities to meet. An entity that bills Medicare for services that were allegedly performed by a physician or other supplier in the entity's employ may not unreasonably refuse to provide access (or unreasonably delay in providing access) to the physician or other supplier with respect to the relevant billing information. We do not believe it is practical or necessary to attempt to define by regulation just how soon after a request an entity has to provide access, or whether, in a given case, an entity would be justified in refusing to provide access if the physician or supplier has already gained access to the records. Rather, we believe that entities should be guided by common sense and when in doubt may wish to err on the side of providing access, because an entity that unreasonably refuses to provide billing information or does not provide it in a timely manner may have its right to receive reassigned benefits revoked under § 424.82(c)(3).

Comment: We received one comment opposing the proposal. According to this commenter, in section 952 of the MMA, the Congress authorized us to make changes to the reassignment rules with respect to contractor arrangements only. The Congress evidenced no intent to change the reassignment rules with respect to employees, and nor is there any evidence of which the commenter is aware that right of access by employee suppliers is a current program integrity issue. The commenter also believes that access to billing information is a matter that should be left to the terms of a provider's employment contract.

Response: For the reasons stated in the CY 2007 PFS proposed rule (71 FR 49057), we believe we are permitted, but not required, to make payment under the reassignment provisions. Moreover, we are under a statutory command, through section 1833(e) of the Act, to not make payment unless we are satisfied that payment is correct. Our rulemaking authority for our proposal is not based on section 952 of the MMA, but rather on our general rulemaking authority found at sections 1102(a) and 1871(a) of the Act. We also believe for the reasons stated in the proposed rule that the same program integrity concerns with respect to contractor access to billing records also apply to employee access to billing records. And, we reiterate that we are aware of allegations of employee suppliers being denied access to their billing records. Moreover, we do not believe it is sufficient to leave it to physicians and other suppliers to negotiate access to billing records as a condition of their employment, as the parties may have unequal bargaining power.

Comment: A commenter stated that if the supplier has claims liability, he or she should have access to the billing records, but that if the supplier does not have claims liability he or she should not have access to the billing records.

Response: Irrespective of whether the supplier has claims liability, we have an interest in knowing whether we are paying correctly for services that were furnished or furnished as billed. Therefore, we wish to provide a right of access to billing information to all suppliers who are furnishing services and reassigning payment to their employers, and we encourage them to avail themselves of this right in order to ensure that we are paying properly.

K. Coverage of Bone Mass Measurement

In an IFC entitled "Medicare Coverage of and Payment for Bone Mass Measurements" published in the Federal Register on June 24, 1998 (63 FR 34320), we implemented section 4106 of the BBA by establishing a new section, § 410.31, Bone Mass Measurement: Conditions for Coverage and Frequency Standards. Section 4106 of the BBA statutorily defined BMM and individuals that are qualified to receive a BMM. The June 24, 1998 IFC, under the "reasonable and necessary" provisions of section 1862(a)(1)(A) of the Act, also established conditions for coverage of the tests that must be ordered by physicians or NPPs. Lastly, as directed by section 4106 of the BBA, we established frequency standards governing the time period when qualified individuals would be eligible to receive covered BMMs.

1. Provisions of the June 24, 1998 IFC

The June 24, 1998 IFC implemented section 4106 of the BBA by establishing conditions for coverage and frequency standards for BMMs to ensure that they are paid for uniformly throughout the Medicare program and that they are reasonable and necessary for Medicare beneficiaries who are eligible to receive these measurements. This section summarizes the provisions discussed in the June 24, 1998 IFC.

a. Coverage Conditions and Frequency Standards

We established conditions for coverage and frequency standards for medically necessary BMMs for five categories of Medicare beneficiaries in § 410.31.

In § 410.31(a), we defined "bone mass measurement" based on the statutory definition in section 4106 of the BBA. In accordance with the "reasonable and necessary" provisions of section 1862(a)(1)(A) of the Act, we established the conditions for coverage of BMMs in § 410.31(b) of the regulations. Consistent with § 410.32 (Diagnostic x-ray tests, diagnostic laboratory tests, and diagnostic tests: Conditions), we provided that coverage be available for the BMM only if it is ordered by the physician or a qualified NPP (as defined in § 410.32(a)) treating the beneficiary following an evaluation of the beneficiary's need for the test, including a determination as to the medically appropriate procedure to be used for the beneficiary. We believed that BMMs were not demonstrably reasonable and necessary unless (among other things) they are ordered by the physician treating the beneficiary following a careful evaluation of the beneficiary's medical need, and they are employed to manage the beneficiary's care.

To ensure that the BMM is performed as accurately and consistently in accordance with appropriate quality assurance guidelines as possible, we required that it be performed under the appropriate supervision of a physician as defined in § 410.32(b)(3). To ensure that the BMM is medically appropriate for the five categories specified in the law, we provided that it be reasonable and necessary for diagnosing, treating, or monitoring the condition of the beneficiary who meets the coverage requirements specified in § 410.31(d).

Furthermore, in § 410.31(c), we set forth limitations on the frequency for covering a BMM. Generally, we cover a BMM for a beneficiary if at least 23 months have passed since the month the last BMM was performed. However, we allow for coverage of follow-up BMMs performed more frequently than once every 23 months when medically necessary. We listed the following examples of situations where more frequent BMMs procedures may be medically necessary to include:

• Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months.

• Allowing for a confirmatory baseline BMM (either central or peripheral) to permit monitoring of beneficiaries in the future if the initial test was performed with a technique that is different from the proposed monitoring method.

b. Beneficiaries Who May Be Covered

In § 410.31(d), we amended our regulations to conform to the statutory requirement that the following categories of beneficiaries may receive Medicare coverage for a medically necessary BMM:

• A woman who has been determined by the physician or a qualified NPP treating her to be estrogen-deficient and at clinical risk for osteoporosis, based on her medical history and other findings.

• An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture.

• An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to 7.5 mg of prednisone, or greater, per day, for more than 3 months.

• An individual with primary hyperparathyroidism.

• An individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy.

c. Waiver of Liability

Section 410.31(e) provides that Medicare payment would be denied for a BMM in accordance with section 1862(a)(1)(A) of the Act if the regulatory standards are not satisfied. Existing regulations concerning limitation on liability are set forth in § 411.400 through § 411.406 and are applicable to denial of BMMs under § 410.31.

d. Payments for BMMs

Medicare payments for covered BMMs are paid for under the PFS (42 CFR part 414) as required by statute. In the June 24, 1998 IFC, we revised the definition of "physician services" in § 414.2 to include bone mass measurements. When BMM procedures are furnished to hospital inpatients and outpatients, the TCs of these procedures are payable under existing payment methods for hospital services. These methods include payments under the prospective payment system, on a reasonable cost basis, or under a special provision for determining payment rates for hospital outpatient radiology services.

In the June 24, 1998 IFC, we revised § 414.50(a), regarding physician billing for purchased diagnostic tests, to clarify that the section does not apply to payment for BMMs.

e. Conforming Changes

In the June 24, 1998 IFC, to allow for appropriate placement in the CFR of the BMM coverage requirements, we redesignated § 410.31 (Prescription drugs used in immunosuppressive therapy) as § 410.30.

2. Additional Scientific Evidence

In 2004, the Surgeon General issued a report, Bone Health and Osteoporosis (U.S. Department of Health and Human Services, Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004). This report provides scientific evidence related to the prevention, assessment, diagnosis, and treatment of bone disease. The report states that identification of those at risk of bone disease and fracture is important so that appropriate interventions can be implemented. However, as the report states, "Assessing the risk of bone disease and fracture remains a challenge. Not all of the risk factors have been identified, and the relative importance of those that are known remains unclear."

As bone strength is not measured directly, bone mineral density (BMD) remains the single best predictor of fracture risk, with the most widely accepted method for measuring BMD being the dual energy x-ray absorptiometry (DXA) for a bone density study at the axial skeleton (for example, hips and spine). As there are many sources of variability in the measurement of BMD, a quality control system related to both the methodology and reporting of test results is important to ensure the validity of DXA analysis.

In addition to DXA of the axial skeleton, bone mass can also be measured using other techniques. These other techniques include DXA bone density study for the appendicular skeleton (for example, radius, wrist, heel); quantitative computerized tomography (QCT), BMD study for the axial skeleton or appendicular skeleton; radiographic absorptiometry (photodensitometry, radiogrammetry); single-photon absorptiometry (SPA); single energy x-ray absorptiometry (SXA) for the appendicular skeleton; and ultrasound BMD study for the appendicular skeleton. For these techniques (except for SPA which was not discussed), the 2004 Surgeon General report states, "While these methods do assess bone density and may provide an indication of fracture risk, it is important to note that the WHO [World Health Organization] recommendations and other guidelines for using BMD and interpreting BMD results for diagnosis are based on DXA measurements of the hip or spine." The report further states, "Incorporating these techniques for bone assessment into future clinical trials and observational studies will help in better understanding their appropriate use as a means of predicting the risk of bone disease and fracture."

3. Changes to the June 24, 1998 IFC

We received 18 public comments on the June 24, 1998 IFC. The majority of the comments had specific recommendations for changes to the IFC. Based on the comments received on the IFC, the Surgeon General's report, and other evidence, we proposed changes to § 410.31. We solicited comments on these proposals.

4. Analysis of and Response to Comments on the June 24, 1998 IFC and the CY 2007 PFS Proposed Rule

In this final rule, we are responding to the public comments that we received on our proposed revisions to § 410.31. In addition, as we stated in CY 2007 proposed rule, we are responding to the public comments received on the June 24, 1998 IFC. We received approximately 35 timely public comments on our proposed revisions to the regulations regarding coverage for bone mass measurements (§ 410.31). Most commenters supported the proposed coverage revisions and noted their specific concerns and provided suggested revisions to several of the coverage provisions. However, most of the commenters expressed significant concerns regarding proposed payment reductions for these tests that would result from initiatives described in other sections of the proposed rule relative to PE and other payment calculations. Comments and our responses regarding the proposed payment reductions are detailed in section II.A.4. of the preamble to this final rule. The following is a summary of our proposals and the comments received and our responses on the coverage for bone mass measurement:

a. "BMM" Definition (§ 410.31(a))

At § 410.31(a)(2), we proposed to revise the definition of "bone mass measurement" to remove coverage for the use of SPA, which uses isotope sources to measure BMD. Many medical experts indicate that SPA has largely been replaced by the newer techniques of DXA, which are believed to be superior in accuracy and precision. Medicare claims data in recent years continue to show a steady decline in the use of the SPA procedure by the beneficiary population. Further, there is a lack of evidence to support continued use of SPA, an older procedure where the metrics have not been correlated with fracture rate.

We proposed to revise the definition of a "bone mass measurement" to read, "Is performed with either a bone densitometer (other than a single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814."

Comment: We requested comments on our proposal to noncover SPA, including any evidence of benefit for this technique, particularly in comparison with other alternatives. Most of the commenters supported the position that SPA has largely been replaced by the newer, more accurate, and precise techniques such as SEXA and DXA, and we should not continue to cover them. However, a commenter from the June 24, 1998 IFC suggested that while use of SPA devices (at the wrist) is declining as newer and faster equipment is becoming available, we should continue to cover their use indefinitely based on the view that their accuracy and precision are close to that of x-ray based techniques at the wrist and heel and that their radiation exposure is low.

Response: We agree with the more recent comments concerning SPA and note that we proposed to noncover SPA tests beginning in CY 2007. In response to the June 24, 1998 IFC comment regarding continuing coverage indefinitely, we note that Medicare claims data in recent years continue to show a steady decline in the use of the SPA procedure by the beneficiary population as the more accurate and precise procedures have become much more widely available. We agree that there is a lack of evidence to support continued use of the older SPA procedure where the metrics have not been correlated with fracture risk. Therefore, we are revising the definition of "bone mass measurement" in § 410.31(a) to remove coverage for the use of SPA. As a result, the status indicator for CPT code 78350 will change from active (A) to noncovered (N) effective January 1, 2007.

Comment: A June 24, 1998 IFC commenter expressed the view that available research and their experience had demonstrated that the use of peripheral DXA at the heel is superior to any other BMD test taken at any other peripheral site. The commenter believes that the heel DXA is a superior approach for the initial osteoporosis screening because of its-(1) strong correlation to fracture probability; (2) the reactive nature of the heel to bone mass changes; (3) patient preference for a less threatening exam; (4) the elimination of radiation exposure to the abdomen that results from a central bone mass measurement; and (5) the ability of the peripheral heel DXA to deliver a service at a lower cost than most other BMM technologies.

Response: Based on our review of the available medical literature, we have determined that there is insufficient evidence to conclude that peripheral DXA at the heel is a superior method of BMD measurement when compared to other peripheral sites. Thus, we are not making any changes to our proposal based on this comment.

Comment: A commenter expressed concern about our statement in the June 24, 1998 IFC indicating that QCT can measure bone density at the spine and hip. The commenter indicated that only central (axial) DXA can measure BMD at the spine or hip and QCT is limited to the spine or the wrist. The commenter also stated that spine QCT exposes the patient to a significantly higher dose of radiation and that the technique is significantly less precise than central DXA or peripheral DXA or ultrasound. The commenter recommended that we drop coverage of this technique once there is sufficient geographic overlap between QCT and the alternative techniques, which are believed to be less costly, safer, and a more precise means of measuring bone mass than the QCT technique.

Response: On the basis of our review of the existing medical literature, we have determined that QCT can provide both central (spine and hip) and peripheral BMD measurements but does expose the patient to significantly higher doses of radiation. Though the appropriate use of QCT has yet to be defined, it may be used as an alternative to spine and hip DXA measurements as a method for measuring BMD (Surgeon General's Report, 2004). Therefore, we are not making any changes to our proposal as a result of this comment.

Comment: Another commenter from the June 24, 1998 IFC stated that there is insufficient evidence to support the clinical utility of BMD measurements of an individual's finger, tibia, or patella, which are performed by the use of either a peripheral x-ray or an ultrasound device, and suggested that measurement of those peripheral sites not be covered under Medicare.

Response: Measurement of peripheral bone density for screening and initial diagnosis can be accomplished by various techniques, though the appropriate use of these technologies in the prediction of bone disease and the risk of fracture has yet to be clearly defined. Therefore, we are not revising our proposal based on this comment.

b. Conditions for Coverage (§ 410.31(b))

In § 410.31(b), we proposed to revise the conditions for coverage for BMMs by requiring that for a medically necessary BMM to be covered for an individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy (§ 410.31(d)(5)) the individual would be required to meet the present conditions for coverage under § 410.31(b), and the monitoring would have to be performed by the use of an DXA system (axial system).

We recognized that in the June 24, 1998 IFC, we allowed the physician or qualified NPP treating the beneficiary more flexibility in ordering those diagnostic measurements, but we proposed to limit that flexibility for the type of BMM that is used for monitoring individuals receiving osteoporosis drug therapy and other purposes (as discussed later in this section) because of new evidence and other information received since publication of the June 24, 1998 IFC that supports the need for requiring the use of the DXA measurement (axial skeleton) in those circumstances. In addition to the 2004 Surgeon General's Report that recognized the superiority of the DXA (axial skeleton) for measuring bone mass over time, the International Society for Clinical Densitometry currently recommends that if an individual has a low bone mass using a peripheral measurement (appendicular skeleton) he or she should have a DXA (axial skeleton) performed for monitoring or confirmatory diagnostic purposes.

Therefore, we also proposed to revise § 410.31(b) by adding a requirement that in the case of any individual who qualifies for a BMM as provided for in § 410.31(d) and who receives a confirmatory baseline BMM to permit monitoring in the future, Medicare may cover a medically necessary BMM for that individual, if the present conditions for coverage under § 410.31(b) are met, and the BMM is performed by a DXA system (axial skeleton) (if the initial measurement was not performed by this system).

As indicated previously in this section, the most widely accepted method for measuring BMD is the use of DXA (Surgeons General's Report 2004) at axial skeletal sites. DXA (axial skeleton) measures BMD at the hip and spine (sites likely to fracture in patients who have osteoporosis). DXA is precise, safe, and low in radiation exposure, and permits more accurate and reliable monitoring of individuals over time. DXA of the femoral neck is the best validated test to predict hip fracture and is comparable to forearm measurements for predicting fractures at other sites (Evidence Report/Technology Assessment No 28, Agency for Healthcare Research and Quality (AHRQ), January 2001).

Comment: Several June 24, 1998 IFC commenters expressed concern regarding the following statement from the June 24, 1998 IFC that "there is a consensus that measurements of the central skeletal sites is the preferred method of assessment" as compared with measurements of peripheral skeletal sites. These commenters stated that peripheral devices provide basically the same measurement benefits as central devices and have the added advantages of being easier to use, allowing greater patient accessibility, and reducing patient radiation exposure. However, the majority of the commenters on both the IFC and the proposed rule, strongly supported the aforementioned statement from the IFC and expressed specific concern that the IFC allowed for coverage of peripheral BMMs that have not been demonstrated to be useful in monitoring patients who are receiving osteoporosis drug therapies. These commenters agreed that only central devices (especially the DXA device) were useful in monitoring patients receiving pharmacologic therapy and they specifically recommended that peripheral tests be limited to screening for osteoporosis, and not be used for monitoring patients receiving FDA-approved osteoporosis drug therapy.

Response: As we indicated in the proposed rule, we agree that the most widely accepted method for measuring BMD is the use of dual x-ray absorptiometry (DXA) (Surgeon General's report 2004) at central skeletal sites. DXA measures BMD at the hip and spine (sites likely to fracture in patients who have osteoporosis), is precise, safe, and low in radiation exposure, and permits monitoring over time. DXA of the femoral neck is the best validated test to predict hip fracture and is comparable to forearm measurements for predicting fracture at other sites (AHRQ report 2001). The World Health Organization (WHO) classification of BMD for the diagnosis of osteoporosis is based primarily on reference data obtained by DXA of the axial skeleton. When monitoring the effectiveness of therapy, these central skeletal sites are more likely than peripheral sites to show an increase in BMD over time. For these reasons, we believe that the use of DXA at central sites is the best method for measuring BMD for both monitoring patients receiving FDA-approved osteoporosis drug therapy, and confirming BMD measurements performed on peripheral devices for patients who may be monitored in the future. In view of the comments received and our review of the medical literature, and other information, we are adopting our revision of § 410.31(b) without change.

Comment: While most of the commenters supported our proposal to limit coverage of monitoring patients receiving osteoporosis drug therapy and for performing confirmatory baseline tests to the DXA of the central (axial) skeleton, several commenters urged us not to preclude coverage of QCT of the central (axial) skeleton for these purposes for individuals who have had an initial screening with a peripheral test. These commenters stated that the QCT technology has been relied upon for some time now by certain hospitals and imaging centers, and it would be unfair to them and their patients to preclude coverage for their tests in the final rule.

Response: We agree with the commenters who supported our proposal to limit coverage of monitoring patients receiving osteoporosis drug therapy, for performing confirmatory baseline test to the DXA of the central (axial) skeleton, and to not allow coverage of the QCT for these purposes. (Surgeon General's Report, 2004). The radiation exposure is significantly higher, for example, with the use of the lumbar spine QCT than is the case with the use of the DXA at central skeletal sites (Surgeon General's Report, 2004). Therefore, we are not making any change to our proposal based on these comments.

Comment: A commenter supported our proposal to change the conditions of coverage and standards on frequency of bone mass measurements to encourage the use of DXA of the axial skeleton for confirmatory baseline tests and for monitoring a patient's response to therapy, but cautioned that the medical literature does not support the use of DXA or other BMMs to assess efficacy of osteoporosis therapies. The commenter recommended that CMS clarify that BMM is not appropriate for monitoring the efficacy of osteoporosis therapies in preventing bone fractures.

Response: We recognize that the goals of monitoring patients are to increase adherence to treatment regimens and determine treatment response even though monitoring by densitometry has not been demonstrated to be effective in improving compliance (NIH Consensus Panel, 2001). Importantly, BMD changes are not correlated with the fracture risk reduction resulting from antiresorptive treatment (Roux, Garnero 2005). Therefore, while the efficacy of antiresorptive treatments has been verified in large trial powered to show reductions in fracture risk, it does not appear that fracture risk can be measured in individual patients being treated for osteoporosis. We are not making any changes to the final rule based on this comment.

c. Bone Mass Measurement: Standards on Frequency of Coverage (§ 410.31(c))

To conform the examples of a BMM exception to the standards on frequency of coverage in § 410.31(c)(2) to the regulation change we proposed in § 410.31(b)(3), we proposed to revise the confirmatory baseline test example in § 410.31(c)(2)(ii) to read, "Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met."

Comment: A number of commenters offered recommendations on the exceptions in paragraph (c)(2) to the general rule in paragraph (c)(1) that provided that "Except as allowed under paragraph (c) (2) of this section, Medicare may cover a bone mass measurement (BMM) for a beneficiary if at least 23 months have passed since the month the last BMM was performed." The exceptions specified were- (1) monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months; and (2) allowing for a confirmatory baseline BMM to permit monitoring of beneficiaries in the future. These commenters indicated that in addition to the exceptions specified in paragraph (c)(2), there were certain individuals who were at higher risk of bone loss due to a disease, drug therapy, or other reasons who should be measured more frequently than once every 2 years. Most of these commenters recommended that these individuals should have a follow-up measurement at least once every 12 or every 12 to 18 months. Another commenter asked us to make an exception under paragraph (c) (2) for individuals with hyperparathyroidism who due to their diagnosis require both a DXA of the axial and the appendicular skeleton upon initial testing.

Response: In establishing the frequency of coverage general rule in § 410.31(c)(1) of the IFC, we relied upon the guidance of the American Association of Clinical Endocrinologists, the ACR, and the National Osteoporosis Foundation, which appeared to be generally in agreement for the need to follow certain clinical guidelines for performing follow-up BMMs to the initial BMM that is performed. Based on that information, we specified in the June 24, 1998 IFC a general frequency of coverage interval of one follow-up examination every 2 years, identifying examples of situations where more frequent BMMs may be covered when medically necessary. We have decided to basically retain that general frequency of coverage standard and continue to allow Medicare contractors to cover additional exceptions to the specified exception examples based on medical necessity, even though there is a lack of evidence that adjusting therapy based on serial densitometry at any level improves outcomes (AHRQ Report 2001). Follow-up testing should be done when the expected change in BMD is at least equal to or exceeds the least significant change, which is the smallest change in BMD that is beyond the range of error, as changes in BMD are usually small in proportion to the error inherent in the test itself (Baim, Wilson et al. , 2005). Each DXA facility should determine its precision error and then calculate the least significant change (Baim, Wilson et al. , 2005). Regarding the comment on individuals with hyperparathyroidism, we recognize that the mechanics of bone loss may be different for these patients than they are for estrogen-deficient post-menopausal women, resulting in fracture risks that may be different and more difficult to determine (Miller, Bilezikian, 2002). Thus, it may be medically necessary for a treating provider to perform both a DXA of the axial and the appendicular skeleton in the initial screening of patients with this diagnosis. However, we believe the evidence is insufficient to establish a national policy exception to the 2-year frequency standard for these individuals as specified in § 410.31(c). Nonetheless, we have decided to allow the treating provider to determine what is medically necessary in any particular case, subject to the review of the local Medicare contractor.

Comment: A June 24, 1998 IFC commenter questioned whether we would cover bone mass measurements for individuals on steroid therapy every 6 months after the initial treatment, as well as a baseline exam at the start of therapy as was suggested in the reference to the recommendations of others in the June 24, 1998 IFC (63 FR 34234).

Response: For those individuals on steroid therapy who are at high risk for osteoporosis, as well as for other medical circumstances where it might be appropriate to cover more than one BMM every 2 years, the treating provider currently has considerable flexibility in accordance with our regulations to determine the frequency of testing in any particular case, subject to the review of the local Medicare contractor. However, in the absence of sufficient evidence in the medical literature to support any specific frequency interval for individuals receiving steroid therapy, we are not establishing any specific frequency interval for coverage of these individuals in this regulatory example of possible exceptions to the general standard in section § 410.31(c) of the final rule. Rather, we are leaving this to our local Medicare contractors, based on the best evidence that is available to them and their medical consultants.

Comment: A June 24, 1998 IFC commenter expressed concern regarding our policy in § 410.31(c)(2)(ii) that allows coverage of a confirmatory baseline BMM (either central or peripheral) to permit monitoring of beneficiaries in the future if the initial test was performed with a technique that is different from the proposed monitoring method. That is, a qualified individual may be tested initially with DXA at the hip and spine and then have a confirmatory test with a peripheral device on which the patient is to be monitored every 2 years. The commenter suggested that this policy be revised to preclude coverage of the confirmatory test by the use of a peripheral device because its precision is significantly poorer than the stationary table DXA. The commenter believes that peripheral devices are best suited for screening and initial diagnosis and not for monitoring a patient's response to drug therapy.

Response: We agree that confirmatory testing with a peripheral device should be precluded from coverage. As stated in the Surgeon General's report, as well as recommendations by the International Society of Clinical Densitometry (Journal of Clinical Densitomery 2004; 7:1-5), central skeletal sites are most appropriate for monitoring the effectiveness of therapy, as they are more likely than peripheral sites to show an increase in BMD in response to treatment. Therefore, we included a provision in the proposed rule revising § 410.31(c)(2)(ii) to preclude coverage of a confirmatory test that is performed with the use of a peripheral device and to limit such coverage to a central (axial) DXA. For the reasons described above, as well as the general support of the public commenters on the proposed rule, we are adopting this revision as final without change.

d. Bone Mass Measurement: Beneficiaries Who May Be Covered (§ 410.31(d))

The Congress has recognized that individuals receiving long-term glucocorticoid steroid therapy are qualified individuals for purposes of section 1861(rr)(1) of the Act. Therapy to prevent bone loss in most patients beginning long-term therapy has been recommended at a prednisone equivalent of greater than 5 mg/day for at least 3 months (McIlwain, 2003). Based on our review of the current evidence, we proposed to reduce the dosage equivalent in § 410.31(d)(3) from an average of 7.5 mg/day of prednisone for at least 3 months to an average of 5.0 mg/day of prednisone for the same period.

Comment: A number of commenters expressed concern that certain categories of individuals that warranted inclusion under the BMM benefit were not covered and they recommended that the IFC be revised to include them in the final rule. However, a commenter noted that the Medicare law needed to be amended so that the legal definition of "qualified" individuals for BMM coverage keeps pace with additional current scientific and clinical evidence on who is at risk for osteoporosis. Overall, more than 27 additional categories of "qualified" individuals were recommended for coverage of bone mass measurements under the benefit. These included patients diagnosed with male hypogonadism, Parkinson's disease, multiple sclerosis, myasthenia gravis, Gaucher's disease, mastocytosis, malabsorption syndromes, history of bulimia, chronic lung disease, renal disease, diabetes mellitus, rheumatoid arthritis, secondary hyperparathyroidism and nonvertebral fractures, tobacco dependence, as well as patients on heparin therapy, anticonvulsant therapy, methotrexate therapy, thyroid replacement therapy, and antiepileptic drug therapy, etc.

Response: We have carefully reviewed the above additional categories of individuals who have been recommended for Medicare coverage under the final rule, and have concluded that they do not qualify for coverage under the specific statutory language mentioned above. Section 1861(rr) of the Act provides that the term "qualified individual" for purposes of this benefit means "an individual who is (in accordance with regulations prescribed by the Secretary)-(A) an estrogen-deficient woman at clinical risk for osteoporosis; (B) an individual with vertebral abnormalities; (C) an individual receiving long-term glucocorticoid steroid therapy; (D) an individual with primary hyperparathyroidism; or (E) an individual being monitored to assess the responsive to or efficacy of an approved osteoporosis drug therapy." Therefore, we believe a change in the Medicare statute would be required in order for us to cover these additional categories of individuals under the BMM benefit.

Comment: Most of the commenters supported our broad interpretation of the statutory category of "An estrogen-deficient woman and at clinical risk for osteoporosis" that was specified in the interim final regulation provision § 410.31(d)(1). A June 24, 1998 IFC commenter noted that because the risk factors associated with osteoporosis are so numerous and complex, it is appropriate to allow a woman's treating physician or other treating practitioner to determine whether she is estrogen-deficient or a clinical risk of osteoporosis. However, several June 24, 1998 IFC commenters were concerned about how the definition would be implemented by Medicare contractors. A commenter expressed concern that because there is not an existing ICD-9-CM diagnosis code to describe the condition of estrogen-deficient, this could result in the need for practitioners to use several other ICD-9-CM codes that describe conditions likely to result from estrogen deficient, and in variations in Medicare coverage from carrier to carrier.

Response: We allowed the treating physician or other treating practitioner the discretion and flexibility to determine whether a female beneficiary is estrogen-deficient and at clinical risk for osteoporosis. Creating a code specifically for reimbursement when the condition is described by other codes is not required. Therefore, we are not making any changes to our proposals based on these comments.

Comment: Several IFC commenters indicated that the beneficiary category in § 410.31(d)(5) of "An individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy" is too limited and should be expanded to include coverage of individuals receiving other treatments, including certain medications that do not have FDA approval for osteoporosis treatment, and certain rehabilitation treatments such as therapy-weight lifting and similar interventions. A commenter noted, for example, that didronel, which has been approved by the FDA for the treatment of Paget's disease, is not FDA-approved for osteoporosis treatment but, its safety and efficacy in reducing or reversing steroid-induced osteoarthritis is supported by a large body medical literature.

Response: We recognize that not all Medicare beneficiaries who are treated for osteoporosis are prescribed FDA-approved osteoporosis drug therapy. However, in implementing the statutory mandate in section 1861(rr)(2) of the Act to include as a "qualified individual" for Medicare-covered bone mass measurements "an individual being monitored to assess the response to, or efficacy of an approved osteoporosis drug therapy," we do not believe it is appropriate for us to extend such coverage to beneficiaries who are receiving non-FDA approved osteoporosis drug therapies. Thus, we are not adopting the changes recommended by the commenters.

Comment: A number of commenters addressed our proposal to revise § 410.31(d)(3) which stated that one of the categories of beneficiaries who was entitled to receive Medicare coverage for a medically necessary BMM was "An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to 7.5 mg of prednisone, or greater, per day for more than 3 months." The majority of these commenters suggested that the minimum requirement of 7.5 mg of prednisone, or greater, per day provision was too strict, and that a dose requirement of 5.0 mg per day was more appropriate. However, several commenters stated that even lower dosage amounts than 5.0 mg have been shown to cause significant bone loss over prolonged periods of time, usually because of comorbidities such as rheumatoid arthritis. A commenter recommended that this beneficiary category be expanded to allow coverage for any patient taking steroids for longer than 3 months regardless of the dose that is taken by the patient. Another commenter was also concerned about the 7.5 mg of prednisone, or greater, per day provision, but suggested a minor change that would allow an individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to an average of 7.5 mg of prednisone, or greater, per day for more than 3 months to be covered under the benefit. This commenter stated that use of the average measurement is more in line with the realities of modern medicine and would clarify that those individuals who are receiving the same dosage at different intervals (every other day) are eligible for coverage.

Response: We agree that the minimum 7.5 mg of prednisone dose provision needs to be lowered and that use of an average dose measurement in specifying this standard is appropriate. Patients with glucocorticoid-induced osteoporosis appear to be at high risk for fractures. Researchers have reported that reductions in bone mass have been seen as early as 3 months after starting therapy (McIlwain, 2003). Therapy to prevent bone loss in most patients beginning long-term therapy has been recommended at a prednisone equivalent of =5 mg/day for at least 3 months (McIlwain, 2003). Based on the comments that we have received and our review of the current evidence, we are adopting our proposal to revise § 410.31(d)(3) to reduce the minimum dosage requirement from 7.5 mg to an average of 5.0 mg/day of prednisone for at least 3 months.

Comment: Several IFC commenters expressed concern that Medicare beneficiaries at risk for osteoporosis due to their use of antiepileptic drugs are not eligible for an initial bone mass screening because they are not included in any of the five categories of patients defined as "qualified individuals." The commenter indicates that if it is not possible to change this under current law is it possible for us to confirm that follow-up monitoring tests would be covered every 2 years for a patient on anti-epileptic drugs who shows signs of osteoporosis and who is then placed on osteoporosis FDA-approved drug therapy.

Response: We agree that patients on antiepileptic drugs may be at increased risk for fractures. Still, the current law does not generally address this group of patients as "qualified" individuals under section 1861(rr) of the Act. Monitoring of individuals on anti-epileptic drugs who may also be FDA-approved drug therapy for osteoporosis, of course, may be covered as provided under the BMM benefit.

e. Use of the NCD Process (§ 410.31(f))

To facilitate future consideration of coverage of additional BMM systems for purposes of proposed paragraphs § 410.31(b)(2) and (b)(3), which will limit coverage of BMMs for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements, we proposed to identify additional BMM systems for those purposes through the NCD process. By using the NCD process, we could conduct a timely assessment of FDA-approved BMMs. Use of an NCD to add coverage of effective BMM systems for these purposes is authorized by the reasonable and necessary provision of sections 1862(a)(1)(A) and 1871(a)(2) of the Act.

Comment: One commenter requests that we give Medicare carriers discretion to cover new and advanced technologies that become available to screen for risk of fracture rather than requiring that such technologies be evaluated through the NCD as specified in the proposed rule. The commenter stated that the NCD process can be long and cumbersome, and that requiring that new technologies be added through this process could prevent beneficiaries from having access to these new and better technologies for some length of time.

Response: The IFC implemented section 4106 of the BBA by establishing conditions for coverage and frequency standards for BMMs to ensure that (among other things) they are paid for uniformly throughout the Medicare program. To ensure that important new and advanced BMM technologies as defined under the statute and regulations are paid for uniformly under the program, we believe they should be identified and evaluated through the NCD process. By relying on the NCD process for this purpose, we believe we will able to conduct a timely assessment of FDA-approved BMMs for possible uniform coverage under the program that is not possible if we left this to local contractor discretion. In most circumstances, the NCD process is required to be completed within 9 to 12 months of the time that we accept a formal request for an NCD on a particular procedure.

Comment: Several commenters noted that the WHO is currently in the process of developing a standardized methodology for determining fracture risk. A commenter indicated that although DXA is one important tool for measuring fracture risk, there are other clinical risk factors that are also important to evaluation, specifically to determine which patients are likely to best respond to treatment. The commenters suggested that employing the new risk assessment methodology may lead to better patient outcomes by helping providers better identify those patients who should be on therapy and they ask CMS to recognize this new assessment methodology for coverage under Medicare Part B when WHO completes its work on it.

Response: We do not know enough about the parameters of the standardized methodology for determining fracture risk that the WHO is developing to respond very specifically to this comment. However, if this standardized methodology for measuring fracture risk relies on the use of a device or technique that meets our definition of a BMM as defined in § 410.31(a), we believe it would be appropriate to consider evaluating any formal request for an NCD for such a device or technique, if it were submitted to us for evaluation.

f. Other Issues

Comment: A commenter questioned why there was no discussion in the IFC about the importance of ethnicity as a risk factor for low bone mass and osteoporosis. The commenter suggests that ethnicity is one of the most important risk factors for low bone mass and osteoporosis.

Response: We agree that ethnicity as well as many other risk factors may result in certain individuals being considered to be more likely to develop osteoporosis than other individuals. For example, the National Osteoporosis Foundation (NOF) and other medical professional organizations have reported that Caucasians and Asians appear to be more at risk for developing osteoporosis than other ethnic groups. However, the NOF has also indicated that significant risk has been reported in people of all ethnic backgrounds, including African-Americans and Hispanic-Americans. The reason that this subject was not discussed in the IFC was that ethnicity was not specifically identified in the BMM Amendment that was enacted in 1997 as a risk factor or medical indication that warranted Medicare coverage of bone mass measurements. Therefore, a careful examination of this subject is beyond the scope of this final rule. However, we expect that in completing an evaluation of the beneficiary's need for the bone mass measurement, as provided in § 410.31(b)(1), the physician or other qualified practitioner (as these terms are defined in the regulation) will take ethnicity and other significant risk factors into account in ordering medically necessary tests for individual patients to the extent that it is possible to do so under the statutory beneficiary categories specified in § 410.31(d).

Comment: Several commenters indicated that the IFC offered insufficient guidance on how to document the medical necessity of bone mass measurements performed on "qualified individuals" (§ 410.31(d)) by the use of ICD-9-CM diagnosis codes. The commenter suggested that we develop national guidelines that would help providers in documenting the medical necessity of bone mass measurements.

Response: The IFC did not provide guidance on the ICD-9-CM diagnosis codes that could be used by physicians or other providers in documenting Medicare claims for bone mass measurements. However, our original intent was that local Medicare contractors were to be responsible for developing those appropriate specific diagnostic coding guidelines for the physicians and other providers in their respective localities and for communicating those guidelines to them and to the general medical community, and they have been doing that successfully since 1998. We expect our contractors will continue to do this as necessary in the future.

Comment: A commenter suggests the need for a unique CPT code or modifier to help distinguish a "confirmatory baseline bone mass measurement" from a BMM that may be in violation of the frequency of coverage standard of one follow-up monitoring test every 2 years.

Response: We do not believe there is a need to establish a unique CPT code or modifier to distinguish a "confirmatory baseline bone mass measurement" for a BMM that may be in violation of the frequency of coverage standard of one follow-up monitoring test every 2 years because local Medicare contractors rely on the use of frequency screens (or edits) in determining whether follow-up tests are medically necessary for individual patients. These frequency screens (or edits) do not require the use of a unique CPT code or modifier by providers in billing for these follow-up tests in order for local contractors to be effective in making their medical necessity determinations.

In view of the comments and our review of the medical literature, and other information, we are adopting our proposed revisions to § 410.31 as final without change.

L. Independent Diagnostic Testing Facility (IDTF) Issues

1. IDTF Changes

During the course of a national review in 2003-2004, the OIG found a potential $71 million in improper payments made to IDTFs (Review of Claims Billed by Independent Diagnostic Testing Facilities for Services Provided to Medicare Beneficiaries During Calendar Year 2001 (A-03-03-00002)). The OIG found that erroneous payments were made as the result of poor or missing documentation or lack of medical necessity. Moreover, in recent years, we have determined with the help of our contractors that a number of IDTFs in California and other States are perpetrating schemes to defraud the Medicare program.

Since 2000, the number of IDTFs in California has increased by 40 percent, which is a far greater percentage increase than the Medicare population in that State. The number of IDTFs billing Medicare in California alone increased more than 400 percent from 2000 to 2005. The increased use of IDTF services has not lowered the use of diagnostic testing within other settings. The increased rates of utilization within IDTFs are likely to be unrealistic due to an increase in the need for diagnostic testing within California's Medicare population. Also, these IDTFs are growing at a rate faster than we can survey these facilities. The actual growth of IDTFs is not a problem. However, the results of the OIG audit make it clear that we need to closely monitor IDTFs and establish standards to ensure quality care for Medicare beneficiaries. To address the erroneous payments identified by the OIG, we proposed to establish IDTF performance standards similar to those in § 424.57 which we adopted for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Suppliers in the Additional Supplier Standards final rule published in the October 11, 2000 Federal Register (65 FR 60366).

In the CY 2007 PFS proposed rule, we proposed that each IDTF be required to be in compliance with the proposed fourteen suppler standards discussed in section II.L.2. of this final rule with comment period to obtain or retain enrollment in the Medicare program (71 FR 49061). Accordingly, at § 410.33(h), we proposed that if an IDTF fails to meet one or more of the standards at the time of enrollment or at the time of re-enrollment, then its enrollment application would be denied. Also, if at any time we determine that an enrolled IDTF no longer meets the performance standards, its billing privileges would be revoked.

We believe that these performance standards are needed to ensure that minimum quality standards are met to protect beneficiaries, as well as the Medicare Trust Fund. These standards are merely good business practices that will help to ensure that suppliers are providing a quality care to Medicare beneficiaries. Examples of the kind of standards are a primary business phone number and address. Another example is a posting of standards for review by patients and the public.

For IDTFs, we proposed to adopt a number of standards that we adopted for DMEPOS suppliers, including supplier standard number 6 which requires a supplier to maintain a comprehensive liability insurance policy of $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF.

Furthermore, we proposed in the new performance standard number 7 that an IDTF agrees not to directly solicit patients. This provision does not preclude the IDTF from public advertisement or marketing its services to physicians and other suppliers, however it does prohibit recruitment of beneficiaries through direct solicitation.

Additionally, the IDTF will be required to grant us, or our designated fee-for-service contractors, including our agents, to have access to the IDTF physical location, all equipment, and beneficiary medical records during normal business hours. For portable equipment, an IDTF will be required to maintain a catalog of portable equipment and be able to produce the cataloged equipment within 2 business days. If the IDTF denies this access, the IDTF's Medicare enrollment will be immediately revoked.

To ensure that equipment used by an IDTF is maintained and operates properly, we sought public comments regarding IDTF supplier standard number 11, which requires that an IDTF must have its testing equipment calibrated per equipment instructions or in compliance with applicable industry standards. Specifically, we sought public comments regarding the organizations or entities that may currently establish testing specifications for diagnostics equipment. Further, if these organizations or entities do not exist, we invited public comments on the establishment of a supplier standard that relies on the manufacturer's maintenance and calibration standards.

2. Performance Standards for IDTFs

The IDTF would be required to meet the following standards as of January 1, 2007 and any newly or reenrolling IDTF would be required to certify in its enrollment application that it meets and will continue to meet the standards. At § 410.33, we proposed to specify that the IDTF is required to-

• Operate its business in compliance with all applicable Federal, State, and local licensure and regulatory requirements for the health and safety of patients;

• Provide complete and accurate information on its enrollment application as stated in the "Requirements for Providers and Suppliers to Establish and Maintain Enrollment final rule" (April 21, 2006, 71 FR 20754). Any change in enrollment information must be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days;

• Maintain a physical facility on an appropriate site. For the purposes of this standard, a post office box or commercial mailbox is not considered a physical facility. The physical facility must contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records;

• Have all applicable testing equipment available at the physical site, excluding portable equipment. A catalog of portable equipment, including equipment serial numbers, must be maintained at the physical site. In addition, portable equipment must be made available for inspection within 2 business days of our inspection request. The IDTF will be required to maintain a current inventory of the equipment (including serial/registration numbers), provide this information to the designated fee-for-service contractor and notify the contractor of any changes in equipment;

• Maintain a primary business phone under the name of the business. The business phone must be located at the designated site of the business. The telephone number or toll free numbers must be available in a local directory and through directory assistance;

• Have a comprehensive liability insurance policy of at least $300,000 or 20 percent of its average annual Medicare billings, whichever amount is greater, that covers both the place of business and all customers and employees of the IDTF. The insurance policy must be carried by a non-relative owned company. The policy must list the serial numbers of any and all equipment used by the IDTF;

• Agree not to directly solicit patients, which includes, but is not limited to, a prohibition on telephone, computer, or in-person contacts. The IDTF will accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. NPPs may order tests as set forth in § 410.32(a)(3);

• Answer beneficiaries' questions and respond to their complaints. Documentation of those contacts must be maintained at the physical site;

• Openly post these standards for review by patients and the public;

• Disclose to the government, any person having ownership, financial or control interest, or any other legal interest in the supplier at the time of enrollment or within 30 days of a change;

• Have its testing equipment calibrated per equipment instructions and in compliance with applicable national standards;

• Have technical staff on duty with the appropriate credentials to perform tests. The IDTF must produce the applicable Federal or State licenses and/or certifications of the individuals performing these services;

• Have proper medical record storage and be able to retrieve medical records upon request from CMS or its designated fee-for-service contractor within 2 business days; and

• Permit CMS, including its agents or its designated fee-for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these standards. The IDTF is required to provide access, during regular business hours, to CMS and beneficiaries, as well as maintain a visible sign posting the normal business hours of the IDTF.

3. Supervision

To ensure quality care is provided to Medicare beneficiaries, we proposed to revise § 410.33(b)(1) to read that physicians will be limited to providing supervision to "no more than three IDTF sites."

4. Place of Service

In addition to establishing specific performance standards for IDTFs, at § 410.33(i), we proposed to define the "point of the actual delivery of service" as the correct "Place of Service" for the claim form in the case of diagnostic testing performed outside the IDTF's physical location. For example, when an IDTF performs a diagnostic test at a beneficiary's residence, we believe that it is reasonable to establish the beneficiary's residence as the "Place of Service." Previously, there has been no set procedure, so therefore, we believe that the information is gathered at the collection point from the beneficiary, and this is the point service. While most diagnostic tests are performed in an office setting, we solicited public comments regarding the types of services that can be safely and appropriately used in a residential setting.

5. Analysis of and Responses to Public Comments

Comment: Several commenters agreed with our proposal to limit the number of IDTFs that a physician can oversee to three. Conversely, some commenters expressed concern about our proposal to limit the number of IDTFs that a physician can oversee.

Response: While we understand the concerns associated with limiting the number of IDTFs that a physician can oversee to three, we believe that limiting the number of IDTFs that a physician can oversee will promote quality of care. We are defining the supervising physician to be the person who is listed in Attachment 2, Section E on the CMS-855B enrollment application.

Comment: Several commenters suggested that the proposed standards be revised to reflect that mobile IDTFs will have different needs and requirements from those IDTFs which are stationary.

Response: We appreciate this comment and have revised our policy in this final rule with comment period to address IDTF performance standards for both fixed and mobile IDTFs.

Comment: Several commenters recommended that we expand the proposed IDTF performance standards to all imaging services.

Response: While we appreciate this comment, we will consider this change in a future rulemaking document.

Comment: One commenter expressed concern regarding our proposal that an IDTF maintain a physical facility on an appropriate site and that IDTFs would be required to maintain a specified number of square feet per facility.

Response: While we understand the commenter's concern, it was never our intent to establish a minimum square foot requirement. We believe that the size of an IDTF can vary depending on the services performed. Accordingly, we believe that the size of a fixed-based IDTF should be of sufficient size to provide the services offered by the IDTF, such as maintaining records, and performing administrative tasks.

Comment: Several commenters recommended that physicians can be proficient in analyzing test results without being considered a specialist in the field relating to that specific type of diagnostic testing.

Response: This issue is outside of the scope of the provisions of the proposed rule, and therefore, we are not providing a response at this time.

Comment: In lieu of the specific performance standards proposed, several commenters recommended that we use accreditation as a method for improving compliance and limiting fraud and abuse with IDTFs.

Response: While we appreciate this comment, we are not able to adopt this recommendation. We believe that it is essential that we obtain additional information from the public before adopting IDTF accreditation standards.

Comment: Several commenters recommended establishing a grace period before carriers begin the revocation process for those IDTFs that fail to meet the new performance standards.

Response: While we understand the concerns of the commenters, we do not believe that it is practical to delay implementation of these standards. With the publication of this final rule with comment period, all IDTFs are being notified of the new performance standards. Moreover, we believe that most IDTFs meet the performance standards that we are adopting, or that they can do so within the time period between the publication of this final rule with comment period and its effective date. In addition, as we put this policy into operation, we will consider phasing-in our implementation approach. In the event that an IDTF's billing privileges are revoked, the supplier can appeal the revocation.

Comment: Several commenters expressed the concern that an unannounced site visit by CMS or our representatives could be potentially disruptive to an IDTF's operations.

Response: We believe that unannounced site visits are a useful tool to ensure that IDTFs are meeting their enrollment requirements and performance standards. We will work closely with our contractors to limit any disruptions during a site visit.

Comment: One commenter recommended that we eliminate the IDTF benefit.

Response: We believe that establishing performance standards and the other changes in this regulation will improve quality and assist us in our efforts to reduce fraud and abuse in the Medicare program. Accordingly, we are finalizing this proposal.

Comment: One commenter recommended eliminating the requirement to maintain a primary business phone located at the designated site for business, especially with regards to mobile IDTFs.

Response: We believe that it is essential that fixed and mobile IDTFs maintain a primary business telephone number. Moreover, we believe the primary business telephone number for fixed-based IDTFs is located at the practice location for the IDTF. For mobile IDTFs, we believe that the primary business telephone number is the home location for the mobile facility.

Comment: Several commenters recommended that we clarify where mobile IDTFs would store patient records.

Response: We believe that it is appropriate for a mobile IDTF to store patient records at their home location.

Comment: In lieu of the proposed performance standards, several commenters recommended that we implement modality specific standards to address the diverse nature of the services provided by IDTFs.

Response: We are not able to adopt this recommendation because we believe that it is essential that we obtain additional information from the public before adopting modality-specific standards.

Comment: Several commenters stated that our proposal for a physician to be responsible for overall operations and administration of an IDTF has no basis, and that a physician should solely play a clinical or technical role.

Response: We believe that a supervising physician, as identified in Attachment 2 of the CMS-855B Medicare enrollment application, is fundamentally responsible for the proper administration of an IDTF's services.

Comment: Several commenters questioned our interpretation for the point-of-service for services provided outside the IDTF, specifically at the beneficiary's residence.

Response: The beneficiary's location will be considered the place of service for pure, home-based testing. Those diagnostic tests which have another element outside of the testing location will continue to have the IDTF as the place of service of that diagnostic procedure.

Comment: Several commenters recommended that there is a need for a supervising physician within an IDTF and that the language in the proposed rule stating that, "a physician could oversee no more than three IDTFs," could be interpreted to mean that a physician does not have to oversee an IDTF.

Response: We concur with this recommendation and believe that this standard should be interpreted as a physician will oversee one to no more than three IDTFs, not that an IDTF does not need a supervising physician.

Comment: We received numerous comments concerning one aspect of performance standard 6. We proposed that the IDTF would have to maintain a comprehensive liability insurance policy of $300,000 or 20 percent of the IDTF's Medicare billings, whichever amount is greater. We received comments suggesting the removal of the 20 percent condition as this would be an undue burden to the IDTF. Additionally, we received comments suggesting that we establish a flat rate such as the $300,000 proposed, having a $300,000 policy for each facility, an increase to a $500,000 flat coverage, a comprehensive insurance policy of $1 million, or an aggregate rate of $3 million.

Response: In order to reduce administrative burden associated with calculating comprehensive liability insurance for suppliers and to ensure compliance of this new standard, we will establish a comprehensive liability insurance amount of $300,000 per location for IDTFs. We agree with the recommendation that comprehensive liability insurance coverage of $300,000 per facility location is more appropriate, given that the likelihood of an incident occurring would increase as the number of facilities increases. We believe that the $300,000 per location represents the reasonable level of coverage for a facility's comprehensive liability insurance and we will change performance standard 6 to reflect this change.

Comment: One commenter suggested that we eliminate the provision that insurance policy must be carried by a non-relative-owned company.

Response: Consistent with our DMEPOS supplier standards, we believe the comprehensive liability insurance must be obtained from a verified third party to ensure that the coverage exists.

Comment: Several commenters recommended our performance standards address State requirements, and that we should develop a Federal set of standards that would not vary from State to State.

Response: While we understand this concern, we believe that each State should continue to establish its own licensing requirements. Further, we believe that all IDTFs must maintain compliance with applicable Federal, State, and local licensure and regulatory requirements.

Comment: Several commenters expressed concern with our proposed supplier standard 7 which states that an IDTF agrees not to directly solicit patients, and these commenters recommended that we remove or clarify standard seven.

Response: We understand the concerns of the commenters, but we are not attempting to prohibit public advertising. Supplier standard 7 is designed to prohibit an IDTF or its representative from direct, person-to-person solicitation of beneficiaries by means of phone, computer, or in-person. Clearly, an IDTF can use public advertisement, including advertising on television, radio, internet, direct mailing, billboards, or newspapers.

Comment: One commenter recommended that complaints by beneficiaries should be documented on paper and kept at a home office location.

Response: At this time, we are not requiring that an IDTF collect and maintain a log of beneficiaries' questions and complaints because we did not propose this requirement in the CY 2007 PFS proposed rule. In a future rulemaking document, we will address a formal collection process for this documentation.

Comment: Several commenters expressed concern regarding the storage and specifications of medical records (namely the comprehensive medical records of the beneficiaries they are currently treating or have treated), as well as how we would be defining current medical records, largely due to the additional burden of HIPAA requirements associated with a patient's comprehensive medical treatments.

Response: We view current medical records as consisting of the services provided by the IDTF to its current and prior patients. Upon request, CMS or its contractors may request comprehensive medical records for an IDTF.

Comment: Several commenters expressed support for IDTF supplier standard 11 which mandates the calibration of all IDTF testing equipment. These commenters recommended that we work with the National Electrical Manufacturers Association (NEMA) prior to establishing any calibration and maintenance requirements.

Response: We appreciate these comments and intend to work with NEMA and other organizations in the development of calibration and maintenance requirements.

Comment: We received a comment stating that IDTFs should not be required to post performance standards.

Response: We believe that posting performance standards educates patients of an IDTF regarding their rights within the IDTF setting. Therefore, we will adopt this standard as proposed.

Comment: Several commenters recommended that we postpone implementing the proposed IDTF performance standards in 2007 and work with industry to develop standards for the CY 2008 PFS.

Response: Given the widespread support of IDTF performance standards, we believe it is appropriate to implement our proposed changes as soon as possible. Therefore, we will implement the IDTF standards in this final rule with comment period.

Comment: Several commenters recommended that our proposed 30-day timeframe for reporting changes in enrollment data was insufficient and that IDTFs should be allowed to continue to report changes within 90 days.

Response: Consistent with the reporting requirements for DMEPOS suppliers, and given the fraud and abuse concerns in this area, we believe that it is appropriate to adopt the 30-day timeframe for IDTFs to report changes in enrollment information.

6. Provisions of the Final Rule.

a. Performance Standards for IDTFs

We received numerous valuable comments concerning the proposed supplier standards and have revised them to reflect the issues brought forth during the comment period. Therefore, we have amended these new standards to reflect the differences in an IDTF's setting and the services which they provide. We are adopting the provisions contained in the proposed rule as final with the following changes.

We are revising supplier standard number 3 to address concerns regarding how performance standards affect mobile IDTFs, rather than fixed location IDTFs. Specifically, we are adopting a position that IDTF performance standards apply to the home location of the mobile IDTF, not the mobile vehicle. Accordingly, the home location of the mobile IDTF, not the mobile IDTF vehicle, is required to maintain patient records, a primary business phone, and meet all other performance standards met by fix location IDTFs.

We are revising supplier standard number 6 to establish a set amount for comprehensive liability insurance in the amount of $300,000 per location (an amount similar to the amount of insurance coverage for DMEPOS suppliers). We are adopting, for IDTFs, supplier standard number 6 which requires a supplier to maintain a comprehensive liability insurance policy of $300,000 for each IDTF location, which covers both the place of business and all customers and employees of the IDTF. We believe that the second part of the proposed provision of 20 percent of its average annual Medicare billings, if greater than the $300,000 would be a burdensome task for supplier to calculate on annual basis and lead to compliance concerns.

We are clarifying supplier standard number 7 that an IDTF agrees not to directly solicit patients. While this provision does not preclude an IDTF from public advertisement or marketing of its services to beneficiaries, physicians and other suppliers, it does prohibit recruitment of beneficiaries through direct solicitation, namely through person-to-person contact, whether it be in-person, by computer, or telephone.

Since we did not include the requirement in the CY 2007 PFS proposed rule, we are revising performance standard 8 and removing the sentence concerning the documentation of contacts concerning beneficiaries' questions and complaints because we believe it would be unfair and confusing to the public, and would present an undue paperwork burden.

We are revising supplier standard number 11 to state that each piece of diagnostic testing equipment be maintained and calibrated to its manufacturer's standards. To ensure that equipment used by an IDTF is maintained and operates properly, we sought public comments regarding IDTF supplier standard number 11, which requires that an IDTF must have its testing equipment calibrated per equipment instructions or in compliance with applicable industry standards. Specifically, we sought public comments regarding the organizations or entities that may currently establish testing specifications for diagnostics equipment. We received a number of comments supporting this proposal with minor changes suggested by leaders within this industry. We are adopting a recommendation that we use each manufacturer's maintenance and calibration standards which they have determined are appropriate for the diagnostic testing equipment they manufacture for use within these IDTFs. We will continue to consult with industry leaders regarding the best approaches to ensure that all IDTF testing equipment is maintained and calibrated in accordance with manufacturer's specifications.

We are clarifying supplier standard number 14 that fixed and mobile IDTFs are required to grant CMS, or our designated fee-for-service contractors, access to the IDTF physical location, all equipment, and beneficiary medical records during normal business hours. We also adopted the position that for portable equipment, an IDTF will be required to maintain a catalog of portable equipment and be able to produce the cataloged equipment within 2 business days. If the IDTF denies CMS or our designated fee-for-service contractor access to its fixed located or the home location for a mobile vehicle, the IDTF's Medicare enrollment will be denied if initially enrolling or revoked if currently enrolled in the Medicare program.

Accordingly, at § 410.33(h), we are stating that if an IDTF fails to meet one or more of the standards at the time of enrollment, then the enrollment application would be denied. Also, we are adopting the position that if at any time we determine that an enrolled IDTF no longer meets one or more of the IDTF performance standards, the IDTF's billing privileges would be revoked.

As specified in § 410.33, the IDTF will be required to meet the following standards as of January 1, 2007 and any newly or reenrolling IDTF will be required to certify in its enrollment application that it meets and will continue to meet the standards.

• Operate its business in compliance with all applicable Federal, State, and local licensure and regulatory requirements for the health and safety of patients;

• Provide complete and accurate information on its enrollment application as stated in the "Requirements for Providers and Suppliers to Establish and Maintain Enrollment final rule" published in the April 21, 2006 Federal Register (71 FR 20754). Any change in enrollment information must be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days;

• Maintain a physical facility on an appropriate site. For the purposes of this standard, a post office box or commercial mailbox is not considered a physical facility. The physical facility, including mobile units, must contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records within the office setting of the IDTF, or IDTF home office, not within the actual mobile unit;

• Have all applicable diagnostic testing equipment available at the physical site, excluding portable diagnostic testing equipment. A catalog of portable diagnostic testing equipment, including diagnostic testing equipment serial numbers, must be maintained at the physical site. In addition, portable diagnostic testing equipment must be made available for inspection within 2 business days of our inspection request. The IDTF will be required to maintain a current inventory of the diagnostic testing equipment (including serial/registration numbers), provide this information to the designated fee-for-service contractor and notify the contractor of any changes in equipment;

• Maintain a primary business phone under the name of the business. The primary business phone must be located at the designated site of the business, or within the home office of mobile IDTF units. The telephone number or toll free numbers must be available in a local directory and through directory assistance;

• Have a comprehensive liability insurance policy of at least $300,000 per location that covers both the place of business and all customers and employees of the IDTF. The insurance policy must be carried by a non-relative owned company. The policy must list the serial numbers of any and all diagnostic equipment used by the IDTF, whether the equipment is stationary, in a mobile unit, or at the beneficiary's residence;

• Agree not to directly solicit patients, which includes, but is not limited to, a prohibition on telephone, computer, or in-person contracts. The IDTF will accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. NPPs may order tests as set forth in § 410.32(a)(3);

• Answer beneficiaries' questions and respond to their complaints;

• Openly post these standards for review by patients and the public;

• Disclose to the government, any person having ownership, financial or control interest, or any other legal interest in the supplier at the time of enrollment or within 30 days of a change;

• Have its testing equipment calibrated and maintained per equipment instructions and in compliance with applicable manufacturers suggested maintenance and calibration standards;

• Have technical staff on duty with the appropriate credentials to perform tests. The IDTF must produce the applicable Federal or State licenses and certifications of the individuals performing these services;

• Have proper medical record storage and be able to retrieve medical records upon request from CMS or our designated fee-for-service contractor within 2 business days; and

• Permit CMS, including our agents or our designated fee-for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these standards. The IDTF is required to provide access, during regular business hours, to CMS and beneficiaries, as well as maintain a visible sign posting the normal business hours of the IDTF.

While we understand that these additional standards could lead certain IDTFs to withdraw from the Medicare program rather than comply with the new standards, we believe that legitimate businesses would not oppose these changes. Moreover, we emphasize that services provided by an IDTF are also readily available to beneficiaries through other avenues such as physicians' offices, outpatient laboratories, outpatient radiology facilities, and outpatient clinics. We believe that the implementation of these standards would improve the quality of services provided to Medicare beneficiaries by IDTFs without any associated access concerns.

b. Supervision

To ensure quality care is provided to Medicare beneficiaries, we are adopting the position to revise § 410.33(b)(1) to read that physicians will be limited to providing supervision to "no more than three (3) IDTF sites." This reference to the supervising physician applies to the individual listed as the supervising physician in the Medicare enrollment application (that is, CMS-855 B, Attachment 2, Section E), not the physician supervising the interpretation of a diagnostic test.

c. Place of Service

In addition to establishing specific performance standards for IDTFs, we are defining the "point of the actual delivery of service" as the correct "Place of Service" on the claim form. In the case of diagnostic testing that is performed completely outside of a fixed facility location, we believe that the point of actual delivery of service is the beneficiary's' residence, or location where the test is being administered. As such, these services should be billed to the designated Medicare contractor. For example, when a diagnostic test is performed at a beneficiary's residence, we believe that it is reasonable to establish the beneficiary's residence as the "Place of Service" and that these services be billed to the designated Medicare contractor where the beneficiary resides. Previously, there has been no set policy regarding diagnostic testing performed by beneficiary. Accordingly, mobile IDTF and portable x-ray supplier services performed in beneficiary's residence would be billed to the designated Medicare contractor where the beneficiary resides, rather than the home location of the mobile IDTF or portable x-ray supplier.

However, when a diagnostic test contains a home-based element (that is, the beneficiary performs a portion of the testing in his or her residence) and a facility-based element (that is, an IDTF reads or monitors the test results), the place of service is not clearly established and the fixed location of the IDTF will remain as the place of service for these tests. Accordingly, diagnostic tests containing both home-based and facility-based elements are billed to the designated Medicare contractor associated with the practice location of the fixed IDTF.

In a future rulemaking effort, we will seek public input regarding the appropriate place of service for diagnostic testing when services are rendered in multiple parts in different locations.

M. Independent Laboratory Billing for the TC of Physician Pathology Services to Hospital Patients

The TC of physician pathology services refers to the preparation of the slide involving tissue or cells that a pathologist will interpret. (In contrast, the pathologist's interpretation of the slide is the PC service. If this service is furnished by the hospital pathologist for a hospital patient, it is separately billable. If the independent laboratory's pathologist furnishes the PC service, it is usually billed with the TC service as a combined service.)

In the CY 2000 PFS final rule (64 FR 59380 and 59408 through 59409), we stated that we would implement a policy to pay only the hospital for the TC of physician pathology services furnished to hospital patients. Before that proposal, any independent laboratory could bill the carrier under the PFS for the TC of physician pathology services for hospital patients. As stated in the CY 2000 PFS final rule, this policy has contributed to the Medicare program paying twice for the TC service, first through the inpatient prospective payment rate to the hospital where the patient is an inpatient and again to the independent laboratory that bills the carrier, instead of the hospital, for the TC service.

Therefore, in the CY 2000 PFS final rule at § 415.130, we provided that, for services furnished on or after January 1, 2001, the carriers would no longer pay claims to the independent laboratory under the PFS for the TC of physician pathology services for hospital patients.

Ordinarily, the provisions in the final PFS are implemented in the following year. However, in this case, the change to § 415.130 was delayed one year (until January 1, 2001), at the request of the industry, to allow independent laboratories and hospitals sufficient time to negotiate arrangements. Moreover, our full implementation of § 415.130 was further delayed through CY 2006. Most recently, under section 732 of the MMA, we were required to pay separately under Medicare Part B for the TC of physician pathology services for services furnished during 2005 and 2006.

However, we continue to believe that hospital prospective payment amounts already compensate hospitals for the TC of physician pathology tests and that additional payment under the PFS is inappropriate. Therefore, we are amending § 415.130 to provide that, for services furnished after December 31, 2006, an independent laboratory may not bill the carrier for the TC of physician pathology services furnished to a hospital inpatient or outpatient. Under § 415.130(d), we will pay under the PFS for the TC of a physician pathology service furnished by an independent laboratory for services provided to an inpatient or outpatient of a "covered hospital" (as defined in § 415.130(a)(1)) on or before December 31, 2006.

We received comments from individuals and groups.

Comment: Several commenters stated that the policy, in the CY 2000 PFS final rule, was based on flawed assumptions and facts, and that the hospital's inpatient payment rate does not include payment for this service.

Response: We addressed specific comments regarding the establishment of the inpatient prospective payment system (IPPS) and the inclusion of the TC physician pathology costs in this payment system in the final rule published in the CY 2000 PFS final rule (64 FR 59408 through 59409). We believe that our discussion in that final rule is still valid.

Comment: Several commenters indicated that hospitals and independent laboratories will have to set up costly and administratively complex billing systems and procedures. These commenters and others asked us to allow hospitals and independent laboratories that have these grandfathered arrangements to continue bill in the same manner.

Response: We are not requiring the hospitals to establish new billing procedures or systems. The billing of TC physician pathology services involves the same billing procedures and processes that the hospital may have established for any outsourced diagnostic tests for hospital inpatients, such as MRI, CT scan, and ultrasound scans. Only hospitals that have outsourced no other diagnostic services other than physician pathology services may have to establish new billing systems or procedures.

Similarly, we are not requiring independent laboratories to establish new billing procedures and systems. Independent laboratories have similar billing systems in operation for clinical laboratory services that are provided to hospital inpatients. Also, neither individual laboratories nor any industry laboratory specialty group for independent laboratories has commented on this increased complexity, cost, and burden.

Comment: One individual commented on a draft instruction that has been sent to the Medicare carriers for comment. The instruction implements the payment policy for physician pathology TC services beginning in 2007.

Response: This item is not a subject of the proposed rule and we are not addressing this comment as part of this rule. The draft Internet Only Manual instructions are reviewed by carriers during their development. There is a formal review process for evaluation of these comments apart from the regulation process.

Comment: Several commenters identified an issue involving proposed § 415.130. The commenters expressed concern that the effect of the proposed regulation would not be limited to the TC of physician services. Proposed § 415.130 reads, "For services furnished after December 31, 2006, an independent laboratory may not bill the carrier for physician pathology services furnished to a hospital inpatient or outpatient."

Response: We appreciate the issue that the commenters have identified through their careful reading of the proposed rule. The quoted sentence omitted the reference to the "technical component" of physician pathology services. We are revising the regulation text accordingly as this was clearly our intent.

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

Section 1833(h) of the Act requires the Secretary to establish fee schedules for clinical laboratory tests under Medicare Part B. We proposed to implement section 942(b) of the MMA which specifies annual procedures for consulting the public on how to establish payment for new clinical laboratory test codes to be included in the annual update of the clinical laboratory fee schedule.

1. Medicare, Medicaid, and SCHIP Benefits Improvement Protection Act of 2000 (BIPA)

Section 531(b) of BIPA mandated that we establish, no later than 1 year after the date of enactment, procedures that permit public consultation for payment determinations for new clinical diagnostic laboratory tests under Medicare Part B in a manner consistent with the procedures established for implementing ICD-9-CM coding modifications. In the CY 2002 PFS final rule (66 FR 58743), we specified the procedures to implement section 531(b) of BIPA.

These procedures were most recently used to determine the payments for new 2006 clinical laboratory fee schedule codes. First, we convened a public meeting to solicit expert input on the nature of the new tests before rate determinations were made. We have held these meetings each year since 2002 to receive this expert input on the next year's codes. Our most recent meeting was announced in the Federal Register on May 27, 2005 (70 FR 30734) and occurred on July 18, 2005. In that meeting, we requested that presenters address the new test codes, each test's purpose, method, cost, and a recommendation for one of two methods (crosswalking or gapfilling) for determining payment for the new clinical laboratory codes. Crosswalking and gapfilling are discussed in section II.N.2.d of this final rule with comment period.

Following the public meeting, we posted a summary of the new codes and the payment recommendations that were presented during the public meeting on our Web site. The summary also displayed our tentative payment determinations and indicated a comment period for interested parties to submit written comments. After reviewing the comments received, we issued Medicare Transmittal 750, 2006 Annual Update for Clinical Laboratory Fee Schedule, which provided all instructions and final rate determinations for the 2006 clinical laboratory fee schedule including the new codes and fees, on November 18, 2005.

2. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA)

In the CY 2007 PFS proposed rule (71 FR 49064), we proposed to implement section 942(b) of the MMA which requires that we establish procedures for consulting the public on how to establish payment for new clinical laboratory test codes to be included in the annual update of the clinical laboratory fee schedule. Similar procedures were already mandated by legislation in section 531(b) of the BIPA which requires payment determinations for new clinical diagnostic laboratory tests under Medicare Part B be made in a manner consistent with the procedures established for implementing ICD-9-CM coding modifications.

Specifically, the MMA requires the Secretary to establish by regulation procedures for determining the basis for and amount of payment for a clinical diagnostic laboratory test that is assigned a new or substantially revised HCPCS code on or after January 1, 2005. We refer to these tests as "new tests."

a. Basis and Scope (§ 414.500)

We proposed to add a new subpart implementing provisions of section 1833(h)(8) of the Act-procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised HCPCS code is assigned on or after January 1, 2005.

We received no comments on this subpart. Therefore, we are finalizing § 414.500 as proposed.

b. Definition (§ 414.502)

As specified in section 942(b) of the MMA, we are defining the term "Substantially Revised Healthcare Common Procedure Coding System Code" to mean a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new analyte or a new methodology for measuring an existing analyte specific test).

We did not receive comments on this subpart. Therefore, we are finalizing § 414.502 as proposed.

c. Procedures for Public Consultation for Payment for a New Clinical Diagnostic Laboratory Test (§ 414.506)

For a clinical laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, section 1833(h)(8)(B) of the Act provides that determinations of payment amounts for new tests shall be made only after the Secretary:

• Makes available to the public (through an Internet Web site and other appropriate mechanisms) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year;

• Publishes a Federal Register notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis for establishing payment amounts for the list of codes made available to the public on the same day the list of codes is made available;

• Convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based) not less than 30 days after publication of the notice in the Federal Register ; and

• Considers the comments and recommendations (and accompanying data) received at the public meeting, develops and makes available to the public (through an Internet Web site and other appropriate mechanisms)-

+ A list of determinations for the appropriate basis for establishing a payment amount for each code, together with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments on the proposed determination; and

+ A list of final determinations of the payment amounts for tests, together with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.

In the CY 2007 PFS proposed rule, we indicated these procedures have been most recently used to finalize the payments for new 2006 clinical laboratory fee schedule codes and we believe that our current process for providing for public consultation on the establishment of payment amounts for new clinical laboratory tests is consistent with the requirements of section 1833(h)(8)(B) of the Act. We currently make available to the public through a posting on the CMS Web site a list of new laboratory test codes for the next calendar year. We publish a Federal Register notice of a meeting to receive public comments and recommendations and convene the meeting with appropriate CMS officials in attendance. We consider the input received at the public meeting and we make available to the public on the CMS Web site a list of the proposed determinations and seek comment. We then make available to the public our final determinations in the instructions that we provide to our claims processing contractors to implement the Medicare Part B clinical laboratory fee schedule each year.

The most significant change required by section 1833(h)(8)(A) of the Act with respect to our procedures for public consultation is that we codify this process in regulations. Therefore, we proposed to codify our current process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule at new Subpart G-Payment for New Clinical Diagnostic Laboratory Tests (§ 414.502 through § 414.506).

Comment: Several comments supported the consultation process for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule. Commenters suggested changes to the meeting and posting of data presented in the meeting. For example, a commenter suggested we should require a 60-day time period from the Federal Register notice of the public meeting and the date of the public meeting. Commenters also requested that we post on the Internet additional detail regarding data and rationale used for public recommendations and final payment decisions.

Response: We want to take this opportunity to explain the timeframes for the annual update to the clinical laboratory fee schedule. The Medicare Part B clinical laboratory fee schedule utilizes the codes developed by the AMA's Current Procedural Terminology (CPT) Editorial Panel. The CPT codes are developed as the result of quarterly meetings throughout the year and the codes to be included in the upcoming year's fee schedule (effective January 1st) are available as early as May. We then list the new clinical laboratory tests codes on our Web site in June along with registration information for the public meeting. We schedule the date of the public meeting not fewer than 30 days after announcing the meeting in the Federal Register. This timeframe results in a July date for the public meeting, followed by a posting of our tentative payment determinations and a comment period in September. The updated clinical laboratory fee schedule is prepared in October for release to our contractors during the first week in November. Our contractors have many information system steps to complete during the months of November and December so that the updated clinical laboratory fee schedule is ready to pay claims effective January 1st of the calendar year.

With the constraints of the this process, we will strive to provide as much time as is feasible between the announcement of the meeting and the meeting itself. As required under both the statute and § 414.506, the public meeting will take place "not fewer" than 30 days after we publish notice of the meeting in the Federal Register. Our proposed regulatory language allows us flexibility to provide additional time when feasible. However, extending the notification period announcing the date of the public meeting to 60 days from the Federal Register notice of the public meeting could cause delays to the rate-setting process and to the timely release of the updated clinical laboratory fee schedule.

Commenters also requested that when we announce public recommendations or our determinations, we should include data and the rationale on which the recommendation or determination is based. However, we note that recommendations from the public meeting have sometimes lacked the detail requested by commenters. We have considered all payment recommendations received from the public, even those that have sometimes lacked the supporting detail requested by commenters. In some cases, companies have expressed concern about revealing data to laboratory competitors during the public meeting. When soliciting public input for the meeting, we will recommend that all participants in the public consultation process strive for transparency and try to provide as much supporting information as possible to assist us and others in evaluating the recommendation. As required by the statute, we will provide the rationale for our payment determinations.

Comment: Two commenters stated that a whole new generation of diagnostic tests will contribute to treatment that is more tailored to the individual so that maintaining the current system for setting payment will not be sufficient because the new generation tests are more complex than the individual test codes currently paid under the clinical laboratory fee schedule. Also, the commenters indicated that some of the new generation tests may be performed by only one laboratory in the country so that establishing a payment amount for the new test becomes a de facto national price which may be insufficient for other laboratories in the future.

Response: We appreciate the commenters' recognition that establishing payment for new technology testing is complex and subject to many professional perspectives. In this rulemaking, we are complying with the MMA mandate to codify a public consultation process for payment of new clinical laboratory test codes. The statute requires that we host a public meeting to receive recommendations on individual test codes added to the Medicare Part B clinical laboratory fee schedule. We state in the public meeting notice that presentations should address the new test code(s) and descriptor(s), the test purpose and method, costs and charges, and other background information. We certainly encourage presenters to include in their presentations market availability of the test and other information on the new technology. Also, a question and answer period is scheduled during the meeting to permit a robust discussion of each new test code. As noted, when we have hosted the public meetings in the past, the laboratory industry has sometimes submitted payment recommendations that are sparse of information and data supporting the payment recommendations. Thus, we do not believe opportunities for information gathering on new technology tests have been fully utilized within the public meeting process. While we can work with laboratories to explore other payment options for new technology tests, we must implement the statutorily required public meeting process. We encourage the laboratory industry to fully participate in this process and to include in its public recommendations data detailed background information on market availability and other concerns that laboratories have for the new technology test codes.

Comment: We received a comment requesting that we establish a reconsideration process that would allow interested parties to request a formal review of payment rate determinations. The commenter suggested that interested parties be given an opportunity to request and receive a reconsideration of a CMS decision to crosswalk or gapfill a new or revised test code, CMS crosswalk determination, a contractor determination of a gapfill price, or a CMS calculation of the NLA for a new test.

Response: We understand the concerns of the commenter, but we are not establishing a formal reconsideration process in this final rule. However, we are revising § 414.508 to provide that, if we gapfill a test, but determine after the first year of gapfilling that carrier-specific gapfilled amounts will not pay for the test appropriately, we may crosswalk the test. Furthermore, we expect to solicit comments on a potential reconsideration process in a future rulemaking.

After careful review of the public comments, we are finalizing § 414.506 as proposed.

d. Payment for a New Clinical Diagnostic Laboratory Test-Crosswalking and Gapfilling (§ 414.508)

We proposed to add new § 414.508 to indicate when, in establishing the payment amount for a new clinical laboratory test, one of two payment methods can be utilized. The first payment method, called "crosswalking," is used if a new test is determined to be comparable to an existing test, multiple existing test codes, or a portion of an existing test code. We proposed that a new test code would be assigned the related existing local fee schedule amounts and national limitation amount (NLA).

In new § 414.508, we proposed to use the second method, called "gapfilling," when no comparable, existing test is available. Currently when using this method, manual instructions are provided to each Medicare carrier to determine a payment amount for its geographic area(s) for use in the first year, and the carrier-specific amounts are used to establish an NLA for following years. Consistent with our current process, the sources of information carriers examine in determining gapfill amounts, if available, include-

• Charges for the test and routine discounts to charges;

• Resources required to perform the test;

• Payment amounts determined by other payers; and

• Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant.

Currently, our manual instructions allow carriers to consider other sources of information as appropriate, including clinical studies and information provided by clinicians practicing in the area, manufacturers, or other interested parties. Carriers are also instructed to establish carrier specific amounts on or before March 31 of the year and to revise their carrier specific amount, if necessary, on or before September 1 of the year. In this manner, a carrier may revise its carrier specific amount based on additional information, but there is also a specific time frame to perform this revision so that we have adequate time to receive and use the carrier specific amounts for the calculation of the next year's clinical laboratory fee schedule.

In light of MMA provisions, we proposed to prospectively eliminate payment of new gapfilled tests at a carrier specific amount after the first year in new § 414.508. Section 1833(h)(8)(A) of the Act gives the Secretary authority to establish procedures for determining the payment amount for laboratory tests for which new or substantially revised HCPCS codes were established on or after January 1, 2005. Under this authority, in new § 414.508(b), we proposed to pay for a new gapfilled laboratory test under our existing methodology for the first year (the carrier would establish a gapfill amount.) Beginning in the second year, the test would be paid at the national limitation amount. This would result in consistent payment in geographic areas for a new test using the median of the carriers' gapfilled amounts.

Comment: Commenters were supportive of our proposal to set the price for gapfilled tests at the NLA. Other commenters suggested that the method used by contractors to determine their price for gapfilled tests should be more specific.

Response: We appreciate the support for our proposal to establish the payment rate for a gapfilled test at the NLA. However, we do not agree specific changes to the gapfilling methodology should be made in the final rule, without a chance to receive multi-stakeholder input on the commenter's suggestions. We do believe that we must engage the clinical laboratory community and our contractors in additional discussions regarding the procedures and data used to determine the payment amounts for gapfilled tests. We will plan to discuss with our contractors their experience establishing the gapfill amounts and also to host a forum or meeting during the upcoming year to listen to additional suggestions from the public. After participating in these additional information gathering steps, we will consider possible changes to the regulations for the 2008 proposed rule and/or additional subregulatory guidance if appropriate.

As discussed above, in response to a comment suggesting that we establish a reconsideration process, we are revising § 414.508 to provide that we may crosswalk a test if we determine that carrier-specific gapfilled amounts will not pay for the test appropriately.

We are finalizing § 414.508 with the exceptions noted above in this section.

3. Other Laboratory Issues

a. Quality

In the CY 2007 PFS proposed rule (71 FR 49064), we discussed that we are exploring the development of measures related to the quality and efficiency of care, including those involving clinical laboratory fee schedule services. We stated our interest to work with physicians, providers and the clinical laboratory community to identify ways to promote utilization decisions such as using a laboratory claims attachment standard involving the Logical Observation Identifiers Names and Codes (LOINC®) database as a means for reporting test result data. This could be one possible component of a comprehensive system of collecting clinical laboratory test data. Detailed information on the LOINC® reporting system is available at the Web site at http://www.loinc.org.

Comment: Several commenters endorsed our interest in working with the laboratory community on laboratory quality of care initiatives. However, two commenters objected to LOINC® reporting system as operationally burdensome for laboratory information systems because it would require merging a data quality field from the laboratory information system to the laboratory billing system, training information systems staff, and sending reference laboratory result data to the referral laboratory who prepares the claim. One of these commenters also stated that regulations on privacy of medical information should be considered. One commenter indicated that the LOINC® reporting system requires narrative reporting for some microbiology tests which is not in a data quality field format.

Response: We are pleased the commenters supported the development of measures related to the quality of clinical laboratory services. We agree that it is imperative to work with physicians, providers and the clinical laboratory community to identify quality measures that can efficiently be incorporated into the laboratory billing system. We understand the reporting of laboratory quality measures must reach compatibility with privacy rules. Furthermore, the important role of quality measures in the evolution of healthcare reporting will remain strong. While changes to information technology may be required, laboratories should be anticipating further interest to include a laboratory quality measure field in laboratory billing systems.

b. Blood Glucose Monitoring in SNFs

In the CY 2007 PFS proposed rule (71 FR 49064), we included a discussion of our longstanding policy on blood glucose monitoring in SNFs submitted for payment under the Medicare Part B clinical laboratory fee schedule. We explained that section 1862(a)(1)(A) of the Act requires that a service be reasonable and necessary for diagnosis and treatment to be eligible for coverage by Medicare. Our regulations at § 410.32(a) already require that, for any diagnostic test, including a clinical diagnostic laboratory test, to be considered reasonable and necessary, it must be both ordered by the physician and the ordering physician must use the result in the management of the beneficiary's specific medical problem. Tests not ordered by the physician who is treating the beneficiary are not reasonable and necessary.

In the context of blood glucose monitoring, we most recently explained this policy in Transmittal AB-00-108, which is available on our Web site at http://www.cms.gov/transmittals/downloads/ab00108.pdf. This interpretation of § 410.32 also is the basis for our policy in section 90.1 of Chapter 7 of the Medicare Claims Processing Manual ("Skilled Nursing Facility Part B Billing," which is available on our Web site at http://www.cms.hhs.gov/manuals/downloads/clm104c07.pdf. )

In addition, separate authority under section 1835(a)(2)(B) of the Act provides that, in the case of certain "medical and other health services" (including clinical diagnostic laboratory services), payment may be made for Part B services that are furnished by a provider of services only if a physician certifies-and recertifies where those services are furnished over a period of time, with such frequency, and accompanied by such supporting material, as may be provided by regulation-that those services were medically necessary. In the CY 2007 PFS proposed rule (71 FR 49065), we proposed to use our authority under section 1835(a)(2)(B) of the Act to amend § 424.24 to provide that, for each blood glucose test furnished to a resident of a SNF, the physician must certify that the test is medically necessary. We also proposed to clarify that a physician's standing order is not sufficient to order a series of blood glucose tests.

Comment: Many commenters explained that it is common medical practice in the nursing home for the physician to certify a standing order for a 1-month time period for the nurse to perform daily glucose monitoring fingerstick tests throughout the month and based on the results, the nursing staff dispense insulin, as needed by the patient. Thus, the commenters objected that the proposal will impose a burden on SNFs who perform tests under these situations.

Response: This amendment to § 424.24 establishes a certification requirement that affects only services that are furnished by a provider of services for which the provider of services seeks payment under Medicare Part B. To the extent payment is available under Medicare Part A or the services are not furnished by a provider of services (as defined under section 1861(u)of the Act), this certification requirement does not apply.

Payment for glucose monitoring is encompassed under other payment systems that are available to the nursing homes. Medicare pays as part of the bundled payment to the facility for beneficiaries in a Part A-covered stay in a hospital or in a SNF. It is when the provider requests Medicare to separately pay for a blood glucose test under the outpatient Part B clinical laboratory fee schedule that the service must meet the certification requirement under § 424.24(f).

We also note that the revisions to § 424.24 does not alter existing policies issued under section 1862(a)(1)(A) of the Act. As discussed above in this section, under § 410.32(a), the test must be ordered by the physician who is treating the beneficiary and the physician must use the results promptly in the management of the beneficiary's specific medical condition.

Comment: Some commenters raised concerns that coverage policies are not consistently describing diabetes care categories, glucose monitoring protocols, and an individual glucose test service. The commenters suggested more specific coverage policies would benefit providers.

Response: We understand the suggestion that refinements to coverage policies could benefit providers. The 2002 NCD for blood glucose tests specifies coverage and frequency limitations for reimbursement under the Part B. The NCD is not specific to nursing home common practices and applies to all providers submitting claims for payment under the clinical laboratory fee schedule. During the years since the release of the NCD, laboratories along with other providers who seek payment from the clinical laboratory fee schedule have had opportunity to carefully review the NCD and request further refinements and examples to enhance the NCD's interrelationship with payment under the clinical laboratory fee schedule. Interested parties can find more information on the coverage policy process on our Web site at http://www.cms.hhs.gov/center/coverage.asp.

With respect to the burden of this certification requirement, we believe that, by enacting section 1835(a)(2)(B) of the Act, the Congress recognized that it may be appropriate for the Secretary to impose conditions of payment for services furnished by providers of services for which providers bill separately under Medicare Part B. We recognize the value of blood glucose testing and strongly support this testing when it is medically necessary. However, we must also ensure that blood glucose testing is medically necessary when furnished by a provider of services for which the provider bills Medicare Part B. We believe that this revision to § 424.24 strikes the appropriate balance between our commitment to beneficiary access to blood glucose testing and our obligation to ensure that each test is medically necessary.

We do not believe that our amendment to § 424.24 imposes a new obligation. As discussed above in this section, § 410.32(a) and our program instructions already require that a laboratory test must be ordered by a physician and the ordering physician must use the result in the management of the beneficiary's specific medical problem. However, as discussed in the proposed rule, we have received inquiries regarding the application of § 410.32(a) in the context of blood glucose testing provided by SNFs. In addition, we received a specific inquiry asking for clarification of section 90.1 of Chapter 7 of the Medicare Claims Processing Manual. Furthermore, we have become aware that some providers have filed claims before Administrative Law Judges challenging our policy regarding blood glucose testing in SNFs.

To the extent there has been confusion regarding our policies, our amendment to § 424.24 provides a clear rule that, for payment to be made for blood glucose tests under Medicare part B to a provider of services, a physician must certify that each test is medically necessary. We also have clarified that a physician's standing order is not sufficient to order a series of blood glucose tests.

Comment: One commenter alerted that some home health providers are engaging in inappropriate physician ordering of clinical diagnostic blood glucose tests, for payment under the Part B benefit, so that the clarification to the regulation should apply not just to SNFs but also to home health agencies.

Response: We agree with the commenter that the regulation should apply to providers of services who bill to the Medicare Part B clinical laboratory fee schedule, including home health agencies. We are revising § 424.24(f) to provide that the certification requirement applies to all providers of services.

Comment: One commenter disagreed with our proposal stating that it would impose an unfair burden on clinical laboratories that provide services to SNFs because the independent laboratory is not informed or responsible for the documentation requirements in the SNF.

Response: Independent clinical laboratories are not providers of services, so our amendment to § 424.24 does not affect these entities. We disagree that an independent clinical laboratory that is providing services to SNF customers should not be informed or ensure the medical necessity documentation is sufficient. Independent clinical laboratories must comply with § 410.32(a). Furthermore, independent clinical laboratories must be certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) (Pub. L. 100-578). Under the standard for test requests at § 493.1241, the laboratory must have a written or electronic request for patient testing from an authorized person. An independent clinical laboratory, whether it is providing services to SNF customers or other provider types, must remain informed and involved to ensure the laboratory service is rendered in accordance with the regulation and instructions applicable for receiving payment under the clinical laboratory fee schedule.

Comment: One commenter asserted that we are obligated to perform a Regulatory Impact Analysis for our proposal to clarify § 424.24 requiring the physician to certify each test is medically necessary and stating that a physician's standing order is not sufficient to order blood glucose tests for payment under the Medicare Part B clinical laboratory fee schedule. Another commenter stated our amendment to § 424.24 does not comport with the Paperwork Reduction Act of 1995 to publish a notice in the Federal Register on collection of information.

Response: We do not believe our amendment to § 424.24 requires a regulatory impact analysis or a Paperwork Reduction Act notice. We believe that § 424.24(f) does not impose any new obligations, but merely codifies as a condition of payment what has long been required under § 410.32(a) and our program instructions.

After careful review of public comments, we are finalizing § 424.24(f) as proposed.

c. Other Lab Issues-Proposed Clinical Diagnostic Laboratory Date of Service (DOS) for Stored Specimens

In the CY 2007 PFS proposed rule (71 FR 49064), we proposed to add new § 414.510 to address concerns regarding the date of service of a clinical diagnostic laboratory test that use a stored (or "archived") specimen. In the final rule of coverage and administrative policies for clinical diagnostic laboratory services (66 FR 58792) that we published in the November 23, 2001 Federal Register , we adopted a policy under which the date of service for clinical diagnostic laboratory services generally is the date the specimen is collected. However, for laboratory tests that use an archived specimen, the date of service is the date the specimen was obtained from the storage. We defined an "archived" specimen as a specimen that is stored for more than 30 calendar days before testing. The date of service for these archived specimens is the date the specimen was obtained from storage. Specimens stored 30 days or less have a date of service of the date the specimen was collected. In situations in which a specimen is taken while the patient is treated in a hospital setting, but then later used for a test after the patient has been discharged from the hospital setting, date of service of a test may affect payment because, if the date of service falls during an inpatient stay or outpatient procedure, payment for the laboratory test usually is bundled with the hospital service. To address concerns raised for tests related to cancer recurrence and therapeutic interventions, we proposed to modify our policy so that the date of service would be the date the specimen is obtained from storage, even if the specimen is obtained less than 31 days from the date it was collected, without violating the unbundling rules as long as the following conditions are met:

• The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital.

• The test could not reasonably have been ordered while the patient was hospitalized.

• The procedure performed while the beneficiary is a patient of the hospital is for purposes other than collection of the specimen needed for the test.

• The test is reasonable and medically necessary.

Comment: One commenter suggested adding a condition stating the test cannot be performed by the hospital laboratory.

Response: We disagree that the regulations should limit the type of laboratory performing the test on the specimen. The purpose of the regulatory change is directed to date of service for specimens.

Comment: Two commenters supported our proposal. However, one commenter expressed concern that on a rare occasion a test that otherwise meets the conditions of the regulation may be ordered by the patient's physician less than 14 days following the date of the discharge from the hospital. The commenter requested the regulation be revised to reflect these rare situations.

Response: At this time, we do not believe it is appropriate to create an exception to the 14-day requirement. We remain very concerned that only tests that can legitimately be distinguished from the care a beneficiary receives in the hospital be subject to this provision regarding the date of service of the test, which results in separate payment for the test. We believe it is more difficult to determine that a test ordered less than 14 days before discharge is appropriately separable from the hospital stay that preceded the test. We would like more information about the circumstances and tests cited by the commenters before taking any additional action in this area. We are very concerned about the possibilities for unbundling care that appropriately should be associated with the hospital stay in these circumstances and will continue to review this policy in the future to ensure that our goal of appropriately recognizing hospital and post-hospital care is achieved.

Comment: Two commenters suggested rewording the second condition which states the test could not reasonably have been ordered while the patient was hospitalized. The commenters suggested the necessity of the test they are concerned with is unrelated to the procedure performed in the hospital but is necessary to determine cancer recurrence and therapeutic interventions after the patient is discharged from the hospital.

Response: We agree that the second criterion could be clarified, to state that it would be inappropriate to have collected the specimen other than during the procedure, and have done so in this final rule. Our intent in establishing this criterion was to ensure that tests that meet the definitions in this provision are not directly related to the care provided in the hospital, and we believe the modification we are finalizing meets that intent more clearly than our original proposal.

Comment: Three commenters discussed several high complexity clinical laboratory tests that are performed on specimens collected as a part of an inpatient procedure. The tests determine the sensitivity of the patient's cancer to particular types of chemotherapy. The specimen is prepared so that the live cancer cells, collected at the time of the procedure, are cultured at the laboratory and ultimately tested. The commenters believe the result of this type of laboratory test does not relate to the procedure performed in the hospital, nor would the result typically affect treatment during the hospital stay if it were available immediately. The commenters requested the regulation specify the date of service for these types of fresh tissue sample tests to be different than the date of service for fixed tissue samples to permit separate payment under Medicare Part B.

Response: We agree with the commenters that these tests, which are almost always used to determine post-hospital chemotherapy care for patients who also require hospital treatment for tumor removal or resection, appear to be unrelated to the hospital treatment in cases where it would be medically inappropriate to collect a test specimen other than at the time of surgery, especially when the specific drugs to be tested are ordered at least 14 days following hospital discharge, as discussed above for tests on stored tissue samples. We are very concerned about unbundling services that are appropriately associated with hospital treatment, and therefore, believe it is critical to move cautiously in the area of determining different dates of service for tests for which the specimen collection occurs during a hospital service. As a result, we are adding § 414.510(b)(4), specifically for chemotherapy sensitivity tests, because we understand that the results of these tests, even if they were available immediately and not several weeks following the collection of the specimen, would almost never affect the treatment regimen at the hospital. Therefore, we see a valid distinction between these tests and other tests of cultured specimens that give results after hospital discharge, but that are directly related to not only the condition for which the patient is hospitalized, but would typically be used for the specific care during the hospital stay as well, if available during the hospital stay. This section will allow separate payment for chemotherapy sensitivity tests, as identified by the Secretary in subregulatory guidance, from the inpatient procedure as long as certain criteria are met.

We are finalizing § 414.510 as proposed with the exceptions noted above in this section.

O. Criteria for National Certifying Bodies That Certify Advanced Practice Nurses

Federal regulatory qualifications for NPs at § 410.75 require that an individual be certified as an NP by a recognized national certifying body that has established standards for NPs. Similarly, Federal regulatory qualifications for clinical nurse specialists (CNSs) at § 410.76 require that an individual be certified as a CNS by a national certifying body that has established standards for CNSs and that is approved by the Secretary.

Currently, there is not a list of recognized or approved national certifying bodies for NPs and CNSs in regulations. However, Chapter 15, section 200 of the Benefit Policy Manual, Pub. 100-02 contains a list of national certifying bodies that are recognized by Medicare as being appropriate for certification of NPs. Although the manual provision regarding CNS services at Chapter 15, section 210 of the Benefit Policy Manual lists only the American Nurses Credentialing Center as an approved national certifying body for CNSs, we indicated that the list of recognized certifying bodies in the manual provision for NP services would also apply for CNSs in the "Revisions to Payment Policies Under the CY 2003 Physician Fee Schedule and Inclusion of Registered Nurses in the Personnel Provision of the Critical Access Hospital Emergency Services Requirement for Frontier Areas and Remote Locations; Payment Policies final rule (December 31, 2002, 67 FR 79987). The national certifying bodies that are listed under the manual instruction at section 200, and that currently apply for both NPs and CNSs (collectively, advanced practice nurses) are as follows:

• American Academy of Nurse Practitioners;

• American Nurses Credentialing Center;

• National Certification Corporation for Obstetric, Gynecologic and Neonatal Nursing Specialties;

• National Certification Board of Pediatric Nurse Practitioners and Nurses;

• Oncology Nurses Certification Corporation;

• Critical Care Certification Corporation.

In the December 31, 2002 final rule, in response to a public comment, we stated, "it is not the agency's intention to be overly restrictive in our program requirements and consequently prevent qualified CNSs who specialize in areas of medicine other than those certified by the American Nurses Credentialing Center (ANCC) from participating under the CNS benefit and from rendering care to patients in need of specialized services. Furthermore, the intent of the revision to the certification requirement for CNSs is to recognize all appropriate national certifying bodies for CNSs as the program does for NPs." Accordingly, in an effort to recognize all appropriate national certifying bodies for CNSs and NPs, we added, at that time, the Oncology Nurses Certification Corporation (ONCC) and the Critical Care Certification Corporation (CCCC) to the list of recognized national certifying bodies for advanced practice nurses.

The National Board on Certification of Hospice and Palliative Care Nurses (NBCHPN) has requested that we now follow the same course of action as we did for the ONCC and the CCCC by adding its name to the list of recognized national certifying bodies. That is, NBCHPN believes that it is an appropriate national certifying body based on its certification experience, principles, services, and the certification exam that it administers to advanced practice nurses who specialize in palliative care for hospice patients.

The NBCHPN stated in information it sent to the agency that its organization is a well-established certification body with more than a 12-year history of certification and that it has been certifying advanced practice hospice and palliative nurses since 2003 in partnership with the ANCC. Starting in 2005, the NBCHPN became sole proprietor of the Advanced Certified Hospice and Palliative Nurse (ACHPN) examination. Master's level NPs and CNSs sit for this ACHPN examination that is based on a role delineation study for the advanced practice level of hospice and palliative nursing. Additionally, the NBCHPN stated that it has met the requirements of the American Board of Nursing Specialties and is an active member of the Board of Specialties, as is the ANCC. The Executive Director of the NBCHPN stated that she believes that the absence of the NBCHPN from the current list of recognized national certifying bodies presents a barrier for advanced practice nurses in the hospice palliative care specialty because they are denied enrollment on the basis that they do not meet the certification qualification requirement. The Web site for the NBCHPN can be found at http://www.nbchpn.com.

We solicited public comments on whether it would be appropriate to include the NBCHPN under the list of recognized and approved national certifying bodies for NPs and CNSs under manual instructions for both NPs and CNSs. We also solicited public comments on criteria or standards that we could use to determine whether an organization is an appropriate national certifying body for advanced practice nurses. We realize that the agency may receive other requests in the future from organizations that wish to be added to the list of recognized or approved national certifying bodies. In anticipation of those requests, we are interested in developing certification standards that would facilitate the process for making these decisions.

We appreciate the comments that we received on these two issues related to the NP and CNS benefits. However, we are delaying our decision about whether to include the NBCHPN under the manual instruction listing of recognized national certifying bodies for NPs and CNSs until we have had more time to examine and investigate the comments that we received about this issue.

In regards to the issue concerning our establishment of certification criteria or standards to determine whether an organization should be listed as a recognized national certifying body for NPs and CNSs (that is, advanced practice nurses), we will consider the information that we received in comments on this issue for future rulemaking, and would consider proposing specific certification standards that an organization must meet in order to be included under the manual instruction listing of recognized national certifying bodies for NPs and CNSs.

P. Chiropractic Services Demonstration

In the CY 2006 PFS final rule with comment period (70 FR 70266), we included a discussion of the 2-year demonstration authorized by section 651 of the MMA to evaluate the feasibility and advisability of covering chiropractic services under Medicare. These services extend beyond the current coverage for manipulation to care for neuromusculoskeletal conditions typical among eligible beneficiaries, and cover diagnostic and other services that a chiropractor is legally authorized to perform by the State or jurisdiction in which the treatment is provided. The demonstration is being conducted in four sites, two rural and two urban. The demonstration must be budget neutral as the statute requires the Secretary to ensure that the aggregate payment made under the Medicare program does not exceed the amount which would be paid in the absence of the demonstration.

Ensuring BN requires that the Secretary develop a strategy for recouping funds should the demonstration result in costs higher than those that would occur in the absence of the demonstration. As we stated in the CY 2006 PFS final rule with comment period (70 FR 70266), we would make adjustments in the national chiropractor fee schedule to recover the costs of the demonstration in excess of the amount estimated to yield BN. We will assess BN by determining the change in costs based on a pre- and post-comparison of costs and the rate of change for specific diagnoses that are treated by chiropractors and physicians in the demonstration sites and control sites. We will not limit our analysis to reviewing only chiropractor claims, because the costs of the expanded chiropractor services may have an impact on other Medicare costs.

Any needed reduction would be made in the 2010 and 2011 physician fee schedules as it will take approximately 2 years to complete the claims analysis. If we determine that the adjustment for BN is greater than 2 percent of spending for the chiropractor fee schedule codes (comprised of the 3 currently covered CPT codes 98940, 98941, and 98942), we would implement the adjustment over a 2-year period. However, if the adjustment is less than 2 percent of spending under the chiropractor fee schedule codes, we would implement the adjustment over a 1-year period. We will include the detailed analysis of BN and the proposed offset during the CY 2009 rulemaking process. Physical therapy (PT) services performed by chiropractors under the demonstration are subject to the PT therapy cap. These services are included under the cap because chiropractors are subject to the same rules as medical doctors for therapy services under the demonstration.

Comment: One commenter indicated that it continues to oppose our methodology for assuring BN under the demonstration. Instead of the application of an adjustment to the national chiropractor fee schedule, the commenter recommends that we make an adjustment to the totality of services payable under the Part B Trust Fund and that this would be consistent with the requirements in section 651(f)(A) of the MMA.

Response: Section 651(f)(1)(B) of the MMA requires that "* * * the Secretary shall ensure that the aggregate payments made by the Secretary under the Medicare program do not exceed the amount which the Secretary would have paid under the Medicare program if the demonstration projects under this section were not implemented." The statute does not specify a specific methodology for ensuring BN. We believe our intended methodology meets the statutory requirements.

Q. Promoting Effective Use of Health Information Technology (HIT)

We recognize the potential for health information technology (HIT) to facilitate improvements in the quality and efficiency of health care services. One recent RAND study found that broad adoption of electronic health records (EHRs) could save more than $81 billion annually and, at the same time, improve quality of care.1The largest potential savings that the study identified was in the hospital setting because of shorter hospital stays promoted by better coordinated care; less nursing time spent on administrative tasks; better use of medications in hospitals; and better utilization of drugs, laboratory services, and radiology services in hospital outpatient settings. The study also identified potential quality gains through enhanced patient safety, decision support tools for evidence-based medicine, and reminder mechanisms for screening and preventive care. Despite these large potential benefits, the study found that only about 20 to 25 percent of hospitals have adopted HIT systems.

Footnotes:

1 RAND News Release: Rand Study Says Computerizing Medical Records Could Save $81 Billion Annually and Improve the Quality of Medical Care, September 14, 2005, available at: http://rand.org/news/press.05/09.14.html.

It is important to note the caveats to the RAND study. The projected savings are across the health care sector, and any Federal savings would be a reduced portion of the total savings. In addition, there are significant assumptions made in the RAND study. National savings are projected in some cases based on one or two small studies. Also, the study assumes patient compliance, in the form of participation in disease management programs and following medical advice. For these reasons, extreme caution should be used in interpreting these results.

In his 2004 State of the Union Address, the President announced a plan to ensure that most Americans have EHRs within 10 years.2One part of this plan involves developing voluntary standards and promoting the adoption of interoperable HIT systems that use these standards. The 2007 Budget states that "The Administration supports the adoption of HIT as a normal cost of doing business to ensure patients receive high quality care."

Footnotes:

2 Transforming Health Care: The President's Health Information Technology Plan, available at: http://www.whhitehouse.gov/infocus/technology/economic_policy200404/chap3.html .

Over the past several years, we have undertaken several activities to promote the adoption and effective use of HIT in coordination with other Federal agencies and with the Office of the National Coordinator for HIT. One of those activities is promotion of data standards for clinical information, as well as for claims and administrative data.

As noted above in this section, the Administration supports the adoption of HIT as a normal cost of doing business. The adoption and use of HIT may contribute to improved processes and outcomes of care, including shortened illnesses and the avoidance of adverse drug reactions.

Nine commenters responded to our HIT proposals. The following is a summary of the comments addressing the use of HIT to enhance quality of care, the costs associated with HIT adoption, the importance of interoperability standards, and the impact of new rules related to Medicare fraud and abuse statutes.

Comment: Several commenters stated that adoption of HIT could lead to improved quality, enhanced patient safety, and increased efficiency. Some commenters noted that HIT can reduce administrative costs; however, more commenters focused on the potential financial barriers to the adoption of HIT.

We received several comments addressing the high costs associated with HIT implementation. Most commenters stated that adoption of HIT is not a normal cost of doing business in health care. Several commenters emphasized that any reduction in physician payment related to the sustainable growth rate (SGR) would make it difficult for physicians to invest in HIT. Some commenters noted that incentives, such as loans, grants, and tax credits, could aid physicians by reducing the burden of cost for implementing HIT. A few commenters stated that implementation of HIT should be a shared expense between providers, purchasers, and payers.

Most commenters highlighted lack of interoperability standards as a current barrier to HIT implementation. Several commenters noted that interoperability standards are a critical component of any HIT system and must include a standard set of policies, procedures, and standards for data collection and documentation. One commenter stated that progress has been slow in disseminating standards and this discourages physician practices from making large investments in HIT that quickly may become obsolete.

One commenter applauded new regulatory provisions related to HIT for physician self-referral and anti-kickback statutes. However, the commenter further stated that Medicare fraud and abuse statutes continue to hinder the adoption of HIT because the rules are still unclear on some issues.

We received a few comments noting that specific issues related to HIT use in health care, such as the protection of patient privacy and data stewardship, still need to be resolved.

Response: We thank all commenters for their thoughtful and valuable discussion of the issues. In the HIT section of the preamble to the proposed rule, we recognized the potential for effective HIT to facilitate improvements in the quality and efficiency of health care services. We also pointed out our promotion of the adoption and effective use of HIT in coordination with other Federal agencies and the Office of the National Coordinator for HIT. Here, we will discuss three areas that we are emphasizing to promote the effective use of HIT, in light of the comments we received: (1) Value-based purchasing, (2) the recent CMS and OIG final rules regarding donation of certain HIT, and (3) infrastructure and interoperability standards.

We continue our work toward the implementation of value-based purchasing payment system reforms because we believe that, among other advantages, value-based purchasing can encourage physicians to invest in activities, such as effective HIT, that have the potential to improve quality and decrease unnecessary costs. However, linking a portion of Medicare payments to valid measures of quality and effective use of resources could give physicians more direct incentives to implement innovative ideas and approaches that may result in improved value of care. We agree with the commenters that noted that the use of effective HIT could increase quality, efficiency, and patient safety. We also agree with the commenters that noted that effective use of HIT can be used to decrease the burden of reporting to value-based purchasing programs. However, we disagree with the commenters that recommended direct government funding of HIT. As stated in the President's 2007 Budget, "the Administration supports the adoption of [HIT] as a normal cost of doing business to ensure patients receive high quality care."

Commenters noted that multiple stakeholders in the health care system, including purchasers and payers, benefit from provider adoption and use of effective HIT and should share in the cost. CMS and OIG have recently issued final rules to allow hospitals and other health care providers under some circumstances to donate electronic prescribing and EHRs technology to physicians and others without running afoul of the Stark (physician self-referral) and anti-kickback statutes. We believe that these rules facilitate the adoption of HIT by physicians and other health care providers who might otherwise have been unable or unwilling to invest in the technology.

We also believe that these regulatory changes help to stimulate the adoption of effective HIT, and that, as HIT use spreads, the benefits relative to the costs of implementation may increase for all stakeholders.

The majority of commenters pointed out that the current lack of HIT infrastructure, including lack of interoperability standards, is a major obstacle to adoption and effective use of HIT. To address the lack of infrastructure, the Secretary has undertaken a national strategy that calls for Federal agencies to collaborate with private stakeholders in the development of architecture, standards, certification processes, and methods of governance to facilitate the adoption of effective HIT. In September 2005, the Secretary selected 16 commissioners to serve on the American Health Information Community (AHIC), which is a federally chartered collaborative forum of private and public interests charged with advising the Secretary on how to make health information digital and interoperable. The goals of the Community include immediate access to vital medical information at the point of care, privacy protection, better data for research, and overall cost savings. The work of the Community has been divided among four workgroups: (1) The EHRs Workgroup, (2) the Chronic Care Workgroup, (3) the Consumer Empowerment Workgroup, and (4) the Biosurveillance Workgroup, (5) the Confidentiality, Privacy, and Security Workgroup, and (6) the Quality Workgroup. The AHIC Workgroups have made recommendations, as their initial "breakthroughs," pertaining to: An electronic medication summary and registration history; secure messaging capabilities for individuals with chronic disease; biosurveillance monitoring; and, through secure means, broadening the availability and access to current and historical laboratory results and interpretations. More information about the Community is available at: http://www.hhs.gov/healthit/ahic.html .

R. Health Care Information Transparency Initiative

The United States (U.S.) faces a dilemma in health care. Although the rate of increase in health care spending slowed last year, costs are still growing at an unsustainable rate. The U.S. spends $1.9 trillion on health care, or 16 percent of the gross domestic product (GDP). By 2015, projections are that health care will consume 20 percent of GDP. As indicated in the 2006 Annual Report of the Boards of Trustees, the Medicare program alone consumes 3.2 percent of the GDP and by 2040 it will consume 8.0 percent of the GDP.

Part of the reason health care costs are rising so quickly is that most consumers of health care, that is, patients, are frequently not aware of the actual cost of their health care. Health insurance coverage shields them from the full cost of services, and they have only limited information about the quality and costs of their care. Consequently, consumers do not have incentives or means to carefully shop for providers offering the best value. Thus, providers of health care are not subject to the competitive pressures that exist in other markets for offering quality services at the best possible price. Reducing the rate of increase in health care prices and avoiding health services that are of little value could help to stem the growth in health care spending, and potentially reduce the number of individuals who are unable to afford health insurance. Part of the President's health care agenda is to expand Health Savings Accounts (HSAs), which would provide consumers with greater financial incentives to compare providers in terms of price and quality, and choose those physicians and services that offer the best value.

In order to exercise those choices, consumers must have accessible and useful information on the price and quality of health care items and services. Typically, health care providers do not publicly quote or publish their prices. Moreover, list prices, or charges, generally differ from the actual prices negotiated and paid by different health plans. Thus, even if consumers were financially motivated to shop for the BP, it would be very difficult at the current time for them to access usable information.

For these reasons, HHS has launched a major health care information transparency initiative. This effort builds on steps taken by CMS to make quality and price information available. For example, Medicare has provided unprecedented information about drug prices in the Medicare prescription drug benefit, and is now adding to these efforts in other areas. Medicare payment information for common elective procedures and other common admissions for all hospitals by county has been posted on our Web site at http://www.cms.hhs.gov/HealthCareConInit/ .

On our Web site, we will be posting geographically-based Medicare payment information for common procedures for ambulatory surgery centers, hospitals, OPDs, and physician offices. In addition, a number of tools providing usable healthcare information are already available to Medicare beneficiaries. Supported by the public and private quality alliances, consumers can access "Compare" Web sites through www.medicare.gov where they can evaluate important aspects of their health care options for care at a hospital, nursing home, home health agency (HHA), and dialysis facility, as well as compare their costs and coverage when choosing a prescription drug plan.

We are developing a new project with the goals of providing Medicare beneficiaries with more comprehensive information on quality and costs, including more complete measures of health outcomes, satisfaction, and volume of services that matter to consumers, and more comprehensive measures of costs for entire episodes of care, not just payments for particular services and admissions. We intend for this Medicare project to incorporate private health care data, Medicaid data, and Medicare data to measure cost and quality of care information at the physician and hospital levels. Under this project, quality, cost, pricing, and patient information will be reported to Medicare beneficiaries in a meaningful and transparent way.

In response to the CY 2007 PFS proposed rule (71 FR 49064), we received the following comments on the transparency issue.

Comment: Most commenters supported our efforts to release quality information to create a more transparent health care system so that patients and consumers will be able to make more informed decisions about their health care. Several commenters questioned the usefulness of price information and many suggested criteria for determining what information would be most credible, accessible and meaningful both to consumers and to providers and other stakeholders. The commenters stated that the information must be valid, reliable, and sensitive to the care being delivered in order for the information to be useable. Several commenters also noted the importance of relying on the AQA (a multi-stakeholder group identifying ambulatory quality measures) and the joint steering committee formed by AQA, the Hospital Quality Alliance (HQA), and the Quality Alliance Steering Committee, to be the forum where all stakeholders come together to identify useful measures. One commenter also noted the important work of the AMA Consortium for Performance Improvement in bringing together multiple physician medical specialties.

Response: We agree that physician price and quality information must be credible, accessible, and meaningful to consumers and other stakeholders. To ensure this is the case for our transparency efforts, we rely heavily on physician groups and broad stakeholder coalitions to help advise as to the measures we are using, particularly for quality and in considering episodes of care. We are actively working with the AMA Consortium for Performance Improvement, the AQA, the National Quality Forum (NQF), and various medical specialty groups to identify useful quality measures. We are conducting research and working directly with the AQA to identify potential episode of care measures. We are building on the model we used for inpatient and ambulatory surgery centers to provide the most accurate information possible when releasing Medicare payment data. By December 2006, we plan to release Medicare data, including the number of services, charges and payment rates for a group of common physicians' services by locality.

Comment: Many comments focused on the usefulness of price information. One commenter questioned the premise that consumers should use price information in health care decisions. Several other commenters noted the limitations of price information and the need for consumers and patients to understand the context for it. They added that providing price information on health care services should not be placed in the same class as shopping for airline tickets or hotel accommodations. They further questioned whether price plays a significant role in choosing a physician or hospital, particularly when a patient is facing a life threatening illness. Other commenters have advised that the price is subject to individual health plan benefit packages and could change depending on the course of beneficiary illness. Further, in an emergency, additional services may be required which will therefore raise the costs of services for beneficiaries.

Response: We agree that making health care decisions, including the selection of providers, is a serious undertaking. For this reason, it is critical that consumers, patients, and their families have information which will help them make important health care decisions. For those patients in the early stages of illness, or those who may need preventive care, choosing a provider based on the knowledge of the potential overall costs of care, and taking into account whether the physician is effective at helping the patient prevent life threatening illnesses, could help the patient avoid unnecessary costs later on.

For patients with life threatening illnesses, cost is also at issue. However, most insurance, including Medicare, does require cost sharing, and if information on price and quality is available it may be possible for beneficiaries to choose high quality providers at a reduced cost, which would therefore minimize the patient's out-of-pocket costs. We also agree that it is important to recognize that beneficiary out-of-pocket costs are in part driven by the type of coverage the beneficiary has and whether the beneficiary has any supplemental coverage. Combining information on multiple services related to the same clinical condition into a broader episode of care could provide a prospective patient and his or her family even more useful cost and quality information. For example, if a patient has a serious illness, he or she (or his or her family) would be better able to choose a physician or other health care provider that more closely suits the patient's preferences by comparing, before treatment: (1) The cost of treatment; (2) the various types of services and treatments associated with that particular illness; and (3) the outcome for patients with similar health conditions.

Comment: One commenter questioned whether releasing price information could increase health care costs because the pricing information could encourage patients to delay necessary care and which presumably may result in more advanced disease. The commenter stated that price information should not be released for E/M, and preventive services.

Response: We believe that the release of price information will not inhibit a patient's use of appropriate health care services, in particular, preventive or evaluative services. It is our expectation that the transparency of price and quality information will encourage patients to obtain health care services that are proven in quality of care and outcomes for patients and the provision of these chosen services should result in a decrease in the overall costs of health care.

Comment: One commenter thought that payment information should be broken into the work component, PE and malpractice. They further suggested arraying information to reflect the relative costliness of different settings of care for the same services, such as ambulatory surgery centers, OPDs, or physicians' offices.

Response: We agree that those separate service components could be of some interest, but we do not understand how they would be of benefit to the patient or consumer when he or she is making health care decisions. Such service component break outs provide no information on out-of-pocket or overall costs as to the specific service or as to a broader episode of care that takes into consideration care delivered across settings and time.

We believe that providing comparative information on the costs of care in different settings when the services and patient needs are similar is an interesting concept. We will consider suggestions as to how this type of data may be provided.

Comment: One commenter stated that it is inappropriate to make public efficiency information, cost and utilization ratings without commensurate quality data, and that efficiency measurement should be restricted to areas where this type of data are available, and risk adjusted. Further, the commenter added that payers should make their methodology and data sources easily available to physicians.

Response: We agree that both cost and quality data are important for consumers to make informed decisions about providers and treatment options. We are exploring a range of options for how to measure efficiency, including risk adjustment options. We also agree that it is important for physicians to understand how cost and quality data are being measured.

Comment: One commenter questioned whether all the resources going into the transparency efforts might be better spent supporting physician adoption of EHRs, patient registries, and group medical visits.

Response: Our transparency efforts are aimed at helping consumers make better informed health care decisions. We have many other initiatives aimed at supporting these other important physician tools, for example, Quality Improvement Organizations (QIOs) are working across the country to provide technical assistance to physicians to help these physicians redesign work practices to adopt EHRs. Several significant initiatives, including the Physician Group Practice demonstration and the Medicare Health Support program are identifying effective care management strategies, including the physician adoption of EHRs, patient registries, and group medical visits as recommended by the commenter. Further, we are working with the Department to lessen the barriers to IT adoption by identifying and endorsing standards for seamless movement of information across settings.

Comment: One commenter said the primary driver of health care costs was the lack of productivity increases in health care and questioned whether providing more information to consumers would have any impact on the efficiency of the system. The commenter stated that the reason for this lack of productivity improvement was due to the labor intensive nature of our health care system since the United States government did not purchase HIT directly for providers.

Response: We agree that health care is labor intensive and that increased adoption of effective HIT has the potential to improve productivity. For these reasons, increasing adoption of effective HIT, including EHRs is one the most important initiatives for this administration. As we have stated previously in our other responses in this section, we have in place a number of initiatives aimed at lessening the barriers to adoption and initiatives supporting both hospitals and physicians. However, we strongly support the notion that market forces, including consumers empowered to make more informed health care decisions, are also critical for improving the value of the health system.

Comment: One commenter stated that health plans should be required to release their fee schedules showing total charges and methods of calculating fees for physicians and hospitals.

Response: The purpose of our transparency initiative is to make it easier for consumers and patients to make better informed health care decisions based on their own unique health circumstances. We have partnered with the Agency for Healthcare Research and Quality, and we are exploring, in the context of the AQA and the Quality Alliance Steering Committee, a variety of options for releasing pricing, payment and episode of care costs.

Comment: One commenter questioned whether physicians could report directly to us or to carriers on the clinical quality measures currently reflected in the Physician Voluntary Reporting Program (PVRP) initiative instead of through the established mechanism of G-codes or CPT category II codes (if available).

Response: Currently, the PVRP data are not reported publicly, as would be the case in a transparency initiative, but are provided confidentially to physicians. These measures are based on the work of a multi-stakeholder consensus process through the National Quality Forum and the AQA. We are also relying on this process to identify physician quality measures for transparency. The PVRP can be a building-block for future efforts to measure physician quality.

Further, we are seeking to benefit the Medicare program by applying quality measures developed by the private sector to comprehensive data on physicians' services to improve the quality of Medicare services, and to provide Medicare beneficiaries with useful quality information. Specifically, under a new Medicare project that will begin in six areas, data from Medicare and private purchasers are being combined to create quality measures that will be reported to Medicare beneficiaries. Information on physician performance on quality will be used for feedback to physicians on services provided to Medicare beneficiaries, and information on physician performance will be made available to beneficiaries. The purpose of this important project is to encourage improvements in the quality of Medicare services, and provide information to Medicare beneficiaries that will permit them to make more informed choices about how and where they will receive their care. Over time, using the experience of these initiatives, we will identify which measures and what data collection mechanisms are best used to release physician specific information to Medicare beneficiaries.

Regarding the earlier comment about G-code reporting, we chose the path of reporting quality measures on claims through G-codes because those claims could be built on existing data systems, creating fewer burdens for physician offices and CMS. Physicians, predominantly, already use claims supported data systems so, therefore, we believe at this time it is the most practical system. In the future, we hope to be able to accept, and for physicians to be able to report, using the electronic means outlined by the commenter. We ask the commenter to work with us to ensure that EHRs and other information systems are designed to collect the clinical data components necessary to measure a broad range of quality indicators.

Comment: A commenter also suggested that group practices should be allowed to create scores for their whole group and report at the aggregate level. The commenter stated that group practices have internal mechanisms, including incentive structures, for improving quality that should be used.

Response: We recognize that comparing groups of physicians by price and quality measures could be useful both for consumers and patients in regions where these groups are widely available. We also appreciate the usefulness of the data for internal quality improvement for physician groups. However, for purposes of consumer choice, it may be important to have physician-specific information. Even with a group, beneficiaries would want to know the physician's treatment patterns, including quality information, to best suit the beneficiary's needs or preferences. We agree that information on both price and quality on individual physicians would be useful for consumers and patients.

S. Bad Debt Payment for Services Associated With Reasonable Charge/Fee Schedules

Under the Medicare program, payment may be made for unrecovered costs (bad debt) attributable to uncollectible deductible and coinsurance of Medicare beneficiaries as specified in § 413.89 and the Provider Reimbursement Manual (PRM) (CMS Pub. 15 Part 1, Chapter 3). Entities currently eligible to receive Medicare bad debt payments, with some limitations, include hospitals, skilled nursing facilities (SNFs), CAHs, RHCs, ESRD facilities, FQHCs, community mental health clinics, health maintenance organizations (HMOs) reimbursed on a cost basis, competitive medical plans (CMPs), and health care pre-payment plans. The bad debt policy for ESRD facilities is set forth in § 413.178.

The current bad debt regulation at § 413.89(i) excludes payment of bad debts specifically for those services furnished by anesthetists paid under a fee schedule. In the February 10, 2003 Federal Register , we published the Provider Bad Debt Payment proposed rule where we proposed to amend the language in the existing bad debt regulations to clarify that bad debts are not recognized or reimbursed for all covered services paid for under a reasonable charge-based methodology or a fee schedule (68 FR 6682). As stated in that proposed rule, the proposed amendment was intended to clarify our longstanding policy and is not a change in policy.

In this final rule with comment period, we are finalizing the amendment to the regulations, as proposed in the February 10, 2003 proposed rule, to clarify that payment of bad debts for covered services paid for under a reasonable charge-based methodology or a fee schedule is not allowable. In the February 10, 2006 Federal Register (71 FR 6991), we issued a notice extending the timeline for publication of a final rule associated with provisions of the February 10, 2003 proposed rule by one year to February 10, 2007. At this time, we are not finalizing other proposed provisions of the February 10, 2003 proposed rule.

We received the following comment regarding this provision from the February 10, 2003 proposed rule.

Comment: A commenter stated that the clarification of policy that bad debt reimbursement is not available for services paid under a fee schedule is a change in policy for outpatient therapy.

Response: During the initial stages of developing the Medicare program in 1966, the issue of "bad debt" arose but was not mentioned explicitly in the statute. However, at that time, based on the intent of the anti-cross-subsidization principle found in the definition of "reasonable cost" at section 1861(v)(1)(A) of the Act, Medicare adopted the policy to pay for the unrecovered costs attributable to uncollectible deductible and coinsurance of Medicare beneficiaries. Accordingly, we believe that this statutory prohibition on cross-subsidization does not apply where services are reimbursed on anything other than the basis of "reasonable costs".

The Medicare program has never allowed payment of bad debts for services paid for on the basis of a fee schedule or reasonable charge methodology, such as but not limited to, services of physicians, suppliers, certified registered nurse anesthetists, or NPs. Under a fee schedule or reasonable charge methodology, Medicare does not share proportionately in an entity's incurred costs but rather makes payment for a specific service. The payment is not related to the cost of a service and thus, does not embody the concept of unrecovered costs due to uncollected amounts of deductibles and coinsurance. Thus, payment of bad debt applies only to services reimbursed on the basis of reasonable cost or to services paid under one of Medicare's prospective payment systems that have a basis in reasonable costs that do not reflect Medicare payment of bad debts during a specified provider base period. Accordingly, when outpatient therapy services began to be paid for on a fee schedule methodology, payment of bad debts associated with these services was no longer available.

Therefore, we do not agree with the commenter and we are revising § 413.89(i) and adding new § 413.178(d) as proposed.

III. Revisions to the Payment Policies of Ambulance Services under the Fee Schedule for Ambulance Services and the Ambulance Inflation Factor Update for CY 2007.

Under the ambulance fee schedule, the Medicare program pays for transportation services for Medicare beneficiaries when other means of transportation are contraindicated. Ambulance services are classified into different levels of ground (including water) and air ambulance services based on the medically necessary treatment provided during transport. These services include the following levels of service:

• For Ground-

+ Basic Life Support (BLS)

+ Advanced Life Support, Level 1 (ALS1)

+ Advanced Life Support, Level 2 (ALS2)

+ Specialty Care Transport (SCT)

+ Paramedic ALS Intercept (PI)

• For Air-

+ Fixed Wing Air Ambulance (FW)

+ Rotary Wing Air Ambulance (RW)

A. History of Medicare Ambulance Services

1. Statutory Coverage of Ambulance Services

Under sections 1834(l) and 1861(s)(7) of the Social Security Act (the Act), Medicare Part B (Supplemental Medical Insurance) covers and pays for ambulance services, to the extent prescribed in regulations, when the use of other methods of transportation would be contraindicated by the beneficiary's medical condition.

The House Ways and Means Committee and Senate Finance Committee Reports that accompanied the 1965 Social Security Amendments suggest that the Congress intended that-

• The ambulance benefit cover transportation services only if other means of transportation are contraindicated by the beneficiary's medical condition; and

• Only ambulance service to local facilities be covered unless necessary services are not available locally, in which case, transportation to the nearest facility furnishing those services is covered (H.R. Rep. No. 213, 89th Cong., 1st Sess. 37 and Rep. No. 404, 89th Cong., 1st Sess. Pt 1, 43 (1965)).

The reports indicate that transportation may also be provided from one hospital to another, to the beneficiary's home, or to an extended care facility.

2. Medicare Regulations for Ambulance Services

Our regulations relating to ambulance services are set forth at 42 CFR part 410, subpart B and 42 CFR part 414, subpart H. Section 410.10(i) lists ambulance services as one of the covered medical and other health services under Medicare Part B. Therefore, ambulance services are subject to basic conditions and limitations set forth at § 410.12 and to specific conditions and limitations included at § 410.40. Part 414, subpart H, describes how payment is made for ambulance services covered by Medicare.

The national fee schedule for ambulance services is being phased in over a 5-year transition period beginning April 1, 2002 as specified in § 414.615. As of January 1, 2006, the total payment amount for air ambulance providers and suppliers is based on 100 percent of the national ambulance fee schedule. In accordance with section 414 of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) (Pub. L. 108-173), we added§ 414.617 which specifies that for ambulance services furnished during the period July 1, 2004 through December 31, 2009, the ground ambulance base rate is subject to a floor amount, which is determined by establishing nine fee schedules based on each of the nine census divisions, and using the same methodology as was used to establish the national fee schedule. If the regional fee schedule methodology for a given census division results in an amount that is lower than or equal to the national ground base rate, then it is not used, and the national fee schedule amount applies for all providers and suppliers in the census division. If the regional fee schedule methodology for a given census division results in an amount that is greater than the national ground base rate, then the fee schedule portion of the base rate for that census division is equal to a blend of the national rate and the regional rate. For CY 2006, this blend is 40 percent regional ground base rate and 60 percent national ground base rate. As of January 1, 2007, the total payment amount for ground ambulance providers and suppliers will be based on either 100 percent of the national ambulance fee schedule or 80 percent of the national ambulance fee schedule and 20 percent of the regional ambulance fee schedule.

B. Provisions of the Final Regulation

In this rule, we are finalizing changes to the fee schedule for payment of ambulance services by adopting revised geographic designations for urban and rural areas as set forth in OMB's Core-Based Statistical Areas (CBSAs) standard. We are adding the definition of "urban area" as defined by the Executive Office of Management and Budget (OMB). In addition, we are removing the definition of "Goldsmith modification" and amending our definition of "rural area" to include areas determined to be rural under the most recent version of the Goldsmith modification.

We are withdrawing our proposal to change the language of our regulation defining "specialty care transport (SCT)" to conform to our existing payment policies. In response to public comments, we are broadening and clarifying our interpretation of the existing language and responding to other issues associated with the definition of SCT.

In addition, we are discontinuing our annual review of the original CF assumptions and of the original air ambulance rates from the initial implementation of the fee schedule in 2002 because we have not identified any significant differences from those assumptions in the 4 years since the implementation of the fee schedule. We will continue to monitor payment and billing data on an ongoing basis and make adjustments to the CF and to air ambulance rates as appropriate to reflect any significant changes in these data.

Finally, in response to public comment, we are withdrawing our proposal to revise our current definition of "Emergency response" to further specify the conditions that warrant a higher payment for immediate response. Our reasons for withdrawing our proposal are explained in section III.B.4. of this preamble.

1. Adoption of New Geographic Standards for the Ambulance Fee Schedule

Historically, the Medicare ambulance fee schedule has used the same geographic area designations as the acute care hospital IPPS and other Medicare payment systems to take into account appropriate urban and rural differences. This provides a consistent and objective national definition for ambulance payment purposes within the ambulance fee schedule and generally across Medicare payment systems. It also utilizes geographic area designations that more realistically reflect rural and urban populations, resulting in more accurate payments for ambulance services. Accordingly, we are adopting OMB's CBSA-based geographic area designations, which have been adopted for the IPPS, to more accurately identify urban and rural areas for ambulance fee schedule payment purposes. We are also adopting the most recent modification of the Goldsmith Modification, consistent with the provisions of section 1834(l), to more accurately determine rural census tracts within metropolitan areas.

These changes will affect whether certain areas are recognized as rural or urban. The distinction between urban and rural is important for ambulance payment purposes because ambulance payments are based on the point of pick-up for the transport, and the point of pick-up for urban and rural transport is paid differently. Of particular significance to the ambulance fee schedule, the changes would affect whether or not certain areas are eligible for certain rural bonus payments under the ambulance fee schedule. For example, the changes would affect whether or not certain areas are recognized as what we refer to as "Super Rural Bonus" areas established by section 414(c) of the MMA and set forth in section 1834(l)(12) of the Act. That section specifies that, for services furnished during the period July 1, 2004 through December 31, 2009, the payment amount for the ground ambulance base rate is increased by a "percent increase" (Super Rural Bonus) where the ambulance transport originates in a rural area (which includes Goldsmith areas) that we determine to be in the lowest 25th percentile of all rural populations arrayed by population density.

a. Core-Based Statistical Areas (CBSAs): Revised Office of Management and Budget (OMB) Metropolitan Area Definitions

In the February 27, 2002 final rule (67 FR 9100), we stated that we could not easily adopt and implement, within the timeframe necessary to implement the fee schedule, a methodology for recognizing geographic population density disparities other than MSA/nonMSA. We also stated that we would consider alternative methodologies that may more appropriately address payment to isolated, low-volume rural ambulance providers and suppliers at a later date. The application of any rural adjustment is determined by the geographic location of the beneficiary at the time he or she is placed on board the ambulance. We are now finalizing the adoption of OMB's revised geographic area designations for urban and rural areas and the most recent modification of the Goldsmith Modification to address payment to those isolated, low-volume rural providers and suppliers.

Prior to the 2000 decennial census, geographic areas were consistently defined by OMB as Metropolitan Statistical Areas (MSAs) with an MSA being defined as an urban area and anything outside an MSA being defined as a rural area. In addition, for purposes of ambulance policy, we recognized the 1990 update of Goldsmith areas (generally, rural census tracts within counties that covered large tracts of land with one predominant urban area only) as rural areas (65 FR 55077 through 55100). In Fall 1998, OMB chartered the Metropolitan Area Standards Review Committee to examine the Metropolitan Area (MA) standards and develop recommendations for possible changes to those standards. Three notices related to the review of the standards were published on the following dates in the Federal Register , providing an opportunity for public comment on the recommendations of the Committee: December 21, 1998 (63 FR 70525 through 70561); October 20, 1999 (64 FR 56627 through 56644); and August 22, 2000 (65 FR 51059 through 51077).

In the December 27, 2000, Federal Register (65 FR 82227 through 82238), OMB announced its new standards. In that notice, OMB defined a CBSA, beginning in 2003, as"a geographic entity associated with at least one core of 10,000 or more population, plus adjacent territory that has a high degree of social and economic integration with the core as measured by commuting ties." CBSAs are conceptually areas that contain a recognized population nucleus and adjacent communities that have a high degree of integration with that nucleus. The purpose of the new OMB standards is to provide nationally consistent definitions for collecting, tabulating, and publishing Federal statistics for a set of geographic areas.

The OMB standards designate and define two categories of CBSAs: Metropolitan Statistical Areas (MSAs); and Micropolitan Statistical Areas (65 FR 82227 through 82238). According to OMB, MSAs are based on urbanized areas of 50,000 or more population and Micropolitan Statistical Areas (referred to in this discussion as Micropolitan Areas) are based on urban clusters of at least 10,000 population but less than 50,000 population. Counties that do not fall within CBSAs are deemed "Outside CBSAs."

Under the ambulance fee schedule, MSAs would continue to be recognized as urban areas and all other areas outside MSAs (including Micropolitan Areas, areas "Outside CBSAs", and areas that are determined to be rural under the most recent modification of the Goldsmith Modification) would be recognized as rural areas. As noted previously, these designations are important because under the ambulance fee schedule, Medicare transports are designated either urban or rural based on the pick-up point of the transport.

As of June 6, 2003, the new OMB definitions recognized 49 new MSAs and 565 new Micropolitan Areas, and extensively revised the composition of many of the existing MSAs. There are 1,090 counties in MSAs under the new definitions (previously, there were 848 counties in MSAs). Of these 1,090 counties, 737 are in the same MSA as they were prior to the changes, 65 are in a different MSA, and 288 were not previously designated to any MSA (69 FR 49027).

There are 674 counties in Micropolitan Areas. Of these, 41 were previously in an MSA, while 633 were not previously designated to an MSA. There are five counties that previously were designated to an MSA, but are no longer designated to either an MSA or a new Micropolitan Area (Carter County, Kentucky; St. James Parish, Louisiana; Kane County, Utah; Culpepper County, Virginia; and King George County, Virginia) (69 FR 49027).

Our adoption of CBSA-based geographic area designations means that ambulance providers and suppliers that pick up Medicare beneficiaries in areas that are now outside of MSAs (but had been within MSA areas) may experience increases in payment, while those ambulance providers and suppliers that pick up Medicare beneficiaries in areas that are now within MSA areas (but had been outside of MSAs) may experience decreases in payment.

The use of updated geographical areas means the recognition of new urban and rural boundaries based on the population migration that occurred over a 10-year period, between 1990 and 2000.

We believe that updating the MSA definition to conform with OMB's CBSA-based geographic area designations, coupled with updating the Goldsmith Modification (that is, using the current Rural Urban Commuting Areas (RUCAs) version, as discussed in section III.B.1.b of this final rule), will more accurately reflect the contemporary urban and rural nature of areas across the country for ambulance payment purposes and cause ambulance fee schedule payments to become more accurate.

As of October 1, 2004, the IPPS adopted OMB's revised metropolitan area definitions to identify "urban areas" for payment purposes. Under the IPPS, MSAs are considered urban areas and Micropolitan Areas and areas "Outside CBSAs" are considered rural areas as specified in § 412.64(b). We are adopting similar CBSA-based designations of "urban area" and "rural area" under the ambulance fee schedule for the reasons discussed. Therefore, we are revising § 414.605 to include a definition of urban area and to reflect OMB's revised CBSA-based geographic area designations in our definition of rural area.

Comment: Some commenters suggested that we should mitigate any financial impact of the CBSA-based geographic changes by holding negatively-affected ambulance companies harmless or by adopting a phase-in of the CBSA-based geographic changes.

Response: While we understand the concern of some ambulance companies about the CBSA-based geographic changes, we think most negative impacts will be mitigated when we incorporate the updated Goldsmith Modification using RUCAs, as we discuss in section III.B.1.b. of this final rule. The RUCAs allow us to continue to recognize sub-county rural areas in CBSA-based MSAs. Further, we believe that accurate payments to rural areas should not be further delayed. Ambulance payments will not reflect the population changes documented by the CY 2000 decennial census and reflected in CBSA-based geographic designations until CY 2007. Finally, ambulance providers and suppliers who benefit from the floor amount based on Regional fee schedules will continue to receive transition payments through CY 2009, mitigating the overall financial impacts of the ambulance fee schedule.

Comment: Several commenters suggested delaying the implementation of the CBSA-based geographic changes until the findings of the GAO report on costs and access as they relate to ambulance services is published. The final report is currently due to be published by December 2007.

Response: We contacted the GAO concerning this report. At this time, the draft findings are not available and GAO is not permitted to discuss the report until its release. In view of the mitigating effects of our use of RUCAs, and in light of the fact that no "super rural bonus" areas are affected by the CBSA-based geographic designations, we think that the better course of action is to finalize our adoption of CBSA-based urban and rural designations. However, we will maintain contact with the GAO and, when their findings are available, we will consider whether any further adjustments are necessary.

b. Updated Goldsmith Modification: Rural Urban Commuting Areas (RUCAs)

The Goldsmith Modification evolved from an outreach grant program sponsored by the Office of Rural Health Policy of the Health Resources and Services Administration (HRSA). This program was created to establish an operational definition of rural populations lacking easy access to health services in Large Area Metropolitan Counties (LAMCs). Dr. Harold F. Goldsmith and his associates created a methodology for identifying rural census tracts located within a large metropolitan county of at least 1,225 square miles. Using a combination of data on population density and commuting patterns, census tracts were identified as being so isolated by distance or physical features that they were more rural than urban in character. The original Goldsmith Modification was developed using data from the 1980 census. To more accurately reflect current demographic and geographic characteristics of the nation, HRSA's Office of Rural Health Policy, in partnership with the Department of Agriculture's Economic Research Service and the University of Washington, developed an update to the Goldsmith modification designated as Rural-Urban Commuting Area Codes (RUCAs) (69 FR 47518 through 47519).

Rather than being limited to LAMCs, RUCAs use urbanization, population density, and daily commuting data to categorize every census tract in the country. Thus, RUCAs are used to identify rural census tracts in all metropolitan counties. Section 1834(l) of the Act requires that we use the most recent modification of the Goldsmith Modification to determine rural census tracts within MSAs. Therefore, we are removing the definition of "Goldsmith modification" at § 414.605 and incorporating a reference to the most current version of the Goldsmith modification, which are the Rural Urban Commuting Areas (RUCAs), in the definition of "rural area."

Comment: We received numerous comments from members of the ambulance industry that were concerned about the geographic status of their pick-up areas. Ambulance companies located in areas that have been traditionally recognized as rural areas were concerned that population shifts based on whole county designations might not accurately reflect pockets of rurality within those counties.

Response: The most recent modification of the Goldsmith Modification, which we are adopting in this final rule, uses RUCAs to recognize levels of rurality in census tracts located in every county across the nation. As a result, many counties that are designated urban at the county level based on population do, indeed, have rural census tracts within them that will be recognized as rural areas through our use of RUCAs. While this may not mean that every commenter will be ultimately satisfied, we believe that using RUCAs to identify sub-county rural areas within urban counties will resolve many of the commenters' concerns.

Comment: Although a number of commenters were supportive of our use of RUCAs, they requested that we clarify how we intend to define rurality using RUCA categories.

Response: The RUCA system is an updated version of the Goldsmith Modification that uses a 10-point scale of rurality. RUCA levels are assigned to a census tract based on the association of a given area's population to the nearest urban commuting area as follows:

(1) Metropolitan-area core: Primary flow within an urbanized area (UA).

(2) Metropolitan-area high commuting: Primary flow 30% or more to a UA.

(3) Metropolitan-area low commuting: Primary flow 5 percent to 30 percent to a UA.

(4) Large town core: Primary flow within a place of 10,000 to 49,999.

(5) Large town high commuting: Primary flow 30 percent or more to a place of 10,000 to 49,999.

(6) Large town low commuting: Primary flow 5 percent to 30 percent to a place of 10,000 to 49,999.

(7) Small town core: Primary flow within a place of 2,500 to 9,999.

(8) Small town high commuting: Primary flow 30 percent or more to a place of 2,500 to 9,999.

(9) Small town low commuting: Primary flow 5 percent to 30 percent to a place of 2,500 to 9,999.

(10) Rural areas: Primary flow to a tract without a place of 2,500 or more.

Furthermore, census tracts under RUCAs can be broken down by zip code for every county, allowing us to modify rural and urban areas within a given county. In the May 26, 2006 proposed rule (71 FR 30358), we did not specify where we would draw the line on the RUCA scale for urban/rural purposes. According to HRSA, the generally accepted breakpoint is to define a level less than 4.0 on the scale as urban and levels equal to or greater than 4.0 on the scale as rural. Under section 330A of the Public Health Service Act, the Office of Rural Health Policy within HRSA determines eligibility for its rural grant programs through the use of the RUCA code methodology. Under this methodology, any rural census tract that is in a RUCA code 4.0 or higher is determined to be a rural census tract. We agree with the majority of the commenters who suggested that we follow HRSA's guidelines and consider areas to be rural if they fall within RUCA levels 4 through 10. One commenter suggested that a rurality level of 2.0 might be a better breakpoint for EMS purposes. However, we believe that HRSA's guidelines accurately identify rural areas for ambulance payment purposes and are generally consistent with Medicare payment policies. We will, therefore, consider any census tract falling at or above RUCA level 4.0 to be a rural area for purposes of payment for ambulance services. We are finalizing our proposal to use the most recent modification of the Goldsmith Modification incorporating RUCAs, as directed by section 1834(l) of the Act. We will use 4.0 on the RUCA scale as the delineation between rural and urban (4.0 and greater is rural and less than 4.0 is urban).

Comment: One commenter discussed zip code areas that "bleed" from one type of geographic area to another, such as from rural to urban. This commenter was concerned that zip codes that were predominantly, but not totally, located within a rural area would not receive rural payments for ambulance pick-ups in those areas due to the urban influence of part of the zip code area.

Response: When we review a claim for ambulance services, we specifically examine the zip code for the pick-up point to determine whether that zip code contains both urban and rural areas. Census tracts under RUCAs can be broken down by zip code for every county, which allows us to identify rural and urban areas within a given county. Generally, we would categorize a zip code as urban or rural, and make payment accordingly, based on where the bulk of the population in that zip code resides.

Comment: Several commenters were concerned about the impact of the proposed CBSA-based geographic changes on the provisions of the Medicare Modernization Act (MMA) for rural service areas, specifically concerning the "Super Rural Bonus" areas.

Response: The "Super Rural Bonus" areas are areas that we determine to be in the lowest 25th percentile of all rural populations arrayed by population density in accordance with section 1834(l)(12) of the Act. Ambulance pick-ups in these areas currently receive a 22.6 percent add-on to their Medicare payments. None of the Super Rural Bonus areas should be adversely affected by the proposed CBSA-based changes, as our use of RUCA levels will preserve the rural status of an area whether or not it is located in a county which is designated as urban under the OMB definitions. Areas that do lose their rural status to become urban have become urban because of a significant increase in the surrounding population.

Comment: One commenter stated that the ambulance is dispatched to the patient to provide care at his or her pick-up point and, therefore, the ambulance payment system should reflect this procedure. Another commenter suggested that we should retain the Goldsmith Modification in its current form and not update payments under the ambulance fee schedule to reflect the use of RUCAs.

Response: We agree that the ambulance pick-up point is the determining factor in establishing payment under the ambulance fee schedule, and we intend to retain this procedure in the payment process. In addition, we agree that we need to recognize levels of rurality, and are doing so by adopting the updated Goldsmith Modification which uses RUCAs to identify rural areas within urban counties. We are directed by section 1834(l) of the Act to use the most recent update of the Goldsmith Modification in the payment process.

Comment: Another commenter suggested that we allow ambulance companies to present data to justify rurality, similar to the IPPS hospital reclassification process.

Response: Once again, we understand the concern of some ambulance companies to retain the rural status of their pick-up areas. However, as discussed in this section, we believe that, where applicable, the use of the RUCAs, and our ability to identify rural zip codes within census tracts, will address this concern in a consistent manner. Therefore, we do not believe it is necessary to complicate the payment process by developing an additional data submission and evaluation methodology. While the commenter directly referred to the hospital reclassification process that is administered under the IPPS, wherein hospitals can apply for geographic reclassification for purposes of determining the wage index adjustment to their inpatient payments, the hospital reclassification process was established by statute specifically for inpatient hospitals. Therefore, this IPPS reclassification methodology does not apply to ambulance services.

2. Specialty Care Transport (SCT)

In the February 27, 2002 Federal Register (67 FR 9100), we published a final rule with comment period entitled "Fee Schedule for Payment of Ambulance Services and Revisions to the Physician Certification Requirements for Coverage of Nonemergency Ambulance Services" that implemented the ambulance fee schedule. In that final rule, we defined SCT in § 414.605 as the "interfacility transportation of a critically injured or ill beneficiary by a ground ambulance vehicle, including medically necessary supplies and services, at a level of service beyond the scope of the EMT [(Emergency Medical Technician)]-Paramedic. SCT is necessary when a beneficiary's condition requires ongoing care that must be furnished by one or more health professionals in an appropriate specialty area, for example, nursing, emergency medicine, respiratory care, cardiovascular care, or a paramedic with additional training."

Additionally, ambulance vehicle staff must be certified as emergency medical technicians and legally authorized to operate all lifesaving and life-sustaining equipment that are on board the vehicle as specified in § 410.41(b)(1). Typically, a SCT level of care occurs when the patient, who is already receiving a high level of care in the transferring facility, requires a further level of care that the transferring facility is not able to provide.

We implemented the SCT level of payment for hospital-to-hospital ground ambulance transports upon implementation of the ambulance fee schedule on April 1, 2002 and we defined SCT at § 414.605. The definition of SCT in § 414.605 refers to "interfacility transportation." As we stated in the preamble to the February 27, 2002 final rule with comment period (67 FR 9100), the SCT level of care includes the situation where a beneficiary is taken by ground ambulance from the hospital to an air ambulance and then from the air ambulance to the final destination hospital. Also, we stated in the preamble for both the September 12, 2000 proposed rule (65 FR 55077) and the February 27, 2002 final rule (67 FR 9108), that SCT was proposed as a level of interhospital service. As stated in our May 26, 2006 proposed rule, we based our payment for SCT-level ground ambulance transports on hospital-to-hospital ambulance transportation data.

Subsequent to the implementation of the ambulance fee schedule, we clarified our definition of SCT as hospital-to-hospital transport in a Program Memorandum to Medicare contractors, which was issued on September 27, 2002. (Program Memorandum Intermediaries/Carriers, Transmittal AB-02-130-Change Request 2295, September 27, 2002). That document and subsequent questions and answers related to the definition of SCT were made available to the public on the Ambulance policy Web page on the CMS Web site.

In addition, we clarified our definition of SCT in the Medicare Benefit Policy Manual, Chapter 10-Ambulance Services, in which we stated that SCT is regarded as a highly-skilled level of care of a critically injured or ill patient during transfer from one hospital to another. We have also clarified our policy in Ambulance Open Door Forums, conference calls, and oral and paper communication written in response to questions posed by individuals and groups representing the ambulance industry.

Despite our previous attempts to clarify the scope of SCT transport, we continued to receive questions from ambulance suppliers and providers and there was confusion on this point among the Medicare contractors. For this reason, we had proposed to change the definition of "specialty care transport" at § 414.605 to read "hospital-to-hospital" transport as opposed to "interfacility" transportation to conform our regulation text to our existing policy.

Comment: Many commenters suggested that we expand the SCT level of ambulance service to include transportation for neonates and adults transported from the scene of an accident to a hospital, as well as transport between hospitals and between hospitals and skilled nursing facilities (SNFs). In addition, commenters requested a clearer definition of the terms "hospital" and "critical care." Some commenters suggested that we reconvene the Negotiated Rulemaking Committee to develop a definition of "critical care."

Response: We carefully considered the commenters" recommendations to expand our interpretation of the term "interfacility" to include other origin and destination points in addition to hospitals. The SCT level of transport is intended to be used only for transfer of the most critically ill beneficiaries, who require ongoing specialized care beyond the scope of the EMT-paramedic. Typically, SCT level transport occurs when a beneficiary who is already receiving a high level of specialized care in one facility is moved to another facility to receive more specialized services. Although such specialized care is usually provided in a hospital, we recognize that some beneficiaries receive specialized care in a skilled nursing facility (SNF) and may require the SCT level of transport from the SNF to a hospital or from a hospital to a SNF. Therefore, we are withdrawing our proposal to revise § 414.605 to read "hospital-to-hospital" instead of "interfacility" and expanding our interpretation of "interfacility" to include both hospitals and SNFs. In addition, in response to comments, we are further clarifying the kinds of facilities that we include as origin or destination points for "interfacility" transport for SCT purposes.

Many of our Medicare contractors indicate that they have been administering the "interfacility" requirement in the SCT definition broadly, paying claims at the SCT level of service beyond the scope of "hospital-to-hospital." An examination of the latest available claims data shows that SCT-level payments are made predominantly for hospital-to-hospital transportation, as expected, with a small percentage of SCT-level ambulance transports involving other origin and destination points, primarily SNFs.

Therefore, for purposes of SCT payment, we consider a "facility" to include a SNF or a hospital that participates in the Medicare program. In addition, we consider the term "facility" to include a hospital-based facility that meets our requirements for provider-based status, as specified at § 413.65. Facilities that meet our requirements for provider-based status, like the main provider with which they are affiliated, are held to high standards of safety and patient care. Therefore, we believe that such facilities, due to their close association with a Medicare hospital and their adherence to high standards of care under our regulations, are also among the facilities equipped to provide the SCT level of care to patients and to provide the additional specialized care that is required under the SCT level of ambulance transport. We will continue to enforce our medical necessity requirements concerning all interfacility transports so that we can remain assured that they are occurring for only the most critical patients.

We appreciate the request by commenters that we clarify the kinds of facilities we consider to be included for SCT payment purposes. As explained above, our claims data indicate that SCT level care is needed primarily during inter-hospital transfers and, in some cases, during transfers between a hospital and a SNF. Therefore, for purposes of SCT payment, we consider a "facility" to include only a SNF or a hospital that participates in the Medicare program, or a hospital-based facility that meets our requirements for provider-based status.

Medicare hospitals include, but are not limited to, rehabilitation hospitals, cancer hospitals, children's hospitals, psychiatric hospitals, Critical Access Hopitals (CAHs), inpatient acute-care hospitals, and Sole Community Hospitals (SCHs).

However, we do not agree with commenters who recommended that a more comprehensive definition of "critical care" is warranted at this time. The Negotiated Rulemaking Committee was unable to precisely define "critical care" at the time it originally convened and recognized that a definition provided at the State or local level would be expected to fit, since there are no national standards available (Summary Minutes, Medicare Ambulance Fee Schedule Negotiated Rulemaking, October 4 and 5, 1999). We have no additional data that would permit us to develop a more precise definition at this time. In addition, we believe that a more precise definition might conflict with State or local parameters already in place, as well as possibly limiting the scope of SCT payments in localities where a broader State or local definition would otherwise apply.

"Critical care" will continue to be interpreted by our Medicare contractors in conjunction with directives provided at the State or local level.

Comment: Many commenters also suggested that we consider including the ongoing monitoring of a patient by a specially-trained health care professional, beyond the scope of the EMT-Paramedic, to be within the realm of the SCT level of service.

Response: We carefully considered these commenters' concerns, and we agree that in cases where a critically injured or ill patient requires the SCT-level of transport from one facility to another, the ongoing care that must be furnished by a health professional in an appropriate specialty area, beyond the scope of the EMT-Paramedic, may include ongoing determinations as to whether the patient requires specialized care during the transport. We do not require that specialized treatment actually be furnished during the transport to satisfy the standard for SCT-level transport. However, we do require that the need for specialized treatment can only be ascertained by a health professional with specialized training beyond the scope of the EMT-Paramedic. We agree with commenters who indicated that an ambulance service should not be expected to bear the cost of an additional health professional to accompany a patient "just in case" the need for specialized treatment arises during transport. When such "specialized monitoring" is medically necessary, we agree that it is part of the ongoing care that falls within the definition of SCT.

Comment: One commenter stated that certain modifiers, such as the "D" modifier representing a stand-alone emergency room or the "I" modifier used when transferring a patient from the airport or helipad to the ambulance, exclude these types of ambulance transports from the SCT level of service.

Response: The commenter is correct that we generally do not recognize either "D" or "I" modifier-type ambulance transports to be SCT level ambulance services. The "D" modifier would be used to describe a non-hospital-based, non-hospital-owned, or non-hospital-operated diagnostic facility or clinic. We have defined the SCT level of ambulance service as interfacility ground transportation, involving transport between hospitals, hospital-based facilities and SNFs. Therefore, a stand-alone emergency room that is not provider-based or a freestanding clinic that is not provider-based would not meet the requirements for an origin or destination point for SCT level transport. The "I" modifier indicates an origin or destination that is a transfer point between ambulances, such as transfer from air to ground ambulance service at a helicopter pad. Unless the origin of the first leg of the transport is a facility and unless the SCT level of care is medically necessary after the transfer occurs, we would not consider the transport from the transfer point to the final destination to be SCT level transport.

3. Recalibration of the Ambulance Fee Schedule Conversion Factor

In the February 27, 2002 final rule with comment period (67 FR 9102 and 9103), we indicated that we would adjust the CF if actual experience under the fee schedule was significantly different from the assumptions used to determine the initial CF and air ambulance rates. We specifically stated that we would monitor payment data and evaluate whether the assumptions used were accurate.

We have continued to review our assumptions annually to determine whether or not a CF adjustment is warranted. We examined the effects of the relative volumes of the different levels of ambulance services (service mix) and the extent of low billing charges to determine whether we should adjust the CF to reflect actual practices. In the 4 years since the implementation of the ambulance fee schedule, no significant differences from our original assumptions have emerged. We have observed only insignificant differences, and, to date, no adjustments in any 1 year have been warranted. It is for this reason that we believe it is appropriate to discontinue our annual review of the original CF assumptions. We also believe that the formal annual review of air ambulance rates should be discontinued as we will monitor all ambulance rates and make adjustments on an "as needed" basis. The ambulance industry has available multiple venues for notifying us of potential issues. These include the ambulance fee schedule open door forums and telephone calls to designated CMS personnel. As an additional safeguard, we generally conduct a review of ambulance data each year in preparation for issuing the Ambulance Inflation Factor (AIF).

Therefore, we are revising § 414.610 (g) to indicate that we will monitor payment and billing data on an ongoing basis and adjust the CF and air ambulance rates as appropriate to reflect annual practices under the fee schedule.

Comment: Commenters were supportive of our proposal to discontinue the annual practice of examining the low biller data and the CF via the rulemaking process.

Response: We appreciate the support of the commenters on these points.

We are finalizing our proposal to discontinue the annual practice of examining the low biller data and the CF, as well as air ambulance rates, and to change the language at § 414.610(g) to reflect this.

4. Hospital-to-Hospital Ambulance Service: Emergency Response

In § 414.605, we define "emergency response" for purposes of ambulance service to mean "responding immediately at the BLS (Basic Life Support) or ALS1 (Advanced Life Support Level 1) level of service to a 911 call or the equivalent in areas without a 911 call system. An immediate response is one in which the ambulance entity begins as quickly as possible to take the steps necessary to respond to the call." In our February 27, 2002 final rule with comment period (67 FR 9100), in our definition of "emergency response" we stated that the additional payment for emergency response is for the additional overhead cost of maintaining the resources required to respond immediately to a call and not for the cost of furnishing a certain level of service to the beneficiary.

The current emergency response definition has created confusion for those transports that originate at a hospital emergency department and the ambulance is transporting the beneficiary to an emergency department at another hospital for either admittance or treatment. For example, in most of these cases, the beneficiary must be stabilized prior to the transport. Therefore, the need to maintain a state of readiness to respond immediately to an urgent call, warranting a higher emergency response payment, does not appear to be applicable to these situations.

Another example occurs when the ambulance is owned by the originating hospital. We stated in a Program Memorandum to the Medicare contractors (Transmittal AB-02-130, Change Request 2295, September 27, 2002) that upon receipt of a call for ambulance services, the dispatcher makes the determination of whether the call constitutes an Emergency response. When the ambulance service is already readily available at the originating hospital, an emergency call may not be necessary, much less through a dispatcher for a 911 service.

While we recognize that there may be instances when an emergency response payment is warranted for a transport between two hospital emergency departments, we believe that payment based on readiness to respond immediately is not justified 100 percent of the time. For this reason, we believed our current definition of Emergency response needed to be clarified to reflect only circumstances where payment for immediate response is truly warranted. We proposed to revise the definition of Emergency response to mean that an ambulance entity-

• Maintains readiness to respond to urgent calls at the BLS or ALS1 level of service; and

• Responds immediately at the BLS or ALS1 level of service to 911 calls, the equivalent in areas without a 911 call system or radio calls within a hospital system when the ambulance entity is owned and operated by the hospital.

Comment: We received many comments on revising the definition of "emergency response". Most commenters expressed concern that this revised definition would put private ambulance services at a disadvantage. They interpreted our proposed definition to include only ambulance services owned and operated by hospitals that respond to radio calls within a hospital system. Essentially, their interpretation of our proposed definition was that only ambulance services owned and operated by hospitals would be able to transport patients at the "emergency response" level of service and, therefore, be able to receive the higher "emergency response" payment as a result.

Response: Certainly, this was not our intent. Our view of the problem we were attempting to address was the issue of "readiness" when responding to a 911 call. We expect "emergency response" payment to be made only in circumstances where readiness to respond immediately is truly required. Therefore, we proposed to clarify the circumstances under which we expected this to occur. However, we agree with comments stating that ambulance service calls generally do not originate through a 911 service but through the hospital's radio dispatch at the location where the ambulance is stationed. Private ambulance services stationed at inpatient hospitals would, therefore, be at a disadvantage if we specify that responding to hospital radio calls only qualifies as "emergency response" when the ambulance entity is owned or operated by the hospital. This would not affect off-site ambulance services whose calls originate through a 911 or equivalent service. We agree that the proposed change in the definition of "emergency response" could have an unintended adverse effect on private ambulance services in these circumstances.

Comment: Several commenters stated that our existing definition of emergency response more clearly reflects the intent of the Negotiated Rulemaking Committee in that all ambulance services should have equal access to the use of the emergency level of service by accessing it through established State protocols, such as 911 or an equivalent service.

Response: We also agree that the current definition of emergency response is consistent with the Negotiated Rulemaking Committee's intent and does not present other problems raised by commenters. For the BLS and ALS1 levels of service, an ambulance service that qualifies for an emergency response is assigned a higher relative value to recognize the additional costs incurred in responding immediately. We think that requiring an ambulance service to respond to a 911 call, or the equivalent in areas without a 911 call system, satisfies this requirement.

Therefore, we are withdrawing our proposal to revise the "emergency response" definition and will retain the current definition at 414.605. We expect that the State protocol (a 911 call or the equivalent in areas without a 911 call system) for requesting emergency ambulance services will be followed in all instances.

C. Analysis of and Responses to Public Comments

We received a total of 102 timely public comments in response to the May 26, 2006 proposed rule (71 FR 30358). Commenters included national trade associations, health care providers, hospitals, CMS contractors, and private citizens.

All public comments were reviewed and grouped by like or related topics. Comments are addressed in the individual sections of discussion to which they apply.

D. Ambulance Inflation Factor (AIF) for 2007

Section 1834(l)(3)(B) of the Act provides the basis for updating payment amounts for ambulance services. Our regulations at § 414.610(f) provide that the ambulance fee schedule must be updated by the AIF annually, based on the CPI for all urban consumers (CPI-U) (U.S. city average) for the 12-month period ending with June of the previous year. For CY 2007, that percentage is 4.3 percent.

Section 414.620 specifies that changes in payment rates resulting from incorporation of the AIF will be announced by notice in the Federal Register without opportunity for prior comment. We find it unnecessary to undertake notice and comment rulemaking because the statute and regulations specify the methods of computation of annual updates. This notice does not change policy, but merely applies the update methods specified in the statute and regulations.

The national fee schedule for ambulance services has been phased in over a 5-year transition period beginning April 1, 2002 as specified in § 414.615.

Prior to January 1, 2006, during the transition period, the AIF was applied separately to both the fee schedule portion of the blended payment amount (regardless of whether a national or regional fee schedule applied) and to the reasonable cost or charge portion of the blended payment amount, respectively, for each ambulance provider or supplier. Then, these two amounts were added together to determine the total payment amount for each provider or supplier. Beginning January 1, 2006, the total payment for air ambulance providers and suppliers is based on 100 percent of the national ambulance fee schedule, while the total payment amount for ground ambulance providers and suppliers is based on either 100 percent of the national ambulance fee schedule or a combination of the national ambulance fee schedule and the regional ambulance fee schedule. As of January 1, 2007, the combination rate will be 80 percent of the national ambulance fee schedule and 20 percent of the regional ambulance fee schedule.

IV. Five-Year Refinement of Relative Value Units Under the Physician Fee Schedule: Responses to Public Comments on the Five Year Review of Work Relative Value Units

A. Scope of the Five-Year Review

This final rule includes the culmination of the third 5-Year Review of work RVUs required by the statute. The work RVUs affected by this review will be effective for services furnished beginning January 1, 2007.

In the June 29, 2006 proposed notice, "Five-Year Review of Work Relative Value Units Under the Physician Fee Schedule and Proposed Changes to the Practice Expense Methodology", we explained the process used to conduct the 5-Year Review of work RVUs. In response to our solicitation of public comments that appeared in the November 15, 2004 Federal Register (69 FR 66370), we received comments from approximately 35 specialty groups, organizations, and individuals involving over 500 Current Procedural Terminology (CPT) codes. After review by our medical staff, we shared these comments with the AMA's Relative Value Update Committee (RUC) along with additional services we had identified as potentially misvalued.

After a comprehensive review process, the RUC submitted work RVU recommendations for all of these codes except for the codes that were withdrawn or referred to the CPT Editorial Panel for further review or action, and CPT code 32020 for which no specialty society expressed an interest in conducting a survey. We analyzed all of the RUC recommendations by evaluating the methodology used by each workgroup to develop the recommendations, the recommended work RVUs, and the rationale for the RUC recommendations. When appropriate and feasible, if we had concerns about the application of a particular methodology, we assessed whether the recommended work RVUs were appropriate by using alternative methodologies.

In conducting our review of the RUC recommendations we considered whether: (1) The code was part of a completed survey process; (2) the methodology used by the specialty society followed the standard RUC process; (3) the survey respondents stated the work had or had not changed in the past 5 years; (4) databases (for example, Society of Thoracic Surgeons (STS), National Surgical Quality Improvement Program (NSQIP), and Medicare diagnosis-related group (DRG)) were used in lieu of the standard RUC methodology or as a supplement to the standard methodology; and (5) the intra-service work per unit of time (IWPUT) calculation was used to determine work RVUs in lieu of the standard RUC process. Although we recognize that the work values of codes may change over time, it is the responsibility of the specialty society to present compelling evidence that a code is misvalued. (For additional information on the review process, please see the June 29, 2006 proposed notice (71 FR 37172).)

B. Review of Comments

Many commenters expressed support for our proposed valuations of many of the services. However, other commenters expressed specific concern or disagreement with the proposed valuation of approximately 106 codes, with the major concern being that the codes would be undervalued.

We convened a multi-specialty panel of physicians to assist us in the review of comments. The comments we did not submit for panel review are discussed at the end of this section. The panels were moderated by our medical staff and consisted of:

• Clinicians representing the commenting specialty(s), based on our determination of those specialties which are most identified with the services in question. Although commenting specialties were welcomed to observe the entire refinement process, they were only involved in the discussion of those services for which they were invited to participate.

• Primary care clinicians nominated by the American Academy of Family Physicians (AAFP) and the American College of Physicians.

• Four carrier medical directors.

• One to two clinicians who practice in related specialties and have knowledge of the services under review.

We submitted 30 codes for evaluation by the panel. The panel discussed the work involved in each procedure under review in comparison to the work associated with other services on the fee schedule. We assembled a set of reference services and asked the panel members to compare the clinical aspects of the work for services they believed were incorrectly valued to one or more of the reference services. In compiling the reference set, we attempted to include: (1) Services that are commonly furnished for which work RVUs are not controversial; (2) services that span the entire spectrum of work intensity from the easiest to the most difficult; and (3) at least three services performed by each of the major specialties so that each specialty would be represented. Group members were encouraged to make comparisons to these reference services. The intent of the panel process was to capture each participant's independent judgment based on the discussion and his or her clinical experience. Following the discussion for each service, each participant rated the work for that procedure. Ratings were individual and confidential; there was no attempt to achieve consensus among the panel members.

We then analyzed the ratings based on a presumption that the RVUs published in the proposed notice were correct. To overcome that presumption, the inaccuracy of the proposed RVUs had to be apparent to the broad range of physicians participating in the panel. Ratings of work were analyzed for consistency among the groups represented on the panel. In general terms, we used statistical tests to determine whether there was enough agreement among the groups on the panel, and if so, whether the agreed-upon RVUs were significantly different from the proposed RVUs that appeared in the June 29, 2006 proposed notice to demonstrate that the proposed RVUs should be modified. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group, and looked for agreement among the remaining groups as to the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the CY 1993 physician fee schedule final rule published in the November 25, 1992 Federal Register which described the statistical tests in detail (57 FR 55938).

Our decision to convene a multi-specialty panel of physicians and to apply the statistical tests described above in this section was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties. Of the 30 codes reviewed by the multi-specialty panel, all were the subject of requests for increased values.

Of the proposed codes that were reviewed, 11 increased, and 19 were not changed.

Table 12 lists the codes reviewed during the 5-Year Review on which we received comments. This table includes the following information:

CPT/HCPCS Code. This is the CPT or alphanumeric HCPCS code for a service.

Modifier. A modifier -26 is shown if the work RVUs represent the professional component (PC) of the service.

Description. This is an abbreviated version of the narrative description of the code.

Proposed Work RVUs. This column includes the work RVUs proposed in the June 29, 2006 proposed notice for each reviewed code.

Requested Work RVUs. This column identifies the work RVUs requested by the commenters. If the commenters requested different RVUs, the table lists the highest requested RVUs.

RUC Recommendation. This column identifies the work RVUs recommended by the RUC that appeared in the June 29, 2006 proposed notice.

HCPAC Recommendation. This column identifies the work RVUs recommended by the HCPAC that appeared in the June 29, 2006 proposed notice.

2007 Work RVUs. This column contains the work RVUs for the CY 2007 physician fee schedule.

Basis for Decision. This column indicates whether the CY 2007 work RVUs resulted from comments received or the refinement panel process.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.007" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.008" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.009" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

C. Discussion of Comments by Clinical Area

1. Dermatology and Plastic Surgery

In addition to comments received in support of our proposed work RVUs for services reviewed by the RUC's Workgroup 1, we received the following comments.

For CPT code 17004, Destruction (e.g., laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), all benign or pre-malignant lesions (e.g., actinic keratoses) other than skin tags or cutaneous vascular proliferative lesions; 15 or more lesions, the RUC considered a change to the work RVUs for this CPT code based on the understanding that when rank order anomalies arising from the 5-Year Review were identified, the specialty could bring these additional codes forward for re-evaluation at the February 2006 RUC meeting. A standard RUC survey was conducted for this code. During the discussion, the RUC agreed that the descriptor of the code needed to be changed, as well as the intra-service descriptor and time to reflect only the destruction of pre-malignant lesions. The RUC agreed that, due to these changes, a work value halfway between the 25th and median survey percentile was appropriate and recommended work RVUs of 1.80 for CPT code 17004.

CMS Proposed Valuation

For CPT code 17004, we believed that the work associated with benign and pre-malignant lesions does not really differ; therefore, the recommended work RVUs for CPT code 17004 were too high. We used a "building block" methodology to develop our proposed RVUs for this service. That is, based on our proposed valuation of CPT code 17003 (the code used for 2-14 lesions), of 0.07 work RVUs for each additional lesion, the 14th lesion would equal 0.91 work RVUs (0.07 × 13 lesions) plus the 0.6 work RVUs for the initial lesion, base code CPT code 17000, which is billed once in conjunction with 17003, for a total of 1.51 work RVUs for the service. We proposed to value CPT code 17004, at the level determined for the 15th lesion, at 1.58 work RVUs by adding the 0.07 work RVU increment of CPT code 17003 and the 0.6 work RVUs for the base code, CPT code 17000, which is not billed in conjunction with CPT code 17004.

Comment: While the American Academy of Dermatology (AAD) was pleased that the RUC-recommended work RVUs were accepted for the 36 CPT codes for the excision of benign and malignant lesions, both the AADA and the RUC disagreed with our proposed valuation of 1.58 work RVUs for CPT code 17004 and requested that we accept the RUC-recommended 1.8 work RVUs. They continue to support the premise that benign and pre-malignant lesions are not comparable and believe that recent changes to the code descriptors made by the CPT editorial panel to CPT codes 17000-17004 and CPT codes 17110-17111 for CPT 2007 also support this position. These descriptor changes specifically differentiate between destruction of pre- malignant and benign lesions, respectively. The RUC and AADA maintain that the destruction of pre-malignant lesions in CPT 17004 requires a greater mental effort and judgment, technical skill, intensity and time than that for the destruction of benign lesions in CPT code 17111. In addition, the commenters presented data collected during the survey process to show that the median number of lesions destroyed in the typical service of CPT code 17004 was 22 lesions, and the average number was 23.439.

Response: We have reviewed the information supplied by the RUC and the AADA, especially for the median number of lesions destroyed in the typical service of CPT code 17004. By applying the same calculations we used in the proposed rule to value the 15th lesion at 1.58 work RVUs, we determined that the RUC proposed work value of 1.8 work RVUs represents 18 lesions for a typical service for CPT code 17004.

Final Decision: Based on these comments and our calculations, we now believe that the RUC recommendation is reasonable and will accept the RUC-recommended work value of 1.80 work RVUs for CPT 17004.

Other Issues

Comment: The American Society of Plastic Surgeons (ASPS) was pleased that we agreed with the RUC recommendations for the codes performed by plastic surgeons. ASPS also clarified that the reason CPT code 19361 was withdrawn from the 5-Year Review process and sent to CPT was due to the ambiguity of the code descriptor, and not due to an invalid survey as was listed in Table 3 of the June 29, 2006 proposed notice (71 FR 37189).

Response: We thank the society for the clarification and regret the erroneous rationale that was noted for the withdrawal of CPT code 19361 from this 5-Year Review process.

2. Orthopedic Surgery

In addition to comments received in support of our proposed work RVUs for services reviewed by the RUC's Workgroup 2, we received comments on the following CPT codes.

For CPT code 27130, Arthroplasty, acetabular and proximal femoral prosthetic replacement (total hip arthroplasty), with or without autograft or allograft; CPT code 27236, Open treatment of femoral fracture, proximal end, neck, internal fixation or prosthetic replacement; and CPT code 27447, Arthroplasty, knee, condyle and plateau; medial AND lateral compartments with or without patella resurfacing (total knee arthroplasty), we originally presented these codes to the workgroup with data other than survey data supporting the work RVU requests. Because of concerns regarding the methodology used by the specialty society, the codes were temporarily withdrawn with the understanding that survey data could be presented at the October 2006 meeting. After reviewing the survey data in October 2006, the RUC did not find any compelling evidence to change the current work RVUs assigned to these services. Based on this review, the RUC recommended maintaining the current work RVUs of 20.09 work RVUs for CPT code 27130, 15.58 work RVUs for CPT code 27236, and 21.45 work RVUs for CPT code 27447, but also recommended using the new physician time survey data for each of these services.

CMS Proposed Valuation

We disagreed with the RUC-recommended values for CPT codes 27130, 27236 and 27447, based on the specialty's presentation to the workgroup in August. We instead proposed alternative work RVUs determined by comparing these codes to services with similar times and adjusting for any differences in hospital visits. As a result of this analysis, we proposed 15.96 work RVUs for CPT code 27130, 12.77 work RVUs for CPT code 27236, and 19.30 work RVUs for CPT code 27447.

Comment: Several commenters, including societies representing orthopedics and the RUC, expressed concern about the methodology we used to develop our proposed work RVUs for these services. Commenters questioned the comparisons we used to arrive at the proposed values (that is, high volume orthopedic procedures being compared to rarely furnished non-orthopedic procedures of lower risk and intensity), and also stated that our proposed work RVUs would create substantial rank order anomalies within the families. The American Academy of Orthopaedic Surgeons/American Association of Orthopaedic Surgeons (AAOS) and the American Society for Surgery of the Hand (ASSH) stated that we had misunderstood the method that was used to develop the RUC-recommended work RVUs for these procedures. They indicated that we were incorrect in stating that a RUC survey had not been conducted for these codes; the work RVU recommendations that were adopted by the RUC are based on surveys conducted by AAOS and are the result of extensive RUC review and discussion.

AAOS acknowledged that the initial recommendations presented by AAOS in August 2005 were based on NSQIP and DRG data due to flaws in the original surveys. However, based on reservations expressed by CMS at that time, subsequent surveys were conducted. The RUC-recommended work RVU recommendations were then based on this survey data and the NSQIP data was used only as an adjunctive methodology to credit or discredit the survey data.

In addition, these codes were compared with other RUC-reviewed codes to show that the recommended values and times placed the codes in proper rank order. The RUC-recommended values are further supported when compared to other procedures within the associated families. The commenters urged us to reconsider our position and accept the RUC recommendations.

Response: The commenters are correct that we based our rejection of the RUC-recommended work RVU for these services (CPT codes 27130, 27236, and 27447) on the August workgroup presentation and had inadvertently overlooked the surveys that were presented at the October meeting. After reviewing the more recent survey data, we now agree that the RUC recommendations appear reasonable. Therefore, based on a review of the information provided by the commenters, we have decided to accept the RUC recommendation to maintain the current work RVUs of 20.09 for CPT code 27130, 15.58 work RVUs for CPT code 27236 and 21.45 work RVUs for CPT code 27447.

3. Gynecology, Urology, Pain Medicine, and Neurosurgery

We received comments disagreeing with our proposed work RVUs on the following two services: CPT code 22612, Arthrodesis, posterior or posterolateral technique, single level; lumbar (with or without lateral transverse technique); and CPT code 63048, Laminectomy, facetectomy and foraminotomy (unilateral or bilateral with decompression of spinal cord, cauda equina and/or nerve root(s), (e.g., spinal or lateral recess stenosis)), single vertebral segment; each additional segment, cervical, thoracic, or lumbar (List separately in addition to code for primary procedure.) . The RUC had recommended increases in work RVUs for these two codes, but less than the increases requested by the specialty society. The RUC agreed that these procedures were undervalued due to increases in length of stay and the incorrect assumptions made in the previous valuation of the service. The specific RUC-recommended work RVUs were 22.00 work RVUs for CPT code 22612 and 3.55 work RVUs for CPT code 63048.

CMS Proposed Valuation

We had technical concerns with the recommendations for CPT codes 22612 and 63048. The workgroup had recommended the survey's 25th percentile for CPT code 22612 to keep the appropriate rank order with the reference service, CPT code 22595, that the RUC stated is a more complex procedure. However, there was a typographical error in the information presented by the specialty society that listed the work RVUs for the reference code as 23.36, rather than the correct value of 19.36 work RVUs. Therefore, the recommended work value of 22.00 RVUs appeared appropriate and we proposed to maintain the current work RVUs of 20.97 for this service.

There was what we believed to be an additional typographical error in the specialty society survey data for CPT code 63048. The summary information presented to the RUC lists the reference code as also being CPT code 63048. Therefore, there is no information submitted that compares the respondents' estimates of complexity and intensity between CPT code 63048 and a reference code. Because we do not have sufficient information to decide if the recommended work RVUs are appropriate, we proposed to maintain the current work RVUs of 3.26 for CPT code 63048.

Comment: We received comments from the North American Spine Society, the American Association of Orthopaedic Surgeons, the American Association of Neurological Surgeons (AANS), and the RUC requesting that we do not implement our proposed RVUs for these services (CPT codes 22612 and 63048), but rather accept the RUC-recommended work RVUs. The commenters stated that we had misunderstood the process used by the presenting societies to develop the suggested RVUs for both codes. The commenters stated that the survey respondents did not notice the values for a reference service, but rather were asked to compare the current work and intensity with the work and intensity of furnishing the procedure in 2000. Therefore, the societies contend, the misprint of the value for what was listed as a "reference" code had no effect on the valuation of CPT code 22595, nor did the absence of a separate reference code for CPT code 63048 negatively affect its valuation. According to the commenters, they believe that the workgroup based its recommendation on the validity of the survey data and the building block methodology presented as additional rationale. The specialty society representing spine surgeons also commented that when the respondents were asked to rate how the complexity and intensity of these services had changed in the past 5 years, the ratings showed that the survey respondents believed that the intensity and complexity for both codes had increased.

The AAFP questioned why we would propose a value for CPT code 22612 that, though equal to the current value, was still higher than a more complex reference code. According to the AAFP, the RUC appeared to be recommending that the ratio of work between CPT codes 22612 and 22595 was 0.942 work RVUs; therefore, we should have recommended a work value of 18.23 work RVUs for CPT code 22612.

Response: We thank the commenters for clarifying the process used in surveying for these services. However, we still have concerns regarding the RUC recommendations for these services. First, though the survey respondents did not see the erroneous work RVUs listed for CPT code 22595, the reference code used for CPT code 22612, the workgroup did account for these errors. As a result, the RUC recommendation for CPT code 22612 was higher than the current work RVUs for CPT code 22595, a procedure the workgroup considered more complex. Second, although the survey respondents may have indicated on the rating scale that CPT codes 22612 and 63048 were more complex procedures in 2005 than they were in 2000, when they were asked simply whether the work for these services had changed in the last 5 years, 80 percent disagreed for CPT code 22612 and 50 percent disagreed for CPT code 63048. Therefore, based on the comments received, we referred this code to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 21.79 work RVUs to CPT code 22612 and 3.47 work RVUs to CPT code 63048.

For CPT code 61697 Surgery of complex intracranial aneurysm, intracranial approach; carotid circulation; CPT code 61700 Surgery of simple intracranial aneurysm, intracranial approach; carotid circulation; and CPT code 61702 Surgery of simple intracranial aneurysm, intracranial approach; vertebrobasilar circulation), we received the following comments.

Comment: The AANS disagreed with the RUC recommendations that we proposed to accept for CPT codes 61697, 61700 and 61702 because of changes made by the workgroup to "standardize the pre-service and post-service times." The commenter stated that the standard 60 minutes of pre-service time was not adequate for such complex neurological procedures and stated reasons for the need for extended times. AANS also objected to the adjustments made by the workgroup to the level and number of post-operative visits by changing each post-operative critical care visit to a single high level subsequent hospital care visit. The society stated its belief that this change "significantly understates the post-operative time and intensity of the work that was described by survey respondents," and urged us to add the time and work RVUs of an additional critical care code, CPT code 99233, to all three services.

Response: We do not believe that, based on this comment, we have sufficient information to make the requested change. Therefore, we referred this code to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 57.31 work RVUs to CPT code 61697.

4. Radiology, Pathology, and Other Miscellaneous Services

In addition to comments received in support of our proposed work RVUs for services reviewed by the RUC's Workgroup 4, we received the following comments.

For CPT code 76075, Dual energy x-ray absorptiometry (DXA), bone density study, one or more sites; axial skeleton (e.g., hips, pelvis, spine), the RUC recommended a reduction from the current 0.30 work RVUs for the DXA service because the workgroup believed that the actual work is less intense and more mechanical than the specialty society's description of the work. The RUC-recommended work RVUs for this code were 0.20 and we agreed with this recommendation.

Comment: Many commenters, including individual providers, national and State organizations, specialty societies, manufacturers, and Congressional and State legislators, wrote expressing concern about the proposed reduction in payments for this service, some of which is attributable to the proposed work RVUs. These commenters expressed concern that the proposed reduction in payment would have a detrimental impact on beneficiary health and is contrary to a Surgeon General's Report that emphasized the importance of such testing.

The ACR commented that, while they participated in the survey process that resulted in the RUC-recommended work RVU for this service, other specialties that provide this service such as family medicine, internal medicine and rheumatology were not represented. ACR encouraged us to consider comments from other specialty societies and organizations furnishing this service, including those that do not participate in the RUC process (such as the International Society for Clinical Densitometry (ISCD)), so that their views may be considered. ACR indicated that it would like to participate should it be determined that this will be addressed through a refinement panel. Other commenters, including specialty organizations and the ISCD, provided additional information regarding this service. Many of the commenters also expressed concern about the payment for CPT code 76077, although this code was not included in the 5-Year Review of work. Changes in payment for this code are attributed to the changes in PE methodology discussed in section II.A. of this final rule with comment period.

Response: We proposed to accept the RUC-recommended work RVU of 0.20 for CPT code 76075, which was lower than the requested 0.30 work RVUs requested by the specialty. Therefore, based on the comments received, we referred this code to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 0.20 work RVUs to 76075. (Note: For 2007, CPT code 76075 has been renumbered to 77080.)

For CPT code 95872, Needle electromyography using single fiber electrode, with quantitative measurement of jitter, blocking and/or fiber density, any/all sites of each muscle studied, the RUC agreed that there was compelling evidence that CPT code 95872 was undervalued and recommended increasing the existing work RVUs from 1.50 to 3.00 work RVUs.

CMS Proposed Valuation

We had concerns that the work recommendation for 95872, which was based on the survey's 75th percentile for work, is inappropriate for this service. To determine our proposed valuation for CPT code 95872, we utilized a multi-tiered approach. First, we calculated the pre-service and post-service work RVUs using the surveyed physician time data. Then, to determine an intra-service work RVU, we subtracted the surveyed intra-service time from the current time and multiplied this difference in time by the calculated IWPUT using the specialty recommended total work RVUs. Adding these calculated work RVUs resulted in a work valuation of slightly less than 2.00 work RVUs, which is approximately the same value as the survey median work RVU. In accordance with this analysis and the survey median, we proposed a work RVU of 2.00.

Comment: The RUC believes, and specialty societies for neurology agree, that the RUC's justification to increase the work of CPT code 95872 to 3.00 work RVUs is reasonable and outweighs our proposed valuation of 2.00 work RVUs, which is solely based on IWPUT. Commenters provided additional information concerning the activities associated with this procedure and requested acceptance of the RUC-recommended work RVUs.

Response: Based on the comments received, we referred this code to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 2.88 work RVUs to CPT code 95872.

5. Evaluation and Management (E/M) Services

Comment: There was strong support for the proposal to increase work RVUs for E/M services from many commenters, including specialty societies, the RUC, MedPAC and individual physicians. For example, specialty societies or organizations representing internal medicine, family physicians, thoracic medicine, rheumatology, endocrinology, neurology, HIV medicine, clinical oncology, group practice, infectious disease, critical care, physical medicine, emergency medicine, geriatrics, geriatric psychiatry, osteopathy, urology, gastroenterology, pediatrics, renal medicine, as well as the RUC, all expressed their appreciation for our acceptance of the RUC recommendations for E/M services. The American College of Physicians stated that our proposed E/M work RVUs are supported by data from the annual National Ambulatory Medical Care Survey which show that patients now have more chronic conditions, are older, and have more diagnoses per encounter. In addition, the commenter contended that the proposed increased values for E/M services would provide an incentive for appropriate E/M service utilization and would also ensure a sufficient supply of primary care physicians. Another commenter applauded the E/M proposals because "they correct the dramatic erosion of the relative weight accorded to E/M services over the past 14 years."

However, an umbrella specialty society for surgery raised several objections to our proposal. First, the commenter contended that the compelling evidence standard was not met because any false assumptions involved in the original valuation of the codes were corrected in the first 5-Year Review and because any increase in work for E/M services has been compensated by the billing of higher-level office visits. Second, the commenter expressed concern that the proposal will lead to rank order anomalies because of the disproportionate distribution of values within the E/M family and suggested that we spread out the increases more proportionately by increasing the values of lower E/M codes and decreasing the proposed increases to CPT codes 99213 and 99214. These concerns were also echoed in the comments from the specialty societies representing colon and rectal surgery, vascular surgery, orthopaedic surgery, hand surgery, prosthetic urology and from other commenters.

The specialty society representing otolaryngology submitted a similar comment that also stated that the proposed increases are excessive and unsupported by a careful analysis of the data, including an analysis of the IWPUT. In addition, the commenter stated that the IWPUTs that result from our proposal are illogical within families of codes and exceed the levels of many complex surgical procedures. The society recommended that we either maintain the 2006 work RVUs or transition the new work RVUs over several years.

The society representing social workers, as well as individual social workers and other NPPs, commented that clinical social workers and other NPPs are unable to use the E/M codes and requested that we withdraw the proposed increase for E/M services until all Medicare providers can receive fair and adequate increases. The society representing psychologists recommended that we reduce the increase for E/M services because it is inequitable to reward some at the expense of others or that they be permitted to bill for E/M services.

Response: We appreciate the strong support shown for our proposed work RVUs for E/M services and are appreciative of the thoughtful concerns raised by other commenters. We certainly understand how contentious this issue has been, particularly in light of the large BN adjustment that our acceptance of the RUC recommendations for these services would require. The concerns surrounding the valuation of E/M services were discussed during at least three RUC meetings before consensus was finally reached. We believe the final RUC recommendations represented acceptable relative values for the E/M services in question. After reviewing the comments, we believe that the RUC recommendations for the E/M services should be implemented in full beginning January 1, 2007.

With regard to the question of compelling evidence of the need for a change to the work RVUs, we believe that the rationale for revision of these RVUs did not rest solely on previous false assumptions, but also on the claim that there has been a change in the complexity of the patient population resulting in more diagnoses per encounter and more ambitious management goals. In reviewing the RUC's recommendations for the 5-Year Review, we found the evidence in support of a change in the work for E/M services as compelling as the evidence presented for most of the codes that we proposed to revise in this 5-Year Review. As to the comments regarding the IWPUTs of the E/M services, we are not yet convinced about the validity of the IWPUT analysis when applied to such "cognitive" services, particularly if such an analysis were to be used to negate the findings of acceptable surveys. In addition, even if there might be merit to the contention that the RUC recommendations will cause some rank order anomalies, we do not have the information that would be needed to rectify this; this is an issue that might be better handled by the RUC and the specialties involved.

Though we are sympathetic to the concerns of those who would not benefit from an increase to E/M services, but would face potential reductions in payment as a result of the BN adjustment, we do not believe that the appropriate answer would be to deprive primary care physicians, and other practitioners who provide these services, of an increase that the commenters otherwise appeared to consider reasonable and commenters did not suggest other viable alternatives. We would be happy to work with any group or individual that believes they have been unfairly impacted by this change to determine if there is any other appropriate other measure that might address their concerns.

We also do not believe that it would be either equitable or appropriate to transition the E/M increases, as suggested by some commenters. The work RVUs for E/M services were accepted by a RUC consensus and we believe them to be reasonable. We have never before transitioned changes in work RVUs that we accept based on RUC recommendations, and we believe it would be unfair in this case to single out these increases for transition when other services that received even greater increases would benefit immediately.

We did not propose to make any changes in our policy regarding the types of suppliers that can bill for E/M services, and are not making any changes at this time. Our Internet Only Manual 100-02 Chapter 15 Section 160 continues to state that "any therapeutic services that are billed by clinical psychologists (CPs) under CPT psychotherapy codes that include medical evaluation and management services are not covered."

Comment: Several commenters representing renal physicians and patients, as well as the RUC, requested that we make an adjustment for the ESRD-related services, which have been valued using the E/M codes as building blocks, by adding the increase in the E/M RVUs to these services.

Response: Since the G-codes now used for these ESRD-related services have markedly different descriptors than the previously valued CPT codes, we are unable to determine at this time which levels of E/M visits are most appropriately associated with these G-codes. As explained in the CY 2004 PFS final rule (68 FR 63218), we established RVUs for these G-codes to equal the aggregate payments for the services provided under the CPT codes that had been previously recognized for these services. Because we based our payment of the G-codes on the aggregate payments for CPT codes 90918-90921, the specific CPT codes that are building-blocks of this payment system cannot be directly correlated. We suggest that the specialty could request that the CPT panel consider revising the CPT codes for these ESRD-related services to mirror our current G-codes; these could then be reviewed by the RUC to determine the level of E/M services that are typically associated with each code.

Comment: An organization representing long term care providers commented that we stated incorrectly at the end of the discussion concerning the RUC recommendations for the E/M services that nursing facility codes are not part of the 5-Year Review process. The commenter clarified that the RUC requested that these codes not be surveyed until after the 5-Year Review, when there could be appropriately valued codes to use as reference services. Though the surveys will be conducted after the RVUs for E/M services are published, the commenter requested that we review the recommendations and update the nursing facility E/M RVUs to become effective in January 2008.

Response: The commenter is correct. The RUC recommended delaying the survey of these services pending RUC recommendations on E/M codes that could be used as reference services. If we receive the RUC's recommendations in time, we will review the recommendations for the work RVUs for nursing facility E/M services and publish our proposals in next year's proposed rule and will consider this part of the third 5-Year Review.

Comment: The specialty society representing home care physicians stated that the home care visit and domiciliary care visit codes were not included in the 5-Year Review; the domiciliary codes so that they could be valued through the RUC and, the home visits so that they could be used as reference codes. The society recommended that we adjust the work RVUs for these codes to reflect the revalued comparable office E/M codes for new and established patients. The commenter contended that the home visit and domiciliary care codes have been "referenced" to the office visit codes in the past and the changes proposed through the 5-Year Review process should be reflected in these derivative code families.

Response: It is unfortunate that these services were not included in the recent 5-Year Review and that the specialty did not propose them for review. We believe that it would be inappropriate to apply increases to these codes without a multi-specialty review of the work involved in these services. However, we would be willing to consider any RUC recommendations that might be forthcoming for revised work RVUs for the home visit and domiciliary care codes. Such a RUC review could be completed at the same time that the RUC is reviewing the nursing facility E/M services previously discussed in this section. As we indicated for the nursing facility E/M codes in the prior response, we would consider forthcoming RUC recommendations for the home care and domiciliary care E/M codes as part of the third 5-Year Review because of the similarity to the other E/M services considered in this review.

We continue to believe acceptance of the RUC recommendations for E/M services is appropriate and will implement the proposed work RVUs for E/M services beginning January 1, 2007.

6. Cardiothoracic Surgery

We received a number of comments concerning the cardiothoracic surgery proposals.

Comment: Commenters were supportive of the proposed valuation of the congenital cardiac surgery services and CPT code 32020, Tube thoracostomy with or without water seal (e.g., for abscess, hemothorax, empyema) (separate procedure ) . However, commenters did not agree with the proposed work RVUs for the general thoracic and adult cardiac surgery codes. One commenter questioned why the work RVUs had not been maintained at the current levels. Commenters representing surgical specialties, including thoracic and cardiac surgery, questioned the methodology we used to arrive at the proposed work RVUs. They believe the proposed work values create rank order anomalies and disturb the relativity within the cardiothoracic family. Additionally, the commenters stated that we failed to include pre- and post-service work in the add-on codes, contrary to a policy stated in the CY 2002 physician fee schedule final rule (67 FR 79966). The commenters provided additional detailed information concerning the STS database, as well as their use of mean values for the intra-service time and the intensity survey methods used to estimate IWPUT.

Response: As we discussed in the June 29, 2006 proposed notice, the general thoracic and adult cardiac surgery codes submitted to the RUC for review did not undergo the standard RUC survey methodology (71 FR 37218). Rather, the data pertaining to these codes were derived from the STS database, a voluntary registry developed by the STS that has reportedly captured data on approximately 70 percent of all cardiac surgical procedures in the United States.

We believe the STS database represents a significant advance in the effort to improve the quality of patient care and we hope that this kind of data collection will be emulated by other specialties. We also believe that the time and visit data contained in this database could be a useful adjunct to the RUC's validation of the standard RUC survey results.

We appreciate the detailed information provided by the commenters in response to the concerns we had outlined in the June 29, 2006 proposed notice. Based upon a review of the specific information provided by the commenters concerning the STS database, as well as the information provided specifically addressing the use of the mean values for the intra-service time and methodology used to estimate IWPUT, we will accept the RUC-recommended work RVUs for these services.

We note that it is our responsibility to assure all medical specialties that we will review and evaluate their services using an approach that is accepted by the RUC and CMS. We will continue to work with the RUC to better determine how to use the alternative data sources such as the STS data to compare the relativity of services. Unless an alternative approach can be found that can be applied to all services, we would not want to see the RUC abandon its survey methodology. We understand that the standard RUC survey process is not flawless, but it does provide an even playing field for all specialties and we would be concerned if each specialty was allowed to develop its own unique method for estimating work RVUs. Therefore, we will work with the RUC and continue to review this issue to determine the appropriate use of data sources other than the RUC survey.

Comment: The STS and the American Association for Thoracic Surgery (AATS) requested that we approve the RUC-recommended work RVUs of 49.41 for CPT code 33548, indicating that this was submitted as part of the 5-Year Review process since the valuation of this service was based on a reference code (CPT code 33542) that was in the refinement process. The commenter also stated that this was part of the RUC recommendations forwarded in September 2005.

Response: We did not receive CPT code 33548 as part of the 5-Year Review process, and therefore, we will maintain the current value for this service.

7. General, Colorectal and Vascular Surgery

For the following services, we received comments that disagreed with our proposed work RVUs.

a. Vascular Surgery

For CPT code 33877, Repair of thoracoabdominal aortic aneurysm with graft, with or without cardiopulmonary bypass ; CPT code 34201, Embolectomy or thrombectomy, with or without catheter; femoropopliteal, aortoiliac artery, by leg incision ; CPT code 35081, Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta ; CPT code 35102 Direct repair of aneurysm, pseudoaneurysm, or excision (partial or total) and graft insertion, with or without patch graft; for aneurysm, pseudoaneurysm, and associated occlusive disease, abdominal aorta involving iliac vessels (common, hypogastric, external) ; CPT code 35556 Bypass graft, with vein; femoral-popliteal ; CPT code 35566 Bypass graft, with vein; femoral-anterior tibial, posterior tibial ; CPT code 35583 In-situ vein bypass; femoral-popliteal ; and CPT code 35585, In-situ vein bypass; femoral-anterior tibial, posterior tibial, or peroneal artery , the RUC reviewed both the survey data and the NSQIP data for these services.

For these codes, the RUC believed that physicians responding to the survey underestimated the intra-service time and that the NSQIP data more accurately reflected the actual intra-service times for these procedures. For CPT code 33877, the RUC accepted a work value greater than the survey's 75th percentile that was derived from a building block approach using the NSQIP data for the service. For CPT codes 34201, 35102, 35556, 35566, and 35585, the RUC used the same methodology and accepted work values greater than the survey's median percentile. However, for CPT codes 35081 and 35583, the recommended increase was no greater than the surveyed median work RVUs.

The RUC-recommended work RVUs for these services were: 33877 = 64.04 work RVUs; 34201 = 18.31 work RVUs; 35081 = 31.00 work RVUs; 35102 = 36.28 work RVUs; 35556 = 27.25 work RVUs; 35566 = 32.00 work RVUs; 35583 = 26.00 work RVUs; and 35585 = 32.00 work RVUs.

CMS Proposed Valuation

We agreed with the RUC-recommended work RVUs for CPT codes 35081 and 35583. We disagreed with the RUC recommendations for CPT codes 33877, 34201, 35102, 35556, 35566, and 35585. For these services, the RUC used the NSQIP time data to increase the work values above the survey median, and for several codes above the 75th percentile. We rejected this use of the NSQIP data and proposed to use the survey median work RVUs for these CPT codes: 33877 = 53.00 work RVUs; 34201 = 17.00 work RVUs; 35102 = 34.00 work RVUs; 35556 = 25.00 work RVUs; 35566 = 30.00 work RVUs; and 35585 = 30.00 work RVUs. All of these proposed work RVUs are higher than the current values.

Comment: We received comments from the American College of Surgeons (ACS) and Society for Vascular Surgery (SVS) concerning these CPT codes. The ACS and the SVS, as well as the RUC, stated that our proposed work RVUs would undervalue several of the vascular surgery procedures. Both the ACS and the RUC maintained that we should accept the RUC recommendations for all these services.

For CPT code 33877, the commenters contended that the proposed value would create a rank order anomaly with the partial esophagectomy service, CPT code 43118, for which we proposed 61.08 work RVUs, even though it is a less intense procedure. The ACS also maintained that, under our proposal, the IWPUT of this service would be too low.

For CPT code 34201, the commenters disagreed with our proposal to reject the NSQIP-derived increase with one noting that we accepted the NSQIP-derived reduction in length of stay for CPT code 34201. The RUC commented that the presenting specialty assumed NSQIP time to be more accurate than RUC survey time and used NSQIP time when available, whether it increased or reduced the RUC survey times.

For CPT code 35102, the commenters asserted that we proposed work RVUs that would decrease the IWPUT to 0.075, which is inconsistent with other similar surgical procedures. Therefore, they urged us to accept the RUC recommendation of 36.28 work RVUs for this service.

For CPT codes 35556, 35566, 35583 and 35585, the commenters maintained that the NSQIP data demonstrated that survey respondents consistently underestimated their intra-service time. The ACS commented that our proposals would lead to low IWPUTs that are considerably less than similar surgical procedures. The RUC commented that we would be creating rank order anomalies between these codes and the total colectomy services, CPT codes 44150 and 44151.

The SVS also disagreed with our proposed work RVUs for seven of its specialty's services, and disagreed with the RUC recommendations for all but one of the codes. In the extensive and detailed comments we received, the society defended the use of the NSQIP data to deviate from the survey median, stating that NSQIP intra-service time and hospital length of stay were used even when it reduced the recommendation compared to the RUC survey.

The commenter also offered additional rationale to support their requested work RVUs for CPT codes 33877, 35101, 35081, 35556, 35566, 35583 and 35585. In each case, the SVS presented the building block components for each service, a comparison with other vascular codes by IWPUT analysis, and a detailed comparison to other selected procedures. The commenters also provided an additional discussion asserting that the number of hospital visits assigned by the RUC, and accepted by us, was underestimated for these services (with the exception of CPT code 33877.)

Response: We appreciate the comments that were submitted on our proposed work RVUs for these vascular surgery services. However, we note that there is disagreement among the commenters, with ACS and the RUC requesting that we accept the RUC recommendations for these codes and the SVS requesting acceptance of yet higher values for all the services (with the exception of CPT code 33877.) In addition, we have concerns that the SVS-recommended IWPUTs, for all but CPT code 33877, might be overstated. Therefore, based on the comments, we are accepting the RUC-recommended work RVUs of 64.04 for CPT code 33877, but referred the other seven codes to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 17.94 work RVUs to CPT code 34201, 31.00 work RVUs to CPT code 35081, 34.00 work RVUs to CPT code 35102, 25.00 work RVUs to CPT code 35556, 30.00 work RVUs to CPT code 35566, 26.00 work RVUs to CPT code 35583, and 30.00 work RVUs to CPT code 35585.

b. Colorectal Surgery

For CPT code 44120, Enterectomy, resection of small intestine; single resection and anastomosis ; CPT code 44130, Enteroenterostomy, anastomosis of intestine, with or without cutaneous enterostomy (separate procedure) ; and CPT code 47600, Cholecystectomy , the RUC believed the physicians responding to the survey underestimated their intra-service time. Therefore, the RUC applied what was believed to be an appropriate IWPUT to the additional NSQIP time and added the resulting work RVUs to the survey median. The RUC-recommended work values for these CPT codes were as follows: 44120 = 20.11 work RVUs; 44130 = 20.87 work RVUs; and 47600 = 15.88 work RVUs.

CMS Proposed Valuation

We had concerns with the RUC recommendation to use the NSQIP data to increase the work RVUs, for CPT codes 44120, 44130 and 47600, above the survey median, and, for 47600, above the 75th percentile. While we support the use of such a database as validation for survey results, we believe that the application of the NSQIP IWPUT to the difference in intra-time between the survey and NSQIP is questionable for the following reasons.

It is still not clear whether the NSQIP data is truly representative and the IWPUT applied to the additional time is higher than the IWPUT for the rest of the intra-time. In addition, this methodology assumes, without evidence, that there is a linear relationship between the survey respondents' estimate of time and estimate of work RVUs; however, even if the survey time estimates had matched the NSQIP data, it is not clear whether or by how much the respondents would have increased their work value estimate. Finally, until we have available valid and representative data such as the NSQIP for all procedures, there is the risk that applying the data randomly could distort the relativity between services. Therefore, we proposed to use the median survey values of 18.00, 20.00 and 14.00 as the work RVUs for CPT codes 44120, 44130 and 47600, respectively.

Comment: We received comments from the ACS and the American Society of Colon and Rectal Surgeons (ASCRS), as well as the RUC, urging us to accept the RUC recommendations for these 3 services. These commenters stated that the median work value that we proposed in the June 29, 2006 proposed notice for CPT code 44120 was incorrect; CPT code 44120 should be 19.00 work RVUs, not 18.00 work RVUs (71 FR 37228).

The ACS presented a lengthy defense of the NSQIP data that was echoed in the ASCRS comments. For example, ACS contended that the NSQIP data on intra-service skin-to-skin time is verified through operating room logs and is the "absolute gold standard" for estimating surgeon intra-service time. The commenters also disagreed that this data cannot be used until it is available for all services, since the best data should always be used rather than relying on "the lowest common denominator." The ACS further stated that a variety of different methodologies have been used to evaluate physician services and we have not, until now, required that one methodology be used for all codes. Finally, the ACS disputed our concerns that the NSQIP might not be representative, though it did agree that the number of Veterans Administration hospitals currently reporting is greater than the number of community and academic hospitals.

For CPT codes 44120 and 44130, ASCRS and ACS, as well as the RUC, contended that two reference codes were considered by the workgroup that led the RUC to agree that the survey median work RVUs underestimated the total work of these procedures and would create rank order anomalies.

For CPT code 47600, the ACS maintained that the RUC's recommendation was based on a belief that the survey's median work RVU underestimated the total work for this procedure because the survey respondents were not considering the correct patient demographics. The commenters stated that, if we did not accept the recommendations where the use of NSQIP resulted in a value greater than the survey median, we should also do the same for those recommendations that were lower than the median. The commenters emphasized that the RUC also used a comparison with a reference code to develop the recommendation for this procedure.

Conversely, the American College of Physicians (ACP) expressed support for our decision to reject the RUC recommendations that were based on extraction of time information from the NSQIP database rather than the survey median. The ACP questioned the representative nature of the data in the database and stated that allowing work values to be adjusted from the survey median, based on dubious relationships between work and time, would hurt the integrity of the RBRVS and should not be allowed.

Response: We appreciate the comments regarding the use of NSQIP data in the valuation of physician work. However, we would consider this the beginning of the discussion, not the end. There are still many issues that need to be fully explored (for example: what the criteria should be for the acceptance of a given database; whether databases can take the place of surveys; whether IWPUT should be used to create work RVUs, rather than to validate them; and, whether there is a linear relationship between survey respondents' estimate of work and time.)

In the case of these three services, CPT codes 44120, 44130 and 47600, although the commenters offered some valid points regarding the use of NSQIP, not all the concerns discussed in the proposed notice and summarized in this section of this final rule with comment period have been thoroughly discussed. Therefore, based on the comments received, we referred this code to a multi-specialty refinement panel for review.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 18.00 work RVUs to CPT code 44120, 20.00 work RVUs to CPT code 44130, and 15.85 work RVUs to CPT code 47600.

For the proctoscopy-anoscopy family of codes in Table 13, the RUC agreed that the surveyed median work RVUs, and often even the 25th percentile, were inconsistent with the reference code. Therefore, the RUC did not reference the surveyed RVUs in arriving at the recommendations. Rather, the RUC used the surveyed times for each service and applied what the workgroup considered an appropriate IWPUT to these times to arrive at the recommended work RVUs for this family.

CPT Code Descriptor
45300 Proctosigmoidoscopy, rigid; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure).
45303 Proctosigmoidoscopy, rigid; with dilation (e.g., balloon, guide wire, bougie).
45305 Proctosigmoidoscopy, rigid; with biopsy, single or multiple.
45307 Proctosigmoidoscopy, rigid; with removal of foreign body.
45308 Proctosigmoidoscopy, rigid; with removal of single tumor, polyp, or other lesion by hot biopsy forceps or bipolar cautery.
45309 Proctosigmoidoscopy, rigid; with removal of single tumor, polyp, or other lesion by snare technique.
45315 Proctosigmoidoscopy, rigid; with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique.
45317 Proctosigmoidoscopy, rigid; with control of bleeding (e.g., injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator).
45320 Proctosigmoidoscopy, rigid; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique (e.g., laser).
45321 Proctosigmoidoscopy, rigid; with decompression of volvulus.
45327 Proctosigmoidoscopy, rigid; with transendoscopic stent placement (includes predilation).
46600 Anoscopy; diagnostic, with or without collection of specimen(s) by brushing or washing (separate procedure).
46604 Anoscopy; with dilation (e.g., balloon, guide wire, bougie).
46606 Anoscopy; with biopsy, single or multiple.
46608 Anoscopy; with removal of foreign body.
46610 Anoscopy; with removal of single tumor, polyp, or other lesion by hot biopsy forceps or bipolar cautery.
46611 Anoscopy; with removal of single tumor, polyp, or other lesion by snare technique.
46612 Anoscopy; with removal of multiple tumors, polyps, or other lesions by hot biopsy forceps, bipolar cautery or snare technique.
46614 Anoscopy; with control of bleeding (e.g., injection, bipolar cautery, unipolar cautery, laser, heater probe, stapler, plasma coagulator).
46615 Anoscopy; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique.

The specific RUC work RVU recommendations for these colon and rectal surgery CPT codes were as follows:45300 = 0.91 work RVUs; 45303 = 2.22 work RVUs; 45305 = 2.01 work RVUs; 45307 = 2.22 work RVUs; 45308 = 2.01 work RVUs; 45309 = 2.22 work RVUs; 45315 = 2.22 work RVUs; 45317 = 1.08 work RVUs; 45320 = 2.43 work RVUs; 45321 = 2.76 work RVUs; 45327 = 3.63 work RVUs; 46600 = 0.49 work RVUs; 46604 = 1.08 work RVUs; 46606 = 1.76 work RVUs; 46608 = 1.95 work RVUs; 46610 = 1.95 work RVUs; 46611 = 1.08 work RVUs; 46612 = 2.14 work RVUs; 46614 = 1.08 work RVUs; and 46615 = 1.18 work RVUs.

CMS Proposed Valuation

We proposed not to accept the RUC recommendations for all the presented codes in the proctoscopy-anoscopy family. We proposed to maintain the current work RVUs for CPT codes 45300, 45303, 45305, 45307, 45308, 45309, 45315, 45317, 45320, 45321, 45327, 46600, 46604, 46606, 46608, 46610, 46611, 46612, 46614 and 46615.

As we stated in the June 29, 2006 proposed notice, we believe that the method used by the RUC to obtain work values for these services was flawed (71 FR 37229). The calculation of the recommended work RVUs depended solely on applying a workgroup-derived IWPUT to the surveyed physician time from surveys that were considered otherwise unusable. We also stated that we do not believe that the use of IWPUT, in the absence of other supporting data, has been previously accepted by the RUC. We believe the RUC has established rules that state that IWPUT cannot be the sole rationale for valuation and it appears that this workgroup might not have adhered to that standard. However, we stated that, if the specialty society wishes to resurvey these codes and the RUC submits work RVU recommendations to us, we would certainly be willing to consider them.

Comment: The ASCRS expressed their appreciation for the opportunity to again present survey data to the RUC for these services and the ACS stated that it will be working with ASCRS to facilitate this process. The RUC commented that the specialty society recommendations for these services were presented at the October 2006 RUC meeting.

Response: At the October 2006 RUC meeting, the Society presented the original surveys with additional rationales to support the requested work RVUs. After much discussion, the RUC decided that the original surveys were still not usable and that new surveys would be needed before a recommendation for revised work RVUs could be made. Therefore, we are maintaining the current work RVUs for this series of codes, as proposed.

Other Issues

Comment: A few commenters, while agreeing with the increase in work RVUs for CPT code 19180 (total mastectomy), expressed concern that the work RVUs for CPT code 19160 (partial mastectomy) were not reviewed. These commenters believed that the work RVUs for CPT code 19160 should be addressed in a similar fashion and the work RVUs should be adjusted to avoid a potentially adverse impact on patient treatment for breast cancer. One of these commenters suggested that this disparity in work RVUs needed to be addressed before the next 5-year review, as this disparity could impact on medical decision-making.

Response: As part of the 5-year review process, the specialtysocieties were asked to identify whether the RUC-recommended changes in the work RVUS created anomalies within a family of codes. Any such potential anomalies identified by the specialty societies were then reviewed at subsequent RUC meetings. Unfortunately, this potential anomaly was not identified or reviewed. However, we will ask the RUC to review this code (CPT code 19160) and will consider this RUC recommendation as part of the third 5-Year Review.

8. Otolaryngology and Ophthalmology

In addition to comments received in support of the proposed work RVUs for services reviewed by the RUC's workgroup 8, we received the following comments.

For CPT code 31360, Laryngectomy; total, without radical neck dissection ; CPT code 31365, Laryngectomy; total, with radical neck dissection ; CPT code 31390, Pharyngolaryngectomy, with radical neck dissection; without reconstruction ; and CPT code 31395, Pharyngolaryngectomy, with radical neck dissection; with reconstruction , the specialty society presented survey data with the rationale that the current work RVUs create rank order anomalies, and that there also has been a change in the patient population. The RUC agreed that increasing the work RVUs of these procedures by accepting the 75th percentile of survey results corrected the specific rank order anomalies and also accounted for the change in the patient population. The RUC-recommended work RVUs for these CPT codes are as follows: 31360 = 28.00 work RVUs; 31365 = 37.00 work RVUs; 31390 = 40.00 work RVUs; and 31395 = 44.00 work RVUs.

For CPT code 31367, Laryngectomy; subtotal supraglottic, without radical neck dissection and CPT code 31368, Laryngectomy; subtotal supraglottic, with radical neck dissection , the specialty society presented survey data with the rationale that the current work values are based on a flawed methodology that creates rank order anomalies, and that there also has been a change in patient population. The RUC agreed with the specialty society and recommended increasing the work RVUs for these services to maintain rank order between the codes in the family and to establish the correct intensity of the procedure based on the change in patient population. The RUC-recommended work RVUs for these CPT codes are as follows: 31367 = 27.36 work RVUs; and 31368 = 36.00 work RVUs.

For CPT code 41155, Glossectomy; composite procedure with resection floor of mouth, mandibular resection, and radical neck dissection (Commando type) , the specialty society presented survey data, noting that the current work RVUs create a rank order anomaly. The RUC agreed that increasing the work RVUs would correct these rank order anomalies and that these increases were justified by the survey results. The RUC-recommended 40.00 work RVUs for CPT code 41155.

For CPT code 42845, Radical resection of tonsil, tonsillar pillars, and/or retromolar trigone; closure with other flap , the specialty society's survey data demonstrated that the code was currently undervalued due to a previous flawed methodology. The RUC believed that the survey results reflected the appropriate physician work and time necessary in performing this procedure and recommended the 32.00 work RVUs for CPT code 42845.

CMS Proposed Valuation

For the laryngopharyngectomy procedures, including CPT codes 31360, 31365, 31367, 31368, 31390 and 31395, the number of hospital days decreased by at least 2 days and the post-operative outpatient visits increased by 1 day. However, in one instance the number of outpatient visits decreased (CPT code 31395). The median values for intra-service times were accepted by the RUC for these services, which is an indication that a lower value than the 75th percentile for work also may be appropriate. Therefore, we proposed using median values for these services resulting in the following work RVUs for these CPT codes: 31360 = 24.00 work RVUs; 31365 = 31.50 work RVUs; 31367 = 24.00 work RVUs; 31368 = 30.50 work RVUs; 31390 = 35.00 work RVUs; and 31395 = 39.50 work RVUs.

CPT code 41155 was valued by the RUC at the 75th percentile for work, but CPT code 41150 was valued based on the median work value. The median values for intra-service times were accepted by the RUC for these services, which is an indication that a value other than the 75th percentile for work also may be appropriate. Therefore, we proposed 36.00 work RVUs of for CPT code 41155.

CPT code 42845 was valued by the RUC at the 75th percentile for work rather than the median as the RUC recommended for the other procedures in this family (CPT codes 42842 and 42844). Therefore, we proposed 29.00 work RVUs for CPT code 42845.

Comment: The RUC and several specialty societies, including the American Head and Neck Society (AHNS) and the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), disagree with the proposed work RVUs for CPT codes 31360, 31365, 31367, 31368, 31390, 31395, 41135, 42845. They provided information, data, and rationales concerning the valuation of these services and, recommended that we accept the RUC recommendations. The specialty societies objected to our proposed RVUs on the grounds that they created rank order anomalies; they believe the reference codes used were a poor choice that resulted in an underestimation of work by the survey respondents; and they believe the codes had been undervalued for years.

Response: Based on the comments received, we referred these codes to a multi-specialty refinement panel for review. Panel review is appropriate for reasons including the RUC acceptance of the median values for intra-service times, which is an indication that a value other than the 75th percentile for work may be appropriate, and the need for further discussion regarding the appropriateness of the reference codes chosen by the survey respondents as comparable services to the codes being valued.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 26.22 work RVUs to CPT code 31360, 35.00 work RVUs to CPT code 31365, 27.00 work RVUs to CPT code 31367, 30.50 work RVUs to CPT code 31368, 38.33 work RVUs to CPT code 31390, 39.50 work RVUs to CPT code 31395, 40.00 work RVUs to CPT code 41155, and 29.00 work RVUs to CPT code 42845.

Miscellaneous Issues

Comment: The American Academy of Ophthalmology (AAO) stated its belief that the 5-Year Review process was fair in its consideration of the ophthalmic codes. However, the AAO expressed disappointment in the decrease in value for cataract surgery (CPT code 66984) and its hope that this "downward reimbursement reward" does not lead to a decrease in research and innovation in medical care. The AAO also expressed disappointment in our decision to unlink the long-standing relationship of the Ophthalmology Examination codes (92002-92014) to the E/M codes. The AAO urged us to reaffirm this linkage and increase those values to reflect the proposed increases in E/M services. If this is not possible, AAO suggested that the work values prior to the linkage in 1996 be restored since they were lowered during the first 5-Year Review to facilitate the linkage process.

Response: We acknowledge that currently the work RVUs for ophthalmology examination services are linked to the work RVUs for certain E/M codes. However, the work RVUs for the E/M codes are being increased based on our acceptance of the rationale that the work required to furnish these services has itself changed. This increase in work RVUs also implies that the E/M services today are not exactly the same services to which we initially linked the eye examination services. Unfortunately, because the specialty did not bring the ophthalmology examination codes to the 5-Year review for evaluation of any change in the work of furnishing these services, it is not known to what extent, if at all, the work for the ophthalmology examination codes would have mirrored the change in the work of the E/M codes. We note that the E/M increases have been added to other services only when the E/M codes were clearly used as the building blocks for valuing the services, for example, for global surgical services with post-operative visits. Therefore, we will implement the work RVUs for CPT codes 92002-92014 as proposed. However, if received in time for next year's proposed rule, we would be willing to consider any RUC recommendations for work RVUs for these services for implementation in FY 2008 and would consider this as part of the third 5-Year Review.

Comment: For CPT code 69210 Removal impacted cerumen (separate procedure), one or both ears , while we accepted the RUC-recommended work RVUs for this service, in the June 29, 2006 proposed notice we had expressed concern about the valuation of this service for the use of this code for routine removal of ear wax and indicated we would monitor the use of this code for the appropriate circumstances (71 FR 37233). The RUC and other specialty societies provided additional information to address our concern with this valuation for the use of this code for routine removal of ear wax during a physical examination of a patient. One commenter believes that there is the potential for misuse of this code due to a lack of understanding by other specialties of the physician work included in this procedure. The commenter recommends that we issue clarifying instructions or an educational article so that this code will be used in a manner consistent with the criteria outlined by AAO-HNS and contained in the July 2005 issue of the AMA's CPT Assistant.

Response: We appreciate these comments and will consider the suggestions made by the commenters.

9. HCPAC codes

In addition to comments received in support of the proposed work RVUs for services reviewed by the HCPAC, we received the following comments.

For CPT code 10060, Incision and drainage of abscess (e.g., carbuncle, suppurative hidradenitis, cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); simple or single ; CPT code 11040, Debridement; skin, partial thickness ; CPT code 11041 Debridement; skin, full thickness ; CPT code 11042 Debridement; skin, and subcutaneous tissue ; and CPT code 29580 Strapping; Unna boot , the HCPAC agreed with the specialty society that there was compelling evidence that the valuation of these services was incorrect due to a flawed methodology used in the previous Harvard valuation for the podiatric codes considered under the 5-Year Review.

For CPT codes 10060 and 29580, the HCPAC supported an increase in the existing work values for these codes and recommended work RVUs of 1.50 for CPT code 10060 and 0.60 work RVUs for CPT code 29580, both of which represent the median of the survey data for these services.

For CPT code 11040, the HCPAC did not support the work RVU increase recommended by the specialty society, but instead recommended 0.55 work RVUs, which represented the 25th percentile work RVU from the survey data.

For CPT code 11041, the HCPAC recommended a decrease in the work RVUs and, based on the median from the survey data, recommended 0.80 work RVUs.

For CPT code 11042, the HCPAC did not agree with the specialty society that the work RVUs should be increased to 1.20 work RVUs. The HCPAC recommended maintaining the current work RVUs of 1.12 for this CPT code, which was slightly higher than the survey's 25th percentile work value of 1.10 work RVUs.

The HCPAC-recommended work values for these services were as follows: 10060 = 1.50 work RVUs; 11040 = 0.55 work RVUs; 11041 = 0.80 work RVUs; 11042 = 1.12 work RVUs; and 29580 = 0.60 work RVUs.

CMS Proposed Valuation

For CPT code 10060, we compared the survey times with the current Harvard-based times used to value this service. These times are comparable and, therefore, we proposed maintaining the current work RVUs of 1.17 for this code.

For CPT codes 11040, 11041 and 11042, the survey times all reflect significant reductions from current Harvard-based times used to value these services. Based on this comparison, which shows decreases in time ranging from 47 percent to 68 percent, we believe that the low values from the surveys more accurately represent the valuation of these services. Therefore, we proposed to assign work RVUs as follows: 11040 = 0.48 work RVUs; 11041 = 0.60 work RVUs; and 11042 = 0.80 work RVUs. In addition, to ensure that the other codes in this family are properly valued, we recommended the RUC review the valuation of CPT codes 11043 and 11044.

For CPT code 29580, we compared the current Harvard-based times with the survey times. For this code, there was a small reduction in survey time as compared to the current Harvard-based time used to value this service, and, therefore, we do not believe the recommended increase in work RVUs is supported. We proposed to assign 0.55 work RVUs to this service, which represents the 25th percentile of the survey and more accurately reflects the time associated with this service.

Comment: The American Podiatric Medical Association (APMA) and the HCPAC disagreed with the rationale we provided to explain our disagreement with the HCPAC-recommended work RVUs for 5 CPT codes (11060, 11040, 11041, 11042, and 29580) that are predominantly provided by the podiatry specialty. The commenters noted that our proposed valuation of these services was based solely on a comparison of the RUC-surveyed times to the Harvard-based times, despite the HCPAC's concurrence with the specialty that the current Harvard work values were incorrect due to a flawed methodology. In addition, the commenters noted that our proposed valuation fails to address the intensity measures inherent to each service. The specialty presented recent literature abstracts to demonstrate that the treatment of diabetic ulcers has become more complicated in recent years and also supports that the diabetic ulcer is the primary cause of infections and, ultimately, leads to amputations in this population. The APMA and the HCPAC urged us to consider these inherent risks in treating this population and to accept the HCPAC-recommended work RVUs.

For CPT codes 11040, 11041 and 11042, the HCPAC recommended an increased work RVU for CPT 11040, a slight decrease in work RVUs for 11041, and the same work RVUs for 11042. Based on their belief that there is increased complexity and inherent risks in treating the diabetic patient, the APMA and the HCPAC in their comments urged us to accept the HCPAC-recommended work RVUs for this family of codes at 0.55 work RVUs, 0.80 work RVUs and 1.2 work RVUs, respectively. The commenters also strongly object to our reliance on a time-based comparison from the RUC surveys and the Harvard data (which the HCPAC and APMA agreed was based on a flawed methodology) to derive the work RVUs for these debridement codes.

For CPT code 11060, the APMA and the HCPAC requested that we accept the HCPAC recommendations for this 10-day global service based on the lack of intensity measures in our valuation that relied on a comparison of the RUC surveyed time to the Harvard-based time which, as mentioned previously, had been determined to be based on a flawed methodology. The APMA believes that by using this time-based comparison and maintaining the current RVUs at 1.17 work RVUs, we are proposing to distort the relativity of CPT 10060 with other comparable services (for example, CPT codes 10140 and 11421) and results in an unreasonably low IWPUT, at 0.009. The HCPAC and the APMA urged us to accept the recommended work value at 1.5 work RVUs that represents an IWPUT of 0.031.

For CPT code 29580, the specialty society indicated that the typical patient requiring the application of an Unna boot is a diabetic with lower extremity edema, often with the presence of an ulcer. The typical patient requires repetitive applications of this Unna boot strapping, so most applications will also require the removal of the Unna boot, a thorough cleansing of the area, physical examination, and a careful reapplication of the strapping material. The APMA believes that our valuation of 0.55 work RVUs-using just the surveyed time, without specifically addressing the intensity measures inherent to the care of the diabetic patient-undervalues this service. The HCPAC and the APMA urged us to adopt the recommended value (survey median) of 0.60 work RVUs.

Response: We appreciate the comments and information forwarded by the HCPAC and the APMA. However, based on our review of the data and literature contained in their comments, we are not convinced that the complexity and intensity measures inherent to the treatment of the diabetic patient have changed significantly over the past 5 years. In addition, we understand the specialty's concern that the Harvard time data was flawed. However, we believe that the lower times presented from the survey do not warrant the recommended work RVUs. Nonetheless, we believe that the HCPAC and the APMA should have the opportunity to present their evidence relative to the work RVUs for these five codes to a multi-specialty panel for review. As such, we have referred CPT codes 10060, 11040, 11041, 11042, and 29580 for refinement.

Final Decision: As a result of our analysis of the refinement panel ratings, we have assigned 1.17 work RVUs to CPT code 10060, 0.50 work RVUs to CPT code 11040, 0.60 work RVUs to CPT code 11041, 0.80 work RVUs to CPT code 11042, and 0.55 work RVUs to CPT code 29580.

Other Issues

Other commenters representing nutritionists and dietitians referenced the medical nutrition codes that were referred to the CPT Editorial Panel, indicating that these services should be assigned work RVUs. This issue is discussed in section II.B.4.c. of this final rule with comment period, as it was specifically addressed in the CY 2007 PFS proposed rule (71 FR 48982).

D. Other Issues Under the 5-Year Review

1. Anesthesia Services

Although anesthesia services are paid under the PFS, they are paid on the basis of an anesthesia code-specific base unit and time units that vary based on the anesthesia time of the case. Since anesthesia services do not have a work value per code as do other medical and surgical services, a work value must be imputed for each anesthesia code.

As a result of its relationship with the RUC and the past recommendations for valuing anesthesia services, which were discussed in detail in the June 29, 2006 proposed notice (71 FR 37237), the American Society of Anesthesiologists (ASA) requested that we address the valuation of anesthesia services reported under CPT codes 00100 through 01999. The ASA furnished an analysis that builds on the methodology used in the last 5-Year Review for the valuation of work for anesthesia services. We recommended that the valuation of anesthesia services, namely the proposed valuation of the post-induction time, be referred to the AMA RUC for review and consideration.

Comment: The RUC indicated that it will consider any specific CMS request and asked that we clarify the scope of review and elements of the anesthesia relativity that is supposed to be addressed. Many commenters, including individuals and a specialty group, expressed concern that the proposed reductions in payment for anesthesia services may lead to future manpower shortages and could affect the provision of surgical services. They asked us to work with the ASA and the RUC to appropriately value the work of anesthesia services.

Response: We understand that the ASA and the RUC will be reviewing this issue in an upcoming meeting and will make a recommendation to CMS in 2007.

A second issue concerning anesthesia services pertains to the impact of the revised work values for E/M services and their relationship to the valuation of pre- and post-anesthesia services, components of the building-block approach. The pre- and post-anesthesia services derive their work values from the lower level E/M codes for new patients, the subsequent hospital care codes, and the initial inpatient consultation codes.

In the June 29, 2006 proposed notice, we proposed to increase the work of the pre- and post-anesthesia components of the 19 anesthesia codes, previously reviewed by the AMA RUC in the last 5-Year Review of work. Specifically, we proposed to increase the anesthesia work to reflect the increased work values for the E/M codes where there were increases in the work of those E/M codes.

Comment: One specialty group noted that we should refer the valuation of pre- and post-anesthesia issues to the RUC for its review and consideration, and should not make any changes in the value of pre- and post-anesthesia services at this time. The ASA requested that we increase the work of all anesthesia services, not just the 19 anesthesia codes, to account for the increase in work values for E/M codes. They noted that all anesthesia services have E/M services included in the pre- and post-anesthesia components and the work of all anesthesia services should be increased.

Response: We disagree with the comment asking us to defer action on re-valuing the work of anesthesia services to account for the increased work of certain E/M codes. We are making the adjustment, but will ask the RUC and the ASA to review the E/M codes assigned to the pre- and post-anesthesia periods to ensure that they are still clinically relevant. While we understand the concerns of the ASA, we are unable to make that type of adjustment across all anesthesia services. The pre- and post-anesthesia components of the anesthesia service are not uniformly linked to the same E/M code. Rather, the E/M code can vary based on the complexity of the anesthesia service. For example, for cataract anesthesia, the pre-anesthesia service is linked to a blend of CPT codes 99201 and 99202 and the post-anesthesia service is linked to CPT code 99211. The work values for each of these E/M codes did not change in this 5-Year Review of work. Conversely, for anesthesia for coronary bypass surgery, the pre-anesthesia service is linked to CPT code 99232 and the post-anesthesia service is linked to a blend of CPT codes 99231 and 99232. The work value for each of these E/M services increased in this 5-Year Review of work. Thus, in the June 29, 2006 proposed notice, we proposed to increase the work for E/M services in anesthesia for coronary bypass surgery but made no adjustment in the work for cataract anesthesia (71 FR 37237).

It is not clear how the pre- and post-anesthesia services of the non-surveyed anesthesia codes would be tied to the 19 surveyed codes and whether the work of the proposed linked E/M services are increased. We will look at this issue in context of any proposed changes that may be made to anesthesia work next year.

2. Discussion of Post-Operative Visits included in the Global Surgical Packages

We have established a national definition for a global surgical package so that payment is made consistently for the same set of services across all contractor jurisdictions. In constructing the RVUs for a global surgery service, all services that are believed to be typically included in the defined global period are built into the final resource-based RVUs and are not separately billable within the defined global period as reflected in the proposed work RVUs in Addenda B and C. This includes pre-surgery work, the intra-service time of actually furnishing the surgical procedure, and the post-operative (follow-up) visits associated with the monitoring and recovery of the patient.

As stated above in this section, we proposed to apply the RUC-recommended new values for the E/M services to all surgical services with a 10-or 90-day global period. However, because of variations in the patient population and in practice patterns, there is some question whether the assumptions about the number and level of visits within the global period reflect the actual post-operative work furnished. Some surgeons have commented that they furnish more visits than are included in the global period for their services. It is also likely that some patients require fewer than the "typical" number of follow-up visits included in the global period.

Although we are not proposing any changes to our global policy at this time, we solicited comments concerning our current policy of including these post-operative visits in the global surgical packages and what advantages or disadvantages might be associated with proposing a change to this policy in the future.

We received several comments concerning incorporating the new E/M values into all surgical services with a 10- or 90-day global period. With respect to our request for comments concerning our current policy of including these post-operative visits in the global surgical packages, we also received many suggestions. These comments and suggestions are addressed in this section.

Comment: Many commenters, including specialties representing primary care physicians and surgeons, as well as the RUC, supported the incorporation of the revised E/M work RVUs into the surgical global periods for each CPT code with a global of 010 and 090 as recommended by the RUC. Commenters, including the RUC, noted that we may have incorrectly implemented the RUC recommendation. They indicated that in implementing this proposal, we used discounted work RVUs, developed for pricing post services under the first 5-Year Review, rather than the undiscounted work RVUs that reflect the actual RVUs accepted by us for the E/M services. This resulted in incorrect, and lower, work RVUs being added to all of the services with post-operative visits in the 010 and 090 global periods and was contrary to the RUC recommendation that the full increase of the E/M be incorporated. The RUC requested that we review the calculations and implement the correct work RVUs for all procedures that have a 010 and 090 global period to reflect their recommendation. Other commenters stated that we should verify the accuracy of the data to ensure that the values, as recommended by the RUC, are appropriately implemented.

A few commenters also suggested that, should changes be made to the valuation of the E/M services, these changes would need to be carried through to the global package revisions.

Response: We have discussed this issue with the RUC and will ensure that the correct undiscounted values are incorporated.

Comment: MedPAC stated that in comparison to other payment systems, the unit of payment under the PFS is very narrow and consists of many discrete services. MedPAC reiterated its longstanding concern that such a unit of payment might give physicians a financial incentive to increase payments by increasing the volume of services, which could lead to unnecessary services being provided. Therefore, in the absence of information suggesting that access to appropriate care is being compromised, MedPAC supports the current concept of packaging/bundling these services to encourage efficient and appropriate care. Several commenters representing surgical specialties agreed with this position, and additionally one commenter stated that such a change might also increase the risk of "fee splitting." The commenter also supports the expansion of the global concept into disease management.

Other commenters suggested that we drop the global surgical model and replace this concept with a system that measures the actual amount of post-service work included in these global surgical services. Commenters suggested that this would "level" the playing field for documentation requirements and be less detrimental to "centers for excellence" which usually provide more care than is currently included within the global period. Commenters also suggested there are additional advantages to eliminating the global surgical model including the valuation of services being straightforward, the reduction of errors in PE valuation, and the facilitation of research, quality improvement and utilization tracking. However, there would be an associated increase in the volume of claims to be processed.

One commenter suggested that we meet with stakeholders prior to implementing such a change, while another commenter urged us to conduct a study on impact of revising the global surgical concept.

Response: We appreciate these comments and suggestions and will consider these along with additional information as we continue to study this issue.

3. Budget Neutrality

As discussed in the June 29, 2006 proposed notice, section 1848(c)(2)(B)(ii) of the Act requires that increases or decreases in RVUs for a year may not cause the amount of expenditures for the year to differ by more than $20 million from what expenditures would have been in the absence of these changes. If this threshold is exceeded, we must make adjustments to preserve budget neutrality (BN). This year, we expected that BN adjustments would be required as a result of changes in RVUs resulting from the 5-Year Review. We considered making the statutorily required BN adjustments (under section 1848(c)(2)(B)(ii)(II) of the Act) to account for the 5-Year Review of physician work by reducing all work RVUs. We estimated that all work RVUs would have to have been reduced by 10 percent under this option. Alternatively, we considered making an adjustment to the PFS CF to meet the provisions of section 1848(c)(2)(B)(ii)(II) of the Act. This option would have required an estimated 5 percent reduction to the CF. We also noted that the application of the BN adjustments to the CF would negatively impact all PFS services; whereas the application of the BN adjustment to the work RVUs would impact only those services that have physician work RVUs. Because the need for BN adjustment would be largely due to changes proposed as a result of the 5-Year Review of work RVUs, we believed it was more equitable to apply the adjustment across services that have work RVUs. We proposed to establish a BN adjustor that would reduce all work RVUs by an estimated 10 percent to meet the BN provisions of section 1848(c)(2)(B)(ii)(II) of the Act.

Comment: We received numerous comments on this issue. Many of the commenters were opposed to our proposal and requested that the adjustment be made to the CF for the following reasons:

(1) Applying the BN adjustor to all work RVUs has been problematic in the past.

(2) By imposing the full burden of BN on the pool of work values, we would be significantly mitigating the improved accuracy of the values that have now been assigned to E/M services.

(3) This approach obfuscates the recommended changes of the RUC and could potentially have an inappropriate effect on relativity.

(4) The application of a separate work adjustor is not consistent with our goal of cost transparency and may adversely affect payments by non-Medicare payers.

These commenters, which include the AMA, the RUC, and the AMA-HCPAC, asserted that applying the BN adjustor to the work RVUs is contrary to our longstanding policy. In addition, they do not believe that we provided an adequate rationale for shifting to this new approach, which we have previously stated is neither appropriate, nor effective. These associations noted that when in the past we applied a BN adjustor to the work RVUs, it caused considerable confusion among many non-Medicare payers, as well as physician practices that use the Medicare relative values as efficiency measures, and that the constant fluctuations in the work RVUs due to BN adjustments impeded the process of establishing work RVUs for new and revised services.

In addition to these objections, numerous specialty societies, organizations, groups, and providers also indicated that an adjustment to the CF is preferable because it would recognize that BN is mandated for monetary reasons. Thus, the CF, as the monetary multiplier in the Medicare payment formula, is the most appropriate place to adjust for BN.

A number of commenters, including representatives of some radiology and oncology providers, were supportive of our proposal because it fairly applies the required BN adjustment to the portion of the fee schedule that was the subject of review.

A few commenters also stated that although the BN adjustment methodology set forth in the June 29, 2006 proposed notice is not ideal, they believe that it is the best of the available alternatives under the circumstances (71 FR 37241). These commenters also believe that making all BN and scaling adjustments on a fee-schedule-wide basis would apparently result in unacceptable fee-schedule-wide reductions and is clearly inequitable for TC services. Another commenter urged us to delay the implementation of the BN adjustor for 1 year to allow more time to explore ways to increase recognition of E/M services without imposing such a financial hardship on select physician and nonphysician providers and to allow physicians and nonphysicians the opportunity to work with us to suggest alternative approaches.

Other commenters also discussed the interaction of the application of the BN adjustment and the DRA OPD cap on imaging services. As required by the DRA, reductions in imaging payments because of the OPD cap result in actual savings to the Medicare program (that is, they are not done in a budget neutral manner). The commenters note that if the BN is applied to the CF and not to the work RVUs, then the impact of the DRA cap on total Medicare spending is lower. This is because applying BN to the CF will narrow the payment differential between imaging services furnished in physicians' offices and hospital OPDs, and thus reduce the effect of the DRA cap on payments for imaging services.

Response: We appreciate the information presented by the commenters. We do not have the authority to delay implementing the BN adjustment and we must apply a BNF to offset the increases in work RVUs effective for 2007.

We are very appreciative of the work the RUC and the specialty societies have done in the past several years to prepare for this 5-Year Review. As a result of their dedication and analysis, the work RVUs are now more accurate and reflective of the time and resources associated with them. We do not believe that applying the BN on the work RVUs would undermine or diminish the RUC or specialty societies' contributions or the resulting improvements.

Section 1848(c)(2)(B)(ii)(II) of the Act requires a BN adjustment. Regardless of whether the BN is achieved by applying an adjustment factor to the work RVUs, as we proposed in the proposed rule, or the CF, which is the preferred option of many of the commenters, the values associated with the work ultimately will be decreased. Therefore, we do not agree with the commenters' suggestions that applying the BN to the work RVUs would do the system a great harm. Specifically, we disagree that it would significantly reverse the improved accuracy of the values that have now been assigned to E/M services. Further, we do not think that this approach would distort the relativity of the RVUs. Because such an adjustment is uniformly applied to all the work RVUs, it does not alter the relationship among them.

We also note that this rule finalizes a change in the PE methodology. Changes to the PE RVUs are being budget neutralized within those PE RVUs. Applying BN adjustments at this time, within each set of RVUs, maintains equity and helps to ensure that the weights between work, PE and malpractice are consistent with the weighting used in the MEI.

Therefore, for the reasons discussed above in this section, we will be applying the statutorily-required BN adjustment to the work RVUs as proposed in the proposed rule. We note that we previously applied a separate adjustor to the work RVUs following the first 5-Year Review of physician work in 1997. We understand that many commenters would find it preferable for us to make the required BN adjustment to the CF. However, we believe the best and most equitable approach to applying BN for this 5-Year Review of work is to adjust the work RVUs for 2007 using a separate adjustor for those RVUs. Achieving BN by adjusting the CF would have the effect of reducing payment for all services on the fee schedule. This would include reductions to RVUs for a number of services that have no physician work and were, therefore, outside the scope of the 5-Year Review. We believe it would be unfair, given the significant negative update to the CF this year, to impose additional reducations resulting from the BN adjustment on codes that have no work values associated with them.

We share the commenters' concerns about transparency and recognize the Medicare PFS is used by other payors and for other purposes than just Medicare payments. To maintain a high level of transparency in the fee schedule, the Addendum B published in this rule will show the RVUs without the BN adjustment applied. This will serve as a reference for any interested party and should help to minimize any confusion about the unadjusted codes. There also is a discussion of the BN work adjustor and the payment formula for 2007 included in the section IX. of this final rule with comment period, "Anesthesia and Physician Fee Schedule Conversion Factors for 2007." Payment for services will be calculated as follows:

Payment = [(RVU work × BN adjustor × GPCI work) + (RVU PE × GPCI PE) + (RVU malpractice × GPCI malpractice)] × CF.

We appreciate the commenters pointing out to us that the approach used in applying BN has an interactive effect with the DRA imaging OPD cap and has an effect on the total Medicare spending on physicians' services. However, as previously described in this section, we continue to believe the most equitable way to adjust for changes in the work RVUs resulting from the 5-Year Review is to apply a BN adjuster to work RVU.

Comment: Some commenters suggested that applying the BN adjustment to the CF could also be applied to the PE BN application, but only after we have addressed all of the RUC's recommendations related to the methodology and the PE relativity is stable. Ultimately, however, PEs for individual services should be evaluated under a 5-Year Review, at which point a similar application for BN to the CF could be appropriate.

Response: We appreciate and will consider these suggestions as we proceed with the implementation of the revised PE methodology.

4. Review Process

Comment: MedPAC and several specialties, as well as the RUC, commented on the process used for the 5-Year Review, including the methodology and data sources used in the review process. MedPAC stated that it continues to have concerns that overvalued services are ignored and referenced the MedPAC March 2006 Report to Congress. In this report, it recommended the creation of a standing panel to-

• Assist in identifying misvalued services;

• Establish a process for analyzing data to ensure automatic review of new services after a certain period; and

• Periodically review all services.

Several specialty societies expressed support for the existing RUC methodologies for estimating intensity, but also supported the use of objective data from large clinical databases and urged us not to discount the use of alternative data sources.

Response: As indicated earlier in this section, we believe that it will be necessary for the RUC and the specialty societies to join us in further dialog concerning the role of alternative databases. There are still many questions that need to be fully explored including: what should the criteria be for the acceptance of a given database; can databases take the place of surveys; can IWPUT be used to create work RVUs, rather than just to validate them; is there a linear relationship between survey respondents' estimate of work and time; and, can survey respondents accurately estimate IWPUTs. We are also continuing to examine how best to identify misvalued services. As part of this initiative, the RUC has indicated that it has established a subcommittee to suggest approaches to identifying overvalued services and the RUC's Research Subcommittee has initiated discussion regarding existing time data and indicated its willingness to consider issues related to any other concerns that we and the specialty societies wish to address regarding the use of databases in the valuation of physician work. We look forward to working with these groups and will carefully evaluate suggestions and recommendations that are provided.

V. Refinement of Relative Value Units for Calendar Year 2007 and Response to Public Comments on Interim Relative Value Units for 2006

[If you choose to comment on issues in this section, please include the caption "Interim Relative Value Units" at the beginning of your comments.]

A. Summary of Issues Discussed Related to the Adjustment of Relative Value Units

Section V.B. and V.C. of this final rule with comment describes the methodology used to review the comments received on the RVUs for physician work and the process used to establish RVUs for new and revised CPT codes. Changes to codes on the PFS reflected in Addendum B are effective for services furnished beginning January 1, 2007

B. Process for Establishing Work Relative Value Units for the 2006 Physician Fee Schedule

The CY 2006 PFS final rule with comment period (70 FR 70116) contained the work RVUs for Medicare payment for existing procedure codes under the PFS and interim RVUs for new and revised codes beginning January 1, 2006. We considered the RVUs for the interim codes to be subject to public comment under the annual refinement process. In this section, we summarize the refinements to the interim work RVUs published in the CY 2006 PFS final rule with comment period and our establishment of the work RVUs for new and revised codes for the CY 2007 PFS.

C. Work Relative Value Unit Refinements of Interim Relative Value Units

1. Methodology (Includes Table titled "2006 Interim Work Relative Value Units for Codes Reviewed Under the Refinement Panel Process ")

Although the RVUs in the CY 2006 PFS final rule with comment period were used to calculate 2006 payment amounts, we considered the RVUs for the new or revised codes to be interim. We accepted comments for a period of 60 days. We received substantive comments for 7 CPT codes with interim work RVUs.

To evaluate these comments, we used a process similar to the process used since 1997. ( See the CY 1998 PFS final rule published in the October 31, 1997 Federal Register (62 FR 59084) for the discussion of refinement of CPT codes with interim work RVUs.) We convened a multi-specialty panel of physicians to assist us in the review of the comments. The comments that we did not submit to panel review are discussed at the end of this section, as well as those that were reviewed by the panel, which are contained in Table 14, 2006 Interim Work Relative Value Units for Codes Reviewed Under the Refinement Panel Process. We invited representatives from the organizations from which we received substantive comments to attend a panel for discussion of the code on which they had commented. The panel was moderated by our medical staff, and consisted of the following voting members:

• Clinicians representing the commenting specialty(ies), based on our determination of those specialties which are most identified with the services in question. Although commenting specialties were welcomed to observe the entire refinement process, they were only involved in the discussion of those services for which they were invited to participate.

• Primary care clinicians nominated by the AAFP and the American College of Physicians.

• Four carrier medical directors.

• One or two clinicians who practice in related specialties and have knowledge of the services under review.

The panel discussed the work involved in the procedure under review in comparison to the work associated with other services under the PFS. We assembled a set of reference services and asked the panel members to compare the clinical aspects of the work for the service a commenter believed was incorrectly valued to one or more of the reference services. In compiling the reference set, we attempted to include: (1) Services that are commonly furnished for which work RVUs are not controversial; (2) services that span the entire spectrum of work intensity from the easiest to the most difficult; and (3) at least three services furnished by each of the major specialties so that each specialty would be represented. The intent of the panel process was to capture each participant's independent judgment based on the discussion and his or her clinical experience. Following the discussion for each service, each participant rated the work for that procedure. Ratings were individual and confidential; there was no attempt to achieve consensus among the panel members.

We then analyzed the ratings based on a presumption that the interim RVUs were correct. To overcome that presumption, the inaccuracy of the interim RVUs had to be apparent to the broad range of physicians participating in each panel.

Ratings of work were analyzed for consistency among the groups represented on each panel. In general terms, we used statistical tests to determine whether there was enough agreement among the groups on the panel and, if so, whether the agreed-upon RVUs were significantly different from the interim RVUs published in Addendum C of the CY 2006 PFS final rule with comment to demonstrate that the interim RVUs should be modified. We did not modify the RVUs unless there was a clear indication for a change. If there was agreement across groups for change, but the groups did not agree on what the new RVUs should be, we eliminated the outlier group, and looked for agreement among the remaining groups as to the basis for new RVUs. We used the same methodology in analyzing the ratings that we first used in the refinement process for the CY 1993 PFS final rule published in the November 25, 1992 Federal Register which described the statistical tests in detail (57 FR 55938). Our decision to convene a multi-specialty panel of physicians and to apply the statistical tests described above in this section was based on our need to balance the interests of those who commented on the work RVUs against the redistributive effects that would occur in other specialties.

Table 14 lists those interim codes reviewed under the refinement panel process described in this section. This table includes the following information:

• CPT Code. This is the CPT code for a service.

• Description. This is an abbreviated version of the narrative description of the code.

• 2006 Work RVU. The work RVUs that appeared in the CY 2006 final rule are shown for each reviewed code.

• Requested Work RVU. This column identifies the work RVUs requested by commenters.

• 2007 Work RVU. This column contains the final RVUs for physician work as a result of the multi-specialty panel ( Note: Values for 10- and 90-day global period codes do not reflect E/M increases. Increases due to E/M changes are reflected in Addenda B.)

CPT code1 Mod Descriptor 2006 Interim work RVU Requested work RVU 2007 work RVU2
22523 PERCUT KYPHOPLASTY, THOR 8.94 8.94 8.94
22524 PERCUT KYPHOPLASTY, LUMBAR 8.54 8.54 8.54
22525 PERCUT KYPHOPLASTY, ADD-ON 4.47 4.67 4.47
88334 INTRAOP CYTO PATH CONSULT 2 0.59 0.80 0.73
95251 GLUC MONITOR, CONT, PHYS IR 0.52 0.85 0.85
1 All CPT codes and descriptions copyright 2005 AMA. All rights reserved and applicable FARS/DFARS clauses apply.
2 Values for 10- and 90-day global period codes do not reflect E/M increases. Increases due to E/M changes are reflected in Addendum B.

2. Interim 2006 Codes

For CPT code 22523, Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device, one vertebral body, unilateral or bilateral cannulation ( e.g. , kyphoplasty); thoracic; CPT code 22524, Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device, one vertebral body, unilateral or bilateral cannulation ( e.g. , kyphoplasty); lumbar; and CPT code 22525, Percutaneous vertebral augmentation, including cavity creation (fracture reduction and bone biopsy included when performed) using mechanical device, one vertebral body, unilateral or bilateral cannulation ( e.g. kyphoplasty); each additional thoracic or lumbar vertebral body (List separately in addition to code for primary procedure), the RUC recommended 8.94 work RVUs for CPT code 22523, 8.54 work RVUs for CPT code 22524 and 4.47 work RVUs for CPT code 22525, which we accepted.

Comment: Commenters disagreed with the RUC-recommended work values for these services, which we had accepted. The commenters believed that the recommended values were primarily based on a comparison to vertobroplasty services and did not reflect important data that is associated with kyphoplasty procedures. Based on these comments, we referred these codes to the multi-specialty validation panel for review.

Response: As a result of the statistical analysis of the 2006 multi-specialty validation panel ratings, we have assigned 8.94 work RVUs to CPT code 22523, 8.54 work RVUs to CPT code 22524 and 4.47 work RVUs to CPT code 22525.

For CPT code 88334, Pathology consultation during surgery; cytologic examination ( e.g. , touch prep, squash prep), each additional site, the RUC recommended a work RVU of 0.80 for this service based on a comparison of this procedure to CPT code 88332, Pathology consultation during surgery; each additional tissue block, with frozen section(s). The RUC reviewed the specialty society's survey data and noted that the surveyed CPT code 88334, when compared to the reference CPT code 88332 has higher intensity/complexity measures (20 minutes) and an additional five minutes of intra-service time (15 minutes). Although CPT code 88334 has an additional 5 minutes of intra-service time, we believed that CPT code 88334 is very similar in work to CPT code 88332, and therefore, should be valued the same. We assigned 0.59 work RVUs to CPT code 88334.

Comment: Commenters did not agree with our comparison of CPT code 88334 to 88332, as there is increased work mainly vested on the necessity to examine every field under 10X magnification in CPT code 88334, which is not inherent in the frozen section process represented by CPT code 88332. Based on these comments, we referred this code to the multi-specialty validation panel for review.

Response: As a result of the statistical analysis of the 2006 multi-specialty validation panel ratings, we have assigned 0.73 work RVUs to CPT code 88334.

For CPT code 95251, Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for up to 72 hours; physician interpretation and report, the RUC recommended a work RVU of 0.85 for this service. We disagree with the RUC's recommendation because we believe the work for this service is similar to CPT code 93268, Patient demand single or multiple event recording with presymptom memory loop, 24-hour attended monitoring, per 30-day period of time; includes transmission, physician review and interpretation, which involves the review of data over a 30-day period. Therefore, we assigned 0.52 work RVUs to 95251.

Comment: Commenters disagreed with our comparison of CPT code 95251 to 93268, as they believe the amount and complexity of the data that needs to be reviewed for CPT code 95251 is considerable. Based on these comments, we referred this code to the multi-specialty validation panel for review.

Response: As a result of the statistical analysis of the 2006 multi-specialty validation panel ratings, we have assigned 0.85 work RVUs to CPT code 95251.

For CPT code 61630, Balloon angioplasty, intracranial (e.g., atherosclerotic stenosis), percutaneous ; CPT code 61635, Transcatheter placement of intravascular stent(s), intracranial (e.g., athersosclerotic stenosis), including balloon angioplasty if performed ; CPT code 61640, Balloon dilatation of intracranial vasospasm, percutaneous, initial vessel ; CPT code 61641, Balloon dilatation of intracranial vasospasm, percutaneous, initial vessel; each additional vessel in same vascular family ; and CPT code 61642, Balloon dilatation of intracranial vasospasm, percutaneous, initial vessel; each additional vessel in different vascular family , the RUC recommended 21.08 work RVUs for CPT code 61630, 23.08 work RVUs for CPT code 61635, 12.32 work RVUs for CPT code 61640, 4.33 work RVUs for CPT code 61641 and 8.66 work RVUs for CPT code 61642. We assigned a status indicator of N for these services because they are noncovered under Medicare due to a National Coverage Decision (NCD).

Comment: Commenters questioned the assignment of the status indicator of N for these services. Commenters also requested that the RVUS be published for these services. ( Note: In the correction notice that appeared in the February 24, 2006 Federal Register (71 FR 9458), RVUs were published for CPT codes 61630 and 61635.)

Response: Based on an NCD regarding the non-coverage of performance of percutaneous transluminal angioplasty to treat obstructive lesions of the vertebral and cerebral arteries we will maintain the status indicator of N for these services. ( Note: The RUC-recommended RVUs for these codes will be reflected in Addendum B.)

For CPT codes 98960, Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; individual patient; CPT code 98961, Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 2-4 patients ; and CPT code 98962, Education and training for patient self-management by a qualified, nonphysician health care professional using a standardized curriculum, face-to-face with the patient (could include caregiver/family) each 30 minutes; 5-8 patients , a status indicator of N was erroneously assigned for these services in the CY 2006 PFS final rule published in the November 21, 2005 Federal Register (70 FR 70282). The status indicator was corrected to B in the correction notice that appeared in the February 24, 2006 Federal Register (71 FR 9458).

Comment: Commenters questioned the assigned status indicator of N for these services and urged acceptance of the RVUs, as physician education is a service covered under Medicare Part B and, as one commenter indicated, included and reported in an E/M code. However, the commenter stated that the E/M service that we might believe is appropriate (CPT code 99211) is not sufficient for the amount of time and work described by these services. Other commenters requested that the RUC-assigned RVUs be published, even if they are not used for Medicare payment, as other payers use the PFS to establish payment.

Response: As stated above in this section, the status indicator for these codes was corrected to a status indicator of B in the correction notice that appeared in the February 24, 2006 Federal Register (71 FR 9458). We believe these services are bundled into E/M services. Other than the diabetic education services (CPT codes G0108 and G0109) specified by the Congress, we do not cover separate education services outside of demonstrations or the Medicare Health Support program. For diabetic education services, CPT codes G0108 and G0109 should be used to bill for these services. CPT codes 98960-98962 will not be recognized as separate services for diabetic education. Additional information on the DSMT benefit is available in § 410.140 through § 410.146, and on our Web site at http://www.cms.hhs.gov/DiabetesSelfManagement/ . We are available to discuss certification requirements with interested providers. As requested by the commenters, we have published the RUC-assigned RVUs for these codes.

For CPT code 99143, Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status, under 5 years of age; first 30 minutes intra-service time , CPT code 99144, Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status, age 5 years or older; first 30 minutes intra-service time , CPT code 99145, Moderate sedation services (other than those services described by codes 00100-01999) provided by the same physician performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status, age 5 years or older; each additional 15 minutes intra-service time , CPT code 99148, Moderate sedation services (other than those services described by codes 00100-01999) provided by a physician other than the health care professional performing the diagnostic or therapeutic service that the sedation supports, under 5 years of age; first 30 minutes intra-service time , CPT code 99149, Moderate sedation services (other than those services described by codes 00100-01999) provided by a physician other than the health care professional performing the diagnostic or therapeutic service that the sedation supports, age 5 years or older; first 30 minutes intra-service time , and CPT code 99150, Moderate sedation services (other than those services described by codes 00100-01999) provided by a physician other than the health care professional performing the diagnostic or therapeutic service that the sedation supports, each additional 15 minutes intra-service time , the CPT Editorial Panel created six new codes to accurately report 2 separate families of moderate sedation. One family describes the provision of moderate sedation services by the physician who is performing the diagnostic or therapeutic service and supervising an independent trained observer while the other family describes moderate sedation services performed by a physician (other than an anesthesiologist) other than the physician performing a diagnostic or therapeutic service. These new codes replace CPT code 99141, Sedation with or without analgesia (conscious sedation); intravenous, intra-muscular or inhalation , and CPT code 99142, Sedation with or without analgesia (conscious sedation); oral, rectal and/or intranasal , which were bundled under the PFS. The RUC recommended 0.70 work RVUs for CPT code 99143, 0.66 work RVUs for CPT code 99144, 0.23 work RVUs for CPT code 99145, 1.75 work RVUs for CPT code 99148, 1.65 work RVUs for CPT code 99149 and 0.47 work RVUs for CPT code 99150. We questioned whether the RUC-assigned values are appropriate and carrier priced these codes in order to gather information for utilization and proper pricing.

Comment: Commenters requested that the RUC-recommended value for these services be accepted as these values were based on valid surveys and vetted through the RUC process. The RUC also indicated it would be happy to provide any additional information that would address any concerns we might have.

Response: We will maintain carrier pricing of these codes and will continue to monitor utilization.

Comment: Commenters requested that we publish the RVUs for noncovered services for which we receive RUC recommendations.

Response: In response to comments, we have published the RVUs for noncovered services for which we received RUC recommendations (with the exception of carrier-priced codes).

In the CY 2006 PFS final rule with comment period (70 FR 66370), we also responded to the RUC recommendations on the PE inputs for the new and revised CPT codes for 2006. We received the following comments:

Comment: Although we assigned non-facility PE inputs based on information provided by the RUC for CPT code 28890, Extracorporeal shock wave, high energy, performed by a physician, requiring anesthesia other than local, including ultrasound guidance, involving the plantar fascia , one commenter expressed concern that the PE RVUs are not sufficient to cover the actual costs associated with the performance of this procedure in the office setting. The commenter acknowledged that a single payment scheme for the purchase or rental of the equipment associated with its service does not exist and believes the expense to be higher than what was represented in the PE database. The commenter indicated that a "technical fee" is frequently paid when the procedure is performed in the office setting. The costs associated with this "technical fee" can include: The shock wave equipment, a specialized transport truck, a service contract with the manufacturer, salary/benefits for technologist and the transport driver, medical director fee, anesthesia fee, supplies and training material, malpractice and liability insurance, and fuel cost.

Response: Under the PFS, the PE component is based on the resources used to furnish each service and, for CPT code 28890, consists of a total of 133 minutes of clinical labor, disposable supplies, including the necessary items to provide the regional anesthetic block, and equipment over $500, including the "shock-wave" machine. The PE methodology utilizes the price of equipment (as if the physician owned it) and considers the time used for performing the procedure (36 minutes). Costs of leasing arrangements or per use fees are not recognized in our PE methodology. Therefore, we are maintaining the direct PE inputs for this service (except as discussed previously in this rule) because they are consistent with the typical clinical labor, supplies, and equipment needed to provide this service in the physician's office.

Comment: We received three comments concerning the PE inputs for CPT codes 36475, Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency, first vein treated , and 36476, Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency, second and subsequent veins treated in a single extremity, each through separate access sites (List separately in addition to code for primary location) . Two comenters supported our proposal to add the tilt table for these services and also suggested the tilt table be added to CPT codes 36478 and 36479-the entire endovenous family. One commenter requested that 15 minutes of clinical labor time be added to CPT codes 36475 and 36476. However, the commenters disagreed with the addition of 15 minutes of clinical labor time to CPT codes 36475 and 36476, indicating that the description of the physician work for these codes states that, when needed, the physician places the patient in the required position. One of these commenters indicated that this was also to be addressed at the February 2006 RUC meeting.

Response: At the February 2006 RUC meeting, the PERC recommended the addition of the tilt table to the family of CPT codes, 36475, 36476, 36478 and 36479. However, the PERC did not accept the additional clinical labor time. The tilt table was added to the PE database for these CPT codes, in concert with the PERC recommendations for CY 2007, and the PE RVUs in Addendum B reflect these changes.

D. Establishment of Interim Work Relative Value Units for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System Codes (HCPCS) for 2007 (Includes Table titled "American Medical Association Specialty Relative Value Update Committee and Health Care Professionals Advisory Committee Recommendations and CMS's Decisions for New and Revised 2007 CPT Codes")

One aspect of establishing RVUs for 2007 was to assign interim work RVUs for all new and revised CPT codes. As described in our November 25, 1992 notice on the 1993 PFS (57 FR 55951) and in section III.B. of the CY 1997 PFS final rule (61 FR 59505), we established a process, based on recommendations received from the AMA's RUC, for establishing interim work RVUs for new and revised codes.

This year we received work RVU recommendations for 230 new and revised CPT codes from the RUC. Of the 230 codes, 56 were modified by editorial changes, 57 were renumbered and the work RVUs associated with these services were assigned to the new codes (not included in Table 15), and 1 code was renumbered and assigned a new work RVU (included in Table 15). Our staff and medical officers reviewed the RUC recommendations by comparing them to our reference set or to other comparable services for which work RVUs had previously been established. We also considered the relationships among the new and revised codes for which we received RUC recommendations and agreed with the majority of the relative relationships reflected in the RUC values. In some instances, although we agreed with the relationships, we nonetheless revised the work RVUs to achieve work neutrality within families of codes. That is, the work RVUs were adjusted so that the sum of the new or revised work RVUs (weighted by projected frequency of use) for a family will be the same as the sum of the current work RVUs (weighted by projected frequency of use) for the family of codes. We reviewed all the RUC recommendations and accepted approximately 98 percent of the RUC-recommended values.

We received one recommendation from the Health Care Professional Advisory Committee (HCPAC), which we accepted.

Table 15, titled "AMA RUC and HCPAC Recommendations and CMS Decisions for New and Revised 2007 CPT Codes," lists the new or revised CPT codes, and their associated work RVUs, that will be interim in 2007. This table includes the following information:

• A "#" identifies a new code for 2007.

• CPT code. This is the CPT code for a service.

• Modifier. A "26" in this column indicates that the work RVUs are for the PC of the code.

• Description. This is an abbreviated version of the narrative description of the code.

• RUC recommendations. This column identifies the work RVUs recommended by the RUC.

• HCPAC recommendations. This column identifies the work RVUs recommended by the HCPAC.

• CMS decision. This column indicates whether we agreed or we disagreed with the RUC recommendation. Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table.

• 2007 Work RVUs. This column establishes the interim 2007 work RVUs for physician work. ( Note: Values for 10- and 90-day global period codes reflect E/M increases from the 5-Year Review.)

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.010" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.011" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.012" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

Table 16, which is titled "AMA RUC Anesthesia Recommendations and CMS Decisions for New and Revised 2007 CPT Codes," lists the new or revised CPT codes for anesthesia and their base units that will be interim in 2007. This table includes the following information:

• CPT code. This is the CPT code for a service.

• Description. This is an abbreviated version of the narrative description of the code.

• RUC recommendations. This column identifies the base units recommended by the RUC.

• CMS decision. This column indicates whether we agreed or we disagreed with the RUC recommendation. Codes for which we did not accept the RUC recommendation are discussed in greater detail following this table.

• 2007 Base Units. This column establishes the 2007 base units for these services.

*CPT code Description RUC recommendation CMS decision 2007 base units
#00625 ANES SPINE TRANTHOR W/O VENT 13.00 Agree 13.00
#00626 ANES, SPINE TRANSTHOR W/VENT 13.00 Agree 15.00
* All CPT codes copyright 2006 AMA.
# New CPT code.

E. Discussion of Codes for Which There Were no RUC Recommendations or for Which the RUC Recommendations Were Not Accepted

The following is a summary of our rationale for not accepting particular RUC work RVUs. It is arranged by type of service in CPT order. This summary refers only to work RVUs.

For CPT code 22857, Total disc arthroplasty (artificial disc), anterior approach, including diskectomy to prepare interspace (other than for decompression), lumbar, single interspace ; CPT code 22862, Revision including replacement of total disc arthroplasty (artificial disc) anterior approach, lumbar, single interspace (includes approach) ; and CPT code 22865, Removal of total disc arthroplasty (artificial disc), anterior approach, lumbar, single interspace , the RUC recommended 25.07 work RVUs for CPT code 22857, 30.57 work RVUs for CPT code 22862 and 29.57 work RVUs for CPT code 22865. We are assigning a status indicator of R (Restricted) to these services due to an NCD for non-coverage of Lumbar Artificial Disc Replacement with the Charite TM lumbar artificial disc for patients over the age of 60.

For CPT code 94005, Home ventilator management care plan oversight of a patient (patient not present) in home, domiciliary or rest home (e.g., assisted living) requiring review of status, review of laboratories and other studies and revision of orders and respiratory care plan (as appropriate), within a calendar month, 30 minutes or more , the RUC-recommended 1.50 work RVUs for this code. We are assigning a status indicator of B (Bundled) to this service because: (1) The patient is not present when this service is rendered and (2) we believe this service is captured in E/M services. ( Note: The RUC-recommended RVUs for this code will be reflected in Addendum B.)

For CPT code 96040, Medical genetics and genetic counseling services, each 30 minutes face-to-face with patient/family , this procedure does not have any physician work and to the extent that these services are covered, we consider them bundled into E/M services and have assigned as status indicator of B. ( Note: The RUC-recommended RVUs for this code will be reflected in Addendum B.)

For CPT code 96904, Whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syndrome or a history of dysplastic nevi, or patients with a personal or familial history of melanoma , this procedure does not have any physician work. We have assigned a status indicator of R (Restricted) to this service, and will only recognize this code when services are performed on patients with melanoma and not when services are performed for screening based on family history (because we did not cover screenings). We will implement edits for situations involving patients with melanoma and/or dysplastic nevus syndrome.

For CPT code 99363, Anticoagulant management for an outpatient taking warfarin, physician review and interpretation of International Normalized Ratio (INR) testing, patient instructions, dosage adjustment (as needed), and ordering of additional tests; initial 90 days of therapy (must include a minimum of 8 INR measurements ; and CPT code 99364, Anticoagulant management for a patient taking warfarin, physician review and interpretation of International Normalized Ratio (INR) testing, patient instructions, dosage adjustment (as needed), and ordering of additional tests; each subsequent 90 days of therapy (must include a minimum of three INR measurements) , the RUC recommended 1.65 work RVUs for CPT code 99363 and 0.63 work RVUs for CPT code 99364. We believe these services are bundled into E/M services and have assigned a status indicator of B to these codes. ( Note: The RUC-recommended RVUs for these codes will be reflected in Addendum B.)

F. Additional Pricing Issue

We are carrier-pricing the global and TC for the codes listed in Table 17. The TC is not paid in the facility setting under the PFS and the RUC did not forward recommendations in the non-facility setting because these services are performed infrequently, if at all in the non-facility setting. Work RVUs will continue to be used to establish payment for the PC.

CPT code * Mod Short descriptor Status indicator
70170 X-RAY EXAM OF TEAR DUCT Carrier Priced.
70170 TC X-RAY EXAM OF TEAR DUCT Carrier Priced.
70555 FMRI BRAIN BY PHYS/PSYCH Carrier Priced.
70555 TC FMRI BRAIN BY PHYS/PSYCH Carrier Priced.
71090 X-RAY EXAM OF EYE SOCKETS Carrier Priced.
71090 TC X-RAY EXAM OF EYE SOCKETS Carrier Priced.
73530 X-RAY EXAM OF HIP Carrier Priced.
73530 TC X-RAY EXAM OF HIP Carrier Priced.
74190 X-RAY EXAM OF PERITONEUM Carrier Priced.
74190 TC X-RAY EXAM OF PERITONEUM Carrier Priced.
74305 X-RAY BILE DUCTS/PANCREAS Carrier Priced.
74305 TC X-RAY BILE DUCTS/PANCREAS Carrier Priced.
74328 X-RAY BILE DUCT ENDOSCOPY Carrier Priced.
74328 TC X-RAY BILE DUCT ENDOSCOPY Carrier Priced.
74330 X-RAY BILE/PANC ENDOSCOPY Carrier Priced.
74330 TC X-RAY BILE/PANC ENDOSCOPY Carrier Priced.
74340 X-RAY GUIDE FOR GI TUBE Carrier Priced.
74340 TC X-RAY GUIDE FOR GI TUBE Carrier Priced.
74355 X-RAY GUIDE, INTESTINAL TUBE Carrier Priced.
74355 TC X-RAY GUIDE, INTESTINAL TUBE Carrier Priced.
74360 X-RAY GUIDE, GI DILATION Carrier Priced.
74360 TC X-RAY GUIDE, GI DILATION Carrier Priced.
74420 CONTRST X-RAY, URINARY TRACT Carrier Priced.
74420 TC CONTRST X-RAY, URINARY TRACT Carrier Priced.
74425 CONTRST X-RAY, URINARY TRACT Carrier Priced.
74425 TC CONTRST X-RAY, URINARY TRACT Carrier Priced.
74445 X-RAY EXAM OF PENIS Carrier Priced.
74445 TC X-RAY EXAM OF PENIS Carrier Priced.
74450 X-RAY, URETHRA/BLADDER Carrier Priced.
74450 TC X-RAY, URETHRA/BLADDER Carrier Priced.
74470 X-RAY EXAM OF KIDNEY LESION Carrier Priced.
74470 TC X-RAY EXAM OF KIDNEY LESION Carrier Priced.
74775 X-RAY EXAM OF PERINEUM Carrier Priced.
74775 TC X-RAY EXAM OF PERINEUM Carrier Priced.
75801 LYMPH VESSEL X-RAY, ARM/LEG Carrier Priced.
75801 TC LYMPH VESSEL X-RAY, ARM/LEG Carrier Priced.
75803 LYMPH VESSEL X-RAY, ARMS/LEGS Carrier Priced.
75803 TC LYMPH VESSEL X-RAY, ARMS/LEGS Carrier Priced.
75805 LYMPH VESSEL X-RAY, TRUNK Carrier Priced.
75805 TC LYMPH VESSEL X-RAY, TRUNK Carrier Priced.
75810 VEIN X-RAY, SPLEEN/LIVER Carrier Priced.
75810 TC VEIN X-RAY, SPLEEN/LIVER Carrier Priced.
75894 X-RAYS, TRANSCATH THERAPY Carrier Priced.
75894 TC X-RAYS, TRANSCATH THERAPY Carrier Priced.
75896 X-RAYS, TRANSCATH THERAPY Carrier Priced.
75896 TC X-RAYS, TRANSCATH THERAPY Carrier Priced.
75898 FOLLOW-UP ANGIOGRAPHY Carrier Priced.
75898 TC FOLLOW-UP ANGIOGRAPHY Carrier Priced.
75940 X-RAY PLACEMENT, VEIN FILTER Carrier Priced.
75940 TC X-RAY PLACEMENT, VEIN FILTER Carrier Priced.
75945 INTRAVASCULAR US Carrier Priced.
75945 TC INTRAVASCULAR US Carrier Priced.
75960 TRANSCATH IV STENT RS I Carrier Priced.
75960 TC TRANSCATH IV STENT RS I Carrier Priced.
75970 VASCULAR BIOPSY Carrier Priced.
75970 TC VASCULAR BIOPSY Carrier Priced.
75980 CONTRAST X-RAY EXAM BILE DUCT Carrier Priced.
75980 TC CONTRAST X-RAY EXAM BILE DUCT Carrier Priced.
75992 ATHERECTOMY, X-RAY EXAM Carrier Priced.
75992 TC ATHERECTOMY, X-RAY EXAM Carrier Priced.
76001 FLUOROSCOPE EXAM, EXTENSIVE Carrier Priced.
76001 TC FLUOROSCOPE EXAM, EXTENSIVE Carrier Priced.
76125 CINE/VIDEO X-RAYS ADD-ON Carrier Priced.
76125 TC CINE/VIDEO X-RAYS ADD-ON Carrier Priced.
76932 ECHO GUIDE FOR HEART BIOPSY Carrier Priced.
76932 TC ECHO GUIDE FOR HEART BIOPSY Carrier Priced.
76940 US GUIDE, TISSUE ABLATION Carrier Priced.
76940 TC US GUIDE, TISSUE ABLATION Carrier Priced.
76941 ECHO GUIDE FOR TRANSFUSION Carrier Priced.
76941 TC ECHO GUIDE FOR TRANSFUSION Carrier Priced.
76945 ECHO GUIDE, VILLUS SAMPLING Carrier Priced.
76945 TC ECHO GUIDE, VILLUS SAMPLING Carrier Priced.
76975 GI ENDOSCOPIC ULTRASOUND Carrier Priced.
76975 TC GI ENDOSCOPIC ULTRASOUND Carrier Priced.
76998 US GUIDE, INTRAOP Carrier Priced.
76998 TC US GUIDE, INTRAOP Carrier Priced.
77013 CT GUIDE FOR TISSUE ABLATION Carrier Priced.
77013 TC CT GUIDE FOR TISSUE ABLATION Carrier Priced.
77022 MRI FOR TISSUE ABLATION Carrier Priced.
77022 TC MRI FOR TISSUE ABLATION Carrier Priced.
92978 INTRAVASC US, HEART ADD-ON Carrier Priced.
92978 TC INTRAVASC US, HEART ADD-ON Carrier Priced.
92979 INTRAVASC US, HEART ADD-ON Carrier Priced.
92979 TC INTRAVASC US, HEART ADD-ON Carrier Priced.
93501 RIGHT HEART CATHETERIZATION Carrier Priced.
93501 TC RIGHT HEART CATHETERIZATION Carrier Priced.
93503 INSERT/PLACE HEART CATHETER Carrier Priced.
93505 BIOPSY OF HEART LINING Carrier Priced.
93505 TC BIOPSY OF HEART LINING Carrier Priced.
93508 CATH PLACEMENT, ANGIOGRAPHY Carrier Priced.
93508 TC CATH PLACEMENT, ANGIOGRAPHY Carrier Priced.
93510 LEFT HEART CATHETERIZATION Carrier Priced.
93510 TC LEFT HEART CATHETERIZATION Carrier Priced.
93511 LEFT HEART CATHETERIZATION Carrier Priced.
93511 TC LEFT HEART CATHETERIZATION Carrier Priced.
93524 LEFT HEART CATHETERIZATION Carrier Priced.
93524 TC LEFT HEART CATHETERIZATION Carrier Priced.
93526 RT LT HEART CATHETERS Carrier Priced.
93526 TC RT LT HEART CATHETERS Carrier Priced.
93527 RT LT HEART CATHETERS Carrier Priced.
93527 TC RT LT HEART CATHETERS Carrier Priced.
93528 RT LT HEART CATHETERS Carrier Priced.
93528 TC RT LT HEART CATHETERS Carrier Priced.
93529 RT, LT HEART CATHETERIZATION Carrier Priced.
93529 TC RT, LT HEART CATHETERIZATION Carrier Priced.
93530 RT HEART CATH, CONGENITAL Carrier Priced.
93530 TC RT HEART CATH, CONGENITAL Carrier Priced.
93531 R L HEART CATH, CONGENITAL Carrier Priced.
93531 TC R L HEART CATH, CONGENITAL Carrier Priced.
93539 INJECTION, CARDIAC CATH Carrier Priced.
93540 INJECTION, CARDIAC CATH Carrier Priced.
93541 INJECTION FOR LUNG ANGIOGRAM Carrier Priced.
93542 INJECTION FOR HEART X-RAYS Carrier Priced.
93543 INJECTION FOR HEART X-RAYS Carrier Priced.
93544 INJECTION FOR AORTOGRAPHY Carrier Priced.
93545 INJECT FOR CORONARY X-RAYS Carrier Priced.
93555 IMAGING, CARDIAC CATH Carrier Priced.
93555 TC IMAGING, CARDIAC CATH Carrier Priced.
93556 IMAGING, CARDIAC CATH Carrier Priced.
93556 TC IMAGING, CARDIAC CATH Carrier Priced.
93561 CARDIAC OUTPUT MEASUREMENT Carrier Priced.
93561 TC CARDIAC OUTPUT MEASUREMENT Carrier Priced.
93562 CARDIAC OUTPUT MEASUREMENT Carrier Priced.
93562 TC CARDIAC OUTPUT MEASUREMENT Carrier Priced.
93571 HEART FLOW RESERVE MEASURE Carrier Priced.
93571 TC HEART FLOW RESERVE MEASURE Carrier Priced.
93600 BUNDLE OF HIS RECORDING Carrier Priced.
93600 TC BUNDLE OF HIS RECORDING Carrier Priced.
93602 INTRA-ATRIAL RECORDING Carrier Priced.
93602 TC INTRA-ATRIAL RECORDING Carrier Priced.
93603 RIGHT VENTRICULAR RECORDING Carrier Priced.
93603 TC RIGHT VENTRICULAR RECORDING Carrier Priced.
93609 MAP TACHYCARDIA, ADD-ON Carrier Priced.
93609 TC MAP TACHYCARDIA, ADD-ON Carrier Priced.
93610 INTRA-ATRIAL PACING Carrier Priced.
93610 TC INTRA-ATRIAL PACING Carrier Priced.
93612 INTRAVENTRICULAR PACING Carrier Priced.
93612 TC INTRAVENTRICULAR PACING Carrier Priced.
93615 ESOPHAGEAL RECORDING Carrier Priced.
93615 TC ESOPHAGEAL RECORDING Carrier Priced.
93618 HEART RHYTHM PACING Carrier Priced.
93618 TC HEART RHYTHM PACING Carrier Priced.
93619 ELECTROPHYSIOLOGY EVALUATION Carrier Priced.
93619 TC ELECTROPHYSIOLOGY EVALUATION Carrier Priced.
93640 EVALUATION HEART DEVICE Carrier Priced.
93640 TC EVALUATION HEART DEVICE Carrier Priced.
93641 ELECTROPHYSIOLOGY EVALUATION Carrier Priced.
93641 TC ELECTROPHYSIOLOGY EVALUATION Carrier Priced.
96020 FUNCTIONAL BRAIN MAPPING Carrier Priced.
96020 TC FUNCTIONAL BRAIN MAPPING Carrier Priced.
* All CPT codes copyright 2006 AMA.

G. Establishment of Interim PE RVUs for New and Revised Physician's Current Procedural Terminology (CPT) Codes and New Healthcare Common Procedure Coding System (HCPCS) Codes for 2007

We have developed a process for establishing interim PE RVUs for new and revised codes that is similar to that used for work RVUs. Under this process, the RUC recommends the PE direct inputs (the staff time, supplies and equipment) associated with each new code. We then review the recommendations in a manner similar to our evaluation of the recommended work RVUs. The RUC recommendations on the PE inputs for the new and revised 2007 codes were submitted to us as interim recommendations.

We have accepted, in the interim, the PE recommendations submitted by the RUC for the codes listed in the table titled "AMA RUC and HCPAC RVU Recommendations and CMS Decisions for New and Revised 2007 CPT Codes" except as noted below in this section.

For CPT code 15731, Forehead flap with preservation of vascular pedicle ( e.g., axial pattern flap, parmedian forehead flap ); and CPT code 15830, Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy , we assigned 5 minutes for each post-operative visit for the digital camera used in the post-operative visits, rather than the entire clinical labor time for each post-operative period.

For CPT code 22527, Percutaneous intradiscal electrothermal annuloplasty, unilateral or bilateral including fluoroscopic guidance; one or more additional levels (List separately in addition to code for primary procedure , we deleted the ambulatory blood pressure monitor because it duplicates the function of the 3-channel ECG machine.

For CPT code 55876, Placement of interstitial device(s) for radiation guidance ( e.g., fiducial markers, dosimeter), prostate (via needle, any approach), single or multiple , we deleted one package of gold markers (contains 3 markers each) because we believe that the typical number of gold markers used in this procedure is 2 or 3 and we entered an interim price of $119 per 3-pack. We are asking the specialty to provide us with: (a) Verification of the typical number of gold markers used in this procedure; and (b) documentation as to the typical price of these markers.

For CPT code 76776, Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation , we deleted the color laser printer because it is contained in the ultrasound room that is also used for the procedure.

For CPT code 77371, Radiation treatment delivery, stereotactic radiosurgery (SRS) (complete course of treatment of cerebral lesion[s] consisting of 1 session); multi-source Cobalt 60 based , we designated, as an interim measure, the $15,000 radiation source with a specific 1-month life (that was included in the list of direct-expense equipment items for this service), as an indirect expense because we believe it does not meet the criteria for inclusion as a direct expense. To the extent that the specialty disagrees with our decision to assign the radiation source cost as an indirect expense, the interim nature of this designation gives the specialty the opportunity to provide us with documentation to support their belief that the radiation source should be considered a direct expense.

For CPT code 94644, Continuous inhalation with aerosol medication for acute airway obstruction; first hour , we did not include the peak flow meter as a supply item for this service because this item is reusable and was previously removed from the PE database at the time the supplies were re-priced.

For CPT code 96040, Medical genetics and genetics counseling services, each 30 minutes face-to-face with patient/family , the payment rate, at $0.567, for "genetic counselor" was created from a non-BLS source that listed a 2003 national annual average salary of $53,377. This salary was inflated to include fringe benefits ($53,377 multiplied by 1.366), then deflated by the MEI to the year 2002 (the same year as the other labor costs in the PE database), then divided by 2080 (the number of hours in a work year), and finally divided by 60 (the number minutes in an hour). We were not able to include a price for the pedigree software equipment as it was not provided with the PE inputs.

For CPT code 96904, Whole body integumentary photography, for monitoring of high risk patients with dysplastic nevus syndrome or a history of dysplastic nevi, or patients with a personal or familial history of melanoma , the payment rate, at $0.383, for "medical photographers", was created from a non-BLS source that gave a 2003 national annual average salary of $36,000. This salary was inflated by a factor of 1.366 to include fringe benefits, then deflated by the MEI to 2002 (the labor base year), then divided by 2080 (the number of annual work hours), and lastly, divided by number 60 (the number of minutes in an hour). We are asking the specialty to submit acceptable documentation for all of the cameras and related equipment that are listed for this service. The prices submitted by the specialty have been entered on an interim basis for CY 2007.

For CPT code 58240, Pelvic exenteration for gynecologic malignancy, with total abdominal hysterectomy or cervicectomy, with or without removal of tube(s), with or without removal of ovary(s), with removal of bladder and ureteral transplantations, and/or abdominoperineal resection of rectum and colon and colostomy, or any combination thereof , the supplies for this service were correctly entered as a quantity of 6-the number of post-operative visits (POVs)-rather than 4, as listed on the PE spreadsheet in the RUC recommendations. The correct labor and equipment times were entered as reflected by the level and number of POVs.

For CPT code 92025, Computerized corneal topography, unilateral or bilateral with interpretation and report , the specific topography equipment (at $44,000) requested for this procedure was not included because we do not believe it is the typical unit used in physician offices. Instead, we used the existing topography unit (at $13,495) and added a printer and computer with monitor to the PE database for this service.

VI. Physician Self-Referral Prohibition: Annual Update to the List of CPT/HCPCS Codes

A. General

Section 1877 of the Act prohibits a physician from referring a Medicare beneficiary for certain designated health services (DHS) to a health care entity with which the physician (or a member of the physician's immediate family) has a financial relationship, unless an exception applies. Section 1877 of the Act also prohibits the DHS entity from submitting claims to Medicare or billing the beneficiary or any other entity for Medicare DHS that are furnished as a result of a prohibited referral.

As specified in our regulations at § 411.351, the following services are DHS:

• Clinical laboratory services.

• Physical therapy, occupational therapy, and speech-language pathology services.

• Radiology and certain other imaging services.

• Radiation therapy services and supplies.

• Durable medical equipment and supplies.

• Parenteral and enteral nutrients, equipment, and supplies.

• Prosthetics, orthotics, and prosthetic devices and supplies.

• Home health services.

• Outpatient prescription drugs.

• Inpatient and outpatient hospital services.

B. Nuclear Medicine

In the CY 2006 PFS proposed rule (70 FR 45764), we sought public comments on a proposal to amend the definitions of "radiation and certain other imaging services" and "radiation therapy services and supplies" at § 411.351 to include nuclear medicine services and supplies. In the CY 2006 PFS final rule with comment (70 FR 70116), we finalized the proposal and provided a delayed effective date of January 1, 2007 for the new provisions. We included a list of the nuclear medicine CPT and HCPCS codes in Table 31 and Addendum H of the CY 2006 PFS final rule with comment (70 FR 70290 through 70295 and 70472 through 70476).

In response to the CY 2006 PFS final rule with comment period, we received public comments from three organizations regarding the nuclear medicine issue. Because we had previously provided an opportunity for comment on the proposal in accordance with the provisions of the Administrative Procedure Act (APA) (5 U.S.C. 551 et seq. ), we are not required to respond further. Nevertheless, we are responding to the only comment that provided significant new information. Specifically, we are responding to the following comment from the AMA.

Comment: The AMA stated that it does not recognize diagnostic and therapeutic nuclear medicine services as a subspecialty of radiology, contrary to our statement in the CY 2006 PFS final rule (70 FR 70285). In that rule and in the proposed rule, we had explained that radiology and other imaging services should include diagnostic nuclear medicine procedures, because, among a number of other reasons, the AMA recognizes nuclear medicine as a subspecialty of radiology. We also noted in the CY 2006 PFS final rule (70 FR 70285) that the AMA had not objected to this statement in the proposed rule. In its comment, the AMA has now stated that its CPT coding categories are not intended to be a determination of subspecialties. The AMA added that nuclear medicine should be recognized as its own specialty, separate from radiology, because it has its own board certification and residency program.

Response: We accept the explanation by the AMA that it does not recognize diagnostic nuclear medicine services as a subspecialty of radiology. However, we continue to believe that we should include all forms of radiological imaging in the DHS category "radiology and other imaging services." As we noted in both the CY 2006 PFS proposed (70 FR 45855) and final rules (70 FR 70285), although there may be differences of opinion as to whether diagnostic nuclear medicine is a subset of radiology, it is an imaging service covered by 1861(s)(3) of the Act, and of the type for which the Congress intended to prohibit referrals.

C. Annual Update to the Code List

1. Background

In § 411.351, we specify that the entire scope of four DHS categories is defined in a list of CPT/HCPCS codes (the Code List), which is updated annually to account for changes in the most recent CPT and HCPCS publications. The DHS categories defined and updated in this manner are:

• Clinical laboratory services.

• Physical therapy, occupational therapy, and speech-language pathology services.

• Radiology and certain other imaging services.

• Radiation therapy services and supplies.

The Code List also identifies those items and services that may qualify for either of the following two exceptions to the physician self-referral prohibition:

• EPO and other dialysis-related drugs furnished in or by an ESRD facility(§ 411.355(g)).

• Preventive screening tests, immunizations or vaccines (§ 411.355(h)).

The Code List was last updated in the CY 2006 PFS final rule with comment period (70 FR 70116).

2. Response to Comments

We did not receive any comments relating to the Code List that became effective January 1, 2006.

3. Revisions Effective for 2007

The updated, comprehensive Code List effective January 1, 2007 appears as Addendum J in this final rule with comment and is available on our Web site at http://www.cms.hhs.gov/PhysicianSelfReferral. Addendum J reflects the addition of CPT code 86960 to the list of CPT codes in the 80000 series that are excluded from the definition of "clinical laboratory services." This code was a new CPT code last year and should have been added to the list of excluded 80000 series codes at that time. In addition, Addendum J reflects the changes indicated in Tables 18 and 19.

Tables 18 and 19 identify the additions and deletions, respectively, to the comprehensive Code List that was published in Addendum H of the CY 2006 PFS final rule (70 FR 70472 through 70476). Tables 18 and 19 also identify the additions and deletions to the lists of codes used to identify the items and services that may qualify for the exceptions in § 411.355(g) (regarding EPO and other dialysis-related outpatient prescription drugs furnished in or by an ESRD facility) and in § 411.355(h) (regarding preventive screening tests, immunizations and vaccines).

The additions specified in Table 18 generally reflect new CPT and HCPCS codes that become effective January 1, 2007, or that became effective since our last update. Although we included nuclear medicine codes in Addendum H of the CY 2006 PFS final rule, we are including them as additions in Table 18 since they will become effective January 1, 2007. In addition, Table 18 also reflects our decision to move several nuclear medicine procedures that had been added last year to the DHS category of "radiology and certain other imaging services" (but not effective until January 1, 2007) to the category of "clinical laboratory services." We determined that the following CPT codes do not involve imaging services and are categorized more appropriately as clinical laboratory services: 78110, 78111, 78120, 78121, 78122, 78130, 78191, 78270, 78271, 78272 and 78725. We are also adding CPT code 86960 to the excluded portion of the "clinical laboratory services" category.

Additionally, we are adding several HCPCS codes for radiopharmaceuticals and high osmolar contrast materials to the category of "radiology of and certain other imaging services. We inadvertently omitted these codes in Addendum H of the CY 2006 PFS final rule with comment.

Table 19 reflects the deletions necessary to conform the Code List to the most recent publications of CPT and HCPCS. It also reflects our decision to delete certain nuclear medicine services (CPT codes 78110, 78111, 78120, 78121, 78122, 78130, 78191, 78270, 78271, 78272 and 78725) from the category of "radiology and certain other imaging services" and to move them to the more appropriate category of "clinical laboratory services."

We will consider comments regarding the codes listed in Tables 18 and 19 and the addition on Addendum J of CPT code 86960 to the list of CPT codes in the 80000 series that are excluded from the definition of "clinical laboratory services." Comments will be considered if we receive them by the date specified in the DATES section of this final rule with comment. We will not consider any comment that advocates a substantive change to any of the DHS defined in § 411.351.

CLINICAL LABORATORY SERVICES
78110 Plasma volume, single.
78111 Plasma volume, multiple.
78120 Red cell mass, single.
78121 Red cell mass, multiple.
78122 Blood volume.
78130 Red cell survival study.
78191 Pylatelet survival.
78270 Vit B-12 absorption exam.
78271 Vit B-12 absrp exam, int fac.
78272 Vit B-12 absorp, combined.
78725 Kidney function study.
G0394 Blood occult test colorectal.
PHYSICAL THERAPY, OCCUPATIONAL THERAPY, AND SPEECH-LANGUAGE PATHOLOGY SERVICES
[No additions].
RADIOLOGY AND CERTAIN OTHER IMAGING SERVICES
0144T Ct heart wo dye; qual calc.
0145T Ct heart w/wo dye funct.
0146T Ccta w/wo dye.
0147T Ccta w/wo, quan calcium.
0148T Ccta w/wo, strxr.
0149T Ccta w/wo, strxr quan calc.
0150T Ccta w/wo, disease strxr.
0151T Ct heart funct add-on.
0159T Cad breast mri.
0174T Cad crx with interp.
0175T Cad crx remote.
70554 Fmri brain by tech.
70555 Fmri brain by phys/psych.
76776 Us exam k transpl w/Doppler.
77014 Ct scan for therapy guide.
77051 Computer dx mammogram add-on.
77052 Comp screen mammogram add-on.
77055 Mammogram, one breast.
77056 Mammogram, both breasts.
77057 Mammogram, screening.
77058 Mri, one breast.
77059 Mri, both breasts.
77071 X-ray stress view.
77072 X-rays for bone age.
77073 X-rays, bone length studies.
77074 X-rays, bone survey, limited.
77075 X-rays, bone survey complete.
77076 X-rays, bone survey, infant.
77077 Joint survey, single view.
77078 Ct bone density, axial.
77079 Ct bone density, peripheral.
77080 Dxa bone density, axial.
77081 Dxa bone density/peripheral.
77082 Dxa bone density, vert fx.
77083 Radiographic absorptiometry.
77084 Magnetic image, bone marrow.
78000 Thyroid, single uptake.
78001 Thyroid, multiple uptakes.
78003 Thyroid suppress/stimul.
78006 Thyroid imaging with uptake.
78007 Thyroid image, mult uptakes.
78010 Thyroid imaging.
78011 Thyroid imaging with flow.
78015 Thyroid met imaging.
78016 Thyroid met imaging/studies.
78018 Thyroid met imaging, body.
78020 Thyroid met uptake.
78070 Parathyroid nuclear imaging.
78075 Adrenal nuclear imaging.
78099 Endocrine nuclear procedure.
78102 Bone marrow imaging, ltd.
78103 Bone marrow imaging, mult.
78104 Bone marrow imaging, body.
78135 Red cell survival kinetics.
78140 Red cell sequestration.
78185 Spleen imaging.
78190 Platelet survival, kinetics.
78195 Lymph system imaging.
78199 Blood/lymph nuclear exam.
78201 Liver imaging.
78202 Liver imaging with flow.
78205 Liver imaging (3D).
78206 Liver image (3D) with flow.
78215 Liver and spleen imaging.
78216 Liver spleen image/flow.
78220 Liver function study.
78223 Hepatobiliary imaging.
78230 Salivary gland imaging.
78231 Serial salivary imaging.
78232 Salivary gland function exam.
78258 Esophageal motility study.
78261 Gastric mucosa imaging.
78262 Gastroesophageal reflux exam.
78264 Gastric emptying study.
78278 Acute GI blood loss imaging.
78282 GI protein loss exam.
78290 Meckel's divert exam.
78291 Leveen/shunt patency exam.
78299 GI nuclear procedure.
78300 Bone imaging, limited area.
78305 Bone imaging, multiple areas.
78306 Bone imaging, whole body.
78315 Bone imaging, 3 phase.
78320 Bone imaging (3D).
78399 Musculosketal nuclear exam.
78414 Non-imaging heart function.
78428 Cardiac shunt imaging.
78445 Vascular flow imaging.
78456 Acute venous thrombus image.
78457 Venous thrombosis imaging.
78458 Ven thrombosis images, bilat.
78459 Heart muscle imaging (PET).
78460 Heart muscle blood, single.
78461 Heart muscle blood, multiple.
78464 Heart image (3d), single.
78465 Heart image (3d), multiple.
78466 Heart infarct image.
78468 Heart infarct image (ef).
78469 Heart infarct image (3D).
78472 Gated heart, planar, single.
78473 Gated heart, multiple.
78478 Heart wall motion add-on.
78480 Heart function add-on.
78481 Heart first pass, single.
78483 Heart first pass, multiple.
78491 Heart image (pet), single.
78492 Heart image (pet), multiple.
78494 Heart image, spect.
78496 Heart first pass add-on.
78499 Cardiovascular nuclear exam.
78580 Lung perfusion imaging.
78584 Lung V/Q image single breath.
78585 Lung V/Q imaging.
78586 Aerosol lung image, single.
78587 Aerosol lung image, multiple.
78588 Perfusion lung image.
78591 Vent image, 1 breath, 1 proj.
78593 Vent image, 1 proj, gas.
78594 Vent image, mult proj, gas.
78596 Lung differential function.
78599 Respiratory nuclear exam.
78600 Brain imaging, ltd static.
78601 Brain imaging, ltd w/flow.
78605 Brain imaging, complete.
78606 Brain imaging, compl w/flow.
78607 Brain imaging (3D).
78608 Brain imaging (PET).
78609 Brain imaging (PET).
78610 Brain flow imaging only.
78615 Cerebral vascular flow image.
78630 Cerebrospinal fluid scan.
78635 CSF ventriculography.
78645 CSF shunt evaluation.
78647 Cerebrospinal fluid scan.
78650 CSF leakage imaging.
78660 Nuclear exam of tear flow.
78699 Nervous system nuclear exam.
78700 Kidney imaging, morphol.
78701 Kidney imaging with flow.
78707 K flow/funct image w/o drug.
78708 K flow/funct image w/drug.
78709 K flow/funct image, multiple.
78710 Kidney imaging (3D).
78730 Urinary bladder retention.
78740 Ureteral reflux study.
78761 Testicular imaging w/flow.
78799 Genitourinary nuclear exam.
78800 Tumor imaging, limited area.
78801 Tumor imaging, mult area.
78802 Tumor imaging, whole body.
78803 Tumor imaging (3D).
78804 Tumor imaging, whole body.
78805 Abscess imaging, ltd area.
78806 Abscess imaging, whole body.
78807 Nuclear localization/abscess.
78811 Tumor imaging (pet), limited.
78812 Tumor image (pet)/skull-thigh.
78813 Tumor image (pet) full body.
78814 Tumor image pet/ct, limited.
78815 Tumorimage pet/ct skull-thigh.
78816 Tumor image pet/ct full body.
78890 Nuclear medicine data proc.
78891 Nuclear med data proc.
78999 Nuclear diagnostic exam.
91111 Esophageal capsule endoscopy.
A4641 Radiopharm dx agent.
A4642 In111 satumomab.
A9500 Tc99m sestamibi.
A9502 Tc99m tetrofosmin.
A9503 Tc99m medronate.
A9504 Tc99m apcitide.
A9505 TL201 thallium.
A9507 In111 capromab.
A9508 I131 iodobenguate, dx.
A9510 Tc99m disofenin.
A9512 Tc99m pertechnetate.
A9516 I123 iodide cap, dx.
A9521 Tc99m exametazime.
A9524 I131 serum albumin, dx.
A9526 Nitrogen N-13 ammonia.
A9528 Iodine I131 iodide cap, dx.
A9529 I131 iodide sol, dx.
A9531 I131 max 100uCi.
A9532 I125 serum albumin, dx.
A9536 Tc99m depreotide.
A9537 Tc99m mebrofenin.
A9538 Tc99m pyrophosphate.
A9539 Tc99m pentetate.
A9540 Tc99m MAA.
A9541 Tc99m sulfur colloid.
A9542 In111 ibritumomab, dx.
A9544 I131 tositumomab, dx.
A9546 CO57/58.
A9547 In111 oxyquinoline.
A9548 In111 pentetate.
A9550 Tc99m gluceptate.
A9551 Tc99m succimer.
A9552 F18 fdg.
A9553 Cr51 chromate.
A9554 I125 iothalamate, dx.
A9555 Rb82 rubidium.
A9556 Ga67 gallium.
A9557 Tc99m bicisate.
A9558 Xe133 xenon 10mci.
A9559 Co57 cyano.
A9560 Tc99m labeled rbc.
A9561 Tc99m oxidronate.
A9562 Tc99m mertiatide.
A9565 In111 pentetreotide.
A9566 Tc99m fanolesomab.
A9567 Technetium TC-99m.
A9568 Tc99m arcitumomab.
A9700 Echocardiography contrast.
G0389 Ultrasound exam AAA screen.
Q9945 LOCM=149mg/ml iodine, 1 ml.
Q9946 LOCM 150-199mg/ml iodine, 1ml.
Q9947 LOCM 200-249mg/ml iodine, 1ml.
Q9948 LOCM 250-299mg/ml/iodine, 1ml.
Q9949 LOCM 300-349mg/ml iodine, 1ml.
Q9950 LOCM 350-399mg/ml iodine, 1ml.
Q9951 LOCM=400 mg/ml iodine, 1ml.
Q9952 Inj Gad-base MR contrast, ml.
Q9953 Inj Fe-base MR contrast, ml.
Q9954 Oral MR contrast, 100 ml.
Q9955 Inj perflexane lip micros, ml.
Q9956 Inj octafluoropropane mic, ml.
Q9957 Inj perflutren lip micros, ml.
Q9958 HOCM =149mg/ml iodine, 1ml.
Q9959 HOCM 150-199mg/ml iodine, 1ml.
Q9960 HOCM 200-249mg/ml iodine, 1ml.
Q9961 HOCM 250-299mg/ml iodine, 1ml.
Q9962 HOCM 300-349mg/ml iodine, 1ml.
Q9963 HOCM 350-399mg/ml iodine, 1ml.
Q9964 HOCM= 400mg/ml iodine, 1ml.
RADIATION THERAPY SERVICES AND SUPPLIES
55875 Transperi needle place, pros.
55876 Place rt device/marker, pros.
77371 Srs, multisource.
77372 Srs, linear based.
77373 Sbrt delivery.
77435 Sbrt management.
79005 Nuclear rx, oral admin.
79101 Nuclear rx, iv admin.
79200 Nuclear rx, intracav admin.
79300 Nuclr rx, interstit colloid.
79403 Hematopoietic nuclear tx.
79440 Nuclear rx, intra-articular.
79445 Nuclear rx, intra-arterial.
79999 Nuclear medicine therapy.
92974 Cath place, cardio brachytx.
A9517 I131 iodide cap, rx.
A9527 Iodine I-125 sodium iodide.
A9530 I131 iodide sol, rx.
A9543 Y90 ibritumomab, rx.
A9545 I131 tositumomab, rx.
A9563 P32 Na phosphate.
A9564 P32 chromic phosphate.
A9600 Sr89 strontium.
A9605 Sm 153 lexidronm.
A9699 Radiopharm rx agent noc.
Q3001 Brachytherapy Radioelements.
DRUGS USED BY PATIENTS UNDERGOING DIALYSIS
Q4081 Epoetin alfa, 100 units ESRD.
PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES
77052 Comp screen mammogram add-on.
77057 Mammogram, screening.
82270 Occult blood, feces.
90660 Flu vaccine, nasal.
G0389 Ultrasound exam AAA screen.
1 CPT codes and descriptions only are copyright 2006 AMA. All rights are reserved and applicable FARS/DFARS clauses apply.

CLINICAL LABORATORY SERVICES
G0107 CA screen; fecal blood test.
PHYSICAL THERAPY, OCCUPATIONAL THERAPY, AND SPEECH-LANGUAGE PATHOLOGY SERVICES
[No deletions].
RADIOLOGY AND CERTAIN OTHER IMAGING SERVICES
76006 X-ray stress view.
76020 X-rays for bone age.
76040 X-rays, bone evaluation.
76061 X-rays, bone survey.
76062 X-rays, bone survey.
76065 X-rays, bone evaluation.
76066 Joint survey, single view.
76070 Ct bone density, axial.
76071 Ct bone density, peripheral.
76075 Dxa bone density, axial.
76076 Dxa bone density/peripheral.
76077 Dxa bone density/v-fracture.
76078 Radiographic absorptiometry.
76082 Computer mammogram add-on.
76083 Computer mammogram add-on.
76090 Mammogram, one breast.
76091 Mammogram, both breasts.
76092 Mammogram, screening.
76093 Magnetic image, breast.
76094 Magnetic image, both breasts.
76370 Ct scan for therapy guide.
76400 Magnetic image, bone marrow.
76778 Us exam kidney transplant.
78110 Plasma volume, single.
78111 Plasma volume, multiple.
78120 Red cell mass, single.
78121 Red cell mass, multiple.
78122 Blood volume.
78130 Red cell survival study.
78191 Platelet survival.
78270 Vit B-12 absorption exam.
78271 Vit B-12 absrp exam, int fac.
78272 Vit B-12 absorp, combined.
78704 Imaging renogram.
78715 Renal vascular flow exam.
78725 Kidney function study.
78760 Testicular imaging.
A9511 Technetium TC 99m depreotide.
A9513 Technetium tc-99m mebrofenin.
A9514 Technetium tc-99m pyrophosphate.
A9515 Technetium tc-99m pentetate.
A9519 Technetiumtc-99m macroag albu.
A9520 Technetiumtc-99m sulfur clld.
A9522 Indium111ibritumomabtiuxetan.
A9533 I131 tositumomab diagnostic.
Q3000 Rubidium RB-82.
Q3002 Gallium ga 67.
Q3003 Technetium tc99m bicisate.
Q3004 Xenon xe 133.
Q3005 Technetium tc99m mertiatide.
Q3006 Technetium tc99m glucepatate.
Q3007 Sodium phosphate p32.
Q3008 Indium 111-in pentetreotide.
Q3009 Technetium tc99m oxidronate.
Q3010 Technetium tc99mlabeledrbcs.
Q3011 Chromic phosphate p32.
Q3012 Cyanocobalamin cobalt co57.
RADIATION THERAPY SERVICES AND SUPPLIES
0082T Stereotactic rad delivery.
0083T Stereotactic rad tx mngmt.
55859 Percut/needle insert, pros.
A9523 Yttrium90ibritumomabtiuxetan.
A9532 I125 serum albumin, dx.
A9534 I131 tositumomab therapeut.
Q3007 Sodium phosphate p32.
Q3011 Chromic phosphate p32.
DRUGS USED BY PATIENTS UNDERGOING DIALYSIS
J0886 Epoetin alfa, esrd.
PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES
76083 Computer mammogram add-on.
76092 Mammogram, screening.
G0107 CA screen; fecal blood test.
1 CPT codes and descriptions only are copyright 2006 AMA. All rights are reserved and applicable FARS/DFARS clauses apply.

VII. Physician Fee Schedule Update for CY 2007

A. Physician Fee Schedule Update

The PFS update is determined using a formula specified by statute. Under section 1848(d)(4) of the Act, the update is equal to the product of 1 plus the percentage increase in the MEI (divided by 100) and 1 plus the UAF. For CY 2007, the MEI is equal to 2.1 percent (1.021). The UAF is -7.0 percent (0.930). The product of the MEI (1.021) and the UAF (0.930) equals the CY 2007 update of -5.0 percent (0.94953).

Our calculations of these figures are explained in this section.

B. The Percentage Change in the Medicare Economic Index (MEI)

The MEI measures the weighted-average annual price change for various inputs needed to produce physicians' services. The MEI is a fixed-weight input price index, with an adjustment for the change in economy-wide multifactor productivity. This index, which has CY 2000 base year weights, is comprised of two broad categories: (1) Physician's own time; and (2) physician's PE.

The physician's own time component represents the net income portion of business receipts and primarily reflects the input of the physician's own time into the production of physicians' services in physicians' offices. This category consists of two subcomponents: (1) Wages and salaries; and (2) fringe benefits.

The physician's PE category represents nonphysician inputs used in the production of services in physicians' offices. This category consists of wages and salaries and fringe benefits for nonphysician staff and other nonlabor inputs. The physician's PE component also includes the following categories of nonlabor inputs: Office expense; medical materials and supplies; professional liability insurance; medical equipment; prescription drugs; and other expenses. The components are adjusted to reflect productivity growth in physicians' offices by the 10-year moving average of productivity in the private nonfarm business sector. Table 20 presents a listing of the MEI cost categories with associated weights and percent changes for price proxies for the 2007 update. For CY 2007, the increase in the MEI is 2.1 percent, which includes a 1.3 percent productivity offset based on the 10-year moving average of multifactor productivity. This is the result of a 3.3 percent increase in physician's own time and a 3.6 percent increase in physician's PE. Within the physician's PE, the largest increase occurred in professional liability insurance, which increased 6.9 percent, and prescription drugs, which increased 7.7 percent.

Cost categories and price measures CY 2000 weights2 CY 2007 percent changes
Medicare Economic Index Total, productivity adjusted3 N/A 2.1
Productivity: 10-year moving average of multifactor productivity, private nonfarm business sector3, 4 N/A 1.3
Medicare Economic Index Total, without productivity adjustment4 100.000 3.5
1. Physician's Own Time5 52.466 3.3
a. Wages and Salaries: Average Hourly Earnings, private nonfarm 42.730 3.3
Fringe Benefits: Employment Cost Index, benefits, private nonfarm 9.735 3.5
2. Physician's Practice Expense5 47.534 3.6
a. Nonphysician Employee Compensation 18.653 2.9
(1) Wages and Salaries: Employment Cost Index, wages and salaries, weighted by occupation 13.808 2.6
(2) Fringe Benefits: Employment Cost Index, fringe benefits, white collar 4.845 4.0
b. Office Expense: Consumer Price Index for Urban Areas (CPI-U), housing 12.209 3.7
c. Drugs and Medical Materials and Supplies 4.319 4.8
(1) Medical Materials and Supplies: Producer Price Index (PPI), surgical appliances and supplies/CPI-U, medical equipment and supplies (equally weighted) 2.011 1.1
(2) Pharmaceuticals: Producer Price Index (PPI ethical prescription drugs) 2.308 7.7
d. Professional Liability Insurance: Professional liability insurance Premiums6 3.865 6.9
e. Medical Equipment: PPI, medical instruments and equipment 2.055 -0.1
f. Other Expenses 6.433 2.2
1. The rates of historical change are estimated for the 12-month period ending June 30, 2006, which is the period used for computing the CY 2007 update. The price proxy values are based upon the latest available Bureau of Labor Statistics data as of August 31, 2006.
2. The weights shown for the MEI components are the 2000 base-year weights, which may not sum to subtotals or totals because of rounding. The MEI is a fixed-weight, Laspeyres-type input price index whose category weights indicate the distribution of expenditures among the inputs to physicians' services for CY 2000. To determine the MEI level for a given year, the price proxy level for each component is multiplied by its 2000 weight. The sum of these products (weights multiplied by the price index levels) over all cost categories yields the composite MEI level for a given year. The annual percent change in the MEI levels is an estimate of price change over time for a fixed market basket of inputs to physicians' services.
3. These numbers may not sum due to rounding and the multiplicative nature of their relationship.
4. On March 23, 2006, Bureau of Labor Statistics introduced a new Multi Factor Productivity (MFP) series based on the 1997 NAICS classification system to replace its SIC based series published until 2005 (the last historical value was for 2002). The new series differs historically from the old MFP series and adds two new historical values through 2004. Therefore, we used the most recently available information (thru CY 2004) to develop the productivity adjustment for the CY 2007 update.
5. The measures of productivity, average hourly earnings, Employment Cost Indexes, as well as the various Producer and CPIs can be found on the BLS Web site at http://stats.bls.gov.
6. Derived from data collected from several major insurers (the latest available historical percent change data are for the period ending second quarter of 2006).

Comment: Several commenters believe we are in violation of the Administrative Procedures Act (APA) for not proposing and soliciting comments on the incorporation of new Bureau of Labor Statistics Multifactor Productivity data in the MEI.

Response: We disagree with the commenters' claim that we are in violation of the APA. The APA requires us to propose and solicit comments on substantive changes to our payment methodology. The PFS update published in this year's proposed rule is based on the same MEI methodology proposed and adopted in the CY 2003 and CY 2004 PFS proposed and final rules. The CY 2003 final rule adopted the use of BLS' private nonfarm business multifactor productivity (MFP) as the official data used to adjust the MEI for productivity. Specifically, consistent with the proposal made in the CY 2003 proposed rule (67 FR 43860), the CY 2003 final rule (67 FR 80023) states "Thus, the productivity adjustment will be based on the latest available actual historical economy-wide multifactor productivity data, as measured by the BLS." For the CY 2007 proposed rule, we followed this methodology and incorporated the latest available BLS private nonfarm business multifactor productivity.

Comment: Several commenters believe the multifactor productivity estimate of 1.3 percent is high in light of the new Medicare initiatives such as the new Welcome to Medicare benefits, the new comprehensive Part D benefit, and compliance related to the Physician Voluntary Reporting Program (PVRP), which impose numerous time and paperwork burdens on physicians.

Response: Our proposed and adopted methodology for calculating the MEI utilizes BLS's private nonfarm business MFP as the proxy for productivity changes. We recognize that productivity in physicians' offices for a given year may not equate to that of the economy-wide measure. For that reason, as well as to remove the effect of normal business cycles, we employ a 10-year moving average as the official measure. Also, CMS, in conjunction with the Assistant Secretary for Planning and Evaluation, is in the process of conducting a study on productivity in the physicians' offices. This work is being done to determine if the presently-used economy-wide measure for multi-factor productivity provides a reasonable target for physicians. We will analyze the results from this study and carefully evaluate its findings and their applicability to future MEI updates.

Comment: Several commenters believe it is not warranted that we assume and calculate increased productivity levels for physicians while the payment update process for other providers does not include assumed or automatic productivity adjustments.

Response: Since its inception in the mid-1970's, the MEI has included a productivity adjustment. The payment system for physicians' services requires that factors affecting the payment update be reflected in the update formula itself. The statutory provision relating to the MEI contemplates that the Secretary would not increase payments except to the extent that the extent that the Secretary finds, on the basis of appropriate economic index data, that such higher level is justified by year-to-year economic changes. We have long maintained that an MEI framework that focuses solely on the inputs portion of the equation effectively ignores the efficiencies that are employed to produce the outputs associated with the provision of care. It is necessary to account for these efficiencies to accurately reflect the net inflationary pressures encountered by physicians.

The intent of the MEI is to represent industry-wide output prices for physicians' services. We note that this index structure is similar to the CPI, which is an economy-wide output price index. The CPI implicitly incorporates a productivity adjustment. Except when the statute directs otherwise, the Medicare update for a number of types of services (for example, clinical diagnostic laboratory services, durable medical equipment, prosthetics and supplies) is based the CPI with its implicit productivity adjustment.

With respect to updates for other types of Medicare providers, such as institutional providers, we note that the underlying payment methodology is completely different from the payment system for physicians' services. Under the Medicare PFS, payments are made for unbundled services such as lab tests, follow-up visits, and x-rays. For institutions compensated by a PPS, a single payment is made for a bundle of services linked to treating a particular category of case (for instance, the services within one diagnosis-related group under the IPPS). Adjustments to payments associated with productivity and other payment framework-related considerations, when paying for bundled services, are addressed in other portions of the update process, such as via MedPAC recommendations and/or in the update itself when approved by the Congress.

Comment: Several commenters requested that we examine and address the broader problem that the MEI only measures changes in specific types of practice costs that existed in 1973. They further stated that inputs to the MEI are vastly different now than when the MEI was first developed in the early 1970s and that an array of government-imposed regulatory requirements now exist that did not in 1973. They claim that physician practice costs for these types of inputs are not currently taken into account for purposes of measuring the MEI, and therefore, the MEI undervalues actual medical cost increases. One commenter added that employee wages used in the MEI formula do not accurately reflect the skill mix of the industry and the MEI needs to be updated to account for the highly skilled staff necessary to deliver today's level of medical care service.

Response: We disagree with the commenter's claim that the MEI only measures changes in specific types of practice costs that existed in 1973. The current MEI is based on costs reported by physicians for 2000, which would reflect changes in the distributions of the cost weights associated with the government-imposed regulatory requirements that applied in 2000. The 2000-based cost weights are derived from the 2003 AMA Physician Socioeconomic Characteristics publication (2003 Patient Care Physician Survey data), which measures physicians' earnings and overall PEs for 2000. This is the latest available AMA data on physician expenses. We are currently researching alternative data sources for rebasing the MEI.

Regarding skill mix, the current MEI uses the occupation mix for nonphysician wages from the 2000 Current Population Survey published by BLS. This reflected the latest occupation mix at the time of our most recent rebasing. We recognize that skill mix can change, thus, we will continue to use the most recently published data available to us for all future rebasings to ensure the MEI reflects the occupational blend at that time.

Comment: Many commenters objected to the 0.5 percentage point reduction of the 2007 PFS update relative to the forecasted update in the President's Budget and urged us to delay or withdraw any changes in the MEI until the proposed changes and the solicitation of public comments appear in a published Federal Register .

Response: As stated previously, we did not make any methodological changes to the calculation of the MEI, and therefore, it is not necessary to delay use of the MFP-adjusted MEI in order to solicit and respond to public comments. As we indicated in the 2003 and 2004 physician fee schedule proposed and final rules, we are using the latest-available historical data in the calculation of the MEI applicable to a year. As such, we are not required to propose or solicit public comments on changes in the MEI that result from use of latest available data. The inclusion of more recent, historical MFP data in the MEI reflects our adopted methodology as finalized in the CY 2003 PFS final rule which states the MEI "productivity adjustment will be based on the latest available actual historical economy-wide multifactor productivity data, as measured by the BLS."

Comment: One commenter believes that there are alternative measures of multifactor productivity available from BLS and the Census Bureau. The commenter states that we should identify and consider these alternatives and seek public comment before changing the data used to calculate the MEI.

Response: In the CY 2003 PFS final rule, we presented the research we had completed on evaluating the most appropriate productivity adjustment for the MEI. This research included an evaluation of all currently available productivity estimates produced by BLS to develop a better understanding of the strengths and weaknesses of these measures. It also included a review of the theoretical foundation of the MEI to develop a better understanding of how labor and multifactor productivity relate to the current physician payment system. Additionally, we studied the sparse and fragmented publicly-available data to begin to develop preliminary estimates of trends in physician specific productivity to better understand the current market conditions facing physicians. For a list of the experts that participated in this analysis, as well as a full description of the options that were identified and evaluated (67 FR 80019).

As stated earlier, CMS and ASPE are jointly sponsoring a study of physicians' office productivity. We will be evaluating the results of that study to determine if the use of BLS's private nonfarm business MFP is a reasonable target for physicians to achieve.

Comment: Several commenters claim that in previous years, there have been extensive discussions in the proposed rule of the upcoming year's update and the MEI. They further state that based on the impact table in the CY 2007 proposed rule, a -0.5 percent percentage point reduction in the update will result in a $375 million cut in physician payments in 2007. One commenter claimed that our actions this year, in contrast to previous years, suggest we are attempting to hide the revision in the MEI for CY 2007.

Response: We disagree with the commenters' claim that in previous years there has been extensive discussion of the upcoming year's MEI update in the proposed rule. With the exception of those updates that include a rebased and revised MEI, a detailed discussion, as well as the percent changes in the MEI cost categories, has been provided only in the final rule. When we rebase and revise the MEI, we do include extensive discussion on the MEI and solicit comments on proposed methodological changes. Given the historical precedent, we disagree with the commenter's suggestion that we were hiding any revision in the MEI.

C. The Update Adjustment Factor (UAF)

Section 1848(d) of the Act provides that the PFS update is equal to the product of the MEI and the UAF. The UAF is applied to make actual and target expenditures (referred to in the statute as "allowed expenditures") equal. Allowed expenditures are equal to actual expenditures in a base period updated each year by the SGR. The SGR sets the annual rate of growth in allowed expenditures and is determined by a formula specified in section 1848(f) of the Act.

1. Calculation Under Current Law

Under section 1848(d)(4)(B) of the Act, the UAF for a year beginning with 2001 is equal to the sum of the following-

Prior Year Adjustment Component. An amount determined by-

+ Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services for the prior year (the year prior to the year for which the update is being determined) and the amount of the actual expenditures for those services for that year;

+ Dividing that difference by the amount of the actual expenditures for those services for that year; and

+ Multiplying that quotient by 0.75.

Cumulative Adjustment Component. An amount determined by-

+ Computing the difference (which may be positive or negative) between the amount of the allowed expenditures for physicians' services from April 1, 1996, through the end of the prior year and the amount of the actual expenditures for those services during that period;

+ Dividing that difference by actual expenditures for those services for the prior year as increased by the SGR for the year for which the UAF is to be determined; and

+ Multiplying that quotient by 0.33.

Section 1848(d)(4)(E) of the Act requires the Secretary to recalculate allowed expenditures consistent with section 1848(f)(3) of the Act. Section 1848(f)(3) specifies that the SGR (and, in turn, allowed expenditures) for the upcoming CY (2007 in this case), the current CY (2006) and the preceding CY (2005) are to be determined on the basis of the best data available as of September 1 of the current year. Allowed expenditures are initially estimated and subsequently revised twice. The second revision occurs after the CY has ended (that is, we are making the final revision to 2005 allowed expenditures in this final rule with comment). Once the SGR and allowed expenditures for a year have been revised twice, they are final.

Table 21 shows annual and cumulative allowed expenditures for physicians' services from April 1, 1996 through the end of the current CY, including the transition period to a CY system that occurred in 1999. Also shown is the SGR corresponding with each period. The calculation of the SGR is discussed in detail below in this section.

Period Annual allowed expenditures ($ in billions) Annual actual expenditures ($ in billions) Cumulative allowed expenditures ($ in billions) Cumulative actual expenditures ($ in billions) FY/CY SGR
4/1/96-3/31/97 $48.9 $48.9 $48.9 $48.9 N/A
4/1/97-3/31/98 50.5 49.4 99.4 98.4 FY 1998=3.2%
4/1/98-3/31/99 52.6 50.5 152.0 148.9 FY 1999=4.2%
1/1/99-3/31/99 13.3 13.1 (1) 148.9 FY 1999=4.2%
4/1/99-12/31/99 42.1 39.5 (2) 188.4 FY 2000=6.9%
1/1/99-12/31/99 55.3 52.6 194.0 188.4 FY 1999/2000(3)
1/1/00-12/31/00 59.4 58.1 253.4 246.5 CY 2000=7.3%
1/1/01-12/31/01 62.0 66.3 315.4 312.8 CY 2001=4.5%
1/1/02-12/31/02 67.2 71.0 382.6 383.7 CY 2002=8.3%
1/1/03-12/31/03 72.1 78.2 454.6 461.9 CY 2003=7.3%
1/1/04-12/31/04 76.8 87.1 531.5 549.0 CY 2004=6.6%
1/1/05-12/31/05 80.0 92.0 611.5 641.0 CY 2005=4.2%
1/1/06-12/31/06 81.7 94.9 693.3 735.9 CY 2006=2.1%
1/1/07-12/31/07 83.2 NA 776.5 NA CY 2007=1.8%
(1) Allowed expenditures for the first quarter of 1999 are based on the FY 1999 SGR.
(2) Allowed expenditures for the last three quarters of 1999 are based on the FY 2000 SGR.
(3) Allowed expenditures in the first year (April 1, 1996-March 31, 1997) are equal to actual expenditures. All subsequent figures are equal to quarterly allowed expenditure figures increased by the applicable SGR. Cumulative allowed expenditures are equal to the sum of annual allowed expenditures. We provide more detailed quarterly allowed and actual expenditure data on our web site at the following address: http://www.cms.hhs.gov/SustainableGRatesConFact/. We expect to update the web site with the most current information later this month.

Consistent with section 1848(d)(4)(E) of the Act, Table 21 includes our final revision of allowed expenditures for 2005, a recalculation of allowed expenditures for 2006, and our initial estimate of allowed expenditures for 2007. To determine the UAF for 2007, the statute requires that we use allowed and actual expenditures from April 1, 1996 through December 31, 2006 and the 2007 SGR. Consistent with section 1848(d)(4)(E) of the Act, we will be making revisions to the 2006 and 2007 SGRs and 2006 and 2007 allowed expenditures. Because we have incomplete actual expenditure data for 2006, we are using an estimate for this period. Any difference between current estimates and final figures will be taken into account in determining the UAF for future years.

We are using figures from Table 21 in the following statutory formula:

ER01DE06.000UAF = Update Adjustment Factor

Target 06 = Allowed Expenditures for 2006 = $81.7 billion

Actual 06 = Estimated Actual Expenditures for 2006 = $94.9 billion

Target 4/96-12/06 = Allowed Expenditures from 4/1/1996-12/31/2006 = $693.3 billion

Actual 4/96-12/06 = Estimated Actual Expenditures from 4/1/1996-12/31/2006 = $735.9 billion

SGR 07 = 1.8 percent (1.018)

ER01DE06.001

Section 1848(d)(4)(D) of the Act indicates that the UAF determined under section 1848(d)(4)(B) of the Act for a year may not be less than -0.070 or greater than 0.03. Since -0.250 is less than -0.070, the UAF for 2006 will be -0.070.

Section 1848(d)(4)(A)(ii) of the Act indicates that 1.0 should be added to the UAF determined under section 1848(d)(4)(B) of the Act. Thus, adding 1.0 to -0.070 makes the UAF equal to 0.930.

VIII. Allowed Expenditures for Physicians' Services and the Sustainable Growth Rate

A. Medicare Sustainable Growth Rate

The SGR is an annual growth rate that applies to physicians' services paid by Medicare. The use of the SGR is intended to control growth in aggregate Medicare expenditures for physicians' services. Payments for services are not withheld if the percentage increase in actual expenditures exceeds the SGR. Rather, the PFS update, as specified in section 1848(d)(4) of the Act, is adjusted based on a comparison of allowed expenditures (determined using the SGR) and actual expenditures. If actual expenditures exceed allowed expenditures, the update is reduced. If actual expenditures are less than allowed expenditures, the update is increased.

Section 1848(f)(2) of the Act specifies that the SGR for a year (beginning with 2001) is equal to the product of the following four factors:

(1) The estimated change in fees for physicians' services;

(2) The estimated change in the average number of Medicare fee-for-service beneficiaries;.

(3) The estimated projected growth in real GDP per capita; and

(4) The estimated change in expenditures due to changes in statute or regulations.

In general, section 1848(f)(3) of the Act requires us to publish SGRs for 3 different time periods, no later than November 1 of each year, using the best data available as of September 1 of each year. Under section 1848(f)(3)(C)(i) of the Act, the SGR is estimated and subsequently revised twice (beginning with the FY and CY 2000 SGRs) based on later data. (The Act also provides for adjustments to be made to the SGRs for FY 1998 and FY 1999. See the February 28, 2003 Federal Register (68 FR 9567) for a discussion of these SGRs). Under section 1848(f)(3)(C)(ii) of the Act, there are no further revisions to the SGR once it has been estimated and subsequently revised in each of the 2 years following the preliminary estimate. In this final rule with comment, we are making our preliminary estimate of the 2007 SGR, a revision to the 2006 SGR, and our final revision to the 2005 SGR.

B. Physicians' Services

Section 1848(f)(4)(A) of the Act defines the scope of physicians' services covered by the SGR. The statute indicates that "the term physicians" services includes other items and services (such as clinical diagnostic laboratory tests and radiology services), specified by the Secretary, that are commonly performed or furnished by a physician or in a physician's office, but does not include services furnished to a Medicare+Choice plan enrollee." We published a definition of physicians' services for use in the SGR in the Federal Register (66 FR 55316) on November 1, 2001. We defined physicians' services to include many of the medical and other health services listed in section 1861(s) of the Act. For purposes of determining allowed expenditures, actual expenditures, and SGRs, we have specified that physicians' services include the following medical and other health services if bills for the items and services are processed and paid by Medicare carriers (and those paid through intermediaries where specified):

• Physicians' services.

• Services and supplies furnished incident to physicians' services.

• Outpatient physical therapy services and outpatient occupational therapy services.

• Antigens prepared by, or under the direct supervision of, a physician.

• Services of PAs, certified registered nurse anesthetists, certified nurse midwives, clinical psychologists, clinical social workers, NPs, and certified nurse specialists.

• Screening tests for prostate cancer, colorectal cancer, and glaucoma.

• Screening mammography, screening pap smears, and screening pelvic exams.

• Diabetes outpatient self-management training (DSMT) services.

• MNT services.

• Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests (including outpatient diagnostic laboratory tests paid through intermediaries).

• X-ray, radium, and radioactive isotope therapy.

• Surgical dressings, splints, casts, and other devices used for the reduction of fractures and dislocations.

• Bone mass measurements.

• An initial preventive physical exam.

• Cardiovascular screening blood tests.

• Diabetes screening tests.

• Telehealth services.

• Physician work and resources to establish and document the need for a power mobility device (70 FR 50940).

Telehealth services and the power mobility device related services were added because they meet the statutory criteria for services to be included in the SGR (that is, these services are commonly performed or furnished by a physician or in a physician's office) (70 FR 70305).

Summary of Comments on the Physician Update and the SGR

We appreciate the comments we received expressing concern about the negative update for 2007 and the SGR formula. Those comments are summarized below, along with our responses.

Comment: Commenters noted that physicians' costs are rising, while fees are being cut. Under current law, the 2006 Medicare Trustees Report projected negative updates of about -5 percent for at least nine consecutive years. The cumulative impact of the projected reductions from 2007 to 2015 was estimated to be about -37 percent. Because commercial insurance carriers and Medicaid base their payment updates upon Medicare's PFS, the overall negative impact is compounded and affects the entire health care industry. In contrast, the MEI increase over this same period is projected to be about 22 percent.

Commenters noted that increases in their practice costs are outpacing most inflationary measures, and they predicted that costs to provide care will soon exceed reimbursement. Many physician practices are small businesses that operate on slim margins. With ever increasing costs, they will not have the resources to absorb payment cuts resulting from the SGR formula. The result will be that patient quality of care will be compromised, with doctors taking drastic measures to cut costs of health care delivery to remain solvent. Eventually, physicians will be unable to absorb the sustained losses, and they will refuse or limit Medicare patients, resulting in reduced access to care. A survey conducted by the AMA found that 45 percent of physicians will either stop accepting or decrease the number of new Medicare patients they accept if payments are cut for 2007. Inadequate access to care will lead to a deterioration in the health status of Medicare beneficiaries. Beneficiaries will be forced to seek care in inpatient settings, which will be more costly for Medicare, less efficient in delivering care, and yield worse health outcomes for beneficiaries.

Commenters recommended that the SGR be replaced with an appropriate inflation rate linked to changes in the actual costs of medical practice. Commenters cited MedPAC's recommendation to replace the SGR with a system that reflects the increases in practice costs and other medical inflation variables, which would be 2.8 percent for 2007. Other commenters suggested using the MEI, which is estimated at 2.1 percent for 2007, to update the CF.

Commenters suggested that we assume the leadership in pushing the Congress to enact legislation preventing a negative update for 2007, and to replace the SGR with a more sustainable system.

Response: We are fully cognizant of the potential implications of more than 9 years of negative physician updates. We remain concerned regarding those trends, and are closely monitoring physicians' participation in the Medicare program, as well as beneficiaries' access to care.

The formula for the SGR and the physician update are dictated by statute. We are required to follow this methodology when calculating the payment rates under the PFS.

We are working closely and collaboratively with medical professionals and the Congress on the most effective Medicare payment methodologies to compensate physicians for providing services to Medicare beneficiaries. We are engaging physicians on issues of quality and performance with the goal of encouraging the most effective approaches to achieve better health outcomes for Medicare beneficiaries. We are committed to developing systems that enable us to encourage quality, and to improve care without increasing overall Medicare costs.

Comment: Commenters requested that we implement administrative changes to the SGR calculation that would prevent a negative physician update for 2007. Specifically, many commenters requested that we remove the cost of Medicare-covered physician-administered drugs from the SGR on a retrospective basis. Commenters noted that expenditures on these drugs increased from $1.8 billion in 1996, to $8.6 billion in 2004, and was estimated at $8.2 billion in 2005. The commenters opined that if we make the administrative changes now, worth about $100 billion, then the cost of legislation revising the payment methodology for physicians' services will drop, and the likelihood of Congressional action to fix the SGR permanently will increase. Commenters expressed frustration that this recalculation has been requested numerous times, yet we have never implemented the change.

Some commenters requested that we remove all nonphysician services from the SGR calculation. Commenters stated that the annual spending growth of many nonphysician services, including drugs and physical therapy, far outstrip the growth of physician services. Commenters requested separate funding pools for physician and nonphysician services, each with its own respective targets, to calculate separate update factors for physician and nonphysician services.

Response: We carefully reviewed our authority to make administrative changes, most notably the feasibility of removing Part B drugs from the SGR baseline. We indicated in the past (most recently in 70 FR 70307) that administrative changes, such as retrospective removal of drugs from the SGR, are statutorily difficult. For example, the statute requires estimates of the SGR to be refined twice based on actual data. We see no legal basis to re-estimate the SGR and recompute allowed expenditures for a year after the SGR has been estimated and revised twice. Further, our current estimates are that these administrative changes, including removing drugs retroactively from the SGR, would not provide relief to the negative updates projected for 2007 and the succeeding several years. As indicated above in this section, we are working with the Congress and health professional organizations on potential reforms that would improve the effectiveness of the payment methodology for physicians without increasing overall Medicare costs.

In reference to removing all "nonphysician services" from the SGR, the statute provides the Secretary with clear authority to specify the services that are included in the SGR. Section 1848(f)(4)(A) of the Act indicates that the term "physicians" services" includes other items and services specified by the Secretary that are commonly performed or furnished by a physician or in a physician's office. We published a definition of physicians' services for use in the SGR in the Federal Register (66 FR 55316) on November 1, 2001. For purposes of determining allowed expenditures, actual expenditures, and SGRs, we defined physicians' services to include many of the medical and other health services listed in section 1861(s) of the Act that meet the criterion of being commonly performed by a physician or are services and supplies furnished incident to physicians' services. We disagree with the comments suggesting that the Secretary should not include drugs and physical therapy services in the definition of physicians' services for purposes of determining allowed expenditures, actual expenditures, and the SGR. Further, we have no authority to create separate targets and update factors for what commenters are identifying as "physician" and "nonphysician" services.

Comment: Commenters noted that payment updates under the SGR are tied to GDP, which bears little relationship to Medicare beneficiaries' health care needs or physician practice costs. Commenters noted that medical needs of individual patients are not related to the growth of the overall economy, and beneficiaries' medical needs do not decline during economic downturns. Commenters stated that MEI is a better reflection than GDP of the growth in health care costs.

Response: Under section 1848(d)(4) of the Act, the PFS update is equal to the product of the percentage increase in the MEI and the UAF. The UAF is determined by comparing allowed and actual expenditures from prior years and the current year, and adjusting the update to account for the difference. The SGR is used to calculate allowed expenditures, and the GDP is one of the components used to calculate the SGR as specified in section 1848(f)(2)(C) of the Act.

The percentage change in the MEI is one of the key components used to update the PFS CF. In accounting for the weighted-average price change for various inputs involved with producing physicians' services, the MEI measures inflation in physician practice costs and general wage levels. Elements of the MEI include measures of physicians' PEs, including nonphysician employee compensation, office expenses, medical material and supplies, professional liability insurance, and medical equipment.

The GDP is a general measure of economic growth. It is not intended to reflect factors specific to operating a medical practice because these are captured in the MEI. Currently, the statute requires that we use the GDP as a component of the SGR, which is then used to calculate the target level of expenditures. Although both MEI and GDP are included in the calculation of the conversion factor, the MEI has a more direct and greater impact on the physician update than GDP.

Comment: Commenters believe that we continue to underestimate the impact of National and Local Coverage Decisions on physician spending. Through these coverage decisions, we are directly responsible for volume increases, and must adjust the SGR target accordingly.

Response: We do not have the authority to pay for a service lacking a defined statutory benefit listed in section 1861(s) of the Act. However, we do have the authority to establish national coverage decisions (NCDs) for items and services that are included in a benefit category listed in section 1861(s) of the Act. Further, we contract with Medicare carriers who may establish local coverage decisions (LCDs) for items and services that have a statutory benefit category.

Factor 4 of the SGR (1848(f)(2)(D)) requires us to estimate expenditures "which will result from changes in law and regulations." NCDs are not required to be issued by regulation, and we are not aware of any NCDs that have been issued via regulation. Although coverage decisions that reduce the coverage available for certain items and services must be published in the Federal Register , they are published as notices. Furthermore, as indicated above, LCDs are issued by contractors and are not binding on CMS or other contractors. As a result, it is unclear that we have the authority to consider NCDs or LCDs in our estimate of factor 4 of the SGR. Furthermore, while we may establish a national coveragae decision (NCD) for a new item of service with a defined statutory benefit category, the NCD does not necessarily increase Medicare spending to the extent that the service has or would have been covered at local carrier dicretion in the absence of a NCD. Because Medicare might cover these services without an NCD, it is unclear whether there are any additional costs associated with the NCDs.

At this time, we do not intend to make any adjustment to the SGR to account for new NCDs. We continue to examine the issue, but we expect that NCDs have, at most, limited impact on Medicare spending for physicians' services. (For a more detailed discussion see 70 FR 70308).

Comment: Commenters stated that additional funds need to be added to the SGR allowed expenditures for all the ancillary costs associated with new benefits. New benefits adjust the target, but they generate other services whose costs are not added to the targeted allowed expenditures. For example, the new AAA ultrasound benefit may reveal health problems that will generate additional visits, tests, and other services that are not reflected in the SGR's legislative factor.

Response: Section 1848(f)(2) of the Act specifies that the SGR for a year (beginning with 2001) is equal to the product of four factors. One of these factors is the estimated change in expenditures due to changes in statute or regulations. For 2007, this factor includes the AAA ultrasound referenced by commenters. Our estimate of changes in expenditures arising from changes in law and regulations include induced spending impacts, when applicable and material. Our estimate of the additional expenditures associated with this new benefit, like all of the figures used to determine the 2007 SGR, is an estimate that will be revised based on subsequent data. A 2-year look back window allows adjustments to the estimates to reflect actual impacts. Any differences between these estimates and the actual measurement of these figures will be included in future revisions of the SGR and allowed expenditures and incorporated into subsequent PFS updates. (See further discussion below for all the new benefits that adjusted the legislative factor in 2005, 2006, and 2007.)

Comment: Commenters suggested that CMS compliance programs, such as HIPAA, increased overhead expenses by 15 to 20 percent, but their costs are not included in SGR allowed expenditures.

Response: The statute provides the Secretary with clear authority to specify the services that are included in the SGR. Section 1848(f)(4)(A) of the Act indicates that the term "physicians" services" includes other items and services specified by the Secretary that are commonly performed or furnished by a physician or in a physician's office. Overhead costs attributable to compliance programs do not meet the definition of physicians' services for determining SGR allowed expenditures.

C. Preliminary Estimate of the SGR for 2007

Our preliminary estimate of the 2007 SGR is 1.8 percent. We first estimated the 2007 SGR in March and made the estimate available to the MedPAC and on our Web site. Table 22 shows that March 2006 estimate and our current estimates of the factors included in the 2007 SGR.

Statutory factors March estimate Current estimate
Fees 2.6 percent (1.026) 2.2 percent (1.022).
Enrollment -2.9 percent (0.971) -0.9 percent (0.991).
Real Per Capita GDP 2.2 percent (1.022) 2.0 percent (1.020).
Law and Regulation -1.0 percent (0.990) -1.5 percent (0.985).
Total 0.7 percent (1.007) 1.80 percent (1.018).
Note: Consistent with section 1848(f)(2) of the Act, the statutory factors are multiplied, not added, to produce the total (that is, 1.022 × 0.991 × 1.020 × 0.985 = 1.018). A more detailed explanation of each figure is provided in section VII.F.1 of this preamble.

D. Revised Sustainable Growth Rate for 2006

Our current estimate of the 2006 SGR is 2.1 percent. Table 23 shows our preliminary estimate of the 2006 SGR that was published in the CY 2006 Final Rule (70 FR 70309) and our current estimate.

Statutory factors Estimate from CY 2006 final rule Current estimate
Fees 2.7 percent (1.027) 2.2 percent (1.022).
Enrollment -3.1 percent (0.969) -2.2 percent (0.978).
Real Per Capita GDP 2.2 percent (1.022) 2.1 percent (1.021).
Law and Regulation 0.0 percent (1.000) 0.0 percent (1.000).
Total 1.7 percent (1.017) 2.1 percent (1.021).

A more detailed explanation of each figure is provided in section VII.F.2 of this preamble.

E. Final Sustainable Growth Rate for 2005

The SGR for 2005 is 4.2 percent. Table 24 shows our preliminary estimate of the 2005 SGR from the CY 2005 PFS final rule with comment period (69 FR 66386), our revised estimate from the CY 2006 PFS final rule with comment period (70 FR 70309) and the final figures determined using the best available data as of September 1, 2006.

Statutory factors Estimate from CY 2005 final rule Estimate from CY 2006 final rule Final
Fees 1.3 percent (1.013) 0.8 percent (1.008) 0.8 percent (1.008).
Enrollment -0.3 percent (0.997) 0.3 percent (1.003) 0.3 percent (1.003).
Real Per Capita GDP 2.2 percent (1.022) 2.2 percent (1.022) 2.1 percent (1.021).
Law and Reg 1.0 percent (1.010) 1.2 percent (1.010) 0.9 percent (1.009).
Total 4.3 percent (1.043) 4.6 percent (1.046) 4.2 percent (1.042).

A more detailed explanation of each figure is provided in section VII.F.3.

F. Calculation of 2007, 2006, and 2005 Sustainable Growth Rates

1. Detail on the 2007 SGR

All of the figures used to determine the 2007 SGR are estimates that will be revised based on subsequent data. Any differences between these estimates and the actual measurement of these figures will be included in future revisions of the SGR and allowed expenditures and incorporated into subsequent PFS updates.

• Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2007

This factor is calculated as a weighted-average of the 2007 fee increases for the different types of services included in the definition of physicians' services for the SGR. Medical and other health services paid using the PFS are estimated to account for approximately 81.4 percent of total allowed charges included in the SGR in 2007 and are updated using the MEI. The MEI for 2007 is 2.1 percent. Diagnostic laboratory tests are estimated to represent approximately 7.5 percent of Medicare allowed charges included in the SGR for 2007. Medicare payments for these tests are updated by the Consumer Price Index for Urban Areas (CPI-U). However, section 629 of the MMA specifies that diagnostic laboratory services will receive an update of 0.0 percent from 2004 through 2008.

Drugs are estimated to represent 11.1 percent of Medicare allowed charges included in the SGR in 2007. We estimated a weighted-average change in fees for drugs included in the SGR (using the ASP+6 percent pricing methodology) of 4.0 percent for 2007.

Table 25 shows the weighted-average of the MEI, laboratory and drug price changes for 2007.

Weight Update
Physician 0.814 2.1
Laboratory 0.075 0.0
Drugs 0.111 4.0
Weighted-average 1.000 2.2

We estimate that the weighted-average increase in fees for physicians' services in 2007 under the SGR (before applying any legislative adjustments) will be 2.2 percent.

• Factor 2-The Percentage Change in the Average Number of Part B Enrollees from 2006 to 2007

This factor is our estimate of the percent change in the average number of fee-for-service enrollees from 2006 to 2007. Services provided to Medicare Advantage (MA) plan enrollees are outside the scope of the SGR and are excluded from this estimate. OACT estimates that the average number of Medicare Part B fee-for-service enrollees will decrease by 0.9 percent from 2006 to 2007. Table 26 illustrates how this figure was determined.

2006 2007
Overall 40.136 million 40.735 million
Medicare Advantage (MA) 6.369 million 7.265 million
Net 33.768 million 33.470 million
Percent Increase -0.9 percent

An important factor affecting fee-for-service enrollment is beneficiary enrollment in MA plans. Because it is difficult to estimate the size of the MA enrollee population before the start of a CY, at this time we do not know how actual enrollment in MA plans will compare to current estimates. For this reason, the estimate may change substantially as actual Medicare fee-for-service enrollment for 2007 becomes known.

• Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2007

We estimate that the growth in real GDP per capita from 2006 to 2007 will be 2.0 percent (based on the 10-year average GDP over the 10 years of 1998-2007). Our past experience indicates that there have also been changes in estimates of real per capita GDP growth made before the year begins and the actual change in GDP computed after the year is complete. Thus, it is possible that this figure will change as actual information on economic performance becomes available to us in 2007.

• Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Statute or Regulations in 2007 Compared With 2006

The statutory and regulatory provisions that will affect expenditures in CY 2007 relative to CY 2006 are estimated to have an impact on expenditures of -1.5 percent. These provisions include the expiration of the work GPCI floor and DRA provisions adding the AAA ultrasound test to the Welcome to Medicare visit as a preventive benefit, and reducing payments for imaging services, which are discussed elsewhere in this final rule with comment.

2. Detail on the 2006 SGR

A more detailed discussion of our revised estimates of the four elements of the 2006 SGR follows.

• Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2006

This factor was calculated as a weighted-average of the 2006 fee increases that apply for the different types of services included in the definition of physicians' services for the SGR.

We estimate that services paid using the PFS account for approximately 83.2 percent of total allowed charges included in the SGR in 2006. These services were updated using the 2006 MEI of 2.8 percent. We estimate that diagnostic laboratory tests represent approximately 7.1 percent of total allowed charges included in the SGR in 2006. Medicare payments for these tests are updated by the CPI-U. However, section 629 of the MMA specifies that diagnostic laboratory services will receive an update of 0.0 percent from 2004 through 2008.

We estimate that drugs represent 9.7 percent of Medicare-allowed charges included in the SGR in 2006. Sections 303 and 304 of the MMA require Medicare to pay for most drugs at 106 percent of ASP beginning January 1, 2005. We now estimate a weighted-average change in fees for drugs included in the SGR of -1.7 percent for 2006. The estimated weighted-average change in the CY 2006 PFS final rule was 4.1 percent. The decline in the estimate is due to the availability of some actual data.

Table 27 shows the weighted-average of the MEI, laboratory and drug price changes for 2006.

Weight Update
Physician 0.832 2.8
Laboratory 0.071 0.0
Drugs 0.097 -1.7
Weighted-average 1.000 2.2

After taking into account the elements described in Table 27, we estimate that the weighted-average increase in fees for physicians' services in 2006 under the SGR (before applying any legislative adjustments) will be 2.2 percent. Our estimate of this factor in the CY 2005 PFS final rule was 2.7 percent.

• Factor 2-The Percentage Change in the Average Number of Part B Enrollees from 2005 to 2006

OACT estimates that the average number of Medicare Part B fee-for-service enrollees (excluding beneficiaries enrolled in M+C plans) decreased by 2.2 percent in 2006. Table 28 illustrates how we determined this figure.

2005 2006
Overall 39.601 million 40.136 million.
Medicare+Choice 5.084 million 6.369 million.
Net 34.518 million 33.768 million.
Percent Increase -2.2 percent.

OACT's estimate of the -2.2 percent change in the number of fee-for-service enrollees, net of M+C enrollment for 2006 compared to 2005, is greater than our original estimate of -3.1 percent in the CY 2006 PFS final rule (70 FR 70310). While our current projection based on data from 8 months of 2006 is greater than our original estimate of -3.1 percent when we had no actual data, it is still possible that our final estimate of this figure will be different once we have complete information on 2006 fee-for-service enrollment.

• Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2006

We estimate that the growth in real GDP per capita will be 2.1 percent for 2006 (based on the 10-year average GDP over the 10 years of 1997-2006). Our past experience indicates that there have also been differences between our estimates of real per capita GDP growth made prior to the year's end and the actual change in this factor. Thus, it is possible that this figure will change further as complete actual information on 2006 economic performance becomes available to us in 2007.

• Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Statute or Regulations in 2006 Compared With 2005

The statutory and regulatory provisions that affect expenditures in CY 2006 relative to CY 2005 are estimated to have a net impact on expenditures of less than 0.05. These provisions include the expiration of the temporary higher payments to physicians in Alaska, the new power wheelchair code for physicians, and the impact of the new IVIG service.

3. Detail On the 2005 SGR

A more detailed discussion of our final revised estimates of the four elements of the 2005 SGR follows.

• Factor 1-Changes in Fees for Physicians' Services (Before Applying Legislative Adjustments) for 2005

This factor was calculated as a weighted-average of the 2005 fee increases that apply for the different types of services included in the definition of physicians' services for the SGR.

Services paid using the PFS accounted for approximately 84.2 percent of total Medicare-allowed charges included in the SGR for 2005 and are updated using the MEI. The MEI for 2005 was 3.1 percent. Diagnostic laboratory tests represented approximately 7.0 percent of total 2005 Medicare-allowed charges included in the SGR and are updated by the CPI-U. However, section 629 of the MMA specifies that diagnostic laboratory services will receive an update of 0.0 percent from 2004 through 2008. Drugs represented approximately 8.8 percent of total Medicare-allowed charges included in the SGR for 2005. Historically, Medicare paid for drugs under section 1842(o) of the Act at 95 percent of the AWP. However, with some exceptions, in 2004 sections 303 and 304 of the MMA generally required Medicare to pay for drugs at 85 percent of the AWP determined as of April 1, 2003, or a specified percentage of AWP based on studies by the Government Accountability Office and the OIG. We implemented section 303 and 304 of the MMA in an interim final rule making changes to the PFS for 2004, which appeared in the Federal Register on January 7, 2004 (69 FR 1086). Beginning on January 1, 2005, sections 303 and 304 of the MMA require Medicare to pay for most drugs at 106 percent of the ASP. Taking into account sections 303 and 304 of the MMA, we estimate a weighted-average change in fees for drugs included in the SGR of -21.0 percent for 2005. Table 29 shows the weighted-average of the MEI, laboratory, and drug price increases for 2005.

Weight Update
Physician 0.842 3.1
Laboratory 0.070 0.0
Drugs 0.088 -21.0
Weighted-average 1.000 0.8

After taking into account the elements described in Table 29, we estimate that the weighted-average increase in fees for physicians' services in 2005 under the SGR (before applying any legislative adjustments) was 0.8 percent. This figure is a final one based on complete data for 2005.

• Factor 2-The Percentage Change in the Average Number of Part B Enrollees from 2004 to 2005

We estimate the increase in the number of fee-for-service enrollees (excluding beneficiaries enrolled in M+C plans) from 2004 to 2005 was 0.3 percent. Our calculation of this factor is based on complete data from 2005. Table 30 illustrates the calculation of this factor.

2004 2005
Overall 39.099 million 39.601 million
Medicare +Choice 4.683 million 5.084 million
Net 34.416 million 34.518 million
Percent Increase 0.3 percent

• Factor 3-Estimated Real Gross Domestic Product Per Capita Growth in 2005

We estimate that the growth in real per capita GDP was 2.1 percent in 2005 (based on the 10-year average GDP over the 10 years of 1996-2005). This figure is a final one based on complete data for 2005.

• Factor 4-Percentage Change in Expenditures for Physicians' Services Resulting From Changes in Statute or Regulations in 2005 Compared With 2004

There are a number of statutory provisions that affected the 2005 SGR. Sections 303 and 304 of the MMA changed Medicare payment for drugs. These provisions also changed Medicare payments for the administration of drugs. Section 303(a)(1) of the MMA amended section 1848(c)(2) of the Act to require the Secretary to make a number of changes that increased Medicare payment for drug administration beginning January 1, 2004. Section 303(a)(4) of the MMA required an additional transitional adjustment (temporary increase) to Medicare's payment for drug administration of 32 percent for 2004 and 3 percent for 2005. We also adopted changes to the codes and payment amounts for drug administration based on recommendations from the AMA's CPT Editorial Panel and Relative Value Update Committee (RUC), under the authority of section 1848(c)(2)(J) of the Act. We further increased PFS payments by paying separately for injections provided on the same day as another PFS service.

Section 413(a) of the MMA established a 5 percent increase in the PFS payment for services provided in physician scarcity areas. Section 413(b) of the MMA improved the procedures for paying the 10 percent PFS bonus payment for services provided in health professional shortage areas (HPSAs). Taken together, all of the statutory provisions for 2005, increased Medicare spending for physicians' services by 0.9 percent.

IX. Anesthesia and Physician Fee Schedule Conversion Factors for CY 2007

The 2007 PFS CF will be $35.9848. The 2007 national average anesthesia CF is $15.3328. Both CFs will be subject to a separate, independent BN adjustor, as described below.

A. Physician Fee Schedule Conversion Factor

Under section 1848(d)(1)(A) of the Act, the PFS CF is equal to the CF for the previous year multiplied by the update determined under section 1848(d)(4) of the Act.

We illustrate the calculation for the 2007 PFS CF in Table 31.

2006 Conversion Factor $37.8975
2007 Update -5.0 percent (0.94953)
2007 Conversion Factor $35.9848

Section 1848(c)(2)(B)(ii)(II) of the Act requires that increases or decreases in RVUs for a year may not cause the amount of expenditures for the year to differ by more than $20 million from what expenditures would have been in the absence of these changes. If this threshold is exceeded, we must make adjustments to preserve BN. The 5-Year Review of work RVUs would result in a change in expenditures that would exceed $20 million if we made no offsetting adjustments to either the CF or RVUs. As discussed in section IV.D of this final rule with comment period, we are applying the following BN adjustor to the work RVUs in order to calculate payment for a service:

2007 Work Adjustor: 10.1 percent (0.8994)

Payment for services under the PFS will now be calculated as follows:

Payment = [(RVU work x BN adjustor x GPCI work) + (RVU PE x GPCI PE) + (RVU malpractice x GPCI malpractice)] x CF.)

B. Anesthesia Fee Schedule Conversion Factor

Anesthesia services do not have RVUs like other PFS services. Therefore, we account for any necessary RVU adjustments through an adjustment to the anesthesia fee schedule CF to simulate changes to RVUs. We modeled the resource-based PE methodology using imputed anesthesia RVUs that were made comparable to other PFS services. The adjustment factor in Table 32 includes the combined effect of the PE adjustment and the BN adjustment. We used the following figures to determine the anesthesia fee schedule CF as shown in Table 32.

2006 Anesthesia Conversion Factor $17.7663
2007 Update -5.0 percent (0.94953)
2007 Combined Adjustment PE and BN 0.9089
2007 Anesthesia Conversion Factor $15.3328

X. Telehealth Originating Site Facility Fee Payment Amount Update

Section 1834(m) of the Act establishes the payment amount for the Medicare telehealth originating site facility fee for telehealth services provided from October 1, 2001 through December 31 2002, at $20. For telehealth services provided on or after January 1 of each subsequent calendar year, the telehealth originating site facility fee is increased by the percentage increase in the MEI as defined in section 1842(i)(3) of the Act. The MEI increase for 2007 is 2.1 percent.

Therefore, for CY 2007, the payment amount for HCPCS code "Q3014, telehealth originating site facility fee" is 80 percent of the lesser of the actual charge or $22.94. The Medicare telehealth originating site facility fee and MEI increase by the applicable time period are shown in Table 33.

Facility Fee MEI increase (percent) Period
$20.00 N/A 10/01/2001-12/31/2002.
20.60 3.0 01/01/2003-12/31/2003.
21.20 2.9 01/01/2004-12/31/2004.
21.86 3.1 01/01/2005-12/31/2005.
22.47 2.8 01/01/2006-12/31/2006.
22.94 2.1 01/01/2007-12/31/2007.

XI. Provisions of the Final Rule

The provisions of this final rule with comment restate the provisions of the CY 2007 PFS proposed rule, except as noted elsewhere in the preamble.

XII. Waiver of Proposed Rulemaking and Delay in Effective Date

We ordinarily publish a notice of proposed rulemaking in the Federal Register and invite public comment on the proposed rule. The notice of proposed rulemaking includes a reference to the legal authority under which the rule is proposed, and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that a notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued.

As discussed in sections IV. and V. of this final rule, we utilize HCPCS codes for Medicare payment purposes. The HCPCS is a national drug coding system comprised of Level I (CPT) codes and Level II (HCPCS National Codes) that are intended to provide uniformity to coding procedures, services, and supplies across all types of medical providers and suppliers. Level I (CPT) codes are copyrighted by the AMA and consist of several categories, including Category I codes which are 5-digit numeric codes, and Category III codes which are temporary codes to track emerging technology, services and procedures.

The AMA issues an annual update of the CPT code set each Fall, with January 1 as the effective date for implementing the updated CPT codes. The HCPCS, including both Level I and Level II codes, is similarly updated annually on a CY basis. Annual coding changes are not available to the public until the Fall immediately preceding the annual January update of the PFS. Because of the timing of the release of these new codes, it is impracticable for CMS to provide prior notice and solicit comment on these codes and the RVUs assigned to them in advance of publication of the final rule that implements the PFS. Yet, it is imperative that these coding changes be accounted for and recognized timely under the PFS for payment because services represented by these codes will be provided to Medicare beneficiaries by physicians during the CY in which they become effective. Moreover, regulations implementing HIPAA (42 CFR parts 160 and 162) require that the HCPCS be used to report health care services, including services paid under the PFS. We also assign interim RVUs to any new codes based on a review of the RUC recommendations for valuing these services. By reviewing these RUC recommendations for the new codes, we are able to assign RVUs to services based on input from the medical community and to establish payment for them, on an interim basis, that corresponds to the relative resources associated with providing the services. If we did not assign RVUs to new codes on an interim basis, the alternative would be to either not pay for these services during the initial CY or have each carrier establish a payment rate for these new codes. We believe both of these alternatives are contrary to the public interest, particularly since the RUC process allows for an assessment of the valuation of these services by the medical community prior to our establishing payment for these codes on an interim basis. Therefore, we believe it would be contrary to the public interest to delay establishment of fee schedule payment amounts for these codes.

For the reasons outlined above in this section, we find good cause to waive the notice of proposed rulemaking for the interim RVUs for selected procedure codes identified in Addendum C and to establish RVUs for these codes on an interim final basis. We are providing a 60-day public comment period.

In addition, we ordinarily publish a notice of proposed rulemaking in the Federal Register and provide a period for public comment before we make final the provisions of the notice. We can waive this procedure, however, if we find good cause that notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and we incorporate a statement of finding and its reasons in the notice issued. We find it unnecessary to undertake notice and comment rulemaking in this instance for the ambulance inflation factor because the law specifies the method of computation of annual updates, and we have no discretion in this matter. Further, we are merely applying the update method specified in statute and regulation. Therefore, under 5 U.S.C. 553(b)(B), for good cause, we waive notice and comment procedures for this ambulance inflation factor update.

XIII. Collection of Information Requirements

Under the Paperwork Reduction Act of 1995, we are required to provide 30-day notice in the Federal Register and solicit public comment before a collection of information requirement is submitted to the OMB for review and approval. In order to fairly evaluate whether an information collection should be approved by OMB, section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires that we solicit comment on the following issues:

• The need for the information collection and its usefulness in carrying out the proper functions of our agency.

• The accuracy of our estimate of the information collection burden.

• The quality, utility, and clarity of the information to be collected.

• Recommendations to minimize the information collection burden on the affected public, including automated collection techniques.

We solicited public comment on each of these issues for the following sections of this document that contain information collection requirements:

Section 410.33Independent Diagnostic Testing Facility

Section 410.33(e)(1) imposes a recordkeeping requirement on multi-State entities. Specifically, an independent diagnostic testing facility (IDTF) that operates across State boundaries must maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates. The burden associated with this requirement is the time and effort it takes the IDTF to collect and maintain the aforementioned information.

While subject to the PRA, we believe this information collection requirement is exempt as defined in 5 CFR 1320.3(b)(2), because the time, effort, and financial resources necessary to comply with the requirement would be incurred by persons in the normal course of their activities (for example, in compiling and maintaining business records) and is considered to be usual and customary.

Section 410.33(g) discusses the application certification standards that an IDTF must meet. An IDTF must complete an enrollment application and certify the information contained in the application. The certification is part of an application that is subject to the PRA. The burden associated with this requirement is the time and effort necessary to complete the application. This requirement is currently approved in OMB No. 0938-0685, with a current expiration date of April 30, 2009.

Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

Section II.F.1 of the preamble provides background information pertaining to the use of average sales price (ASP) as the basis for our drug payment methodology. In accordance with section 1857 of the Act, Medicare Part B covered drugs and biologicals not paid on a cost of prospective payment basis are paid based on the ASP. The ASP data reporting requirements are outlined in section 1927(b) of the Act, and were implemented in the interim final rule with comment period that published on April 6, 2004 (69 FR 17935).

The collection of ASP data imposes a reporting requirement on the public. The burden associated with this requirement is the time and effort required by manufacturers of Medicare Part B drugs and biologicals to calculate, record, and submit the required data to CMS. While this requirement is subject to the PRA, it is currently approved under OMB control number 0938-0921, with an expiration date of May 31, 2009.

As required by section 3504(h) of the Paperwork Reduction Act of 1995, we have submitted a copy of this document to the OMB for its review of these information collection requirements.

XIV. Response to Comments

Because of the large number of public comments we normally receive on Federal Register documents, we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date and time specified in the "DATES" section of this preamble, and, when we proceed with a subsequent document, we will respond to the comments in the preamble to that document.

XV. Regulatory Impact Analysis

We have examined the impact of this rule as required by Executive Order 12866 (September 1993, Regulatory Planning and Review), the Regulatory Flexibility Act (RFA) (September 19, 1980 Pub. L. 96-354), section 1102(b) of the Social Security Act, the Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), and Executive Order 13132.

Executive Order 12866 (as amended by Executive Order 13258, which merely reassigns responsibilities of duties) directs agencies to assess all costs and benefits of available regulatory alternatives and, when regulation is necessary, to select regulatory approaches that maximize net benefits (including potential economic, environmental, public health and safety effects, distributive impacts, and equity). A regulatory impact analysis must be prepared for final rules with economically significant effects (that is, a final rule that would have an annual effect on the economy of $100 million or more in any one year, or would adversely affect in a material way the economy, a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local, or tribal governments or communities). As indicated in more detail below in this section, we estimate that the PFS provisions included in this final rule with comment period will redistribute more than $100 million in 1 year. We are considering this final rule with comment period to be economically significant because its provisions are estimated to result in an increase, decrease or aggregate redistribution of Medicare spending that will exceed $100 million. Therefore, this final rule with comment period is a major rule and we have prepared a regulatory impact analysis.

The RFA requires that we analyze regulatory options for small businesses and other entities. We prepare a regulatory flexibility analysis unless we certify that a rule would not have a significant economic impact on a substantial number of small entities. The analysis must include a justification concerning the reason action is being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities.

Section 1102(b) of the Act requires us to prepare a regulatory impact analysis for any final rule that may have a significant impact on the operations of a substantial number of small rural hospitals. This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we define a small rural hospital as a hospital that is located outside a Metropolitan Statistical Area and has fewer than 100 beds. We have determined that this final rule with comment period would have minimal impact on small hospitals located in rural areas. Of the 201 hospital-based ESRD facilities located in rural areas, only 40 are affiliated with hospitals with fewer than 100 beds.

For purposes of the RFA, physicians, NPPs, and suppliers are considered small businesses if they generate revenues of $6 million or less. Approximately 95 percent of physicians are considered to be small entities. There are about 980,000 physicians, other practitioners and medical suppliers that receive Medicare payment under the PFS.

For purposes of the RFA, approximately 80 percent of clinical diagnostic laboratories are considered small businesses according to the Small Business Administration's size standards.

In addition, most ESRD facilities are considered small entities, either based on nonprofit status or by having revenues of $29 million or less in any year. We consider a substantial number of entities to be affected if the final rule is estimated to impact more than 5 percent of the total number of small entities. Based on our analysis of the 932 nonprofit ESRD facilities considered small entities in accordance with the above definitions, we estimate that the combined impact of the changes to payment for renal dialysis services included in this final rule with comment period would have a 0.8 percent increase in overall payments relative to current overall payments.

IDTFs are suppliers under the Medicare program. For purposes of the RFA, suppliers with annual sales of $6 million or less are considered to be small entities. (Individuals and States are not included in the definition of a small entity.) We believe that our standards for IDTFs will help bar fraudulent suppliers from participating in the Medicare program and provide an added level of protection to Medicare beneficiaries. Therefore, we expect to have an impact on an unknown number of persons and entities who will effectively be prevented from practicing their aberrant billing activities. The vast majority of suppliers would not be significantly affected by this final rule with comment period. The reduction in program overpayments and the added level of protection to beneficiaries that we expect to achieve as a result of this final rule with comment period justifies the relatively small burden this final rule with comment period would impose on all small entities.

Ambulance providers and suppliers for purposes of the RFA are also considered to be small entities. While we expect the initial change in geographic designations to have little, if any, overall effect on ambulance payments, application of the ambulance inflation factor (AIF) will result in an increase in payment rates for all ambulance services furnished by all types of ambulance providers.

The analysis and discussion provided in this section, as well as elsewhere in this final rule with comment period, complies with the RFA requirements.

Section 202 of the Unfunded Mandates Reform Act of 1995 also requires that agencies assess anticipated costs and benefits before issuing any rule that may result in expenditures in any year by State, local, or tribal governments, in the aggregate, or by the private sector, of $120 million. Medicare beneficiaries are considered to be part of the private sector for this purpose.

We have examined this final rule with comment period in accordance with Executive Order 13132 and have determined that this regulation would not have any significant impact on the rights, roles, or responsibilities of State, local, or tribal governments. A discussion concerning the impact of this rule on beneficiaries is found later in this section.

We have prepared the following analysis, which, together with the information provided in the rest of this preamble, meets all assessment requirements. The analysis explains the rationale for and purposes of this final rule with comment period; details the costs and benefits of the rule; analyzes alternatives; and presents the measures we proposed to use to minimize the burden on small entities. As indicated elsewhere in this final rule with comment period, we proposed to change our methodology for calculating resource-based PE RVUs and make a variety of other changes to our regulations, payments, or payment policies to ensure that our payment systems reflect changes in medical practice and the relative value of services. We provide information for each of the policy changes in the relevant sections of this final rule with comment period. We are unaware of any relevant Federal rules that duplicate, overlap or conflict with this final rule with comment period. The relevant sections of this final rule with comment period contain a description of significant alternatives if applicable.

A. RVU Impacts

1. Resource-Based Work and PE RVUs

Section 1848(c)(2)(B)(ii) of the Act requires that increases or decreases in RVUs may not cause the amount of expenditures for the year to differ by more than $20 million from what expenditures would have been in the absence of these changes. If this threshold is exceeded, we make adjustments to preserve BN. This year, the estimated $4 billion impact of changes in work RVUs resulting from the 5-Year Review require that a budget-neutrality adjustment be made.

As discussed in the June 29, 2006 proposed notice, we proposed making the statutorily required BN adjustment to account for the 5-Year Review of physician work by reducing all work RVUs. We estimated that all work RVUs would have to be reduced by 10 percent under this option. As discussed in section IV.D.1 of this final rule with comment period, we carefully reviewed the comments received concerning this issue, and to meet the BN provisions of section 1848(c)(2)(B)(ii)(II) of the Act, we are applying a BN adjustor of 0.8994 or -10.1 percent to the work RVUs.

Table 34 shows the specialty-level impact of the work and PE RVU changes.

Our estimates of changes in Medicare revenues for PFS services compare payment rates for CY 2006 with proposed payment rates for CY 2007 using CY 2005 Medicare utilization for all years. We are using CY 2005 Medicare claims processed and paid through March 30, 2005, that we estimate are 98 percent complete. To the extent that there are year-to-year changes in the volume and mix of services provided by physicians, the actual impact on total Medicare revenues will be different than those shown in Table 34. The payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here because physicians furnish services to both Medicare and non-Medicare patients and specialties may receive substantial Medicare revenues for services that are not paid under the PFS. For instance, independent laboratories receive approximately 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the PFS.

Table 34 shows only the payment impact on PFS services. The following is an explanation of the information represented in Table 34. Note that this table does include the impact of the CY 2007 update.

• Specialty: The physician specialty or type of practitioner/supplier.

• Allowed Charges: Allowed charges are the Medicare Fee Schedule amounts for covered services and include copayments and deductibles (which are the financial responsibility of the beneficiary). These amounts have been summed across all services provided by physicians, practitioners, or suppliers with a specialty to arrive at the total allowed charges for the specialty.

• Impact of Work RVU Changes from the five year review of work

• Impact of PE RVU changes. The impact is shown for both 2007, which is the first year of the four year transition using the new methodology, and 2010, which is the year in which the methodology is fully implemented.

• Combined impact of the finalized work and PE RVUs for both 2007 and 2010.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.013" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.014" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.015" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

2. Section 5102 of the DRA Adjustments for Payments for Imaging Services

As required by section 5102(a) of the DRA and described in section II.E.1. of this final rule with comment period, we are removing, from the PE RVUs under the PFS the 0.3 percent increase made to the PE RVUs in the CY 2006 PFS final rule with comment period to ensure the BN of the impact of the multiple imaging policy adopted for CY 2006. Section 5102(a) of the DRA exempts the CY 2006 and 2007 impact of the multiple imaging policy from BN. Because we proposed to maintain the current 25 percent payment reduction for multiple imaging procedures in CY 2007, there is no additional impact resulting from our policies for CY 2007. Section 5102 of the DRA also exempts the estimated savings from the application of the OPPS-based payment limitation on PFS imaging services from the PFS BN requirement. We estimate that the combined impact of the BN exemptions in section 5102 of the DRA would reduce PFS expenditures by approximately 0.9 percent in CY 2007.

3. Combined Impacts

Table 35 shows the specialty-level impact of: The work and PE RVU changes, section 5102 of the DRA, and our most recent estimate (-5.0 percent) of the CY 2007 Medicare PFS update. Additionally, the impacts in this final rule with comment period reflect the use of updated physician time data from the AMA-RUC.

Our estimates of changes in Medicare revenues for PFS services compare payment rates for CY 2006 with proposed payment rates for CY 2007 using CY 2005 Medicare utilization for all years. We are using CY 2005 Medicare claims processed and paid through March 30, 2005, that we estimate are 98 percent complete. To the extent that there are year-to-year changes in the volume and mix of services provided by physicians, the actual impact on total Medicare revenues will be different than those shown in Table 35. The payment impacts reflect averages for each specialty based on Medicare utilization. The payment impact for an individual physician would be different from the average, based on the mix of services the physician provides. The average change in total revenues would be less than the impact displayed here because physicians furnish services to both Medicare and non-Medicare patients and specialties may receive substantial Medicare revenues for services that are not paid under the PFS. For instance, independent laboratories receive approximately 80 percent of their Medicare revenues from clinical laboratory services that are not paid under the PFS.

Table 35 shows only the payment impact on PFS services. The following is an explanation of the information represented in Table 35.

• Specialty: The physician specialty or type of practitioner/supplier.

• Allowed Charges: Allowed charges are the Medicare Fee Schedule amounts for covered services and include copayments and deductibles (which are the financial responsibility of the beneficiary.) These amounts have been summed across all services provided by physicians, practitioners, or suppliers with a specialty to arrive at the total allowed charges for the specialty.

• Impact of Work and PE RVU Changes using the methodology finalized in this rule.

• Impact of section 5102 of the DRA: The CY 2007 percentage decrease in allowed charges attributed to section 5102 of the DRA.

• Combined impact of the finalized work and PE RVUs and section 5102 of the DRA.

• CY 2007 Update: The percentage decrease in allowed charges attributed to the CY 2007 PFS conversion factor update (-5.0 percent).

• Combined impact with CY 2007 update: The CY 2007 percentage decrease in allowed charges attributed to the impact of the work and PE RVU changes, section 5102 of the DRA, and the CY 2007 update.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.016" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.017" is not available. Please view the graphic in the PDF version of this document.]

Table 36 shows the impact on total payments for selected high-volume procedures of all of the changes previously discussed. We selected these procedures because they are the most commonly provided by a broad spectrum of physician specialties. There are separate columns that show the change in the facility rates and the nonfacility rates. For an explanation of facility and nonfacility PE refer to Addendum A of this final rule with comment period.

[Federal Register graphic "ER01DE06.018" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.019" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

B. Geographic Practice Cost Indices (GPCI)-Payment Localities

As discussed in section II.B. of the preamble to this final rule with comment period, we proposed new GPCIs for 2007. In the CY 2005 PFS final rule with comment period, we published 2005 and 2006 GPCI and GAF values reflecting the 2-year phase-in of updated GPCI data. In 2007, the proposed GPCI and GAF values will reflect the removal of the 1.000 MMA floor from the physician work GPCI. The negative impact of these changes on a number of payment localities is shown in section II.B. in Table 7.

C. Global Period for Remote Afterloading High Intensity Brachytherapy Procedures

As discussed in section II.D.1. of this final rule with comment period, we are revising the global period for these services. We do not anticipate this change will have a significant impact on Medicare expenditures. Current brachytherapy coding allows for billing only one time for the entire physician services provided during a 90-day period. Any expected increase in the billing of brachytherapy physician services is offset by the reduction in the work RVUs.

D. DRA 5112: Addition of the Ultrasound Screening for Abdominal Aortic Aneurysm to "Welcome to Medicare" Benefit

As discussed in section II.E.3. of this final rule with comment period, section 5112 of the DRA authorizes coverage of an ultrasound screening for abdominal aortic aneurysms effective January 1, 2007, subject to certain eligibility and other limitations. We estimate that this new benefit would result in an increase in Medicare expenditures to physicians and other practitioners and suppliers of ultrasound services and related follow-up tests and treatment that may be required as a result of the coverage of these screening examinations. However, this is not expected to have a significant cost impact on the Medicare program because of the limited scope of the benefit.

E. DRA 5113: Colorectal Screening Exemption From Part B Deductible

As discussed in section II.E.4. of this final rule with comment period, beginning January 1, 2007, colorectal cancer screening services as described in section 1861(pp)(1) of the Act are no longer subject to the Part B deductible. While waiver of this deductible will be beneficial to Medicare beneficiaries, we do not anticipate that this change will have a significant cost impact on the Medicare program.

F. Section 5114: Addition of Diabetes Outpatient Self-Management Training Services (DSMT) and Medical Nutrition Therapy (MNT) for the FQHC Program

As discussed in section II.E.5. of this final rule with comment period, section 5114 of the DRA amended section 1861(aa)(3) the Act to add DSMT and MNT to the list of Medicare covered and reimbursed services under the Medicare FQHC benefit, effective for services provided on or after January 1, 2006. Although this statutory change has already been implemented in administrative instructions, we proposed to conform the regulations to meet the new statutory requirement. FQHCs certified as DSMT and MNT providers have been allowed to bundle the cost of those services into their FQHC payment rates. But before the enactment of the DRA, the provision of these services would not generate a separate FQHC visit payment. Effective for services furnished on or after January 1, 2006, FQHCs that are certified providers of DSMT and MNT services can receive per visit payments for covered services furnished by registered dietitians or nutrition professionals. Because there are a limited number of qualified centers for DSMT and MNT services, the increase in Medicare expenditures should be negligible.

G. Payment for Covered Outpatient Drugs and Biologicals (ASP Issues)

While it is difficult to quantify the impact of clarifications in ASP reporting guidelines on Medicare expenditures, we expect that the changes discussed in section II.F. of this final rule with comment period, for payment for covered outpatient drugs and biologicals, will have a minimal impact on Medicare expenditures.

H. Provisions Related to Payment for Renal Dialysis Services Furnished by End State Renal Disease (ESRD) Facilities

In section II.G. of this final rule with comment period, we discuss the ESRD-related provisions. To understand the impact of the changes affecting payments to different categories of ESRD facilities, it is necessary to compare estimated payments under the current year (2006 payments) to estimated payments under the revisions to the composite rate payment system as discussed in II.G. of this final rule with comment period (2007 payments). To estimate the impact among various classes of ESRD facilities, it is imperative that the estimates of current payments and projected payments contain similar inputs. Therefore, we simulated payments only for those ESRD facilities that we are able to calculate both current 2006 payments and 2007 payments.

ESRD providers were grouped into the categories based on characteristics provided in the Online Survey and Certification and Reporting (OSCAR) file and the most recent cost report data from the Healthcare Cost Report Information System (HCRIS). We also used the June 2006 update of CY 2005 National Claims History file as a basis for Medicare dialysis treatments and separately billable drugs and biologicals. Due to data limitations, we are unable to estimate current and proposed payments for 130 of the 4,669 ESRD facilities that bill for ESRD dialysis treatments.

Number of facilities Number of dialysis treatments (in millions) Effect of changes in wage index1 Overall effect2
All Providers 4,539 34.4 0.0 0.5
Independent 3,958 30.7 -0.1 0.5
Hospital Based 581 3.7 0.4 1.0
By Facility Size:
Less than 5000 treatments 1,628 4.6 -0.3 0.2
5000 to 9999 treatments 1,756 12.9 0.0 0.5
Greater than 9999 treatments 1,155 16.9 0.1 0.6
By Type of Ownership:
Profit 3,607 27.8 -0.1 0.4
Nonprofit 932 6.6 0.3 0.8
By Geographic Location:
Rural 1,217 7.0 -0.6 0.0
Urban 3,322 27.4 0.1 0.7
By Region:
New England 152 1.2 1.1 1.6
Middle Atlantic 549 4.4 0.6 1.1
East North Central 716 5.4 -0.5 0.1
West North Central 341 1.9 -0.4 0.1
South Atlantic 1,014 7.9 0.0 0.5
East South Central 358 2.6 -1.1 -0.6
West South Central 633 4.7 -0.7 -0.1
Mountain 245 1.6 0.1 0.7
Pacific 500 4.2 1.1 1.7
Puerto Rico 31 0.4 -1.6 -1.1
1 This column shows the effect of wage index changes on ESRD providers. Composite rate payments computed using the current wage index are compared to composite rate payments using the CY 2007 wage index changes.
2 This column shows the percent change between CY 2007 and CY 2006 composite rate payments to ESRD facilities. The CY 2007 payments include the CY 2007 wage adjusted composite rate, and the 15.1 percent drug add-on times treatments. The CY 2006 payments to ESRD facilities includes the CY 2006 wage adjusted composite rate and the 14.5 percent drug add-on times treatments.

Table 37 shows the impact of this year's changes to CY 2007 payments to hospital-based and independent ESRD facilities. The first column of Table 37 identifies the type of ESRD provider, the second column indicates the number of ESRD facilities for each type, and the third column indicates the number of dialysis treatments.

The fourth column shows the effect of CY 2007 changes to the ESRD wage index as it affects the composite rate payments to ESRD facilities. The fourth column compares aggregate ESRD wage adjusted composite rate payments in the second year of the transition (CY 2007) to aggregate ESRD wage adjusted composite rate payments in first year of the transition (CY 2006). In the second year of the transition (CY 2007), ESRD facilities receive 50 percent of the CBSA wage adjusted composite rate and 50 percent of the MSA wage adjusted composite rate. In the first year of the transition, ESRD facilities receive 25 percent of the CBSA wage adjusted composite rate and 75 percent of the MSA wage adjusted composite rate. The overall effect to all ESRD providers in aggregate is zero because the CY 2007 ESRD wage index has been multiplied by a BNF to comply with the statutory requirement that any wage index revisions be done in a manner that results in the same aggregate amount of expenditures as would have been made without any changes in the wage index. The decreases shown among census regions is primarily due to reducing the wage index floor, as there were areas in these areas with wage index values below the floor.

The fifth column shows the overall effect of the changes in composite rate payments to ESRD providers. The overall effect is measured as the difference between the projected CY 2007 payment with all changes in this final rule and CY 2006 payment. This payment amount is computed by multiplying the wage adjusted composite rate with the drug add-on for each provider times the number of dialysis treatments from 2005 claims. The projected CY 2007 payment is the transition year 2 wage-adjusted composite rate for each provider (with the 15.1 percent drug add-on) times dialysis treatments from CY 2005 claims. The CY 2006 current payment is the transition year 1 wage-adjusted composite rate for each provider (with the current 14.5 percent drug add-on) times dialysis treatments from CY 2005 claims.

The overall impact to ESRD providers in aggregate is 0.5 percent. This increase corresponds to the 0.5 percent increase to the drug add-on. The variation seen in column 5 is due to variation in changes in the wage index (column 4). All provider types receive the same 0.5 percent increase to the drug add-on.

Comment: We received a comment requesting that we update the impact table to reflect the current Puerto Rico ESRD provider count and treatment count.

Response: The impact table shows the same provider count the commenter suggested. However, our tabulation of the 2005 claims data indicates that there are 0.4 million treatments rather than the 0.55 million treatment count furnished by the commenter.

I. Private Contracts and Opt-out Provision

The changes discussed in this final rule with comment period, for private contracts and the opt-out provision, are currently estimated to have no significant impact on Medicare expenditures as the number of physicians and practitioners who opt-out of Medicare is very small.

J. Supplier Access to Claims Billed on Reassignment

The reassignment provisions discussed in section II.J.2. of this final rule with comment period are amending the reassignment regulations so that employees will have the same "unrestricted access to billing records," that has been afforded to independent contractors since January 1, 2005. We are simply extending this right to access one's billing records to employees. This change should have no impact on Medicare expenditures.

K. Coverage of Bone Mass Measurement

As discussed in section II.K. of this final rule with comment period, we discuss several revisions to § 410.31 relative to the definition of the term "Bone Mass Measurement" (§ 410.31(a)(2)), the conditions for coverage (§ 410.31(b)), the examples of exceptions to the standards on frequency of coverage (§ 410.31(c)(2)), and the category of individuals receiving glucocorticoid (steroid) therapy (§ 410.31(d)(3)). We also discuss the addition of a new paragraph (f) that would allow CMS, through the NCD process, to identify additional BMM systems for monitoring individuals receiving osteoporosis drug therapy and for performing confirmatory baseline measurements. We do not expect that this addition would have a significant cost impact on the Medicare program in the next several years.

Based on the projected impact of the first three changes that would place greater reliance on the use of the more expensive DXA (axial skeleton) devices, we estimate that this revised benefit would result in an increase in Medicare payments for providers who use the DXA (axial skeleton) devices and a somewhat smaller decrease in payments to providers who use QCT (axial skeleton) and peripheral devices. However, we do not expect that these changes would have a significant cost impact on the Medicare program because, at present, a very small percentage of our total Medicare payments for bone mass measurements are being made to providers who use QCT or peripheral devices. In addition, we estimate that lowering the eligibility standard for coverage of individuals on steroid therapy from 7.5 mg/day to 5.0 mg/day of prednisone (the fourth change) would result in an increase in Medicare payment for testing of additional patients, but this modest lowering of the steroid standard is not expected to have a significant cost impact on the program.

L. IDTF Changes

The costs associated with these changes are as follows.

1. Liability Insurance Requirement (§ 424.57(c)(10))

We estimate that only 10 percent of IDTFs do not already have liability insurance that meets this requirement. Based on Medicare data as of June 2005, 10 percent of the total number of IDTF's is approximately 559 suppliers. Using the previously highest estimate received ($1,800 annually), results in an approximate additional liability insurance cost of $1 million annually (559 times $1,800) to the IDTF industry due to this final rule with comment period.

2. Primary Business Telephone Listed Under the Name of the Business Locally or Toll-free for Beneficiaries Requirement (§ 424.57(c)(9))

We estimate that only 1 percent of IDTFs do not already meet this requirement. Based on Medicare data as of June 2005, we determined that 1 percent of IDTFs is approximately 56 suppliers. Therefore, 56 times the approximate $600 annual cost of telephone service results in an additional cost of $33,600 annually. Total Cost = $1 million + $33,600 = approximately $1.04 million annually.

M. Independent Lab Billing for TC Component of Physician Pathology Services for Hospital Patients

The most current information on the number of affected hospitals and the impact on laboratories and hospitals comes from a report issued by GAO in September 2003.

The GAO estimated that approximately 95 percent of the total of all Medicare hospitals on the prospective payment system, as well as CAHs sent the TC of physician pathology services to independent laboratories and the independent laboratories billed the carrier under the PFS.

The GAO estimated that the median number of services sent by each hospital to outside independent laboratories was small, approximately 81 services. The GAO was unable to identify the number of laboratories billing for the TC service because a single laboratory may submit claims under multiple provider numbers. In general, the impact on the individual hospital is small; however, we do not know the impact on the individual independent laboratory.

If the independent laboratories had not received payments from the carriers for these TC services for hospital patients, the GAO estimates that Medicare spending would have been $42 million less in 2001 and beneficiary cost sharing obligations for inpatient and outpatient services would have been reduced by $2 million.

Based on what they learned from the hospital industry, the GAO thought that Medicare beneficiaries' access to pathology services would not likely be affected if independent laboratories could no longer bill the carrier for these services. Hospital representatives indicated that they would likely continue to use independent laboratories to provide TC pathology services.

It is unclear if the hospitals contracting with independent laboratories would pay the laboratories at the same rates that the laboratories received by billing the Medicare carriers under the PFS.

N. Public Consultation for Medicare Payment for New Outpatient Clinical Diagnostic Laboratory Tests

This codification of our process for public consultation for new clinical diagnostic laboratory tests paid under the Medicare Part B clinical laboratory fee schedule does not increase or decrease payment amounts for existing clinical diagnostic laboratory tests because it does not alter our current methodology for calculating payment amounts for existing clinical diagnostic laboratory tests. For new tests, this change primarily codifies an existing process for the determination of payment amounts. Because any new laboratory tests to be gapfilled are unknown to us at the current time, we do not have any data to estimate the impact of our policy to pay for new gapfilled lab tests at the median of the local carrier amounts for all carriers rather than the lower of that amount and the local carrier amount.

O. Bad Debt Payment for Services Associated With Reasonable Charge/Fee Schedules

This is a clarification of a longstanding policy and, therefore, has no associated dollar impact.

P. Revisions to Payment Policies Under the Ambulance Fee Schedule and the Ambulance Inflation Factor Update for CY 2007

We believe that the overall effect of adopting the CBSA-based geographic definitions, as well as the RUCAs will result in a redistribution of payments from urban to rural areas in some States and from rural to urban areas in other States; however, the RUCAs will enable rural areas with a rurality level of 4.0 or greater in all counties in all States to remain rural rather than only recognizing those rural areas in large counties per the Goldsmith Modification. We have included three tables to reflect the impact of the geographic changes. These three tables reflect the CBSA-based definitions, as well as the RUCAs. Table 38 is a State-by-State analysis of urban and rural areas after all geographic changes have been implemented. As can be seen in this table, there is not a great deal of difference between the number of zip codes that move from rural to urban (2,328-5.56 percent) and the number of zip codes that move from urban to rural (1,870-4.46 percent). There are a total of 41,888 zip codes-an average of 89.98 percent of all zip codes do not change their geographic designation. Table 39 is an analysis of all the areas to which commenters referred as specific concerns for them in response to the proposed rule. The table is arranged by State, and, within each State, by zip code area based on the information provided by the commenters (some commenters mentioned counties or townships). We translated those concerns into the appropriate zip code areas within each State. This table shows the actual RUCA rurality level of each of these zip code areas. If the area is, indeed, designated urban (a rurality level of less than 4.0), a "yes" is indicated in the "Urban Zip?" column, and the associated town or city is named in the following column as a reference point. Approximately half of the areas about which commenters were specifically concerned remained rural once the RUCA rurality level was applied. The third and final table is Addendum I which shows all zip codes nationally by State and the rurality level associated with each zip code.

In addition, we contend that with the use of updated geographical areas where rural areas are redesignated as urban areas, it will be more likely than not, that some level of population growth has occurred resulting in more ambulance trips overall than had occurred prior to the use of the updated geographical areas, even though these trips are paid at a lower rate per trip (areas designated as rural generally receive a higher payment per trip than areas designated as urban).

In contrast, where urban areas are redesignated as rural, there will be fewer trips than were reported prior to the use of the updated geographical areas, but at higher rates. Thus, although ambulance suppliers and providers may bill fewer rural trips at the higher rate or more urban trips at the lower rate, we anticipate that the overall payments will remain the same. For these reasons, we estimate that this proposed rule will have no fiscal impact on the Medicare program because payments will, in effect, be redistributed.

We estimate that the total program expenditure for CY 2007 for ambulance services covered by the Medicare program is approximately $4.8 billion. Application of an AIF of 4.3 percent will result in an additional total program expenditure for CY 2007 of approximately $206 million over CY 2006 expenditures.

With respect to our SCT policies, while we believe ambulance suppliers and providers may now better understand the interfacility requirements and the personnel requirements for payment of SCT services, we do not expect any significant net impact on Medicare expenditures.

BILLING CODE 4120-01-P

[Federal Register graphic "ER01DE06.020" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.021" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.022" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.023" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.024" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.025" is not available. Please view the graphic in the PDF version of this document.]

[Federal Register graphic "ER01DE06.026" is not available. Please view the graphic in the PDF version of this document.]

BILLING CODE 4120-01-C

Q. Alternatives Considered

This final rule with comment period contains a range of policies, including some provisions related to specific MMA provisions. The preamble provides descriptions of the statutory provisions that are addressed, identifies those policies when discretion has been exercised, presents rationale for our decisions and, where relevant, alternatives that were considered.

R. Impact on Beneficiaries

There are a number of changes made in this final rule with comment period that would have an effect on beneficiaries. In general, we believe these changes, particularly the DRA provisions that provide for an exception to the application of the Part B deductible with respect to colorectal cancer screening tests and coverage of an ultrasound screening for the early detection of AAAs as part of the IPPE benefit (referred to as the Welcome to Medicare benefit) will improve beneficiary access to services that are currently covered or expand the Medicare benefit package to include new services. As explained in more detail below in this section, the regulatory provisions may affect beneficiary liability in some cases. Any changes in aggregate beneficiary liability from a particular provision would be a function of the coinsurance (20 percent if applicable for the particular provision after the beneficiary has met the deductible) and the effect of the aggregate cost (savings) of the provision on the calculation of the Medicare Part B premium rate (generally 25 percent of the provision's cost or savings).

To illustrate this point, as shown in Table 36, the 2006 national payment amount in the nonfacility setting for CPT code 99203 (Office/outpatient visit, new), is $97.02 which means that currently a beneficiary is responsible for 20 percent of this amount, or $19.40. Based on this final rule with comment period, the 2007 national payment amount in the nonfacility setting for CPT code 99203, as shown in Table 36, is $87.44 which means that, in 2007, the beneficiary coinsurance for this service would be $17.49.

Policies discussed above in this section that do affect overall spending, such as DRA 5102 imaging provisions, would similarly impact beneficiaries' coinsurance.

S. Accounting Statement

As required by OMB Circular A-4 (available at http://www.whitehouse.gov/omb/circulars/a004/a-4.pdf ), in Table 40, we have prepared an accounting statement showing the classification of the expenditures associated with this final rule with comment period. This table provides our best estimate of the decrease in Medicare payments under the physician fee schedule as a result of the provisions presented in this final rule with comment period for CY 2007. All expenditures are classified as transfers.

Category Transfers
Annualized Monetized Transfers Estimated decrease in expenditures of $3.7 billion.
From Whom To Whom? Federal Government to physicians, other practitioners and suppliers who receive payment under the Medicare Physician Fee Schedule; ESRD Medicare Providers; ambulance suppliers, and Medicare suppliers billing for Part B drugs.

In accordance with the provisions of Executive Order 12866, this final rule was reviewed by the Office of Management and Budget.

List of Subjects

42 CFR Part 405

Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medical devices, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.

42 CFR Part 410

Health facilities, Health professions, Kidney diseases, Laboratories, Medicare, Reporting and recordkeeping requirements, Rural areas, X-rays.

42 CFR Part 411.

Kidney diseases, Medicare, Physician Referral, Reporting and recordkeeping requirements.

42 CFR Part 413

Health facilities, Kidney diseases, Medicare, Reporting and recordkeeping requirements.

42 CFR part 414

Administrative practice and procedure, Health facilities, Health professions, Kidney diseases, Medicare, Reporting and recordkeeping.

42 CFR Part 415

Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.

42 CFR Part 424

Emergency medical services, Health facilities, Health professions, Medicare, Reporting and recordkeeping requirements.

For the reasons set forth in the preamble, the Centers for Medicare Medicaid Services amends 42 CFR chapter IV as follows:

PART 405-FEDERAL HEALTH INSURANCE FOR THE AGED AND DISABLED

1. The authority citation for part 405 continues to read as follows:

Authority:

Secs. 1102, 1861, 1862(a), 1871, 1874, 1881, and 1886(k) of the Social Security Act (42 U.S.C. 1302, 1395x, 1395y(a), 1395hh, 1395kk, 1395rr, and 1395ww(k)), and sec. 353 of the Public Health Service Act (42 U.S.C. 263a).

Subpart D-Private Contracts

2. Section 405.400 is amended by revising the definition of "Practitioner" to read as follows:

§ 405.400 Definitions.

Practitioner means a physician assistant, nurse practitioner, clinical nurse specialist, certified registered nurse anesthetist, certified nurse midwife, clinical psychologist, clinical social worker, registered dietitian or nutrition professional, who is currently legally authorized to practice in that capacity by each State in which he or she furnishes services to patients or clients.

Subpart X-Rural Health Clinic and Federally Qualified Health Center Services Payment for Rural Health Clinic and Federally Qualified Health Center Services

3. Section 405.2446 is amended by adding paragraph (b)(10) to read as follows:

§ 405.2446 Scope of services.

(b) * * *

(10) Medical nutrition therapy services as specified in part 410, subpart G of this chapter, and diabetes outpatient self-management training services as specified in part 410, subpart H of this chapter.

4. Section 405.2463 is revised to read as follows:

§ 405.2463 What constitutes a visit.

(a) Visit -(1) General. (i) For rural health clinics, a visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, visiting nurse, clinical psychologist, or clinical social worker.

(ii) For FQHCs, a visit is-

(A) A face-to-face encounter, as described in paragraph (a)(1)(i) of this section; or

(B) A face-to-face encounter between a patient and a qualified provider of medical nutrition therapy services as defined in part 410, subpart G of this chapter; or a qualified provider of outpatient diabetes self-management training services as defined in part 410, subpart H of this chapter.

(2) Medical visit. A medical visit is a face-to-face encounter between a clinic or center patient and a physician, physician assistant, nurse practitioner, nurse midwife, or a visiting nurse; and for FQHCs only, a medical visit also includes a separately billable medical nutrition therapy visit or a diabetes outpatient self-management training visit.

(3) Other health visit. An other health visit is a face-to-face encounter between a clinic or center patient and a clinical psychologist, clinical social worker, or other health professional for mental health services.

(b) Encounters. Encounters with more than one health professional and multiple encounters with the same health professional that take place on the same day and at a single location constitute a single visit, except when one of the following conditions exist:

(1) After the first encounter, the patient suffers illness or injury requiring additional diagnosis or treatment.

(2) The patient has a medical visit and other health visit(s), as defined in paragraph (a) of this section.

(c) Payment. Medicare pays for more than one visit per day when the conditions in paragraph (b) of this section are met or a separate visit under paragraph (a)(1)(ii)(B) of this section is made.

PART 410-SUPPLEMENTARY MEDICAL INSURANCE (SMI) BENEFITS

5. The authority citation for part 410 continues to read as follows:

Authority:

Secs. 1102, 1834, and 1871 of the Social Security Act (42 U.S.C. 1302, 1395m, and 1395hh).

Subpart B-Medical and Other Health Services

6. In § 410.16 paragraph (a) is amended by revising paragraph (7) of the definition of "initial preventive physical examination" to read as follows:

§ 410.16 Initial preventive physical examination: Conditions for and limitations on coverage.

(a) * * *

Initial preventive physical examination * * *.

(7) Education, counseling, and referral, including a written plan such as a checklist provided to the beneficiary for obtaining the appropriate screening and other preventive services that are covered as separate Medicare Part B benefits as described in section 1861(s)(10), section 1861(jj), section 1861(nn), section 1861(oo), section 1861(pp), section 1861(qq)(1), section 1861(rr), section 1861(uu), section 1861(vv), section 1861(xx)(1), section 1861(yy), and section 1861(bbb) of the Act.

7. A new § 410.19 is added to read as follows:

§ 410.19 Ultrasound screening for abdominal aortic aneurysms: Condition for and limitation on coverage.

(a) Definitions: As used in this section, the following definitions apply:

Eligible beneficiary means an individual who-

(1) Has received a referral for an ultrasound screening for an abdominal aortic aneurysm as a result of an initial preventive physical examination (as defined in section 1861(ww)(1) of the Act);

(2) Has not been previously furnished an ultrasound screening for an abdominal aortic aneurysm under Medicare program; and

(3) Is included in at least one of the following risk categories:

(i) Has a family history of an abdominal aortic aneurysm.

(ii) Is a man age 65 to 75 who has smoked at least 100 cigarettes in his lifetime.

(iii) Is an individual who manifests other risk factors in a beneficiary category recommended for screening by the United States Preventive Services Task Force regarding abdominal aortic aneurysms, as specified by the Secretary through a national coverage determination process.

Ultrasound screening for abdominal aortic aneurysms means the following services furnished to an asymptomatic individual for the early detection of an abdominal aortic aneurysm:

(1) A procedure using soundwaves (or other procedures using alternative technologies of commensurate accuracy and cost, as specified by the Secretary through a national coverage determination process) provided for the early detection of abdominal aortic aneurysms.

(2) Includes a physician's interpretation of the results of the procedure.

(b) Conditions for coverage of an ultrasound screening for abdominal aortic aneurysms. Medicare Part B pays for one ultrasound screening for an abdominal aortic aneurysm provided to eligible beneficiaries, as described in this section, after a referral from a physician or a qualified nonphysician practitioner as defined in § 410.16(a), when the test is performed by a provider or supplier that is authorized to provide covered ultrasound diagnostic services.

(c) Limitation on coverage of ultrasound screening for abdominal aortic aneurysms. Payment may not be made for an ultrasound screening for an abdominal aortic aneurysm that is performed for an individual that does not meet the definition of "eligible beneficiary" specified in this section.

8. Section 410.31 is revised to read as follows:

§ 410.31 Bone mass measurement: Conditions for coverage and frequency standards.

(a) Definition. As used in this section unless specified otherwise, the following definition applies:

Bone mass measurement means a radiologic, radioisotopic, or other procedure that meets the following conditions:

(1) Is performed for the purpose of identifying bone mass, detecting bone loss, or determining bone quality.

(2) Is performed with either a bone densitometer (other than single-photon or dual-photon absorptiometry) or with a bone sonometer system that has been cleared for marketing for this use by the FDA under 21 CFR part 807, or approved for marketing by the FDA for this use under 21 CFR part 814.

(3) Includes a physician's interpretation of the results of the procedure.

(b) Conditions for coverage. (1) Medicare covers a medically necessary bone mass measurement if the following conditions are met:

(i) Following an evaluation of the beneficiary's need for the measurement, including a determination as to the medically appropriate procedure to be used for the beneficiary, it is ordered by the physician or a qualified nonphysician practitioner (as these terms are defined in § 410.32(a)) treating the beneficiary.

(ii) It is performed under the appropriate level of supervision of a physician (as set forth in § 410.32(b)).

(iii) It is reasonable and necessary for diagnosing and treating the condition of a beneficiary who meets the conditions described in paragraph (d) of this section.

(2) Medicare covers a medically necessary bone mass measurement for an individual defined under paragraph (d)(5) of this section if the conditions under paragraph (b)(1) of this section are met and the monitoring is performed by the use of a dual energy x-ray absorptiometry system (axial skeleton).

(3) Medicare covers a medically necessary confirmatory baseline bone mass measurement for an individual defined under paragraph (d) of this section, if the conditions under paragraph (b)(1) of this section are met and the confirmatory baseline bone mass measurement is performed by a dual energy x-ray absorptiometry system (axial skeleton) and the initial measurement was not performed by a dual energy x-ray absorptiometry system (axial skeleton).

(c) Standards on frequency of coverage -(1) General rule. Except as allowed under paragraph (c)(2) of this section, Medicare may cover a bone mass measurement for a beneficiary if at least 23 months have passed since the month the last bone mass measurement was performed.

(2) Exception. If medically necessary, Medicare may cover a bone mass measurement for a beneficiary more frequently than allowed under paragraph (c)(1) of this section. Examples of situations where more frequent bone mass measurement procedures may be medically necessary include, but are not limited to the following medical circumstances:

(i) Monitoring beneficiaries on long-term glucocorticoid (steroid) therapy of more than 3 months.

(ii) Allowing for a confirmatory baseline measurement to permit monitoring of beneficiaries in the future if the requirements of paragraph (b)(3) of this section are met.

(d) Beneficiaries who may be covered. The following categories of beneficiaries may receive Medicare coverage for a medically necessary bone mass measurement:

(1) A woman who has been determined by the physician (or a qualified nonphysician practitioner) treating her to be estrogen-deficient and at clinical risk for osteoporosis, based on her medical history and other findings.

(2) An individual with vertebral abnormalities as demonstrated by an x-ray to be indicative of osteoporosis, osteopenia, or vertebral fracture.

(3) An individual receiving (or expecting to receive) glucocorticoid (steroid) therapy equivalent to an average of 5.0 mg of prednisone, or greater, per day for more than 3 months.

(4) An individual with primary hyperparathyroidism.

(5) An individual being monitored to assess the response to or efficacy of an FDA-approved osteoporosis drug therapy.

(e) Denial as not reasonable and necessary. If CMS determines that a bone mass measurement does not meet the conditions for coverage in paragraphs (b) or (d) of this section, or the standards on frequency of coverage in paragraph (c) of this section, it is excluded from Medicare coverage as not "reasonable" and "necessary" under section 1862(a)(1)(A) of the Act and § 411.15(k) of this chapter.

(f) Use of the National Coverage Determination Process. For the purposes of paragraphs (b)(2) and (b)(3) of this section, CMS may determine through the National Coverage Determination process that additional bone mass measurement systems are reasonable and necessary under section 1862(a)(1) of the Act for monitoring and confirming baseline bone mass measurements.

9. Section 410.33 is amended by-

A. Revising paragraph (b)(1).

B. Revising paragraph (e).

C. Adding paragraphs (g) and (h).

The revision and additions read as follows:

§ 410.33 Independent diagnostic testing facility.

(b) Supervising physician. (1) Each supervising physician must be limited to providing supervision to no more than three IDTF sites. The IDTF supervising physician is responsible for the overall operation and administration of the IDTFs, including the employment of personnel who are competent to perform test procedures, record and report test results promptly, accurately and proficiently, and for assuring compliance with the applicable regulations.

(e) Multi-State entities. (1) An IDTF that operates across State boundaries must-

(i) Maintain documentation that its supervising physicians and technicians are licensed and certified in each of the States in which it operates; and

(ii) Operate in compliance with all applicable Federal, State, and local licensure and regulatory requirements with regard to the health and safety of patients.

(2) The point of the actual delivery of service means the place of service on the claim form. When the IDTF performs or administers an entire diagnostic test at the beneficiary's location, the beneficiary's location is the place of service. When one or more aspects of the diagnostic testing are performed at the IDTF, the IDTF is the place of service.

(g) Application certification standards. The IDTF must certify in its enrollment application that it meets the following standards and related requirements:

(1) Operates its business in compliance with all applicable Federal and State licensure and regulatory requirements for the health and safety of patients.

(2) Provides complete and accurate information on its enrollment application. Any change in enrollment information must be reported to the designated fee-for-service contractor on the Medicare enrollment application within 30 calendar days of the change.

(3) Maintains a physical facility on an appropriate site. For the purposes of this standard, a post office box or commercial mail box is not considered a physical facility. The physical facility, including mobile units, must contain space for equipment appropriate to the services designated on the enrollment application, facilities for hand washing, adequate patient privacy accommodations, and the storage of both business records and current medical records within the office setting of the IDTF, or IDTF home office, not within the actual mobile unit.

(4) Has all applicable diagnostic testing equipment available at the physical site excluding portable diagnostic testing equipment. The IDTF must-

(i) Maintain a catalog of portable diagnostic equipment, including diagnostic testing equipment serial numbers at the physical site;

(ii) Make portable diagnostic testing equipment available for inspection within 2 business days of a CMS inspection request.

(iii) Maintain a current inventory of the diagnostic testing equipment, including serial and registration numbers and provide this information to the designated fee-for-service contractor upon request, and notify the contractor of any changes in equipment within 90 days.

(5) Maintain a primary business phone under the name of the designated business. The IDTF must have its-

(i) Primary business phone located at the designated site of the business or within the home office of the mobile IDTF units.

(ii) Telephone or toll free telephone numbers available in a local directory and through directory assistance.

(6) Have a comprehensive liability insurance policy of at least $300,000 per location that covers both the place of business and all customers and employees of the IDTF. The policy must be carried by a nonrelative-owned company and list the serial numbers of any and all diagnostic equipment used by the IDTF, whether the equipment is stationary, in a mobile unit, or at the beneficiary's residence.

(7) Agree not to directly solicit patients, which include, but is not limited to, a prohibition on telephone, computer, or in-person contacts. The IDTF must accept only those patients referred for diagnostic testing by an attending physician, who is furnishing a consultation or treating a beneficiary for a specific medical problem and who uses the results in the management of the beneficiary's specific medical problem. Nonphysician practitioners may order tests as set forth in § 410.32(a)(3).

(8) Answer beneficiaries' questions and respond to their complaints.

(9) Openly post these standards for review by patients and the public.

(10) Disclose to the government any person having ownership, financial, or control interest or any other legal interest in the supplier at the time of enrollment or within 30 days of a change.

(11) Have its testing equipment calibrated and maintained per equipment instructions and in compliance with applicable manufacturers suggested maintenance and calibration standards.

(12) Have technical staff on duty with the appropriate credentials to perform tests. The IDTF must be able to produce the applicable Federal or State licenses or certifications of the individuals performing these services.

(13) Have proper medical record storage and be able to retrieve medical records upon request from CMS or its fee-for-service contractor within 2 business days.

(14) Permit CMS, including its agents, or its designated fee-for-service contractors, to conduct unannounced, on-site inspections to confirm the IDTF's compliance with these standards. The IDTF must-

(i) Be accessible during regular business hours to CMS and beneficiaries; and

(ii) Maintain a visible sign posting its normal business hours.

(h) Failure to meet standards. If an IDTF fails to meet one or more of the standards in paragraph (g) of this section at the time of enrollment, its enrollment will be denied. CMS will revoke a supplier's billing privileges if and IDTF is found not to meet the standards in paragraph (g) or (b)(1) of this section.

Subpart I-Payment of SMI Benefits

10. Section 410.160 is amended by adding paragraphs (b)(7) and (b)(8) to read as follows:

§ 410.160 Part B annual deductible.

(b) * * *

(7) Beginning January 1, 2007, colorectal cancer screening tests as described in § 410.37.

(8) Beginning January 1, 2007, ultrasound screening for abdominal aortic aneurysms described in § 410.19.

PART 411-EXCLUSIONS FROM MEDICARE AND LIMITATIONS ON MEDICARE PAYMENT

11. The authority citation for part 411 is amended to read as follows:

Authority:

Secs. 1102, 1860D-1 through 1860D-42, 1871, and 1877 of the Social Security Act (42 U.S.C. 1302, 1395w-101 through 1395w-152, 1395hh, and 1395nn).

Subpart A-General Exclusions and Exclusion of Particular Services

12. Section 411.15 is amended by-

A. Revising paragraph (a)(1).

B. Adding a new paragraph (k)(12).

C. Revising paragraph (o).

The revisions and addition read as follows:

§ 411.15 Particular services excluded from coverage.

(a) * * *

(1) Examinations performed for a purpose other than treatment or diagnosis of a specific illness, symptoms, complaint, or injury, except for screening mammography, colorectal cancer screening tests, screening pelvic exams, prostate cancer screening tests, glaucoma screening exams, initial preventive physical examinations, or ultrasound screening for abdominal aortic aneurysms that meet the criteria specified in paragraphs (k)(6) through (k)(12) of this section.

(k) * * *

(12) In the case of ultrasound screening for abdominal aortic aneurysms, with the goal of early detection of abdominal aortic aneurysms, subject to the conditions and limitation specified in § 410.19 of this chapter.

(o) Experimental or investigational devices. Experimental or investigational devices, except for certain devices-

(1) Categorized by the FDA as a Category A or B device defined in § 405.201(b) of this chapter; and

(2) Furnished in accordance with the CMS clinical research policy.

PART 413-PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES

13. The authority citation for part 413 continues to read as follows:

Authority:

Secs. 1102, 1138(b), 1812(d), 1814(b), 1815, 1833(a), (i), and (n), 1871, 1881, 1883, and 1886 of the Social Security Act (42 U.S.C. 1302, 1320b-8(b), 1395d(d), 1395f(b), 1395g, 1395l(a), (i), and (n), 1395hh, 1395rr, 1395tt, and 1395ww).

Subpart F-Specific Categories of Costs

14. Section 413.89 is amended by revising paragraphs (a) and (i) to read as follows:

§ 413.89 Bad debts, charity, and courtesy allowances.

(a) Principle. Bad debts, charity, and courtesy allowances are deductions from revenue and are not to be included in allowable cost. However, subject to the limitations described under paragraph (h) of this section and the exception for services described under paragraph (i) of this section, bad debts attributable to the deductibles and coinsurance amounts are reimbursable under the program.

(i) Exception. Bad debts arising from covered services paid under a reasonable charge-based methodology or a fee schedule are not reimbursable under the program.

Subpart H-Payment for End-Stage Renal Disease (ESRD) Services and Organ Procurement Costs

15. Section 413.178 is amended by adding paragraph (d) to read as follows:

§ 413.178 Bad debts.

(d) Bad debts arising from covered ESRD services paid under a reasonable charge-based methodology or a fee schedule are not reimbursable under the program.

PART 414-PAYMENT FOR PART B MEDICAL AND OTHER HEALTH SERVICES

16. The authority citation for Part 414 continues to read as follows:

Authority:

Secs. 1102, 1871, and 1881(b)(l) of the Social Security Act (42 U.S.C. 1302, 1395hh, and 1395rr(b)(l)).

17. A new subpart G is added as follows:

Subpart G-Payment for New Clinical Diagnostic Laboratory Tests

Sec. 414.500 Basis and scope.414.502 Definitions.414.504 [Reserved]414.506 Procedures for public consultation for payment for a new clinical diagnostic laboratory test.414.508 Payment for a new clinical diagnostic laboratory test.414.510 Laboratory date of service for specimens.

Subpart G-Payment for New Clinical Diagnostic Laboratory Tests

§ 414.500 Basis and scope.

This subpart implements provisions of 1833(h)(8) of the Act-procedures for determining the basis for, and amount of, payment for a new clinical diagnostic laboratory test with respect to which a new or substantially revised Healthcare Common Procedure Coding System code is assigned on or after January 1, 2005.

§ 414.502 Definitions.

For purposes of this subpart-

Substantially Revised Healthcare Common Procedure Coding System Code means a code for which there has been a substantive change to the definition of the test or procedure to which the code applies (such as a new analyte or a new methodology for measuring an existing analyte specific test).

§ 414.504 [Reserved]

§ 414.506 Procedures for public consultation for payment for a new clinical diagnostic laboratory test.

For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment after the performance of the following:

(a) CMS makes available to the public (through CMS's Internet Web site) a list that includes codes for which establishment of a payment amount is being considered for the next calendar year.

(b) CMS publishes a Federal Register notice of a meeting to receive public comments and recommendations (and data on which recommendations are based) on the appropriate basis, as specified in § 414.508, for establishing payment amounts for the list of codes made available to the public.

(c) Not fewer than 30 days after publication of the notice in the Federal Register , CMS convenes a meeting that includes representatives of CMS officials involved in determining payment amounts, to receive public comments and recommendations (and data on which the recommendations are based).

(d) Considering the comments and recommendations (and accompanying data) received at the public meeting, CMS develops and makes available to the public (through an Internet Web site and other appropriate mechanisms) a list of-

(1) Proposed determinations with respect to the appropriate basis for establishing a payment amount for each code, with an explanation of the reasons for each determination, the data on which the determinations are based, and a request for public written comments within a specified time period on the proposed determination; and

(2) Final determinations of the payment amounts for tests, with the rationale for each determination, the data on which the determinations are based, and responses to comments and suggestions from the public.

§ 414.508 Payment for a new clinical diagnostic laboratory test.

For a new clinical diagnostic laboratory test that is assigned a new or substantially revised code on or after January 1, 2005, CMS determines the payment amount based on either of the following:

(a) Crosswalking. Crosswalking is used if it is determined that a new test is comparable to an existing test, multiple existing test codes, or a portion of an existing test code.

(1) CMS assigns to the new test code, the local fee schedule amounts and national limitation amount of the existing test.

(2) Payment for the new test code is made at the lesser of the local fee schedule amount or the national limitation amount.

(b) Gapfilling. Gapfilling is used when no comparable existing test is available.

(1) In the first year, carrier-specific amounts are established for the new test code using the following sources of information to determine gapfill amounts, if available:

(i) Charges for the test and routine discounts to charges;

(ii) Resources required to perform the test;

(iii) Payment amounts determined by other payers; and

(iv) Charges, payment amounts, and resources required for other tests that may be comparable or otherwise relevant.

(2) In the second year, the test code is paid at the national limitation amount, which is the median of the carrier-specific amounts.

(3) After the first year of gapfilling, CMS determines whether the carrier-specific amounts will pay for the test appropriately. If CMS determines that the carrier-specific amounts will not pay for the test appropriately, CMS may crosswalk the test.

§ 414.510 Laboratory date of service for specimens.

The date of service for a laboratory test is as follows:

(a) Except as provided under paragraph (b) of this section, the date of service of the test must be the date the specimen was collected.

(b)(1) If a specimen was collected over a period that spans 2 calendar days, then the date of service must be the date the collection ended.

(2) In the case of a test performed on a stored specimen, if a specimen was stored for-

(i) Less than or equal to 30 calendar days from the date it was collected, the date of service of the test must be the date the test was performed only if-

(A) The test is ordered by the patient's physician at least 14 days following the date of the patient's discharge from the hospital;

(B) The specimen was collected while the patient was undergoing a hospital surgical procedure;

(C) It would be medically inappropriate to have collected the sample other than during the hospital procedure for which the patient was admitted;

(D) The results of the test do not guide treatment provided during the hospital stay; and

(E) The test was reasonable and medically necessary for the treatment of an illness.

(ii) More than 30 calendar days before testing, the specimen is considered to have been archived and the date of service of the test must be the date the specimen was obtained from storage.

(3) In the case of a chemotherapy sensitivity test performed on live tissue, the date of service of the test must be the date the test was performed only if-

(i) The decision regarding the specific chemotherapeutic agents to test is made at least 14 days after discharge;

(ii) The specimen was collected while the patient was undergoing a hospital surgical procedure;

(iii) It would be medically inappropriate to have collected the sample other than during the hospital procedure for which the patient was admitted;

(iv) The results of the test do not guide treatment provided during the hospital stay; and,

(v) The test was reasonable and medically necessary for the treatment of an illness.

(4) For purposes of this section, "chemotherapy sensitivity test" means a test identified by the Secretary as a test that requires a fresh tissue sample to test the sensitivity of tumor cells to various chemotherapeutic agents. The Secretary identifies such tests through program instructions.

Subpart H-Fee Schedule for Ambulance Services

18. Section 414.605 is amended by-

A. Removing the definition of "Goldsmith modification."

B. Revising the definition of "rural area."

C. Adding the definition of "urban area" in alphabetical order.

The revisions and addition read as follows:

§ 414.605 Definitions.

Rural area means an area located outside an urban area, or a rural census tract within a Metropolitan Statistical Area as determined under the most recent version of the Goldsmith modification as determined by the Office of Rural Health Policy of the Health Resources and Services Administration.

Urban area means a Metropolitan Statistical Area, as defined by the Executive Office of Management and Budget.

19. Section 414.610 is amended by revising paragraph (g) to read as follows:

§ 414.610 Basis of payment.

(g) Adjustments. The Secretary monitors payment and billing data on an ongoing basis and adjusts the CF and air ambulance rates as appropriate to reflect actual practices under the fee schedule. These rates are not adjusted solely because of changes in the total number of ambulance transports.

Subpart J-Submission of Manufacturer's Average Sales Price Data

20. Section 414.802 is amended by adding the definition of "Bona fide service fees" in alphabetical order to read as follows:

§ 414.802 Definitions.

Bona fide service fees means fees paid by a manufacturer to an entity, that represent fair market value for a bona fide, itemized service actually performed on behalf of the manufacturer that the manufacturer would otherwise perform (or contract for) in the absence of the service arrangement, and that are not passed on in whole or in part to a client or customer of an entity, whether or not the entity takes title to the drug.

21. Section 414.804 is amended by revising paragraphs (a)(1) through (a)(4) to read as follows:

§ 414.804 Basis of payment.

(a) * * *

(1) The manufacturer's average sales price for a quarter for a drug represented by a particular 11-digit National Drug Code must be calculated as the manufacturer's sales to all purchasers in the United States for that particular 11-digit National Drug Code (after excluding sales as specified in paragraph (a)(4) of this section and then deducting price concessions as specified in paragraphs (a)(2) and (a)(3) of this section) divided by the total number of units sold by the manufacturer in that quarter (after excluding units associated with sales as specified in paragraph (a)(4) of this section).

(2) Price concessions. (i) In calculating the manufacturer's average sales price, a manufacturer must deduct price concessions. Price concessions include the following types of transactions and items:

(A) Volume discounts.

(B) Prompt pay discounts.

(C) Cash discounts.

(D) Free goods that are contingent on any purchase requirement.

(E) Chargebacks and rebates (other than rebates under the Medicaid program).

(ii) For the purposes of paragraph (a)(2)(i), bona fide services fees are not considered price concessions.

(3) To the extent that data on price concessions, as described in paragraph (a)(2) of this section, are available on a lagged basis, the manufacturer must estimate this amount in accordance with the methodology described in this paragraph.

(i)(A) For each National Drug Code with at least 12 months of sales (including products for which the manufacturer has redesignated the National Drug Code for the specific product and package size and has 12 months of sales across the prior and current National Drug Codes), after adjusting for exempted sales, the manufacturer calculates a percentage equal to the sum of the price concessions for the most recent 12-month period available associated with sales subject to the average sales price reporting requirement divided by the total in dollars for the sales subject to the average sales price reporting requirement for the same 12-month period.

(B) For each National Drug Code with less than 12 months of sales, the calculation described in paragraph (i)(A) of this section is performed for the time period equaling the total number of months of sales.

(ii) The manufacturer multiplies the applicable percentage described in paragraph (a)(3)(i)(A) or (a)(3)(i)(B) of this section by the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted. (The manufacturer must carry a sufficient number of decimal places in the calculation of the price concessions percentage in order to round accurately the net total sales amount for the quarter to the nearest whole dollar.) The result of this multiplication is then subtracted from the total in dollars for the sales subject to the average sales price reporting requirement (after adjusting for exempted sales) for the quarter being submitted.

(iii) The manufacturer uses the result of the calculation described in paragraph (a)(3)(ii) of this section as the numerator and the number of units sold in the quarter (after adjusting for exempted sales) as the denominator to calculate the manufacturer's average sales price for the National Drug Code for the quarter being submitted.

(iv) Example. After adjusting for exempted sales, the total lagged price concessions (discounts, rebates, etc.) over the most recent 12-month period available associated with sales for National Drug Code 12345-6789-01 subject to the ASP reporting requirement equal $200,000, and the total in dollars for the sales subject to the average sales price reporting requirement for the same period equals $600,000. The lagged price concessions percentage for this period equals 200,000/600,000 = 0.33333. The total in dollars for the sales subject to the average sales price reporting requirement for the quarter being reported, after accounting for non-lagged price concessions, equals $50,000 for 10,000 units sold. The manufacturer's average sales price calculation for this National Drug Code for this quarter is: $50,000-(0.33333 × $50,000) = $33,334 (net total sales amount); $33,334/10,000 = $3.33 (average sales price).

(4) Exempted sales. (i) In calculating the manufacturer's average sales price, a manufacturer must exclude sales that are exempt from inclusion in the determination of the best price under section 1927(c)(1)(C)(i) of the Act and sales that are merely nominal in amount as applied for purposes of section 1927(c)(1)(C)(ii)(III) of the Act, as limited by section 1927(c)(1)(D) of the Act.

(ii) In determining nominal sales exempted under section 1927(c)(1)(C)(ii)(III) of the Act, the manufacturer calculates the average manufacturer price as defined in section 1927(k) of the Act and then identifies sales that are eligible to be considered a nominal sale under section 1927(c)(1)(D) of the Act and are at less than 10 percent of the average manufacturer price. To identify nominal sales, the manufacturer must use the average manufacturer price for the calendar quarter that is the same calendar quarter as the average sales price reporting period.

Subpart K-Payment for Drugs and Biologicals Under Part B

22. Section 414.904 is amended by revising paragraphs (d)(2)(iii) and (d)(3) to read as follows:

§ 414.904 Average sales price as the basis for payment.

(d) * * *

(2) * * *

(iii) Effective for drugs and biologicals furnished in CY 2006 and subsequent calendar years, the payment for such drugs and biologicals furnished in connection with renal dialysis services and separately billed by freestanding and hospital-based renal dialysis facilities not paid on a cost basis is the amount determined under section 1847A of the Act.

(3) Widely available market price and average manufacturer price. If the Inspector General finds that the average sales price exceeds the widely available market price or the average manufacturer price by 5 percent or more in CYs 2005, 2006, and 2007, the payment limit in the quarter following the transmittal of this information to the Secretary is the lesser of the widely available market price or 103 percent of the average manufacturer price.

PART 415-SERVICES FURNISHED BY PHYSICIANS IN PROVIDERS, SUPERVISING PHYSICIANS IN TEACHING SETTINGS, AND RESIDENTS IN CERTAIN SETTINGS

23. The authority citation for part 415 continues to read as follows:

Authority:

Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

Subpart C-Part B Carrier Payments for Physician Services to Beneficiaries in Providers

24. Section 415.130 is amended by revising paragraph (d) to read as follows:

§ 415.130 Conditions for payment: Physician pathology services.

(d) Physician pathology services furnished by an independent laboratory. The technical component of physician pathology services furnished by an independent laboratory to a hospital inpatient or outpatient on or before December 31, 2006 may be paid to the laboratory by the carrier under the physician fee schedule if the Medicare beneficiary is a patient of a covered hospital as defined in paragraph (a)(1) of this section. For services furnished after December 31, 2006, an independent laboratory may not bill the carrier for the technical component of physician pathology services furnished to a hospital inpatient or outpatient.

PART 424-CONDITIONS FOR MEDICARE PAYMENT

25. The authority citation for part 424 continues to read as follows:

Authority:

Secs. 1102 and 1871 of the Social Security Act (42 U.S.C. 1302 and 1395hh).

Subpart B-Certification and Plan of Treatment Requirements

26. Section 424.24 is amended by-

A. Redesignating paragraph (f) as paragraph (g).

B. Adding a new paragraph (f).

The addition reads as follows:

§ 424.24 Requirements for medical and other health services furnished by providers under Medicare Part B.

(f) Blood glucose testing. For each blood glucose test, the physician must certify that the test is medically necessary. A physician's standing order is not sufficient to order a series of blood glucose tests payable under the clinical laboratory fee schedule.

Subpart F-Limitations on Assignment and Reassignment of Claims

27. Section 424.80 is amended by-

A. Revising the heading of paragraph (d).

B. Revising paragraph (d)(2)

The revisions read as follows:

§ 424.80 Prohibition of reassignment of claims by suppliers.

(d) Reassignment to an entity under an employer-employee relationship or under a contractual arrangement: Conditions and limitations. (1) * * *

(2) Access to records. The supplier who furnishes the service has unrestricted access to claims submitted by an entity for services provided by that supplier. This paragraph applies irrespective of whether the supplier is an employee or whether the service is provided under a contractual arrangement. If an entity refuses to provide, upon request, the billing information to the supplier performing the service, the entity's right to receive reassigned benefits may be revoked under § 424.82(c)(3).

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare-Supplementary Medical Insurance Program)

Dated: October 31, 2006.

Leslie V. Norwalk,

Acting Adminstrator, Centers for Medicare Medicaid Services.

Approved: November 1, 2006.

Michael O. Leavitt,

Secretary.

Note:

These addenda will not appear in the Code of Federal Regulations.

Addendum A: Explanation and Use of Addenda B

The addenda on the following pages provide various data pertaining to the Medicare fee schedule for physicians' services furnished in 2007. Addendum B contains the RVUs for work, non-facility PE, facility PE, and malpractice expense, and other information for all services included in the PFS.

In previous years, we have listed many services in Addendum B that are not paid under the PFS. To avoid publishing as many pages of codes for these services, we are not including clinical laboratory codes or the alphanumeric codes (Healthcare Common Procedure Coding System (HCPCS) codes not included in CPT) not paid under the PFS in Addendum B.

Addendum B-2007 Relative Value Units and Related Information Used in Determining Medicare Payments for 2007

This addendum contains the following information for each CPT code and alphanumeric HCPCS code, except for: Alphanumeric codes beginning with B (enteral and parenteral therapy), E (durable medical equipment), K (temporary codes for nonphysicians' services or items), or L (orthotics); and codes for anesthesiology. Please also note the following:

• An "NA" in the "Non-facility PE RVUs" column of Addendum B means that CMS has not developed a PE RVU in the non-facility setting for the service because it is typically performed in the hospital (for example, an open heart surgery is generally performed in the hospital setting and not a physician's office). If there is an "NA" in the non-facility PE RVU column, and the contractor determines that this service can be performed in the non-facility setting, the service will be paid at the facility PE RVU rate.

• Services that have an "NA" in the "Facility PE RVUs" column of Addendum B are typically not paid using the PFS when provided in a facility setting. These services (which include "incident to" services and the technical portion of diagnostic tests) are generally paid under either the outpatient hospital prospective payment system or bundled into the hospital inpatient prospective payment system payment.

1. CPT/HCPCS code. This is the CPT or alphanumeric HCPCS number for the service. Alphanumeric HCPCS codes are included at the end of this addendum.

2. Modifier. A modifier is shown if there is a technical component (modifier TC) and a professional component (PC) (modifier -26) for the service. If there is a PC and a TC for the service, Addendum B contains three entries for the code. A code for: The global values (both professional and technical); modifier -26 (PC); and, modifier TC. The global service is not designated by a modifier, and physicians must bill using the code without a modifier if the physician furnishes both the PC and the TC of the service.

Modifier-53 is shown for a discontinued procedure, for example, a colonoscopy that is not completed. There will be RVUs for a code with this modifier.

3. Status indicator. This indicator shows whether the CPT/HCPCS code is in the PFS and whether it is separately payable if the service is covered.

A = Active code. These codes are separately payable under the PFS if covered. There will be RVUs for codes with this status. The presence of an "A" indicator does not mean that Medicare has made a national coverage determination regarding the service. Carriers remain responsible for coverage decisions in the absence of a national Medicare policy.

B = Bundled code. Payments for covered services are always bundled into payment for other services not specified. If RVUs are shown, they are not used for Medicare payment. If these services are covered, payment for them is subsumed by the payment for the services to which they are incident (an example is a telephone call from a hospital nurse regarding care of a patient).

C = Carriers price the code. Carriers will establish RVUs and payment amounts for these services, generally on an individual case basis following review of documentation, such as an operative report.

D* = Deleted/discontinued code.

E = Excluded from the PFS by regulation. These codes are for items and services that CMS chose to exclude from the fee schedule payment by regulation. No RVUs are shown, and no payment may be made under the PFS for these codes. Payment for them, when covered, continues under reasonable charge procedures.

F = Deleted/discontinued codes. (Code not subject to a 90-day grace period.) These codes are deleted effective with the beginning of the year and are never subject to a grace period. This indicator is no longer effective beginning with the 2005 fee schedule as of January 1, 2005.

G = Code not valid for Medicare purposes. Medicare uses another code for reporting of, and payment for, these services. (Codes subject to a 90-day grace period.) This indicator is no longer effective with the 2005 PFS as of January 1, 2005.

H* = Deleted modifier. For 2000 and later years, either the TC or PC component shown for the code has been deleted and the deleted component is shown in the database with the H status indicator.

I = Not valid for Medicare purposes. Medicare uses another code for the reporting of, and the payment for these services. (Codes not subject to a 90-day grace period.)

L = Local codes. Carriers will apply this status to all local codes in effect on January 1, 1998 or subsequently approved by central office for use. Carriers will complete the RVUs and payment amounts for these codes.

M = Measurement codes, used for reporting purposes only. There are no RVUs and no payment amounts for these codes. Medicare uses them to aid with performance measurement. No separate payment is made. These codes should be billed with a zero (($0.00) charge and are denied) on the MPFSDB.

N = Non-covered service. These codes are noncovered services. Medicare payment may not be made for these codes. If RVUs are shown, they are not used for Medicare payment.

R = Restricted coverage. Special coverage instructions apply. If the service is covered and no RVUs are shown, it is carrier-priced.

T = There are RVUs for these services, but they are only paid if there are no other services payable under the PFS billed on the same date by the same provider. If any other services payable under the PFS are billed on the same date by the same provider, these services are bundled into the service(s) for which payment is made.

X = Statutory exclusion. These codes represent an item or service that is not within the statutory definition of "physicians" services" for PFS payment purposes. No RVUs are shown for these codes, and no payment may be made under the PFS. (Examples are ambulance services and clinical diagnostic laboratory services.)

4. Description of code. This is an abbreviated version of the narrative description of the code.

5. Physician work RVUs. These are the RVUs for the physician work for this service in 2007. As stated in the June 29, 2006 proposed notice, the RVUs for codes with a 10-or 90-day global period reflect the application of the RUC-recommended values for the E/ M services that are included as part of the global period for the service.

Note:

The separate budget neutrality adjustor is not reflected in these physician work RVUs.

6. Fully implemented non-facility practice expense RVUs. These are the fully implemented resource-based PE RVUs for non-facility settings.

7. Transitional Non-facility practice expense RVUs. These are the 2007 resource-based PE RVUs for non-facility settings.

8. Fully implemented facility practice expense RVUs. These are the fully implemented resource-based PE RVUs for facility settings.

9. Transitional facility practice expense RVUs. These are the 2007 resource-based PE RVUs for facility settings.

10. Malpractice expense RVUs. These are the RVUs for the malpractice expense for the service for 2006.

11. Non-facility total. This is the sum of the work, fully implemented non-facility PE, and malpractice expense RVUs.

12. Transitional non-facility total. This is the sum of the work, 2007 transitional non-facility PE, and malpractice expense RVUs.

13. Facility total. This is the sum of the work, fully implemented facility PE, and malpractice expense RVUs.

14. Transitional facility total. This is the sum of the work, 2007 transitional facility PE, and malpractice expense RVUs.

15. Global period. This indicator shows the number of days in the global period for the code (0, 10, or 90 days). An explanation of the alpha codes follows:

MMM = Code describes a service furnished in uncomplicated maternity cases including antepartum care, delivery, and postpartum care. The usual global surgical concept does not apply. See the 1999 Physicians' Current Procedural Terminology for specific definitions.

XXX = The global concept does not apply.

YYY = The global period is to be set by the carrier (for example, unlisted surgery codes).

ZZZ = Code related to another service that is always included in the global period of the other service. (Note: Physician work and PE are associated with intra service time and in some instances in the post service time. *Codes with these indicators had a 90-day grace period before January 1, 2005.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
0016T C Thermotx choroid vasc lesion 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0017T C Photocoagulat macular drusen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0019T C Extracorp shock wv tx,ms nos 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0024T C Transcath cardiac reduction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0026T C Measure remnant lipoproteins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0027T C Endoscopic epidural lysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0028T C Dexa body composition study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0029T C Magnetic tx for incontinence 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0030T C Antiprothrombin antibody 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0031T C Speculoscopy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0032T C Speculoscopy w/direct sample 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0041T C Detect ur infect agnt w/cpas 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0042T C Ct perfusion w/contrast, cbf 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0043T C Co expired gas analysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0046T C Cath lavage, mammary duct(s) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0047T C Cath lavage, mammary duct(s) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0048T C Implant ventricular device 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0049T C External circulation assist 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0050T C Removal circulation assist 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0051T C Implant total heart system 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0052T C Replace component heart syst 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0053T C Replace component heart syst 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0054T C Bone surgery using computer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0055T C Bone surgery using computer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0056T C Bone surgery using computer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0058T C Cryopreservation, ovary tiss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0059T C Cryopreservation, oocyte 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0060T C Electrical impedance scan 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0061T C Destruction of tumor, breast 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0062T C Rep intradisc annulus;1 lev 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0063T C Rep intradisc annulus;1lev 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0064T C Spectroscop eval expired gas 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0065T C Ocular photoscreen bilat 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0066T N Ct colonography;screen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0066T TC N Ct colonography;screen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0066T 26 N Ct colonography;screen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0067T C Ct colonography;dx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0067T TC C Ct colonography;dx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0067T 26 C Ct colonography;dx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
0068T C Interp/rept heart sound 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0069T C Analysis only heart sound 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0070T C Interp only heart sound 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0071T C U/s leiomyomata ablate 200 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0072T C U/s leiomyomata ablate 200 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0073T A Delivery, comp imrt 0.00 13.15 16.80 NA NA 0.13 13.28 16.93 NA NA XXX
0074T N Online physician e/m 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0075T C Perq stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0075T TC C Perq stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0075T 26 C Perq stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0076T C Si stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0076T TC C Si stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0076T 26 C Si stent/chest vert art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0077T C Cereb therm perfusion probe 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0078T C Endovasc aort repr w/device 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0079T C Endovasc visc extnsn repr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0080T C Endovasc aort repr rad si 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0081T C Endovasc visc extnsn si 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0084T C Temp prostate urethral stent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0085T C Breath test heart reject 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0086T C L ventricle fill pressure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0087T C Sperm eval hyaluronan 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0088T C Rf tongue base vol reduxn 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0089T C Actigraphy testing, 3-day 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0090T C Cervical artific disc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0092T C Artific disc addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0093T C Cervical artific diskectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0095T C Artific diskectomy addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0096T C Rev cervical artific disc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0098T C Rev artific disc addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0099T C Implant corneal ring 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0100T C Prosth retina receivegen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0101T C Extracorp shockwv tx,hi enrg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0102T C Extracorp shockwv tx,anesth 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0103T C Holotranscobalamin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0104T C At rest cardio gas rebreathe 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0105T C Exerc cardio gas rebreathe 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0106T C Touch quant sensory test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0107T C Vibrate quant sensory test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0108T C Cool quant sensory test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0109T C Heat quant sensory test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0110T C Nos quant sensory test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0111T C Rbc membranes fatty acids 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
0115T C Med tx mngmt 15 min 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0116T C Med tx mngmt subsqt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0117T C Med tx mngmt addl 15 min 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0123T C Scleral fistulization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0124T C Conjunctival drug placement 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0126T C Chd risk imt study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0130T C Chron care drug investigatn 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0133T C Esophageal implant injexn 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0135T C Perq cryoablate renal tumor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0137T C Prostate saturation sampling 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0140T C Exhaled breath condensate ph 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0141T I Perq islet transplant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0142T I Open islet transplant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0143T I Laparoscopic islet transplnt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0144T C CT heart wo dye; qual calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0144T TC C CT heart wo dye; qual calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0144T 26 C CT heart wo dye; qual calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0145T C CT heart w/wo dye funct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0145T TC C CT heart w/wo dye funct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0145T 26 C CT heart w/wo dye funct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0146T C CCTA w/wo dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0146T TC C CCTA w/wo dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0146T 26 C CCTA w/wo dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0147T C CCTA w/wo, quan calcium 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0147T TC C CCTA w/wo, quan calcium 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0147T 26 C CCTA w/wo, quan calcium 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0148T C CCTA w/wo, strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0148T TC C CCTA w/wo, strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0148T 26 C CCTA w/wo, strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0149T C CCTA w/wo, strxr quan calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0149T TC C CCTA w/wo, strxr quan calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0149T 26 C CCTA w/wo, strxr quan calc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0150T C CCTA w/wo, disease strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0150T TC C CCTA w/wo, disease strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0150T 26 C CCTA w/wo, disease strxr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0151T C CT heart funct add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0151T TC C CT heart funct add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0151T 26 C CT heart funct add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0152T C Computer chest add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0153T C Tcath sensor aneurysm sac 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0154T C Study sensor aneurysm sac 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0155T C Lap impl gast curve electrd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0156T C Lap remv gast curve electrd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
0157T C Open impl gast curve electrd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0158T C Open remv gast curve electrd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0159T C Cad breast mri 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
0159T TC C Cad breast mri 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
0159T 26 C Cad breast mri 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
0160T C Tcranial magn stim tx plan 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0161T C Tcranial magn stim tx deliv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0162T C Anal program gast neurostim 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0163T C Lumb artif diskectomy addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
0164T C Remove lumb artif disc addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
0165T C Revise lumb artif disc addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
0166T C Tcath vsd close w/o bypass 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0167T C Tcath vsd close w bypass 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0168T C Rhinophototx light app bilat 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0169T C Place stereo cath brain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0170T C Anorectal fistula plug rpr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0171T C Lumbar spine proces distract 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0172T C Lumbar spine proces addl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0173T C Iop monit io pressure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0174T C Cad cxr with interp 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0175T C Cad cxr remote 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0176T C Aqu canal dilat w/o retent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
0177T C Aqu canal dilat w retent 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
10021 A Fna w/o image 1.27 2.11 2.14 0.36 0.50 0.10 3.48 3.51 1.73 1.87 XXX
10022 A Fna w/image 1.27 2.02 2.41 0.35 0.40 0.08 3.37 3.76 1.70 1.75 XXX
10040 A Acne surgery 1.19 1.32 1.09 0.99 0.84 0.05 2.56 2.33 2.23 2.08 010
10060 A Drainage of skin abscess 1.19 1.51 1.29 1.09 0.97 0.12 2.82 2.60 2.40 2.28 010
10061 A Drainage of skin abscess 2.42 2.09 1.89 1.54 1.51 0.26 4.77 4.57 4.22 4.19 010
10080 A Drainage of pilonidal cyst 1.19 2.65 2.99 1.10 1.11 0.11 3.95 4.29 2.40 2.41 010
10081 A Drainage of pilonidal cyst 2.47 3.47 3.92 1.45 1.49 0.24 6.18 6.63 4.16 4.20 010
10120 A Remove foreign body 1.23 1.95 2.12 0.95 0.97 0.12 3.30 3.47 2.30 2.32 010
10121 A Remove foreign body 2.71 3.51 3.51 1.66 1.75 0.33 6.55 6.55 4.70 4.79 010
10140 A Drainage of hematoma/fluid 1.55 2.26 1.89 1.30 1.29 0.19 4.00 3.63 3.04 3.03 010
10160 A Puncture drainage of lesion 1.22 1.84 1.66 1.07 1.08 0.14 3.20 3.02 2.43 2.44 010
10180 A Complex drainage, wound 2.27 3.28 3.06 1.83 1.94 0.35 5.90 5.68 4.45 4.56 010
11000 A Debride infected skin 0.60 0.73 0.62 0.17 0.21 0.07 1.40 1.29 0.84 0.88 000
11001 A Debride infected skin add-on 0.30 0.23 0.23 0.08 0.10 0.04 0.57 0.57 0.42 0.44 ZZZ
11004 A Debride genitalia perineum 10.80 NA NA 3.23 3.73 0.67 NA NA 14.70 15.20 000
11005 A Debride abdom wall 14.24 NA NA 4.23 5.23 0.96 NA NA 19.43 20.43 000
11006 A Debride genit/per/abdom wall 13.10 NA NA 3.82 4.59 1.28 NA NA 18.20 18.97 000
11008 A Remove mesh from abd wall 5.00 NA NA 1.37 1.86 0.61 NA NA 6.98 7.47 ZZZ
11010 A Debride skin, fx 4.19 6.72 6.83 2.34 2.55 0.66 11.57 11.68 7.19 7.40 010
11011 A Debride skin/muscle, fx 4.94 7.04 7.88 2.05 2.27 0.74 12.72 13.56 7.73 7.95 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
11012 A Debride skin/muscle/bone, fx 6.87 8.98 11.32 3.14 3.67 1.16 17.01 19.35 11.17 11.70 000
11040 A Debride skin, partial 0.50 0.68 0.56 0.17 0.20 0.06 1.24 1.12 0.73 0.76 000
11041 A Debride skin, full 0.60 0.73 0.68 0.19 0.30 0.10 1.43 1.38 0.89 1.00 000
11042 A Debride skin/tissue 0.80 0.96 0.97 0.25 0.39 0.13 1.89 1.90 1.18 1.32 000
11043 A Debride tissue/muscle 3.04 3.64 3.45 2.71 2.62 0.32 7.00 6.81 6.07 5.98 010
11044 A Debride tissue/muscle/bone 4.11 4.95 4.58 3.68 3.73 0.43 9.49 9.12 8.22 8.27 010
11055 R Trim skin lesion 0.43 0.82 0.63 0.12 0.16 0.05 1.30 1.11 0.60 0.64 000
11056 R Trim skin lesions, 2 to 4 0.61 0.89 0.70 0.17 0.22 0.07 1.57 1.38 0.85 0.90 000
11057 R Trim skin lesions, over 4 0.79 1.00 0.81 0.21 0.28 0.10 1.89 1.70 1.10 1.17 000
11100 A Biopsy, skin lesion 0.81 1.89 1.41 0.40 0.38 0.03 2.73 2.25 1.24 1.22 000
11101 A Biopsy, skin add-on 0.41 0.42 0.35 0.21 0.20 0.02 0.85 0.78 0.64 0.63 ZZZ
11200 A Removal of skin tags 0.79 1.23 1.09 0.90 0.80 0.04 2.06 1.92 1.73 1.63 010
11201 A Remove skin tags add-on 0.29 0.16 0.16 0.11 0.12 0.02 0.47 0.47 0.42 0.43 ZZZ
11300 A Shave skin lesion 0.51 1.19 1.04 0.21 0.21 0.03 1.73 1.58 0.75 0.75 000
11301 A Shave skin lesion 0.85 1.51 1.21 0.39 0.38 0.04 2.40 2.10 1.28 1.27 000
11302 A Shave skin lesion 1.05 1.78 1.42 0.50 0.47 0.05 2.88 2.52 1.60 1.57 000
11303 A Shave skin lesion 1.24 2.03 1.69 0.57 0.53 0.07 3.34 3.00 1.88 1.84 000
11305 A Shave skin lesion 0.67 1.07 0.91 0.21 0.26 0.07 1.81 1.65 0.95 1.00 000
11306 A Shave skin lesion 0.99 1.43 1.18 0.39 0.41 0.07 2.49 2.24 1.45 1.47 000
11307 A Shave skin lesion 1.14 1.71 1.40 0.49 0.49 0.07 2.92 2.61 1.70 1.70 000
11308 A Shave skin lesion 1.41 1.75 1.53 0.53 0.58 0.13 3.29 3.07 2.07 2.12 000
11310 A Shave skin lesion 0.73 1.39 1.18 0.33 0.32 0.04 2.16 1.95 1.10 1.09 000
11311 A Shave skin lesion 1.05 1.65 1.34 0.50 0.49 0.05 2.75 2.44 1.60 1.59 000
11312 A Shave skin lesion 1.20 1.94 1.55 0.58 0.56 0.06 3.20 2.81 1.84 1.82 000
11313 A Shave skin lesion 1.62 2.21 1.90 0.76 0.73 0.10 3.93 3.62 2.48 2.45 000
11400 A Exc tr-ext b9+marg 0.5 cm 0.87 1.88 1.96 0.94 0.90 0.06 2.81 2.89 1.87 1.83 010
11401 A Exc tr-ext b9+marg 0.6-1 cm 1.25 2.18 2.08 1.15 1.05 0.10 3.53 3.43 2.50 2.40 010
11402 A Exc tr-ext b9+marg 1.1-2 cm 1.42 2.39 2.26 1.21 1.11 0.13 3.94 3.81 2.76 2.66 010
11403 A Exc tr-ext b9+marg 2.1-3 cm 1.81 2.55 2.43 1.57 1.38 0.17 4.53 4.41 3.55 3.36 010
11404 A Exc tr-ext b9+marg 3.1-4 cm 2.08 2.86 2.74 1.64 1.46 0.21 5.15 5.03 3.93 3.75 010
11406 A Exc tr-ext b9+marg 4.0 cm 3.47 3.50 3.17 2.08 1.76 0.32 7.29 6.96 5.87 5.55 010
11420 A Exc h-f-nk-sp b9+marg 0.5 1.00 1.83 1.78 0.94 0.93 0.09 2.92 2.87 2.03 2.02 010
11421 A Exc h-f-nk-sp b9+marg 0.6-1 1.44 2.22 2.10 1.17 1.13 0.13 3.79 3.67 2.74 2.70 010
11422 A Exc h-f-nk-sp b9+marg 1.1-2 1.65 2.42 2.29 1.53 1.38 0.16 4.23 4.10 3.34 3.19 010
11423 A Exc h-f-nk-sp b9+marg 2.1-3 2.03 2.65 2.60 1.66 1.50 0.20 4.88 4.83 3.89 3.73 010
11424 A Exc h-f-nk-sp b9+marg 3.1-4 2.45 2.97 2.84 1.78 1.65 0.25 5.67 5.54 4.48 4.35 010
11426 A Exc h-f-nk-sp b9+marg 4 cm 4.04 3.59 3.51 2.32 2.16 0.44 8.07 7.99 6.80 6.64 010
11440 A Exc face-mm b9+marg 0.5 cm 1.02 2.01 2.15 1.32 1.31 0.08 3.11 3.25 2.42 2.41 010
11441 A Exc face-mm b9+marg 0.6-1 cm 1.50 2.39 2.35 1.56 1.51 0.13 4.02 3.98 3.19 3.14 010
11442 A Exc face-mm b9+marg 1.1-2 cm 1.74 2.63 2.56 1.66 1.59 0.16 4.53 4.46 3.56 3.49 010
11443 A Exc face-mm b9+marg 2.1-3 cm 2.31 2.87 2.90 1.84 1.82 0.22 5.40 5.43 4.37 4.35 010
11444 A Exc face-mm b9+marg 3.1-4 cm 3.16 3.28 3.42 2.09 2.16 0.30 6.74 6.88 5.55 5.62 010
11446 A Exc face-mm b9+marg 4 cm 4.75 4.06 4.05 2.67 2.75 0.43 9.24 9.23 7.85 7.93 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
11450 A Removal, sweat gland lesion 3.14 5.14 5.06 2.43 2.12 0.34 8.62 8.54 5.91 5.60 090
11451 A Removal, sweat gland lesion 4.35 6.11 6.48 2.79 2.60 0.53 10.99 11.36 7.67 7.48 090
11462 A Removal, sweat gland lesion 2.92 5.31 5.16 2.48 2.13 0.32 8.55 8.40 5.72 5.37 090
11463 A Removal, sweat gland lesion 4.35 6.61 6.77 2.99 2.76 0.54 11.50 11.66 7.88 7.65 090
11470 A Removal, sweat gland lesion 3.66 5.58 5.19 2.71 2.37 0.40 9.64 9.25 6.77 6.43 090
11471 A Removal, sweat gland lesion 4.81 6.46 6.64 3.00 2.82 0.58 11.85 12.03 8.39 8.21 090
11600 A Exc tr-ext mlg+marg 0.5 cm 1.58 2.75 2.66 1.15 1.02 0.10 4.43 4.34 2.83 2.70 010
11601 A Exc tr-ext mlg+marg 0.6-1 cm 2.02 3.46 2.89 1.53 1.30 0.12 5.60 5.03 3.67 3.44 010
11602 A Exc tr-ext mlg+marg 1.1-2 cm 2.22 3.85 3.08 1.72 1.38 0.12 6.19 5.42 4.06 3.72 010
11603 A Exc tr-ext mlg+marg 2.1-3 cm 2.77 4.06 3.32 1.89 1.47 0.16 6.99 6.25 4.82 4.40 010
11604 A Exc tr-ext mlg+marg 3.1-4 cm 3.12 4.36 3.62 1.96 1.53 0.20 7.68 6.94 5.28 4.85 010
11606 A Exc tr-ext mlg+marg 4 cm 4.97 5.49 4.42 2.48 1.92 0.36 10.82 9.75 7.81 7.25 010
11620 A Exc h-f-nk-sp mlg+marg 0.5 1.59 2.85 2.66 1.20 1.01 0.09 4.53 4.34 2.88 2.69 010
11621 A Exc h-f-nk-sp mlg+marg 0.6-1 2.03 3.51 2.90 1.56 1.32 0.12 5.66 5.05 3.71 3.47 010
11622 A Exc h-f-nk-sp mlg+marg 1.1-2 2.36 3.91 3.20 1.77 1.49 0.14 6.41 5.70 4.27 3.99 010
11623 A Exc h-f-nk-sp mlg+marg 2.1-3 3.06 4.13 3.53 1.98 1.68 0.20 7.39 6.79 5.24 4.94 010
11624 A Exc h-f-nk-sp mlg+marg 3.1-4 3.57 4.44 3.92 2.11 1.86 0.27 8.28 7.76 5.95 5.70 010
11626 A Exc h-f-nk-sp mlg+mar 4 cm 4.56 4.96 4.71 2.35 2.38 0.45 9.97 9.72 7.36 7.39 010
11640 A Exc face-mm malig+marg 0.5 1.62 3.06 2.75 1.30 1.16 0.11 4.79 4.48 3.03 2.89 010
11641 A Exc face-mm malig+marg 0.6-1 2.12 3.64 3.18 1.63 1.56 0.16 5.92 5.46 3.91 3.84 010
11642 A Exc face-mm malig+marg 1.1-2 2.57 4.04 3.56 1.86 1.75 0.19 6.80 6.32 4.62 4.51 010
11643 A Exc face-mm malig+marg 2.1-3 3.37 4.29 3.92 2.13 2.00 0.26 7.92 7.55 5.76 5.63 010
11644 A Exc face-mm malig+marg 3.1-4 4.29 5.06 4.78 2.48 2.46 0.37 9.72 9.44 7.14 7.12 010
11646 A Exc face-mm mlg+marg 4 cm 6.21 5.88 5.78 3.15 3.39 0.61 12.70 12.60 9.97 10.21 010
11719 R Trim nail(s) 0.17 0.38 0.28 0.05 0.07 0.02 0.57 0.47 0.24 0.26 000
11720 A Debride nail, 1-5 0.32 0.47 0.37 0.09 0.11 0.04 0.83 0.73 0.45 0.47 000
11721 A Debride nail, 6 or more 0.54 0.55 0.47 0.15 0.20 0.07 1.16 1.08 0.76 0.81 000
11730 A Removal of nail plate 1.10 1.35 1.11 0.30 0.40 0.14 2.59 2.35 1.54 1.64 000
11732 A Remove nail plate, add-on 0.57 0.55 0.47 0.15 0.20 0.07 1.19 1.11 0.79 0.84 ZZZ
11740 A Drain blood from under nail 0.37 0.80 0.61 0.44 0.37 0.04 1.21 1.02 0.85 0.78 000
11750 A Removal of nail bed 2.40 2.99 2.37 1.92 1.79 0.22 5.61 4.99 4.54 4.41 010
11752 A Remove nail bed/finger tip 3.48 4.14 3.28 2.84 2.95 0.35 7.97 7.11 6.67 6.78 010
11755 A Biopsy, nail unit 1.31 2.04 1.69 0.77 0.77 0.14 3.49 3.14 2.22 2.22 000
11760 A Repair of nail bed 1.60 3.45 2.83 1.45 1.70 0.21 5.26 4.64 3.26 3.51 010
11762 A Reconstruction of nail bed 2.91 3.74 3.10 1.72 2.19 0.36 7.01 6.37 4.99 5.46 010
11765 A Excision of nail fold, toe 0.71 2.69 2.01 1.02 0.83 0.08 3.48 2.80 1.81 1.62 010
11770 A Removal of pilonidal lesion 2.63 3.47 3.48 1.54 1.51 0.33 6.43 6.44 4.50 4.47 010
11771 A Removal of pilonidal lesion 5.98 6.66 5.90 3.72 3.41 0.74 13.38 12.62 10.44 10.13 090
11772 A Removal of pilonidal lesion 7.23 7.97 7.62 5.52 5.18 0.89 16.09 15.74 13.64 13.30 090
11900 A Injection into skin lesions 0.52 0.92 0.72 0.26 0.22 0.02 1.46 1.26 0.80 0.76 000
11901 A Added skin lesions injection 0.80 1.02 0.75 0.41 0.37 0.03 1.85 1.58 1.24 1.20 000
11920 R Correct skin color defects 1.61 2.42 3.38 1.15 1.11 0.24 4.27 5.23 3.00 2.96 000
11921 R Correct skin color defects 1.93 2.70 3.65 1.30 1.28 0.29 4.92 5.87 3.52 3.50 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
11922 R Correct skin color defects 0.49 0.94 1.09 0.23 0.25 0.07 1.50 1.65 0.79 0.81 ZZZ
11950 R Therapy for contour defects 0.84 0.87 1.07 0.36 0.38 0.06 1.77 1.97 1.26 1.28 000
11951 R Therapy for contour defects 1.19 1.19 1.42 0.54 0.52 0.11 2.49 2.72 1.84 1.82 000
11952 R Therapy for contour defects 1.69 1.75 1.83 0.84 0.72 0.16 3.60 3.68 2.69 2.57 000
11954 R Therapy for contour defects 1.85 1.77 2.27 0.78 0.87 0.25 3.87 4.37 2.88 2.97 000
11960 A Insert tissue expander(s) 11.01 NA NA 10.76 10.48 1.31 NA NA 23.08 22.80 090
11970 A Replace tissue expander 7.86 NA NA 6.35 6.19 1.05 NA NA 15.26 15.10 090
11971 A Remove tissue expander(s) 3.21 7.48 8.70 4.09 3.87 0.32 11.01 12.23 7.62 7.40 090
11975 N Insert contraceptive cap 1.48 1.52 1.45 0.34 0.51 0.17 3.17 3.10 1.99 2.16 XXX
11976 R Removal of contraceptive cap 1.78 1.70 1.72 0.47 0.63 0.21 3.69 3.71 2.46 2.62 000
11977 N Removal/reinsert contra cap 3.30 1.97 2.20 0.76 1.14 0.37 5.64 5.87 4.43 4.81 XXX
11980 A Implant hormone pellet(s) 1.48 1.16 1.10 0.56 0.55 0.13 2.77 2.71 2.17 2.16 000
11981 A Insert drug implant device 1.48 1.92 1.76 0.60 0.66 0.12 3.52 3.36 2.20 2.26 XXX
11982 A Remove drug implant device 1.78 2.04 1.97 0.73 0.81 0.17 3.99 3.92 2.68 2.76 XXX
11983 A Remove/insert drug implant 3.30 2.68 2.38 1.36 1.44 0.23 6.21 5.91 4.89 4.97 XXX
12001 A Repair superficial wound(s) 1.72 1.73 1.92 0.73 0.76 0.15 3.60 3.79 2.60 2.63 010
12002 A Repair superficial wound(s) 1.88 1.79 1.98 0.84 0.89 0.17 3.84 4.03 2.89 2.94 010
12004 A Repair superficial wound(s) 2.26 2.07 2.26 0.93 0.99 0.21 4.54 4.73 3.40 3.46 010
12005 A Repair superficial wound(s) 2.88 2.52 2.75 1.08 1.17 0.27 5.67 5.90 4.23 4.32 010
12006 A Repair superficial wound(s) 3.68 3.03 3.30 1.31 1.46 0.35 7.06 7.33 5.34 5.49 010
12007 A Repair superficial wound(s) 4.13 3.39 3.71 1.50 1.73 0.45 7.97 8.29 6.08 6.31 010
12011 A Repair superficial wound(s) 1.78 1.90 2.07 0.76 0.78 0.16 3.84 4.01 2.70 2.72 010
12013 A Repair superficial wound(s) 2.01 2.06 2.22 0.89 0.92 0.18 4.25 4.41 3.08 3.11 010
12014 A Repair superficial wound(s) 2.48 2.28 2.50 0.98 1.04 0.23 4.99 5.21 3.69 3.75 010
12015 A Repair superficial wound(s) 3.21 2.76 3.04 1.13 1.22 0.29 6.26 6.54 4.63 4.72 010
12016 A Repair superficial wound(s) 3.94 3.16 3.45 1.30 1.47 0.37 7.47 7.76 5.61 5.78 010
12017 A Repair superficial wound(s) 4.72 NA NA 1.50 1.79 0.47 NA NA 6.69 6.98 010
12018 A Repair superficial wound(s) 5.54 NA NA 2.01 2.19 0.64 NA NA 8.19 8.37 010
12020 A Closure of split wound 2.64 3.75 3.80 1.79 1.89 0.30 6.69 6.74 4.73 4.83 010
12021 A Closure of split wound 1.86 1.85 1.83 1.33 1.39 0.24 3.95 3.93 3.43 3.49 010
12031 A Layer closure of wound(s) 2.17 3.90 2.69 1.79 1.17 0.17 6.24 5.03 4.13 3.51 010
12032 A Layer closure of wound(s) 2.49 5.22 4.19 2.30 1.92 0.16 7.87 6.84 4.95 4.57 010
12034 A Layer closure of wound(s) 2.94 4.58 3.54 2.00 1.59 0.25 7.77 6.73 5.19 4.78 010
12035 A Layer closure of wound(s) 3.44 5.26 5.21 2.11 2.14 0.39 9.09 9.04 5.94 5.97 010
12036 A Layer closure of wound(s) 4.06 5.37 5.51 2.24 2.47 0.55 9.98 10.12 6.85 7.08 010
12037 A Layer closure of wound(s) 4.68 5.94 6.05 2.62 2.88 0.66 11.28 11.39 7.96 8.22 010
12041 A Layer closure of wound(s) 2.39 3.85 2.87 1.78 1.29 0.19 6.43 5.45 4.36 3.87 010
12042 A Layer closure of wound(s) 2.76 4.49 3.57 2.14 1.63 0.17 7.42 6.50 5.07 4.56 010
12044 A Layer closure of wound(s) 3.16 5.34 3.74 1.94 1.69 0.27 8.77 7.17 5.37 5.12 010
12045 A Layer closure of wound(s) 3.65 5.07 5.21 2.08 2.23 0.41 9.13 9.27 6.14 6.29 010
12046 A Layer closure of wound(s) 4.26 5.63 6.28 2.29 2.64 0.54 10.43 11.08 7.09 7.44 010
12047 A Layer closure of wound(s) 4.66 6.17 6.30 2.54 2.95 0.58 11.41 11.54 7.78 8.19 010
12051 A Layer closure of wound(s) 2.49 4.12 3.48 1.94 1.57 0.20 6.81 6.17 4.63 4.26 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
12052 A Layer closure of wound(s) 2.81 4.89 3.64 2.60 1.72 0.17 7.87 6.62 5.58 4.70 010
12053 A Layer closure of wound(s) 3.14 5.36 3.77 2.13 1.68 0.23 8.73 7.14 5.50 5.05 010
12054 A Layer closure of wound(s) 3.47 5.40 4.02 2.08 1.74 0.30 9.17 7.79 5.85 5.51 010
12055 A Layer closure of wound(s) 4.44 6.05 4.87 2.15 2.13 0.45 10.94 9.76 7.04 7.02 010
12056 A Layer closure of wound(s) 5.25 6.23 6.62 2.42 2.89 0.59 12.07 12.46 8.26 8.73 010
12057 A Layer closure of wound(s) 5.97 7.47 6.47 2.86 3.53 0.56 14.00 13.00 9.39 10.06 010
13100 A Repair of wound or lesion 3.14 4.44 4.15 2.49 2.35 0.26 7.84 7.55 5.89 5.75 010
13101 A Repair of wound or lesion 3.93 5.99 4.99 3.02 2.77 0.26 10.18 9.18 7.21 6.96 010
13102 A Repair wound/lesion add-on 1.24 1.37 1.22 0.55 0.57 0.13 2.74 2.59 1.92 1.94 ZZZ
13120 A Repair of wound or lesion 3.32 4.60 4.26 2.61 2.41 0.26 8.18 7.84 6.19 5.99 010
13121 A Repair of wound or lesion 4.36 6.74 5.32 3.69 3.02 0.25 11.35 9.93 8.30 7.63 010
13122 A Repair wound/lesion add-on 1.44 1.40 1.48 0.61 0.63 0.15 2.99 3.07 2.20 2.22 ZZZ
13131 A Repair of wound or lesion 3.80 5.03 4.53 2.91 2.74 0.26 9.09 8.59 6.97 6.80 010
13132 A Repair of wound or lesion 6.48 7.97 6.42 5.04 4.38 0.32 14.77 13.22 11.84 11.18 010
13133 A Repair wound/lesion add-on 2.19 1.88 1.72 1.00 1.02 0.18 4.25 4.09 3.37 3.39 ZZZ
13150 A Repair of wound or lesion 3.82 4.72 4.83 2.74 2.76 0.34 8.88 8.99 6.90 6.92 010
13151 A Repair of wound or lesion 4.46 5.55 4.99 3.27 3.17 0.31 10.32 9.76 8.04 7.94 010
13152 A Repair of wound or lesion 6.34 7.60 6.42 3.99 4.03 0.40 14.34 13.16 10.73 10.77 010
13153 A Repair wound/lesion add-on 2.38 2.03 1.96 1.03 1.11 0.24 4.65 4.58 3.65 3.73 ZZZ
13160 A Late closure of wound 11.84 NA NA 7.13 7.15 1.54 NA NA 20.51 20.53 090
14000 A Skin tissue rearrangement 6.83 9.00 8.14 6.12 5.63 0.59 16.42 15.56 13.54 13.05 090
14001 A Skin tissue rearrangement 9.60 11.20 9.86 7.67 7.22 0.82 21.62 20.28 18.09 17.64 090
14020 A Skin tissue rearrangement 7.66 10.07 8.98 6.95 6.64 0.64 18.37 17.28 15.25 14.94 090
14021 A Skin tissue rearrangement 11.18 12.57 10.63 8.79 8.41 0.81 24.56 22.62 20.78 20.40 090
14040 A Skin tissue rearrangement 8.44 10.26 9.17 7.07 7.17 0.62 19.32 18.23 16.13 16.23 090
14041 A Skin tissue rearrangement 12.67 13.72 11.37 9.51 8.88 0.73 27.12 24.77 22.91 22.28 090
14060 A Skin tissue rearrangement 9.07 9.74 9.02 7.25 7.39 0.68 19.49 18.77 17.00 17.14 090
14061 A Skin tissue rearrangement 13.67 15.01 12.45 10.37 9.72 0.76 29.44 26.88 24.80 24.15 090
14300 A Skin tissue rearrangement 13.26 13.67 11.77 9.62 9.28 1.16 28.09 26.19 24.04 23.70 090
14350 A Skin tissue rearrangement 10.82 NA NA 7.05 7.12 1.34 NA NA 19.21 19.28 090
15002 A Wnd prep, ch/inf, trk/arm/lg 3.65 4.12 4.12 1.65 1.65 0.49 8.26 8.26 5.79 5.79 000
15003 A Wnd prep, ch/inf addl 100 cm 0.80 0.92 0.92 0.28 0.28 0.11 1.83 1.83 1.19 1.19 ZZZ
15004 A Wnd prep ch/inf, f/n/hf/g 4.58 4.77 4.77 1.97 1.97 0.62 9.97 9.97 7.17 7.17 000
15005 A Wnd prep, f/n/hf/g, addl cm 1.60 1.28 1.28 0.56 0.56 0.22 3.10 3.10 2.38 2.38 ZZZ
15040 A Harvest cultured skin graft 2.00 3.86 4.39 1.05 1.11 0.24 6.10 6.63 3.29 3.35 000
15050 A Skin pinch graft 5.37 7.71 7.11 5.09 5.11 0.57 13.65 13.05 11.03 11.05 090
15100 A Skin splt grft, trnk/arm/leg 9.74 9.91 11.91 6.82 7.57 1.28 20.93 22.93 17.84 18.59 090
15101 A Skin splt grft t/a/l, add-on 1.72 2.51 3.43 0.88 1.10 0.24 4.47 5.39 2.84 3.06 ZZZ
15110 A Epidrm autogrft trnk/arm/leg 10.88 9.01 10.26 6.61 6.90 1.31 21.20 22.45 18.80 19.09 090
15111 A Epidrm autogrft t/a/l add-on 1.85 0.90 1.19 0.65 0.76 0.26 3.01 3.30 2.76 2.87 ZZZ
15115 A Epidrm a-grft face/nck/hf/g 11.19 9.31 9.24 6.83 7.22 1.15 21.65 21.58 19.17 19.56 090
15116 A Epidrm a-grft f/n/hf/g addl 2.50 1.24 1.50 0.91 1.07 0.33 4.07 4.33 3.74 3.90 ZZZ
15120 A Skn splt a-grft fac/nck/hf/g 10.96 11.33 10.87 7.48 7.71 1.16 23.45 22.99 19.60 19.83 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
15121 A Skn splt a-grft f/n/hf/g add 2.67 3.47 4.24 1.34 1.72 0.36 6.50 7.27 4.37 4.75 ZZZ
15130 A Derm autograft, trnk/arm/leg 7.41 8.09 9.42 5.71 6.18 0.97 16.47 17.80 14.09 14.56 090
15131 A Derm autograft t/a/l add-on 1.50 0.71 0.98 0.53 0.61 0.21 2.42 2.69 2.24 2.32 ZZZ
15135 A Derm autograft face/nck/hf/g 10.91 9.56 9.79 7.14 7.88 1.23 21.70 21.93 19.28 20.02 090
15136 A Derm autograft, f/n/hf/g add 1.50 0.69 0.84 0.55 0.64 0.20 2.39 2.54 2.25 2.34 ZZZ
15150 A Cult epiderm grft t/arm/leg 9.30 7.29 8.17 6.01 6.33 1.14 17.73 18.61 16.45 16.77 090
15151 A Cult epiderm grft t/a/l addl 2.00 0.92 1.21 0.71 0.82 0.28 3.20 3.49 2.99 3.10 ZZZ
15152 A Cult epiderm graft t/a/l +% 2.50 1.09 1.44 0.89 1.02 0.35 3.94 4.29 3.74 3.87 ZZZ
15155 A Cult epiderm graft, f/n/hf/g 10.05 7.74 7.80 6.40 6.82 1.05 18.84 18.90 17.50 17.92 090
15156 A Cult epidrm grft f/n/hfg add 2.75 1.20 1.47 1.00 1.18 0.36 4.31 4.58 4.11 4.29 ZZZ
15157 A Cult epiderm grft f/n/hfg +% 3.00 1.39 1.68 1.09 1.29 0.39 4.78 5.07 4.48 4.68 ZZZ
15170 A Acell graft trunk/arms/legs 5.99 3.68 3.79 2.39 2.37 0.55 10.22 10.33 8.93 8.91 090
15171 A Acell graft t/arm/leg add-on 1.55 0.66 0.68 0.52 0.60 0.19 2.40 2.42 2.26 2.34 ZZZ
15175 A Acellular graft, f/n/hf/g 7.99 5.33 5.40 3.84 3.96 0.82 14.14 14.21 12.65 12.77 090
15176 A Acell graft, f/n/hf/g add-on 2.45 1.08 1.10 0.83 0.95 0.29 3.82 3.84 3.57 3.69 ZZZ
15200 A Skin full graft, trunk 8.97 9.97 9.54 6.42 6.26 0.98 19.92 19.49 16.37 16.21 090
15201 A Skin full graft trunk add-on 1.32 2.13 2.45 0.58 0.61 0.19 3.64 3.96 2.09 2.12 ZZZ
15220 A Skin full graft sclp/arm/leg 7.95 10.46 9.50 6.73 6.69 0.84 19.25 18.29 15.52 15.48 090
15221 A Skin full graft add-on 1.19 2.03 2.25 0.52 0.55 0.16 3.38 3.60 1.87 1.90 ZZZ
15240 A Skin full grft face/genit/hf 10.15 12.05 10.66 8.94 8.20 0.92 23.12 21.73 20.01 19.27 090
15241 A Skin full graft add-on 1.86 2.54 2.47 0.83 0.89 0.23 4.63 4.56 2.92 2.98 ZZZ
15260 A Skin full graft een lips 11.39 13.08 10.93 9.43 8.79 0.69 25.16 23.01 21.51 20.87 090
15261 A Skin full graft add-on 2.23 2.97 2.76 1.17 1.34 0.21 5.41 5.20 3.61 3.78 ZZZ
15300 A Apply skinallogrft, t/arm/lg 4.65 3.38 3.25 2.13 2.21 0.49 8.52 8.39 7.27 7.35 090
15301 A Apply sknallogrft t/a/l addl 1.00 0.48 0.47 0.34 0.39 0.14 1.62 1.61 1.48 1.53 ZZZ
15320 A Apply skin allogrft f/n/hf/g 5.36 3.77 3.66 2.35 2.49 0.58 9.71 9.60 8.29 8.43 090
15321 A Aply sknallogrft f/n/hfg add 1.50 0.69 0.69 0.51 0.57 0.21 2.40 2.40 2.22 2.28 ZZZ
15330 A Aply acell alogrft t/arm/leg 3.99 3.16 3.18 1.93 2.15 0.49 7.64 7.66 6.41 6.63 090
15331 A Aply acell grft t/a/l add-on 1.00 0.47 0.46 0.34 0.39 0.14 1.61 1.60 1.48 1.53 ZZZ
15335 A Apply acell graft, f/n/hf/g 4.50 3.42 3.46 2.09 2.35 0.55 8.47 8.51 7.14 7.40 090
15336 A Aply acell grft f/n/hf/g add 1.43 0.72 0.70 0.49 0.55 0.20 2.35 2.33 2.12 2.18 ZZZ
15340 A Apply cult skin substitute 3.76 3.80 3.95 2.74 2.75 0.41 7.97 8.12 6.91 6.92 010
15341 A Apply cult skin sub add-on 0.50 0.72 0.64 0.17 0.19 0.06 1.28 1.20 0.73 0.75 ZZZ
15360 A Apply cult derm sub, t/a/l 3.93 4.46 4.47 3.27 3.13 0.43 8.82 8.83 7.63 7.49 090
15361 A Aply cult derm sub t/a/l add 1.15 0.58 0.58 0.39 0.44 0.14 1.87 1.87 1.68 1.73 ZZZ
15365 A Apply cult derm sub f/n/hf/g 4.21 4.36 4.50 3.21 3.20 0.46 9.03 9.17 7.88 7.87 090
15366 A Apply cult derm f/hf/g add 1.45 0.69 0.70 0.49 0.56 0.17 2.31 2.32 2.11 2.18 ZZZ
15400 A Apply skin xenograft, t/a/l 4.38 4.97 4.25 3.76 3.95 0.47 9.82 9.10 8.61 8.80 090
15401 A Apply skn xenogrft t/a/l add 1.00 1.02 1.67 0.35 0.42 0.14 2.16 2.81 1.49 1.56 ZZZ
15420 A Apply skin xgraft, f/n/hf/g 4.89 5.11 4.86 3.93 3.83 0.52 10.52 10.27 9.34 9.24 090
15421 A Apply skn xgrft f/n/hf/g add 1.50 1.20 1.29 0.53 0.60 0.21 2.91 3.00 2.24 2.31 ZZZ
15430 A Apply acellular xenograft 5.93 7.11 6.95 6.53 6.59 0.66 13.70 13.54 13.12 13.18 090
15431 C Apply acellular xgraft add 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
15570 A Form skin pedicle flap 10.00 10.45 11.09 6.57 6.71 1.34 21.79 22.43 17.91 18.05 090
15572 A Form skin pedicle flap 9.94 9.89 9.59 6.78 6.53 1.20 21.03 20.73 17.92 17.67 090
15574 A Form skin pedicle flap 10.52 10.50 10.64 7.04 7.60 1.20 22.22 22.36 18.76 19.32 090
15576 A Form skin pedicle flap 9.24 9.72 9.74 6.60 6.81 0.87 19.83 19.85 16.71 16.92 090
15600 A Skin graft 1.95 5.31 7.03 2.75 2.98 0.27 7.53 9.25 4.97 5.20 090
15610 A Skin graft 2.46 5.59 4.92 3.07 3.33 0.35 8.40 7.73 5.88 6.14 090
15620 A Skin graft 3.62 6.40 7.44 3.87 3.88 0.35 10.37 11.41 7.84 7.85 090
15630 A Skin graft 3.95 7.03 7.04 4.31 4.19 0.34 11.32 11.33 8.60 8.48 090
15650 A Transfer skin pedicle flap 4.64 7.12 7.14 4.30 4.23 0.42 12.18 12.20 9.36 9.29 090
15731 A Forehead flap w/vasc pedicle 14.12 12.13 12.13 9.56 9.56 1.28 27.53 27.53 24.96 24.96 090
15732 A Muscle-skin graft, head/neck 19.70 14.97 17.27 11.41 12.01 2.00 36.67 38.97 33.11 33.71 090
15734 A Muscle-skin graft, trunk 19.62 16.00 17.58 12.16 12.32 2.62 38.24 39.82 34.40 34.56 090
15736 A Muscle-skin graft, arm 16.92 13.99 17.17 10.18 10.96 2.46 33.37 36.55 29.56 30.34 090
15738 A Muscle-skin graft, leg 18.92 14.24 17.04 10.63 11.45 2.66 35.82 38.62 32.21 33.03 090
15740 A Island pedicle flap graft 11.57 13.63 11.01 9.52 8.58 0.63 25.83 23.21 21.72 20.78 090
15750 A Neurovascular pedicle graft 12.73 NA NA 9.04 9.04 1.42 NA NA 23.19 23.19 090
15756 A Free myo/skin flap microvasc 36.74 NA NA 18.90 20.15 4.62 NA NA 60.26 61.51 090
15757 A Free skin flap, microvasc 36.95 NA NA 17.08 20.46 3.90 NA NA 57.93 61.31 090
15758 A Free fascial flap, microvasc 36.70 NA NA 16.92 20.41 4.24 NA NA 57.86 61.35 090
15760 A Composite skin graft 9.68 10.35 10.10 7.04 7.21 0.85 20.88 20.63 17.57 17.74 090
15770 A Derma-fat-fascia graft 8.73 NA NA 6.66 6.68 1.05 NA NA 16.44 16.46 090
15775 R Hair transplant punch grafts 3.95 3.50 4.05 1.72 1.41 0.52 7.97 8.52 6.19 5.88 000
15776 R Hair transplant punch grafts 5.53 3.91 4.99 1.60 2.50 0.72 10.16 11.24 7.85 8.75 000
15780 A Abrasion treatment of skin 8.50 11.84 11.60 6.91 7.92 0.67 21.01 20.77 16.08 17.09 090
15781 A Abrasion treatment of skin 4.91 8.68 7.35 5.68 5.44 0.34 13.93 12.60 10.93 10.69 090
15782 A Abrasion treatment of skin 4.36 9.63 9.80 5.58 6.31 0.34 14.33 14.50 10.28 11.01 090
15783 A Abrasion treatment of skin 4.33 8.13 7.19 5.13 4.42 0.28 12.74 11.80 9.74 9.03 090
15786 A Abrasion, lesion, single 2.05 3.81 3.47 1.26 1.31 0.11 5.97 5.63 3.42 3.47 010
15787 A Abrasion, lesions, add-on 0.33 0.83 1.03 0.11 0.15 0.04 1.20 1.40 0.48 0.52 ZZZ
15788 R Chemical peel, face, epiderm 2.09 8.55 7.17 3.73 3.24 0.11 10.75 9.37 5.93 5.44 090
15789 R Chemical peel, face, dermal 4.91 9.26 8.38 5.77 5.04 0.20 14.37 13.49 10.88 10.15 090
15792 R Chemical peel, nonfacial 1.86 6.83 7.03 3.47 4.21 0.13 8.82 9.02 5.46 6.20 090
15793 A Chemical peel, nonfacial 3.82 5.56 6.10 3.31 4.11 0.19 9.57 10.11 7.32 8.12 090
15819 A Plastic surgery, neck 10.45 NA NA 6.83 7.09 0.97 NA NA 18.25 18.51 090
15820 A Revision of lower eyelid 6.09 6.53 6.86 5.32 5.50 0.40 13.02 13.35 11.81 11.99 090
15821 A Revision of lower eyelid 6.66 6.78 7.21 5.47 5.65 0.45 13.89 14.32 12.58 12.76 090
15822 A Revision of upper eyelid 4.51 5.38 5.72 4.23 4.43 0.37 10.26 10.60 9.11 9.31 090
15823 A Revision of upper eyelid 8.12 7.65 7.80 6.36 6.41 0.50 16.27 16.42 14.98 15.03 090
15824 R Removal of forehead wrinkles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15825 R Removal of neck wrinkles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15826 R Removal of brow wrinkles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15828 R Removal of face wrinkles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15829 R Removal of skin wrinkles 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
15830 R Exc skin abd 16.90 NA NA 10.15 10.15 2.93 NA NA 29.98 29.98 090
15832 A Excise excessive skin tissue 12.65 NA NA 8.43 8.36 1.66 NA NA 22.74 22.67 090
15833 A Excise excessive skin tissue 11.70 NA NA 7.16 7.95 1.49 NA NA 20.35 21.14 090
15834 A Excise excessive skin tissue 11.97 NA NA 7.86 7.73 1.61 NA NA 21.44 21.31 090
15835 A Excise excessive skin tissue 12.79 NA NA 7.92 7.64 1.60 NA NA 22.31 22.03 090
15836 A Excise excessive skin tissue 10.41 NA NA 7.12 6.87 1.34 NA NA 18.87 18.62 090
15837 A Excise excessive skin tissue 9.37 8.77 8.61 5.80 6.98 1.18 19.32 19.16 16.35 17.53 090
15838 A Excise excessive skin tissue 8.07 NA NA 4.97 5.79 0.58 NA NA 13.62 14.44 090
15839 A Excise excessive skin tissue 10.32 9.42 8.97 6.25 6.36 1.22 20.96 20.51 17.79 17.90 090
15840 A Graft for face nerve palsy 14.76 NA NA 8.75 9.67 1.32 NA NA 24.83 25.75 090
15841 A Graft for face nerve palsy 25.69 NA NA 13.33 14.58 2.55 NA NA 41.57 42.82 090
15842 A Flap for face nerve palsy 40.68 NA NA 21.64 22.59 4.94 NA NA 67.26 68.21 090
15845 A Skin and muscle repair, face 14.04 NA NA 8.90 9.20 0.81 NA NA 23.75 24.05 090
15847 C Exc skin abd add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
15850 B Removal of sutures 0.78 1.19 1.47 0.18 0.27 0.05 2.02 2.30 1.01 1.10 XXX
15851 A Removal of sutures 0.86 1.33 1.59 0.24 0.29 0.06 2.25 2.51 1.16 1.21 000
15852 A Dressing change not for burn 0.86 NA NA 0.26 0.31 0.09 NA NA 1.21 1.26 000
15860 A Test for blood flow in graft 1.95 NA NA 0.71 0.76 0.27 NA NA 2.93 2.98 000
15876 R Suction assisted lipectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15877 R Suction assisted lipectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15878 R Suction assisted lipectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15879 R Suction assisted lipectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
15920 A Removal of tail bone ulcer 8.15 NA NA 5.86 5.63 1.04 NA NA 15.05 14.82 090
15922 A Removal of tail bone ulcer 10.23 NA NA 7.11 7.19 1.42 NA NA 18.76 18.84 090
15931 A Remove sacrum pressure sore 9.96 NA NA 5.57 5.65 1.25 NA NA 16.78 16.86 090
15933 A Remove sacrum pressure sore 11.60 NA NA 7.39 7.74 1.52 NA NA 20.51 20.86 090
15934 A Remove sacrum pressure sore 13.54 NA NA 7.72 7.96 1.79 NA NA 23.05 23.29 090
15935 A Remove sacrum pressure sore 15.58 NA NA 10.34 10.33 2.10 NA NA 28.02 28.01 090
15936 A Remove sacrum pressure sore 13.04 NA NA 7.60 8.07 1.77 NA NA 22.41 22.88 090
15937 A Remove sacrum pressure sore 15.00 NA NA 9.14 9.65 2.07 NA NA 26.21 26.72 090
15940 A Remove hip pressure sore 10.11 NA NA 5.91 6.11 1.31 NA NA 17.33 17.53 090
15941 A Remove hip pressure sore 12.24 NA NA 8.66 9.25 1.66 NA NA 22.56 23.15 090
15944 A Remove hip pressure sore 12.27 NA NA 8.42 8.56 1.65 NA NA 22.34 22.48 090
15945 A Remove hip pressure sore 13.57 NA NA 9.35 9.57 1.85 NA NA 24.77 24.99 090
15946 A Remove hip pressure sore 23.80 NA NA 14.26 14.34 3.17 NA NA 41.23 41.31 090
15950 A Remove thigh pressure sore 7.91 NA NA 5.43 5.42 1.04 NA NA 14.38 14.37 090
15951 A Remove thigh pressure sore 11.41 NA NA 8.11 7.92 1.49 NA NA 21.01 20.82 090
15952 A Remove thigh pressure sore 12.14 NA NA 7.90 7.79 1.60 NA NA 21.64 21.53 090
15953 A Remove thigh pressure sore 13.39 NA NA 9.28 9.06 1.80 NA NA 24.47 24.25 090
15956 A Remove thigh pressure sore 16.59 NA NA 9.79 10.53 2.22 NA NA 28.60 29.34 090
15958 A Remove thigh pressure sore 16.55 NA NA 10.48 10.90 2.26 NA NA 29.29 29.71 090
15999 C Removal of pressure sore 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
16000 A Initial treatment of burn(s) 0.89 0.73 0.83 0.24 0.26 0.08 1.70 1.80 1.21 1.23 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
16020 A Dress/debrid p-thick burn, s 0.80 1.11 1.25 0.56 0.58 0.08 1.99 2.13 1.44 1.46 000
16025 A Dress/debrid p-thick burn, m 1.85 1.61 1.72 0.89 0.94 0.19 3.65 3.76 2.93 2.98 000
16030 A Dress/debrid p-thick burn, l 2.08 1.98 2.12 0.97 1.08 0.24 4.30 4.44 3.29 3.40 000
16035 A Incision of burn scab, initi 3.74 NA NA 1.29 1.51 0.46 NA NA 5.49 5.71 090
16036 A Escharotomy; addÆl incision 1.50 NA NA 0.49 0.57 0.20 NA NA 2.19 2.27 ZZZ
17000 A Destruct premalg lesion 0.62 1.42 1.08 0.75 0.59 0.03 2.07 1.73 1.40 1.24 010
17003 A Destruct premalg les, 2-14 0.07 0.10 0.11 0.03 0.06 0.01 0.18 0.19 0.11 0.14 ZZZ
17004 A Destroy premlg lesions 15+ 1.82 2.43 2.33 1.39 1.54 0.11 4.36 4.26 3.32 3.47 010
17106 A Destruction of skin lesions 4.62 4.72 4.63 3.32 3.33 0.35 9.69 9.60 8.29 8.30 090
17107 A Destruction of skin lesions 9.19 7.36 7.24 5.27 5.41 0.63 17.18 17.06 15.09 15.23 090
17108 A Destruction of skin lesions 13.22 9.56 9.34 6.99 7.49 0.54 23.32 23.10 20.75 21.25 090
17110 A Destruct b9 lesion, 1-14 0.67 1.76 1.66 0.87 0.74 0.05 2.48 2.38 1.59 1.46 010
17111 A Destruct lesion, 15 or more 0.94 2.29 1.83 1.14 0.89 0.05 3.28 2.82 2.13 1.88 010
17250 A Chemical cautery, tissue 0.50 1.32 1.25 0.38 0.35 0.06 1.88 1.81 0.94 0.91 000
17260 A Destruction of skin lesions 0.93 1.43 1.32 0.73 0.69 0.04 2.40 2.29 1.70 1.66 010
17261 A Destruction of skin lesions 1.19 2.51 1.84 1.09 0.90 0.05 3.75 3.08 2.33 2.14 010
17262 A Destruction of skin lesions 1.60 2.86 2.13 1.30 1.09 0.06 4.52 3.79 2.96 2.75 010
17263 A Destruction of skin lesions 1.81 3.09 2.31 1.40 1.17 0.07 4.97 4.19 3.28 3.05 010
17264 A Destruction of skin lesions 1.96 3.30 2.49 1.47 1.21 0.08 5.34 4.53 3.51 3.25 010
17266 A Destruction of skin lesions 2.36 3.56 2.77 1.64 1.33 0.09 6.01 5.22 4.09 3.78 010
17270 A Destruction of skin lesions 1.34 2.46 1.89 1.12 0.93 0.05 3.85 3.28 2.51 2.32 010
17271 A Destruction of skin lesions 1.51 2.69 2.00 1.25 1.05 0.06 4.26 3.57 2.82 2.62 010
17272 A Destruction of skin lesions 1.79 3.00 2.24 1.40 1.18 0.07 4.86 4.10 3.26 3.04 010
17273 A Destruction of skin lesions 2.07 3.25 2.46 1.53 1.29 0.08 5.40 4.61 3.68 3.44 010
17274 A Destruction of skin lesions 2.61 3.66 2.84 1.79 1.53 0.10 6.37 5.55 4.50 4.24 010
17276 A Destruction of skin lesions 3.22 3.95 3.19 2.04 1.77 0.16 7.33 6.57 5.42 5.15 010
17280 A Destruction of skin lesions 1.19 2.38 1.80 1.05 0.87 0.05 3.62 3.04 2.29 2.11 010
17281 A Destruction of skin lesions 1.74 2.77 2.12 1.36 1.16 0.07 4.58 3.93 3.17 2.97 010
17282 A Destruction of skin lesions 2.06 3.18 2.41 1.53 1.31 0.08 5.32 4.55 3.67 3.45 010
17283 A Destruction of skin lesions 2.66 3.60 2.81 1.81 1.57 0.11 6.37 5.58 4.58 4.34 010
17284 A Destruction of skin lesions 3.23 4.05 3.20 2.09 1.84 0.13 7.41 6.56 5.45 5.20 010
17286 A Destruction of skin lesions 4.45 4.45 3.87 2.52 2.46 0.23 9.13 8.55 7.20 7.14 010
17311 A Mohs, 1 stage, h/n/hf/g 6.20 10.79 10.79 3.16 3.16 0.24 17.23 17.23 9.60 9.60 000
17312 A Mohs addl stage 3.30 6.92 6.92 1.68 1.68 0.13 10.35 10.35 5.11 5.11 ZZZ
17313 A Mohs, 1 stage, t/a/l 5.56 9.95 9.95 2.83 2.83 0.22 15.73 15.73 8.61 8.61 000
17314 A Mohs, addl stage, t/a/l 3.06 6.41 6.41 1.55 1.55 0.12 9.59 9.59 4.73 4.73 ZZZ
17315 A Mohs surg, addl block 0.87 1.15 1.15 0.44 0.44 0.03 2.05 2.05 1.34 1.34 ZZZ
17340 A Cryotherapy of skin 0.76 0.34 0.36 0.34 0.36 0.05 1.15 1.17 1.15 1.17 010
17360 A Skin peel therapy 1.44 1.85 1.54 1.02 0.91 0.06 3.35 3.04 2.52 2.41 010
17380 R Hair removal by electrolysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
17999 C Skin tissue procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
19000 A Drainage of breast lesion 0.84 1.82 1.94 0.23 0.29 0.08 2.74 2.86 1.15 1.21 000
19001 A Drain breast lesion add-on 0.42 0.23 0.25 0.12 0.14 0.04 0.69 0.71 0.58 0.60 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
19020 A Incision of breast lesion 3.74 6.58 6.39 3.02 2.76 0.45 10.77 10.58 7.21 6.95 090
19030 A Injection for breast x-ray 1.53 2.46 2.76 0.43 0.48 0.09 4.08 4.38 2.05 2.10 000
19100 A Bx breast percut w/o image 1.27 2.05 2.07 0.33 0.40 0.16 3.48 3.50 1.76 1.83 000
19101 A Biopsy of breast, open 3.20 4.28 4.45 1.75 1.87 0.39 7.87 8.04 5.34 5.46 010
19102 A Bx breast percut w/image 2.00 3.22 3.68 0.56 0.64 0.14 5.36 5.82 2.70 2.78 000
19103 A Bx breast percut w/device 3.69 9.55 11.01 1.01 1.18 0.30 13.54 15.00 5.00 5.17 000
19105 A Cryosurg ablate fa, each 3.69 45.93 45.93 1.00 1.00 0.30 49.92 49.92 4.99 4.99 000
19110 A Nipple exploration 4.35 6.35 5.93 3.24 2.96 0.57 11.27 10.85 8.16 7.88 090
19112 A Excise breast duct fistula 3.72 6.22 6.10 3.14 2.80 0.48 10.42 10.30 7.34 7.00 090
19120 A Removal of breast lesion 5.84 5.06 4.67 3.36 3.14 0.73 11.63 11.24 9.93 9.71 090
19125 A Excision, breast lesion 6.59 5.53 4.97 3.64 3.37 0.80 12.92 12.36 11.03 10.76 090
19126 A Excision, addl breast lesion 2.93 NA NA 0.76 0.94 0.38 NA NA 4.07 4.25 ZZZ
19260 A Removal of chest wall lesion 17.60 NA NA 10.26 10.93 2.14 NA NA 30.00 30.67 090
19271 A Revision of chest wall 21.86 NA NA 15.88 17.43 2.63 NA NA 40.37 41.92 090
19272 A Extensive chest wall surgery 24.82 NA NA 16.99 18.45 3.00 NA NA 44.81 46.27 090
19290 A Place needle wire, breast 1.27 2.68 2.81 0.36 0.41 0.07 4.02 4.15 1.70 1.75 000
19291 A Place needle wire, breast 0.63 1.05 1.17 0.18 0.20 0.04 1.72 1.84 0.85 0.87 ZZZ
19295 A Place breast clip, percut 0.00 2.19 2.57 0.00 2.02 0.01 2.20 2.58 0.01 2.03 ZZZ
19296 A Place po breast cath for rad 3.63 83.51 114.92 1.20 1.45 0.36 87.50 118.91 5.19 5.44 000
19297 A Place breast cath for rad 1.72 NA NA 0.47 0.60 0.17 NA NA 2.36 2.49 ZZZ
19298 A Place breast rad tube/caths 6.00 23.09 37.39 2.20 2.36 0.43 29.52 43.82 8.63 8.79 000
19300 A Removal of breast tissue 5.20 7.95 7.34 3.82 3.50 0.69 13.84 13.23 9.71 9.39 090
19301 A Partical mastectomy 6.03 NA NA 3.60 3.47 0.79 NA NA 10.42 10.29 090
19302 A P-mastectomy w/ln removal 13.88 NA NA 6.15 6.29 1.80 NA NA 21.83 21.97 090
19303 A Mast, simple, complete 15.67 NA NA 7.00 5.52 1.18 NA NA 23.85 22.37 090
19304 A Mast, subq 7.81 NA NA 4.93 4.80 1.04 NA NA 13.78 13.65 090
19305 A Mast, radical 17.23 NA NA 8.16 8.01 1.93 NA NA 27.32 27.17 090
19306 A Mast, rad, urban type 17.85 NA NA 8.62 8.33 2.08 NA NA 28.55 28.26 090
19307 A Mast, mod rad 17.95 NA NA 8.77 8.34 2.13 NA NA 28.85 28.42 090
19316 A Suspension of breast 10.98 NA NA 7.28 7.45 1.64 NA NA 19.90 20.07 090
19318 A Reduction of large breast 15.91 NA NA 10.25 10.94 2.93 NA NA 29.09 29.78 090
19324 A Enlarge breast 6.65 NA NA 4.69 4.84 0.84 NA NA 12.18 12.33 090
19325 A Enlarge breast with implant 8.52 NA NA 6.62 6.55 1.33 NA NA 16.47 16.40 090
19328 A Removal of breast implant 6.35 NA NA 5.13 5.05 0.91 NA NA 12.39 12.31 090
19330 A Removal of implant material 8.39 NA NA 6.34 6.11 1.26 NA NA 15.99 15.76 090
19340 A Immediate breast prosthesis 6.32 NA NA 2.96 3.07 1.06 NA NA 10.34 10.45 ZZZ
19342 A Delayed breast prosthesis 12.40 NA NA 9.23 9.00 1.84 NA NA 23.47 23.24 090
19350 A Breast reconstruction 8.99 10.09 12.90 6.77 7.07 1.41 20.49 23.30 17.17 17.47 090
19355 A Correct inverted nipple(s) 8.37 7.85 9.65 5.03 4.78 0.92 17.14 18.94 14.32 14.07 090
19357 A Breast reconstruction 20.57 NA NA 15.91 15.69 2.94 NA NA 39.42 39.20 090
19361 A Breast reconstr w/lat flap 23.17 NA NA 17.30 13.65 2.93 NA NA 43.40 39.75 090
19364 A Breast reconstruction 42.40 NA NA 23.56 23.55 6.24 NA NA 72.20 72.19 090
19366 A Breast reconstruction 21.70 NA NA 10.28 11.26 3.25 NA NA 35.23 36.21 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
19367 A Breast reconstruction 26.59 NA NA 15.75 16.46 4.04 NA NA 46.38 47.09 090
19368 A Breast reconstruction 33.61 NA NA 18.79 18.89 5.54 NA NA 57.94 58.04 090
19369 A Breast reconstruction 31.02 NA NA 16.41 17.90 4.51 NA NA 51.94 53.43 090
19370 A Surgery of breast capsule 8.99 NA NA 7.02 6.93 1.29 NA NA 17.30 17.21 090
19371 A Removal of breast capsule 10.42 NA NA 7.92 7.85 1.62 NA NA 19.96 19.89 090
19380 A Revise breast reconstruction 10.21 NA NA 7.85 7.74 1.44 NA NA 19.50 19.39 090
19396 A Design custom breast implant 2.17 4.54 1.95 1.27 1.06 0.30 7.01 4.42 3.74 3.53 000
19499 C Breast surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
20000 A Incision of abscess 2.14 2.78 2.71 1.53 1.68 0.25 5.17 5.10 3.92 4.07 010
20005 A Incision of deep abscess 3.55 3.70 3.54 2.04 2.20 0.46 7.71 7.55 6.05 6.21 010
20100 A Explore wound, neck 10.33 NA NA 3.67 4.26 1.21 NA NA 15.21 15.80 010
20101 A Explore wound, chest 3.22 6.37 6.03 1.51 1.59 0.44 10.03 9.69 5.17 5.25 010
20102 A Explore wound, abdomen 3.95 6.89 7.32 1.85 1.89 0.49 11.33 11.76 6.29 6.33 010
20103 A Explore wound, extremity 5.31 7.68 8.36 2.75 3.23 0.75 13.74 14.42 8.81 9.29 010
20150 A Excise epiphyseal bar 14.60 NA NA 7.81 7.23 2.04 NA NA 24.45 23.87 090
20200 A Muscle biopsy 1.46 3.13 3.06 0.70 0.74 0.23 4.82 4.75 2.39 2.43 000
20205 A Deep muscle biopsy 2.35 3.81 3.87 1.11 1.17 0.33 6.49 6.55 3.79 3.85 000
20206 A Needle biopsy, muscle 0.99 4.99 6.12 0.50 0.60 0.07 6.05 7.18 1.56 1.66 000
20220 A Bone biopsy, trocar/needle 1.27 2.59 4.07 0.61 0.75 0.08 3.94 5.42 1.96 2.10 000
20225 A Bone biopsy, trocar/needle 1.87 12.62 21.49 0.99 1.10 0.22 14.71 23.58 3.08 3.19 000
20240 A Bone biopsy, excisional 3.25 NA NA 2.09 2.44 0.44 NA NA 5.78 6.13 010
20245 A Bone biopsy, excisional 8.77 NA NA 5.82 6.38 1.31 NA NA 15.90 16.46 010
20250 A Open bone biopsy 5.16 NA NA 3.73 3.56 1.02 NA NA 9.91 9.74 010
20251 A Open bone biopsy 5.69 NA NA 3.91 4.10 1.15 NA NA 10.75 10.94 010
20500 A Injection of sinus tract 1.25 1.27 2.01 0.83 1.36 0.12 2.64 3.38 2.20 2.73 010
20501 A Inject sinus tract for x-ray 0.76 2.22 2.74 0.22 0.24 0.04 3.02 3.54 1.02 1.04 000
20520 A Removal of foreign body 1.87 2.58 2.83 1.45 1.68 0.21 4.66 4.91 3.53 3.76 010
20525 A Removal of foreign body 3.51 7.05 8.62 2.21 2.52 0.51 11.07 12.64 6.23 6.54 010
20526 A Ther injection, carp tunnel 0.94 0.82 0.93 0.42 0.50 0.13 1.89 2.00 1.49 1.57 000
20550 A Inj tendon sheath/ligament 0.75 0.63 0.69 0.29 0.25 0.09 1.47 1.53 1.13 1.09 000
20551 A Inj tendon origin/insertion 0.75 0.63 0.67 0.29 0.32 0.08 1.46 1.50 1.12 1.15 000
20552 A Inj trigger point, 1/2 muscl 0.66 0.58 0.69 0.25 0.21 0.05 1.29 1.40 0.96 0.92 000
20553 A Inject trigger points, =/ 3 0.75 0.64 0.78 0.27 0.23 0.04 1.43 1.57 1.06 1.02 000
20600 A Drain/inject, joint/bursa 0.66 0.67 0.66 0.32 0.34 0.08 1.41 1.40 1.06 1.08 000
20605 A Drain/inject, joint/bursa 0.68 0.74 0.76 0.33 0.35 0.08 1.50 1.52 1.09 1.11 000
20610 A Drain/inject, joint/bursa 0.79 1.06 0.98 0.40 0.42 0.11 1.96 1.88 1.30 1.32 000
20612 A Aspirate/inj ganglion cyst 0.70 0.70 0.71 0.32 0.35 0.10 1.50 1.51 1.12 1.15 000
20615 A Treatment of bone cyst 2.30 2.70 3.31 1.41 1.73 0.20 5.20 5.81 3.91 4.23 010
20650 A Insert and remove bone pin 2.25 2.51 2.40 1.49 1.54 0.31 5.07 4.96 4.05 4.10 010
20660 A Apply, rem fixation device 2.51 3.39 3.14 1.52 1.59 0.59 6.49 6.24 4.62 4.69 000
20661 A Application of head brace 5.14 NA NA 6.03 5.19 1.14 NA NA 12.31 11.47 090
20662 A Application of pelvis brace 6.26 NA NA 4.89 5.36 0.56 NA NA 11.71 12.18 090
20663 A Application of thigh brace 5.62 NA NA 5.17 4.92 0.94 NA NA 11.73 11.48 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
20664 A Halo brace application 9.86 NA NA 8.19 7.33 1.75 NA NA 19.80 18.94 090
20665 A Removal of fixation device 1.33 1.45 1.98 1.03 1.27 0.19 2.97 3.50 2.55 2.79 010
20670 A Removal of support implant 1.76 6.65 10.32 1.69 2.00 0.28 8.69 12.36 3.73 4.04 010
20680 A Removal of support implant 5.90 8.16 8.63 4.11 3.82 0.56 14.62 15.09 10.57 10.28 090
20690 A Apply bone fixation device 3.67 NA NA 2.29 2.46 0.59 NA NA 6.55 6.72 090
20692 A Apply bone fixation device 6.40 NA NA 3.30 3.65 1.05 NA NA 10.75 11.10 090
20693 A Adjust bone fixation device 5.97 NA NA 4.54 5.22 0.98 NA NA 11.49 12.17 090
20694 A Remove bone fixation device 4.20 5.35 6.69 3.57 3.92 0.71 10.26 11.60 8.48 8.83 090
20802 A Replantation, arm, complete 42.30 NA NA 24.78 21.91 3.82 NA NA 70.90 68.03 090
20805 A Replant forearm, complete 51.14 NA NA 26.11 32.26 4.85 NA NA 82.10 88.25 090
20808 A Replantation hand, complete 62.77 NA NA 39.72 41.60 6.88 NA NA 109.37 111.25 090
20816 A Replantation digit, complete 31.74 NA NA 24.63 34.50 4.53 NA NA 60.90 70.77 090
20822 A Replantation digit, complete 26.42 NA NA 22.54 31.58 4.19 NA NA 53.15 62.19 090
20824 A Replantation thumb, complete 31.74 NA NA 25.93 33.89 4.62 NA NA 62.29 70.25 090
20827 A Replantation thumb, complete 27.24 NA NA 24.10 33.38 3.67 NA NA 55.01 64.29 090
20838 A Replantation foot, complete 42.56 NA NA 13.52 20.09 1.12 NA NA 57.20 63.77 090
20900 A Removal of bone for graft 5.77 9.30 8.65 4.97 5.50 0.94 16.01 15.36 11.68 12.21 090
20902 A Removal of bone for graft 7.98 NA NA 5.87 6.63 1.30 NA NA 15.15 15.91 090
20910 A Remove cartilage for graft 5.41 NA NA 4.69 5.06 0.71 NA NA 10.81 11.18 090
20912 A Remove cartilage for graft 6.42 NA NA 4.76 5.53 0.69 NA NA 11.87 12.64 090
20920 A Removal of fascia for graft 5.42 NA NA 4.40 4.27 0.66 NA NA 10.48 10.35 090
20922 A Removal of fascia for graft 6.84 7.57 7.55 5.02 4.91 0.70 15.11 15.09 12.56 12.45 090
20924 A Removal of tendon for graft 6.59 NA NA 5.04 5.67 1.04 NA NA 12.67 13.30 090
20926 A Removal of tissue for graft 5.70 NA NA 4.44 4.67 0.87 NA NA 11.01 11.24 090
20930 B Spinal bone allograft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
20931 A Spinal bone allograft 1.81 NA NA 0.70 0.87 0.43 NA NA 2.94 3.11 ZZZ
20936 B Spinal bone autograft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
20937 A Spinal bone autograft 2.79 NA NA 1.11 1.37 0.54 NA NA 4.44 4.70 ZZZ
20938 A Spinal bone autograft 3.02 NA NA 1.18 1.47 0.64 NA NA 4.84 5.13 ZZZ
20950 A Fluid pressure, muscle 1.26 4.14 6.17 0.88 0.96 0.20 5.60 7.63 2.34 2.42 000
20955 A Fibula bone graft, microvasc 40.02 NA NA 18.50 22.83 4.90 NA NA 63.42 67.75 090
20956 A Iliac bone graft, microvasc 40.93 NA NA 20.95 23.79 7.03 NA NA 68.91 71.75 090
20957 A Mt bone graft, microvasc 42.33 NA NA 19.65 19.12 7.07 NA NA 69.05 68.52 090
20962 A Other bone graft, microvasc 39.21 NA NA 21.46 25.26 6.57 NA NA 67.24 71.04 090
20969 A Bone/skin graft, microvasc 45.11 NA NA 20.79 25.17 4.80 NA NA 70.70 75.08 090
20970 A Bone/skin graft, iliac crest 44.26 NA NA 20.52 24.17 6.62 NA NA 71.40 75.05 090
20972 A Bone/skin graft, metatarsal 44.19 NA NA 17.83 19.89 5.32 NA NA 67.34 69.40 090
20973 A Bone/skin graft, great toe 46.95 NA NA 15.20 22.67 5.56 NA NA 67.71 75.18 090
20974 A Electrical bone stimulation 0.62 0.99 0.77 0.49 0.53 0.11 1.72 1.50 1.22 1.26 000
20975 A Electrical bone stimulation 2.60 NA NA 1.49 1.66 0.51 NA NA 4.60 4.77 000
20979 A Us bone stimulation 0.62 0.58 0.75 0.20 0.31 0.09 1.29 1.46 0.91 1.02 000
20982 A Ablate, bone tumor(s) perq 7.27 78.40 101.76 2.35 2.82 0.69 86.36 109.72 10.31 10.78 000
20999 C Musculoskeletal surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
21010 A Incision of jaw joint 10.90 NA NA 5.97 6.81 1.11 NA NA 17.98 18.82 090
21015 A Resection of facial tumor 5.59 NA NA 4.35 4.85 0.70 NA NA 10.64 11.14 090
21025 A Excision of bone, lower jaw 11.07 12.54 12.32 8.77 9.21 1.32 24.93 24.71 21.16 21.60 090
21026 A Excision of facial bone(s) 5.54 8.74 8.08 5.89 6.21 0.60 14.88 14.22 12.03 12.35 090
21029 A Contour of face bone lesion 8.26 9.34 9.36 6.37 6.85 0.94 18.54 18.56 15.57 16.05 090
21030 A Excise max/zygoma b9 tumor 4.80 7.20 6.55 4.71 4.95 0.54 12.54 11.89 10.05 10.29 090
21031 A Remove exostosis, mandible 3.26 5.98 5.37 3.53 3.60 0.48 9.72 9.11 7.27 7.34 090
21032 A Remove exostosis, maxilla 3.28 6.07 5.52 3.40 3.48 0.47 9.82 9.27 7.15 7.23 090
21034 A Excise max/zygoma mlg tumor 17.17 13.31 15.27 9.67 11.91 1.72 32.20 34.16 28.56 30.80 090
21040 A Excise mandible lesion 4.80 7.27 6.61 4.71 4.72 0.54 12.61 11.95 10.05 10.06 090
21044 A Removal of jaw bone lesion 12.61 NA NA 7.60 8.93 1.12 NA NA 21.33 22.66 090
21045 A Extensive jaw surgery 18.13 NA NA 10.18 11.81 1.52 NA NA 29.83 31.46 090
21046 A Remove mandible cyst complex 13.97 NA NA 11.72 11.86 1.86 NA NA 27.55 27.69 090
21047 A Excise lwr jaw cyst w/repair 19.83 NA NA 9.92 12.56 2.13 NA NA 31.88 34.52 090
21048 A Remove maxilla cyst complex 14.47 NA NA 11.48 11.97 1.77 NA NA 27.72 28.21 090
21049 A Excis uppr jaw cyst w/repair 19.08 NA NA 9.25 12.08 1.59 NA NA 29.92 32.75 090
21050 A Removal of jaw joint 11.54 NA NA 8.28 9.15 1.47 NA NA 21.29 22.16 090
21060 A Remove jaw joint cartilage 10.91 NA NA 7.61 8.36 1.38 NA NA 19.90 20.65 090
21070 A Remove coronoid process 8.50 NA NA 6.21 6.88 1.27 NA NA 15.98 16.65 090
21076 A Prepare face/oral prosthesis 13.40 7.97 11.26 4.90 8.73 2.00 23.37 26.66 20.30 24.13 010
21077 A Prepare face/oral prosthesis 33.70 18.75 28.19 12.57 22.64 4.56 57.01 66.45 50.83 60.90 090
21079 A Prepare face/oral prosthesis 22.31 13.89 19.60 8.45 14.98 3.16 39.36 45.07 33.92 40.45 090
21080 A Prepare face/oral prosthesis 25.06 16.10 22.39 9.41 16.87 3.75 44.91 51.20 38.22 45.68 090
21081 A Prepare face/oral prosthesis 22.85 14.84 20.44 8.66 15.28 3.21 40.90 46.50 34.72 41.34 090
21082 A Prepare face/oral prosthesis 20.84 15.02 18.26 8.57 13.94 3.12 38.98 42.22 32.53 37.90 090
21083 A Prepare face/oral prosthesis 19.27 14.79 17.79 8.05 12.84 2.89 36.95 39.95 30.21 35.00 090
21084 A Prepare face/oral prosthesis 22.48 16.37 20.92 8.99 15.52 2.19 41.04 45.59 33.66 40.19 090
21085 A Prepare face/oral prosthesis 8.99 6.90 7.94 3.64 6.00 1.27 17.16 18.20 13.90 16.26 010
21086 A Prepare face/oral prosthesis 24.88 12.93 21.04 8.82 16.78 3.72 41.53 49.64 37.42 45.38 090
21087 A Prepare face/oral prosthesis 24.88 13.17 20.75 9.02 16.65 3.45 41.50 49.08 37.35 44.98 090
21088 C Prepare face/oral prosthesis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
21089 C Prepare face/oral prosthesis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
21100 A Maxillofacial fixation 4.56 13.76 12.09 5.11 4.83 0.34 18.66 16.99 10.01 9.73 090
21110 A Interdental fixation 5.80 13.27 10.49 9.91 8.75 0.72 19.79 17.01 16.43 15.27 090
21116 A Injection, jaw joint x-ray 0.81 2.38 3.84 0.21 0.30 0.06 3.25 4.71 1.08 1.17 000
21120 A Reconstruction of chin 4.99 10.09 10.46 6.96 7.36 0.60 15.68 16.05 12.55 12.95 090
21121 A Reconstruction of chin 7.70 10.63 9.96 7.56 7.76 0.90 19.23 18.56 16.16 16.36 090
21122 A Reconstruction of chin 8.59 NA NA 7.75 8.40 1.07 NA NA 17.41 18.06 090
21123 A Reconstruction of chin 11.22 NA NA 10.14 10.64 1.40 NA NA 22.76 23.26 090
21125 A Augmentation, lower jaw bone 10.68 68.54 58.55 7.14 8.03 0.79 80.01 70.02 18.61 19.50 090
21127 A Augmentation, lower jaw bone 12.24 87.23 53.91 8.01 9.09 1.52 100.99 67.67 21.77 22.85 090
21137 A Reduction of forehead 10.12 NA NA 6.43 7.41 1.32 NA NA 17.87 18.85 090
21138 A Reduction of forehead 12.73 NA NA 8.83 9.36 1.75 NA NA 23.31 23.84 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
21139 A Reduction of forehead 14.90 NA NA 8.50 10.42 1.18 NA NA 24.58 26.50 090
21141 A Reconstruct midface, lefort 19.27 NA NA 11.69 13.16 2.36 NA NA 33.32 34.79 090
21142 A Reconstruct midface, lefort 19.98 NA NA 10.64 12.28 2.39 NA NA 33.01 34.65 090
21143 A Reconstruct midface, lefort 20.75 NA NA 8.80 12.93 1.66 NA NA 31.21 35.34 090
21145 A Reconstruct midface, lefort 23.64 NA NA 12.72 13.61 2.85 NA NA 39.21 40.10 090
21146 A Reconstruct midface, lefort 24.54 NA NA 9.16 13.79 3.10 NA NA 36.80 41.43 090
21147 A Reconstruct midface, lefort 26.14 NA NA 13.75 14.73 1.85 NA NA 41.74 42.72 090
21150 A Reconstruct midface, lefort 25.78 NA NA 13.05 15.83 2.56 NA NA 41.39 44.17 090
21151 A Reconstruct midface, lefort 28.84 NA NA 11.57 20.11 2.31 NA NA 42.72 51.26 090
21154 A Reconstruct midface, lefort 31.05 NA NA 21.78 22.79 2.49 NA NA 55.32 56.33 090
21155 A Reconstruct midface, lefort 34.98 NA NA 13.28 21.24 6.66 NA NA 54.92 62.88 090
21159 A Reconstruct midface, lefort 42.90 NA NA 15.10 25.59 8.20 NA NA 66.20 76.69 090
21160 A Reconstruct midface, lefort 46.95 NA NA 24.15 26.64 4.14 NA NA 75.24 77.73 090
21172 A Reconstruct orbit/forehead 28.07 NA NA 13.88 13.78 3.56 NA NA 45.51 45.41 090
21175 A Reconstruct orbit/forehead 33.43 NA NA 13.17 16.64 4.84 NA NA 51.44 54.91 090
21179 A Reconstruct entire forehead 22.53 NA NA 11.17 13.39 2.81 NA NA 36.51 38.73 090
21180 A Reconstruct entire forehead 25.46 NA NA 12.78 14.73 3.49 NA NA 41.73 43.68 090
21181 A Contour cranial bone lesion 10.18 NA NA 7.10 7.37 1.32 NA NA 18.60 18.87 090
21182 A Reconstruct cranial bone 32.45 NA NA 14.40 17.93 2.81 NA NA 49.66 53.19 090
21183 A Reconstruct cranial bone 35.57 NA NA 15.57 19.52 4.48 NA NA 55.62 59.57 090
21184 A Reconstruct cranial bone 38.49 NA NA 21.42 21.81 5.72 NA NA 65.63 66.02 090
21188 A Reconstruction of midface 22.97 NA NA 14.93 17.89 1.70 NA NA 39.60 42.56 090
21193 A Reconst lwr jaw w/o graft 18.65 NA NA 9.93 11.97 2.24 NA NA 30.82 32.86 090
21194 A Reconst lwr jaw w/graft 21.54 NA NA 11.48 13.18 2.03 NA NA 35.05 36.75 090
21195 A Reconst lwr jaw w/o fixation 18.88 NA NA 13.47 14.48 1.64 NA NA 33.99 35.00 090
21196 A Reconst lwr jaw w/fixation 20.55 NA NA 13.41 15.12 2.08 NA NA 36.04 37.75 090
21198 A Reconstr lwr jaw segment 15.48 NA NA 11.21 12.33 1.44 NA NA 28.13 29.25 090
21199 A Reconstr lwr jaw w/advance 16.62 NA NA 6.96 8.57 1.39 NA NA 24.97 26.58 090
21206 A Reconstruct upper jaw bone 15.36 NA NA 11.25 12.29 1.33 NA NA 27.94 28.98 090
21208 A Augmentation of facial bones 11.15 32.41 24.85 7.83 9.14 1.09 44.65 37.09 20.07 21.38 090
21209 A Reduction of facial bones 7.58 12.40 11.20 7.52 7.93 0.90 20.88 19.68 16.00 16.41 090
21210 A Face bone graft 11.40 43.70 29.58 7.81 8.97 1.30 56.40 42.28 20.51 21.67 090
21215 A Lower jaw bone graft 11.94 86.14 52.95 8.10 9.05 1.53 99.61 66.42 21.57 22.52 090
21230 A Rib cartilage graft 11.06 NA NA 6.94 7.77 1.29 NA NA 19.29 20.12 090
21235 A Ear cartilage graft 7.31 9.88 9.85 6.05 6.32 0.61 17.80 17.77 13.97 14.24 090
21240 A Reconstruction of jaw joint 15.77 NA NA 9.64 11.45 2.25 NA NA 27.66 29.47 090
21242 A Reconstruction of jaw joint 14.32 NA NA 8.95 10.87 1.79 NA NA 25.06 26.98 090
21243 A Reconstruction of jaw joint 24.03 NA NA 14.17 16.62 3.26 NA NA 41.46 43.91 090
21244 A Reconstruction of lower jaw 13.35 NA NA 11.07 11.84 1.25 NA NA 25.67 26.44 090
21245 A Reconstruction of jaw 12.88 13.48 14.17 8.14 9.42 1.19 27.55 28.24 22.21 23.49 090
21246 A Reconstruction of jaw 12.78 NA NA 6.81 8.48 1.35 NA NA 20.94 22.61 090
21247 A Reconstruct lower jaw bone 24.05 NA NA 12.11 16.04 2.84 NA NA 39.00 42.93 090
21248 A Reconstruction of jaw 12.54 12.64 12.26 7.59 8.95 1.55 26.73 26.35 21.68 23.04 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
21249 A Reconstruction of jaw 18.57 16.25 16.60 10.10 12.04 2.49 37.31 37.66 31.16 33.10 090
21255 A Reconstruct lower jaw bone 18.14 NA NA 13.51 15.48 2.39 NA NA 34.04 36.01 090
21256 A Reconstruction of orbit 17.42 NA NA 9.98 11.36 1.50 NA NA 28.90 30.28 090
21260 A Revise eye sockets 17.74 NA NA 9.39 11.92 0.97 NA NA 28.10 30.63 090
21261 A Revise eye sockets 33.78 NA NA 14.69 21.85 3.43 NA NA 51.90 59.06 090
21263 A Revise eye sockets 30.72 NA NA 13.99 17.80 2.63 NA NA 47.34 51.15 090
21267 A Revise eye sockets 20.45 NA NA 16.34 18.91 1.71 NA NA 38.50 41.07 090
21268 A Revise eye sockets 26.78 NA NA 16.04 19.17 3.66 NA NA 46.48 49.61 090
21270 A Augmentation, cheek bone 10.52 11.23 11.55 5.99 6.94 0.72 22.47 22.79 17.23 18.18 090
21275 A Revision, orbitofacial bones 11.65 NA NA 7.58 8.02 1.29 NA NA 20.52 20.96 090
21280 A Revision of eyelid 6.92 NA NA 5.91 5.92 0.42 NA NA 13.25 13.26 090
21282 A Revision of eyelid 4.11 NA NA 4.30 4.44 0.26 NA NA 8.67 8.81 090
21295 A Revision of jaw muscle/bone 1.82 NA NA 2.61 2.55 0.16 NA NA 4.59 4.53 090
21296 A Revision of jaw muscle/bone 4.67 NA NA 5.49 5.06 0.34 NA NA 10.50 10.07 090
21299 C Cranio/maxillofacial surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
21310 A Treatment of nose fracture 0.58 1.96 2.20 0.11 0.14 0.05 2.59 2.83 0.74 0.77 000
21315 A Treatment of nose fracture 1.78 4.47 4.29 1.67 1.83 0.14 6.39 6.21 3.59 3.75 010
21320 A Treatment of nose fracture 1.86 4.06 3.95 1.27 1.53 0.18 6.10 5.99 3.31 3.57 010
21325 A Treatment of nose fracture 4.07 NA NA 6.79 8.16 0.31 NA NA 11.17 12.54 090
21330 A Treatment of nose fracture 5.68 NA NA 7.52 9.16 0.56 NA NA 13.76 15.40 090
21335 A Treatment of nose fracture 8.91 NA NA 7.84 9.18 0.74 NA NA 17.49 18.83 090
21336 A Treat nasal septal fracture 6.56 NA NA 8.24 9.27 0.55 NA NA 15.35 16.38 090
21337 A Treat nasal septal fracture 3.26 5.91 6.07 3.41 3.53 0.28 9.45 9.61 6.95 7.07 090
21338 A Treat nasoethmoid fracture 6.76 NA NA 9.73 12.95 0.82 NA NA 17.31 20.53 090
21339 A Treat nasoethmoid fracture 8.39 NA NA 10.80 13.13 0.96 NA NA 20.15 22.48 090
21340 A Treatment of nose fracture 11.33 NA NA 7.21 8.10 1.15 NA NA 19.69 20.58 090
21343 A Treatment of sinus fracture 14.11 NA NA 12.68 14.77 1.47 NA NA 28.26 30.35 090
21344 A Treatment of sinus fracture 21.36 NA NA 13.37 15.72 2.44 NA NA 37.17 39.52 090
21345 A Treat nose/jaw fracture 8.87 9.76 9.82 6.07 6.90 0.92 19.55 19.61 15.86 16.69 090
21346 A Treat nose/jaw fracture 11.29 NA NA 10.87 11.87 1.21 NA NA 23.37 24.37 090
21347 A Treat nose/jaw fracture 13.37 NA NA 11.73 15.08 1.47 NA NA 26.57 29.92 090
21348 A Treat nose/jaw fracture 17.36 NA NA 6.29 9.91 2.49 NA NA 26.14 29.76 090
21355 A Treat cheek bone fracture 4.32 5.63 6.08 3.04 3.37 0.34 10.29 10.74 7.70 8.03 010
21356 A Treat cheek bone fracture 4.70 6.84 7.05 3.99 4.41 0.46 12.00 12.21 9.15 9.57 010
21360 A Treat cheek bone fracture 7.03 NA NA 5.35 5.79 0.74 NA NA 13.12 13.56 090
21365 A Treat cheek bone fracture 16.52 NA NA 9.11 10.40 1.70 NA NA 27.33 28.62 090
21366 A Treat cheek bone fracture 18.44 NA NA 10.46 11.11 2.50 NA NA 31.40 32.05 090
21385 A Treat eye socket fracture 9.46 NA NA 7.01 7.96 0.97 NA NA 17.44 18.39 090
21386 A Treat eye socket fracture 9.46 NA NA 5.86 6.77 0.97 NA NA 16.29 17.20 090
21387 A Treat eye socket fracture 10.00 NA NA 7.38 8.56 1.08 NA NA 18.46 19.64 090
21390 A Treat eye socket fracture 11.07 NA NA 7.17 7.64 0.90 NA NA 19.14 19.61 090
21395 A Treat eye socket fracture 14.62 NA NA 7.96 8.76 1.44 NA NA 24.02 24.82 090
21400 A Treat eye socket fracture 1.44 2.74 2.64 1.98 1.90 0.15 4.33 4.23 3.57 3.49 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
21401 A Treat eye socket fracture 3.57 7.24 7.80 3.15 3.41 0.38 11.19 11.75 7.10 7.36 090
21406 A Treat eye socket fracture 7.31 NA NA 5.17 5.85 0.73 NA NA 13.21 13.89 090
21407 A Treat eye socket fracture 8.91 NA NA 5.99 6.64 0.94 NA NA 15.84 16.49 090
21408 A Treat eye socket fracture 12.67 NA NA 8.08 8.68 1.44 NA NA 22.19 22.79 090
21421 A Treat mouth roof fracture 5.80 12.12 10.03 9.01 8.49 0.73 18.65 16.56 15.54 15.02 090
21422 A Treat mouth roof fracture 8.62 NA NA 6.88 7.78 0.99 NA NA 16.49 17.39 090
21423 A Treat mouth roof fracture 10.71 NA NA 7.41 8.84 1.27 NA NA 19.39 20.82 090
21431 A Treat craniofacial fracture 7.74 NA NA 9.40 9.49 0.70 NA NA 17.84 17.93 090
21432 A Treat craniofacial fracture 8.76 NA NA 7.26 7.86 0.81 NA NA 16.83 17.43 090
21433 A Treat craniofacial fracture 26.13 NA NA 12.56 15.44 2.79 NA NA 41.48 44.36 090
21435 A Treat craniofacial fracture 20.02 NA NA 10.73 12.21 1.99 NA NA 32.74 34.22 090
21436 A Treat craniofacial fracture 30.01 NA NA 14.45 17.28 3.10 NA NA 47.56 50.39 090
21440 A Treat dental ridge fracture 3.28 10.30 7.90 7.65 6.53 0.38 13.96 11.56 11.31 10.19 090
21445 A Treat dental ridge fracture 6.04 12.49 10.44 8.65 8.44 0.78 19.31 17.26 15.47 15.26 090
21450 A Treat lower jaw fracture 3.55 10.39 8.13 7.65 7.07 0.33 14.27 12.01 11.53 10.95 090
21451 A Treat lower jaw fracture 5.46 12.93 10.25 9.65 8.71 0.63 19.02 16.34 15.74 14.80 090
21452 A Treat lower jaw fracture 2.29 11.74 12.70 5.90 4.93 0.27 14.30 15.26 8.46 7.49 090
21453 A Treat lower jaw fracture 6.40 14.76 11.75 11.63 10.96 0.74 21.90 18.89 18.77 18.10 090
21454 A Treat lower jaw fracture 7.17 NA NA 5.76 6.14 0.82 NA NA 13.75 14.13 090
21461 A Treat lower jaw fracture 9.07 41.16 28.64 12.67 12.66 0.98 51.21 38.69 22.72 22.71 090
21462 A Treat lower jaw fracture 10.77 42.36 31.30 13.25 12.85 1.27 54.40 43.34 25.29 24.89 090
21465 A Treat lower jaw fracture 12.88 NA NA 8.42 9.46 1.50 NA NA 22.80 23.84 090
21470 A Treat lower jaw fracture 17.24 NA NA 10.26 11.58 1.97 NA NA 29.47 30.79 090
21480 A Reset dislocated jaw 0.61 1.50 1.70 0.18 0.19 0.06 2.17 2.37 0.85 0.86 000
21485 A Reset dislocated jaw 4.58 12.19 9.21 9.19 8.04 0.51 17.28 14.30 14.28 13.13 090
21490 A Repair dislocated jaw 12.71 NA NA 7.95 9.26 1.97 NA NA 22.63 23.94 090
21495 A Treat hyoid bone fracture 6.55 NA NA 9.65 8.73 0.46 NA NA 16.66 15.74 090
21497 A Interdental wiring 4.45 11.98 9.33 9.18 8.03 0.50 16.93 14.28 14.13 12.98 090
21499 C Head surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
21501 A Drain neck/chest lesion 3.87 6.39 6.41 3.44 3.73 0.43 10.69 10.71 7.74 8.03 090
21502 A Drain chest lesion 7.43 NA NA 4.78 5.42 0.97 NA NA 13.18 13.82 090
21510 A Drainage of bone lesion 6.06 NA NA 4.74 5.43 0.80 NA NA 11.60 12.29 090
21550 A Biopsy of neck/chest 2.08 4.26 3.75 1.73 1.72 0.16 6.50 5.99 3.97 3.96 010
21555 A Remove lesion, neck/chest 4.40 5.74 5.57 3.41 3.25 0.56 10.70 10.53 8.37 8.21 090
21556 A Remove lesion, neck/chest 5.63 NA NA 4.02 4.08 0.65 NA NA 10.30 10.36 090
21557 A Remove tumor, neck/chest 8.91 NA NA 4.46 5.13 1.08 NA NA 14.45 15.12 090
21600 A Partial removal of rib 7.14 NA NA 5.82 5.75 0.99 NA NA 13.95 13.88 090
21610 A Partial removal of rib 15.76 NA NA 8.21 8.70 3.08 NA NA 27.05 27.54 090
21615 A Removal of rib 10.31 NA NA 5.47 6.38 1.45 NA NA 17.23 18.14 090
21616 A Removal of rib and nerves 12.54 NA NA 7.12 7.80 1.87 NA NA 21.53 22.21 090
21620 A Partial removal of sternum 7.16 NA NA 4.90 5.70 0.98 NA NA 13.04 13.84 090
21627 A Sternal debridement 7.18 NA NA 5.64 6.14 1.02 NA NA 13.84 14.34 090
21630 A Extensive sternum surgery 19.01 NA NA 10.75 11.57 2.59 NA NA 32.35 33.17 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
21632 A Extensive sternum surgery 19.51 NA NA 9.58 10.73 2.66 NA NA 31.75 32.90 090
21685 A Hyoid myotomy suspension 14.89 NA NA 7.99 9.48 1.06 NA NA 23.94 25.43 090
21700 A Revision of neck muscle 6.23 NA NA 4.03 4.34 0.32 NA NA 10.58 10.89 090
21705 A Revision of neck muscle/rib 9.83 NA NA 4.71 5.36 1.43 NA NA 15.97 16.62 090
21720 A Revision of neck muscle 5.72 NA NA 4.36 2.94 0.91 NA NA 10.99 9.57 090
21725 A Revision of neck muscle 7.10 NA NA 4.60 5.23 1.21 NA NA 12.91 13.54 090
21740 A Reconstruction of sternum 17.47 NA NA 8.85 8.60 2.37 NA NA 28.69 28.44 090
21742 C Repair stern/nuss w/o scope 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
21743 C Repair sternum/nuss w/scope 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
21750 A Repair of sternum separation 11.35 NA NA 5.43 5.94 1.63 NA NA 18.41 18.92 090
21800 A Treatment of rib fracture 0.98 1.35 1.34 1.35 1.34 0.09 2.42 2.41 2.42 2.41 090
21805 A Treatment of rib fracture 2.80 NA NA 3.53 3.28 0.38 NA NA 6.71 6.46 090
21810 A Treatment of rib fracture(s) 6.92 NA NA 5.21 5.03 0.94 NA NA 13.07 12.89 090
21820 A Treat sternum fracture 1.31 1.80 1.82 1.80 1.77 0.16 3.27 3.29 3.27 3.24 090
21825 A Treat sternum fracture 7.65 NA NA 5.46 6.16 1.11 NA NA 14.22 14.92 090
21899 C Neck/chest surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
21920 A Biopsy soft tissue of back 2.08 4.42 3.57 1.89 1.58 0.14 6.64 5.79 4.11 3.80 010
21925 A Biopsy soft tissue of back 4.54 5.44 5.24 3.43 3.29 0.60 10.58 10.38 8.57 8.43 090
21930 A Remove lesion, back or flank 5.06 6.01 5.79 3.76 3.49 0.66 11.73 11.51 9.48 9.21 090
21935 A Remove tumor, back 18.38 NA NA 8.60 9.37 2.48 NA NA 29.46 30.23 090
22010 A Id, p-spine, c/t/cerv-thor 12.57 NA NA 7.87 8.63 1.74 NA NA 22.18 22.94 090
22015 A Id, p-spine, l/s/ls 12.46 NA NA 7.83 8.57 1.72 NA NA 22.01 22.75 090
22100 A Remove part of neck vertebra 10.80 NA NA 8.09 7.67 2.14 NA NA 21.03 20.61 090
22101 A Remove part, thorax vertebra 10.88 NA NA 8.02 7.82 1.91 NA NA 20.81 20.61 090
22102 A Remove part, lumbar vertebra 10.88 NA NA 7.27 7.90 1.88 NA NA 20.03 20.66 090
22103 A Remove extra spine segment 2.34 NA NA 0.90 1.13 0.44 NA NA 3.68 3.91 ZZZ
22110 A Remove part of neck vertebra 13.80 NA NA 9.17 9.16 2.77 NA NA 25.74 25.73 090
22112 A Remove part, thorax vertebra 13.87 NA NA 9.02 9.21 2.53 NA NA 25.42 25.61 090
22114 A Remove part, lumbar vertebra 13.87 NA NA 9.12 9.22 2.64 NA NA 25.63 25.73 090
22116 A Remove extra spine segment 2.32 NA NA 0.89 1.10 0.50 NA NA 3.71 3.92 ZZZ
22210 A Revision of neck spine 25.13 NA NA 14.86 15.27 5.46 NA NA 45.45 45.86 090
22212 A Revision of thorax spine 20.74 NA NA 12.55 13.09 3.91 NA NA 37.20 37.74 090
22214 A Revision of lumbar spine 20.77 NA NA 12.67 13.53 3.92 NA NA 37.36 38.22 090
22216 A Revise, extra spine segment 6.03 NA NA 2.39 2.95 1.29 NA NA 9.71 10.27 ZZZ
22220 A Revision of neck spine 22.69 NA NA 13.56 13.61 5.08 NA NA 41.33 41.38 090
22222 A Revision of thorax spine 22.84 NA NA 12.30 11.42 4.13 NA NA 39.27 38.39 090
22224 A Revision of lumbar spine 22.84 NA NA 13.25 13.98 4.19 NA NA 40.28 41.01 090
22226 A Revise, extra spine segment 6.03 NA NA 2.18 2.86 1.29 NA NA 9.50 10.18 ZZZ
22305 A Treat spine process fracture 2.08 2.15 2.27 1.81 1.89 0.39 4.62 4.74 4.28 4.36 090
22310 A Treat spine fracture 3.69 3.01 2.85 2.53 2.40 0.50 7.20 7.04 6.72 6.59 090
22315 A Treat spine fracture 9.91 9.82 9.72 7.43 7.36 1.86 21.59 21.49 19.20 19.13 090
22318 A Treat odontoid fx w/o graft 22.54 NA NA 13.42 13.39 5.30 NA NA 41.26 41.23 090
22319 A Treat odontoid fx w/graft 25.15 NA NA 14.18 14.58 6.05 NA NA 45.38 45.78 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
22325 A Treat spine fracture 19.62 NA NA 12.10 12.08 3.88 NA NA 35.60 35.58 090
22326 A Treat neck spine fracture 20.64 NA NA 12.24 12.59 4.43 NA NA 37.31 37.66 090
22327 A Treat thorax spine fracture 20.52 NA NA 12.37 12.36 3.99 NA NA 36.88 36.87 090
22328 A Treat each add spine fx 4.60 NA NA 1.83 2.15 0.94 NA NA 7.37 7.69 ZZZ
22505 A Manipulation of spine 1.87 NA NA 1.06 0.97 0.36 NA NA 3.29 3.20 010
22520 A Percut vertebroplasty thor 9.17 42.34 56.83 4.07 4.84 1.72 53.23 67.72 14.96 15.73 010
22521 A Percut vertebroplasty lumb 8.60 43.56 52.87 3.90 4.69 1.60 53.76 63.07 14.10 14.89 010
22522 A Percut vertebroplasty addÆl 4.30 NA NA 1.30 1.59 0.82 NA NA 6.42 6.71 ZZZ
22523 A Percut kyphoplasty, thor 9.21 NA NA 4.69 5.60 1.72 NA NA 15.62 16.53 010
22524 A Percut kyphoplasty, lumbar 8.81 NA NA 4.54 5.40 1.60 NA NA 14.95 15.81 010
22525 A Percut kyphoplasty, add-on 4.47 NA NA 1.66 2.12 0.82 NA NA 6.95 7.41 ZZZ
22526 A Idet, single level 6.07 46.51 46.51 2.08 2.08 1.16 53.74 53.74 9.31 9.31 010
22527 A Idet, 1 or more levels 3.03 39.89 39.89 0.70 0.70 0.58 43.50 43.50 4.31 4.31 ZZZ
22532 A Lat thorax spine fusion 25.81 NA NA 13.92 14.60 4.35 NA NA 44.08 44.76 090
22533 A Lat lumbar spine fusion 24.61 NA NA 13.52 13.57 3.16 NA NA 41.29 41.34 090
22534 A Lat thor/lumb, addÆl seg 5.99 NA NA 2.35 2.86 1.25 NA NA 9.59 10.10 ZZZ
22548 A Neck spine fusion 26.86 NA NA 15.32 15.68 5.61 NA NA 47.79 48.15 090
22554 A Neck spine fusion 17.54 NA NA 10.84 11.97 4.46 NA NA 32.84 33.97 090
22556 A Thorax spine fusion 24.50 NA NA 13.15 14.34 4.35 NA NA 42.00 43.19 090
22558 A Lumbar spine fusion 23.33 NA NA 11.57 12.86 3.16 NA NA 38.06 39.35 090
22585 A Additional spinal fusion 5.52 NA NA 2.12 2.62 1.25 NA NA 8.89 9.39 ZZZ
22590 A Spine skull spinal fusion 21.56 NA NA 13.24 13.30 4.79 NA NA 39.59 39.65 090
22595 A Neck spinal fusion 20.44 NA NA 12.74 12.81 4.41 NA NA 37.59 37.66 090
22600 A Neck spine fusion 17.20 NA NA 11.37 11.24 3.73 NA NA 32.30 32.17 090
22610 A Thorax spine fusion 17.08 NA NA 10.96 11.30 3.53 NA NA 31.57 31.91 090
22612 A Lumbar spine fusion 23.38 NA NA 12.72 13.83 4.47 NA NA 40.57 41.68 090
22614 A Spine fusion, extra segment 6.43 NA NA 2.53 3.15 1.38 NA NA 10.34 10.96 ZZZ
22630 A Lumbar spine fusion 21.89 NA NA 12.75 13.39 4.73 NA NA 39.37 40.01 090
22632 A Spine fusion, extra segment 5.22 NA NA 2.04 2.51 1.16 NA NA 8.42 8.89 ZZZ
22800 A Fusion of spine 19.30 NA NA 11.22 12.38 3.76 NA NA 34.28 35.44 090
22802 A Fusion of spine 31.91 NA NA 16.28 18.76 6.17 NA NA 54.36 56.84 090
22804 A Fusion of spine 37.30 NA NA 18.33 21.60 7.00 NA NA 62.63 65.90 090
22808 A Fusion of spine 27.31 NA NA 13.94 15.71 4.93 NA NA 46.18 47.95 090
22810 A Fusion of spine 31.30 NA NA 15.00 17.52 5.15 NA NA 51.45 53.97 090
22812 A Fusion of spine 34.00 NA NA 16.90 19.27 5.30 NA NA 56.20 58.57 090
22818 A Kyphectomy, 1-2 segments 34.18 NA NA 16.75 18.34 6.47 NA NA 57.40 58.99 090
22819 A Kyphectomy, 3 or more 39.18 NA NA 19.61 19.94 7.67 NA NA 66.46 66.79 090
22830 A Exploration of spinal fusion 11.13 NA NA 7.15 7.76 2.30 NA NA 20.58 21.19 090
22840 A Insert spine fixation device 12.52 NA NA 4.91 6.10 2.79 NA NA 20.22 21.41 ZZZ
22841 B Insert spine fixation device 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
22842 A Insert spine fixation device 12.56 NA NA 4.93 6.11 2.75 NA NA 20.24 21.42 ZZZ
22843 A Insert spine fixation device 13.44 NA NA 5.32 6.28 2.86 NA NA 21.62 22.58 ZZZ
22844 A Insert spine fixation device 16.42 NA NA 6.54 8.20 3.19 NA NA 26.15 27.81 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
22845 A Insert spine fixation device 11.94 NA NA 4.62 5.71 2.86 NA NA 19.42 20.51 ZZZ
22846 A Insert spine fixation device 12.40 NA NA 4.80 5.95 2.96 NA NA 20.16 21.31 ZZZ
22847 A Insert spine fixation device 13.78 NA NA 5.42 6.62 3.00 NA NA 22.20 23.40 ZZZ
22848 A Insert pelv fixation device 5.99 NA NA 2.39 2.98 1.15 NA NA 9.53 10.12 ZZZ
22849 A Reinsert spinal fixation 19.08 NA NA 10.37 11.39 3.90 NA NA 33.35 34.37 090
22850 A Remove spine fixation device 9.74 NA NA 6.55 6.88 2.05 NA NA 18.34 18.67 090
22851 A Apply spine prosth device 6.70 NA NA 2.62 3.18 1.49 NA NA 10.81 11.37 ZZZ
22852 A Remove spine fixation device 9.29 NA NA 6.26 6.66 1.90 NA NA 17.45 17.85 090
22855 A Remove spine fixation device 15.77 NA NA 9.38 9.59 3.52 NA NA 28.67 28.88 090
22857 R Lumbar artif diskectomy 26.93 NA NA 8.80 8.80 3.56 NA NA 39.29 39.29 090
22862 R Revise lumbar artif disc 32.43 NA NA 10.07 10.07 5.36 NA NA 47.86 47.86 090
22865 R Remove lumb artif disc 31.55 NA NA 9.87 9.87 5.18 NA NA 46.60 46.60 090
22899 C Spine surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
22900 A Remove abdominal wall lesion 6.14 NA NA 3.53 3.30 0.76 NA NA 10.43 10.20 090
22999 C Abdomen surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
23000 A Removal of calcium deposits 4.40 7.78 8.34 3.69 4.24 0.68 12.86 13.42 8.77 9.32 090
23020 A Release shoulder joint 9.24 NA NA 6.53 7.30 1.54 NA NA 17.31 18.08 090
23030 A Drain shoulder lesion 3.44 6.27 7.11 2.42 2.78 0.57 10.28 11.12 6.43 6.79 010
23031 A Drain shoulder bursa 2.76 6.45 7.51 2.22 2.60 0.46 9.67 10.73 5.44 5.82 010
23035 A Drain shoulder bone lesion 9.04 NA NA 7.04 7.96 1.47 NA NA 17.55 18.47 090
23040 A Exploratory shoulder surgery 9.63 NA NA 6.82 7.60 1.60 NA NA 18.05 18.83 090
23044 A Exploratory shoulder surgery 7.48 NA NA 5.60 6.22 1.24 NA NA 14.32 14.94 090
23065 A Biopsy shoulder tissues 2.28 2.96 2.60 1.74 1.65 0.20 5.44 5.08 4.22 4.13 010
23066 A Biopsy shoulder tissues 4.21 7.64 7.66 3.59 3.88 0.63 12.48 12.50 8.43 8.72 090
23075 A Removal of shoulder lesion 2.41 3.70 3.67 1.74 1.77 0.34 6.45 6.42 4.49 4.52 010
23076 A Removal of shoulder lesion 7.77 NA NA 5.33 5.50 1.13 NA NA 14.23 14.40 090
23077 A Remove tumor of shoulder 18.08 NA NA 9.85 10.12 2.34 NA NA 30.27 30.54 090
23100 A Biopsy of shoulder joint 6.09 NA NA 5.16 5.53 1.04 NA NA 12.29 12.66 090
23101 A Shoulder joint surgery 5.63 NA NA 4.58 5.14 0.96 NA NA 11.17 11.73 090
23105 A Remove shoulder joint lining 8.36 NA NA 6.14 6.88 1.42 NA NA 15.92 16.66 090
23106 A Incision of collarbone joint 6.02 NA NA 4.62 5.43 0.99 NA NA 11.63 12.44 090
23107 A Explore treat shoulder joint 8.75 NA NA 6.29 7.12 1.49 NA NA 16.53 17.36 090
23120 A Partial removal, collar bone 7.23 NA NA 5.51 6.22 1.23 NA NA 13.97 14.68 090
23125 A Removal of collar bone 9.52 NA NA 6.38 7.27 1.62 NA NA 17.52 18.41 090
23130 A Remove shoulder bone, part 7.63 NA NA 6.12 6.88 1.30 NA NA 15.05 15.81 090
23140 A Removal of bone lesion 7.01 NA NA 4.81 5.12 1.08 NA NA 12.90 13.21 090
23145 A Removal of bone lesion 9.28 NA NA 5.84 7.04 1.49 NA NA 16.61 17.81 090
23146 A Removal of bone lesion 7.96 NA NA 6.00 6.83 1.35 NA NA 15.31 16.14 090
23150 A Removal of humerus lesion 8.79 NA NA 6.09 6.71 1.32 NA NA 16.20 16.82 090
23155 A Removal of humerus lesion 10.72 NA NA 7.38 8.09 1.81 NA NA 19.91 20.62 090
23156 A Removal of humerus lesion 8.99 NA NA 6.44 7.15 1.50 NA NA 16.93 17.64 090
23170 A Remove collar bone lesion 7.10 NA NA 5.08 5.79 1.12 NA NA 13.30 14.01 090
23172 A Remove shoulder blade lesion 7.20 NA NA 5.03 5.97 1.01 NA NA 13.24 14.18 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
23174 A Remove humerus lesion 9.90 NA NA 7.33 8.10 1.65 NA NA 18.88 19.65 090
23180 A Remove collar bone lesion 8.85 NA NA 7.09 8.52 1.47 NA NA 17.41 18.84 090
23182 A Remove shoulder blade lesion 8.47 NA NA 6.92 8.14 1.37 NA NA 16.76 17.98 090
23184 A Remove humerus lesion 9.76 NA NA 7.56 8.87 1.63 NA NA 18.95 20.26 090
23190 A Partial removal of scapula 7.36 NA NA 5.44 5.99 1.17 NA NA 13.97 14.52 090
23195 A Removal of head of humerus 10.24 NA NA 6.82 7.50 1.71 NA NA 18.77 19.45 090
23200 A Removal of collar bone 12.69 NA NA 7.51 8.42 1.94 NA NA 22.14 23.05 090
23210 A Removal of shoulder blade 13.16 NA NA 8.28 8.81 2.03 NA NA 23.47 24.00 090
23220 A Partial removal of humerus 15.36 NA NA 9.12 10.40 2.49 NA NA 26.97 28.25 090
23221 A Partial removal of humerus 18.41 NA NA 6.61 10.44 3.06 NA NA 28.08 31.91 090
23222 A Partial removal of humerus 25.44 NA NA 13.64 15.25 3.95 NA NA 43.03 44.64 090
23330 A Remove shoulder foreign body 1.87 3.36 3.60 1.54 1.80 0.24 5.47 5.71 3.65 3.91 010
23331 A Remove shoulder foreign body 7.51 NA NA 5.91 6.57 1.27 NA NA 14.69 15.35 090
23332 A Remove shoulder foreign body 12.23 NA NA 8.06 9.01 2.03 NA NA 22.32 23.27 090
23350 A Injection for shoulder x-ray 1.00 2.55 3.23 0.29 0.32 0.06 3.61 4.29 1.35 1.38 000
23395 A Muscle transfer,shoulder/arm 18.29 NA NA 11.32 12.48 2.94 NA NA 32.55 33.71 090
23397 A Muscle transfers 16.62 NA NA 9.75 10.97 2.74 NA NA 29.11 30.33 090
23400 A Fixation of shoulder blade 13.73 NA NA 8.60 9.70 2.30 NA NA 24.63 25.73 090
23405 A Incision of tendon muscle 8.43 NA NA 5.99 6.69 1.45 NA NA 15.87 16.57 090
23406 A Incise tendon(s) muscle(s) 10.90 NA NA 6.98 8.00 1.88 NA NA 19.76 20.78 090
23410 A Repair rotator cuff, acute 12.63 NA NA 7.87 9.02 2.17 NA NA 22.67 23.82 090
23412 A Repair rotator cuff, chronic 13.55 NA NA 8.27 9.49 2.32 NA NA 24.14 25.36 090
23415 A Release of shoulder ligament 10.09 NA NA 6.64 7.65 1.74 NA NA 18.47 19.48 090
23420 A Repair of shoulder 14.75 NA NA 9.82 10.59 2.32 NA NA 26.89 27.66 090
23430 A Repair biceps tendon 10.05 NA NA 6.83 7.78 1.74 NA NA 18.62 19.57 090
23440 A Remove/transplant tendon 10.53 NA NA 6.85 7.91 1.83 NA NA 19.21 20.27 090
23450 A Repair shoulder capsule 13.58 NA NA 8.24 9.44 2.33 NA NA 24.15 25.35 090
23455 A Repair shoulder capsule 14.55 NA NA 8.64 9.99 2.50 NA NA 25.69 27.04 090
23460 A Repair shoulder capsule 15.68 NA NA 9.40 10.88 2.67 NA NA 27.75 29.23 090
23462 A Repair shoulder capsule 15.60 NA NA 9.15 10.35 2.60 NA NA 27.35 28.55 090
23465 A Repair shoulder capsule 16.16 NA NA 9.66 10.80 2.77 NA NA 28.59 29.73 090
23466 A Repair shoulder capsule 15.55 NA NA 10.14 11.06 2.47 NA NA 28.16 29.08 090
23470 A Reconstruct shoulder joint 17.75 NA NA 10.25 11.75 2.99 NA NA 30.99 32.49 090
23472 A Reconstruct shoulder joint 22.47 NA NA 12.32 13.89 3.67 NA NA 38.46 40.03 090
23480 A Revision of collar bone 11.42 NA NA 7.40 8.43 1.95 NA NA 20.77 21.80 090
23485 A Revision of collar bone 13.79 NA NA 8.38 9.51 2.34 NA NA 24.51 25.64 090
23490 A Reinforce clavicle 12.04 NA NA 6.55 8.16 1.47 NA NA 20.06 21.67 090
23491 A Reinforce shoulder bones 14.40 NA NA 8.93 10.27 2.47 NA NA 25.80 27.14 090
23500 A Treat clavicle fracture 2.13 2.64 2.81 2.64 2.55 0.30 5.07 5.24 5.07 4.98 090
23505 A Treat clavicle fracture 3.74 4.02 4.31 3.63 3.79 0.61 8.37 8.66 7.98 8.14 090
23515 A Treat clavicle fracture 7.47 NA NA 5.61 6.32 1.28 NA NA 14.36 15.07 090
23520 A Treat clavicle dislocation 2.21 2.64 2.80 2.64 2.72 0.34 5.19 5.35 5.19 5.27 090
23525 A Treat clavicle dislocation 3.67 4.51 4.53 3.93 3.94 0.46 8.64 8.66 8.06 8.07 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
23530 A Treat clavicle dislocation 7.37 NA NA 5.29 5.77 1.20 NA NA 13.86 14.34 090
23532 A Treat clavicle dislocation 8.08 NA NA 6.10 6.75 1.38 NA NA 15.56 16.21 090
23540 A Treat clavicle dislocation 2.28 2.62 2.80 2.62 2.43 0.29 5.19 5.37 5.19 5.00 090
23545 A Treat clavicle dislocation 3.32 3.75 4.08 3.28 3.34 0.35 7.42 7.75 6.95 7.01 090
23550 A Treat clavicle dislocation 7.48 NA NA 5.54 6.16 1.25 NA NA 14.27 14.89 090
23552 A Treat clavicle dislocation 8.70 NA NA 6.29 7.06 1.46 NA NA 16.45 17.22 090
23570 A Treat shoulder blade fx 2.28 2.80 2.96 2.80 2.87 0.36 5.44 5.60 5.44 5.51 090
23575 A Treat shoulder blade fx 4.12 4.36 4.75 3.87 4.20 0.59 9.07 9.46 8.58 8.91 090
23585 A Treat scapula fracture 9.15 NA NA 6.54 7.37 1.54 NA NA 17.23 18.06 090
23600 A Treat humerus fracture 3.00 4.08 4.43 3.66 3.58 0.48 7.56 7.91 7.14 7.06 090
23605 A Treat humerus fracture 4.94 5.42 5.97 4.63 4.99 0.84 11.20 11.75 10.41 10.77 090
23615 A Treat humerus fracture 10.93 NA NA 8.35 8.71 1.62 NA NA 20.90 21.26 090
23616 A Treat humerus fracture 21.68 NA NA 11.62 13.51 3.70 NA NA 37.00 38.89 090
23620 A Treat humerus fracture 2.46 3.42 3.56 3.15 3.02 0.40 6.28 6.42 6.01 5.88 090
23625 A Treat humerus fracture 3.99 4.44 4.82 3.92 4.19 0.67 9.10 9.48 8.58 8.85 090
23630 A Treat humerus fracture 7.47 NA NA 5.71 6.40 1.27 NA NA 14.45 15.14 090
23650 A Treat shoulder dislocation 3.44 3.27 3.65 2.81 2.77 0.30 7.01 7.39 6.55 6.51 090
23655 A Treat shoulder dislocation 4.64 NA NA 4.18 4.17 0.69 NA NA 9.51 9.50 090
23660 A Treat shoulder dislocation 7.55 NA NA 5.65 6.20 1.29 NA NA 14.49 15.04 090
23665 A Treat dislocation/fracture 4.54 4.84 5.21 4.26 4.61 0.71 10.09 10.46 9.51 9.86 090
23670 A Treat dislocation/fracture 8.02 NA NA 5.90 6.60 1.36 NA NA 15.28 15.98 090
23675 A Treat dislocation/fracture 6.13 6.16 6.66 5.18 5.67 1.01 13.30 13.80 12.32 12.81 090
23680 A Treat dislocation/fracture 10.30 NA NA 7.04 7.84 1.76 NA NA 19.10 19.90 090
23700 A Fixation of shoulder 2.54 NA NA 1.92 2.11 0.44 NA NA 4.90 5.09 010
23800 A Fusion of shoulder joint 14.59 NA NA 7.64 9.72 2.36 NA NA 24.59 26.67 090
23802 A Fusion of shoulder joint 18.17 NA NA 11.08 10.40 2.71 NA NA 31.96 31.28 090
23900 A Amputation of arm girdle 20.57 NA NA 10.73 11.47 3.19 NA NA 34.49 35.23 090
23920 A Amputation at shoulder joint 16.03 NA NA 9.60 9.84 2.47 NA NA 28.10 28.34 090
23921 A Amputation follow-up surgery 5.61 NA NA 4.89 5.03 0.78 NA NA 11.28 11.42 090
23929 C Shoulder surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
23930 A Drainage of arm lesion 2.96 4.94 5.98 1.98 2.23 0.43 8.33 9.37 5.37 5.62 010
23931 A Drainage of arm bursa 1.81 4.31 5.51 1.75 2.07 0.28 6.40 7.60 3.84 4.16 010
23935 A Drain arm/elbow bone lesion 6.27 NA NA 5.15 5.72 1.05 NA NA 12.47 13.04 090
24000 A Exploratory elbow surgery 5.99 NA NA 4.79 5.26 0.97 NA NA 11.75 12.22 090
24006 A Release elbow joint 9.62 NA NA 6.71 7.49 1.50 NA NA 17.83 18.61 090
24065 A Biopsy arm/elbow soft tissue 2.10 4.16 3.45 1.93 1.79 0.17 6.43 5.72 4.20 4.06 010
24066 A Biopsy arm/elbow soft tissue 5.26 8.25 8.76 3.93 4.08 0.80 14.31 14.82 9.99 10.14 090
24075 A Remove arm/elbow lesion 3.96 7.16 7.30 3.27 3.37 0.56 11.68 11.82 7.79 7.89 090
24076 A Remove arm/elbow lesion 6.36 NA NA 4.60 4.80 0.95 NA NA 11.91 12.11 090
24077 A Remove tumor of arm/elbow 11.95 NA NA 7.00 7.56 1.73 NA NA 20.68 21.24 090
24100 A Biopsy elbow joint lining 4.98 NA NA 4.29 4.46 0.85 NA NA 10.12 10.29 090
24101 A Explore/treat elbow joint 6.19 NA NA 5.10 5.72 1.03 NA NA 12.32 12.94 090
24102 A Remove elbow joint lining 8.15 NA NA 5.85 6.61 1.33 NA NA 15.33 16.09 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
24105 A Removal of elbow bursa 3.67 NA NA 4.04 4.30 0.61 NA NA 8.32 8.58 090
24110 A Remove humerus lesion 7.46 NA NA 5.68 6.42 1.28 NA NA 14.42 15.16 090
24115 A Remove/graft bone lesion 10.00 NA NA 6.85 7.12 1.68 NA NA 18.53 18.80 090
24116 A Remove/graft bone lesion 12.11 NA NA 7.70 8.73 2.06 NA NA 21.87 22.90 090
24120 A Remove elbow lesion 6.71 NA NA 5.23 5.75 1.10 NA NA 13.04 13.56 090
24125 A Remove/graft bone lesion 8.02 NA NA 6.05 6.13 1.06 NA NA 15.13 15.21 090
24126 A Remove/graft bone lesion 8.50 NA NA 6.24 6.83 1.16 NA NA 15.90 16.49 090
24130 A Removal of head of radius 6.31 NA NA 5.15 5.80 1.04 NA NA 12.50 13.15 090
24134 A Removal of arm bone lesion 10.10 NA NA 7.52 8.52 1.64 NA NA 19.26 20.26 090
24136 A Remove radius bone lesion 8.29 NA NA 5.70 6.84 1.38 NA NA 15.37 16.51 090
24138 A Remove elbow bone lesion 8.33 NA NA 6.74 7.52 1.34 NA NA 16.41 17.19 090
24140 A Partial removal of arm bone 9.43 NA NA 7.24 8.64 1.51 NA NA 18.18 19.58 090
24145 A Partial removal of radius 7.70 NA NA 6.32 7.63 1.25 NA NA 15.27 16.58 090
24147 A Partial removal of elbow 7.69 NA NA 6.93 8.18 1.30 NA NA 15.92 17.17 090
24149 A Radical resection of elbow 15.92 NA NA 10.94 11.45 2.35 NA NA 29.21 29.72 090
24150 A Extensive humerus surgery 13.70 NA NA 8.58 9.64 2.33 NA NA 24.61 25.67 090
24151 A Extensive humerus surgery 16.08 NA NA 9.82 11.09 2.60 NA NA 28.50 29.77 090
24152 A Extensive radius surgery 10.24 NA NA 6.35 7.39 1.48 NA NA 18.07 19.11 090
24153 A Extensive radius surgery 11.73 NA NA 4.87 5.40 0.74 NA NA 17.34 17.87 090
24155 A Removal of elbow joint 11.97 NA NA 7.64 8.21 1.93 NA NA 21.54 22.11 090
24160 A Remove elbow joint implant 7.89 NA NA 5.85 6.63 1.30 NA NA 15.04 15.82 090
24164 A Remove radius head implant 6.34 NA NA 4.94 5.56 1.03 NA NA 12.31 12.93 090
24200 A Removal of arm foreign body 1.78 2.76 3.25 1.38 1.57 0.20 4.74 5.23 3.36 3.55 010
24201 A Removal of arm foreign body 4.61 7.85 9.32 3.70 4.10 0.72 13.18 14.65 9.03 9.43 090
24220 A Injection for elbow x-ray 1.31 2.50 3.35 0.39 0.43 0.08 3.89 4.74 1.78 1.82 000
24300 A Manipulate elbow w/anesth 3.86 NA NA 5.19 5.58 0.65 NA NA 9.70 10.09 090
24301 A Muscle/tendon transfer 10.26 NA NA 6.91 7.86 1.66 NA NA 18.83 19.78 090
24305 A Arm tendon lengthening 7.51 NA NA 5.72 6.46 1.15 NA NA 14.38 15.12 090
24310 A Revision of arm tendon 6.03 NA NA 4.80 5.39 0.96 NA NA 11.79 12.38 090
24320 A Repair of arm tendon 10.74 NA NA 7.15 7.44 1.74 NA NA 19.63 19.92 090
24330 A Revision of arm muscles 9.67 NA NA 6.69 7.58 1.60 NA NA 17.96 18.85 090
24331 A Revision of arm muscles 10.83 NA NA 6.57 8.15 1.78 NA NA 19.18 20.76 090
24332 A Tenolysis, triceps 7.77 NA NA 5.81 6.53 1.23 NA NA 14.81 15.53 090
24340 A Repair of biceps tendon 7.96 NA NA 6.02 6.74 1.36 NA NA 15.34 16.06 090
24341 A Repair arm tendon/muscle 9.24 NA NA 7.54 7.83 1.36 NA NA 18.14 18.43 090
24342 A Repair of ruptured tendon 10.74 NA NA 7.15 8.18 1.86 NA NA 19.75 20.78 090
24343 A Repr elbow lat ligmnt w/tiss 8.99 NA NA 7.06 7.88 1.43 NA NA 17.48 18.30 090
24344 A Reconstruct elbow lat ligmnt 14.97 NA NA 10.11 11.17 2.37 NA NA 27.45 28.51 090
24345 A Repr elbw med ligmnt w/tissu 8.99 NA NA 7.01 7.77 1.44 NA NA 17.44 18.20 090
24346 A Reconstruct elbow med ligmnt 14.97 NA NA 10.11 11.03 2.34 NA NA 27.42 28.34 090
24350 A Repair of tennis elbow 5.32 NA NA 4.90 5.41 0.87 NA NA 11.09 11.60 090
24351 A Repair of tennis elbow 5.97 NA NA 5.02 5.70 1.02 NA NA 12.01 12.69 090
24352 A Repair of tennis elbow 6.49 NA NA 5.24 5.95 1.10 NA NA 12.83 13.54 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
24354 A Repair of tennis elbow 6.54 NA NA 5.27 5.93 1.07 NA NA 12.88 13.54 090
24356 A Revision of tennis elbow 6.74 NA NA 5.35 6.07 1.11 NA NA 13.20 13.92 090
24360 A Reconstruct elbow joint 12.53 NA NA 8.01 9.11 2.06 NA NA 22.60 23.70 090
24361 A Reconstruct elbow joint 14.27 NA NA 8.86 10.15 2.19 NA NA 25.32 26.61 090
24362 A Reconstruct elbow joint 15.18 NA NA 9.37 9.87 2.61 NA NA 27.16 27.66 090
24363 A Replace elbow joint 22.47 NA NA 12.36 13.37 3.02 NA NA 37.85 38.86 090
24365 A Reconstruct head of radius 8.51 NA NA 5.96 6.89 1.41 NA NA 15.88 16.81 090
24366 A Reconstruct head of radius 9.25 NA NA 6.35 7.24 1.52 NA NA 17.12 18.01 090
24400 A Revision of humerus 11.19 NA NA 7.65 8.55 1.93 NA NA 20.77 21.67 090
24410 A Revision of humerus 14.96 NA NA 9.37 10.08 2.58 NA NA 26.91 27.62 090
24420 A Revision of humerus 13.58 NA NA 8.89 10.13 2.18 NA NA 24.65 25.89 090
24430 A Repair of humerus 15.07 NA NA 9.34 9.64 2.22 NA NA 26.63 26.93 090
24435 A Repair humerus with graft 14.74 NA NA 9.90 10.64 2.28 NA NA 26.92 27.66 090
24470 A Revision of elbow joint 8.81 NA NA 6.44 7.40 1.48 NA NA 16.73 17.69 090
24495 A Decompression of forearm 8.30 NA NA 6.65 8.22 1.18 NA NA 16.13 17.70 090
24498 A Reinforce humerus 12.16 NA NA 7.78 8.89 2.07 NA NA 22.01 23.12 090
24500 A Treat humerus fracture 3.29 4.44 4.75 3.81 3.71 0.50 8.23 8.54 7.60 7.50 090
24505 A Treat humerus fracture 5.25 5.86 6.42 4.91 5.27 0.89 12.00 12.56 11.05 11.41 090
24515 A Treat humerus fracture 11.97 NA NA 8.12 9.07 2.03 NA NA 22.12 23.07 090
24516 A Treat humerus fracture 12.07 NA NA 7.74 8.77 2.03 NA NA 21.84 22.87 090
24530 A Treat humerus fracture 3.57 4.73 5.08 4.01 4.03 0.57 8.87 9.22 8.15 8.17 090
24535 A Treat humerus fracture 6.96 6.82 7.59 5.88 6.44 1.18 14.96 15.73 14.02 14.58 090
24538 A Treat humerus fracture 9.63 NA NA 7.25 8.34 1.64 NA NA 18.52 19.61 090
24545 A Treat humerus fracture 10.88 NA NA 7.27 8.16 1.83 NA NA 19.98 20.87 090
24546 A Treat humerus fracture 15.99 NA NA 9.54 10.88 2.74 NA NA 28.27 29.61 090
24560 A Treat humerus fracture 2.87 4.04 4.37 3.38 3.24 0.44 7.35 7.68 6.69 6.55 090
24565 A Treat humerus fracture 5.64 5.86 6.42 4.99 5.39 0.93 12.43 12.99 11.56 11.96 090
24566 A Treat humerus fracture 8.86 NA NA 6.99 7.87 1.30 NA NA 17.15 18.03 090
24575 A Treat humerus fracture 11.02 NA NA 7.30 8.13 1.87 NA NA 20.19 21.02 090
24576 A Treat humerus fracture 2.94 4.43 4.68 3.73 3.72 0.46 7.83 8.08 7.13 7.12 090
24577 A Treat humerus fracture 5.87 6.02 6.70 5.09 5.65 0.95 12.84 13.52 11.91 12.47 090
24579 A Treat humerus fracture 11.96 NA NA 7.90 8.60 2.03 NA NA 21.89 22.59 090
24582 A Treat humerus fracture 9.89 NA NA 8.23 8.89 1.48 NA NA 19.60 20.26 090
24586 A Treat elbow fracture 15.64 NA NA 9.41 10.78 2.65 NA NA 27.70 29.07 090
24587 A Treat elbow fracture 15.65 NA NA 9.43 10.62 2.53 NA NA 27.61 28.80 090
24600 A Treat elbow dislocation 4.28 3.87 4.61 3.30 3.45 0.50 8.65 9.39 8.08 8.23 090
24605 A Treat elbow dislocation 5.50 NA NA 4.97 5.26 0.89 NA NA 11.36 11.65 090
24615 A Treat elbow dislocation 9.72 NA NA 6.61 7.52 1.60 NA NA 17.93 18.84 090
24620 A Treat elbow fracture 7.07 NA NA 5.49 6.06 1.07 NA NA 13.63 14.20 090
24635 A Treat elbow fracture 13.56 NA NA 10.25 13.10 2.29 NA NA 26.10 28.95 090
24640 A Treat elbow dislocation 1.22 1.47 1.75 0.81 0.80 0.12 2.81 3.09 2.15 2.14 010
24650 A Treat radius fracture 2.22 3.43 3.69 3.00 2.81 0.35 6.00 6.26 5.57 5.38 090
24655 A Treat radius fracture 4.48 5.19 5.76 4.42 4.70 0.70 10.37 10.94 9.60 9.88 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
24665 A Treat radius fracture 8.22 NA NA 6.55 7.27 1.41 NA NA 16.18 16.90 090
24666 A Treat radius fracture 9.74 NA NA 7.02 7.81 1.62 NA NA 18.38 19.17 090
24670 A Treat ulnar fracture 2.60 3.73 4.02 3.16 3.09 0.41 6.74 7.03 6.17 6.10 090
24675 A Treat ulnar fracture 4.79 5.30 5.83 4.51 4.86 0.81 10.90 11.43 10.11 10.46 090
24685 A Treat ulnar fracture 8.92 NA NA 6.50 7.27 1.52 NA NA 16.94 17.71 090
24800 A Fusion of elbow joint 11.27 NA NA 7.68 8.48 1.63 NA NA 20.58 21.38 090
24802 A Fusion/graft of elbow joint 14.18 NA NA 8.61 9.94 2.38 NA NA 25.17 26.50 090
24900 A Amputation of upper arm 10.04 NA NA 6.49 6.92 1.53 NA NA 18.06 18.49 090
24920 A Amputation of upper arm 10.02 NA NA 6.50 6.83 1.61 NA NA 18.13 18.46 090
24925 A Amputation follow-up surgery 7.19 NA NA 4.95 5.80 1.14 NA NA 13.28 14.13 090
24930 A Amputation follow-up surgery 10.72 NA NA 5.93 6.91 1.68 NA NA 18.33 19.31 090
24931 A Amputate upper arm implant 13.32 NA NA 8.42 6.40 1.90 NA NA 23.64 21.62 090
24935 A Revision of amputation 16.30 NA NA 8.90 8.24 2.14 NA NA 27.34 26.68 090
24940 C Revision of upper arm 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
24999 C Upper arm/elbow surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
25000 A Incision of tendon sheath 3.44 NA NA 5.06 6.42 0.55 NA NA 9.05 10.41 090
25001 A Incise flexor carpi radialis 3.68 NA NA 3.87 4.14 0.55 NA NA 8.10 8.37 090
25020 A Decompress forearm 1 space 5.97 NA NA 6.90 8.90 0.93 NA NA 13.80 15.80 090
25023 A Decompress forearm 1 space 13.69 NA NA 11.53 14.09 2.04 NA NA 27.26 29.82 090
25024 A Decompress forearm 2 spaces 10.62 NA NA 7.27 7.42 1.36 NA NA 19.25 19.40 090
25025 A Decompress forearm 2 spaces 17.77 NA NA 9.14 9.76 1.83 NA NA 28.74 29.36 090
25028 A Drainage of forearm lesion 5.30 NA NA 6.24 7.68 0.81 NA NA 12.35 13.79 090
25031 A Drainage of forearm bursa 4.18 NA NA 5.46 7.31 0.63 NA NA 10.27 12.12 090
25035 A Treat forearm bone lesion 7.54 NA NA 8.87 12.41 1.24 NA NA 17.65 21.19 090
25040 A Explore/treat wrist joint 7.41 NA NA 5.93 6.96 1.15 NA NA 14.49 15.52 090
25065 A Biopsy forearm soft tissues 2.01 4.29 3.49 1.97 1.92 0.15 6.45 5.65 4.13 4.08 010
25066 A Biopsy forearm soft tissues 4.18 NA NA 5.46 6.66 0.64 NA NA 10.28 11.48 090
25075 A Removal forearm lesion subcu 3.78 NA NA 4.89 5.64 0.55 NA NA 9.22 9.97 090
25076 A Removal forearm lesion deep 4.97 NA NA 6.89 8.88 0.74 NA NA 12.60 14.59 090
25077 A Remove tumor, forearm/wrist 9.90 NA NA 8.95 11.30 1.42 NA NA 20.27 22.62 090
25085 A Incision of wrist capsule 5.55 NA NA 5.48 6.71 0.85 NA NA 11.88 13.11 090
25100 A Biopsy of wrist joint 3.94 NA NA 4.30 5.03 0.59 NA NA 8.83 9.56 090
25101 A Explore/treat wrist joint 4.74 NA NA 4.84 5.63 0.75 NA NA 10.33 11.12 090
25105 A Remove wrist joint lining 5.91 NA NA 5.85 6.94 0.92 NA NA 12.68 13.77 090
25107 A Remove wrist joint cartilage 7.50 NA NA 7.20 8.06 0.99 NA NA 15.69 16.55 090
25109 A Excise tendon forearm/wrist 6.81 NA NA 5.32 5.32 0.96 NA NA 13.09 13.09 090
25110 A Remove wrist tendon lesion 3.96 NA NA 5.28 6.61 0.62 NA NA 9.86 11.19 090
25111 A Remove wrist tendon lesion 3.44 NA NA 4.11 4.55 0.53 NA NA 8.08 8.52 090
25112 A Reremove wrist tendon lesion 4.58 NA NA 4.56 5.08 0.70 NA NA 9.84 10.36 090
25115 A Remove wrist/forearm lesion 9.89 NA NA 10.27 13.09 1.31 NA NA 21.47 24.29 090
25116 A Remove wrist/forearm lesion 7.38 NA NA 9.11 12.13 1.11 NA NA 17.60 20.62 090
25118 A Excise wrist tendon sheath 4.42 NA NA 4.66 5.47 0.68 NA NA 9.76 10.57 090
25119 A Partial removal of ulna 6.10 NA NA 5.89 7.17 0.96 NA NA 12.95 14.23 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
25120 A Removal of forearm lesion 6.16 NA NA 7.92 11.04 1.00 NA NA 15.08 18.20 090
25125 A Remove/graft forearm lesion 7.55 NA NA 8.77 11.82 1.06 NA NA 17.38 20.43 090
25126 A Remove/graft forearm lesion 7.62 NA NA 8.80 11.96 1.27 NA NA 17.69 20.85 090
25130 A Removal of wrist lesion 5.32 NA NA 5.23 6.12 0.80 NA NA 11.35 12.24 090
25135 A Remove graft wrist lesion 6.96 NA NA 6.17 7.18 1.02 NA NA 14.15 15.16 090
25136 A Remove graft wrist lesion 6.03 NA NA 5.55 6.33 1.03 NA NA 12.61 13.39 090
25145 A Remove forearm bone lesion 6.43 NA NA 8.13 11.08 1.01 NA NA 15.57 18.52 090
25150 A Partial removal of ulna 7.27 NA NA 6.41 7.76 1.14 NA NA 14.82 16.17 090
25151 A Partial removal of radius 7.57 NA NA 8.53 11.67 1.18 NA NA 17.28 20.42 090
25170 A Extensive forearm surgery 11.34 NA NA 10.54 14.00 1.78 NA NA 23.66 27.12 090
25210 A Removal of wrist bone 6.01 NA NA 5.58 6.49 0.88 NA NA 12.47 13.38 090
25215 A Removal of wrist bones 8.02 NA NA 6.88 8.28 1.19 NA NA 16.09 17.49 090
25230 A Partial removal of radius 5.28 NA NA 4.99 5.85 0.79 NA NA 11.06 11.92 090
25240 A Partial removal of ulna 5.22 NA NA 5.29 6.54 0.81 NA NA 11.32 12.57 090
25246 A Injection for wrist x-ray 1.45 2.55 3.22 0.44 0.47 0.09 4.09 4.76 1.98 2.01 000
25248 A Remove forearm foreign body 5.20 NA NA 6.54 8.03 0.72 NA NA 12.46 13.95 090
25250 A Removal of wrist prosthesis 6.66 NA NA 5.37 5.92 1.01 NA NA 13.04 13.59 090
25251 A Removal of wrist prosthesis 9.70 NA NA 6.77 7.63 1.26 NA NA 17.73 18.59 090
25259 A Manipulate wrist w/anesthes 3.86 NA NA 5.15 5.58 0.62 NA NA 9.63 10.06 090
25260 A Repair forearm tendon/muscle 7.89 NA NA 9.28 12.30 1.19 NA NA 18.36 21.38 090
25263 A Repair forearm tendon/muscle 7.90 NA NA 9.00 12.20 1.18 NA NA 18.08 21.28 090
25265 A Repair forearm tendon/muscle 9.96 NA NA 10.08 13.25 1.47 NA NA 21.51 24.68 090
25270 A Repair forearm tendon/muscle 6.06 NA NA 7.92 11.00 0.95 NA NA 14.93 18.01 090
25272 A Repair forearm tendon/muscle 7.10 NA NA 8.38 11.69 1.11 NA NA 16.59 19.90 090
25274 A Repair forearm tendon/muscle 8.82 NA NA 9.24 12.53 1.36 NA NA 19.42 22.71 090
25275 A Repair forearm tendon sheath 8.82 NA NA 6.57 7.33 1.31 NA NA 16.70 17.46 090
25280 A Revise wrist/forearm tendon 7.28 NA NA 8.49 11.60 1.08 NA NA 16.85 19.96 090
25290 A Incise wrist/forearm tendon 5.34 NA NA 9.15 13.53 0.82 NA NA 15.31 19.69 090
25295 A Release wrist/forearm tendon 6.61 NA NA 8.17 11.16 1.00 NA NA 15.78 18.77 090
25300 A Fusion of tendons at wrist 8.88 NA NA 7.29 8.16 1.26 NA NA 17.43 18.30 090
25301 A Fusion of tendons at wrist 8.47 NA NA 6.80 7.75 1.29 NA NA 16.56 17.51 090
25310 A Transplant forearm tendon 8.26 NA NA 8.85 11.99 1.21 NA NA 18.32 21.46 090
25312 A Transplant forearm tendon 9.70 NA NA 9.65 12.87 1.41 NA NA 20.76 23.98 090
25315 A Revise palsy hand tendon(s) 10.56 NA NA 10.08 13.32 1.58 NA NA 22.22 25.46 090
25316 A Revise palsy hand tendon(s) 12.76 NA NA 11.10 14.94 1.75 NA NA 25.61 29.45 090
25320 A Repair/revise wrist joint 12.38 NA NA 10.46 11.16 1.61 NA NA 24.45 25.15 090
25332 A Revise wrist joint 11.60 NA NA 7.81 8.83 1.84 NA NA 21.25 22.27 090
25335 A Realignment of hand 13.25 NA NA 7.07 10.46 1.93 NA NA 22.25 25.64 090
25337 A Reconstruct ulna/radioulnar 11.44 NA NA 9.45 10.67 1.61 NA NA 22.50 23.72 090
25350 A Revision of radius 8.97 NA NA 9.28 12.80 1.46 NA NA 19.71 23.23 090
25355 A Revision of radius 10.41 NA NA 10.08 13.48 1.74 NA NA 22.23 25.63 090
25360 A Revision of ulna 8.62 NA NA 9.12 12.68 1.41 NA NA 19.15 22.71 090
25365 A Revise radius ulna 12.77 NA NA 11.08 14.50 2.16 NA NA 26.01 29.43 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
25370 A Revise radius or ulna 13.93 NA NA 11.96 15.04 2.29 NA NA 28.18 31.26 090
25375 A Revise radius ulna 13.41 NA NA 11.32 15.15 2.27 NA NA 27.00 30.83 090
25390 A Shorten radius or ulna 10.58 NA NA 9.98 13.43 1.65 NA NA 22.21 25.66 090
25391 A Lengthen radius or ulna 14.14 NA NA 11.71 15.34 2.22 NA NA 28.07 31.70 090
25392 A Shorten radius ulna 14.44 NA NA 11.86 14.94 2.11 NA NA 28.41 31.49 090
25393 A Lengthen radius ulna 16.42 NA NA 13.47 16.55 2.77 NA NA 32.66 35.74 090
25394 A Repair carpal bone, shorten 10.71 NA NA 6.85 7.76 1.59 NA NA 19.15 20.06 090
25400 A Repair radius or ulna 11.16 NA NA 10.19 13.94 1.83 NA NA 23.18 26.93 090
25405 A Repair/graft radius or ulna 14.87 NA NA 11.95 15.94 2.33 NA NA 29.15 33.14 090
25415 A Repair radius ulna 13.66 NA NA 11.02 15.14 2.18 NA NA 26.86 30.98 090
25420 A Repair/graft radius ulna 16.89 NA NA 12.83 16.91 2.62 NA NA 32.34 36.42 090
25425 A Repair/graft radius or ulna 13.58 NA NA 14.17 19.59 2.09 NA NA 29.84 35.26 090
25426 A Repair/graft radius ulna 16.31 NA NA 12.50 15.54 2.55 NA NA 31.36 34.40 090
25430 A Vasc graft into carpal bone 9.57 NA NA 7.11 7.28 1.27 NA NA 17.95 18.12 090
25431 A Repair nonunion carpal bone 10.75 NA NA 7.33 8.13 1.91 NA NA 19.99 20.79 090
25440 A Repair/graft wrist bone 10.56 NA NA 7.56 8.94 1.63 NA NA 19.75 21.13 090
25441 A Reconstruct wrist joint 13.15 NA NA 8.62 9.66 2.08 NA NA 23.85 24.89 090
25442 A Reconstruct wrist joint 10.98 NA NA 7.42 8.52 1.53 NA NA 19.93 21.03 090
25443 A Reconstruct wrist joint 10.52 NA NA 6.69 8.25 1.37 NA NA 18.58 20.14 090
25444 A Reconstruct wrist joint 11.28 NA NA 7.75 8.71 1.72 NA NA 20.75 21.71 090
25445 A Reconstruct wrist joint 9.76 NA NA 6.78 7.69 1.55 NA NA 18.09 19.00 090
25446 A Wrist replacement 17.16 NA NA 9.99 11.44 2.48 NA NA 29.63 31.08 090
25447 A Repair wrist joint(s) 10.95 NA NA 7.95 8.48 1.61 NA NA 20.51 21.04 090
25449 A Remove wrist joint implant 14.80 NA NA 9.19 10.30 2.22 NA NA 26.21 27.32 090
25450 A Revision of wrist joint 7.94 NA NA 7.28 9.46 1.36 NA NA 16.58 18.76 090
25455 A Revision of wrist joint 9.57 NA NA 6.41 9.75 0.96 NA NA 16.94 20.28 090
25490 A Reinforce radius 9.61 NA NA 9.50 12.67 1.43 NA NA 20.54 23.71 090
25491 A Reinforce ulna 10.03 NA NA 9.71 13.27 1.60 NA NA 21.34 24.90 090
25492 A Reinforce radius and ulna 12.52 NA NA 10.56 14.12 2.15 NA NA 25.23 28.79 090
25500 A Treat fracture of radius 2.51 3.33 3.51 2.89 2.76 0.35 6.19 6.37 5.75 5.62 090
25505 A Treat fracture of radius 5.30 5.87 6.37 5.03 5.32 0.90 12.07 12.57 11.23 11.52 090
25515 A Treat fracture of radius 9.37 NA NA 6.78 7.29 1.59 NA NA 17.74 18.25 090
25520 A Treat fracture of radius 6.35 6.00 6.65 5.43 5.90 1.08 13.43 14.08 12.86 13.33 090
25525 A Treat fracture of radius 12.69 NA NA 8.78 9.69 2.13 NA NA 23.60 24.51 090
25526 A Treat fracture of radius 13.43 NA NA 10.26 12.69 2.20 NA NA 25.89 28.32 090
25530 A Treat fracture of ulna 2.15 3.46 3.69 2.96 2.89 0.34 5.95 6.18 5.45 5.38 090
25535 A Treat fracture of ulna 5.22 5.69 5.93 4.95 5.21 0.89 11.80 12.04 11.06 11.32 090
25545 A Treat fracture of ulna 9.09 NA NA 6.67 7.41 1.53 NA NA 17.29 18.03 090
25560 A Treat fracture radius ulna 2.50 3.38 3.61 2.87 2.67 0.35 6.23 6.46 5.72 5.52 090
25565 A Treat fracture radius ulna 5.71 5.97 6.52 5.00 5.32 0.93 12.61 13.16 11.64 11.96 090
25574 A Treat fracture radius ulna 7.47 NA NA 6.65 7.06 1.21 NA NA 15.33 15.74 090
25575 A Treat fracture radius/ulna 12.02 NA NA 9.02 9.39 1.82 NA NA 22.86 23.23 090
25600 A Treat fracture radius/ulna 2.69 3.68 3.99 3.18 3.02 0.42 6.79 7.10 6.29 6.13 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
25605 A Treat fracture radius/ulna 7.02 6.91 7.15 6.19 6.21 1.00 14.93 15.17 14.21 14.23 090
25606 A Treat fx distal radial 8.10 NA NA 6.75 8.41 1.26 NA NA 16.11 17.77 090
25607 A Treat fx rad extra-articul 9.35 NA NA 7.26 7.26 1.36 NA NA 17.97 17.97 090
25608 A Treat fx rad intra-articul 10.86 NA NA 7.88 7.88 1.84 NA NA 20.58 20.58 090
25609 A Treat fx radial 3+ frag 14.12 NA NA 9.77 9.77 2.38 NA NA 26.27 26.27 090
25622 A Treat wrist bone fracture 2.68 3.90 4.18 3.36 3.17 0.41 6.99 7.27 6.45 6.26 090
25624 A Treat wrist bone fracture 4.62 5.59 6.12 4.74 4.99 0.76 10.97 11.50 10.12 10.37 090
25628 A Treat wrist bone fracture 9.50 NA NA 7.38 7.71 1.37 NA NA 18.25 18.58 090
25630 A Treat wrist bone fracture 2.94 3.76 4.08 3.25 3.02 0.45 7.15 7.47 6.64 6.41 090
25635 A Treat wrist bone fracture 4.47 5.39 5.80 4.57 4.07 0.74 10.60 11.01 9.78 9.28 090
25645 A Treat wrist bone fracture 7.31 NA NA 5.84 6.43 1.20 NA NA 14.35 14.94 090
25650 A Treat wrist bone fracture 3.12 3.85 4.20 3.46 3.24 0.45 7.42 7.77 7.03 6.81 090
25651 A Pin ulnar styloid fracture 5.68 NA NA 5.15 5.40 0.86 NA NA 11.69 11.94 090
25652 A Treat fracture ulnar styloid 7.92 NA NA 6.25 6.81 1.21 NA NA 15.38 15.94 090
25660 A Treat wrist dislocation 4.84 NA NA 4.49 4.66 0.58 NA NA 9.91 10.08 090
25670 A Treat wrist dislocation 7.98 NA NA 6.02 6.75 1.28 NA NA 15.28 16.01 090
25671 A Pin radioulnar dislocation 6.32 NA NA 5.55 6.00 1.00 NA NA 12.87 13.32 090
25675 A Treat wrist dislocation 4.75 4.89 5.46 4.16 4.53 0.62 10.26 10.83 9.53 9.90 090
25676 A Treat wrist dislocation 8.17 NA NA 6.31 7.05 1.34 NA NA 15.82 16.56 090
25680 A Treat wrist fracture 6.08 NA NA 4.40 4.66 0.78 NA NA 11.26 11.52 090
25685 A Treat wrist fracture 9.97 NA NA 6.74 7.54 1.60 NA NA 18.31 19.11 090
25690 A Treat wrist dislocation 5.58 NA NA 4.85 5.34 0.88 NA NA 11.31 11.80 090
25695 A Treat wrist dislocation 8.40 NA NA 6.23 6.88 1.32 NA NA 15.95 16.60 090
25800 A Fusion of wrist joint 9.95 NA NA 7.33 8.65 1.57 NA NA 18.85 20.17 090
25805 A Fusion/graft of wrist joint 11.59 NA NA 8.23 9.75 1.81 NA NA 21.63 23.15 090
25810 A Fusion/graft of wrist joint 11.75 NA NA 8.62 9.58 1.68 NA NA 22.05 23.01 090
25820 A Fusion of hand bones 7.52 NA NA 6.32 7.47 1.22 NA NA 15.06 16.21 090
25825 A Fuse hand bones with graft 9.54 NA NA 7.63 8.83 1.41 NA NA 18.58 19.78 090
25830 A Fusion, radioulnar jnt/ulna 10.69 NA NA 10.48 13.43 1.55 NA NA 22.72 25.67 090
25900 A Amputation of forearm 9.46 NA NA 9.28 11.74 1.30 NA NA 20.04 22.50 090
25905 A Amputation of forearm 9.48 NA NA 8.47 11.34 1.40 NA NA 19.35 22.22 090
25907 A Amputation follow-up surgery 7.98 NA NA 7.78 10.77 1.10 NA NA 16.86 19.85 090
25909 A Amputation follow-up surgery 9.20 NA NA 9.05 11.47 1.44 NA NA 19.69 22.11 090
25915 A Amputation of forearm 17.38 NA NA 8.13 16.19 2.94 NA NA 28.45 36.51 090
25920 A Amputate hand at wrist 8.92 NA NA 6.78 7.58 1.35 NA NA 17.05 17.85 090
25922 A Amputate hand at wrist 7.54 NA NA 6.55 6.93 1.12 NA NA 15.21 15.59 090
25924 A Amputation follow-up surgery 8.70 NA NA 6.77 7.76 1.32 NA NA 16.79 17.78 090
25927 A Amputation of hand 8.98 NA NA 8.65 10.92 1.27 NA NA 18.90 21.17 090
25929 A Amputation follow-up surgery 7.71 NA NA 5.46 5.77 1.14 NA NA 14.31 14.62 090
25931 A Amputation follow-up surgery 7.93 NA NA 8.58 10.74 1.15 NA NA 17.66 19.82 090
25999 C Forearm or wrist surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
26010 A Drainage of finger abscess 1.56 4.00 5.17 1.51 1.60 0.18 5.74 6.91 3.25 3.34 010
26011 A Drainage of finger abscess 2.21 6.26 8.17 1.99 2.24 0.33 8.80 10.71 4.53 4.78 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
26020 A Drain hand tendon sheath 4.97 NA NA 4.78 5.21 0.73 NA NA 10.48 10.91 090
26025 A Drainage of palm bursa 4.99 NA NA 4.49 4.96 0.76 NA NA 10.24 10.71 090
26030 A Drainage of palm bursa(s) 6.16 NA NA 5.03 5.55 0.92 NA NA 12.11 12.63 090
26034 A Treat hand bone lesion 6.49 NA NA 5.58 6.16 1.01 NA NA 13.08 13.66 090
26035 A Decompress fingers/hand 11.14 NA NA 8.11 7.93 1.47 NA NA 20.72 20.54 090
26037 A Decompress fingers/hand 7.48 NA NA 5.57 6.13 1.13 NA NA 14.18 14.74 090
26040 A Release palm contracture 3.38 NA NA 3.63 3.95 0.53 NA NA 7.54 7.86 090
26045 A Release palm contracture 5.62 NA NA 4.90 5.46 0.93 NA NA 11.45 12.01 090
26055 A Incise finger tendon sheath 3.00 9.03 13.02 3.84 3.92 0.43 12.46 16.45 7.27 7.35 090
26060 A Incision of finger tendon 2.85 NA NA 3.07 3.40 0.45 NA NA 6.37 6.70 090
26070 A Explore/treat hand joint 3.73 NA NA 3.04 3.28 0.48 NA NA 7.25 7.49 090
26075 A Explore/treat finger joint 3.83 NA NA 3.43 3.69 0.53 NA NA 7.79 8.05 090
26080 A Explore/treat finger joint 4.36 NA NA 4.37 4.73 0.66 NA NA 9.39 9.75 090
26100 A Biopsy hand joint lining 3.71 NA NA 3.58 3.99 0.54 NA NA 7.83 8.24 090
26105 A Biopsy finger joint lining 3.75 NA NA 3.76 4.11 0.59 NA NA 8.10 8.45 090
26110 A Biopsy finger joint lining 3.57 NA NA 3.62 3.94 0.53 NA NA 7.72 8.04 090
26115 A Removal hand lesion subcut 3.92 9.82 12.27 4.25 4.64 0.59 14.33 16.78 8.76 9.15 090
26116 A Removal hand lesion, deep 5.61 NA NA 5.34 5.84 0.84 NA NA 11.79 12.29 090
26117 A Remove tumor, hand/finger 8.62 NA NA 6.29 6.87 1.26 NA NA 16.17 16.75 090
26121 A Release palm contracture 7.61 NA NA 5.99 6.72 1.17 NA NA 14.77 15.50 090
26123 A Release palm contracture 10.63 NA NA 8.31 8.72 1.43 NA NA 20.37 20.78 090
26125 A Release palm contracture 4.60 NA NA 1.93 2.31 0.70 NA NA 7.23 7.61 ZZZ
26130 A Remove wrist joint lining 5.48 NA NA 4.88 5.23 0.94 NA NA 11.30 11.65 090
26135 A Revise finger joint, each 7.02 NA NA 5.55 6.23 1.07 NA NA 13.64 14.32 090
26140 A Revise finger joint, each 6.23 NA NA 5.22 5.84 0.92 NA NA 12.37 12.99 090
26145 A Tendon excision, palm/finger 6.38 NA NA 5.23 5.85 0.97 NA NA 12.58 13.20 090
26160 A Remove tendon sheath lesion 3.46 8.99 11.53 3.94 4.08 0.49 12.94 15.48 7.89 8.03 090
26170 A Removal of palm tendon, each 4.82 NA NA 4.40 4.81 0.69 NA NA 9.91 10.32 090
26180 A Removal of finger tendon 5.24 NA NA 4.81 5.26 0.78 NA NA 10.83 11.28 090
26185 A Remove finger bone 6.32 NA NA 5.84 5.98 0.81 NA NA 12.97 13.11 090
26200 A Remove hand bone lesion 5.56 NA NA 4.60 5.16 0.88 NA NA 11.04 11.60 090
26205 A Remove/graft bone lesion 7.82 NA NA 5.90 6.64 1.20 NA NA 14.92 15.66 090
26210 A Removal of finger lesion 5.21 NA NA 4.79 5.26 0.79 NA NA 10.79 11.26 090
26215 A Remove/graft finger lesion 7.16 NA NA 5.58 6.13 0.98 NA NA 13.72 14.27 090
26230 A Partial removal of hand bone 6.38 NA NA 5.05 5.70 1.01 NA NA 12.44 13.09 090
26235 A Partial removal, finger bone 6.24 NA NA 5.00 5.61 0.95 NA NA 12.19 12.80 090
26236 A Partial removal, finger bone 5.37 NA NA 4.59 5.14 0.81 NA NA 10.77 11.32 090
26250 A Extensive hand surgery 7.61 NA NA 5.24 6.13 1.07 NA NA 13.92 14.81 090
26255 A Extensive hand surgery 12.80 NA NA 8.51 9.16 1.69 NA NA 23.00 23.65 090
26260 A Extensive finger surgery 7.09 NA NA 5.41 5.99 1.01 NA NA 13.51 14.09 090
26261 A Extensive finger surgery 9.28 NA NA 7.05 6.39 1.14 NA NA 17.47 16.81 090
26262 A Partial removal of finger 5.72 NA NA 4.70 5.17 0.88 NA NA 11.30 11.77 090
26320 A Removal of implant from hand 4.02 NA NA 3.81 4.19 0.59 NA NA 8.42 8.80 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
26340 A Manipulate finger w/anesth 2.62 NA NA 4.63 4.82 0.39 NA NA 7.64 7.83 090
26350 A Repair finger/hand tendon 6.07 NA NA 9.48 13.33 0.93 NA NA 16.48 20.33 090
26352 A Repair/graft hand tendon 7.75 NA NA 10.05 14.03 1.13 NA NA 18.93 22.91 090
26356 A Repair finger/hand tendon 10.22 NA NA 13.76 17.22 1.21 NA NA 25.19 28.65 090
26357 A Repair finger/hand tendon 8.65 NA NA 10.28 14.29 1.33 NA NA 20.26 24.27 090
26358 A Repair/graft hand tendon 9.22 NA NA 10.85 15.19 1.38 NA NA 21.45 25.79 090
26370 A Repair finger/hand tendon 7.17 NA NA 9.51 13.71 1.12 NA NA 17.80 22.00 090
26372 A Repair/graft hand tendon 8.89 NA NA 10.52 15.03 1.40 NA NA 20.81 25.32 090
26373 A Repair finger/hand tendon 8.29 NA NA 10.18 14.58 1.23 NA NA 19.70 24.10 090
26390 A Revise hand/finger tendon 9.31 NA NA 9.13 12.24 1.40 NA NA 19.84 22.95 090
26392 A Repair/graft hand tendon 10.38 NA NA 11.07 15.31 1.57 NA NA 23.02 27.26 090
26410 A Repair hand tendon 4.68 NA NA 7.56 10.85 0.73 NA NA 12.97 16.26 090
26412 A Repair/graft hand tendon 6.37 NA NA 8.56 12.09 0.97 NA NA 15.90 19.43 090
26415 A Excision, hand/finger tendon 8.40 NA NA 6.73 10.52 0.98 NA NA 16.11 19.90 090
26416 A Graft hand or finger tendon 9.44 NA NA 8.71 13.12 0.79 NA NA 18.94 23.35 090
26418 A Repair finger tendon 4.33 NA NA 8.08 11.26 0.67 NA NA 13.08 16.26 090
26420 A Repair/graft finger tendon 6.83 NA NA 8.75 12.41 1.07 NA NA 16.65 20.31 090
26426 A Repair finger/hand tendon 6.21 NA NA 8.54 12.01 0.95 NA NA 15.70 19.17 090
26428 A Repair/graft finger tendon 7.28 NA NA 9.28 12.72 1.09 NA NA 17.65 21.09 090
26432 A Repair finger tendon 4.07 NA NA 6.70 9.37 0.64 NA NA 11.41 14.08 090
26433 A Repair finger tendon 4.61 NA NA 6.95 9.83 0.72 NA NA 12.28 15.16 090
26434 A Repair/graft finger tendon 6.15 NA NA 7.90 10.63 0.93 NA NA 14.98 17.71 090
26437 A Realignment of tendons 5.88 NA NA 7.73 10.61 0.89 NA NA 14.50 17.38 090
26440 A Release palm/finger tendon 5.07 NA NA 8.44 12.18 0.75 NA NA 14.26 18.00 090
26442 A Release palm finger tendon 9.50 NA NA 11.66 14.87 1.20 NA NA 22.36 25.57 090
26445 A Release hand/finger tendon 4.36 NA NA 8.10 11.88 0.65 NA NA 13.11 16.89 090
26449 A Release forearm/hand tendon 8.34 NA NA 11.33 14.66 1.06 NA NA 20.73 24.06 090
26450 A Incision of palm tendon 3.71 NA NA 5.12 6.78 0.59 NA NA 9.42 11.08 090
26455 A Incision of finger tendon 3.68 NA NA 5.06 6.73 0.58 NA NA 9.32 10.99 090
26460 A Incise hand/finger tendon 3.50 NA NA 5.02 6.61 0.55 NA NA 9.07 10.66 090
26471 A Fusion of finger tendons 5.79 NA NA 7.69 10.35 0.88 NA NA 14.36 17.02 090
26474 A Fusion of finger tendons 5.38 NA NA 7.50 10.42 0.76 NA NA 13.64 16.56 090
26476 A Tendon lengthening 5.24 NA NA 7.42 10.05 0.79 NA NA 13.45 16.08 090
26477 A Tendon shortening 5.21 NA NA 7.48 10.17 0.81 NA NA 13.50 16.19 090
26478 A Lengthening of hand tendon 5.86 NA NA 7.65 10.79 0.90 NA NA 14.41 17.55 090
26479 A Shortening of hand tendon 5.80 NA NA 7.71 10.60 0.92 NA NA 14.43 17.32 090
26480 A Transplant hand tendon 6.76 NA NA 9.58 13.68 1.02 NA NA 17.36 21.46 090
26483 A Transplant/graft hand tendon 8.36 NA NA 10.22 14.18 1.26 NA NA 19.84 23.80 090
26485 A Transplant palm tendon 7.77 NA NA 9.96 14.01 1.15 NA NA 18.88 22.93 090
26489 A Transplant/graft palm tendon 9.74 NA NA 10.29 11.62 1.26 NA NA 21.29 22.62 090
26490 A Revise thumb tendon 8.48 NA NA 8.94 11.85 1.21 NA NA 18.63 21.54 090
26492 A Tendon transfer with graft 9.70 NA NA 9.82 12.66 1.40 NA NA 20.92 23.76 090
26494 A Hand tendon/muscle transfer 8.54 NA NA 9.02 11.98 1.28 NA NA 18.84 21.80 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
26496 A Revise thumb tendon 9.66 NA NA 9.50 12.30 1.45 NA NA 20.61 23.41 090
26497 A Finger tendon transfer 9.64 NA NA 9.46 12.54 1.41 NA NA 20.51 23.59 090
26498 A Finger tendon transfer 14.07 NA NA 11.58 15.02 2.11 NA NA 27.76 31.20 090
26499 A Revision of finger 9.05 NA NA 8.80 11.98 1.35 NA NA 19.20 22.38 090
26500 A Hand tendon reconstruction 6.02 NA NA 7.82 10.54 0.90 NA NA 14.74 17.46 090
26502 A Hand tendon reconstruction 7.20 NA NA 8.39 11.11 1.13 NA NA 16.72 19.44 090
26508 A Release thumb contracture 6.07 NA NA 7.76 10.70 0.98 NA NA 14.81 17.75 090
26510 A Thumb tendon transfer 5.49 NA NA 7.59 10.40 0.79 NA NA 13.87 16.68 090
26516 A Fusion of knuckle joint 7.21 NA NA 8.24 11.23 1.10 NA NA 16.55 19.54 090
26517 A Fusion of knuckle joints 8.96 NA NA 9.28 12.45 1.41 NA NA 19.65 22.82 090
26518 A Fusion of knuckle joints 9.15 NA NA 9.23 12.35 1.35 NA NA 19.73 22.85 090
26520 A Release knuckle contracture 5.36 NA NA 8.82 12.62 0.80 NA NA 14.98 18.78 090
26525 A Release finger contracture 5.39 NA NA 8.83 12.69 0.81 NA NA 15.03 18.89 090
26530 A Revise knuckle joint 6.76 NA NA 5.47 5.97 1.04 NA NA 13.27 13.77 090
26531 A Revise knuckle with implant 7.99 NA NA 6.22 6.90 1.17 NA NA 15.38 16.06 090
26535 A Revise finger joint 5.30 NA NA 4.10 3.83 0.71 NA NA 10.11 9.84 090
26536 A Revise/implant finger joint 6.44 NA NA 9.16 9.53 0.96 NA NA 16.56 16.93 090
26540 A Repair hand joint 6.49 NA NA 8.01 10.91 0.99 NA NA 15.49 18.39 090
26541 A Repair hand joint with graft 8.69 NA NA 9.08 12.31 1.28 NA NA 19.05 22.28 090
26542 A Repair hand joint with graft 6.84 NA NA 8.14 11.06 1.02 NA NA 16.00 18.92 090
26545 A Reconstruct finger joint 6.99 NA NA 8.37 11.19 1.05 NA NA 16.41 19.23 090
26546 A Repair nonunion hand 10.53 NA NA 11.46 14.14 1.44 NA NA 23.43 26.11 090
26548 A Reconstruct finger joint 8.10 NA NA 8.83 11.85 1.20 NA NA 18.13 21.15 090
26550 A Construct thumb replacement 21.54 NA NA 15.48 17.06 2.46 NA NA 39.48 41.06 090
26551 A Great toe-hand transfer 48.23 NA NA 21.70 29.76 7.98 NA NA 77.91 85.97 090
26553 A Single transfer, toe-hand 47.92 NA NA 20.69 22.18 2.42 NA NA 71.03 72.52 090
26554 A Double transfer, toe-hand 56.73 NA NA 19.35 32.99 9.44 NA NA 85.52 99.16 090
26555 A Positional change of finger 16.94 NA NA 13.95 17.12 2.49 NA NA 33.38 36.55 090
26556 A Toe joint transfer 49.43 NA NA 17.83 29.45 2.58 NA NA 69.84 81.46 090
26560 A Repair of web finger 5.43 NA NA 7.10 9.13 0.85 NA NA 13.38 15.41 090
26561 A Repair of web finger 10.98 NA NA 9.48 11.63 1.45 NA NA 21.91 24.06 090
26562 A Repair of web finger 16.40 NA NA 14.12 16.39 2.24 NA NA 32.76 35.03 090
26565 A Correct metacarpal flaw 6.80 NA NA 7.91 10.99 1.00 NA NA 15.71 18.79 090
26567 A Correct finger deformity 6.88 NA NA 8.18 11.01 1.04 NA NA 16.10 18.93 090
26568 A Lengthen metacarpal/finger 9.15 NA NA 10.18 14.12 1.49 NA NA 20.82 24.76 090
26580 A Repair hand deformity 19.50 NA NA 11.36 13.07 2.29 NA NA 33.15 34.86 090
26587 A Reconstruct extra finger 14.36 NA NA 8.49 9.03 1.53 NA NA 24.38 24.92 090
26590 A Repair finger deformity 18.51 NA NA 10.52 13.09 2.78 NA NA 31.81 34.38 090
26591 A Repair muscles of hand 3.30 NA NA 6.28 8.79 0.48 NA NA 10.06 12.57 090
26593 A Release muscles of hand 5.38 NA NA 7.76 10.29 0.78 NA NA 13.92 16.45 090
26596 A Excision constricting tissue 9.02 NA NA 7.50 8.49 1.43 NA NA 17.95 18.94 090
26600 A Treat metacarpal fracture 2.48 3.83 3.67 3.48 2.86 0.30 6.61 6.45 6.26 5.64 090
26605 A Treat metacarpal fracture 2.92 4.08 4.44 3.51 3.62 0.49 7.49 7.85 6.92 7.03 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
26607 A Treat metacarpal fracture 5.40 NA NA 4.91 5.93 0.87 NA NA 11.18 12.20 090
26608 A Treat metacarpal fracture 5.43 NA NA 5.27 6.01 0.88 NA NA 11.58 12.32 090
26615 A Treat metacarpal fracture 5.38 NA NA 4.78 5.17 0.86 NA NA 11.02 11.41 090
26641 A Treat thumb dislocation 4.01 4.17 4.47 3.52 3.53 0.39 8.57 8.87 7.92 7.93 090
26645 A Treat thumb fracture 4.47 4.60 5.03 3.92 4.12 0.67 9.74 10.17 9.06 9.26 090
26650 A Treat thumb fracture 5.80 NA NA 5.65 6.43 0.94 NA NA 12.39 13.17 090
26665 A Treat thumb fracture 7.72 NA NA 5.93 6.44 0.90 NA NA 14.55 15.06 090
26670 A Treat hand dislocation 3.74 3.54 4.08 2.96 2.95 0.39 7.67 8.21 7.09 7.08 090
26675 A Treat hand dislocation 4.71 4.88 5.32 4.18 4.40 0.77 10.36 10.80 9.66 9.88 090
26676 A Pin hand dislocation 5.60 NA NA 5.59 6.42 0.91 NA NA 12.10 12.93 090
26685 A Treat hand dislocation 7.09 NA NA 5.47 5.97 1.09 NA NA 13.65 14.15 090
26686 A Treat hand dislocation 8.06 NA NA 6.18 6.72 1.24 NA NA 15.48 16.02 090
26700 A Treat knuckle dislocation 3.74 3.33 3.65 2.96 2.89 0.35 7.42 7.74 7.05 6.98 090
26705 A Treat knuckle dislocation 4.26 4.82 5.20 4.11 4.25 0.66 9.74 10.12 9.03 9.17 090
26706 A Pin knuckle dislocation 5.19 NA NA 4.74 5.00 0.81 NA NA 10.74 11.00 090
26715 A Treat knuckle dislocation 5.79 NA NA 4.95 5.37 0.91 NA NA 11.65 12.07 090
26720 A Treat finger fracture, each 1.70 2.58 2.73 2.31 2.12 0.24 4.52 4.67 4.25 4.06 090
26725 A Treat finger fracture, each 3.39 4.09 4.60 3.43 3.48 0.53 8.01 8.52 7.35 7.40 090
26727 A Treat finger fracture, each 5.30 NA NA 5.24 5.98 0.84 NA NA 11.38 12.12 090
26735 A Treat finger fracture, each 6.03 NA NA 5.04 5.42 0.95 NA NA 12.02 12.40 090
26740 A Treat finger fracture, each 1.99 2.95 3.09 2.67 2.69 0.31 5.25 5.39 4.97 4.99 090
26742 A Treat finger fracture, each 3.90 4.35 4.83 3.64 3.82 0.58 8.83 9.31 8.12 8.30 090
26746 A Treat finger fracture, each 5.86 NA NA 5.01 5.42 0.91 NA NA 11.78 12.19 090
26750 A Treat finger fracture, each 1.74 2.24 2.42 2.24 2.07 0.22 4.20 4.38 4.20 4.03 090
26755 A Treat finger fracture, each 3.15 3.80 4.27 2.99 3.00 0.42 7.37 7.84 6.56 6.57 090
26756 A Pin finger fracture, each 4.46 NA NA 4.89 5.51 0.71 NA NA 10.06 10.68 090
26765 A Treat finger fracture, each 4.21 NA NA 4.04 4.30 0.66 NA NA 8.91 9.17 090
26770 A Treat finger dislocation 3.07 2.91 3.30 2.54 2.44 0.27 6.25 6.64 5.88 5.78 090
26775 A Treat finger dislocation 3.78 4.56 5.03 3.83 3.82 0.54 8.88 9.35 8.15 8.14 090
26776 A Pin finger dislocation 4.87 NA NA 5.04 5.76 0.77 NA NA 10.68 11.40 090
26785 A Treat finger dislocation 4.25 NA NA 4.10 4.42 0.68 NA NA 9.03 9.35 090
26820 A Thumb fusion with graft 8.33 NA NA 8.71 12.12 1.30 NA NA 18.34 21.75 090
26841 A Fusion of thumb 7.21 NA NA 8.69 12.10 1.18 NA NA 17.08 20.49 090
26842 A Thumb fusion with graft 8.37 NA NA 8.97 12.27 1.32 NA NA 18.66 21.96 090
26843 A Fusion of hand joint 7.67 NA NA 8.19 11.31 1.15 NA NA 17.01 20.13 090
26844 A Fusion/graft of hand joint 8.86 NA NA 9.18 12.32 1.33 NA NA 19.37 22.51 090
26850 A Fusion of knuckle 7.03 NA NA 8.31 11.23 1.06 NA NA 16.40 19.32 090
26852 A Fusion of knuckle with graft 8.59 NA NA 9.17 11.96 1.22 NA NA 18.98 21.77 090
26860 A Fusion of finger joint 4.76 NA NA 7.54 10.28 0.73 NA NA 13.03 15.77 090
26861 A Fusion of finger jnt, add-on 1.74 NA NA 0.72 0.88 0.27 NA NA 2.73 2.89 ZZZ
26862 A Fusion/graft of finger joint 7.44 NA NA 8.72 11.44 1.10 NA NA 17.26 19.98 090
26863 A Fuse/graft added joint 3.89 NA NA 1.61 1.99 0.56 NA NA 6.06 6.44 ZZZ
26910 A Amputate metacarpal bone 7.67 NA NA 8.32 10.50 1.16 NA NA 17.15 19.33 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
26951 A Amputation of finger/thumb 5.85 NA NA 8.39 9.71 0.71 NA NA 14.95 16.27 090
26952 A Amputation of finger/thumb 6.37 NA NA 7.99 10.74 0.95 NA NA 15.31 18.06 090
26989 C Hand/finger surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
26990 A Drainage of pelvis lesion 7.84 NA NA 6.28 6.98 1.22 NA NA 15.34 16.04 090
26991 A Drainage of pelvis bursa 6.97 8.55 10.51 4.86 5.29 1.11 16.63 18.59 12.94 13.37 090
26992 A Drainage of bone lesion 13.37 NA NA 8.67 9.95 2.17 NA NA 24.21 25.49 090
27000 A Incision of hip tendon 5.66 NA NA 4.57 5.10 0.98 NA NA 11.21 11.74 090
27001 A Incision of hip tendon 7.05 NA NA 5.24 5.88 1.24 NA NA 13.53 14.17 090
27003 A Incision of hip tendon 7.70 NA NA 5.85 6.32 1.12 NA NA 14.67 15.14 090
27005 A Incision of hip tendon 9.96 NA NA 6.82 7.57 1.73 NA NA 18.51 19.26 090
27006 A Incision of hip tendons 9.99 NA NA 6.86 7.70 1.70 NA NA 18.55 19.39 090
27025 A Incision of hip/thigh fascia 12.66 NA NA 8.12 8.44 1.85 NA NA 22.63 22.95 090
27030 A Drainage of hip joint 13.54 NA NA 8.14 9.27 2.27 NA NA 23.95 25.08 090
27033 A Exploration of hip joint 13.99 NA NA 8.49 9.56 2.33 NA NA 24.81 25.88 090
27035 A Denervation of hip joint 17.23 NA NA 9.74 10.86 2.16 NA NA 29.13 30.25 090
27036 A Excision of hip joint/muscle 14.18 NA NA 9.01 9.75 2.27 NA NA 25.46 26.20 090
27040 A Biopsy of soft tissues 2.89 4.99 5.17 1.77 1.95 0.27 8.15 8.33 4.93 5.11 010
27041 A Biopsy of soft tissues 10.07 NA NA 5.70 6.41 1.35 NA NA 17.12 17.83 090
27047 A Remove hip/pelvis lesion 7.51 7.07 7.10 4.55 4.72 1.03 15.61 15.64 13.09 13.26 090
27048 A Remove hip/pelvis lesion 6.44 NA NA 4.64 4.76 0.92 NA NA 12.00 12.12 090
27049 A Remove tumor, hip/pelvis 15.20 NA NA 8.24 8.36 2.07 NA NA 25.51 25.63 090
27050 A Biopsy of sacroiliac joint 4.65 NA NA 3.76 4.26 0.60 NA NA 9.01 9.51 090
27052 A Biopsy of hip joint 7.27 NA NA 5.68 5.83 1.08 NA NA 14.03 14.18 090
27054 A Removal of hip joint lining 9.09 NA NA 6.51 7.13 1.47 NA NA 17.07 17.69 090
27060 A Removal of ischial bursa 5.78 NA NA 4.43 4.39 0.80 NA NA 11.01 10.97 090
27062 A Remove femur lesion/bursa 5.66 NA NA 4.64 5.05 0.93 NA NA 11.23 11.64 090
27065 A Removal of hip bone lesion 6.44 NA NA 5.12 5.36 1.01 NA NA 12.57 12.81 090
27066 A Removal of hip bone lesion 11.06 NA NA 7.49 8.20 1.80 NA NA 20.35 21.06 090
27067 A Remove/graft hip bone lesion 14.57 NA NA 8.86 10.21 1.85 NA NA 25.28 26.63 090
27070 A Partial removal of hip bone 11.44 NA NA 7.97 8.84 1.75 NA NA 21.16 22.03 090
27071 A Partial removal of hip bone 12.25 NA NA 8.56 9.73 1.93 NA NA 22.74 23.91 090
27075 A Extensive hip surgery 36.77 NA NA 16.74 18.59 5.66 NA NA 59.17 61.02 090
27076 A Extensive hip surgery 24.25 NA NA 12.83 14.09 3.71 NA NA 40.79 42.05 090
27077 A Extensive hip surgery 42.54 NA NA 20.10 22.02 6.14 NA NA 68.78 70.70 090
27078 A Extensive hip surgery 14.54 NA NA 8.87 9.67 2.23 NA NA 25.64 26.44 090
27079 A Extensive hip surgery 14.91 NA NA 7.50 9.03 1.95 NA NA 24.36 25.89 090
27080 A Removal of tail bone 6.80 NA NA 4.75 4.81 0.93 NA NA 12.48 12.54 090
27086 A Remove hip foreign body 1.89 3.75 4.35 1.54 1.75 0.25 5.89 6.49 3.68 3.89 010
27087 A Remove hip foreign body 8.72 NA NA 5.67 6.41 1.35 NA NA 15.74 16.48 090
27090 A Removal of hip prosthesis 11.57 NA NA 7.47 8.45 1.95 NA NA 20.99 21.97 090
27091 A Removal of hip prosthesis 24.15 NA NA 13.11 13.77 3.85 NA NA 41.11 41.77 090
27093 A Injection for hip x-ray 1.30 2.97 4.09 0.42 0.47 0.13 4.40 5.52 1.85 1.90 000
27095 A Injection for hip x-ray 1.50 3.61 5.19 0.48 0.51 0.14 5.25 6.83 2.12 2.15 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27096 A Inject sacroiliac joint 1.40 2.48 3.88 0.33 0.33 0.08 3.96 5.36 1.81 1.81 000
27097 A Revision of hip tendon 9.16 NA NA 6.36 6.40 1.57 NA NA 17.09 17.13 090
27098 A Transfer tendon to pelvis 9.20 NA NA 4.89 6.49 0.95 NA NA 15.04 16.64 090
27100 A Transfer of abdominal muscle 11.21 NA NA 7.41 8.35 1.86 NA NA 20.48 21.42 090
27105 A Transfer of spinal muscle 11.90 NA NA 7.96 8.86 1.73 NA NA 21.59 22.49 090
27110 A Transfer of iliopsoas muscle 13.63 NA NA 8.67 9.00 2.19 NA NA 24.49 24.82 090
27111 A Transfer of iliopsoas muscle 12.46 NA NA 8.17 8.89 1.95 NA NA 22.58 23.30 090
27120 A Reconstruction of hip socket 19.10 NA NA 10.85 11.59 3.09 NA NA 33.04 33.78 090
27122 A Reconstruction of hip socket 15.95 NA NA 9.54 10.67 2.62 NA NA 28.11 29.24 090
27125 A Partial hip replacement 16.46 NA NA 9.72 10.40 2.55 NA NA 28.73 29.41 090
27130 A Total hip arthroplasty 21.61 NA NA 11.95 12.96 3.51 NA NA 37.07 38.08 090
27132 A Total hip arthroplasty 25.49 NA NA 13.64 15.13 4.05 NA NA 43.18 44.67 090
27134 A Revise hip joint replacement 30.13 NA NA 14.94 17.08 4.95 NA NA 50.02 52.16 090
27137 A Revise hip joint replacement 22.55 NA NA 11.90 13.42 3.68 NA NA 38.13 39.65 090
27138 A Revise hip joint replacement 23.55 NA NA 12.30 13.87 3.85 NA NA 39.70 41.27 090
27140 A Transplant femur ridge 12.66 NA NA 7.84 9.02 2.12 NA NA 22.62 23.80 090
27146 A Incision of hip bone 18.72 NA NA 10.78 11.79 2.97 NA NA 32.47 33.48 090
27147 A Revision of hip bone 21.87 NA NA 12.05 12.95 3.58 NA NA 37.50 38.40 090
27151 A Incision of hip bones 23.92 NA NA 12.50 9.09 3.92 NA NA 40.34 36.93 090
27156 A Revision of hip bones 26.03 NA NA 13.61 15.45 4.22 NA NA 43.86 45.70 090
27158 A Revision of pelvis 20.89 NA NA 7.12 10.01 3.17 NA NA 31.18 34.07 090
27161 A Incision of neck of femur 17.74 NA NA 10.47 11.69 2.95 NA NA 31.16 32.38 090
27165 A Incision/fixation of femur 20.06 NA NA 11.77 12.63 3.11 NA NA 34.94 35.80 090
27170 A Repair/graft femur head/neck 17.46 NA NA 9.86 10.94 2.82 NA NA 30.14 31.22 090
27175 A Treat slipped epiphysis 9.29 NA NA 5.83 6.46 1.46 NA NA 16.58 17.21 090
27176 A Treat slipped epiphysis 12.78 NA NA 8.30 8.83 2.23 NA NA 23.31 23.84 090
27177 A Treat slipped epiphysis 15.94 NA NA 9.74 10.60 2.62 NA NA 28.30 29.16 090
27178 A Treat slipped epiphysis 12.78 NA NA 8.29 8.39 2.09 NA NA 23.16 23.26 090
27179 A Revise head/neck of femur 13.83 NA NA 8.59 9.64 2.26 NA NA 24.68 25.73 090
27181 A Treat slipped epiphysis 15.98 NA NA 9.86 10.12 1.57 NA NA 27.41 27.67 090
27185 A Revision of femur epiphysis 9.67 NA NA 6.71 7.32 2.40 NA NA 18.78 19.39 090
27187 A Reinforce hip bones 14.09 NA NA 8.76 9.93 2.38 NA NA 25.23 26.40 090
27193 A Treat pelvic ring fracture 5.98 4.66 4.98 4.66 4.98 0.96 11.60 11.92 11.60 11.92 090
27194 A Treat pelvic ring fracture 10.08 NA NA 6.65 7.40 1.65 NA NA 18.38 19.13 090
27200 A Treat tail bone fracture 1.87 2.08 2.19 2.08 2.13 0.28 4.23 4.34 4.23 4.28 090
27202 A Treat tail bone fracture 7.25 NA NA 11.14 15.43 1.06 NA NA 19.45 23.74 090
27215 A Treat pelvic fracture(s) 10.45 NA NA 6.55 6.95 1.98 NA NA 18.98 19.38 090
27216 A Treat pelvic ring fracture 15.73 NA NA 9.29 9.52 2.64 NA NA 27.66 27.89 090
27217 A Treat pelvic ring fracture 14.65 NA NA 8.74 9.79 2.42 NA NA 25.81 26.86 090
27218 A Treat pelvic ring fracture 20.93 NA NA 11.45 11.41 3.49 NA NA 35.87 35.83 090
27220 A Treat hip socket fracture 6.72 5.29 5.61 5.19 5.52 1.07 13.08 13.40 12.98 13.31 090
27222 A Treat hip socket fracture 13.97 NA NA 8.52 9.61 2.20 NA NA 24.69 25.78 090
27226 A Treat hip wall fracture 15.45 NA NA 9.04 8.12 2.49 NA NA 26.98 26.06 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27227 A Treat hip fracture(s) 25.21 NA NA 13.50 14.93 4.06 NA NA 42.77 44.20 090
27228 A Treat hip fracture(s) 29.13 NA NA 15.10 16.99 4.67 NA NA 48.90 50.79 090
27230 A Treat thigh fracture 5.69 4.99 5.38 4.92 5.06 0.95 11.63 12.02 11.56 11.70 090
27232 A Treat thigh fracture 11.66 NA NA 6.02 6.88 1.86 NA NA 19.54 20.40 090
27235 A Treat thigh fracture 12.88 NA NA 8.08 9.11 2.12 NA NA 23.08 24.11 090
27236 A Treat thigh fracture 17.43 NA NA 10.26 10.85 2.72 NA NA 30.41 31.00 090
27238 A Treat thigh fracture 5.64 NA NA 4.70 5.03 0.89 NA NA 11.23 11.56 090
27240 A Treat thigh fracture 13.66 NA NA 8.12 9.13 2.17 NA NA 23.95 24.96 090
27244 A Treat thigh fracture 17.08 NA NA 9.75 10.91 2.78 NA NA 29.61 30.77 090
27245 A Treat thigh fracture 21.09 NA NA 11.52 13.19 3.53 NA NA 36.14 37.81 090
27246 A Treat thigh fracture 4.75 3.94 4.33 3.94 4.30 0.81 9.50 9.89 9.50 9.86 090
27248 A Treat thigh fracture 10.80 NA NA 7.03 7.92 1.82 NA NA 19.65 20.54 090
27250 A Treat hip dislocation 7.21 NA NA 4.30 4.54 0.62 NA NA 12.13 12.37 090
27252 A Treat hip dislocation 10.92 NA NA 6.53 7.21 1.66 NA NA 19.11 19.79 090
27253 A Treat hip dislocation 13.46 NA NA 8.28 9.41 2.25 NA NA 23.99 25.12 090
27254 A Treat hip dislocation 18.80 NA NA 10.61 11.67 3.18 NA NA 32.59 33.65 090
27256 A Treat hip dislocation 4.25 2.40 3.24 1.41 1.91 0.46 7.11 7.95 6.12 6.62 010
27257 A Treat hip dislocation 5.35 NA NA 2.56 2.75 0.69 NA NA 8.60 8.79 010
27258 A Treat hip dislocation 16.04 NA NA 9.50 10.53 2.65 NA NA 28.19 29.22 090
27259 A Treat hip dislocation 23.03 NA NA 12.96 13.83 3.75 NA NA 39.74 40.61 090
27265 A Treat hip dislocation 5.12 NA NA 3.99 4.59 0.63 NA NA 9.74 10.34 090
27266 A Treat hip dislocation 7.67 NA NA 5.57 6.15 1.29 NA NA 14.53 15.11 090
27275 A Manipulation of hip joint 2.29 NA NA 1.90 2.05 0.39 NA NA 4.58 4.73 010
27280 A Fusion of sacroiliac joint 14.49 NA NA 9.10 9.97 2.54 NA NA 26.13 27.00 090
27282 A Fusion of pubic bones 11.71 NA NA 7.86 7.97 1.87 NA NA 21.44 21.55 090
27284 A Fusion of hip joint 24.91 NA NA 12.92 14.30 3.93 NA NA 41.76 43.14 090
27286 A Fusion of hip joint 24.97 NA NA 13.54 15.23 3.13 NA NA 41.64 43.33 090
27290 A Amputation of leg at hip 24.38 NA NA 12.56 13.69 3.44 NA NA 40.38 41.51 090
27295 A Amputation of leg at hip 19.54 NA NA 9.83 10.94 2.96 NA NA 32.33 33.44 090
27299 C Pelvis/hip joint surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
27301 A Drain thigh/knee lesion 6.67 8.18 9.60 4.67 5.02 1.04 15.89 17.31 12.38 12.73 090
27303 A Drainage of bone lesion 8.52 NA NA 6.09 6.76 1.43 NA NA 16.04 16.71 090
27305 A Incise thigh tendon fascia 6.09 NA NA 4.63 5.04 1.01 NA NA 11.73 12.14 090
27306 A Incision of thigh tendon 4.66 NA NA 4.07 4.56 0.85 NA NA 9.58 10.07 090
27307 A Incision of thigh tendons 5.97 NA NA 4.82 5.24 1.04 NA NA 11.83 12.25 090
27310 A Exploration of knee joint 9.88 NA NA 6.85 7.40 1.61 NA NA 18.34 18.89 090
27323 A Biopsy, thigh soft tissues 2.30 4.12 3.66 1.91 1.89 0.24 6.66 6.20 4.45 4.43 010
27324 A Biopsy, thigh soft tissues 4.95 NA NA 3.84 4.10 0.75 NA NA 9.54 9.80 090
27325 A Neurectomy, hamstring 7.09 NA NA 5.45 5.08 1.09 NA NA 13.63 13.26 090
27326 A Neurectomy, popliteal 6.36 NA NA 4.77 5.12 1.06 NA NA 12.19 12.54 090
27327 A Removal of thigh lesion 4.52 6.04 6.00 3.61 3.69 0.64 11.20 11.16 8.77 8.85 090
27328 A Removal of thigh lesion 5.62 NA NA 4.06 4.29 0.84 NA NA 10.52 10.75 090
27329 A Remove tumor, thigh/knee 15.68 NA NA 8.58 8.91 2.15 NA NA 26.41 26.74 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27330 A Biopsy, knee joint lining 5.02 NA NA 4.12 4.46 0.86 NA NA 10.00 10.34 090
27331 A Explore/treat knee joint 5.93 NA NA 4.85 5.35 1.02 NA NA 11.80 12.30 090
27332 A Removal of knee cartilage 8.34 NA NA 6.17 6.88 1.43 NA NA 15.94 16.65 090
27333 A Removal of knee cartilage 7.43 NA NA 5.74 6.44 1.26 NA NA 14.43 15.13 090
27334 A Remove knee joint lining 9.07 NA NA 6.51 7.19 1.51 NA NA 17.09 17.77 090
27335 A Remove knee joint lining 10.43 NA NA 7.08 7.94 1.75 NA NA 19.26 20.12 090
27340 A Removal of kneecap bursa 4.23 NA NA 4.05 4.43 0.72 NA NA 9.00 9.38 090
27345 A Removal of knee cyst 5.98 NA NA 4.90 5.44 1.00 NA NA 11.88 12.42 090
27347 A Remove knee cyst 6.58 NA NA 5.26 5.38 0.98 NA NA 12.82 12.94 090
27350 A Removal of kneecap 8.54 NA NA 6.30 7.01 1.41 NA NA 16.25 16.96 090
27355 A Remove femur lesion 7.89 NA NA 5.88 6.55 1.32 NA NA 15.09 15.76 090
27356 A Remove femur lesion/graft 9.97 NA NA 6.88 7.61 1.65 NA NA 18.50 19.23 090
27357 A Remove femur lesion/graft 11.02 NA NA 7.56 8.42 1.96 NA NA 20.54 21.40 090
27358 A Remove femur lesion/fixation 4.73 NA NA 1.91 2.37 0.82 NA NA 7.46 7.92 ZZZ
27360 A Partial removal, leg bone(s) 11.34 NA NA 8.15 9.20 1.84 NA NA 21.33 22.38 090
27365 A Extensive leg surgery 17.93 NA NA 10.56 11.40 2.80 NA NA 31.29 32.13 090
27370 A Injection for knee x-ray 0.96 2.72 3.47 0.32 0.32 0.08 3.76 4.51 1.36 1.36 000
27372 A Removal of foreign body 5.12 8.28 9.61 4.05 4.53 0.84 14.24 15.57 10.01 10.49 090
27380 A Repair of kneecap tendon 7.34 NA NA 6.09 6.98 1.24 NA NA 14.67 15.56 090
27381 A Repair/graft kneecap tendon 10.64 NA NA 7.58 8.71 1.80 NA NA 20.02 21.15 090
27385 A Repair of thigh muscle 8.00 NA NA 6.37 7.32 1.36 NA NA 15.73 16.68 090
27386 A Repair/graft of thigh muscle 10.99 NA NA 8.00 9.13 1.86 NA NA 20.85 21.98 090
27390 A Incision of thigh tendon 5.44 NA NA 4.57 4.98 0.92 NA NA 10.93 11.34 090
27391 A Incision of thigh tendons 7.38 NA NA 5.55 6.31 1.23 NA NA 14.16 14.92 090
27392 A Incision of thigh tendons 9.51 NA NA 6.76 7.38 1.57 NA NA 17.84 18.46 090
27393 A Lengthening of thigh tendon 6.50 NA NA 5.02 5.63 1.10 NA NA 12.62 13.23 090
27394 A Lengthening of thigh tendons 8.68 NA NA 6.21 6.97 1.47 NA NA 16.36 17.12 090
27395 A Lengthening of thigh tendons 12.10 NA NA 8.02 9.00 2.05 NA NA 22.17 23.15 090
27396 A Transplant of thigh tendon 8.04 NA NA 5.94 6.74 1.34 NA NA 15.32 16.12 090
27397 A Transplants of thigh tendons 12.46 NA NA 8.44 8.89 1.83 NA NA 22.73 23.18 090
27400 A Revise thigh muscles/tendons 9.21 NA NA 6.19 6.99 1.31 NA NA 16.71 17.51 090
27403 A Repair of knee cartilage 8.51 NA NA 6.11 6.91 1.44 NA NA 16.06 16.86 090
27405 A Repair of knee ligament 8.96 NA NA 6.46 7.23 1.51 NA NA 16.93 17.70 090
27407 A Repair of knee ligament 10.71 NA NA 6.71 7.92 1.79 NA NA 19.21 20.42 090
27409 A Repair of knee ligaments 13.57 NA NA 8.47 9.58 2.25 NA NA 24.29 25.40 090
27412 A Autochondrocyte implant knee 24.53 NA NA 13.71 14.53 4.36 NA NA 42.60 43.42 090
27415 A Osteochondral knee allograft 19.79 NA NA 11.90 12.39 4.36 NA NA 36.05 36.54 090
27418 A Repair degenerated kneecap 11.46 NA NA 7.64 8.59 1.89 NA NA 20.99 21.94 090
27420 A Revision of unstable kneecap 10.14 NA NA 6.98 7.83 1.72 NA NA 18.84 19.69 090
27422 A Revision of unstable kneecap 10.09 NA NA 6.93 7.82 1.71 NA NA 18.73 19.62 090
27424 A Revision/removal of kneecap 10.12 NA NA 6.94 7.80 1.71 NA NA 18.77 19.63 090
27425 A Lat retinacular release open 5.28 NA NA 4.72 5.32 0.90 NA NA 10.90 11.50 090
27427 A Reconstruction, knee 9.67 NA NA 6.73 7.53 1.63 NA NA 18.03 18.83 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27428 A Reconstruction, knee 15.33 NA NA 10.16 10.97 2.43 NA NA 27.92 28.73 090
27429 A Reconstruction, knee 17.24 NA NA 11.37 12.15 2.71 NA NA 31.32 32.10 090
27430 A Revision of thigh muscles 10.04 NA NA 6.91 7.73 1.70 NA NA 18.65 19.47 090
27435 A Incision of knee joint 10.68 NA NA 7.71 8.29 1.70 NA NA 20.09 20.67 090
27437 A Revise kneecap 8.82 NA NA 6.25 6.99 1.49 NA NA 16.56 17.30 090
27438 A Revise kneecap with implant 11.77 NA NA 7.60 8.31 1.96 NA NA 21.33 22.04 090
27440 A Revision of knee joint 10.97 NA NA 7.19 6.29 1.82 NA NA 19.98 19.08 090
27441 A Revision of knee joint 11.42 NA NA 7.54 6.92 1.89 NA NA 20.85 20.23 090
27442 A Revision of knee joint 12.25 NA NA 7.81 8.64 2.10 NA NA 22.16 22.99 090
27443 A Revision of knee joint 11.29 NA NA 7.43 8.40 1.91 NA NA 20.63 21.60 090
27445 A Revision of knee joint 18.52 NA NA 10.58 11.91 3.09 NA NA 32.19 33.52 090
27446 A Revision of knee joint 16.26 NA NA 9.41 10.81 2.81 NA NA 28.48 29.88 090
27447 A Total knee arthroplasty 23.04 NA NA 12.75 14.14 3.80 NA NA 39.59 40.98 090
27448 A Incision of thigh 11.48 NA NA 7.46 8.32 1.95 NA NA 20.89 21.75 090
27450 A Incision of thigh 14.47 NA NA 8.85 10.15 2.43 NA NA 25.75 27.05 090
27454 A Realignment of thigh bone 18.97 NA NA 10.79 12.07 3.13 NA NA 32.89 34.17 090
27455 A Realignment of knee 13.24 NA NA 8.43 9.52 2.25 NA NA 23.92 25.01 090
27457 A Realignment of knee 13.92 NA NA 8.29 9.51 2.35 NA NA 24.56 25.78 090
27465 A Shortening of thigh bone 18.44 NA NA 10.40 10.27 2.48 NA NA 31.32 31.19 090
27466 A Lengthening of thigh bone 17.13 NA NA 10.20 11.42 2.78 NA NA 30.11 31.33 090
27468 A Shorten/lengthen thighs 19.82 NA NA 11.33 12.10 3.31 NA NA 34.46 35.23 090
27470 A Repair of thigh 16.97 NA NA 10.26 11.41 2.80 NA NA 30.03 31.18 090
27472 A Repair/graft of thigh 18.57 NA NA 10.77 12.20 3.08 NA NA 32.42 33.85 090
27475 A Surgery to stop leg growth 8.82 NA NA 6.88 7.13 1.36 NA NA 17.06 17.31 090
27477 A Surgery to stop leg growth 10.03 NA NA 6.67 7.47 1.74 NA NA 18.44 19.24 090
27479 A Surgery to stop leg growth 13.04 NA NA 5.06 8.50 2.79 NA NA 20.89 24.33 090
27485 A Surgery to stop leg growth 9.02 NA NA 6.26 7.12 1.53 NA NA 16.81 17.67 090
27486 A Revise/replace knee joint 20.92 NA NA 11.79 13.07 3.37 NA NA 36.08 37.36 090
27487 A Revise/replace knee joint 26.91 NA NA 14.21 15.97 4.40 NA NA 45.52 47.28 090
27488 A Removal of knee prosthesis 17.40 NA NA 10.38 11.37 2.75 NA NA 30.53 31.52 090
27495 A Reinforce thigh 16.40 NA NA 9.74 10.99 2.72 NA NA 28.86 30.11 090
27496 A Decompression of thigh/knee 6.66 NA NA 5.02 5.46 0.99 NA NA 12.67 13.11 090
27497 A Decompression of thigh/knee 7.70 NA NA 4.67 5.24 1.15 NA NA 13.52 14.09 090
27498 A Decompression of thigh/knee 8.54 NA NA 5.37 5.81 1.24 NA NA 15.15 15.59 090
27499 A Decompression of thigh/knee 9.31 NA NA 5.84 6.58 1.47 NA NA 16.62 17.36 090
27500 A Treatment of thigh fracture 6.21 5.44 5.95 4.66 4.91 1.02 12.67 13.18 11.89 12.14 090
27501 A Treatment of thigh fracture 6.34 5.05 5.61 4.96 5.28 1.03 12.42 12.98 12.33 12.65 090
27502 A Treatment of thigh fracture 11.24 NA NA 6.95 7.82 1.79 NA NA 19.98 20.85 090
27503 A Treatment of thigh fracture 11.13 NA NA 7.29 8.04 1.85 NA NA 20.27 21.02 090
27506 A Treatment of thigh fracture 19.42 NA NA 11.26 12.40 3.04 NA NA 33.72 34.86 090
27507 A Treatment of thigh fracture 14.39 NA NA 8.23 9.44 2.43 NA NA 25.05 26.26 090
27508 A Treatment of thigh fracture 6.08 5.71 6.27 5.08 5.38 0.97 12.76 13.32 12.13 12.43 090
27509 A Treatment of thigh fracture 8.02 NA NA 6.57 7.61 1.34 NA NA 15.93 16.97 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27510 A Treatment of thigh fracture 9.68 NA NA 6.36 7.09 1.53 NA NA 17.57 18.30 090
27511 A Treatment of thigh fracture 13.94 NA NA 9.13 10.68 2.38 NA NA 25.45 27.00 090
27513 A Treatment of thigh fracture 19.45 NA NA 11.89 13.38 3.13 NA NA 34.47 35.96 090
27514 A Treatment of thigh fracture 19.09 NA NA 12.01 13.02 3.01 NA NA 34.11 35.12 090
27516 A Treat thigh fx growth plate 5.45 5.69 6.19 5.06 5.40 0.81 11.95 12.45 11.32 11.66 090
27517 A Treat thigh fx growth plate 8.98 NA NA 6.07 7.11 1.22 NA NA 16.27 17.31 090
27519 A Treat thigh fx growth plate 15.80 NA NA 9.92 11.17 2.56 NA NA 28.28 29.53 090
27520 A Treat kneecap fracture 2.93 4.10 4.43 3.53 3.46 0.47 7.50 7.83 6.93 6.86 090
27524 A Treat kneecap fracture 10.25 NA NA 7.00 7.92 1.75 NA NA 19.00 19.92 090
27530 A Treat knee fracture 3.97 4.83 5.19 4.27 4.38 0.65 9.45 9.81 8.89 9.00 090
27532 A Treat knee fracture 7.43 6.45 7.13 5.68 6.26 1.26 15.14 15.82 14.37 14.95 090
27535 A Treat knee fracture 11.80 NA NA 8.28 9.65 2.01 NA NA 22.09 23.46 090
27536 A Treat knee fracture 17.19 NA NA 10.33 11.29 2.74 NA NA 30.26 31.22 090
27538 A Treat knee fracture(s) 4.95 5.54 5.98 4.92 5.12 0.84 11.33 11.77 10.71 10.91 090
27540 A Treat knee fracture 13.45 NA NA 8.05 9.15 2.28 NA NA 23.78 24.88 090
27550 A Treat knee dislocation 5.84 5.31 5.84 4.61 4.85 0.76 11.91 12.44 11.21 11.45 090
27552 A Treat knee dislocation 8.04 NA NA 6.14 6.75 1.36 NA NA 15.54 16.15 090
27556 A Treat knee dislocation 14.95 NA NA 9.35 11.08 2.51 NA NA 26.81 28.54 090
27557 A Treat knee dislocation 17.31 NA NA 10.63 12.50 2.98 NA NA 30.92 32.79 090
27558 A Treat knee dislocation 18.01 NA NA 10.66 12.45 3.09 NA NA 31.76 33.55 090
27560 A Treat kneecap dislocation 3.88 3.93 4.61 3.41 3.24 0.40 8.21 8.89 7.69 7.52 090
27562 A Treat kneecap dislocation 5.86 NA NA 4.46 4.69 0.94 NA NA 11.26 11.49 090
27566 A Treat kneecap dislocation 12.59 NA NA 7.89 8.96 2.13 NA NA 22.61 23.68 090
27570 A Fixation of knee joint 1.76 NA NA 1.62 1.73 0.30 NA NA 3.68 3.79 010
27580 A Fusion of knee 20.90 NA NA 12.38 14.20 3.38 NA NA 36.66 38.48 090
27590 A Amputate leg at thigh 13.35 NA NA 6.12 6.53 1.75 NA NA 21.22 21.63 090
27591 A Amputate leg at thigh 13.82 NA NA 7.44 8.34 2.03 NA NA 23.29 24.19 090
27592 A Amputate leg at thigh 10.86 NA NA 5.48 6.00 1.45 NA NA 17.79 18.31 090
27594 A Amputation follow-up surgery 7.17 NA NA 4.75 5.07 1.02 NA NA 12.94 13.26 090
27596 A Amputation follow-up surgery 11.15 NA NA 6.05 6.62 1.57 NA NA 18.77 19.34 090
27598 A Amputate lower leg at knee 11.08 NA NA 6.34 6.85 1.65 NA NA 19.07 19.58 090
27599 C Leg surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
27600 A Decompression of lower leg 5.94 NA NA 3.84 4.36 0.86 NA NA 10.64 11.16 090
27601 A Decompression of lower leg 5.94 NA NA 4.26 4.70 0.80 NA NA 11.00 11.44 090
27602 A Decompression of lower leg 7.71 NA NA 4.37 4.94 1.10 NA NA 13.18 13.75 090
27603 A Drain lower leg lesion 5.12 7.01 7.37 3.90 4.10 0.74 12.87 13.23 9.76 9.96 090
27604 A Drain lower leg bursa 4.51 6.46 6.18 3.44 3.83 0.69 11.66 11.38 8.64 9.03 090
27605 A Incision of achilles tendon 2.89 5.27 7.08 1.80 2.19 0.41 8.57 10.38 5.10 5.49 010
27606 A Incision of achilles tendon 4.15 NA NA 2.68 3.19 0.69 NA NA 7.52 8.03 010
27607 A Treat lower leg bone lesion 8.51 NA NA 5.79 6.08 1.31 NA NA 15.61 15.90 090
27610 A Explore/treat ankle joint 9.01 NA NA 6.20 6.80 1.40 NA NA 16.61 17.21 090
27612 A Exploration of ankle joint 8.01 NA NA 5.39 5.92 1.13 NA NA 14.53 15.06 090
27613 A Biopsy lower leg soft tissue 2.19 3.86 3.39 1.76 1.79 0.20 6.25 5.78 4.15 4.18 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27614 A Biopsy lower leg soft tissue 5.71 7.87 7.32 4.03 4.34 0.78 14.36 13.81 10.52 10.83 090
27615 A Remove tumor, lower leg 12.93 NA NA 8.12 9.07 1.84 NA NA 22.89 23.84 090
27618 A Remove lower leg lesion 5.14 6.38 6.10 3.79 3.94 0.72 12.24 11.96 9.65 9.80 090
27619 A Remove lower leg lesion 8.47 10.05 9.65 5.32 5.79 1.25 19.77 19.37 15.04 15.51 090
27620 A Explore/treat ankle joint 6.04 NA NA 4.62 5.25 0.97 NA NA 11.63 12.26 090
27625 A Remove ankle joint lining 8.37 NA NA 5.63 6.25 1.28 NA NA 15.28 15.90 090
27626 A Remove ankle joint lining 8.98 NA NA 5.99 6.69 1.48 NA NA 16.45 17.15 090
27630 A Removal of tendon lesion 4.85 7.94 7.66 3.81 4.24 0.74 13.53 13.25 9.40 9.83 090
27635 A Remove lower leg bone lesion 7.91 NA NA 5.70 6.48 1.31 NA NA 14.92 15.70 090
27637 A Remove/graft leg bone lesion 10.17 NA NA 7.19 8.02 1.66 NA NA 19.02 19.85 090
27638 A Remove/graft leg bone lesion 10.87 NA NA 7.01 7.97 1.85 NA NA 19.73 20.69 090
27640 A Partial removal of tibia 12.10 NA NA 8.24 9.79 1.89 NA NA 22.23 23.78 090
27641 A Partial removal of fibula 9.73 NA NA 6.82 7.96 1.46 NA NA 18.01 19.15 090
27645 A Extensive lower leg surgery 14.78 NA NA 9.54 11.42 2.42 NA NA 26.74 28.62 090
27646 A Extensive lower leg surgery 13.21 NA NA 8.45 10.39 2.06 NA NA 23.72 25.66 090
27647 A Extensive ankle/heel surgery 12.85 NA NA 6.70 7.38 1.76 NA NA 21.31 21.99 090
27648 A Injection for ankle x-ray 0.96 2.62 3.30 0.30 0.32 0.08 3.66 4.34 1.34 1.36 000
27650 A Repair achilles tendon 9.94 NA NA 6.34 7.22 1.59 NA NA 17.87 18.75 090
27652 A Repair/graft achilles tendon 10.64 NA NA 6.51 7.65 1.72 NA NA 18.87 20.01 090
27654 A Repair of achilles tendon 10.32 NA NA 6.03 6.86 1.58 NA NA 17.93 18.76 090
27656 A Repair leg fascia defect 4.62 8.06 8.41 3.69 3.75 0.69 13.37 13.72 9.00 9.06 090
27658 A Repair of leg tendon, each 5.03 NA NA 3.92 4.40 0.79 NA NA 9.74 10.22 090
27659 A Repair of leg tendon, each 6.99 NA NA 4.91 5.46 1.09 NA NA 12.99 13.54 090
27664 A Repair of leg tendon, each 4.64 NA NA 3.95 4.40 0.76 NA NA 9.35 9.80 090
27665 A Repair of leg tendon, each 5.46 NA NA 4.50 4.85 0.89 NA NA 10.85 11.20 090
27675 A Repair lower leg tendons 7.24 NA NA 4.78 5.49 1.11 NA NA 13.13 13.84 090
27676 A Repair lower leg tendons 8.61 NA NA 5.80 6.51 1.37 NA NA 15.78 16.49 090
27680 A Release of lower leg tendon 5.79 NA NA 4.40 4.93 0.93 NA NA 11.12 11.65 090
27681 A Release of lower leg tendons 6.94 NA NA 4.79 5.63 1.15 NA NA 12.88 13.72 090
27685 A Revision of lower leg tendon 6.57 8.84 7.68 4.65 5.26 0.97 16.38 15.22 12.19 12.80 090
27686 A Revise lower leg tendons 7.64 NA NA 5.41 6.22 1.24 NA NA 14.29 15.10 090
27687 A Revision of calf tendon 6.30 NA NA 4.56 5.12 1.00 NA NA 11.86 12.42 090
27690 A Revise lower leg tendon 8.96 NA NA 5.53 6.15 1.33 NA NA 15.82 16.44 090
27691 A Revise lower leg tendon 10.28 NA NA 6.76 7.51 1.64 NA NA 18.68 19.43 090
27692 A Revise additional leg tendon 1.87 NA NA 0.73 0.88 0.32 NA NA 2.92 3.07 ZZZ
27695 A Repair of ankle ligament 6.58 NA NA 5.03 5.66 1.05 NA NA 12.66 13.29 090
27696 A Repair of ankle ligaments 8.46 NA NA 5.47 6.19 1.28 NA NA 15.21 15.93 090
27698 A Repair of ankle ligament 9.49 NA NA 5.97 6.70 1.47 NA NA 16.93 17.66 090
27700 A Revision of ankle joint 9.54 NA NA 5.21 5.56 1.30 NA NA 16.05 16.40 090
27702 A Reconstruct ankle joint 14.28 NA NA 8.77 10.04 2.38 NA NA 25.43 26.70 090
27703 A Reconstruction, ankle joint 16.79 NA NA 9.95 10.91 2.77 NA NA 29.51 30.47 090
27704 A Removal of ankle implant 7.69 NA NA 5.72 5.62 1.27 NA NA 14.68 14.58 090
27705 A Incision of tibia 10.74 NA NA 6.95 7.87 1.81 NA NA 19.50 20.42 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27707 A Incision of fibula 4.67 NA NA 4.51 4.83 0.76 NA NA 9.94 10.26 090
27709 A Incision of tibia fibula 17.32 NA NA 9.99 8.60 1.74 NA NA 29.05 27.66 090
27712 A Realignment of lower leg 15.67 NA NA 9.23 10.36 2.48 NA NA 27.38 28.51 090
27715 A Revision of lower leg 15.36 NA NA 9.06 10.34 2.50 NA NA 26.92 28.20 090
27720 A Repair of tibia 12.22 NA NA 8.00 9.05 2.05 NA NA 22.27 23.32 090
27722 A Repair/graft of tibia 12.31 NA NA 8.10 8.87 2.06 NA NA 22.47 23.24 090
27724 A Repair/graft of tibia 19.18 NA NA 10.38 11.87 3.17 NA NA 32.73 34.22 090
27725 A Repair of lower leg 17.15 NA NA 10.63 11.59 2.72 NA NA 30.50 31.46 090
27727 A Repair of lower leg 14.69 NA NA 8.65 9.92 2.44 NA NA 25.78 27.05 090
27730 A Repair of tibia epiphysis 7.59 NA NA 5.32 6.15 1.73 NA NA 14.64 15.47 090
27732 A Repair of fibula epiphysis 5.37 NA NA 4.69 4.87 0.77 NA NA 10.83 11.01 090
27734 A Repair lower leg epiphyses 8.72 NA NA 6.22 6.27 1.35 NA NA 16.29 16.34 090
27740 A Repair of leg epiphyses 9.49 NA NA 6.67 7.66 1.62 NA NA 17.78 18.77 090
27742 A Repair of leg epiphyses 10.49 NA NA 5.93 5.65 1.80 NA NA 18.22 17.94 090
27745 A Reinforce tibia 10.37 NA NA 7.04 7.89 1.76 NA NA 19.17 20.02 090
27750 A Treatment of tibia fracture 3.26 4.32 4.65 3.74 3.82 0.55 8.13 8.46 7.55 7.63 090
27752 A Treatment of tibia fracture 6.15 5.98 6.48 5.15 5.54 1.01 13.14 13.64 12.31 12.70 090
27756 A Treatment of tibia fracture 7.33 NA NA 5.78 6.29 1.17 NA NA 14.28 14.79 090
27758 A Treatment of tibia fracture 12.40 NA NA 8.09 8.91 2.04 NA NA 22.53 23.35 090
27759 A Treatment of tibia fracture 14.31 NA NA 8.76 9.92 2.39 NA NA 25.46 26.62 090
27760 A Treatment of ankle fracture 3.09 4.29 4.58 3.69 3.62 0.48 7.86 8.15 7.26 7.19 090
27762 A Treatment of ankle fracture 5.33 5.58 6.14 4.76 5.14 0.85 11.76 12.32 10.94 11.32 090
27766 A Treatment of ankle fracture 8.73 NA NA 6.31 6.99 1.44 NA NA 16.48 17.16 090
27780 A Treatment of fibula fracture 2.72 3.89 4.11 3.33 3.24 0.41 7.02 7.24 6.46 6.37 090
27781 A Treatment of fibula fracture 4.47 4.97 5.36 4.35 4.57 0.73 10.17 10.56 9.55 9.77 090
27784 A Treatment of fibula fracture 7.41 NA NA 5.63 6.26 1.23 NA NA 14.27 14.90 090
27786 A Treatment of ankle fracture 2.91 4.06 4.36 3.44 3.36 0.46 7.43 7.73 6.81 6.73 090
27788 A Treatment of ankle fracture 4.52 5.00 5.48 4.28 4.56 0.74 10.26 10.74 9.54 9.82 090
27792 A Treatment of ankle fracture 7.91 NA NA 5.97 6.71 1.32 NA NA 15.20 15.94 090
27808 A Treatment of ankle fracture 2.91 4.39 4.70 3.71 3.70 0.46 7.76 8.07 7.08 7.07 090
27810 A Treatment of ankle fracture 5.20 5.46 6.05 4.61 5.02 0.82 11.48 12.07 10.63 11.04 090
27814 A Treatment of ankle fracture 11.10 NA NA 7.31 8.25 1.86 NA NA 20.27 21.21 090
27816 A Treatment of ankle fracture 2.96 4.02 4.29 3.36 3.40 0.43 7.41 7.68 6.75 6.79 090
27818 A Treatment of ankle fracture 5.57 5.44 6.14 4.48 5.00 0.82 11.83 12.53 10.87 11.39 090
27822 A Treatment of ankle fracture 12.12 NA NA 8.89 10.21 1.92 NA NA 22.93 24.25 090
27823 A Treatment of ankle fracture 14.26 NA NA 9.54 10.99 2.26 NA NA 26.06 27.51 090
27824 A Treat lower leg fracture 3.20 3.74 3.98 3.55 3.56 0.45 7.39 7.63 7.20 7.21 090
27825 A Treat lower leg fracture 6.60 5.88 6.42 4.86 5.25 1.02 13.50 14.04 12.48 12.87 090
27826 A Treat lower leg fracture 8.97 NA NA 7.03 8.37 1.47 NA NA 17.47 18.81 090
27827 A Treat lower leg fracture 15.75 NA NA 10.85 12.28 2.44 NA NA 29.04 30.47 090
27828 A Treat lower leg fracture 18.19 NA NA 12.39 13.55 2.82 NA NA 33.40 34.56 090
27829 A Treat lower leg joint 5.68 NA NA 5.53 6.47 0.95 NA NA 12.16 13.10 090
27830 A Treat lower leg dislocation 3.85 4.31 4.37 3.76 3.83 0.54 8.70 8.76 8.15 8.22 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
27831 A Treat lower leg dislocation 4.62 NA NA 4.01 4.35 0.73 NA NA 9.36 9.70 090
27832 A Treat lower leg dislocation 6.67 NA NA 4.77 5.82 1.03 NA NA 12.47 13.52 090
27840 A Treat ankle dislocation 4.65 NA NA 3.64 3.73 0.46 NA NA 8.75 8.84 090
27842 A Treat ankle dislocation 6.34 NA NA 4.92 5.07 1.00 NA NA 12.26 12.41 090
27846 A Treat ankle dislocation 10.16 NA NA 6.90 7.67 1.71 NA NA 18.77 19.54 090
27848 A Treat ankle dislocation 11.56 NA NA 7.75 9.22 1.95 NA NA 21.26 22.73 090
27860 A Fixation of ankle joint 2.36 NA NA 1.70 1.91 0.39 NA NA 4.45 4.66 010
27870 A Fusion of ankle joint, open 15.21 NA NA 9.24 10.20 2.37 NA NA 26.82 27.78 090
27871 A Fusion of tibiofibular joint 9.42 NA NA 6.55 7.32 1.59 NA NA 17.56 18.33 090
27880 A Amputation of lower leg 15.24 NA NA 6.77 7.04 1.76 NA NA 23.77 24.04 090
27881 A Amputation of lower leg 13.32 NA NA 7.47 8.50 1.99 NA NA 22.78 23.81 090
27882 A Amputation of lower leg 9.67 NA NA 5.52 6.24 1.29 NA NA 16.48 17.20 090
27884 A Amputation follow-up surgery 8.64 NA NA 5.10 5.59 1.22 NA NA 14.96 15.45 090
27886 A Amputation follow-up surgery 9.88 NA NA 5.75 6.32 1.40 NA NA 17.03 17.60 090
27888 A Amputation of foot at ankle 10.23 NA NA 6.27 7.19 1.51 NA NA 18.01 18.93 090
27889 A Amputation of foot at ankle 10.72 NA NA 5.33 6.19 1.46 NA NA 17.51 18.37 090
27892 A Decompression of leg 7.82 NA NA 4.87 5.41 1.10 NA NA 13.79 14.33 090
27893 A Decompression of leg 7.78 NA NA 5.14 5.38 1.10 NA NA 14.02 14.26 090
27894 A Decompression of leg 12.42 NA NA 7.38 7.67 1.65 NA NA 21.45 21.74 090
27899 C Leg/ankle surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
28001 A Drainage of bursa of foot 2.75 4.05 3.25 1.65 1.88 0.33 7.13 6.33 4.73 4.96 010
28002 A Treatment of foot infection 5.78 6.78 5.44 3.66 3.74 0.61 13.17 11.83 10.05 10.13 010
28003 A Treatment of foot infection 8.95 7.88 6.64 4.67 5.08 1.12 17.95 16.71 14.74 15.15 090
28005 A Treat foot bone lesion 9.30 NA NA 5.55 5.92 1.16 NA NA 16.01 16.38 090
28008 A Incision of foot fascia 4.50 6.24 4.97 3.06 3.17 0.57 11.31 10.04 8.13 8.24 090
28010 A Incision of toe tendon 2.89 2.90 2.50 2.38 2.37 0.36 6.15 5.75 5.63 5.62 090
28011 A Incision of toe tendons 4.19 3.86 3.44 3.09 3.25 0.59 8.64 8.22 7.87 8.03 090
28020 A Exploration of foot joint 5.06 7.57 6.40 3.71 4.03 0.72 13.35 12.18 9.49 9.81 090
28022 A Exploration of foot joint 4.72 6.95 5.63 3.37 3.73 0.62 12.29 10.97 8.71 9.07 090
28024 A Exploration of toe joint 4.43 6.71 5.59 3.22 3.75 0.58 11.72 10.60 8.23 8.76 090
28035 A Decompression of tibia nerve 5.14 7.51 6.27 3.71 4.00 0.70 13.35 12.11 9.55 9.84 090
28043 A Excision of foot lesion 3.58 4.85 4.07 2.79 3.08 0.46 8.89 8.11 6.83 7.12 090
28045 A Excision of foot lesion 4.77 7.13 5.81 3.33 3.53 0.63 12.53 11.21 8.73 8.93 090
28046 A Resection of tumor, foot 10.55 10.52 9.20 5.91 6.33 1.36 22.43 21.11 17.82 18.24 090
28050 A Biopsy of foot joint lining 4.30 6.92 5.40 3.30 3.52 0.60 11.82 10.30 8.20 8.42 090
28052 A Biopsy of foot joint lining 3.98 6.47 5.30 2.98 3.32 0.53 10.98 9.81 7.49 7.83 090
28054 A Biopsy of toe joint lining 3.49 6.25 5.10 2.81 3.13 0.46 10.20 9.05 6.76 7.08 090
28055 A Neurectomy, foot 6.20 NA NA 3.53 3.62 0.74 NA NA 10.47 10.56 090
28060 A Partial removal, foot fascia 5.29 7.20 5.90 3.64 3.81 0.70 13.19 11.89 9.63 9.80 090
28062 A Removal of foot fascia 6.58 7.94 6.87 3.92 3.99 0.83 15.35 14.28 11.33 11.40 090
28070 A Removal of foot joint lining 5.15 7.28 5.73 3.52 3.74 0.73 13.16 11.61 9.40 9.62 090
28072 A Removal of foot joint lining 4.63 7.64 6.05 3.67 4.14 0.68 12.95 11.36 8.98 9.45 090
28080 A Removal of foot lesion 4.65 7.74 5.77 4.26 3.83 0.47 12.86 10.89 9.38 8.95 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
28086 A Excise foot tendon sheath 4.83 7.83 7.94 3.82 4.47 0.76 13.42 13.53 9.41 10.06 090
28088 A Excise foot tendon sheath 3.90 7.00 6.06 3.21 3.72 0.61 11.51 10.57 7.72 8.23 090
28090 A Removal of foot lesion 4.46 6.84 5.57 3.24 3.40 0.59 11.89 10.62 8.29 8.45 090
28092 A Removal of toe lesions 3.69 6.55 5.55 3.05 3.40 0.49 10.73 9.73 7.23 7.58 090
28100 A Removal of ankle/heel lesion 5.72 8.25 8.03 4.12 4.55 0.82 14.79 14.57 10.66 11.09 090
28102 A Remove/graft foot lesion 7.80 NA NA 5.01 5.71 1.14 NA NA 13.95 14.65 090
28103 A Remove/graft foot lesion 6.56 NA NA 4.22 4.51 0.91 NA NA 11.69 11.98 090
28104 A Removal of foot lesion 5.17 7.30 5.94 3.53 3.82 0.70 13.17 11.81 9.40 9.69 090
28106 A Remove/graft foot lesion 7.23 NA NA 4.52 4.45 0.97 NA NA 12.72 12.65 090
28107 A Remove/graft foot lesion 5.62 7.90 6.87 3.80 4.10 0.74 14.26 13.23 10.16 10.46 090
28108 A Removal of toe lesions 4.21 6.43 5.05 3.05 3.20 0.53 11.17 9.79 7.79 7.94 090
28110 A Part removal of metatarsal 4.13 7.02 5.66 3.13 3.20 0.54 11.69 10.33 7.80 7.87 090
28111 A Part removal of metatarsal 5.06 7.37 6.55 3.36 3.58 0.67 13.10 12.28 9.09 9.31 090
28112 A Part removal of metatarsal 4.54 7.30 6.18 3.33 3.51 0.61 12.45 11.33 8.48 8.66 090
28113 A Part removal of metatarsal 5.88 8.50 6.66 4.72 4.41 0.63 15.01 13.17 11.23 10.92 090
28114 A Removal of metatarsal heads 11.61 13.43 12.07 8.37 8.37 1.42 26.46 25.10 21.40 21.40 090
28116 A Revision of foot 8.94 9.60 7.49 5.47 5.25 1.03 19.57 17.46 15.44 15.22 090
28118 A Removal of heel bone 6.02 8.00 6.68 4.09 4.28 0.84 14.86 13.54 10.95 11.14 090
28119 A Removal of heel spur 5.45 7.30 5.89 3.65 3.70 0.70 13.45 12.04 9.80 9.85 090
28120 A Part removal of ankle/heel 5.64 8.14 7.50 4.02 4.31 0.77 14.55 13.91 10.43 10.72 090
28122 A Partial removal of foot bone 7.56 8.60 7.27 4.89 5.17 0.98 17.14 15.81 13.43 13.71 090
28124 A Partial removal of toe 4.88 6.85 5.46 3.52 3.62 0.60 12.33 10.94 9.00 9.10 090
28126 A Partial removal of toe 3.56 6.01 4.66 2.70 2.92 0.45 10.02 8.67 6.71 6.93 090
28130 A Removal of ankle bone 9.30 NA NA 5.96 6.52 1.26 NA NA 16.52 17.08 090
28140 A Removal of metatarsal 7.03 7.91 7.39 4.20 4.62 0.92 15.86 15.34 12.15 12.57 090
28150 A Removal of toe 4.14 6.47 5.24 3.06 3.23 0.53 11.14 9.91 7.73 7.90 090
28153 A Partial removal of toe 3.71 6.24 4.79 2.93 2.74 0.47 10.42 8.97 7.11 6.92 090
28160 A Partial removal of toe 3.79 6.42 5.03 3.00 3.25 0.49 10.70 9.31 7.28 7.53 090
28171 A Extensive foot surgery 9.85 NA NA 5.43 5.42 1.33 NA NA 16.61 16.60 090
28173 A Extensive foot surgery 9.05 8.89 7.92 4.75 5.08 1.12 19.06 18.09 14.92 15.25 090
28175 A Extensive foot surgery 6.17 7.22 6.08 3.70 3.70 0.73 14.12 12.98 10.60 10.60 090
28190 A Removal of foot foreign body 1.98 4.03 3.55 1.36 1.45 0.22 6.23 5.75 3.56 3.65 010
28192 A Removal of foot foreign body 4.69 6.80 5.80 3.26 3.55 0.61 12.10 11.10 8.56 8.85 090
28193 A Removal of foot foreign body 5.79 7.40 6.05 3.69 3.86 0.73 13.92 12.57 10.21 10.38 090
28200 A Repair of foot tendon 4.65 6.95 5.56 3.29 3.49 0.61 12.21 10.82 8.55 8.75 090
28202 A Repair/graft of foot tendon 6.96 8.05 7.42 4.14 4.40 0.91 15.92 15.29 12.01 12.27 090
28208 A Repair of foot tendon 4.42 6.73 5.29 3.23 3.28 0.58 11.73 10.29 8.23 8.28 090
28210 A Repair/graft of foot tendon 6.41 7.61 6.56 3.96 4.01 0.81 14.83 13.78 11.18 11.23 090
28220 A Release of foot tendon 4.58 6.47 5.12 3.13 3.35 0.57 11.62 10.27 8.28 8.50 090
28222 A Release of foot tendons 5.67 6.97 5.67 3.39 3.94 0.69 13.33 12.03 9.75 10.30 090
28225 A Release of foot tendon 3.70 6.09 4.73 2.78 2.87 0.46 10.25 8.89 6.94 7.03 090
28226 A Release of foot tendons 4.58 7.03 5.35 3.36 3.65 0.58 12.19 10.51 8.52 8.81 090
28230 A Incision of foot tendon(s) 4.28 6.35 5.09 2.94 3.49 0.55 11.18 9.92 7.77 8.32 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
28232 A Incision of toe tendon 3.43 5.99 4.89 2.72 3.16 0.44 9.86 8.76 6.59 7.03 090
28234 A Incision of foot tendon 3.43 6.33 5.09 3.09 3.29 0.44 10.20 8.96 6.96 7.16 090
28238 A Revision of foot tendon 7.85 8.43 7.54 4.43 4.81 1.06 17.34 16.45 13.34 13.72 090
28240 A Release of big toe 4.40 6.48 5.09 3.04 3.37 0.58 11.46 10.07 8.02 8.35 090
28250 A Revision of foot fascia 5.97 7.50 6.09 3.82 4.05 0.82 14.29 12.88 10.61 10.84 090
28260 A Release of midfoot joint 8.08 8.68 6.91 4.79 4.94 1.14 17.90 16.13 14.01 14.16 090
28261 A Revision of foot tendon 12.91 10.85 9.17 6.50 7.10 1.57 25.33 23.65 20.98 21.58 090
28262 A Revision of foot and ankle 17.01 15.61 14.07 9.85 10.65 2.60 35.22 33.68 29.46 30.26 090
28264 A Release of midfoot joint 10.53 10.49 8.42 6.11 6.99 1.54 22.56 20.49 18.18 19.06 090
28270 A Release of foot contracture 4.82 6.99 5.42 3.51 3.68 0.62 12.43 10.86 8.95 9.12 090
28272 A Release of toe joint, each 3.84 5.89 4.61 2.70 2.81 0.46 10.19 8.91 7.00 7.11 090
28280 A Fusion of toes 5.24 7.41 6.53 3.63 4.27 0.73 13.38 12.50 9.60 10.24 090
28285 A Repair of hammertoe 4.65 6.78 5.34 3.41 3.42 0.59 12.02 10.58 8.65 8.66 090
28286 A Repair of hammertoe 4.61 6.56 5.23 3.10 3.21 0.57 11.74 10.41 8.28 8.39 090
28288 A Partial removal of foot bone 5.81 8.70 6.62 4.78 4.86 0.65 15.16 13.08 11.24 11.32 090
28289 A Repair hallux rigidus 8.11 9.53 8.37 5.44 5.68 1.02 18.66 17.50 14.57 14.81 090
28290 A Correction of bunion 5.72 8.24 6.75 4.02 4.55 0.82 14.78 13.29 10.56 11.09 090
28292 A Correction of bunion 8.72 10.46 8.21 6.27 5.72 0.91 20.09 17.84 15.90 15.35 090
28293 A Correction of bunion 11.10 14.65 11.72 7.07 6.34 1.13 26.88 23.95 19.30 18.57 090
28294 A Correction of bunion 8.63 9.22 7.88 4.68 4.70 1.09 18.94 17.60 14.40 14.42 090
28296 A Correction of bunion 9.31 9.71 8.54 4.91 5.29 1.19 20.21 19.04 15.41 15.79 090
28297 A Correction of bunion 9.31 10.52 9.34 5.41 6.04 1.32 21.15 19.97 16.04 16.67 090
28298 A Correction of bunion 8.01 9.32 7.74 4.65 4.91 1.05 18.38 16.80 13.71 13.97 090
28299 A Correction of bunion 11.39 10.68 9.24 5.86 6.01 1.37 23.44 22.00 18.62 18.77 090
28300 A Incision of heel bone 9.61 NA NA 6.15 6.81 1.54 NA NA 17.30 17.96 090
28302 A Incision of ankle bone 9.62 NA NA 5.81 6.61 1.42 NA NA 16.85 17.65 090
28304 A Incision of midfoot bones 9.29 9.61 8.36 5.16 5.59 1.27 20.17 18.92 15.72 16.15 090
28305 A Incise/graft midfoot bones 10.63 NA NA 5.70 6.47 1.27 NA NA 17.60 18.37 090
28306 A Incision of metatarsal 5.91 8.39 7.22 3.91 4.11 0.84 15.14 13.97 10.66 10.86 090
28307 A Incision of metatarsal 6.39 9.55 10.65 4.51 5.09 0.90 16.84 17.94 11.80 12.38 090
28308 A Incision of metatarsal 5.36 7.96 6.30 3.88 3.73 0.70 14.02 12.36 9.94 9.79 090
28309 A Incision of metatarsals 13.96 NA NA 7.85 7.93 2.05 NA NA 23.86 23.94 090
28310 A Revision of big toe 5.48 7.57 6.20 3.46 3.53 0.70 13.75 12.38 9.64 9.71 090
28312 A Revision of toe 4.60 7.42 5.93 3.28 3.54 0.63 12.65 11.16 8.51 8.77 090
28313 A Repair deformity of toe 5.06 7.39 5.80 3.70 4.55 0.73 13.18 11.59 9.49 10.34 090
28315 A Removal of sesamoid bone 4.91 6.76 5.36 3.30 3.32 0.63 12.30 10.90 8.84 8.86 090
28320 A Repair of foot bones 9.25 NA NA 5.83 6.49 1.43 NA NA 16.51 17.17 090
28322 A Repair of metatarsals 8.41 10.03 9.39 5.53 6.13 1.27 19.71 19.07 15.21 15.81 090
28340 A Resect enlarged toe tissue 7.04 8.13 6.86 4.14 4.22 0.84 16.01 14.74 12.02 12.10 090
28341 A Resect enlarged toe 8.60 8.75 7.39 4.55 4.75 1.01 18.36 17.00 14.16 14.36 090
28344 A Repair extra toe(s) 4.31 6.80 6.01 3.20 3.52 0.51 11.62 10.83 8.02 8.34 090
28345 A Repair webbed toe(s) 5.98 7.83 6.60 3.94 4.50 0.80 14.61 13.38 10.72 11.28 090
28360 A Reconstruct cleft foot 14.67 NA NA 6.32 9.45 2.29 NA NA 23.28 26.41 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
28400 A Treatment of heel fracture 2.22 3.39 3.57 2.94 3.02 0.35 5.96 6.14 5.51 5.59 090
28405 A Treatment of heel fracture 4.63 4.55 4.76 3.79 4.41 0.73 9.91 10.12 9.15 9.77 090
28406 A Treatment of heel fracture 6.44 NA NA 5.70 6.52 1.11 NA NA 13.25 14.07 090
28415 A Treat heel fracture 17.54 NA NA 10.98 12.71 2.67 NA NA 31.19 32.92 090
28420 A Treat/graft heel fracture 17.07 NA NA 10.26 12.25 2.81 NA NA 30.14 32.13 090
28430 A Treatment of ankle fracture 2.14 3.14 3.33 2.59 2.57 0.31 5.59 5.78 5.04 5.02 090
28435 A Treatment of ankle fracture 3.45 3.78 3.86 3.09 3.58 0.55 7.78 7.86 7.09 7.58 090
28436 A Treatment of ankle fracture 4.78 NA NA 5.01 5.69 0.81 NA NA 10.60 11.28 090
28445 A Treat ankle fracture 17.07 NA NA 9.80 10.72 2.59 NA NA 29.46 30.38 090
28450 A Treat midfoot fracture, each 1.95 2.94 3.07 2.44 2.46 0.28 5.17 5.30 4.67 4.69 090
28455 A Treat midfoot fracture, each 3.15 3.70 3.49 3.07 3.33 0.44 7.29 7.08 6.66 6.92 090
28456 A Treat midfoot fracture 2.75 NA NA 3.63 4.02 0.44 NA NA 6.82 7.21 090
28465 A Treat midfoot fracture, each 7.13 NA NA 5.10 6.01 1.10 NA NA 13.33 14.24 090
28470 A Treat metatarsal fracture 1.99 2.82 3.05 2.38 2.43 0.30 5.11 5.34 4.67 4.72 090
28475 A Treat metatarsal fracture 2.97 3.18 3.29 2.56 3.05 0.44 6.59 6.70 5.97 6.46 090
28476 A Treat metatarsal fracture 3.46 NA NA 4.36 4.83 0.54 NA NA 8.36 8.83 090
28485 A Treat metatarsal fracture 5.77 NA NA 4.60 5.23 0.83 NA NA 11.20 11.83 090
28490 A Treat big toe fracture 1.12 2.11 2.04 1.69 1.65 0.14 3.37 3.30 2.95 2.91 090
28495 A Treat big toe fracture 1.62 2.49 2.25 1.89 2.02 0.20 4.31 4.07 3.71 3.84 090
28496 A Treat big toe fracture 2.39 7.19 7.99 2.91 3.12 0.36 9.94 10.74 5.66 5.87 090
28505 A Treat big toe fracture 3.86 7.51 7.95 3.30 3.75 0.56 11.93 12.37 7.72 8.17 090
28510 A Treatment of toe fracture 1.12 1.69 1.57 1.62 1.55 0.14 2.95 2.83 2.88 2.81 090
28515 A Treatment of toe fracture 1.50 2.26 1.98 1.85 1.88 0.18 3.94 3.66 3.53 3.56 090
28525 A Treat toe fracture 3.37 6.89 7.36 2.93 3.31 0.49 10.75 11.22 6.79 7.17 090
28530 A Treat sesamoid bone fracture 1.08 1.65 1.49 1.36 1.42 0.14 2.87 2.71 2.58 2.64 090
28531 A Treat sesamoid bone fracture 2.51 5.84 6.91 2.15 2.08 0.34 8.69 9.76 5.00 4.93 090
28540 A Treat foot dislocation 2.10 2.80 2.50 2.35 2.39 0.26 5.16 4.86 4.71 4.75 090
28545 A Treat foot dislocation 2.51 3.33 2.59 2.74 2.44 0.37 6.21 5.47 5.62 5.32 090
28546 A Treat foot dislocation 3.28 7.67 7.10 3.48 4.16 0.52 11.47 10.90 7.28 7.96 090
28555 A Repair foot dislocation 6.42 9.82 9.88 5.00 5.50 1.04 17.28 17.34 12.46 12.96 090
28570 A Treat foot dislocation 1.70 2.60 2.47 2.01 2.25 0.23 4.53 4.40 3.94 4.18 090
28575 A Treat foot dislocation 3.38 4.38 3.89 3.69 3.71 0.56 8.32 7.83 7.63 7.65 090
28576 A Treat foot dislocation 4.48 NA NA 4.03 4.14 0.69 NA NA 9.20 9.31 090
28585 A Repair foot dislocation 8.17 9.96 7.98 5.33 5.71 1.25 19.38 17.40 14.75 15.13 090
28600 A Treat foot dislocation 1.94 3.06 2.87 2.40 2.61 0.27 5.27 5.08 4.61 4.82 090
28605 A Treat foot dislocation 2.78 3.77 3.28 3.17 3.13 0.40 6.95 6.46 6.35 6.31 090
28606 A Treat foot dislocation 4.97 NA NA 4.33 4.60 0.82 NA NA 10.12 10.39 090
28615 A Repair foot dislocation 8.96 NA NA 7.02 7.79 1.30 NA NA 17.28 18.05 090
28630 A Treat toe dislocation 1.72 1.96 1.67 0.96 0.99 0.20 3.88 3.59 2.88 2.91 010
28635 A Treat toe dislocation 1.93 2.28 2.09 1.34 1.48 0.26 4.47 4.28 3.53 3.67 010
28636 A Treat toe dislocation 2.77 4.35 3.99 2.05 2.48 0.43 7.55 7.19 5.25 5.68 010
28645 A Repair toe dislocation 4.27 6.89 5.44 3.23 3.26 0.57 11.73 10.28 8.07 8.10 090
28660 A Treat toe dislocation 1.25 1.31 1.27 0.79 0.79 0.13 2.69 2.65 2.17 2.17 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
28665 A Treat toe dislocation 1.94 1.86 1.54 1.36 1.41 0.26 4.06 3.74 3.56 3.61 010
28666 A Treat toe dislocation 2.66 NA NA 1.93 2.42 0.43 NA NA 5.02 5.51 010
28675 A Repair of toe dislocation 2.97 6.70 7.03 2.88 3.23 0.45 10.12 10.45 6.30 6.65 090
28705 A Fusion of foot bones 20.12 NA NA 10.85 12.04 3.09 NA NA 34.06 35.25 090
28715 A Fusion of foot bones 14.40 NA NA 8.58 9.46 2.17 NA NA 25.15 26.03 090
28725 A Fusion of foot bones 11.97 NA NA 7.00 7.93 1.87 NA NA 20.84 21.77 090
28730 A Fusion of foot bones 12.21 NA NA 7.85 8.32 1.71 NA NA 21.77 22.24 090
28735 A Fusion of foot bones 12.03 NA NA 7.04 7.63 1.69 NA NA 20.76 21.35 090
28737 A Revision of foot bones 10.83 NA NA 6.18 6.65 1.47 NA NA 18.48 18.95 090
28740 A Fusion of foot bones 9.09 10.97 10.89 6.10 6.37 1.22 21.28 21.20 16.41 16.68 090
28750 A Fusion of big toe joint 8.37 10.88 11.65 5.99 6.49 1.13 20.38 21.15 15.49 15.99 090
28755 A Fusion of big toe joint 4.79 7.31 6.40 3.40 3.66 0.65 12.75 11.84 8.84 9.10 090
28760 A Fusion of big toe joint 8.94 10.03 8.49 5.41 5.49 1.05 20.02 18.48 15.40 15.48 090
28800 A Amputation of midfoot 8.65 NA NA 5.11 5.62 1.15 NA NA 14.91 15.42 090
28805 A Amputation thru metatarsal 12.55 NA NA 6.04 5.74 1.18 NA NA 19.77 19.47 090
28810 A Amputation toe metatarsal 6.52 NA NA 4.13 4.39 0.86 NA NA 11.51 11.77 090
28820 A Amputation of toe 4.89 7.73 7.60 3.61 3.74 0.61 13.23 13.10 9.11 9.24 090
28825 A Partial amputation of toe 3.71 7.20 7.04 3.17 3.40 0.50 11.41 11.25 7.38 7.61 090
28890 A High energy eswt, plantar f 3.36 4.79 5.48 2.34 2.15 0.41 8.56 9.25 6.11 5.92 090
28899 C Foot/toes surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
29000 A Application of body cast 2.25 4.73 3.40 1.85 1.76 0.41 7.39 6.06 4.51 4.42 000
29010 A Application of body cast 2.06 3.36 3.30 1.33 1.66 0.45 5.87 5.81 3.84 4.17 000
29015 A Application of body cast 2.41 3.36 3.07 1.49 1.57 0.28 6.05 5.76 4.18 4.26 000
29020 A Application of body cast 2.11 3.80 3.34 1.51 1.44 0.28 6.19 5.73 3.90 3.83 000
29025 A Application of body cast 2.40 3.60 3.26 1.59 1.79 0.44 6.44 6.10 4.43 4.63 000
29035 A Application of body cast 1.77 3.67 3.63 1.47 1.55 0.28 5.72 5.68 3.52 3.60 000
29040 A Application of body cast 2.22 3.61 2.75 1.50 1.51 0.36 6.19 5.33 4.08 4.09 000
29044 A Application of body cast 2.12 3.94 3.96 1.65 1.84 0.35 6.41 6.43 4.12 4.31 000
29046 A Application of body cast 2.41 4.17 3.47 1.80 2.02 0.42 7.00 6.30 4.63 4.85 000
29049 A Application of figure eight 0.89 1.12 1.26 0.60 0.55 0.13 2.14 2.28 1.62 1.57 000
29055 A Application of shoulder cast 1.78 2.90 2.96 1.31 1.43 0.30 4.98 5.04 3.39 3.51 000
29058 A Application of shoulder cast 1.31 1.25 1.48 0.69 0.71 0.17 2.73 2.96 2.17 2.19 000
29065 A Application of long arm cast 0.87 1.27 1.32 0.70 0.74 0.15 2.29 2.34 1.72 1.76 000
29075 A Application of forearm cast 0.77 1.23 1.25 0.66 0.68 0.13 2.13 2.15 1.56 1.58 000
29085 A Apply hand/wrist cast 0.87 1.26 1.28 0.69 0.65 0.14 2.27 2.29 1.70 1.66 000
29086 A Apply finger cast 0.62 1.03 0.98 0.53 0.50 0.07 1.72 1.67 1.22 1.19 000
29105 A Apply long arm splint 0.87 1.09 1.20 0.53 0.52 0.12 2.08 2.19 1.52 1.51 000
29125 A Apply forearm splint 0.59 0.96 1.01 0.43 0.40 0.07 1.62 1.67 1.09 1.06 000
29126 A Apply forearm splint 0.77 1.01 1.16 0.48 0.47 0.07 1.85 2.00 1.32 1.31 000
29130 A Application of finger splint 0.50 0.43 0.46 0.19 0.18 0.06 0.99 1.02 0.75 0.74 000
29131 A Application of finger splint 0.55 0.62 0.71 0.26 0.25 0.03 1.20 1.29 0.84 0.83 000
29200 A Strapping of chest 0.65 0.61 0.69 0.35 0.34 0.04 1.30 1.38 1.04 1.03 000
29220 A Strapping of low back 0.64 0.61 0.69 0.35 0.38 0.04 1.29 1.37 1.03 1.06 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
29240 A Strapping of shoulder 0.71 0.67 0.81 0.39 0.37 0.06 1.44 1.58 1.16 1.14 000
29260 A Strapping of elbow or wrist 0.55 0.65 0.72 0.36 0.33 0.05 1.25 1.32 0.96 0.93 000
29280 A Strapping of hand or finger 0.51 0.66 0.77 0.37 0.33 0.03 1.20 1.31 0.91 0.87 000
29305 A Application of hip cast 2.03 3.37 3.35 1.61 1.72 0.35 5.75 5.73 3.99 4.10 000
29325 A Application of hip casts 2.32 3.67 3.57 1.75 1.90 0.40 6.39 6.29 4.47 4.62 000
29345 A Application of long leg cast 1.40 1.66 1.74 0.95 1.03 0.24 3.30 3.38 2.59 2.67 000
29355 A Application of long leg cast 1.53 1.63 1.69 0.95 1.08 0.26 3.42 3.48 2.74 2.87 000
29358 A Apply long leg cast brace 1.43 2.04 2.06 0.94 1.05 0.25 3.72 3.74 2.62 2.73 000
29365 A Application of long leg cast 1.18 1.57 1.64 0.85 0.93 0.20 2.95 3.02 2.23 2.31 000
29405 A Apply short leg cast 0.86 1.20 1.22 0.66 0.70 0.14 2.20 2.22 1.66 1.70 000
29425 A Apply short leg cast 1.01 1.24 1.23 0.67 0.72 0.15 2.40 2.39 1.83 1.88 000
29435 A Apply short leg cast 1.18 1.53 1.55 0.81 0.90 0.20 2.91 2.93 2.19 2.28 000
29440 A Addition of walker to cast 0.57 0.62 0.67 0.25 0.27 0.08 1.27 1.32 0.90 0.92 000
29445 A Apply rigid leg cast 1.78 1.62 1.76 0.94 0.96 0.27 3.67 3.81 2.99 3.01 000
29450 A Application of leg cast 2.08 1.54 1.49 0.88 1.04 0.27 3.89 3.84 3.23 3.39 000
29505 A Application, long leg splint 0.69 1.06 1.15 0.45 0.45 0.08 1.83 1.92 1.22 1.22 000
29515 A Application lower leg splint 0.73 0.96 0.89 0.46 0.46 0.09 1.78 1.71 1.28 1.28 000
29520 A Strapping of hip 0.54 0.67 0.81 0.38 0.45 0.03 1.24 1.38 0.95 1.02 000
29530 A Strapping of knee 0.57 0.64 0.75 0.36 0.34 0.05 1.26 1.37 0.98 0.96 000
29540 A Strapping of ankle and/or ft 0.51 0.55 0.45 0.32 0.31 0.06 1.12 1.02 0.89 0.88 000
29550 A Strapping of toes 0.47 0.57 0.46 0.31 0.29 0.06 1.10 0.99 0.84 0.82 000
29580 A Application of paste boot 0.55 0.72 0.67 0.34 0.35 0.07 1.34 1.29 0.96 0.97 000
29590 A Application of foot splint 0.76 0.61 0.54 0.27 0.29 0.09 1.46 1.39 1.12 1.14 000
29700 A Removal/revision of cast 0.57 0.96 0.91 0.26 0.28 0.08 1.61 1.56 0.91 0.93 000
29705 A Removal/revision of cast 0.76 0.77 0.81 0.37 0.38 0.13 1.66 1.70 1.26 1.27 000
29710 A Removal/revision of cast 1.34 1.44 1.51 0.64 0.69 0.20 2.98 3.05 2.18 2.23 000
29715 A Removal/revision of cast 0.94 1.13 1.16 0.41 0.40 0.09 2.16 2.19 1.44 1.43 000
29720 A Repair of body cast 0.68 1.14 1.16 0.34 0.38 0.12 1.94 1.96 1.14 1.18 000
29730 A Windowing of cast 0.75 0.75 0.80 0.35 0.35 0.12 1.62 1.67 1.22 1.22 000
29740 A Wedging of cast 1.12 1.05 1.13 0.49 0.49 0.18 2.35 2.43 1.79 1.79 000
29750 A Wedging of clubfoot cast 1.26 0.92 1.03 0.45 0.55 0.21 2.39 2.50 1.92 2.02 000
29799 C Casting/strapping procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
29800 A Jaw arthroscopy/surgery 6.73 NA NA 4.96 6.47 0.99 NA NA 12.68 14.19 090
29804 A Jaw arthroscopy/surgery 8.71 NA NA 5.70 7.14 1.38 NA NA 15.79 17.23 090
29805 A Shoulder arthroscopy, dx 5.94 NA NA 4.75 5.44 1.02 NA NA 11.71 12.40 090
29806 A Shoulder arthroscopy/surgery 14.95 NA NA 9.45 10.73 2.50 NA NA 26.90 28.18 090
29807 A Shoulder arthroscopy/surgery 14.48 NA NA 9.32 10.57 2.42 NA NA 26.22 27.47 090
29819 A Shoulder arthroscopy/surgery 7.68 NA NA 5.68 6.51 1.32 NA NA 14.68 15.51 090
29820 A Shoulder arthroscopy/surgery 7.12 NA NA 5.22 5.97 1.22 NA NA 13.56 14.31 090
29821 A Shoulder arthroscopy/surgery 7.78 NA NA 5.70 6.53 1.33 NA NA 14.81 15.64 090
29822 A Shoulder arthroscopy/surgery 7.49 NA NA 5.63 6.43 1.28 NA NA 14.40 15.20 090
29823 A Shoulder arthroscopy/surgery 8.24 NA NA 6.09 6.94 1.41 NA NA 15.74 16.59 090
29824 A Shoulder arthroscopy/surgery 8.82 NA NA 6.59 7.30 1.42 NA NA 16.83 17.54 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
29825 A Shoulder arthroscopy/surgery 7.68 NA NA 5.69 6.49 1.32 NA NA 14.69 15.49 090
29826 A Shoulder arthroscopy/surgery 9.05 NA NA 6.25 7.21 1.55 NA NA 16.85 17.81 090
29827 A Arthroscop rotator cuff repr 15.44 NA NA 9.43 11.01 2.67 NA NA 27.54 29.12 090
29830 A Elbow arthroscopy 5.80 NA NA 4.53 5.14 0.99 NA NA 11.32 11.93 090
29834 A Elbow arthroscopy/surgery 6.33 NA NA 4.89 5.60 1.08 NA NA 12.30 13.01 090
29835 A Elbow arthroscopy/surgery 6.53 NA NA 5.01 5.66 1.13 NA NA 12.67 13.32 090
29836 A Elbow arthroscopy/surgery 7.61 NA NA 5.60 6.49 1.22 NA NA 14.43 15.32 090
29837 A Elbow arthroscopy/surgery 6.92 NA NA 5.17 5.89 1.19 NA NA 13.28 14.00 090
29838 A Elbow arthroscopy/surgery 7.77 NA NA 5.72 6.60 1.30 NA NA 14.79 15.67 090
29840 A Wrist arthroscopy 5.59 NA NA 4.66 5.16 0.84 NA NA 11.09 11.59 090
29843 A Wrist arthroscopy/surgery 6.06 NA NA 4.95 5.45 0.92 NA NA 11.93 12.43 090
29844 A Wrist arthroscopy/surgery 6.42 NA NA 4.99 5.61 1.04 NA NA 12.45 13.07 090
29845 A Wrist arthroscopy/surgery 7.58 NA NA 5.55 6.24 0.99 NA NA 14.12 14.81 090
29846 A Wrist arthroscopy/surgery 6.80 NA NA 5.14 5.82 1.07 NA NA 13.01 13.69 090
29847 A Wrist arthroscopy/surgery 7.13 NA NA 5.21 5.95 1.08 NA NA 13.42 14.16 090
29848 A Wrist endoscopy/surgery 6.24 NA NA 5.33 5.53 0.86 NA NA 12.43 12.63 090
29850 A Knee arthroscopy/surgery 8.18 NA NA 5.26 5.10 1.25 NA NA 14.69 14.53 090
29851 A Knee arthroscopy/surgery 13.08 NA NA 8.32 9.42 2.35 NA NA 23.75 24.85 090
29855 A Tibial arthroscopy/surgery 10.60 NA NA 7.38 8.42 1.85 NA NA 19.83 20.87 090
29856 A Tibial arthroscopy/surgery 14.12 NA NA 8.76 10.19 2.40 NA NA 25.28 26.71 090
29860 A Hip arthroscopy, dx 8.85 NA NA 6.25 6.78 1.36 NA NA 16.46 16.99 090
29861 A Hip arthroscopy/surgery 9.95 NA NA 6.66 7.17 1.59 NA NA 18.20 18.71 090
29862 A Hip arthroscopy/surgery 10.97 NA NA 7.64 8.33 1.62 NA NA 20.23 20.92 090
29863 A Hip arthroscopy/surgery 10.97 NA NA 7.55 8.27 1.42 NA NA 19.94 20.66 090
29866 A Autgrft implnt, knee w/scope 14.48 NA NA 9.57 10.91 2.40 NA NA 26.45 27.79 090
29867 A Allgrft implnt, knee w/scope 18.18 NA NA 11.28 12.74 2.79 NA NA 32.25 33.71 090
29868 A Meniscal trnspl, knee w/scpe 24.89 NA NA 14.00 16.09 4.36 NA NA 43.25 45.34 090
29870 A Knee arthroscopy, dx 5.11 NA NA 4.19 4.72 0.85 NA NA 10.15 10.68 090
29871 A Knee arthroscopy/drainage 6.60 NA NA 5.04 5.66 1.14 NA NA 12.78 13.40 090
29873 A Knee arthroscopy/surgery 6.09 NA NA 5.62 6.33 1.04 NA NA 12.75 13.46 090
29874 A Knee arthroscopy/surgery 7.10 NA NA 5.20 5.85 1.11 NA NA 13.41 14.06 090
29875 A Knee arthroscopy/surgery 6.36 NA NA 4.93 5.62 1.09 NA NA 12.38 13.07 090
29876 A Knee arthroscopy/surgery 8.72 NA NA 6.24 6.83 1.37 NA NA 16.33 16.92 090
29877 A Knee arthroscopy/surgery 8.15 NA NA 6.00 6.56 1.28 NA NA 15.43 15.99 090
29879 A Knee arthroscopy/surgery 8.84 NA NA 6.29 6.91 1.39 NA NA 16.52 17.14 090
29880 A Knee arthroscopy/surgery 9.30 NA NA 6.49 7.14 1.47 NA NA 17.26 17.91 090
29881 A Knee arthroscopy/surgery 8.56 NA NA 6.19 6.77 1.34 NA NA 16.09 16.67 090
29882 A Knee arthroscopy/surgery 9.45 NA NA 6.53 7.06 1.50 NA NA 17.48 18.01 090
29883 A Knee arthroscopy/surgery 11.61 NA NA 7.67 8.71 1.93 NA NA 21.21 22.25 090
29884 A Knee arthroscopy/surgery 8.13 NA NA 6.02 6.53 1.27 NA NA 15.42 15.93 090
29885 A Knee arthroscopy/surgery 10.03 NA NA 7.07 7.75 1.58 NA NA 18.68 19.36 090
29886 A Knee arthroscopy/surgery 8.34 NA NA 6.09 6.66 1.30 NA NA 15.73 16.30 090
29887 A Knee arthroscopy/surgery 9.98 NA NA 7.06 7.71 1.57 NA NA 18.61 19.26 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
29888 A Knee arthroscopy/surgery 14.14 NA NA 8.38 9.75 2.42 NA NA 24.94 26.31 090
29889 A Knee arthroscopy/surgery 17.15 NA NA 10.78 12.02 2.79 NA NA 30.72 31.96 090
29891 A Ankle arthroscopy/surgery 9.47 NA NA 6.72 7.31 1.39 NA NA 17.58 18.17 090
29892 A Ankle arthroscopy/surgery 10.07 NA NA 6.62 7.46 1.41 NA NA 18.10 18.94 090
29893 A Scope, plantar fasciotomy 6.08 8.90 6.94 4.73 4.18 0.63 15.61 13.65 11.44 10.89 090
29894 A Ankle arthroscopy/surgery 7.26 NA NA 4.74 5.29 1.15 NA NA 13.15 13.70 090
29895 A Ankle arthroscopy/surgery 7.04 NA NA 4.58 5.25 1.11 NA NA 12.73 13.40 090
29897 A Ankle arthroscopy/surgery 7.23 NA NA 4.99 5.66 1.17 NA NA 13.39 14.06 090
29898 A Ankle arthroscopy/surgery 8.38 NA NA 5.33 5.98 1.28 NA NA 14.99 15.64 090
29899 A Ankle arthroscopy/surgery 15.21 NA NA 9.34 10.24 2.41 NA NA 26.96 27.86 090
29900 A Mcp joint arthroscopy, dx 5.74 NA NA 4.80 5.60 0.94 NA NA 11.48 12.28 090
29901 A Mcp joint arthroscopy, surg 6.45 NA NA 5.57 6.09 1.06 NA NA 13.08 13.60 090
29902 A Mcp joint arthroscopy, surg 7.02 NA NA 3.68 5.83 1.12 NA NA 11.82 13.97 090
29999 C Arthroscopy of joint 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
30000 A Drainage of nose lesion 1.45 3.72 3.98 1.24 1.35 0.12 5.29 5.55 2.81 2.92 010
30020 A Drainage of nose lesion 1.45 3.87 3.42 1.28 1.42 0.12 5.44 4.99 2.85 2.99 010
30100 A Intranasal biopsy 0.94 2.42 2.08 0.70 0.79 0.07 3.43 3.09 1.71 1.80 000
30110 A Removal of nose polyp(s) 1.65 3.64 3.34 1.34 1.51 0.14 5.43 5.13 3.13 3.30 010
30115 A Removal of nose polyp(s) 4.38 NA NA 5.51 5.70 0.41 NA NA 10.30 10.49 090
30117 A Removal of intranasal lesion 3.20 16.92 14.09 4.55 4.61 0.26 20.38 17.55 8.01 8.07 090
30118 A Removal of intranasal lesion 9.81 NA NA 7.85 8.86 0.78 NA NA 18.44 19.45 090
30120 A Revision of nose 5.31 6.92 6.60 4.97 5.74 0.52 12.75 12.43 10.80 11.57 090
30124 A Removal of nose lesion 3.14 NA NA 3.66 3.62 0.25 NA NA 7.05 7.01 090
30125 A Removal of nose lesion 7.21 NA NA 7.03 8.00 0.63 NA NA 14.87 15.84 090
30130 A Excise inferior turbinate 3.41 NA NA 5.31 5.52 0.31 NA NA 9.03 9.24 090
30140 A Resect inferior turbinate 3.48 NA NA 6.58 6.29 0.35 NA NA 10.41 10.12 090
30150 A Partial removal of nose 9.44 NA NA 8.64 10.42 0.93 NA NA 19.01 20.79 090
30160 A Removal of nose 9.88 NA NA 8.21 9.71 0.88 NA NA 18.97 20.47 090
30200 A Injection treatment of nose 0.78 1.88 1.69 0.62 0.71 0.06 2.72 2.53 1.46 1.55 000
30210 A Nasal sinus therapy 1.10 2.32 2.16 1.17 1.28 0.09 3.51 3.35 2.36 2.47 010
30220 A Insert nasal septal button 1.56 5.41 4.53 1.31 1.48 0.12 7.09 6.21 2.99 3.16 010
30300 A Remove nasal foreign body 1.06 4.13 4.51 1.79 1.88 0.08 5.27 5.65 2.93 3.02 010
30310 A Remove nasal foreign body 1.98 NA NA 2.73 3.01 0.16 NA NA 4.87 5.15 010
30320 A Remove nasal foreign body 4.56 NA NA 5.98 6.78 0.39 NA NA 10.93 11.73 090
30400 R Reconstruction of nose 10.58 NA NA 13.80 15.07 1.04 NA NA 25.42 26.69 090
30410 R Reconstruction of nose 13.72 NA NA 14.43 17.39 1.42 NA NA 29.57 32.53 090
30420 R Reconstruction of nose 16.62 NA NA 14.89 17.16 1.46 NA NA 32.97 35.24 090
30430 R Revision of nose 7.96 NA NA 12.87 15.23 0.77 NA NA 21.60 23.96 090
30435 R Revision of nose 12.45 NA NA 14.86 18.23 1.22 NA NA 28.53 31.90 090
30450 R Revision of nose 19.38 NA NA 16.36 20.51 1.97 NA NA 37.71 41.86 090
30460 A Revision of nose 10.24 NA NA 7.24 9.27 1.03 NA NA 18.51 20.54 090
30462 A Revision of nose 20.12 NA NA 14.54 18.82 2.54 NA NA 37.20 41.48 090
30465 A Repair nasal stenosis 12.20 NA NA 10.39 11.58 1.06 NA NA 23.65 24.84 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
30520 A Repair of nasal septum 6.85 NA NA 7.42 6.85 0.46 NA NA 14.73 14.16 090
30540 A Repair nasal defect 7.81 NA NA 7.06 8.72 0.67 NA NA 15.54 17.20 090
30545 A Repair nasal defect 11.50 NA NA 10.15 11.46 1.71 NA NA 23.36 24.67 090
30560 A Release of nasal adhesions 1.28 4.94 4.81 1.88 2.07 0.10 6.32 6.19 3.26 3.45 010
30580 A Repair upper jaw fistula 6.76 8.19 7.88 4.75 5.53 0.89 15.84 15.53 12.40 13.18 090
30600 A Repair mouth/nose fistula 6.07 7.52 7.52 4.10 4.79 0.70 14.29 14.29 10.87 11.56 090
30620 A Intranasal reconstruction 6.04 NA NA 8.15 8.66 0.57 NA NA 14.76 15.27 090
30630 A Repair nasal septum defect 7.18 NA NA 7.13 7.75 0.61 NA NA 14.92 15.54 090
30801 A Ablate inf turbinate, superf 1.11 4.02 4.10 1.97 1.93 0.09 5.22 5.30 3.17 3.13 010
30802 A Cauterization, inner nose 2.05 4.62 4.61 2.32 2.35 0.16 6.83 6.82 4.53 4.56 010
30901 A Control of nosebleed 1.21 1.21 1.32 0.29 0.31 0.11 2.53 2.64 1.61 1.63 000
30903 A Control of nosebleed 1.54 3.08 2.80 0.39 0.47 0.13 4.75 4.47 2.06 2.14 000
30905 A Control of nosebleed 1.97 3.73 3.57 0.48 0.69 0.17 5.87 5.71 2.62 2.83 000
30906 A Repeat control of nosebleed 2.45 3.98 3.91 0.68 1.07 0.20 6.63 6.56 3.33 3.72 000
30915 A Ligation, nasal sinus artery 7.36 NA NA 5.88 6.49 0.58 NA NA 13.82 14.43 090
30920 A Ligation, upper jaw artery 11.03 NA NA 8.23 8.79 0.80 NA NA 20.06 20.62 090
30930 A Ther fx, nasal inf turbinate 1.28 NA NA 1.53 1.60 0.12 NA NA 2.93 3.00 010
30999 C Nasal surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
31000 A Irrigation, maxillary sinus 1.17 3.01 2.88 1.25 1.36 0.09 4.27 4.14 2.51 2.62 010
31002 A Irrigation, sphenoid sinus 1.93 NA NA 2.52 3.06 0.15 NA NA 4.60 5.14 010
31020 A Exploration, maxillary sinus 2.99 8.07 8.42 5.19 5.18 0.29 11.35 11.70 8.47 8.46 090
31030 A Exploration, maxillary sinus 5.95 9.79 11.07 6.05 6.51 0.60 16.34 17.62 12.60 13.06 090
31032 A Explore sinus, remove polyps 6.61 NA NA 6.53 7.06 0.59 NA NA 13.73 14.26 090
31040 A Exploration behind upper jaw 9.66 NA NA 7.30 9.19 0.87 NA NA 17.83 19.72 090
31050 A Exploration, sphenoid sinus 5.31 NA NA 6.17 6.31 0.49 NA NA 11.97 12.11 090
31051 A Sphenoid sinus surgery 7.16 NA NA 7.74 8.12 0.62 NA NA 15.52 15.90 090
31070 A Exploration of frontal sinus 4.32 NA NA 5.73 5.88 0.38 NA NA 10.43 10.58 090
31075 A Exploration of frontal sinus 9.40 NA NA 8.59 9.45 0.75 NA NA 18.74 19.60 090
31080 A Removal of frontal sinus 12.54 NA NA 10.47 12.77 1.23 NA NA 24.24 26.54 090
31081 A Removal of frontal sinus 13.99 NA NA 14.79 14.20 2.47 NA NA 31.25 30.66 090
31084 A Removal of frontal sinus 14.75 NA NA 11.98 13.12 1.19 NA NA 27.92 29.06 090
31085 A Removal of frontal sinus 15.44 NA NA 13.04 13.73 1.73 NA NA 30.21 30.90 090
31086 A Removal of frontal sinus 14.16 NA NA 11.82 12.92 1.07 NA NA 27.05 28.15 090
31087 A Removal of frontal sinus 14.39 NA NA 10.83 12.11 1.44 NA NA 26.66 27.94 090
31090 A Exploration of sinuses 10.88 NA NA 12.38 12.51 0.94 NA NA 24.20 24.33 090
31200 A Removal of ethmoid sinus 5.03 NA NA 7.45 8.77 0.29 NA NA 12.77 14.09 090
31201 A Removal of ethmoid sinus 8.49 NA NA 8.32 8.96 0.82 NA NA 17.63 18.27 090
31205 A Removal of ethmoid sinus 10.47 NA NA 9.59 11.31 0.67 NA NA 20.73 22.45 090
31225 A Removal of upper jaw 26.44 NA NA 16.55 17.50 1.59 NA NA 44.58 45.53 090
31230 A Removal of upper jaw 30.56 NA NA 17.27 18.84 1.78 NA NA 49.61 51.18 090
31231 A Nasal endoscopy, dx 1.10 3.34 3.37 0.70 0.84 0.09 4.53 4.56 1.89 2.03 000
31233 A Nasal/sinus endoscopy, dx 2.18 3.95 4.21 1.02 1.37 0.20 6.33 6.59 3.40 3.75 000
31235 A Nasal/sinus endoscopy, dx 2.64 4.30 4.76 1.15 1.58 0.26 7.20 7.66 4.05 4.48 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
31237 A Nasal/sinus endoscopy, surg 2.98 4.53 5.03 1.25 1.72 0.28 7.79 8.29 4.51 4.98 000
31238 A Nasal/sinus endoscopy, surg 3.26 4.46 5.04 1.34 1.90 0.27 7.99 8.57 4.87 5.43 000
31239 A Nasal/sinus endoscopy, surg 9.23 NA NA 6.34 7.59 0.62 NA NA 16.19 17.44 010
31240 A Nasal/sinus endoscopy, surg 2.61 NA NA 1.15 1.59 0.24 NA NA 4.00 4.44 000
31254 A Revision of ethmoid sinus 4.64 NA NA 1.74 2.57 0.45 NA NA 6.83 7.66 000
31255 A Removal of ethmoid sinus 6.95 NA NA 2.42 3.69 0.73 NA NA 10.10 11.37 000
31256 A Exploration maxillary sinus 3.29 NA NA 1.34 1.92 0.33 NA NA 4.96 5.54 000
31267 A Endoscopy, maxillary sinus 5.45 NA NA 1.98 2.96 0.55 NA NA 7.98 8.96 000
31276 A Sinus endoscopy, surgical 8.84 NA NA 2.97 4.58 0.92 NA NA 12.73 14.34 000
31287 A Nasal/sinus endoscopy, surg 3.91 NA NA 1.52 2.22 0.39 NA NA 5.82 6.52 000
31288 A Nasal/sinus endoscopy, surg 4.57 NA NA 1.72 2.54 0.46 NA NA 6.75 7.57 000
31290 A Nasal/sinus endoscopy, surg 18.50 NA NA 8.19 11.09 1.40 NA NA 28.09 30.99 010
31291 A Nasal/sinus endoscopy, surg 19.45 NA NA 8.80 11.55 1.69 NA NA 29.94 32.69 010
31292 A Nasal/sinus endoscopy, surg 15.79 NA NA 7.37 9.80 1.21 NA NA 24.37 26.80 010
31293 A Nasal/sinus endoscopy, surg 17.36 NA NA 8.00 10.54 1.28 NA NA 26.64 29.18 010
31294 A Nasal/sinus endoscopy, surg 20.20 NA NA 8.92 11.88 1.53 NA NA 30.65 33.61 010
31299 C Sinus surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
31300 A Removal of larynx lesion 15.71 NA NA 13.59 14.63 1.17 NA NA 30.47 31.51 090
31320 A Diagnostic incision, larynx 5.62 NA NA 9.20 10.03 0.46 NA NA 15.28 16.11 090
31360 A Removal of larynx 29.57 NA NA 18.32 17.12 1.38 NA NA 49.27 48.07 090
31365 A Removal of larynx 38.47 NA NA 20.91 20.50 1.98 NA NA 61.36 60.95 090
31367 A Partial removal of larynx 30.23 NA NA 20.48 21.54 1.79 NA NA 52.50 53.56 090
31368 A Partial removal of larynx 33.85 NA NA 22.44 24.73 2.21 NA NA 58.50 60.79 090
31370 A Partial removal of larynx 27.23 NA NA 20.39 21.79 1.75 NA NA 49.37 50.77 090
31375 A Partial removal of larynx 25.73 NA NA 19.49 20.16 1.63 NA NA 46.85 47.52 090
31380 A Partial removal of larynx 25.23 NA NA 19.17 20.24 1.71 NA NA 46.11 47.18 090
31382 A Partial removal of larynx 28.23 NA NA 20.68 21.38 1.68 NA NA 50.59 51.29 090
31390 A Removal of larynx pharynx 42.17 NA NA 23.64 24.20 2.24 NA NA 68.05 68.61 090
31395 A Reconstruct larynx pharynx 43.46 NA NA 25.96 27.72 2.49 NA NA 71.91 73.67 090
31400 A Revision of larynx 11.48 NA NA 11.54 13.21 0.83 NA NA 23.85 25.52 090
31420 A Removal of epiglottis 11.32 NA NA 7.94 9.14 0.83 NA NA 20.09 21.29 090
31500 A Insert emergency airway 2.33 NA NA 0.44 0.52 0.17 NA NA 2.94 3.02 000
31502 A Change of windpipe airway 0.65 NA NA 0.20 0.26 0.05 NA NA 0.90 0.96 000
31505 A Diagnostic laryngoscopy 0.61 1.34 1.42 0.55 0.60 0.05 2.00 2.08 1.21 1.26 000
31510 A Laryngoscopy with biopsy 1.92 2.98 3.22 0.92 1.17 0.16 5.06 5.30 3.00 3.25 000
31511 A Remove foreign body, larynx 2.16 2.76 3.03 0.95 1.03 0.19 5.11 5.38 3.30 3.38 000
31512 A Removal of larynx lesion 2.07 2.73 3.08 0.97 1.26 0.18 4.98 5.33 3.22 3.51 000
31513 A Injection into vocal cord 2.10 NA NA 0.99 1.34 0.17 NA NA 3.26 3.61 000
31515 A Laryngoscopy for aspiration 1.80 3.07 3.42 0.85 1.01 0.14 5.01 5.36 2.79 2.95 000
31520 A Dx laryngoscopy, newborn 2.56 NA NA 1.11 1.45 0.20 NA NA 3.87 4.21 000
31525 A Dx laryngoscopy excl nb 2.63 3.24 3.54 1.13 1.53 0.21 6.08 6.38 3.97 4.37 000
31526 A Dx laryngoscopy w/oper scope 2.57 NA NA 1.13 1.57 0.21 NA NA 3.91 4.35 000
31527 A Laryngoscopy for treatment 3.27 NA NA 1.31 1.73 0.26 NA NA 4.84 5.26 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
31528 A Laryngoscopy and dilation 2.37 NA NA 0.99 1.34 0.19 NA NA 3.55 3.90 000
31529 A Laryngoscopy and dilation 2.68 NA NA 1.12 1.56 0.22 NA NA 4.02 4.46 000
31530 A Laryngoscopy w/fb removal 3.38 NA NA 1.32 1.79 0.29 NA NA 4.99 5.46 000
31531 A Laryngoscopy w/fb op scope 3.58 NA NA 1.43 2.06 0.29 NA NA 5.30 5.93 000
31535 A Laryngoscopy w/biopsy 3.16 NA NA 1.30 1.82 0.26 NA NA 4.72 5.24 000
31536 A Laryngoscopy w/bx op scope 3.55 NA NA 1.42 2.04 0.29 NA NA 5.26 5.88 000
31540 A Laryngoscopy w/exc of tumor 4.12 NA NA 1.59 2.30 0.33 NA NA 6.04 6.75 000
31541 A Larynscop w/tumr exc + scope 4.52 NA NA 1.70 2.51 0.37 NA NA 6.59 7.40 000
31545 A Remove vc lesion w/scope 6.30 NA NA 2.26 3.17 0.37 NA NA 8.93 9.84 000
31546 A Remove vc lesion scope/graft 9.73 NA NA 3.77 4.67 0.78 NA NA 14.28 15.18 000
31560 A Laryngoscop w/arytenoidectom 5.45 NA NA 1.92 2.84 0.43 NA NA 7.80 8.72 000
31561 A Larynscop, remve cart + scop 5.99 NA NA 2.08 3.05 0.49 NA NA 8.56 9.53 000
31570 A Laryngoscope w/vc inj 3.86 3.96 5.24 1.51 2.16 0.31 8.13 9.41 5.68 6.33 000
31571 A Laryngoscop w/vc inj + scope 4.26 NA NA 1.63 2.36 0.35 NA NA 6.24 6.97 000
31575 A Diagnostic laryngoscopy 1.10 1.57 1.82 0.70 0.84 0.09 2.76 3.01 1.89 2.03 000
31576 A Laryngoscopy with biopsy 1.97 3.28 3.57 0.96 1.21 0.14 5.39 5.68 3.07 3.32 000
31577 A Remove foreign body, larynx 2.47 3.23 3.63 1.11 1.43 0.21 5.91 6.31 3.79 4.11 000
31578 A Removal of larynx lesion 2.84 3.68 4.13 1.21 1.44 0.23 6.75 7.20 4.28 4.51 000
31579 A Diagnostic laryngoscopy 2.26 2.64 3.50 1.04 1.37 0.18 5.08 5.94 3.48 3.81 000
31580 A Revision of larynx 14.46 NA NA 13.49 15.31 1.00 NA NA 28.95 30.77 090
31582 A Revision of larynx 22.87 NA NA 20.51 24.48 1.76 NA NA 45.14 49.11 090
31584 A Treat larynx fracture 20.35 NA NA 14.32 17.19 1.72 NA NA 36.39 39.26 090
31587 A Revision of larynx 15.12 NA NA 8.05 8.96 0.97 NA NA 24.14 25.05 090
31588 A Revision of larynx 14.62 NA NA 11.46 13.07 1.06 NA NA 27.14 28.75 090
31590 A Reinnervate larynx 7.63 NA NA 12.10 14.67 0.84 NA NA 20.57 23.14 090
31595 A Larynx nerve surgery 8.75 NA NA 8.94 10.15 0.68 NA NA 18.37 19.58 090
31599 C Larynx surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
31600 A Incision of windpipe 7.17 NA NA 2.22 2.95 0.80 NA NA 10.19 10.92 000
31601 A Incision of windpipe 4.44 NA NA 1.63 2.21 0.40 NA NA 6.47 7.05 000
31603 A Incision of windpipe 4.14 NA NA 1.13 1.57 0.44 NA NA 5.71 6.15 000
31605 A Incision of windpipe 3.57 NA NA 0.83 1.10 0.40 NA NA 4.80 5.07 000
31610 A Incision of windpipe 9.29 NA NA 7.19 7.99 0.79 NA NA 17.27 18.07 090
31611 A Surgery/speech prosthesis 5.92 NA NA 6.50 6.92 0.46 NA NA 12.88 13.30 090
31612 A Puncture/clear windpipe 0.91 1.07 1.09 0.25 0.33 0.08 2.06 2.08 1.24 1.32 000
31613 A Repair windpipe opening 4.63 NA NA 5.80 5.94 0.42 NA NA 10.85 10.99 090
31614 A Repair windpipe opening 8.47 NA NA 8.90 8.76 0.58 NA NA 17.95 17.81 090
31615 A Visualization of windpipe 2.09 2.22 2.50 0.96 1.14 0.16 4.47 4.75 3.21 3.39 000
31620 A Endobronchial us add-on 1.40 6.00 5.73 0.35 0.50 0.11 7.51 7.24 1.86 2.01 ZZZ
31622 A Dx bronchoscope/wash 2.78 5.23 5.55 0.91 1.02 0.18 8.19 8.51 3.87 3.98 000
31623 A Dx bronchoscope/brush 2.88 6.01 6.32 0.92 1.02 0.13 9.02 9.33 3.93 4.03 000
31624 A Dx bronchoscope/lavage 2.88 5.36 5.67 0.92 1.02 0.13 8.37 8.68 3.93 4.03 000
31625 A Bronchoscopy w/biopsy(s) 3.36 5.50 5.73 1.04 1.17 0.18 9.04 9.27 4.58 4.71 000
31628 A Bronchoscopy/lung bx, each 3.80 7.00 7.02 1.14 1.26 0.18 10.98 11.00 5.12 5.24 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
31629 A Bronchoscopy/needle bx, each 4.09 12.05 13.70 1.21 1.35 0.16 16.30 17.95 5.46 5.60 000
31630 A Bronchoscopy dilate/fx repr 3.81 NA NA 1.26 1.61 0.32 NA NA 5.39 5.74 000
31631 A Bronchoscopy, dilate w/stent 4.36 NA NA 1.41 1.67 0.34 NA NA 6.11 6.37 000
31632 A Bronchoscopy/lung bx, add'l 1.03 0.87 0.83 0.25 0.30 0.18 2.08 2.04 1.46 1.51 ZZZ
31633 A Bronchoscopy/needle bx add'l 1.32 1.00 0.94 0.32 0.38 0.16 2.48 2.42 1.80 1.86 ZZZ
31635 A Bronchoscopy w/fb removal 3.67 5.19 5.88 1.15 1.36 0.24 9.10 9.79 5.06 5.27 000
31636 A Bronchoscopy, bronch stents 4.30 NA NA 1.38 1.67 0.31 NA NA 5.99 6.28 000
31637 A Bronchoscopy, stent add-on 1.58 NA NA 0.42 0.53 0.13 NA NA 2.13 2.24 ZZZ
31638 A Bronchoscopy, revise stent 4.88 NA NA 1.56 1.87 0.22 NA NA 6.66 6.97 000
31640 A Bronchoscopy w/tumor excise 4.93 NA NA 1.54 1.94 0.46 NA NA 6.93 7.33 000
31641 A Bronchoscopy, treat blockage 5.02 NA NA 1.51 1.79 0.35 NA NA 6.88 7.16 000
31643 A Diag bronchoscope/catheter 3.49 NA NA 1.07 1.19 0.20 NA NA 4.76 4.88 000
31645 A Bronchoscopy, clear airways 3.16 4.76 5.05 0.99 1.09 0.16 8.08 8.37 4.31 4.41 000
31646 A Bronchoscopy, reclear airway 2.72 4.47 4.76 0.88 0.97 0.14 7.33 7.62 3.74 3.83 000
31656 A Bronchoscopy, inj for x-ray 2.17 5.27 6.79 0.65 0.79 0.15 7.59 9.11 2.97 3.11 000
31715 A Injection for bronchus x-ray 1.11 NA NA 0.28 0.33 0.07 NA NA 1.46 1.51 000
31717 A Bronchial brush biopsy 2.12 5.83 7.65 0.77 0.79 0.14 8.09 9.91 3.03 3.05 000
31720 A Clearance of airways 1.06 NA NA 0.26 0.31 0.07 NA NA 1.39 1.44 000
31725 A Clearance of airways 1.96 NA NA 0.45 0.55 0.14 NA NA 2.55 2.65 000
31730 A Intro, windpipe wire/tube 2.85 25.35 7.98 0.74 0.94 0.21 28.41 11.04 3.80 4.00 000
31750 A Repair of windpipe 15.19 NA NA 16.21 17.22 1.05 NA NA 32.45 33.46 090
31755 A Repair of windpipe 17.19 NA NA 22.30 23.97 1.29 NA NA 40.78 42.45 090
31760 A Repair of windpipe 23.36 NA NA 9.76 10.47 2.95 NA NA 36.07 36.78 090
31766 A Reconstruction of windpipe 31.58 NA NA 11.46 13.10 4.53 NA NA 47.57 49.21 090
31770 A Repair/graft of bronchus 23.48 NA NA 8.80 9.88 2.84 NA NA 35.12 36.20 090
31775 A Reconstruct bronchus 24.51 NA NA 8.91 11.07 3.02 NA NA 36.44 38.60 090
31780 A Reconstruct windpipe 19.70 NA NA 8.12 10.32 1.65 NA NA 29.47 31.67 090
31781 A Reconstruct windpipe 24.77 NA NA 9.28 11.41 2.25 NA NA 36.30 38.43 090
31785 A Remove windpipe lesion 18.29 NA NA 5.60 9.04 1.59 NA NA 25.48 28.92 090
31786 A Remove windpipe lesion 25.34 NA NA 9.79 12.27 3.30 NA NA 38.43 40.91 090
31800 A Repair of windpipe injury 8.10 NA NA 8.33 9.01 0.79 NA NA 17.22 17.90 090
31805 A Repair of windpipe injury 13.34 NA NA 6.32 6.99 1.83 NA NA 21.49 22.16 090
31820 A Closure of windpipe lesion 4.58 5.46 5.61 3.02 3.49 0.38 10.42 10.57 7.98 8.45 090
31825 A Repair of windpipe defect 6.98 6.85 7.46 4.08 5.05 0.53 14.36 14.97 11.59 12.56 090
31830 A Revise windpipe scar 4.54 5.62 5.73 3.37 3.83 0.44 10.60 10.71 8.35 8.81 090
31899 C Airways surgical procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
32000 A Drainage of chest 1.54 2.30 2.86 0.41 0.46 0.08 3.92 4.48 2.03 2.08 000
32002 A Treatment of collapsed lung 2.19 2.73 3.09 0.94 1.03 0.12 5.04 5.40 3.25 3.34 000
32005 A Treat lung lining chemically 2.19 5.04 6.10 0.59 0.67 0.23 7.46 8.52 3.01 3.09 000
32019 A Insert pleural catheter 4.17 15.15 18.76 1.42 1.59 0.42 19.74 23.35 6.01 6.18 000
32020 A Insertion of chest tube 3.29 NA NA 0.94 1.25 0.43 NA NA 4.66 4.97 000
32035 A Exploration of chest 11.20 NA NA 6.07 5.91 1.26 NA NA 18.53 18.37 090
32036 A Exploration of chest 12.21 NA NA 6.40 6.42 1.43 NA NA 20.04 20.06 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
32095 A Biopsy through chest wall 10.06 NA NA 5.19 5.32 1.22 NA NA 16.47 16.60 090
32100 A Exploration/biopsy of chest 16.08 NA NA 7.06 7.63 2.24 NA NA 25.38 25.95 090
32110 A Explore/repair chest 25.15 NA NA 9.99 10.55 3.22 NA NA 38.36 38.92 090
32120 A Re-exploration of chest 14.27 NA NA 6.88 7.02 1.63 NA NA 22.78 22.92 090
32124 A Explore chest free adhesions 15.33 NA NA 7.05 7.17 1.90 NA NA 24.28 24.40 090
32140 A Removal of lung lesion(s) 16.54 NA NA 7.44 7.62 1.97 NA NA 25.95 26.13 090
32141 A Remove/treat lung lesions 27.10 NA NA 10.34 8.25 2.01 NA NA 39.45 37.36 090
32150 A Removal of lung lesion(s) 16.70 NA NA 7.50 7.58 2.01 NA NA 26.21 26.29 090
32151 A Remove lung foreign body 16.82 NA NA 8.75 8.19 2.04 NA NA 27.61 27.05 090
32160 A Open chest heart massage 13.02 NA NA 5.86 5.41 1.31 NA NA 20.19 19.74 090
32200 A Drain, open, lung lesion 18.48 NA NA 8.77 8.65 2.14 NA NA 29.39 29.27 090
32201 A Drain, percut, lung lesion 3.99 18.73 20.21 1.13 1.26 0.24 22.96 24.44 5.36 5.49 000
32215 A Treat chest lining 12.93 NA NA 6.39 6.77 1.69 NA NA 21.01 21.39 090
32220 A Release of lung 26.41 NA NA 12.07 12.73 3.57 NA NA 42.05 42.71 090
32225 A Partial release of lung 16.63 NA NA 7.51 7.62 2.07 NA NA 26.21 26.32 090
32310 A Removal of chest lining 15.16 NA NA 6.94 7.28 2.00 NA NA 24.10 24.44 090
32320 A Free/remove chest lining 27.04 NA NA 11.58 12.01 3.52 NA NA 42.14 42.57 090
32400 A Needle biopsy chest lining 1.76 2.01 2.09 0.48 0.53 0.10 3.87 3.95 2.34 2.39 000
32402 A Open biopsy chest lining 8.89 NA NA 4.78 5.03 1.07 NA NA 14.74 14.99 090
32405 A Biopsy, lung or mediastinum 1.93 0.55 0.64 0.55 0.61 0.11 2.59 2.68 2.59 2.65 000
32420 A Puncture/clear lung 2.18 NA NA 0.61 0.66 0.12 NA NA 2.91 2.96 000
32440 A Removal of lung 27.17 NA NA 11.08 12.44 3.69 NA NA 41.94 43.30 090
32442 A Sleeve pneumonectomy 56.37 NA NA 18.56 15.71 3.85 NA NA 78.78 75.93 090
32445 A Removal of lung 63.60 NA NA 23.01 16.30 3.72 NA NA 90.33 83.62 090
32480 A Partial removal of lung 25.71 NA NA 10.34 11.63 3.50 NA NA 39.55 40.84 090
32482 A Bilobectomy 27.28 NA NA 11.17 12.48 3.67 NA NA 42.12 43.43 090
32484 A Segmentectomy 25.30 NA NA 9.64 10.95 3.04 NA NA 37.98 39.29 090
32486 A Sleeve lobectomy 42.80 NA NA 15.21 13.73 3.52 NA NA 61.53 60.05 090
32488 A Completion pneumonectomy 42.83 NA NA 15.69 14.26 3.81 NA NA 62.33 60.90 090
32491 R Lung volume reduction 25.09 NA NA 10.65 12.13 2.99 NA NA 38.73 40.21 090
32500 A Partial removal of lung 24.48 NA NA 10.39 11.86 3.26 NA NA 38.13 39.60 090
32501 A Repair bronchus add-on 4.68 NA NA 1.37 1.50 0.65 NA NA 6.70 6.83 ZZZ
32503 A Resect apical lung tumor 31.61 NA NA 12.26 14.37 4.38 NA NA 48.25 50.36 090
32504 A Resect apical lung tum/chest 36.41 NA NA 13.69 15.93 5.09 NA NA 55.19 57.43 090
32540 A Removal of lung lesion 30.22 NA NA 12.20 10.27 2.08 NA NA 44.50 42.57 090
32601 A Thoracoscopy, diagnostic 5.45 NA NA 2.10 2.29 0.80 NA NA 8.35 8.54 000
32602 A Thoracoscopy, diagnostic 5.95 NA NA 2.24 2.45 0.87 NA NA 9.06 9.27 000
32603 A Thoracoscopy, diagnostic 7.80 NA NA 2.98 3.02 1.14 NA NA 11.92 11.96 000
32604 A Thoracoscopy, diagnostic 8.77 NA NA 3.06 3.35 1.25 NA NA 13.08 13.37 000
32605 A Thoracoscopy, diagnostic 6.92 NA NA 2.55 2.81 1.00 NA NA 10.47 10.73 000
32606 A Thoracoscopy, diagnostic 8.39 NA NA 3.01 3.25 1.22 NA NA 12.62 12.86 000
32650 A Thoracoscopy, surgical 10.77 NA NA 5.29 6.39 1.58 NA NA 17.64 18.74 090
32651 A Thoracoscopy, surgical 18.70 NA NA 7.75 7.36 1.87 NA NA 28.32 27.93 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
32652 A Thoracoscopy, surgical 29.00 NA NA 11.23 10.41 2.73 NA NA 42.96 42.14 090
32653 A Thoracoscopy, surgical 18.09 NA NA 7.47 7.10 1.89 NA NA 27.45 27.08 090
32654 A Thoracoscopy, surgical 20.44 NA NA 7.98 7.64 1.63 NA NA 30.05 29.71 090
32655 A Thoracoscopy, surgical 16.09 NA NA 7.03 7.19 1.90 NA NA 25.02 25.18 090
32656 A Thoracoscopy, surgical 13.18 NA NA 6.01 7.46 1.90 NA NA 21.09 22.54 090
32657 A Thoracoscopy, surgical 12.85 NA NA 6.07 7.28 2.00 NA NA 20.92 22.13 090
32658 A Thoracoscopy, surgical 11.65 NA NA 5.61 6.92 1.70 NA NA 18.96 20.27 090
32659 A Thoracoscopy, surgical 11.86 NA NA 5.93 7.07 1.62 NA NA 19.41 20.55 090
32660 A Thoracoscopy, surgical 17.69 NA NA 7.47 8.98 2.09 NA NA 27.25 28.76 090
32661 A Thoracoscopy, surgical 13.27 NA NA 6.20 7.39 1.93 NA NA 21.40 22.59 090
32662 A Thoracoscopy, surgical 14.91 NA NA 6.71 8.29 2.18 NA NA 23.80 25.38 090
32663 A Thoracoscopy, surgical 24.56 NA NA 9.47 10.44 2.73 NA NA 36.76 37.73 090
32664 A Thoracoscopy, surgical 14.22 NA NA 6.40 7.32 2.33 NA NA 22.95 23.87 090
32665 A Thoracoscopy, surgical 21.45 NA NA 8.65 8.26 2.16 NA NA 32.26 31.87 090
32800 A Repair lung hernia 15.59 NA NA 7.10 7.33 1.99 NA NA 24.68 24.91 090
32810 A Close chest after drainage 14.83 NA NA 7.10 7.42 1.94 NA NA 23.87 24.19 090
32815 A Close bronchial fistula 49.79 NA NA 18.95 12.97 3.28 NA NA 72.02 66.04 090
32820 A Reconstruct injured chest 22.33 NA NA 11.82 12.08 2.53 NA NA 36.68 36.94 090
32850 X Donor pneumonectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
32851 A Lung transplant, single 40.94 NA NA 20.90 25.97 5.58 NA NA 67.42 72.49 090
32852 A Lung transplant with bypass 44.65 NA NA 23.73 30.80 6.02 NA NA 74.40 81.47 090
32853 A Lung transplant, double 50.11 NA NA 23.29 29.64 7.07 NA NA 80.47 86.82 090
32854 A Lung transplant with bypass 53.88 NA NA 26.52 32.68 7.22 NA NA 87.62 93.78 090
32855 C Prepare donor lung, single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
32856 C Prepare donor lung, double 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
32900 A Removal of rib(s) 23.69 NA NA 9.79 9.86 2.94 NA NA 36.42 36.49 090
32905 A Revise repair chest wall 23.17 NA NA 9.62 10.00 3.16 NA NA 35.95 36.33 090
32906 A Revise repair chest wall 29.18 NA NA 11.32 11.88 3.98 NA NA 44.48 45.04 090
32940 A Revision of lung 21.22 NA NA 8.62 9.26 2.89 NA NA 32.73 33.37 090
32960 A Therapeutic pneumothorax 1.84 1.53 1.68 0.63 0.58 0.16 3.53 3.68 2.63 2.58 000
32997 A Total lung lavage 7.31 NA NA 1.87 1.90 0.55 NA NA 9.73 9.76 000
32998 A Perq rf ablate tx, pul tumor 5.68 68.64 68.64 1.77 1.77 0.36 74.68 74.68 7.81 7.81 000
32999 C Chest surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
33010 A Drainage of heart sac 2.24 NA NA 1.04 0.85 0.14 NA NA 3.42 3.23 000
33011 A Repeat drainage of heart sac 2.24 NA NA 1.11 0.89 0.15 NA NA 3.50 3.28 000
33015 A Incision of heart sac 8.44 NA NA 5.05 4.98 0.65 NA NA 14.14 14.07 090
33020 A Incision of heart sac 14.87 NA NA 6.51 6.71 1.80 NA NA 23.18 23.38 090
33025 A Incision of heart sac 13.65 NA NA 5.96 6.25 1.81 NA NA 21.42 21.71 090
33030 A Partial removal of heart sac 22.27 NA NA 9.22 9.45 2.84 NA NA 34.33 34.56 090
33031 A Partial removal of heart sac 25.30 NA NA 9.93 10.01 3.14 NA NA 38.37 38.45 090
33050 A Removal of heart sac lesion 16.85 NA NA 7.58 7.78 2.15 NA NA 26.58 26.78 090
33120 A Removal of heart lesion 27.33 NA NA 10.75 11.37 3.70 NA NA 41.78 42.40 090
33130 A Removal of heart lesion 24.05 NA NA 9.45 9.95 3.01 NA NA 36.51 37.01 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33140 A Heart revascularize (tmr) 28.26 NA NA 10.65 10.82 2.86 NA NA 41.77 41.94 090
33141 A Heart tmr w/other procedure 2.54 NA NA 0.80 1.39 0.69 NA NA 4.03 4.62 ZZZ
33202 A Insert epicard eltrd, open 13.15 NA NA 6.22 6.22 1.71 NA NA 21.08 21.08 090
33203 A Insert epicard eltrd, endo 13.92 NA NA 6.29 6.29 1.39 NA NA 21.60 21.60 090
33206 A Insertion of heart pacemaker 7.31 NA NA 5.19 4.64 0.52 NA NA 13.02 12.47 090
33207 A Insertion of heart pacemaker 9.05 NA NA 5.83 4.95 0.59 NA NA 15.47 14.59 090
33208 A Insertion of heart pacemaker 8.12 NA NA 5.47 4.95 0.56 NA NA 14.15 13.63 090
33210 A Insertion of heart electrode 3.30 NA NA 1.73 1.37 0.18 NA NA 5.21 4.85 000
33211 A Insertion of heart electrode 3.39 NA NA 1.69 1.41 0.21 NA NA 5.29 5.01 000
33212 A Insertion of pulse generator 5.51 NA NA 3.77 3.46 0.43 NA NA 9.71 9.40 090
33213 A Insertion of pulse generator 6.36 NA NA 4.30 3.87 0.45 NA NA 11.11 10.68 090
33214 A Upgrade of pacemaker system 7.78 NA NA 5.44 5.03 0.58 NA NA 13.80 13.39 090
33215 A Reposition pacing-defib lead 4.89 NA NA 3.55 3.27 0.37 NA NA 8.81 8.53 090
33216 A Insert lead pace-defib, one 5.81 NA NA 4.63 4.31 0.36 NA NA 10.80 10.48 090
33217 A Insert lead pace-defib, dual 5.78 NA NA 4.54 4.31 0.39 NA NA 10.71 10.48 090
33218 A Repair lead pace-defib, one 5.97 NA NA 4.87 4.44 0.37 NA NA 11.21 10.78 090
33220 A Repair lead pace-defib, dual 6.05 NA NA 4.94 4.44 0.37 NA NA 11.36 10.86 090
33222 A Revise pocket, pacemaker 5.01 NA NA 4.37 4.31 0.42 NA NA 9.80 9.74 090
33223 A Revise pocket, pacing-defib 6.49 NA NA 5.02 4.70 0.45 NA NA 11.96 11.64 090
33224 A Insert pacing lead connect 9.04 NA NA 5.10 4.28 0.54 NA NA 14.68 13.86 000
33225 A L ventric pacing lead add-on 8.33 NA NA 4.53 3.57 0.45 NA NA 13.31 12.35 ZZZ
33226 A Reposition l ventric lead 8.68 NA NA 4.94 4.10 0.59 NA NA 14.21 13.37 000
33233 A Removal of pacemaker system 3.33 NA NA 3.33 3.29 0.22 NA NA 6.88 6.84 090
33234 A Removal of pacemaker system 7.85 NA NA 5.58 5.08 0.56 NA NA 13.99 13.49 090
33235 A Removal pacemaker electrode 9.93 NA NA 7.41 6.96 0.73 NA NA 18.07 17.62 090
33236 A Remove electrode/thoracotomy 12.64 NA NA 6.67 7.24 1.69 NA NA 21.00 21.57 090
33237 A Remove electrode/thoracotomy 13.75 NA NA 7.70 7.76 1.59 NA NA 23.04 23.10 090
33238 A Remove electrode/thoracotomy 15.28 NA NA 8.33 8.23 2.03 NA NA 25.64 25.54 090
33240 A Insert pulse generator 7.61 NA NA 5.41 4.79 0.41 NA NA 13.43 12.81 090
33241 A Remove pulse generator 3.26 NA NA 3.07 2.99 0.18 NA NA 6.51 6.43 090
33243 A Remove eltrd/thoracotomy 23.42 NA NA 11.02 11.35 2.10 NA NA 36.54 36.87 090
33244 A Remove eltrd, transven 13.84 NA NA 9.66 9.08 0.99 NA NA 24.49 23.91 090
33249 A Eltrd/insert pace-defib 15.02 NA NA 10.47 8.89 0.77 NA NA 26.26 24.68 090
33250 A Ablate heart dysrhythm focus 25.78 NA NA 10.12 10.80 3.19 NA NA 39.09 39.77 090
33251 A Ablate heart dysrhythm focus 28.80 NA NA 11.09 11.52 3.60 NA NA 43.49 43.92 090
33254 A Ablate atria, lmtd 23.58 NA NA 9.94 9.94 3.35 NA NA 36.87 36.87 090
33255 A Ablate atria w/o bypass, ext 28.91 NA NA 11.57 11.57 3.94 NA NA 44.42 44.42 090
33256 A Ablate atria w/bypass, exten 34.77 NA NA 13.37 13.37 4.95 NA NA 53.09 53.09 090
33261 A Ablate heart dysrhythm focus 28.80 NA NA 11.30 11.65 3.46 NA NA 43.56 43.91 090
33265 A Ablate atria w/bypass, endo 23.58 NA NA 9.94 9.94 3.35 NA NA 36.87 36.87 090
33266 A Ablate atria w/o bypass endo 32.91 NA NA 12.80 12.80 4.80 NA NA 50.51 50.51 090
33282 A Implant pat-active ht record 4.70 NA NA 4.33 4.10 0.23 NA NA 9.26 9.03 090
33284 A Remove pat-active ht record 3.04 NA NA 3.42 3.50 0.14 NA NA 6.60 6.68 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33300 A Repair of heart wound 44.89 NA NA 15.61 10.83 2.66 NA NA 63.16 58.38 090
33305 A Repair of heart wound 76.85 NA NA 25.20 14.26 3.13 NA NA 105.18 94.24 090
33310 A Exploratory heart surgery 20.22 NA NA 8.80 9.39 2.59 NA NA 31.61 32.20 090
33315 A Exploratory heart surgery 26.05 NA NA 10.42 10.77 3.28 NA NA 39.75 40.10 090
33320 A Repair major blood vessel(s) 18.46 NA NA 8.71 8.34 2.08 NA NA 29.25 28.88 090
33321 A Repair major vessel 20.71 NA NA 10.31 9.91 2.91 NA NA 33.93 33.53 090
33322 A Repair major blood vessel(s) 24.30 NA NA 9.79 10.22 2.86 NA NA 36.95 37.38 090
33330 A Insert major vessel graft 25.17 NA NA 9.75 10.13 2.82 NA NA 37.74 38.12 090
33332 A Insert major vessel graft 24.46 NA NA 9.59 10.28 3.03 NA NA 37.08 37.77 090
33335 A Insert major vessel graft 33.79 NA NA 12.95 13.24 4.28 NA NA 51.02 51.31 090
33400 A Repair of aortic valve 41.37 NA NA 15.16 15.54 4.11 NA NA 60.64 61.02 090
33401 A Valvuloplasty, open 24.41 NA NA 9.76 12.57 3.57 NA NA 37.74 40.55 090
33403 A Valvuloplasty, w/cp bypass 25.39 NA NA 10.48 13.35 3.55 NA NA 39.42 42.29 090
33404 A Prepare heart-aorta conduit 31.25 NA NA 12.22 13.96 4.33 NA NA 47.80 49.54 090
33405 A Replacement of aortic valve 41.19 NA NA 15.43 17.58 5.33 NA NA 61.95 64.10 090
33406 A Replacement of aortic valve 52.55 NA NA 18.77 19.03 5.45 NA NA 76.77 77.03 090
33410 A Replacement of aortic valve 46.28 NA NA 16.89 16.66 4.69 NA NA 67.86 67.63 090
33411 A Replacement of aortic valve 61.94 NA NA 21.53 19.44 5.48 NA NA 88.95 86.86 090
33412 A Replacement of aortic valve 43.77 NA NA 16.49 19.42 6.39 NA NA 66.65 69.58 090
33413 A Replacement of aortic valve 59.74 NA NA 20.57 20.75 6.53 NA NA 86.84 87.02 090
33414 A Repair of aortic valve 39.29 NA NA 15.21 14.40 4.57 NA NA 59.07 58.26 090
33415 A Revision, subvalvular tissue 37.19 NA NA 12.96 12.26 4.14 NA NA 54.29 53.59 090
33416 A Revise ventricle muscle 36.43 NA NA 13.59 13.52 4.57 NA NA 54.59 54.52 090
33417 A Repair of aortic valve 29.17 NA NA 12.10 13.23 4.10 NA NA 45.37 46.50 090
33420 A Revision of mitral valve 25.67 NA NA 8.98 9.42 1.82 NA NA 36.47 36.91 090
33422 A Revision of mitral valve 29.61 NA NA 12.45 13.35 3.94 NA NA 46.00 46.90 090
33425 A Repair of mitral valve 49.83 NA NA 17.90 14.26 4.07 NA NA 71.80 68.16 090
33426 A Repair of mitral valve 43.15 NA NA 16.03 16.86 5.03 NA NA 64.21 65.04 090
33427 A Repair of mitral valve 44.70 NA NA 16.02 18.53 6.09 NA NA 66.81 69.32 090
33430 A Replacement of mitral valve 50.75 NA NA 18.97 17.71 5.10 NA NA 74.82 73.56 090
33460 A Revision of tricuspid valve 44.62 NA NA 15.50 12.35 3.45 NA NA 63.57 60.42 090
33463 A Valvuloplasty, tricuspid 56.95 NA NA 19.76 14.62 3.87 NA NA 80.58 75.44 090
33464 A Valvuloplasty, tricuspid 44.49 NA NA 16.23 14.20 4.15 NA NA 64.87 62.84 090
33465 A Replace tricuspid valve 50.59 NA NA 17.77 14.16 4.39 NA NA 72.75 69.14 090
33468 A Revision of tricuspid valve 32.82 NA NA 15.37 14.08 4.07 NA NA 52.26 50.97 090
33470 A Revision of pulmonary valve 21.32 NA NA 8.70 10.19 1.03 NA NA 31.05 32.54 090
33471 A Valvotomy, pulmonary valve 22.83 NA NA 7.69 9.24 3.39 NA NA 33.91 35.46 090
33472 A Revision of pulmonary valve 22.90 NA NA 7.21 10.70 3.55 NA NA 33.66 37.15 090
33474 A Revision of pulmonary valve 39.27 NA NA 17.24 12.47 3.22 NA NA 59.73 54.96 090
33475 A Replacement, pulmonary valve 42.27 NA NA 15.72 15.46 4.93 NA NA 62.92 62.66 090
33476 A Revision of heart chamber 26.41 NA NA 11.43 11.83 2.42 NA NA 40.26 40.66 090
33478 A Revision of heart chamber 27.38 NA NA 10.98 12.53 3.89 NA NA 42.25 43.80 090
33496 A Repair, prosth valve clot 29.71 NA NA 11.47 12.42 4.13 NA NA 45.31 46.26 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33500 A Repair heart vessel fistula 27.82 NA NA 11.05 11.36 3.87 NA NA 42.74 43.05 090
33501 A Repair heart vessel fistula 19.43 NA NA 8.27 8.28 1.91 NA NA 29.61 29.62 090
33502 A Coronary artery correction 21.69 NA NA 9.27 10.62 3.00 NA NA 33.96 35.31 090
33503 A Coronary artery graft 22.29 NA NA 10.66 9.96 1.78 NA NA 34.73 34.03 090
33504 A Coronary artery graft 25.30 NA NA 10.14 11.39 3.36 NA NA 38.80 40.05 090
33505 A Repair artery w/tunnel 38.35 NA NA 12.28 12.75 2.19 NA NA 52.82 53.29 090
33506 A Repair artery, translocation 37.80 NA NA 15.56 14.81 4.66 NA NA 58.02 57.27 090
33507 A Repair art, intramural 31.35 NA NA 11.76 13.17 4.06 NA NA 47.17 48.58 090
33508 A Endoscopic vein harvest 0.31 NA NA 0.10 0.10 0.04 NA NA 0.45 0.45 ZZZ
33510 A CABG, vein, single 34.87 NA NA 13.19 15.55 4.41 NA NA 52.47 54.83 090
33511 A CABG, vein, two 38.34 NA NA 14.46 16.42 4.56 NA NA 57.36 59.32 090
33512 A CABG, vein, three 43.87 NA NA 16.24 17.26 4.67 NA NA 64.78 65.80 090
33513 A CABG, vein, four 45.26 NA NA 16.82 17.54 4.88 NA NA 66.96 67.68 090
33514 A CABG, vein, five 47.97 NA NA 17.64 17.95 4.77 NA NA 70.38 70.69 090
33516 A Cabg, vein, six or more 49.65 NA NA 18.57 18.74 5.13 NA NA 73.35 73.52 090
33517 A CABG, artery-vein, single 3.61 NA NA 1.11 0.91 0.39 NA NA 5.11 4.91 ZZZ
33518 A CABG, artery-vein, two 7.93 NA NA 2.43 1.79 0.73 NA NA 11.09 10.45 ZZZ
33519 A CABG, artery-vein, three 10.49 NA NA 3.21 2.54 1.04 NA NA 14.74 14.07 ZZZ
33521 A CABG, artery-vein, four 12.59 NA NA 3.88 3.27 1.37 NA NA 17.84 17.23 ZZZ
33522 A CABG, artery-vein, five 14.14 NA NA 4.32 3.94 1.78 NA NA 20.24 19.86 ZZZ
33523 A Cabg, art-vein, six or more 16.08 NA NA 4.96 4.64 2.13 NA NA 23.17 22.85 ZZZ
33530 A Coronary artery, bypass/reop 10.13 NA NA 3.10 2.21 0.88 NA NA 14.11 13.22 ZZZ
33533 A CABG, arterial, single 33.64 NA NA 12.81 15.55 4.56 NA NA 51.01 53.75 090
33534 A CABG, arterial, two 39.77 NA NA 14.98 17.03 4.70 NA NA 59.45 61.50 090
33535 A CABG, arterial, three 44.64 NA NA 16.61 17.75 5.03 NA NA 66.28 67.42 090
33536 A Cabg, arterial, four or more 48.32 NA NA 17.55 18.11 5.44 NA NA 71.31 71.87 090
33542 A Removal of heart lesion 48.08 NA NA 17.51 14.12 4.38 NA NA 69.97 66.58 090
33545 A Repair of heart damage 56.93 NA NA 20.52 16.85 5.21 NA NA 82.66 78.99 090
33548 A Restore/remodel, ventricle 53.96 NA NA 20.04 19.48 5.53 NA NA 79.53 78.97 090
33572 A Open coronary endarterectomy 4.44 NA NA 1.34 1.42 0.65 NA NA 6.43 6.51 ZZZ
33600 A Closure of valve 30.15 NA NA 12.45 12.50 4.42 NA NA 47.02 47.07 090
33602 A Closure of valve 29.18 NA NA 13.60 12.73 3.82 NA NA 46.60 45.73 090
33606 A Anastomosis/artery-aorta 31.37 NA NA 12.10 13.28 4.41 NA NA 47.88 49.06 090
33608 A Repair anomaly w/conduit 31.72 NA NA 13.40 13.93 4.74 NA NA 49.86 50.39 090
33610 A Repair by enlargement 31.24 NA NA 11.28 13.02 4.56 NA NA 47.08 48.82 090
33611 A Repair double ventricle 35.49 NA NA 12.57 13.74 4.37 NA NA 52.43 53.60 090
33612 A Repair double ventricle 36.49 NA NA 12.91 14.59 5.30 NA NA 54.70 56.38 090
33615 A Repair, modified fontan 35.76 NA NA 12.53 12.99 4.32 NA NA 52.61 53.07 090
33617 A Repair single ventricle 38.96 NA NA 16.41 16.10 5.66 NA NA 61.03 60.72 090
33619 A Repair single ventricle 48.60 NA NA 18.25 20.16 6.46 NA NA 73.31 75.22 090
33641 A Repair heart septum defect 29.50 NA NA 11.02 9.93 3.23 NA NA 43.75 42.66 090
33645 A Revision of heart veins 27.98 NA NA 10.98 11.57 3.79 NA NA 42.75 43.34 090
33647 A Repair heart septum defects 29.37 NA NA 12.30 13.40 3.32 NA NA 44.99 46.09 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33660 A Repair of heart defects 31.75 NA NA 11.45 12.97 4.49 NA NA 47.69 49.21 090
33665 A Repair of heart defects 34.77 NA NA 12.42 13.48 4.00 NA NA 51.19 52.25 090
33670 A Repair of heart chambers 36.58 NA NA 12.25 12.94 4.65 NA NA 53.48 54.17 090
33675 A Close mult vsd 35.87 NA NA 17.82 17.82 4.95 NA NA 58.64 58.64 090
33676 A Close mult vsd w/resection 36.87 NA NA 18.17 18.17 5.44 NA NA 60.48 60.48 090
33677 A Cl mult vsd w/rem pul band 38.37 NA NA 18.82 18.82 5.68 NA NA 62.87 62.87 090
33681 A Repair heart septum defect 32.16 NA NA 13.24 14.32 4.45 NA NA 49.85 50.93 090
33684 A Repair heart septum defect 34.29 NA NA 19.66 15.13 3.39 NA NA 57.34 52.81 090
33688 A Repair heart septum defect 34.67 NA NA 9.41 10.21 4.73 NA NA 48.81 49.61 090
33690 A Reinforce pulmonary artery 20.20 NA NA 8.60 9.77 1.97 NA NA 30.77 31.94 090
33692 A Repair of heart defects 31.38 NA NA 9.20 12.74 4.58 NA NA 45.16 48.70 090
33694 A Repair of heart defects 35.49 NA NA 10.06 13.18 5.28 NA NA 50.83 53.95 090
33697 A Repair of heart defects 37.49 NA NA 21.95 16.64 4.09 NA NA 63.53 58.22 090
33702 A Repair of heart defects 27.11 NA NA 11.46 12.29 3.68 NA NA 42.25 43.08 090
33710 A Repair of heart defects 30.28 NA NA 11.65 13.38 4.43 NA NA 46.36 48.09 090
33720 A Repair of heart defect 27.13 NA NA 11.13 11.99 3.84 NA NA 42.10 42.96 090
33722 A Repair of heart defect 29.05 NA NA 8.66 12.55 1.30 NA NA 39.01 42.90 090
33724 A Repair venous anomaly 27.55 NA NA 10.56 10.56 4.00 NA NA 42.11 42.11 090
33726 A Repair pul venous stenosis 37.04 NA NA 13.46 13.46 5.03 NA NA 55.53 55.53 090
33730 A Repair heart-vein defect(s) 36.01 NA NA 13.29 13.91 5.03 NA NA 54.33 54.95 090
33732 A Repair heart-vein defect 28.80 NA NA 14.82 13.74 3.68 NA NA 47.30 46.22 090
33735 A Revision of heart chamber 22.04 NA NA 9.45 9.08 1.92 NA NA 33.41 33.04 090
33736 A Revision of heart chamber 24.16 NA NA 10.74 11.57 3.09 NA NA 37.99 38.82 090
33737 A Revision of heart chamber 22.34 NA NA 7.53 10.08 3.25 NA NA 33.12 35.67 090
33750 A Major vessel shunt 22.06 NA NA 11.40 10.51 1.16 NA NA 34.62 33.73 090
33755 A Major vessel shunt 22.44 NA NA 7.78 8.55 3.26 NA NA 33.48 34.25 090
33762 A Major vessel shunt 22.44 NA NA 7.13 9.40 3.14 NA NA 32.71 34.98 090
33764 A Major vessel shunt graft 22.44 NA NA 9.22 9.97 3.01 NA NA 34.67 35.42 090
33766 A Major vessel shunt 23.41 NA NA 8.53 10.89 3.70 NA NA 35.64 38.00 090
33767 A Major vessel shunt 25.14 NA NA 9.42 11.15 3.82 NA NA 38.38 40.11 090
33768 A Cavopulmonary shunting 8.00 NA NA 2.21 2.55 1.19 NA NA 11.40 11.74 ZZZ
33770 A Repair great vessels defect 39.02 NA NA 10.56 13.65 5.74 NA NA 55.32 58.41 090
33771 A Repair great vessels defect 40.58 NA NA 10.55 11.92 5.68 NA NA 56.81 58.18 090
33774 A Repair great vessels defect 31.54 NA NA 12.38 14.09 4.81 NA NA 48.73 50.44 090
33775 A Repair great vessels defect 32.83 NA NA 10.10 13.77 4.99 NA NA 47.92 51.59 090
33776 A Repair great vessels defect 34.53 NA NA 13.32 15.18 5.09 NA NA 52.94 54.80 090
33777 A Repair great vessels defect 33.95 NA NA 9.93 14.19 5.49 NA NA 49.37 53.63 090
33778 A Repair great vessels defect 42.62 NA NA 15.19 16.47 6.20 NA NA 64.01 65.29 090
33779 A Repair great vessels defect 43.15 NA NA 11.37 14.37 2.92 NA NA 57.44 60.44 090
33780 A Repair great vessels defect 43.85 NA NA 11.68 17.23 3.68 NA NA 59.21 64.76 090
33781 A Repair great vessels defect 43.16 NA NA 14.16 13.54 5.97 NA NA 63.29 62.67 090
33786 A Repair arterial trunk 41.74 NA NA 11.42 15.39 5.71 NA NA 58.87 62.84 090
33788 A Revision of pulmonary artery 27.26 NA NA 9.70 11.39 4.03 NA NA 40.99 42.68 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33800 A Aortic suspension 17.23 NA NA 7.30 7.91 2.46 NA NA 26.99 27.60 090
33802 A Repair vessel defect 18.24 NA NA 7.53 8.80 2.27 NA NA 28.04 29.31 090
33803 A Repair vessel defect 20.18 NA NA 7.93 9.30 3.20 NA NA 31.31 32.68 090
33813 A Repair septal defect 21.23 NA NA 8.96 10.42 3.13 NA NA 33.32 34.78 090
33814 A Repair septal defect 26.41 NA NA 10.44 12.09 3.85 NA NA 40.70 42.35 090
33820 A Revise major vessel 16.61 NA NA 8.41 8.37 2.35 NA NA 27.37 27.33 090
33822 A Revise major vessel 17.63 NA NA 5.93 8.20 2.68 NA NA 26.24 28.51 090
33824 A Revise major vessel 20.10 NA NA 8.57 9.63 2.89 NA NA 31.56 32.62 090
33840 A Remove aorta constriction 21.21 NA NA 8.95 9.96 2.16 NA NA 32.32 33.33 090
33845 A Remove aorta constriction 22.77 NA NA 9.57 10.91 3.22 NA NA 35.56 36.90 090
33851 A Remove aorta constriction 21.85 NA NA 9.12 10.29 3.18 NA NA 34.15 35.32 090
33852 A Repair septal defect 24.28 NA NA 9.85 10.98 2.16 NA NA 36.29 37.42 090
33853 A Repair septal defect 32.35 NA NA 13.00 14.37 4.48 NA NA 49.83 51.20 090
33860 A Ascending aortic graft 59.33 NA NA 20.58 17.48 5.76 NA NA 85.67 82.57 090
33861 A Ascending aortic graft 43.94 NA NA 16.07 17.30 6.37 NA NA 66.38 67.61 090
33863 A Ascending aortic graft 58.71 NA NA 19.98 19.01 6.59 NA NA 85.28 84.31 090
33870 A Transverse aortic arch graft 45.93 NA NA 16.64 17.95 6.62 NA NA 69.19 70.50 090
33875 A Thoracic aortic graft 35.68 NA NA 13.12 13.85 4.89 NA NA 53.69 54.42 090
33877 A Thoracoabdominal graft 68.85 NA NA 21.75 17.67 5.94 NA NA 96.54 92.46 090
33880 A Endovasc taa repr incl subcl 34.48 NA NA 10.50 12.73 2.75 NA NA 47.73 49.96 090
33881 A Endovasc taa repr w/o subcl 29.48 NA NA 9.27 11.29 2.33 NA NA 41.08 43.10 090
33883 A Insert endovasc prosth, taa 20.99 NA NA 6.95 8.62 2.11 NA NA 30.05 31.72 090
33884 A Endovasc prosth, taa, add-on 8.20 NA NA 2.00 2.43 0.86 NA NA 11.06 11.49 ZZZ
33886 A Endovasc prosth, delayed 17.99 NA NA 6.20 7.72 1.80 NA NA 25.99 27.51 090
33889 A Artery transpose/endovas taa 15.92 NA NA 4.15 4.92 2.18 NA NA 22.25 23.02 000
33891 A Car-car bp grft/endovas taa 20.00 NA NA 6.30 6.80 2.73 NA NA 29.03 29.53 000
33910 A Remove lung artery emboli 29.59 NA NA 11.28 11.39 3.70 NA NA 44.57 44.68 090
33915 A Remove lung artery emboli 24.83 NA NA 9.41 9.58 1.44 NA NA 35.68 35.85 090
33916 A Surgery of great vessel 28.30 NA NA 10.87 11.22 3.67 NA NA 42.84 43.19 090
33917 A Repair pulmonary artery 25.14 NA NA 10.38 11.73 3.70 NA NA 39.22 40.57 090
33920 A Repair pulmonary atresia 32.58 NA NA 11.32 13.20 4.38 NA NA 48.28 50.16 090
33922 A Transect pulmonary artery 24.09 NA NA 11.47 11.04 3.10 NA NA 38.66 38.23 090
33924 A Remove pulmonary shunt 5.49 NA NA 2.14 1.92 0.82 NA NA 8.45 8.23 ZZZ
33925 A Rpr pul art unifocal w/o cpb 31.25 NA NA 10.16 13.54 4.61 NA NA 46.02 49.40 090
33926 A Repr pul art, unifocal w/cpb 44.68 NA NA 14.32 16.84 6.22 NA NA 65.22 67.74 090
33930 X Removal of donor heart/lung 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
33933 C Prepare donor heart/lung 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
33935 R Transplantation, heart/lung 61.68 NA NA 23.24 27.39 9.06 NA NA 93.98 98.13 090
33940 X Removal of donor heart 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
33944 C Prepare donor heart 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
33945 R Transplantation of heart 89.08 NA NA 30.80 23.74 6.26 NA NA 126.14 119.08 090
33960 A External circulation assist 19.33 NA NA 5.63 5.09 2.67 NA NA 27.63 27.09 000
33961 A External circulation assist 10.91 NA NA 2.95 3.45 0.88 NA NA 14.74 15.24 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33967 A Insert ia percut device 4.84 NA NA 2.48 2.00 0.35 NA NA 7.67 7.19 000
33968 A Remove aortic assist device 0.64 NA NA 0.27 0.24 0.07 NA NA 0.98 0.95 000
33970 A Aortic circulation assist 6.74 NA NA 2.56 2.35 0.82 NA NA 10.12 9.91 000
33971 A Aortic circulation assist 11.91 NA NA 6.08 6.02 1.25 NA NA 19.24 19.18 090
33973 A Insert balloon device 9.75 NA NA 3.92 3.46 1.26 NA NA 14.93 14.47 000
33974 A Remove intra-aortic balloon 14.93 NA NA 7.81 7.86 1.74 NA NA 24.48 24.53 090
33975 A Implant ventricular device 20.97 NA NA 6.64 6.37 3.07 NA NA 30.68 30.41 XXX
33976 A Implant ventricular device 22.97 NA NA 7.92 7.64 3.26 NA NA 34.15 33.87 XXX
33977 A Remove ventricular device 20.07 NA NA 9.36 10.64 2.81 NA NA 32.24 33.52 090
33978 A Remove ventricular device 22.51 NA NA 10.47 11.43 3.31 NA NA 36.29 37.25 090
33979 A Insert intracorporeal device 45.93 NA NA 14.39 14.79 6.97 NA NA 67.29 67.69 XXX
33980 A Remove intracorporeal device 64.86 NA NA 24.94 25.17 8.59 NA NA 98.39 98.62 090
33999 C Cardiac surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
34001 A Removal of artery clot 17.78 NA NA 6.62 6.69 1.85 NA NA 26.25 26.32 090
34051 A Removal of artery clot 16.91 NA NA 6.89 7.56 2.21 NA NA 26.01 26.68 090
34101 A Removal of artery clot 10.85 NA NA 4.40 5.11 1.41 NA NA 16.66 17.37 090
34111 A Removal of arm artery clot 10.85 NA NA 4.47 5.13 1.40 NA NA 16.72 17.38 090
34151 A Removal of artery clot 26.41 NA NA 8.81 10.00 3.56 NA NA 38.78 39.97 090
34201 A Removal of artery clot 19.38 NA NA 6.77 5.75 1.45 NA NA 27.60 26.58 090
34203 A Removal of leg artery clot 17.73 NA NA 6.52 7.68 2.36 NA NA 26.61 27.77 090
34401 A Removal of vein clot 26.41 NA NA 9.58 10.39 3.10 NA NA 39.09 39.90 090
34421 A Removal of vein clot 13.29 NA NA 5.22 6.02 1.55 NA NA 20.06 20.86 090
34451 A Removal of vein clot 28.41 NA NA 9.66 11.00 3.84 NA NA 41.91 43.25 090
34471 A Removal of vein clot 21.00 NA NA 7.66 5.89 1.18 NA NA 29.84 28.07 090
34490 A Removal of vein clot 10.83 NA NA 4.45 5.18 1.41 NA NA 16.69 17.42 090
34501 A Repair valve, femoral vein 16.74 NA NA 6.91 8.10 2.35 NA NA 26.00 27.19 090
34502 A Reconstruct vena cava 27.86 NA NA 10.76 11.91 3.63 NA NA 42.25 43.40 090
34510 A Transposition of vein valve 19.80 NA NA 7.24 8.87 2.33 NA NA 29.37 31.00 090
34520 A Cross-over vein graft 19.05 NA NA 9.25 8.65 2.29 NA NA 30.59 29.99 090
34530 A Leg vein fusion 17.77 NA NA 7.87 8.43 1.74 NA NA 27.38 27.94 090
34800 A Endovas aaa repr w/sm tube 21.46 NA NA 7.39 8.72 2.46 NA NA 31.31 32.64 090
34802 A Endovas aaa repr w/2-p part 23.71 NA NA 8.18 9.38 2.33 NA NA 34.22 35.42 090
34803 A Endovas aaa repr w/3-p part 24.74 NA NA 8.09 9.68 2.01 NA NA 34.84 36.43 090
34804 A Endovas aaa repr w/1-p part 23.71 NA NA 8.06 9.37 2.30 NA NA 34.07 35.38 090
34805 A Endovas aaa repr w/long tube 22.59 NA NA 7.23 9.04 2.01 NA NA 31.83 33.64 090
34808 A Endovas iliac a device addon 4.12 NA NA 1.10 1.30 0.59 NA NA 5.81 6.01 ZZZ
34812 A Xpose for endoprosth, femorl 6.74 NA NA 1.72 2.10 1.18 NA NA 9.64 10.02 000
34813 A Femoral endovas graft add-on 4.79 NA NA 1.20 1.48 0.67 NA NA 6.66 6.94 ZZZ
34820 A Xpose for endoprosth, iliac 9.74 NA NA 2.46 3.04 1.50 NA NA 13.70 14.28 000
34825 A Endovasc extend prosth, init 12.72 NA NA 5.12 5.89 1.28 NA NA 19.12 19.89 090
34826 A Endovasc exten prosth, addÆl 4.12 NA NA 1.14 1.31 0.44 NA NA 5.70 5.87 ZZZ
34830 A Open aortic tube prosth repr 35.10 NA NA 10.77 12.96 4.55 NA NA 50.42 52.61 090
34831 A Open aortoiliac prosth repr 37.85 NA NA 12.09 11.82 4.89 NA NA 54.83 54.56 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
34832 A Open aortofemor prosth repr 37.85 NA NA 11.60 13.87 4.85 NA NA 54.30 56.57 090
34833 A Xpose for endoprosth, iliac 11.98 NA NA 3.29 4.15 1.70 NA NA 16.97 17.83 000
34834 A Xpose, endoprosth, brachial 5.34 NA NA 1.60 2.04 0.76 NA NA 7.70 8.14 000
34900 A Endovasc iliac repr w/graft 16.77 NA NA 6.22 7.24 2.00 NA NA 24.99 26.01 090
35001 A Repair defect of artery 20.70 NA NA 7.62 9.07 2.81 NA NA 31.13 32.58 090
35002 A Repair artery rupture, neck 22.12 NA NA 7.80 9.22 3.00 NA NA 32.92 34.34 090
35005 A Repair defect of artery 19.18 NA NA 7.55 8.52 1.77 NA NA 28.50 29.47 090
35011 A Repair defect of artery 18.50 NA NA 6.40 7.59 2.55 NA NA 27.45 28.64 090
35013 A Repair artery rupture, arm 23.10 NA NA 7.93 9.24 3.10 NA NA 34.13 35.44 090
35021 A Repair defect of artery 22.09 NA NA 8.67 9.23 2.87 NA NA 33.63 34.19 090
35022 A Repair artery rupture, chest 25.62 NA NA 9.46 9.75 3.17 NA NA 38.25 38.54 090
35045 A Repair defect of arm artery 17.94 NA NA 6.53 7.26 2.45 NA NA 26.92 27.65 090
35081 A Repair defect of artery 33.37 NA NA 11.05 11.36 4.01 NA NA 48.43 48.74 090
35082 A Repair artery rupture, aorta 41.93 NA NA 13.12 14.75 5.44 NA NA 60.49 62.12 090
35091 A Repair defect of artery 35.35 NA NA 10.39 12.77 5.14 NA NA 50.88 53.26 090
35092 A Repair artery rupture, aorta 50.81 NA NA 15.02 16.98 6.40 NA NA 72.23 74.19 090
35102 A Repair defect of artery 36.37 NA NA 11.62 12.17 4.48 NA NA 52.47 53.02 090
35103 A Repair artery rupture, groin 43.49 NA NA 13.25 15.19 5.76 NA NA 62.50 64.44 090
35111 A Repair defect of artery 26.17 NA NA 8.58 9.99 3.47 NA NA 38.22 39.63 090
35112 A Repair artery rupture,spleen 32.44 NA NA 10.48 11.59 4.08 NA NA 47.00 48.11 090
35121 A Repair defect of artery 31.41 NA NA 10.47 11.89 4.30 NA NA 46.18 47.60 090
35122 A Repair artery rupture, belly 37.76 NA NA 12.07 13.37 4.75 NA NA 54.58 55.88 090
35131 A Repair defect of artery 26.29 NA NA 8.89 10.28 3.80 NA NA 38.98 40.37 090
35132 A Repair artery rupture, groin 32.44 NA NA 10.27 11.85 4.30 NA NA 47.01 48.59 090
35141 A Repair defect of artery 20.83 NA NA 7.11 8.46 2.90 NA NA 30.84 32.19 090
35142 A Repair artery rupture, thigh 25.03 NA NA 8.41 9.87 3.36 NA NA 36.80 38.26 090
35151 A Repair defect of artery 23.61 NA NA 7.91 9.46 3.24 NA NA 34.76 36.31 090
35152 A Repair artery rupture, knee 27.53 NA NA 9.06 10.79 3.61 NA NA 40.20 41.93 090
35180 A Repair blood vessel lesion 15.01 NA NA 5.75 6.64 1.00 NA NA 21.76 22.65 090
35182 A Repair blood vessel lesion 31.58 NA NA 11.75 12.53 4.36 NA NA 47.69 48.47 090
35184 A Repair blood vessel lesion 18.72 NA NA 6.91 7.95 2.53 NA NA 28.16 29.20 090
35188 A Repair blood vessel lesion 15.05 NA NA 6.23 7.28 2.16 NA NA 23.44 24.49 090
35189 A Repair blood vessel lesion 29.85 NA NA 10.10 11.49 4.01 NA NA 43.96 45.35 090
35190 A Repair blood vessel lesion 13.33 NA NA 5.31 6.18 1.80 NA NA 20.44 21.31 090
35201 A Repair blood vessel lesion 16.84 NA NA 6.44 7.60 2.34 NA NA 25.62 26.78 090
35206 A Repair blood vessel lesion 13.76 NA NA 5.40 6.26 1.87 NA NA 21.03 21.89 090
35207 A Repair blood vessel lesion 10.85 NA NA 6.72 7.19 1.48 NA NA 19.05 19.52 090
35211 A Repair blood vessel lesion 24.50 NA NA 10.09 10.48 3.20 NA NA 37.79 38.18 090
35216 A Repair blood vessel lesion 36.47 NA NA 13.87 10.20 2.65 NA NA 52.99 49.32 090
35221 A Repair blood vessel lesion 26.54 NA NA 8.54 9.58 3.37 NA NA 38.45 39.49 090
35226 A Repair blood vessel lesion 15.22 NA NA 5.89 7.05 2.02 NA NA 23.13 24.29 090
35231 A Repair blood vessel lesion 21.08 NA NA 7.73 9.25 2.89 NA NA 31.70 33.22 090
35236 A Repair blood vessel lesion 17.94 NA NA 6.50 7.54 2.43 NA NA 26.87 27.91 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
35241 A Repair blood vessel lesion 25.50 NA NA 9.93 10.82 3.53 NA NA 38.96 39.85 090
35246 A Repair blood vessel lesion 28.15 NA NA 12.02 11.57 3.86 NA NA 44.03 43.58 090
35251 A Repair blood vessel lesion 31.83 NA NA 9.78 11.29 4.13 NA NA 45.74 47.25 090
35256 A Repair blood vessel lesion 18.98 NA NA 6.61 7.92 2.63 NA NA 28.22 29.53 090
35261 A Repair blood vessel lesion 18.88 NA NA 7.22 7.81 2.61 NA NA 28.71 29.30 090
35266 A Repair blood vessel lesion 15.75 NA NA 5.70 6.68 2.10 NA NA 23.55 24.53 090
35271 A Repair blood vessel lesion 24.50 NA NA 9.65 10.30 3.16 NA NA 37.31 37.96 090
35276 A Repair blood vessel lesion 25.72 NA NA 9.61 10.80 3.49 NA NA 38.82 40.01 090
35281 A Repair blood vessel lesion 29.93 NA NA 9.76 11.22 3.97 NA NA 43.66 45.12 090
35286 A Repair blood vessel lesion 17.06 NA NA 6.43 7.65 2.35 NA NA 25.84 27.06 090
35301 A Rechanneling of artery 19.53 NA NA 6.87 8.04 2.68 NA NA 29.08 30.25 090
35302 A Rechanneling of artery 21.27 NA NA 7.14 7.14 2.98 NA NA 31.39 31.39 090
35303 A Rechanneling of artery 23.52 NA NA 7.72 7.72 3.26 NA NA 34.50 34.50 090
35304 A Rechanneling of artery 24.52 NA NA 7.97 7.97 3.41 NA NA 35.90 35.90 090
35305 A Rechanneling of artery 23.52 NA NA 7.72 7.72 3.26 NA NA 34.50 34.50 090
35306 A Rechanneling of artery 9.25 NA NA 2.38 2.38 1.34 NA NA 12.97 12.97 ZZZ
35311 A Rechanneling of artery 28.52 NA NA 9.66 11.22 3.42 NA NA 41.60 43.16 090
35321 A Rechanneling of artery 16.51 NA NA 5.97 7.03 2.25 NA NA 24.73 25.79 090
35331 A Rechanneling of artery 27.61 NA NA 9.00 10.67 3.83 NA NA 40.44 42.11 090
35341 A Rechanneling of artery 26.10 NA NA 8.53 10.28 3.78 NA NA 38.41 40.16 090
35351 A Rechanneling of artery 24.53 NA NA 7.93 9.18 3.35 NA NA 35.81 37.06 090
35355 A Rechanneling of artery 19.78 NA NA 6.53 7.69 2.67 NA NA 28.98 30.14 090
35361 A Rechanneling of artery 30.11 NA NA 9.69 11.20 4.15 NA NA 43.95 45.46 090
35363 A Rechanneling of artery 32.22 NA NA 10.55 12.07 4.33 NA NA 47.10 48.62 090
35371 A Rechanneling of artery 15.23 NA NA 5.48 6.58 2.14 NA NA 22.85 23.95 090
35372 A Rechanneling of artery 18.50 NA NA 6.30 7.61 2.63 NA NA 27.43 28.74 090
35390 A Reoperation, carotid add-on 3.19 NA NA 0.85 1.01 0.46 NA NA 4.50 4.66 ZZZ
35400 A Angioscopy 3.00 NA NA 0.75 1.02 0.43 NA NA 4.18 4.45 ZZZ
35450 A Repair arterial blockage 10.05 NA NA 3.18 3.47 1.25 NA NA 14.48 14.77 000
35452 A Repair arterial blockage 6.90 NA NA 2.11 2.48 0.94 NA NA 9.95 10.32 000
35454 A Repair arterial blockage 6.03 NA NA 1.82 2.19 0.87 NA NA 8.72 9.09 000
35456 A Repair arterial blockage 7.34 NA NA 2.29 2.64 1.04 NA NA 10.67 11.02 000
35458 A Repair arterial blockage 9.48 NA NA 2.90 3.33 1.26 NA NA 13.64 14.07 000
35459 A Repair arterial blockage 8.62 NA NA 2.52 3.01 1.21 NA NA 12.35 12.84 000
35460 A Repair venous blockage 6.03 NA NA 1.78 2.15 0.83 NA NA 8.64 9.01 000
35470 A Repair arterial blockage 8.62 60.53 81.78 3.41 3.37 0.69 69.84 91.09 12.72 12.68 000
35471 A Repair arterial blockage 10.05 65.60 91.60 4.66 4.13 0.67 76.32 102.32 15.38 14.85 000
35472 A Repair arterial blockage 6.90 47.16 60.05 2.76 2.75 0.58 54.64 67.53 10.24 10.23 000
35473 A Repair arterial blockage 6.03 46.08 56.40 2.47 2.43 0.51 52.62 62.94 9.01 8.97 000
35474 A Repair arterial blockage 7.35 59.59 80.70 2.93 2.90 0.57 67.51 88.62 10.85 10.82 000
35475 R Repair arterial blockage 9.48 47.48 53.95 3.25 3.48 0.62 57.58 64.05 13.35 13.58 000
35476 A Repair venous blockage 6.03 35.61 42.45 1.97 2.26 0.34 41.98 48.82 8.34 8.63 000
35480 A Atherectomy, open 11.06 NA NA 3.98 4.03 1.28 NA NA 16.32 16.37 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
35481 A Atherectomy, open 7.60 NA NA 2.49 2.78 1.13 NA NA 11.22 11.51 000
35482 A Atherectomy, open 6.64 NA NA 2.12 2.45 0.89 NA NA 9.65 9.98 000
35483 A Atherectomy, open 8.09 NA NA 2.78 2.96 1.15 NA NA 12.02 12.20 000
35484 A Atherectomy, open 10.42 NA NA 3.05 3.59 1.27 NA NA 14.74 15.28 000
35485 A Atherectomy, open 9.48 NA NA 2.99 3.40 1.35 NA NA 13.82 14.23 000
35490 A Atherectomy, percutaneous 11.06 NA NA 6.33 5.11 0.71 NA NA 18.10 16.88 000
35491 A Atherectomy, percutaneous 7.60 NA NA 3.96 3.46 0.74 NA NA 12.30 11.80 000
35492 A Atherectomy, percutaneous 6.64 NA NA 3.64 3.30 0.43 NA NA 10.71 10.37 000
35493 A Atherectomy, percutaneous 8.09 NA NA 4.15 3.89 0.56 NA NA 12.80 12.54 000
35494 A Atherectomy, percutaneous 10.42 NA NA 5.16 4.64 0.59 NA NA 16.17 15.65 000
35495 A Atherectomy, percutaneous 9.48 NA NA 4.64 4.45 0.69 NA NA 14.81 14.62 000
35500 A Harvest vein for bypass 6.44 NA NA 1.68 1.94 0.93 NA NA 9.05 9.31 ZZZ
35501 A Artery bypass graft 28.99 NA NA 11.51 9.22 4.10 NA NA 44.60 42.31 090
35506 A Artery bypass graft 25.23 NA NA 8.44 9.21 2.87 NA NA 36.54 37.31 090
35508 A Artery bypass graft 25.99 NA NA 9.09 9.35 2.78 NA NA 37.86 38.12 090
35509 A Artery bypass graft 27.99 NA NA 10.68 9.24 3.92 NA NA 42.59 41.15 090
35510 A Artery bypass graft 24.29 NA NA 7.76 9.57 2.12 NA NA 34.17 35.98 090
35511 A Artery bypass graft 22.12 NA NA 7.28 8.83 2.91 NA NA 32.31 33.86 090
35512 A Artery bypass graft 23.79 NA NA 7.48 9.37 2.12 NA NA 33.39 35.28 090
35515 A Artery bypass graft 25.99 NA NA 8.38 9.06 2.78 NA NA 37.15 37.83 090
35516 A Artery bypass graft 24.11 NA NA 7.76 7.04 2.34 NA NA 34.21 33.49 090
35518 A Artery bypass graft 22.57 NA NA 7.50 8.60 3.03 NA NA 33.10 34.20 090
35521 A Artery bypass graft 24.00 NA NA 8.11 9.40 3.13 NA NA 35.24 36.53 090
35522 A Artery bypass graft 23.05 NA NA 7.46 9.18 2.12 NA NA 32.63 34.35 090
35525 A Artery bypass graft 21.59 NA NA 7.14 8.81 2.12 NA NA 30.85 32.52 090
35526 A Artery bypass graft 31.47 NA NA 18.38 13.97 3.63 NA NA 53.48 49.07 090
35531 A Artery bypass graft 38.98 NA NA 11.89 13.83 5.18 NA NA 56.05 57.99 090
35533 A Artery bypass graft 29.79 NA NA 9.94 11.28 3.85 NA NA 43.58 44.92 090
35536 A Artery bypass graft 33.60 NA NA 10.53 12.34 4.62 NA NA 48.75 50.56 090
35537 A Artery bypass graft 41.75 NA NA 13.22 13.22 5.72 NA NA 60.69 60.69 090
35538 A Artery bypass graft 46.82 NA NA 14.60 14.60 6.39 NA NA 67.81 67.81 090
35539 A Artery bypass graft 43.98 NA NA 13.73 13.73 6.02 NA NA 63.73 63.73 090
35540 A Artery bypass graft 49.20 NA NA 15.10 15.10 6.76 NA NA 71.06 71.06 090
35548 A Artery bypass graft 22.57 NA NA 7.86 9.03 2.98 NA NA 33.41 34.58 090
35549 A Artery bypass graft 24.34 NA NA 9.15 10.07 3.30 NA NA 36.79 37.71 090
35551 A Artery bypass graft 27.72 NA NA 9.86 11.08 3.75 NA NA 41.33 42.55 090
35556 A Artery bypass graft 26.62 NA NA 8.88 9.51 3.10 NA NA 38.60 39.23 090
35558 A Artery bypass graft 23.00 NA NA 8.05 9.17 3.00 NA NA 34.05 35.17 090
35560 A Artery bypass graft 33.90 NA NA 10.74 12.67 4.75 NA NA 49.39 51.32 090
35563 A Artery bypass graft 25.99 NA NA 8.57 10.03 3.52 NA NA 38.08 39.54 090
35565 A Artery bypass graft 25.00 NA NA 8.46 9.71 3.30 NA NA 36.76 38.01 090
35566 A Artery bypass graft 32.22 NA NA 10.14 11.07 3.83 NA NA 46.19 47.12 090
35571 A Artery bypass graft 25.39 NA NA 8.40 10.23 3.43 NA NA 37.22 39.05 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
35572 A Harvest femoropopliteal vein 6.81 NA NA 1.88 2.15 0.99 NA NA 9.68 9.95 ZZZ
35583 A Vein bypass graft 27.62 NA NA 8.96 9.85 3.17 NA NA 39.75 40.64 090
35585 A Vein bypass graft 32.22 NA NA 10.32 11.74 4.02 NA NA 46.56 47.98 090
35587 A Vein bypass graft 26.08 NA NA 8.64 10.75 3.52 NA NA 38.24 40.35 090
35600 A Harvest artery for cabg 4.94 NA NA 1.54 1.60 0.73 NA NA 7.21 7.27 ZZZ
35601 A Artery bypass graft 26.99 NA NA 10.48 9.09 3.72 NA NA 41.19 39.80 090
35606 A Artery bypass graft 22.36 NA NA 7.64 8.67 2.70 NA NA 32.70 33.73 090
35612 A Artery bypass graft 16.71 NA NA 6.36 7.50 2.09 NA NA 25.16 26.30 090
35616 A Artery bypass graft 21.74 NA NA 7.10 7.85 2.20 NA NA 31.04 31.79 090
35621 A Artery bypass graft 20.95 NA NA 6.99 8.25 2.92 NA NA 30.86 32.12 090
35623 A Bypass graft, not vein 25.79 NA NA 8.60 10.02 3.46 NA NA 37.85 39.27 090
35626 A Artery bypass graft 29.06 NA NA 10.20 11.53 4.08 NA NA 43.34 44.67 090
35631 A Artery bypass graft 35.90 NA NA 10.98 13.12 4.96 NA NA 51.84 53.98 090
35636 A Artery bypass graft 31.62 NA NA 9.88 11.69 4.10 NA NA 45.60 47.41 090
35637 A Artery bypass graft 32.92 NA NA 10.92 10.92 4.44 NA NA 48.28 48.28 090
35638 A Artery bypass graft 33.47 NA NA 11.06 11.06 4.52 NA NA 49.05 49.05 090
35642 A Artery bypass graft 18.85 NA NA 7.67 8.43 2.28 NA NA 28.80 29.56 090
35645 A Artery bypass graft 18.34 NA NA 7.31 8.03 2.50 NA NA 28.15 28.87 090
35646 A Artery bypass graft 32.84 NA NA 10.73 12.51 4.44 NA NA 48.01 49.79 090
35647 A Artery bypass graft 29.62 NA NA 9.75 11.27 3.99 NA NA 43.36 44.88 090
35650 A Artery bypass graft 20.08 NA NA 6.75 7.96 2.72 NA NA 29.55 30.76 090
35651 A Artery bypass graft 25.97 NA NA 8.81 10.24 3.36 NA NA 38.14 39.57 090
35654 A Artery bypass graft 26.17 NA NA 8.54 10.12 3.53 NA NA 38.24 39.82 090
35656 A Artery bypass graft 20.39 NA NA 7.02 8.21 2.80 NA NA 30.21 31.40 090
35661 A Artery bypass graft 20.22 NA NA 7.26 8.51 2.72 NA NA 30.20 31.45 090
35663 A Artery bypass graft 23.80 NA NA 8.09 9.50 3.11 NA NA 35.00 36.41 090
35665 A Artery bypass graft 22.22 NA NA 7.60 8.98 3.01 NA NA 32.83 34.21 090
35666 A Artery bypass graft 23.53 NA NA 8.71 10.16 3.16 NA NA 35.40 36.85 090
35671 A Artery bypass graft 20.64 NA NA 7.94 9.01 2.78 NA NA 31.36 32.43 090
35681 A Composite bypass graft 1.60 NA NA 0.42 0.50 0.23 NA NA 2.25 2.33 ZZZ
35682 A Composite bypass graft 7.19 NA NA 1.77 2.23 1.03 NA NA 9.99 10.45 ZZZ
35683 A Composite bypass graft 8.49 NA NA 2.11 2.64 1.20 NA NA 11.80 12.33 ZZZ
35685 A Bypass graft patency/patch 4.04 NA NA 1.00 1.26 0.58 NA NA 5.62 5.88 ZZZ
35686 A Bypass graft/av fist patency 3.34 NA NA 0.84 1.06 0.47 NA NA 4.65 4.87 ZZZ
35691 A Arterial transposition 18.32 NA NA 6.29 7.87 2.59 NA NA 27.20 28.78 090
35693 A Arterial transposition 15.64 NA NA 6.04 7.30 2.22 NA NA 23.90 25.16 090
35694 A Arterial transposition 19.19 NA NA 6.54 8.09 2.70 NA NA 28.43 29.98 090
35695 A Arterial transposition 19.97 NA NA 6.60 8.06 2.74 NA NA 29.31 30.77 090
35697 A Reimplant artery each 3.00 NA NA 0.77 0.96 0.41 NA NA 4.18 4.37 ZZZ
35700 A Reoperation, bypass graft 3.08 NA NA 0.80 0.97 0.44 NA NA 4.32 4.49 ZZZ
35701 A Exploration, carotid artery 9.11 NA NA 4.27 4.93 1.12 NA NA 14.50 15.16 090
35721 A Exploration, femoral artery 7.66 NA NA 3.74 4.26 1.03 NA NA 12.43 12.95 090
35741 A Exploration popliteal artery 8.61 NA NA 3.96 4.49 1.12 NA NA 13.69 14.22 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
35761 A Exploration of artery/vein 5.84 NA NA 3.47 3.88 0.75 NA NA 10.06 10.47 090
35800 A Explore neck vessels 7.99 NA NA 3.95 4.48 0.95 NA NA 12.89 13.42 090
35820 A Explore chest vessels 36.81 NA NA 13.20 8.70 1.95 NA NA 51.96 47.46 090
35840 A Explore abdominal vessels 10.87 NA NA 4.86 5.18 1.34 NA NA 17.07 17.39 090
35860 A Explore limb vessels 6.72 NA NA 3.47 3.89 0.78 NA NA 10.97 11.39 090
35870 A Repair vessel graft defect 24.39 NA NA 8.19 9.37 3.01 NA NA 35.59 36.77 090
35875 A Removal of clot in graft 10.64 NA NA 4.39 4.98 1.41 NA NA 16.44 17.03 090
35876 A Removal of clot in graft 17.74 NA NA 6.12 7.16 2.40 NA NA 26.26 27.30 090
35879 A Revise graft w/vein 17.28 NA NA 6.12 7.30 2.28 NA NA 25.68 26.86 090
35881 A Revise graft w/vein 19.22 NA NA 6.68 8.17 2.56 NA NA 28.46 29.95 090
35883 A Revise graft w/nonauto graft 23.07 NA NA 8.96 8.96 3.19 NA NA 35.22 35.22 090
35884 A Revise graft w/vein 24.57 NA NA 9.43 9.43 3.41 NA NA 37.41 37.41 090
35901 A Excision, graft, neck 8.26 NA NA 4.29 5.05 1.15 NA NA 13.70 14.46 090
35903 A Excision, graft, extremity 9.44 NA NA 4.69 5.79 1.30 NA NA 15.43 16.53 090
35905 A Excision, graft, thorax 33.39 NA NA 10.72 12.57 4.44 NA NA 48.55 50.40 090
35907 A Excision, graft, abdomen 37.14 NA NA 11.28 13.44 4.92 NA NA 53.34 55.50 090
36000 A Place needle in vein 0.18 0.46 0.54 0.06 0.05 0.01 0.65 0.73 0.25 0.24 XXX
36002 A Pseudoaneurysm injection trt 1.96 2.12 2.68 0.77 0.92 0.17 4.25 4.81 2.90 3.05 000
36005 A Injection ext venography 0.95 8.25 7.80 0.35 0.32 0.05 9.25 8.80 1.35 1.32 000
36010 A Place catheter in vein 2.43 10.77 17.17 0.71 0.77 0.20 13.40 19.80 3.34 3.40 XXX
36011 A Place catheter in vein 3.14 19.01 25.62 0.92 1.03 0.27 22.42 29.03 4.33 4.44 XXX
36012 A Place catheter in vein 3.51 19.49 19.09 1.11 1.17 0.23 23.23 22.83 4.85 4.91 XXX
36013 A Place catheter in artery 2.52 19.05 20.78 0.97 0.76 0.25 21.82 23.55 3.74 3.53 XXX
36014 A Place catheter in artery 3.02 18.12 19.62 0.93 1.01 0.19 21.33 22.83 4.14 4.22 XXX
36015 A Place catheter in artery 3.51 17.56 22.14 0.89 1.12 0.21 21.28 25.86 4.61 4.84 XXX
36100 A Establish access to artery 3.02 11.13 11.84 1.21 1.14 0.26 14.41 15.12 4.49 4.42 XXX
36120 A Establish access to artery 2.01 9.04 10.29 0.56 0.63 0.14 11.19 12.44 2.71 2.78 XXX
36140 A Establish access to artery 2.01 10.28 12.15 0.69 0.65 0.16 12.45 14.32 2.86 2.82 XXX
36145 A Artery to vein shunt 2.01 9.84 11.87 0.57 0.64 0.11 11.96 13.99 2.69 2.76 XXX
36160 A Establish access to aorta 2.52 11.52 12.99 0.74 0.82 0.26 14.30 15.77 3.52 3.60 XXX
36200 A Place catheter in aorta 3.02 13.27 15.70 0.96 1.00 0.24 16.53 18.96 4.22 4.26 XXX
36215 A Place catheter in artery 4.67 25.27 26.59 1.77 1.65 0.27 30.21 31.53 6.71 6.59 XXX
36216 A Place catheter in artery 5.27 27.05 28.57 1.90 1.82 0.31 32.63 34.15 7.48 7.40 XXX
36217 A Place catheter in artery 6.29 44.27 52.65 2.16 2.17 0.44 51.00 59.38 8.89 8.90 XXX
36218 A Place catheter in artery 1.01 3.61 4.72 0.34 0.34 0.07 4.69 5.80 1.42 1.42 ZZZ
36245 A Place catheter in artery 4.67 28.42 31.17 2.06 1.78 0.31 33.40 36.15 7.04 6.76 XXX
36246 A Place catheter in artery 5.27 26.82 29.18 1.88 1.84 0.38 32.47 34.83 7.53 7.49 XXX
36247 A Place catheter in artery 6.29 44.34 48.22 2.26 2.17 0.47 51.10 54.98 9.02 8.93 XXX
36248 A Place catheter in artery 1.01 3.10 3.81 0.36 0.35 0.07 4.18 4.89 1.44 1.43 ZZZ
36260 A Insertion of infusion pump 9.82 NA NA 4.82 4.87 1.29 NA NA 15.93 15.98 090
36261 A Revision of infusion pump 5.55 NA NA 3.19 3.54 0.70 NA NA 9.44 9.79 090
36262 A Removal of infusion pump 4.05 NA NA 2.66 2.73 0.54 NA NA 7.25 7.32 090
36299 C Vessel injection procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
36400 A Bl draw 3 yrs fem/jugular 0.38 0.33 0.29 0.11 0.10 0.03 0.74 0.70 0.52 0.51 XXX
36405 A Bl draw 3 yrs scalp vein 0.31 0.29 0.27 0.08 0.08 0.03 0.63 0.61 0.42 0.42 XXX
36406 A Bl draw 3 yrs other vein 0.18 0.30 0.29 0.08 0.06 0.01 0.49 0.48 0.27 0.25 XXX
36410 A Non-routine bl draw 3 yrs 0.18 0.31 0.30 0.05 0.05 0.01 0.50 0.49 0.24 0.24 XXX
36415 X Routine venipuncture 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
36416 B Capillary blood draw 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
36420 A Vein access cutdown 1 yr 1.01 NA NA 0.21 0.26 0.07 NA NA 1.29 1.34 XXX
36425 A Vein access cutdown 1 yr 0.76 NA NA 0.22 0.22 0.06 NA NA 1.04 1.04 XXX
36430 A Blood transfusion service 0.00 0.93 0.99 0.00 0.76 0.06 0.99 1.05 0.06 0.82 XXX
36440 A Bl push transfuse, 2 yr or 1.03 NA NA 0.44 0.33 0.10 NA NA 1.57 1.46 XXX
36450 A Bl exchange/transfuse, nb 2.23 NA NA 0.80 0.73 0.21 NA NA 3.24 3.17 XXX
36455 A Bl exchange/transfuse non-nb 2.43 NA NA 0.75 0.95 0.15 NA NA 3.33 3.53 XXX
36460 A Transfusion service, fetal 6.58 NA NA 1.69 2.10 0.79 NA NA 9.06 9.47 XXX
36468 R Injection(s), spider veins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
36469 R Injection(s), spider veins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
36470 A Injection therapy of vein 1.09 2.42 2.62 0.65 0.71 0.12 3.63 3.83 1.86 1.92 010
36471 A Injection therapy of veins 1.60 2.56 2.94 0.80 0.92 0.19 4.35 4.73 2.59 2.71 010
36475 A Endovenous rf, 1st vein 6.72 36.10 47.57 1.95 2.39 0.37 43.19 54.66 9.04 9.48 000
36476 A Endovenous rf, vein add-on 3.38 5.92 7.39 0.88 1.08 0.18 9.48 10.95 4.44 4.64 ZZZ
36478 A Endovenous laser, 1st vein 6.72 31.10 42.85 2.03 2.41 0.37 38.19 49.94 9.12 9.50 000
36479 A Endovenous laser vein addon 3.38 6.38 7.59 0.99 1.10 0.18 9.94 11.15 4.55 4.66 ZZZ
36481 A Insertion of catheter, vein 6.98 NA NA 2.08 2.46 0.55 NA NA 9.61 9.99 000
36500 A Insertion of catheter, vein 3.51 NA NA 1.17 1.32 0.20 NA NA 4.88 5.03 000
36510 A Insertion of catheter, vein 1.09 1.09 3.19 0.31 0.54 0.10 2.28 4.38 1.50 1.73 000
36511 A Apheresis wbc 1.74 NA NA 0.58 0.69 0.08 NA NA 2.40 2.51 000
36512 A Apheresis rbc 1.74 NA NA 0.61 0.71 0.08 NA NA 2.43 2.53 000
36513 A Apheresis platelets 1.74 NA NA 0.52 0.68 0.17 NA NA 2.43 2.59 000
36514 A Apheresis plasma 1.74 10.42 15.33 0.54 0.67 0.08 12.24 17.15 2.36 2.49 000
36515 A Apheresis, adsorp/reinfuse 1.74 44.78 60.92 0.52 0.63 0.08 46.60 62.74 2.34 2.45 000
36516 A Apheresis, selective 1.22 49.33 75.37 0.39 0.46 0.08 50.63 76.67 1.69 1.76 000
36522 A Photopheresis 1.67 34.98 33.02 0.87 0.94 0.13 36.78 34.82 2.67 2.74 000
36540 B Collect blood venous device 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
36550 A Declot vascular device 0.00 0.32 0.37 0.06 0.31 0.37 0.69 0.74 0.43 0.68 XXX
36555 A Insert non-tunnel cv cath 2.68 4.09 5.34 0.62 0.76 0.11 6.88 8.13 3.41 3.55 000
36556 A Insert non-tunnel cv cath 2.50 2.85 4.93 0.57 0.70 0.19 5.54 7.62 3.26 3.39 000
36557 A Insert tunneled cv cath 5.11 14.29 19.43 2.24 2.55 0.57 19.97 25.11 7.92 8.23 010
36558 A Insert tunneled cv cath 4.81 14.36 19.37 2.18 2.46 0.57 19.74 24.75 7.56 7.84 010
36560 A Insert tunneled cv cath 6.26 20.75 27.44 2.52 2.90 0.57 27.58 34.27 9.35 9.73 010
36561 A Insert tunneled cv cath 6.01 21.79 27.63 2.54 2.85 0.57 28.37 34.21 9.12 9.43 010
36563 A Insert tunneled cv cath 6.21 22.81 25.76 2.60 2.89 0.84 29.86 32.81 9.65 9.94 010
36565 A Insert tunneled cv cath 6.01 17.44 22.89 2.48 2.83 0.57 24.02 29.47 9.06 9.41 010
36566 A Insert tunneled cv cath 6.51 112.19 47.17 2.64 2.99 0.57 119.27 54.25 9.72 10.07 010
36568 A Insert picc cath 1.92 5.53 7.03 0.55 0.57 0.11 7.56 9.06 2.58 2.60 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
36569 A Insert picc cath 1.82 4.19 6.55 0.55 0.57 0.19 6.20 8.56 2.56 2.58 000
36570 A Insert picvad cath 5.33 22.38 30.47 2.26 2.61 0.57 28.28 36.37 8.16 8.51 010
36571 A Insert picvad cath 5.31 24.27 31.00 2.36 2.62 0.57 30.15 36.88 8.24 8.50 010
36575 A Repair tunneled cv cath 0.67 3.19 3.84 0.21 0.25 0.20 4.06 4.71 1.08 1.12 000
36576 A Repair tunneled cv cath 3.21 5.69 6.63 1.50 1.76 0.19 9.09 10.03 4.90 5.16 010
36578 A Replace tunneled cv cath 3.51 8.70 10.52 1.82 2.18 0.19 12.40 14.22 5.52 5.88 010
36580 A Replace cvad cath 1.31 3.82 6.16 0.39 0.41 0.19 5.32 7.66 1.89 1.91 000
36581 A Replace tunneled cv cath 3.45 14.84 18.33 1.55 1.83 0.19 18.48 21.97 5.19 5.47 010
36582 A Replace tunneled cv cath 5.21 20.00 24.51 2.20 2.70 0.19 25.40 29.91 7.60 8.10 010
36583 A Replace tunneled cv cath 5.26 20.04 24.53 2.27 2.73 0.19 25.49 29.98 7.72 8.18 010
36584 A Replace picc cath 1.20 3.73 6.16 0.52 0.54 0.19 5.12 7.55 1.91 1.93 000
36585 A Replace picvad cath 4.81 21.71 26.29 2.17 2.59 0.19 26.71 31.29 7.17 7.59 010
36589 A Removal tunneled cv cath 2.27 1.79 2.13 1.17 1.34 0.24 4.30 4.64 3.68 3.85 010
36590 A Removal tunneled cv cath 3.32 3.55 3.42 1.56 1.68 0.44 7.31 7.18 5.32 5.44 010
36595 A Mech remov tunneled cv cath 3.59 10.24 15.50 1.20 1.39 0.21 14.04 19.30 5.00 5.19 000
36596 A Mech remov tunneled cv cath 0.75 2.44 3.38 0.39 0.47 0.05 3.24 4.18 1.19 1.27 000
36597 A Reposition venous catheter 1.21 1.90 2.28 0.38 0.43 0.07 3.18 3.56 1.66 1.71 000
36598 T Inj w/fluor, eval cv device 0.74 2.15 2.52 0.24 2.04 0.05 2.94 3.31 1.03 2.83 000
36600 A Withdrawal of arterial blood 0.32 0.50 0.49 0.08 0.09 0.02 0.84 0.83 0.42 0.43 XXX
36620 A Insertion catheter, artery 1.15 NA NA 0.17 0.22 0.07 NA NA 1.39 1.44 000
36625 A Insertion catheter, artery 2.11 NA NA 0.49 0.52 0.26 NA NA 2.86 2.89 000
36640 A Insertion catheter, artery 2.10 NA NA 0.91 1.01 0.21 NA NA 3.22 3.32 000
36660 A Insertion catheter, artery 1.40 NA NA 0.20 0.38 0.14 NA NA 1.74 1.92 000
36680 A Insert needle, bone cavity 1.20 NA NA 0.33 0.45 0.11 NA NA 1.64 1.76 000
36800 A Insertion of cannula 2.43 NA NA 1.55 1.74 0.25 NA NA 4.23 4.42 000
36810 A Insertion of cannula 3.96 NA NA 1.34 1.60 0.45 NA NA 5.75 6.01 000
36815 A Insertion of cannula 2.62 NA NA 1.03 1.14 0.35 NA NA 4.00 4.11 000
36818 A Av fuse, uppr arm, cephalic 11.81 NA NA 4.81 5.73 1.90 NA NA 18.52 19.44 090
36819 A Av fuse, uppr arm, basilic 14.39 NA NA 5.22 6.08 1.96 NA NA 21.57 22.43 090
36820 A Av fusion/forearm vein 14.39 NA NA 5.31 6.11 1.95 NA NA 21.65 22.45 090
36821 A Av fusion direct any site 9.15 NA NA 4.01 4.49 1.23 NA NA 14.39 14.87 090
36822 A Insertion of cannula(s) 5.51 NA NA 3.79 4.23 0.79 NA NA 10.09 10.53 090
36823 A Insertion of cannula(s) 22.82 NA NA 8.80 9.23 2.89 NA NA 34.51 34.94 090
36825 A Artery-vein autograft 10.00 NA NA 4.31 4.87 1.35 NA NA 15.66 16.22 090
36830 A Artery-vein nonautograft 12.00 NA NA 4.23 4.98 1.66 NA NA 17.89 18.64 090
36831 A Open thrombect av fistula 8.01 NA NA 3.25 3.77 1.09 NA NA 12.35 12.87 090
36832 A Av fistula revision, open 10.50 NA NA 3.84 4.50 1.44 NA NA 15.78 16.44 090
36833 A Av fistula revision 11.95 NA NA 4.23 4.96 1.65 NA NA 17.83 18.56 090
36834 A Repair A-V aneurysm 11.11 NA NA 4.33 4.68 1.37 NA NA 16.81 17.16 090
36835 A Artery to vein shunt 7.43 NA NA 3.88 4.21 0.98 NA NA 12.29 12.62 090
36838 A Dist revas ligation, hemo 21.59 NA NA 7.09 8.81 3.02 NA NA 31.70 33.42 090
36860 A External cannula declotting 2.01 3.32 2.16 0.62 0.67 0.11 5.44 4.28 2.74 2.79 000
36861 A Cannula declotting 2.52 NA NA 1.22 1.42 0.27 NA NA 4.01 4.21 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
36870 A Percut thrombect av fistula 5.17 39.08 49.54 2.50 2.99 0.29 44.54 55.00 7.96 8.45 090
37140 A Revision of circulation 25.12 NA NA 8.82 10.07 2.02 NA NA 35.96 37.21 090
37145 A Revision of circulation 26.13 NA NA 9.06 10.41 3.26 NA NA 38.45 39.80 090
37160 A Revision of circulation 23.13 NA NA 8.11 8.97 2.82 NA NA 34.06 34.92 090
37180 A Revision of circulation 26.13 NA NA 8.95 9.96 3.35 NA NA 38.43 39.44 090
37181 A Splice spleen/kidney veins 28.26 NA NA 9.32 10.58 3.41 NA NA 40.99 42.25 090
37182 A Insert hepatic shunt (tips) 16.97 NA NA 5.11 5.82 1.00 NA NA 23.08 23.79 000
37183 A Remove hepatic shunt (tips) 7.99 NA NA 2.51 2.89 0.47 NA NA 10.97 11.35 000
37184 A Prim art mech thrombectomy 8.66 47.39 65.62 2.78 3.21 0.55 56.60 74.83 11.99 12.42 000
37185 A Prim art m-thrombect add-on 3.28 15.41 21.01 0.94 1.07 0.21 18.90 24.50 4.43 4.56 ZZZ
37186 A Sec art m-thrombect add-on 4.92 32.55 45.18 1.41 1.60 0.32 37.79 50.42 6.65 6.84 ZZZ
37187 A Venous mech thrombectomy 8.03 46.31 64.21 2.59 3.00 0.51 54.85 72.75 11.13 11.54 000
37188 A Venous m-thrombectomy add-on 5.71 40.43 56.59 1.93 2.25 0.37 46.51 62.67 8.01 8.33 000
37195 C Thrombolytic therapy, stroke 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
37200 A Transcatheter biopsy 4.55 NA NA 1.32 1.46 0.27 NA NA 6.14 6.28 000
37201 A Transcatheter therapy infuse 4.99 NA NA 2.11 2.43 0.33 NA NA 7.43 7.75 000
37202 A Transcatheter therapy infuse 5.67 NA NA 3.42 3.13 0.43 NA NA 9.52 9.23 000
37203 A Transcatheter retrieval 5.02 28.86 31.87 1.81 1.98 0.29 34.17 37.18 7.12 7.29 000
37204 A Transcatheter occlusion 18.11 NA NA 5.30 5.75 1.48 NA NA 24.89 25.34 000
37205 A Transcath iv stent, percut 8.27 NA NA 3.81 3.77 0.60 NA NA 12.68 12.64 000
37206 A Transcath iv stent/perc addl 4.12 NA NA 1.56 1.46 0.31 NA NA 5.99 5.89 ZZZ
37207 A Transcath iv stent, open 8.27 NA NA 2.43 2.98 1.17 NA NA 11.87 12.42 000
37208 A Transcath iv stent/open addl 4.12 NA NA 1.05 1.30 0.59 NA NA 5.76 6.01 ZZZ
37209 A Change iv cath at thromb tx 2.27 NA NA 0.67 0.72 0.15 NA NA 3.09 3.14 000
37210 A Embolization uterine fibroid 10.60 46.03 46.03 3.13 3.13 0.60 57.23 57.23 14.33 14.33 000
37215 R Transcath stent, cca w/eps 19.58 NA NA 10.08 9.34 1.09 NA NA 30.75 30.01 090
37216 N Transcath stent, cca w/o eps 18.85 NA NA 5.75 8.05 1.04 NA NA 25.64 27.94 090
37250 A Iv us first vessel add-on 2.10 NA NA 0.81 0.77 0.21 NA NA 3.12 3.08 ZZZ
37251 A Iv us each add vessel add-on 1.60 NA NA 0.52 0.54 0.19 NA NA 2.31 2.33 ZZZ
37500 A Endoscopy ligate perf veins 11.54 NA NA 5.42 6.49 1.54 NA NA 18.50 19.57 090
37501 C Vascular endoscopy procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
37565 A Ligation of neck vein 11.97 NA NA 5.11 5.49 1.33 NA NA 18.41 18.79 090
37600 A Ligation of neck artery 12.34 NA NA 4.81 6.18 1.41 NA NA 18.56 19.93 090
37605 A Ligation of neck artery 14.20 NA NA 5.57 6.57 1.99 NA NA 21.76 22.76 090
37606 A Ligation of neck artery 8.72 NA NA 4.89 4.64 1.23 NA NA 14.84 14.59 090
37607 A Ligation of a-v fistula 6.19 NA NA 3.08 3.44 0.85 NA NA 10.12 10.48 090
37609 A Temporal artery procedure 3.02 4.20 4.43 1.84 1.93 0.36 7.58 7.81 5.22 5.31 010
37615 A Ligation of neck artery 7.72 NA NA 4.01 4.09 0.68 NA NA 12.41 12.49 090
37616 A Ligation of chest artery 18.89 NA NA 7.92 8.04 2.33 NA NA 29.14 29.26 090
37617 A Ligation of abdomen artery 23.71 NA NA 7.89 8.85 2.98 NA NA 34.58 35.54 090
37618 A Ligation of extremity artery 5.95 NA NA 3.37 3.55 0.67 NA NA 9.99 10.17 090
37620 A Revision of major vein 11.49 NA NA 4.94 5.52 0.91 NA NA 17.34 17.92 090
37650 A Revision of major vein 8.41 NA NA 4.19 4.56 1.01 NA NA 13.61 13.98 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
37660 A Revision of major vein 22.20 NA NA 8.02 8.79 2.49 NA NA 32.71 33.48 090
37700 A Revise leg vein 3.76 NA NA 2.43 2.70 0.53 NA NA 6.72 6.99 090
37718 A Ligate/strip short leg vein 7.05 NA NA 3.51 3.92 0.14 NA NA 10.70 11.11 090
37722 A Ligate/strip long leg vein 8.08 NA NA 3.77 4.25 0.86 NA NA 12.71 13.19 090
37735 A Removal of leg veins/lesion 10.81 NA NA 4.65 5.29 1.48 NA NA 16.94 17.58 090
37760 A Ligation, leg veins, open 10.69 NA NA 4.53 5.14 1.44 NA NA 16.66 17.27 090
37765 A Phleb veins-extrem-to 20 7.63 NA NA 3.56 4.36 0.48 NA NA 11.67 12.47 090
37766 A Phleb veins-extrem 20+ 9.58 NA NA 4.09 5.01 0.48 NA NA 14.15 15.07 090
37780 A Revision of leg vein 3.87 NA NA 2.48 2.76 0.53 NA NA 6.88 7.16 090
37785 A Ligate/divide/excise vein 3.87 4.90 5.12 2.58 2.69 0.54 9.31 9.53 6.99 7.10 090
37788 A Revascularization, penis 23.21 NA NA 12.15 9.85 2.26 NA NA 37.62 35.32 090
37790 A Penile venous occlusion 8.37 NA NA 5.13 4.56 0.59 NA NA 14.09 13.52 090
37799 C Vascular surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
38100 A Removal of spleen, total 19.47 NA NA 6.90 6.35 1.92 NA NA 28.29 27.74 090
38101 A Removal of spleen, partial 19.47 NA NA 7.31 6.72 2.05 NA NA 28.83 28.24 090
38102 A Removal of spleen, total 4.79 NA NA 1.26 1.55 0.63 NA NA 6.68 6.97 ZZZ
38115 A Repair of ruptured spleen 21.80 NA NA 7.56 6.87 2.09 NA NA 31.45 30.76 090
38120 A Laparoscopy, splenectomy 16.97 NA NA 6.94 7.27 2.25 NA NA 26.16 26.49 090
38129 C Laparoscope proc, spleen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
38200 A Injection for spleen x-ray 2.64 NA NA 0.96 0.91 0.14 NA NA 3.74 3.69 000
38204 B Bl donor search management 2.00 0.00 0.00 0.00 0.00 0.06 2.06 2.06 2.06 2.06 XXX
38205 R Harvest allogenic stem cells 1.50 NA NA 0.55 0.64 0.07 NA NA 2.12 2.21 000
38206 R Harvest auto stem cells 1.50 NA NA 0.55 0.64 0.07 NA NA 2.12 2.21 000
38207 I Cryopreserve stem cells 0.47 0.00 0.00 0.00 0.00 0.01 0.48 0.48 0.48 0.48 XXX
38208 I Thaw preserved stem cells 0.56 0.00 0.00 0.00 0.00 0.02 0.58 0.58 0.58 0.58 XXX
38209 I Wash harvest stem cells 0.24 0.00 0.00 0.00 0.00 0.01 0.25 0.25 0.25 0.25 XXX
38210 I T-cell depletion of harvest 0.94 0.00 0.00 0.00 0.00 0.03 0.97 0.97 0.97 0.97 XXX
38211 I Tumor cell deplete of harvst 0.71 0.00 0.00 0.00 0.00 0.02 0.73 0.73 0.73 0.73 XXX
38212 I Rbc depletion of harvest 0.47 0.00 0.00 0.00 0.00 0.02 0.49 0.49 0.49 0.49 XXX
38213 I Platelet deplete of harvest 0.24 0.00 0.00 0.00 0.00 0.01 0.25 0.25 0.25 0.25 XXX
38214 I Volume deplete of harvest 0.24 0.00 0.00 0.00 0.00 0.01 0.25 0.25 0.25 0.25 XXX
38215 I Harvest stem cell concentrte 0.55 0.00 0.00 0.00 0.00 0.02 0.57 0.57 0.57 0.57 XXX
38220 A Bone marrow aspiration 1.08 2.66 3.46 0.45 0.50 0.05 3.79 4.59 1.58 1.63 XXX
38221 A Bone marrow biopsy 1.37 2.78 3.64 0.58 0.63 0.07 4.22 5.08 2.02 2.07 XXX
38230 R Bone marrow collection 4.80 NA NA 2.80 3.12 0.48 NA NA 8.08 8.40 010
38240 R Bone marrow/stem transplant 2.24 NA NA 0.96 1.01 0.11 NA NA 3.31 3.36 XXX
38241 R Bone marrow/stem transplant 2.24 NA NA 0.95 1.02 0.11 NA NA 3.30 3.37 XXX
38242 A Lymphocyte infuse transplant 1.71 NA NA 0.71 0.76 0.08 NA NA 2.50 2.55 000
38300 A Drainage, lymph node lesion 2.28 3.58 4.12 1.74 1.97 0.25 6.11 6.65 4.27 4.50 010
38305 A Drainage, lymph node lesion 6.55 NA NA 3.38 4.18 0.88 NA NA 10.81 11.61 090
38308 A Incision of lymph channels 6.73 NA NA 3.54 3.69 0.85 NA NA 11.12 11.27 090
38380 A Thoracic duct procedure 8.34 NA NA 4.70 5.44 0.74 NA NA 13.78 14.52 090
38381 A Thoracic duct procedure 13.32 NA NA 6.08 6.68 1.85 NA NA 21.25 21.85 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
38382 A Thoracic duct procedure 10.51 NA NA 5.45 5.68 1.37 NA NA 17.33 17.56 090
38500 A Biopsy/removal, lymph nodes 3.76 3.73 3.70 2.02 2.07 0.49 7.98 7.95 6.27 6.32 010
38505 A Needle biopsy, lymph nodes 1.14 2.00 2.04 0.67 0.75 0.09 3.23 3.27 1.90 1.98 000
38510 A Biopsy/removal, lymph nodes 6.69 5.20 5.46 2.98 3.36 0.72 12.61 12.87 10.39 10.77 010
38520 A Biopsy/removal, lymph nodes 6.95 NA NA 3.70 3.96 0.84 NA NA 11.49 11.75 090
38525 A Biopsy/removal, lymph nodes 6.35 NA NA 3.46 3.33 0.80 NA NA 10.61 10.48 090
38530 A Biopsy/removal, lymph nodes 8.26 NA NA 4.09 4.32 1.12 NA NA 13.47 13.70 090
38542 A Explore deep node(s), neck 6.08 NA NA 3.77 4.30 0.60 NA NA 10.45 10.98 090
38550 A Removal, neck/armpit lesion 6.99 NA NA 4.22 3.99 0.88 NA NA 12.09 11.86 090
38555 A Removal, neck/armpit lesion 15.42 NA NA 7.27 8.22 1.76 NA NA 24.45 25.40 090
38562 A Removal, pelvic lymph nodes 10.92 NA NA 5.77 5.77 1.20 NA NA 17.89 17.89 090
38564 A Removal, abdomen lymph nodes 11.29 NA NA 5.23 5.24 1.32 NA NA 17.84 17.85 090
38570 A Laparoscopy, lymph node biop 9.28 NA NA 3.99 3.98 1.13 NA NA 14.40 14.39 010
38571 A Laparoscopy, lymphadenectomy 14.70 NA NA 6.95 5.97 1.15 NA NA 22.80 21.82 010
38572 A Laparoscopy, lymphadenectomy 16.86 NA NA 6.21 6.86 1.91 NA NA 24.98 25.63 010
38589 C Laparoscope proc, lymphatic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
38700 A Removal of lymph nodes, neck 12.68 NA NA 6.01 6.18 0.72 NA NA 19.41 19.58 090
38720 A Removal of lymph nodes, neck 21.72 NA NA 9.38 9.36 1.20 NA NA 32.30 32.28 090
38724 A Removal of lymph nodes, neck 23.72 NA NA 10.00 9.87 1.28 NA NA 35.00 34.87 090
38740 A Remove armpit lymph nodes 10.57 NA NA 5.02 4.96 1.32 NA NA 16.91 16.85 090
38745 A Remove armpit lymph nodes 13.71 NA NA 6.06 6.07 1.74 NA NA 21.51 21.52 090
38746 A Remove thoracic lymph nodes 4.88 NA NA 1.45 1.57 0.72 NA NA 7.05 7.17 ZZZ
38747 A Remove abdominal lymph nodes 4.88 NA NA 1.27 1.57 0.64 NA NA 6.79 7.09 ZZZ
38760 A Remove groin lymph nodes 13.49 NA NA 5.98 6.09 1.72 NA NA 21.19 21.30 090
38765 A Remove groin lymph nodes 21.78 NA NA 8.66 8.77 2.48 NA NA 32.92 33.03 090
38770 A Remove pelvis lymph nodes 13.98 NA NA 6.97 6.05 1.40 NA NA 22.35 21.43 090
38780 A Remove abdomen lymph nodes 17.56 NA NA 8.02 8.16 1.89 NA NA 27.47 27.61 090
38790 A Inject for lymphatic x-ray 1.29 NA NA 0.70 0.75 0.13 NA NA 2.12 2.17 000
38792 A Identify sentinel node 0.52 NA NA 0.46 0.45 0.06 NA NA 1.04 1.03 000
38794 A Access thoracic lymph duct 4.51 NA NA 2.84 3.30 0.32 NA NA 7.67 8.13 090
38999 C Blood/lymph system procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
39000 A Exploration of chest 7.49 NA NA 4.34 4.57 0.89 NA NA 12.72 12.95 090
39010 A Exploration of chest 13.11 NA NA 6.14 7.19 1.76 NA NA 21.01 22.06 090
39200 A Removal chest lesion 15.04 NA NA 6.26 7.21 2.03 NA NA 23.33 24.28 090
39220 A Removal chest lesion 19.47 NA NA 8.06 9.04 2.46 NA NA 29.99 30.97 090
39400 A Visualization of chest 8.00 NA NA 4.18 4.68 0.82 NA NA 13.00 13.50 010
39499 C Chest procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
39501 A Repair diaphragm laceration 13.89 NA NA 5.92 6.32 1.78 NA NA 21.59 21.99 090
39502 A Repair paraesophageal hernia 17.09 NA NA 6.63 7.01 2.17 NA NA 25.89 26.27 090
39503 A Repair of diaphragm hernia 108.67 NA NA 30.82 32.73 10.98 NA NA 150.47 152.38 090
39520 A Repair of diaphragm hernia 16.63 NA NA 6.90 7.76 2.24 NA NA 25.77 26.63 090
39530 A Repair of diaphragm hernia 16.22 NA NA 6.39 6.95 2.11 NA NA 24.72 25.28 090
39531 A Repair of diaphragm hernia 17.23 NA NA 6.59 7.18 2.22 NA NA 26.04 26.63 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
39540 A Repair of diaphragm hernia 14.51 NA NA 5.62 6.07 1.80 NA NA 21.93 22.38 090
39541 A Repair of diaphragm hernia 15.67 NA NA 6.18 6.48 1.93 NA NA 23.78 24.08 090
39545 A Revision of diaphragm 14.58 NA NA 7.21 7.46 1.84 NA NA 23.63 23.88 090
39560 A Resect diaphragm, simple 12.97 NA NA 5.54 6.10 1.59 NA NA 20.10 20.66 090
39561 A Resect diaphragm, complex 19.75 NA NA 9.35 9.34 2.45 NA NA 31.55 31.54 090
39599 C Diaphragm surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
40490 A Biopsy of lip 1.22 2.09 1.75 0.59 0.61 0.05 3.36 3.02 1.86 1.88 000
40500 A Partial excision of lip 4.35 7.79 7.12 4.30 4.32 0.38 12.52 11.85 9.03 9.05 090
40510 A Partial excision of lip 4.74 6.58 6.60 3.54 3.89 0.49 11.81 11.83 8.77 9.12 090
40520 A Partial excision of lip 4.71 6.88 7.38 3.77 4.03 0.52 12.11 12.61 9.00 9.26 090
40525 A Reconstruct lip with flap 7.61 NA NA 5.34 6.06 0.85 NA NA 13.80 14.52 090
40527 A Reconstruct lip with flap 9.20 NA NA 5.97 7.01 0.97 NA NA 16.14 17.18 090
40530 A Partial removal of lip 5.45 7.35 7.70 4.15 4.47 0.55 13.35 13.70 10.15 10.47 090
40650 A Repair lip 3.69 5.94 6.58 3.16 3.26 0.38 10.01 10.65 7.23 7.33 090
40652 A Repair lip 4.32 7.07 7.57 4.04 4.21 0.52 11.91 12.41 8.88 9.05 090
40654 A Repair lip 5.37 8.13 8.48 4.73 4.88 0.60 14.10 14.45 10.70 10.85 090
40700 A Repair cleft lip/nasal 13.97 NA NA 9.32 9.13 0.95 NA NA 24.24 24.05 090
40701 A Repair cleft lip/nasal 17.03 NA NA 11.44 11.36 1.65 NA NA 30.12 30.04 090
40702 A Repair cleft lip/nasal 14.09 NA NA 7.32 8.02 1.23 NA NA 22.64 23.34 090
40720 A Repair cleft lip/nasal 14.54 NA NA 9.22 9.72 1.80 NA NA 25.56 26.06 090
40761 A Repair cleft lip/nasal 15.69 NA NA 9.05 9.97 1.94 NA NA 26.68 27.60 090
40799 C Lip surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
40800 A Drainage of mouth lesion 1.19 3.83 3.18 1.88 1.80 0.13 5.15 4.50 3.20 3.12 010
40801 A Drainage of mouth lesion 2.57 4.86 4.23 2.58 2.70 0.31 7.74 7.11 5.46 5.58 010
40804 A Removal, foreign body, mouth 1.26 3.63 3.45 1.76 1.83 0.11 5.00 4.82 3.13 3.20 010
40805 A Removal, foreign body, mouth 2.73 5.06 4.63 2.59 2.76 0.32 8.11 7.68 5.64 5.81 010
40806 A Incision of lip fold 0.31 2.37 1.97 0.50 0.50 0.04 2.72 2.32 0.85 0.85 000
40808 A Biopsy of mouth lesion 0.98 3.52 2.87 1.58 1.51 0.10 4.60 3.95 2.66 2.59 010
40810 A Excision of mouth lesion 1.33 3.57 3.05 1.67 1.66 0.13 5.03 4.51 3.13 3.12 010
40812 A Excise/repair mouth lesion 2.33 4.51 3.92 2.28 2.37 0.28 7.12 6.53 4.89 4.98 010
40814 A Excise/repair mouth lesion 3.45 5.63 5.11 3.66 3.83 0.41 9.49 8.97 7.52 7.69 090
40816 A Excision of mouth lesion 3.70 5.80 5.33 3.71 3.93 0.40 9.90 9.43 7.81 8.03 090
40818 A Excise oral mucosa for graft 2.72 5.78 5.32 3.73 3.91 0.21 8.71 8.25 6.66 6.84 090
40819 A Excise lip or cheek fold 2.45 4.87 4.28 3.07 3.09 0.29 7.61 7.02 5.81 5.83 090
40820 A Treatment of mouth lesion 1.30 5.14 4.23 2.85 2.54 0.11 6.55 5.64 4.26 3.95 010
40830 A Repair mouth laceration 1.78 4.09 3.81 2.02 2.07 0.19 6.06 5.78 3.99 4.04 010
40831 A Repair mouth laceration 2.50 5.35 4.83 2.76 2.98 0.30 8.15 7.63 5.56 5.78 010
40840 R Reconstruction of mouth 9.03 10.06 9.85 5.63 6.64 1.08 20.17 19.96 15.74 16.75 090
40842 R Reconstruction of mouth 9.03 9.76 9.99 5.40 6.44 1.08 19.87 20.10 15.51 16.55 090
40843 R Reconstruction of mouth 12.62 11.82 11.92 6.12 7.39 1.39 25.83 25.93 20.13 21.40 090
40844 R Reconstruction of mouth 16.57 14.88 15.54 8.89 10.89 2.00 33.45 34.11 27.46 29.46 090
40845 R Reconstruction of mouth 19.13 15.37 16.64 9.78 12.35 2.01 36.51 37.78 30.92 33.49 090
40899 C Mouth surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
41000 A Drainage of mouth lesion 1.32 2.50 2.36 1.31 1.39 0.12 3.94 3.80 2.75 2.83 010
41005 A Drainage of mouth lesion 1.28 4.22 3.55 1.72 1.72 0.12 5.62 4.95 3.12 3.12 010
41006 A Drainage of mouth lesion 3.28 5.30 4.92 2.76 3.07 0.35 8.93 8.55 6.39 6.70 090
41007 A Drainage of mouth lesion 3.14 5.34 5.19 2.74 2.95 0.31 8.79 8.64 6.19 6.40 090
41008 A Drainage of mouth lesion 3.40 5.42 4.87 2.82 3.11 0.42 9.24 8.69 6.64 6.93 090
41009 A Drainage of mouth lesion 3.63 5.81 5.18 3.15 3.47 0.47 9.91 9.28 7.25 7.57 090
41010 A Incision of tongue fold 1.08 3.36 3.41 1.35 1.54 0.07 4.51 4.56 2.50 2.69 010
41015 A Drainage of mouth lesion 4.00 6.22 5.61 3.95 4.09 0.46 10.68 10.07 8.41 8.55 090
41016 A Drainage of mouth lesion 4.11 6.18 5.75 4.05 4.18 0.53 10.82 10.39 8.69 8.82 090
41017 A Drainage of mouth lesion 4.11 6.33 5.81 4.11 4.25 0.53 10.97 10.45 8.75 8.89 090
41018 A Drainage of mouth lesion 5.14 6.57 6.24 4.36 4.52 0.68 12.39 12.06 10.18 10.34 090
41100 A Biopsy of tongue 1.39 2.58 2.46 1.13 1.35 0.15 4.12 4.00 2.67 2.89 010
41105 A Biopsy of tongue 1.44 2.57 2.37 1.15 1.28 0.13 4.14 3.94 2.72 2.85 010
41108 A Biopsy of floor of mouth 1.07 2.40 2.15 1.03 1.11 0.10 3.57 3.32 2.20 2.28 010
41110 A Excision of tongue lesion 1.53 3.47 3.10 1.55 1.62 0.13 5.13 4.76 3.21 3.28 010
41112 A Excision of tongue lesion 2.77 5.12 4.63 3.16 3.21 0.28 8.17 7.68 6.21 6.26 090
41113 A Excision of tongue lesion 3.23 5.40 4.91 3.33 3.44 0.34 8.97 8.48 6.90 7.01 090
41114 A Excision of tongue lesion 8.71 NA NA 6.02 6.90 0.83 NA NA 15.56 16.44 090
41115 A Excision of tongue fold 1.76 4.26 3.53 1.76 1.83 0.18 6.20 5.47 3.70 3.77 010
41116 A Excision of mouth lesion 2.47 5.32 4.59 2.67 2.77 0.23 8.02 7.29 5.37 5.47 090
41120 A Partial removal of tongue 10.91 NA NA 13.31 14.81 0.79 NA NA 25.01 26.51 090
41130 A Partial removal of tongue 15.51 NA NA 14.68 15.81 0.93 NA NA 31.12 32.25 090
41135 A Tongue and neck surgery 29.83 NA NA 20.15 22.45 1.89 NA NA 51.87 54.17 090
41140 A Removal of tongue 28.81 NA NA 21.56 25.39 2.27 NA NA 52.64 56.47 090
41145 A Tongue removal, neck surgery 37.59 NA NA 26.62 29.56 2.55 NA NA 66.76 69.70 090
41150 A Tongue, mouth, jaw surgery 29.52 NA NA 21.36 23.87 1.95 NA NA 52.83 55.34 090
41153 A Tongue, mouth, neck surgery 33.28 NA NA 22.13 24.30 2.01 NA NA 57.42 59.59 090
41155 A Tongue, jaw, neck surgery 43.96 NA NA 25.50 26.48 2.34 NA NA 71.80 72.78 090
41250 A Repair tongue laceration 1.93 3.79 3.00 1.59 1.28 0.18 5.90 5.11 3.70 3.39 010
41251 A Repair tongue laceration 2.29 3.15 3.24 1.65 1.58 0.22 5.66 5.75 4.16 4.09 010
41252 A Repair tongue laceration 2.99 4.35 4.01 1.98 2.18 0.29 7.63 7.29 5.26 5.46 010
41500 A Fixation of tongue 3.74 NA NA 6.54 7.22 0.30 NA NA 10.58 11.26 090
41510 A Tongue to lip surgery 3.45 NA NA 7.05 7.71 0.20 NA NA 10.70 11.36 090
41520 A Reconstruction, tongue fold 2.77 5.72 4.90 3.22 3.52 0.27 8.76 7.94 6.26 6.56 090
41599 C Tongue and mouth surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
41800 A Drainage of gum lesion 1.21 4.74 3.13 2.10 1.49 0.12 6.07 4.46 3.43 2.82 010
41805 A Removal foreign body, gum 1.28 4.72 3.18 2.75 2.35 0.13 6.13 4.59 4.16 3.76 010
41806 A Removal foreign body,jawbone 2.73 5.91 4.16 3.41 3.13 0.37 9.01 7.26 6.51 6.23 010
41820 R Excision, gum, each quadrant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
41821 R Excision of gum flap 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
41822 R Excision of gum lesion 2.35 4.66 4.08 1.80 1.85 0.31 7.32 6.74 4.46 4.51 010
41823 R Excision of gum lesion 3.63 6.50 5.80 3.77 3.95 0.47 10.60 9.90 7.87 8.05 090
41825 A Excision of gum lesion 1.35 3.62 3.20 1.44 2.04 0.15 5.12 4.70 2.94 3.54 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
41826 A Excision of gum lesion 2.35 5.12 3.10 2.60 2.23 0.30 7.77 5.75 5.25 4.88 010
41827 A Excision of gum lesion 3.72 6.61 5.79 3.38 3.59 0.35 10.68 9.86 7.45 7.66 090
41828 R Excision of gum lesion 3.11 4.13 3.88 1.68 2.64 0.44 7.68 7.43 5.23 6.19 010
41830 R Removal of gum tissue 3.38 6.04 5.23 3.16 3.51 0.44 9.86 9.05 6.98 7.33 010
41850 R Treatment of gum lesion 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
41870 R Gum graft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
41872 R Repair gum 2.90 5.89 5.24 3.28 3.42 0.30 9.09 8.44 6.48 6.62 090
41874 R Repair tooth socket 3.13 5.76 5.07 2.79 3.08 0.45 9.34 8.65 6.37 6.66 090
41899 C Dental surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
42000 A Drainage mouth roof lesion 1.25 2.34 2.51 1.15 1.23 0.12 3.71 3.88 2.52 2.60 010
42100 A Biopsy roof of mouth 1.33 2.19 2.11 1.22 1.33 0.13 3.65 3.57 2.68 2.79 010
42104 A Excision lesion, mouth roof 1.66 3.43 2.76 1.60 1.56 0.16 5.25 4.58 3.42 3.38 010
42106 A Excision lesion, mouth roof 2.12 4.41 3.52 2.06 2.35 0.25 6.78 5.89 4.43 4.72 010
42107 A Excision lesion, mouth roof 4.48 6.34 5.87 3.58 3.86 0.44 11.26 10.79 8.50 8.78 090
42120 A Remove palate/lesion 11.70 NA NA 11.51 11.71 0.52 NA NA 23.73 23.93 090
42140 A Excision of uvula 1.65 4.24 3.85 1.95 2.06 0.13 6.02 5.63 3.73 3.84 090
42145 A Repair palate, pharynx/uvula 9.63 NA NA 6.85 7.33 0.65 NA NA 17.13 17.61 090
42160 A Treatment mouth roof lesion 1.82 3.63 4.10 1.62 2.12 0.17 5.62 6.09 3.61 4.11 010
42180 A Repair palate 2.52 3.22 3.11 1.79 2.02 0.21 5.95 5.84 4.52 4.75 010
42182 A Repair palate 3.84 4.05 3.92 2.41 2.88 0.40 8.29 8.16 6.65 7.12 010
42200 A Reconstruct cleft palate 12.41 NA NA 8.26 9.72 1.27 NA NA 21.94 23.40 090
42205 A Reconstruct cleft palate 13.57 NA NA 7.60 9.45 1.58 NA NA 22.75 24.60 090
42210 A Reconstruct cleft palate 14.91 NA NA 9.87 11.06 2.17 NA NA 26.95 28.14 090
42215 A Reconstruct cleft palate 8.88 NA NA 7.34 8.64 1.31 NA NA 17.53 18.83 090
42220 A Reconstruct cleft palate 7.07 NA NA 6.80 6.79 0.73 NA NA 14.60 14.59 090
42225 A Reconstruct cleft palate 9.66 NA NA 12.12 15.83 0.86 NA NA 22.64 26.35 090
42226 A Lengthening of palate 10.24 NA NA 11.44 13.89 1.01 NA NA 22.69 25.14 090
42227 A Lengthening of palate 9.81 NA NA 9.78 14.10 0.98 NA NA 20.57 24.89 090
42235 A Repair palate 7.92 NA NA 10.34 11.48 0.72 NA NA 18.98 20.12 090
42260 A Repair nose to lip fistula 10.10 9.65 10.06 5.93 6.78 1.26 21.01 21.42 17.29 18.14 090
42280 A Preparation, palate mold 1.56 2.25 2.03 0.85 1.07 0.19 4.00 3.78 2.60 2.82 010
42281 A Insertion, palate prosthesis 1.95 2.83 2.68 1.57 1.80 0.17 4.95 4.80 3.69 3.92 010
42299 C Palate/uvula surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
42300 A Drainage of salivary gland 1.95 2.93 2.85 1.61 1.76 0.16 5.04 4.96 3.72 3.87 010
42305 A Drainage of salivary gland 6.23 NA NA 3.71 4.47 0.51 NA NA 10.45 11.21 090
42310 A Drainage of salivary gland 1.58 2.19 2.24 1.32 1.49 0.13 3.90 3.95 3.03 3.20 010
42320 A Drainage of salivary gland 2.37 3.56 3.34 1.78 2.01 0.21 6.14 5.92 4.36 4.59 010
42330 A Removal of salivary stone 2.23 3.20 3.16 1.62 1.79 0.19 5.62 5.58 4.04 4.21 010
42335 A Removal of salivary stone 3.35 5.46 5.04 2.69 3.03 0.29 9.10 8.68 6.33 6.67 090
42340 A Removal of salivary stone 4.64 6.31 6.11 3.26 3.76 0.42 11.37 11.17 8.32 8.82 090
42400 A Biopsy of salivary gland 0.78 1.88 1.71 0.59 0.69 0.06 2.72 2.55 1.43 1.53 000
42405 A Biopsy of salivary gland 3.31 3.74 3.94 2.02 2.34 0.28 7.33 7.53 5.61 5.93 010
42408 A Excision of salivary cyst 4.58 6.10 5.96 3.10 3.48 0.45 11.13 10.99 8.13 8.51 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
42409 A Drainage of salivary cyst 2.85 5.07 4.66 2.40 2.67 0.27 8.19 7.78 5.52 5.79 090
42410 A Excise parotid gland/lesion 9.46 NA NA 4.99 5.91 0.91 NA NA 15.36 16.28 090
42415 A Excise parotid gland/lesion 17.99 NA NA 7.87 10.11 1.43 NA NA 27.29 29.53 090
42420 A Excise parotid gland/lesion 20.87 NA NA 8.72 11.46 1.65 NA NA 31.24 33.98 090
42425 A Excise parotid gland/lesion 13.31 NA NA 6.17 8.00 1.05 NA NA 20.53 22.36 090
42426 A Excise parotid gland/lesion 22.54 NA NA 8.98 12.00 1.81 NA NA 33.33 36.35 090
42440 A Excise submaxillary gland 7.05 NA NA 3.53 4.48 0.59 NA NA 11.17 12.12 090
42450 A Excise sublingual gland 4.66 5.90 5.90 3.70 4.11 0.42 10.98 10.98 8.78 9.19 090
42500 A Repair salivary duct 4.34 5.82 5.72 3.66 4.05 0.41 10.57 10.47 8.41 8.80 090
42505 A Repair salivary duct 6.23 6.80 7.04 4.39 5.12 0.55 13.58 13.82 11.17 11.90 090
42507 A Parotid duct diversion 6.16 NA NA 5.95 6.39 0.49 NA NA 12.60 13.04 090
42508 A Parotid duct diversion 9.22 NA NA 7.56 8.15 1.04 NA NA 17.82 18.41 090
42509 A Parotid duct diversion 11.65 NA NA 8.76 9.83 0.93 NA NA 21.34 22.41 090
42510 A Parotid duct diversion 8.26 NA NA 6.43 7.45 0.66 NA NA 15.35 16.37 090
42550 A Injection for salivary x-ray 1.25 2.10 2.93 0.35 0.40 0.07 3.42 4.25 1.67 1.72 000
42600 A Closure of salivary fistula 4.86 6.51 6.56 3.38 3.94 0.43 11.80 11.85 8.67 9.23 090
42650 A Dilation of salivary duct 0.77 1.20 1.13 0.61 0.69 0.07 2.04 1.97 1.45 1.53 000
42660 A Dilation of salivary duct 1.13 1.42 1.37 0.73 0.82 0.09 2.64 2.59 1.95 2.04 000
42665 A Ligation of salivary duct 2.57 4.74 4.31 2.24 2.50 0.23 7.54 7.11 5.04 5.30 090
42699 C Salivary surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
42700 A Drainage of tonsil abscess 1.64 2.76 2.68 1.53 1.66 0.13 4.53 4.45 3.30 3.43 010
42720 A Drainage of throat abscess 6.31 4.34 4.71 2.91 3.57 0.44 11.09 11.46 9.66 10.32 010
42725 A Drainage of throat abscess 12.28 NA NA 6.69 7.84 0.91 NA NA 19.88 21.03 090
42800 A Biopsy of throat 1.41 2.28 2.21 1.19 1.35 0.11 3.80 3.73 2.71 2.87 010
42802 A Biopsy of throat 1.56 3.84 4.53 1.54 1.93 0.12 5.52 6.21 3.22 3.61 010
42804 A Biopsy of upper nose/throat 1.26 3.34 3.64 1.38 1.64 0.10 4.70 5.00 2.74 3.00 010
42806 A Biopsy of upper nose/throat 1.60 3.56 3.94 1.49 1.82 0.13 5.29 5.67 3.22 3.55 010
42808 A Excise pharynx lesion 2.32 2.99 3.07 1.47 1.82 0.19 5.50 5.58 3.98 4.33 010
42809 A Remove pharynx foreign body 1.83 2.14 2.28 1.26 1.31 0.16 4.13 4.27 3.25 3.30 010
42810 A Excision of neck cyst 3.30 5.75 5.72 3.43 3.51 0.29 9.34 9.31 7.02 7.10 090
42815 A Excision of neck cyst 7.23 NA NA 5.77 6.25 0.61 NA NA 13.61 14.09 090
42820 A Remove tonsils and adenoids 4.17 NA NA 2.57 3.11 0.31 NA NA 7.05 7.59 090
42821 A Remove tonsils and adenoids 4.31 NA NA 2.73 3.31 0.35 NA NA 7.39 7.97 090
42825 A Removal of tonsils 3.45 NA NA 2.45 2.99 0.25 NA NA 6.15 6.69 090
42826 A Removal of tonsils 3.40 NA NA 2.46 2.89 0.27 NA NA 6.13 6.56 090
42830 A Removal of adenoids 2.60 NA NA 2.23 2.48 0.20 NA NA 5.03 5.28 090
42831 A Removal of adenoids 2.75 NA NA 2.44 2.74 0.22 NA NA 5.41 5.71 090
42835 A Removal of adenoids 2.33 NA NA 1.77 2.29 0.21 NA NA 4.31 4.83 090
42836 A Removal of adenoids 3.21 NA NA 2.45 2.83 0.26 NA NA 5.92 6.30 090
42842 A Extensive surgery of throat 12.02 NA NA 11.08 11.01 0.71 NA NA 23.81 23.74 090
42844 A Extensive surgery of throat 17.57 NA NA 14.17 15.72 1.16 NA NA 32.90 34.45 090
42845 A Extensive surgery of throat 32.35 NA NA 19.29 22.21 1.99 NA NA 53.63 56.55 090
42860 A Excision of tonsil tags 2.25 NA NA 2.13 2.33 0.18 NA NA 4.56 4.76 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
42870 A Excision of lingual tonsil 5.44 NA NA 8.02 8.43 0.44 NA NA 13.90 14.31 090
42890 A Partial removal of pharynx 18.92 NA NA 13.98 14.11 1.05 NA NA 33.95 34.08 090
42892 A Revision of pharyngeal walls 25.77 NA NA 17.59 17.28 1.28 NA NA 44.64 44.33 090
42894 A Revision of pharyngeal walls 33.61 NA NA 21.36 21.86 1.87 NA NA 56.84 57.34 090
42900 A Repair throat wound 5.26 NA NA 2.75 3.43 0.50 NA NA 8.51 9.19 010
42950 A Reconstruction of throat 8.16 NA NA 10.30 11.48 0.72 NA NA 19.18 20.36 090
42953 A Repair throat, esophagus 9.33 NA NA 12.97 16.24 0.88 NA NA 23.18 26.45 090
42955 A Surgical opening of throat 7.92 NA NA 9.34 10.34 0.80 NA NA 18.06 19.06 090
42960 A Control throat bleeding 2.35 NA NA 1.61 1.87 0.19 NA NA 4.15 4.41 010
42961 A Control throat bleeding 5.69 NA NA 4.15 4.76 0.45 NA NA 10.29 10.90 090
42962 A Control throat bleeding 7.31 NA NA 4.77 5.63 0.58 NA NA 12.66 13.52 090
42970 A Control nose/throat bleeding 5.76 NA NA 3.52 4.02 0.39 NA NA 9.67 10.17 090
42971 A Control nose/throat bleeding 6.54 NA NA 4.15 4.88 0.51 NA NA 11.20 11.93 090
42972 A Control nose/throat bleeding 7.53 NA NA 4.50 5.40 0.62 NA NA 12.65 13.55 090
42999 C Throat surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43020 A Incision of esophagus 8.14 NA NA 4.35 5.15 0.87 NA NA 13.36 14.16 090
43030 A Throat muscle surgery 7.91 NA NA 4.20 5.17 0.70 NA NA 12.81 13.78 090
43045 A Incision of esophagus 21.70 NA NA 10.06 10.54 2.59 NA NA 34.35 34.83 090
43100 A Excision of esophagus lesion 9.55 NA NA 5.10 5.94 0.93 NA NA 15.58 16.42 090
43101 A Excision of esophagus lesion 16.99 NA NA 7.22 7.72 2.32 NA NA 26.53 27.03 090
43107 A Removal of esophagus 43.97 NA NA 16.57 17.84 5.24 NA NA 65.78 67.05 090
43108 A Removal of esophagus 82.66 NA NA 25.71 17.09 4.08 NA NA 112.45 103.83 090
43112 A Removal of esophagus 47.27 NA NA 17.08 18.79 5.81 NA NA 70.16 71.87 090
43113 A Removal of esophagus 79.85 NA NA 27.82 18.29 4.43 NA NA 112.10 102.57 090
43116 A Partial removal of esophagus 92.78 NA NA 28.93 19.75 3.06 NA NA 124.77 115.59 090
43117 A Partial removal of esophagus 43.52 NA NA 15.32 16.78 5.19 NA NA 64.03 65.49 090
43118 A Partial removal of esophagus 66.86 NA NA 21.36 15.68 4.11 NA NA 92.33 86.65 090
43121 A Partial removal of esophagus 51.22 NA NA 18.28 14.82 3.91 NA NA 73.41 69.95 090
43122 A Partial removal of esophagus 43.97 NA NA 15.73 16.98 5.42 NA NA 65.12 66.37 090
43123 A Partial removal of esophagus 82.91 NA NA 25.89 17.05 4.16 NA NA 112.96 104.12 090
43124 A Removal of esophagus 68.83 NA NA 23.97 15.80 3.74 NA NA 96.54 88.37 090
43130 A Removal of esophagus pouch 12.41 NA NA 6.01 7.17 1.16 NA NA 19.58 20.74 090
43135 A Removal of esophagus pouch 26.09 NA NA 9.99 8.57 2.34 NA NA 38.42 37.00 090
43200 A Esophagus endoscopy 1.59 3.54 3.98 0.93 1.04 0.13 5.26 5.70 2.65 2.76 000
43201 A Esoph scope w/submucous inj 2.09 5.55 4.86 1.19 1.12 0.15 7.79 7.10 3.43 3.36 000
43202 A Esophagus endoscopy, biopsy 1.89 5.12 5.44 0.99 0.95 0.15 7.16 7.48 3.03 2.99 000
43204 A Esoph scope w/sclerosis inj 3.76 NA NA 1.97 1.63 0.30 NA NA 6.03 5.69 000
43205 A Esophagus endoscopy/ligation 3.78 NA NA 2.07 1.66 0.28 NA NA 6.13 5.72 000
43215 A Esophagus endoscopy 2.60 NA NA 1.28 1.22 0.22 NA NA 4.10 4.04 000
43216 A Esophagus endoscopy/lesion 2.40 3.00 1.55 1.23 1.10 0.20 5.60 4.15 3.83 3.70 000
43217 A Esophagus endoscopy 2.90 6.55 6.85 1.42 1.25 0.26 9.71 10.01 4.58 4.41 000
43219 A Esophagus endoscopy 2.80 NA NA 1.55 1.40 0.24 NA NA 4.59 4.44 000
43220 A Esoph endoscopy, dilation 2.10 NA NA 1.13 1.01 0.17 NA NA 3.40 3.28 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
43226 A Esoph endoscopy, dilation 2.34 NA NA 1.29 1.10 0.19 NA NA 3.82 3.63 000
43227 A Esoph endoscopy, repair 3.59 NA NA 1.84 1.55 0.28 NA NA 5.71 5.42 000
43228 A Esoph endoscopy, ablation 3.76 NA NA 1.87 1.63 0.34 NA NA 5.97 5.73 000
43231 A Esoph endoscopy w/us exam 3.19 NA NA 1.75 1.42 0.23 NA NA 5.17 4.84 000
43232 A Esoph endoscopy w/us fn bx 4.47 NA NA 2.39 1.96 0.34 NA NA 7.20 6.77 000
43234 A Upper GI endoscopy, exam 2.01 4.96 5.23 1.02 0.91 0.17 7.14 7.41 3.20 3.09 000
43235 A Uppr gi endoscopy, diagnosis 2.39 5.26 5.19 1.37 1.11 0.19 7.84 7.77 3.95 3.69 000
43236 A Uppr gi scope w/submuc inj 2.92 6.69 6.47 1.67 1.33 0.21 9.82 9.60 4.80 4.46 000
43237 A Endoscopic us exam, esoph 3.98 NA NA 2.17 1.74 0.43 NA NA 6.58 6.15 000
43238 A Uppr gi endoscopy w/us fn bx 5.02 NA NA 2.57 2.11 0.43 NA NA 8.02 7.56 000
43239 A Upper GI endoscopy, biopsy 2.87 6.02 5.79 1.57 1.29 0.22 9.11 8.88 4.66 4.38 000
43240 A Esoph endoscope w/drain cyst 6.85 NA NA 3.49 2.82 0.56 NA NA 10.90 10.23 000
43241 A Upper GI endoscopy with tube 2.59 NA NA 1.43 1.18 0.21 NA NA 4.23 3.98 000
43242 A Uppr gi endoscopy w/us fn bx 7.30 NA NA 3.73 2.98 0.53 NA NA 11.56 10.81 000
43243 A Upper gi endoscopy inject 4.56 NA NA 2.40 1.94 0.33 NA NA 7.29 6.83 000
43244 A Upper GI endoscopy/ligation 5.04 NA NA 2.68 2.14 0.37 NA NA 8.09 7.55 000
43245 A Uppr gi scope dilate strictr 3.18 NA NA 1.65 1.39 0.26 NA NA 5.09 4.83 000
43246 A Place gastrostomy tube 4.32 NA NA 2.14 1.80 0.34 NA NA 6.80 6.46 000
43247 A Operative upper GI endoscopy 3.38 NA NA 1.80 1.48 0.27 NA NA 5.45 5.13 000
43248 A Uppr gi endoscopy/guide wire 3.15 NA NA 1.80 1.43 0.23 NA NA 5.18 4.81 000
43249 A Esoph endoscopy, dilation 2.90 NA NA 1.64 1.32 0.22 NA NA 4.76 4.44 000
43250 A Upper GI endoscopy/tumor 3.20 NA NA 1.65 1.40 0.26 NA NA 5.11 4.86 000
43251 A Operative upper GI endoscopy 3.69 NA NA 1.95 1.60 0.29 NA NA 5.93 5.58 000
43255 A Operative upper GI endoscopy 4.81 NA NA 2.56 2.05 0.35 NA NA 7.72 7.21 000
43256 A Uppr gi endoscopy w/stent 4.34 NA NA 2.28 1.85 0.32 NA NA 6.94 6.51 000
43257 A Uppr gi scope w/thrml txmnt 5.50 NA NA 2.04 2.16 0.36 NA NA 7.90 8.02 000
43258 A Operative upper GI endoscopy 4.54 NA NA 2.41 1.94 0.33 NA NA 7.28 6.81 000
43259 A Endoscopic ultrasound exam 5.19 NA NA 2.72 2.17 0.35 NA NA 8.26 7.71 000
43260 A Endo cholangiopancreatograph 5.95 NA NA 3.11 2.49 0.43 NA NA 9.49 8.87 000
43261 A Endo cholangiopancreatograph 6.26 NA NA 3.27 2.61 0.46 NA NA 9.99 9.33 000
43262 A Endo cholangiopancreatograph 7.38 NA NA 3.78 3.03 0.54 NA NA 11.70 10.95 000
43263 A Endo cholangiopancreatograph 7.28 NA NA 3.79 3.02 0.54 NA NA 11.61 10.84 000
43264 A Endo cholangiopancreatograph 8.89 NA NA 4.52 3.61 0.65 NA NA 14.06 13.15 000
43265 A Endo cholangiopancreatograph 10.00 NA NA 5.03 4.03 0.73 NA NA 15.76 14.76 000
43267 A Endo cholangiopancreatograph 7.38 NA NA 3.69 3.01 0.54 NA NA 11.61 10.93 000
43268 A Endo cholangiopancreatograph 7.38 NA NA 3.94 3.15 0.54 NA NA 11.86 11.07 000
43269 A Endo cholangiopancreatograph 8.20 NA NA 4.18 3.35 0.60 NA NA 12.98 12.15 000
43271 A Endo cholangiopancreatograph 7.38 NA NA 3.79 3.03 0.54 NA NA 11.71 10.95 000
43272 A Endo cholangiopancreatograph 7.38 NA NA 3.86 3.05 0.54 NA NA 11.78 10.97 000
43280 A Laparoscopy, fundoplasty 18.00 NA NA 6.70 7.13 2.28 NA NA 26.98 27.41 090
43289 C Laparoscope proc, esoph 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43300 A Repair of esophagus 9.21 NA NA 5.20 6.08 1.12 NA NA 15.53 16.41 090
43305 A Repair esophagus and fistula 17.98 NA NA 7.65 9.93 1.54 NA NA 27.17 29.45 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
43310 A Repair of esophagus 26.18 NA NA 10.10 10.82 3.61 NA NA 39.89 40.61 090
43312 A Repair esophagus and fistula 29.23 NA NA 9.97 11.41 4.01 NA NA 43.21 44.65 090
43313 A Esophagoplasty congenital 48.17 NA NA 17.28 18.43 5.47 NA NA 70.92 72.07 090
43314 A Tracheo-esophagoplasty cong 53.15 NA NA 18.37 18.98 6.65 NA NA 78.17 78.78 090
43320 A Fuse esophagus stomach 23.18 NA NA 8.83 9.11 2.74 NA NA 34.75 35.03 090
43324 A Revise esophagus stomach 22.86 NA NA 8.39 8.67 2.76 NA NA 34.01 34.29 090
43325 A Revise esophagus stomach 22.47 NA NA 8.37 8.68 2.60 NA NA 33.44 33.75 090
43326 A Revise esophagus stomach 22.15 NA NA 9.33 9.30 2.85 NA NA 34.33 34.30 090
43330 A Repair of esophagus 22.06 NA NA 8.23 8.46 2.63 NA NA 32.92 33.15 090
43331 A Repair of esophagus 22.93 NA NA 9.54 9.72 2.94 NA NA 35.41 35.59 090
43340 A Fuse esophagus intestine 22.86 NA NA 9.09 8.99 2.46 NA NA 34.41 34.31 090
43341 A Fuse esophagus intestine 24.10 NA NA 10.08 10.03 2.92 NA NA 37.10 37.05 090
43350 A Surgical opening, esophagus 19.31 NA NA 8.02 8.34 1.42 NA NA 28.75 29.07 090
43351 A Surgical opening, esophagus 21.87 NA NA 9.59 9.74 2.47 NA NA 33.93 34.08 090
43352 A Surgical opening, esophagus 17.68 NA NA 8.17 8.33 2.06 NA NA 27.91 28.07 090
43360 A Gastrointestinal repair 39.90 NA NA 15.81 15.26 4.97 NA NA 60.68 60.13 090
43361 A Gastrointestinal repair 45.50 NA NA 16.89 16.88 4.50 NA NA 66.89 66.88 090
43400 A Ligate esophagus veins 25.47 NA NA 13.73 10.51 1.96 NA NA 41.16 37.94 090
43401 A Esophagus surgery for veins 26.36 NA NA 9.44 9.47 3.05 NA NA 38.85 38.88 090
43405 A Ligate/staple esophagus 24.55 NA NA 10.37 9.78 2.84 NA NA 37.76 37.17 090
43410 A Repair esophagus wound 16.28 NA NA 7.55 7.61 1.72 NA NA 25.55 25.61 090
43415 A Repair esophagus wound 28.70 NA NA 11.93 11.79 3.53 NA NA 44.16 44.02 090
43420 A Repair esophagus opening 16.65 NA NA 6.96 7.29 1.43 NA NA 25.04 25.37 090
43425 A Repair esophagus opening 24.91 NA NA 10.37 10.07 3.03 NA NA 38.31 38.01 090
43450 A Dilate esophagus 1.38 2.66 2.64 0.93 0.75 0.11 4.15 4.13 2.42 2.24 000
43453 A Dilate esophagus 1.51 6.28 6.12 1.02 0.80 0.11 7.90 7.74 2.64 2.42 000
43456 A Dilate esophagus 2.57 12.96 13.55 1.48 1.20 0.20 15.73 16.32 4.25 3.97 000
43458 A Dilate esophagus 3.06 6.93 6.72 1.64 1.37 0.24 10.23 10.02 4.94 4.67 000
43460 A Pressure treatment esophagus 3.79 NA NA 1.74 1.55 0.31 NA NA 5.84 5.65 000
43496 C Free jejunum flap, microvasc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
43499 C Esophagus surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43500 A Surgical opening of stomach 12.71 NA NA 5.24 5.04 1.45 NA NA 19.40 19.20 090
43501 A Surgical repair of stomach 22.47 NA NA 8.13 8.26 2.65 NA NA 33.25 33.38 090
43502 A Surgical repair of stomach 25.56 NA NA 9.02 9.34 3.10 NA NA 37.68 38.00 090
43510 A Surgical opening of stomach 15.01 NA NA 6.86 6.65 1.48 NA NA 23.35 23.14 090
43520 A Incision of pyloric muscle 11.21 NA NA 4.85 5.15 1.36 NA NA 17.42 17.72 090
43600 A Biopsy of stomach 1.91 NA NA 0.82 0.70 0.14 NA NA 2.87 2.75 000
43605 A Biopsy of stomach 13.64 NA NA 5.43 5.32 1.58 NA NA 20.65 20.54 090
43610 A Excision of stomach lesion 16.26 NA NA 6.08 6.13 1.94 NA NA 24.28 24.33 090
43611 A Excision of stomach lesion 20.25 NA NA 7.55 7.56 2.36 NA NA 30.16 30.17 090
43620 A Removal of stomach 33.91 NA NA 11.09 11.62 3.96 NA NA 48.96 49.49 090
43621 A Removal of stomach 39.40 NA NA 12.47 12.10 4.04 NA NA 55.91 55.54 090
43622 A Removal of stomach 39.90 NA NA 12.62 12.59 4.30 NA NA 56.82 56.79 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
43631 A Removal of stomach, partial 24.38 NA NA 8.63 9.02 2.99 NA NA 36.00 36.39 090
43632 A Removal of stomach, partial 35.01 NA NA 11.36 9.70 2.99 NA NA 49.36 47.70 090
43633 A Removal of stomach, partial 33.01 NA NA 10.86 9.71 3.06 NA NA 46.93 45.78 090
43634 A Removal of stomach, partial 36.51 NA NA 11.88 10.53 3.33 NA NA 51.72 50.37 090
43635 A Removal of stomach, partial 2.06 NA NA 0.53 0.66 0.27 NA NA 2.86 2.99 ZZZ
43640 A Vagotomy pylorus repair 19.43 NA NA 7.37 7.28 2.26 NA NA 29.06 28.97 090
43641 A Vagotomy pylorus repair 19.68 NA NA 7.72 7.45 2.25 NA NA 29.65 29.38 090
43644 A Lap gastric bypass/roux-en-y 29.24 NA NA 10.23 10.97 3.16 NA NA 42.63 43.37 090
43645 A Lap gastr bypass incl smll i 31.37 NA NA 11.14 11.79 3.54 NA NA 46.05 46.70 090
43647 C Lap impl electrode, antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43648 C Lap revise/remv eltrd antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43651 A Laparoscopy, vagus nerve 10.13 NA NA 4.63 4.73 1.33 NA NA 16.09 16.19 090
43652 A Laparoscopy, vagus nerve 12.13 NA NA 5.18 5.61 1.55 NA NA 18.86 19.29 090
43653 A Laparoscopy, gastrostomy 8.38 NA NA 4.39 4.23 1.01 NA NA 13.78 13.62 090
43659 C Laparoscope proc, stom 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43750 A Place gastrostomy tube 4.62 NA NA 1.90 2.12 0.43 NA NA 6.95 7.17 010
43752 A Nasal/orogastric w/stent 0.81 NA NA 0.23 0.25 0.02 NA NA 1.06 1.08 000
43760 A Change gastrostomy tube 1.10 12.83 4.77 0.39 0.44 0.09 14.02 5.96 1.58 1.63 000
43761 A Reposition gastrostomy tube 2.01 0.91 1.11 0.59 0.64 0.13 3.05 3.25 2.73 2.78 000
43770 A Lap, place gastr adjust band 17.85 NA NA 7.47 7.65 2.19 NA NA 27.51 27.69 090
43771 A Lap, revise adjust gast band 20.64 NA NA 8.16 8.48 2.55 NA NA 31.35 31.67 090
43772 A Lap, remove adjust gast band 15.62 NA NA 5.99 6.31 1.93 NA NA 23.54 23.86 090
43773 A Lap, change adjust gast band 20.64 NA NA 8.16 8.48 2.56 NA NA 31.36 31.68 090
43774 A Lap remov adj gast band/port 15.66 NA NA 6.14 6.46 1.85 NA NA 23.65 23.97 090
43800 A Reconstruction of pylorus 15.35 NA NA 5.88 5.89 1.82 NA NA 23.05 23.06 090
43810 A Fusion of stomach and bowel 16.80 NA NA 6.28 6.20 1.94 NA NA 25.02 24.94 090
43820 A Fusion of stomach and bowel 22.40 NA NA 8.14 6.84 2.04 NA NA 32.58 31.28 090
43825 A Fusion of stomach and bowel 21.63 NA NA 7.92 7.99 2.54 NA NA 32.09 32.16 090
43830 A Place gastrostomy tube 10.75 NA NA 5.19 4.93 1.25 NA NA 17.19 16.93 090
43831 A Place gastrostomy tube 8.38 NA NA 5.15 4.67 1.03 NA NA 14.56 14.08 090
43832 A Place gastrostomy tube 17.26 NA NA 7.14 6.92 1.98 NA NA 26.38 26.16 090
43840 A Repair of stomach lesion 22.70 NA NA 8.22 7.13 2.06 NA NA 32.98 31.89 090
43842 N V-band gastroplasty 20.90 NA NA 6.75 7.53 2.45 NA NA 30.10 30.88 090
43843 A Gastroplasty w/o v-band 21.08 NA NA 7.81 7.77 2.46 NA NA 31.35 31.31 090
43845 A Gastroplasty duodenal switch 33.12 NA NA 12.43 11.19 4.06 NA NA 49.61 48.37 090
43846 A Gastric bypass for obesity 27.23 NA NA 10.05 10.03 3.19 NA NA 40.47 40.45 090
43847 A Gastric bypass incl small i 30.10 NA NA 10.67 10.84 3.56 NA NA 44.33 44.50 090
43848 A Revision gastroplasty 32.57 NA NA 11.35 11.70 3.88 NA NA 47.80 48.15 090
43850 A Revise stomach-bowel fusion 27.45 NA NA 9.44 9.72 3.28 NA NA 40.17 40.45 090
43855 A Revise stomach-bowel fusion 28.56 NA NA 9.78 10.19 3.47 NA NA 41.81 42.22 090
43860 A Revise stomach-bowel fusion 27.76 NA NA 9.53 9.85 3.31 NA NA 40.60 40.92 090
43865 A Revise stomach-bowel fusion 28.92 NA NA 10.12 10.41 3.51 NA NA 42.55 42.84 090
43870 A Repair stomach opening 11.36 NA NA 5.04 4.64 1.27 NA NA 17.67 17.27 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
43880 A Repair stomach-bowel fistula 27.05 NA NA 9.37 9.76 3.27 NA NA 39.69 40.08 090
43881 C Impl/redo electrd, antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43882 C Revise/remove electrd antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43886 A Revise gastric port, open 4.54 NA NA 3.38 3.19 0.25 NA NA 8.17 7.98 090
43887 A Remove gastric port, open 4.24 NA NA 2.94 2.81 0.51 NA NA 7.69 7.56 090
43888 A Change gastric port, open 6.34 NA NA 3.86 3.79 0.70 NA NA 10.90 10.83 090
43999 C Stomach surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
44005 A Freeing of bowel adhesion 18.38 NA NA 6.64 6.69 2.15 NA NA 27.17 27.22 090
44010 A Incision of small bowel 14.18 NA NA 5.55 5.47 1.64 NA NA 21.37 21.29 090
44015 A Insert needle cath bowel 2.62 NA NA 0.69 0.83 0.35 NA NA 3.66 3.80 ZZZ
44020 A Explore small intestine 16.14 NA NA 6.03 5.96 1.86 NA NA 24.03 23.96 090
44021 A Decompress small bowel 16.23 NA NA 6.31 6.05 1.87 NA NA 24.41 24.15 090
44025 A Incision of large bowel 16.43 NA NA 6.16 6.06 1.90 NA NA 24.49 24.39 090
44050 A Reduce bowel obstruction 15.44 NA NA 5.86 5.93 1.86 NA NA 23.16 23.23 090
44055 A Correct malrotation of bowel 25.53 NA NA 8.56 8.68 2.91 NA NA 37.00 37.12 090
44100 A Biopsy of bowel 2.01 NA NA 0.90 0.76 0.17 NA NA 3.08 2.94 000
44110 A Excise intestine lesion(s) 13.96 NA NA 5.56 5.31 1.55 NA NA 21.07 20.82 090
44111 A Excision of bowel lesion(s) 16.44 NA NA 6.18 6.12 1.87 NA NA 24.49 24.43 090
44120 A Removal of small intestine 20.74 NA NA 7.21 7.11 2.25 NA NA 30.20 30.10 090
44121 A Removal of small intestine 4.44 NA NA 1.14 1.43 0.58 NA NA 6.16 6.45 ZZZ
44125 A Removal of small intestine 19.93 NA NA 7.08 7.21 2.27 NA NA 29.28 29.41 090
44126 A Enterectomy w/o taper, cong 42.02 NA NA 13.91 14.06 4.69 NA NA 60.62 60.77 090
44127 A Enterectomy w/taper, cong 49.09 NA NA 14.80 15.48 5.77 NA NA 69.66 70.34 090
44128 A Enterectomy cong, add-on 4.44 NA NA 1.05 1.41 0.61 NA NA 6.10 6.46 ZZZ
44130 A Bowel to bowel fusion 21.98 NA NA 8.02 6.66 1.88 NA NA 31.88 30.52 090
44132 R Enterectomy, cadaver donor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44133 R Enterectomy, live donor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44135 R Intestine transplnt, cadaver 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44136 R Intestine transplant, live 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44137 C Remove intestinal allograft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44139 A Mobilization of colon 2.23 NA NA 0.57 0.71 0.28 NA NA 3.08 3.22 ZZZ
44140 A Partial removal of colon 22.46 NA NA 8.14 8.52 2.71 NA NA 33.31 33.69 090
44141 A Partial removal of colon 29.75 NA NA 11.90 10.51 2.53 NA NA 44.18 42.79 090
44143 A Partial removal of colon 27.63 NA NA 10.35 10.60 3.05 NA NA 41.03 41.28 090
44144 A Partial removal of colon 29.75 NA NA 10.70 9.88 2.86 NA NA 43.31 42.49 090
44145 A Partial removal of colon 28.45 NA NA 9.58 10.50 3.29 NA NA 41.32 42.24 090
44146 A Partial removal of colon 35.14 NA NA 13.42 12.99 3.41 NA NA 51.97 51.54 090
44147 A Partial removal of colon 33.56 NA NA 11.05 9.27 2.56 NA NA 47.17 45.39 090
44150 A Removal of colon 29.99 NA NA 12.68 12.19 3.04 NA NA 45.71 45.22 090
44151 A Removal of colon/ileostomy 34.73 NA NA 14.10 13.57 3.49 NA NA 52.32 51.79 090
44155 A Removal of colon/ileostomy 34.23 NA NA 13.56 13.37 3.28 NA NA 51.07 50.88 090
44156 A Removal of colon/ileostomy 37.23 NA NA 14.79 14.97 3.95 NA NA 55.97 56.15 090
44157 A Colectomy w/ileoanal anast 35.49 NA NA 15.67 15.67 3.93 NA NA 55.09 55.09 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
44158 A Colectomy w/neo-rectum pouch 36.49 NA NA 15.97 15.97 4.06 NA NA 56.52 56.52 090
44160 A Removal of colon 20.78 NA NA 7.57 7.70 2.37 NA NA 30.72 30.85 090
44180 A Lap, enterolysis 0.77 NA NA 2.15 5.21 1.86 NA NA 4.78 7.84 090
44186 A Lap, jejunostomy 0.53 NA NA 2.15 4.13 1.27 NA NA 3.95 5.93 090
44187 A Lap, ileo/jejuno-stomy 17.27 NA NA 8.19 8.25 1.96 NA NA 27.42 27.48 090
44188 A Lap, colostomy 19.20 NA NA 8.77 8.82 2.24 NA NA 30.21 30.26 090
44202 A Lap, enterectomy 23.26 NA NA 8.37 8.78 2.85 NA NA 34.48 34.89 090
44203 A Lap resect s/intestine, addl 4.44 NA NA 1.14 1.41 0.57 NA NA 6.15 6.42 ZZZ
44204 A Laparo partial colectomy 26.29 NA NA 9.00 9.71 3.11 NA NA 38.40 39.11 090
44205 A Lap colectomy part w/ileum 22.86 NA NA 7.88 8.60 2.75 NA NA 33.49 34.21 090
44206 A Lap part colectomy w/stoma 29.63 NA NA 10.58 11.08 3.46 NA NA 43.67 44.17 090
44207 A L colectomy/coloproctostomy 31.79 NA NA 10.24 11.17 3.67 NA NA 45.70 46.63 090
44208 A L colectomy/coloproctostomy 33.86 NA NA 12.17 12.89 3.88 NA NA 49.91 50.63 090
44210 A Laparo total proctocolectomy 29.88 NA NA 11.27 11.72 3.42 NA NA 44.57 45.02 090
44211 A Lap colectomy w/proctectomy 36.87 NA NA 13.85 14.47 4.17 NA NA 54.89 55.51 090
44212 A Laparo total proctocolectomy 34.37 NA NA 13.26 13.58 3.78 NA NA 51.41 51.73 090
44213 A Lap, mobil splenic fl add-on 3.50 NA NA 0.89 1.14 0.44 NA NA 4.83 5.08 ZZZ
44227 A Lap, close enterostomy 28.49 NA NA 9.59 10.36 3.38 NA NA 41.46 42.23 090
44238 C Laparoscope proc, intestine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
44300 A Open bowel to skin 13.65 NA NA 5.58 5.51 1.60 NA NA 20.83 20.76 090
44310 A Ileostomy/jejunostomy 17.49 NA NA 6.45 6.63 1.99 NA NA 25.93 26.11 090
44312 A Revision of ileostomy 9.33 NA NA 4.65 4.16 0.92 NA NA 14.90 14.41 090
44314 A Revision of ileostomy 16.61 NA NA 6.88 6.63 1.75 NA NA 25.24 24.99 090
44316 A Devise bowel pouch 23.46 NA NA 9.35 8.74 2.38 NA NA 35.19 34.58 090
44320 A Colostomy 19.75 NA NA 7.66 7.65 2.26 NA NA 29.67 29.66 090
44322 A Colostomy with biopsies 13.15 NA NA 9.41 8.78 1.54 NA NA 24.10 23.47 090
44340 A Revision of colostomy 9.12 NA NA 4.96 4.44 0.99 NA NA 15.07 14.55 090
44345 A Revision of colostomy 17.06 NA NA 6.96 6.90 1.97 NA NA 25.99 25.93 090
44346 A Revision of colostomy 19.47 NA NA 7.58 7.43 2.13 NA NA 29.18 29.03 090
44360 A Small bowel endoscopy 2.59 NA NA 1.53 1.21 0.19 NA NA 4.31 3.99 000
44361 A Small bowel endoscopy/biopsy 2.87 NA NA 1.67 1.32 0.21 NA NA 4.75 4.40 000
44363 A Small bowel endoscopy 3.49 NA NA 1.96 1.53 0.27 NA NA 5.72 5.29 000
44364 A Small bowel endoscopy 3.73 NA NA 2.04 1.63 0.27 NA NA 6.04 5.63 000
44365 A Small bowel endoscopy 3.31 NA NA 1.81 1.47 0.24 NA NA 5.36 5.02 000
44366 A Small bowel endoscopy 4.40 NA NA 2.42 1.90 0.32 NA NA 7.14 6.62 000
44369 A Small bowel endoscopy 4.51 NA NA 2.46 1.91 0.33 NA NA 7.30 6.75 000
44370 A Small bowel endoscopy/stent 4.79 NA NA 2.58 2.12 0.37 NA NA 7.74 7.28 000
44372 A Small bowel endoscopy 4.40 NA NA 2.16 1.84 0.35 NA NA 6.91 6.59 000
44373 A Small bowel endoscopy 3.49 NA NA 1.74 1.50 0.27 NA NA 5.50 5.26 000
44376 A Small bowel endoscopy 5.25 NA NA 2.48 2.14 0.42 NA NA 8.15 7.81 000
44377 A Small bowel endoscopy/biopsy 5.52 NA NA 2.84 2.31 0.40 NA NA 8.76 8.23 000
44378 A Small bowel endoscopy 7.12 NA NA 3.61 2.92 0.52 NA NA 11.25 10.56 000
44379 A S bowel endoscope w/stent 7.46 NA NA 3.34 3.02 0.62 NA NA 11.42 11.10 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
44380 A Small bowel endoscopy 1.05 NA NA 0.75 0.60 0.08 NA NA 1.88 1.73 000
44382 A Small bowel endoscopy 1.27 NA NA 0.79 0.67 0.12 NA NA 2.18 2.06 000
44383 A Ileoscopy w/stent 2.94 NA NA 1.64 1.36 0.21 NA NA 4.79 4.51 000
44385 A Endoscopy of bowel pouch 1.82 4.88 3.73 0.90 0.79 0.15 6.85 5.70 2.87 2.76 000
44386 A Endoscopy, bowel pouch/biop 2.12 6.73 6.66 1.06 0.93 0.20 9.05 8.98 3.38 3.25 000
44388 A Colonoscopy 2.82 6.10 5.34 1.37 1.21 0.26 9.18 8.42 4.45 4.29 000
44389 A Colonoscopy with biopsy 3.13 7.07 6.73 1.60 1.35 0.27 10.47 10.13 5.00 4.75 000
44390 A Colonoscopy for foreign body 3.82 7.96 7.32 1.81 1.57 0.32 12.10 11.46 5.95 5.71 000
44391 A Colonoscopy for bleeding 4.31 8.95 8.78 2.24 1.83 0.34 13.60 13.43 6.89 6.48 000
44392 A Colonoscopy polypectomy 3.81 7.37 6.78 1.74 1.55 0.34 11.52 10.93 5.89 5.70 000
44393 A Colonoscopy, lesion removal 4.83 7.87 7.14 2.07 1.91 0.42 13.12 12.39 7.32 7.16 000
44394 A Colonoscopy w/snare 4.42 8.46 7.97 2.09 1.81 0.38 13.26 12.77 6.89 6.61 000
44397 A Colonoscopy w/stent 4.70 NA NA 2.33 1.93 0.39 NA NA 7.42 7.02 000
44500 A Intro, gastrointestinal tube 0.49 NA NA 0.14 0.16 0.03 NA NA 0.66 0.68 000
44602 A Suture, small intestine 24.64 NA NA 7.71 6.72 2.12 NA NA 34.47 33.48 090
44603 A Suture, small intestine 28.03 NA NA 9.08 7.72 2.42 NA NA 39.53 38.17 090
44604 A Suture, large intestine 18.06 NA NA 6.12 6.37 2.12 NA NA 26.30 26.55 090
44605 A Repair of bowel lesion 22.00 NA NA 7.95 8.28 2.52 NA NA 32.47 32.80 090
44615 A Intestinal stricturoplasty 18.08 NA NA 6.61 6.66 2.07 NA NA 26.76 26.81 090
44620 A Repair bowel opening 14.35 NA NA 5.54 5.38 1.51 NA NA 21.40 21.24 090
44625 A Repair bowel opening 17.20 NA NA 6.22 6.28 1.86 NA NA 25.28 25.34 090
44626 A Repair bowel opening 27.82 NA NA 9.00 9.61 3.27 NA NA 40.09 40.70 090
44640 A Repair bowel-skin fistula 24.12 NA NA 8.13 8.46 2.78 NA NA 35.03 35.36 090
44650 A Repair bowel fistula 25.04 NA NA 8.38 8.76 2.93 NA NA 36.35 36.73 090
44660 A Repair bowel-bladder fistula 23.83 NA NA 9.79 8.70 2.14 NA NA 35.76 34.67 090
44661 A Repair bowel-bladder fistula 27.27 NA NA 9.48 9.53 2.81 NA NA 39.56 39.61 090
44680 A Surgical revision, intestine 17.88 NA NA 6.59 6.48 2.00 NA NA 26.47 26.36 090
44700 A Suspend bowel w/prosthesis 17.40 NA NA 6.29 6.57 1.84 NA NA 25.53 25.81 090
44701 A Intraop colon lavage add-on 3.10 NA NA 0.78 0.99 0.37 NA NA 4.25 4.46 ZZZ
44715 C Prepare donor intestine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
44720 A Prep donor intestine/venous 5.00 NA NA 1.26 1.60 0.37 NA NA 6.63 6.97 XXX
44721 A Prep donor intestine/artery 7.00 NA NA 1.83 2.25 0.97 NA NA 9.80 10.22 XXX
44799 C Unlisted procedure intestine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
44800 A Excision of bowel pouch 11.94 NA NA 5.54 5.42 1.47 NA NA 18.95 18.83 090
44820 A Excision of mesentery lesion 13.63 NA NA 5.63 5.52 1.59 NA NA 20.85 20.74 090
44850 A Repair of mesentery 12.03 NA NA 5.03 5.01 1.39 NA NA 18.45 18.43 090
44899 C Bowel surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
44900 A Drain app abscess, open 12.44 NA NA 5.04 4.78 1.33 NA NA 18.81 18.55 090
44901 A Drain app abscess, percut 3.37 18.75 25.61 0.95 1.07 0.22 22.34 29.20 4.54 4.66 000
44950 A Appendectomy 10.52 NA NA 4.07 4.25 1.31 NA NA 15.90 16.08 090
44955 A Appendectomy add-on 1.53 NA NA 0.41 0.51 0.20 NA NA 2.14 2.24 ZZZ
44960 A Appendectomy 14.39 NA NA 5.44 5.36 1.63 NA NA 21.46 21.38 090
44970 A Laparoscopy, appendectomy 9.35 NA NA 4.21 4.11 1.14 NA NA 14.70 14.60 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
44979 C Laparoscope proc, app 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
45000 A Drainage of pelvic abscess 6.20 NA NA 3.50 3.10 0.52 NA NA 10.22 9.82 090
45005 A Drainage of rectal abscess 2.00 3.94 4.02 1.58 1.58 0.25 6.19 6.27 3.83 3.83 010
45020 A Drainage of rectal abscess 8.43 NA NA 4.52 3.58 0.55 NA NA 13.50 12.56 090
45100 A Biopsy of rectum 3.96 NA NA 2.83 2.48 0.44 NA NA 7.23 6.88 090
45108 A Removal of anorectal lesion 5.04 NA NA 3.06 2.84 0.59 NA NA 8.69 8.47 090
45110 A Removal of rectum 30.57 NA NA 11.97 12.29 3.36 NA NA 45.90 46.22 090
45111 A Partial removal of rectum 17.89 NA NA 7.05 7.13 2.07 NA NA 27.01 27.09 090
45112 A Removal of rectum 33.05 NA NA 10.43 11.43 3.43 NA NA 46.91 47.91 090
45113 A Partial proctectomy 33.09 NA NA 11.67 12.36 3.49 NA NA 48.25 48.94 090
45114 A Partial removal of rectum 30.63 NA NA 10.43 10.76 3.36 NA NA 44.42 44.75 090
45116 A Partial removal of rectum 27.56 NA NA 9.45 9.88 2.88 NA NA 39.89 40.32 090
45119 A Remove rectum w/reservoir 33.35 NA NA 11.79 12.29 3.36 NA NA 48.50 49.00 090
45120 A Removal of rectum 26.25 NA NA 9.47 9.96 2.90 NA NA 38.62 39.11 090
45121 A Removal of rectum and colon 28.93 NA NA 10.33 10.91 3.25 NA NA 42.51 43.09 090
45123 A Partial proctectomy 18.70 NA NA 7.12 6.92 1.86 NA NA 27.68 27.48 090
45126 A Pelvic exenteration 48.89 NA NA 17.38 18.75 4.33 NA NA 70.60 71.97 090
45130 A Excision of rectal prolapse 18.37 NA NA 6.79 6.77 1.80 NA NA 26.96 26.94 090
45135 A Excision of rectal prolapse 22.15 NA NA 9.35 8.65 2.36 NA NA 33.86 33.16 090
45136 A Excise ileoanal reservior 30.63 NA NA 11.94 12.37 2.82 NA NA 45.39 45.82 090
45150 A Excision of rectal stricture 5.77 NA NA 3.42 3.08 0.61 NA NA 9.80 9.46 090
45160 A Excision of rectal lesion 16.17 NA NA 6.61 6.63 1.68 NA NA 24.46 24.48 090
45170 A Excision of rectal lesion 12.48 NA NA 5.41 5.28 1.35 NA NA 19.24 19.11 090
45190 A Destruction, rectal tumor 10.29 NA NA 5.60 4.87 1.13 NA NA 17.02 16.29 090
45300 A Proctosigmoidoscopy dx 0.38 1.93 1.63 0.35 0.30 0.04 2.35 2.05 0.77 0.72 000
45303 A Proctosigmoidoscopy dilate 0.44 19.40 18.86 0.38 0.34 0.05 19.89 19.35 0.87 0.83 000
45305 A Proctosigmoidoscopy w/bx 1.01 3.24 2.78 0.53 0.51 0.11 4.36 3.90 1.65 1.63 000
45307 A Proctosigmoidoscopy fb 0.94 3.30 3.10 0.51 0.49 0.11 4.35 4.15 1.56 1.54 000
45308 A Proctosigmoidoscopy removal 0.83 3.27 2.31 0.49 0.45 0.09 4.19 3.23 1.41 1.37 000
45309 A Proctosigmoidoscopy removal 2.01 3.75 3.05 0.83 0.84 0.22 5.98 5.28 3.06 3.07 000
45315 A Proctosigmoidoscopy removal 1.40 3.58 3.04 0.65 0.64 0.15 5.13 4.59 2.20 2.19 000
45317 A Proctosigmoidoscopy bleed 1.50 3.48 2.69 0.66 0.66 0.15 5.13 4.34 2.31 2.31 000
45320 A Proctosigmoidoscopy ablate 1.58 3.95 3.17 0.75 0.72 0.16 5.69 4.91 2.49 2.46 000
45321 A Proctosigmoidoscopy volvul 1.17 NA NA 0.65 0.58 0.13 NA NA 1.95 1.88 000
45327 A Proctosigmoidoscopy w/stent 1.65 NA NA 0.82 0.72 0.16 NA NA 2.63 2.53 000
45330 A Diagnostic sigmoidoscopy 0.96 2.49 2.33 0.62 0.53 0.08 3.53 3.37 1.66 1.57 000
45331 A Sigmoidoscopy and biopsy 1.15 3.24 3.11 0.79 0.64 0.09 4.48 4.35 2.03 1.88 000
45332 A Sigmoidoscopy w/fb removal 1.79 5.60 5.15 1.04 0.86 0.16 7.55 7.10 2.99 2.81 000
45333 A Sigmoidoscopy polypectomy 1.79 5.61 5.06 0.99 0.85 0.15 7.55 7.00 2.93 2.79 000
45334 A Sigmoidoscopy for bleeding 2.73 NA NA 1.55 1.24 0.20 NA NA 4.48 4.17 000
45335 A Sigmoidoscopy w/submuc inj 1.46 5.31 3.74 0.91 0.75 0.11 6.88 5.31 2.48 2.32 000
45337 A Sigmoidoscopy decompress 2.36 NA NA 1.25 1.06 0.21 NA NA 3.82 3.63 000
45338 A Sigmoidoscopy w/tumr remove 2.34 5.84 5.37 1.28 1.07 0.19 8.37 7.90 3.81 3.60 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
45339 A Sigmoidoscopy w/ablate tumr 3.14 5.74 4.03 1.69 1.38 0.26 9.14 7.43 5.09 4.78 000
45340 A Sig w/balloon dilation 1.89 10.20 7.18 1.05 0.89 0.15 12.24 9.22 3.09 2.93 000
45341 A Sigmoidoscopy w/ultrasound 2.60 NA NA 1.48 1.17 0.19 NA NA 4.27 3.96 000
45342 A Sigmoidoscopy w/us guide bx 4.05 NA NA 2.20 1.71 0.30 NA NA 6.55 6.06 000
45345 A Sigmoidoscopy w/stent 2.92 NA NA 1.56 1.26 0.23 NA NA 4.71 4.41 000
45355 A Surgical colonoscopy 3.51 NA NA 1.57 1.43 0.36 NA NA 5.44 5.30 000
45378 A Diagnostic colonoscopy 3.69 6.37 6.20 1.85 1.57 0.30 10.36 10.19 5.84 5.56 000
45378 53 A Diagnostic colonoscopy 0.96 2.49 2.33 0.62 0.53 0.08 3.53 3.37 1.66 1.57 000
45379 A Colonoscopy w/fb removal 4.68 8.15 7.78 2.25 1.92 0.39 13.22 12.85 7.32 6.99 000
45380 A Colonoscopy and biopsy 4.43 7.73 7.33 2.27 1.87 0.35 12.51 12.11 7.05 6.65 000
45381 A Colonoscopy, submucous inj 4.19 7.71 7.26 2.19 1.79 0.30 12.20 11.75 6.68 6.28 000
45382 A Colonoscopy/control bleeding 5.68 10.34 10.04 2.93 2.37 0.41 16.43 16.13 9.02 8.46 000
45383 A Lesion removal colonoscopy 5.86 8.56 8.08 2.69 2.34 0.48 14.90 14.42 9.03 8.68 000
45384 A Lesion remove colonoscopy 4.69 7.21 6.90 2.24 1.93 0.38 12.28 11.97 7.31 7.00 000
45385 A Lesion removal colonoscopy 5.30 8.35 7.94 2.63 2.18 0.42 14.07 13.66 8.35 7.90 000
45386 A Colonoscopy dilate stricture 4.57 12.29 12.37 2.21 1.89 0.39 17.25 17.33 7.17 6.85 000
45387 A Colonoscopy w/stent 5.90 NA NA 2.95 2.49 0.48 NA NA 9.33 8.87 000
45391 A Colonoscopy w/endoscope us 5.09 NA NA 2.60 2.13 0.42 NA NA 8.11 7.64 000
45392 A Colonoscopy w/endoscopic fnb 6.54 NA NA 3.17 2.65 0.42 NA NA 10.13 9.61 000
45395 A Lap, removal of rectum 32.79 NA NA 13.03 13.51 3.63 NA NA 49.45 49.93 090
45397 A Lap, remove rectum w/pouch 36.29 NA NA 13.67 14.11 3.67 NA NA 53.63 54.07 090
45400 A Laparoscopic proc 19.31 NA NA 7.21 7.68 2.03 NA NA 28.55 29.02 090
45402 A Lap proctopexy w/sig resect 26.38 NA NA 8.91 9.71 2.82 NA NA 38.11 38.91 090
45499 C Laparoscope proc, rectum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
45500 A Repair of rectum 7.64 NA NA 4.39 3.75 0.75 NA NA 12.78 12.14 090
45505 A Repair of rectum 8.20 NA NA 5.14 4.17 0.86 NA NA 14.20 13.23 090
45520 A Treatment of rectal prolapse 0.55 3.04 1.99 0.41 0.38 0.05 3.64 2.59 1.01 0.98 000
45540 A Correct rectal prolapse 18.02 NA NA 5.83 6.55 1.85 NA NA 25.70 26.42 090
45541 A Correct rectal prolapse 14.72 NA NA 6.63 6.11 1.55 NA NA 22.90 22.38 090
45550 A Repair rectum/remove sigmoid 24.67 NA NA 9.06 9.17 2.62 NA NA 36.35 36.46 090
45560 A Repair of rectocele 11.42 NA NA 5.55 5.18 1.13 NA NA 18.10 17.73 090
45562 A Exploration/repair of rectum 17.82 NA NA 8.18 7.28 1.84 NA NA 27.84 26.94 090
45563 A Exploration/repair of rectum 26.22 NA NA 10.95 10.62 3.11 NA NA 40.28 39.95 090
45800 A Repair rect/bladder fistula 20.18 NA NA 9.30 7.89 1.86 NA NA 31.34 29.93 090
45805 A Repair fistula w/colostomy 23.19 NA NA 9.27 9.44 2.03 NA NA 34.49 34.66 090
45820 A Repair rectourethral fistula 20.24 NA NA 9.39 8.06 1.58 NA NA 31.21 29.88 090
45825 A Repair fistula w/colostomy 24.01 NA NA 11.05 10.12 2.32 NA NA 37.38 36.45 090
45900 A Reduction of rectal prolapse 2.96 NA NA 1.69 1.55 0.30 NA NA 4.95 4.81 010
45905 A Dilation of anal sphincter 2.32 NA NA 1.65 1.49 0.27 NA NA 4.24 4.08 010
45910 A Dilation of rectal narrowing 2.82 NA NA 1.81 1.70 0.30 NA NA 4.93 4.82 010
45915 A Remove rectal obstruction 3.16 4.25 4.30 2.05 2.08 0.30 7.71 7.76 5.51 5.54 010
45990 A Surg dx exam, anorectal 1.80 NA NA 0.80 0.79 0.17 NA NA 2.77 2.76 000
45999 C Rectum surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
46020 A Placement of seton 2.94 3.26 2.56 2.36 1.98 0.31 6.51 5.81 5.61 5.23 010
46030 A Removal of rectal marker 1.24 1.88 1.48 0.82 0.74 0.14 3.26 2.86 2.20 2.12 010
46040 A Incision of rectal abscess 5.26 6.51 5.75 3.98 3.68 0.62 12.39 11.63 9.86 9.56 090
46045 A Incision of rectal abscess 5.79 NA NA 3.94 3.15 0.54 NA NA 10.27 9.48 090
46050 A Incision of anal abscess 1.21 3.17 2.70 0.98 0.88 0.14 4.52 4.05 2.33 2.23 010
46060 A Incision of rectal abscess 6.24 NA NA 4.42 3.54 0.67 NA NA 11.33 10.45 090
46070 A Incision of anal septum 2.74 NA NA 2.33 1.96 0.36 NA NA 5.43 5.06 090
46080 A Incision of anal sphincter 2.50 3.05 2.53 1.13 1.13 0.30 5.85 5.33 3.93 3.93 010
46083 A Incise external hemorrhoid 1.42 2.34 2.48 0.96 0.93 0.15 3.91 4.05 2.53 2.50 010
46200 A Removal of anal fissure 3.48 6.28 4.46 3.73 3.08 0.39 10.15 8.33 7.60 6.95 090
46210 A Removal of anal crypt 2.73 5.93 5.32 3.36 2.81 0.31 8.97 8.36 6.40 5.85 090
46211 A Removal of anal crypts 4.31 7.12 5.83 4.11 3.65 0.48 11.91 10.62 8.90 8.44 090
46220 A Removal of anal tag 1.58 2.98 2.46 1.09 0.99 0.17 4.73 4.21 2.84 2.74 010
46221 A Ligation of hemorrhoid(s) 2.31 3.72 2.91 2.00 1.81 0.23 6.26 5.45 4.54 4.35 010
46230 A Removal of anal tags 2.59 3.49 3.18 1.34 1.30 0.30 6.38 6.07 4.23 4.19 010
46250 A Hemorrhoidectomy 4.17 5.95 5.46 2.85 2.67 0.48 10.60 10.11 7.50 7.32 090
46255 A Hemorrhoidectomy 4.88 6.37 5.97 3.10 2.90 0.58 11.83 11.43 8.56 8.36 090
46257 A Remove hemorrhoids fissure 5.68 NA NA 3.82 3.11 0.64 NA NA 10.14 9.43 090
46258 A Remove hemorrhoids fistula 6.28 NA NA 4.02 3.46 0.68 NA NA 10.98 10.42 090
46260 A Hemorrhoidectomy 6.65 NA NA 4.07 3.40 0.76 NA NA 11.48 10.81 090
46261 A Remove hemorrhoids fissure 7.63 NA NA 4.35 3.79 0.79 NA NA 12.77 12.21 090
46262 A Remove hemorrhoids fistula 7.80 NA NA 4.70 3.97 0.83 NA NA 13.33 12.60 090
46270 A Removal of anal fistula 4.81 6.26 5.31 3.85 3.09 0.46 11.53 10.58 9.12 8.36 090
46275 A Removal of anal fistula 5.31 6.60 5.12 3.97 3.22 0.52 12.43 10.95 9.80 9.05 090
46280 A Removal of anal fistula 6.28 NA NA 4.29 3.51 0.66 NA NA 11.23 10.45 090
46285 A Removal of anal fistula 5.31 6.51 4.45 3.96 3.05 0.44 12.26 10.20 9.71 8.80 090
46288 A Repair anal fistula 7.68 NA NA 4.70 3.93 0.79 NA NA 13.17 12.40 090
46320 A Removal of hemorrhoid clot 1.62 2.40 2.19 0.89 0.86 0.18 4.20 3.99 2.69 2.66 010
46500 A Injection into hemorrhoid(s) 1.64 3.60 2.48 1.26 1.18 0.16 5.40 4.28 3.06 2.98 010
46505 A Chemodenervation anal musc 3.13 3.29 3.10 2.31 2.05 0.14 6.56 6.37 5.58 5.32 010
46600 A Diagnostic anoscopy 0.50 1.43 1.53 0.37 0.35 0.05 1.98 2.08 0.92 0.90 000
46604 A Anoscopy and dilation 1.31 12.51 9.97 0.58 0.61 0.12 13.94 11.40 2.01 2.04 000
46606 A Anoscopy and biopsy 0.81 3.88 3.81 0.48 0.44 0.09 4.78 4.71 1.38 1.34 000
46608 A Anoscopy, remove for body 1.51 3.90 4.28 0.62 0.64 0.16 5.57 5.95 2.29 2.31 000
46610 A Anoscopy, remove lesion 1.32 4.12 4.05 0.67 0.63 0.15 5.59 5.52 2.14 2.10 000
46611 A Anoscopy 1.81 2.80 3.20 0.72 0.77 0.19 4.80 5.20 2.72 2.77 000
46612 A Anoscopy, remove lesions 2.34 5.24 5.20 0.96 0.98 0.28 7.86 7.82 3.58 3.60 000
46614 A Anoscopy, control bleeding 2.01 2.56 2.38 0.83 0.84 0.20 4.77 4.59 3.04 3.05 000
46615 A Anoscopy 2.68 2.26 2.43 0.97 1.05 0.33 5.27 5.44 3.98 4.06 000
46700 A Repair of anal stricture 9.68 NA NA 5.19 4.45 0.94 NA NA 15.81 15.07 090
46705 A Repair of anal stricture 7.32 NA NA 4.04 3.77 0.91 NA NA 12.27 12.00 090
46706 A Repr of anal fistula w/glue 2.41 NA NA 1.45 1.30 0.28 NA NA 4.14 3.99 010
46710 A Repr per/vag pouch sngl proc 17.01 NA NA 7.83 7.77 1.38 NA NA 26.22 26.16 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
46712 A Repr per/vag pouch dbl proc 36.32 NA NA 14.26 14.85 3.67 NA NA 54.25 54.84 090
46715 A Rep perf anoper fistu 7.54 NA NA 3.74 3.61 0.92 NA NA 12.20 12.07 090
46716 A Rep perf anoper/vestib fistu 17.14 NA NA 9.59 8.38 1.58 NA NA 28.31 27.10 090
46730 A Construction of absent anus 30.17 NA NA 11.55 11.90 2.47 NA NA 44.19 44.54 090
46735 A Construction of absent anus 35.66 NA NA 13.63 13.56 3.21 NA NA 52.50 52.43 090
46740 A Construction of absent anus 33.42 NA NA 14.57 13.56 2.42 NA NA 50.41 49.40 090
46742 A Repair of imperforated anus 39.66 NA NA 16.09 17.06 3.20 NA NA 58.95 59.92 090
46744 A Repair of cloacal anomaly 58.46 NA NA 21.37 21.18 6.40 NA NA 86.23 86.04 090
46746 A Repair of cloacal anomaly 64.93 NA NA 19.68 23.78 7.70 NA NA 92.31 96.41 090
46748 A Repair of cloacal anomaly 70.91 NA NA 21.07 22.99 3.37 NA NA 95.35 97.27 090
46750 A Repair of anal sphincter 12.02 NA NA 5.83 5.25 1.10 NA NA 18.95 18.37 090
46751 A Repair of anal sphincter 9.19 NA NA 4.42 5.16 0.94 NA NA 14.55 15.29 090
46753 A Reconstruction of anus 8.81 NA NA 4.63 4.04 0.94 NA NA 14.38 13.79 090
46754 A Removal of suture from anus 2.88 3.72 3.62 2.28 1.82 0.19 6.79 6.69 5.35 4.89 010
46760 A Repair of anal sphincter 17.21 NA NA 8.24 7.37 1.59 NA NA 27.04 26.17 090
46761 A Repair of anal sphincter 15.16 NA NA 6.51 6.13 1.43 NA NA 23.10 22.72 090
46762 A Implant artificial sphincter 14.66 NA NA 6.87 5.85 1.24 NA NA 22.77 21.75 090
46900 A Destruction, anal lesion(s) 1.91 3.63 2.84 1.31 1.28 0.17 5.71 4.92 3.39 3.36 010
46910 A Destruction, anal lesion(s) 1.88 3.88 3.15 1.21 1.10 0.19 5.95 5.22 3.28 3.17 010
46916 A Cryosurgery, anal lesion(s) 1.88 3.80 3.31 1.61 1.45 0.11 5.79 5.30 3.60 3.44 010
46917 A Laser surgery, anal lesions 1.88 8.62 9.00 1.21 1.14 0.21 10.71 11.09 3.30 3.23 010
46922 A Excision of anal lesion(s) 1.88 4.10 3.48 1.20 1.10 0.22 6.20 5.58 3.30 3.20 010
46924 A Destruction, anal lesion(s) 2.78 9.60 8.91 1.55 1.40 0.26 12.64 11.95 4.59 4.44 010
46934 A Destruction of hemorrhoids 3.79 5.40 5.15 2.81 2.92 0.32 9.51 9.26 6.92 7.03 090
46935 A Destruction of hemorrhoids 2.44 3.68 3.52 1.09 1.18 0.23 6.35 6.19 3.76 3.85 010
46936 A Destruction of hemorrhoids 3.70 6.15 5.19 2.62 2.52 0.34 10.19 9.23 6.66 6.56 090
46937 A Cryotherapy of rectal lesion 2.70 4.16 3.12 1.90 1.39 0.14 7.00 5.96 4.74 4.23 010
46938 A Cryotherapy of rectal lesion 4.70 5.78 4.44 3.64 3.20 0.58 11.06 9.72 8.92 8.48 090
46940 A Treatment of anal fissure 2.33 2.84 2.20 1.05 1.08 0.23 5.40 4.76 3.61 3.64 010
46942 A Treatment of anal fissure 2.05 2.79 2.07 0.96 1.01 0.19 5.03 4.31 3.20 3.25 010
46945 A Ligation of hemorrhoids 2.13 4.81 3.65 2.99 2.60 0.19 7.13 5.97 5.31 4.92 090
46946 A Ligation of hemorrhoids 2.60 4.64 3.95 2.66 2.46 0.27 7.51 6.82 5.53 5.33 090
46947 A Hemorrhoidopexy by stapling 5.49 NA NA 3.11 2.81 0.75 NA NA 9.35 9.05 090
46999 C Anus surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
47000 A Needle biopsy of liver 1.90 7.28 4.12 0.58 0.62 0.12 9.30 6.14 2.60 2.64 000
47001 A Needle biopsy, liver add-on 1.90 NA NA 0.49 0.61 0.25 NA NA 2.64 2.76 ZZZ
47010 A Open drainage, liver lesion 19.27 NA NA 8.15 8.33 1.81 NA NA 29.23 29.41 090
47011 A Percut drain, liver lesion 3.69 NA NA 1.05 1.17 0.22 NA NA 4.96 5.08 000
47015 A Inject/aspirate liver cyst 18.37 NA NA 7.80 7.56 1.84 NA NA 28.01 27.77 090
47100 A Wedge biopsy of liver 12.78 NA NA 6.33 6.11 1.53 NA NA 20.64 20.42 090
47120 A Partial removal of liver 38.82 NA NA 14.08 14.88 4.66 NA NA 57.56 58.36 090
47122 A Extensive removal of liver 59.35 NA NA 18.83 20.79 7.21 NA NA 85.39 87.35 090
47125 A Partial removal of liver 52.91 NA NA 17.09 18.90 6.47 NA NA 76.47 78.28 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
47130 A Partial removal of liver 57.06 NA NA 18.09 20.24 6.96 NA NA 82.11 84.26 090
47133 X Removal of donor liver 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
47135 R Transplantation of liver 83.29 NA NA 27.87 30.59 9.96 NA NA 121.12 123.84 090
47136 R Transplantation of liver 70.39 NA NA 23.77 26.20 8.44 NA NA 102.60 105.03 090
47140 A Partial removal, donor liver 59.22 NA NA 21.75 22.14 5.19 NA NA 86.16 86.55 090
47141 A Partial removal, donor liver 71.27 NA NA 25.51 26.55 5.19 NA NA 101.97 103.01 090
47142 A Partial removal, donor liver 79.21 NA NA 27.55 28.98 5.19 NA NA 111.95 113.38 090
47143 C Prep donor liver, whole 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
47144 C Prep donor liver, 3-segment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
47145 C Prep donor liver, lobe split 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
47146 A Prep donor liver/venous 6.00 NA NA 1.54 1.92 0.83 NA NA 8.37 8.75 XXX
47147 A Prep donor liver/arterial 7.00 NA NA 1.79 2.24 0.97 NA NA 9.76 10.21 XXX
47300 A Surgery for liver lesion 18.01 NA NA 7.67 7.33 1.99 NA NA 27.67 27.33 090
47350 A Repair liver wound 22.36 NA NA 8.89 8.87 2.59 NA NA 33.84 33.82 090
47360 A Repair liver wound 31.18 NA NA 11.38 11.52 3.38 NA NA 45.94 46.08 090
47361 A Repair liver wound 52.47 NA NA 16.82 18.09 5.87 NA NA 75.16 76.43 090
47362 A Repair liver wound 23.41 NA NA 9.31 8.86 2.51 NA NA 35.23 34.78 090
47370 A Laparo ablate liver tumor rf 20.67 NA NA 7.67 8.02 2.56 NA NA 30.90 31.25 090
47371 A Laparo ablate liver cryosurg 20.67 NA NA 8.14 8.14 2.61 NA NA 31.42 31.42 090
47379 C Laparoscope procedure, liver 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
47380 A Open ablate liver tumor rf 24.43 NA NA 8.52 9.14 2.87 NA NA 35.82 36.44 090
47381 A Open ablate liver tumor cryo 24.72 NA NA 9.01 9.44 2.85 NA NA 36.58 37.01 090
47382 A Percut ablate liver rf 15.19 NA NA 5.12 5.83 0.96 NA NA 21.27 21.98 010
47399 C Liver surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
47400 A Incision of liver duct 36.23 NA NA 13.12 13.35 3.08 NA NA 52.43 52.66 090
47420 A Incision of bile duct 21.92 NA NA 8.63 8.72 2.63 NA NA 33.18 33.27 090
47425 A Incision of bile duct 22.20 NA NA 8.59 8.75 2.62 NA NA 33.41 33.57 090
47460 A Incise bile duct sphincter 20.41 NA NA 9.01 8.52 2.21 NA NA 31.63 31.14 090
47480 A Incision of gallbladder 13.12 NA NA 6.65 6.09 1.42 NA NA 21.19 20.63 090
47490 A Incision of gallbladder 8.05 NA NA 4.61 5.32 0.43 NA NA 13.09 13.80 090
47500 A Injection for liver x-rays 1.96 NA NA 0.57 0.62 0.12 NA NA 2.65 2.70 000
47505 A Injection for liver x-rays 0.76 NA NA 0.22 0.24 0.04 NA NA 1.02 1.04 000
47510 A Insert catheter, bile duct 7.94 NA NA 3.99 4.76 0.46 NA NA 12.39 13.16 090
47511 A Insert bile duct drain 10.74 NA NA 4.22 4.87 0.62 NA NA 15.58 16.23 090
47525 A Change bile duct catheter 5.55 13.94 14.80 2.27 2.67 0.33 19.82 20.68 8.15 8.55 010
47530 A Revise/reinsert bile tube 5.96 28.88 32.56 2.98 3.53 0.37 35.21 38.89 9.31 9.86 090
47550 A Bile duct endoscopy add-on 3.02 NA NA 0.78 0.96 0.40 NA NA 4.20 4.38 ZZZ
47552 A Biliary endoscopy thru skin 6.03 NA NA 2.10 2.30 0.42 NA NA 8.55 8.75 000
47553 A Biliary endoscopy thru skin 6.34 NA NA 1.84 2.01 0.37 NA NA 8.55 8.72 000
47554 A Biliary endoscopy thru skin 9.05 NA NA 2.92 3.24 0.96 NA NA 12.93 13.25 000
47555 A Biliary endoscopy thru skin 7.55 NA NA 2.22 2.40 0.45 NA NA 10.22 10.40 000
47556 A Biliary endoscopy thru skin 8.55 NA NA 2.47 2.70 0.50 NA NA 11.52 11.75 000
47560 A Laparoscopy w/cholangio 4.88 NA NA 1.25 1.57 0.65 NA NA 6.78 7.10 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
47561 A Laparo w/cholangio/biopsy 5.17 NA NA 1.56 1.82 0.66 NA NA 7.39 7.65 000
47562 A Laparoscopic cholecystectomy 11.63 NA NA 5.29 5.06 1.46 NA NA 18.38 18.15 090
47563 A Laparo cholecystectomy/graph 12.03 NA NA 5.09 5.24 1.58 NA NA 18.70 18.85 090
47564 A Laparo cholecystectomy/explr 14.21 NA NA 5.46 5.82 1.89 NA NA 21.56 21.92 090
47570 A Laparo cholecystoenterostomy 12.56 NA NA 5.04 5.28 1.65 NA NA 19.25 19.49 090
47579 C Laparoscope proc, biliary 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
47600 A Removal of gallbladder 17.35 NA NA 7.25 6.40 1.80 NA NA 26.40 25.55 090
47605 A Removal of gallbladder 15.90 NA NA 6.41 6.47 1.95 NA NA 24.26 24.32 090
47610 A Removal of gallbladder 20.84 NA NA 7.73 7.87 2.49 NA NA 31.06 31.20 090
47612 A Removal of gallbladder 21.13 NA NA 7.73 7.84 2.48 NA NA 31.34 31.45 090
47620 A Removal of gallbladder 22.99 NA NA 8.23 8.44 2.74 NA NA 33.96 34.17 090
47630 A Remove bile duct stone 9.57 NA NA 4.18 4.71 0.65 NA NA 14.40 14.93 090
47700 A Exploration of bile ducts 16.39 NA NA 7.27 7.37 2.07 NA NA 25.73 25.83 090
47701 A Bile duct revision 28.62 NA NA 10.11 11.13 3.68 NA NA 42.41 43.43 090
47711 A Excision of bile duct tumor 25.77 NA NA 9.59 9.83 3.05 NA NA 38.41 38.65 090
47712 A Excision of bile duct tumor 33.59 NA NA 11.59 12.20 3.93 NA NA 49.11 49.72 090
47715 A Excision of bile duct cyst 21.42 NA NA 8.59 8.46 2.49 NA NA 32.50 32.37 090
47719 A Fusion of bile duct cyst 19.07 NA NA 7.97 7.85 2.15 NA NA 29.19 29.07 090
47720 A Fuse gallbladder bowel 18.21 NA NA 7.74 7.53 2.11 NA NA 28.06 27.85 090
47721 A Fuse upper gi structures 21.86 NA NA 8.62 8.57 2.53 NA NA 33.01 32.96 090
47740 A Fuse gallbladder bowel 21.10 NA NA 8.52 8.40 2.42 NA NA 32.04 31.92 090
47741 A Fuse gallbladder bowel 24.08 NA NA 9.27 9.27 2.83 NA NA 36.18 36.18 090
47760 A Fuse bile ducts and bowel 38.14 NA NA 13.14 11.41 3.42 NA NA 54.70 52.97 090
47765 A Fuse liver ducts bowel 52.01 NA NA 16.99 12.33 3.30 NA NA 72.30 67.64 090
47780 A Fuse bile ducts and bowel 42.14 NA NA 14.16 11.93 3.50 NA NA 59.80 57.57 090
47785 A Fuse bile ducts and bowel 56.01 NA NA 17.95 14.16 4.10 NA NA 78.06 74.27 090
47800 A Reconstruction of bile ducts 26.04 NA NA 9.78 9.98 3.08 NA NA 38.90 39.10 090
47801 A Placement, bile duct support 17.47 NA NA 7.60 8.01 1.16 NA NA 26.23 26.64 090
47802 A Fuse liver duct intestine 24.80 NA NA 9.54 9.62 2.86 NA NA 37.20 37.28 090
47900 A Suture bile duct injury 22.31 NA NA 8.77 8.83 2.65 NA NA 33.73 33.79 090
47999 C Bile tract surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
48000 A Drainage of abdomen 31.82 NA NA 10.87 11.34 3.48 NA NA 46.17 46.64 090
48001 A Placement of drain, pancreas 39.56 NA NA 12.74 13.58 4.69 NA NA 56.99 57.83 090
48020 A Removal of pancreatic stone 18.96 NA NA 7.63 7.38 2.13 NA NA 28.72 28.47 090
48100 A Biopsy of pancreas, open 14.38 NA NA 5.88 5.66 1.62 NA NA 21.88 21.66 090
48102 A Needle biopsy, pancreas 4.68 8.98 8.21 1.58 1.85 0.28 13.94 13.17 6.54 6.81 010
48105 A Resect/debride pancreas 49.05 NA NA 16.00 16.41 5.56 NA NA 70.61 71.02 090
48120 A Removal of pancreas lesion 18.33 NA NA 6.93 6.86 2.10 NA NA 27.36 27.29 090
48140 A Partial removal of pancreas 26.19 NA NA 9.40 9.49 3.03 NA NA 38.62 38.71 090
48145 A Partial removal of pancreas 27.26 NA NA 9.76 9.80 3.18 NA NA 40.20 40.24 090
48146 A Pancreatectomy 30.42 NA NA 11.87 11.95 3.50 NA NA 45.79 45.87 090
48148 A Removal of pancreatic duct 20.26 NA NA 8.09 7.72 2.30 NA NA 30.65 30.28 090
48150 A Partial removal of pancreas 52.63 NA NA 18.11 19.14 6.32 NA NA 77.06 78.09 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
48152 A Pancreatectomy 48.47 NA NA 16.65 17.80 5.80 NA NA 70.92 72.07 090
48153 A Pancreatectomy 52.61 NA NA 17.98 19.14 6.31 NA NA 76.90 78.06 090
48154 A Pancreatectomy 48.70 NA NA 17.01 17.91 5.84 NA NA 71.55 72.45 090
48155 A Removal of pancreas 29.27 NA NA 11.98 11.73 3.27 NA NA 44.52 44.27 090
48160 N Pancreas removal/transplant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
48400 A Injection, intraop add-on 1.95 NA NA 0.85 0.69 0.15 NA NA 2.95 2.79 ZZZ
48500 A Surgery of pancreatic cyst 18.03 NA NA 8.04 7.50 2.03 NA NA 28.10 27.56 090
48510 A Drain pancreatic pseudocyst 17.06 NA NA 7.53 7.46 1.83 NA NA 26.42 26.35 090
48511 A Drain pancreatic pseudocyst 3.99 19.06 20.43 1.14 1.27 0.24 23.29 24.66 5.37 5.50 000
48520 A Fuse pancreas cyst and bowel 18.07 NA NA 6.80 6.72 2.06 NA NA 26.93 26.85 090
48540 A Fuse pancreas cyst and bowel 21.86 NA NA 7.76 8.02 2.61 NA NA 32.23 32.49 090
48545 A Pancreatorrhaphy 22.10 NA NA 8.11 8.01 2.38 NA NA 32.59 32.49 090
48547 A Duodenal exclusion 30.25 NA NA 10.32 10.43 3.42 NA NA 43.99 44.10 090
48548 A Fuse pancreas and bowel 27.96 NA NA 9.93 10.09 3.28 NA NA 41.17 41.33 090
48550 X Donor pancreatectomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
48551 C Prep donor pancreas 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
48552 A Prep donor pancreas/venous 4.30 NA NA 1.14 1.38 0.31 NA NA 5.75 5.99 XXX
48554 R Transpl allograft pancreas 37.03 NA NA 20.54 18.82 4.19 NA NA 61.76 60.04 090
48556 A Removal, allograft pancreas 19.24 NA NA 9.42 8.40 2.08 NA NA 30.74 29.72 090
48999 C Pancreas surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
49000 A Exploration of abdomen 12.44 NA NA 5.22 5.33 1.52 NA NA 19.18 19.29 090
49002 A Reopening of abdomen 17.55 NA NA 6.44 5.37 1.37 NA NA 25.36 24.29 090
49010 A Exploration behind abdomen 15.98 NA NA 6.34 6.00 1.51 NA NA 23.83 23.49 090
49020 A Drain abdominal abscess 26.46 NA NA 9.84 10.10 2.85 NA NA 39.15 39.41 090
49021 A Drain abdominal abscess 3.37 18.57 20.43 0.96 1.07 0.20 22.14 24.00 4.53 4.64 000
49040 A Drain, open, abdom abscess 16.41 NA NA 6.51 6.44 1.70 NA NA 24.62 24.55 090
49041 A Drain, percut, abdom abscess 3.99 18.77 19.33 1.14 1.27 0.24 23.00 23.56 5.37 5.50 000
49060 A Drain, open, retrop abscess 18.42 NA NA 7.17 7.36 1.75 NA NA 27.34 27.53 090
49061 A Drain, percut, retroper absc 3.69 18.66 19.38 1.06 1.17 0.22 22.57 23.29 4.97 5.08 000
49062 A Drain to peritoneal cavity 12.12 NA NA 5.23 5.37 1.39 NA NA 18.74 18.88 090
49080 A Puncture, peritoneal cavity 1.35 2.58 3.63 0.40 0.45 0.08 4.01 5.06 1.83 1.88 000
49081 A Removal of abdominal fluid 1.26 2.85 2.65 0.43 0.43 0.09 4.20 4.00 1.78 1.78 000
49180 A Biopsy, abdominal mass 1.73 2.27 2.89 0.50 0.55 0.10 4.10 4.72 2.33 2.38 000
49200 A Removal of abdominal lesion 10.94 NA NA 4.86 4.98 1.24 NA NA 17.04 17.16 090
49201 A Remove abdom lesion, complex 15.67 NA NA 6.46 6.88 1.88 NA NA 24.01 24.43 090
49215 A Excise sacral spine tumor 37.66 NA NA 12.77 13.72 4.38 NA NA 54.81 55.76 090
49220 A Multiple surgery, abdomen 15.70 NA NA 6.26 6.53 1.89 NA NA 23.85 24.12 090
49250 A Excision of umbilicus 8.93 NA NA 4.30 4.27 1.08 NA NA 14.31 14.28 090
49255 A Removal of omentum 12.41 NA NA 5.65 5.61 1.43 NA NA 19.49 19.45 090
49320 A Diag laparo separate proc 5.09 NA NA 2.45 2.59 0.65 NA NA 8.19 8.33 010
49321 A Laparoscopy, biopsy 5.39 NA NA 2.56 2.62 0.70 NA NA 8.65 8.71 010
49322 A Laparoscopy, aspiration 5.96 NA NA 2.64 2.90 0.71 NA NA 9.31 9.57 010
49323 A Laparo drain lymphocele 10.13 NA NA 4.69 4.54 1.20 NA NA 16.02 15.87 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
49324 A Lap insertion perm ip cath 6.27 NA NA 2.80 2.80 0.73 NA NA 9.80 9.80 010
49325 A Lap revision perm ip cath 6.77 NA NA 2.93 2.93 0.86 NA NA 10.56 10.56 010
49326 A Lap w/omentopexy add-on 3.50 NA NA 0.92 0.92 0.44 NA NA 4.86 4.86 ZZZ
49329 C Laparo proc, abdm/per/oment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
49400 A Air injection into abdomen 1.88 2.30 2.88 0.53 0.60 0.15 4.33 4.91 2.56 2.63 000
49402 A Remove foreign body, adbomen 14.01 NA NA 5.58 5.51 1.62 NA NA 21.21 21.14 090
49419 A Insrt abdom cath for chemotx 7.03 NA NA 3.39 3.52 0.81 NA NA 11.23 11.36 090
49420 A Insert abdom drain, temp 2.22 NA NA 1.15 1.11 0.21 NA NA 3.58 3.54 000
49421 A Insert abdom drain, perm 5.87 NA NA 3.13 3.15 0.74 NA NA 9.74 9.76 090
49422 A Remove perm cannula/catheter 6.26 NA NA 2.62 2.82 0.83 NA NA 9.71 9.91 010
49423 A Exchange drainage catheter 1.46 12.46 13.67 0.46 0.51 0.09 14.01 15.22 2.01 2.06 000
49424 A Assess cyst, contrast inject 0.76 2.90 3.51 0.25 0.28 0.04 3.70 4.31 1.05 1.08 000
49425 A Insert abdomen-venous drain 12.13 NA NA 5.27 5.51 1.54 NA NA 18.94 19.18 090
49426 A Revise abdomen-venous shunt 10.33 NA NA 4.50 4.70 1.28 NA NA 16.11 16.31 090
49427 A Injection, abdominal shunt 0.89 NA NA 0.26 0.29 0.07 NA NA 1.22 1.25 000
49428 A Ligation of shunt 6.79 NA NA 3.08 3.71 0.80 NA NA 10.67 11.30 010
49429 A Removal of shunt 7.41 NA NA 2.99 3.31 1.02 NA NA 11.42 11.74 010
49435 A Insert subq exten to ip cath 2.25 NA NA 0.60 0.60 0.28 NA NA 3.13 3.13 ZZZ
49436 A Embedded ip cath exit-site 2.69 NA NA 1.63 1.63 0.28 NA NA 4.60 4.60 010
49491 A Rpr hern preemie reduc 12.42 NA NA 5.43 5.15 1.40 NA NA 19.25 18.97 090
49492 A Rpr ing hern premie, blocked 15.32 NA NA 5.85 6.04 1.81 NA NA 22.98 23.17 090
49495 A Rpr ing hernia baby, reduc 6.15 NA NA 2.99 2.96 0.74 NA NA 9.88 9.85 090
49496 A Rpr ing hernia baby, blocked 9.32 NA NA 4.36 4.29 1.07 NA NA 14.75 14.68 090
49500 A Rpr ing hernia, init, reduce 5.76 NA NA 3.62 3.24 0.71 NA NA 10.09 9.71 090
49501 A Rpr ing hernia, init blocked 9.28 NA NA 4.25 4.21 1.12 NA NA 14.65 14.61 090
49505 A Prp i/hern init reduc 5 yr 7.88 NA NA 3.89 3.78 1.03 NA NA 12.80 12.69 090
49507 A Prp i/hern init block 5 yr 9.97 NA NA 4.47 4.46 1.27 NA NA 15.71 15.70 090
49520 A Rerepair ing hernia, reduce 9.91 NA NA 4.39 4.42 1.28 NA NA 15.58 15.61 090
49521 A Rerepair ing hernia, blocked 12.36 NA NA 5.01 5.18 1.59 NA NA 18.96 19.13 090
49525 A Repair ing hernia, sliding 8.85 NA NA 4.14 4.09 1.13 NA NA 14.12 14.07 090
49540 A Repair lumbar hernia 10.66 NA NA 4.65 4.72 1.37 NA NA 16.68 16.75 090
49550 A Rpr rem hernia, init, reduce 8.91 NA NA 4.12 4.12 1.14 NA NA 14.17 14.17 090
49553 A Rpr fem hernia, init blocked 9.84 NA NA 4.42 4.41 1.24 NA NA 15.50 15.49 090
49555 A Rerepair fem hernia, reduce 9.31 NA NA 4.23 4.25 1.20 NA NA 14.74 14.76 090
49557 A Rerepair fem hernia, blocked 11.54 NA NA 4.87 4.95 1.47 NA NA 17.88 17.96 090
49560 A Rpr ventral hern init, reduc 11.84 NA NA 4.90 5.08 1.52 NA NA 18.26 18.44 090
49561 A Rpr ventral hern init, block 15.30 NA NA 5.83 6.00 1.89 NA NA 23.02 23.19 090
49565 A Rerepair ventrl hern, reduce 12.29 NA NA 5.14 5.19 1.52 NA NA 18.95 19.00 090
49566 A Rerepair ventrl hern, block 15.45 NA NA 5.89 6.06 1.91 NA NA 23.25 23.42 090
49568 A Hernia repair w/mesh 4.88 NA NA 1.26 1.57 0.64 NA NA 6.78 7.09 ZZZ
49570 A Rpr epigastric hern, reduce 5.97 NA NA 3.34 3.21 0.75 NA NA 10.06 9.93 090
49572 A Rpr epigastric hern, blocked 7.79 NA NA 3.84 3.56 0.88 NA NA 12.51 12.23 090
49580 A Rpr umbil hern, reduc 5 yr 4.39 NA NA 3.00 2.69 0.54 NA NA 7.93 7.62 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
49582 A Rpr umbil hern, block 5 yr 7.05 NA NA 3.62 3.50 0.88 NA NA 11.55 11.43 090
49585 A Rpr umbil hern, reduc 5 yr 6.51 NA NA 3.52 3.35 0.82 NA NA 10.85 10.68 090
49587 A Rpr umbil hern, block 5 yr 7.96 NA NA 3.88 3.77 0.99 NA NA 12.83 12.72 090
49590 A Repair spigelian hernia 8.82 NA NA 4.11 4.09 1.13 NA NA 14.06 14.04 090
49600 A Repair umbilical lesion 11.47 NA NA 5.19 5.29 1.32 NA NA 17.98 18.08 090
49605 A Repair umbilical lesion 86.85 NA NA 26.45 27.99 9.39 NA NA 122.69 124.23 090
49606 A Repair umbilical lesion 18.92 NA NA 6.64 7.42 2.46 NA NA 28.02 28.80 090
49610 A Repair umbilical lesion 10.83 NA NA 4.70 5.07 1.07 NA NA 16.60 16.97 090
49611 A Repair umbilical lesion 9.26 NA NA 3.63 6.14 0.78 NA NA 13.67 16.18 090
49650 A Laparo hernia repair initial 6.30 NA NA 3.35 3.23 0.93 NA NA 10.58 10.46 090
49651 A Laparo hernia repair recur 8.29 NA NA 4.23 4.09 1.14 NA NA 13.66 13.52 090
49659 C Laparo proc, hernia repair 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
49900 A Repair of abdominal wall 12.26 NA NA 6.30 6.24 1.62 NA NA 20.18 20.12 090
49904 A Omental flap, extra-abdom 22.16 NA NA 12.34 14.49 2.70 NA NA 37.20 39.35 090
49905 A Omental flap, intra-abdom 6.54 NA NA 1.75 2.16 0.75 NA NA 9.04 9.45 ZZZ
49906 C Free omental flap, microvasc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
49999 C Abdomen surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
50010 A Exploration of kidney 12.13 NA NA 6.94 5.64 0.93 NA NA 20.00 18.70 090
50020 A Renal abscess, open drain 17.88 NA NA 8.51 7.93 1.34 NA NA 27.73 27.15 090
50021 A Renal abscess, percut drain 3.37 19.98 21.23 0.97 1.07 0.20 23.55 24.80 4.54 4.64 000
50040 A Drainage of kidney 16.48 NA NA 8.91 7.33 1.03 NA NA 26.42 24.84 090
50045 A Exploration of kidney 16.67 NA NA 8.55 7.08 1.24 NA NA 26.46 24.99 090
50060 A Removal of kidney stone 20.80 NA NA 11.24 8.68 1.36 NA NA 33.40 30.84 090
50065 A Incision of kidney 22.17 NA NA 11.84 7.51 1.59 NA NA 35.60 31.27 090
50070 A Incision of kidney 21.70 NA NA 11.65 9.07 1.44 NA NA 34.79 32.21 090
50075 A Removal of kidney stone 26.91 NA NA 13.98 10.91 1.81 NA NA 42.70 39.63 090
50080 A Removal of kidney stone 15.61 NA NA 8.72 6.88 1.04 NA NA 25.37 23.53 090
50081 A Removal of kidney stone 23.32 NA NA 12.47 9.68 1.54 NA NA 37.33 34.54 090
50100 A Revise kidney blood vessels 17.30 NA NA 7.20 7.64 2.07 NA NA 26.57 27.01 090
50120 A Exploration of kidney 17.06 NA NA 8.91 7.30 1.21 NA NA 27.18 25.57 090
50125 A Explore and drain kidney 17.67 NA NA 9.97 7.71 1.43 NA NA 29.07 26.81 090
50130 A Removal of kidney stone 18.67 NA NA 10.24 7.93 1.22 NA NA 30.13 27.82 090
50135 A Exploration of kidney 20.44 NA NA 10.96 8.57 1.33 NA NA 32.73 30.34 090
50200 A Biopsy of kidney 2.63 NA NA 1.08 1.24 0.16 NA NA 3.87 4.03 000
50205 A Biopsy of kidney 12.19 NA NA 5.60 5.16 1.30 NA NA 19.09 18.65 090
50220 A Remove kidney, open 18.53 NA NA 9.74 7.86 1.35 NA NA 29.62 27.74 090
50225 A Removal kidney open, complex 21.73 NA NA 11.27 8.92 1.50 NA NA 34.50 32.15 090
50230 A Removal kidney open, radical 23.68 NA NA 11.96 9.42 1.55 NA NA 37.19 34.65 090
50234 A Removal of kidney ureter 23.90 NA NA 12.36 9.71 1.59 NA NA 37.85 35.20 090
50236 A Removal of kidney ureter 26.74 NA NA 14.28 11.25 1.77 NA NA 42.79 39.76 090
50240 A Partial removal of kidney 24.01 NA NA 12.93 9.98 1.55 NA NA 38.49 35.54 090
50250 A Cryoablate renal mass open 22.06 NA NA 10.79 9.56 1.39 NA NA 34.24 33.01 090
50280 A Removal of kidney lesion 16.94 NA NA 9.45 7.37 1.19 NA NA 27.58 25.50 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
50290 A Removal of kidney lesion 16.00 NA NA 8.27 6.91 1.41 NA NA 25.68 24.32 090
50300 X Remove cadaver donor kidney 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
50320 A Remove kidney, living donor 22.28 NA NA 12.46 11.10 2.36 NA NA 37.10 35.74 090
50323 C Prep cadaver renal allograft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
50325 C Prep donor renal graft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
50327 A Prep renal graft/venous 4.00 NA NA 1.11 1.29 0.29 NA NA 5.40 5.58 XXX
50328 A Prep renal graft/arterial 3.50 NA NA 0.98 1.13 0.26 NA NA 4.74 4.89 XXX
50329 A Prep renal graft/ureteral 3.34 NA NA 0.97 1.09 0.25 NA NA 4.56 4.68 XXX
50340 A Removal of kidney 13.86 NA NA 7.64 6.78 1.65 NA NA 23.15 22.29 090
50360 A Transplantation of kidney 40.45 NA NA 18.86 16.32 3.82 NA NA 63.13 60.59 090
50365 A Transplantation of kidney 45.68 NA NA 19.55 18.53 4.43 NA NA 69.66 68.64 090
50370 A Remove transplanted kidney 18.68 NA NA 9.31 7.68 1.68 NA NA 29.67 28.04 090
50380 A Reimplantation of kidney 29.66 NA NA 16.42 13.12 2.51 NA NA 48.59 45.29 090
50382 A Change ureter stent, percut 5.50 24.85 33.30 1.67 1.81 0.34 30.69 39.14 7.51 7.65 000
50384 A Remove ureter stent, percut 5.00 19.53 31.30 1.52 1.66 0.31 24.84 36.61 6.83 6.97 000
50387 A Change ext/int ureter stent 2.00 12.00 16.66 0.60 0.65 0.12 14.12 18.78 2.72 2.77 000
50389 A Remove renal tube w/fluoro 1.10 6.36 11.15 0.33 0.36 0.07 7.53 12.32 1.50 1.53 000
50390 A Drainage of kidney lesion 1.96 NA NA 0.57 0.62 0.12 NA NA 2.65 2.70 000
50391 A Instll rx agnt into rnal tub 1.96 1.51 1.56 0.80 0.67 0.14 3.61 3.66 2.90 2.77 000
50392 A Insert kidney drain 3.37 NA NA 1.26 1.46 0.20 NA NA 4.83 5.03 000
50393 A Insert ureteral tube 4.15 NA NA 1.50 1.71 0.25 NA NA 5.90 6.11 000
50394 A Injection for kidney x-ray 0.76 1.76 2.45 0.52 0.63 0.05 2.57 3.26 1.33 1.44 000
50395 A Create passage to kidney 3.37 NA NA 1.37 1.47 0.21 NA NA 4.95 5.05 000
50396 A Measure kidney pressure 2.09 NA NA 0.93 1.04 0.13 NA NA 3.15 3.26 000
50398 A Change kidney tube 1.46 11.29 15.06 0.46 0.51 0.09 12.84 16.61 2.01 2.06 000
50400 A Revision of kidney/ureter 21.12 NA NA 11.26 8.72 1.38 NA NA 33.76 31.22 090
50405 A Revision of kidney/ureter 25.68 NA NA 13.34 10.10 1.79 NA NA 40.81 37.57 090
50500 A Repair of kidney wound 21.07 NA NA 9.32 8.62 2.02 NA NA 32.41 31.71 090
50520 A Close kidney-skin fistula 18.73 NA NA 9.52 7.95 1.49 NA NA 29.74 28.17 090
50525 A Repair renal-abdomen fistula 24.21 NA NA 11.06 9.51 1.84 NA NA 37.11 35.56 090
50526 A Repair renal-abdomen fistula 26.13 NA NA 8.15 9.43 1.97 NA NA 36.25 37.53 090
50540 A Revision of horseshoe kidney 20.95 NA NA 10.92 8.97 1.36 NA NA 33.23 31.28 090
50541 A Laparo ablate renal cyst 16.76 NA NA 8.89 7.08 1.13 NA NA 26.78 24.97 090
50542 A Laparo ablate renal mass 21.18 NA NA 11.33 8.93 1.39 NA NA 33.90 31.50 090
50543 A Laparo partial nephrectomy 27.18 NA NA 14.39 11.24 1.81 NA NA 43.38 40.23 090
50544 A Laparoscopy, pyeloplasty 23.27 NA NA 11.66 9.31 1.58 NA NA 36.51 34.16 090
50545 A Laparo radical nephrectomy 24.93 NA NA 12.51 10.01 1.71 NA NA 39.15 36.65 090
50546 A Laparoscopic nephrectomy 21.69 NA NA 11.52 9.15 1.57 NA NA 34.78 32.41 090
50547 A Laparo removal donor kidney 26.24 NA NA 12.68 11.50 2.77 NA NA 41.69 40.51 090
50548 A Laparo remove w/ureter 25.26 NA NA 12.44 9.99 1.73 NA NA 39.43 36.98 090
50549 C Laparoscope proc, renal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
50551 A Kidney endoscopy 5.59 4.62 4.26 2.69 2.15 0.40 10.61 10.25 8.68 8.14 000
50553 A Kidney endoscopy 5.98 4.32 4.35 2.48 2.25 0.39 10.69 10.72 8.85 8.62 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
50555 A Kidney endoscopy biopsy 6.52 5.13 4.89 3.06 2.51 0.45 12.10 11.86 10.03 9.48 000
50557 A Kidney endoscopy treatment 6.61 5.30 4.76 3.11 2.50 0.47 12.38 11.84 10.19 9.58 000
50561 A Kidney endoscopy treatment 7.58 5.76 5.25 3.43 2.84 0.54 13.88 13.37 11.55 10.96 000
50562 A Renal scope w/tumor resect 10.90 NA NA 5.48 4.60 0.73 NA NA 17.11 16.23 090
50570 A Kidney endoscopy 9.53 NA NA 4.33 3.49 0.68 NA NA 14.54 13.70 000
50572 A Kidney endoscopy 10.33 NA NA 4.67 3.79 0.85 NA NA 15.85 14.97 000
50574 A Kidney endoscopy biopsy 11.00 NA NA 4.82 4.01 0.77 NA NA 16.59 15.78 000
50575 A Kidney endoscopy 13.96 NA NA 6.15 5.01 0.99 NA NA 21.10 19.96 000
50576 A Kidney endoscopy treatment 10.97 NA NA 4.94 3.98 0.78 NA NA 16.69 15.73 000
50580 A Kidney endoscopy treatment 11.84 NA NA 5.24 4.28 0.83 NA NA 17.91 16.95 000
50590 A Fragmenting of kidney stone 9.64 17.21 13.60 6.26 4.65 0.65 27.50 23.89 16.55 14.94 090
50592 A Perc rf ablate renal tumor 6.77 73.56 130.16 2.65 2.90 0.43 80.76 137.36 9.85 10.10 010
50600 A Exploration of ureter 17.04 NA NA 8.70 7.17 1.13 NA NA 26.87 25.34 090
50605 A Insert ureteral support 16.66 NA NA 8.04 7.06 1.45 NA NA 26.15 25.17 090
50610 A Removal of ureter stone 17.12 NA NA 9.22 7.53 1.43 NA NA 27.77 26.08 090
50620 A Removal of ureter stone 16.30 NA NA 9.07 7.02 1.07 NA NA 26.44 24.39 090
50630 A Removal of ureter stone 16.08 NA NA 8.40 6.80 1.09 NA NA 25.57 23.97 090
50650 A Removal of ureter 18.67 NA NA 10.27 7.98 1.23 NA NA 30.17 27.88 090
50660 A Removal of ureter 20.87 NA NA 11.00 8.71 1.38 NA NA 33.25 30.96 090
50684 A Injection for ureter x-ray 0.76 4.00 4.73 0.62 0.51 0.05 4.81 5.54 1.43 1.32 000
50686 A Measure ureter pressure 1.51 2.03 3.09 0.70 0.79 0.11 3.65 4.71 2.32 2.41 000
50688 A Change of ureter tube/stent 1.18 NA NA 0.85 1.01 0.07 NA NA 2.10 2.26 010
50690 A Injection for ureter x-ray 1.16 1.36 1.71 0.68 0.71 0.07 2.59 2.94 1.91 1.94 000
50700 A Revision of ureter 16.54 NA NA 8.41 7.44 1.27 NA NA 26.22 25.25 090
50715 A Release of ureter 20.49 NA NA 8.71 8.73 2.14 NA NA 31.34 31.36 090
50722 A Release of ureter 17.80 NA NA 8.04 7.86 1.91 NA NA 27.75 27.57 090
50725 A Release/revise ureter 20.05 NA NA 9.77 8.47 1.52 NA NA 31.34 30.04 090
50727 A Revise ureter 8.17 NA NA 5.79 4.65 0.61 NA NA 14.57 13.43 090
50728 A Revise ureter 12.00 NA NA 7.25 5.98 1.00 NA NA 20.25 18.98 090
50740 A Fusion of ureter kidney 19.92 NA NA 9.07 8.07 1.97 NA NA 30.96 29.96 090
50750 A Fusion of ureter kidney 21.07 NA NA 9.90 8.46 1.38 NA NA 32.35 30.91 090
50760 A Fusion of ureters 19.92 NA NA 9.91 8.23 1.55 NA NA 31.38 29.70 090
50770 A Splicing of ureters 21.07 NA NA 10.83 8.69 1.45 NA NA 33.35 31.21 090
50780 A Reimplant ureter in bladder 19.80 NA NA 10.25 8.25 1.51 NA NA 31.56 29.56 090
50782 A Reimplant ureter in bladder 19.51 NA NA 8.54 8.71 1.61 NA NA 29.66 29.83 090
50783 A Reimplant ureter in bladder 20.52 NA NA 10.14 8.69 1.99 NA NA 32.65 31.20 090
50785 A Reimplant ureter in bladder 22.08 NA NA 11.33 9.05 1.45 NA NA 34.86 32.58 090
50800 A Implant ureter in bowel 16.23 NA NA 9.43 7.20 1.19 NA NA 26.85 24.62 090
50810 A Fusion of ureter bowel 22.38 NA NA 9.65 9.22 2.32 NA NA 34.35 33.92 090
50815 A Urine shunt to intestine 22.06 NA NA 11.76 9.27 1.54 NA NA 35.36 32.87 090
50820 A Construct bowel bladder 23.89 NA NA 12.14 9.51 1.90 NA NA 37.93 35.30 090
50825 A Construct bowel bladder 30.48 NA NA 15.28 12.16 2.08 NA NA 47.84 44.72 090
50830 A Revise urine flow 33.57 NA NA 16.11 13.15 2.38 NA NA 52.06 49.10 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
50840 A Replace ureter by bowel 22.19 NA NA 12.08 9.34 1.47 NA NA 35.74 33.00 090
50845 A Appendico-vesicostomy 22.21 NA NA 12.57 9.81 1.57 NA NA 36.35 33.59 090
50860 A Transplant ureter to skin 16.93 NA NA 9.17 7.25 1.29 NA NA 27.39 25.47 090
50900 A Repair of ureter 14.89 NA NA 8.18 6.64 1.14 NA NA 24.21 22.67 090
50920 A Closure ureter/skin fistula 15.66 NA NA 8.50 7.05 1.01 NA NA 25.17 23.72 090
50930 A Closure ureter/bowel fistula 20.04 NA NA 10.38 8.57 1.28 NA NA 31.70 29.89 090
50940 A Release of ureter 15.78 NA NA 8.32 6.87 1.26 NA NA 25.36 23.91 090
50945 A Laparoscopy ureterolithotomy 17.87 NA NA 8.89 7.50 1.36 NA NA 28.12 26.73 090
50947 A Laparo new ureter/bladder 25.63 NA NA 12.65 10.42 2.17 NA NA 40.45 38.22 090
50948 A Laparo new ureter/bladder 23.69 NA NA 12.18 9.56 1.71 NA NA 37.58 34.96 090
50949 C Laparoscope proc, ureter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
50951 A Endoscopy of ureter 5.83 4.88 4.44 2.82 2.24 0.41 11.12 10.68 9.06 8.48 000
50953 A Endoscopy of ureter 6.23 5.04 4.56 3.32 2.60 0.43 11.70 11.22 9.98 9.26 000
50955 A Ureter endoscopy biopsy 6.74 5.23 6.12 3.51 2.89 0.48 12.45 13.34 10.73 10.11 000
50957 A Ureter endoscopy treatment 6.78 5.37 4.76 3.18 2.57 0.48 12.63 12.02 10.44 9.83 000
50961 A Ureter endoscopy treatment 6.04 4.78 4.47 2.79 2.33 0.41 11.23 10.92 9.24 8.78 000
50970 A Ureter endoscopy 7.13 NA NA 3.34 2.68 0.52 NA NA 10.99 10.33 000
50972 A Ureter endoscopy catheter 6.88 NA NA 3.05 2.61 0.49 NA NA 10.42 9.98 000
50974 A Ureter endoscopy biopsy 9.16 NA NA 3.98 3.32 0.64 NA NA 13.78 13.12 000
50976 A Ureter endoscopy treatment 9.03 NA NA 3.70 3.22 0.66 NA NA 13.39 12.91 000
50980 A Ureter endoscopy treatment 6.84 NA NA 3.13 2.56 0.48 NA NA 10.45 9.88 000
51000 A Drainage of bladder 0.78 0.94 1.69 0.28 0.25 0.05 1.77 2.52 1.11 1.08 000
51005 A Drainage of bladder 1.02 2.40 4.13 0.30 0.33 0.10 3.52 5.25 1.42 1.45 000
51010 A Drainage of bladder 4.27 4.76 5.39 2.39 2.00 0.28 9.31 9.94 6.94 6.55 010
51020 A Incise treat bladder 7.56 NA NA 5.37 4.23 0.47 NA NA 13.40 12.26 090
51030 A Incise treat bladder 7.68 NA NA 4.83 4.19 0.58 NA NA 13.09 12.45 090
51040 A Incise drain bladder 4.43 NA NA 3.74 3.01 0.31 NA NA 8.48 7.75 090
51045 A Incise bladder/drain ureter 7.68 NA NA 5.27 4.26 0.52 NA NA 13.47 12.46 090
51050 A Removal of bladder stone 7.87 NA NA 5.43 4.09 0.49 NA NA 13.79 12.45 090
51060 A Removal of ureter stone 9.82 NA NA 6.49 5.00 0.62 NA NA 16.93 15.44 090
51065 A Remove ureter calculus 9.82 NA NA 6.42 4.87 0.63 NA NA 16.87 15.32 090
51080 A Drainage of bladder abscess 6.61 NA NA 4.28 3.73 0.43 NA NA 11.32 10.77 090
51500 A Removal of bladder cyst 10.92 NA NA 5.86 5.22 1.03 NA NA 17.81 17.17 090
51520 A Removal of bladder lesion 10.08 NA NA 6.58 5.15 0.69 NA NA 17.35 15.92 090
51525 A Removal of bladder lesion 15.29 NA NA 8.76 6.78 0.99 NA NA 25.04 23.06 090
51530 A Removal of bladder lesion 13.58 NA NA 7.39 6.15 1.05 NA NA 22.02 20.78 090
51535 A Repair of ureter lesion 13.77 NA NA 7.60 6.48 1.23 NA NA 22.60 21.48 090
51550 A Partial removal of bladder 17.10 NA NA 9.00 7.29 1.31 NA NA 27.41 25.70 090
51555 A Partial removal of bladder 23.03 NA NA 11.64 9.40 1.70 NA NA 36.37 34.13 090
51565 A Revise bladder ureter(s) 23.50 NA NA 12.22 9.77 1.63 NA NA 37.35 34.90 090
51570 A Removal of bladder 27.31 NA NA 13.55 10.69 1.72 NA NA 42.58 39.72 090
51575 A Removal of bladder nodes 34.00 NA NA 17.03 13.27 2.17 NA NA 53.20 49.44 090
51580 A Remove bladder/revise tract 35.14 NA NA 17.87 13.83 2.25 NA NA 55.26 51.22 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
51585 A Removal of bladder nodes 39.41 NA NA 19.91 15.25 2.49 NA NA 61.81 57.15 090
51590 A Remove bladder/revise tract 36.15 NA NA 17.70 13.88 2.28 NA NA 56.13 52.31 090
51595 A Remove bladder/revise tract 41.12 NA NA 20.06 15.61 2.60 NA NA 63.78 59.33 090
51596 A Remove bladder/create pouch 44.01 NA NA 21.67 16.83 2.78 NA NA 68.46 63.62 090
51597 A Removal of pelvic structures 42.61 NA NA 20.37 16.21 2.82 NA NA 65.80 61.64 090
51600 A Injection for bladder x-ray 0.88 4.09 4.81 0.29 0.29 0.06 5.03 5.75 1.23 1.23 000
51605 A Preparation for bladder xray 0.64 NA NA 0.41 0.37 0.04 NA NA 1.09 1.05 000
51610 A Injection for bladder x-ray 1.05 1.87 2.18 0.68 0.62 0.07 2.99 3.30 1.80 1.74 000
51700 A Irrigation of bladder 0.88 1.51 1.58 0.35 0.30 0.06 2.45 2.52 1.29 1.24 000
51701 A Insert bladder catheter 0.50 1.04 1.45 0.25 0.21 0.04 1.58 1.99 0.79 0.75 000
51702 A Insert temp bladder cath 0.50 1.53 1.94 0.34 0.27 0.04 2.07 2.48 0.88 0.81 000
51703 A Insert bladder cath, complex 1.47 2.28 2.62 0.82 0.63 0.10 3.85 4.19 2.39 2.20 000
51705 A Change of bladder tube 1.03 2.03 2.21 0.86 0.67 0.07 3.13 3.31 1.96 1.77 010
51710 A Change of bladder tube 1.50 2.74 3.18 1.20 0.88 0.11 4.35 4.79 2.81 2.49 010
51715 A Endoscopic injection/implant 3.73 4.46 4.04 1.78 1.46 0.29 8.48 8.06 5.80 5.48 000
51720 A Treatment of bladder lesion 1.50 1.64 1.72 0.76 0.71 0.14 3.28 3.36 2.40 2.35 000
51725 A Simple cystometrogram 1.51 4.28 5.26 4.28 5.26 0.16 5.95 6.93 5.95 6.93 000
51725 TC A Simple cystometrogram 0.00 3.70 4.75 3.70 4.75 0.04 3.74 4.79 3.74 4.79 000
51725 26 A Simple cystometrogram 1.51 0.58 0.51 0.58 0.51 0.12 2.21 2.14 2.21 2.14 000
51726 A Complex cystometrogram 1.71 7.11 7.41 7.11 7.41 0.18 9.00 9.30 9.00 9.30 000
51726 TC A Complex cystometrogram 0.00 6.45 6.82 6.45 6.82 0.05 6.50 6.87 6.50 6.87 000
51726 26 A Complex cystometrogram 1.71 0.66 0.59 0.66 0.59 0.13 2.50 2.43 2.50 2.43 000
51736 A Urine flow measurement 0.61 0.91 0.67 0.91 0.67 0.06 1.58 1.34 1.58 1.34 000
51736 TC A Urine flow measurement 0.00 0.68 0.46 0.68 0.46 0.01 0.69 0.47 0.69 0.47 000
51736 26 A Urine flow measurement 0.61 0.23 0.21 0.23 0.21 0.05 0.89 0.87 0.89 0.87 000
51741 A Electro-uroflowmetry, first 1.14 1.27 0.91 1.27 0.91 0.11 2.52 2.16 2.52 2.16 000
51741 TC A Electro-uroflowmetry, first 0.00 0.82 0.52 0.82 0.52 0.02 0.84 0.54 0.84 0.54 000
51741 26 A Electro-uroflowmetry, first 1.14 0.45 0.39 0.45 0.39 0.09 1.68 1.62 1.68 1.62 000
51772 A Urethra pressure profile 1.61 5.03 5.44 5.03 5.44 0.20 6.84 7.25 6.84 7.25 000
51772 TC A Urethra pressure profile 0.00 4.47 4.89 4.47 4.89 0.05 4.52 4.94 4.52 4.94 000
51772 26 A Urethra pressure profile 1.61 0.56 0.55 0.56 0.55 0.15 2.32 2.31 2.32 2.31 000
51784 A Anal/urinary muscle study 1.53 3.83 3.95 3.83 3.95 0.16 5.52 5.64 5.52 5.64 000
51784 TC A Anal/urinary muscle study 0.00 3.30 3.44 3.30 3.44 0.04 3.34 3.48 3.34 3.48 000
51784 26 A Anal/urinary muscle study 1.53 0.53 0.51 0.53 0.51 0.12 2.18 2.16 2.18 2.16 000
51785 A Anal/urinary muscle study 1.53 4.50 4.46 4.50 4.46 0.15 6.18 6.14 6.18 6.14 000
51785 TC A Anal/urinary muscle study 0.00 3.93 3.94 3.93 3.94 0.04 3.97 3.98 3.97 3.98 000
51785 26 A Anal/urinary muscle study 1.53 0.57 0.52 0.57 0.52 0.11 2.21 2.16 2.21 2.16 000
51792 A Urinary reflex study 1.10 4.96 5.74 4.96 5.74 0.20 6.26 7.04 6.26 7.04 000
51792 TC A Urinary reflex study 0.00 4.56 5.33 4.56 5.33 0.13 4.69 5.46 4.69 5.46 000
51792 26 A Urinary reflex study 1.10 0.40 0.41 0.40 0.41 0.07 1.57 1.58 1.57 1.58 000
51795 A Urine voiding pressure study 1.53 6.72 7.15 6.72 7.15 0.22 8.47 8.90 8.47 8.90 000
51795 TC A Urine voiding pressure study 0.00 6.13 6.63 6.13 6.63 0.10 6.23 6.73 6.23 6.73 000
51795 26 A Urine voiding pressure study 1.53 0.59 0.52 0.59 0.52 0.12 2.24 2.17 2.24 2.17 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
51797 A Intraabdominal pressure test 1.60 4.84 5.55 4.84 5.55 0.17 6.61 7.32 6.61 7.32 000
51797 TC A Intraabdominal pressure test 0.00 4.23 5.00 4.23 5.00 0.05 4.28 5.05 4.28 5.05 000
51797 26 A Intraabdominal pressure test 1.60 0.61 0.55 0.61 0.55 0.12 2.33 2.27 2.33 2.27 000
51798 A Us urine capacity measure 0.00 0.59 0.40 NA NA 0.08 0.67 0.48 NA NA XXX
51800 A Revision of bladder/urethra 18.74 NA NA 10.21 8.22 1.32 NA NA 30.27 28.28 090
51820 A Revision of urinary tract 19.41 NA NA 10.65 8.87 1.75 NA NA 31.81 30.03 090
51840 A Attach bladder/urethra 11.28 NA NA 5.81 5.62 1.06 NA NA 18.15 17.96 090
51841 A Attach bladder/urethra 13.60 NA NA 6.87 6.50 1.24 NA NA 21.71 21.34 090
51845 A Repair bladder neck 10.07 NA NA 5.92 5.04 0.79 NA NA 16.78 15.90 090
51860 A Repair of bladder wound 12.49 NA NA 6.87 6.03 1.16 NA NA 20.52 19.68 090
51865 A Repair of bladder wound 15.69 NA NA 8.56 7.14 1.23 NA NA 25.48 24.06 090
51880 A Repair of bladder opening 7.81 NA NA 4.76 4.15 0.72 NA NA 13.29 12.68 090
51900 A Repair bladder/vagina lesion 14.48 NA NA 8.11 6.57 1.21 NA NA 23.80 22.26 090
51920 A Close bladder-uterus fistula 13.26 NA NA 7.86 6.19 1.18 NA NA 22.30 20.63 090
51925 A Hysterectomy/bladder repair 17.35 NA NA 10.38 9.05 2.04 NA NA 29.77 28.44 090
51940 A Correction of bladder defect 30.48 NA NA 11.52 11.93 2.15 NA NA 44.15 44.56 090
51960 A Revision of bladder bowel 25.20 NA NA 13.31 10.55 1.63 NA NA 40.14 37.38 090
51980 A Construct bladder opening 12.44 NA NA 7.36 5.87 0.86 NA NA 20.66 19.17 090
51990 A Laparo urethral suspension 13.26 NA NA 5.98 6.10 1.39 NA NA 20.63 20.75 090
51992 A Laparo sling operation 14.77 NA NA 6.66 6.32 1.41 NA NA 22.84 22.50 090
51999 C Laparoscope proc, bla 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
52000 A Cystoscopy 2.23 3.69 3.40 1.34 0.91 0.14 6.06 5.77 3.71 3.28 000
52001 A Cystoscopy, removal of clots 5.44 5.14 5.09 2.65 2.06 0.39 10.97 10.92 8.48 7.89 000
52005 A Cystoscopy ureter catheter 2.37 5.76 5.61 1.40 1.02 0.17 8.30 8.15 3.94 3.56 000
52007 A Cystoscopy and biopsy 3.02 10.73 15.01 1.65 1.28 0.22 13.97 18.25 4.89 4.52 000
52010 A Cystoscopy duct catheter 3.02 8.15 10.10 1.66 1.28 0.21 11.38 13.33 4.89 4.51 000
52204 A Cystoscopy w/biopsy(s) 2.59 8.34 12.97 1.41 1.03 0.17 11.10 15.73 4.17 3.79 000
52214 A Cystoscopy and treatment 3.70 19.90 33.55 1.88 1.47 0.26 23.86 37.51 5.84 5.43 000
52224 A Cystoscopy and treatment 3.14 19.08 32.11 1.65 1.28 0.22 22.44 35.47 5.01 4.64 000
52234 A Cystoscopy and treatment 4.62 NA NA 2.34 1.83 0.33 NA NA 7.29 6.78 000
52235 A Cystoscopy and treatment 5.44 NA NA 2.71 2.13 0.39 NA NA 8.54 7.96 000
52240 A Cystoscopy and treatment 9.71 NA NA 4.48 3.60 0.69 NA NA 14.88 14.00 000
52250 A Cystoscopy and radiotracer 4.49 NA NA 2.38 1.83 0.32 NA NA 7.19 6.64 000
52260 A Cystoscopy and treatment 3.91 NA NA 2.00 1.57 0.28 NA NA 6.19 5.76 000
52265 A Cystoscopy and treatment 2.94 7.68 11.93 1.55 1.22 0.22 10.84 15.09 4.71 4.38 000
52270 A Cystoscopy revise urethra 3.36 7.05 10.04 1.78 1.38 0.24 10.65 13.64 5.38 4.98 000
52275 A Cystoscopy revise urethra 4.69 9.34 14.00 2.34 1.83 0.33 14.36 19.02 7.36 6.85 000
52276 A Cystoscopy and treatment 4.99 NA NA 2.51 1.96 0.35 NA NA 7.85 7.30 000
52277 A Cystoscopy and treatment 6.16 NA NA 2.95 2.40 0.44 NA NA 9.55 9.00 000
52281 A Cystoscopy and treatment 2.80 5.32 6.65 1.58 1.21 0.20 8.32 9.65 4.58 4.21 000
52282 A Cystoscopy, implant stent 6.39 NA NA 3.05 2.44 0.45 NA NA 9.89 9.28 000
52283 A Cystoscopy and treatment 3.73 4.13 3.99 1.92 1.52 0.26 8.12 7.98 5.91 5.51 000
52285 A Cystoscopy and treatment 3.60 4.39 4.11 1.89 1.47 0.26 8.25 7.97 5.75 5.33 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
52290 A Cystoscopy and treatment 4.58 NA NA 2.33 1.82 0.32 NA NA 7.23 6.72 000
52300 A Cystoscopy and treatment 5.30 NA NA 2.68 2.10 0.38 NA NA 8.36 7.78 000
52301 A Cystoscopy and treatment 5.50 NA NA 2.16 2.03 0.46 NA NA 8.12 7.99 000
52305 A Cystoscopy and treatment 5.30 NA NA 2.57 2.03 0.38 NA NA 8.25 7.71 000
52310 A Cystoscopy and treatment 2.81 4.04 4.53 1.47 1.14 0.20 7.05 7.54 4.48 4.15 000
52315 A Cystoscopy and treatment 5.20 6.69 8.17 2.55 2.01 0.37 12.26 13.74 8.12 7.58 000
52317 A Remove bladder stone 6.71 17.14 25.99 3.09 2.48 0.48 24.33 33.18 10.28 9.67 000
52318 A Remove bladder stone 9.18 NA NA 4.17 3.36 0.65 NA NA 14.00 13.19 000
52320 A Cystoscopy and treatment 4.69 NA NA 2.27 1.79 0.33 NA NA 7.29 6.81 000
52325 A Cystoscopy, stone removal 6.15 NA NA 2.89 2.31 0.44 NA NA 9.48 8.90 000
52327 A Cystoscopy, inject material 5.18 17.83 28.32 2.39 1.96 0.37 23.38 33.87 7.94 7.51 000
52330 A Cystoscopy and treatment 5.03 20.45 34.23 2.41 1.92 0.36 25.84 39.62 7.80 7.31 000
52332 A Cystoscopy and treatment 2.83 12.45 7.42 1.60 1.19 0.21 15.49 10.46 4.64 4.23 000
52334 A Create passage to kidney 4.82 NA NA 2.35 1.89 0.35 NA NA 7.52 7.06 000
52341 A Cysto w/ureter stricture tx 6.11 NA NA 3.11 2.44 0.43 NA NA 9.65 8.98 000
52342 A Cysto w/up stricture tx 6.61 NA NA 3.35 2.59 0.46 NA NA 10.42 9.66 000
52343 A Cysto w/renal stricture tx 7.31 NA NA 3.62 2.84 0.51 NA NA 11.44 10.66 000
52344 A Cysto/uretero, stricture tx 7.81 NA NA 4.00 3.09 0.55 NA NA 12.36 11.45 000
52345 A Cysto/uretero w/up stricture 8.31 NA NA 4.22 3.27 0.58 NA NA 13.11 12.16 000
52346 A Cystouretero w/renal strict 9.34 NA NA 4.62 3.62 0.65 NA NA 14.61 13.61 000
52351 A Cystouretero or pyeloscope 5.85 NA NA 3.03 2.36 0.41 NA NA 9.29 8.62 000
52352 A Cystouretero w/stone remove 6.87 NA NA 3.56 2.77 0.49 NA NA 10.92 10.13 000
52353 A Cystouretero w/lithotripsy 7.96 NA NA 4.01 3.14 0.57 NA NA 12.54 11.67 000
52354 A Cystouretero w/biopsy 7.33 NA NA 3.75 2.94 0.52 NA NA 11.60 10.79 000
52355 A Cystouretero w/excise tumor 8.81 NA NA 4.35 3.44 0.63 NA NA 13.79 12.88 000
52400 A Cystouretero w/congen repr 10.06 NA NA 5.54 4.18 0.68 NA NA 16.28 14.92 090
52402 A Cystourethro cut ejacul duct 5.27 NA NA 2.24 1.84 0.40 NA NA 7.91 7.51 000
52450 A Incision of prostate 7.63 NA NA 5.59 4.15 0.54 NA NA 13.76 12.32 090
52500 A Revision of bladder neck 9.39 NA NA 6.31 4.52 0.60 NA NA 16.30 14.51 090
52510 A Dilation prostatic urethra 7.49 NA NA 5.00 3.58 0.48 NA NA 12.97 11.55 090
52601 A Prostatectomy (TURP) 15.13 NA NA 8.64 5.99 0.87 NA NA 24.64 21.99 090
52606 A Control postop bleeding 8.84 NA NA 5.63 4.07 0.57 NA NA 15.04 13.48 090
52612 A Prostatectomy, first stage 9.07 NA NA 6.00 4.30 0.56 NA NA 15.63 13.93 090
52614 A Prostatectomy, second stage 7.81 NA NA 5.49 3.88 0.48 NA NA 13.78 12.17 090
52620 A Remove residual prostate 7.19 NA NA 4.68 3.41 0.47 NA NA 12.34 11.07 090
52630 A Remove prostate regrowth 7.65 NA NA 4.90 3.62 0.51 NA NA 13.06 11.78 090
52640 A Relieve bladder contracture 6.89 NA NA 4.50 3.35 0.47 NA NA 11.86 10.71 090
52647 A Laser surgery of prostate 11.15 42.04 65.97 7.05 5.16 0.73 53.92 77.85 18.93 17.04 090
52648 A Laser surgery of prostate 12.00 42.58 66.10 7.38 5.44 0.79 55.37 78.89 20.17 18.23 090
52700 A Drainage of prostate abscess 7.39 NA NA 5.05 3.65 0.48 NA NA 12.92 11.52 090
53000 A Incision of urethra 2.30 NA NA 1.83 1.61 0.16 NA NA 4.29 4.07 010
53010 A Incision of urethra 4.35 NA NA 3.84 3.14 0.24 NA NA 8.43 7.73 090
53020 A Incision of urethra 1.77 NA NA 0.97 0.75 0.13 NA NA 2.87 2.65 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
53025 A Incision of urethra 1.13 NA NA 0.83 0.59 0.08 NA NA 2.04 1.80 000
53040 A Drainage of urethra abscess 6.49 NA NA 4.48 3.69 0.45 NA NA 11.42 10.63 090
53060 A Drainage of urethra abscess 2.65 1.99 2.06 1.46 1.39 0.28 4.92 4.99 4.39 4.32 010
53080 A Drainage of urinary leakage 6.82 NA NA 4.98 5.71 0.52 NA NA 12.32 13.05 090
53085 A Drainage of urinary leakage 11.05 NA NA 4.60 6.70 0.92 NA NA 16.57 18.67 090
53200 A Biopsy of urethra 2.59 1.72 1.42 1.32 1.07 0.20 4.51 4.21 4.11 3.86 000
53210 A Removal of urethra 13.59 NA NA 7.88 6.34 0.89 NA NA 22.36 20.82 090
53215 A Removal of urethra 16.72 NA NA 9.34 7.30 1.10 NA NA 27.16 25.12 090
53220 A Treatment of urethra lesion 7.53 NA NA 5.08 4.05 0.49 NA NA 13.10 12.07 090
53230 A Removal of urethra lesion 10.31 NA NA 6.55 5.17 0.73 NA NA 17.59 16.21 090
53235 A Removal of urethra lesion 10.86 NA NA 7.04 5.44 0.72 NA NA 18.62 17.02 090
53240 A Surgery for urethra pouch 6.98 NA NA 4.84 3.85 0.52 NA NA 12.34 11.35 090
53250 A Removal of urethra gland 6.42 NA NA 4.76 3.66 0.49 NA NA 11.67 10.57 090
53260 A Treatment of urethra lesion 3.00 2.48 2.30 1.87 1.53 0.25 5.73 5.55 5.12 4.78 010
53265 A Treatment of urethra lesion 3.14 2.99 2.78 2.03 1.57 0.24 6.37 6.16 5.41 4.95 010
53270 A Removal of urethra gland 3.11 2.30 2.23 1.73 1.59 0.30 5.71 5.64 5.14 5.00 010
53275 A Repair of urethra defect 4.54 NA NA 2.82 2.39 0.32 NA NA 7.68 7.25 010
53400 A Revise urethra, stage 1 13.98 NA NA 8.31 6.59 0.98 NA NA 23.27 21.55 090
53405 A Revise urethra, stage 2 15.51 NA NA 9.07 7.00 1.10 NA NA 25.68 23.61 090
53410 A Reconstruction of urethra 17.53 NA NA 9.97 7.78 1.16 NA NA 28.66 26.47 090
53415 A Reconstruction of urethra 20.55 NA NA 11.14 8.28 1.37 NA NA 33.06 30.20 090
53420 A Reconstruct urethra, stage 1 15.04 NA NA 6.61 6.36 0.96 NA NA 22.61 22.36 090
53425 A Reconstruct urethra, stage 2 16.94 NA NA 9.42 7.52 1.13 NA NA 27.49 25.59 090
53430 A Reconstruction of urethra 17.30 NA NA 8.81 7.45 1.15 NA NA 27.26 25.90 090
53431 A Reconstruct urethra/bladder 21.03 NA NA 11.21 8.84 1.41 NA NA 33.65 31.28 090
53440 A Male sling procedure 15.34 NA NA 9.39 6.83 0.96 NA NA 25.69 23.13 090
53442 A Remove/revise male sling 13.29 NA NA 8.56 6.21 0.82 NA NA 22.67 20.32 090
53444 A Insert tandem cuff 14.06 NA NA 8.18 6.45 0.94 NA NA 23.18 21.45 090
53445 A Insert uro/ves nck sphincter 15.21 NA NA 8.96 7.55 0.99 NA NA 25.16 23.75 090
53446 A Remove uro sphincter 10.89 NA NA 7.17 5.70 0.72 NA NA 18.78 17.31 090
53447 A Remove/replace ur sphincter 14.15 NA NA 8.58 6.96 0.95 NA NA 23.68 22.06 090
53448 A Remov/replc ur sphinctr comp 23.26 NA NA 12.68 9.95 1.50 NA NA 37.44 34.71 090
53449 A Repair uro sphincter 10.43 NA NA 6.76 5.23 0.68 NA NA 17.87 16.34 090
53450 A Revision of urethra 6.67 NA NA 4.85 3.68 0.43 NA NA 11.95 10.78 090
53460 A Revision of urethra 7.65 NA NA 5.21 4.07 0.50 NA NA 13.36 12.22 090
53500 A Urethrlys, transvag w/ scope 12.87 NA NA 7.53 6.53 0.90 NA NA 21.30 20.30 090
53502 A Repair of urethra injury 8.16 NA NA 5.09 4.26 0.62 NA NA 13.87 13.04 090
53505 A Repair of urethra injury 8.16 NA NA 5.50 4.27 0.54 NA NA 14.20 12.97 090
53510 A Repair of urethra injury 10.83 NA NA 6.85 5.58 0.74 NA NA 18.42 17.15 090
53515 A Repair of urethra injury 14.09 NA NA 7.96 6.43 1.05 NA NA 23.10 21.57 090
53520 A Repair of urethra defect 9.35 NA NA 6.23 4.91 0.61 NA NA 16.19 14.87 090
53600 A Dilate urethra stricture 1.21 1.16 1.15 0.58 0.47 0.09 2.46 2.45 1.88 1.77 000
53601 A Dilate urethra stricture 0.98 1.38 1.30 0.53 0.41 0.07 2.43 2.35 1.58 1.46 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
53605 A Dilate urethra stricture 1.28 NA NA 0.53 0.44 0.09 NA NA 1.90 1.81 000
53620 A Dilate urethra stricture 1.62 1.72 1.92 0.85 0.66 0.11 3.45 3.65 2.58 2.39 000
53621 A Dilate urethra stricture 1.35 1.82 2.01 0.69 0.54 0.10 3.27 3.46 2.14 1.99 000
53660 A Dilation of urethra 0.71 1.32 1.31 0.46 0.35 0.05 2.08 2.07 1.22 1.11 000
53661 A Dilation of urethra 0.72 1.30 1.30 0.43 0.33 0.05 2.07 2.07 1.20 1.10 000
53665 A Dilation of urethra 0.76 NA NA 0.27 0.26 0.06 NA NA 1.09 1.08 000
53850 A Prostatic microwave thermotx 9.98 49.30 82.87 6.01 4.46 0.67 59.95 93.52 16.66 15.11 090
53852 A Prostatic rf thermotx 10.68 46.49 78.20 6.82 4.98 0.70 57.87 89.58 18.20 16.36 090
53853 A Prostatic water thermother 5.54 29.12 48.79 4.43 3.25 0.37 35.03 54.70 10.34 9.16 090
53899 C Urology surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
54000 A Slitting of prepuce 1.56 2.72 2.86 1.50 1.07 0.11 4.39 4.53 3.17 2.74 010
54001 A Slitting of prepuce 2.21 3.07 3.15 1.69 1.26 0.15 5.43 5.51 4.05 3.62 010
54015 A Drain penis lesion 5.33 NA NA 3.24 2.72 0.38 NA NA 8.95 8.43 010
54050 A Destruction, penis lesion(s) 1.26 2.08 1.77 1.39 1.12 0.08 3.42 3.11 2.73 2.46 010
54055 A Destruction, penis lesion(s) 1.23 2.00 1.68 1.26 0.92 0.08 3.31 2.99 2.57 2.23 010
54056 A Cryosurgery, penis lesion(s) 1.26 2.37 1.86 1.54 1.23 0.06 3.69 3.18 2.86 2.55 010
54057 A Laser surg, penis lesion(s) 1.26 2.61 2.31 1.36 0.96 0.09 3.96 3.66 2.71 2.31 010
54060 A Excision of penis lesion(s) 1.95 3.11 3.10 1.66 1.21 0.13 5.19 5.18 3.74 3.29 010
54065 A Destruction, penis lesion(s) 2.44 3.30 2.80 2.01 1.43 0.13 5.87 5.37 4.58 4.00 010
54100 A Biopsy of penis 1.90 3.37 2.94 1.39 0.96 0.10 5.37 4.94 3.39 2.96 000
54105 A Biopsy of penis 3.51 4.04 4.22 2.49 2.07 0.25 7.80 7.98 6.25 5.83 010
54110 A Treatment of penis lesion 10.79 NA NA 6.65 5.23 0.72 NA NA 18.16 16.74 090
54111 A Treat penis lesion, graft 14.29 NA NA 8.22 6.38 0.96 NA NA 23.47 21.63 090
54112 A Treat penis lesion, graft 16.83 NA NA 9.54 7.48 1.11 NA NA 27.48 25.42 090
54115 A Treatment of penis lesion 6.82 5.90 4.75 5.07 3.86 0.43 13.15 12.00 12.32 11.11 090
54120 A Partial removal of penis 10.88 NA NA 6.89 5.23 0.68 NA NA 18.45 16.79 090
54125 A Removal of penis 14.43 NA NA 8.35 6.45 0.95 NA NA 23.73 21.83 090
54130 A Remove penis nodes 21.66 NA NA 11.56 9.02 1.52 NA NA 34.74 32.20 090
54135 A Remove penis nodes 27.99 NA NA 14.51 11.25 1.88 NA NA 44.38 41.12 090
54150 A Circumcision w/regionl block 1.90 2.40 1.50 0.75 1.09 0.16 4.46 3.56 2.81 3.15 000
54160 A Circumcision, neonate 2.50 3.69 4.03 1.47 1.19 0.19 6.38 6.72 4.16 3.88 010
54161 A Circum 28 days or older 3.29 NA NA 2.24 1.73 0.23 NA NA 5.76 5.25 010
54162 A Lysis penil circumic lesion 3.27 4.02 4.49 2.28 1.65 0.21 7.50 7.97 5.76 5.13 010
54163 A Repair of circumcision 3.27 NA NA 2.91 2.23 0.21 NA NA 6.39 5.71 010
54164 A Frenulotomy of penis 2.77 NA NA 2.66 2.04 0.18 NA NA 5.61 4.99 010
54200 A Treatment of penis lesion 1.08 2.03 1.85 1.32 1.06 0.08 3.19 3.01 2.48 2.22 010
54205 A Treatment of penis lesion 8.84 NA NA 6.18 5.06 0.56 NA NA 15.58 14.46 090
54220 A Treatment of penis lesion 2.42 3.34 3.72 1.38 1.06 0.17 5.93 6.31 3.97 3.65 000
54230 A Prepare penis study 1.34 1.41 1.16 0.91 0.70 0.09 2.84 2.59 2.34 2.13 000
54231 A Dynamic cavernosometry 2.04 1.87 1.50 1.19 0.95 0.16 4.07 3.70 3.39 3.15 000
54235 A Penile injection 1.19 1.40 1.07 0.90 0.66 0.08 2.67 2.34 2.17 1.93 000
54240 A Penis study 1.31 1.52 1.16 1.52 1.16 0.17 3.00 2.64 3.00 2.64 000
54240 TC A Penis study 0.00 1.02 0.71 1.02 0.71 0.06 1.08 0.77 1.08 0.77 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
54240 26 A Penis study 1.31 0.50 0.45 0.50 0.45 0.11 1.92 1.87 1.92 1.87 000
54250 A Penis study 2.22 1.26 1.00 1.26 1.00 0.18 3.66 3.40 3.66 3.40 000
54250 TC A Penis study 0.00 0.37 0.24 0.37 0.24 0.02 0.39 0.26 0.39 0.26 000
54250 26 A Penis study 2.22 0.89 0.76 0.89 0.76 0.16 3.27 3.14 3.27 3.14 000
54300 A Revision of penis 11.07 NA NA 6.88 5.89 0.76 NA NA 18.71 17.72 090
54304 A Revision of penis 13.15 NA NA 7.98 6.74 0.88 NA NA 22.01 20.77 090
54308 A Reconstruction of urethra 12.49 NA NA 7.66 6.38 0.84 NA NA 20.99 19.71 090
54312 A Reconstruction of urethra 14.36 NA NA 8.68 7.41 1.24 NA NA 24.28 23.01 090
54316 A Reconstruction of urethra 17.90 NA NA 10.20 8.51 1.21 NA NA 29.31 27.62 090
54318 A Reconstruction of urethra 12.28 NA NA 6.26 5.90 1.39 NA NA 19.93 19.57 090
54322 A Reconstruction of urethra 13.85 NA NA 8.02 6.84 0.92 NA NA 22.79 21.61 090
54324 A Reconstruction of urethra 17.40 NA NA 9.96 8.45 1.14 NA NA 28.50 26.99 090
54326 A Reconstruction of urethra 16.87 NA NA 9.76 8.27 1.11 NA NA 27.74 26.25 090
54328 A Revise penis/urethra 16.74 NA NA 9.87 7.90 0.98 NA NA 27.59 25.62 090
54332 A Revise penis/urethra 18.22 NA NA 10.33 8.37 1.21 NA NA 29.76 27.80 090
54336 A Revise penis/urethra 21.44 NA NA 12.03 10.72 2.21 NA NA 35.68 34.37 090
54340 A Secondary urethral surgery 9.58 NA NA 6.50 5.40 0.63 NA NA 16.71 15.61 090
54344 A Secondary urethral surgery 16.91 NA NA 9.93 8.29 1.54 NA NA 28.38 26.74 090
54348 A Secondary urethral surgery 18.17 NA NA 6.33 7.84 1.23 NA NA 25.73 27.24 090
54352 A Reconstruct urethra/penis 25.95 NA NA 13.90 11.85 2.25 NA NA 42.10 40.05 090
54360 A Penis plastic surgery 12.65 NA NA 7.63 6.42 0.84 NA NA 21.12 19.91 090
54380 A Repair penis 14.03 NA NA 5.67 6.37 0.93 NA NA 20.63 21.33 090
54385 A Repair penis 16.38 NA NA 8.41 8.29 0.86 NA NA 25.65 25.53 090
54390 A Repair penis and bladder 22.59 NA NA 7.41 8.90 1.54 NA NA 31.54 33.03 090
54400 A Insert semi-rigid prosthesis 9.09 NA NA 5.87 4.72 0.64 NA NA 15.60 14.45 090
54401 A Insert self-contd prosthesis 10.26 NA NA 8.29 6.36 0.73 NA NA 19.28 17.35 090
54405 A Insert multi-comp penis pros 14.39 NA NA 8.32 6.51 0.95 NA NA 23.66 21.85 090
54406 A Remove muti-comp penis pros 12.76 NA NA 7.79 6.01 0.86 NA NA 21.41 19.63 090
54408 A Repair multi-comp penis pros 13.73 NA NA 8.40 6.39 0.90 NA NA 23.03 21.02 090
54410 A Remove/replace penis prosth 16.48 NA NA 9.56 7.35 1.10 NA NA 27.14 24.93 090
54411 A Remov/replc penis pros, comp 18.14 NA NA 10.63 7.93 1.13 NA NA 29.90 27.20 090
54415 A Remove self-contd penis pros 8.75 NA NA 6.12 4.67 0.58 NA NA 15.45 14.00 090
54416 A Remv/repl penis contain pros 11.87 NA NA 8.04 6.03 0.77 NA NA 20.68 18.67 090
54417 A Remv/replc penis pros, compl 15.94 NA NA 9.33 6.95 1.00 NA NA 26.27 23.89 090
54420 A Revision of penis 12.26 NA NA 7.69 6.09 0.81 NA NA 20.76 19.16 090
54430 A Revision of penis 10.93 NA NA 7.06 5.59 0.72 NA NA 18.71 17.24 090
54435 A Revision of penis 6.71 NA NA 5.01 3.96 0.43 NA NA 12.15 11.10 090
54440 C Repair of penis 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 090
54450 A Preputial stretching 1.12 0.86 0.93 0.49 0.45 0.08 2.06 2.13 1.69 1.65 000
54500 A Biopsy of testis 1.31 NA NA 0.80 0.62 0.10 NA NA 2.21 2.03 000
54505 A Biopsy of testis 3.47 NA NA 2.44 2.04 0.27 NA NA 6.18 5.78 010
54512 A Excise lesion testis 9.23 NA NA 5.77 4.53 0.67 NA NA 15.67 14.43 090
54520 A Removal of testis 5.25 NA NA 3.78 3.03 0.50 NA NA 9.53 8.78 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
54522 A Orchiectomy, partial 10.15 NA NA 5.82 5.10 0.89 NA NA 16.86 16.14 090
54530 A Removal of testis 9.31 NA NA 6.19 4.72 0.66 NA NA 16.16 14.69 090
54535 A Extensive testis surgery 13.06 NA NA 7.67 6.07 0.95 NA NA 21.68 20.08 090
54550 A Exploration for testis 8.31 NA NA 5.42 4.21 0.59 NA NA 14.32 13.11 090
54560 A Exploration for testis 11.97 NA NA 6.34 5.45 0.90 NA NA 19.21 18.32 090
54600 A Reduce testis torsion 7.54 NA NA 5.23 3.96 0.51 NA NA 13.28 12.01 090
54620 A Suspension of testis 5.16 NA NA 3.31 2.65 0.37 NA NA 8.84 8.18 010
54640 A Suspension of testis 7.57 NA NA 5.53 4.18 0.62 NA NA 13.72 12.37 090
54650 A Orchiopexy (Fowler-Stephens) 12.24 NA NA 7.81 6.00 1.16 NA NA 21.21 19.40 090
54660 A Revision of testis 5.64 NA NA 4.47 3.36 0.44 NA NA 10.55 9.44 090
54670 A Repair testis injury 6.57 NA NA 4.88 3.87 0.47 NA NA 11.92 10.91 090
54680 A Relocation of testis(es) 13.91 NA NA 7.86 6.57 1.16 NA NA 22.93 21.64 090
54690 A Laparoscopy, orchiectomy 11.60 NA NA 6.24 5.26 1.02 NA NA 18.86 17.88 090
54692 A Laparoscopy, orchiopexy 13.64 NA NA 7.75 6.00 1.30 NA NA 22.69 20.94 090
54699 C Laparoscope proc, testis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
54700 A Drainage of scrotum 3.44 NA NA 2.42 2.05 0.28 NA NA 6.14 5.77 010
54800 A Biopsy of epididymis 2.33 NA NA 1.00 0.93 0.23 NA NA 3.56 3.49 000
54830 A Remove epididymis lesion 5.91 NA NA 4.51 3.39 0.41 NA NA 10.83 9.71 090
54840 A Remove epididymis lesion 5.22 NA NA 3.87 3.05 0.37 NA NA 9.46 8.64 090
54860 A Removal of epididymis 6.85 NA NA 4.96 3.72 0.45 NA NA 12.26 11.02 090
54861 A Removal of epididymis 9.57 NA NA 6.38 4.82 0.63 NA NA 16.58 15.02 090
54865 A Explore epididymis 5.67 NA NA 4.35 3.29 0.40 NA NA 10.42 9.36 090
54900 A Fusion of spermatic ducts 14.05 NA NA 5.23 5.64 0.93 NA NA 20.21 20.62 090
54901 A Fusion of spermatic ducts 18.92 NA NA 6.57 7.28 1.83 NA NA 27.32 28.03 090
55000 A Drainage of hydrocele 1.43 1.86 2.01 0.92 0.72 0.11 3.40 3.55 2.46 2.26 000
55040 A Removal of hydrocele 5.39 NA NA 4.01 3.17 0.43 NA NA 9.83 8.99 090
55041 A Removal of hydroceles 8.41 NA NA 5.78 4.42 0.60 NA NA 14.79 13.43 090
55060 A Repair of hydrocele 6.05 NA NA 4.50 3.43 0.46 NA NA 11.01 9.94 090
55100 A Drainage of scrotum abscess 2.40 3.51 3.63 2.13 1.70 0.17 6.08 6.20 4.70 4.27 010
55110 A Explore scrotum 6.23 NA NA 4.55 3.48 0.43 NA NA 11.21 10.14 090
55120 A Removal of scrotum lesion 5.62 NA NA 4.33 3.29 0.39 NA NA 10.34 9.30 090
55150 A Removal of scrotum 8.01 NA NA 5.53 4.26 0.56 NA NA 14.10 12.83 090
55175 A Revision of scrotum 5.77 NA NA 4.41 3.35 0.37 NA NA 10.55 9.49 090
55180 A Revision of scrotum 11.63 NA NA 7.41 5.87 0.90 NA NA 19.94 18.40 090
55200 A Incision of sperm duct 4.50 8.24 11.29 3.40 2.63 0.33 13.07 16.12 8.23 7.46 090
55250 A Removal of sperm duct(s) 3.32 7.70 10.53 3.02 2.41 0.25 11.27 14.10 6.59 5.98 090
55300 A Prepare, sperm duct x-ray 3.50 NA NA 1.61 1.39 0.25 NA NA 5.36 5.14 000
55400 A Repair of sperm duct 8.53 NA NA 5.56 4.43 0.64 NA NA 14.73 13.60 090
55450 A Ligation of sperm duct 4.38 6.00 6.74 2.89 2.12 0.29 10.67 11.41 7.56 6.79 010
55500 A Removal of hydrocele 6.12 NA NA 4.27 3.38 0.55 NA NA 10.94 10.05 090
55520 A Removal of sperm cord lesion 6.56 NA NA 3.83 3.39 0.75 NA NA 11.14 10.70 090
55530 A Revise spermatic cord veins 5.69 NA NA 4.19 3.30 0.45 NA NA 10.33 9.44 090
55535 A Revise spermatic cord veins 7.09 NA NA 4.92 3.77 0.47 NA NA 12.48 11.33 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
55540 A Revise hernia sperm veins 8.20 NA NA 4.30 3.92 0.94 NA NA 13.44 13.06 090
55550 A Laparo ligate spermatic vein 7.10 NA NA 4.60 3.62 0.57 NA NA 12.27 11.29 090
55559 C Laparo proc, spermatic cord 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
55600 A Incise sperm duct pouch 6.91 NA NA 4.99 3.74 0.62 NA NA 12.52 11.27 090
55605 A Incise sperm duct pouch 8.63 NA NA 4.95 4.45 0.64 NA NA 14.22 13.72 090
55650 A Remove sperm duct pouch 12.52 NA NA 7.38 5.79 0.92 NA NA 20.82 19.23 090
55680 A Remove sperm pouch lesion 5.59 NA NA 3.91 3.20 0.47 NA NA 9.97 9.26 090
55700 A Biopsy of prostate 2.58 3.74 4.08 1.36 0.82 0.11 6.43 6.77 4.05 3.51 000
55705 A Biopsy of prostate 4.58 NA NA 2.92 2.45 0.32 NA NA 7.82 7.35 010
55720 A Drainage of prostate abscess 7.67 NA NA 4.87 4.08 0.95 NA NA 13.49 12.70 090
55725 A Drainage of prostate abscess 9.90 NA NA 6.37 4.95 0.70 NA NA 16.97 15.55 090
55801 A Removal of prostate 19.62 NA NA 10.80 8.40 1.34 NA NA 31.76 29.36 090
55810 A Extensive prostate surgery 24.14 NA NA 12.66 9.86 1.60 NA NA 38.40 35.60 090
55812 A Extensive prostate surgery 29.69 NA NA 15.26 12.04 2.05 NA NA 47.00 43.78 090
55815 A Extensive prostate surgery 32.75 NA NA 16.73 13.09 2.17 NA NA 51.65 48.01 090
55821 A Removal of prostate 15.63 NA NA 8.89 6.87 1.01 NA NA 25.53 23.51 090
55831 A Removal of prostate 17.06 NA NA 9.49 7.35 1.10 NA NA 27.65 25.51 090
55840 A Extensive prostate surgery 24.45 NA NA 12.99 10.19 1.61 NA NA 39.05 36.25 090
55842 A Extensive prostate surgery 26.31 NA NA 13.85 10.83 1.73 NA NA 41.89 38.87 090
55845 A Extensive prostate surgery 30.52 NA NA 15.29 12.01 2.03 NA NA 47.84 44.56 090
55860 A Surgical exposure, prostate 15.71 NA NA 8.84 7.00 1.02 NA NA 25.57 23.73 090
55862 A Extensive prostate surgery 19.89 NA NA 10.98 8.62 1.49 NA NA 32.36 30.00 090
55865 A Extensive prostate surgery 24.39 NA NA 13.14 10.22 1.63 NA NA 39.16 36.24 090
55866 A Laparo radical prostatectomy 32.25 NA NA 16.38 12.87 2.17 NA NA 50.80 47.29 090
55870 A Electroejaculation 2.58 2.47 1.77 1.46 1.18 0.16 5.21 4.51 4.20 3.92 000
55873 A Cryoablate prostate 20.25 NA NA 11.57 9.59 1.38 NA NA 33.20 31.22 090
55875 A Transperi needle place, pros 13.31 NA NA 8.03 6.38 0.89 NA NA 22.23 20.58 090
55876 A Place rt device/marker, pros 1.73 2.04 2.04 1.03 1.03 0.28 4.05 4.05 3.04 3.04 000
55899 C Genital surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
55970 N Sex transformation, M to F 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
55980 N Sex transformation, F to M 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
56405 A I D of vulva/perineum 1.46 1.17 1.29 1.15 1.14 0.17 2.80 2.92 2.78 2.77 010
56420 A Drainage of gland abscess 1.41 1.50 2.08 0.77 0.97 0.16 3.07 3.65 2.34 2.54 010
56440 A Surgery for vulva lesion 2.86 NA NA 1.58 1.68 0.34 NA NA 4.78 4.88 010
56441 A Lysis of labial lesion(s) 1.99 1.71 1.79 1.56 1.45 0.20 3.90 3.98 3.75 3.64 010
56442 A Hymenotomy 0.68 NA NA 0.51 0.51 0.08 NA NA 1.27 1.27 000
56501 A Destroy, vulva lesions, sim 1.55 1.63 1.74 1.22 1.24 0.18 3.36 3.47 2.95 2.97 010
56515 A Destroy vulva lesion/s compl 3.03 2.36 2.50 1.72 1.79 0.33 5.72 5.86 5.08 5.15 010
56605 A Biopsy of vulva/perineum 1.10 0.90 1.03 0.35 0.43 0.13 2.13 2.26 1.58 1.66 000
56606 A Biopsy of vulva/perineum 0.55 0.36 0.46 0.15 0.20 0.07 0.98 1.08 0.77 0.82 ZZZ
56620 A Partial removal of vulva 8.44 NA NA 4.41 4.70 0.90 NA NA 13.75 14.04 090
56625 A Complete removal of vulva 9.55 NA NA 4.78 5.18 1.02 NA NA 15.35 15.75 090
56630 A Extensive vulva surgery 14.67 NA NA 6.31 6.70 1.49 NA NA 22.47 22.86 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
56631 A Extensive vulva surgery 18.81 NA NA 7.77 8.54 1.96 NA NA 28.54 29.31 090
56632 A Extensive vulva surgery 21.61 NA NA 9.36 9.47 2.39 NA NA 33.36 33.47 090
56633 A Extensive vulva surgery 19.47 NA NA 7.82 8.40 1.98 NA NA 29.27 29.85 090
56634 A Extensive vulva surgery 20.48 NA NA 8.22 9.12 2.17 NA NA 30.87 31.77 090
56637 A Extensive vulva surgery 24.57 NA NA 9.28 10.62 2.61 NA NA 36.46 37.80 090
56640 A Extensive vulva surgery 24.65 NA NA 9.10 10.23 2.89 NA NA 36.64 37.77 090
56700 A Partial removal of hymen 2.79 NA NA 1.76 1.81 0.30 NA NA 4.85 4.90 010
56740 A Remove vagina gland lesion 4.83 NA NA 2.30 2.50 0.56 NA NA 7.69 7.89 010
56800 A Repair of vagina 3.90 NA NA 1.99 2.14 0.44 NA NA 6.33 6.48 010
56805 A Repair clitoris 19.75 NA NA 9.31 9.39 2.15 NA NA 31.21 31.29 090
56810 A Repair of perineum 4.26 NA NA 2.05 2.23 0.49 NA NA 6.80 6.98 010
56820 A Exam of vulva w/scope 1.50 1.19 1.28 0.53 0.62 0.18 2.87 2.96 2.21 2.30 000
56821 A Exam/biopsy of vulva w/scope 2.05 1.52 1.69 0.69 0.86 0.25 3.82 3.99 2.99 3.16 000
57000 A Exploration of vagina 2.99 NA NA 1.71 1.72 0.31 NA NA 5.01 5.02 010
57010 A Drainage of pelvic abscess 6.74 NA NA 3.82 3.81 0.71 NA NA 11.27 11.26 090
57020 A Drainage of pelvic fluid 1.50 0.75 0.89 0.44 0.55 0.18 2.43 2.57 2.12 2.23 000
57022 A I d vaginal hematoma, pp 2.70 NA NA 1.43 1.48 0.26 NA NA 4.39 4.44 010
57023 A I d vag hematoma, non-ob 5.13 NA NA 2.39 2.53 0.58 NA NA 8.10 8.24 010
57061 A Destroy vag lesions, simple 1.27 1.50 1.61 1.11 1.12 0.15 2.92 3.03 2.53 2.54 010
57065 A Destroy vag lesions, complex 2.63 2.01 2.22 1.49 1.63 0.31 4.95 5.16 4.43 4.57 010
57100 A Biopsy of vagina 1.20 0.92 1.04 0.37 0.45 0.14 2.26 2.38 1.71 1.79 000
57105 A Biopsy of vagina 1.71 1.58 1.74 1.33 1.40 0.20 3.49 3.65 3.24 3.31 010
57106 A Remove vagina wall, partial 7.35 NA NA 4.25 4.20 0.73 NA NA 12.33 12.28 090
57107 A Remove vagina tissue, part 24.43 NA NA 9.10 10.12 2.72 NA NA 36.25 37.27 090
57109 A Vaginectomy partial w/nodes 28.25 NA NA 10.40 11.03 3.22 NA NA 41.87 42.50 090
57110 A Remove vagina wall, complete 15.38 NA NA 6.22 7.01 1.74 NA NA 23.34 24.13 090
57111 A Remove vagina tissue, compl 28.25 NA NA 10.26 12.02 3.18 NA NA 41.69 43.45 090
57112 A Vaginectomy w/nodes, compl 30.37 NA NA 11.67 11.99 3.08 NA NA 45.12 45.44 090
57120 A Closure of vagina 8.18 NA NA 4.17 4.49 0.89 NA NA 13.24 13.56 090
57130 A Remove vagina lesion 2.44 1.97 2.11 1.48 1.53 0.29 4.70 4.84 4.21 4.26 010
57135 A Remove vagina lesion 2.68 2.01 2.20 1.52 1.62 0.31 5.00 5.19 4.51 4.61 010
57150 A Treat vagina infection 0.55 0.57 0.97 0.15 0.20 0.07 1.19 1.59 0.77 0.82 000
57155 A Insert uteri tandems/ovoids 6.79 NA NA 3.53 4.30 0.43 NA NA 10.75 11.52 090
57160 A Insert pessary/other device 0.89 1.03 1.02 0.26 0.32 0.10 2.02 2.01 1.25 1.31 000
57170 A Fitting of diaphragm/cap 0.91 0.56 1.25 0.25 0.31 0.11 1.58 2.27 1.27 1.33 000
57180 A Treat vaginal bleeding 1.60 1.83 2.08 0.92 1.18 0.19 3.62 3.87 2.71 2.97 010
57200 A Repair of vagina 4.34 NA NA 2.93 2.90 0.46 NA NA 7.73 7.70 090
57210 A Repair vagina/perineum 5.63 NA NA 3.25 3.39 0.62 NA NA 9.50 9.64 090
57220 A Revision of urethra 4.77 NA NA 3.00 3.08 0.51 NA NA 8.28 8.36 090
57230 A Repair of urethral lesion 6.22 NA NA 3.77 3.49 0.54 NA NA 10.53 10.25 090
57240 A Repair bladder vagina 11.42 NA NA 5.46 4.22 0.62 NA NA 17.50 16.26 090
57250 A Repair rectum vagina 11.42 NA NA 5.01 3.93 0.65 NA NA 17.08 16.00 090
57260 A Repair of vagina 14.36 NA NA 5.82 5.08 0.97 NA NA 21.15 20.41 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
57265 A Extensive repair of vagina 15.86 NA NA 6.29 6.10 1.32 NA NA 23.47 23.28 090
57267 A Insert mesh/pelvic flr addon 4.88 NA NA 1.53 1.86 0.64 NA NA 7.05 7.38 ZZZ
57268 A Repair of bowel bulge 7.47 NA NA 4.28 4.21 0.79 NA NA 12.54 12.47 090
57270 A Repair of bowel pouch 13.57 NA NA 5.68 6.10 1.42 NA NA 20.67 21.09 090
57280 A Suspension of vagina 16.62 NA NA 7.01 7.27 1.68 NA NA 25.31 25.57 090
57282 A Colpopexy, extraperitoneal 7.84 NA NA 4.40 4.48 1.02 NA NA 13.26 13.34 090
57283 A Colpopexy, intraperitoneal 11.58 NA NA 5.21 5.74 1.02 NA NA 17.81 18.34 090
57284 A Repair paravaginal defect 13.51 NA NA 6.75 7.04 1.41 NA NA 21.67 21.96 090
57287 A Revise/remove sling repair 11.49 NA NA 6.50 5.73 0.90 NA NA 18.89 18.12 090
57288 A Repair bladder defect 14.01 NA NA 7.13 6.21 1.12 NA NA 22.26 21.34 090
57289 A Repair bladder vagina 12.69 NA NA 6.21 6.08 1.21 NA NA 20.11 19.98 090
57291 A Construction of vagina 8.54 NA NA 4.37 4.78 0.93 NA NA 13.84 14.25 090
57292 A Construct vagina with graft 13.91 NA NA 6.06 6.71 1.58 NA NA 21.55 22.20 090
57295 A Revise vag graft via vagina 7.74 NA NA 4.01 4.33 0.91 NA NA 12.66 12.98 090
57296 A Revise vag graft, open abd 16.46 NA NA 6.75 6.75 1.68 NA NA 24.89 24.89 090
57300 A Repair rectum-vagina fistula 8.58 NA NA 4.47 4.33 0.87 NA NA 13.92 13.78 090
57305 A Repair rectum-vagina fistula 15.24 NA NA 6.19 6.24 1.73 NA NA 23.16 23.21 090
57307 A Fistula repair colostomy 17.02 NA NA 7.02 7.00 2.02 NA NA 26.06 26.04 090
57308 A Fistula repair, transperine 10.48 NA NA 4.90 5.04 1.14 NA NA 16.52 16.66 090
57310 A Repair urethrovaginal lesion 7.55 NA NA 5.12 4.15 0.54 NA NA 13.21 12.24 090
57311 A Repair urethrovaginal lesion 8.81 NA NA 5.22 4.39 0.65 NA NA 14.68 13.85 090
57320 A Repair bladder-vagina lesion 8.78 NA NA 5.41 4.62 0.69 NA NA 14.88 14.09 090
57330 A Repair bladder-vagina lesion 13.11 NA NA 7.25 6.09 1.06 NA NA 21.42 20.26 090
57335 A Repair vagina 19.87 NA NA 9.05 9.03 1.92 NA NA 30.84 30.82 090
57400 A Dilation of vagina 2.27 NA NA 0.98 1.08 0.26 NA NA 3.51 3.61 000
57410 A Pelvic examination 1.75 NA NA 0.92 0.90 0.18 NA NA 2.85 2.83 000
57415 A Remove vaginal foreign body 2.44 NA NA 1.50 1.44 0.24 NA NA 4.18 4.12 010
57420 A Exam of vagina w/scope 1.60 1.23 1.32 0.57 0.65 0.19 3.02 3.11 2.36 2.44 000
57421 A Exam/biopsy of vag w/scope 2.20 1.59 1.78 0.73 0.90 0.27 4.06 4.25 3.20 3.37 000
57425 A Laparoscopy, surg, colpopexy 16.93 NA NA 6.96 6.71 1.76 NA NA 25.65 25.40 090
57452 A Exam of cervix w/scope 1.50 1.17 1.25 0.74 0.76 0.18 2.85 2.93 2.42 2.44 000
57454 A Bx/curett of cervix w/scope 2.33 1.39 1.58 0.96 1.10 0.28 4.00 4.19 3.57 3.71 000
57455 A Biopsy of cervix w/scope 1.99 1.49 1.66 0.66 0.82 0.24 3.72 3.89 2.89 3.05 000
57456 A Endocerv curettage w/scope 1.85 1.45 1.60 0.63 0.77 0.22 3.52 3.67 2.70 2.84 000
57460 A Bx of cervix w/scope, leep 2.83 4.26 5.45 1.10 1.31 0.34 7.43 8.62 4.27 4.48 000
57461 A Conz of cervix w/scope, leep 3.43 4.55 5.71 1.07 1.37 0.41 8.39 9.55 4.91 5.21 000
57500 A Biopsy of cervix 1.20 1.99 2.40 0.64 0.63 0.12 3.31 3.72 1.96 1.95 000
57505 A Endocervical curettage 1.16 1.30 1.42 1.06 1.09 0.14 2.60 2.72 2.36 2.39 010
57510 A Cauterization of cervix 1.90 1.30 1.50 0.90 1.01 0.23 3.43 3.63 3.03 3.14 010
57511 A Cryocautery of cervix 1.92 1.59 1.76 1.26 1.34 0.23 3.74 3.91 3.41 3.49 010
57513 A Laser surgery of cervix 1.92 1.56 1.68 1.27 1.37 0.23 3.71 3.83 3.42 3.52 010
57520 A Conization of cervix 4.06 3.35 3.79 2.50 2.78 0.49 7.90 8.34 7.05 7.33 090
57522 A Conization of cervix 3.62 2.75 3.05 2.25 2.40 0.41 6.78 7.08 6.28 6.43 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
57530 A Removal of cervix 5.19 NA NA 3.09 3.31 0.58 NA NA 8.86 9.08 090
57531 A Removal of cervix, radical 29.77 NA NA 10.74 12.56 3.35 NA NA 43.86 45.68 090
57540 A Removal of residual cervix 13.19 NA NA 5.61 6.08 1.49 NA NA 20.29 20.76 090
57545 A Remove cervix/repair pelvis 14.00 NA NA 6.21 6.56 1.52 NA NA 21.73 22.08 090
57550 A Removal of residual cervix 6.24 NA NA 3.62 3.77 0.67 NA NA 10.53 10.68 090
57555 A Remove cervix/repair vagina 9.84 NA NA 4.76 5.00 1.09 NA NA 15.69 15.93 090
57556 A Remove cervix, repair bowel 9.26 NA NA 4.66 4.80 0.92 NA NA 14.84 14.98 090
57558 A Dc of cervical stump 1.69 1.34 1.44 1.05 1.12 0.20 3.23 3.33 2.94 3.01 010
57700 A Revision of cervix 4.22 NA NA 3.27 3.14 0.41 NA NA 7.90 7.77 090
57720 A Revision of cervix 4.53 NA NA 2.89 3.05 0.49 NA NA 7.91 8.07 090
57800 A Dilation of cervical canal 0.77 0.70 0.75 0.41 0.46 0.09 1.56 1.61 1.27 1.32 000
58100 A Biopsy of uterus lining 1.53 1.12 1.27 0.58 0.69 0.18 2.83 2.98 2.29 2.40 000
58110 A Bx done w/colposcopy add-on 0.77 0.39 0.51 0.21 0.29 0.09 1.25 1.37 1.07 1.15 ZZZ
58120 A Dilation and curettage 3.54 2.68 2.40 1.65 1.82 0.39 6.61 6.33 5.58 5.75 010
58140 A Myomectomy abdom method 15.69 NA NA 6.21 6.88 1.82 NA NA 23.72 24.39 090
58145 A Myomectomy vag method 8.81 NA NA 4.24 4.65 0.97 NA NA 14.02 14.43 090
58146 A Myomectomy abdom complex 20.24 NA NA 7.30 8.58 2.33 NA NA 29.87 31.15 090
58150 A Total hysterectomy 17.21 NA NA 6.55 7.25 1.85 NA NA 25.61 26.31 090
58152 A Total hysterectomy 21.73 NA NA 8.12 9.42 2.48 NA NA 32.33 33.63 090
58180 A Partial hysterectomy 16.50 NA NA 6.34 7.17 1.64 NA NA 24.48 25.31 090
58200 A Extensive hysterectomy 23.00 NA NA 8.18 9.54 2.55 NA NA 33.73 35.09 090
58210 A Extensive hysterectomy 30.76 NA NA 10.77 12.59 3.38 NA NA 44.91 46.73 090
58240 A Removal of pelvis contents 49.02 NA NA 17.78 17.65 4.23 NA NA 71.03 70.90 090
58260 A Vaginal hysterectomy 14.02 NA NA 5.78 6.46 1.57 NA NA 21.37 22.05 090
58262 A Vag hyst including t/o 15.81 NA NA 6.25 7.10 1.80 NA NA 23.86 24.71 090
58263 A Vag hyst w/t/o vag repair 17.10 NA NA 6.62 7.57 1.95 NA NA 25.67 26.62 090
58267 A Vag hyst w/urinary repair 18.23 NA NA 7.01 8.03 2.07 NA NA 27.31 28.33 090
58270 A Vag hyst w/enterocele repair 15.20 NA NA 5.94 6.78 1.74 NA NA 22.88 23.72 090
58275 A Hysterectomy/revise vagina 16.90 NA NA 6.66 7.49 1.92 NA NA 25.48 26.31 090
58280 A Hysterectomy/revise vagina 18.20 NA NA 7.03 7.95 2.07 NA NA 27.30 28.22 090
58285 A Extensive hysterectomy 23.30 NA NA 8.05 9.47 2.71 NA NA 34.06 35.48 090
58290 A Vag hyst complex 20.17 NA NA 7.38 8.69 2.30 NA NA 29.85 31.16 090
58291 A Vag hyst incl t/o, complex 21.96 NA NA 7.81 9.36 2.53 NA NA 32.30 33.85 090
58292 A Vag hyst t/o repair, compl 23.25 NA NA 8.29 9.84 2.68 NA NA 34.22 35.77 090
58293 A Vag hyst w/uro repair, compl 24.23 NA NA 8.48 10.11 2.79 NA NA 35.50 37.13 090
58294 A Vag hyst w/enterocele, compl 21.45 NA NA 7.24 8.97 2.40 NA NA 31.09 32.82 090
58300 N Insert intrauterine device 1.01 0.62 1.22 0.23 0.34 0.12 1.75 2.35 1.36 1.47 XXX
58301 A Remove intrauterine device 1.27 1.04 1.25 0.35 0.45 0.15 2.46 2.67 1.77 1.87 000
58321 A Artificial insemination 0.92 0.96 1.10 0.25 0.34 0.10 1.98 2.12 1.27 1.36 000
58322 A Artificial insemination 1.10 1.03 1.16 0.31 0.39 0.13 2.26 2.39 1.54 1.62 000
58323 A Sperm washing 0.23 0.15 0.44 0.07 0.09 0.03 0.41 0.70 0.33 0.35 000
58340 A Catheter for hysterography 0.88 2.11 2.90 0.55 0.63 0.09 3.08 3.87 1.52 1.60 000
58345 A Reopen fallopian tube 4.67 NA NA 2.04 2.33 0.41 NA NA 7.12 7.41 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
58346 A Insert heyman uteri capsule 7.48 NA NA 3.81 3.89 0.56 NA NA 11.85 11.93 090
58350 A Reopen fallopian tube 1.03 1.32 1.45 0.87 0.91 0.12 2.47 2.60 2.02 2.06 010
58353 A Endometr ablate, thermal 3.57 22.66 32.41 1.71 1.97 0.43 26.66 36.41 5.71 5.97 010
58356 A Endometrial cryoablation 6.36 42.90 56.80 1.85 2.48 0.82 50.08 63.98 9.03 9.66 010
58400 A Suspension of uterus 7.06 NA NA 3.82 3.90 0.75 NA NA 11.63 11.71 090
58410 A Suspension of uterus 13.70 NA NA 5.88 6.29 1.45 NA NA 21.03 21.44 090
58520 A Repair of ruptured uterus 13.38 NA NA 5.45 5.89 1.47 NA NA 20.30 20.74 090
58540 A Revision of uterus 15.61 NA NA 6.20 6.76 1.79 NA NA 23.60 24.16 090
58541 A Lsh, uterus 250 g or less 14.57 NA NA 6.14 6.14 1.68 NA NA 22.39 22.39 090
58542 A Lsh w/t/o ut 250 g or less 16.43 NA NA 6.66 6.66 1.69 NA NA 24.78 24.78 090
58543 A Lsh uterus above 250 g 16.74 NA NA 6.73 6.73 1.73 NA NA 25.20 25.20 090
58544 A Lsh w/t/o uterus above 250 g 18.24 NA NA 7.16 7.16 1.89 NA NA 27.29 27.29 090
58545 A Laparoscopic myomectomy 15.45 NA NA 5.93 6.87 1.78 NA NA 23.16 24.10 090
58546 A Laparo-myomectomy, complex 19.84 NA NA 7.10 8.46 2.31 NA NA 29.25 30.61 090
58548 A Lap radical hyst 31.45 NA NA 12.74 12.74 3.52 NA NA 47.71 47.71 090
58550 A Laparo-asst vag hysterectomy 14.97 NA NA 6.16 7.01 1.73 NA NA 22.86 23.71 090
58552 A Laparo-vag hyst incl t/o 16.78 NA NA 6.59 7.66 1.73 NA NA 25.10 26.17 090
58553 A Laparo-vag hyst, complex 19.96 NA NA 7.13 8.47 2.31 NA NA 29.40 30.74 090
58554 A Laparo-vag hyst w/t/o, compl 22.98 NA NA 8.33 9.88 2.28 NA NA 33.59 35.14 090
58555 A Hysteroscopy, dx, sep proc 3.33 2.72 2.32 1.24 1.47 0.40 6.45 6.05 4.97 5.20 000
58558 A Hysteroscopy, biopsy 4.74 3.57 2.52 1.67 2.05 0.57 8.88 7.83 6.98 7.36 000
58559 A Hysteroscopy, lysis 6.16 NA NA 2.05 2.56 0.74 NA NA 8.95 9.46 000
58560 A Hysteroscopy, resect septum 6.99 NA NA 2.29 2.88 0.84 NA NA 10.12 10.71 000
58561 A Hysteroscopy, remove myoma 9.99 NA NA 3.14 4.00 1.21 NA NA 14.34 15.20 000
58562 A Hysteroscopy, remove fb 5.20 3.48 2.63 1.77 2.21 0.63 9.31 8.46 7.60 8.04 000
58563 A Hysteroscopy, ablation 6.16 36.94 51.38 2.06 2.58 0.74 43.84 58.28 8.96 9.48 000
58565 A Hysteroscopy, sterilization 7.06 34.05 45.68 3.36 3.77 1.19 42.30 53.93 11.61 12.02 090
58578 C Laparo proc, uterus 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
58579 C Hysteroscope procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
58600 A Division of fallopian tube 5.86 NA NA 2.91 3.23 0.66 NA NA 9.43 9.75 090
58605 A Division of fallopian tube 5.25 NA NA 2.67 3.00 0.59 NA NA 8.51 8.84 090
58611 A Ligate oviduct(s) add-on 1.45 NA NA 0.40 0.53 0.18 NA NA 2.03 2.16 ZZZ
58615 A Occlude fallopian tube(s) 3.91 NA NA 1.98 2.52 0.47 NA NA 6.36 6.90 010
58660 A Laparoscopy, lysis 11.54 NA NA 4.52 5.07 1.40 NA NA 17.46 18.01 090
58661 A Laparoscopy, remove adnexa 11.30 NA NA 4.01 4.84 1.34 NA NA 16.65 17.48 010
58662 A Laparoscopy, excise lesions 12.08 NA NA 4.78 5.53 1.43 NA NA 18.29 19.04 090
58670 A Laparoscopy, tubal cautery 5.86 NA NA 2.95 3.19 0.67 NA NA 9.48 9.72 090
58671 A Laparoscopy, tubal block 5.86 NA NA 2.94 3.19 0.68 NA NA 9.48 9.73 090
58672 A Laparoscopy, fimbrioplasty 12.88 NA NA 4.75 5.82 1.60 NA NA 19.23 20.30 090
58673 A Laparoscopy, salpingostomy 13.99 NA NA 5.19 6.23 1.70 NA NA 20.88 21.92 090
58679 C Laparo proc, oviduct-ovary 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
58700 A Removal of fallopian tube 12.84 NA NA 5.53 5.87 1.51 NA NA 19.88 20.22 090
58720 A Removal of ovary/tube(s) 12.08 NA NA 5.10 5.60 1.39 NA NA 18.57 19.07 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
58740 A Revise fallopian tube(s) 14.79 NA NA 6.07 6.87 1.72 NA NA 22.58 23.38 090
58750 A Repair oviduct 15.56 NA NA 6.08 7.04 1.85 NA NA 23.49 24.45 090
58752 A Revise ovarian tube(s) 15.56 NA NA 6.00 6.71 1.81 NA NA 23.37 24.08 090
58760 A Remove tubal obstruction 13.85 NA NA 5.61 6.44 1.80 NA NA 21.26 22.09 090
58770 A Create new tubal opening 14.69 NA NA 5.76 6.62 1.74 NA NA 22.19 23.05 090
58800 A Drainage of ovarian cyst(s) 4.54 3.10 3.51 2.60 2.83 0.43 8.07 8.48 7.57 7.80 090
58805 A Drainage of ovarian cyst(s) 6.34 NA NA 3.40 3.48 0.69 NA NA 10.43 10.51 090
58820 A Drain ovary abscess, open 4.62 NA NA 2.88 3.19 0.52 NA NA 8.02 8.33 090
58822 A Drain ovary abscess, percut 11.71 NA NA 5.05 5.17 1.16 NA NA 17.92 18.04 090
58823 A Drain pelvic abscess, percut 3.37 19.03 20.75 0.95 1.08 0.24 22.64 24.36 4.56 4.69 000
58825 A Transposition, ovary(s) 11.70 NA NA 4.98 5.59 1.32 NA NA 18.00 18.61 090
58900 A Biopsy of ovary(s) 6.51 NA NA 3.42 3.53 0.69 NA NA 10.62 10.73 090
58920 A Partial removal of ovary(s) 11.87 NA NA 5.23 5.49 1.43 NA NA 18.53 18.79 090
58925 A Removal of ovarian cyst(s) 12.33 NA NA 5.27 5.58 1.41 NA NA 19.01 19.32 090
58940 A Removal of ovary(s) 8.12 NA NA 4.04 4.09 0.91 NA NA 13.07 13.12 090
58943 A Removal of ovary(s) 19.42 NA NA 7.24 8.29 2.23 NA NA 28.89 29.94 090
58950 A Resect ovarian malignancy 18.24 NA NA 7.30 8.13 2.05 NA NA 27.59 28.42 090
58951 A Resect ovarian malignancy 24.15 NA NA 8.64 9.99 2.64 NA NA 35.43 36.78 090
58952 A Resect ovarian malignancy 27.15 NA NA 9.85 11.28 3.03 NA NA 40.03 41.46 090
58953 A Tah, rad dissect for debulk 33.97 NA NA 11.71 13.83 3.84 NA NA 49.52 51.64 090
58954 A Tah rad debulk/lymph remove 36.97 NA NA 12.56 14.92 4.18 NA NA 53.71 56.07 090
58956 A Bso, omentectomy w/tah 22.65 NA NA 8.63 9.89 4.01 NA NA 35.29 36.55 090
58957 A Resect recurrent gyn mal 26.06 NA NA 9.63 9.63 2.95 NA NA 38.64 38.64 090
58958 A Resect recur gyn mal w/lym 29.06 NA NA 10.44 10.44 3.29 NA NA 42.79 42.79 090
58960 A Exploration of abdomen 15.68 NA NA 6.29 7.09 1.80 NA NA 23.77 24.57 090
58970 A Retrieval of oocyte 3.52 1.82 2.19 1.26 1.43 0.43 5.77 6.14 5.21 5.38 000
58974 C Transfer of embryo 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
58976 A Transfer of embryo 3.82 1.93 2.49 1.20 1.67 0.47 6.22 6.78 5.49 5.96 000
58999 C Genital surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
59000 A Amniocentesis, diagnostic 1.30 1.72 1.98 0.55 0.64 0.31 3.33 3.59 2.16 2.25 000
59001 A Amniocentesis, therapeutic 3.00 NA NA 1.08 1.33 0.71 NA NA 4.79 5.04 000
59012 A Fetal cord puncture,prenatal 3.44 NA NA 1.15 1.44 0.82 NA NA 5.41 5.70 000
59015 A Chorion biopsy 2.20 1.41 1.52 0.80 0.98 0.52 4.13 4.24 3.52 3.70 000
59020 A Fetal contract stress test 0.66 1.06 0.85 1.06 0.85 0.26 1.98 1.77 1.98 1.77 000
59020 TC A Fetal contract stress test 0.00 0.88 0.61 0.88 0.61 0.10 0.98 0.71 0.98 0.71 000
59020 26 A Fetal contract stress test 0.66 0.18 0.24 0.18 0.24 0.16 1.00 1.06 1.00 1.06 000
59025 A Fetal non-stress test 0.53 0.63 0.49 0.63 0.49 0.15 1.31 1.17 1.31 1.17 000
59025 TC A Fetal non-stress test 0.00 0.48 0.29 0.48 0.29 0.02 0.50 0.31 0.50 0.31 000
59025 26 A Fetal non-stress test 0.53 0.15 0.20 0.15 0.20 0.13 0.81 0.86 0.81 0.86 000
59030 A Fetal scalp blood sample 1.99 NA NA 0.56 0.72 0.47 NA NA 3.02 3.18 000
59050 A Fetal monitor w/report 0.89 NA NA 0.25 0.33 0.21 NA NA 1.35 1.43 XXX
59051 A Fetal monitor/interpret only 0.74 NA NA 0.21 0.27 0.17 NA NA 1.12 1.18 XXX
59070 A Transabdom amnioinfus w/us 5.24 4.33 4.95 1.76 2.17 0.28 9.85 10.47 7.28 7.69 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
59072 A Umbilical cord occlud w/us 8.99 NA NA 2.86 3.06 0.16 NA NA 12.01 12.21 000
59074 A Fetal fluid drainage w/us 5.24 3.86 4.39 1.70 2.16 0.28 9.38 9.91 7.22 7.68 000
59076 A Fetal shunt placement, w/us 8.99 NA NA 2.40 2.94 0.16 NA NA 11.55 12.09 000
59100 A Remove uterus lesion 13.26 NA NA 5.81 6.29 2.95 NA NA 22.02 22.50 090
59120 A Treat ectopic pregnancy 12.56 NA NA 5.42 6.04 2.73 NA NA 20.71 21.33 090
59121 A Treat ectopic pregnancy 12.64 NA NA 5.37 6.08 2.79 NA NA 20.80 21.51 090
59130 A Treat ectopic pregnancy 14.98 NA NA 6.05 5.11 3.39 NA NA 24.42 23.48 090
59135 A Treat ectopic pregnancy 14.82 NA NA 5.07 6.68 3.31 NA NA 23.20 24.81 090
59136 A Treat ectopic pregnancy 14.15 NA NA 5.72 6.38 3.14 NA NA 23.01 23.67 090
59140 A Treat ectopic pregnancy 5.86 NA NA 2.88 2.38 1.29 NA NA 10.03 9.53 090
59150 A Treat ectopic pregnancy 12.19 NA NA 5.21 5.80 2.79 NA NA 20.19 20.78 090
59151 A Treat ectopic pregnancy 12.01 NA NA 4.89 5.76 2.74 NA NA 19.64 20.51 090
59160 A D c after delivery 2.73 1.98 2.96 1.18 1.89 0.64 5.35 6.33 4.55 5.26 010
59200 A Insert cervical dilator 0.79 0.93 1.13 0.22 0.28 0.19 1.91 2.11 1.20 1.26 000
59300 A Episiotomy or vaginal repair 2.41 2.19 2.18 1.03 0.98 0.57 5.17 5.16 4.01 3.96 000
59320 A Revision of cervix 2.48 NA NA 1.00 1.18 0.59 NA NA 4.07 4.25 000
59325 A Revision of cervix 4.06 NA NA 1.23 1.73 0.88 NA NA 6.17 6.67 000
59350 A Repair of uterus 4.94 NA NA 1.40 1.75 1.17 NA NA 7.51 7.86 000
59400 A Obstetrical care 26.80 NA NA 14.26 15.06 5.50 NA NA 46.56 47.36 MMM
59409 A Obstetrical care 13.48 NA NA 3.75 4.91 3.22 NA NA 20.45 21.61 MMM
59410 A Obstetrical care 15.29 NA NA 4.95 5.96 3.52 NA NA 23.76 24.77 MMM
59412 A Antepartum manipulation 1.71 NA NA 0.64 0.77 0.40 NA NA 2.75 2.88 MMM
59414 A Deliver placenta 1.61 NA NA 0.44 0.59 0.38 NA NA 2.43 2.58 MMM
59425 A Antepartum care only 6.22 4.22 4.21 1.70 1.81 1.14 11.58 11.57 9.06 9.17 MMM
59426 A Antepartum care only 11.04 7.77 7.60 3.02 3.17 1.98 20.79 20.62 16.04 16.19 MMM
59430 A Care after delivery 2.13 1.08 1.19 0.71 0.88 0.50 3.71 3.82 3.34 3.51 MMM
59510 A Cesarean delivery 30.34 NA NA 15.91 16.92 6.25 NA NA 52.50 53.51 MMM
59514 A Cesarean delivery only 15.95 NA NA 4.49 5.78 3.80 NA NA 24.24 25.53 MMM
59515 A Cesarean delivery 18.26 NA NA 6.21 7.43 4.13 NA NA 28.60 29.82 MMM
59525 A Remove uterus after cesarean 8.53 NA NA 2.39 3.07 1.95 NA NA 12.87 13.55 ZZZ
59610 A Vbac delivery 28.21 NA NA 14.51 15.52 5.87 NA NA 48.59 49.60 MMM
59612 A Vbac delivery only 15.04 NA NA 4.26 5.60 3.59 NA NA 22.89 24.23 MMM
59614 A Vbac care after delivery 16.59 NA NA 5.15 6.49 3.89 NA NA 25.63 26.97 MMM
59618 A Attempted vbac delivery 31.78 NA NA 16.28 17.74 6.61 NA NA 54.67 56.13 MMM
59620 A Attempted vbac delivery only 17.50 NA NA 4.80 6.27 4.17 NA NA 26.47 27.94 MMM
59622 A Attempted vbac after care 19.70 NA NA 6.66 8.14 4.50 NA NA 30.86 32.34 MMM
59812 A Treatment of miscarriage 4.39 3.08 2.68 2.35 2.49 0.95 8.42 8.02 7.69 7.83 090
59820 A Care of miscarriage 4.68 4.04 4.33 3.45 3.53 0.95 9.67 9.96 9.08 9.16 090
59821 A Treatment of miscarriage 4.97 3.80 4.15 3.15 3.34 1.06 9.83 10.18 9.18 9.37 090
59830 A Treat uterus infection 6.51 NA NA 3.44 3.85 1.44 NA NA 11.39 11.80 090
59840 R Abortion 3.01 2.01 2.09 1.79 2.04 0.71 5.73 5.81 5.51 5.76 010
59841 R Abortion 5.57 3.15 3.41 2.59 2.88 1.24 9.96 10.22 9.40 9.69 010
59850 R Abortion 5.90 NA NA 2.63 3.10 1.28 NA NA 9.81 10.28 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
59851 R Abortion 5.92 NA NA 3.28 3.63 1.28 NA NA 10.48 10.83 090
59852 R Abortion 8.23 NA NA 3.79 4.73 1.81 NA NA 13.83 14.77 090
59855 R Abortion 6.38 NA NA 2.98 3.40 1.45 NA NA 10.81 11.23 090
59856 R Abortion 7.74 NA NA 3.85 4.01 1.79 NA NA 13.38 13.54 090
59857 R Abortion 9.30 NA NA 3.13 4.32 2.02 NA NA 14.45 15.64 090
59866 R Abortion (mpr) 3.99 NA NA 1.24 1.73 0.87 NA NA 6.10 6.59 000
59870 A Evacuate mole of uterus 6.40 NA NA 4.28 4.43 1.42 NA NA 12.10 12.25 090
59871 A Remove cerclage suture 2.13 NA NA 0.93 1.08 0.50 NA NA 3.56 3.71 000
59897 C Fetal invas px w/us 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
59898 C Laparo proc, ob care/deliver 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
59899 C Maternity care procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
60000 A Drain thyroid/tongue cyst 1.78 2.03 1.95 1.65 1.70 0.15 3.96 3.88 3.58 3.63 010
60001 A Aspirate/inject thyriod cyst 0.97 1.86 1.52 0.27 0.32 0.07 2.90 2.56 1.31 1.36 000
60100 A Biopsy of thyroid 1.56 1.20 1.35 0.43 0.51 0.10 2.86 3.01 2.09 2.17 000
60200 A Remove thyroid lesion 9.91 NA NA 5.25 5.80 1.01 NA NA 16.17 16.72 090
60210 A Partial thyroid excision 11.15 NA NA 5.05 5.49 1.23 NA NA 17.43 17.87 090
60212 A Partial thyroid excision 16.32 NA NA 6.80 7.45 1.95 NA NA 25.07 25.72 090
60220 A Partial removal of thyroid 12.29 NA NA 5.40 5.96 1.32 NA NA 19.01 19.57 090
60225 A Partial removal of thyroid 14.67 NA NA 6.69 7.22 1.64 NA NA 23.00 23.53 090
60240 A Removal of thyroid 16.18 NA NA 6.16 7.23 1.86 NA NA 24.20 25.27 090
60252 A Removal of thyroid 21.88 NA NA 8.43 9.68 2.30 NA NA 32.61 33.86 090
60254 A Extensive thyroid surgery 28.29 NA NA 10.44 13.22 2.61 NA NA 41.34 44.12 090
60260 A Repeat thyroid surgery 18.18 NA NA 7.02 8.24 1.94 NA NA 27.14 28.36 090
60270 A Removal of thyroid 23.07 NA NA 8.96 10.08 2.33 NA NA 34.36 35.48 090
60271 A Removal of thyroid 17.54 NA NA 6.83 8.14 1.75 NA NA 26.12 27.43 090
60280 A Remove thyroid duct lesion 6.05 NA NA 4.12 4.53 0.54 NA NA 10.71 11.12 090
60281 A Remove thyroid duct lesion 8.71 NA NA 4.67 5.54 0.73 NA NA 14.11 14.98 090
60500 A Explore parathyroid glands 16.69 NA NA 6.73 7.23 2.01 NA NA 25.43 25.93 090
60502 A Re-explore parathyroids 21.01 NA NA 8.46 9.13 2.54 NA NA 32.01 32.68 090
60505 A Explore parathyroid glands 22.91 NA NA 9.24 10.50 2.65 NA NA 34.80 36.06 090
60512 A Autotransplant parathyroid 4.44 NA NA 1.19 1.51 0.53 NA NA 6.16 6.48 ZZZ
60520 A Removal of thymus gland 17.07 NA NA 6.93 7.95 2.20 NA NA 26.20 27.22 090
60521 A Removal of thymus gland 19.11 NA NA 8.27 9.22 2.82 NA NA 30.20 31.15 090
60522 A Removal of thymus gland 23.37 NA NA 9.76 10.89 3.27 NA NA 36.40 37.53 090
60540 A Explore adrenal gland 17.91 NA NA 8.12 7.72 1.75 NA NA 27.78 27.38 090
60545 A Explore adrenal gland 20.82 NA NA 8.89 8.62 2.08 NA NA 31.79 31.52 090
60600 A Remove carotid body lesion 24.99 NA NA 8.77 10.41 2.20 NA NA 35.96 37.60 090
60605 A Remove carotid body lesion 31.86 NA NA 12.23 12.25 2.50 NA NA 46.59 46.61 090
60650 A Laparoscopy adrenalectomy 20.63 NA NA 8.20 8.04 2.29 NA NA 31.12 30.96 090
60659 C Laparo proc, endocrine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
60699 C Endocrine surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
61000 A Remove cranial cavity fluid 1.58 NA NA 1.23 1.02 0.13 NA NA 2.94 2.73 000
61001 A Remove cranial cavity fluid 1.49 NA NA 1.21 1.10 0.16 NA NA 2.86 2.75 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
61020 A Remove brain cavity fluid 1.51 NA NA 1.59 1.40 0.34 NA NA 3.44 3.25 000
61026 A Injection into brain canal 1.69 NA NA 1.49 1.42 0.33 NA NA 3.51 3.44 000
61050 A Remove brain canal fluid 1.51 NA NA 1.09 1.23 0.11 NA NA 2.71 2.85 000
61055 A Injection into brain canal 2.10 NA NA 1.21 1.37 0.17 NA NA 3.48 3.64 000
61070 A Brain canal shunt procedure 0.89 NA NA 1.15 1.05 0.17 NA NA 2.21 2.11 000
61105 A Twist drill hole 5.40 NA NA 4.93 4.18 1.32 NA NA 11.65 10.90 090
61107 A Drill skull for implantation 4.99 NA NA 1.89 2.37 1.29 NA NA 8.17 8.65 000
61108 A Drill skull for drainage 11.51 NA NA 8.52 7.49 2.64 NA NA 22.67 21.64 090
61120 A Burr hole for puncture 9.52 NA NA 6.75 6.18 2.10 NA NA 18.37 17.80 090
61140 A Pierce skull for biopsy 17.10 NA NA 10.52 10.04 4.12 NA NA 31.74 31.26 090
61150 A Pierce skull for drainage 18.80 NA NA 10.88 10.50 4.32 NA NA 34.00 33.62 090
61151 A Pierce skull for drainage 13.41 NA NA 8.59 8.01 3.01 NA NA 25.01 24.43 090
61154 A Pierce skull remove clot 16.92 NA NA 10.89 9.83 4.21 NA NA 32.02 30.96 090
61156 A Pierce skull for drainage 17.37 NA NA 10.01 9.88 4.23 NA NA 31.61 31.48 090
61210 A Pierce skull, implant device 5.83 NA NA 2.23 2.74 1.50 NA NA 9.56 10.07 000
61215 A Insert brain-fluid device 5.77 NA NA 5.48 4.37 1.26 NA NA 12.51 11.40 090
61250 A Pierce skull explore 11.41 NA NA 7.64 7.05 2.77 NA NA 21.82 21.23 090
61253 A Pierce skull explore 13.41 NA NA 7.87 7.76 2.62 NA NA 23.90 23.79 090
61304 A Open skull for exploration 23.31 NA NA 12.79 12.82 5.63 NA NA 41.73 41.76 090
61305 A Open skull for exploration 28.51 NA NA 15.30 15.31 6.09 NA NA 49.90 49.91 090
61312 A Open skull for drainage 30.07 NA NA 15.57 15.17 6.36 NA NA 52.00 51.60 090
61313 A Open skull for drainage 27.94 NA NA 15.70 15.03 6.45 NA NA 50.09 49.42 090
61314 A Open skull for drainage 25.77 NA NA 14.43 13.38 6.28 NA NA 46.48 45.43 090
61315 A Open skull for drainage 29.52 NA NA 15.80 15.96 7.16 NA NA 52.48 52.64 090
61316 A Implt cran bone flap to abdo 1.39 NA NA 0.53 0.58 0.35 NA NA 2.27 2.32 ZZZ
61320 A Open skull for drainage 27.32 NA NA 14.49 14.69 6.62 NA NA 48.43 48.63 090
61321 A Open skull for drainage 30.40 NA NA 14.51 15.72 7.14 NA NA 52.05 53.26 090
61322 A Decompressive craniotomy 34.08 NA NA 18.05 16.26 7.63 NA NA 59.76 57.97 090
61323 A Decompressive lobectomy 34.93 NA NA 17.28 16.38 8.03 NA NA 60.24 59.34 090
61330 A Decompress eye socket 25.17 NA NA 12.08 13.31 2.32 NA NA 39.57 40.80 090
61332 A Explore/biopsy eye socket 28.50 NA NA 13.68 15.11 4.83 NA NA 47.01 48.44 090
61333 A Explore orbit/remove lesion 29.17 NA NA 13.56 15.07 3.92 NA NA 46.65 48.16 090
61334 A Explore orbit/remove object 19.50 NA NA 9.25 10.29 1.75 NA NA 30.50 31.54 090
61340 A Subtemporal decompression 20.01 NA NA 11.55 11.23 4.84 NA NA 36.40 36.08 090
61343 A Incise skull (press relief) 31.73 NA NA 16.38 16.70 7.64 NA NA 55.75 56.07 090
61345 A Relieve cranial pressure 29.10 NA NA 15.47 15.41 7.04 NA NA 51.61 51.55 090
61440 A Incise skull for surgery 28.53 NA NA 14.27 14.22 6.90 NA NA 49.70 49.65 090
61450 A Incise skull for surgery 27.59 NA NA 12.89 13.93 5.79 NA NA 46.27 47.31 090
61458 A Incise skull for brain wound 28.71 NA NA 15.23 15.44 7.03 NA NA 50.97 51.18 090
61460 A Incise skull for surgery 30.11 NA NA 15.37 16.15 6.04 NA NA 51.52 52.30 090
61470 A Incise skull for surgery 27.52 NA NA 13.31 13.72 5.90 NA NA 46.73 47.14 090
61480 A Incise skull for surgery 27.95 NA NA 8.15 13.49 6.73 NA NA 42.83 48.17 090
61490 A Incise skull for surgery 27.12 NA NA 14.55 14.38 6.92 NA NA 48.59 48.42 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
61500 A Removal of skull lesion 19.05 NA NA 10.77 10.79 4.11 NA NA 33.93 33.95 090
61501 A Remove infected skull bone 16.22 NA NA 9.66 9.32 3.22 NA NA 29.10 28.76 090
61510 A Removal of brain lesion 30.63 NA NA 17.32 16.85 7.35 NA NA 55.30 54.83 090
61512 A Remove brain lining lesion 36.99 NA NA 18.85 19.47 9.08 NA NA 64.92 65.54 090
61514 A Removal of brain abscess 27.10 NA NA 14.74 14.51 6.54 NA NA 48.38 48.15 090
61516 A Removal of brain lesion 26.45 NA NA 14.50 14.32 6.35 NA NA 47.30 47.12 090
61517 A Implt brain chemotx add-on 1.38 NA NA 0.52 0.61 0.35 NA NA 2.25 2.34 ZZZ
61518 A Removal of brain lesion 39.69 NA NA 20.75 21.01 9.65 NA NA 70.09 70.35 090
61519 A Remove brain lining lesion 43.28 NA NA 21.16 22.27 10.63 NA NA 75.07 76.18 090
61520 A Removal of brain lesion 56.89 NA NA 26.11 29.27 11.21 NA NA 94.21 97.37 090
61521 A Removal of brain lesion 46.84 NA NA 22.54 23.79 11.39 NA NA 80.77 82.02 090
61522 A Removal of brain abscess 31.41 NA NA 15.77 16.25 7.62 NA NA 54.80 55.28 090
61524 A Removal of brain lesion 29.76 NA NA 16.01 15.75 7.16 NA NA 52.93 52.67 090
61526 A Removal of brain lesion 53.90 NA NA 22.15 27.65 7.07 NA NA 83.12 88.62 090
61530 A Removal of brain lesion 45.43 NA NA 18.59 23.44 6.15 NA NA 70.17 75.02 090
61531 A Implant brain electrodes 16.28 NA NA 10.39 9.44 3.79 NA NA 30.46 29.51 090
61533 A Implant brain electrodes 21.36 NA NA 11.94 11.63 5.12 NA NA 38.42 38.11 090
61534 A Removal of brain lesion 22.88 NA NA 13.39 12.41 5.44 NA NA 41.71 40.73 090
61535 A Remove brain electrodes 13.05 NA NA 9.03 7.82 3.02 NA NA 25.10 23.89 090
61536 A Removal of brain lesion 37.59 NA NA 18.76 19.53 9.21 NA NA 65.56 66.33 090
61537 A Removal of brain tissue 36.35 NA NA 17.80 15.51 6.94 NA NA 61.09 58.80 090
61538 A Removal of brain tissue 39.35 NA NA 19.10 16.26 6.94 NA NA 65.39 62.55 090
61539 A Removal of brain tissue 34.15 NA NA 15.75 17.26 8.32 NA NA 58.22 59.73 090
61540 A Removal of brain tissue 31.30 NA NA 16.15 16.97 8.32 NA NA 55.77 56.59 090
61541 A Incision of brain tissue 30.81 NA NA 16.34 16.24 6.60 NA NA 53.75 53.65 090
61542 A Removal of brain tissue 33.03 NA NA 16.46 17.48 8.03 NA NA 57.52 58.54 090
61543 A Removal of brain tissue 31.18 NA NA 16.59 16.43 7.56 NA NA 55.33 55.17 090
61544 A Remove treat brain lesion 27.26 NA NA 14.60 14.02 5.97 NA NA 47.83 47.25 090
61545 A Excision of brain tumor 46.23 NA NA 22.72 23.84 10.63 NA NA 79.58 80.70 090
61546 A Removal of pituitary gland 33.31 NA NA 16.89 17.34 7.67 NA NA 57.87 58.32 090
61548 A Removal of pituitary gland 23.27 NA NA 11.56 12.48 3.43 NA NA 38.26 39.18 090
61550 A Release of skull seams 15.44 NA NA 5.64 6.61 0.98 NA NA 22.06 23.03 090
61552 A Release of skull seams 20.27 NA NA 6.64 8.49 1.06 NA NA 27.97 29.82 090
61556 A Incise skull/sutures 24.00 NA NA 12.94 11.76 4.65 NA NA 41.59 40.41 090
61557 A Incise skull/sutures 23.16 NA NA 13.91 13.69 5.80 NA NA 42.87 42.65 090
61558 A Excision of skull/sutures 26.35 NA NA 8.16 12.68 1.36 NA NA 35.87 40.39 090
61559 A Excision of skull/sutures 33.82 NA NA 19.40 19.33 8.51 NA NA 61.73 61.66 090
61563 A Excision of skull tumor 28.35 NA NA 14.57 15.07 5.17 NA NA 48.09 48.59 090
61564 A Excision of skull tumor 34.59 NA NA 16.53 17.84 8.78 NA NA 59.90 61.21 090
61566 A Removal of brain tissue 32.32 NA NA 16.91 17.56 6.94 NA NA 56.17 56.82 090
61567 A Incision of brain tissue 36.84 NA NA 17.10 19.78 6.54 NA NA 60.48 63.16 090
61570 A Remove foreign body, brain 26.38 NA NA 14.37 14.03 5.88 NA NA 46.63 46.29 090
61571 A Incise skull for brain wound 28.29 NA NA 15.43 15.21 6.79 NA NA 50.51 50.29 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
61575 A Skull base/brainstem surgery 36.43 NA NA 15.92 18.70 5.34 NA NA 57.69 60.47 090
61576 A Skull base/brainstem surgery 55.11 NA NA 26.26 32.61 5.58 NA NA 86.95 93.30 090
61580 A Craniofacial approach, skull 34.34 NA NA 21.02 24.44 3.37 NA NA 58.73 62.15 090
61581 A Craniofacial approach, skull 38.88 NA NA 25.23 23.89 3.92 NA NA 68.03 66.69 090
61582 A Craniofacial approach, skull 34.93 NA NA 30.66 28.14 7.21 NA NA 72.80 70.28 090
61583 A Craniofacial approach, skull 38.41 NA NA 26.09 25.36 9.21 NA NA 73.71 72.98 090
61584 A Orbitocranial approach/skull 37.61 NA NA 25.81 24.84 8.18 NA NA 71.60 70.63 090
61585 A Orbitocranial approach/skull 42.46 NA NA 25.16 26.16 7.03 NA NA 74.65 75.65 090
61586 A Resect nasopharynx, skull 27.28 NA NA 24.16 22.98 4.37 NA NA 55.81 54.63 090
61590 A Infratemporal approach/skull 46.87 NA NA 23.59 27.36 5.31 NA NA 75.77 79.54 090
61591 A Infratemporal approach/skull 46.87 NA NA 24.23 28.20 5.66 NA NA 76.76 80.73 090
61592 A Orbitocranial approach/skull 42.98 NA NA 27.88 26.85 10.07 NA NA 80.93 79.90 090
61595 A Transtemporal approach/skull 33.57 NA NA 19.59 21.66 3.98 NA NA 57.14 59.21 090
61596 A Transcochlear approach/skull 39.31 NA NA 18.79 23.03 3.40 NA NA 61.50 65.74 090
61597 A Transcondylar approach/skull 40.73 NA NA 23.14 23.03 8.84 NA NA 72.71 72.60 090
61598 A Transpetrosal approach/skull 36.41 NA NA 21.31 22.75 5.70 NA NA 63.42 64.86 090
61600 A Resect/excise cranial lesion 29.84 NA NA 18.60 19.48 3.79 NA NA 52.23 53.11 090
61601 A Resect/excise cranial lesion 31.04 NA NA 22.56 21.01 6.63 NA NA 60.23 58.68 090
61605 A Resect/excise cranial lesion 32.40 NA NA 17.90 20.95 2.86 NA NA 53.16 56.21 090
61606 A Resect/excise cranial lesion 41.94 NA NA 24.64 25.02 8.97 NA NA 75.55 75.93 090
61607 A Resect/excise cranial lesion 40.82 NA NA 20.93 23.07 6.90 NA NA 68.65 70.79 090
61608 A Resect/excise cranial lesion 45.45 NA NA 26.88 26.66 10.75 NA NA 83.08 82.86 090
61609 A Transect artery, sinus 9.88 NA NA 3.81 4.59 2.56 NA NA 16.25 17.03 ZZZ
61610 A Transect artery, sinus 29.63 NA NA 11.43 12.71 7.68 NA NA 48.74 50.02 ZZZ
61611 A Transect artery, sinus 7.41 NA NA 2.86 3.58 1.89 NA NA 12.16 12.88 ZZZ
61612 A Transect artery, sinus 27.84 NA NA 8.34 12.07 4.31 NA NA 40.49 44.22 ZZZ
61613 A Remove aneurysm, sinus 44.94 NA NA 27.87 26.66 8.45 NA NA 81.26 80.05 090
61615 A Resect/excise lesion, skull 35.63 NA NA 19.60 21.94 4.73 NA NA 59.96 62.30 090
61616 A Resect/excise lesion, skull 46.60 NA NA 26.91 28.22 8.26 NA NA 81.77 83.08 090
61618 A Repair dura 18.58 NA NA 10.25 10.39 3.72 NA NA 32.55 32.69 090
61619 A Repair dura 22.01 NA NA 11.17 11.97 3.95 NA NA 37.13 37.93 090
61623 A Endovasc tempory vessel occl 9.95 NA NA 3.16 3.85 1.05 NA NA 14.16 14.85 000
61624 A Transcath occlusion, cns 20.12 NA NA 6.30 6.74 1.96 NA NA 28.38 28.82 000
61626 A Transcath occlusion, non-cns 16.60 NA NA 4.91 5.36 1.24 NA NA 22.75 23.20 000
61630 N Intracranial angioplasty 22.07 NA NA 6.44 10.98 2.02 NA NA 30.53 35.07 090
61635 N Intracran angioplsty w/stent 24.28 NA NA 6.95 11.89 2.21 NA NA 33.44 38.38 090
61640 N Dilate ic vasospasm, init 12.32 NA NA 2.85 2.85 0.71 NA NA 15.88 15.88 000
61641 N Dilate ic vasospasm add-on 4.33 NA NA 1.00 1.00 0.25 NA NA 5.58 5.58 ZZZ
61642 N Dilate ic vasospasm add-on 8.66 NA NA 2.00 2.00 0.50 NA NA 11.16 11.16 ZZZ
61680 A Intracranial vessel surgery 32.40 NA NA 17.11 17.35 7.95 NA NA 57.46 57.70 090
61682 A Intracranial vessel surgery 63.31 NA NA 27.79 31.11 15.90 NA NA 107.00 110.32 090
61684 A Intracranial vessel surgery 41.49 NA NA 20.79 21.70 10.31 NA NA 72.59 73.50 090
61686 A Intracranial vessel surgery 67.32 NA NA 30.80 33.74 16.71 NA NA 114.83 117.77 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
61690 A Intracranial vessel surgery 31.18 NA NA 16.13 16.57 6.94 NA NA 54.25 54.69 090
61692 A Intracranial vessel surgery 54.43 NA NA 25.06 26.87 13.43 NA NA 92.92 94.73 090
61697 A Brain aneurysm repr, complx 63.22 NA NA 29.29 28.33 12.85 NA NA 105.36 104.40 090
61698 A Brain aneurysm repr, complx 69.45 NA NA 31.45 27.88 12.54 NA NA 113.44 109.87 090
61700 A Brain aneurysm repr, simple 50.44 NA NA 24.39 26.95 13.02 NA NA 87.85 90.41 090
61702 A Inner skull vessel surgery 59.86 NA NA 28.41 26.63 10.79 NA NA 99.06 97.28 090
61703 A Clamp neck artery 18.70 NA NA 10.98 10.59 4.06 NA NA 33.74 33.35 090
61705 A Revise circulation to head 37.97 NA NA 17.87 18.91 8.87 NA NA 64.71 65.75 090
61708 A Revise circulation to head 37.07 NA NA 12.85 14.58 2.51 NA NA 52.43 54.16 090
61710 A Revise circulation to head 31.19 NA NA 12.75 13.42 4.52 NA NA 48.46 49.13 090
61711 A Fusion of skull arteries 38.10 NA NA 18.86 19.57 9.42 NA NA 66.38 67.09 090
61720 A Incise skull/brain surgery 17.52 NA NA 8.24 9.54 2.79 NA NA 28.55 29.85 090
61735 A Incise skull/brain surgery 22.22 NA NA 11.48 11.99 2.73 NA NA 36.43 36.94 090
61750 A Incise skull/brain biopsy 19.73 NA NA 11.13 10.74 4.72 NA NA 35.58 35.19 090
61751 A Brain biopsy w/ct/mr guide 18.64 NA NA 11.57 11.01 4.56 NA NA 34.77 34.21 090
61760 A Implant brain electrodes 22.24 NA NA 12.10 9.56 5.42 NA NA 39.76 37.22 090
61770 A Incise skull for treatment 23.09 NA NA 10.06 11.70 3.55 NA NA 36.70 38.34 090
61790 A Treat trigeminal nerve 11.50 NA NA 7.87 6.40 2.82 NA NA 22.19 20.72 090
61791 A Treat trigeminal tract 15.31 NA NA 7.70 8.61 3.40 NA NA 26.41 27.32 090
61793 A Focus radiation beam 17.75 NA NA 9.94 10.08 4.46 NA NA 32.15 32.29 090
61795 A Brain surgery using computer 4.03 NA NA 1.40 1.87 0.79 NA NA 6.22 6.69 ZZZ
61850 A Implant neuroelectrodes 13.26 NA NA 5.63 7.16 3.22 NA NA 22.11 23.64 090
61860 A Implant neuroelectrodes 22.16 NA NA 11.36 11.89 4.95 NA NA 38.47 39.00 090
61863 A Implant neuroelectrode 20.56 NA NA 12.64 11.99 5.43 NA NA 38.63 37.98 090
61864 A Implant neuroelectrde, addl 4.49 NA NA 1.73 2.14 5.43 NA NA 11.65 12.06 ZZZ
61867 A Implant neuroelectrode 32.88 NA NA 16.95 17.75 5.43 NA NA 55.26 56.06 090
61868 A Implant neuroelectrde, addÆl 7.91 NA NA 3.02 3.76 5.43 NA NA 16.36 17.10 ZZZ
61870 A Implant neuroelectrodes 16.24 NA NA 8.78 9.47 3.87 NA NA 28.89 29.58 090
61875 A Implant neuroelectrodes 16.36 NA NA 5.33 7.76 2.95 NA NA 24.64 27.07 090
61880 A Revise/remove neuroelectrode 6.87 NA NA 5.53 4.81 1.66 NA NA 14.06 13.34 090
61885 A Insrt/redo neurostim 1 array 7.37 NA NA 7.48 5.85 1.59 NA NA 16.44 14.81 090
61886 A Implant neurostim arrays 9.73 NA NA 8.82 6.97 1.97 NA NA 20.52 18.67 090
61888 A Revise/remove neuroreceiver 5.20 NA NA 3.63 3.66 1.33 NA NA 10.16 10.19 010
62000 A Treat skull fracture 13.83 NA NA 7.28 5.95 1.06 NA NA 22.17 20.84 090
62005 A Treat skull fracture 17.53 NA NA 9.61 9.00 3.87 NA NA 31.01 30.40 090
62010 A Treatment of head injury 21.30 NA NA 12.08 11.80 5.14 NA NA 38.52 38.24 090
62100 A Repair brain fluid leakage 23.40 NA NA 12.05 12.60 4.84 NA NA 40.29 40.84 090
62115 A Reduction of skull defect 22.71 NA NA 14.15 12.27 5.51 NA NA 42.37 40.49 090
62116 A Reduction of skull defect 24.90 NA NA 13.44 13.38 6.11 NA NA 44.45 44.39 090
62117 A Reduction of skull defect 28.26 NA NA 14.92 15.26 4.53 NA NA 47.71 48.05 090
62120 A Repair skull cavity lesion 24.39 NA NA 15.93 17.84 3.00 NA NA 43.32 45.23 090
62121 A Incise skull repair 22.93 NA NA 14.22 15.14 4.17 NA NA 41.32 42.24 090
62140 A Repair of skull defect 14.45 NA NA 8.71 8.42 3.47 NA NA 26.63 26.34 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
62141 A Repair of skull defect 15.97 NA NA 9.43 9.14 3.76 NA NA 29.16 28.87 090
62142 A Remove skull plate/flap 11.73 NA NA 7.81 7.20 2.73 NA NA 22.27 21.66 090
62143 A Replace skull plate/flap 14.05 NA NA 8.89 8.25 3.37 NA NA 26.31 25.67 090
62145 A Repair of skull brain 19.99 NA NA 10.35 10.76 4.50 NA NA 34.84 35.25 090
62146 A Repair of skull with graft 17.18 NA NA 9.21 9.53 3.62 NA NA 30.01 30.33 090
62147 A Repair of skull with graft 20.57 NA NA 10.75 11.16 4.32 NA NA 35.64 36.05 090
62148 A Retr bone flap to fix skull 2.00 NA NA 0.78 0.84 0.48 NA NA 3.26 3.32 ZZZ
62160 A Neuroendoscopy add-on 3.00 NA NA 1.15 1.44 0.77 NA NA 4.92 5.21 ZZZ
62161 A Dissect brain w/scope 21.10 NA NA 12.29 12.14 5.19 NA NA 38.58 38.43 090
62162 A Remove colloid cyst w/scope 26.67 NA NA 14.05 14.65 5.91 NA NA 46.63 47.23 090
62163 A Neuroendoscopy w/fb removal 16.40 NA NA 10.66 10.11 4.01 NA NA 31.07 30.52 090
62164 A Remove brain tumor w/scope 29.27 NA NA 15.15 15.00 5.38 NA NA 49.80 49.65 090
62165 A Remove pituit tumor w/scope 23.10 NA NA 11.67 12.95 3.01 NA NA 37.78 39.06 090
62180 A Establish brain cavity shunt 22.45 NA NA 12.17 12.25 4.98 NA NA 39.60 39.68 090
62190 A Establish brain cavity shunt 12.07 NA NA 7.76 7.25 2.80 NA NA 22.63 22.12 090
62192 A Establish brain cavity shunt 13.25 NA NA 8.49 7.84 3.02 NA NA 24.76 24.11 090
62194 A Replace/irrigate catheter 5.68 NA NA 3.75 2.76 0.92 NA NA 10.35 9.36 010
62200 A Establish brain cavity shunt 19.19 NA NA 10.84 10.84 4.65 NA NA 34.68 34.68 090
62201 A Brain cavity shunt w/scope 15.89 NA NA 10.64 9.74 3.68 NA NA 30.21 29.31 090
62220 A Establish brain cavity shunt 14.00 NA NA 8.49 8.11 3.35 NA NA 25.84 25.46 090
62223 A Establish brain cavity shunt 13.90 NA NA 9.52 8.56 3.14 NA NA 26.56 25.60 090
62225 A Replace/irrigate catheter 6.11 NA NA 5.54 4.45 1.39 NA NA 13.04 11.95 090
62230 A Replace/revise brain shunt 11.35 NA NA 7.36 6.70 2.71 NA NA 21.42 20.76 090
62252 A Csf shunt reprogram 0.74 1.78 1.55 NA NA 0.21 2.73 2.50 NA NA XXX
62252 TC A Csf shunt reprogram 0.00 1.50 1.20 NA NA 0.02 1.52 1.22 NA NA XXX
62252 26 A Csf shunt reprogram 0.74 0.28 0.35 0.28 0.35 0.19 1.21 1.28 1.21 1.28 XXX
62256 A Remove brain cavity shunt 7.30 NA NA 5.94 5.00 1.72 NA NA 14.96 14.02 090
62258 A Replace brain cavity shunt 15.54 NA NA 9.37 8.88 3.74 NA NA 28.65 28.16 090
62263 A Epidural lysis mult sessions 6.41 9.04 11.78 2.86 3.11 0.41 15.86 18.60 9.68 9.93 010
62264 A Epidural lysis on single day 4.42 5.62 7.20 1.27 1.38 0.27 10.31 11.89 5.96 6.07 010
62268 A Drain spinal cord cyst 4.73 6.44 10.26 1.63 2.01 0.43 11.60 15.42 6.79 7.17 000
62269 A Needle biopsy, spinal cord 5.01 6.62 12.67 1.61 1.88 0.37 12.00 18.05 6.99 7.26 000
62270 A Spinal fluid tap, diagnostic 1.37 2.30 2.82 0.53 0.55 0.08 3.75 4.27 1.98 2.00 000
62272 A Drain cerebro spinal fluid 1.35 3.06 3.47 0.60 0.68 0.18 4.59 5.00 2.13 2.21 000
62273 A Inject epidural patch 2.15 1.66 2.45 0.57 0.68 0.13 3.94 4.73 2.85 2.96 000
62280 A Treat spinal cord lesion 2.63 4.21 6.25 1.06 1.02 0.30 7.14 9.18 3.99 3.95 010
62281 A Treat spinal cord lesion 2.66 3.69 5.16 0.89 0.89 0.19 6.54 8.01 3.74 3.74 010
62282 A Treat spinal canal lesion 2.33 3.90 7.25 1.06 0.96 0.17 6.40 9.75 3.56 3.46 010
62284 A Injection for myelogram 1.54 3.58 4.62 0.62 0.67 0.13 5.25 6.29 2.29 2.34 000
62287 A Percutaneous diskectomy 8.88 NA NA 4.08 5.18 0.58 NA NA 13.54 14.64 090
62290 A Inject for spine disk x-ray 3.00 4.31 6.43 1.09 1.31 0.23 7.54 9.66 4.32 4.54 000
62291 A Inject for spine disk x-ray 2.91 4.09 5.47 1.02 1.18 0.26 7.26 8.64 4.19 4.35 000
62292 A Injection into disk lesion 9.14 NA NA 3.19 4.15 0.82 NA NA 13.15 14.11 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
62294 A Injection into spinal artery 12.77 NA NA 5.56 5.58 1.24 NA NA 19.57 19.59 090
62310 A Inject spine c/t 1.91 2.98 4.35 0.57 0.63 0.12 5.01 6.38 2.60 2.66 000
62311 A Inject spine l/s (cd) 1.54 2.65 4.35 0.53 0.58 0.09 4.28 5.98 2.16 2.21 000
62318 A Inject spine w/cath, c/t 2.04 3.19 5.09 0.48 0.61 0.12 5.35 7.25 2.64 2.77 000
62319 A Inject spine w/cath l/s (cd) 1.87 2.85 4.45 0.47 0.58 0.11 4.83 6.43 2.45 2.56 000
62350 A Implant spinal canal cath 8.04 NA NA 4.16 4.00 1.02 NA NA 13.22 13.06 090
62351 A Implant spinal canal cath 11.54 NA NA 7.79 7.29 2.25 NA NA 21.58 21.08 090
62355 A Remove spinal canal catheter 6.60 NA NA 3.61 3.27 0.71 NA NA 10.92 10.58 090
62360 A Insert spine infusion device 3.68 NA NA 3.45 2.87 0.34 NA NA 7.47 6.89 090
62361 A Implant spine infusion pump 6.59 NA NA 4.00 3.94 0.80 NA NA 11.39 11.33 090
62362 A Implant spine infusion pump 8.58 NA NA 4.77 4.46 1.18 NA NA 14.53 14.22 090
62365 A Remove spine infusion device 6.57 NA NA 3.85 3.65 0.86 NA NA 11.28 11.08 090
62367 A Analyze spine infusion pump 0.48 0.41 0.56 0.11 0.10 0.03 0.92 1.07 0.62 0.61 XXX
62368 A Analyze spine infusion pump 0.75 0.59 0.67 0.18 0.17 0.06 1.40 1.48 0.99 0.98 XXX
63001 A Removal of spinal lamina 17.51 NA NA 10.01 9.64 3.77 NA NA 31.29 30.92 090
63003 A Removal of spinal lamina 17.64 NA NA 9.91 9.87 3.73 NA NA 31.28 31.24 090
63005 A Removal of spinal lamina 16.28 NA NA 9.86 9.94 3.35 NA NA 29.49 29.57 090
63011 A Removal of spinal lamina 15.78 NA NA 9.30 8.53 3.38 NA NA 28.46 27.69 090
63012 A Removal of spinal lamina 16.72 NA NA 9.94 10.08 3.49 NA NA 30.15 30.29 090
63015 A Removal of spinal lamina 20.70 NA NA 12.16 11.94 4.76 NA NA 37.62 37.40 090
63016 A Removal of spinal lamina 21.90 NA NA 12.09 11.86 4.59 NA NA 38.58 38.35 090
63017 A Removal of spinal lamina 17.18 NA NA 10.54 10.43 3.64 NA NA 31.36 31.25 090
63020 A Neck spine disk surgery 16.05 NA NA 10.09 9.78 3.72 NA NA 29.86 29.55 090
63030 A Low back disk surgery 13.03 NA NA 8.74 8.50 3.01 NA NA 24.78 24.54 090
63035 A Spinal disk surgery add-on 3.15 NA NA 1.22 1.50 0.79 NA NA 5.16 5.44 ZZZ
63040 A Laminotomy, single cervical 20.18 NA NA 11.20 11.43 4.68 NA NA 36.06 36.29 090
63042 A Laminotomy, single lumbar 18.61 NA NA 10.78 11.20 4.26 NA NA 33.65 34.07 090
63043 C Laminotomy, addÆl cervical 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
63044 C Laminotomy, addÆl lumbar 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
63045 A Removal of spinal lamina 17.82 NA NA 10.53 10.40 3.99 NA NA 32.34 32.21 090
63046 A Removal of spinal lamina 17.12 NA NA 9.98 10.13 3.56 NA NA 30.66 30.81 090
63047 A Removal of spinal lamina 15.22 NA NA 9.49 9.79 3.24 NA NA 27.95 28.25 090
63048 A Remove spinal lamina add-on 3.47 NA NA 1.35 1.58 0.72 NA NA 5.54 5.77 ZZZ
63050 A Cervical laminoplasty 21.88 NA NA 8.91 11.11 4.67 NA NA 35.46 37.66 090
63051 A C-laminoplasty w/graft/plate 25.38 NA NA 11.79 13.05 4.67 NA NA 41.84 43.10 090
63055 A Decompress spinal cord 23.42 NA NA 12.55 12.99 5.29 NA NA 41.26 41.70 090
63056 A Decompress spinal cord 21.73 NA NA 11.54 12.31 4.76 NA NA 38.03 38.80 090
63057 A Decompress spine cord add-on 5.25 NA NA 2.00 2.47 1.22 NA NA 8.47 8.94 ZZZ
63064 A Decompress spinal cord 26.09 NA NA 13.58 14.21 5.71 NA NA 45.38 46.01 090
63066 A Decompress spine cord add-on 3.26 NA NA 1.26 1.56 0.69 NA NA 5.21 5.51 ZZZ
63075 A Neck spine disk surgery 19.47 NA NA 11.24 11.87 4.63 NA NA 35.34 35.97 090
63076 A Neck spine disk surgery 4.04 NA NA 1.56 1.93 0.96 NA NA 6.56 6.93 ZZZ
63077 A Spine disk surgery, thorax 22.75 NA NA 11.28 12.41 3.99 NA NA 38.02 39.15 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
63078 A Spine disk surgery, thorax 3.28 NA NA 1.22 1.54 0.66 NA NA 5.16 5.48 ZZZ
63081 A Removal of vertebral body 25.97 NA NA 13.78 14.19 5.56 NA NA 45.31 45.72 090
63082 A Remove vertebral body add-on 4.36 NA NA 1.69 2.09 1.02 NA NA 7.07 7.47 ZZZ
63085 A Removal of vertebral body 29.34 NA NA 13.89 15.08 4.49 NA NA 47.72 48.91 090
63086 A Remove vertebral body add-on 3.19 NA NA 1.19 1.49 0.59 NA NA 4.97 5.27 ZZZ
63087 A Removal of vertebral body 37.38 NA NA 16.99 18.84 6.22 NA NA 60.59 62.44 090
63088 A Remove vertebral body add-on 4.32 NA NA 1.66 2.04 0.82 NA NA 6.80 7.18 ZZZ
63090 A Removal of vertebral body 30.78 NA NA 14.24 15.58 4.22 NA NA 49.24 50.58 090
63091 A Remove vertebral body add-on 3.03 NA NA 1.14 1.38 0.48 NA NA 4.65 4.89 ZZZ
63101 A Removal of vertebral body 33.92 NA NA 17.38 18.80 5.71 NA NA 57.01 58.43 090
63102 A Removal of vertebral body 33.92 NA NA 17.09 18.73 5.71 NA NA 56.72 58.36 090
63103 A Remove vertebral body add-on 4.82 NA NA 1.82 2.33 0.69 NA NA 7.33 7.84 ZZZ
63170 A Incise spinal cord tract(s) 22.08 NA NA 12.80 12.10 4.87 NA NA 39.75 39.05 090
63172 A Drainage of spinal cyst 19.66 NA NA 11.44 10.84 4.49 NA NA 35.59 34.99 090
63173 A Drainage of spinal cyst 24.18 NA NA 13.56 12.99 5.70 NA NA 43.44 42.87 090
63180 A Revise spinal cord ligaments 20.40 NA NA 10.98 10.98 3.96 NA NA 35.34 35.34 090
63182 A Revise spinal cord ligaments 22.69 NA NA 7.18 10.01 5.32 NA NA 35.19 38.02 090
63185 A Incise spinal column/nerves 16.36 NA NA 10.19 8.62 2.80 NA NA 29.35 27.78 090
63190 A Incise spinal column/nerves 18.76 NA NA 10.26 10.16 3.25 NA NA 32.27 32.17 090
63191 A Incise spinal column/nerves 18.79 NA NA 10.89 10.58 6.36 NA NA 36.04 35.73 090
63194 A Incise spinal column cord 21.97 NA NA 8.89 11.01 3.27 NA NA 34.13 36.25 090
63195 A Incise spinal column cord 21.54 NA NA 12.35 11.37 4.88 NA NA 38.77 37.79 090
63196 A Incise spinal column cord 25.14 NA NA 14.08 13.56 5.78 NA NA 45.00 44.48 090
63197 A Incise spinal column cord 23.95 NA NA 13.61 12.55 5.38 NA NA 42.94 41.88 090
63198 A Incise spinal column cord 29.75 NA NA 8.93 8.56 6.45 NA NA 45.13 44.76 090
63199 A Incise spinal column cord 31.32 NA NA 9.29 13.60 1.40 NA NA 42.01 46.32 090
63200 A Release of spinal cord 21.31 NA NA 11.92 11.45 4.97 NA NA 38.20 37.73 090
63250 A Revise spinal cord vessels 43.73 NA NA 21.43 20.30 9.04 NA NA 74.20 73.07 090
63251 A Revise spinal cord vessels 44.49 NA NA 21.71 22.36 10.44 NA NA 76.64 77.29 090
63252 A Revise spinal cord vessels 44.48 NA NA 21.59 22.07 10.67 NA NA 76.74 77.22 090
63265 A Excise intraspinal lesion 23.69 NA NA 13.27 12.89 5.45 NA NA 42.41 42.03 090
63266 A Excise intraspinal lesion 24.55 NA NA 13.44 13.24 5.56 NA NA 43.55 43.35 090
63267 A Excise intraspinal lesion 19.32 NA NA 11.35 11.14 4.38 NA NA 35.05 34.84 090
63268 A Excise intraspinal lesion 19.89 NA NA 10.95 10.51 3.70 NA NA 34.54 34.10 090
63270 A Excise intraspinal lesion 29.67 NA NA 15.96 15.59 6.84 NA NA 52.47 52.10 090
63271 A Excise intraspinal lesion 29.79 NA NA 15.57 15.56 6.92 NA NA 52.28 52.27 090
63272 A Excise intraspinal lesion 27.37 NA NA 14.52 14.64 6.20 NA NA 48.09 48.21 090
63273 A Excise intraspinal lesion 26.34 NA NA 14.02 14.25 5.76 NA NA 46.12 46.35 090
63275 A Biopsy/excise spinal tumor 25.73 NA NA 13.67 13.74 5.82 NA NA 45.22 45.29 090
63276 A Biopsy/excise spinal tumor 25.56 NA NA 13.92 13.73 5.85 NA NA 45.33 45.14 090
63277 A Biopsy/excise spinal tumor 22.26 NA NA 12.31 12.46 5.03 NA NA 39.60 39.75 090
63278 A Biopsy/excise spinal tumor 21.99 NA NA 12.22 12.34 4.56 NA NA 38.77 38.89 090
63280 A Biopsy/excise spinal tumor 30.14 NA NA 16.25 16.29 7.29 NA NA 53.68 53.72 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
63281 A Biopsy/excise spinal tumor 29.84 NA NA 16.05 16.13 7.19 NA NA 53.08 53.16 090
63282 A Biopsy/excise spinal tumor 28.00 NA NA 15.35 15.33 6.78 NA NA 50.13 50.11 090
63283 A Biopsy/excise spinal tumor 26.61 NA NA 14.38 14.58 6.28 NA NA 47.27 47.47 090
63285 A Biopsy/excise spinal tumor 37.90 NA NA 19.34 19.78 9.21 NA NA 66.45 66.89 090
63286 A Biopsy/excise spinal tumor 37.47 NA NA 19.08 19.69 9.24 NA NA 65.79 66.40 090
63287 A Biopsy/excise spinal tumor 39.93 NA NA 19.79 20.26 9.42 NA NA 69.14 69.61 090
63290 A Biopsy/excise spinal tumor 40.67 NA NA 20.38 20.53 9.05 NA NA 70.10 70.25 090
63295 A Repair of laminectomy defect 5.25 NA NA 1.34 1.94 1.03 NA NA 7.62 8.22 ZZZ
63300 A Removal of vertebral body 26.67 NA NA 13.72 14.15 5.99 NA NA 46.38 46.81 090
63301 A Removal of vertebral body 31.42 NA NA 15.20 15.46 5.41 NA NA 52.03 52.29 090
63302 A Removal of vertebral body 31.00 NA NA 14.96 15.62 5.55 NA NA 51.51 52.17 090
63303 A Removal of vertebral body 33.42 NA NA 14.79 16.37 4.69 NA NA 52.90 54.48 090
63304 A Removal of vertebral body 33.70 NA NA 17.29 17.27 6.43 NA NA 57.42 57.40 090
63305 A Removal of vertebral body 36.09 NA NA 17.76 17.97 5.73 NA NA 59.58 59.79 090
63306 A Removal of vertebral body 35.40 NA NA 15.81 17.30 8.35 NA NA 59.56 61.05 090
63307 A Removal of vertebral body 34.81 NA NA 17.93 17.08 4.47 NA NA 57.21 56.36 090
63308 A Remove vertebral body add-on 5.24 NA NA 1.96 2.44 1.29 NA NA 8.49 8.97 ZZZ
63600 A Remove spinal cord lesion 15.02 NA NA 4.54 5.18 1.52 NA NA 21.08 21.72 090
63610 A Stimulation of spinal cord 8.72 13.95 48.25 1.57 2.08 0.86 23.53 57.83 11.15 11.66 000
63615 A Remove lesion of spinal cord 17.22 NA NA 6.06 8.46 2.85 NA NA 26.13 28.53 090
63650 A Implant neuroelectrodes 7.57 NA NA 2.91 3.11 0.53 NA NA 11.01 11.21 090
63655 A Implant neuroelectrodes 11.43 NA NA 7.91 7.15 2.44 NA NA 21.78 21.02 090
63660 A Revise/remove neuroelectrode 6.87 NA NA 3.33 3.54 0.78 NA NA 10.98 11.19 090
63685 A Insrt/redo spine n generator 7.87 NA NA 3.71 4.03 1.05 NA NA 12.63 12.95 090
63688 A Revise/remove neuroreceiver 6.10 NA NA 3.59 3.56 0.89 NA NA 10.58 10.55 090
63700 A Repair of spinal herniation 17.32 NA NA 9.88 10.20 3.53 NA NA 30.73 31.05 090
63702 A Repair of spinal herniation 19.26 NA NA 11.03 11.03 4.13 NA NA 34.42 34.42 090
63704 A Repair of spinal herniation 22.23 NA NA 12.71 12.86 4.58 NA NA 39.52 39.67 090
63706 A Repair of spinal herniation 25.15 NA NA 15.27 14.00 6.25 NA NA 46.67 45.40 090
63707 A Repair spinal fluid leakage 12.52 NA NA 7.96 7.77 2.52 NA NA 23.00 22.81 090
63709 A Repair spinal fluid leakage 15.52 NA NA 9.14 9.33 3.10 NA NA 27.76 27.95 090
63710 A Graft repair of spine defect 15.27 NA NA 9.35 9.11 3.41 NA NA 28.03 27.79 090
63740 A Install spinal shunt 12.50 NA NA 8.33 7.59 2.94 NA NA 23.77 23.03 090
63741 A Install spinal shunt 9.02 NA NA 4.85 4.78 1.66 NA NA 15.53 15.46 090
63744 A Revision of spinal shunt 8.86 NA NA 6.12 5.47 1.90 NA NA 16.88 16.23 090
63746 A Removal of spinal shunt 7.25 NA NA 4.78 4.02 1.53 NA NA 13.56 12.80 090
64400 A N block inj, trigeminal 1.11 1.39 1.77 0.45 0.44 0.07 2.57 2.95 1.63 1.62 000
64402 A N block inj, facial 1.25 1.45 1.57 0.53 0.58 0.09 2.79 2.91 1.87 1.92 000
64405 A N block inj, occipital 1.32 1.16 1.39 0.51 0.47 0.08 2.56 2.79 1.91 1.87 000
64408 A N block inj, vagus 1.41 1.46 1.55 0.72 0.82 0.10 2.97 3.06 2.23 2.33 000
64410 A N block inj, phrenic 1.43 1.80 2.33 0.52 0.48 0.09 3.32 3.85 2.04 2.00 000
64412 A N block inj, spinal accessor 1.18 2.03 2.50 0.55 0.46 0.08 3.29 3.76 1.81 1.72 000
64413 A N block inj, cervical plexus 1.40 1.28 1.70 0.47 0.49 0.08 2.76 3.18 1.95 1.97 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
64415 A N block inj, brachial plexus 1.48 1.48 2.47 0.34 0.43 0.09 3.05 4.04 1.91 2.00 000
64416 A N block cont infuse, b plex 3.85 NA NA 0.58 0.74 0.31 NA NA 4.74 4.90 010
64417 A N block inj, axillary 1.44 1.49 2.65 0.35 0.46 0.11 3.04 4.20 1.90 2.01 000
64418 A N block inj, suprascapular 1.32 1.87 2.43 0.52 0.46 0.07 3.26 3.82 1.91 1.85 000
64420 A N block inj, intercost, sng 1.18 2.36 3.50 0.44 0.43 0.08 3.62 4.76 1.70 1.69 000
64421 A N block inj, intercost, mlt 1.68 3.48 5.43 0.52 0.52 0.11 5.27 7.22 2.31 2.31 000
64425 A N block inj, ilio-ing/hypogi 1.75 1.32 1.57 0.55 0.54 0.13 3.20 3.45 2.43 2.42 000
64430 A N block inj, pudendal 1.46 2.40 2.48 0.79 0.61 0.10 3.96 4.04 2.35 2.17 000
64435 A N block inj, paracervical 1.45 1.97 2.38 0.55 0.66 0.16 3.58 3.99 2.16 2.27 000
64445 A N block inj, sciatic, sng 1.48 1.65 2.42 0.52 0.51 0.10 3.23 4.00 2.10 2.09 000
64446 A N blk inj, sciatic, cont inf 3.61 NA NA 0.59 0.90 0.20 NA NA 4.40 4.71 010
64447 A N block inj fem, single 1.50 NA NA 0.21 0.38 0.09 NA NA 1.80 1.97 000
64448 A N block inj fem, cont inf 3.36 NA NA 0.47 0.73 0.18 NA NA 4.01 4.27 010
64449 A N block inj, lumbar plexus 3.24 NA NA 0.49 0.84 0.15 NA NA 3.88 4.23 010
64450 A N block, other peripheral 1.27 1.29 1.25 0.50 0.49 0.13 2.69 2.65 1.90 1.89 000
64470 A Inj paravertebral c/t 1.85 3.79 6.37 0.70 0.71 0.11 5.75 8.33 2.66 2.67 000
64472 A Inj paravertebral c/t add-on 1.29 1.20 2.05 0.33 0.34 0.08 2.57 3.42 1.70 1.71 ZZZ
64475 A Inj paravertebral l/s 1.41 3.64 6.07 0.59 0.62 0.10 5.15 7.58 2.10 2.13 000
64476 A Inj paravertebral l/s add-on 0.98 1.09 1.86 0.23 0.24 0.07 2.14 2.91 1.28 1.29 ZZZ
64479 A Inj foramen epidural c/t 2.20 3.71 6.55 0.80 0.87 0.12 6.03 8.87 3.12 3.19 000
64480 A Inj foramen epidural add-on 1.54 1.46 2.50 0.37 0.45 0.10 3.10 4.14 2.01 2.09 ZZZ
64483 A Inj foramen epidural l/s 1.90 3.76 6.86 0.74 0.81 0.11 5.77 8.87 2.75 2.82 000
64484 A Inj foramen epidural add-on 1.33 1.59 2.86 0.32 0.36 0.08 3.00 4.27 1.73 1.77 ZZZ
64505 A N block, spenopalatine gangl 1.36 1.10 1.21 0.73 0.68 0.10 2.56 2.67 2.19 2.14 000
64508 A N block, carotid sinus s/p 1.12 1.87 2.96 0.49 0.68 0.07 3.06 4.15 1.68 1.87 000
64510 A N block, stellate ganglion 1.22 1.88 3.06 0.43 0.49 0.07 3.17 4.35 1.72 1.78 000
64517 A N block inj, hypogas plxs 2.20 1.65 2.45 0.64 0.81 0.11 3.96 4.76 2.95 3.12 000
64520 A N block, lumbar/thoracic 1.35 2.56 4.50 0.51 0.54 0.08 3.99 5.93 1.94 1.97 000
64530 A N block inj, celiac pelus 1.58 2.58 3.98 0.58 0.63 0.10 4.26 5.66 2.26 2.31 000
64550 A Apply neurostimulator 0.18 0.20 0.26 0.06 0.05 0.01 0.39 0.45 0.25 0.24 000
64553 A Implant neuroelectrodes 2.33 2.50 2.75 1.37 1.73 0.18 5.01 5.26 3.88 4.24 010
64555 A Implant neuroelectrodes 2.29 2.55 2.96 1.36 1.23 0.19 5.03 5.44 3.84 3.71 010
64560 A Implant neuroelectrodes 2.38 2.48 2.59 1.34 1.30 0.22 5.08 5.19 3.94 3.90 010
64561 A Implant neuroelectrodes 7.07 19.89 27.51 3.90 3.05 0.51 27.47 35.09 11.48 10.63 010
64565 A Implant neuroelectrodes 1.78 2.47 3.08 1.29 1.27 0.13 4.38 4.99 3.20 3.18 010
64573 A Implant neuroelectrodes 8.15 NA NA 5.50 5.31 1.60 NA NA 15.25 15.06 090
64575 A Implant neuroelectrodes 4.37 NA NA 1.96 2.49 0.61 NA NA 6.94 7.47 090
64577 A Implant neuroelectrodes 4.64 NA NA 2.84 3.17 1.04 NA NA 8.52 8.85 090
64580 A Implant neuroelectrodes 4.14 NA NA 2.69 3.34 0.36 NA NA 7.19 7.84 090
64581 A Implant neuroelectrodes 14.15 NA NA 6.79 5.73 1.05 NA NA 21.99 20.93 090
64585 A Revise/remove neuroelectrode 2.08 5.74 9.90 2.23 2.16 0.20 8.02 12.18 4.51 4.44 010
64590 A Insrt/redo pn/gastr stimul 2.42 6.39 6.95 2.47 2.33 0.19 9.00 9.56 5.08 4.94 010
64595 A Revise/rmv pn/gastr stimul 1.75 6.46 9.41 2.20 1.99 0.19 8.40 11.35 4.14 3.93 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
64600 A Injection treatment of nerve 3.46 5.24 8.32 1.59 1.64 0.34 9.04 12.12 5.39 5.44 010
64605 A Injection treatment of nerve 5.62 7.49 9.04 2.36 2.23 0.79 13.90 15.45 8.77 8.64 010
64610 A Injection treatment of nerve 7.17 9.40 9.00 3.56 3.67 1.58 18.15 17.75 12.31 12.42 010
64612 A Destroy nerve, face muscle 1.98 1.63 2.27 1.38 1.34 0.11 3.72 4.36 3.47 3.43 010
64613 A Destroy nerve, neck muscle 1.98 1.37 2.54 1.14 1.20 0.11 3.46 4.63 3.23 3.29 010
64614 A Destroy nerve, extrem musc 2.20 1.62 2.82 1.32 1.31 0.10 3.92 5.12 3.62 3.61 010
64620 A Injection treatment of nerve 2.86 3.36 4.64 1.14 1.28 0.20 6.42 7.70 4.20 4.34 010
64622 A Destr paravertebrl nerve l/s 3.02 4.00 6.82 1.25 1.34 0.18 7.20 10.02 4.45 4.54 010
64623 A Destr paravertebral n add-on 0.99 1.61 2.62 0.21 0.22 0.06 2.66 3.67 1.26 1.27 ZZZ
64626 A Destr paravertebrl nerve c/t 3.82 4.60 6.99 1.82 1.93 0.20 8.62 11.01 5.84 5.95 010
64627 A Destr paravertebral n add-on 1.16 2.31 3.98 0.24 0.26 0.07 3.54 5.21 1.47 1.49 ZZZ
64630 A Injection treatment of nerve 3.02 2.78 2.74 1.87 1.53 0.22 6.02 5.98 5.11 4.77 010
64640 A Injection treatment of nerve 2.78 2.46 3.75 1.46 1.75 0.29 5.53 6.82 4.53 4.82 010
64650 A Chemodenerv eccrine glands 0.70 0.77 0.85 0.18 0.27 0.06 1.53 1.61 0.94 1.03 000
64653 A Chemodenerv eccrine glands 0.88 0.82 0.90 0.22 0.34 0.08 1.78 1.86 1.18 1.30 000
64680 A Injection treatment of nerve 2.64 3.93 6.02 1.08 1.34 0.18 6.75 8.84 3.90 4.16 010
64681 A Injection treatment of nerve 3.78 4.80 8.17 1.28 1.87 0.28 8.86 12.23 5.34 5.93 010
64702 A Revise finger/toe nerve 6.10 NA NA 5.33 4.23 0.61 NA NA 12.04 10.94 090
64704 A Revise hand/foot nerve 4.61 NA NA 3.23 3.29 0.61 NA NA 8.45 8.51 090
64708 A Revise arm/leg nerve 6.22 NA NA 4.32 4.73 0.96 NA NA 11.50 11.91 090
64712 A Revision of sciatic nerve 7.98 NA NA 4.56 4.86 0.95 NA NA 13.49 13.79 090
64713 A Revision of arm nerve(s) 11.29 NA NA 6.50 6.03 1.83 NA NA 19.62 19.15 090
64714 A Revise low back nerve(s) 10.44 NA NA 4.93 4.38 1.19 NA NA 16.56 16.01 090
64716 A Revision of cranial nerve 6.86 NA NA 5.23 5.79 0.63 NA NA 12.72 13.28 090
64718 A Revise ulnar nerve at elbow 7.06 NA NA 6.27 6.06 1.05 NA NA 14.38 14.17 090
64719 A Revise ulnar nerve at wrist 4.89 NA NA 4.19 4.44 0.77 NA NA 9.85 10.10 090
64721 A Carpal tunnel surgery 4.84 4.74 5.21 4.68 5.19 0.73 10.31 10.78 10.25 10.76 090
64722 A Relieve pressure on nerve(s) 4.74 NA NA 2.83 2.99 0.48 NA NA 8.05 8.21 090
64726 A Release foot/toe nerve 4.21 NA NA 2.76 2.78 0.54 NA NA 7.51 7.53 090
64727 A Internal nerve revision 3.10 NA NA 1.25 1.44 0.48 NA NA 4.83 5.02 ZZZ
64732 A Incision of brow nerve 4.81 NA NA 4.33 3.71 0.98 NA NA 10.12 9.50 090
64734 A Incision of cheek nerve 5.45 NA NA 4.67 4.21 0.89 NA NA 11.01 10.55 090
64736 A Incision of chin nerve 5.13 NA NA 3.91 3.99 0.52 NA NA 9.56 9.64 090
64738 A Incision of jaw nerve 6.26 NA NA 4.28 4.53 1.08 NA NA 11.62 11.87 090
64740 A Incision of tongue nerve 6.12 NA NA 4.44 4.95 0.69 NA NA 11.25 11.76 090
64742 A Incision of facial nerve 6.75 NA NA 4.41 4.63 0.73 NA NA 11.89 12.11 090
64744 A Incise nerve, back of head 5.64 NA NA 4.62 3.98 1.16 NA NA 11.42 10.78 090
64746 A Incise diaphragm nerve 6.46 NA NA 3.87 4.34 0.82 NA NA 11.15 11.62 090
64752 A Incision of vagus nerve 7.59 NA NA 4.04 4.22 0.93 NA NA 12.56 12.74 090
64755 A Incision of stomach nerves 14.97 NA NA 5.80 5.67 1.84 NA NA 22.61 22.48 090
64760 A Incision of vagus nerve 7.49 NA NA 3.84 3.55 0.81 NA NA 12.14 11.85 090
64761 A Incision of pelvis nerve 6.94 NA NA 3.95 3.63 0.53 NA NA 11.42 11.10 090
64763 A Incise hip/thigh nerve 7.46 NA NA 5.13 5.18 0.94 NA NA 13.53 13.58 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
64766 A Incise hip/thigh nerve 9.34 NA NA 5.31 5.26 1.06 NA NA 15.71 15.66 090
64771 A Sever cranial nerve 8.02 NA NA 5.36 5.50 1.23 NA NA 14.61 14.75 090
64772 A Incision of spinal nerve 7.74 NA NA 5.35 5.03 1.40 NA NA 14.49 14.17 090
64774 A Remove skin nerve lesion 5.70 NA NA 4.00 3.87 0.74 NA NA 10.44 10.31 090
64776 A Remove digit nerve lesion 5.52 NA NA 3.77 3.70 0.76 NA NA 10.05 9.98 090
64778 A Digit nerve surgery add-on 3.11 NA NA 1.22 1.43 0.46 NA NA 4.79 5.00 ZZZ
64782 A Remove limb nerve lesion 6.76 NA NA 4.14 3.86 0.86 NA NA 11.76 11.48 090
64783 A Limb nerve surgery add-on 3.71 NA NA 1.44 1.73 0.51 NA NA 5.66 5.95 ZZZ
64784 A Remove nerve lesion 10.49 NA NA 6.26 6.51 1.38 NA NA 18.13 18.38 090
64786 A Remove sciatic nerve lesion 16.12 NA NA 9.10 9.65 2.61 NA NA 27.83 28.38 090
64787 A Implant nerve end 4.29 NA NA 1.64 2.00 0.58 NA NA 6.51 6.87 ZZZ
64788 A Remove skin nerve lesion 5.14 NA NA 3.91 3.57 0.73 NA NA 9.78 9.44 090
64790 A Removal of nerve lesion 11.97 NA NA 6.89 7.12 2.11 NA NA 20.97 21.20 090
64792 A Removal of nerve lesion 15.71 NA NA 8.50 8.74 2.49 NA NA 26.70 26.94 090
64795 A Biopsy of nerve 3.01 NA NA 1.45 1.53 0.52 NA NA 4.98 5.06 000
64802 A Remove sympathetic nerves 10.24 NA NA 4.23 4.91 1.29 NA NA 15.76 16.44 090
64804 A Remove sympathetic nerves 15.78 NA NA 5.99 6.87 2.15 NA NA 23.92 24.80 090
64809 A Remove sympathetic nerves 14.61 NA NA 6.63 5.98 1.50 NA NA 22.74 22.09 090
64818 A Remove sympathetic nerves 11.24 NA NA 4.29 5.03 1.33 NA NA 16.86 17.60 090
64820 A Remove sympathetic nerves 10.64 NA NA 7.14 7.13 1.49 NA NA 19.27 19.26 090
64821 A Remove sympathetic nerves 9.19 NA NA 6.73 7.19 1.24 NA NA 17.16 17.62 090
64822 A Remove sympathetic nerves 9.19 NA NA 6.53 7.06 1.30 NA NA 17.02 17.55 090
64823 A Remove sympathetic nerves 10.80 NA NA 7.22 7.90 1.57 NA NA 19.59 20.27 090
64831 A Repair of digit nerve 10.23 NA NA 6.77 7.00 1.41 NA NA 18.41 18.64 090
64832 A Repair nerve add-on 5.65 NA NA 2.41 2.80 0.85 NA NA 8.91 9.30 ZZZ
64834 A Repair of hand or foot nerve 10.71 NA NA 6.67 6.99 1.54 NA NA 18.92 19.24 090
64835 A Repair of hand or foot nerve 11.60 NA NA 7.42 7.62 1.74 NA NA 20.76 20.96 090
64836 A Repair of hand or foot nerve 11.60 NA NA 7.15 7.53 1.68 NA NA 20.43 20.81 090
64837 A Repair nerve add-on 6.25 NA NA 2.74 3.11 0.97 NA NA 9.96 10.33 ZZZ
64840 A Repair of leg nerve 13.87 NA NA 5.16 7.48 1.37 NA NA 20.40 22.72 090
64856 A Repair/transpose nerve 14.94 NA NA 8.74 9.07 2.13 NA NA 25.81 26.14 090
64857 A Repair arm/leg nerve 15.69 NA NA 9.08 9.49 2.22 NA NA 26.99 27.40 090
64858 A Repair sciatic nerve 17.69 NA NA 10.42 10.68 3.34 NA NA 31.45 31.71 090
64859 A Nerve surgery 4.25 NA NA 1.94 2.13 0.67 NA NA 6.86 7.05 ZZZ
64861 A Repair of arm nerves 20.74 NA NA 10.16 11.37 4.09 NA NA 34.99 36.20 090
64862 A Repair of low back nerves 20.94 NA NA 6.76 10.64 4.32 NA NA 32.02 35.90 090
64864 A Repair of facial nerve 13.31 NA NA 7.20 8.37 1.26 NA NA 21.77 22.94 090
64865 A Repair of facial nerve 15.96 NA NA 10.06 12.66 1.50 NA NA 27.52 30.12 090
64866 A Fusion of facial/other nerve 16.70 NA NA 12.44 12.98 2.05 NA NA 31.19 31.73 090
64868 A Fusion of facial/other nerve 14.80 NA NA 9.19 10.87 1.43 NA NA 25.42 27.10 090
64870 A Fusion of facial/other nerve 16.95 NA NA 8.55 8.68 1.30 NA NA 26.80 26.93 090
64872 A Subsequent repair of nerve 1.99 NA NA 0.83 1.02 0.29 NA NA 3.11 3.30 ZZZ
64874 A Repair revise nerve add-on 2.98 NA NA 1.24 1.46 0.42 NA NA 4.64 4.86 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
64876 A Repair nerve/shorten bone 3.37 NA NA 0.78 1.50 0.47 NA NA 4.62 5.34 ZZZ
64885 A Nerve graft, head or neck 17.50 NA NA 9.04 10.96 1.63 NA NA 28.17 30.09 090
64886 A Nerve graft, head or neck 20.72 NA NA 9.96 12.65 2.09 NA NA 32.77 35.46 090
64890 A Nerve graft, hand or foot 16.11 NA NA 9.24 9.80 2.30 NA NA 27.65 28.21 090
64891 A Nerve graft, hand or foot 17.22 NA NA 10.07 8.20 1.63 NA NA 28.92 27.05 090
64892 A Nerve graft, arm or leg 15.61 NA NA 9.09 8.92 2.48 NA NA 27.18 27.01 090
64893 A Nerve graft, arm or leg 16.74 NA NA 9.88 9.87 2.62 NA NA 29.24 29.23 090
64895 A Nerve graft, hand or foot 20.26 NA NA 10.27 9.81 2.58 NA NA 33.11 32.65 090
64896 A Nerve graft, hand or foot 21.81 NA NA 12.07 11.25 3.17 NA NA 37.05 36.23 090
64897 A Nerve graft, arm or leg 19.25 NA NA 10.59 10.67 2.55 NA NA 32.39 32.47 090
64898 A Nerve graft, arm or leg 20.82 NA NA 11.50 11.72 2.78 NA NA 35.10 35.32 090
64901 A Nerve graft add-on 10.20 NA NA 3.94 4.93 1.37 NA NA 15.51 16.50 ZZZ
64902 A Nerve graft add-on 11.81 NA NA 4.38 5.57 1.55 NA NA 17.74 18.93 ZZZ
64905 A Nerve pedicle transfer 14.98 NA NA 7.01 8.12 2.01 NA NA 24.00 25.11 090
64907 A Nerve pedicle transfer 19.90 NA NA 6.35 10.98 3.17 NA NA 29.42 34.05 090
64910 A Nerve repair w/allograft 11.21 NA NA 5.21 5.21 1.74 NA NA 18.16 18.16 090
64911 A Neurorraphy w/vein autograft 14.21 NA NA 5.97 5.97 1.91 NA NA 22.09 22.09 090
64999 C Nervous system surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
65091 A Revise eye 7.13 NA NA 6.95 8.00 0.32 NA NA 14.40 15.45 090
65093 A Revise eye with implant 6.93 NA NA 7.04 8.29 0.34 NA NA 14.31 15.56 090
65101 A Removal of eye 8.10 NA NA 8.19 9.19 0.35 NA NA 16.64 17.64 090
65103 A Remove eye/insert implant 8.64 NA NA 8.42 9.40 0.37 NA NA 17.43 18.41 090
65105 A Remove eye/attach implant 9.70 NA NA 9.12 10.13 0.42 NA NA 19.24 20.25 090
65110 A Removal of eye 15.42 NA NA 11.71 13.18 0.81 NA NA 27.94 29.41 090
65112 A Remove eye/revise socket 18.18 NA NA 13.21 15.40 1.30 NA NA 32.69 34.88 090
65114 A Remove eye/revise socket 19.32 NA NA 13.86 15.72 1.02 NA NA 34.20 36.06 090
65125 A Revise ocular implant 3.18 6.78 8.30 3.18 3.50 0.19 10.15 11.67 6.55 6.87 090
65130 A Insert ocular implant 8.22 NA NA 8.03 8.88 0.35 NA NA 16.60 17.45 090
65135 A Insert ocular implant 8.40 NA NA 8.01 8.99 0.36 NA NA 16.77 17.75 090
65140 A Attach ocular implant 9.23 NA NA 8.65 9.57 0.40 NA NA 18.28 19.20 090
65150 A Revise ocular implant 6.32 NA NA 6.51 7.61 0.31 NA NA 13.14 14.24 090
65155 A Reinsert ocular implant 9.87 NA NA 8.92 10.09 0.50 NA NA 19.29 20.46 090
65175 A Removal of ocular implant 7.22 NA NA 7.32 8.19 0.31 NA NA 14.85 15.72 090
65205 A Remove foreign body from eye 0.71 0.59 0.63 0.34 0.30 0.03 1.33 1.37 1.08 1.04 000
65210 A Remove foreign body from eye 0.84 0.74 0.79 0.41 0.39 0.04 1.62 1.67 1.29 1.27 000
65220 A Remove foreign body from eye 0.71 0.60 0.63 0.29 0.28 0.05 1.36 1.39 1.05 1.04 000
65222 A Remove foreign body from eye 0.93 0.81 0.87 0.44 0.40 0.04 1.78 1.84 1.41 1.37 000
65235 A Remove foreign body from eye 8.78 NA NA 7.05 6.82 0.37 NA NA 16.20 15.97 090
65260 A Remove foreign body from eye 12.29 NA NA 9.13 9.52 0.57 NA NA 21.99 22.38 090
65265 A Remove foreign body from eye 14.06 NA NA 10.01 10.47 0.62 NA NA 24.69 25.15 090
65270 A Repair of eye wound 1.92 3.87 4.88 1.24 1.35 0.09 5.88 6.89 3.25 3.36 010
65272 A Repair of eye wound 4.49 6.51 7.41 3.31 3.30 0.19 11.19 12.09 7.99 7.98 090
65273 A Repair of eye wound 5.03 NA NA 3.47 3.55 0.22 NA NA 8.72 8.80 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
65275 A Repair of eye wound 6.14 6.46 6.35 4.04 3.97 0.26 12.86 12.75 10.44 10.37 090
65280 A Repair of eye wound 8.87 NA NA 6.10 6.20 0.38 NA NA 15.35 15.45 090
65285 A Repair of eye wound 14.43 NA NA 8.83 9.12 0.64 NA NA 23.90 24.19 090
65286 A Repair of eye wound 6.45 8.98 10.60 4.59 4.61 0.27 15.70 17.32 11.31 11.33 090
65290 A Repair of eye socket wound 6.35 NA NA 4.61 4.71 0.31 NA NA 11.27 11.37 090
65400 A Removal of eye lesion 7.27 7.71 8.18 6.09 6.11 0.30 15.28 15.75 13.66 13.68 090
65410 A Biopsy of cornea 1.47 1.72 2.01 0.90 0.95 0.07 3.26 3.55 2.44 2.49 000
65420 A Removal of eye lesion 4.24 7.04 8.40 4.10 4.36 0.21 11.49 12.85 8.55 8.81 090
65426 A Removal of eye lesion 5.93 8.43 9.74 4.76 4.88 0.25 14.61 15.92 10.94 11.06 090
65430 A Corneal smear 1.47 1.13 1.25 0.90 0.96 0.07 2.67 2.79 2.44 2.50 000
65435 A Curette/treat cornea 0.92 0.89 0.97 0.68 0.70 0.04 1.85 1.93 1.64 1.66 000
65436 A Curette/treat cornea 4.72 3.92 4.05 3.58 3.65 0.21 8.85 8.98 8.51 8.58 090
65450 A Treatment of corneal lesion 3.35 3.79 4.00 3.71 3.88 0.16 7.30 7.51 7.22 7.39 090
65600 A Revision of cornea 4.07 4.60 4.91 3.54 3.40 0.17 8.84 9.15 7.78 7.64 090
65710 A Corneal transplant 14.09 NA NA 10.60 11.05 0.61 NA NA 25.30 25.75 090
65730 A Corneal transplant 15.99 NA NA 11.41 11.87 0.70 NA NA 28.10 28.56 090
65750 A Corneal transplant 16.60 NA NA 11.13 11.76 0.74 NA NA 28.47 29.10 090
65755 A Corneal transplant 16.49 NA NA 11.10 11.69 0.73 NA NA 28.32 28.91 090
65760 N Revision of cornea 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
65765 N Revision of cornea 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
65767 N Corneal tissue transplant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
65770 A Revise cornea with implant 19.41 NA NA 12.24 12.96 0.87 NA NA 32.52 33.24 090
65771 N Radial keratotomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
65772 A Correction of astigmatism 4.96 5.02 5.40 4.08 4.12 0.21 10.19 10.57 9.25 9.29 090
65775 A Correction of astigmatism 6.73 NA NA 5.52 5.84 0.28 NA NA 12.53 12.85 090
65780 A Ocular reconst, transplant 10.43 NA NA 9.29 10.04 0.44 NA NA 20.16 20.91 090
65781 A Ocular reconst, transplant 17.84 NA NA 12.11 13.28 0.44 NA NA 30.39 31.56 090
65782 A Ocular reconst, transplant 15.16 NA NA 10.67 11.66 0.44 NA NA 26.27 27.26 090
65800 A Drainage of eye 1.91 1.46 1.71 1.08 1.16 0.09 3.46 3.71 3.08 3.16 000
65805 A Drainage of eye 1.91 1.77 2.07 1.08 1.16 0.09 3.77 4.07 3.08 3.16 000
65810 A Drainage of eye 5.67 NA NA 4.87 4.74 0.24 NA NA 10.78 10.65 090
65815 A Drainage of eye 5.85 8.15 9.54 4.76 4.80 0.25 14.25 15.64 10.86 10.90 090
65820 A Relieve inner eye pressure 8.72 NA NA 7.94 8.77 0.40 NA NA 17.06 17.89 090
65850 A Incision of eye 11.24 NA NA 7.65 8.24 0.52 NA NA 19.41 20.00 090
65855 A Laser surgery of eye 3.90 3.63 4.14 2.75 3.01 0.19 7.72 8.23 6.84 7.10 010
65860 A Incise inner eye adhesions 3.56 3.38 3.88 2.18 2.42 0.18 7.12 7.62 5.92 6.16 090
65865 A Incise inner eye adhesions 5.66 NA NA 4.88 5.44 0.28 NA NA 10.82 11.38 090
65870 A Incise inner eye adhesions 7.21 NA NA 5.94 6.29 0.31 NA NA 13.46 13.81 090
65875 A Incise inner eye adhesions 7.61 NA NA 6.39 6.69 0.32 NA NA 14.32 14.62 090
65880 A Incise inner eye adhesions 8.16 NA NA 6.61 6.93 0.35 NA NA 15.12 15.44 090
65900 A Remove eye lesion 12.26 NA NA 9.25 10.00 0.54 NA NA 22.05 22.80 090
65920 A Remove implant of eye 9.74 NA NA 7.80 8.08 0.41 NA NA 17.95 18.23 090
65930 A Remove blood clot from eye 8.24 NA NA 6.04 6.63 0.37 NA NA 14.65 15.24 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
66020 A Injection treatment of eye 1.61 2.49 2.96 1.33 1.41 0.08 4.18 4.65 3.02 3.10 010
66030 A Injection treatment of eye 1.27 2.36 2.81 1.19 1.26 0.06 3.69 4.14 2.52 2.59 010
66130 A Remove eye lesion 7.74 7.79 9.16 5.11 5.49 0.38 15.91 17.28 13.23 13.61 090
66150 A Glaucoma surgery 10.18 NA NA 9.13 9.33 0.46 NA NA 19.77 19.97 090
66155 A Glaucoma surgery 10.17 NA NA 9.11 9.29 0.41 NA NA 19.69 19.87 090
66160 A Glaucoma surgery 12.04 NA NA 9.88 10.11 0.50 NA NA 22.42 22.65 090
66165 A Glaucoma surgery 9.89 NA NA 9.06 9.20 0.40 NA NA 19.35 19.49 090
66170 A Glaucoma surgery 14.57 NA NA 12.02 12.17 0.60 NA NA 27.19 27.34 090
66172 A Incision of eye 18.26 NA NA 15.25 15.21 0.74 NA NA 34.25 34.21 090
66180 A Implant eye shunt 16.02 NA NA 10.18 10.62 0.71 NA NA 26.91 27.35 090
66185 A Revise eye shunt 9.35 NA NA 7.35 7.37 0.40 NA NA 17.10 17.12 090
66220 A Repair eye lesion 8.98 NA NA 7.28 7.15 0.40 NA NA 16.66 16.53 090
66225 A Repair/graft eye lesion 12.38 NA NA 8.51 8.68 0.55 NA NA 21.44 21.61 090
66250 A Follow-up surgery of eye 6.92 9.53 11.15 5.48 5.48 0.30 16.75 18.37 12.70 12.70 090
66500 A Incision of iris 3.75 NA NA 4.09 4.50 0.18 NA NA 8.02 8.43 090
66505 A Incision of iris 4.13 NA NA 4.46 4.86 0.20 NA NA 8.79 9.19 090
66600 A Remove iris and lesion 9.89 NA NA 8.62 8.32 0.43 NA NA 18.94 18.64 090
66605 A Removal of iris 13.99 NA NA 9.51 9.89 0.77 NA NA 24.27 24.65 090
66625 A Removal of iris 5.19 NA NA 4.38 4.64 0.26 NA NA 9.83 10.09 090
66630 A Removal of iris 7.10 NA NA 5.58 5.68 0.31 NA NA 12.99 13.09 090
66635 A Removal of iris 7.19 NA NA 5.61 5.71 0.31 NA NA 13.11 13.21 090
66680 A Repair iris ciliary body 6.24 NA NA 5.27 5.27 0.27 NA NA 11.78 11.78 090
66682 A Repair iris ciliary body 7.15 NA NA 6.97 6.70 0.31 NA NA 14.43 14.16 090
66700 A Destruction, ciliary body 5.06 4.98 5.18 3.77 3.89 0.24 10.28 10.48 9.07 9.19 090
66710 A Ciliary transsleral therapy 5.06 4.76 5.07 3.74 3.82 0.23 10.05 10.36 9.03 9.11 090
66711 A Ciliary endoscopic ablation 7.70 NA NA 6.56 6.49 0.30 NA NA 14.56 14.49 090
66720 A Destruction, ciliary body 4.86 5.50 5.72 4.44 4.65 0.26 10.62 10.84 9.56 9.77 090
66740 A Destruction, ciliary body 5.06 4.70 4.99 3.77 3.92 0.23 9.99 10.28 9.06 9.21 090
66761 A Revision of iris 4.87 5.20 5.49 4.36 4.32 0.20 10.27 10.56 9.43 9.39 090
66762 A Revision of iris 5.25 5.29 5.56 4.24 4.28 0.23 10.77 11.04 9.72 9.76 090
66770 A Removal of inner eye lesion 5.98 5.75 6.00 4.79 4.80 0.26 11.99 12.24 11.03 11.04 090
66820 A Incision, secondary cataract 3.93 NA NA 4.78 5.55 0.19 NA NA 8.90 9.67 090
66821 A After cataract laser surgery 3.32 3.94 4.05 3.53 3.60 0.11 7.37 7.48 6.96 7.03 090
66825 A Reposition intraocular lens 8.82 NA NA 8.07 8.81 0.40 NA NA 17.29 18.03 090
66830 A Removal of lens lesion 9.27 NA NA 6.65 6.88 0.36 NA NA 16.28 16.51 090
66840 A Removal of lens material 8.98 NA NA 6.59 6.79 0.39 NA NA 15.96 16.16 090
66850 A Removal of lens material 10.32 NA NA 7.40 7.58 0.45 NA NA 18.17 18.35 090
66852 A Removal of lens material 11.18 NA NA 7.74 8.01 0.49 NA NA 19.41 19.68 090
66920 A Extraction of lens 9.93 NA NA 6.95 7.21 0.44 NA NA 17.32 17.58 090
66930 A Extraction of lens 11.38 NA NA 7.82 8.06 0.49 NA NA 19.69 19.93 090
66940 A Extraction of lens 10.14 NA NA 7.34 7.54 0.43 NA NA 17.91 18.11 090
66982 A Cataract surgery, complex 14.83 NA NA 9.40 9.75 0.63 NA NA 24.86 25.21 090
66983 A Cataract surg w/iol, 1 stage 10.20 NA NA 6.37 6.18 0.14 NA NA 16.71 16.52 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
66984 A Cataract surg w/iol, 1 stage 10.36 NA NA 6.70 7.24 0.39 NA NA 17.45 17.99 090
66985 A Insert lens prosthesis 9.73 NA NA 7.41 7.44 0.36 NA NA 17.50 17.53 090
66986 A Exchange lens prosthesis 12.26 NA NA 8.44 8.99 0.60 NA NA 21.30 21.85 090
66990 A Ophthalmic endoscope add-on 1.51 NA NA 0.58 0.66 0.07 NA NA 2.16 2.24 ZZZ
66999 C Eye surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
67005 A Partial removal of eye fluid 5.77 NA NA 4.77 4.84 0.28 NA NA 10.82 10.89 090
67010 A Partial removal of eye fluid 6.94 NA NA 5.22 5.36 0.34 NA NA 12.50 12.64 090
67015 A Release of eye fluid 7.00 NA NA 5.94 6.32 0.34 NA NA 13.28 13.66 090
67025 A Replace eye fluid 7.91 8.15 8.95 6.17 6.21 0.34 16.40 17.20 14.42 14.46 090
67027 A Implant eye drug system 11.43 NA NA 7.71 7.93 0.54 NA NA 19.68 19.90 090
67028 A Injection eye drug 2.52 2.24 2.59 1.31 1.42 0.12 4.88 5.23 3.95 4.06 000
67030 A Incise inner eye strands 5.91 NA NA 5.81 5.84 0.24 NA NA 11.96 11.99 090
67031 A Laser surgery, eye strands 4.34 4.24 4.51 3.56 3.62 0.18 8.76 9.03 8.08 8.14 090
67036 A Removal of inner eye fluid 13.09 NA NA 8.46 8.96 0.58 NA NA 22.13 22.63 090
67038 A Strip retinal membrane 23.30 NA NA 14.16 15.16 1.04 NA NA 38.50 39.50 090
67039 A Laser treatment of retina 16.39 NA NA 11.22 11.94 0.71 NA NA 28.32 29.04 090
67040 A Laser treatment of retina 19.23 NA NA 12.61 13.41 0.85 NA NA 32.69 33.49 090
67101 A Repair detached retina 8.60 8.80 9.04 6.45 6.51 0.37 17.77 18.01 15.42 15.48 090
67105 A Repair detached retina 8.35 7.70 7.99 6.05 6.13 0.37 16.42 16.71 14.77 14.85 090
67107 A Repair detached retina 16.35 NA NA 10.86 11.19 0.73 NA NA 27.94 28.27 090
67108 A Repair detached retina 22.49 NA NA 13.62 14.22 1.02 NA NA 37.13 37.73 090
67110 A Repair detached retina 10.02 9.28 9.99 7.29 7.37 0.44 19.74 20.45 17.75 17.83 090
67112 A Rerepair detached retina 18.45 NA NA 11.42 11.71 0.83 NA NA 30.70 30.99 090
67115 A Release encircling material 5.93 NA NA 5.11 5.09 0.25 NA NA 11.29 11.27 090
67120 A Remove eye implant material 6.92 7.61 8.34 5.50 5.52 0.29 14.82 15.55 12.71 12.73 090
67121 A Remove eye implant material 12.00 NA NA 8.35 8.49 0.53 NA NA 20.88 21.02 090
67141 A Treatment of retina 6.00 5.63 5.80 4.86 4.86 0.26 11.89 12.06 11.12 11.12 090
67145 A Treatment of retina 6.17 5.55 5.68 4.92 4.93 0.27 11.99 12.12 11.36 11.37 090
67208 A Treatment of retinal lesion 7.50 5.89 6.06 5.44 5.49 0.33 13.72 13.89 13.27 13.32 090
67210 A Treatment of retinal lesion 9.35 6.21 6.48 5.72 5.84 0.44 16.00 16.27 15.51 15.63 090
67218 A Treatment of retinal lesion 20.22 NA NA 11.24 11.92 0.92 NA NA 32.38 33.06 090
67220 A Treatment of choroid lesion 14.19 9.66 10.23 8.58 8.90 0.65 24.50 25.07 23.42 23.74 090
67221 R Ocular photodynamic ther 3.45 3.04 4.01 1.47 1.72 0.20 6.69 7.66 5.12 5.37 000
67225 A Eye photodynamic ther add-on 0.47 0.24 0.25 0.18 0.20 0.02 0.73 0.74 0.67 0.69 ZZZ
67227 A Treatment of retinal lesion 7.38 6.24 6.50 5.39 5.49 0.33 13.95 14.21 13.10 13.20 090
67228 A Treatment of retinal lesion 13.67 10.36 11.20 8.09 8.43 0.63 24.66 25.50 22.39 22.73 090
67250 A Reinforce eye wall 9.46 NA NA 7.95 8.87 0.47 NA NA 17.88 18.80 090
67255 A Reinforce/graft eye wall 9.97 NA NA 8.78 9.61 0.44 NA NA 19.19 20.02 090
67299 C Eye surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
67311 A Revise eye muscle 7.59 NA NA 5.74 5.95 0.37 NA NA 13.70 13.91 090
67312 A Revise two eye muscles 9.48 NA NA 6.49 6.69 0.43 NA NA 16.40 16.60 090
67314 A Revise eye muscle 8.59 NA NA 6.44 6.52 0.39 NA NA 15.42 15.50 090
67316 A Revise two eye muscles 10.73 NA NA 7.26 7.44 0.49 NA NA 18.48 18.66 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
67318 A Revise eye muscle(s) 8.92 NA NA 6.83 6.91 0.41 NA NA 16.16 16.24 090
67320 A Revise eye muscle(s) add-on 5.40 NA NA 2.07 1.98 0.22 NA NA 7.69 7.60 ZZZ
67331 A Eye surgery follow-up add-on 5.13 NA NA 1.95 1.86 0.21 NA NA 7.29 7.20 ZZZ
67332 A Rerevise eye muscles add-on 5.56 NA NA 2.13 2.05 0.23 NA NA 7.92 7.84 ZZZ
67334 A Revise eye muscle w/suture 5.05 NA NA 1.92 1.82 0.20 NA NA 7.17 7.07 ZZZ
67335 A Eye suture during surgery 2.49 NA NA 0.95 1.08 0.13 NA NA 3.57 3.70 ZZZ
67340 A Revise eye muscle add-on 6.00 NA NA 2.29 2.22 0.25 NA NA 8.54 8.47 ZZZ
67343 A Release eye tissue 8.29 NA NA 6.32 6.46 0.37 NA NA 14.98 15.12 090
67345 A Destroy nerve of eye muscle 2.98 2.29 2.51 1.80 1.96 0.17 5.44 5.66 4.95 5.11 010
67346 A Biopsy, eye muscle 2.87 NA NA 1.71 1.83 0.15 NA NA 4.73 4.85 000
67399 C Eye muscle surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
67400 A Explore/biopsy eye socket 10.97 NA NA 9.79 10.89 0.56 NA NA 21.32 22.42 090
67405 A Explore/drain eye socket 9.00 NA NA 8.53 9.46 0.44 NA NA 17.97 18.90 090
67412 A Explore/treat eye socket 10.17 NA NA 8.87 10.42 0.48 NA NA 19.52 21.07 090
67413 A Explore/treat eye socket 10.09 NA NA 9.02 10.33 0.50 NA NA 19.61 20.92 090
67414 A Explr/decompress eye socket 17.78 NA NA 12.12 12.06 0.65 NA NA 30.55 30.49 090
67415 A Aspiration, orbital contents 1.76 NA NA 0.64 0.73 0.09 NA NA 2.49 2.58 000
67420 A Explore/treat eye socket 21.62 NA NA 14.75 16.73 1.15 NA NA 37.52 39.50 090
67430 A Explore/treat eye socket 14.99 NA NA 12.78 14.36 0.86 NA NA 28.63 30.21 090
67440 A Explore/drain eye socket 14.56 NA NA 12.23 13.75 0.70 NA NA 27.49 29.01 090
67445 A Explr/decompress eye socket 18.96 NA NA 12.71 13.61 0.90 NA NA 32.57 33.47 090
67450 A Explore/biopsy eye socket 15.11 NA NA 12.71 14.20 0.68 NA NA 28.50 29.99 090
67500 A Inject/treat eye socket 1.44 0.62 0.66 0.49 0.34 0.05 2.11 2.15 1.98 1.83 000
67505 A Inject/treat eye socket 1.27 0.54 0.65 0.41 0.34 0.05 1.86 1.97 1.73 1.66 000
67515 A Inject/treat eye socket 1.40 0.82 0.65 0.65 0.45 0.03 2.25 2.08 2.08 1.88 000
67550 A Insert eye socket implant 11.52 NA NA 10.13 11.01 0.72 NA NA 22.37 23.25 090
67560 A Revise eye socket implant 11.93 NA NA 10.16 11.07 0.60 NA NA 22.69 23.60 090
67570 A Decompress optic nerve 14.21 NA NA 11.42 13.04 0.68 NA NA 26.31 27.93 090
67599 C Orbit surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
67700 A Drainage of eyelid abscess 1.37 4.41 5.62 1.22 1.26 0.07 5.85 7.06 2.66 2.70 010
67710 A Incision of eyelid 1.04 3.78 4.97 1.12 1.19 0.05 4.87 6.06 2.21 2.28 010
67715 A Incision of eyelid fold 1.24 3.90 5.00 1.20 1.27 0.06 5.20 6.30 2.50 2.57 010
67800 A Remove eyelid lesion 1.39 1.44 1.58 0.94 1.02 0.07 2.90 3.04 2.40 2.48 010
67801 A Remove eyelid lesions 1.89 1.74 1.91 1.13 1.23 0.09 3.72 3.89 3.11 3.21 010
67805 A Remove eyelid lesions 2.24 2.26 2.46 1.48 1.61 0.11 4.61 4.81 3.83 3.96 010
67808 A Remove eyelid lesion(s) 4.47 NA NA 3.74 3.76 0.19 NA NA 8.40 8.42 090
67810 A Biopsy of eyelid 1.48 3.96 3.49 0.70 0.69 0.06 5.50 5.03 2.24 2.23 000
67820 A Revise eyelashes 0.71 0.46 0.57 0.46 0.54 0.04 1.21 1.32 1.21 1.29 000
67825 A Revise eyelashes 1.40 1.45 1.66 1.31 1.39 0.07 2.92 3.13 2.78 2.86 010
67830 A Revise eyelashes 1.72 4.09 5.17 1.38 1.47 0.08 5.89 6.97 3.18 3.27 010
67835 A Revise eyelashes 5.61 NA NA 4.23 4.52 0.28 NA NA 10.12 10.41 090
67840 A Remove eyelid lesion 2.06 4.00 5.10 1.52 1.62 0.10 6.16 7.26 3.68 3.78 010
67850 A Treat eyelid lesion 1.71 3.31 3.36 1.47 1.47 0.07 5.09 5.14 3.25 3.25 010
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
67875 A Closure of eyelid by suture 1.35 2.44 3.09 0.87 0.92 0.07 3.86 4.51 2.29 2.34 000
67880 A Revision of eyelid 4.47 5.60 6.36 3.71 3.78 0.19 10.26 11.02 8.37 8.44 090
67882 A Revision of eyelid 5.87 6.59 7.37 4.66 4.77 0.25 12.71 13.49 10.78 10.89 090
67900 A Repair brow defect 6.69 7.56 8.69 4.78 5.13 0.38 14.63 15.76 11.85 12.20 090
67901 A Repair eyelid defect 7.47 9.29 6.37 5.53 5.43 0.54 17.30 14.38 13.54 13.44 090
67902 A Repair eyelid defect 9.68 NA NA 6.67 5.76 0.60 NA NA 16.95 16.04 090
67903 A Repair eyelid defect 6.42 6.86 8.89 4.54 5.27 0.47 13.75 15.78 11.43 12.16 090
67904 A Repair eyelid defect 7.83 8.45 9.34 5.61 5.33 0.41 16.69 17.58 13.85 13.57 090
67906 A Repair eyelid defect 6.84 NA NA 4.69 4.95 0.46 NA NA 11.99 12.25 090
67908 A Repair eyelid defect 5.19 5.74 6.41 4.30 5.08 0.28 11.21 11.88 9.77 10.55 090
67909 A Revise eyelid defect 5.46 6.42 7.63 4.37 4.81 0.31 12.19 13.40 10.14 10.58 090
67911 A Revise eyelid defect 7.38 NA NA 5.28 4.91 0.31 NA NA 12.97 12.60 090
67912 A Correction eyelid w/implant 6.23 13.17 17.49 4.80 5.35 0.28 19.68 24.00 11.31 11.86 090
67914 A Repair eyelid defect 3.70 4.89 5.98 2.79 2.99 0.19 8.78 9.87 6.68 6.88 090
67915 A Repair eyelid defect 3.21 4.54 5.62 2.59 2.75 0.16 7.91 8.99 5.96 6.12 090
67916 A Repair eyelid defect 5.37 6.56 7.68 4.31 4.65 0.28 12.21 13.33 9.96 10.30 090
67917 A Repair eyelid defect 6.08 6.95 8.08 4.60 4.95 0.36 13.39 14.52 11.04 11.39 090
67921 A Repair eyelid defect 3.42 4.76 5.83 2.67 2.84 0.17 8.35 9.42 6.26 6.43 090
67922 A Repair eyelid defect 3.09 4.45 5.55 2.53 2.70 0.15 7.69 8.79 5.77 5.94 090
67923 A Repair eyelid defect 5.94 6.66 7.76 4.52 4.86 0.30 12.90 14.00 10.76 11.10 090
67924 A Repair eyelid defect 5.84 7.14 8.48 4.25 4.57 0.30 13.28 14.62 10.39 10.71 090
67930 A Repair eyelid wound 3.62 4.51 5.41 1.88 2.10 0.19 8.32 9.22 5.69 5.91 010
67935 A Repair eyelid wound 6.27 6.99 8.14 3.77 4.25 0.39 13.65 14.80 10.43 10.91 090
67938 A Remove eyelid foreign body 1.35 3.94 5.02 1.27 1.26 0.06 5.35 6.43 2.68 2.67 010
67950 A Revision of eyelid 5.88 6.84 8.18 4.53 5.04 0.36 13.08 14.42 10.77 11.28 090
67961 A Revision of eyelid 5.75 7.04 8.27 4.49 4.90 0.33 13.12 14.35 10.57 10.98 090
67966 A Revision of eyelid 8.83 8.35 8.94 6.01 5.67 0.37 17.55 18.14 15.21 14.87 090
67971 A Reconstruction of eyelid 9.87 NA NA 6.49 7.08 0.53 NA NA 16.89 17.48 090
67973 A Reconstruction of eyelid 12.96 NA NA 8.14 9.02 0.75 NA NA 21.85 22.73 090
67974 A Reconstruction of eyelid 12.93 NA NA 8.16 8.96 0.75 NA NA 21.84 22.64 090
67975 A Reconstruction of eyelid 9.21 NA NA 6.25 6.78 0.50 NA NA 15.96 16.49 090
67999 C Revision of eyelid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
68020 A Incise/drain eyelid lining 1.39 1.28 1.38 1.10 1.18 0.06 2.73 2.83 2.55 2.63 010
68040 A Treatment of eyelid lesions 0.85 0.62 0.69 0.37 0.42 0.04 1.51 1.58 1.26 1.31 000
68100 A Biopsy of eyelid lining 1.35 2.40 3.04 0.89 0.94 0.07 3.82 4.46 2.31 2.36 000
68110 A Remove eyelid lining lesion 1.79 3.15 3.86 1.54 1.62 0.09 5.03 5.74 3.42 3.50 010
68115 A Remove eyelid lining lesion 2.38 4.44 5.58 1.76 1.87 0.12 6.94 8.08 4.26 4.37 010
68130 A Remove eyelid lining lesion 4.99 6.86 8.25 4.20 4.50 0.24 12.09 13.48 9.43 9.73 090
68135 A Remove eyelid lining lesion 1.86 1.64 1.77 1.53 1.62 0.09 3.59 3.72 3.48 3.57 010
68200 A Treat eyelid by injection 0.49 0.47 0.52 0.30 0.32 0.02 0.98 1.03 0.81 0.83 000
68320 A Revise/graft eyelid lining 6.44 9.44 10.82 5.52 5.52 0.27 16.15 17.53 12.23 12.23 090
68325 A Revise/graft eyelid lining 8.43 NA NA 6.23 6.46 0.44 NA NA 15.10 15.33 090
68326 A Revise/graft eyelid lining 8.22 NA NA 6.18 6.35 0.35 NA NA 14.75 14.92 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
68328 A Revise/graft eyelid lining 9.25 NA NA 6.74 7.15 0.54 NA NA 16.53 16.94 090
68330 A Revise eyelid lining 5.63 7.65 8.97 4.64 4.70 0.24 13.52 14.84 10.51 10.57 090
68335 A Revise/graft eyelid lining 8.26 NA NA 6.20 6.34 0.36 NA NA 14.82 14.96 090
68340 A Separate eyelid adhesions 4.84 7.08 8.42 4.02 4.08 0.21 12.13 13.47 9.07 9.13 090
68360 A Revise eyelid lining 5.04 6.62 7.69 4.11 4.16 0.22 11.88 12.95 9.37 9.42 090
68362 A Revise eyelid lining 8.41 NA NA 6.24 6.36 0.36 NA NA 15.01 15.13 090
68371 A Harvest eye tissue, alograft 4.97 NA NA 4.23 4.61 0.44 NA NA 9.64 10.02 010
68399 C Eyelid lining surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
68400 A Incise/drain tear gland 1.71 4.42 5.53 1.24 1.68 0.08 6.21 7.32 3.03 3.47 010
68420 A Incise/drain tear sac 2.32 4.69 5.82 1.48 1.95 0.11 7.12 8.25 3.91 4.38 010
68440 A Incise tear duct opening 0.96 1.28 1.88 1.22 1.26 0.05 2.29 2.89 2.23 2.27 010
68500 A Removal of tear gland 12.49 NA NA 9.07 9.57 0.55 NA NA 22.11 22.61 090
68505 A Partial removal, tear gland 12.41 NA NA 9.21 10.29 0.55 NA NA 22.17 23.25 090
68510 A Biopsy of tear gland 4.60 5.38 6.84 2.14 2.10 0.23 10.21 11.67 6.97 6.93 000
68520 A Removal of tear sac 8.58 NA NA 6.74 7.25 0.37 NA NA 15.69 16.20 090
68525 A Biopsy of tear sac 4.42 NA NA 1.68 1.94 0.22 NA NA 6.32 6.58 000
68530 A Clearance of tear duct 3.67 5.74 7.56 2.17 2.52 0.18 9.59 11.41 6.02 6.37 010
68540 A Remove tear gland lesion 11.93 NA NA 8.81 9.25 0.52 NA NA 21.26 21.70 090
68550 A Remove tear gland lesion 14.86 NA NA 10.64 11.17 0.80 NA NA 26.30 26.83 090
68700 A Repair tear ducts 7.67 NA NA 5.81 5.94 0.32 NA NA 13.80 13.93 090
68705 A Revise tear duct opening 2.08 3.12 3.91 1.65 1.76 0.10 5.30 6.09 3.83 3.94 010
68720 A Create tear sac drain 9.78 NA NA 7.18 7.69 0.44 NA NA 17.40 17.91 090
68745 A Create tear duct drain 9.70 NA NA 7.54 7.78 0.52 NA NA 17.76 18.00 090
68750 A Create tear duct drain 9.87 NA NA 7.72 8.13 0.43 NA NA 18.02 18.43 090
68760 A Close tear duct opening 1.75 2.66 3.32 1.51 1.60 0.09 4.50 5.16 3.35 3.44 010
68761 A Close tear duct opening 1.38 1.88 2.17 1.29 1.31 0.06 3.32 3.61 2.73 2.75 010
68770 A Close tear system fistula 8.09 NA NA 5.95 3.87 0.35 NA NA 14.39 12.31 090
68801 A Dilate tear duct opening 0.96 1.82 1.91 1.46 1.48 0.05 2.83 2.92 2.47 2.49 010
68810 A Probe nasolacrimal duct 2.63 3.50 3.62 2.78 2.70 0.10 6.23 6.35 5.51 5.43 010
68811 A Probe nasolacrimal duct 2.39 NA NA 2.19 2.36 0.13 NA NA 4.71 4.88 010
68815 A Probe nasolacrimal duct 3.24 6.56 7.82 2.52 2.74 0.17 9.97 11.23 5.93 6.15 010
68840 A Explore/irrigate tear ducts 1.27 1.56 1.59 1.33 1.17 0.06 2.89 2.92 2.66 2.50 010
68850 A Injection for tear sac x-ray 0.80 0.69 0.83 0.57 0.65 0.04 1.53 1.67 1.41 1.49 000
68899 C Tear duct system surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
69000 A Drain external ear lesion 1.47 2.71 2.84 1.26 1.34 0.12 4.30 4.43 2.85 2.93 010
69005 A Drain external ear lesion 2.13 2.76 2.89 1.48 1.74 0.17 5.06 5.19 3.78 4.04 010
69020 A Drain outer ear canal lesion 1.50 3.85 3.96 1.78 1.99 0.12 5.47 5.58 3.40 3.61 010
69090 N Pierce earlobes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
69100 A Biopsy of external ear 0.81 1.86 1.75 0.41 0.40 0.03 2.70 2.59 1.25 1.24 000
69105 A Biopsy of external ear canal 0.85 2.49 2.38 0.66 0.74 0.07 3.41 3.30 1.58 1.66 000
69110 A Remove external ear, partial 3.47 7.62 6.96 4.32 4.43 0.30 11.39 10.73 8.09 8.20 090
69120 A Removal of external ear 4.08 NA NA 5.11 5.91 0.38 NA NA 9.57 10.37 090
69140 A Remove ear canal lesion(s) 8.03 NA NA 12.39 13.06 0.65 NA NA 21.07 21.74 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
69145 A Remove ear canal lesion(s) 2.65 6.55 5.97 3.13 3.26 0.21 9.41 8.83 5.99 6.12 090
69150 A Extensive ear canal surgery 13.49 NA NA 10.66 12.72 1.22 NA NA 25.37 27.43 090
69155 A Extensive ear/neck surgery 23.06 NA NA 15.03 18.41 1.93 NA NA 40.02 43.40 090
69200 A Clear outer ear canal 0.77 2.03 2.29 0.57 0.56 0.06 2.86 3.12 1.40 1.39 000
69205 A Clear outer ear canal 1.20 NA NA 1.15 1.31 0.10 NA NA 2.45 2.61 010
69210 A Remove impacted ear wax 0.61 0.56 0.61 0.16 0.21 0.05 1.22 1.27 0.82 0.87 000
69220 A Clean out mastoid cavity 0.83 2.38 2.37 0.62 0.70 0.07 3.28 3.27 1.52 1.60 000
69222 A Clean out mastoid cavity 1.42 3.68 3.81 1.75 1.98 0.12 5.22 5.35 3.29 3.52 010
69300 R Revise external ear 6.69 9.77 5.61 4.69 4.34 0.72 17.18 13.02 12.10 11.75 YYY
69310 A Rebuild outer ear canal 10.85 NA NA 14.30 15.79 0.85 NA NA 26.00 27.49 090
69320 A Rebuild outer ear canal 17.03 NA NA 18.32 20.96 1.37 NA NA 36.72 39.36 090
69399 C Outer ear surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
69400 A Inflate middle ear canal 0.83 2.61 2.27 0.62 0.66 0.07 3.51 3.17 1.52 1.56 000
69401 A Inflate middle ear canal 0.63 1.47 1.30 0.56 0.63 0.05 2.15 1.98 1.24 1.31 000
69405 A Catheterize middle ear canal 2.65 3.41 3.48 1.81 2.19 0.21 6.27 6.34 4.67 5.05 010
69420 A Incision of eardrum 1.35 3.06 3.13 1.43 1.55 0.11 4.52 4.59 2.89 3.01 010
69421 A Incision of eardrum 1.75 NA NA 1.70 2.05 0.15 NA NA 3.60 3.95 010
69424 A Remove ventilating tube 0.85 2.18 2.18 0.62 0.67 0.07 3.10 3.10 1.54 1.59 000
69433 A Create eardrum opening 1.54 3.07 3.09 1.47 1.60 0.13 4.74 4.76 3.14 3.27 010
69436 A Create eardrum opening 1.98 NA NA 1.74 2.15 0.19 NA NA 3.91 4.32 010
69440 A Exploration of middle ear 7.62 NA NA 8.39 8.68 0.61 NA NA 16.62 16.91 090
69450 A Eardrum revision 5.61 NA NA 7.03 7.03 0.45 NA NA 13.09 13.09 090
69501 A Mastoidectomy 9.12 NA NA 7.90 8.73 0.73 NA NA 17.75 18.58 090
69502 A Mastoidectomy 12.44 NA NA 10.15 11.23 1.00 NA NA 23.59 24.67 090
69505 A Remove mastoid structures 13.05 NA NA 14.94 16.63 1.05 NA NA 29.04 30.73 090
69511 A Extensive mastoid surgery 13.58 NA NA 15.02 16.86 1.09 NA NA 29.69 31.53 090
69530 A Extensive mastoid surgery 20.24 NA NA 18.19 20.77 1.54 NA NA 39.97 42.55 090
69535 A Remove part of temporal bone 37.27 NA NA 24.53 30.10 2.93 NA NA 64.73 70.30 090
69540 A Remove ear lesion 1.22 3.63 3.71 1.72 1.91 0.10 4.95 5.03 3.04 3.23 010
69550 A Remove ear lesion 11.04 NA NA 13.17 14.44 0.89 NA NA 25.10 26.37 090
69552 A Remove ear lesion 19.69 NA NA 16.74 19.69 1.59 NA NA 38.02 40.97 090
69554 A Remove ear lesion 35.71 NA NA 22.78 28.44 2.92 NA NA 61.41 67.07 090
69601 A Mastoid surgery revision 13.31 NA NA 10.98 12.25 1.07 NA NA 25.36 26.63 090
69602 A Mastoid surgery revision 13.64 NA NA 11.71 12.85 1.10 NA NA 26.45 27.59 090
69603 A Mastoid surgery revision 14.08 NA NA 15.18 17.57 1.14 NA NA 30.40 32.79 090
69604 A Mastoid surgery revision 14.08 NA NA 11.82 13.22 1.14 NA NA 27.04 28.44 090
69605 A Mastoid surgery revision 18.55 NA NA 17.69 20.14 1.50 NA NA 37.74 40.19 090
69610 A Repair of eardrum 4.44 4.52 5.29 2.35 3.04 0.36 9.32 10.09 7.15 7.84 010
69620 A Repair of eardrum 5.94 10.10 10.87 5.36 6.06 0.48 16.52 17.29 11.78 12.48 090
69631 A Repair eardrum structures 9.93 NA NA 10.61 11.05 0.80 NA NA 21.34 21.78 090
69632 A Rebuild eardrum structures 12.82 NA NA 12.22 13.16 1.03 NA NA 26.07 27.01 090
69633 A Rebuild eardrum structures 12.17 NA NA 12.04 12.80 0.98 NA NA 25.19 25.95 090
69635 A Repair eardrum structures 13.39 NA NA 14.97 16.30 1.08 NA NA 29.44 30.77 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
69636 A Rebuild eardrum structures 15.29 NA NA 16.76 18.67 1.23 NA NA 33.28 35.19 090
69637 A Rebuild eardrum structures 15.18 NA NA 16.73 18.60 1.22 NA NA 33.13 35.00 090
69641 A Revise middle ear mastoid 12.77 NA NA 11.45 12.45 1.03 NA NA 25.25 26.25 090
69642 A Revise middle ear mastoid 16.91 NA NA 14.23 15.77 1.36 NA NA 32.50 34.04 090
69643 A Revise middle ear mastoid 15.45 NA NA 12.98 14.36 1.24 NA NA 29.67 31.05 090
69644 A Revise middle ear mastoid 17.09 NA NA 17.27 19.62 1.37 NA NA 35.73 38.08 090
69645 A Revise middle ear mastoid 16.57 NA NA 17.17 19.31 1.33 NA NA 35.07 37.21 090
69646 A Revise middle ear mastoid 18.23 NA NA 17.60 19.97 1.46 NA NA 37.29 39.66 090
69650 A Release middle ear bone 9.71 NA NA 8.74 9.62 0.78 NA NA 19.23 20.11 090
69660 A Revise middle ear bone 11.94 NA NA 9.64 10.80 0.96 NA NA 22.54 23.70 090
69661 A Revise middle ear bone 15.80 NA NA 12.34 14.11 1.27 NA NA 29.41 31.18 090
69662 A Revise middle ear bone 15.49 NA NA 11.45 13.18 1.25 NA NA 28.19 29.92 090
69666 A Repair middle ear structures 9.80 NA NA 9.02 9.73 0.79 NA NA 19.61 20.32 090
69667 A Repair middle ear structures 9.81 NA NA 8.93 9.72 0.79 NA NA 19.53 20.32 090
69670 A Remove mastoid air cells 11.62 NA NA 10.27 11.35 0.93 NA NA 22.82 23.90 090
69676 A Remove middle ear nerve 9.58 NA NA 9.74 10.50 0.81 NA NA 20.13 20.89 090
69700 A Close mastoid fistula 8.28 NA NA 7.75 8.87 0.67 NA NA 16.70 17.82 090
69710 N Implant/replace hearing aid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
69711 A Remove/repair hearing aid 10.50 NA NA 9.54 10.48 0.83 NA NA 20.87 21.81 090
69714 A Implant temple bone w/stimul 14.31 NA NA 10.72 12.18 1.13 NA NA 26.16 27.62 090
69715 A Temple bne implnt w/stimulat 18.80 NA NA 12.14 14.31 1.48 NA NA 32.42 34.59 090
69717 A Temple bone implant revision 15.29 NA NA 11.42 13.71 0.90 NA NA 27.61 29.90 090
69718 A Revise temple bone implant 19.05 NA NA 20.38 16.57 3.22 NA NA 42.65 38.84 090
69720 A Release facial nerve 14.57 NA NA 12.90 14.12 1.16 NA NA 28.63 29.85 090
69725 A Release facial nerve 27.44 NA NA 16.59 19.25 2.45 NA NA 46.48 49.14 090
69740 A Repair facial nerve 16.18 NA NA 11.32 12.89 1.27 NA NA 28.77 30.34 090
69745 A Repair facial nerve 16.91 NA NA 12.06 14.24 1.14 NA NA 30.11 32.29 090
69799 C Middle ear surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
69801 A Incise inner ear 8.61 NA NA 8.84 9.31 0.69 NA NA 18.14 18.61 090
69802 A Incise inner ear 13.39 NA NA 10.68 11.91 1.06 NA NA 25.13 26.36 090
69805 A Explore inner ear 14.55 NA NA 9.96 11.40 1.12 NA NA 25.63 27.07 090
69806 A Explore inner ear 12.52 NA NA 9.50 10.66 1.00 NA NA 23.02 24.18 090
69820 A Establish inner ear window 10.40 NA NA 9.91 10.89 0.90 NA NA 21.21 22.19 090
69840 A Revise inner ear window 10.32 NA NA 11.73 12.81 0.79 NA NA 22.84 23.92 090
69905 A Remove inner ear 11.15 NA NA 10.20 11.06 0.90 NA NA 22.25 23.11 090
69910 A Remove inner ear mastoid 13.80 NA NA 9.94 11.43 1.07 NA NA 24.81 26.30 090
69915 A Incise inner ear nerve 22.65 NA NA 13.59 15.74 1.70 NA NA 37.94 40.09 090
69930 A Implant cochlear device 17.60 NA NA 11.99 14.06 1.36 NA NA 30.95 33.02 090
69949 C Inner ear surgery procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
69950 A Incise inner ear nerve 27.44 NA NA 15.54 18.06 2.29 NA NA 45.27 47.79 090
69955 A Release facial nerve 29.22 NA NA 17.57 20.43 2.49 NA NA 49.28 52.14 090
69960 A Release inner ear canal 29.22 NA NA 15.70 18.96 2.18 NA NA 47.10 50.36 090
69970 A Remove inner ear lesion 32.21 NA NA 18.08 21.97 2.42 NA NA 52.71 56.60 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
69979 C Temporal bone surgery 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
69990 R Microsurgery add-on 3.46 NA NA 1.31 1.67 0.89 NA NA 5.66 6.02 ZZZ
70010 A Contrast x-ray of brain 1.19 2.61 4.20 NA NA 0.27 4.07 5.66 NA NA XXX
70010 TC A Contrast x-ray of brain 0.00 2.27 3.82 NA NA 0.22 2.49 4.04 NA NA XXX
70010 26 A Contrast x-ray of brain 1.19 0.34 0.38 0.34 0.38 0.05 1.58 1.62 1.58 1.62 XXX
70015 A Contrast x-ray of brain 1.19 2.68 1.98 NA NA 0.16 4.03 3.33 NA NA XXX
70015 TC A Contrast x-ray of brain 0.00 2.33 1.60 NA NA 0.08 2.41 1.68 NA NA XXX
70015 26 A Contrast x-ray of brain 1.19 0.35 0.38 0.35 0.38 0.08 1.62 1.65 1.62 1.65 XXX
70030 A X-ray eye for foreign body 0.17 0.57 0.51 NA NA 0.03 0.77 0.71 NA NA XXX
70030 TC A X-ray eye for foreign body 0.00 0.52 0.45 NA NA 0.02 0.54 0.47 NA NA XXX
70030 26 A X-ray eye for foreign body 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
70100 A X-ray exam of jaw 0.18 0.59 0.59 NA NA 0.03 0.80 0.80 NA NA XXX
70100 TC A X-ray exam of jaw 0.00 0.55 0.53 NA NA 0.02 0.57 0.55 NA NA XXX
70100 26 A X-ray exam of jaw 0.18 0.04 0.06 0.04 0.06 0.01 0.23 0.25 0.23 0.25 XXX
70110 A X-ray exam of jaw 0.25 0.75 0.72 NA NA 0.05 1.05 1.02 NA NA XXX
70110 TC A X-ray exam of jaw 0.00 0.68 0.64 NA NA 0.04 0.72 0.68 NA NA XXX
70110 26 A X-ray exam of jaw 0.25 0.07 0.08 0.07 0.08 0.01 0.33 0.34 0.33 0.34 XXX
70120 A X-ray exam of mastoids 0.18 0.66 0.68 NA NA 0.05 0.89 0.91 NA NA XXX
70120 TC A X-ray exam of mastoids 0.00 0.61 0.62 NA NA 0.04 0.65 0.66 NA NA XXX
70120 26 A X-ray exam of mastoids 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
70130 A X-ray exam of mastoids 0.34 1.10 0.95 NA NA 0.07 1.51 1.36 NA NA XXX
70130 TC A X-ray exam of mastoids 0.00 1.00 0.84 NA NA 0.05 1.05 0.89 NA NA XXX
70130 26 A X-ray exam of mastoids 0.34 0.10 0.11 0.10 0.11 0.02 0.46 0.47 0.46 0.47 XXX
70134 A X-ray exam of middle ear 0.34 0.88 0.85 NA NA 0.07 1.29 1.26 NA NA XXX
70134 TC A X-ray exam of middle ear 0.00 0.78 0.74 NA NA 0.05 0.83 0.79 NA NA XXX
70134 26 A X-ray exam of middle ear 0.34 0.10 0.11 0.10 0.11 0.02 0.46 0.47 0.46 0.47 XXX
70140 A X-ray exam of facial bones 0.19 0.51 0.64 NA NA 0.05 0.75 0.88 NA NA XXX
70140 TC A X-ray exam of facial bones 0.00 0.47 0.58 NA NA 0.04 0.51 0.62 NA NA XXX
70140 26 A X-ray exam of facial bones 0.19 0.04 0.06 0.04 0.06 0.01 0.24 0.26 0.24 0.26 XXX
70150 A X-ray exam of facial bones 0.26 0.80 0.85 NA NA 0.06 1.12 1.17 NA NA XXX
70150 TC A X-ray exam of facial bones 0.00 0.73 0.77 NA NA 0.05 0.78 0.82 NA NA XXX
70150 26 A X-ray exam of facial bones 0.26 0.07 0.08 0.07 0.08 0.01 0.34 0.35 0.34 0.35 XXX
70160 A X-ray exam of nasal bones 0.17 0.65 0.60 NA NA 0.03 0.85 0.80 NA NA XXX
70160 TC A X-ray exam of nasal bones 0.00 0.61 0.54 NA NA 0.02 0.63 0.56 NA NA XXX
70160 26 A X-ray exam of nasal bones 0.17 0.04 0.06 0.04 0.06 0.01 0.22 0.24 0.22 0.24 XXX
70170 C X-ray exam of tear duct 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
70170 TC C X-ray exam of tear duct 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
70170 26 A X-ray exam of tear duct 0.30 0.08 0.10 0.08 0.10 0.01 0.39 0.41 0.39 0.41 XXX
70190 A X-ray exam of eye sockets 0.21 0.68 0.69 NA NA 0.05 0.94 0.95 NA NA XXX
70190 TC A X-ray exam of eye sockets 0.00 0.62 0.62 NA NA 0.04 0.66 0.66 NA NA XXX
70190 26 A X-ray exam of eye sockets 0.21 0.06 0.07 0.06 0.07 0.01 0.28 0.29 0.28 0.29 XXX
70200 A X-ray exam of eye sockets 0.28 0.82 0.86 NA NA 0.06 1.16 1.20 NA NA XXX
70200 TC A X-ray exam of eye sockets 0.00 0.74 0.77 NA NA 0.05 0.79 0.82 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
70200 26 A X-ray exam of eye sockets 0.28 0.08 0.09 0.08 0.09 0.01 0.37 0.38 0.37 0.38 XXX
70210 A X-ray exam of sinuses 0.17 0.55 0.65 NA NA 0.05 0.77 0.87 NA NA XXX
70210 TC A X-ray exam of sinuses 0.00 0.51 0.59 NA NA 0.04 0.55 0.63 NA NA XXX
70210 26 A X-ray exam of sinuses 0.17 0.04 0.06 0.04 0.06 0.01 0.22 0.24 0.22 0.24 XXX
70220 A X-ray exam of sinuses 0.25 0.69 0.82 NA NA 0.06 1.00 1.13 NA NA XXX
70220 TC A X-ray exam of sinuses 0.00 0.62 0.74 NA NA 0.05 0.67 0.79 NA NA XXX
70220 26 A X-ray exam of sinuses 0.25 0.07 0.08 0.07 0.08 0.01 0.33 0.34 0.33 0.34 XXX
70240 A X-ray exam, pituitary saddle 0.19 0.58 0.51 NA NA 0.03 0.80 0.73 NA NA XXX
70240 TC A X-ray exam, pituitary saddle 0.00 0.53 0.45 NA NA 0.02 0.55 0.47 NA NA XXX
70240 26 A X-ray exam, pituitary saddle 0.19 0.05 0.06 0.05 0.06 0.01 0.25 0.26 0.25 0.26 XXX
70250 A X-ray exam of skull 0.24 0.66 0.70 NA NA 0.05 0.95 0.99 NA NA XXX
70250 TC A X-ray exam of skull 0.00 0.60 0.62 NA NA 0.04 0.64 0.66 NA NA XXX
70250 26 A X-ray exam of skull 0.24 0.06 0.08 0.06 0.08 0.01 0.31 0.33 0.31 0.33 XXX
70260 A X-ray exam of skull 0.34 0.83 0.96 NA NA 0.08 1.25 1.38 NA NA XXX
70260 TC A X-ray exam of skull 0.00 0.74 0.85 NA NA 0.06 0.80 0.91 NA NA XXX
70260 26 A X-ray exam of skull 0.34 0.09 0.11 0.09 0.11 0.02 0.45 0.47 0.45 0.47 XXX
70300 A X-ray exam of teeth 0.10 0.24 0.30 NA NA 0.03 0.37 0.43 NA NA XXX
70300 TC A X-ray exam of teeth 0.00 0.21 0.25 NA NA 0.02 0.23 0.27 NA NA XXX
70300 26 A X-ray exam of teeth 0.10 0.03 0.05 0.03 0.05 0.01 0.14 0.16 0.14 0.16 XXX
70310 A X-ray exam of teeth 0.16 0.82 0.58 NA NA 0.03 1.01 0.77 NA NA XXX
70310 TC A X-ray exam of teeth 0.00 0.77 0.51 NA NA 0.02 0.79 0.53 NA NA XXX
70310 26 A X-ray exam of teeth 0.16 0.05 0.07 0.05 0.07 0.01 0.22 0.24 0.22 0.24 XXX
70320 A Full mouth x-ray of teeth 0.22 0.96 0.89 NA NA 0.06 1.24 1.17 NA NA XXX
70320 TC A Full mouth x-ray of teeth 0.00 0.90 0.81 NA NA 0.05 0.95 0.86 NA NA XXX
70320 26 A Full mouth x-ray of teeth 0.22 0.06 0.08 0.06 0.08 0.01 0.29 0.31 0.29 0.31 XXX
70328 A X-ray exam of jaw joint 0.18 0.59 0.56 NA NA 0.03 0.80 0.77 NA NA XXX
70328 TC A X-ray exam of jaw joint 0.00 0.54 0.50 NA NA 0.02 0.56 0.52 NA NA XXX
70328 26 A X-ray exam of jaw joint 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
70330 A X-ray exam of jaw joints 0.24 0.96 0.93 NA NA 0.06 1.26 1.23 NA NA XXX
70330 TC A X-ray exam of jaw joints 0.00 0.89 0.85 NA NA 0.05 0.94 0.90 NA NA XXX
70330 26 A X-ray exam of jaw joints 0.24 0.07 0.08 0.07 0.08 0.01 0.32 0.33 0.32 0.33 XXX
70332 A X-ray exam of jaw joint 0.54 1.42 2.08 NA NA 0.14 2.10 2.76 NA NA XXX
70332 TC A X-ray exam of jaw joint 0.00 1.26 1.89 NA NA 0.12 1.38 2.01 NA NA XXX
70332 26 A X-ray exam of jaw joint 0.54 0.16 0.19 0.16 0.19 0.02 0.72 0.75 0.72 0.75 XXX
70336 A Magnetic image, jaw joint 1.48 11.62 11.67 NA NA 0.66 13.76 13.81 NA NA XXX
70336 TC A Magnetic image, jaw joint 0.00 11.20 11.20 NA NA 0.59 11.79 11.79 NA NA XXX
70336 26 A Magnetic image, jaw joint 1.48 0.42 0.47 0.42 0.47 0.07 1.97 2.02 1.97 2.02 XXX
70350 A X-ray head for orthodontia 0.17 0.32 0.42 NA NA 0.03 0.52 0.62 NA NA XXX
70350 TC A X-ray head for orthodontia 0.00 0.27 0.35 NA NA 0.02 0.29 0.37 NA NA XXX
70350 26 A X-ray head for orthodontia 0.17 0.05 0.07 0.05 0.07 0.01 0.23 0.25 0.23 0.25 XXX
70355 A Panoramic x-ray of jaws 0.20 0.29 0.56 NA NA 0.05 0.54 0.81 NA NA XXX
70355 TC A Panoramic x-ray of jaws 0.00 0.23 0.49 NA NA 0.04 0.27 0.53 NA NA XXX
70355 26 A Panoramic x-ray of jaws 0.20 0.06 0.07 0.06 0.07 0.01 0.27 0.28 0.27 0.28 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
70360 A X-ray exam of neck 0.17 0.53 0.50 NA NA 0.03 0.73 0.70 NA NA XXX
70360 TC A X-ray exam of neck 0.00 0.48 0.44 NA NA 0.02 0.50 0.46 NA NA XXX
70360 26 A X-ray exam of neck 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
70370 A Throat x-ray fluoroscopy 0.32 1.59 1.46 NA NA 0.08 1.99 1.86 NA NA XXX
70370 TC A Throat x-ray fluoroscopy 0.00 1.50 1.36 NA NA 0.07 1.57 1.43 NA NA XXX
70370 26 A Throat x-ray fluoroscopy 0.32 0.09 0.10 0.09 0.10 0.01 0.42 0.43 0.42 0.43 XXX
70371 A Speech evaluation, complex 0.84 1.40 2.14 NA NA 0.16 2.40 3.14 NA NA XXX
70371 TC A Speech evaluation, complex 0.00 1.17 1.87 NA NA 0.12 1.29 1.99 NA NA XXX
70371 26 A Speech evaluation, complex 0.84 0.23 0.27 0.23 0.27 0.04 1.11 1.15 1.11 1.15 XXX
70373 A Contrast x-ray of larynx 0.44 1.57 1.83 NA NA 0.13 2.14 2.40 NA NA XXX
70373 TC A Contrast x-ray of larynx 0.00 1.46 1.70 NA NA 0.11 1.57 1.81 NA NA XXX
70373 26 A Contrast x-ray of larynx 0.44 0.11 0.13 0.11 0.13 0.02 0.57 0.59 0.57 0.59 XXX
70380 A X-ray exam of salivary gland 0.17 0.80 0.75 NA NA 0.05 1.02 0.97 NA NA XXX
70380 TC A X-ray exam of salivary gland 0.00 0.75 0.69 NA NA 0.04 0.79 0.73 NA NA XXX
70380 26 A X-ray exam of salivary gland 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
70390 A X-ray exam of salivary duct 0.38 2.20 1.98 NA NA 0.13 2.71 2.49 NA NA XXX
70390 TC A X-ray exam of salivary duct 0.00 2.09 1.86 NA NA 0.11 2.20 1.97 NA NA XXX
70390 26 A X-ray exam of salivary duct 0.38 0.11 0.12 0.11 0.12 0.02 0.51 0.52 0.51 0.52 XXX
70450 A Ct head/brain w/o dye 0.85 4.62 4.91 NA NA 0.29 5.76 6.05 NA NA XXX
70450 TC A Ct head/brain w/o dye 0.00 4.38 4.64 NA NA 0.25 4.63 4.89 NA NA XXX
70450 26 A Ct head/brain w/o dye 0.85 0.24 0.27 0.24 0.27 0.04 1.13 1.16 1.13 1.16 XXX
70460 A Ct head/brain w/dye 1.13 6.14 6.06 NA NA 0.35 7.62 7.54 NA NA XXX
70460 TC A Ct head/brain w/dye 0.00 5.82 5.70 NA NA 0.30 6.12 6.00 NA NA XXX
70460 26 A Ct head/brain w/dye 1.13 0.32 0.36 0.32 0.36 0.05 1.50 1.54 1.50 1.54 XXX
70470 A Ct head/brain w/o w/dye 1.27 7.48 7.49 NA NA 0.43 9.18 9.19 NA NA XXX
70470 TC A Ct head/brain w/o w/dye 0.00 7.12 7.08 NA NA 0.37 7.49 7.45 NA NA XXX
70470 26 A Ct head/brain w/o w/dye 1.27 0.36 0.41 0.36 0.41 0.06 1.69 1.74 1.69 1.74 XXX
70480 A Ct orbit/ear/fossa w/o dye 1.28 7.99 5.86 NA NA 0.31 9.58 7.45 NA NA XXX
70480 TC A Ct orbit/ear/fossa w/o dye 0.00 7.63 5.45 NA NA 0.25 7.88 5.70 NA NA XXX
70480 26 A Ct orbit/ear/fossa w/o dye 1.28 0.36 0.41 0.36 0.41 0.06 1.70 1.75 1.70 1.75 XXX
70481 A Ct orbit/ear/fossa w/dye 1.38 9.43 6.95 NA NA 0.36 11.17 8.69 NA NA XXX
70481 TC A Ct orbit/ear/fossa w/dye 0.00 9.04 6.51 NA NA 0.30 9.34 6.81 NA NA XXX
70481 26 A Ct orbit/ear/fossa w/dye 1.38 0.39 0.44 0.39 0.44 0.06 1.83 1.88 1.83 1.88 XXX
70482 A Ct orbit/ear/fossa w/ow/dye 1.45 10.81 8.36 NA NA 0.43 12.69 10.24 NA NA XXX
70482 TC A Ct orbit/ear/fossa w/ow/dye 0.00 10.40 7.90 NA NA 0.37 10.77 8.27 NA NA XXX
70482 26 A Ct orbit/ear/fossa w/ow/dye 1.45 0.41 0.46 0.41 0.46 0.06 1.92 1.97 1.92 1.97 XXX
70486 A Ct maxillofacial w/o dye 1.14 6.39 5.42 NA NA 0.30 7.83 6.86 NA NA XXX
70486 TC A Ct maxillofacial w/o dye 0.00 6.07 5.06 NA NA 0.25 6.32 5.31 NA NA XXX
70486 26 A Ct maxillofacial w/o dye 1.14 0.32 0.36 0.32 0.36 0.05 1.51 1.55 1.51 1.55 XXX
70487 A Ct maxillofacial w/dye 1.30 7.89 6.55 NA NA 0.36 9.55 8.21 NA NA XXX
70487 TC A Ct maxillofacial w/dye 0.00 7.52 6.13 NA NA 0.30 7.82 6.43 NA NA XXX
70487 26 A Ct maxillofacial w/dye 1.30 0.37 0.42 0.37 0.42 0.06 1.73 1.78 1.73 1.78 XXX
70488 A Ct maxillofacial w/o w/dye 1.42 9.81 8.11 NA NA 0.43 11.66 9.96 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
70488 TC A Ct maxillofacial w/o w/dye 0.00 9.41 7.66 NA NA 0.37 9.78 8.03 NA NA XXX
70488 26 A Ct maxillofacial w/o w/dye 1.42 0.40 0.45 0.40 0.45 0.06 1.88 1.93 1.88 1.93 XXX
70490 A Ct soft tissue neck w/o dye 1.28 6.12 5.39 NA NA 0.31 7.71 6.98 NA NA XXX
70490 TC A Ct soft tissue neck w/o dye 0.00 5.75 4.98 NA NA 0.25 6.00 5.23 NA NA XXX
70490 26 A Ct soft tissue neck w/o dye 1.28 0.37 0.41 0.37 0.41 0.06 1.71 1.75 1.71 1.75 XXX
70491 A Ct soft tissue neck w/dye 1.38 7.58 6.48 NA NA 0.36 9.32 8.22 NA NA XXX
70491 TC A Ct soft tissue neck w/dye 0.00 7.19 6.04 NA NA 0.30 7.49 6.34 NA NA XXX
70491 26 A Ct soft tissue neck w/dye 1.38 0.39 0.44 0.39 0.44 0.06 1.83 1.88 1.83 1.88 XXX
70492 A Ct sft tsue nck w/o w/dye 1.45 9.50 8.04 NA NA 0.43 11.38 9.92 NA NA XXX
70492 TC A Ct sft tsue nck w/o w/dye 0.00 9.09 7.58 NA NA 0.37 9.46 7.95 NA NA XXX
70492 26 A Ct sft tsue nck w/o w/dye 1.45 0.41 0.46 0.41 0.46 0.06 1.92 1.97 1.92 1.97 XXX
70496 A Ct angiography, head 1.75 16.19 12.43 NA NA 0.66 18.60 14.84 NA NA XXX
70496 TC A Ct angiography, head 0.00 15.68 11.87 NA NA 0.58 16.26 12.45 NA NA XXX
70496 26 A Ct angiography, head 1.75 0.51 0.56 0.51 0.56 0.08 2.34 2.39 2.34 2.39 XXX
70498 A Ct angiography, neck 1.75 16.29 12.45 NA NA 0.66 18.70 14.86 NA NA XXX
70498 TC A Ct angiography, neck 0.00 15.77 11.89 NA NA 0.58 16.35 12.47 NA NA XXX
70498 26 A Ct angiography, neck 1.75 0.52 0.56 0.52 0.56 0.08 2.35 2.39 2.35 2.39 XXX
70540 A Mri orbit/face/neck w/o dye 1.35 13.49 12.11 NA NA 0.45 15.29 13.91 NA NA XXX
70540 TC A Mri orbit/face/neck w/o dye 0.00 13.11 11.68 NA NA 0.39 13.50 12.07 NA NA XXX
70540 26 A Mri orbit/face/neck w/o dye 1.35 0.38 0.43 0.38 0.43 0.06 1.79 1.84 1.79 1.84 XXX
70542 A Mri orbit/face/neck w/dye 1.62 14.46 14.09 NA NA 0.54 16.62 16.25 NA NA XXX
70542 TC A Mri orbit/face/neck w/dye 0.00 14.00 13.58 NA NA 0.47 14.47 14.05 NA NA XXX
70542 26 A Mri orbit/face/neck w/dye 1.62 0.46 0.51 0.46 0.51 0.07 2.15 2.20 2.15 2.20 XXX
70543 A Mri orbt/fac/nck w/o w/dye 2.15 17.82 23.65 NA NA 0.94 20.91 26.74 NA NA XXX
70543 TC A Mri orbt/fac/nck w/o w/dye 0.00 17.21 22.96 NA NA 0.84 18.05 23.80 NA NA XXX
70543 26 A Mri orbt/fac/nck w/o w/dye 2.15 0.61 0.69 0.61 0.69 0.10 2.86 2.94 2.86 2.94 XXX
70544 A Mr angiography head w/o dye 1.20 15.03 12.46 NA NA 0.64 16.87 14.30 NA NA XXX
70544 TC A Mr angiography head w/o dye 0.00 14.69 12.07 NA NA 0.59 15.28 12.66 NA NA XXX
70544 26 A Mr angiography head w/o dye 1.20 0.34 0.39 0.34 0.39 0.05 1.59 1.64 1.59 1.64 XXX
70545 A Mr angiography head w/dye 1.20 14.98 12.44 NA NA 0.64 16.82 14.28 NA NA XXX
70545 TC A Mr angiography head w/dye 0.00 14.64 12.06 NA NA 0.59 15.23 12.65 NA NA XXX
70545 26 A Mr angiography head w/dye 1.20 0.34 0.38 0.34 0.38 0.05 1.59 1.63 1.59 1.63 XXX
70546 A Mr angiograph head w/ow/dye 1.80 22.88 22.97 NA NA 0.67 25.35 25.44 NA NA XXX
70546 TC A Mr angiograph head w/ow/dye 0.00 22.37 22.40 NA NA 0.59 22.96 22.99 NA NA XXX
70546 26 A Mr angiograph head w/ow/dye 1.80 0.51 0.57 0.51 0.57 0.08 2.39 2.45 2.39 2.45 XXX
70547 A Mr angiography neck w/o dye 1.20 15.01 12.45 NA NA 0.64 16.85 14.29 NA NA XXX
70547 TC A Mr angiography neck w/o dye 0.00 14.67 12.07 NA NA 0.59 15.26 12.66 NA NA XXX
70547 26 A Mr angiography neck w/o dye 1.20 0.34 0.38 0.34 0.38 0.05 1.59 1.63 1.59 1.63 XXX
70548 A Mr angiography neck w/dye 1.20 15.81 12.65 NA NA 0.64 17.65 14.49 NA NA XXX
70548 TC A Mr angiography neck w/dye 0.00 15.47 12.27 NA NA 0.59 16.06 12.86 NA NA XXX
70548 26 A Mr angiography neck w/dye 1.20 0.34 0.38 0.34 0.38 0.05 1.59 1.63 1.59 1.63 XXX
70549 A Mr angiograph neck w/ow/dye 1.80 22.85 22.96 NA NA 0.67 25.32 25.43 NA NA XXX
70549 TC A Mr angiograph neck w/ow/dye 0.00 22.34 22.39 NA NA 0.59 22.93 22.98 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
70549 26 A Mr angiograph neck w/ow/dye 1.80 0.51 0.57 0.51 0.57 0.08 2.39 2.45 2.39 2.45 XXX
70551 A Mri brain w/o dye 1.48 13.72 12.20 NA NA 0.66 15.86 14.34 NA NA XXX
70551 TC A Mri brain w/o dye 0.00 13.30 11.73 NA NA 0.59 13.89 12.32 NA NA XXX
70551 26 A Mri brain w/o dye 1.48 0.42 0.47 0.42 0.47 0.07 1.97 2.02 1.97 2.02 XXX
70552 A Mri brain w/dye 1.78 14.76 14.22 NA NA 0.78 17.32 16.78 NA NA XXX
70552 TC A Mri brain w/dye 0.00 14.26 13.65 NA NA 0.70 14.96 14.35 NA NA XXX
70552 26 A Mri brain w/dye 1.78 0.50 0.57 0.50 0.57 0.08 2.36 2.43 2.36 2.43 XXX
70553 A Mri brain w/o w/dye 2.36 17.15 23.53 NA NA 1.41 20.92 27.30 NA NA XXX
70553 TC A Mri brain w/o w/dye 0.00 16.48 22.78 NA NA 1.31 17.79 24.09 NA NA XXX
70553 26 A Mri brain w/o w/dye 2.36 0.67 0.75 0.67 0.75 0.10 3.13 3.21 3.13 3.21 XXX
70554 A Fmri brain by tech 2.11 13.49 13.49 NA NA 0.92 16.52 16.52 NA NA XXX
70554 TC A Fmri brain by tech 0.00 12.89 12.89 NA NA 0.82 13.71 13.71 NA NA XXX
70554 26 A Fmri brain by tech 2.11 0.60 0.60 0.60 0.60 0.10 2.81 2.81 2.81 2.81 XXX
70555 C Fmri brain by phys/psych 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
70555 TC C Fmri brain by phys/psych 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70555 26 A Fmri brain by phys/psych 2.54 0.72 0.72 0.72 0.72 0.11 3.37 3.37 3.37 3.37 XXX
70557 C Mri brain w/o dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70557 TC C Mri brain w/o dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70557 26 A Mri brain w/o dye 2.90 0.84 1.06 0.84 1.06 0.08 3.82 4.04 3.82 4.04 XXX
70558 C Mri brain w/dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70558 TC C Mri brain w/dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70558 26 A Mri brain w/dye 3.20 1.02 1.19 1.02 1.19 0.10 4.32 4.49 4.32 4.49 XXX
70559 C Mri brain w/o w/dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70559 TC C Mri brain w/o w/dye 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
70559 26 A Mri brain w/o w/dye 3.20 0.95 1.17 0.95 1.17 0.12 4.27 4.49 4.27 4.49 XXX
71010 A Chest x-ray 0.18 0.40 0.50 NA NA 0.03 0.61 0.71 NA NA XXX
71010 TC A Chest x-ray 0.00 0.35 0.44 NA NA 0.02 0.37 0.46 NA NA XXX
71010 26 A Chest x-ray 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
71015 A Chest x-ray 0.21 0.54 0.58 NA NA 0.03 0.78 0.82 NA NA XXX
71015 TC A Chest x-ray 0.00 0.48 0.51 NA NA 0.02 0.50 0.53 NA NA XXX
71015 26 A Chest x-ray 0.21 0.06 0.07 0.06 0.07 0.01 0.28 0.29 0.28 0.29 XXX
71020 A Chest x-ray 0.22 0.54 0.66 NA NA 0.05 0.81 0.93 NA NA XXX
71020 TC A Chest x-ray 0.00 0.48 0.59 NA NA 0.04 0.52 0.63 NA NA XXX
71020 26 A Chest x-ray 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
71021 A Chest x-ray 0.27 0.67 0.79 NA NA 0.06 1.00 1.12 NA NA XXX
71021 TC A Chest x-ray 0.00 0.60 0.70 NA NA 0.05 0.65 0.75 NA NA XXX
71021 26 A Chest x-ray 0.27 0.07 0.09 0.07 0.09 0.01 0.35 0.37 0.35 0.37 XXX
71022 A Chest x-ray 0.31 0.84 0.84 NA NA 0.06 1.21 1.21 NA NA XXX
71022 TC A Chest x-ray 0.00 0.76 0.74 NA NA 0.05 0.81 0.79 NA NA XXX
71022 26 A Chest x-ray 0.31 0.08 0.10 0.08 0.10 0.01 0.40 0.42 0.40 0.42 XXX
71023 A Chest x-ray and fluoroscopy 0.38 1.53 1.06 NA NA 0.06 1.97 1.50 NA NA XXX
71023 TC A Chest x-ray and fluoroscopy 0.00 1.39 0.93 NA NA 0.05 1.44 0.98 NA NA XXX
71023 26 A Chest x-ray and fluoroscopy 0.38 0.14 0.13 0.14 0.13 0.01 0.53 0.52 0.53 0.52 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
71030 A Chest x-ray 0.31 0.87 0.88 NA NA 0.06 1.24 1.25 NA NA XXX
71030 TC A Chest x-ray 0.00 0.78 0.78 NA NA 0.05 0.83 0.83 NA NA XXX
71030 26 A Chest x-ray 0.31 0.09 0.10 0.09 0.10 0.01 0.41 0.42 0.41 0.42 XXX
71034 A Chest x-ray and fluoroscopy 0.46 1.96 1.69 NA NA 0.10 2.52 2.25 NA NA XXX
71034 TC A Chest x-ray and fluoroscopy 0.00 1.79 1.53 NA NA 0.08 1.87 1.61 NA NA XXX
71034 26 A Chest x-ray and fluoroscopy 0.46 0.17 0.16 0.17 0.16 0.02 0.65 0.64 0.65 0.64 XXX
71035 A Chest x-ray 0.18 0.72 0.62 NA NA 0.03 0.93 0.83 NA NA XXX
71035 TC A Chest x-ray 0.00 0.67 0.56 NA NA 0.02 0.69 0.58 NA NA XXX
71035 26 A Chest x-ray 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
71040 A Contrast x-ray of bronchi 0.58 1.99 1.74 NA NA 0.11 2.68 2.43 NA NA XXX
71040 TC A Contrast x-ray of bronchi 0.00 1.84 1.56 NA NA 0.08 1.92 1.64 NA NA XXX
71040 26 A Contrast x-ray of bronchi 0.58 0.15 0.18 0.15 0.18 0.03 0.76 0.79 0.76 0.79 XXX
71060 A Contrast x-ray of bronchi 0.74 2.91 2.56 NA NA 0.16 3.81 3.46 NA NA XXX
71060 TC A Contrast x-ray of bronchi 0.00 2.70 2.33 NA NA 0.13 2.83 2.46 NA NA XXX
71060 26 A Contrast x-ray of bronchi 0.74 0.21 0.23 0.21 0.23 0.03 0.98 1.00 0.98 1.00 XXX
71090 C X-ray pacemaker insertion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
71090 TC C X-ray pacemaker insertion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
71090 26 A X-ray pacemaker insertion 0.54 0.29 0.23 0.29 0.23 0.02 0.85 0.79 0.85 0.79 XXX
71100 A X-ray exam of ribs 0.22 0.58 0.63 NA NA 0.05 0.85 0.90 NA NA XXX
71100 TC A X-ray exam of ribs 0.00 0.52 0.56 NA NA 0.04 0.56 0.60 NA NA XXX
71100 26 A X-ray exam of ribs 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
71101 A X-ray exam of ribs/chest 0.27 0.71 0.75 NA NA 0.05 1.03 1.07 NA NA XXX
71101 TC A X-ray exam of ribs/chest 0.00 0.64 0.66 NA NA 0.04 0.68 0.70 NA NA XXX
71101 26 A X-ray exam of ribs/chest 0.27 0.07 0.09 0.07 0.09 0.01 0.35 0.37 0.35 0.37 XXX
71110 A X-ray exam of ribs 0.27 0.73 0.84 NA NA 0.06 1.06 1.17 NA NA XXX
71110 TC A X-ray exam of ribs 0.00 0.66 0.75 NA NA 0.05 0.71 0.80 NA NA XXX
71110 26 A X-ray exam of ribs 0.27 0.07 0.09 0.07 0.09 0.01 0.35 0.37 0.35 0.37 XXX
71111 A X-ray exam of ribs/chest 0.32 1.00 1.00 NA NA 0.07 1.39 1.39 NA NA XXX
71111 TC A X-ray exam of ribs/chest 0.00 0.92 0.90 NA NA 0.06 0.98 0.96 NA NA XXX
71111 26 A X-ray exam of ribs/chest 0.32 0.08 0.10 0.08 0.10 0.01 0.41 0.43 0.41 0.43 XXX
71120 A X-ray exam of breastbone 0.20 0.59 0.69 NA NA 0.05 0.84 0.94 NA NA XXX
71120 TC A X-ray exam of breastbone 0.00 0.53 0.62 NA NA 0.04 0.57 0.66 NA NA XXX
71120 26 A X-ray exam of breastbone 0.20 0.06 0.07 0.06 0.07 0.01 0.27 0.28 0.27 0.28 XXX
71130 A X-ray exam of breastbone 0.22 0.72 0.77 NA NA 0.05 0.99 1.04 NA NA XXX
71130 TC A X-ray exam of breastbone 0.00 0.65 0.70 NA NA 0.04 0.69 0.74 NA NA XXX
71130 26 A X-ray exam of breastbone 0.22 0.07 0.07 0.07 0.07 0.01 0.30 0.30 0.30 0.30 XXX
71250 A Ct thorax w/o dye 1.16 6.08 6.24 NA NA 0.36 7.60 7.76 NA NA XXX
71250 TC A Ct thorax w/o dye 0.00 5.75 5.87 NA NA 0.31 6.06 6.18 NA NA XXX
71250 26 A Ct thorax w/o dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
71260 A Ct thorax w/dye 1.24 7.54 7.50 NA NA 0.42 9.20 9.16 NA NA XXX
71260 TC A Ct thorax w/dye 0.00 7.19 7.10 NA NA 0.37 7.56 7.47 NA NA XXX
71260 26 A Ct thorax w/dye 1.24 0.35 0.40 0.35 0.40 0.05 1.64 1.69 1.64 1.69 XXX
71270 A Ct thorax w/o w/dye 1.38 9.52 9.36 NA NA 0.52 11.42 11.26 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
71270 TC A Ct thorax w/o w/dye 0.00 9.13 8.92 NA NA 0.46 9.59 9.38 NA NA XXX
71270 26 A Ct thorax w/o w/dye 1.38 0.39 0.44 0.39 0.44 0.06 1.83 1.88 1.83 1.88 XXX
71275 A Ct angiography, chest 1.92 11.10 12.53 NA NA 0.48 13.50 14.93 NA NA XXX
71275 TC A Ct angiography, chest 0.00 10.54 11.92 NA NA 0.39 10.93 12.31 NA NA XXX
71275 26 A Ct angiography, chest 1.92 0.56 0.61 0.56 0.61 0.09 2.57 2.62 2.57 2.62 XXX
71550 A Mri chest w/o dye 1.46 15.58 12.65 NA NA 0.51 17.55 14.62 NA NA XXX
71550 TC A Mri chest w/o dye 0.00 15.17 12.19 NA NA 0.45 15.62 12.64 NA NA XXX
71550 26 A Mri chest w/o dye 1.46 0.41 0.46 0.41 0.46 0.06 1.93 1.98 1.93 1.98 XXX
71551 A Mri chest w/dye 1.73 17.01 14.76 NA NA 0.60 19.34 17.09 NA NA XXX
71551 TC A Mri chest w/dye 0.00 16.51 14.21 NA NA 0.52 17.03 14.73 NA NA XXX
71551 26 A Mri chest w/dye 1.73 0.50 0.55 0.50 0.55 0.08 2.31 2.36 2.31 2.36 XXX
71552 A Mri chest w/o w/dye 2.26 21.36 24.56 NA NA 0.78 24.40 27.60 NA NA XXX
71552 TC A Mri chest w/o w/dye 0.00 20.71 23.84 NA NA 0.68 21.39 24.52 NA NA XXX
71552 26 A Mri chest w/o w/dye 2.26 0.65 0.72 0.65 0.72 0.10 3.01 3.08 3.01 3.08 XXX
71555 R Mri angio chest w or w/o dye 1.81 14.67 12.52 NA NA 0.67 17.15 15.00 NA NA XXX
71555 TC R Mri angio chest w or w/o dye 0.00 14.11 11.93 NA NA 0.59 14.70 12.52 NA NA XXX
71555 26 R Mri angio chest w or w/o dye 1.81 0.56 0.59 0.56 0.59 0.08 2.45 2.48 2.45 2.48 XXX
72010 A X-ray exam of spine 0.45 1.40 1.23 NA NA 0.08 1.93 1.76 NA NA XXX
72010 TC A X-ray exam of spine 0.00 1.28 1.09 NA NA 0.06 1.34 1.15 NA NA XXX
72010 26 A X-ray exam of spine 0.45 0.12 0.14 0.12 0.14 0.02 0.59 0.61 0.59 0.61 XXX
72020 A X-ray exam of spine 0.15 0.43 0.46 NA NA 0.03 0.61 0.64 NA NA XXX
72020 TC A X-ray exam of spine 0.00 0.39 0.41 NA NA 0.02 0.41 0.43 NA NA XXX
72020 26 A X-ray exam of spine 0.15 0.04 0.05 0.04 0.05 0.01 0.20 0.21 0.20 0.21 XXX
72040 A X-ray exam of neck spine 0.22 0.73 0.69 NA NA 0.05 1.00 0.96 NA NA XXX
72040 TC A X-ray exam of neck spine 0.00 0.67 0.62 NA NA 0.04 0.71 0.66 NA NA XXX
72040 26 A X-ray exam of neck spine 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
72050 A X-ray exam of neck spine 0.31 1.01 1.00 NA NA 0.07 1.39 1.38 NA NA XXX
72050 TC A X-ray exam of neck spine 0.00 0.92 0.90 NA NA 0.06 0.98 0.96 NA NA XXX
72050 26 A X-ray exam of neck spine 0.31 0.09 0.10 0.09 0.10 0.01 0.41 0.42 0.41 0.42 XXX
72052 A X-ray exam of neck spine 0.36 1.31 1.27 NA NA 0.08 1.75 1.71 NA NA XXX
72052 TC A X-ray exam of neck spine 0.00 1.21 1.15 NA NA 0.06 1.27 1.21 NA NA XXX
72052 26 A X-ray exam of neck spine 0.36 0.10 0.12 0.10 0.12 0.02 0.48 0.50 0.48 0.50 XXX
72069 A X-ray exam of trunk spine 0.22 0.73 0.61 NA NA 0.03 0.98 0.86 NA NA XXX
72069 TC A X-ray exam of trunk spine 0.00 0.66 0.53 NA NA 0.02 0.68 0.55 NA NA XXX
72069 26 A X-ray exam of trunk spine 0.22 0.07 0.08 0.07 0.08 0.01 0.30 0.31 0.30 0.31 XXX
72070 A X-ray exam of thoracic spine 0.22 0.60 0.69 NA NA 0.05 0.87 0.96 NA NA XXX
72070 TC A X-ray exam of thoracic spine 0.00 0.54 0.62 NA NA 0.04 0.58 0.66 NA NA XXX
72070 26 A X-ray exam of thoracic spine 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
72072 A X-ray exam of thoracic spine 0.22 0.72 0.78 NA NA 0.06 1.00 1.06 NA NA XXX
72072 TC A X-ray exam of thoracic spine 0.00 0.66 0.71 NA NA 0.05 0.71 0.76 NA NA XXX
72072 26 A X-ray exam of thoracic spine 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
72074 A X-ray exam of thoracic spine 0.22 0.89 0.96 NA NA 0.07 1.18 1.25 NA NA XXX
72074 TC A X-ray exam of thoracic spine 0.00 0.83 0.89 NA NA 0.06 0.89 0.95 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
72074 26 A X-ray exam of thoracic spine 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
72080 A X-ray exam of trunk spine 0.22 0.67 0.72 NA NA 0.05 0.94 0.99 NA NA XXX
72080 TC A X-ray exam of trunk spine 0.00 0.60 0.65 NA NA 0.04 0.64 0.69 NA NA XXX
72080 26 A X-ray exam of trunk spine 0.22 0.07 0.07 0.07 0.07 0.01 0.30 0.30 0.30 0.30 XXX
72090 A X-ray exam of trunk spine 0.28 0.97 0.81 NA NA 0.05 1.30 1.14 NA NA XXX
72090 TC A X-ray exam of trunk spine 0.00 0.88 0.72 NA NA 0.04 0.92 0.76 NA NA XXX
72090 26 A X-ray exam of trunk spine 0.28 0.09 0.09 0.09 0.09 0.01 0.38 0.38 0.38 0.38 XXX
72100 A X-ray exam of lower spine 0.22 0.78 0.75 NA NA 0.05 1.05 1.02 NA NA XXX
72100 TC A X-ray exam of lower spine 0.00 0.71 0.68 NA NA 0.04 0.75 0.72 NA NA XXX
72100 26 A X-ray exam of lower spine 0.22 0.07 0.07 0.07 0.07 0.01 0.30 0.30 0.30 0.30 XXX
72110 A X-ray exam of lower spine 0.31 1.08 1.03 NA NA 0.07 1.46 1.41 NA NA XXX
72110 TC A X-ray exam of lower spine 0.00 0.99 0.93 NA NA 0.06 1.05 0.99 NA NA XXX
72110 26 A X-ray exam of lower spine 0.31 0.09 0.10 0.09 0.10 0.01 0.41 0.42 0.41 0.42 XXX
72114 A X-ray exam of lower spine 0.36 1.49 1.36 NA NA 0.08 1.93 1.80 NA NA XXX
72114 TC A X-ray exam of lower spine 0.00 1.38 1.24 NA NA 0.06 1.44 1.30 NA NA XXX
72114 26 A X-ray exam of lower spine 0.36 0.11 0.12 0.11 0.12 0.02 0.49 0.50 0.49 0.50 XXX
72120 A X-ray exam of lower spine 0.22 1.03 0.98 NA NA 0.07 1.32 1.27 NA NA XXX
72120 TC A X-ray exam of lower spine 0.00 0.96 0.91 NA NA 0.06 1.02 0.97 NA NA XXX
72120 26 A X-ray exam of lower spine 0.22 0.07 0.07 0.07 0.07 0.01 0.30 0.30 0.30 0.30 XXX
72125 A Ct neck spine w/o dye 1.16 6.08 6.24 NA NA 0.36 7.60 7.76 NA NA XXX
72125 TC A Ct neck spine w/o dye 0.00 5.75 5.87 NA NA 0.31 6.06 6.18 NA NA XXX
72125 26 A Ct neck spine w/o dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
72126 A Ct neck spine w/dye 1.22 7.54 7.49 NA NA 0.42 9.18 9.13 NA NA XXX
72126 TC A Ct neck spine w/dye 0.00 7.19 7.10 NA NA 0.37 7.56 7.47 NA NA XXX
72126 26 A Ct neck spine w/dye 1.22 0.35 0.39 0.35 0.39 0.05 1.62 1.66 1.62 1.66 XXX
72127 A Ct neck spine w/o w/dye 1.27 9.36 9.30 NA NA 0.52 11.15 11.09 NA NA XXX
72127 TC A Ct neck spine w/o w/dye 0.00 9.00 8.89 NA NA 0.46 9.46 9.35 NA NA XXX
72127 26 A Ct neck spine w/o w/dye 1.27 0.36 0.41 0.36 0.41 0.06 1.69 1.74 1.69 1.74 XXX
72128 A Ct chest spine w/o dye 1.16 6.08 6.24 NA NA 0.36 7.60 7.76 NA NA XXX
72128 TC A Ct chest spine w/o dye 0.00 5.75 5.87 NA NA 0.31 6.06 6.18 NA NA XXX
72128 26 A Ct chest spine w/o dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
72129 A Ct chest spine w/dye 1.22 7.54 7.49 NA NA 0.42 9.18 9.13 NA NA XXX
72129 TC A Ct chest spine w/dye 0.00 7.19 7.10 NA NA 0.37 7.56 7.47 NA NA XXX
72129 26 A Ct chest spine w/dye 1.22 0.35 0.39 0.35 0.39 0.05 1.62 1.66 1.62 1.66 XXX
72130 A Ct chest spine w/o w/dye 1.27 9.31 9.29 NA NA 0.52 11.10 11.08 NA NA XXX
72130 TC A Ct chest spine w/o w/dye 0.00 8.95 8.88 NA NA 0.46 9.41 9.34 NA NA XXX
72130 26 A Ct chest spine w/o w/dye 1.27 0.36 0.41 0.36 0.41 0.06 1.69 1.74 1.69 1.74 XXX
72131 A Ct lumbar spine w/o dye 1.16 6.07 6.24 NA NA 0.36 7.59 7.76 NA NA XXX
72131 TC A Ct lumbar spine w/o dye 0.00 5.74 5.87 NA NA 0.31 6.05 6.18 NA NA XXX
72131 26 A Ct lumbar spine w/o dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
72132 A Ct lumbar spine w/dye 1.22 7.52 7.49 NA NA 0.42 9.16 9.13 NA NA XXX
72132 TC A Ct lumbar spine w/dye 0.00 7.17 7.10 NA NA 0.37 7.54 7.47 NA NA XXX
72132 26 A Ct lumbar spine w/dye 1.22 0.35 0.39 0.35 0.39 0.05 1.62 1.66 1.62 1.66 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
72133 A Ct lumbar spine w/o w/dye 1.27 9.54 9.34 NA NA 0.52 11.33 11.13 NA NA XXX
72133 TC A Ct lumbar spine w/o w/dye 0.00 9.18 8.93 NA NA 0.46 9.64 9.39 NA NA XXX
72133 26 A Ct lumbar spine w/o w/dye 1.27 0.36 0.41 0.36 0.41 0.06 1.69 1.74 1.69 1.74 XXX
72141 A Mri neck spine w/o dye 1.60 11.86 11.76 NA NA 0.66 14.12 14.02 NA NA XXX
72141 TC A Mri neck spine w/o dye 0.00 11.40 11.25 NA NA 0.59 11.99 11.84 NA NA XXX
72141 26 A Mri neck spine w/o dye 1.60 0.46 0.51 0.46 0.51 0.07 2.13 2.18 2.13 2.18 XXX
72142 A Mri neck spine w/dye 1.92 14.80 14.26 NA NA 0.79 17.51 16.97 NA NA XXX
72142 TC A Mri neck spine w/dye 0.00 14.25 13.64 NA NA 0.70 14.95 14.34 NA NA XXX
72142 26 A Mri neck spine w/dye 1.92 0.55 0.62 0.55 0.62 0.09 2.56 2.63 2.56 2.63 XXX
72146 A Mri chest spine w/o dye 1.60 11.87 12.69 NA NA 0.71 14.18 15.00 NA NA XXX
72146 TC A Mri chest spine w/o dye 0.00 11.41 12.18 NA NA 0.64 12.05 12.82 NA NA XXX
72146 26 A Mri chest spine w/o dye 1.60 0.46 0.51 0.46 0.51 0.07 2.13 2.18 2.13 2.18 XXX
72147 A Mri chest spine w/dye 1.92 12.81 13.76 NA NA 0.79 15.52 16.47 NA NA XXX
72147 TC A Mri chest spine w/dye 0.00 12.27 13.15 NA NA 0.70 12.97 13.85 NA NA XXX
72147 26 A Mri chest spine w/dye 1.92 0.54 0.61 0.54 0.61 0.09 2.55 2.62 2.55 2.62 XXX
72148 A Mri lumbar spine w/o dye 1.48 11.84 12.66 NA NA 0.71 14.03 14.85 NA NA XXX
72148 TC A Mri lumbar spine w/o dye 0.00 11.41 12.18 NA NA 0.64 12.05 12.82 NA NA XXX
72148 26 A Mri lumbar spine w/o dye 1.48 0.43 0.48 0.43 0.48 0.07 1.98 2.03 1.98 2.03 XXX
72149 A Mri lumbar spine w/dye 1.78 14.77 14.23 NA NA 0.78 17.33 16.79 NA NA XXX
72149 TC A Mri lumbar spine w/dye 0.00 14.26 13.65 NA NA 0.70 14.96 14.35 NA NA XXX
72149 26 A Mri lumbar spine w/dye 1.78 0.51 0.58 0.51 0.58 0.08 2.37 2.44 2.37 2.44 XXX
72156 A Mri neck spine w/o w/dye 2.57 16.87 23.52 NA NA 1.42 20.86 27.51 NA NA XXX
72156 TC A Mri neck spine w/o w/dye 0.00 16.14 22.70 NA NA 1.31 17.45 24.01 NA NA XXX
72156 26 A Mri neck spine w/o w/dye 2.57 0.73 0.82 0.73 0.82 0.11 3.41 3.50 3.41 3.50 XXX
72157 A Mri chest spine w/o w/dye 2.57 15.34 23.12 NA NA 1.42 19.33 27.11 NA NA XXX
72157 TC A Mri chest spine w/o w/dye 0.00 14.61 22.31 NA NA 1.31 15.92 23.62 NA NA XXX
72157 26 A Mri chest spine w/o w/dye 2.57 0.73 0.81 0.73 0.81 0.11 3.41 3.49 3.41 3.49 XXX
72158 A Mri lumbar spine w/o w/dye 2.36 16.81 23.45 NA NA 1.41 20.58 27.22 NA NA XXX
72158 TC A Mri lumbar spine w/o w/dye 0.00 16.14 22.70 NA NA 1.31 17.45 24.01 NA NA XXX
72158 26 A Mri lumbar spine w/o w/dye 2.36 0.67 0.75 0.67 0.75 0.10 3.13 3.21 3.13 3.21 XXX
72159 N Mr angio spine w/ow/dye 1.80 14.49 13.31 NA NA 0.74 17.03 15.85 NA NA XXX
72159 TC N Mr angio spine w/ow/dye 0.00 14.07 12.69 NA NA 0.64 14.71 13.33 NA NA XXX
72159 26 N Mr angio spine w/ow/dye 1.80 0.42 0.62 0.42 0.62 0.10 2.32 2.52 2.32 2.52 XXX
72170 A X-ray exam of pelvis 0.17 0.47 0.56 NA NA 0.03 0.67 0.76 NA NA XXX
72170 TC A X-ray exam of pelvis 0.00 0.42 0.50 NA NA 0.02 0.44 0.52 NA NA XXX
72170 26 A X-ray exam of pelvis 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
72190 A X-ray exam of pelvis 0.21 0.81 0.76 NA NA 0.05 1.07 1.02 NA NA XXX
72190 TC A X-ray exam of pelvis 0.00 0.74 0.69 NA NA 0.04 0.78 0.73 NA NA XXX
72190 26 A X-ray exam of pelvis 0.21 0.07 0.07 0.07 0.07 0.01 0.29 0.29 0.29 0.29 XXX
72191 A Ct angiograph pelv w/ow/dye 1.81 10.72 12.15 NA NA 0.47 13.00 14.43 NA NA XXX
72191 TC A Ct angiograph pelv w/ow/dye 0.00 10.19 11.57 NA NA 0.39 10.58 11.96 NA NA XXX
72191 26 A Ct angiograph pelv w/ow/dye 1.81 0.53 0.58 0.53 0.58 0.08 2.42 2.47 2.42 2.47 XXX
72192 A Ct pelvis w/o dye 1.09 5.67 6.12 NA NA 0.36 7.12 7.57 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
72192 TC A Ct pelvis w/o dye 0.00 5.36 5.77 NA NA 0.31 5.67 6.08 NA NA XXX
72192 26 A Ct pelvis w/o dye 1.09 0.31 0.35 0.31 0.35 0.05 1.45 1.49 1.45 1.49 XXX
72193 A Ct pelvis w/dye 1.16 7.11 7.20 NA NA 0.41 8.68 8.77 NA NA XXX
72193 TC A Ct pelvis w/dye 0.00 6.78 6.83 NA NA 0.36 7.14 7.19 NA NA XXX
72193 26 A Ct pelvis w/dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
72194 A Ct pelvis w/o w/dye 1.22 9.56 9.06 NA NA 0.48 11.26 10.76 NA NA XXX
72194 TC A Ct pelvis w/o w/dye 0.00 9.21 8.67 NA NA 0.43 9.64 9.10 NA NA XXX
72194 26 A Ct pelvis w/o w/dye 1.22 0.35 0.39 0.35 0.39 0.05 1.62 1.66 1.62 1.66 XXX
72195 A Mri pelvis w/o dye 1.46 13.71 12.19 NA NA 0.51 15.68 14.16 NA NA XXX
72195 TC A Mri pelvis w/o dye 0.00 13.29 11.72 NA NA 0.45 13.74 12.17 NA NA XXX
72195 26 A Mri pelvis w/o dye 1.46 0.42 0.47 0.42 0.47 0.06 1.94 1.99 1.94 1.99 XXX
72196 A Mri pelvis w/dye 1.73 14.67 14.18 NA NA 0.60 17.00 16.51 NA NA XXX
72196 TC A Mri pelvis w/dye 0.00 14.18 13.63 NA NA 0.52 14.70 14.15 NA NA XXX
72196 26 A Mri pelvis w/dye 1.73 0.49 0.55 0.49 0.55 0.08 2.30 2.36 2.30 2.36 XXX
72197 A Mri pelvis w/o w/dye 2.26 17.96 23.71 NA NA 1.02 21.24 26.99 NA NA XXX
72197 TC A Mri pelvis w/o w/dye 0.00 17.32 22.99 NA NA 0.92 18.24 23.91 NA NA XXX
72197 26 A Mri pelvis w/o w/dye 2.26 0.64 0.72 0.64 0.72 0.10 3.00 3.08 3.00 3.08 XXX
72198 A Mr angio pelvis w/o w/dye 1.80 14.29 12.41 NA NA 0.67 16.76 14.88 NA NA XXX
72198 TC A Mr angio pelvis w/o w/dye 0.00 13.77 11.84 NA NA 0.59 14.36 12.43 NA NA XXX
72198 26 A Mr angio pelvis w/o w/dye 1.80 0.52 0.57 0.52 0.57 0.08 2.40 2.45 2.40 2.45 XXX
72200 A X-ray exam sacroiliac joints 0.17 0.57 0.58 NA NA 0.03 0.77 0.78 NA NA XXX
72200 TC A X-ray exam sacroiliac joints 0.00 0.52 0.52 NA NA 0.02 0.54 0.54 NA NA XXX
72200 26 A X-ray exam sacroiliac joints 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
72202 A X-ray exam sacroiliac joints 0.19 0.69 0.69 NA NA 0.05 0.93 0.93 NA NA XXX
72202 TC A X-ray exam sacroiliac joints 0.00 0.64 0.63 NA NA 0.04 0.68 0.67 NA NA XXX
72202 26 A X-ray exam sacroiliac joints 0.19 0.05 0.06 0.05 0.06 0.01 0.25 0.26 0.25 0.26 XXX
72220 A X-ray exam of tailbone 0.17 0.54 0.61 NA NA 0.05 0.76 0.83 NA NA XXX
72220 TC A X-ray exam of tailbone 0.00 0.50 0.55 NA NA 0.04 0.54 0.59 NA NA XXX
72220 26 A X-ray exam of tailbone 0.17 0.04 0.06 0.04 0.06 0.01 0.22 0.24 0.22 0.24 XXX
72240 A Contrast x-ray of neck spine 0.91 2.37 4.37 NA NA 0.29 3.57 5.57 NA NA XXX
72240 TC A Contrast x-ray of neck spine 0.00 2.12 4.09 NA NA 0.25 2.37 4.34 NA NA XXX
72240 26 A Contrast x-ray of neck spine 0.91 0.25 0.28 0.25 0.28 0.04 1.20 1.23 1.20 1.23 XXX
72255 A Contrast x-ray, thorax spine 0.91 2.13 3.98 NA NA 0.26 3.30 5.15 NA NA XXX
72255 TC A Contrast x-ray, thorax spine 0.00 1.89 3.72 NA NA 0.22 2.11 3.94 NA NA XXX
72255 26 A Contrast x-ray, thorax spine 0.91 0.24 0.26 0.24 0.26 0.04 1.19 1.21 1.19 1.21 XXX
72265 A Contrast x-ray, lower spine 0.83 2.34 3.83 NA NA 0.26 3.43 4.92 NA NA XXX
72265 TC A Contrast x-ray, lower spine 0.00 2.11 3.58 NA NA 0.22 2.33 3.80 NA NA XXX
72265 26 A Contrast x-ray, lower spine 0.83 0.23 0.25 0.23 0.25 0.04 1.10 1.12 1.10 1.12 XXX
72270 A Contrast x-ray, spine 1.33 3.69 5.81 NA NA 0.39 5.41 7.53 NA NA XXX
72270 TC A Contrast x-ray, spine 0.00 3.31 5.40 NA NA 0.33 3.64 5.73 NA NA XXX
72270 26 A Contrast x-ray, spine 1.33 0.38 0.41 0.38 0.41 0.06 1.77 1.80 1.77 1.80 XXX
72275 A Epidurography 0.76 1.67 2.15 NA NA 0.26 2.69 3.17 NA NA XXX
72275 TC A Epidurography 0.00 1.48 1.95 NA NA 0.22 1.70 2.17 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
72275 26 A Epidurography 0.76 0.19 0.20 0.19 0.20 0.04 0.99 1.00 0.99 1.00 XXX
72285 A X-ray c/t spine disk 1.16 1.36 6.90 NA NA 0.50 3.02 8.56 NA NA XXX
72285 TC A X-ray c/t spine disk 0.00 1.09 6.56 NA NA 0.43 1.52 6.99 NA NA XXX
72285 26 A X-ray c/t spine disk 1.16 0.27 0.34 0.27 0.34 0.07 1.50 1.57 1.50 1.57 XXX
72291 C Perq vertebroplasty, fluor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
72291 TC C Perq vertebroplasty, fluor 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
72291 26 A Perq vertebroplasty, fluor 1.31 0.41 0.46 0.41 0.46 0.10 1.82 1.87 1.82 1.87 XXX
72292 C Perq vertebroplasty, ct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
72292 TC C Perq vertebroplasty, ct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
72292 26 A Perq vertebroplasty, ct 1.38 0.41 0.46 0.41 0.46 0.07 1.86 1.91 1.86 1.91 XXX
72295 A X-ray of lower spine disk 0.83 1.36 6.44 NA NA 0.46 2.65 7.73 NA NA XXX
72295 TC A X-ray of lower spine disk 0.00 1.14 6.18 NA NA 0.40 1.54 6.58 NA NA XXX
72295 26 A X-ray of lower spine disk 0.83 0.22 0.26 0.22 0.26 0.06 1.11 1.15 1.11 1.15 XXX
73000 A X-ray exam of collar bone 0.16 0.53 0.56 NA NA 0.03 0.72 0.75 NA NA XXX
73000 TC A X-ray exam of collar bone 0.00 0.48 0.51 NA NA 0.02 0.50 0.53 NA NA XXX
73000 26 A X-ray exam of collar bone 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
73010 A X-ray exam of shoulder blade 0.17 0.56 0.58 NA NA 0.03 0.76 0.78 NA NA XXX
73010 TC A X-ray exam of shoulder blade 0.00 0.51 0.52 NA NA 0.02 0.53 0.54 NA NA XXX
73010 26 A X-ray exam of shoulder blade 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73020 A X-ray exam of shoulder 0.15 0.43 0.50 NA NA 0.03 0.61 0.68 NA NA XXX
73020 TC A X-ray exam of shoulder 0.00 0.38 0.45 NA NA 0.02 0.40 0.47 NA NA XXX
73020 26 A X-ray exam of shoulder 0.15 0.05 0.05 0.05 0.05 0.01 0.21 0.21 0.21 0.21 XXX
73030 A X-ray exam of shoulder 0.18 0.55 0.61 NA NA 0.05 0.78 0.84 NA NA XXX
73030 TC A X-ray exam of shoulder 0.00 0.49 0.55 NA NA 0.04 0.53 0.59 NA NA XXX
73030 26 A X-ray exam of shoulder 0.18 0.06 0.06 0.06 0.06 0.01 0.25 0.25 0.25 0.25 XXX
73040 A Contrast x-ray of shoulder 0.54 2.11 2.24 NA NA 0.14 2.79 2.92 NA NA XXX
73040 TC A Contrast x-ray of shoulder 0.00 1.95 2.06 NA NA 0.12 2.07 2.18 NA NA XXX
73040 26 A Contrast x-ray of shoulder 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
73050 A X-ray exam of shoulders 0.20 0.71 0.73 NA NA 0.05 0.96 0.98 NA NA XXX
73050 TC A X-ray exam of shoulders 0.00 0.64 0.66 NA NA 0.04 0.68 0.70 NA NA XXX
73050 26 A X-ray exam of shoulders 0.20 0.07 0.07 0.07 0.07 0.01 0.28 0.28 0.28 0.28 XXX
73060 A X-ray exam of humerus 0.17 0.55 0.61 NA NA 0.05 0.77 0.83 NA NA XXX
73060 TC A X-ray exam of humerus 0.00 0.50 0.55 NA NA 0.04 0.54 0.59 NA NA XXX
73060 26 A X-ray exam of humerus 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73070 A X-ray exam of elbow 0.15 0.54 0.56 NA NA 0.03 0.72 0.74 NA NA XXX
73070 TC A X-ray exam of elbow 0.00 0.49 0.51 NA NA 0.02 0.51 0.53 NA NA XXX
73070 26 A X-ray exam of elbow 0.15 0.05 0.05 0.05 0.05 0.01 0.21 0.21 0.21 0.21 XXX
73080 A X-ray exam of elbow 0.17 0.72 0.66 NA NA 0.05 0.94 0.88 NA NA XXX
73080 TC A X-ray exam of elbow 0.00 0.67 0.60 NA NA 0.04 0.71 0.64 NA NA XXX
73080 26 A X-ray exam of elbow 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73085 A Contrast x-ray of elbow 0.54 1.74 2.15 NA NA 0.14 2.42 2.83 NA NA XXX
73085 TC A Contrast x-ray of elbow 0.00 1.58 1.97 NA NA 0.12 1.70 2.09 NA NA XXX
73085 26 A Contrast x-ray of elbow 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
73090 A X-ray exam of forearm 0.16 0.52 0.56 NA NA 0.03 0.71 0.75 NA NA XXX
73090 TC A X-ray exam of forearm 0.00 0.48 0.51 NA NA 0.02 0.50 0.53 NA NA XXX
73090 26 A X-ray exam of forearm 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
73092 A X-ray exam of arm, infant 0.16 0.55 0.55 NA NA 0.03 0.74 0.74 NA NA XXX
73092 TC A X-ray exam of arm, infant 0.00 0.51 0.50 NA NA 0.02 0.53 0.52 NA NA XXX
73092 26 A X-ray exam of arm, infant 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
73100 A X-ray exam of wrist 0.16 0.59 0.55 NA NA 0.03 0.78 0.74 NA NA XXX
73100 TC A X-ray exam of wrist 0.00 0.54 0.50 NA NA 0.02 0.56 0.52 NA NA XXX
73100 26 A X-ray exam of wrist 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
73110 A X-ray exam of wrist 0.17 0.74 0.63 NA NA 0.03 0.94 0.83 NA NA XXX
73110 TC A X-ray exam of wrist 0.00 0.69 0.57 NA NA 0.02 0.71 0.59 NA NA XXX
73110 26 A X-ray exam of wrist 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73115 A Contrast x-ray of wrist 0.54 2.28 1.89 NA NA 0.12 2.94 2.55 NA NA XXX
73115 TC A Contrast x-ray of wrist 0.00 2.11 1.71 NA NA 0.10 2.21 1.81 NA NA XXX
73115 26 A Contrast x-ray of wrist 0.54 0.17 0.18 0.17 0.18 0.02 0.73 0.74 0.73 0.74 XXX
73120 A X-ray exam of hand 0.16 0.54 0.54 NA NA 0.03 0.73 0.73 NA NA XXX
73120 TC A X-ray exam of hand 0.00 0.49 0.49 NA NA 0.02 0.51 0.51 NA NA XXX
73120 26 A X-ray exam of hand 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
73130 A X-ray exam of hand 0.17 0.63 0.60 NA NA 0.03 0.83 0.80 NA NA XXX
73130 TC A X-ray exam of hand 0.00 0.58 0.54 NA NA 0.02 0.60 0.56 NA NA XXX
73130 26 A X-ray exam of hand 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73140 A X-ray exam of finger(s) 0.13 0.65 0.51 NA NA 0.03 0.81 0.67 NA NA XXX
73140 TC A X-ray exam of finger(s) 0.00 0.61 0.47 NA NA 0.02 0.63 0.49 NA NA XXX
73140 26 A X-ray exam of finger(s) 0.13 0.04 0.04 0.04 0.04 0.01 0.18 0.18 0.18 0.18 XXX
73200 A Ct upper extremity w/o dye 1.09 6.03 5.50 NA NA 0.30 7.42 6.89 NA NA XXX
73200 TC A Ct upper extremity w/o dye 0.00 5.72 5.15 NA NA 0.25 5.97 5.40 NA NA XXX
73200 26 A Ct upper extremity w/o dye 1.09 0.31 0.35 0.31 0.35 0.05 1.45 1.49 1.45 1.49 XXX
73201 A Ct upper extremity w/dye 1.16 7.45 6.58 NA NA 0.36 8.97 8.10 NA NA XXX
73201 TC A Ct upper extremity w/dye 0.00 7.12 6.21 NA NA 0.31 7.43 6.52 NA NA XXX
73201 26 A Ct upper extremity w/dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
73202 A Ct uppr extremity w/ow/dye 1.22 10.06 8.38 NA NA 0.44 11.72 10.04 NA NA XXX
73202 TC A Ct uppr extremity w/ow/dye 0.00 9.71 7.99 NA NA 0.39 10.10 8.38 NA NA XXX
73202 26 A Ct uppr extremity w/ow/dye 1.22 0.35 0.39 0.35 0.39 0.05 1.62 1.66 1.62 1.66 XXX
73206 A Ct angio upr extrm w/ow/dye 1.81 10.21 11.22 NA NA 0.47 12.49 13.50 NA NA XXX
73206 TC A Ct angio upr extrm w/ow/dye 0.00 9.67 10.64 NA NA 0.39 10.06 11.03 NA NA XXX
73206 26 A Ct angio upr extrm w/ow/dye 1.81 0.54 0.58 0.54 0.58 0.08 2.43 2.47 2.43 2.47 XXX
73218 A Mri upper extremity w/o dye 1.35 14.04 12.24 NA NA 0.45 15.84 14.04 NA NA XXX
73218 TC A Mri upper extremity w/o dye 0.00 13.65 11.81 NA NA 0.39 14.04 12.20 NA NA XXX
73218 26 A Mri upper extremity w/o dye 1.35 0.39 0.43 0.39 0.43 0.06 1.80 1.84 1.80 1.84 XXX
73219 A Mri upper extremity w/dye 1.62 14.65 14.15 NA NA 0.54 16.81 16.31 NA NA XXX
73219 TC A Mri upper extremity w/dye 0.00 14.18 13.63 NA NA 0.47 14.65 14.10 NA NA XXX
73219 26 A Mri upper extremity w/dye 1.62 0.47 0.52 0.47 0.52 0.07 2.16 2.21 2.16 2.21 XXX
73220 A Mri uppr extremity w/ow/dye 2.15 18.09 23.72 NA NA 0.94 21.18 26.81 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
73220 TC A Mri uppr extremity w/ow/dye 0.00 17.48 23.03 NA NA 0.84 18.32 23.87 NA NA XXX
73220 26 A Mri uppr extremity w/ow/dye 2.15 0.61 0.69 0.61 0.69 0.10 2.86 2.94 2.86 2.94 XXX
73221 A Mri joint upr extrem w/o dye 1.35 12.98 11.98 NA NA 0.45 14.78 13.78 NA NA XXX
73221 TC A Mri joint upr extrem w/o dye 0.00 12.58 11.55 NA NA 0.39 12.97 11.94 NA NA XXX
73221 26 A Mri joint upr extrem w/o dye 1.35 0.40 0.43 0.40 0.43 0.06 1.81 1.84 1.81 1.84 XXX
73222 A Mri joint upr extrem w/dye 1.62 13.63 13.89 NA NA 0.54 15.79 16.05 NA NA XXX
73222 TC A Mri joint upr extrem w/dye 0.00 13.16 13.37 NA NA 0.47 13.63 13.84 NA NA XXX
73222 26 A Mri joint upr extrem w/dye 1.62 0.47 0.52 0.47 0.52 0.07 2.16 2.21 2.16 2.21 XXX
73223 A Mri joint upr extr w/ow/dye 2.15 16.13 23.40 NA NA 0.94 19.22 26.49 NA NA XXX
73223 TC A Mri joint upr extr w/ow/dye 0.00 16.13 22.69 NA NA 0.84 16.97 23.53 NA NA XXX
73223 26 A Mri joint upr extr w/ow/dye 2.15 0.00 0.71 0.00 0.71 0.10 2.25 2.96 2.25 2.96 XXX
73225 N Mr angio upr extr w/ow/dye 1.73 14.47 12.38 NA NA 0.69 16.89 14.80 NA NA XXX
73225 TC N Mr angio upr extr w/ow/dye 0.00 14.07 11.78 NA NA 0.59 14.66 12.37 NA NA XXX
73225 26 N Mr angio upr extr w/ow/dye 1.73 0.40 0.60 0.40 0.60 0.10 2.23 2.43 2.23 2.43 XXX
73500 A X-ray exam of hip 0.17 0.46 0.52 NA NA 0.03 0.66 0.72 NA NA XXX
73500 TC A X-ray exam of hip 0.00 0.41 0.46 NA NA 0.02 0.43 0.48 NA NA XXX
73500 26 A X-ray exam of hip 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73510 A X-ray exam of hip 0.21 0.74 0.67 NA NA 0.05 1.00 0.93 NA NA XXX
73510 TC A X-ray exam of hip 0.00 0.68 0.60 NA NA 0.04 0.72 0.64 NA NA XXX
73510 26 A X-ray exam of hip 0.21 0.06 0.07 0.06 0.07 0.01 0.28 0.29 0.28 0.29 XXX
73520 A X-ray exam of hips 0.26 0.75 0.76 NA NA 0.05 1.06 1.07 NA NA XXX
73520 TC A X-ray exam of hips 0.00 0.67 0.67 NA NA 0.04 0.71 0.71 NA NA XXX
73520 26 A X-ray exam of hips 0.26 0.08 0.09 0.08 0.09 0.01 0.35 0.36 0.35 0.36 XXX
73525 A Contrast x-ray of hip 0.54 1.72 2.15 NA NA 0.15 2.41 2.84 NA NA XXX
73525 TC A Contrast x-ray of hip 0.00 1.56 1.97 NA NA 0.12 1.68 2.09 NA NA XXX
73525 26 A Contrast x-ray of hip 0.54 0.16 0.18 0.16 0.18 0.03 0.73 0.75 0.73 0.75 XXX
73530 C X-ray exam of hip 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
73530 TC C X-ray exam of hip 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
73530 26 A X-ray exam of hip 0.29 0.08 0.10 0.08 0.10 0.01 0.38 0.40 0.38 0.40 XXX
73540 A X-ray exam of pelvis hips 0.20 0.78 0.68 NA NA 0.05 1.03 0.93 NA NA XXX
73540 TC A X-ray exam of pelvis hips 0.00 0.71 0.61 NA NA 0.04 0.75 0.65 NA NA XXX
73540 26 A X-ray exam of pelvis hips 0.20 0.07 0.07 0.07 0.07 0.01 0.28 0.28 0.28 0.28 XXX
73542 A X-ray exam, sacroiliac joint 0.59 1.10 1.98 NA NA 0.15 1.84 2.72 NA NA XXX
73542 TC A X-ray exam, sacroiliac joint 0.00 0.96 1.82 NA NA 0.12 1.08 1.94 NA NA XXX
73542 26 A X-ray exam, sacroiliac joint 0.59 0.14 0.16 0.14 0.16 0.03 0.76 0.78 0.76 0.78 XXX
73550 A X-ray exam of thigh 0.17 0.52 0.61 NA NA 0.05 0.74 0.83 NA NA XXX
73550 TC A X-ray exam of thigh 0.00 0.47 0.55 NA NA 0.04 0.51 0.59 NA NA XXX
73550 26 A X-ray exam of thigh 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73560 A X-ray exam of knee, 1 or 2 0.17 0.56 0.58 NA NA 0.03 0.76 0.78 NA NA XXX
73560 TC A X-ray exam of knee, 1 or 2 0.00 0.51 0.52 NA NA 0.02 0.53 0.54 NA NA XXX
73560 26 A X-ray exam of knee, 1 or 2 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73562 A X-ray exam of knee, 3 0.18 0.71 0.65 NA NA 0.05 0.94 0.88 NA NA XXX
73562 TC A X-ray exam of knee, 3 0.00 0.65 0.59 NA NA 0.04 0.69 0.63 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
73562 26 A X-ray exam of knee, 3 0.18 0.06 0.06 0.06 0.06 0.01 0.25 0.25 0.25 0.25 XXX
73564 A X-ray exam, knee, 4 or more 0.22 0.83 0.73 NA NA 0.05 1.10 1.00 NA NA XXX
73564 TC A X-ray exam, knee, 4 or more 0.00 0.76 0.66 NA NA 0.04 0.80 0.70 NA NA XXX
73564 26 A X-ray exam, knee, 4 or more 0.22 0.07 0.07 0.07 0.07 0.01 0.30 0.30 0.30 0.30 XXX
73565 A X-ray exam of knees 0.17 0.64 0.57 NA NA 0.03 0.84 0.77 NA NA XXX
73565 TC A X-ray exam of knees 0.00 0.58 0.51 NA NA 0.02 0.60 0.53 NA NA XXX
73565 26 A X-ray exam of knees 0.17 0.06 0.06 0.06 0.06 0.01 0.24 0.24 0.24 0.24 XXX
73580 A Contrast x-ray of knee joint 0.54 2.32 2.67 NA NA 0.17 3.03 3.38 NA NA XXX
73580 TC A Contrast x-ray of knee joint 0.00 2.15 2.50 NA NA 0.14 2.29 2.64 NA NA XXX
73580 26 A Contrast x-ray of knee joint 0.54 0.17 0.17 0.17 0.17 0.03 0.74 0.74 0.74 0.74 XXX
73590 A X-ray exam of lower leg 0.17 0.51 0.57 NA NA 0.03 0.71 0.77 NA NA XXX
73590 TC A X-ray exam of lower leg 0.00 0.46 0.51 NA NA 0.02 0.48 0.53 NA NA XXX
73590 26 A X-ray exam of lower leg 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73592 A X-ray exam of leg, infant 0.16 0.57 0.55 NA NA 0.03 0.76 0.74 NA NA XXX
73592 TC A X-ray exam of leg, infant 0.00 0.53 0.50 NA NA 0.02 0.55 0.52 NA NA XXX
73592 26 A X-ray exam of leg, infant 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
73600 A X-ray exam of ankle 0.16 0.55 0.54 NA NA 0.03 0.74 0.73 NA NA XXX
73600 TC A X-ray exam of ankle 0.00 0.50 0.49 NA NA 0.02 0.52 0.51 NA NA XXX
73600 26 A X-ray exam of ankle 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
73610 A X-ray exam of ankle 0.17 0.64 0.61 NA NA 0.03 0.84 0.81 NA NA XXX
73610 TC A X-ray exam of ankle 0.00 0.59 0.55 NA NA 0.02 0.61 0.57 NA NA XXX
73610 26 A X-ray exam of ankle 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73615 A Contrast x-ray of ankle 0.54 1.83 2.17 NA NA 0.15 2.52 2.86 NA NA XXX
73615 TC A Contrast x-ray of ankle 0.00 1.67 1.99 NA NA 0.12 1.79 2.11 NA NA XXX
73615 26 A Contrast x-ray of ankle 0.54 0.16 0.18 0.16 0.18 0.03 0.73 0.75 0.73 0.75 XXX
73620 A X-ray exam of foot 0.16 0.52 0.54 NA NA 0.03 0.71 0.73 NA NA XXX
73620 TC A X-ray exam of foot 0.00 0.48 0.49 NA NA 0.02 0.50 0.51 NA NA XXX
73620 26 A X-ray exam of foot 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
73630 A X-ray exam of foot 0.17 0.63 0.60 NA NA 0.03 0.83 0.80 NA NA XXX
73630 TC A X-ray exam of foot 0.00 0.58 0.54 NA NA 0.02 0.60 0.56 NA NA XXX
73630 26 A X-ray exam of foot 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
73650 A X-ray exam of heel 0.16 0.54 0.53 NA NA 0.03 0.73 0.72 NA NA XXX
73650 TC A X-ray exam of heel 0.00 0.49 0.48 NA NA 0.02 0.51 0.50 NA NA XXX
73650 26 A X-ray exam of heel 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
73660 A X-ray exam of toe(s) 0.13 0.62 0.50 NA NA 0.03 0.78 0.66 NA NA XXX
73660 TC A X-ray exam of toe(s) 0.00 0.58 0.46 NA NA 0.02 0.60 0.48 NA NA XXX
73660 26 A X-ray exam of toe(s) 0.13 0.04 0.04 0.04 0.04 0.01 0.18 0.18 0.18 0.18 XXX
73700 A Ct lower extremity w/o dye 1.09 6.04 5.50 NA NA 0.30 7.43 6.89 NA NA XXX
73700 TC A Ct lower extremity w/o dye 0.00 5.73 5.15 NA NA 0.25 5.98 5.40 NA NA XXX
73700 26 A Ct lower extremity w/o dye 1.09 0.31 0.35 0.31 0.35 0.05 1.45 1.49 1.45 1.49 XXX
73701 A Ct lower extremity w/dye 1.16 7.50 6.60 NA NA 0.36 9.02 8.12 NA NA XXX
73701 TC A Ct lower extremity w/dye 0.00 7.17 6.23 NA NA 0.31 7.48 6.54 NA NA XXX
73701 26 A Ct lower extremity w/dye 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
73702 A Ct lwr extremity w/ow/dye 1.22 10.14 8.40 NA NA 0.44 11.80 10.06 NA NA XXX
73702 TC A Ct lwr extremity w/ow/dye 0.00 9.78 8.01 NA NA 0.39 10.17 8.40 NA NA XXX
73702 26 A Ct lwr extremity w/ow/dye 1.22 0.36 0.39 0.36 0.39 0.05 1.63 1.66 1.63 1.66 XXX
73706 A Ct angio lwr extr w/ow/dye 1.90 11.69 11.61 NA NA 0.47 14.06 13.98 NA NA XXX
73706 TC A Ct angio lwr extr w/ow/dye 0.00 11.09 10.99 NA NA 0.39 11.48 11.38 NA NA XXX
73706 26 A Ct angio lwr extr w/ow/dye 1.90 0.60 0.62 0.60 0.62 0.08 2.58 2.60 2.58 2.60 XXX
73718 A Mri lower extremity w/o dye 1.35 13.64 12.14 NA NA 0.45 15.44 13.94 NA NA XXX
73718 TC A Mri lower extremity w/o dye 0.00 13.25 11.71 NA NA 0.39 13.64 12.10 NA NA XXX
73718 26 A Mri lower extremity w/o dye 1.35 0.39 0.43 0.39 0.43 0.06 1.80 1.84 1.80 1.84 XXX
73719 A Mri lower extremity w/dye 1.62 14.58 14.12 NA NA 0.54 16.74 16.28 NA NA XXX
73719 TC A Mri lower extremity w/dye 0.00 14.12 13.61 NA NA 0.47 14.59 14.08 NA NA XXX
73719 26 A Mri lower extremity w/dye 1.62 0.46 0.51 0.46 0.51 0.07 2.15 2.20 2.15 2.20 XXX
73720 A Mri lwr extremity w/ow/dye 2.15 18.05 23.70 NA NA 0.94 21.14 26.79 NA NA XXX
73720 TC A Mri lwr extremity w/ow/dye 0.00 17.44 23.02 NA NA 0.84 18.28 23.86 NA NA XXX
73720 26 A Mri lwr extremity w/ow/dye 2.15 0.61 0.68 0.61 0.68 0.10 2.86 2.93 2.86 2.93 XXX
73721 A Mri jnt of lwr extre w/o dye 1.35 13.26 12.05 NA NA 0.45 15.06 13.85 NA NA XXX
73721 TC A Mri jnt of lwr extre w/o dye 0.00 12.86 11.62 NA NA 0.39 13.25 12.01 NA NA XXX
73721 26 A Mri jnt of lwr extre w/o dye 1.35 0.40 0.43 0.40 0.43 0.06 1.81 1.84 1.81 1.84 XXX
73722 A Mri joint of lwr extr w/dye 1.62 13.88 13.95 NA NA 0.54 16.04 16.11 NA NA XXX
73722 TC A Mri joint of lwr extr w/dye 0.00 13.40 13.43 NA NA 0.47 13.87 13.90 NA NA XXX
73722 26 A Mri joint of lwr extr w/dye 1.62 0.48 0.52 0.48 0.52 0.07 2.17 2.21 2.17 2.21 XXX
73723 A Mri joint lwr extr w/ow/dye 2.15 16.70 23.37 NA NA 0.94 19.79 26.46 NA NA XXX
73723 TC A Mri joint lwr extr w/ow/dye 0.00 16.09 22.68 NA NA 0.84 16.93 23.52 NA NA XXX
73723 26 A Mri joint lwr extr w/ow/dye 2.15 0.61 0.69 0.61 0.69 0.10 2.86 2.94 2.86 2.94 XXX
73725 R Mr ang lwr ext w or w/o dye 1.82 14.34 12.44 NA NA 0.67 16.83 14.93 NA NA XXX
73725 TC R Mr ang lwr ext w or w/o dye 0.00 13.82 11.86 NA NA 0.59 14.41 12.45 NA NA XXX
73725 26 R Mr ang lwr ext w or w/o dye 1.82 0.52 0.58 0.52 0.58 0.08 2.42 2.48 2.42 2.48 XXX
74000 A X-ray exam of abdomen 0.18 0.43 0.55 NA NA 0.03 0.64 0.76 NA NA XXX
74000 TC A X-ray exam of abdomen 0.00 0.38 0.49 NA NA 0.02 0.40 0.51 NA NA XXX
74000 26 A X-ray exam of abdomen 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
74010 A X-ray exam of abdomen 0.23 0.74 0.68 NA NA 0.05 1.02 0.96 NA NA XXX
74010 TC A X-ray exam of abdomen 0.00 0.68 0.60 NA NA 0.04 0.72 0.64 NA NA XXX
74010 26 A X-ray exam of abdomen 0.23 0.06 0.08 0.06 0.08 0.01 0.30 0.32 0.30 0.32 XXX
74020 A X-ray exam of abdomen 0.27 0.74 0.72 NA NA 0.05 1.06 1.04 NA NA XXX
74020 TC A X-ray exam of abdomen 0.00 0.67 0.63 NA NA 0.04 0.71 0.67 NA NA XXX
74020 26 A X-ray exam of abdomen 0.27 0.07 0.09 0.07 0.09 0.01 0.35 0.37 0.35 0.37 XXX
74022 A X-ray exam series, abdomen 0.32 0.91 0.85 NA NA 0.06 1.29 1.23 NA NA XXX
74022 TC A X-ray exam series, abdomen 0.00 0.82 0.75 NA NA 0.05 0.87 0.80 NA NA XXX
74022 26 A X-ray exam series, abdomen 0.32 0.09 0.10 0.09 0.10 0.01 0.42 0.43 0.42 0.43 XXX
74150 A Ct abdomen w/o dye 1.19 5.70 5.97 NA NA 0.35 7.24 7.51 NA NA XXX
74150 TC A Ct abdomen w/o dye 0.00 5.36 5.59 NA NA 0.30 5.66 5.89 NA NA XXX
74150 26 A Ct abdomen w/o dye 1.19 0.34 0.38 0.34 0.38 0.05 1.58 1.62 1.58 1.62 XXX
74160 A Ct abdomen w/dye 1.27 8.32 7.53 NA NA 0.42 10.01 9.22 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
74160 TC A Ct abdomen w/dye 0.00 7.96 7.12 NA NA 0.36 8.32 7.48 NA NA XXX
74160 26 A Ct abdomen w/dye 1.27 0.36 0.41 0.36 0.41 0.06 1.69 1.74 1.69 1.74 XXX
74170 A Ct abdomen w/o w/dye 1.40 11.54 9.60 NA NA 0.49 13.43 11.49 NA NA XXX
74170 TC A Ct abdomen w/o w/dye 0.00 11.14 9.15 NA NA 0.43 11.57 9.58 NA NA XXX
74170 26 A Ct abdomen w/o w/dye 1.40 0.40 0.45 0.40 0.45 0.06 1.86 1.91 1.86 1.91 XXX
74175 A Ct angio abdom w/o w/dye 1.90 11.60 12.39 NA NA 0.47 13.97 14.76 NA NA XXX
74175 TC A Ct angio abdom w/o w/dye 0.00 11.04 11.78 NA NA 0.39 11.43 12.17 NA NA XXX
74175 26 A Ct angio abdom w/o w/dye 1.90 0.56 0.61 0.56 0.61 0.08 2.54 2.59 2.54 2.59 XXX
74181 A Mri abdomen w/o dye 1.46 11.79 11.71 NA NA 0.51 13.76 13.68 NA NA XXX
74181 TC A Mri abdomen w/o dye 0.00 11.38 11.25 NA NA 0.45 11.83 11.70 NA NA XXX
74181 26 A Mri abdomen w/o dye 1.46 0.41 0.46 0.41 0.46 0.06 1.93 1.98 1.93 1.98 XXX
74182 A Mri abdomen w/dye 1.73 16.49 14.63 NA NA 0.60 18.82 16.96 NA NA XXX
74182 TC A Mri abdomen w/dye 0.00 16.00 14.08 NA NA 0.52 16.52 14.60 NA NA XXX
74182 26 A Mri abdomen w/dye 1.73 0.49 0.55 0.49 0.55 0.08 2.30 2.36 2.30 2.36 XXX
74183 A Mri abdomen w/o w/dye 2.26 18.00 23.72 NA NA 1.02 21.28 27.00 NA NA XXX
74183 TC A Mri abdomen w/o w/dye 0.00 17.36 23.00 NA NA 0.92 18.28 23.92 NA NA XXX
74183 26 A Mri abdomen w/o w/dye 2.26 0.64 0.72 0.64 0.72 0.10 3.00 3.08 3.00 3.08 XXX
74185 R Mri angio, abdom w orw/o dye 1.80 14.30 12.42 NA NA 0.67 16.77 14.89 NA NA XXX
74185 TC R Mri angio, abdom w orw/o dye 0.00 13.78 11.85 NA NA 0.59 14.37 12.44 NA NA XXX
74185 26 R Mri angio, abdom w orw/o dye 1.80 0.52 0.57 0.52 0.57 0.08 2.40 2.45 2.40 2.45 XXX
74190 C X-ray exam of peritoneum 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74190 TC C X-ray exam of peritoneum 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74190 26 A X-ray exam of peritoneum 0.48 0.14 0.16 0.14 0.16 0.02 0.64 0.66 0.64 0.66 XXX
74210 A Contrst x-ray exam of throat 0.36 1.65 1.40 NA NA 0.08 2.09 1.84 NA NA XXX
74210 TC A Contrst x-ray exam of throat 0.00 1.55 1.28 NA NA 0.06 1.61 1.34 NA NA XXX
74210 26 A Contrst x-ray exam of throat 0.36 0.10 0.12 0.10 0.12 0.02 0.48 0.50 0.48 0.50 XXX
74220 A Contrast x-ray, esophagus 0.46 1.89 1.48 NA NA 0.08 2.43 2.02 NA NA XXX
74220 TC A Contrast x-ray, esophagus 0.00 1.76 1.33 NA NA 0.06 1.82 1.39 NA NA XXX
74220 26 A Contrast x-ray, esophagus 0.46 0.13 0.15 0.13 0.15 0.02 0.61 0.63 0.61 0.63 XXX
74230 A Cine/vid x-ray, throat/esoph 0.53 1.81 1.57 NA NA 0.09 2.43 2.19 NA NA XXX
74230 TC A Cine/vid x-ray, throat/esoph 0.00 1.66 1.40 NA NA 0.07 1.73 1.47 NA NA XXX
74230 26 A Cine/vid x-ray, throat/esoph 0.53 0.15 0.17 0.15 0.17 0.02 0.70 0.72 0.70 0.72 XXX
74235 C Remove esophagus obstruction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74235 TC C Remove esophagus obstruction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74235 26 A Remove esophagus obstruction 1.19 0.38 0.39 0.38 0.39 0.05 1.62 1.63 1.62 1.63 XXX
74240 A X-ray exam, upper gi tract 0.69 2.14 1.80 NA NA 0.11 2.94 2.60 NA NA XXX
74240 TC A X-ray exam, upper gi tract 0.00 1.95 1.58 NA NA 0.08 2.03 1.66 NA NA XXX
74240 26 A X-ray exam, upper gi tract 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
74241 A X-ray exam, upper gi tract 0.69 2.40 1.89 NA NA 0.11 3.20 2.69 NA NA XXX
74241 TC A X-ray exam, upper gi tract 0.00 2.21 1.67 NA NA 0.08 2.29 1.75 NA NA XXX
74241 26 A X-ray exam, upper gi tract 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
74245 A X-ray exam, upper gi tract 0.91 3.70 2.94 NA NA 0.17 4.78 4.02 NA NA XXX
74245 TC A X-ray exam, upper gi tract 0.00 3.44 2.65 NA NA 0.13 3.57 2.78 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
74245 26 A X-ray exam, upper gi tract 0.91 0.26 0.29 0.26 0.29 0.04 1.21 1.24 1.21 1.24 XXX
74246 A Contrst x-ray uppr gi tract 0.69 2.62 2.06 NA NA 0.13 3.44 2.88 NA NA XXX
74246 TC A Contrst x-ray uppr gi tract 0.00 2.42 1.84 NA NA 0.10 2.52 1.94 NA NA XXX
74246 26 A Contrst x-ray uppr gi tract 0.69 0.20 0.22 0.20 0.22 0.03 0.92 0.94 0.92 0.94 XXX
74247 A Contrst x-ray uppr gi tract 0.69 3.00 2.18 NA NA 0.14 3.83 3.01 NA NA XXX
74247 TC A Contrst x-ray uppr gi tract 0.00 2.81 1.96 NA NA 0.11 2.92 2.07 NA NA XXX
74247 26 A Contrst x-ray uppr gi tract 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
74249 A Contrst x-ray uppr gi tract 0.91 4.07 3.17 NA NA 0.18 5.16 4.26 NA NA XXX
74249 TC A Contrst x-ray uppr gi tract 0.00 3.81 2.88 NA NA 0.14 3.95 3.02 NA NA XXX
74249 26 A Contrst x-ray uppr gi tract 0.91 0.26 0.29 0.26 0.29 0.04 1.21 1.24 1.21 1.24 XXX
74250 A X-ray exam of small bowel 0.47 2.33 1.68 NA NA 0.09 2.89 2.24 NA NA XXX
74250 TC A X-ray exam of small bowel 0.00 2.20 1.53 NA NA 0.07 2.27 1.60 NA NA XXX
74250 26 A X-ray exam of small bowel 0.47 0.13 0.15 0.13 0.15 0.02 0.62 0.64 0.62 0.64 XXX
74251 A X-ray exam of small bowel 0.69 9.46 3.52 NA NA 0.10 10.25 4.31 NA NA XXX
74251 TC A X-ray exam of small bowel 0.00 9.27 3.30 NA NA 0.07 9.34 3.37 NA NA XXX
74251 26 A X-ray exam of small bowel 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
74260 A X-ray exam of small bowel 0.50 7.87 3.21 NA NA 0.10 8.47 3.81 NA NA XXX
74260 TC A X-ray exam of small bowel 0.00 7.73 3.05 NA NA 0.08 7.81 3.13 NA NA XXX
74260 26 A X-ray exam of small bowel 0.50 0.14 0.16 0.14 0.16 0.02 0.66 0.68 0.66 0.68 XXX
74270 A Contrast x-ray exam of colon 0.69 3.35 2.29 NA NA 0.14 4.18 3.12 NA NA XXX
74270 TC A Contrast x-ray exam of colon 0.00 3.16 2.07 NA NA 0.11 3.27 2.18 NA NA XXX
74270 26 A Contrast x-ray exam of colon 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
74280 A Contrast x-ray exam of colon 0.99 4.64 3.07 NA NA 0.17 5.80 4.23 NA NA XXX
74280 TC A Contrast x-ray exam of colon 0.00 4.36 2.76 NA NA 0.13 4.49 2.89 NA NA XXX
74280 26 A Contrast x-ray exam of colon 0.99 0.28 0.31 0.28 0.31 0.04 1.31 1.34 1.31 1.34 XXX
74283 A Contrast x-ray exam of colon 2.02 3.22 3.23 NA NA 0.23 5.47 5.48 NA NA XXX
74283 TC A Contrast x-ray exam of colon 0.00 2.66 2.59 NA NA 0.14 2.80 2.73 NA NA XXX
74283 26 A Contrast x-ray exam of colon 2.02 0.56 0.64 0.56 0.64 0.09 2.67 2.75 2.67 2.75 XXX
74290 A Contrast x-ray, gallbladder 0.32 1.47 0.99 NA NA 0.06 1.85 1.37 NA NA XXX
74290 TC A Contrast x-ray, gallbladder 0.00 1.38 0.89 NA NA 0.05 1.43 0.94 NA NA XXX
74290 26 A Contrast x-ray, gallbladder 0.32 0.09 0.10 0.09 0.10 0.01 0.42 0.43 0.42 0.43 XXX
74291 A Contrast x-rays, gallbladder 0.20 1.55 0.76 NA NA 0.03 1.78 0.99 NA NA XXX
74291 TC A Contrast x-rays, gallbladder 0.00 1.49 0.69 NA NA 0.02 1.51 0.71 NA NA XXX
74291 26 A Contrast x-rays, gallbladder 0.20 0.06 0.07 0.06 0.07 0.01 0.27 0.28 0.27 0.28 XXX
74300 C X-ray bile ducts/pancreas 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74300 TC C X-ray bile ducts/pancreas 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74300 26 A X-ray bile ducts/pancreas 0.36 0.10 0.12 0.10 0.12 0.02 0.48 0.50 0.48 0.50 XXX
74301 C X-rays at surgery add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
74301 TC C X-rays at surgery add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
74301 26 A X-rays at surgery add-on 0.21 0.06 0.07 0.06 0.07 0.01 0.28 0.29 0.28 0.29 ZZZ
74305 C X-ray bile ducts/pancreas 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74305 TC C X-ray bile ducts/pancreas 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74305 26 A X-ray bile ducts/pancreas 0.42 0.12 0.14 0.12 0.14 0.02 0.56 0.58 0.56 0.58 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
74320 A Contrast x-ray of bile ducts 0.54 2.00 3.00 NA NA 0.19 2.73 3.73 NA NA XXX
74320 TC A Contrast x-ray of bile ducts 0.00 1.84 2.82 NA NA 0.17 2.01 2.99 NA NA XXX
74320 26 A Contrast x-ray of bile ducts 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
74327 A X-ray bile stone removal 0.70 2.78 2.19 NA NA 0.14 3.62 3.03 NA NA XXX
74327 TC A X-ray bile stone removal 0.00 2.58 1.97 NA NA 0.11 2.69 2.08 NA NA XXX
74327 26 A X-ray bile stone removal 0.70 0.20 0.22 0.20 0.22 0.03 0.93 0.95 0.93 0.95 XXX
74328 C X-ray bile duct endoscopy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74328 TC C X-ray bile duct endoscopy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74328 26 A X-ray bile duct endoscopy 0.70 0.22 0.23 0.22 0.23 0.03 0.95 0.96 0.95 0.96 XXX
74329 C X-ray for pancreas endoscopy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74329 TC C X-ray for pancreas endoscopy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74329 26 A X-ray for pancreas endoscopy 0.70 0.22 0.23 0.22 0.23 0.03 0.95 0.96 0.95 0.96 XXX
74330 C X-ray bile/panc endoscopy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74330 TC C X-ray bile/panc endoscopy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74330 26 A X-ray bile/panc endoscopy 0.90 0.27 0.29 0.27 0.29 0.04 1.21 1.23 1.21 1.23 XXX
74340 C X-ray guide for GI tube 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74340 TC C X-ray guide for GI tube 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74340 26 A X-ray guide for GI tube 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
74350 A X-ray guide, stomach tube 0.76 2.07 3.07 NA NA 0.20 3.03 4.03 NA NA XXX
74350 TC A X-ray guide, stomach tube 0.00 1.85 2.83 NA NA 0.17 2.02 3.00 NA NA XXX
74350 26 A X-ray guide, stomach tube 0.76 0.22 0.24 0.22 0.24 0.03 1.01 1.03 1.01 1.03 XXX
74355 C X-ray guide, intestinal tube 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74355 TC C X-ray guide, intestinal tube 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74355 26 A X-ray guide, intestinal tube 0.76 0.22 0.24 0.22 0.24 0.03 1.01 1.03 1.01 1.03 XXX
74360 C X-ray guide, GI dilation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74360 TC C X-ray guide, GI dilation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74360 26 A X-ray guide, GI dilation 0.54 0.24 0.20 0.24 0.20 0.02 0.80 0.76 0.80 0.76 XXX
74363 C X-ray, bile duct dilation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74363 TC C X-ray, bile duct dilation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74363 26 A X-ray, bile duct dilation 0.88 0.26 0.28 0.26 0.28 0.04 1.18 1.20 1.18 1.20 XXX
74400 A Contrst x-ray, urinary tract 0.49 2.45 2.00 NA NA 0.13 3.07 2.62 NA NA XXX
74400 TC A Contrst x-ray, urinary tract 0.00 2.31 1.84 NA NA 0.11 2.42 1.95 NA NA XXX
74400 26 A Contrst x-ray, urinary tract 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
74410 A Contrst x-ray, urinary tract 0.49 2.59 2.23 NA NA 0.13 3.21 2.85 NA NA XXX
74410 TC A Contrst x-ray, urinary tract 0.00 2.43 2.07 NA NA 0.11 2.54 2.18 NA NA XXX
74410 26 A Contrst x-ray, urinary tract 0.49 0.16 0.16 0.16 0.16 0.02 0.67 0.67 0.67 0.67 XXX
74415 A Contrst x-ray, urinary tract 0.49 3.09 2.49 NA NA 0.14 3.72 3.12 NA NA XXX
74415 TC A Contrst x-ray, urinary tract 0.00 2.95 2.33 NA NA 0.12 3.07 2.45 NA NA XXX
74415 26 A Contrst x-ray, urinary tract 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
74420 C Contrst x-ray, urinary tract 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74420 TC C Contrst x-ray, urinary tract 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74420 26 A Contrst x-ray, urinary tract 0.36 0.12 0.12 0.12 0.12 0.02 0.50 0.50 0.50 0.50 XXX
74425 C Contrst x-ray, urinary tract 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
74425 TC C Contrst x-ray, urinary tract 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74425 26 A Contrst x-ray, urinary tract 0.36 0.10 0.12 0.10 0.12 0.02 0.48 0.50 0.48 0.50 XXX
74430 A Contrast x-ray, bladder 0.32 1.87 1.33 NA NA 0.08 2.27 1.73 NA NA XXX
74430 TC A Contrast x-ray, bladder 0.00 1.77 1.23 NA NA 0.06 1.83 1.29 NA NA XXX
74430 26 A Contrast x-ray, bladder 0.32 0.10 0.10 0.10 0.10 0.02 0.44 0.44 0.44 0.44 XXX
74440 A X-ray, male genital tract 0.38 2.17 1.48 NA NA 0.08 2.63 1.94 NA NA XXX
74440 TC A X-ray, male genital tract 0.00 2.02 1.35 NA NA 0.06 2.08 1.41 NA NA XXX
74440 26 A X-ray, male genital tract 0.38 0.15 0.13 0.15 0.13 0.02 0.55 0.53 0.55 0.53 XXX
74445 C X-ray exam of penis 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74445 TC C X-ray exam of penis 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74445 26 A X-ray exam of penis 1.14 0.43 0.39 0.43 0.39 0.07 1.64 1.60 1.64 1.60 XXX
74450 C X-ray, urethra/bladder 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74450 TC C X-ray, urethra/bladder 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74450 26 A X-ray, urethra/bladder 0.33 0.11 0.11 0.11 0.11 0.02 0.46 0.46 0.46 0.46 XXX
74455 A X-ray, urethra/bladder 0.33 2.11 1.79 NA NA 0.12 2.56 2.24 NA NA XXX
74455 TC A X-ray, urethra/bladder 0.00 1.99 1.68 NA NA 0.10 2.09 1.78 NA NA XXX
74455 26 A X-ray, urethra/bladder 0.33 0.12 0.11 0.12 0.11 0.02 0.47 0.46 0.47 0.46 XXX
74470 C X-ray exam of kidney lesion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74470 TC C X-ray exam of kidney lesion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74470 26 A X-ray exam of kidney lesion 0.54 0.15 0.17 0.15 0.17 0.02 0.71 0.73 0.71 0.73 XXX
74475 A X-ray control, cath insert 0.54 1.99 3.69 NA NA 0.24 2.77 4.47 NA NA XXX
74475 TC A X-ray control, cath insert 0.00 1.83 3.51 NA NA 0.22 2.05 3.73 NA NA XXX
74475 26 A X-ray control, cath insert 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
74480 A X-ray control, cath insert 0.54 2.00 3.69 NA NA 0.24 2.78 4.47 NA NA XXX
74480 TC A X-ray control, cath insert 0.00 1.84 3.51 NA NA 0.22 2.06 3.73 NA NA XXX
74480 26 A X-ray control, cath insert 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
74485 A X-ray guide, GU dilation 0.54 2.18 3.03 NA NA 0.20 2.92 3.77 NA NA XXX
74485 TC A X-ray guide, GU dilation 0.00 2.00 2.86 NA NA 0.17 2.17 3.03 NA NA XXX
74485 26 A X-ray guide, GU dilation 0.54 0.18 0.17 0.18 0.17 0.03 0.75 0.74 0.75 0.74 XXX
74710 A X-ray measurement of pelvis 0.34 0.61 1.03 NA NA 0.08 1.03 1.45 NA NA XXX
74710 TC A X-ray measurement of pelvis 0.00 0.51 0.92 NA NA 0.06 0.57 0.98 NA NA XXX
74710 26 A X-ray measurement of pelvis 0.34 0.10 0.11 0.10 0.11 0.02 0.46 0.47 0.46 0.47 XXX
74740 A X-ray, female genital tract 0.38 1.67 1.50 NA NA 0.09 2.14 1.97 NA NA XXX
74740 TC A X-ray, female genital tract 0.00 1.56 1.37 NA NA 0.07 1.63 1.44 NA NA XXX
74740 26 A X-ray, female genital tract 0.38 0.11 0.13 0.11 0.13 0.02 0.51 0.53 0.51 0.53 XXX
74742 C X-ray, fallopian tube 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74742 TC C X-ray, fallopian tube 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
74742 26 A X-ray, fallopian tube 0.61 0.15 0.19 0.15 0.19 0.03 0.79 0.83 0.79 0.83 XXX
74775 C X-ray exam of perineum 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74775 TC C X-ray exam of perineum 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
74775 26 A X-ray exam of perineum 0.62 0.17 0.20 0.17 0.20 0.03 0.82 0.85 0.82 0.85 XXX
75552 A Heart mri for morph w/o dye 1.60 18.32 13.38 NA NA 0.66 20.58 15.64 NA NA XXX
75552 TC A Heart mri for morph w/o dye 0.00 17.80 12.85 NA NA 0.59 18.39 13.44 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75552 26 A Heart mri for morph w/o dye 1.60 0.52 0.53 0.52 0.53 0.07 2.19 2.20 2.19 2.20 XXX
75553 A Heart mri for morph w/dye 2.00 23.65 14.80 NA NA 0.66 26.31 17.46 NA NA XXX
75553 TC A Heart mri for morph w/dye 0.00 22.72 14.08 NA NA 0.59 23.31 14.67 NA NA XXX
75553 26 A Heart mri for morph w/dye 2.00 0.93 0.72 0.93 0.72 0.07 3.00 2.79 3.00 2.79 XXX
75554 A Cardiac MRI/function 1.83 26.45 15.50 NA NA 0.66 28.94 17.99 NA NA XXX
75554 TC A Cardiac MRI/function 0.00 25.67 14.82 NA NA 0.59 26.26 15.41 NA NA XXX
75554 26 A Cardiac MRI/function 1.83 0.78 0.68 0.78 0.68 0.07 2.68 2.58 2.68 2.58 XXX
75555 A Cardiac MRI/limited study 1.74 27.01 15.64 NA NA 0.66 29.41 18.04 NA NA XXX
75555 TC A Cardiac MRI/limited study 0.00 26.18 14.95 NA NA 0.59 26.77 15.54 NA NA XXX
75555 26 A Cardiac MRI/limited study 1.74 0.83 0.69 0.83 0.69 0.07 2.64 2.50 2.64 2.50 XXX
75556 N Cardiac MRI/flow mapping 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75600 A Contrast x-ray exam of aorta 0.49 6.39 11.20 NA NA 0.67 7.55 12.36 NA NA XXX
75600 TC A Contrast x-ray exam of aorta 0.00 6.14 10.99 NA NA 0.65 6.79 11.64 NA NA XXX
75600 26 A Contrast x-ray exam of aorta 0.49 0.25 0.21 0.25 0.21 0.02 0.76 0.72 0.76 0.72 XXX
75605 A Contrast x-ray exam of aorta 1.14 3.52 10.63 NA NA 0.70 5.36 12.47 NA NA XXX
75605 TC A Contrast x-ray exam of aorta 0.00 3.03 10.21 NA NA 0.65 3.68 10.86 NA NA XXX
75605 26 A Contrast x-ray exam of aorta 1.14 0.49 0.42 0.49 0.42 0.05 1.68 1.61 1.68 1.61 XXX
75625 A Contrast x-ray exam of aorta 1.14 3.25 10.55 NA NA 0.71 5.10 12.40 NA NA XXX
75625 TC A Contrast x-ray exam of aorta 0.00 2.85 10.16 NA NA 0.65 3.50 10.81 NA NA XXX
75625 26 A Contrast x-ray exam of aorta 1.14 0.40 0.39 0.40 0.39 0.06 1.60 1.59 1.60 1.59 XXX
75630 A X-ray aorta, leg arteries 1.79 3.72 11.24 NA NA 0.80 6.31 13.83 NA NA XXX
75630 TC A X-ray aorta, leg arteries 0.00 3.01 10.60 NA NA 0.69 3.70 11.29 NA NA XXX
75630 26 A X-ray aorta, leg arteries 1.79 0.71 0.64 0.71 0.64 0.11 2.61 2.54 2.61 2.54 XXX
75635 A Ct angio abdominal arteries 2.40 12.15 15.56 NA NA 0.50 15.05 18.46 NA NA XXX
75635 TC A Ct angio abdominal arteries 0.00 11.40 14.78 NA NA 0.39 11.79 15.17 NA NA XXX
75635 26 A Ct angio abdominal arteries 2.40 0.75 0.78 0.75 0.78 0.11 3.26 3.29 3.26 3.29 XXX
75650 A Artery x-rays, head neck 1.49 3.37 10.66 NA NA 0.72 5.58 12.87 NA NA XXX
75650 TC A Artery x-rays, head neck 0.00 2.85 10.16 NA NA 0.65 3.50 10.81 NA NA XXX
75650 26 A Artery x-rays, head neck 1.49 0.52 0.50 0.52 0.50 0.07 2.08 2.06 2.08 2.06 XXX
75658 A Artery x-rays, arm 1.31 3.73 10.74 NA NA 0.72 5.76 12.77 NA NA XXX
75658 TC A Artery x-rays, arm 0.00 3.26 10.27 NA NA 0.65 3.91 10.92 NA NA XXX
75658 26 A Artery x-rays, arm 1.31 0.47 0.47 0.47 0.47 0.07 1.85 1.85 1.85 1.85 XXX
75660 A Artery x-rays, head neck 1.31 3.78 10.73 NA NA 0.71 5.80 12.75 NA NA XXX
75660 TC A Artery x-rays, head neck 0.00 3.31 10.28 NA NA 0.65 3.96 10.93 NA NA XXX
75660 26 A Artery x-rays, head neck 1.31 0.47 0.45 0.47 0.45 0.06 1.84 1.82 1.84 1.82 XXX
75662 A Artery x-rays, head neck 1.66 4.96 11.14 NA NA 0.71 7.33 13.51 NA NA XXX
75662 TC A Artery x-rays, head neck 0.00 4.26 10.52 NA NA 0.65 4.91 11.17 NA NA XXX
75662 26 A Artery x-rays, head neck 1.66 0.70 0.62 0.70 0.62 0.06 2.42 2.34 2.42 2.34 XXX
75665 A Artery x-rays, head neck 1.31 3.92 10.76 NA NA 0.74 5.97 12.81 NA NA XXX
75665 TC A Artery x-rays, head neck 0.00 3.48 10.32 NA NA 0.65 4.13 10.97 NA NA XXX
75665 26 A Artery x-rays, head neck 1.31 0.44 0.44 0.44 0.44 0.09 1.84 1.84 1.84 1.84 XXX
75671 A Artery x-rays, head neck 1.66 4.84 11.08 NA NA 0.72 7.22 13.46 NA NA XXX
75671 TC A Artery x-rays, head neck 0.00 4.27 10.52 NA NA 0.65 4.92 11.17 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75671 26 A Artery x-rays, head neck 1.66 0.57 0.56 0.57 0.56 0.07 2.30 2.29 2.30 2.29 XXX
75676 A Artery x-rays, neck 1.31 3.71 10.71 NA NA 0.72 5.74 12.74 NA NA XXX
75676 TC A Artery x-rays, neck 0.00 3.26 10.27 NA NA 0.65 3.91 10.92 NA NA XXX
75676 26 A Artery x-rays, neck 1.31 0.45 0.44 0.45 0.44 0.07 1.83 1.82 1.83 1.82 XXX
75680 A Artery x-rays, neck 1.66 4.41 10.96 NA NA 0.72 6.79 13.34 NA NA XXX
75680 TC A Artery x-rays, neck 0.00 3.81 10.40 NA NA 0.65 4.46 11.05 NA NA XXX
75680 26 A Artery x-rays, neck 1.66 0.60 0.56 0.60 0.56 0.07 2.33 2.29 2.33 2.29 XXX
75685 A Artery x-rays, spine 1.31 3.71 10.70 NA NA 0.71 5.73 12.72 NA NA XXX
75685 TC A Artery x-rays, spine 0.00 3.25 10.26 NA NA 0.65 3.90 10.91 NA NA XXX
75685 26 A Artery x-rays, spine 1.31 0.46 0.44 0.46 0.44 0.06 1.83 1.81 1.83 1.81 XXX
75705 A Artery x-rays, spine 2.18 3.81 10.95 NA NA 0.78 6.77 13.91 NA NA XXX
75705 TC A Artery x-rays, spine 0.00 3.15 10.24 NA NA 0.65 3.80 10.89 NA NA XXX
75705 26 A Artery x-rays, spine 2.18 0.66 0.71 0.66 0.71 0.13 2.97 3.02 2.97 3.02 XXX
75710 A Artery x-rays, arm/leg 1.14 3.87 10.72 NA NA 0.72 5.73 12.58 NA NA XXX
75710 TC A Artery x-rays, arm/leg 0.00 3.46 10.32 NA NA 0.65 4.11 10.97 NA NA XXX
75710 26 A Artery x-rays, arm/leg 1.14 0.41 0.40 0.41 0.40 0.07 1.62 1.61 1.62 1.61 XXX
75716 A Artery x-rays, arms/legs 1.31 4.75 10.96 NA NA 0.72 6.78 12.99 NA NA XXX
75716 TC A Artery x-rays, arms/legs 0.00 4.28 10.52 NA NA 0.65 4.93 11.17 NA NA XXX
75716 26 A Artery x-rays, arms/legs 1.31 0.47 0.44 0.47 0.44 0.07 1.85 1.82 1.85 1.82 XXX
75722 A Artery x-rays, kidney 1.14 3.78 10.70 NA NA 0.70 5.62 12.54 NA NA XXX
75722 TC A Artery x-rays, kidney 0.00 3.32 10.28 NA NA 0.65 3.97 10.93 NA NA XXX
75722 26 A Artery x-rays, kidney 1.14 0.46 0.42 0.46 0.42 0.05 1.65 1.61 1.65 1.61 XXX
75724 A Artery x-rays, kidneys 1.49 5.13 11.15 NA NA 0.70 7.32 13.34 NA NA XXX
75724 TC A Artery x-rays, kidneys 0.00 4.37 10.54 NA NA 0.65 5.02 11.19 NA NA XXX
75724 26 A Artery x-rays, kidneys 1.49 0.76 0.61 0.76 0.61 0.05 2.30 2.15 2.30 2.15 XXX
75726 A Artery x-rays, abdomen 1.14 3.51 10.61 NA NA 0.70 5.35 12.45 NA NA XXX
75726 TC A Artery x-rays, abdomen 0.00 3.16 10.24 NA NA 0.65 3.81 10.89 NA NA XXX
75726 26 A Artery x-rays, abdomen 1.14 0.35 0.37 0.35 0.37 0.05 1.54 1.56 1.54 1.56 XXX
75731 A Artery x-rays, adrenal gland 1.14 3.72 10.66 NA NA 0.71 5.57 12.51 NA NA XXX
75731 TC A Artery x-rays, adrenal gland 0.00 3.32 10.28 NA NA 0.65 3.97 10.93 NA NA XXX
75731 26 A Artery x-rays, adrenal gland 1.14 0.40 0.38 0.40 0.38 0.06 1.60 1.58 1.60 1.58 XXX
75733 A Artery x-rays, adrenals 1.31 5.11 11.06 NA NA 0.71 7.13 13.08 NA NA XXX
75733 TC A Artery x-rays, adrenals 0.00 4.53 10.58 NA NA 0.65 5.18 11.23 NA NA XXX
75733 26 A Artery x-rays, adrenals 1.31 0.58 0.48 0.58 0.48 0.06 1.95 1.85 1.95 1.85 XXX
75736 A Artery x-rays, pelvis 1.14 3.69 10.66 NA NA 0.71 5.54 12.51 NA NA XXX
75736 TC A Artery x-rays, pelvis 0.00 3.30 10.28 NA NA 0.65 3.95 10.93 NA NA XXX
75736 26 A Artery x-rays, pelvis 1.14 0.39 0.38 0.39 0.38 0.06 1.59 1.58 1.59 1.58 XXX
75741 A Artery x-rays, lung 1.31 2.96 10.52 NA NA 0.71 4.98 12.54 NA NA XXX
75741 TC A Artery x-rays, lung 0.00 2.55 10.09 NA NA 0.65 3.20 10.74 NA NA XXX
75741 26 A Artery x-rays, lung 1.31 0.41 0.43 0.41 0.43 0.06 1.78 1.80 1.78 1.80 XXX
75743 A Artery x-rays, lungs 1.66 3.30 10.68 NA NA 0.72 5.68 13.06 NA NA XXX
75743 TC A Artery x-rays, lungs 0.00 2.79 10.15 NA NA 0.65 3.44 10.80 NA NA XXX
75743 26 A Artery x-rays, lungs 1.66 0.51 0.53 0.51 0.53 0.07 2.24 2.26 2.24 2.26 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75746 A Artery x-rays, lung 1.14 3.30 10.56 NA NA 0.70 5.14 12.40 NA NA XXX
75746 TC A Artery x-rays, lung 0.00 2.96 10.19 NA NA 0.65 3.61 10.84 NA NA XXX
75746 26 A Artery x-rays, lung 1.14 0.34 0.37 0.34 0.37 0.05 1.53 1.56 1.53 1.56 XXX
75756 A Artery x-rays, chest 1.14 4.38 10.88 NA NA 0.69 6.21 12.71 NA NA XXX
75756 TC A Artery x-rays, chest 0.00 3.77 10.39 NA NA 0.65 4.42 11.04 NA NA XXX
75756 26 A Artery x-rays, chest 1.14 0.61 0.49 0.61 0.49 0.04 1.79 1.67 1.79 1.67 XXX
75774 A Artery x-ray, each vessel 0.36 2.43 10.15 2.43 10.15 0.67 3.46 11.18 3.46 11.18 ZZZ
75774 TC A Artery x-ray, each vessel 0.00 2.31 10.03 2.31 10.03 0.65 2.96 10.68 2.96 10.68 ZZZ
75774 26 A Artery x-ray, each vessel 0.36 0.12 0.12 0.12 0.12 0.02 0.50 0.50 0.50 0.50 ZZZ
75790 A Visualize A-V shunt 1.84 2.94 2.20 NA NA 0.17 4.95 4.21 NA NA XXX
75790 TC A Visualize A-V shunt 0.00 2.42 1.62 NA NA 0.08 2.50 1.70 NA NA XXX
75790 26 A Visualize A-V shunt 1.84 0.52 0.58 0.52 0.58 0.09 2.45 2.51 2.45 2.51 XXX
75801 C Lymph vessel x-ray, arm/leg 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75801 TC C Lymph vessel x-ray, arm/leg 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75801 26 A Lymph vessel x-ray, arm/leg 0.81 0.22 0.26 0.22 0.26 0.08 1.11 1.15 1.11 1.15 XXX
75803 C Lymph vessel x-ray,arms/legs 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75803 TC C Lymph vessel x-ray,arms/legs 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75803 26 A Lymph vessel x-ray,arms/legs 1.17 0.31 0.36 0.31 0.36 0.05 1.53 1.58 1.53 1.58 XXX
75805 C Lymph vessel x-ray, trunk 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75805 TC C Lymph vessel x-ray, trunk 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75805 26 A Lymph vessel x-ray, trunk 0.81 0.22 0.26 0.22 0.26 0.05 1.08 1.12 1.08 1.12 XXX
75807 C Lymph vessel x-ray, trunk 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75807 TC C Lymph vessel x-ray, trunk 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75807 26 A Lymph vessel x-ray, trunk 1.17 0.34 0.37 0.34 0.37 0.05 1.56 1.59 1.56 1.59 XXX
75809 A Nonvascular shunt, x-ray 0.47 2.05 1.22 NA NA 0.07 2.59 1.76 NA NA XXX
75809 TC A Nonvascular shunt, x-ray 0.00 1.92 1.07 NA NA 0.05 1.97 1.12 NA NA XXX
75809 26 A Nonvascular shunt, x-ray 0.47 0.13 0.15 0.13 0.15 0.02 0.62 0.64 0.62 0.64 XXX
75810 C Vein x-ray, spleen/liver 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75810 TC C Vein x-ray, spleen/liver 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75810 26 A Vein x-ray, spleen/liver 1.14 0.34 0.36 0.34 0.36 0.05 1.53 1.55 1.53 1.55 XXX
75820 A Vein x-ray, arm/leg 0.70 2.92 1.62 NA NA 0.09 3.71 2.41 NA NA XXX
75820 TC A Vein x-ray, arm/leg 0.00 2.65 1.38 NA NA 0.06 2.71 1.44 NA NA XXX
75820 26 A Vein x-ray, arm/leg 0.70 0.27 0.24 0.27 0.24 0.03 1.00 0.97 1.00 0.97 XXX
75822 A Vein x-ray, arms/legs 1.06 3.00 2.12 NA NA 0.13 4.19 3.31 NA NA XXX
75822 TC A Vein x-ray, arms/legs 0.00 2.68 1.78 NA NA 0.08 2.76 1.86 NA NA XXX
75822 26 A Vein x-ray, arms/legs 1.06 0.32 0.34 0.32 0.34 0.05 1.43 1.45 1.43 1.45 XXX
75825 A Vein x-ray, trunk 1.14 2.77 10.42 NA NA 0.72 4.63 12.28 NA NA XXX
75825 TC A Vein x-ray, trunk 0.00 2.44 10.06 NA NA 0.65 3.09 10.71 NA NA XXX
75825 26 A Vein x-ray, trunk 1.14 0.33 0.36 0.33 0.36 0.07 1.54 1.57 1.54 1.57 XXX
75827 A Vein x-ray, chest 1.14 2.81 10.43 NA NA 0.70 4.65 12.27 NA NA XXX
75827 TC A Vein x-ray, chest 0.00 2.48 10.07 NA NA 0.65 3.13 10.72 NA NA XXX
75827 26 A Vein x-ray, chest 1.14 0.33 0.36 0.33 0.36 0.05 1.52 1.55 1.52 1.55 XXX
75831 A Vein x-ray, kidney 1.14 2.88 10.45 NA NA 0.71 4.73 12.30 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75831 TC A Vein x-ray, kidney 0.00 2.55 10.09 NA NA 0.65 3.20 10.74 NA NA XXX
75831 26 A Vein x-ray, kidney 1.14 0.33 0.36 0.33 0.36 0.06 1.53 1.56 1.53 1.56 XXX
75833 A Vein x-ray, kidneys 1.49 3.50 10.70 NA NA 0.74 5.73 12.93 NA NA XXX
75833 TC A Vein x-ray, kidneys 0.00 3.06 10.22 NA NA 0.65 3.71 10.87 NA NA XXX
75833 26 A Vein x-ray, kidneys 1.49 0.44 0.48 0.44 0.48 0.09 2.02 2.06 2.02 2.06 XXX
75840 A Vein x-ray, adrenal gland 1.14 3.17 10.53 NA NA 0.72 5.03 12.39 NA NA XXX
75840 TC A Vein x-ray, adrenal gland 0.00 2.74 10.14 NA NA 0.65 3.39 10.79 NA NA XXX
75840 26 A Vein x-ray, adrenal gland 1.14 0.43 0.39 0.43 0.39 0.07 1.64 1.60 1.64 1.60 XXX
75842 A Vein x-ray, adrenal glands 1.49 3.44 10.67 NA NA 0.72 5.65 12.88 NA NA XXX
75842 TC A Vein x-ray, adrenal glands 0.00 3.00 10.20 NA NA 0.65 3.65 10.85 NA NA XXX
75842 26 A Vein x-ray, adrenal glands 1.49 0.44 0.47 0.44 0.47 0.07 2.00 2.03 2.00 2.03 XXX
75860 A Vein x-ray, neck 1.14 3.37 10.59 NA NA 0.69 5.20 12.42 NA NA XXX
75860 TC A Vein x-ray, neck 0.00 2.88 10.17 NA NA 0.65 3.53 10.82 NA NA XXX
75860 26 A Vein x-ray, neck 1.14 0.49 0.42 0.49 0.42 0.04 1.67 1.60 1.67 1.60 XXX
75870 A Vein x-ray, skull 1.14 3.11 10.52 NA NA 0.70 4.95 12.36 NA NA XXX
75870 TC A Vein x-ray, skull 0.00 2.73 10.13 NA NA 0.65 3.38 10.78 NA NA XXX
75870 26 A Vein x-ray, skull 1.14 0.38 0.39 0.38 0.39 0.05 1.57 1.58 1.57 1.58 XXX
75872 A Vein x-ray, skull 1.14 3.85 10.70 NA NA 0.79 5.78 12.63 NA NA XXX
75872 TC A Vein x-ray, skull 0.00 3.42 10.31 NA NA 0.65 4.07 10.96 NA NA XXX
75872 26 A Vein x-ray, skull 1.14 0.43 0.39 0.43 0.39 0.14 1.71 1.67 1.71 1.67 XXX
75880 A Vein x-ray, eye socket 0.70 2.87 1.61 NA NA 0.09 3.66 2.40 NA NA XXX
75880 TC A Vein x-ray, eye socket 0.00 2.65 1.38 NA NA 0.06 2.71 1.44 NA NA XXX
75880 26 A Vein x-ray, eye socket 0.70 0.22 0.23 0.22 0.23 0.03 0.95 0.96 0.95 0.96 XXX
75885 A Vein x-ray, liver 1.44 2.95 10.54 NA NA 0.71 5.10 12.69 NA NA XXX
75885 TC A Vein x-ray, liver 0.00 2.53 10.08 NA NA 0.65 3.18 10.73 NA NA XXX
75885 26 A Vein x-ray, liver 1.44 0.42 0.46 0.42 0.46 0.06 1.92 1.96 1.92 1.96 XXX
75887 A Vein x-ray, liver 1.44 3.17 10.60 NA NA 0.71 5.32 12.75 NA NA XXX
75887 TC A Vein x-ray, liver 0.00 2.70 10.13 NA NA 0.65 3.35 10.78 NA NA XXX
75887 26 A Vein x-ray, liver 1.44 0.47 0.47 0.47 0.47 0.06 1.97 1.97 1.97 1.97 XXX
75889 A Vein x-ray, liver 1.14 2.87 10.44 NA NA 0.70 4.71 12.28 NA NA XXX
75889 TC A Vein x-ray, liver 0.00 2.53 10.08 NA NA 0.65 3.18 10.73 NA NA XXX
75889 26 A Vein x-ray, liver 1.14 0.34 0.36 0.34 0.36 0.05 1.53 1.55 1.53 1.55 XXX
75891 A Vein x-ray, liver 1.14 2.84 10.44 NA NA 0.70 4.68 12.28 NA NA XXX
75891 TC A Vein x-ray, liver 0.00 2.51 10.08 NA NA 0.65 3.16 10.73 NA NA XXX
75891 26 A Vein x-ray, liver 1.14 0.33 0.36 0.33 0.36 0.05 1.52 1.55 1.52 1.55 XXX
75893 A Venous sampling by catheter 0.54 2.71 10.27 NA NA 0.67 3.92 11.48 NA NA XXX
75893 TC A Venous sampling by catheter 0.00 2.55 10.09 NA NA 0.65 3.20 10.74 NA NA XXX
75893 26 A Venous sampling by catheter 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
75894 C X-rays, transcath therapy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75894 TC C X-rays, transcath therapy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75894 26 A X-rays, transcath therapy 1.31 0.39 0.42 0.39 0.42 0.08 1.78 1.81 1.78 1.81 XXX
75896 C X-rays, transcath therapy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75896 TC C X-rays, transcath therapy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75896 26 A X-rays, transcath therapy 1.31 0.49 0.46 0.49 0.46 0.05 1.85 1.82 1.85 1.82 XXX
75898 C Follow-up angiography 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75898 TC C Follow-up angiography 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75898 26 A Follow-up angiography 1.65 0.56 0.55 0.56 0.55 0.07 2.28 2.27 2.28 2.27 XXX
75900 C Intravascular cath exchange 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75900 TC C Intravascular cath exchange 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75900 26 A Intravascular cath exchange 0.49 0.15 0.16 0.15 0.16 0.03 0.67 0.68 0.67 0.68 XXX
75901 A Remove cva device obstruct 0.49 3.94 2.09 NA NA 0.85 5.28 3.43 NA NA XXX
75901 TC A Remove cva device obstruct 0.00 3.80 1.93 NA NA 0.83 4.63 2.76 NA NA XXX
75901 26 A Remove cva device obstruct 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
75902 A Remove cva lumen obstruct 0.39 1.54 1.47 NA NA 0.85 2.78 2.71 NA NA XXX
75902 TC A Remove cva lumen obstruct 0.00 1.43 1.34 NA NA 0.83 2.26 2.17 NA NA XXX
75902 26 A Remove cva lumen obstruct 0.39 0.11 0.13 0.11 0.13 0.02 0.52 0.54 0.52 0.54 XXX
75940 C X-ray placement, vein filter 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75940 TC C X-ray placement, vein filter 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75940 26 A X-ray placement, vein filter 0.54 0.16 0.18 0.16 0.18 0.04 0.74 0.76 0.74 0.76 XXX
75945 C Intravascular us 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75945 TC C Intravascular us 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75945 26 A Intravascular us 0.40 0.15 0.14 0.15 0.14 0.04 0.59 0.58 0.59 0.58 XXX
75946 C Intravascular us add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75946 TC C Intravascular us add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75946 26 A Intravascular us add-on 0.40 0.13 0.14 0.13 0.14 0.05 0.58 0.59 0.58 0.59 ZZZ
75952 C Endovasc repair abdom aorta 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75952 TC C Endovasc repair abdom aorta 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75952 26 A Endovasc repair abdom aorta 4.49 1.27 1.44 1.27 1.44 0.43 6.19 6.36 6.19 6.36 XXX
75953 C Abdom aneurysm endovas rpr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75953 TC C Abdom aneurysm endovas rpr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75953 26 A Abdom aneurysm endovas rpr 1.36 0.39 0.44 0.39 0.44 0.13 1.88 1.93 1.88 1.93 XXX
75954 C Iliac aneurysm endovas rpr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75954 TC C Iliac aneurysm endovas rpr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75954 26 A Iliac aneurysm endovas rpr 2.25 0.64 0.75 0.64 0.75 0.15 3.04 3.15 3.04 3.15 XXX
75956 C Xray, endovasc thor ao repr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75956 TC C Xray, endovasc thor ao repr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75956 26 A Xray, endovasc thor ao repr 7.00 1.78 2.47 1.78 2.47 0.69 9.47 10.16 9.47 10.16 XXX
75957 C Xray, endovasc thor ao repr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75957 TC C Xray, endovasc thor ao repr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75957 26 A Xray, endovasc thor ao repr 6.00 1.56 2.12 1.56 2.12 0.59 8.15 8.71 8.15 8.71 XXX
75958 C Xray, place prox ext thor ao 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75958 TC C Xray, place prox ext thor ao 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75958 26 A Xray, place prox ext thor ao 4.00 0.98 1.41 0.98 1.41 0.39 5.37 5.80 5.37 5.80 XXX
75959 C Xray, place dist ext thor ao 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75959 TC C Xray, place dist ext thor ao 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75959 26 A Xray, place dist ext thor ao 3.50 0.86 1.24 0.86 1.24 0.34 4.70 5.08 4.70 5.08 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75960 C Transcath iv stent rsi 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75960 TC C Transcath iv stent rsi 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75960 26 A Transcath iv stent rsi 0.82 0.31 0.29 0.31 0.29 0.05 1.18 1.16 1.18 1.16 XXX
75961 A Retrieval, broken catheter 4.24 4.30 9.99 NA NA 0.73 9.27 14.96 NA NA XXX
75961 TC A Retrieval, broken catheter 0.00 3.03 8.63 NA NA 0.55 3.58 9.18 NA NA XXX
75961 26 A Retrieval, broken catheter 4.24 1.27 1.36 1.27 1.36 0.18 5.69 5.78 5.69 5.78 XXX
75962 A Repair arterial blockage 0.54 3.43 12.80 NA NA 0.86 4.83 14.20 NA NA XXX
75962 TC A Repair arterial blockage 0.00 3.24 12.62 NA NA 0.83 4.07 13.45 NA NA XXX
75962 26 A Repair arterial blockage 0.54 0.19 0.18 0.19 0.18 0.03 0.76 0.75 0.76 0.75 XXX
75964 A Repair artery blockage, each 0.36 2.31 6.96 2.31 6.96 0.46 3.13 7.78 3.13 7.78 ZZZ
75964 TC A Repair artery blockage, each 0.00 2.19 6.84 2.19 6.84 0.43 2.62 7.27 2.62 7.27 ZZZ
75964 26 A Repair artery blockage, each 0.36 0.12 0.12 0.12 0.12 0.03 0.51 0.51 0.51 0.51 ZZZ
75966 A Repair arterial blockage 1.31 4.12 13.18 NA NA 0.89 6.32 15.38 NA NA XXX
75966 TC A Repair arterial blockage 0.00 3.55 12.69 NA NA 0.83 4.38 13.52 NA NA XXX
75966 26 A Repair arterial blockage 1.31 0.57 0.49 0.57 0.49 0.06 1.94 1.86 1.94 1.86 XXX
75968 A Repair artery blockage, each 0.36 2.38 6.99 2.38 6.99 0.45 3.19 7.80 3.19 7.80 ZZZ
75968 TC A Repair artery blockage, each 0.00 2.23 6.85 2.23 6.85 0.43 2.66 7.28 2.66 7.28 ZZZ
75968 26 A Repair artery blockage, each 0.36 0.15 0.14 0.15 0.14 0.02 0.53 0.52 0.53 0.52 ZZZ
75970 C Vascular biopsy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75970 TC C Vascular biopsy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75970 26 A Vascular biopsy 0.83 0.26 0.28 0.26 0.28 0.04 1.13 1.15 1.13 1.15 XXX
75978 A Repair venous blockage 0.54 3.11 12.72 NA NA 0.85 4.50 14.11 NA NA XXX
75978 TC A Repair venous blockage 0.00 2.95 12.54 NA NA 0.83 3.78 13.37 NA NA XXX
75978 26 A Repair venous blockage 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
75980 C Contrast xray exam bile duct 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75980 TC C Contrast xray exam bile duct 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75980 26 A Contrast xray exam bile duct 1.44 0.42 0.46 0.42 0.46 0.06 1.92 1.96 1.92 1.96 XXX
75982 C Contrast xray exam bile duct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75982 TC C Contrast xray exam bile duct 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75982 26 A Contrast xray exam bile duct 1.44 0.42 0.46 0.42 0.46 0.06 1.92 1.96 1.92 1.96 XXX
75984 A Xray control catheter change 0.72 2.16 2.18 NA NA 0.14 3.02 3.04 NA NA XXX
75984 TC A Xray control catheter change 0.00 1.95 1.95 NA NA 0.11 2.06 2.06 NA NA XXX
75984 26 A Xray control catheter change 0.72 0.21 0.23 0.21 0.23 0.03 0.96 0.98 0.96 0.98 XXX
75989 A Abscess drainage under x-ray 1.19 2.07 3.18 NA NA 0.22 3.48 4.59 NA NA XXX
75989 TC A Abscess drainage under x-ray 0.00 1.73 2.80 NA NA 0.17 1.90 2.97 NA NA XXX
75989 26 A Abscess drainage under x-ray 1.19 0.34 0.38 0.34 0.38 0.05 1.58 1.62 1.58 1.62 XXX
75992 C Atherectomy, x-ray exam 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75992 TC C Atherectomy, x-ray exam 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
75992 26 A Atherectomy, x-ray exam 0.54 0.23 0.20 0.23 0.20 0.03 0.80 0.77 0.80 0.77 XXX
75993 C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75993 TC C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75993 26 A Atherectomy, x-ray exam 0.36 0.15 0.14 0.15 0.14 0.02 0.53 0.52 0.53 0.52 ZZZ
75994 C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
75994 TC C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75994 26 A Atherectomy, x-ray exam 1.31 0.62 0.50 0.62 0.50 0.07 2.00 1.88 2.00 1.88 XXX
75995 C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75995 TC C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
75995 26 A Atherectomy, x-ray exam 1.31 0.50 0.48 0.50 0.48 0.05 1.86 1.84 1.86 1.84 XXX
75996 C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75996 TC C Atherectomy, x-ray exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
75996 26 A Atherectomy, x-ray exam 0.36 0.14 0.13 0.14 0.13 0.02 0.52 0.51 0.52 0.51 ZZZ
76000 A Fluoroscope examination 0.17 2.64 1.68 NA NA 0.08 2.89 1.93 NA NA XXX
76000 TC A Fluoroscope examination 0.00 2.59 1.63 NA NA 0.07 2.66 1.70 NA NA XXX
76000 26 A Fluoroscope examination 0.17 0.05 0.05 0.05 0.05 0.01 0.23 0.23 0.23 0.23 XXX
76001 C Fluoroscope exam, extensive 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76001 TC C Fluoroscope exam, extensive 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76001 26 A Fluoroscope exam, extensive 0.67 0.21 0.22 0.21 0.22 0.05 0.93 0.94 0.93 0.94 XXX
76010 A X-ray, nose to rectum 0.18 0.51 0.57 NA NA 0.03 0.72 0.78 NA NA XXX
76010 TC A X-ray, nose to rectum 0.00 0.46 0.51 NA NA 0.02 0.48 0.53 NA NA XXX
76010 26 A X-ray, nose to rectum 0.18 0.05 0.06 0.05 0.06 0.01 0.24 0.25 0.24 0.25 XXX
76080 A X-ray exam of fistula 0.54 1.01 1.18 NA NA 0.08 1.63 1.80 NA NA XXX
76080 TC A X-ray exam of fistula 0.00 0.85 1.00 NA NA 0.06 0.91 1.06 NA NA XXX
76080 26 A X-ray exam of fistula 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
76098 A X-ray exam, breast specimen 0.16 0.29 0.43 NA NA 0.03 0.48 0.62 NA NA XXX
76098 TC A X-ray exam, breast specimen 0.00 0.25 0.38 NA NA 0.02 0.27 0.40 NA NA XXX
76098 26 A X-ray exam, breast specimen 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
76100 A X-ray exam of body section 0.58 3.41 1.93 NA NA 0.10 4.09 2.61 NA NA XXX
76100 TC A X-ray exam of body section 0.00 3.22 1.74 NA NA 0.07 3.29 1.81 NA NA XXX
76100 26 A X-ray exam of body section 0.58 0.19 0.19 0.19 0.19 0.03 0.80 0.80 0.80 0.80 XXX
76101 A Complex body section x-ray 0.58 5.17 2.50 NA NA 0.11 5.86 3.19 NA NA XXX
76101 TC A Complex body section x-ray 0.00 4.99 2.31 NA NA 0.08 5.07 2.39 NA NA XXX
76101 26 A Complex body section x-ray 0.58 0.18 0.19 0.18 0.19 0.03 0.79 0.80 0.79 0.80 XXX
76102 A Complex body section x-rays 0.58 7.61 3.35 NA NA 0.14 8.33 4.07 NA NA XXX
76102 TC A Complex body section x-rays 0.00 7.43 3.16 NA NA 0.11 7.54 3.27 NA NA XXX
76102 26 A Complex body section x-rays 0.58 0.18 0.19 0.18 0.19 0.03 0.79 0.80 0.79 0.80 XXX
76120 A Cine/video x-rays 0.38 1.83 1.34 NA NA 0.08 2.29 1.80 NA NA XXX
76120 TC A Cine/video x-rays 0.00 1.70 1.21 NA NA 0.06 1.76 1.27 NA NA XXX
76120 26 A Cine/video x-rays 0.38 0.13 0.13 0.13 0.13 0.02 0.53 0.53 0.53 0.53 XXX
76125 C Cine/video x-rays add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
76125 TC C Cine/video x-rays add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
76125 26 A Cine/video x-rays add-on 0.27 0.10 0.09 0.10 0.09 0.01 0.38 0.37 0.38 0.37 ZZZ
76140 I X-ray consultation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76150 A X-ray exam, dry process 0.00 0.67 0.48 NA NA 0.02 0.69 0.50 NA NA XXX
76350 C Special x-ray contrast study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76376 A 3d render w/o postprocess 0.20 1.32 2.95 NA NA 0.10 1.62 3.25 NA NA XXX
76376 TC A 3d render w/o postprocess 0.00 1.26 2.88 NA NA 0.08 1.34 2.96 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
76376 26 A 3d render w/o postprocess 0.20 0.06 0.07 0.06 0.07 0.02 0.28 0.29 0.28 0.29 XXX
76377 A 3d rendering w/postprocess 0.79 1.28 3.09 NA NA 0.39 2.46 4.27 NA NA XXX
76377 TC A 3d rendering w/postprocess 0.00 1.05 2.83 NA NA 0.31 1.36 3.14 NA NA XXX
76377 26 A 3d rendering w/postprocess 0.79 0.23 0.26 0.23 0.26 0.08 1.10 1.13 1.10 1.13 XXX
76380 A CAT scan follow-up study 0.98 4.45 3.98 NA NA 0.22 5.65 5.18 NA NA XXX
76380 TC A CAT scan follow-up study 0.00 4.17 3.67 NA NA 0.18 4.35 3.85 NA NA XXX
76380 26 A CAT scan follow-up study 0.98 0.28 0.31 0.28 0.31 0.04 1.30 1.33 1.30 1.33 XXX
76390 N Mr spectroscopy 1.40 9.31 10.94 NA NA 0.66 11.37 13.00 NA NA XXX
76390 TC N Mr spectroscopy 0.00 8.99 10.51 NA NA 0.59 9.58 11.10 NA NA XXX
76390 26 N Mr spectroscopy 1.40 0.32 0.43 0.32 0.43 0.07 1.79 1.90 1.79 1.90 XXX
76496 C Fluoroscopic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76496 TC C Fluoroscopic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76496 26 C Fluoroscopic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76497 C Ct procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76497 TC C Ct procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76497 26 C Ct procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76498 C Mri procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76498 TC C Mri procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76498 26 C Mri procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76499 C Radiographic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76499 TC C Radiographic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76499 26 C Radiographic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76506 A Echo exam of head 0.63 2.70 1.92 NA NA 0.14 3.47 2.69 NA NA XXX
76506 TC A Echo exam of head 0.00 2.51 1.69 NA NA 0.08 2.59 1.77 NA NA XXX
76506 26 A Echo exam of head 0.63 0.19 0.23 0.19 0.23 0.06 0.88 0.92 0.88 0.92 XXX
76510 A Ophth us, b quant a 1.55 2.31 2.73 NA NA 0.10 3.96 4.38 NA NA XXX
76510 TC A Ophth us, b quant a 0.00 1.72 2.07 NA NA 0.07 1.79 2.14 NA NA XXX
76510 26 A Ophth us, b quant a 1.55 0.59 0.66 0.59 0.66 0.03 2.17 2.24 2.17 2.24 XXX
76511 A Ophth us, quant a only 0.94 1.40 2.17 NA NA 0.10 2.44 3.21 NA NA XXX
76511 TC A Ophth us, quant a only 0.00 1.04 1.78 NA NA 0.07 1.11 1.85 NA NA XXX
76511 26 A Ophth us, quant a only 0.94 0.36 0.39 0.36 0.39 0.03 1.33 1.36 1.33 1.36 XXX
76512 A Ophth us, b w/non-quant a 0.94 1.19 1.97 NA NA 0.12 2.25 3.03 NA NA XXX
76512 TC A Ophth us, b w/non-quant a 0.00 0.84 1.57 NA NA 0.10 0.94 1.67 NA NA XXX
76512 26 A Ophth us, b w/non-quant a 0.94 0.35 0.40 0.35 0.40 0.02 1.31 1.36 1.31 1.36 XXX
76513 A Echo exam of eye, water bath 0.66 1.57 1.75 NA NA 0.12 2.35 2.53 NA NA XXX
76513 TC A Echo exam of eye, water bath 0.00 1.32 1.47 NA NA 0.10 1.42 1.57 NA NA XXX
76513 26 A Echo exam of eye, water bath 0.66 0.25 0.28 0.25 0.28 0.02 0.93 0.96 0.93 0.96 XXX
76514 A Echo exam of eye, thickness 0.17 0.17 0.15 NA NA 0.02 0.36 0.34 NA NA XXX
76514 TC A Echo exam of eye, thickness 0.00 0.11 0.07 NA NA 0.01 0.12 0.08 NA NA XXX
76514 26 A Echo exam of eye, thickness 0.17 0.06 0.08 0.06 0.08 0.01 0.24 0.26 0.24 0.26 XXX
76516 A Echo exam of eye 0.54 1.19 1.39 NA NA 0.08 1.81 2.01 NA NA XXX
76516 TC A Echo exam of eye 0.00 0.99 1.16 NA NA 0.07 1.06 1.23 NA NA XXX
76516 26 A Echo exam of eye 0.54 0.20 0.23 0.20 0.23 0.01 0.75 0.78 0.75 0.78 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
76519 A Echo exam of eye 0.54 1.32 1.49 NA NA 0.08 1.94 2.11 NA NA XXX
76519 TC A Echo exam of eye 0.00 1.11 1.26 NA NA 0.07 1.18 1.33 NA NA XXX
76519 26 A Echo exam of eye 0.54 0.21 0.23 0.21 0.23 0.01 0.76 0.78 0.76 0.78 XXX
76529 A Echo exam of eye 0.57 1.17 1.32 NA NA 0.10 1.84 1.99 NA NA XXX
76529 TC A Echo exam of eye 0.00 0.96 1.09 NA NA 0.08 1.04 1.17 NA NA XXX
76529 26 A Echo exam of eye 0.57 0.21 0.23 0.21 0.23 0.02 0.80 0.82 0.80 0.82 XXX
76536 A Us exam of head and neck 0.56 2.53 1.83 NA NA 0.10 3.19 2.49 NA NA XXX
76536 TC A Us exam of head and neck 0.00 2.38 1.66 NA NA 0.08 2.46 1.74 NA NA XXX
76536 26 A Us exam of head and neck 0.56 0.15 0.17 0.15 0.17 0.02 0.73 0.75 0.73 0.75 XXX
76604 A Us exam, chest 0.55 1.70 1.54 NA NA 0.09 2.34 2.18 NA NA XXX
76604 TC A Us exam, chest 0.00 1.55 1.37 NA NA 0.07 1.62 1.44 NA NA XXX
76604 26 A Us exam, chest 0.55 0.15 0.17 0.15 0.17 0.02 0.72 0.74 0.72 0.74 XXX
76645 A Us exam, breast(s) 0.54 1.97 1.41 NA NA 0.08 2.59 2.03 NA NA XXX
76645 TC A Us exam, breast(s) 0.00 1.82 1.24 NA NA 0.06 1.88 1.30 NA NA XXX
76645 26 A Us exam, breast(s) 0.54 0.15 0.17 0.15 0.17 0.02 0.71 0.73 0.71 0.73 XXX
76700 A Us exam, abdom, complete 0.81 2.84 2.39 NA NA 0.15 3.80 3.35 NA NA XXX
76700 TC A Us exam, abdom, complete 0.00 2.61 2.13 NA NA 0.11 2.72 2.24 NA NA XXX
76700 26 A Us exam, abdom, complete 0.81 0.23 0.26 0.23 0.26 0.04 1.08 1.11 1.08 1.11 XXX
76705 A Echo exam of abdomen 0.59 2.21 1.77 NA NA 0.11 2.91 2.47 NA NA XXX
76705 TC A Echo exam of abdomen 0.00 2.04 1.58 NA NA 0.08 2.12 1.66 NA NA XXX
76705 26 A Echo exam of abdomen 0.59 0.17 0.19 0.17 0.19 0.03 0.79 0.81 0.79 0.81 XXX
76770 A Us exam abdo back wall, comp 0.74 2.77 2.36 NA NA 0.14 3.65 3.24 NA NA XXX
76770 TC A Us exam abdo back wall, comp 0.00 2.55 2.12 NA NA 0.11 2.66 2.23 NA NA XXX
76770 26 A Us exam abdo back wall, comp 0.74 0.22 0.24 0.22 0.24 0.03 0.99 1.01 0.99 1.01 XXX
76775 A Us exam abdo back wall, lim 0.58 0.00 1.61 NA NA 0.11 0.69 2.30 NA NA XXX
76775 TC A Us exam abdo back wall, lim 0.00 0.00 1.42 NA NA 0.08 0.08 1.50 NA NA XXX
76775 26 A Us exam abdo back wall, lim 0.58 0.00 0.19 0.00 0.19 0.03 0.61 0.80 0.61 0.80 XXX
76776 A Us exam k transpl w/doppler 0.76 3.19 2.45 NA NA 0.14 4.09 3.35 NA NA XXX
76776 TC A Us exam k transpl w/doppler 0.00 2.98 2.22 NA NA 0.11 3.09 2.33 NA NA XXX
76776 26 A Us exam k transpl w/doppler 0.76 0.21 0.23 0.21 0.23 0.03 1.00 1.02 1.00 1.02 XXX
76800 A Us exam, spinal canal 1.13 2.26 1.89 NA NA 0.13 3.52 3.15 NA NA XXX
76800 TC A Us exam, spinal canal 0.00 1.97 1.56 NA NA 0.08 2.05 1.64 NA NA XXX
76800 26 A Us exam, spinal canal 1.13 0.29 0.33 0.29 0.33 0.05 1.47 1.51 1.47 1.51 XXX
76801 A Ob us 14 wks, single fetus 0.99 2.36 2.43 NA NA 0.16 3.51 3.58 NA NA XXX
76801 TC A Ob us 14 wks, single fetus 0.00 2.08 2.10 NA NA 0.12 2.20 2.22 NA NA XXX
76801 26 A Ob us 14 wks, single fetus 0.99 0.28 0.33 0.28 0.33 0.04 1.31 1.36 1.31 1.36 XXX
76802 A Ob us 14 wks, addÆl fetus 0.83 0.93 1.24 0.93 1.24 0.16 1.92 2.23 1.92 2.23 ZZZ
76802 TC A Ob us 14 wks, addÆl fetus 0.00 0.69 0.96 0.69 0.96 0.12 0.81 1.08 0.81 1.08 ZZZ
76802 26 A Ob us 14 wks, addÆl fetus 0.83 0.24 0.28 0.24 0.28 0.04 1.11 1.15 1.11 1.15 ZZZ
76805 A Ob us /= 14 wks, sngl fetus 0.99 2.91 2.56 NA NA 0.16 4.06 3.71 NA NA XXX
76805 TC A Ob us /= 14 wks, sngl fetus 0.00 2.63 2.23 NA NA 0.12 2.75 2.35 NA NA XXX
76805 26 A Ob us /= 14 wks, sngl fetus 0.99 0.28 0.33 0.28 0.33 0.04 1.31 1.36 1.31 1.36 XXX
76810 A Ob us /= 14 wks, addl fetus 0.98 1.59 1.44 1.59 1.44 0.26 2.83 2.68 2.83 2.68 ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
76810 TC A Ob us /= 14 wks, addl fetus 0.00 1.32 1.12 1.32 1.12 0.22 1.54 1.34 1.54 1.34 ZZZ
76810 26 A Ob us /= 14 wks, addl fetus 0.98 0.27 0.32 0.27 0.32 0.04 1.29 1.34 1.29 1.34 ZZZ
76811 A Ob us, detailed, sngl fetus 1.90 2.98 3.93 NA NA 0.52 5.40 6.35 NA NA XXX
76811 TC A Ob us, detailed, sngl fetus 0.00 2.45 3.26 NA NA 0.43 2.88 3.69 NA NA XXX
76811 26 A Ob us, detailed, sngl fetus 1.90 0.53 0.67 0.53 0.67 0.09 2.52 2.66 2.52 2.66 XXX
76812 A Ob us, detailed, addl fetus 1.78 3.87 2.25 3.87 2.25 0.49 6.14 4.52 6.14 4.52 ZZZ
76812 TC A Ob us, detailed, addl fetus 0.00 3.37 1.63 3.37 1.63 0.41 3.78 2.04 3.78 2.04 ZZZ
76812 26 A Ob us, detailed, addl fetus 1.78 0.50 0.62 0.50 0.62 0.08 2.36 2.48 2.36 2.48 ZZZ
76813 A Ob us nuchal meas, 1 gest 1.18 2.06 2.06 NA NA 0.19 3.43 3.43 NA NA XXX
76813 TC A Ob us nuchal meas, 1 gest 0.00 1.73 1.73 NA NA 0.14 1.87 1.87 NA NA XXX
76813 26 A Ob us nuchal meas, 1 gest 1.18 0.33 0.33 0.33 0.33 0.05 1.56 1.56 1.56 1.56 XXX
76814 A Ob us nuchal meas, add-on 0.99 1.11 1.11 NA NA 0.19 2.29 2.29 NA NA XXX
76814 TC A Ob us nuchal meas, add-on 0.00 0.84 0.84 NA NA 0.14 0.98 0.98 NA NA XXX
76814 26 A Ob us nuchal meas, add-on 0.99 0.27 0.27 0.27 0.27 0.05 1.31 1.31 1.31 1.31 XXX
76815 A Ob us, limited, fetus(s) 0.65 1.73 1.67 NA NA 0.11 2.49 2.43 NA NA XXX
76815 TC A Ob us, limited, fetus(s) 0.00 1.55 1.45 NA NA 0.08 1.63 1.53 NA NA XXX
76815 26 A Ob us, limited, fetus(s) 0.65 0.18 0.22 0.18 0.22 0.03 0.86 0.90 0.86 0.90 XXX
76816 A Ob us, follow-up, per fetus 0.85 2.33 1.66 NA NA 0.10 3.28 2.61 NA NA XXX
76816 TC A Ob us, follow-up, per fetus 0.00 2.09 1.36 NA NA 0.06 2.15 1.42 NA NA XXX
76816 26 A Ob us, follow-up, per fetus 0.85 0.24 0.30 0.24 0.30 0.04 1.13 1.19 1.13 1.19 XXX
76817 A Transvaginal us, obstetric 0.75 1.94 1.82 NA NA 0.09 2.78 2.66 NA NA XXX
76817 TC A Transvaginal us, obstetric 0.00 1.73 1.57 NA NA 0.06 1.79 1.63 NA NA XXX
76817 26 A Transvaginal us, obstetric 0.75 0.21 0.25 0.21 0.25 0.03 0.99 1.03 0.99 1.03 XXX
76818 A Fetal biophys profile w/nst 1.05 2.15 2.04 NA NA 0.15 3.35 3.24 NA NA XXX
76818 TC A Fetal biophys profile w/nst 0.00 1.86 1.67 NA NA 0.10 1.96 1.77 NA NA XXX
76818 26 A Fetal biophys profile w/nst 1.05 0.29 0.37 0.29 0.37 0.05 1.39 1.47 1.39 1.47 XXX
76819 A Fetal biophys profil w/o nst 0.77 1.57 1.81 NA NA 0.13 2.47 2.71 NA NA XXX
76819 TC A Fetal biophys profil w/o nst 0.00 1.36 1.55 NA NA 0.10 1.46 1.65 NA NA XXX
76819 26 A Fetal biophys profil w/o nst 0.77 0.21 0.26 0.21 0.26 0.03 1.01 1.06 1.01 1.06 XXX
76820 A Umbilical artery echo 0.50 0.55 1.49 NA NA 0.15 1.20 2.14 NA NA XXX
76820 TC A Umbilical artery echo 0.00 0.41 1.31 NA NA 0.12 0.53 1.43 NA NA XXX
76820 26 A Umbilical artery echo 0.50 0.14 0.18 0.14 0.18 0.03 0.67 0.71 0.67 0.71 XXX
76821 A Middle cerebral artery echo 0.70 1.83 1.87 NA NA 0.15 2.68 2.72 NA NA XXX
76821 TC A Middle cerebral artery echo 0.00 1.63 1.62 NA NA 0.12 1.75 1.74 NA NA XXX
76821 26 A Middle cerebral artery echo 0.70 0.20 0.25 0.20 0.25 0.03 0.93 0.98 0.93 0.98 XXX
76825 A Echo exam of fetal heart 1.67 4.29 3.00 NA NA 0.18 6.14 4.85 NA NA XXX
76825 TC A Echo exam of fetal heart 0.00 3.80 2.43 NA NA 0.11 3.91 2.54 NA NA XXX
76825 26 A Echo exam of fetal heart 1.67 0.49 0.57 0.49 0.57 0.07 2.23 2.31 2.23 2.31 XXX
76826 A Echo exam of fetal heart 0.83 2.71 1.43 NA NA 0.08 3.62 2.34 NA NA XXX
76826 TC A Echo exam of fetal heart 0.00 2.47 1.15 NA NA 0.05 2.52 1.20 NA NA XXX
76826 26 A Echo exam of fetal heart 0.83 0.24 0.28 0.24 0.28 0.03 1.10 1.14 1.10 1.14 XXX
76827 A Echo exam of fetal heart 0.58 1.04 1.71 NA NA 0.14 1.76 2.43 NA NA XXX
76827 TC A Echo exam of fetal heart 0.00 0.87 1.51 NA NA 0.12 0.99 1.63 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
76827 26 A Echo exam of fetal heart 0.58 0.17 0.20 0.17 0.20 0.02 0.77 0.80 0.77 0.80 XXX
76828 A Echo exam of fetal heart 0.56 0.63 1.16 NA NA 0.11 1.30 1.83 NA NA XXX
76828 TC A Echo exam of fetal heart 0.00 0.47 0.95 NA NA 0.08 0.55 1.03 NA NA XXX
76828 26 A Echo exam of fetal heart 0.56 0.16 0.21 0.16 0.21 0.03 0.75 0.80 0.75 0.80 XXX
76830 A Transvaginal us, non-ob 0.69 2.62 1.97 NA NA 0.13 3.44 2.79 NA NA XXX
76830 TC A Transvaginal us, non-ob 0.00 2.43 1.75 NA NA 0.10 2.53 1.85 NA NA XXX
76830 26 A Transvaginal us, non-ob 0.69 0.19 0.22 0.19 0.22 0.03 0.91 0.94 0.91 0.94 XXX
76831 A Echo exam, uterus 0.72 2.67 2.00 NA NA 0.13 3.52 2.85 NA NA XXX
76831 TC A Echo exam, uterus 0.00 2.47 1.76 NA NA 0.10 2.57 1.86 NA NA XXX
76831 26 A Echo exam, uterus 0.72 0.20 0.24 0.20 0.24 0.03 0.95 0.99 0.95 0.99 XXX
76856 A Us exam, pelvic, complete 0.69 2.67 1.99 NA NA 0.13 3.49 2.81 NA NA XXX
76856 TC A Us exam, pelvic, complete 0.00 2.46 1.76 NA NA 0.10 2.56 1.86 NA NA XXX
76856 26 A Us exam, pelvic, complete 0.69 0.21 0.23 0.21 0.23 0.03 0.93 0.95 0.93 0.95 XXX
76857 A Us exam, pelvic, limited 0.38 2.46 1.99 NA NA 0.08 2.92 2.45 NA NA XXX
76857 TC A Us exam, pelvic, limited 0.00 2.32 1.86 NA NA 0.06 2.38 1.92 NA NA XXX
76857 26 A Us exam, pelvic, limited 0.38 0.14 0.13 0.14 0.13 0.02 0.54 0.53 0.54 0.53 XXX
76870 A Us exam, scrotum 0.64 2.67 1.97 NA NA 0.13 3.44 2.74 NA NA XXX
76870 TC A Us exam, scrotum 0.00 2.48 1.76 NA NA 0.10 2.58 1.86 NA NA XXX
76870 26 A Us exam, scrotum 0.64 0.19 0.21 0.19 0.21 0.03 0.86 0.88 0.86 0.88 XXX
76872 A Us, transrectal 0.69 3.37 2.52 NA NA 0.14 4.20 3.35 NA NA XXX
76872 TC A Us, transrectal 0.00 3.10 2.29 NA NA 0.10 3.20 2.39 NA NA XXX
76872 26 A Us, transrectal 0.69 0.27 0.23 0.27 0.23 0.04 1.00 0.96 1.00 0.96 XXX
76873 A Echograp trans r, pros study 1.55 3.43 2.81 NA NA 0.25 5.23 4.61 NA NA XXX
76873 TC A Echograp trans r, pros study 0.00 2.87 2.29 NA NA 0.16 3.03 2.45 NA NA XXX
76873 26 A Echograp trans r, pros study 1.55 0.56 0.52 0.56 0.52 0.09 2.20 2.16 2.20 2.16 XXX
76880 A Us exam, extremity 0.59 3.05 1.97 NA NA 0.11 3.75 2.67 NA NA XXX
76880 TC A Us exam, extremity 0.00 2.89 1.79 NA NA 0.08 2.97 1.87 NA NA XXX
76880 26 A Us exam, extremity 0.59 0.16 0.18 0.16 0.18 0.03 0.78 0.80 0.78 0.80 XXX
76885 A Us exam infant hips, dynamic 0.74 3.03 2.08 NA NA 0.13 3.90 2.95 NA NA XXX
76885 TC A Us exam infant hips, dynamic 0.00 2.83 1.85 NA NA 0.10 2.93 1.95 NA NA XXX
76885 26 A Us exam infant hips, dynamic 0.74 0.20 0.23 0.20 0.23 0.03 0.97 1.00 0.97 1.00 XXX
76886 A Us exam infant hips, static 0.62 2.20 1.76 NA NA 0.11 2.93 2.49 NA NA XXX
76886 TC A Us exam infant hips, static 0.00 2.03 1.57 NA NA 0.08 2.11 1.65 NA NA XXX
76886 26 A Us exam infant hips, static 0.62 0.17 0.19 0.17 0.19 0.03 0.82 0.84 0.82 0.84 XXX
76930 A Echo guide, cardiocentesis 0.67 2.08 1.85 NA NA 0.12 2.87 2.64 NA NA XXX
76930 TC A Echo guide, cardiocentesis 0.00 1.74 1.58 NA NA 0.10 1.84 1.68 NA NA XXX
76930 26 A Echo guide, cardiocentesis 0.67 0.34 0.27 0.34 0.27 0.02 1.03 0.96 1.03 0.96 XXX
76932 C Echo guide for heart biopsy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76932 TC C Echo guide for heart biopsy 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76932 26 A Echo guide for heart biopsy 0.67 0.35 0.28 0.35 0.28 0.02 1.04 0.97 1.04 0.97 XXX
76936 A Echo guide for artery repair 1.99 5.81 6.67 NA NA 0.47 8.27 9.13 NA NA XXX
76936 TC A Echo guide for artery repair 0.00 5.17 6.01 NA NA 0.34 5.51 6.35 NA NA XXX
76936 26 A Echo guide for artery repair 1.99 0.64 0.66 0.64 0.66 0.13 2.76 2.78 2.76 2.78 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
76937 A Us guide, vascular access 0.30 0.58 0.51 0.58 0.51 0.13 1.01 0.94 1.01 0.94 ZZZ
76937 TC A Us guide, vascular access 0.00 0.49 0.41 0.49 0.41 0.10 0.59 0.51 0.59 0.51 ZZZ
76937 26 A Us guide, vascular access 0.30 0.09 0.10 0.09 0.10 0.03 0.42 0.43 0.42 0.43 ZZZ
76940 C Us guide, tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76940 TC C Us guide, tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76940 26 A Us guide, tissue ablation 2.00 0.58 0.63 0.58 0.63 0.31 2.89 2.94 2.89 2.94 XXX
76941 C Echo guide for transfusion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76941 TC C Echo guide for transfusion 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76941 26 A Echo guide for transfusion 1.34 0.43 0.46 0.43 0.46 0.07 1.84 1.87 1.84 1.87 XXX
76942 A Echo guide for biopsy 0.67 4.64 3.43 NA NA 0.13 5.44 4.23 NA NA XXX
76942 TC A Echo guide for biopsy 0.00 4.42 3.21 NA NA 0.10 4.52 3.31 NA NA XXX
76942 26 A Echo guide for biopsy 0.67 0.22 0.22 0.22 0.22 0.03 0.92 0.92 0.92 0.92 XXX
76945 C Echo guide, villus sampling 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76945 TC C Echo guide, villus sampling 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76945 26 A Echo guide, villus sampling 0.67 0.20 0.22 0.20 0.22 0.03 0.90 0.92 0.90 0.92 XXX
76946 A Echo guide for amniocentesis 0.38 0.44 1.35 NA NA 0.12 0.94 1.85 NA NA XXX
76946 TC A Echo guide for amniocentesis 0.00 0.33 1.22 NA NA 0.10 0.43 1.32 NA NA XXX
76946 26 A Echo guide for amniocentesis 0.38 0.11 0.13 0.11 0.13 0.02 0.51 0.53 0.51 0.53 XXX
76948 A Echo guide, ova aspiration 0.38 0.43 1.34 NA NA 0.12 0.93 1.84 NA NA XXX
76948 TC A Echo guide, ova aspiration 0.00 0.33 1.22 NA NA 0.10 0.43 1.32 NA NA XXX
76948 26 A Echo guide, ova aspiration 0.38 0.10 0.12 0.10 0.12 0.02 0.50 0.52 0.50 0.52 XXX
76950 A Echo guidance radiotherapy 0.58 1.22 1.43 NA NA 0.10 1.90 2.11 NA NA XXX
76950 TC A Echo guidance radiotherapy 0.00 1.02 1.24 NA NA 0.07 1.09 1.31 NA NA XXX
76950 26 A Echo guidance radiotherapy 0.58 0.20 0.19 0.20 0.19 0.03 0.81 0.80 0.81 0.80 XXX
76965 A Echo guidance radiotherapy 1.34 1.22 4.80 NA NA 0.37 2.93 6.51 NA NA XXX
76965 TC A Echo guidance radiotherapy 0.00 0.70 4.35 NA NA 0.29 0.99 4.64 NA NA XXX
76965 26 A Echo guidance radiotherapy 1.34 0.52 0.45 0.52 0.45 0.08 1.94 1.87 1.94 1.87 XXX
76970 A Ultrasound exam follow-up 0.40 2.07 1.41 NA NA 0.08 2.55 1.89 NA NA XXX
76970 TC A Ultrasound exam follow-up 0.00 1.96 1.28 NA NA 0.06 2.02 1.34 NA NA XXX
76970 26 A Ultrasound exam follow-up 0.40 0.11 0.13 0.11 0.13 0.02 0.53 0.55 0.53 0.55 XXX
76975 C GI endoscopic ultrasound 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76975 TC C GI endoscopic ultrasound 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76975 26 A GI endoscopic ultrasound 0.81 0.29 0.28 0.29 0.28 0.04 1.14 1.13 1.14 1.13 XXX
76977 A Us bone density measure 0.05 0.10 0.66 NA NA 0.06 0.21 0.77 NA NA XXX
76977 TC A Us bone density measure 0.00 0.09 0.64 NA NA 0.05 0.14 0.69 NA NA XXX
76977 26 A Us bone density measure 0.05 0.01 0.02 0.01 0.02 0.01 0.07 0.08 0.07 0.08 XXX
76998 C Us guide, intraop 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76998 TC C Us guide, intraop 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
76998 26 A Us guide, intraop 1.20 0.34 0.39 0.34 0.39 0.13 1.67 1.72 1.67 1.72 XXX
76999 C Echo examination procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76999 TC C Echo examination procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
76999 26 C Echo examination procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77001 A Fluoroguide for vein device 0.38 2.58 1.73 NA NA 0.11 3.07 2.22 NA NA ZZZ
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77001 TC A Fluoroguide for vein device 0.00 2.47 1.60 NA NA 0.10 2.57 1.70 NA NA ZZZ
77001 26 A Fluoroguide for vein device 0.38 0.11 0.13 0.11 0.13 0.01 0.50 0.52 0.50 0.52 ZZZ
77002 A Needle localization by xray 0.54 1.15 1.40 NA NA 0.09 1.78 2.03 NA NA XXX
77002 TC A Needle localization by xray 0.00 1.01 1.24 NA NA 0.07 1.08 1.31 NA NA XXX
77002 26 A Needle localization by xray 0.54 0.14 0.16 0.14 0.16 0.02 0.70 0.72 0.70 0.72 XXX
77003 A Fluoroguide for spine inject 0.60 0.74 1.28 NA NA 0.10 1.44 1.98 NA NA XXX
77003 TC A Fluoroguide for spine inject 0.00 0.60 1.13 NA NA 0.07 0.67 1.20 NA NA XXX
77003 26 A Fluoroguide for spine inject 0.60 0.14 0.15 0.14 0.15 0.03 0.77 0.78 0.77 0.78 XXX
77011 A Ct scan for localization 1.21 19.50 11.38 NA NA 0.47 21.18 13.06 NA NA XXX
77011 TC A Ct scan for localization 0.00 19.16 10.99 NA NA 0.42 19.58 11.41 NA NA XXX
77011 26 A Ct scan for localization 1.21 0.34 0.39 0.34 0.39 0.05 1.60 1.65 1.60 1.65 XXX
77012 A Ct scan for needle biopsy 1.16 2.14 7.02 NA NA 0.47 3.77 8.65 NA NA XXX
77012 TC A Ct scan for needle biopsy 0.00 1.81 6.65 NA NA 0.42 2.23 7.07 NA NA XXX
77012 26 A Ct scan for needle biopsy 1.16 0.33 0.37 0.33 0.37 0.05 1.54 1.58 1.54 1.58 XXX
77013 C Ct guide for tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
77013 TC C Ct guide for tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
77013 26 A Ct guide for tissue ablation 3.99 1.19 1.27 1.19 1.27 0.18 5.36 5.44 5.36 5.44 XXX
77014 A Ct scan for therapy guide 0.85 4.43 3.53 NA NA 0.20 5.48 4.58 NA NA XXX
77014 TC A Ct scan for therapy guide 0.00 4.16 3.25 NA NA 0.16 4.32 3.41 NA NA XXX
77014 26 A Ct scan for therapy guide 0.85 0.27 0.28 0.27 0.28 0.04 1.16 1.17 1.16 1.17 XXX
77021 A Mr guidance for needle place 1.50 9.20 11.08 NA NA 0.64 11.34 13.22 NA NA XXX
77021 TC A Mr guidance for needle place 0.00 8.76 10.59 NA NA 0.55 9.31 11.14 NA NA XXX
77021 26 A Mr guidance for needle place 1.50 0.44 0.49 0.44 0.49 0.09 2.03 2.08 2.03 2.08 XXX
77022 C Mri for tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
77022 TC C Mri for tissue ablation 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
77022 26 A Mri for tissue ablation 4.24 1.22 1.34 1.22 1.34 0.24 5.70 5.82 5.70 5.82 XXX
77031 A Stereotact guide for brst bx 1.59 1.71 6.19 NA NA 0.46 3.76 8.24 NA NA XXX
77031 TC A Stereotact guide for brst bx 0.00 1.27 5.69 NA NA 0.37 1.64 6.06 NA NA XXX
77031 26 A Stereotact guide for brst bx 1.59 0.44 0.50 0.44 0.50 0.09 2.12 2.18 2.12 2.18 XXX
77032 A Guidance for needle, breast 0.56 0.56 1.26 NA NA 0.09 1.21 1.91 NA NA XXX
77032 TC A Guidance for needle, breast 0.00 0.40 1.08 NA NA 0.07 0.47 1.15 NA NA XXX
77032 26 A Guidance for needle, breast 0.56 0.16 0.18 0.16 0.18 0.02 0.74 0.76 0.74 0.76 XXX
77051 A Computer dx mammogram add-on 0.06 0.19 0.38 0.19 0.38 0.02 0.27 0.46 0.27 0.46 ZZZ
77051 TC A Computer dx mammogram add-on 0.00 0.17 0.36 0.17 0.36 0.01 0.18 0.37 0.18 0.37 ZZZ
77051 26 A Computer dx mammogram add-on 0.06 0.02 0.02 0.02 0.02 0.01 0.09 0.09 0.09 0.09 ZZZ
77052 A Comp screen mammogram add-on 0.06 0.19 0.38 0.19 0.38 0.02 0.27 0.46 0.27 0.46 ZZZ
77052 TC A Comp screen mammogram add-on 0.00 0.17 0.36 0.17 0.36 0.01 0.18 0.37 0.18 0.37 ZZZ
77052 26 A Comp screen mammogram add-on 0.06 0.02 0.02 0.02 0.02 0.01 0.09 0.09 0.09 0.09 ZZZ
77053 A X-ray of mammary duct 0.36 0.59 2.21 NA NA 0.16 1.11 2.73 NA NA XXX
77053 TC A X-ray of mammary duct 0.00 0.49 2.09 NA NA 0.14 0.63 2.23 NA NA XXX
77053 26 A X-ray of mammary duct 0.36 0.10 0.12 0.10 0.12 0.02 0.48 0.50 0.48 0.50 XXX
77054 A X-ray of mammary ducts 0.45 1.56 3.25 NA NA 0.21 2.22 3.91 NA NA XXX
77054 TC A X-ray of mammary ducts 0.00 1.43 3.10 NA NA 0.19 1.62 3.29 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77054 26 A X-ray of mammary ducts 0.45 0.13 0.15 0.13 0.15 0.02 0.60 0.62 0.60 0.62 XXX
77055 A Mammogram, one breast 0.70 1.51 1.34 NA NA 0.09 2.30 2.13 NA NA XXX
77055 TC A Mammogram, one breast 0.00 1.31 1.12 NA NA 0.06 1.37 1.18 NA NA XXX
77055 26 A Mammogram, one breast 0.70 0.20 0.22 0.20 0.22 0.03 0.93 0.95 0.93 0.95 XXX
77056 A Mammogram, both breasts 0.87 1.93 1.68 NA NA 0.11 2.91 2.66 NA NA XXX
77056 TC A Mammogram, both breasts 0.00 1.69 1.41 NA NA 0.07 1.76 1.48 NA NA XXX
77056 26 A Mammogram, both breasts 0.87 0.24 0.27 0.24 0.27 0.04 1.15 1.18 1.15 1.18 XXX
77057 A Mammogram, screening 0.70 1.33 1.43 NA NA 0.10 2.13 2.23 NA NA XXX
77057 TC A Mammogram, screening 0.00 1.13 1.21 NA NA 0.07 1.20 1.28 NA NA XXX
77057 26 A Mammogram, screening 0.70 0.20 0.22 0.20 0.22 0.03 0.93 0.95 0.93 0.95 XXX
77058 A Mri, one breast 1.63 20.61 18.76 NA NA 0.99 23.23 21.38 NA NA XXX
77058 TC A Mri, one breast 0.00 20.15 18.25 NA NA 0.92 21.07 19.17 NA NA XXX
77058 26 A Mri, one breast 1.63 0.46 0.51 0.46 0.51 0.07 2.16 2.21 2.16 2.21 XXX
77059 A Mri, both breasts 1.63 20.51 23.46 NA NA 1.31 23.45 26.40 NA NA XXX
77059 TC A Mri, both breasts 0.00 20.05 22.95 NA NA 1.24 21.29 24.19 NA NA XXX
77059 26 A Mri, both breasts 1.63 0.46 0.51 0.46 0.51 0.07 2.16 2.21 2.16 2.21 XXX
77071 A X-ray stress view 0.41 0.76 0.33 0.76 0.33 0.06 1.23 0.80 1.23 0.80 XXX
77072 A X-rays for bone age 0.19 0.39 0.39 NA NA 0.03 0.61 0.61 NA NA XXX
77072 TC A X-rays for bone age 0.00 0.34 0.34 NA NA 0.02 0.36 0.36 NA NA XXX
77072 26 A X-rays for bone age 0.19 0.05 0.05 0.05 0.05 0.01 0.25 0.25 0.25 0.25 XXX
77073 A X-rays, bone length studies 0.27 0.64 0.81 NA NA 0.06 0.97 1.14 NA NA XXX
77073 TC A X-rays, bone length studies 0.00 0.55 0.72 NA NA 0.05 0.60 0.77 NA NA XXX
77073 26 A X-rays, bone length studies 0.27 0.09 0.09 0.09 0.09 0.01 0.37 0.37 0.37 0.37 XXX
77074 A X-rays, bone survey, limited 0.45 1.34 1.20 NA NA 0.08 1.87 1.73 NA NA XXX
77074 TC A X-rays, bone survey, limited 0.00 1.21 1.05 NA NA 0.06 1.27 1.11 NA NA XXX
77074 26 A X-rays, bone survey, limited 0.45 0.13 0.15 0.13 0.15 0.02 0.60 0.62 0.60 0.62 XXX
77075 A X-rays, bone survey complete 0.54 2.14 1.76 NA NA 0.10 2.78 2.40 NA NA XXX
77075 TC A X-rays, bone survey complete 0.00 1.98 1.58 NA NA 0.08 2.06 1.66 NA NA XXX
77075 26 A X-rays, bone survey complete 0.54 0.16 0.18 0.16 0.18 0.02 0.72 0.74 0.72 0.74 XXX
77076 A X-rays, bone survey, infant 0.70 1.91 1.20 NA NA 0.08 2.69 1.98 NA NA XXX
77076 TC A X-rays, bone survey, infant 0.00 1.73 0.98 NA NA 0.05 1.78 1.03 NA NA XXX
77076 26 A X-rays, bone survey, infant 0.70 0.18 0.22 0.18 0.22 0.03 0.91 0.95 0.91 0.95 XXX
77077 A Joint survey, single view 0.31 0.64 1.07 NA NA 0.08 1.03 1.46 NA NA XXX
77077 TC A Joint survey, single view 0.00 0.53 0.97 NA NA 0.06 0.59 1.03 NA NA XXX
77077 26 A Joint survey, single view 0.31 0.11 0.10 0.11 0.10 0.02 0.44 0.43 0.44 0.43 XXX
77078 A Ct bone density, axial 0.25 4.52 3.41 NA NA 0.17 4.94 3.83 NA NA XXX
77078 TC A Ct bone density, axial 0.00 4.45 3.33 NA NA 0.16 4.61 3.49 NA NA XXX
77078 26 A Ct bone density, axial 0.25 0.07 0.08 0.07 0.08 0.01 0.33 0.34 0.33 0.34 XXX
77079 A Ct bone density, peripheral 0.22 0.72 2.45 NA NA 0.06 1.00 2.73 NA NA XXX
77079 TC A Ct bone density, peripheral 0.00 0.66 2.38 NA NA 0.05 0.71 2.43 NA NA XXX
77079 26 A Ct bone density, peripheral 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
77080 A Dxa bone density, axial 0.20 0.79 2.59 NA NA 0.18 1.17 2.97 NA NA XXX
77080 TC A Dxa bone density, axial 0.00 0.73 2.50 NA NA 0.17 0.90 2.67 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77080 26 A Dxa bone density, axial 0.20 0.06 0.09 0.06 0.09 0.01 0.27 0.30 0.27 0.30 XXX
77081 A Dxa bone density/peripheral 0.22 0.69 0.80 NA NA 0.06 0.97 1.08 NA NA XXX
77081 TC A Dxa bone density/peripheral 0.00 0.63 0.72 NA NA 0.05 0.68 0.77 NA NA XXX
77081 26 A Dxa bone density/peripheral 0.22 0.06 0.08 0.06 0.08 0.01 0.29 0.31 0.29 0.31 XXX
77082 A Dxa bone density, vert fx 0.17 0.41 0.71 NA NA 0.06 0.64 0.94 NA NA XXX
77082 TC A Dxa bone density, vert fx 0.00 0.36 0.65 NA NA 0.05 0.41 0.70 NA NA XXX
77082 26 A Dxa bone density, vert fx 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
77083 A Radiographic absorptiometry 0.20 0.37 0.71 NA NA 0.06 0.63 0.97 NA NA XXX
77083 TC A Radiographic absorptiometry 0.00 0.32 0.64 NA NA 0.05 0.37 0.69 NA NA XXX
77083 26 A Radiographic absorptiometry 0.20 0.05 0.07 0.05 0.07 0.01 0.26 0.28 0.26 0.28 XXX
77084 A Magnetic image, bone marrow 1.60 13.81 12.24 NA NA 0.66 16.07 14.50 NA NA XXX
77084 TC A Magnetic image, bone marrow 0.00 13.33 11.73 NA NA 0.59 13.92 12.32 NA NA XXX
77084 26 A Magnetic image, bone marrow 1.60 0.48 0.51 0.48 0.51 0.07 2.15 2.18 2.15 2.18 XXX
77261 A Radiation therapy planning 1.39 0.49 0.51 0.49 0.51 0.07 1.95 1.97 1.95 1.97 XXX
77262 A Radiation therapy planning 2.11 0.71 0.74 0.71 0.74 0.11 2.93 2.96 2.93 2.96 XXX
77263 A Radiation therapy planning 3.14 1.06 1.10 1.06 1.10 0.16 4.36 4.40 4.36 4.40 XXX
77280 A Set radiation therapy field 0.70 4.45 3.89 NA NA 0.22 5.37 4.81 NA NA XXX
77280 TC A Set radiation therapy field 0.00 4.21 3.66 NA NA 0.18 4.39 3.84 NA NA XXX
77280 26 A Set radiation therapy field 0.70 0.24 0.23 0.24 0.23 0.04 0.98 0.97 0.98 0.97 XXX
77285 A Set radiation therapy field 1.05 8.06 6.45 NA NA 0.35 9.46 7.85 NA NA XXX
77285 TC A Set radiation therapy field 0.00 7.71 6.11 NA NA 0.30 8.01 6.41 NA NA XXX
77285 26 A Set radiation therapy field 1.05 0.35 0.34 0.35 0.34 0.05 1.45 1.44 1.45 1.44 XXX
77290 A Set radiation therapy field 1.56 13.47 8.63 NA NA 0.43 15.46 10.62 NA NA XXX
77290 TC A Set radiation therapy field 0.00 12.94 8.12 NA NA 0.35 13.29 8.47 NA NA XXX
77290 26 A Set radiation therapy field 1.56 0.53 0.51 0.53 0.51 0.08 2.17 2.15 2.17 2.15 XXX
77295 A Set radiation therapy field 4.56 7.51 23.92 NA NA 1.71 13.78 30.19 NA NA XXX
77295 TC A Set radiation therapy field 0.00 5.96 22.44 NA NA 1.48 7.44 23.92 NA NA XXX
77295 26 A Set radiation therapy field 4.56 1.55 1.48 1.55 1.48 0.23 6.34 6.27 6.34 6.27 XXX
77299 C Radiation therapy planning 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77299 TC C Radiation therapy planning 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77299 26 C Radiation therapy planning 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77300 A Radiation therapy dose plan 0.62 1.19 1.45 NA NA 0.10 1.91 2.17 NA NA XXX
77300 TC A Radiation therapy dose plan 0.00 0.98 1.25 NA NA 0.07 1.05 1.32 NA NA XXX
77300 26 A Radiation therapy dose plan 0.62 0.21 0.20 0.21 0.20 0.03 0.86 0.85 0.86 0.85 XXX
77301 A Radiotherapy dose plan, imrt 7.99 57.55 37.25 NA NA 1.88 67.42 47.12 NA NA XXX
77301 TC A Radiotherapy dose plan, imrt 0.00 54.86 34.66 NA NA 1.48 56.34 36.14 NA NA XXX
77301 26 A Radiotherapy dose plan, imrt 7.99 2.69 2.59 2.69 2.59 0.40 11.08 10.98 11.08 10.98 XXX
77305 A Teletx isodose plan simple 0.70 0.91 1.79 NA NA 0.15 1.76 2.64 NA NA XXX
77305 TC A Teletx isodose plan simple 0.00 0.67 1.56 NA NA 0.11 0.78 1.67 NA NA XXX
77305 26 A Teletx isodose plan simple 0.70 0.24 0.23 0.24 0.23 0.04 0.98 0.97 0.98 0.97 XXX
77310 A Teletx isodose plan intermed 1.05 1.26 2.32 NA NA 0.18 2.49 3.55 NA NA XXX
77310 TC A Teletx isodose plan intermed 0.00 0.91 1.98 NA NA 0.13 1.04 2.11 NA NA XXX
77310 26 A Teletx isodose plan intermed 1.05 0.35 0.34 0.35 0.34 0.05 1.45 1.44 1.45 1.44 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77315 A Teletx isodose plan complex 1.56 2.11 2.90 NA NA 0.22 3.89 4.68 NA NA XXX
77315 TC A Teletx isodose plan complex 0.00 1.58 2.39 NA NA 0.14 1.72 2.53 NA NA XXX
77315 26 A Teletx isodose plan complex 1.56 0.53 0.51 0.53 0.51 0.08 2.17 2.15 2.17 2.15 XXX
77321 A Special teletx port plan 0.95 1.52 3.64 NA NA 0.26 2.73 4.85 NA NA XXX
77321 TC A Special teletx port plan 0.00 1.20 3.33 NA NA 0.21 1.41 3.54 NA NA XXX
77321 26 A Special teletx port plan 0.95 0.32 0.31 0.32 0.31 0.05 1.32 1.31 1.32 1.31 XXX
77326 A Brachytx isodose calc simp 0.93 3.01 2.75 NA NA 0.18 4.12 3.86 NA NA XXX
77326 TC A Brachytx isodose calc simp 0.00 2.69 2.44 NA NA 0.13 2.82 2.57 NA NA XXX
77326 26 A Brachytx isodose calc simp 0.93 0.32 0.31 0.32 0.31 0.05 1.30 1.29 1.30 1.29 XXX
77327 A Brachytx isodose calc interm 1.39 4.12 3.97 NA NA 0.25 5.76 5.61 NA NA XXX
77327 TC A Brachytx isodose calc interm 0.00 3.65 3.52 NA NA 0.18 3.83 3.70 NA NA XXX
77327 26 A Brachytx isodose calc interm 1.39 0.47 0.45 0.47 0.45 0.07 1.93 1.91 1.93 1.91 XXX
77328 A Brachytx isodose plan compl 2.09 5.28 5.54 NA NA 0.36 7.73 7.99 NA NA XXX
77328 TC A Brachytx isodose plan compl 0.00 4.57 4.86 NA NA 0.25 4.82 5.11 NA NA XXX
77328 26 A Brachytx isodose plan compl 2.09 0.71 0.68 0.71 0.68 0.11 2.91 2.88 2.91 2.88 XXX
77331 A Special radiation dosimetry 0.87 0.81 0.79 NA NA 0.06 1.74 1.72 NA NA XXX
77331 TC A Special radiation dosimetry 0.00 0.52 0.51 NA NA 0.02 0.54 0.53 NA NA XXX
77331 26 A Special radiation dosimetry 0.87 0.29 0.28 0.29 0.28 0.04 1.20 1.19 1.20 1.19 XXX
77332 A Radiation treatment aid(s) 0.54 1.57 1.53 NA NA 0.10 2.21 2.17 NA NA XXX
77332 TC A Radiation treatment aid(s) 0.00 1.38 1.35 NA NA 0.07 1.45 1.42 NA NA XXX
77332 26 A Radiation treatment aid(s) 0.54 0.19 0.18 0.19 0.18 0.03 0.76 0.75 0.76 0.75 XXX
77333 A Radiation treatment aid(s) 0.84 0.52 1.75 NA NA 0.15 1.51 2.74 NA NA XXX
77333 TC A Radiation treatment aid(s) 0.00 0.24 1.48 NA NA 0.11 0.35 1.59 NA NA XXX
77333 26 A Radiation treatment aid(s) 0.84 0.28 0.27 0.28 0.27 0.04 1.16 1.15 1.16 1.15 XXX
77334 A Radiation treatment aid(s) 1.24 2.74 3.43 NA NA 0.23 4.21 4.90 NA NA XXX
77334 TC A Radiation treatment aid(s) 0.00 2.32 3.02 NA NA 0.17 2.49 3.19 NA NA XXX
77334 26 A Radiation treatment aid(s) 1.24 0.42 0.41 0.42 0.41 0.06 1.72 1.71 1.72 1.71 XXX
77336 A Radiation physics consult 0.00 1.14 2.52 NA NA 0.16 1.30 2.68 NA NA XXX
77370 A Radiation physics consult 0.00 3.05 3.38 NA NA 0.18 3.23 3.56 NA NA XXX
77371 A Srs, multisource 0.00 30.25 30.25 NA NA 0.13 30.38 30.38 NA NA XXX
77372 A Srs, linear based 0.00 22.93 22.93 NA NA 0.13 23.06 23.06 NA NA XXX
77373 A Sbrt delivery 0.00 42.87 42.87 NA NA 0.13 43.00 43.00 NA NA XXX
77399 C External radiation dosimetry 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77399 TC C External radiation dosimetry 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77399 26 C External radiation dosimetry 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77401 A Radiation treatment delivery 0.00 0.50 1.45 NA NA 0.11 0.61 1.56 NA NA XXX
77402 A Radiation treatment delivery 0.00 4.18 2.37 NA NA 0.11 4.29 2.48 NA NA XXX
77403 A Radiation treatment delivery 0.00 3.76 2.27 NA NA 0.11 3.87 2.38 NA NA XXX
77404 A Radiation treatment delivery 0.00 4.22 2.38 NA NA 0.11 4.33 2.49 NA NA XXX
77406 A Radiation treatment delivery 0.00 4.21 2.38 NA NA 0.11 4.32 2.49 NA NA XXX
77407 A Radiation treatment delivery 0.00 5.43 2.93 NA NA 0.12 5.55 3.05 NA NA XXX
77408 A Radiation treatment delivery 0.00 5.21 2.87 NA NA 0.12 5.33 2.99 NA NA XXX
77409 A Radiation treatment delivery 0.00 5.82 3.02 NA NA 0.12 5.94 3.14 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77411 A Radiation treatment delivery 0.00 5.76 3.01 NA NA 0.12 5.88 3.13 NA NA XXX
77412 A Radiation treatment delivery 0.00 6.84 3.46 NA NA 0.13 6.97 3.59 NA NA XXX
77413 A Radiation treatment delivery 0.00 6.86 3.46 NA NA 0.13 6.99 3.59 NA NA XXX
77414 A Radiation treatment delivery 0.00 7.72 3.68 NA NA 0.13 7.85 3.81 NA NA XXX
77416 A Radiation treatment delivery 0.00 7.71 3.68 NA NA 0.13 7.84 3.81 NA NA XXX
77417 A Radiology port film(s) 0.00 0.36 0.53 NA NA 0.04 0.40 0.57 NA NA XXX
77418 A Radiation tx delivery, imrt 0.00 13.15 16.80 NA NA 0.13 13.28 16.93 NA NA XXX
77421 A Stereoscopic x-ray guidance 0.39 2.00 3.11 NA NA 0.12 2.51 3.62 NA NA XXX
77421 TC A Stereoscopic x-ray guidance 0.00 1.87 2.98 NA NA 0.10 1.97 3.08 NA NA XXX
77421 26 A Stereoscopic x-ray guidance 0.39 0.13 0.13 0.13 0.13 0.02 0.54 0.54 0.54 0.54 XXX
77422 A Neutron beam tx, simple 0.00 13.19 4.58 NA NA 0.13 13.32 4.71 NA NA XXX
77423 A Neutron beam tx, complex 0.00 8.59 3.84 NA NA 0.13 8.72 3.97 NA NA XXX
77427 A Radiation tx management, x5 3.70 1.43 1.15 1.43 1.15 0.17 5.30 5.02 5.30 5.02 XXX
77431 A Radiation therapy management 1.81 0.80 0.71 0.80 0.71 0.09 2.70 2.61 2.70 2.61 XXX
77432 A Stereotactic radiation trmt 7.92 2.71 2.85 2.71 2.85 0.41 11.04 11.18 11.04 11.18 XXX
77435 A Sbrt management 13.00 4.63 4.63 NA NA 0.67 18.30 18.30 NA NA XXX
77470 A Special radiation treatment 2.09 1.95 9.35 NA NA 0.70 4.74 12.14 NA NA XXX
77470 TC A Special radiation treatment 0.00 1.24 8.67 NA NA 0.59 1.83 9.26 NA NA XXX
77470 26 A Special radiation treatment 2.09 0.71 0.68 0.71 0.68 0.11 2.91 2.88 2.91 2.88 XXX
77499 C Radiation therapy management 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77499 TC C Radiation therapy management 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77499 26 C Radiation therapy management 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77520 C Proton trmt, simple w/o comp 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77522 C Proton trmt, simple w/comp 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77523 C Proton trmt, intermediate 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77525 C Proton treatment, complex 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77600 R Hyperthermia treatment 1.56 9.71 5.09 NA NA 0.24 11.51 6.89 NA NA XXX
77600 TC R Hyperthermia treatment 0.00 9.28 4.61 NA NA 0.16 9.44 4.77 NA NA XXX
77600 26 R Hyperthermia treatment 1.56 0.43 0.48 0.43 0.48 0.08 2.07 2.12 2.07 2.12 XXX
77605 R Hyperthermia treatment 2.09 17.34 7.87 NA NA 0.38 19.81 10.34 NA NA XXX
77605 TC R Hyperthermia treatment 0.00 16.71 7.22 NA NA 0.22 16.93 7.44 NA NA XXX
77605 26 R Hyperthermia treatment 2.09 0.63 0.65 0.63 0.65 0.16 2.88 2.90 2.88 2.90 XXX
77610 R Hyperthermia treatment 1.56 17.04 6.93 NA NA 0.24 18.84 8.73 NA NA XXX
77610 TC R Hyperthermia treatment 0.00 16.52 6.42 NA NA 0.16 16.68 6.58 NA NA XXX
77610 26 R Hyperthermia treatment 1.56 0.52 0.51 0.52 0.51 0.08 2.16 2.15 2.16 2.15 XXX
77615 R Hyperthermia treatment 2.09 25.91 10.02 NA NA 0.33 28.33 12.44 NA NA XXX
77615 TC R Hyperthermia treatment 0.00 25.21 9.35 NA NA 0.22 25.43 9.57 NA NA XXX
77615 26 R Hyperthermia treatment 2.09 0.70 0.67 0.70 0.67 0.11 2.90 2.87 2.90 2.87 XXX
77620 R Hyperthermia treatment 1.56 9.46 5.05 NA NA 0.36 11.38 6.97 NA NA XXX
77620 TC R Hyperthermia treatment 0.00 9.07 4.56 NA NA 0.16 9.23 4.72 NA NA XXX
77620 26 R Hyperthermia treatment 1.56 0.39 0.49 0.39 0.49 0.20 2.15 2.25 2.15 2.25 XXX
77750 A Infuse radioactive materials 4.94 4.61 3.33 4.61 3.33 0.32 9.87 8.59 9.87 8.59 090
77750 TC A Infuse radioactive materials 0.00 2.94 1.73 2.94 1.73 0.07 3.01 1.80 3.01 1.80 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
77750 26 A Infuse radioactive materials 4.94 1.67 1.60 1.67 1.60 0.25 6.86 6.79 6.86 6.79 090
77761 A Apply intrcav radiat simple 3.82 6.32 4.27 6.32 4.27 0.33 10.47 8.42 10.47 8.42 090
77761 TC A Apply intrcav radiat simple 0.00 5.06 3.14 5.06 3.14 0.14 5.20 3.28 5.20 3.28 090
77761 26 A Apply intrcav radiat simple 3.82 1.26 1.13 1.26 1.13 0.19 5.27 5.14 5.27 5.14 090
77762 A Apply intrcav radiat interm 5.73 7.70 6.01 7.70 6.01 0.48 13.91 12.22 13.91 12.22 090
77762 TC A Apply intrcav radiat interm 0.00 5.76 4.15 5.76 4.15 0.19 5.95 4.34 5.95 4.34 090
77762 26 A Apply intrcav radiat interm 5.73 1.94 1.86 1.94 1.86 0.29 7.96 7.88 7.96 7.88 090
77763 A Apply intrcav radiat compl 8.60 10.39 8.03 10.39 8.03 0.66 19.65 17.29 19.65 17.29 090
77763 TC A Apply intrcav radiat compl 0.00 7.51 5.25 7.51 5.25 0.23 7.74 5.48 7.74 5.48 090
77763 26 A Apply intrcav radiat compl 8.60 2.88 2.78 2.88 2.78 0.43 11.91 11.81 11.91 11.81 090
77776 A Apply interstit radiat simpl 4.67 7.51 4.23 7.51 4.23 0.57 12.75 9.47 12.75 9.47 090
77776 TC A Apply interstit radiat simpl 0.00 5.80 3.09 5.80 3.09 0.13 5.93 3.22 5.93 3.22 090
77776 26 A Apply interstit radiat simpl 4.67 1.71 1.14 1.71 1.14 0.44 6.82 6.25 6.82 6.25 090
77777 A Apply interstit radiat inter 7.49 7.90 6.92 7.90 6.92 0.61 16.00 15.02 16.00 15.02 090
77777 TC A Apply interstit radiat inter 0.00 5.40 4.52 5.40 4.52 0.22 5.62 4.74 5.62 4.74 090
77777 26 A Apply interstit radiat inter 7.49 2.50 2.40 2.50 2.40 0.39 10.38 10.28 10.38 10.28 090
77778 A Apply interstit radiat compl 11.23 11.43 9.38 11.43 9.38 0.84 23.50 21.45 23.50 21.45 090
77778 TC A Apply interstit radiat compl 0.00 7.62 5.75 7.62 5.75 0.27 7.89 6.02 7.89 6.02 090
77778 26 A Apply interstit radiat compl 11.23 3.81 3.63 3.81 3.63 0.57 15.61 15.43 15.61 15.43 090
77781 A High intensity brachytherapy 1.21 4.43 16.73 NA NA 1.14 6.78 19.08 NA NA XXX
77781 TC A High intensity brachytherapy 0.00 4.02 16.23 NA NA 1.06 5.08 17.29 NA NA XXX
77781 26 A High intensity brachytherapy 1.21 0.41 0.50 0.41 0.50 0.08 1.70 1.79 1.70 1.79 XXX
77782 A High intensity brachytherapy 2.04 12.47 18.94 NA NA 1.19 15.70 22.17 NA NA XXX
77782 TC A High intensity brachytherapy 0.00 11.78 18.17 NA NA 1.06 12.84 19.23 NA NA XXX
77782 26 A High intensity brachytherapy 2.04 0.69 0.77 0.69 0.77 0.13 2.86 2.94 2.86 2.94 XXX
77783 A High intensity brachytherapy 3.27 24.34 22.20 NA NA 1.25 28.86 26.72 NA NA XXX
77783 TC A High intensity brachytherapy 0.00 23.23 21.03 NA NA 1.06 24.29 22.09 NA NA XXX
77783 26 A High intensity brachytherapy 3.27 1.11 1.17 1.11 1.17 0.19 4.57 4.63 4.57 4.63 XXX
77784 A High intensity brachytherapy 5.15 45.87 28.04 NA NA 1.35 52.37 34.54 NA NA XXX
77784 TC A High intensity brachytherapy 0.00 44.12 26.26 NA NA 1.06 45.18 27.32 NA NA XXX
77784 26 A High intensity brachytherapy 5.15 1.75 1.78 1.75 1.78 0.29 7.19 7.22 7.19 7.22 XXX
77789 A Apply surface radiation 1.14 2.07 1.14 2.07 1.14 0.08 3.29 2.36 3.29 2.36 000
77789 TC A Apply surface radiation 0.00 1.67 0.76 1.67 0.76 0.02 1.69 0.78 1.69 0.78 000
77789 26 A Apply surface radiation 1.14 0.40 0.38 0.40 0.38 0.06 1.60 1.58 1.60 1.58 000
77790 A Radiation handling 1.05 1.47 1.00 NA NA 0.07 2.59 2.12 NA NA XXX
77790 TC A Radiation handling 0.00 1.12 0.66 NA NA 0.02 1.14 0.68 NA NA XXX
77790 26 A Radiation handling 1.05 0.35 0.34 0.35 0.34 0.05 1.45 1.44 1.45 1.44 XXX
77799 C Radium/radioisotope therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77799 TC C Radium/radioisotope therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
77799 26 C Radium/radioisotope therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78000 A Thyroid, single uptake 0.19 1.72 1.21 NA NA 0.07 1.98 1.47 NA NA XXX
78000 TC A Thyroid, single uptake 0.00 1.67 1.15 NA NA 0.06 1.73 1.21 NA NA XXX
78000 26 A Thyroid, single uptake 0.19 0.05 0.06 0.05 0.06 0.01 0.25 0.26 0.25 0.26 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78001 A Thyroid, multiple uptakes 0.26 2.12 1.59 NA NA 0.08 2.46 1.93 NA NA XXX
78001 TC A Thyroid, multiple uptakes 0.00 2.05 1.50 NA NA 0.07 2.12 1.57 NA NA XXX
78001 26 A Thyroid, multiple uptakes 0.26 0.07 0.09 0.07 0.09 0.01 0.34 0.36 0.34 0.36 XXX
78003 A Thyroid suppress/stimul 0.33 1.76 1.26 NA NA 0.07 2.16 1.66 NA NA XXX
78003 TC A Thyroid suppress/stimul 0.00 1.67 1.15 NA NA 0.06 1.73 1.21 NA NA XXX
78003 26 A Thyroid suppress/stimul 0.33 0.09 0.11 0.09 0.11 0.01 0.43 0.45 0.43 0.45 XXX
78006 A Thyroid imaging with uptake 0.49 5.86 3.38 NA NA 0.15 6.50 4.02 NA NA XXX
78006 TC A Thyroid imaging with uptake 0.00 5.72 3.22 NA NA 0.13 5.85 3.35 NA NA XXX
78006 26 A Thyroid imaging with uptake 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78007 A Thyroid image, mult uptakes 0.50 2.81 2.76 NA NA 0.16 3.47 3.42 NA NA XXX
78007 TC A Thyroid image, mult uptakes 0.00 2.67 2.60 NA NA 0.14 2.81 2.74 NA NA XXX
78007 26 A Thyroid image, mult uptakes 0.50 0.14 0.16 0.14 0.16 0.02 0.66 0.68 0.66 0.68 XXX
78010 A Thyroid imaging 0.39 3.94 2.45 NA NA 0.13 4.46 2.97 NA NA XXX
78010 TC A Thyroid imaging 0.00 3.83 2.32 NA NA 0.11 3.94 2.43 NA NA XXX
78010 26 A Thyroid imaging 0.39 0.11 0.13 0.11 0.13 0.02 0.52 0.54 0.52 0.54 XXX
78011 A Thyroid imaging with flow 0.45 4.27 2.99 NA NA 0.15 4.87 3.59 NA NA XXX
78011 TC A Thyroid imaging with flow 0.00 4.14 2.84 NA NA 0.13 4.27 2.97 NA NA XXX
78011 26 A Thyroid imaging with flow 0.45 0.13 0.15 0.13 0.15 0.02 0.60 0.62 0.60 0.62 XXX
78015 A Thyroid met imaging 0.67 5.10 3.38 NA NA 0.17 5.94 4.22 NA NA XXX
78015 TC A Thyroid met imaging 0.00 4.91 3.16 NA NA 0.14 5.05 3.30 NA NA XXX
78015 26 A Thyroid met imaging 0.67 0.19 0.22 0.19 0.22 0.03 0.89 0.92 0.89 0.92 XXX
78016 A Thyroid met imaging/studies 0.82 8.12 4.85 NA NA 0.21 9.15 5.88 NA NA XXX
78016 TC A Thyroid met imaging/studies 0.00 7.89 4.58 NA NA 0.18 8.07 4.76 NA NA XXX
78016 26 A Thyroid met imaging/studies 0.82 0.23 0.27 0.23 0.27 0.03 1.08 1.12 1.08 1.12 XXX
78018 A Thyroid met imaging, body 0.86 7.47 6.16 NA NA 0.33 8.66 7.35 NA NA XXX
78018 TC A Thyroid met imaging, body 0.00 7.23 5.87 NA NA 0.29 7.52 6.16 NA NA XXX
78018 26 A Thyroid met imaging, body 0.86 0.24 0.29 0.24 0.29 0.04 1.14 1.19 1.14 1.19 XXX
78020 A Thyroid met uptake 0.60 1.68 1.56 1.68 1.56 0.16 2.44 2.32 2.44 2.32 ZZZ
78020 TC A Thyroid met uptake 0.00 1.51 1.36 1.51 1.36 0.14 1.65 1.50 1.65 1.50 ZZZ
78020 26 A Thyroid met uptake 0.60 0.17 0.20 0.17 0.20 0.02 0.79 0.82 0.79 0.82 ZZZ
78070 A Parathyroid nuclear imaging 0.82 3.19 4.21 NA NA 0.15 4.16 5.18 NA NA XXX
78070 TC A Parathyroid nuclear imaging 0.00 2.96 3.94 NA NA 0.11 3.07 4.05 NA NA XXX
78070 26 A Parathyroid nuclear imaging 0.82 0.23 0.27 0.23 0.27 0.04 1.09 1.13 1.09 1.13 XXX
78075 A Adrenal nuclear imaging 0.74 11.04 7.02 NA NA 0.32 12.10 8.08 NA NA XXX
78075 TC A Adrenal nuclear imaging 0.00 10.83 6.77 NA NA 0.29 11.12 7.06 NA NA XXX
78075 26 A Adrenal nuclear imaging 0.74 0.21 0.25 0.21 0.25 0.03 0.98 1.02 0.98 1.02 XXX
78099 C Endocrine nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78099 TC C Endocrine nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78099 26 C Endocrine nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78102 A Bone marrow imaging, ltd 0.55 3.91 2.65 NA NA 0.14 4.60 3.34 NA NA XXX
78102 TC A Bone marrow imaging, ltd 0.00 3.76 2.47 NA NA 0.12 3.88 2.59 NA NA XXX
78102 26 A Bone marrow imaging, ltd 0.55 0.15 0.18 0.15 0.18 0.02 0.72 0.75 0.72 0.75 XXX
78103 A Bone marrow imaging, mult 0.75 5.09 3.85 NA NA 0.20 6.04 4.80 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78103 TC A Bone marrow imaging, mult 0.00 4.88 3.60 NA NA 0.17 5.05 3.77 NA NA XXX
78103 26 A Bone marrow imaging, mult 0.75 0.21 0.25 0.21 0.25 0.03 0.99 1.03 0.99 1.03 XXX
78104 A Bone marrow imaging, body 0.80 5.96 4.75 NA NA 0.25 7.01 5.80 NA NA XXX
78104 TC A Bone marrow imaging, body 0.00 5.71 4.48 NA NA 0.22 5.93 4.70 NA NA XXX
78104 26 A Bone marrow imaging, body 0.80 0.25 0.27 0.25 0.27 0.03 1.08 1.10 1.08 1.10 XXX
78110 A Plasma volume, single 0.19 2.03 1.28 NA NA 0.07 2.29 1.54 NA NA XXX
78110 TC A Plasma volume, single 0.00 1.98 1.21 NA NA 0.06 2.04 1.27 NA NA XXX
78110 26 A Plasma volume, single 0.19 0.05 0.07 0.05 0.07 0.01 0.25 0.27 0.25 0.27 XXX
78111 A Plasma volume, multiple 0.22 2.02 2.50 NA NA 0.15 2.39 2.87 NA NA XXX
78111 TC A Plasma volume, multiple 0.00 1.96 2.42 NA NA 0.14 2.10 2.56 NA NA XXX
78111 26 A Plasma volume, multiple 0.22 0.06 0.08 0.06 0.08 0.01 0.29 0.31 0.29 0.31 XXX
78120 A Red cell mass, single 0.23 1.96 1.85 NA NA 0.12 2.31 2.20 NA NA XXX
78120 TC A Red cell mass, single 0.00 1.89 1.77 NA NA 0.11 2.00 1.88 NA NA XXX
78120 26 A Red cell mass, single 0.23 0.07 0.08 0.07 0.08 0.01 0.31 0.32 0.31 0.32 XXX
78121 A Red cell mass, multiple 0.32 2.06 2.79 NA NA 0.15 2.53 3.26 NA NA XXX
78121 TC A Red cell mass, multiple 0.00 1.97 2.68 NA NA 0.14 2.11 2.82 NA NA XXX
78121 26 A Red cell mass, multiple 0.32 0.09 0.11 0.09 0.11 0.01 0.42 0.44 0.42 0.44 XXX
78122 A Blood volume 0.45 2.09 4.09 NA NA 0.26 2.80 4.80 NA NA XXX
78122 TC A Blood volume 0.00 1.97 3.94 NA NA 0.24 2.21 4.18 NA NA XXX
78122 26 A Blood volume 0.45 0.12 0.15 0.12 0.15 0.02 0.59 0.62 0.59 0.62 XXX
78130 A Red cell survival study 0.61 3.32 3.12 NA NA 0.17 4.10 3.90 NA NA XXX
78130 TC A Red cell survival study 0.00 3.14 2.92 NA NA 0.14 3.28 3.06 NA NA XXX
78130 26 A Red cell survival study 0.61 0.18 0.20 0.18 0.20 0.03 0.82 0.84 0.82 0.84 XXX
78135 A Red cell survival kinetics 0.64 8.09 5.84 NA NA 0.28 9.01 6.76 NA NA XXX
78135 TC A Red cell survival kinetics 0.00 7.91 5.63 NA NA 0.25 8.16 5.88 NA NA XXX
78135 26 A Red cell survival kinetics 0.64 0.18 0.21 0.18 0.21 0.03 0.85 0.88 0.85 0.88 XXX
78140 A Red cell sequestration 0.61 2.68 3.77 NA NA 0.24 3.53 4.62 NA NA XXX
78140 TC A Red cell sequestration 0.00 2.51 3.58 NA NA 0.21 2.72 3.79 NA NA XXX
78140 26 A Red cell sequestration 0.61 0.17 0.19 0.17 0.19 0.03 0.81 0.83 0.81 0.83 XXX
78185 A Spleen imaging 0.40 4.90 3.10 NA NA 0.15 5.45 3.65 NA NA XXX
78185 TC A Spleen imaging 0.00 4.79 2.97 NA NA 0.13 4.92 3.10 NA NA XXX
78185 26 A Spleen imaging 0.40 0.11 0.13 0.11 0.13 0.02 0.53 0.55 0.53 0.55 XXX
78190 A Platelet survival, kinetics 1.09 8.77 6.77 NA NA 0.38 10.24 8.24 NA NA XXX
78190 TC A Platelet survival, kinetics 0.00 8.44 6.39 NA NA 0.30 8.74 6.69 NA NA XXX
78190 26 A Platelet survival, kinetics 1.09 0.33 0.38 0.33 0.38 0.08 1.50 1.55 1.50 1.55 XXX
78191 A Platelet survival 0.61 3.21 6.46 NA NA 0.40 4.22 7.47 NA NA XXX
78191 TC A Platelet survival 0.00 3.04 6.27 NA NA 0.37 3.41 6.64 NA NA XXX
78191 26 A Platelet survival 0.61 0.17 0.19 0.17 0.19 0.03 0.81 0.83 0.81 0.83 XXX
78195 A Lymph system imaging 1.20 8.15 5.40 NA NA 0.28 9.63 6.88 NA NA XXX
78195 TC A Lymph system imaging 0.00 7.82 5.01 NA NA 0.22 8.04 5.23 NA NA XXX
78195 26 A Lymph system imaging 1.20 0.33 0.39 0.33 0.39 0.06 1.59 1.65 1.59 1.65 XXX
78199 C Blood/lymph nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78199 TC C Blood/lymph nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78199 26 C Blood/lymph nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78201 A Liver imaging 0.44 4.48 3.00 NA NA 0.15 5.07 3.59 NA NA XXX
78201 TC A Liver imaging 0.00 4.36 2.86 NA NA 0.13 4.49 2.99 NA NA XXX
78201 26 A Liver imaging 0.44 0.12 0.14 0.12 0.14 0.02 0.58 0.60 0.58 0.60 XXX
78202 A Liver imaging with flow 0.51 5.06 3.55 NA NA 0.16 5.73 4.22 NA NA XXX
78202 TC A Liver imaging with flow 0.00 4.92 3.39 NA NA 0.14 5.06 3.53 NA NA XXX
78202 26 A Liver imaging with flow 0.51 0.14 0.16 0.14 0.16 0.02 0.67 0.69 0.67 0.69 XXX
78205 A Liver imaging (3D) 0.71 4.93 5.85 NA NA 0.34 5.98 6.90 NA NA XXX
78205 TC A Liver imaging (3D) 0.00 4.73 5.62 NA NA 0.31 5.04 5.93 NA NA XXX
78205 26 A Liver imaging (3D) 0.71 0.20 0.23 0.20 0.23 0.03 0.94 0.97 0.94 0.97 XXX
78206 A Liver image (3d) with flow 0.96 13.75 8.12 NA NA 0.15 14.86 9.23 NA NA XXX
78206 TC A Liver image (3d) with flow 0.00 13.48 7.80 NA NA 0.11 13.59 7.91 NA NA XXX
78206 26 A Liver image (3d) with flow 0.96 0.27 0.32 0.27 0.32 0.04 1.27 1.32 1.27 1.32 XXX
78215 A Liver and spleen imaging 0.49 4.52 3.46 NA NA 0.16 5.17 4.11 NA NA XXX
78215 TC A Liver and spleen imaging 0.00 4.38 3.30 NA NA 0.14 4.52 3.44 NA NA XXX
78215 26 A Liver and spleen imaging 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78216 A Liver spleen image/flow 0.57 2.63 3.41 NA NA 0.20 3.40 4.18 NA NA XXX
78216 TC A Liver spleen image/flow 0.00 2.47 3.23 NA NA 0.18 2.65 3.41 NA NA XXX
78216 26 A Liver spleen image/flow 0.57 0.16 0.18 0.16 0.18 0.02 0.75 0.77 0.75 0.77 XXX
78220 A Liver function study 0.49 2.84 3.63 NA NA 0.21 3.54 4.33 NA NA XXX
78220 TC A Liver function study 0.00 2.70 3.47 NA NA 0.19 2.89 3.66 NA NA XXX
78220 26 A Liver function study 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78223 A Hepatobiliary imaging 0.84 7.99 4.95 NA NA 0.23 9.06 6.02 NA NA XXX
78223 TC A Hepatobiliary imaging 0.00 7.75 4.68 NA NA 0.19 7.94 4.87 NA NA XXX
78223 26 A Hepatobiliary imaging 0.84 0.24 0.27 0.24 0.27 0.04 1.12 1.15 1.12 1.15 XXX
78230 A Salivary gland imaging 0.45 3.91 2.72 NA NA 0.15 4.51 3.32 NA NA XXX
78230 TC A Salivary gland imaging 0.00 3.79 2.58 NA NA 0.13 3.92 2.71 NA NA XXX
78230 26 A Salivary gland imaging 0.45 0.12 0.14 0.12 0.14 0.02 0.59 0.61 0.59 0.61 XXX
78231 A Serial salivary imaging 0.52 2.63 3.17 NA NA 0.19 3.34 3.88 NA NA XXX
78231 TC A Serial salivary imaging 0.00 2.48 3.00 NA NA 0.17 2.65 3.17 NA NA XXX
78231 26 A Serial salivary imaging 0.52 0.15 0.17 0.15 0.17 0.02 0.69 0.71 0.69 0.71 XXX
78232 A Salivary gland function exam 0.47 2.60 3.42 NA NA 0.20 3.27 4.09 NA NA XXX
78232 TC A Salivary gland function exam 0.00 2.47 3.27 NA NA 0.18 2.65 3.45 NA NA XXX
78232 26 A Salivary gland function exam 0.47 0.13 0.15 0.13 0.15 0.02 0.62 0.64 0.62 0.64 XXX
78258 A Esophageal motility study 0.74 5.57 3.74 NA NA 0.17 6.48 4.65 NA NA XXX
78258 TC A Esophageal motility study 0.00 5.32 3.49 NA NA 0.14 5.46 3.63 NA NA XXX
78258 26 A Esophageal motility study 0.74 0.25 0.25 0.25 0.25 0.03 1.02 1.02 1.02 1.02 XXX
78261 A Gastric mucosa imaging 0.69 5.69 4.68 NA NA 0.25 6.63 5.62 NA NA XXX
78261 TC A Gastric mucosa imaging 0.00 5.50 4.45 NA NA 0.22 5.72 4.67 NA NA XXX
78261 26 A Gastric mucosa imaging 0.69 0.19 0.23 0.19 0.23 0.03 0.91 0.95 0.91 0.95 XXX
78262 A Gastroesophageal reflux exam 0.68 5.65 4.77 NA NA 0.25 6.58 5.70 NA NA XXX
78262 TC A Gastroesophageal reflux exam 0.00 5.46 4.55 NA NA 0.22 5.68 4.77 NA NA XXX
78262 26 A Gastroesophageal reflux exam 0.68 0.19 0.22 0.19 0.22 0.03 0.90 0.93 0.90 0.93 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78264 A Gastric emptying study 0.78 6.73 4.98 NA NA 0.25 7.76 6.01 NA NA XXX
78264 TC A Gastric emptying study 0.00 6.51 4.73 NA NA 0.22 6.73 4.95 NA NA XXX
78264 26 A Gastric emptying study 0.78 0.22 0.25 0.22 0.25 0.03 1.03 1.06 1.03 1.06 XXX
78267 X Breath tst attain/anal c-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78268 X Breath test analysis, c-14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78270 A Vit B-12 absorption exam 0.20 1.81 1.67 NA NA 0.11 2.12 1.98 NA NA XXX
78270 TC A Vit B-12 absorption exam 0.00 1.76 1.60 NA NA 0.10 1.86 1.70 NA NA XXX
78270 26 A Vit B-12 absorption exam 0.20 0.05 0.07 0.05 0.07 0.01 0.26 0.28 0.26 0.28 XXX
78271 A Vit b-12 absrp exam, int fac 0.20 1.83 1.75 NA NA 0.11 2.14 2.06 NA NA XXX
78271 TC A Vit b-12 absrp exam, int fac 0.00 1.78 1.68 NA NA 0.10 1.88 1.78 NA NA XXX
78271 26 A Vit b-12 absrp exam, int fac 0.20 0.05 0.07 0.05 0.07 0.01 0.26 0.28 0.26 0.28 XXX
78272 A Vit B-12 absorp, combined 0.27 1.95 2.30 NA NA 0.14 2.36 2.71 NA NA XXX
78272 TC A Vit B-12 absorp, combined 0.00 1.88 2.21 NA NA 0.13 2.01 2.34 NA NA XXX
78272 26 A Vit B-12 absorp, combined 0.27 0.07 0.09 0.07 0.09 0.01 0.35 0.37 0.35 0.37 XXX
78278 A Acute GI blood loss imaging 0.99 8.06 5.92 NA NA 0.29 9.34 7.20 NA NA XXX
78278 TC A Acute GI blood loss imaging 0.00 7.78 5.60 NA NA 0.25 8.03 5.85 NA NA XXX
78278 26 A Acute GI blood loss imaging 0.99 0.28 0.32 0.28 0.32 0.04 1.31 1.35 1.31 1.35 XXX
78282 C GI protein loss exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78282 TC C GI protein loss exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78282 26 A GI protein loss exam 0.38 0.10 0.12 0.10 0.12 0.02 0.50 0.52 0.50 0.52 XXX
78290 A MeckelÆs divert exam 0.68 7.97 4.45 NA NA 0.19 8.84 5.32 NA NA XXX
78290 TC A MeckelÆs divert exam 0.00 7.78 4.23 NA NA 0.16 7.94 4.39 NA NA XXX
78290 26 A MeckelÆs divert exam 0.68 0.19 0.22 0.19 0.22 0.03 0.90 0.93 0.90 0.93 XXX
78291 A Leveen/shunt patency exam 0.88 5.82 3.98 NA NA 0.20 6.90 5.06 NA NA XXX
78291 TC A Leveen/shunt patency exam 0.00 5.57 3.69 NA NA 0.16 5.73 3.85 NA NA XXX
78291 26 A Leveen/shunt patency exam 0.88 0.25 0.29 0.25 0.29 0.04 1.17 1.21 1.17 1.21 XXX
78299 C GI nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78299 TC C GI nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78299 26 C GI nuclear procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78300 A Bone imaging, limited area 0.62 3.94 3.00 NA NA 0.17 4.73 3.79 NA NA XXX
78300 TC A Bone imaging, limited area 0.00 3.76 2.80 NA NA 0.14 3.90 2.94 NA NA XXX
78300 26 A Bone imaging, limited area 0.62 0.18 0.20 0.18 0.20 0.03 0.83 0.85 0.83 0.85 XXX
78305 A Bone imaging, multiple areas 0.83 5.13 4.24 NA NA 0.23 6.19 5.30 NA NA XXX
78305 TC A Bone imaging, multiple areas 0.00 4.90 3.97 NA NA 0.19 5.09 4.16 NA NA XXX
78305 26 A Bone imaging, multiple areas 0.83 0.23 0.27 0.23 0.27 0.04 1.10 1.14 1.10 1.14 XXX
78306 A Bone imaging, whole body 0.86 5.68 4.84 NA NA 0.26 6.80 5.96 NA NA XXX
78306 TC A Bone imaging, whole body 0.00 5.44 4.56 NA NA 0.22 5.66 4.78 NA NA XXX
78306 26 A Bone imaging, whole body 0.86 0.24 0.28 0.24 0.28 0.04 1.14 1.18 1.14 1.18 XXX
78315 A Bone imaging, 3 phase 1.02 8.07 5.86 NA NA 0.29 9.38 7.17 NA NA XXX
78315 TC A Bone imaging, 3 phase 0.00 7.78 5.53 NA NA 0.25 8.03 5.78 NA NA XXX
78315 26 A Bone imaging, 3 phase 1.02 0.29 0.33 0.29 0.33 0.04 1.35 1.39 1.35 1.39 XXX
78320 A Bone imaging (3D) 1.04 5.00 5.95 NA NA 0.35 6.39 7.34 NA NA XXX
78320 TC A Bone imaging (3D) 0.00 4.71 5.61 NA NA 0.31 5.02 5.92 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78320 26 A Bone imaging (3D) 1.04 0.29 0.34 0.29 0.34 0.04 1.37 1.42 1.37 1.42 XXX
78350 N Bone mineral, single photon 0.22 0.00 0.82 NA NA 0.06 0.28 1.10 NA NA XXX
78350 TC N Bone mineral, single photon 0.00 0.00 0.75 NA NA 0.05 0.05 0.80 NA NA XXX
78350 26 N Bone mineral, single photon 0.22 0.00 0.07 0.00 0.07 0.01 0.23 0.30 0.23 0.30 XXX
78351 N Bone mineral, dual photon 0.30 NA NA 0.07 0.11 0.01 NA NA 0.38 0.42 XXX
78399 C Musculoskeletal nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78399 TC C Musculoskeletal nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78399 26 C Musculoskeletal nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78414 C Non-imaging heart function 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78414 TC C Non-imaging heart function 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78414 26 A Non-imaging heart function 0.45 0.14 0.16 0.14 0.16 0.02 0.61 0.63 0.61 0.63 XXX
78428 A Cardiac shunt imaging 0.78 5.26 3.22 NA NA 0.16 6.20 4.16 NA NA XXX
78428 TC A Cardiac shunt imaging 0.00 4.88 2.91 NA NA 0.13 5.01 3.04 NA NA XXX
78428 26 A Cardiac shunt imaging 0.78 0.38 0.31 0.38 0.31 0.03 1.19 1.12 1.19 1.12 XXX
78445 A Vascular flow imaging 0.49 4.34 2.61 NA NA 0.13 4.96 3.23 NA NA XXX
78445 TC A Vascular flow imaging 0.00 4.18 2.44 NA NA 0.11 4.29 2.55 NA NA XXX
78445 26 A Vascular flow imaging 0.49 0.16 0.17 0.16 0.17 0.02 0.67 0.68 0.67 0.68 XXX
78456 A Acute venous thrombus image 1.00 9.86 5.71 NA NA 0.33 11.19 7.04 NA NA XXX
78456 TC A Acute venous thrombus image 0.00 9.36 5.33 NA NA 0.29 9.65 5.62 NA NA XXX
78456 26 A Acute venous thrombus image 1.00 0.50 0.38 0.50 0.38 0.04 1.54 1.42 1.54 1.42 XXX
78457 A Venous thrombosis imaging 0.77 4.53 3.32 NA NA 0.17 5.47 4.26 NA NA XXX
78457 TC A Venous thrombosis imaging 0.00 4.31 3.07 NA NA 0.14 4.45 3.21 NA NA XXX
78457 26 A Venous thrombosis imaging 0.77 0.22 0.25 0.22 0.25 0.03 1.02 1.05 1.02 1.05 XXX
78458 A Ven thrombosis images, bilat 0.90 4.30 4.33 NA NA 0.25 5.45 5.48 NA NA XXX
78458 TC A Ven thrombosis images, bilat 0.00 4.05 4.03 NA NA 0.21 4.26 4.24 NA NA XXX
78458 26 A Ven thrombosis images, bilat 0.90 0.25 0.30 0.25 0.30 0.04 1.19 1.24 1.19 1.24 XXX
78459 C Heart muscle imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78459 TC C Heart muscle imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78459 26 A Heart muscle imaging (PET) 1.50 0.54 0.56 0.54 0.56 0.05 2.09 2.11 2.09 2.11 XXX
78460 A Heart muscle blood, single 0.86 4.44 3.10 NA NA 0.17 5.47 4.13 NA NA XXX
78460 TC A Heart muscle blood, single 0.00 4.17 2.81 NA NA 0.13 4.30 2.94 NA NA XXX
78460 26 A Heart muscle blood, single 0.86 0.27 0.29 0.27 0.29 0.04 1.17 1.19 1.17 1.19 XXX
78461 A Heart muscle blood, multiple 1.23 3.79 4.81 NA NA 0.30 5.32 6.34 NA NA XXX
78461 TC A Heart muscle blood, multiple 0.00 3.40 4.39 NA NA 0.25 3.65 4.64 NA NA XXX
78461 26 A Heart muscle blood, multiple 1.23 0.39 0.42 0.39 0.42 0.05 1.67 1.70 1.67 1.70 XXX
78464 A Heart image (3d), single 1.09 5.75 7.03 NA NA 0.41 7.25 8.53 NA NA XXX
78464 TC A Heart image (3d), single 0.00 5.27 6.62 NA NA 0.37 5.64 6.99 NA NA XXX
78464 26 A Heart image (3d), single 1.09 0.48 0.41 0.48 0.41 0.04 1.61 1.54 1.61 1.54 XXX
78465 A Heart image (3d), multiple 1.46 11.36 12.08 NA NA 0.67 13.49 14.21 NA NA XXX
78465 TC A Heart image (3d), multiple 0.00 10.66 11.51 NA NA 0.62 11.28 12.13 NA NA XXX
78465 26 A Heart image (3d), multiple 1.46 0.70 0.57 0.70 0.57 0.05 2.21 2.08 2.21 2.08 XXX
78466 A Heart infarct image 0.69 4.34 3.23 NA NA 0.17 5.20 4.09 NA NA XXX
78466 TC A Heart infarct image 0.00 4.10 2.99 NA NA 0.14 4.24 3.13 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78466 26 A Heart infarct image 0.69 0.24 0.24 0.24 0.24 0.03 0.96 0.96 0.96 0.96 XXX
78468 A Heart infarct image (ef) 0.80 5.98 4.45 NA NA 0.22 7.00 5.47 NA NA XXX
78468 TC A Heart infarct image (ef) 0.00 5.56 4.14 NA NA 0.19 5.75 4.33 NA NA XXX
78468 26 A Heart infarct image (ef) 0.80 0.42 0.31 0.42 0.31 0.03 1.25 1.14 1.25 1.14 XXX
78469 A Heart infarct image (3D) 0.92 6.21 5.70 NA NA 0.31 7.44 6.93 NA NA XXX
78469 TC A Heart infarct image (3D) 0.00 5.77 5.36 NA NA 0.28 6.05 5.64 NA NA XXX
78469 26 A Heart infarct image (3D) 0.92 0.44 0.34 0.44 0.34 0.03 1.39 1.29 1.39 1.29 XXX
78472 A Gated heart, planar, single 0.98 5.95 5.87 NA NA 0.34 7.27 7.19 NA NA XXX
78472 TC A Gated heart, planar, single 0.00 5.56 5.52 NA NA 0.30 5.86 5.82 NA NA XXX
78472 26 A Gated heart, planar, single 0.98 0.39 0.35 0.39 0.35 0.04 1.41 1.37 1.41 1.37 XXX
78473 A Gated heart, multiple 1.47 7.54 8.46 NA NA 0.48 9.49 10.41 NA NA XXX
78473 TC A Gated heart, multiple 0.00 6.94 7.93 NA NA 0.42 7.36 8.35 NA NA XXX
78473 26 A Gated heart, multiple 1.47 0.60 0.53 0.60 0.53 0.06 2.13 2.06 2.13 2.06 XXX
78478 A Heart wall motion add-on 0.50 0.80 1.54 NA NA 0.12 1.42 2.16 NA NA XXX
78478 TC A Heart wall motion add-on 0.00 0.56 1.31 NA NA 0.10 0.66 1.41 NA NA XXX
78478 26 A Heart wall motion add-on 0.50 0.24 0.23 0.24 0.23 0.02 0.76 0.75 0.76 0.75 XXX
78480 A Heart function add-on 0.30 0.70 1.51 NA NA 0.12 1.12 1.93 NA NA XXX
78480 TC A Heart function add-on 0.00 0.55 1.31 NA NA 0.10 0.65 1.41 NA NA XXX
78480 26 A Heart function add-on 0.30 0.15 0.20 0.15 0.20 0.02 0.47 0.52 0.47 0.52 XXX
78481 A Heart first pass, single 0.98 5.07 5.46 NA NA 0.31 6.36 6.75 NA NA XXX
78481 TC A Heart first pass, single 0.00 4.57 5.06 NA NA 0.28 4.85 5.34 NA NA XXX
78481 26 A Heart first pass, single 0.98 0.50 0.40 0.50 0.40 0.03 1.51 1.41 1.51 1.41 XXX
78483 A Heart first pass, multiple 1.47 6.86 8.02 NA NA 0.46 8.79 9.95 NA NA XXX
78483 TC A Heart first pass, multiple 0.00 6.07 7.42 NA NA 0.41 6.48 7.83 NA NA XXX
78483 26 A Heart first pass, multiple 1.47 0.79 0.60 0.79 0.60 0.05 2.31 2.12 2.31 2.12 XXX
78491 C Heart image (pet), single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78491 TC C Heart image (pet), single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78491 26 A Heart image (pet), single 1.50 0.60 0.59 0.60 0.59 0.06 2.16 2.15 2.16 2.15 XXX
78492 C Heart image (pet), multiple 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78492 TC C Heart image (pet), multiple 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78492 26 A Heart image (pet), multiple 1.87 0.91 0.78 0.91 0.78 0.07 2.85 2.72 2.85 2.72 XXX
78494 A Heart image, spect 1.19 6.19 7.17 NA NA 0.35 7.73 8.71 NA NA XXX
78494 TC A Heart image, spect 0.00 5.65 6.72 NA NA 0.30 5.95 7.02 NA NA XXX
78494 26 A Heart image, spect 1.19 0.54 0.45 0.54 0.45 0.05 1.78 1.69 1.78 1.69 XXX
78496 A Heart first pass add-on 0.50 0.92 5.67 0.92 5.67 0.32 1.74 6.49 1.74 6.49 ZZZ
78496 TC A Heart first pass add-on 0.00 0.67 5.47 0.67 5.47 0.30 0.97 5.77 0.97 5.77 ZZZ
78496 26 A Heart first pass add-on 0.50 0.25 0.20 0.25 0.20 0.02 0.77 0.72 0.77 0.72 ZZZ
78499 C Cardiovascular nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78499 TC C Cardiovascular nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78499 26 C Cardiovascular nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78580 A Lung perfusion imaging 0.74 4.83 3.97 NA NA 0.21 5.78 4.92 NA NA XXX
78580 TC A Lung perfusion imaging 0.00 4.61 3.73 NA NA 0.18 4.79 3.91 NA NA XXX
78580 26 A Lung perfusion imaging 0.74 0.22 0.24 0.22 0.24 0.03 0.99 1.01 0.99 1.01 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78584 A Lung V/Q image single breath 0.99 2.74 3.34 NA NA 0.21 3.94 4.54 NA NA XXX
78584 TC A Lung V/Q image single breath 0.00 2.46 3.02 NA NA 0.17 2.63 3.19 NA NA XXX
78584 26 A Lung V/Q image single breath 0.99 0.28 0.32 0.28 0.32 0.04 1.31 1.35 1.31 1.35 XXX
78585 A Lung V/Q imaging 1.09 8.09 6.53 NA NA 0.35 9.53 7.97 NA NA XXX
78585 TC A Lung V/Q imaging 0.00 7.78 6.18 NA NA 0.30 8.08 6.48 NA NA XXX
78585 26 A Lung V/Q imaging 1.09 0.31 0.35 0.31 0.35 0.05 1.45 1.49 1.45 1.49 XXX
78586 A Aerosol lung image, single 0.40 3.89 3.02 NA NA 0.16 4.45 3.58 NA NA XXX
78586 TC A Aerosol lung image, single 0.00 3.78 2.89 NA NA 0.14 3.92 3.03 NA NA XXX
78586 26 A Aerosol lung image, single 0.40 0.11 0.13 0.11 0.13 0.02 0.53 0.55 0.53 0.55 XXX
78587 A Aerosol lung image, multiple 0.49 5.12 3.51 NA NA 0.16 5.77 4.16 NA NA XXX
78587 TC A Aerosol lung image, multiple 0.00 4.98 3.35 NA NA 0.14 5.12 3.49 NA NA XXX
78587 26 A Aerosol lung image, multiple 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78588 A Perfusion lung image 1.09 8.11 4.70 NA NA 0.23 9.43 6.02 NA NA XXX
78588 TC A Perfusion lung image 0.00 7.81 4.35 NA NA 0.18 7.99 4.53 NA NA XXX
78588 26 A Perfusion lung image 1.09 0.30 0.35 0.30 0.35 0.05 1.44 1.49 1.44 1.49 XXX
78591 A Vent image, 1 breath, 1 proj 0.40 3.87 3.21 NA NA 0.16 4.43 3.77 NA NA XXX
78591 TC A Vent image, 1 breath, 1 proj 0.00 3.76 3.08 NA NA 0.14 3.90 3.22 NA NA XXX
78591 26 A Vent image, 1 breath, 1 proj 0.40 0.11 0.13 0.11 0.13 0.02 0.53 0.55 0.53 0.55 XXX
78593 A Vent image, 1 proj, gas 0.49 4.51 3.84 NA NA 0.20 5.20 4.53 NA NA XXX
78593 TC A Vent image, 1 proj, gas 0.00 4.37 3.68 NA NA 0.18 4.55 3.86 NA NA XXX
78593 26 A Vent image, 1 proj, gas 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78594 A Vent image, mult proj, gas 0.53 4.99 5.12 NA NA 0.27 5.79 5.92 NA NA XXX
78594 TC A Vent image, mult proj, gas 0.00 4.84 4.95 NA NA 0.25 5.09 5.20 NA NA XXX
78594 26 A Vent image, mult proj, gas 0.53 0.15 0.17 0.15 0.17 0.02 0.70 0.72 0.70 0.72 XXX
78596 A Lung differential function 1.27 8.33 7.70 NA NA 0.42 10.02 9.39 NA NA XXX
78596 TC A Lung differential function 0.00 7.98 7.30 NA NA 0.37 8.35 7.67 NA NA XXX
78596 26 A Lung differential function 1.27 0.35 0.40 0.35 0.40 0.05 1.67 1.72 1.67 1.72 XXX
78599 C Respiratory nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78599 TC C Respiratory nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78599 26 C Respiratory nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78600 A Brain imaging, ltd static 0.44 6.83 3.98 NA NA 0.16 7.43 4.58 NA NA XXX
78600 TC A Brain imaging, ltd static 0.00 6.71 3.84 NA NA 0.14 6.85 3.98 NA NA XXX
78600 26 A Brain imaging, ltd static 0.44 0.12 0.14 0.12 0.14 0.02 0.58 0.60 0.58 0.60 XXX
78601 A Brain imaging, ltd w/flow 0.51 5.02 3.93 NA NA 0.20 5.73 4.64 NA NA XXX
78601 TC A Brain imaging, ltd w/flow 0.00 4.88 3.77 NA NA 0.18 5.06 3.95 NA NA XXX
78601 26 A Brain imaging, ltd w/flow 0.51 0.14 0.16 0.14 0.16 0.02 0.67 0.69 0.67 0.69 XXX
78605 A Brain imaging, complete 0.53 4.46 3.80 NA NA 0.20 5.19 4.53 NA NA XXX
78605 TC A Brain imaging, complete 0.00 4.31 3.63 NA NA 0.18 4.49 3.81 NA NA XXX
78605 26 A Brain imaging, complete 0.53 0.15 0.17 0.15 0.17 0.02 0.70 0.72 0.70 0.72 XXX
78606 A Brain imaging, compl w/flow 0.64 8.07 5.08 NA NA 0.24 8.95 5.96 NA NA XXX
78606 TC A Brain imaging, compl w/flow 0.00 7.89 4.88 NA NA 0.21 8.10 5.09 NA NA XXX
78606 26 A Brain imaging, compl w/flow 0.64 0.18 0.20 0.18 0.20 0.03 0.85 0.87 0.85 0.87 XXX
78607 A Brain imaging (3D) 1.23 14.39 8.83 NA NA 0.40 16.02 10.46 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78607 TC A Brain imaging (3D) 0.00 14.04 8.42 NA NA 0.35 14.39 8.77 NA NA XXX
78607 26 A Brain imaging (3D) 1.23 0.35 0.41 0.35 0.41 0.05 1.63 1.69 1.63 1.69 XXX
78608 C Brain imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78608 TC C Brain imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78608 26 A Brain imaging (PET) 1.50 0.43 0.49 0.43 0.49 0.06 1.99 2.05 1.99 2.05 XXX
78609 C Brain imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78609 TC C Brain imaging (PET) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78609 26 A Brain imaging (PET) 1.50 0.43 0.49 0.43 0.49 0.06 1.99 2.05 1.99 2.05 XXX
78610 A Brain flow imaging only 0.30 4.19 2.32 NA NA 0.11 4.60 2.73 NA NA XXX
78610 TC A Brain flow imaging only 0.00 4.10 2.21 NA NA 0.10 4.20 2.31 NA NA XXX
78610 26 A Brain flow imaging only 0.30 0.09 0.11 0.09 0.11 0.01 0.40 0.42 0.40 0.42 XXX
78615 A Cerebral vascular flow image 0.42 5.06 4.26 NA NA 0.23 5.71 4.91 NA NA XXX
78615 TC A Cerebral vascular flow image 0.00 4.94 4.12 NA NA 0.21 5.15 4.33 NA NA XXX
78615 26 A Cerebral vascular flow image 0.42 0.12 0.14 0.12 0.14 0.02 0.56 0.58 0.56 0.58 XXX
78630 A Cerebrospinal fluid scan 0.68 8.11 5.98 NA NA 0.30 9.09 6.96 NA NA XXX
78630 TC A Cerebrospinal fluid scan 0.00 7.92 5.76 NA NA 0.27 8.19 6.03 NA NA XXX
78630 26 A Cerebrospinal fluid scan 0.68 0.19 0.22 0.19 0.22 0.03 0.90 0.93 0.90 0.93 XXX
78635 A CSF ventriculography 0.61 8.05 4.10 NA NA 0.16 8.82 4.87 NA NA XXX
78635 TC A CSF ventriculography 0.00 7.88 3.88 NA NA 0.14 8.02 4.02 NA NA XXX
78635 26 A CSF ventriculography 0.61 0.17 0.22 0.17 0.22 0.02 0.80 0.85 0.80 0.85 XXX
78645 A CSF shunt evaluation 0.57 7.97 4.71 NA NA 0.20 8.74 5.48 NA NA XXX
78645 TC A CSF shunt evaluation 0.00 7.81 4.53 NA NA 0.18 7.99 4.71 NA NA XXX
78645 26 A CSF shunt evaluation 0.57 0.16 0.18 0.16 0.18 0.02 0.75 0.77 0.75 0.77 XXX
78647 A Cerebrospinal fluid scan 0.90 13.60 8.06 NA NA 0.35 14.85 9.31 NA NA XXX
78647 TC A Cerebrospinal fluid scan 0.00 13.36 7.77 NA NA 0.31 13.67 8.08 NA NA XXX
78647 26 A Cerebrospinal fluid scan 0.90 0.24 0.29 0.24 0.29 0.04 1.18 1.23 1.18 1.23 XXX
78650 A CSF leakage imaging 0.61 8.17 5.68 NA NA 0.27 9.05 6.56 NA NA XXX
78650 TC A CSF leakage imaging 0.00 7.99 5.48 NA NA 0.24 8.23 5.72 NA NA XXX
78650 26 A CSF leakage imaging 0.61 0.18 0.20 0.18 0.20 0.03 0.82 0.84 0.82 0.84 XXX
78660 A Nuclear exam of tear flow 0.53 4.03 2.74 NA NA 0.14 4.70 3.41 NA NA XXX
78660 TC A Nuclear exam of tear flow 0.00 3.87 2.56 NA NA 0.12 3.99 2.68 NA NA XXX
78660 26 A Nuclear exam of tear flow 0.53 0.16 0.18 0.16 0.18 0.02 0.71 0.73 0.71 0.73 XXX
78699 C Nervous system nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78699 TC C Nervous system nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78699 26 C Nervous system nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78700 A Kidney imaging, morphol 0.45 4.26 3.47 NA NA 0.18 4.89 4.10 NA NA XXX
78700 TC A Kidney imaging, morphol 0.00 4.12 3.32 NA NA 0.16 4.28 3.48 NA NA XXX
78700 26 A Kidney imaging, morphol 0.45 0.14 0.15 0.14 0.15 0.02 0.61 0.62 0.61 0.62 XXX
78701 A Kidney imaging with flow 0.49 5.04 4.06 NA NA 0.20 5.73 4.75 NA NA XXX
78701 TC A Kidney imaging with flow 0.00 4.90 3.90 NA NA 0.18 5.08 4.08 NA NA XXX
78701 26 A Kidney imaging with flow 0.49 0.14 0.16 0.14 0.16 0.02 0.65 0.67 0.65 0.67 XXX
78707 A K flow/funct image w/o drug 0.96 5.15 4.88 NA NA 0.27 6.38 6.11 NA NA XXX
78707 TC A K flow/funct image w/o drug 0.00 4.88 4.57 NA NA 0.23 5.11 4.80 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78707 26 A K flow/funct image w/o drug 0.96 0.27 0.31 0.27 0.31 0.04 1.27 1.31 1.27 1.31 XXX
78708 A K flow/funct image w/drug 1.21 3.17 4.45 NA NA 0.28 4.66 5.94 NA NA XXX
78708 TC A K flow/funct image w/drug 0.00 2.83 4.06 NA NA 0.23 3.06 4.29 NA NA XXX
78708 26 A K flow/funct image w/drug 1.21 0.34 0.39 0.34 0.39 0.05 1.60 1.65 1.60 1.65 XXX
78709 A K flow/funct image, multiple 1.41 8.35 5.79 NA NA 0.29 10.05 7.49 NA NA XXX
78709 TC A K flow/funct image, multiple 0.00 7.95 5.34 NA NA 0.23 8.18 5.57 NA NA XXX
78709 26 A K flow/funct image, multiple 1.41 0.40 0.45 0.40 0.45 0.06 1.87 1.92 1.87 1.92 XXX
78710 A Kidney imaging (3D) 0.66 5.02 5.85 NA NA 0.34 6.02 6.85 NA NA XXX
78710 TC A Kidney imaging (3D) 0.00 4.83 5.64 NA NA 0.31 5.14 5.95 NA NA XXX
78710 26 A Kidney imaging (3D) 0.66 0.19 0.21 0.19 0.21 0.03 0.88 0.90 0.88 0.90 XXX
78725 A Kidney function study 0.38 2.26 2.00 NA NA 0.13 2.77 2.51 NA NA XXX
78725 TC A Kidney function study 0.00 2.15 1.87 NA NA 0.11 2.26 1.98 NA NA XXX
78725 26 A Kidney function study 0.38 0.11 0.13 0.11 0.13 0.02 0.51 0.53 0.51 0.53 XXX
78730 A Urinary bladder retention 0.15 1.97 1.68 NA NA 0.10 2.22 1.93 NA NA ZZZ
78730 TC A Urinary bladder retention 0.00 1.91 1.57 NA NA 0.08 1.99 1.65 NA NA ZZZ
78730 26 A Urinary bladder retention 0.15 0.06 0.11 0.06 0.11 0.02 0.23 0.28 0.23 0.28 ZZZ
78740 A Ureteral reflux study 0.57 5.17 3.02 NA NA 0.15 5.89 3.74 NA NA XXX
78740 TC A Ureteral reflux study 0.00 5.01 2.84 NA NA 0.12 5.13 2.96 NA NA XXX
78740 26 A Ureteral reflux study 0.57 0.16 0.18 0.16 0.18 0.03 0.76 0.78 0.76 0.78 XXX
78761 A Testicular imaging w/flow 0.71 4.58 3.73 NA NA 0.20 5.49 4.64 NA NA XXX
78761 TC A Testicular imaging w/flow 0.00 4.38 3.50 NA NA 0.17 4.55 3.67 NA NA XXX
78761 26 A Testicular imaging w/flow 0.71 0.20 0.23 0.20 0.23 0.03 0.94 0.97 0.94 0.97 XXX
78799 C Genitourinary nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78799 TC C Genitourinary nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78799 26 C Genitourinary nuclear exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78800 A Tumor imaging, limited area 0.66 4.06 3.73 NA NA 0.22 4.94 4.61 NA NA XXX
78800 TC A Tumor imaging, limited area 0.00 3.88 3.52 NA NA 0.18 4.06 3.70 NA NA XXX
78800 26 A Tumor imaging, limited area 0.66 0.18 0.21 0.18 0.21 0.04 0.88 0.91 0.88 0.91 XXX
78801 A Tumor imaging, mult areas 0.79 5.75 4.81 NA NA 0.27 6.81 5.87 NA NA XXX
78801 TC A Tumor imaging, mult areas 0.00 5.53 4.55 NA NA 0.22 5.75 4.77 NA NA XXX
78801 26 A Tumor imaging, mult areas 0.79 0.22 0.26 0.22 0.26 0.05 1.06 1.10 1.06 1.10 XXX
78802 A Tumor imaging, whole body 0.86 7.68 6.29 NA NA 0.34 8.88 7.49 NA NA XXX
78802 TC A Tumor imaging, whole body 0.00 7.44 6.01 NA NA 0.30 7.74 6.31 NA NA XXX
78802 26 A Tumor imaging, whole body 0.86 0.24 0.28 0.24 0.28 0.04 1.14 1.18 1.14 1.18 XXX
78803 A Tumor imaging (3D) 1.09 14.15 8.73 NA NA 0.40 15.64 10.22 NA NA XXX
78803 TC A Tumor imaging (3D) 0.00 13.84 8.37 NA NA 0.35 14.19 8.72 NA NA XXX
78803 26 A Tumor imaging (3D) 1.09 0.31 0.36 0.31 0.36 0.05 1.45 1.50 1.45 1.50 XXX
78804 A Tumor imaging, whole body 1.07 14.02 12.08 NA NA 0.34 15.43 13.49 NA NA XXX
78804 TC A Tumor imaging, whole body 0.00 13.72 11.73 NA NA 0.30 14.02 12.03 NA NA XXX
78804 26 A Tumor imaging, whole body 1.07 0.30 0.35 0.30 0.35 0.04 1.41 1.46 1.41 1.46 XXX
78805 A Abscess imaging, ltd area 0.73 3.94 3.73 NA NA 0.21 4.88 4.67 NA NA XXX
78805 TC A Abscess imaging, ltd area 0.00 3.74 3.49 NA NA 0.18 3.92 3.67 NA NA XXX
78805 26 A Abscess imaging, ltd area 0.73 0.20 0.24 0.20 0.24 0.03 0.96 1.00 0.96 1.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
78806 A Abscess imaging, whole body 0.86 7.85 7.01 NA NA 0.39 9.10 8.26 NA NA XXX
78806 TC A Abscess imaging, whole body 0.00 7.61 6.73 NA NA 0.35 7.96 7.08 NA NA XXX
78806 26 A Abscess imaging, whole body 0.86 0.24 0.28 0.24 0.28 0.04 1.14 1.18 1.14 1.18 XXX
78807 A Nuclear localization/abscess 1.09 13.41 8.56 NA NA 0.39 14.89 10.04 NA NA XXX
78807 TC A Nuclear localization/abscess 0.00 13.11 8.19 NA NA 0.35 13.46 8.54 NA NA XXX
78807 26 A Nuclear localization/abscess 1.09 0.30 0.37 0.30 0.37 0.04 1.43 1.50 1.43 1.50 XXX
78811 C Tumor imaging (pet), limited 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78811 TC C Tumor imaging (pet), limited 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78811 26 A Tumor imaging (pet), limited 1.54 0.44 0.51 0.44 0.51 0.11 2.09 2.16 2.09 2.16 XXX
78812 C Tumor image (pet)/skul-thigh 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78812 TC C Tumor image (pet)/skul-thigh 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78812 26 A Tumor image (pet)/skul-thigh 1.93 0.56 0.64 0.56 0.64 0.11 2.60 2.68 2.60 2.68 XXX
78813 C Tumor image (pet) full body 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78813 TC C Tumor image (pet) full body 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78813 26 A Tumor image (pet) full body 2.00 0.58 0.66 0.58 0.66 0.11 2.69 2.77 2.69 2.77 XXX
78814 C Tumor image pet/ct, limited 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78814 TC C Tumor image pet/ct, limited 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78814 26 A Tumor image pet/ct, limited 2.20 0.62 0.73 0.62 0.73 0.11 2.93 3.04 2.93 3.04 XXX
78815 C Tumorimage pet/ct skul-thigh 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78815 TC C Tumorimage pet/ct skul-thigh 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78815 26 A Tumorimage pet/ct skul-thigh 2.44 0.70 0.81 0.70 0.81 0.11 3.25 3.36 3.25 3.36 XXX
78816 C Tumor image pet/ct full body 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78816 TC C Tumor image pet/ct full body 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78816 26 A Tumor image pet/ct full body 2.50 0.72 0.83 0.72 0.83 0.11 3.33 3.44 3.33 3.44 XXX
78890 B Nuclear medicine data proc 0.05 0.38 1.10 NA NA 0.07 0.50 1.22 NA NA XXX
78890 TC B Nuclear medicine data proc 0.00 0.37 1.08 NA NA 0.06 0.43 1.14 NA NA XXX
78890 26 B Nuclear medicine data proc 0.05 0.01 0.02 0.01 0.02 0.01 0.07 0.08 0.07 0.08 XXX
78891 B Nuclear med data proc 0.10 0.86 2.22 NA NA 0.14 1.10 2.46 NA NA XXX
78891 TC B Nuclear med data proc 0.00 0.84 2.18 NA NA 0.13 0.97 2.31 NA NA XXX
78891 26 B Nuclear med data proc 0.10 0.02 0.04 0.02 0.04 0.01 0.13 0.15 0.13 0.15 XXX
78999 C Nuclear diagnostic exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78999 TC C Nuclear diagnostic exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
78999 26 C Nuclear diagnostic exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79005 A Nuclear rx, oral admin 1.80 1.70 2.85 NA NA 0.22 3.72 4.87 NA NA XXX
79005 TC A Nuclear rx, oral admin 0.00 1.20 2.27 NA NA 0.14 1.34 2.41 NA NA XXX
79005 26 A Nuclear rx, oral admin 1.80 0.50 0.58 0.50 0.58 0.08 2.38 2.46 2.38 2.46 XXX
79101 A Nuclear rx, iv admin 1.96 2.04 2.98 NA NA 0.22 4.22 5.16 NA NA XXX
79101 TC A Nuclear rx, iv admin 0.00 1.37 2.31 NA NA 0.14 1.51 2.45 NA NA XXX
79101 26 A Nuclear rx, iv admin 1.96 0.67 0.67 0.67 0.67 0.08 2.71 2.71 2.71 2.71 XXX
79200 A Nuclear rx, intracav admin 1.99 2.13 3.01 NA NA 0.23 4.35 5.23 NA NA XXX
79200 TC A Nuclear rx, intracav admin 0.00 1.55 2.35 NA NA 0.14 1.69 2.49 NA NA XXX
79200 26 A Nuclear rx, intracav admin 1.99 0.58 0.66 0.58 0.66 0.09 2.66 2.74 2.66 2.74 XXX
79300 C Nuclr rx, interstit colloid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
79300 TC C Nuclr rx, interstit colloid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79300 26 A Nuclr rx, interstit colloid 1.60 0.55 0.56 0.55 0.56 0.13 2.28 2.29 2.28 2.29 XXX
79403 A Hematopoietic nuclear tx 2.25 2.77 4.57 NA NA 0.24 5.26 7.06 NA NA XXX
79403 TC A Hematopoietic nuclear tx 0.00 2.09 3.73 NA NA 0.14 2.23 3.87 NA NA XXX
79403 26 A Hematopoietic nuclear tx 2.25 0.68 0.84 0.68 0.84 0.10 3.03 3.19 3.03 3.19 XXX
79440 A Nuclear rx, intra-articular 1.99 1.65 2.92 NA NA 0.22 3.86 5.13 NA NA XXX
79440 TC A Nuclear rx, intra-articular 0.00 1.09 2.24 NA NA 0.14 1.23 2.38 NA NA XXX
79440 26 A Nuclear rx, intra-articular 1.99 0.56 0.68 0.56 0.68 0.08 2.63 2.75 2.63 2.75 XXX
79445 C Nuclear rx, intra-arterial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79445 TC C Nuclear rx, intra-arterial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79445 26 A Nuclear rx, intra-arterial 2.40 0.70 0.79 0.70 0.79 0.12 3.22 3.31 3.22 3.31 XXX
79999 C Nuclear medicine therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79999 TC C Nuclear medicine therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
79999 26 C Nuclear medicine therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
80500 A Lab pathology consultation 0.37 0.19 0.21 0.11 0.15 0.01 0.57 0.59 0.49 0.53 XXX
80502 A Lab pathology consultation 1.33 0.30 0.48 0.24 0.47 0.04 1.67 1.85 1.61 1.84 XXX
83020 26 A Hemoglobin electrophoresis 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
83912 26 A Genetic examination 0.37 0.11 0.12 0.11 0.12 0.01 0.49 0.50 0.49 0.50 XXX
84165 26 A Protein e-phoresis, serum 0.37 0.11 0.13 0.11 0.13 0.01 0.49 0.51 0.49 0.51 XXX
84166 26 A Protein e-phoresis/urine/csf 0.37 0.11 0.13 0.11 0.13 0.01 0.49 0.51 0.49 0.51 XXX
84181 26 A Western blot test 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
84182 26 A Protein, western blot test 0.37 0.12 0.15 0.12 0.15 0.02 0.51 0.54 0.51 0.54 XXX
85060 A Blood smear interpretation 0.45 0.14 0.17 0.14 0.17 0.02 0.61 0.64 0.61 0.64 XXX
85097 A Bone marrow interpretation 0.94 1.29 1.76 0.28 0.38 0.04 2.27 2.74 1.26 1.36 XXX
85390 26 A Fibrinolysins screen 0.37 0.12 0.13 0.12 0.13 0.01 0.50 0.51 0.50 0.51 XXX
85396 A Clotting assay, whole blood 0.37 NA NA 0.05 0.13 0.04 NA NA 0.46 0.54 XXX
85576 26 A Blood platelet aggregation 0.37 0.12 0.15 0.12 0.15 0.01 0.50 0.53 0.50 0.53 XXX
86077 A Physician blood bank service 0.94 0.38 0.39 0.30 0.37 0.03 1.35 1.36 1.27 1.34 XXX
86078 A Physician blood bank service 0.94 0.38 0.44 0.30 0.38 0.03 1.35 1.41 1.27 1.35 XXX
86079 A Physician blood bank service 0.94 0.38 0.43 0.30 0.38 0.03 1.35 1.40 1.27 1.35 XXX
86255 26 A Fluorescent antibody, screen 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
86256 26 A Fluorescent antibody, titer 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
86320 26 A Serum immunoelectrophoresis 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
86325 26 A Other immunoelectrophoresis 0.37 0.11 0.13 0.11 0.13 0.01 0.49 0.51 0.49 0.51 XXX
86327 26 A Immunoelectrophoresis assay 0.42 0.13 0.17 0.13 0.17 0.02 0.57 0.61 0.57 0.61 XXX
86334 26 A Immunofix e-phoresis, serum 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
86335 26 A Immunfix e-phorsis/urine/csf 0.37 0.12 0.14 0.12 0.14 0.01 0.50 0.52 0.50 0.52 XXX
86485 C Skin test, candida 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
86490 A Coccidioidomycosis skin test 0.00 0.12 0.25 NA NA 0.02 0.14 0.27 NA NA XXX
86510 A Histoplasmosis skin test 0.00 0.14 0.28 NA NA 0.02 0.16 0.30 NA NA XXX
86580 A TB intradermal test 0.00 0.16 0.23 NA NA 0.02 0.18 0.25 NA NA XXX
87164 26 A Dark field examination 0.37 0.12 0.12 0.12 0.12 0.01 0.50 0.50 0.50 0.50 XXX
87207 26 A Smear, special stain 0.37 0.11 0.15 0.11 0.15 0.01 0.49 0.53 0.49 0.53 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
88104 A Cytopath fl nongyn, smears 0.56 1.14 0.93 NA NA 0.04 1.74 1.53 NA NA XXX
88104 TC A Cytopath fl nongyn, smears 0.00 0.99 0.71 NA NA 0.02 1.01 0.73 NA NA XXX
88104 26 A Cytopath fl nongyn, smears 0.56 0.15 0.22 0.15 0.22 0.02 0.73 0.80 0.73 0.80 XXX
88106 A Cytopath fl nongyn, filter 0.56 1.48 1.39 NA NA 0.04 2.08 1.99 NA NA XXX
88106 TC A Cytopath fl nongyn, filter 0.00 1.33 1.17 NA NA 0.02 1.35 1.19 NA NA XXX
88106 26 A Cytopath fl nongyn, filter 0.56 0.15 0.22 0.15 0.22 0.02 0.73 0.80 0.73 0.80 XXX
88107 A Cytopath fl nongyn, sm/fltr 0.76 1.98 1.66 NA NA 0.05 2.79 2.47 NA NA XXX
88107 TC A Cytopath fl nongyn, sm/fltr 0.00 1.75 1.35 NA NA 0.02 1.77 1.37 NA NA XXX
88107 26 A Cytopath fl nongyn, sm/fltr 0.76 0.23 0.31 0.23 0.31 0.03 1.02 1.10 1.02 1.10 XXX
88108 A Cytopath, concentrate tech 0.56 1.45 1.27 NA NA 0.04 2.05 1.87 NA NA XXX
88108 TC A Cytopath, concentrate tech 0.00 1.30 1.05 NA NA 0.02 1.32 1.07 NA NA XXX
88108 26 A Cytopath, concentrate tech 0.56 0.15 0.22 0.15 0.22 0.02 0.73 0.80 0.73 0.80 XXX
88112 A Cytopath, cell enhance tech 1.18 1.49 1.85 NA NA 0.04 2.71 3.07 NA NA XXX
88112 TC A Cytopath, cell enhance tech 0.00 1.19 1.39 NA NA 0.02 1.21 1.41 NA NA XXX
88112 26 A Cytopath, cell enhance tech 1.18 0.30 0.46 0.30 0.46 0.02 1.50 1.66 1.50 1.66 XXX
88125 A Forensic cytopathology 0.26 0.25 0.27 NA NA 0.02 0.53 0.55 NA NA XXX
88125 TC A Forensic cytopathology 0.00 0.19 0.17 NA NA 0.01 0.20 0.18 NA NA XXX
88125 26 A Forensic cytopathology 0.26 0.06 0.10 0.06 0.10 0.01 0.33 0.37 0.33 0.37 XXX
88141 A Cytopath, c/v, interpret 0.42 0.37 0.21 0.37 0.21 0.02 0.81 0.65 0.81 0.65 XXX
88160 A Cytopath smear, other source 0.50 0.89 0.85 NA NA 0.04 1.43 1.39 NA NA XXX
88160 TC A Cytopath smear, other source 0.00 0.76 0.66 NA NA 0.02 0.78 0.68 NA NA XXX
88160 26 A Cytopath smear, other source 0.50 0.13 0.19 0.13 0.19 0.02 0.65 0.71 0.65 0.71 XXX
88161 A Cytopath smear, other source 0.50 1.11 0.99 NA NA 0.04 1.65 1.53 NA NA XXX
88161 TC A Cytopath smear, other source 0.00 0.96 0.79 NA NA 0.02 0.98 0.81 NA NA XXX
88161 26 A Cytopath smear, other source 0.50 0.15 0.20 0.15 0.20 0.02 0.67 0.72 0.67 0.72 XXX
88162 A Cytopath smear, other source 0.76 1.15 1.05 NA NA 0.05 1.96 1.86 NA NA XXX
88162 TC A Cytopath smear, other source 0.00 0.98 0.76 NA NA 0.02 1.00 0.78 NA NA XXX
88162 26 A Cytopath smear, other source 0.76 0.17 0.29 0.17 0.29 0.03 0.96 1.08 0.96 1.08 XXX
88172 A Cytopathology eval of fna 0.60 0.85 0.76 NA NA 0.04 1.49 1.40 NA NA XXX
88172 TC A Cytopathology eval of fna 0.00 0.67 0.52 NA NA 0.02 0.69 0.54 NA NA XXX
88172 26 A Cytopathology eval of fna 0.60 0.18 0.24 0.18 0.24 0.02 0.80 0.86 0.80 0.86 XXX
88173 A Cytopath eval, fna, report 1.39 2.29 2.18 NA NA 0.07 3.75 3.64 NA NA XXX
88173 TC A Cytopath eval, fna, report 0.00 1.89 1.64 NA NA 0.02 1.91 1.66 NA NA XXX
88173 26 A Cytopath eval, fna, report 1.39 0.40 0.54 0.40 0.54 0.05 1.84 1.98 1.84 1.98 XXX
88182 A Cell marker study 0.77 1.91 1.97 NA NA 0.07 2.75 2.81 NA NA XXX
88182 TC A Cell marker study 0.00 1.79 1.69 NA NA 0.04 1.83 1.73 NA NA XXX
88182 26 A Cell marker study 0.77 0.12 0.28 0.12 0.28 0.03 0.92 1.08 0.92 1.08 XXX
88184 A Flowcytometry/ tc, 1 marker 0.00 2.44 1.60 NA NA 0.02 2.46 1.62 NA NA XXX
88185 A Flowcytometry/tc, add-on 0.00 1.48 0.85 NA NA 0.02 1.50 0.87 NA NA ZZZ
88187 A Flowcytometry/read, 2-8 1.36 0.39 0.44 0.39 0.44 0.01 1.76 1.81 1.76 1.81 XXX
88188 A Flowcytometry/read, 9-15 1.69 0.44 0.54 0.44 0.54 0.01 2.14 2.24 2.14 2.24 XXX
88189 A Flowcytometry/read, 16 2.23 0.48 0.68 0.48 0.68 0.01 2.72 2.92 2.72 2.92 XXX
88199 C Cytopathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
88199 TC C Cytopathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88199 26 C Cytopathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88291 A Cyto/molecular report 0.52 0.27 0.20 0.27 0.20 0.02 0.81 0.74 0.81 0.74 XXX
88299 C Cytogenetic study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88300 A Surgical path, gross 0.08 0.58 0.49 NA NA 0.02 0.68 0.59 NA NA XXX
88300 TC A Surgical path, gross 0.00 0.56 0.46 NA NA 0.01 0.57 0.47 NA NA XXX
88300 26 A Surgical path, gross 0.08 0.02 0.03 0.02 0.03 0.01 0.11 0.12 0.11 0.12 XXX
88302 A Tissue exam by pathologist 0.13 1.28 1.10 NA NA 0.03 1.44 1.26 NA NA XXX
88302 TC A Tissue exam by pathologist 0.00 1.24 1.04 NA NA 0.02 1.26 1.06 NA NA XXX
88302 26 A Tissue exam by pathologist 0.13 0.04 0.06 0.04 0.06 0.01 0.18 0.20 0.18 0.20 XXX
88304 A Tissue exam by pathologist 0.22 1.53 1.37 NA NA 0.03 1.78 1.62 NA NA XXX
88304 TC A Tissue exam by pathologist 0.00 1.47 1.29 NA NA 0.02 1.49 1.31 NA NA XXX
88304 26 A Tissue exam by pathologist 0.22 0.06 0.08 0.06 0.08 0.01 0.29 0.31 0.29 0.31 XXX
88305 A Tissue exam by pathologist 0.75 2.16 1.97 NA NA 0.07 2.98 2.79 NA NA XXX
88305 TC A Tissue exam by pathologist 0.00 1.95 1.67 NA NA 0.04 1.99 1.71 NA NA XXX
88305 26 A Tissue exam by pathologist 0.75 0.21 0.30 0.21 0.30 0.03 0.99 1.08 0.99 1.08 XXX
88307 A Tissue exam by pathologist 1.59 4.46 3.48 NA NA 0.12 6.17 5.19 NA NA XXX
88307 TC A Tissue exam by pathologist 0.00 3.98 2.85 NA NA 0.06 4.04 2.91 NA NA XXX
88307 26 A Tissue exam by pathologist 1.59 0.48 0.63 0.48 0.63 0.06 2.13 2.28 2.13 2.28 XXX
88309 A Tissue exam by pathologist 2.80 6.25 4.86 NA NA 0.14 9.19 7.80 NA NA XXX
88309 TC A Tissue exam by pathologist 0.00 5.41 3.92 NA NA 0.06 5.47 3.98 NA NA XXX
88309 26 A Tissue exam by pathologist 2.80 0.84 0.94 0.84 0.94 0.08 3.72 3.82 3.72 3.82 XXX
88311 A Decalcify tissue 0.24 0.25 0.23 NA NA 0.02 0.51 0.49 NA NA XXX
88311 TC A Decalcify tissue 0.00 0.18 0.14 NA NA 0.01 0.19 0.15 NA NA XXX
88311 26 A Decalcify tissue 0.24 0.07 0.09 0.07 0.09 0.01 0.32 0.34 0.32 0.34 XXX
88312 A Special stains 0.54 2.46 1.76 NA NA 0.03 3.03 2.33 NA NA XXX
88312 TC A Special stains 0.00 2.31 1.55 NA NA 0.01 2.32 1.56 NA NA XXX
88312 26 A Special stains 0.54 0.15 0.21 0.15 0.21 0.02 0.71 0.77 0.71 0.77 XXX
88313 A Special stains 0.24 1.91 1.42 NA NA 0.02 2.17 1.68 NA NA XXX
88313 TC A Special stains 0.00 1.85 1.33 NA NA 0.01 1.86 1.34 NA NA XXX
88313 26 A Special stains 0.24 0.06 0.09 0.06 0.09 0.01 0.31 0.34 0.31 0.34 XXX
88314 A Histochemical stain 0.45 1.97 2.04 NA NA 0.04 2.46 2.53 NA NA XXX
88314 TC A Histochemical stain 0.00 1.83 1.86 NA NA 0.02 1.85 1.88 NA NA XXX
88314 26 A Histochemical stain 0.45 0.14 0.18 0.14 0.18 0.02 0.61 0.65 0.61 0.65 XXX
88318 A Chemical histochemistry 0.42 2.96 1.98 NA NA 0.03 3.41 2.43 NA NA XXX
88318 TC A Chemical histochemistry 0.00 2.83 1.81 NA NA 0.01 2.84 1.82 NA NA XXX
88318 26 A Chemical histochemistry 0.42 0.13 0.17 0.13 0.17 0.02 0.57 0.61 0.57 0.61 XXX
88319 A Enzyme histochemistry 0.53 3.22 3.36 NA NA 0.04 3.79 3.93 NA NA XXX
88319 TC A Enzyme histochemistry 0.00 3.07 3.16 NA NA 0.02 3.09 3.18 NA NA XXX
88319 26 A Enzyme histochemistry 0.53 0.15 0.20 0.15 0.20 0.02 0.70 0.75 0.70 0.75 XXX
88321 A Microslide consultation 1.63 0.74 0.78 0.49 0.54 0.05 2.42 2.46 2.17 2.22 XXX
88323 A Microslide consultation 1.83 2.19 1.88 NA NA 0.07 4.09 3.78 NA NA XXX
88323 TC A Microslide consultation 0.00 1.73 1.34 NA NA 0.02 1.75 1.36 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
88323 26 A Microslide consultation 1.83 0.46 0.54 0.46 0.54 0.05 2.34 2.42 2.34 2.42 XXX
88325 A Comprehensive review of data 2.50 2.24 2.76 0.63 0.87 0.07 4.81 5.33 3.20 3.44 XXX
88329 A Path consult introp 0.67 0.68 0.66 0.20 0.27 0.02 1.37 1.35 0.89 0.96 XXX
88331 A Path consult intraop, 1 bloc 1.19 1.24 1.14 NA NA 0.08 2.51 2.41 NA NA XXX
88331 TC A Path consult intraop, 1 bloc 0.00 0.86 0.66 NA NA 0.04 0.90 0.70 NA NA XXX
88331 26 A Path consult intraop, 1 bloc 1.19 0.38 0.48 0.38 0.48 0.04 1.61 1.71 1.61 1.71 XXX
88332 A Path consult intraop, addÆl 0.59 0.47 0.46 NA NA 0.04 1.10 1.09 NA NA XXX
88332 TC A Path consult intraop, addÆl 0.00 0.29 0.23 NA NA 0.02 0.31 0.25 NA NA XXX
88332 26 A Path consult intraop, addÆl 0.59 0.18 0.23 0.18 0.23 0.02 0.79 0.84 0.79 0.84 XXX
88333 A Intraop cyto path consult, 1 1.20 1.35 1.15 NA NA 0.08 2.63 2.43 NA NA XXX
88333 TC A Intraop cyto path consult, 1 0.00 0.97 0.66 NA NA 0.04 1.01 0.70 NA NA XXX
88333 26 A Intraop cyto path consult, 1 1.20 0.38 0.49 0.38 0.49 0.04 1.62 1.73 1.62 1.73 XXX
88334 A Intraop cyto path consult, 2 0.73 0.78 0.65 NA NA 0.04 1.55 1.42 NA NA XXX
88334 TC A Intraop cyto path consult, 2 0.00 0.56 0.40 NA NA 0.02 0.58 0.42 NA NA XXX
88334 26 A Intraop cyto path consult, 2 0.73 0.22 0.25 0.22 0.25 0.02 0.97 1.00 0.97 1.00 XXX
88342 A Immunohistochemistry 0.85 2.01 1.60 NA NA 0.05 2.91 2.50 NA NA XXX
88342 TC A Immunohistochemistry 0.00 1.78 1.27 NA NA 0.02 1.80 1.29 NA NA XXX
88342 26 A Immunohistochemistry 0.85 0.23 0.33 0.23 0.33 0.03 1.11 1.21 1.11 1.21 XXX
88346 A Immunofluorescent study 0.86 1.94 1.67 NA NA 0.05 2.85 2.58 NA NA XXX
88346 TC A Immunofluorescent study 0.00 1.71 1.34 NA NA 0.02 1.73 1.36 NA NA XXX
88346 26 A Immunofluorescent study 0.86 0.23 0.33 0.23 0.33 0.03 1.12 1.22 1.12 1.22 XXX
88347 A Immunofluorescent study 0.86 1.33 1.28 NA NA 0.05 2.24 2.19 NA NA XXX
88347 TC A Immunofluorescent study 0.00 1.14 0.97 NA NA 0.02 1.16 0.99 NA NA XXX
88347 26 A Immunofluorescent study 0.86 0.19 0.31 0.19 0.31 0.03 1.08 1.20 1.08 1.20 XXX
88348 A Electron microscopy 1.51 17.88 11.48 NA NA 0.13 19.52 13.12 NA NA XXX
88348 TC A Electron microscopy 0.00 17.47 10.90 NA NA 0.07 17.54 10.97 NA NA XXX
88348 26 A Electron microscopy 1.51 0.41 0.58 0.41 0.58 0.06 1.98 2.15 1.98 2.15 XXX
88349 A Scanning electron microscopy 0.76 8.84 4.88 NA NA 0.09 9.69 5.73 NA NA XXX
88349 TC A Scanning electron microscopy 0.00 8.62 4.58 NA NA 0.06 8.68 4.64 NA NA XXX
88349 26 A Scanning electron microscopy 0.76 0.22 0.30 0.22 0.30 0.03 1.01 1.09 1.01 1.09 XXX
88355 A Analysis, skeletal muscle 1.85 3.31 7.41 NA NA 0.13 5.29 9.39 NA NA XXX
88355 TC A Analysis, skeletal muscle 0.00 2.92 6.72 NA NA 0.06 2.98 6.78 NA NA XXX
88355 26 A Analysis, skeletal muscle 1.85 0.39 0.69 0.39 0.69 0.07 2.31 2.61 2.31 2.61 XXX
88356 A Analysis, nerve 3.02 6.63 4.79 NA NA 0.19 9.84 8.00 NA NA XXX
88356 TC A Analysis, nerve 0.00 5.84 3.65 NA NA 0.07 5.91 3.72 NA NA XXX
88356 26 A Analysis, nerve 3.02 0.79 1.14 0.79 1.14 0.12 3.93 4.28 3.93 4.28 XXX
88358 A Analysis, tumor 0.95 1.10 0.91 NA NA 0.17 2.22 2.03 NA NA XXX
88358 TC A Analysis, tumor 0.00 0.94 0.57 NA NA 0.07 1.01 0.64 NA NA XXX
88358 26 A Analysis, tumor 0.95 0.16 0.34 0.16 0.34 0.10 1.21 1.39 1.21 1.39 XXX
88360 A Tumor immunohistochem/manual 1.10 2.28 1.87 NA NA 0.08 3.46 3.05 NA NA XXX
88360 TC A Tumor immunohistochem/manual 0.00 2.00 1.45 NA NA 0.02 2.02 1.47 NA NA XXX
88360 26 A Tumor immunohistochem/manual 1.10 0.28 0.42 0.28 0.42 0.06 1.44 1.58 1.44 1.58 XXX
88361 A Tumor immunohistochem/comput 1.18 2.72 2.94 NA NA 0.17 4.07 4.29 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
88361 TC A Tumor immunohistochem/comput 0.00 2.46 2.51 NA NA 0.07 2.53 2.58 NA NA XXX
88361 26 A Tumor immunohistochem/comput 1.18 0.26 0.43 0.26 0.43 0.10 1.54 1.71 1.54 1.71 XXX
88362 A Nerve teasing preparations 2.17 5.24 4.83 NA NA 0.15 7.56 7.15 NA NA XXX
88362 TC A Nerve teasing preparations 0.00 4.63 3.99 NA NA 0.06 4.69 4.05 NA NA XXX
88362 26 A Nerve teasing preparations 2.17 0.61 0.84 0.61 0.84 0.09 2.87 3.10 2.87 3.10 XXX
88365 A Insitu hybridization (fish) 1.20 2.90 2.32 NA NA 0.05 4.15 3.57 NA NA XXX
88365 TC A Insitu hybridization (fish) 0.00 2.66 1.88 NA NA 0.02 2.68 1.90 NA NA XXX
88365 26 A Insitu hybridization (fish) 1.20 0.24 0.44 0.24 0.44 0.03 1.47 1.67 1.47 1.67 XXX
88367 A Insitu hybridization, auto 1.30 5.16 4.31 NA NA 0.12 6.58 5.73 NA NA XXX
88367 TC A Insitu hybridization, auto 0.00 4.94 3.85 NA NA 0.06 5.00 3.91 NA NA XXX
88367 26 A Insitu hybridization, auto 1.30 0.22 0.46 0.22 0.46 0.06 1.58 1.82 1.58 1.82 XXX
88368 A Insitu hybridization, manual 1.40 4.69 2.96 NA NA 0.12 6.21 4.48 NA NA XXX
88368 TC A Insitu hybridization, manual 0.00 4.48 2.46 NA NA 0.06 4.54 2.52 NA NA XXX
88368 26 A Insitu hybridization, manual 1.40 0.21 0.50 0.21 0.50 0.06 1.67 1.96 1.67 1.96 XXX
88371 26 A Protein, western blot tissue 0.37 0.10 0.12 0.10 0.12 0.01 0.48 0.50 0.48 0.50 XXX
88372 26 A Protein analysis w/probe 0.37 0.11 0.15 0.11 0.15 0.01 0.49 0.53 0.49 0.53 XXX
88380 C Microdissection 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88380 TC C Microdissection 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88380 26 C Microdissection 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88384 C Eval molecular probes, 11-50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88384 TC C Eval molecular probes, 11-50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88384 26 C Eval molecular probes, 11-50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88385 A Eval molecul probes, 51-250 1.50 14.35 8.90 NA NA 0.12 15.97 10.52 NA NA XXX
88385 TC A Eval molecul probes, 51-250 0.00 14.13 8.36 NA NA 0.06 14.19 8.42 NA NA XXX
88385 26 A Eval molecul probes, 51-250 1.50 0.22 0.54 0.22 0.54 0.06 1.78 2.10 1.78 2.10 XXX
88386 A Eval molecul probes, 251-500 1.88 14.25 8.84 NA NA 0.16 16.29 10.88 NA NA XXX
88386 TC A Eval molecul probes, 251-500 0.00 13.97 8.15 NA NA 0.08 14.05 8.23 NA NA XXX
88386 26 A Eval molecul probes, 251-500 1.88 0.28 0.69 0.28 0.69 0.08 2.24 2.65 2.24 2.65 XXX
88399 C Surgical pathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88399 TC C Surgical pathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
88399 26 C Surgical pathology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
89049 A Chct for mal hyperthermia 1.40 3.69 3.59 0.22 0.26 0.06 5.15 5.05 1.68 1.72 XXX
89060 26 A Exam,synovial fluid crystals 0.37 0.12 0.15 0.12 0.15 0.01 0.50 0.53 0.50 0.53 XXX
89100 A Sample intestinal contents 0.60 8.84 3.58 0.60 0.31 0.03 9.47 4.21 1.23 0.94 XXX
89105 A Sample intestinal contents 0.50 7.57 3.56 0.45 0.24 0.02 8.09 4.08 0.97 0.76 XXX
89130 A Sample stomach contents 0.45 6.86 3.02 0.39 0.20 0.02 7.33 3.49 0.86 0.67 XXX
89132 A Sample stomach contents 0.19 6.46 2.78 0.29 0.12 0.01 6.66 2.98 0.49 0.32 XXX
89135 A Sample stomach contents 0.79 8.84 3.63 0.68 0.36 0.04 9.67 4.46 1.51 1.19 XXX
89136 A Sample stomach contents 0.21 6.99 3.05 0.32 0.15 0.01 7.21 3.27 0.54 0.37 XXX
89140 A Sample stomach contents 0.94 6.75 3.25 0.49 0.33 0.04 7.73 4.23 1.47 1.31 XXX
89141 A Sample stomach contents 0.85 5.34 3.43 0.38 0.34 0.03 6.22 4.31 1.26 1.22 XXX
89220 A Sputum specimen collection 0.00 0.36 0.41 NA NA 0.02 0.38 0.43 NA NA XXX
89230 A Collect sweat for test 0.00 0.08 0.10 NA NA 0.02 0.10 0.12 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
89240 C Pathology lab procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90281 I Human ig, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90283 I Human ig, iv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90287 I Botulinum antitoxin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90288 I Botulism ig, iv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90291 I Cmv ig, iv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90296 E Diphtheria antitoxin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90371 E Hep b ig, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90375 E Rabies ig, im/sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90376 E Rabies ig, heat treated 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90378 X Rsv ig, im, 50mg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90379 I Rsv ig, iv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90384 I Rh ig, full-dose, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90385 E Rh ig, minidose, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90386 I Rh ig, iv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90389 I Tetanus ig, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90393 E Vaccina ig, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90396 E Varicella-zoster ig, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90399 I Immune globulin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90465 A Immune admin 1 inj, 8 yrs 0.17 0.45 0.35 NA NA 0.01 0.63 0.53 NA NA XXX
90466 A Immune admin addl inj, 8 y 0.15 0.12 0.13 0.04 0.11 0.01 0.28 0.29 0.20 0.27 ZZZ
90467 R Immune admin o or n, 8 yrs 0.17 0.17 0.17 0.07 0.09 0.01 0.35 0.35 0.25 0.27 XXX
90468 R Immune admin o/n, addl 8 y 0.15 0.10 0.11 0.03 0.05 0.01 0.26 0.27 0.19 0.21 ZZZ
90471 A Immunization admin 0.17 0.45 0.35 NA NA 0.01 0.63 0.53 NA NA XXX
90472 A Immunization admin, each add 0.15 0.12 0.13 0.04 0.11 0.01 0.28 0.29 0.20 0.27 ZZZ
90473 R Immune admin oral/nasal 0.17 0.16 0.18 0.04 0.06 0.01 0.34 0.36 0.22 0.24 XXX
90474 R Immune admin oral/nasal addl 0.15 0.07 0.09 0.03 0.05 0.01 0.23 0.25 0.19 0.21 ZZZ
90476 E Adenovirus vaccine, type 4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90477 E Adenovirus vaccine, type 7 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90581 E Anthrax vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90585 E Bcg vaccine, percut 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90586 E Bcg vaccine, intravesical 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90632 E Hep a vaccine, adult im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90633 E Hep a vacc, ped/adol, 2 dose 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90634 E Hep a vacc, ped/adol, 3 dose 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90636 E Hep a/hep b vacc, adult im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90645 E Hib vaccine, hboc, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90646 E Hib vaccine, prp-d, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90647 E Hib vaccine, prp-omp, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90648 E Hib vaccine, prp-t, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90649 E H papilloma vacc 3 dose im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90655 X Flu vaccine no preserv 6-35m 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90656 X Flu vaccine no preserv 3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
90657 X Flu vaccine, 3 yrs, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90658 X Flu vaccine, 3 yrs , im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90660 X Flu vaccine, nasal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90665 E Lyme disease vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90669 N Pneumococcal vacc, ped 5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90675 E Rabies vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90676 E Rabies vaccine, id 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90680 E Rotovirus vacc 3 dose, oral 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90690 E Typhoid vaccine, oral 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90691 E Typhoid vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90692 E Typhoid vaccine, h-p, sc/id 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90693 E Typhoid vaccine, akd, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90698 E Dtap-hib-ip vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90700 E Dtap vaccine, 7 yrs, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90701 E Dtp vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90702 E Dt vaccine 7, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90703 E Tetanus vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90704 E Mumps vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90705 E Measles vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90706 E Rubella vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90707 E Mmr vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90708 E Measles-rubella vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90710 E Mmrv vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90712 E Oral poliovirus vaccine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90713 E Poliovirus, ipv, sc/im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90714 E Td vaccine no prsrv /= 7 im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90715 E Tdap vaccine 7 im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90716 E Chicken pox vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90717 E Yellow fever vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90718 E Td vaccine 7, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90719 E Diphtheria vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90720 E Dtp/hib vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90721 E Dtap/hib vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90723 I Dtap-hep b-ipv vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90725 E Cholera vaccine, injectable 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90727 E Plague vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90732 X Pneumococcal vaccine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90733 E Meningococcal vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90734 E Meningococcal vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90735 E Encephalitis vaccine, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90736 E Zoster vacc, sc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90740 X Hepb vacc, ill pat 3 dose im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90743 X Hep b vacc, adol, 2 dose, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
90744 X Hepb vacc ped/adol 3 dose im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90746 X Hep b vaccine, adult, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90747 X Hepb vacc, ill pat 4 dose im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90748 I Hep b/hib vaccine, im 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90749 E Vaccine toxoid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90760 A Hydration iv infusion, init 0.17 1.30 1.40 NA NA 0.07 1.54 1.64 NA NA XXX
90761 A Hydrate iv infusion, add-on 0.09 0.31 0.38 NA NA 0.04 0.44 0.51 NA NA ZZZ
90765 A Ther/proph/diag iv inf, init 0.21 1.61 1.72 NA NA 0.07 1.89 2.00 NA NA XXX
90766 A Ther/proph/dg iv inf, add-on 0.18 0.37 0.44 NA NA 0.04 0.59 0.66 NA NA ZZZ
90767 A Tx/proph/dg addl seq iv inf 0.19 0.68 0.84 NA NA 0.04 0.91 1.07 NA NA ZZZ
90768 A Ther/diag concurrent inf 0.17 0.33 0.41 NA NA 0.04 0.54 0.62 NA NA ZZZ
90772 A Ther/proph/diag inj, sc/im 0.17 0.45 0.35 NA NA 0.01 0.63 0.53 NA NA XXX
90773 A Ther/proph/diag inj, ia 0.17 0.30 0.31 NA NA 0.02 0.49 0.50 NA NA XXX
90774 A Ther/proph/diag inj, iv push 0.18 1.33 1.31 NA NA 0.04 1.55 1.53 NA NA XXX
90775 A Ther/proph/diag inj add-on 0.10 0.51 0.56 NA NA 0.04 0.65 0.70 NA NA ZZZ
90779 C Ther/prop/diag inj/inf proc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90801 A Psy dx interview 2.80 1.49 1.25 0.60 0.85 0.06 4.35 4.11 3.46 3.71 XXX
90802 A Intac psy dx interview 3.01 1.51 1.28 0.66 0.90 0.07 4.59 4.36 3.74 3.98 XXX
90804 A Psytx, office, 20-30 min 1.21 0.55 0.51 0.22 0.34 0.03 1.79 1.75 1.46 1.58 XXX
90805 A Psytx, off, 20-30 min w/em 1.37 0.60 0.53 0.24 0.38 0.03 2.00 1.93 1.64 1.78 XXX
90806 A Psytx, off, 45-50 min 1.86 0.52 0.66 0.33 0.53 0.04 2.42 2.56 2.23 2.43 XXX
90807 A Psytx, off, 45-50 min w/em 2.02 0.71 0.70 0.36 0.56 0.05 2.78 2.77 2.43 2.63 XXX
90808 A Psytx, office, 75-80 min 2.79 0.68 0.94 0.49 0.80 0.06 3.53 3.79 3.34 3.65 XXX
90809 A Psytx, off, 75-80, w/em 2.95 0.87 0.97 0.53 0.82 0.07 3.89 3.99 3.55 3.84 XXX
90810 A Intac psytx, off, 20-30 min 1.32 0.52 0.51 0.24 0.38 0.04 1.88 1.87 1.60 1.74 XXX
90811 A Intac psytx, 20-30, w/em 1.48 0.72 0.61 0.26 0.41 0.04 2.24 2.13 1.78 1.93 XXX
90812 A Intac psytx, off, 45-50 min 1.97 0.64 0.75 0.35 0.57 0.04 2.65 2.76 2.36 2.58 XXX
90813 A Intac psytx, 45-50 min w/em 2.13 0.84 0.79 0.38 0.60 0.05 3.02 2.97 2.56 2.78 XXX
90814 A Intac psytx, off, 75-80 min 2.90 0.79 1.02 0.52 0.87 0.06 3.75 3.98 3.48 3.83 XXX
90815 A Intac psytx, 75-80 w/em 3.06 1.00 1.04 0.54 0.85 0.07 4.13 4.17 3.67 3.98 XXX
90816 A Psytx, hosp, 20-30 min 1.25 NA NA 0.32 0.43 0.03 NA NA 1.60 1.71 XXX
90817 A Psytx, hosp, 20-30 min w/em 1.41 NA NA 0.36 0.44 0.03 NA NA 1.80 1.88 XXX
90818 A Psytx, hosp, 45-50 min 1.89 NA NA 0.43 0.63 0.04 NA NA 2.36 2.56 XXX
90819 A Psytx, hosp, 45-50 min w/em 2.05 NA NA 0.47 0.61 0.05 NA NA 2.57 2.71 XXX
90821 A Psytx, hosp, 75-80 min 2.83 NA NA 0.60 0.91 0.06 NA NA 3.49 3.80 XXX
90822 A Psytx, hosp, 75-80 min w/em 2.99 NA NA 0.64 0.87 0.08 NA NA 3.71 3.94 XXX
90823 A Intac psytx, hosp, 20-30 min 1.36 NA NA 0.34 0.45 0.03 NA NA 1.73 1.84 XXX
90824 A Intac psytx, hsp 20-30 w/em 1.52 NA NA 0.38 0.46 0.04 NA NA 1.94 2.02 XXX
90826 A Intac psytx, hosp, 45-50 min 2.01 NA NA 0.46 0.66 0.05 NA NA 2.52 2.72 XXX
90827 A Intac psytx, hsp 45-50 w/em 2.16 NA NA 0.49 0.63 0.05 NA NA 2.70 2.84 XXX
90828 A Intac psytx, hosp, 75-80 min 2.94 NA NA 0.61 0.95 0.06 NA NA 3.61 3.95 XXX
90829 A Intac psytx, hsp 75-80 w/em 3.10 NA NA 0.66 0.90 0.07 NA NA 3.83 4.07 XXX
90845 A Psychoanalysis 1.79 0.39 0.53 0.32 0.49 0.04 2.22 2.36 2.15 2.32 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
90846 R Family psytx w/o patient 1.83 0.51 0.62 0.43 0.60 0.04 2.38 2.49 2.30 2.47 XXX
90847 R Family psytx w/patient 2.21 0.74 0.80 0.49 0.69 0.05 3.00 3.06 2.75 2.95 XXX
90849 R Multiple family group psytx 0.59 0.30 0.28 0.20 0.23 0.02 0.91 0.89 0.81 0.84 XXX
90853 A Group psychotherapy 0.59 0.27 0.26 0.20 0.22 0.01 0.87 0.86 0.80 0.82 XXX
90857 A Intac group psytx 0.63 0.36 0.31 0.21 0.24 0.01 1.00 0.95 0.85 0.88 XXX
90862 A Medication management 0.95 0.62 0.46 0.27 0.31 0.02 1.59 1.43 1.24 1.28 XXX
90865 A Narcosynthesis 2.84 1.19 1.32 0.65 0.85 0.12 4.15 4.28 3.61 3.81 XXX
90870 A Electroconvulsive therapy 1.88 1.91 1.93 0.39 0.54 0.04 3.83 3.85 2.31 2.46 000
90875 N Psychophysiological therapy 1.20 0.52 0.81 0.28 0.42 0.04 1.76 2.05 1.52 1.66 XXX
90876 N Psychophysiological therapy 1.90 0.67 1.04 0.44 0.66 0.05 2.62 2.99 2.39 2.61 XXX
90880 A Hypnotherapy 2.19 0.57 0.92 0.39 0.62 0.05 2.81 3.16 2.63 2.86 XXX
90882 N Environmental manipulation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90885 B Psy evaluation of records 0.97 0.22 0.33 0.22 0.33 0.02 1.21 1.32 1.21 1.32 XXX
90887 B Consultation with family 1.48 0.61 0.77 0.34 0.51 0.04 2.13 2.29 1.86 2.03 XXX
90889 B Preparation of report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90899 C Psychiatric service/therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90901 A Biofeedback train, any meth 0.41 0.47 0.61 0.11 0.13 0.02 0.90 1.04 0.54 0.56 000
90911 A Biofeedback peri/uro/rectal 0.89 1.37 1.51 0.30 0.31 0.06 2.32 2.46 1.25 1.26 000
90918 I ESRD related services, month 11.16 4.68 5.75 3.74 5.52 0.36 16.20 17.27 15.26 17.04 XXX
90919 I ESRD related services, month 8.53 3.02 3.76 2.55 3.64 0.29 11.84 12.58 11.37 12.46 XXX
90920 I ESRD related services, month 7.26 2.73 3.50 2.27 3.38 0.23 10.22 10.99 9.76 10.87 XXX
90921 I ESRD related services, month 4.46 1.70 2.26 1.61 2.23 0.14 6.30 6.86 6.21 6.83 XXX
90922 I ESRD related services, day 0.37 0.16 0.20 0.12 0.19 0.01 0.54 0.58 0.50 0.57 XXX
90923 I Esrd related services, day 0.28 0.10 0.12 0.08 0.12 0.01 0.39 0.41 0.37 0.41 XXX
90924 I Esrd related services, day 0.24 0.09 0.11 0.08 0.11 0.01 0.34 0.36 0.33 0.36 XXX
90925 I Esrd related services, day 0.15 0.05 0.07 0.05 0.07 0.01 0.21 0.23 0.21 0.23 XXX
90935 A Hemodialysis, one evaluation 1.22 NA NA 0.55 0.64 0.04 NA NA 1.81 1.90 000
90937 A Hemodialysis, repeated eval 2.11 NA NA 0.79 0.93 0.07 NA NA 2.97 3.11 000
90940 X Hemodialysis access study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90945 A Dialysis, one evaluation 1.28 NA NA 0.56 0.66 0.04 NA NA 1.88 1.98 000
90947 A Dialysis, repeated eval 2.16 NA NA 0.80 0.94 0.07 NA NA 3.03 3.17 000
90989 X Dialysis training, complete 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90993 X Dialysis training, incompl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
90997 A Hemoperfusion 1.84 NA NA 0.51 0.62 0.06 NA NA 2.41 2.52 000
90999 C Dialysis procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91000 A Esophageal intubation 0.73 2.19 0.80 2.19 0.80 0.04 2.96 1.57 2.96 1.57 000
91000 TC A Esophageal intubation 0.00 1.95 0.55 1.95 0.55 0.01 1.96 0.56 1.96 0.56 000
91000 26 A Esophageal intubation 0.73 0.24 0.25 0.24 0.25 0.03 1.00 1.01 1.00 1.01 000
91010 A Esophagus motility study 1.25 3.65 4.22 3.65 4.22 0.12 5.02 5.59 5.02 5.59 000
91010 TC A Esophagus motility study 0.00 3.09 3.75 3.09 3.75 0.06 3.15 3.81 3.15 3.81 000
91010 26 A Esophagus motility study 1.25 0.56 0.47 0.56 0.47 0.06 1.87 1.78 1.87 1.78 000
91011 A Esophagus motility study 1.50 5.30 5.25 5.30 5.25 0.13 6.93 6.88 6.93 6.88 000
91011 TC A Esophagus motility study 0.00 4.58 4.67 4.58 4.67 0.06 4.64 4.73 4.64 4.73 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
91011 26 A Esophagus motility study 1.50 0.72 0.58 0.72 0.58 0.07 2.29 2.15 2.29 2.15 000
91012 A Esophagus motility study 1.46 5.48 5.69 5.48 5.69 0.13 7.07 7.28 7.07 7.28 000
91012 TC A Esophagus motility study 0.00 4.78 5.13 4.78 5.13 0.07 4.85 5.20 4.85 5.20 000
91012 26 A Esophagus motility study 1.46 0.70 0.56 0.70 0.56 0.06 2.22 2.08 2.22 2.08 000
91020 A Gastric motility studies 1.44 4.78 4.58 4.78 4.58 0.13 6.35 6.15 6.35 6.15 000
91020 TC A Gastric motility studies 0.00 4.16 4.06 4.16 4.06 0.06 4.22 4.12 4.22 4.12 000
91020 26 A Gastric motility studies 1.44 0.62 0.52 0.62 0.52 0.07 2.13 2.03 2.13 2.03 000
91022 A Duodenal motility study 1.44 3.09 4.08 3.09 4.08 0.13 4.66 5.65 4.66 5.65 000
91022 TC A Duodenal motility study 0.00 2.47 3.54 2.47 3.54 0.06 2.53 3.60 2.53 3.60 000
91022 26 A Duodenal motility study 1.44 0.62 0.54 0.62 0.54 0.07 2.13 2.05 2.13 2.05 000
91030 A Acid perfusion of esophagus 0.91 2.90 2.55 2.90 2.55 0.06 3.87 3.52 3.87 3.52 000
91030 TC A Acid perfusion of esophagus 0.00 2.47 2.20 2.47 2.20 0.02 2.49 2.22 2.49 2.22 000
91030 26 A Acid perfusion of esophagus 0.91 0.43 0.35 0.43 0.35 0.04 1.38 1.30 1.38 1.30 000
91034 A Gastroesophageal reflux test 0.97 4.10 4.96 4.10 4.96 0.12 5.19 6.05 5.19 6.05 000
91034 TC A Gastroesophageal reflux test 0.00 3.68 4.60 3.68 4.60 0.06 3.74 4.66 3.74 4.66 000
91034 26 A Gastroesophageal reflux test 0.97 0.42 0.36 0.42 0.36 0.06 1.45 1.39 1.45 1.39 000
91035 A G-esoph reflx tst w/electrod 1.59 11.29 10.92 11.29 10.92 0.12 13.00 12.63 13.00 12.63 000
91035 TC A G-esoph reflx tst w/electrod 0.00 10.57 10.32 10.57 10.32 0.06 10.63 10.38 10.63 10.38 000
91035 26 A G-esoph reflx tst w/electrod 1.59 0.72 0.60 0.72 0.60 0.06 2.37 2.25 2.37 2.25 000
91037 A Esoph imped function test 0.97 3.38 3.04 3.38 3.04 0.12 4.47 4.13 4.47 4.13 000
91037 TC A Esoph imped function test 0.00 2.95 2.68 2.95 2.68 0.06 3.01 2.74 3.01 2.74 000
91037 26 A Esoph imped function test 0.97 0.43 0.36 0.43 0.36 0.06 1.46 1.39 1.46 1.39 000
91038 A Esoph imped funct test 1h 1.10 2.78 2.36 2.78 2.36 0.12 4.00 3.58 4.00 3.58 000
91038 TC A Esoph imped funct test 1h 0.00 2.27 1.94 2.27 1.94 0.06 2.33 2.00 2.33 2.00 000
91038 26 A Esoph imped funct test 1h 1.10 0.51 0.42 0.51 0.42 0.06 1.67 1.58 1.67 1.58 000
91040 A Esoph balloon distension tst 0.97 9.27 10.67 9.27 10.67 0.12 10.36 11.76 10.36 11.76 000
91040 TC A Esoph balloon distension tst 0.00 8.89 10.32 8.89 10.32 0.06 8.95 10.38 8.95 10.38 000
91040 26 A Esoph balloon distension tst 0.97 0.38 0.35 0.38 0.35 0.06 1.41 1.38 1.41 1.38 000
91052 A Gastric analysis test 0.79 2.98 2.59 2.98 2.59 0.05 3.82 3.43 3.82 3.43 000
91052 TC A Gastric analysis test 0.00 2.60 2.28 2.60 2.28 0.02 2.62 2.30 2.62 2.30 000
91052 26 A Gastric analysis test 0.79 0.38 0.31 0.38 0.31 0.03 1.20 1.13 1.20 1.13 000
91055 A Gastric intubation for smear 0.94 2.41 2.81 2.41 2.81 0.07 3.42 3.82 3.42 3.82 000
91055 TC A Gastric intubation for smear 0.00 2.13 2.54 2.13 2.54 0.02 2.15 2.56 2.15 2.56 000
91055 26 A Gastric intubation for smear 0.94 0.28 0.27 0.28 0.27 0.05 1.27 1.26 1.27 1.26 000
91065 A Breath hydrogen test 0.20 1.29 1.42 1.29 1.42 0.03 1.52 1.65 1.52 1.65 000
91065 TC A Breath hydrogen test 0.00 1.23 1.35 1.23 1.35 0.02 1.25 1.37 1.25 1.37 000
91065 26 A Breath hydrogen test 0.20 0.06 0.07 0.06 0.07 0.01 0.27 0.28 0.27 0.28 000
91100 A Pass intestine bleeding tube 1.08 2.14 2.63 0.37 0.30 0.07 3.29 3.78 1.52 1.45 000
91105 A Gastric intubation treatment 0.37 1.74 2.01 0.07 0.09 0.03 2.14 2.41 0.47 0.49 000
91110 A Gi tract capsule endoscopy 3.64 20.51 21.77 NA NA 0.16 24.31 25.57 NA NA XXX
91110 TC A Gi tract capsule endoscopy 0.00 18.81 20.38 NA NA 0.07 18.88 20.45 NA NA XXX
91110 26 A Gi tract capsule endoscopy 3.64 1.70 1.39 1.70 1.39 0.09 5.43 5.12 5.43 5.12 XXX
91111 A Esophageal capsule endoscopy 1.00 18.65 18.65 NA NA 0.05 19.70 19.70 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
91111 TC A Esophageal capsule endoscopy 0.00 18.19 18.19 NA NA 0.02 18.21 18.21 NA NA XXX
91111 26 A Esophageal capsule endoscopy 1.00 0.46 0.46 0.46 0.46 0.03 1.49 1.49 1.49 1.49 XXX
91120 A Rectal sensation test 0.97 9.04 10.49 9.04 10.49 0.11 10.12 11.57 10.12 11.57 XXX
91120 TC A Rectal sensation test 0.00 8.73 10.16 8.73 10.16 0.04 8.77 10.20 8.77 10.20 XXX
91120 26 A Rectal sensation test 0.97 0.31 0.33 0.31 0.33 0.07 1.35 1.37 1.35 1.37 XXX
91122 A Anal pressure record 1.77 3.74 4.76 3.74 4.76 0.21 5.72 6.74 5.72 6.74 000
91122 TC A Anal pressure record 0.00 3.21 4.18 3.21 4.18 0.08 3.29 4.26 3.29 4.26 000
91122 26 A Anal pressure record 1.77 0.53 0.58 0.53 0.58 0.13 2.43 2.48 2.43 2.48 000
91123 B Irrigate fecal impaction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91132 C Electrogastrography 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91132 TC C Electrogastrography 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91132 26 A Electrogastrography 0.52 0.26 0.20 0.26 0.20 0.02 0.80 0.74 0.80 0.74 XXX
91133 C Electrogastrography w/test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91133 TC C Electrogastrography w/test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91133 26 A Electrogastrography w/test 0.66 0.30 0.25 0.30 0.25 0.03 0.99 0.94 0.99 0.94 XXX
91299 C Gastroenterology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91299 TC C Gastroenterology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
91299 26 C Gastroenterology procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92002 A Eye exam, new patient 0.88 0.97 0.97 0.28 0.33 0.02 1.87 1.87 1.18 1.23 XXX
92004 A Eye exam, new patient 1.67 1.59 1.67 0.55 0.65 0.04 3.30 3.38 2.26 2.36 XXX
92012 A Eye exam established pat 0.67 0.93 1.01 0.24 0.28 0.02 1.62 1.70 0.93 0.97 XXX
92014 A Eye exam treatment 1.10 1.31 1.39 0.39 0.45 0.03 2.44 2.52 1.52 1.58 XXX
92015 N Refraction 0.38 0.10 1.14 0.09 0.14 0.01 0.49 1.53 0.48 0.53 XXX
92018 A New eye exam treatment 2.50 NA NA 0.93 1.04 0.07 NA NA 3.50 3.61 XXX
92019 A Eye exam treatment 1.31 NA NA 0.45 0.53 0.03 NA NA 1.79 1.87 XXX
92020 A Special eye evaluation 0.37 0.26 0.32 0.13 0.15 0.01 0.64 0.70 0.51 0.53 XXX
92025 A Corneal topography 0.35 0.44 0.44 0.44 0.44 0.02 0.81 0.81 0.81 0.81 XXX
92025 TC A Corneal topography 0.00 0.32 0.32 0.32 0.32 0.01 0.33 0.33 0.33 0.33 XXX
92025 26 A Corneal topography 0.35 0.12 0.12 0.12 0.12 0.01 0.48 0.48 0.48 0.48 XXX
92060 A Special eye evaluation 0.69 0.79 0.75 NA NA 0.03 1.51 1.47 NA NA XXX
92060 TC A Special eye evaluation 0.00 0.55 0.47 NA NA 0.01 0.56 0.48 NA NA XXX
92060 26 A Special eye evaluation 0.69 0.24 0.28 0.24 0.28 0.02 0.95 0.99 0.95 0.99 XXX
92065 A Orthoptic/pleoptic training 0.37 0.88 0.62 NA NA 0.02 1.27 1.01 NA NA XXX
92065 TC A Orthoptic/pleoptic training 0.00 0.79 0.48 NA NA 0.01 0.80 0.49 NA NA XXX
92065 26 A Orthoptic/pleoptic training 0.37 0.09 0.14 0.09 0.14 0.01 0.47 0.52 0.47 0.52 XXX
92070 A Fitting of contact lens 0.70 0.94 1.04 0.24 0.30 0.02 1.66 1.76 0.96 1.02 XXX
92081 A Visual field examination(s) 0.36 0.96 0.95 NA NA 0.02 1.34 1.33 NA NA XXX
92081 TC A Visual field examination(s) 0.00 0.85 0.81 NA NA 0.01 0.86 0.82 NA NA XXX
92081 26 A Visual field examination(s) 0.36 0.11 0.14 0.11 0.14 0.01 0.48 0.51 0.48 0.51 XXX
92082 A Visual field examination(s) 0.44 1.36 1.26 NA NA 0.02 1.82 1.72 NA NA XXX
92082 TC A Visual field examination(s) 0.00 1.21 1.08 NA NA 0.01 1.22 1.09 NA NA XXX
92082 26 A Visual field examination(s) 0.44 0.15 0.18 0.15 0.18 0.01 0.60 0.63 0.60 0.63 XXX
92083 A Visual field examination(s) 0.50 1.56 1.46 NA NA 0.02 2.08 1.98 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
92083 TC A Visual field examination(s) 0.00 1.38 1.25 NA NA 0.01 1.39 1.26 NA NA XXX
92083 26 A Visual field examination(s) 0.50 0.18 0.21 0.18 0.21 0.01 0.69 0.72 0.69 0.72 XXX
92100 A Serial tonometry exam(s) 0.92 1.28 1.33 0.30 0.35 0.02 2.22 2.27 1.24 1.29 XXX
92120 A Tonography eye evaluation 0.81 1.00 1.05 0.27 0.31 0.02 1.83 1.88 1.10 1.14 XXX
92130 A Water provocation tonography 0.81 1.21 1.26 0.29 0.35 0.02 2.04 2.09 1.12 1.18 XXX
92135 A Opthalmic dx imaging 0.35 0.80 0.79 NA NA 0.02 1.17 1.16 NA NA XXX
92135 TC A Opthalmic dx imaging 0.00 0.68 0.65 NA NA 0.01 0.69 0.66 NA NA XXX
92135 26 A Opthalmic dx imaging 0.35 0.12 0.14 0.12 0.14 0.01 0.48 0.50 0.48 0.50 XXX
92136 A Ophthalmic biometry 0.54 1.46 1.60 NA NA 0.08 2.08 2.22 NA NA XXX
92136 TC A Ophthalmic biometry 0.00 1.25 1.37 NA NA 0.07 1.32 1.44 NA NA XXX
92136 26 A Ophthalmic biometry 0.54 0.21 0.23 0.21 0.23 0.01 0.76 0.78 0.76 0.78 XXX
92140 A Glaucoma provocative tests 0.50 0.92 0.97 0.16 0.20 0.01 1.43 1.48 0.67 0.71 XXX
92225 A Special eye exam, initial 0.38 0.25 0.23 0.13 0.15 0.01 0.64 0.62 0.52 0.54 XXX
92226 A Special eye exam, subsequent 0.33 0.24 0.22 0.12 0.14 0.01 0.58 0.56 0.46 0.48 XXX
92230 A Eye exam with photos 0.60 0.73 1.33 0.21 0.20 0.02 1.35 1.95 0.83 0.82 XXX
92235 A Eye exam with photos 0.81 2.32 2.54 NA NA 0.08 3.21 3.43 NA NA XXX
92235 TC A Eye exam with photos 0.00 2.01 2.18 NA NA 0.06 2.07 2.24 NA NA XXX
92235 26 A Eye exam with photos 0.81 0.31 0.36 0.31 0.36 0.02 1.14 1.19 1.14 1.19 XXX
92240 A Icg angiography 1.10 4.48 5.70 NA NA 0.09 5.67 6.89 NA NA XXX
92240 TC A Icg angiography 0.00 4.06 5.22 NA NA 0.06 4.12 5.28 NA NA XXX
92240 26 A Icg angiography 1.10 0.42 0.48 0.42 0.48 0.03 1.55 1.61 1.55 1.61 XXX
92250 A Eye exam with photos 0.44 1.33 1.48 NA NA 0.02 1.79 1.94 NA NA XXX
92250 TC A Eye exam with photos 0.00 1.18 1.30 NA NA 0.01 1.19 1.31 NA NA XXX
92250 26 A Eye exam with photos 0.44 0.15 0.18 0.15 0.18 0.01 0.60 0.63 0.60 0.63 XXX
92260 A Ophthalmoscopy/dynamometry 0.20 0.23 0.25 0.07 0.09 0.01 0.44 0.46 0.28 0.30 XXX
92265 A Eye muscle evaluation 0.81 1.01 1.37 NA NA 0.06 1.88 2.24 NA NA XXX
92265 TC A Eye muscle evaluation 0.00 0.76 1.10 NA NA 0.02 0.78 1.12 NA NA XXX
92265 26 A Eye muscle evaluation 0.81 0.25 0.27 0.25 0.27 0.04 1.10 1.12 1.10 1.12 XXX
92270 A Electro-oculography 0.81 1.38 1.50 NA NA 0.05 2.24 2.36 NA NA XXX
92270 TC A Electro-oculography 0.00 1.14 1.19 NA NA 0.02 1.16 1.21 NA NA XXX
92270 26 A Electro-oculography 0.81 0.24 0.31 0.24 0.31 0.03 1.08 1.15 1.08 1.15 XXX
92275 A Electroretinography 1.01 2.47 2.08 NA NA 0.05 3.53 3.14 NA NA XXX
92275 TC A Electroretinography 0.00 2.10 1.66 NA NA 0.02 2.12 1.68 NA NA XXX
92275 26 A Electroretinography 1.01 0.37 0.42 0.37 0.42 0.03 1.41 1.46 1.41 1.46 XXX
92283 A Color vision examination 0.17 1.01 0.89 NA NA 0.02 1.20 1.08 NA NA XXX
92283 TC A Color vision examination 0.00 0.96 0.82 NA NA 0.01 0.97 0.83 NA NA XXX
92283 26 A Color vision examination 0.17 0.05 0.07 0.05 0.07 0.01 0.23 0.25 0.23 0.25 XXX
92284 A Dark adaptation eye exam 0.24 1.24 1.72 NA NA 0.02 1.50 1.98 NA NA XXX
92284 TC A Dark adaptation eye exam 0.00 1.15 1.64 NA NA 0.01 1.16 1.65 NA NA XXX
92284 26 A Dark adaptation eye exam 0.24 0.09 0.08 0.09 0.08 0.01 0.34 0.33 0.34 0.33 XXX
92285 A Eye photography 0.20 0.82 0.95 NA NA 0.02 1.04 1.17 NA NA XXX
92285 TC A Eye photography 0.00 0.75 0.86 NA NA 0.01 0.76 0.87 NA NA XXX
92285 26 A Eye photography 0.20 0.07 0.09 0.07 0.09 0.01 0.28 0.30 0.28 0.30 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
92286 A Internal eye photography 0.66 2.15 2.83 NA NA 0.04 2.85 3.53 NA NA XXX
92286 TC A Internal eye photography 0.00 1.91 2.55 NA NA 0.02 1.93 2.57 NA NA XXX
92286 26 A Internal eye photography 0.66 0.24 0.28 0.24 0.28 0.02 0.92 0.96 0.92 0.96 XXX
92287 A Internal eye photography 0.81 1.97 2.28 0.31 0.31 0.02 2.80 3.11 1.14 1.14 XXX
92310 N Contact lens fitting 1.17 1.05 1.10 0.27 0.41 0.04 2.26 2.31 1.48 1.62 XXX
92311 A Contact lens fitting 1.08 1.30 1.14 0.33 0.35 0.03 2.41 2.25 1.44 1.46 XXX
92312 A Contact lens fitting 1.26 1.50 1.19 0.36 0.47 0.03 2.79 2.48 1.65 1.76 XXX
92313 A Contact lens fitting 0.92 1.48 1.17 0.34 0.30 0.02 2.42 2.11 1.28 1.24 XXX
92314 N Prescription of contact lens 0.69 1.13 0.99 0.16 0.24 0.01 1.83 1.69 0.86 0.94 XXX
92315 A Prescription of contact lens 0.45 1.33 0.97 0.14 0.16 0.01 1.79 1.43 0.60 0.62 XXX
92316 A Prescription of contact lens 0.68 1.67 1.10 0.24 0.28 0.02 2.37 1.80 0.94 0.98 XXX
92317 A Prescription of contact lens 0.45 1.44 1.07 0.14 0.15 0.01 1.90 1.53 0.60 0.61 XXX
92325 A Modification of contact lens 0.00 0.85 0.51 NA NA 0.01 0.86 0.52 NA NA XXX
92326 A Replacement of contact lens 0.00 0.75 1.41 NA NA 0.06 0.81 1.47 NA NA XXX
92340 N Fitting of spectacles 0.37 0.44 0.64 0.08 0.13 0.01 0.82 1.02 0.46 0.51 XXX
92341 N Fitting of spectacles 0.47 0.46 0.67 0.11 0.16 0.01 0.94 1.15 0.59 0.64 XXX
92342 N Fitting of spectacles 0.53 0.48 0.69 0.12 0.19 0.01 1.02 1.23 0.66 0.73 XXX
92352 B Special spectacles fitting 0.37 0.56 0.65 0.08 0.13 0.01 0.94 1.03 0.46 0.51 XXX
92353 B Special spectacles fitting 0.50 0.59 0.70 0.12 0.17 0.02 1.11 1.22 0.64 0.69 XXX
92354 B Special spectacles fitting 0.00 0.28 6.72 NA NA 0.10 0.38 6.82 NA NA XXX
92355 B Special spectacles fitting 0.00 0.44 3.36 NA NA 0.01 0.45 3.37 NA NA XXX
92358 B Eye prosthesis service 0.00 0.23 0.79 NA NA 0.05 0.28 0.84 NA NA XXX
92370 N Repair adjust spectacles 0.32 0.39 0.51 0.07 0.12 0.02 0.73 0.85 0.41 0.46 XXX
92371 B Repair adjust spectacles 0.00 0.24 0.53 NA NA 0.02 0.26 0.55 NA NA XXX
92499 C Eye service or procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92499 TC C Eye service or procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92499 26 C Eye service or procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92502 A Ear and throat examination 1.51 NA NA 0.79 1.03 0.05 NA NA 2.35 2.59 000
92504 A Ear microscopy examination 0.18 0.55 0.51 0.05 0.08 0.01 0.74 0.70 0.24 0.27 XXX
92506 A Speech/hearing evaluation 0.86 3.28 2.76 0.25 0.36 0.03 4.17 3.65 1.14 1.25 XXX
92507 A Speech/hearing therapy 0.52 1.18 1.13 0.15 0.21 0.02 1.72 1.67 0.69 0.75 XXX
92508 A Speech/hearing therapy 0.26 0.51 0.51 0.08 0.11 0.01 0.78 0.78 0.35 0.38 XXX
92511 A Nasopharyngoscopy 0.84 2.92 3.21 0.62 0.74 0.03 3.79 4.08 1.49 1.61 000
92512 A Nasal function studies 0.55 0.94 1.09 0.16 0.18 0.02 1.51 1.66 0.73 0.75 XXX
92516 A Facial nerve function test 0.43 1.15 1.19 0.13 0.20 0.01 1.59 1.63 0.57 0.64 XXX
92520 A Laryngeal function studies 0.75 0.87 0.60 0.21 0.35 0.03 1.65 1.38 0.99 1.13 XXX
92526 A Oral function therapy 0.55 1.67 1.65 0.16 0.19 0.02 2.24 2.22 0.73 0.76 XXX
92531 B Spontaneous nystagmus study 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92532 B Positional nystagmus test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92533 B Caloric vestibular test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92534 B Optokinetic nystagmus test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92541 A Spontaneous nystagmus test 0.40 1.10 1.05 NA NA 0.04 1.54 1.49 NA NA XXX
92541 TC A Spontaneous nystagmus test 0.00 0.99 0.88 NA NA 0.02 1.01 0.90 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
92541 26 A Spontaneous nystagmus test 0.40 0.11 0.17 0.11 0.17 0.02 0.53 0.59 0.53 0.59 XXX
92542 A Positional nystagmus test 0.33 1.24 1.16 NA NA 0.03 1.60 1.52 NA NA XXX
92542 TC A Positional nystagmus test 0.00 1.15 1.02 NA NA 0.02 1.17 1.04 NA NA XXX
92542 26 A Positional nystagmus test 0.33 0.09 0.14 0.09 0.14 0.01 0.43 0.48 0.43 0.48 XXX
92543 A Caloric vestibular test 0.10 0.64 0.59 NA NA 0.02 0.76 0.71 NA NA XXX
92543 TC A Caloric vestibular test 0.00 0.61 0.54 NA NA 0.01 0.62 0.55 NA NA XXX
92543 26 A Caloric vestibular test 0.10 0.03 0.05 0.03 0.05 0.01 0.14 0.16 0.14 0.16 XXX
92544 A Optokinetic nystagmus test 0.26 1.00 0.93 NA NA 0.03 1.29 1.22 NA NA XXX
92544 TC A Optokinetic nystagmus test 0.00 0.93 0.82 NA NA 0.02 0.95 0.84 NA NA XXX
92544 26 A Optokinetic nystagmus test 0.26 0.07 0.11 0.07 0.11 0.01 0.34 0.38 0.34 0.38 XXX
92545 A Oscillating tracking test 0.23 0.98 0.85 NA NA 0.03 1.24 1.11 NA NA XXX
92545 TC A Oscillating tracking test 0.00 0.92 0.75 NA NA 0.02 0.94 0.77 NA NA XXX
92545 26 A Oscillating tracking test 0.23 0.06 0.10 0.06 0.10 0.01 0.30 0.34 0.30 0.34 XXX
92546 A Sinusoidal rotational test 0.29 1.80 1.94 NA NA 0.03 2.12 2.26 NA NA XXX
92546 TC A Sinusoidal rotational test 0.00 1.72 1.82 NA NA 0.02 1.74 1.84 NA NA XXX
92546 26 A Sinusoidal rotational test 0.29 0.08 0.12 0.08 0.12 0.01 0.38 0.42 0.38 0.42 XXX
92547 A Supplemental electrical test 0.00 0.11 0.09 0.11 0.09 0.06 0.17 0.15 0.17 0.15 ZZZ
92548 A Posturography 0.50 1.64 2.10 NA NA 0.15 2.29 2.75 NA NA XXX
92548 TC A Posturography 0.00 1.50 1.87 NA NA 0.13 1.63 2.00 NA NA XXX
92548 26 A Posturography 0.50 0.14 0.23 0.14 0.23 0.02 0.66 0.75 0.66 0.75 XXX
92551 N Pure tone hearing test, air 0.00 0.25 0.25 NA NA 0.01 0.26 0.26 NA NA XXX
92552 A Pure tone audiometry, air 0.00 0.56 0.47 NA NA 0.04 0.60 0.51 NA NA XXX
92553 A Audiometry, air bone 0.00 0.71 0.67 NA NA 0.06 0.77 0.73 NA NA XXX
92555 A Speech threshold audiometry 0.00 0.38 0.38 NA NA 0.04 0.42 0.42 NA NA XXX
92556 A Speech audiometry, complete 0.00 0.51 0.56 NA NA 0.06 0.57 0.62 NA NA XXX
92557 A Comprehensive hearing test 0.00 1.26 1.21 NA NA 0.12 1.38 1.33 NA NA XXX
92559 N Group audiometric testing 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92560 N Bekesy audiometry, screen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92561 A Bekesy audiometry, diagnosis 0.00 0.68 0.71 NA NA 0.06 0.74 0.77 NA NA XXX
92562 A Loudness balance test 0.00 0.67 0.48 NA NA 0.04 0.71 0.52 NA NA XXX
92563 A Tone decay hearing test 0.00 0.48 0.41 NA NA 0.04 0.52 0.45 NA NA XXX
92564 A Sisi hearing test 0.00 0.43 0.46 NA NA 0.05 0.48 0.51 NA NA XXX
92565 A Stenger test, pure tone 0.00 0.23 0.36 NA NA 0.04 0.27 0.40 NA NA XXX
92567 A Tympanometry 0.00 0.49 0.51 NA NA 0.06 0.55 0.57 NA NA XXX
92568 A Acoustic refl threshold tst 0.00 0.15 0.32 NA NA 0.04 0.19 0.36 NA NA XXX
92569 A Acoustic reflex decay test 0.00 0.15 0.35 NA NA 0.04 0.19 0.39 NA NA XXX
92571 A Filtered speech hearing test 0.00 0.40 0.39 NA NA 0.04 0.44 0.43 NA NA XXX
92572 A Staggered spondaic word test 0.00 0.60 0.22 NA NA 0.01 0.61 0.23 NA NA XXX
92575 A Sensorineural acuity test 0.00 1.09 0.50 NA NA 0.02 1.11 0.52 NA NA XXX
92576 A Synthetic sentence test 0.00 0.54 0.47 NA NA 0.05 0.59 0.52 NA NA XXX
92577 A Stenger test, speech 0.00 0.24 0.60 NA NA 0.07 0.31 0.67 NA NA XXX
92579 A Visual audiometry (vra) 0.00 0.84 0.76 NA NA 0.06 0.90 0.82 NA NA XXX
92582 A Conditioning play audiometry 0.00 1.07 0.82 NA NA 0.06 1.13 0.88 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
92583 A Select picture audiometry 0.00 0.69 0.84 NA NA 0.08 0.77 0.92 NA NA XXX
92584 A Electrocochleography 0.00 1.16 2.14 NA NA 0.21 1.37 2.35 NA NA XXX
92585 A Auditor evoke potent, compre 0.50 1.91 2.02 NA NA 0.17 2.58 2.69 NA NA XXX
92585 TC A Auditor evoke potent, compre 0.00 1.77 1.83 NA NA 0.14 1.91 1.97 NA NA XXX
92585 26 A Auditor evoke potent, compre 0.50 0.14 0.19 0.14 0.19 0.03 0.67 0.72 0.67 0.72 XXX
92586 A Auditor evoke potent, limit 0.00 1.40 1.74 NA NA 0.14 1.54 1.88 NA NA XXX
92587 A Evoked auditory test 0.13 0.62 1.19 NA NA 0.12 0.87 1.44 NA NA XXX
92587 TC A Evoked auditory test 0.00 0.58 1.13 NA NA 0.11 0.69 1.24 NA NA XXX
92587 26 A Evoked auditory test 0.13 0.04 0.06 0.04 0.06 0.01 0.18 0.20 0.18 0.20 XXX
92588 A Evoked auditory test 0.36 1.02 1.48 NA NA 0.14 1.52 1.98 NA NA XXX
92588 TC A Evoked auditory test 0.00 0.92 1.33 NA NA 0.13 1.05 1.46 NA NA XXX
92588 26 A Evoked auditory test 0.36 0.10 0.15 0.10 0.15 0.01 0.47 0.52 0.47 0.52 XXX
92590 N Hearing aid exam, one ear 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92591 N Hearing aid exam, both ears 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92592 N Hearing aid check, one ear 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92593 N Hearing aid check, both ears 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92594 N Electro hearng aid test, one 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92595 N Electro hearng aid tst, both 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92596 A Ear protector evaluation 0.00 0.93 0.68 NA NA 0.06 0.99 0.74 NA NA XXX
92597 A Oral speech device eval 0.86 1.69 1.69 0.25 0.40 0.03 2.58 2.58 1.14 1.29 XXX
92601 A Cochlear implt f/up exam 7 0.00 4.87 3.84 NA NA 0.07 4.94 3.91 NA NA XXX
92602 A Reprogram cochlear implt 7 0.00 3.34 2.62 NA NA 0.07 3.41 2.69 NA NA XXX
92603 A Cochlear implt f/up exam 7 0.00 3.17 2.40 NA NA 0.07 3.24 2.47 NA NA XXX
92604 A Reprogram cochlear implt 7 0.00 2.09 1.54 NA NA 0.07 2.16 1.61 NA NA XXX
92605 B Eval for nonspeech device rx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92606 B Non-speech device service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92607 A Ex for speech device rx, 1hr 0.00 4.27 3.38 NA NA 0.05 4.32 3.43 NA NA XXX
92608 A Ex for speech device rx addl 0.00 0.86 0.63 NA NA 0.05 0.91 0.68 NA NA XXX
92609 A Use of speech device service 0.00 2.29 1.77 NA NA 0.04 2.33 1.81 NA NA XXX
92610 A Evaluate swallowing function 0.00 1.61 2.98 NA NA 0.08 1.69 3.06 NA NA XXX
92611 A Motion fluoroscopy/swallow 0.00 1.85 3.04 NA NA 0.08 1.93 3.12 NA NA XXX
92612 A Endoscopy swallow tst (fees) 1.27 2.74 2.74 0.37 0.59 0.04 4.05 4.05 1.68 1.90 XXX
92613 A Endoscopy swallow tst (fees) 0.71 0.23 0.36 0.23 0.35 0.05 0.99 1.12 0.99 1.11 XXX
92614 A Laryngoscopic sensory test 1.27 2.24 2.44 0.37 0.59 0.04 3.55 3.75 1.68 1.90 XXX
92615 A Eval laryngoscopy sense tst 0.63 0.19 0.31 0.19 0.31 0.05 0.87 0.99 0.87 0.99 XXX
92616 A Fees w/laryngeal sense test 1.88 2.92 3.27 0.54 0.88 0.06 4.86 5.21 2.48 2.82 XXX
92617 A Interprt fees/laryngeal test 0.79 0.23 0.39 0.23 0.39 0.05 1.07 1.23 1.07 1.23 XXX
92620 A Auditory function, 60 min 0.00 1.87 1.32 NA NA 0.06 1.93 1.38 NA NA XXX
92621 A Auditory function, + 15 min 0.00 0.40 0.29 NA NA 0.06 0.46 0.35 NA NA ZZZ
92625 A Tinnitus assessment 0.00 1.82 1.30 1.82 1.30 0.06 1.88 1.36 1.88 1.36 XXX
92626 A Eval aud rehab status 0.00 1.85 2.11 NA NA 0.06 1.91 2.17 NA NA XXX
92627 A Eval aud status rehab add-on 0.00 0.42 0.52 0.42 0.52 0.02 0.44 0.54 0.44 0.54 ZZZ
92630 I Aud rehab pre-ling hear loss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
92633 I Aud rehab postling hear loss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92640 A Aud brainstem implt programg 0.00 1.40 1.40 1.40 1.40 0.01 1.41 1.41 1.41 1.41 XXX
92700 C Ent procedure/service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
92950 A Heart/lung resuscitation cpr 3.79 3.24 3.96 0.79 0.93 0.28 7.31 8.03 4.86 5.00 000
92953 A Temporary external pacing 0.23 NA NA 0.07 0.07 0.02 NA NA 0.32 0.32 000
92960 A Cardioversion electric, ext 2.25 4.40 5.83 1.48 1.25 0.07 6.72 8.15 3.80 3.57 000
92961 A Cardioversion, electric, int 4.59 NA NA 2.52 2.19 0.29 NA NA 7.40 7.07 000
92970 A Cardioassist, internal 3.51 NA NA 1.63 1.20 0.16 NA NA 5.30 4.87 000
92971 A Cardioassist, external 1.77 NA NA 1.09 0.91 0.06 NA NA 2.92 2.74 000
92973 A Percut coronary thrombectomy 3.28 NA NA 1.82 1.42 0.23 NA NA 5.33 4.93 ZZZ
92974 A Cath place, cardio brachytx 3.00 NA NA 1.70 1.31 0.21 NA NA 4.91 4.52 ZZZ
92975 A Dissolve clot, heart vessel 7.24 NA NA 3.94 3.09 0.50 NA NA 11.68 10.83 000
92977 A Dissolve clot, heart vessel 0.00 1.70 6.46 NA NA 0.46 2.16 6.92 NA NA XXX
92978 C Intravasc us, heart add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
92978 TC C Intravasc us, heart add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
92978 26 A Intravasc us, heart add-on 1.80 1.00 0.78 1.00 0.78 0.06 2.86 2.64 2.86 2.64 ZZZ
92979 C Intravasc us, heart add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
92979 TC C Intravasc us, heart add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
92979 26 A Intravasc us, heart add-on 1.44 0.80 0.62 0.80 0.62 0.06 2.30 2.12 2.30 2.12 ZZZ
92980 A Insert intracoronary stent 14.82 NA NA 8.43 6.65 1.03 NA NA 24.28 22.50 000
92981 A Insert intracoronary stent 4.16 NA NA 2.31 1.80 0.29 NA NA 6.76 6.25 ZZZ
92982 A Coronary artery dilation 10.96 NA NA 6.30 4.97 0.76 NA NA 18.02 16.69 000
92984 A Coronary artery dilation 2.97 NA NA 1.64 1.28 0.21 NA NA 4.82 4.46 ZZZ
92986 A Revision of aortic valve 22.70 NA NA 15.88 12.84 1.51 NA NA 40.09 37.05 090
92987 A Revision of mitral valve 23.48 NA NA 16.33 13.24 1.59 NA NA 41.40 38.31 090
92990 A Revision of pulmonary valve 18.12 NA NA 11.32 10.17 1.20 NA NA 30.64 29.49 090
92992 C Revision of heart chamber 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
92993 C Revision of heart chamber 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 090
92995 A Coronary atherectomy 12.07 NA NA 6.92 5.45 0.84 NA NA 19.83 18.36 000
92996 A Coronary atherectomy add-on 3.26 NA NA 1.81 1.41 0.10 NA NA 5.17 4.77 ZZZ
92997 A Pul art balloon repr, percut 11.98 NA NA 5.27 4.93 0.40 NA NA 17.65 17.31 000
92998 A Pul art balloon repr, percut 5.99 NA NA 2.79 2.35 0.28 NA NA 9.06 8.62 ZZZ
93000 A Electrocardiogram, complete 0.17 0.34 0.47 NA NA 0.03 0.54 0.67 NA NA XXX
93005 A Electrocardiogram, tracing 0.00 0.27 0.41 NA NA 0.02 0.29 0.43 NA NA XXX
93010 A Electrocardiogram report 0.17 0.07 0.06 0.07 0.06 0.01 0.25 0.24 0.25 0.24 XXX
93012 A Transmission of ecg 0.00 4.15 5.55 NA NA 0.18 4.33 5.73 NA NA XXX
93014 A Report on transmitted ecg 0.52 0.21 0.20 0.21 0.20 0.02 0.75 0.74 0.75 0.74 XXX
93015 A Cardiovascular stress test 0.75 1.91 1.95 NA NA 0.14 2.80 2.84 NA NA XXX
93016 A Cardiovascular stress test 0.45 0.23 0.19 0.23 0.19 0.02 0.70 0.66 0.70 0.66 XXX
93017 A Cardiovascular stress test 0.00 1.53 1.64 NA NA 0.11 1.64 1.75 NA NA XXX
93018 A Cardiovascular stress test 0.30 0.15 0.12 0.15 0.12 0.01 0.46 0.43 0.46 0.43 XXX
93024 A Cardiac drug stress test 1.17 2.41 1.79 NA NA 0.12 3.70 3.08 NA NA XXX
93024 TC A Cardiac drug stress test 0.00 1.82 1.30 NA NA 0.08 1.90 1.38 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93024 26 A Cardiac drug stress test 1.17 0.59 0.49 0.59 0.49 0.04 1.80 1.70 1.80 1.70 XXX
93025 A Microvolt t-wave assess 0.75 3.90 6.67 NA NA 0.14 4.79 7.56 NA NA XXX
93025 TC A Microvolt t-wave assess 0.00 3.52 6.36 NA NA 0.11 3.63 6.47 NA NA XXX
93025 26 A Microvolt t-wave assess 0.75 0.38 0.31 0.38 0.31 0.03 1.16 1.09 1.16 1.09 XXX
93040 A Rhythm ECG with report 0.16 0.19 0.20 NA NA 0.02 0.37 0.38 NA NA XXX
93041 A Rhythm ECG, tracing 0.00 0.14 0.15 NA NA 0.01 0.15 0.16 NA NA XXX
93042 A Rhythm ECG, report 0.16 0.05 0.05 0.05 0.05 0.01 0.22 0.22 0.22 0.22 XXX
93224 A ECG monitor/report, 24 hrs 0.52 2.32 3.29 NA NA 0.24 3.08 4.05 NA NA XXX
93225 A ECG monitor/record, 24 hrs 0.00 1.06 1.20 NA NA 0.08 1.14 1.28 NA NA XXX
93226 A ECG monitor/report, 24 hrs 0.00 0.98 1.88 NA NA 0.14 1.12 2.02 NA NA XXX
93227 A ECG monitor/review, 24 hrs 0.52 0.28 0.21 0.28 0.21 0.02 0.82 0.75 0.82 0.75 XXX
93230 A ECG monitor/report, 24 hrs 0.52 2.28 3.49 NA NA 0.26 3.06 4.27 NA NA XXX
93231 A Ecg monitor/record, 24 hrs 0.00 0.92 1.37 NA NA 0.11 1.03 1.48 NA NA XXX
93232 A ECG monitor/report, 24 hrs 0.00 1.13 1.92 NA NA 0.13 1.26 2.05 NA NA XXX
93233 A ECG monitor/review, 24 hrs 0.52 0.23 0.20 0.23 0.20 0.02 0.77 0.74 0.77 0.74 XXX
93235 A ECG monitor/report, 24 hrs 0.45 0.22 2.15 NA NA 0.16 0.83 2.76 NA NA XXX
93236 C ECG monitor/report, 24 hrs 0.00 0.00 0.00 NA NA 0.00 0.00 0.00 NA NA XXX
93237 A ECG monitor/review, 24 hrs 0.45 0.22 0.18 0.22 0.18 0.02 0.69 0.65 0.69 0.65 XXX
93268 A ECG record/review 0.52 5.75 7.02 NA NA 0.28 6.55 7.82 NA NA XXX
93270 A ECG recording 0.00 0.29 1.00 NA NA 0.08 0.37 1.08 NA NA XXX
93271 A Ecg/monitoring and analysis 0.00 5.24 5.82 NA NA 0.18 5.42 6.00 NA NA XXX
93272 A Ecg/review, interpret only 0.52 0.22 0.20 0.22 0.20 0.02 0.76 0.74 0.76 0.74 XXX
93278 A ECG/signal-averaged 0.25 0.61 1.09 NA NA 0.12 0.98 1.46 NA NA XXX
93278 TC A ECG/signal-averaged 0.00 0.51 0.99 NA NA 0.11 0.62 1.10 NA NA XXX
93278 26 A ECG/signal-averaged 0.25 0.10 0.10 0.10 0.10 0.01 0.36 0.36 0.36 0.36 XXX
93303 A Echo transthoracic 1.30 4.60 4.41 NA NA 0.27 6.17 5.98 NA NA XXX
93303 TC A Echo transthoracic 0.00 4.02 3.90 NA NA 0.23 4.25 4.13 NA NA XXX
93303 26 A Echo transthoracic 1.30 0.58 0.51 0.58 0.51 0.04 1.92 1.85 1.92 1.85 XXX
93304 A Echo transthoracic 0.75 3.16 2.46 NA NA 0.15 4.06 3.36 NA NA XXX
93304 TC A Echo transthoracic 0.00 2.84 2.17 NA NA 0.13 2.97 2.30 NA NA XXX
93304 26 A Echo transthoracic 0.75 0.32 0.29 0.32 0.29 0.02 1.09 1.06 1.09 1.06 XXX
93307 A Echo exam of heart 0.92 3.75 4.10 NA NA 0.26 4.93 5.28 NA NA XXX
93307 TC A Echo exam of heart 0.00 3.28 3.72 NA NA 0.23 3.51 3.95 NA NA XXX
93307 26 A Echo exam of heart 0.92 0.47 0.38 0.47 0.38 0.03 1.42 1.33 1.42 1.33 XXX
93308 A Echo exam of heart 0.53 2.63 2.26 NA NA 0.15 3.31 2.94 NA NA XXX
93308 TC A Echo exam of heart 0.00 2.35 2.04 NA NA 0.13 2.48 2.17 NA NA XXX
93308 26 A Echo exam of heart 0.53 0.28 0.22 0.28 0.22 0.02 0.83 0.77 0.83 0.77 XXX
93312 A Echo transesophageal 2.20 7.51 5.31 NA NA 0.37 10.08 7.88 NA NA XXX
93312 TC A Echo transesophageal 0.00 6.48 4.46 NA NA 0.29 6.77 4.75 NA NA XXX
93312 26 A Echo transesophageal 2.20 1.03 0.85 1.03 0.85 0.08 3.31 3.13 3.31 3.13 XXX
93313 A Echo transesophageal 0.95 NA NA 0.14 0.19 0.06 NA NA 1.15 1.20 XXX
93314 A Echo transesophageal 1.25 7.21 4.99 NA NA 0.33 8.79 6.57 NA NA XXX
93314 TC A Echo transesophageal 0.00 6.63 4.49 NA NA 0.29 6.92 4.78 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93314 26 A Echo transesophageal 1.25 0.58 0.50 0.58 0.50 0.04 1.87 1.79 1.87 1.79 XXX
93315 C Echo transesophageal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93315 TC C Echo transesophageal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93315 26 A Echo transesophageal 2.78 1.35 1.10 1.35 1.10 0.09 4.22 3.97 4.22 3.97 XXX
93316 A Echo transesophageal 0.95 NA NA 0.26 0.25 0.05 NA NA 1.26 1.25 XXX
93317 C Echo transesophageal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93317 TC C Echo transesophageal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93317 26 A Echo transesophageal 1.83 0.76 0.69 0.76 0.69 0.08 2.67 2.60 2.67 2.60 XXX
93318 C Echo transesophageal intraop 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93318 TC C Echo transesophageal intraop 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93318 26 A Echo transesophageal intraop 2.20 0.91 0.59 0.91 0.59 0.14 3.25 2.93 3.25 2.93 XXX
93320 A Doppler echo exam, heart 0.38 1.68 1.82 1.68 1.82 0.13 2.19 2.33 2.19 2.33 ZZZ
93320 TC A Doppler echo exam, heart 0.00 1.49 1.66 1.49 1.66 0.12 1.61 1.78 1.61 1.78 ZZZ
93320 26 A Doppler echo exam, heart 0.38 0.19 0.16 0.19 0.16 0.01 0.58 0.55 0.58 0.55 ZZZ
93321 A Doppler echo exam, heart 0.15 0.62 1.04 0.62 1.04 0.09 0.86 1.28 0.86 1.28 ZZZ
93321 TC A Doppler echo exam, heart 0.00 0.54 0.97 0.54 0.97 0.08 0.62 1.05 0.62 1.05 ZZZ
93321 26 A Doppler echo exam, heart 0.15 0.08 0.07 0.08 0.07 0.01 0.24 0.23 0.24 0.23 ZZZ
93325 A Doppler color flow add-on 0.07 0.66 2.36 0.66 2.36 0.22 0.95 2.65 0.95 2.65 ZZZ
93325 TC A Doppler color flow add-on 0.00 0.63 2.33 0.63 2.33 0.21 0.84 2.54 0.84 2.54 ZZZ
93325 26 A Doppler color flow add-on 0.07 0.03 0.03 0.03 0.03 0.01 0.11 0.11 0.11 0.11 ZZZ
93350 A Echo transthoracic 1.48 5.12 3.03 NA NA 0.18 6.78 4.69 NA NA XXX
93350 TC A Echo transthoracic 0.00 4.33 2.40 NA NA 0.13 4.46 2.53 NA NA XXX
93350 26 A Echo transthoracic 1.48 0.79 0.63 0.79 0.63 0.05 2.32 2.16 2.32 2.16 XXX
93501 C Right heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93501 TC C Right heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93501 26 A Right heart catheterization 3.02 1.64 1.27 1.64 1.27 0.21 4.87 4.50 4.87 4.50 000
93503 C Insert/place heart catheter 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93505 C Biopsy of heart lining 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93505 TC C Biopsy of heart lining 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93505 26 A Biopsy of heart lining 4.37 2.37 1.85 2.37 1.85 0.30 7.04 6.52 7.04 6.52 000
93508 C Cath placement, angiography 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93508 TC C Cath placement, angiography 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93508 26 A Cath placement, angiography 4.09 2.27 2.13 2.27 2.13 0.28 6.64 6.50 6.64 6.50 000
93510 C Left heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93510 TC C Left heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93510 26 A Left heart catheterization 4.32 2.38 2.22 2.38 2.22 0.30 7.00 6.84 7.00 6.84 000
93511 C Left heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93511 TC C Left heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93511 26 A Left heart catheterization 5.02 2.67 2.50 2.67 2.50 0.35 8.04 7.87 8.04 7.87 000
93514 C Left heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93514 TC C Left heart catheterization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93514 26 A Left heart catheterization 7.04 3.20 3.14 3.20 3.14 0.49 10.73 10.67 10.73 10.67 000
93524 C Left heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93524 TC C Left heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93524 26 A Left heart catheterization 6.94 3.79 3.33 3.79 3.33 0.48 11.21 10.75 11.21 10.75 000
93526 C Rt Lt heart catheters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93526 TC C Rt Lt heart catheters 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93526 26 A Rt Lt heart catheters 5.98 3.29 2.93 3.29 2.93 0.42 9.69 9.33 9.69 9.33 000
93527 C Rt Lt heart catheters 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93527 TC C Rt Lt heart catheters 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93527 26 A Rt Lt heart catheters 7.27 4.03 3.49 4.03 3.49 0.51 11.81 11.27 11.81 11.27 000
93528 C Rt Lt heart catheters 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93528 TC C Rt Lt heart catheters 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93528 26 A Rt Lt heart catheters 8.99 4.68 4.19 4.68 4.19 0.62 14.29 13.80 14.29 13.80 000
93529 C Rt, lt heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93529 TC C Rt, lt heart catheterization 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93529 26 A Rt, lt heart catheterization 4.79 2.64 2.36 2.64 2.36 0.33 7.76 7.48 7.76 7.48 000
93530 C Rt heart cath, congenital 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93530 TC C Rt heart cath, congenital 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93530 26 A Rt heart cath, congenital 4.22 1.87 1.92 1.87 1.92 0.29 6.38 6.43 6.38 6.43 000
93531 C R l heart cath, congenital 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93531 TC C R l heart cath, congenital 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93531 26 A R l heart cath, congenital 8.34 3.77 3.63 3.77 3.63 0.58 12.69 12.55 12.69 12.55 000
93532 C R l heart cath, congenital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93532 TC C R l heart cath, congenital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93532 26 A R l heart cath, congenital 9.99 4.09 4.21 4.09 4.21 0.69 14.77 14.89 14.77 14.89 000
93533 C R l heart cath, congenital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93533 TC C R l heart cath, congenital 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93533 26 A R l heart cath, congenital 6.69 3.09 2.87 3.09 2.87 0.47 10.25 10.03 10.25 10.03 000
93539 C Injection, cardiac cath 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93540 C Injection, cardiac cath 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93541 C Injection for lung angiogram 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93542 C Injection for heart x-rays 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93543 C Injection for heart x-rays 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93544 C Injection for aortography 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93545 C Inject for coronary x-rays 0.00 NA NA 0.00 0.00 0.00 NA NA 0.00 0.00 000
93555 C Imaging, cardiac cath 0.00 0.00 0.00 NA NA 0.00 0.00 0.00 NA NA XXX
93555 TC C Imaging, cardiac cath 0.00 0.00 0.00 NA NA 0.00 0.00 0.00 NA NA XXX
93555 26 A Imaging, cardiac cath 0.81 0.45 0.35 0.45 0.35 0.03 1.29 1.19 1.29 1.19 XXX
93556 C Imaging, cardiac cath 0.00 0.00 0.00 NA NA 0.00 0.00 0.00 NA NA XXX
93556 TC C Imaging, cardiac cath 0.00 0.00 0.00 NA NA 0.00 0.00 0.00 NA NA XXX
93556 26 A Imaging, cardiac cath 0.83 0.46 0.36 0.46 0.36 0.03 1.32 1.22 1.32 1.22 XXX
93561 C Cardiac output measurement 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93561 TC C Cardiac output measurement 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93561 26 A Cardiac output measurement 0.50 0.14 0.16 0.14 0.16 0.02 0.66 0.68 0.66 0.68 000
93562 C Cardiac output measurement 0.00 NA NA NA NA 0.00 NA NA NA NA 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93562 TC C Cardiac output measurement 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93562 26 A Cardiac output measurement 0.16 0.03 0.05 0.03 0.05 0.01 0.20 0.22 0.20 0.22 000
93571 C Heart flow reserve measure 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
93571 TC C Heart flow reserve measure 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
93571 26 A Heart flow reserve measure 1.80 0.99 0.76 0.99 0.76 0.06 2.85 2.62 2.85 2.62 ZZZ
93572 C Heart flow reserve measure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93572 TC C Heart flow reserve measure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93572 26 A Heart flow reserve measure 1.44 0.75 0.56 0.75 0.56 0.04 2.23 2.04 2.23 2.04 ZZZ
93580 A Transcath closure of asd 17.97 NA NA 9.73 7.97 1.25 NA NA 28.95 27.19 000
93581 A Transcath closure of vsd 24.39 NA NA 13.39 10.39 1.72 NA NA 39.50 36.50 000
93600 C Bundle of His recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93600 TC C Bundle of His recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93600 26 A Bundle of His recording 2.12 1.11 0.90 1.11 0.90 0.16 3.39 3.18 3.39 3.18 000
93602 C Intra-atrial recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93602 TC C Intra-atrial recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93602 26 A Intra-atrial recording 2.12 1.09 0.89 1.09 0.89 0.17 3.38 3.18 3.38 3.18 000
93603 C Right ventricular recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93603 TC C Right ventricular recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93603 26 A Right ventricular recording 2.12 1.08 0.88 1.08 0.88 0.18 3.38 3.18 3.38 3.18 000
93609 C Map tachycardia, add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
93609 TC C Map tachycardia, add-on 0.00 NA NA NA NA 0.00 NA NA NA NA ZZZ
93609 26 A Map tachycardia, add-on 4.99 2.73 2.15 2.73 2.15 0.35 8.07 7.49 8.07 7.49 ZZZ
93610 C Intra-atrial pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93610 TC C Intra-atrial pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93610 26 A Intra-atrial pacing 3.02 1.53 1.25 1.53 1.25 0.24 4.79 4.51 4.79 4.51 000
93612 C Intraventricular pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93612 TC C Intraventricular pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93612 26 A Intraventricular pacing 3.02 1.48 1.24 1.48 1.24 0.25 4.75 4.51 4.75 4.51 000
93613 A Electrophys map 3d, add-on 6.99 NA NA 3.83 3.03 0.49 NA NA 11.31 10.51 ZZZ
93615 C Esophageal recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93615 TC C Esophageal recording 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93615 26 A Esophageal recording 0.99 0.49 0.33 0.49 0.33 0.03 1.51 1.35 1.51 1.35 000
93616 C Esophageal recording 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93616 TC C Esophageal recording 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93616 26 A Esophageal recording 1.49 0.43 0.43 0.43 0.43 0.09 2.01 2.01 2.01 2.01 000
93618 C Heart rhythm pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93618 TC C Heart rhythm pacing 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93618 26 A Heart rhythm pacing 4.25 2.36 1.84 2.36 1.84 0.30 6.91 6.39 6.91 6.39 000
93619 C Electrophysiology evaluation 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93619 TC C Electrophysiology evaluation 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93619 26 A Electrophysiology evaluation 7.31 3.93 3.37 3.93 3.37 0.51 11.75 11.19 11.75 11.19 000
93620 C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93620 TC C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93620 26 A Electrophysiology evaluation 11.57 6.34 5.22 6.34 5.22 0.80 18.71 17.59 18.71 17.59 000
93621 C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93621 TC C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93621 26 A Electrophysiology evaluation 2.10 1.15 0.90 1.15 0.90 0.15 3.40 3.15 3.40 3.15 ZZZ
93622 C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93622 TC C Electrophysiology evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93622 26 A Electrophysiology evaluation 3.10 1.68 1.33 1.68 1.33 0.22 5.00 4.65 5.00 4.65 ZZZ
93623 C Stimulation, pacing heart 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93623 TC C Stimulation, pacing heart 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93623 26 A Stimulation, pacing heart 2.85 1.56 1.22 1.56 1.22 0.20 4.61 4.27 4.61 4.27 ZZZ
93624 A Electrophysiologic study 4.80 NA NA 2.67 4.29 0.46 NA NA 7.93 9.55 000
93624 TC A Electrophysiologic study 0.00 NA NA 0.00 1.98 0.13 NA NA 0.13 2.11 000
93624 26 A Electrophysiologic study 4.80 2.67 2.31 2.67 2.31 0.33 7.80 7.44 7.80 7.44 000
93631 C Heart pacing, mapping 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93631 TC C Heart pacing, mapping 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 000
93631 26 A Heart pacing, mapping 7.59 2.76 2.77 2.76 2.77 0.97 11.32 11.33 11.32 11.33 000
93640 C Evaluation heart device 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93640 TC C Evaluation heart device 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93640 26 A Evaluation heart device 3.51 1.92 1.50 1.92 1.50 0.24 5.67 5.25 5.67 5.25 000
93641 C Electrophysiology evaluation 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93641 TC C Electrophysiology evaluation 0.00 NA NA NA NA 0.00 NA NA NA NA 000
93641 26 A Electrophysiology evaluation 5.92 3.23 2.54 3.23 2.54 0.41 9.56 8.87 9.56 8.87 000
93642 A Electrophysiology evaluation 4.88 7.45 8.90 7.45 8.90 0.57 12.90 14.35 12.90 14.35 000
93642 TC A Electrophysiology evaluation 0.00 4.77 6.57 4.77 6.57 0.42 5.19 6.99 5.19 6.99 000
93642 26 A Electrophysiology evaluation 4.88 2.68 2.33 2.68 2.33 0.15 7.71 7.36 7.71 7.36 000
93650 A Ablate heart dysrhythm focus 10.49 NA NA 6.06 4.84 0.73 NA NA 17.28 16.06 000
93651 A Ablate heart dysrhythm focus 16.23 NA NA 8.88 6.96 1.13 NA NA 26.24 24.32 000
93652 A Ablate heart dysrhythm focus 17.65 NA NA 9.68 7.58 1.23 NA NA 28.56 26.46 000
93660 A Tilt table evaluation 1.89 3.05 2.58 3.05 2.58 0.08 5.02 4.55 5.02 4.55 000
93660 TC A Tilt table evaluation 0.00 2.04 1.77 2.04 1.77 0.02 2.06 1.79 2.06 1.79 000
93660 26 A Tilt table evaluation 1.89 1.01 0.81 1.01 0.81 0.06 2.96 2.76 2.96 2.76 000
93662 C Intracardiac ecg (ice) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93662 TC C Intracardiac ecg (ice) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
93662 26 A Intracardiac ecg (ice) 2.80 1.53 1.22 1.53 1.22 0.09 4.42 4.11 4.42 4.11 ZZZ
93668 N Peripheral vascular rehab 0.00 0.40 0.40 NA NA 0.01 0.41 0.41 NA NA XXX
93701 A Bioimpedance, thoracic 0.17 0.70 0.91 NA NA 0.02 0.89 1.10 NA NA XXX
93701 TC A Bioimpedance, thoracic 0.00 0.64 0.84 NA NA 0.01 0.65 0.85 NA NA XXX
93701 26 A Bioimpedance, thoracic 0.17 0.06 0.07 0.06 0.07 0.01 0.24 0.25 0.24 0.25 XXX
93720 A Total body plethysmography 0.17 1.19 0.87 NA NA 0.07 1.43 1.11 NA NA XXX
93721 A Plethysmography tracing 0.00 1.14 0.82 NA NA 0.06 1.20 0.88 NA NA XXX
93722 A Plethysmography report 0.17 0.05 0.05 0.05 0.05 0.01 0.23 0.23 0.23 0.23 XXX
93724 A Analyze pacemaker system 4.88 3.53 5.29 3.53 5.29 0.39 8.80 10.56 8.80 10.56 000
93724 TC A Analyze pacemaker system 0.00 0.91 3.20 0.91 3.20 0.24 1.15 3.44 1.15 3.44 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93724 26 A Analyze pacemaker system 4.88 2.62 2.09 2.62 2.09 0.15 7.65 7.12 7.65 7.12 000
93727 A Analyze ilr system 0.52 0.65 0.31 0.65 0.31 0.02 1.19 0.85 1.19 0.85 XXX
93731 A Analyze pacemaker system 0.45 0.79 0.70 NA NA 0.05 1.29 1.20 NA NA XXX
93731 TC A Analyze pacemaker system 0.00 0.55 0.51 NA NA 0.04 0.59 0.55 NA NA XXX
93731 26 A Analyze pacemaker system 0.45 0.24 0.19 0.24 0.19 0.01 0.70 0.65 0.70 0.65 XXX
93732 A Analyze pacemaker system 0.92 1.17 0.94 NA NA 0.07 2.16 1.93 NA NA XXX
93732 TC A Analyze pacemaker system 0.00 0.67 0.55 NA NA 0.04 0.71 0.59 NA NA XXX
93732 26 A Analyze pacemaker system 0.92 0.50 0.39 0.50 0.39 0.03 1.45 1.34 1.45 1.34 XXX
93733 A Telephone analy, pacemaker 0.17 0.92 0.83 NA NA 0.07 1.16 1.07 NA NA XXX
93733 TC A Telephone analy, pacemaker 0.00 0.84 0.76 NA NA 0.06 0.90 0.82 NA NA XXX
93733 26 A Telephone analy, pacemaker 0.17 0.08 0.07 0.08 0.07 0.01 0.26 0.25 0.26 0.25 XXX
93734 A Analyze pacemaker system 0.38 0.70 0.55 NA NA 0.03 1.11 0.96 NA NA XXX
93734 TC A Analyze pacemaker system 0.00 0.50 0.39 NA NA 0.02 0.52 0.41 NA NA XXX
93734 26 A Analyze pacemaker system 0.38 0.20 0.16 0.20 0.16 0.01 0.59 0.55 0.59 0.55 XXX
93735 A Analyze pacemaker system 0.74 0.97 0.78 NA NA 0.06 1.77 1.58 NA NA XXX
93735 TC A Analyze pacemaker system 0.00 0.57 0.47 NA NA 0.04 0.61 0.51 NA NA XXX
93735 26 A Analyze pacemaker system 0.74 0.40 0.31 0.40 0.31 0.02 1.16 1.07 1.16 1.07 XXX
93736 A Telephonic analy, pacemaker 0.15 0.90 0.74 NA NA 0.07 1.12 0.96 NA NA XXX
93736 TC A Telephonic analy, pacemaker 0.00 0.83 0.68 NA NA 0.06 0.89 0.74 NA NA XXX
93736 26 A Telephonic analy, pacemaker 0.15 0.07 0.06 0.07 0.06 0.01 0.23 0.22 0.23 0.22 XXX
93740 B Temperature gradient studies 0.16 0.04 0.15 NA NA 0.02 0.22 0.33 NA NA XXX
93740 TC B Temperature gradient studies 0.00 0.00 0.11 NA NA 0.01 0.01 0.12 NA NA XXX
93740 26 B Temperature gradient studies 0.16 0.04 0.04 0.04 0.04 0.01 0.21 0.21 0.21 0.21 XXX
93741 A Analyze ht pace device sngl 0.80 1.04 0.99 NA NA 0.07 1.91 1.86 NA NA XXX
93741 TC A Analyze ht pace device sngl 0.00 0.60 0.65 NA NA 0.04 0.64 0.69 NA NA XXX
93741 26 A Analyze ht pace device sngl 0.80 0.44 0.34 0.44 0.34 0.03 1.27 1.17 1.27 1.17 XXX
93742 A Analyze ht pace device sngl 0.91 1.18 1.07 NA NA 0.07 2.16 2.05 NA NA XXX
93742 TC A Analyze ht pace device sngl 0.00 0.67 0.67 NA NA 0.04 0.71 0.71 NA NA XXX
93742 26 A Analyze ht pace device sngl 0.91 0.51 0.40 0.51 0.40 0.03 1.45 1.34 1.45 1.34 XXX
93743 A Analyze ht pace device dual 1.03 1.22 1.15 NA NA 0.07 2.32 2.25 NA NA XXX
93743 TC A Analyze ht pace device dual 0.00 0.65 0.71 NA NA 0.04 0.69 0.75 NA NA XXX
93743 26 A Analyze ht pace device dual 1.03 0.57 0.44 0.57 0.44 0.03 1.63 1.50 1.63 1.50 XXX
93744 A Analyze ht pace device dual 1.18 1.37 1.19 NA NA 0.08 2.63 2.45 NA NA XXX
93744 TC A Analyze ht pace device dual 0.00 0.72 0.68 NA NA 0.04 0.76 0.72 NA NA XXX
93744 26 A Analyze ht pace device dual 1.18 0.65 0.51 0.65 0.51 0.04 1.87 1.73 1.87 1.73 XXX
93745 C Set-up cardiovert-defibrill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93745 TC C Set-up cardiovert-defibrill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93745 26 C Set-up cardiovert-defibrill 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93760 N Cephalic thermogram 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93762 N Peripheral thermogram 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93770 B Measure venous pressure 0.16 0.04 0.07 NA NA 0.02 0.22 0.25 NA NA XXX
93770 TC B Measure venous pressure 0.00 0.00 0.02 NA NA 0.01 0.01 0.03 NA NA XXX
93770 26 B Measure venous pressure 0.16 0.04 0.05 0.04 0.05 0.01 0.21 0.22 0.21 0.22 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93784 A Ambulatory BP monitoring 0.38 1.54 1.54 NA NA 0.03 1.95 1.95 NA NA XXX
93786 A Ambulatory BP recording 0.00 0.88 0.90 NA NA 0.01 0.89 0.91 NA NA XXX
93788 A Ambulatory BP analysis 0.00 0.52 0.51 NA NA 0.01 0.53 0.52 NA NA XXX
93790 A Review/report BP recording 0.38 0.14 0.13 0.14 0.13 0.01 0.53 0.52 0.53 0.52 XXX
93797 A Cardiac rehab 0.18 0.32 0.31 0.09 0.08 0.01 0.51 0.50 0.28 0.27 000
93798 A Cardiac rehab/monitor 0.28 0.44 0.46 0.13 0.12 0.01 0.73 0.75 0.42 0.41 000
93799 C Cardiovascular procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93799 TC C Cardiovascular procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93799 26 C Cardiovascular procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
93875 A Extracranial study 0.22 2.50 2.38 NA NA 0.12 2.84 2.72 NA NA XXX
93875 TC A Extracranial study 0.00 2.43 2.30 NA NA 0.11 2.54 2.41 NA NA XXX
93875 26 A Extracranial study 0.22 0.07 0.08 0.07 0.08 0.01 0.30 0.31 0.30 0.31 XXX
93880 A Extracranial study 0.60 6.01 5.67 NA NA 0.39 7.00 6.66 NA NA XXX
93880 TC A Extracranial study 0.00 5.81 5.47 NA NA 0.35 6.16 5.82 NA NA XXX
93880 26 A Extracranial study 0.60 0.20 0.20 0.20 0.20 0.04 0.84 0.84 0.84 0.84 XXX
93882 A Extracranial study 0.40 4.04 3.63 NA NA 0.26 4.70 4.29 NA NA XXX
93882 TC A Extracranial study 0.00 3.93 3.50 NA NA 0.22 4.15 3.72 NA NA XXX
93882 26 A Extracranial study 0.40 0.11 0.13 0.11 0.13 0.04 0.55 0.57 0.55 0.57 XXX
93886 A Intracranial study 0.94 6.83 6.77 NA NA 0.45 8.22 8.16 NA NA XXX
93886 TC A Intracranial study 0.00 6.55 6.42 NA NA 0.39 6.94 6.81 NA NA XXX
93886 26 A Intracranial study 0.94 0.28 0.35 0.28 0.35 0.06 1.28 1.35 1.28 1.35 XXX
93888 A Intracranial study 0.62 4.73 4.36 NA NA 0.32 5.67 5.30 NA NA XXX
93888 TC A Intracranial study 0.00 4.54 4.14 NA NA 0.27 4.81 4.41 NA NA XXX
93888 26 A Intracranial study 0.62 0.19 0.22 0.19 0.22 0.05 0.86 0.89 0.86 0.89 XXX
93890 A Tcd, vasoreactivity study 1.00 6.08 5.20 NA NA 0.45 7.53 6.65 NA NA XXX
93890 TC A Tcd, vasoreactivity study 0.00 5.78 4.82 NA NA 0.39 6.17 5.21 NA NA XXX
93890 26 A Tcd, vasoreactivity study 1.00 0.30 0.38 0.30 0.38 0.06 1.36 1.44 1.36 1.44 XXX
93892 A Tcd, emboli detect w/o inj 1.15 6.59 5.52 NA NA 0.45 8.19 7.12 NA NA XXX
93892 TC A Tcd, emboli detect w/o inj 0.00 6.25 5.09 NA NA 0.39 6.64 5.48 NA NA XXX
93892 26 A Tcd, emboli detect w/o inj 1.15 0.34 0.43 0.34 0.43 0.06 1.55 1.64 1.55 1.64 XXX
93893 A Tcd, emboli detect w/inj 1.15 6.28 5.34 NA NA 0.45 7.88 6.94 NA NA XXX
93893 TC A Tcd, emboli detect w/inj 0.00 5.94 4.91 NA NA 0.39 6.33 5.30 NA NA XXX
93893 26 A Tcd, emboli detect w/inj 1.15 0.34 0.43 0.34 0.43 0.06 1.55 1.64 1.55 1.64 XXX
93922 A Extremity study 0.25 3.07 2.78 NA NA 0.15 3.47 3.18 NA NA XXX
93922 TC A Extremity study 0.00 2.99 2.70 NA NA 0.13 3.12 2.83 NA NA XXX
93922 26 A Extremity study 0.25 0.08 0.08 0.08 0.08 0.02 0.35 0.35 0.35 0.35 XXX
93923 A Extremity study 0.45 4.60 4.18 NA NA 0.26 5.31 4.89 NA NA XXX
93923 TC A Extremity study 0.00 4.47 4.03 NA NA 0.22 4.69 4.25 NA NA XXX
93923 26 A Extremity study 0.45 0.13 0.15 0.13 0.15 0.04 0.62 0.64 0.62 0.64 XXX
93924 A Extremity study 0.50 5.81 5.05 NA NA 0.30 6.61 5.85 NA NA XXX
93924 TC A Extremity study 0.00 5.65 4.88 NA NA 0.25 5.90 5.13 NA NA XXX
93924 26 A Extremity study 0.50 0.16 0.17 0.16 0.17 0.05 0.71 0.72 0.71 0.72 XXX
93925 A Lower extremity study 0.58 7.82 7.05 NA NA 0.39 8.79 8.02 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
93925 TC A Lower extremity study 0.00 7.64 6.85 NA NA 0.35 7.99 7.20 NA NA XXX
93925 26 A Lower extremity study 0.58 0.18 0.20 0.18 0.20 0.04 0.80 0.82 0.80 0.82 XXX
93926 A Lower extremity study 0.39 5.05 4.31 NA NA 0.27 5.71 4.97 NA NA XXX
93926 TC A Lower extremity study 0.00 4.94 4.18 NA NA 0.23 5.17 4.41 NA NA XXX
93926 26 A Lower extremity study 0.39 0.11 0.13 0.11 0.13 0.04 0.54 0.56 0.54 0.56 XXX
93930 A Upper extremity study 0.46 6.09 5.54 NA NA 0.41 6.96 6.41 NA NA XXX
93930 TC A Upper extremity study 0.00 5.95 5.38 NA NA 0.37 6.32 5.75 NA NA XXX
93930 26 A Upper extremity study 0.46 0.14 0.16 0.14 0.16 0.04 0.64 0.66 0.64 0.66 XXX
93931 A Upper extremity study 0.31 4.11 3.64 NA NA 0.27 4.69 4.22 NA NA XXX
93931 TC A Upper extremity study 0.00 4.02 3.54 NA NA 0.24 4.26 3.78 NA NA XXX
93931 26 A Upper extremity study 0.31 0.09 0.10 0.09 0.10 0.03 0.43 0.44 0.43 0.44 XXX
93965 A Extremity study 0.35 2.94 2.83 NA NA 0.14 3.43 3.32 NA NA XXX
93965 TC A Extremity study 0.00 2.84 2.71 NA NA 0.12 2.96 2.83 NA NA XXX
93965 26 A Extremity study 0.35 0.10 0.12 0.10 0.12 0.02 0.47 0.49 0.47 0.49 XXX
93970 A Extremity study 0.68 6.00 5.44 NA NA 0.46 7.14 6.58 NA NA XXX
93970 TC A Extremity study 0.00 5.81 5.22 NA NA 0.40 6.21 5.62 NA NA XXX
93970 26 A Extremity study 0.68 0.19 0.22 0.19 0.22 0.06 0.93 0.96 0.93 0.96 XXX
93971 A Extremity study 0.45 3.90 3.67 NA NA 0.30 4.65 4.42 NA NA XXX
93971 TC A Extremity study 0.00 3.77 3.52 NA NA 0.27 4.04 3.79 NA NA XXX
93971 26 A Extremity study 0.45 0.13 0.15 0.13 0.15 0.03 0.61 0.63 0.61 0.63 XXX
93975 A Vascular study 1.80 8.23 7.78 NA NA 0.56 10.59 10.14 NA NA XXX
93975 TC A Vascular study 0.00 7.64 7.18 NA NA 0.43 8.07 7.61 NA NA XXX
93975 26 A Vascular study 1.80 0.59 0.60 0.59 0.60 0.13 2.52 2.53 2.52 2.53 XXX
93976 A Vascular study 1.21 4.33 4.33 NA NA 0.35 5.89 5.89 NA NA XXX
93976 TC A Vascular study 0.00 3.97 3.94 NA NA 0.30 4.27 4.24 NA NA XXX
93976 26 A Vascular study 1.21 0.36 0.39 0.36 0.39 0.05 1.62 1.65 1.62 1.65 XXX
93978 A Vascular study 0.65 5.84 4.85 NA NA 0.43 6.92 5.93 NA NA XXX
93978 TC A Vascular study 0.00 5.63 4.63 NA NA 0.37 6.00 5.00 NA NA XXX
93978 26 A Vascular study 0.65 0.21 0.22 0.21 0.22 0.06 0.92 0.93 0.92 0.93 XXX
93979 A Vascular study 0.44 4.23 3.46 NA NA 0.27 4.94 4.17 NA NA XXX
93979 TC A Vascular study 0.00 4.07 3.31 NA NA 0.24 4.31 3.55 NA NA XXX
93979 26 A Vascular study 0.44 0.16 0.15 0.16 0.15 0.03 0.63 0.62 0.63 0.62 XXX
93980 A Penile vascular study 1.25 3.50 3.02 NA NA 0.42 5.17 4.69 NA NA XXX
93980 TC A Penile vascular study 0.00 3.03 2.59 NA NA 0.34 3.37 2.93 NA NA XXX
93980 26 A Penile vascular study 1.25 0.47 0.43 0.47 0.43 0.08 1.80 1.76 1.80 1.76 XXX
93981 A Penile vascular study 0.44 2.75 2.85 NA NA 0.33 3.52 3.62 NA NA XXX
93981 TC A Penile vascular study 0.00 2.59 2.70 NA NA 0.31 2.90 3.01 NA NA XXX
93981 26 A Penile vascular study 0.44 0.16 0.15 0.16 0.15 0.02 0.62 0.61 0.62 0.61 XXX
93990 A Doppler flow testing 0.25 5.16 4.28 NA NA 0.26 5.67 4.79 NA NA XXX
93990 TC A Doppler flow testing 0.00 5.10 4.20 NA NA 0.23 5.33 4.43 NA NA XXX
93990 26 A Doppler flow testing 0.25 0.06 0.08 0.06 0.08 0.03 0.34 0.36 0.34 0.36 XXX
94002 A Vent mgmt inpat, init day 1.99 NA NA 0.39 0.34 0.09 NA NA 2.47 2.42 XXX
94003 A Vent mgmt inpat, subq day 1.37 NA NA 0.33 0.33 0.06 NA NA 1.76 1.76 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
94004 A Vent mgmt nf per day 1.00 NA NA 0.24 0.24 0.04 NA NA 1.28 1.28 XXX
94005 B Home vent mgmt supervision 1.50 0.69 0.69 NA NA 0.06 2.25 2.25 NA NA XXX
94010 A Breathing capacity test 0.17 0.73 0.69 NA NA 0.03 0.93 0.89 NA NA XXX
94010 TC A Breathing capacity test 0.00 0.69 0.64 NA NA 0.02 0.71 0.66 NA NA XXX
94010 26 A Breathing capacity test 0.17 0.04 0.05 0.04 0.05 0.01 0.22 0.23 0.22 0.23 XXX
94014 A Patient recorded spirometry 0.52 0.82 0.77 NA NA 0.03 1.37 1.32 NA NA XXX
94015 A Patient recorded spirometry 0.00 0.68 0.61 NA NA 0.01 0.69 0.62 NA NA XXX
94016 A Review patient spirometry 0.52 0.14 0.16 0.14 0.16 0.02 0.68 0.70 0.68 0.70 XXX
94060 A Evaluation of wheezing 0.31 1.31 1.13 1.31 1.13 0.07 1.69 1.51 1.69 1.51 XXX
94060 TC A Evaluation of wheezing 0.00 1.23 1.04 1.23 1.04 0.06 1.29 1.10 1.29 1.10 XXX
94060 26 A Evaluation of wheezing 0.31 0.08 0.09 0.08 0.09 0.01 0.40 0.41 0.40 0.41 XXX
94070 A Evaluation of wheezing 0.60 0.99 0.86 NA NA 0.13 1.72 1.59 NA NA XXX
94070 TC A Evaluation of wheezing 0.00 0.84 0.69 NA NA 0.10 0.94 0.79 NA NA XXX
94070 26 A Evaluation of wheezing 0.60 0.15 0.17 0.15 0.17 0.03 0.78 0.80 0.78 0.80 XXX
94150 B Vital capacity test 0.07 0.48 0.48 NA NA 0.02 0.57 0.57 NA NA XXX
94150 TC B Vital capacity test 0.00 0.46 0.45 NA NA 0.01 0.47 0.46 NA NA XXX
94150 26 B Vital capacity test 0.07 0.02 0.03 0.02 0.03 0.01 0.10 0.11 0.10 0.11 XXX
94200 A Lung function test (MBC/MVV) 0.11 0.48 0.45 NA NA 0.03 0.62 0.59 NA NA XXX
94200 TC A Lung function test (MBC/MVV) 0.00 0.45 0.42 NA NA 0.02 0.47 0.44 NA NA XXX
94200 26 A Lung function test (MBC/MVV) 0.11 0.03 0.03 0.03 0.03 0.01 0.15 0.15 0.15 0.15 XXX
94240 A Residual lung capacity 0.26 0.81 0.70 NA NA 0.06 1.13 1.02 NA NA XXX
94240 TC A Residual lung capacity 0.00 0.75 0.62 NA NA 0.05 0.80 0.67 NA NA XXX
94240 26 A Residual lung capacity 0.26 0.06 0.08 0.06 0.08 0.01 0.33 0.35 0.33 0.35 XXX
94250 A Expired gas collection 0.11 0.51 0.61 NA NA 0.02 0.64 0.74 NA NA XXX
94250 TC A Expired gas collection 0.00 0.48 0.58 NA NA 0.01 0.49 0.59 NA NA XXX
94250 26 A Expired gas collection 0.11 0.03 0.03 0.03 0.03 0.01 0.15 0.15 0.15 0.15 XXX
94260 A Thoracic gas volume 0.13 0.76 0.63 NA NA 0.05 0.94 0.81 NA NA XXX
94260 TC A Thoracic gas volume 0.00 0.73 0.59 NA NA 0.04 0.77 0.63 NA NA XXX
94260 26 A Thoracic gas volume 0.13 0.03 0.04 0.03 0.04 0.01 0.17 0.18 0.17 0.18 XXX
94350 A Lung nitrogen washout curve 0.26 0.62 0.73 NA NA 0.05 0.93 1.04 NA NA XXX
94350 TC A Lung nitrogen washout curve 0.00 0.55 0.65 NA NA 0.04 0.59 0.69 NA NA XXX
94350 26 A Lung nitrogen washout curve 0.26 0.07 0.08 0.07 0.08 0.01 0.34 0.35 0.34 0.35 XXX
94360 A Measure airflow resistance 0.26 0.95 0.77 NA NA 0.07 1.28 1.10 NA NA XXX
94360 TC A Measure airflow resistance 0.00 0.89 0.69 NA NA 0.06 0.95 0.75 NA NA XXX
94360 26 A Measure airflow resistance 0.26 0.06 0.08 0.06 0.08 0.01 0.33 0.35 0.33 0.35 XXX
94370 A Breath airway closing volume 0.26 0.59 0.69 NA NA 0.03 0.88 0.98 NA NA XXX
94370 TC A Breath airway closing volume 0.00 0.52 0.61 NA NA 0.02 0.54 0.63 NA NA XXX
94370 26 A Breath airway closing volume 0.26 0.07 0.08 0.07 0.08 0.01 0.34 0.35 0.34 0.35 XXX
94375 A Respiratory flow volume loop 0.31 0.72 0.63 NA NA 0.03 1.06 0.97 NA NA XXX
94375 TC A Respiratory flow volume loop 0.00 0.64 0.54 NA NA 0.02 0.66 0.56 NA NA XXX
94375 26 A Respiratory flow volume loop 0.31 0.08 0.09 0.08 0.09 0.01 0.40 0.41 0.40 0.41 XXX
94400 A CO2 breathing response curve 0.40 1.02 0.89 NA NA 0.09 1.51 1.38 NA NA XXX
94400 TC A CO2 breathing response curve 0.00 0.92 0.77 NA NA 0.06 0.98 0.83 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
94400 26 A CO2 breathing response curve 0.40 0.10 0.12 0.10 0.12 0.03 0.53 0.55 0.53 0.55 XXX
94450 A Hypoxia response curve 0.40 1.03 0.89 NA NA 0.04 1.47 1.33 NA NA XXX
94450 TC A Hypoxia response curve 0.00 0.94 0.78 NA NA 0.02 0.96 0.80 NA NA XXX
94450 26 A Hypoxia response curve 0.40 0.09 0.11 0.09 0.11 0.02 0.51 0.53 0.51 0.53 XXX
94452 A Hast w/report 0.31 1.13 1.05 NA NA 0.04 1.48 1.40 NA NA XXX
94452 TC A Hast w/report 0.00 1.05 0.96 NA NA 0.02 1.07 0.98 NA NA XXX
94452 26 A Hast w/report 0.31 0.08 0.09 0.08 0.09 0.02 0.41 0.42 0.41 0.42 XXX
94453 A Hast w/oxygen titrate 0.40 1.58 1.53 NA NA 0.04 2.02 1.97 NA NA XXX
94453 TC A Hast w/oxygen titrate 0.00 1.48 1.41 NA NA 0.02 1.50 1.43 NA NA XXX
94453 26 A Hast w/oxygen titrate 0.40 0.10 0.12 0.10 0.12 0.02 0.52 0.54 0.52 0.54 XXX
94610 A Surfactant admin thru tube 1.16 0.35 0.35 0.35 0.35 0.26 1.77 1.77 1.77 1.77 XXX
94620 A Pulmonary stress test/simple 0.64 0.79 2.06 NA NA 0.13 1.56 2.83 NA NA XXX
94620 TC A Pulmonary stress test/simple 0.00 0.62 1.87 NA NA 0.10 0.72 1.97 NA NA XXX
94620 26 A Pulmonary stress test/simple 0.64 0.17 0.19 0.17 0.19 0.03 0.84 0.86 0.84 0.86 XXX
94621 A Pulm stress test/complex 1.42 3.17 2.45 NA NA 0.16 4.75 4.03 NA NA XXX
94621 TC A Pulm stress test/complex 0.00 2.71 2.00 NA NA 0.10 2.81 2.10 NA NA XXX
94621 26 A Pulm stress test/complex 1.42 0.46 0.45 0.46 0.45 0.06 1.94 1.93 1.94 1.93 XXX
94640 A Airway inhalation treatment 0.00 0.36 0.32 NA NA 0.02 0.38 0.34 NA NA XXX
94642 C Aerosol inhalation treatment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94644 A Cbt, 1st hour 0.00 0.92 0.92 NA NA 0.02 0.94 0.94 NA NA XXX
94645 A Cbt, each addl hour 0.00 0.34 0.34 NA NA 0.02 0.36 0.36 NA NA XXX
94660 A Pos airway pressure, CPAP 0.76 0.82 0.69 0.20 0.22 0.04 1.62 1.49 1.00 1.02 XXX
94662 A Neg press ventilation, cnp 0.76 NA NA 0.19 0.22 0.03 NA NA 0.98 1.01 XXX
94664 A Evaluate pt use of inhaler 0.00 0.40 0.33 NA NA 0.04 0.44 0.37 NA NA XXX
94667 A Chest wall manipulation 0.00 0.54 0.53 NA NA 0.05 0.59 0.58 NA NA XXX
94668 A Chest wall manipulation 0.00 0.50 0.46 NA NA 0.02 0.52 0.48 NA NA XXX
94680 A Exhaled air analysis, o2 0.26 1.10 1.67 1.10 1.67 0.07 1.43 2.00 1.43 2.00 XXX
94680 TC A Exhaled air analysis, o2 0.00 1.03 1.59 1.03 1.59 0.06 1.09 1.65 1.09 1.65 XXX
94680 26 A Exhaled air analysis, o2 0.26 0.07 0.08 0.07 0.08 0.01 0.34 0.35 0.34 0.35 XXX
94681 A Exhaled air analysis, o2/co2 0.20 1.06 2.16 NA NA 0.13 1.39 2.49 NA NA XXX
94681 TC A Exhaled air analysis, o2/co2 0.00 1.01 2.10 NA NA 0.12 1.13 2.22 NA NA XXX
94681 26 A Exhaled air analysis, o2/co2 0.20 0.05 0.06 0.05 0.06 0.01 0.26 0.27 0.26 0.27 XXX
94690 A Exhaled air analysis 0.07 1.04 1.75 NA NA 0.05 1.16 1.87 NA NA XXX
94690 TC A Exhaled air analysis 0.00 1.02 1.73 NA NA 0.04 1.06 1.77 NA NA XXX
94690 26 A Exhaled air analysis 0.07 0.02 0.02 0.02 0.02 0.01 0.10 0.10 0.10 0.10 XXX
94720 A Monoxide diffusing capacity 0.26 1.15 1.04 NA NA 0.07 1.48 1.37 NA NA XXX
94720 TC A Monoxide diffusing capacity 0.00 1.09 0.96 NA NA 0.06 1.15 1.02 NA NA XXX
94720 26 A Monoxide diffusing capacity 0.26 0.06 0.08 0.06 0.08 0.01 0.33 0.35 0.33 0.35 XXX
94725 A Membrane diffusion capacity 0.26 0.96 2.43 NA NA 0.13 1.35 2.82 NA NA XXX
94725 TC A Membrane diffusion capacity 0.00 0.89 2.35 NA NA 0.12 1.01 2.47 NA NA XXX
94725 26 A Membrane diffusion capacity 0.26 0.07 0.08 0.07 0.08 0.01 0.34 0.35 0.34 0.35 XXX
94750 A Pulmonary compliance study 0.23 1.69 1.43 NA NA 0.05 1.97 1.71 NA NA XXX
94750 TC A Pulmonary compliance study 0.00 1.63 1.36 NA NA 0.04 1.67 1.40 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
94750 26 A Pulmonary compliance study 0.23 0.06 0.07 0.06 0.07 0.01 0.30 0.31 0.30 0.31 XXX
94760 T Measure blood oxygen level 0.00 0.06 0.05 NA NA 0.02 0.08 0.07 NA NA XXX
94761 T Measure blood oxygen level 0.00 0.11 0.08 NA NA 0.06 0.17 0.14 NA NA XXX
94762 A Measure blood oxygen level 0.00 0.84 0.56 NA NA 0.10 0.94 0.66 NA NA XXX
94770 A Exhaled carbon dioxide test 0.15 0.77 0.76 NA NA 0.08 1.00 0.99 NA NA XXX
94770 TC A Exhaled carbon dioxide test 0.00 0.74 0.72 NA NA 0.07 0.81 0.79 NA NA XXX
94770 26 A Exhaled carbon dioxide test 0.15 0.03 0.04 0.03 0.04 0.01 0.19 0.20 0.19 0.20 XXX
94772 C Breath recording, infant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94772 TC C Breath recording, infant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94772 26 C Breath recording, infant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94774 C Ped home apnea rec, compl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94775 C Ped home apnea rec, hk-up 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94776 C Ped home apnea rec, downld 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94777 C Ped home apnea rec, report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94799 C Pulmonary service/procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94799 TC C Pulmonary service/procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
94799 26 C Pulmonary service/procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95004 A Percut allergy skin tests 0.00 0.16 0.12 NA NA 0.01 0.17 0.13 NA NA XXX
95010 A Percut allergy titrate test 0.15 0.29 0.31 0.04 0.06 0.01 0.45 0.47 0.20 0.22 XXX
95012 A Exhaled nitric oxide meas 0.00 0.48 0.48 NA NA 0.01 0.49 0.49 NA NA XXX
95015 A Id allergy titrate-drug/bug 0.15 0.20 0.16 0.04 0.06 0.01 0.36 0.32 0.20 0.22 XXX
95024 A Id allergy test, drug/bug 0.00 0.21 0.17 NA NA 0.01 0.22 0.18 NA NA XXX
95027 A Id allergy titrate-airborne 0.00 0.24 0.17 NA NA 0.01 0.25 0.18 NA NA XXX
95028 A Id allergy test-delayed type 0.00 0.29 0.25 NA NA 0.01 0.30 0.26 NA NA XXX
95044 A Allergy patch tests 0.00 0.15 0.19 NA NA 0.01 0.16 0.20 NA NA XXX
95052 A Photo patch test 0.00 0.15 0.23 NA NA 0.01 0.16 0.24 NA NA XXX
95056 A Photosensitivity tests 0.00 1.21 0.43 NA NA 0.01 1.22 0.44 NA NA XXX
95060 A Eye allergy tests 0.00 NA NA 0.00 0.35 0.02 NA NA 0.02 0.37 XXX
95065 A Nose allergy test 0.00 NA NA 0.00 0.20 0.01 NA NA 0.01 0.21 XXX
95070 A Bronchial allergy tests 0.00 0.79 1.91 NA NA 0.02 0.81 1.93 NA NA XXX
95071 A Bronchial allergy tests 0.00 0.88 2.41 NA NA 0.02 0.90 2.43 NA NA XXX
95075 A Ingestion challenge test 0.95 0.67 0.78 0.26 0.35 0.03 1.65 1.76 1.24 1.33 XXX
95115 A Immunotherapy, one injection 0.00 0.22 0.35 0.00 0.29 0.02 0.24 0.37 0.02 0.31 XXX
95117 A Immunotherapy injections 0.00 0.27 0.44 0.00 0.38 0.02 0.29 0.46 0.02 0.40 XXX
95120 I Immunotherapy, one injection 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95125 I Immunotherapy, many antigens 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95130 I Immunotherapy, insect venom 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95131 I Immunotherapy, insect venoms 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95132 I Immunotherapy, insect venoms 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95133 I Immunotherapy, insect venoms 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95134 I Immunotherapy, insect venoms 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95144 A Antigen therapy services 0.06 0.26 0.21 0.02 0.02 0.01 0.33 0.28 0.09 0.09 XXX
95145 A Antigen therapy services 0.06 0.34 0.33 0.02 0.02 0.01 0.41 0.40 0.09 0.09 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
95146 A Antigen therapy services 0.06 0.65 0.49 0.02 0.03 0.01 0.72 0.56 0.09 0.10 XXX
95147 A Antigen therapy services 0.06 0.64 0.48 0.02 0.02 0.01 0.71 0.55 0.09 0.09 XXX
95148 A Antigen therapy services 0.06 0.94 0.67 0.02 0.03 0.01 1.01 0.74 0.09 0.10 XXX
95149 A Antigen therapy services 0.06 1.25 0.91 0.02 0.03 0.01 1.32 0.98 0.09 0.10 XXX
95165 A Antigen therapy services 0.06 0.25 0.21 0.02 0.02 0.01 0.32 0.28 0.09 0.09 XXX
95170 A Antigen therapy services 0.06 0.19 0.15 0.02 0.03 0.01 0.26 0.22 0.09 0.10 XXX
95180 A Rapid desensitization 2.01 1.59 1.92 0.73 0.88 0.04 3.64 3.97 2.78 2.93 XXX
95199 C Allergy immunology services 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95250 A Glucose monitoring, cont 0.00 3.49 3.95 NA NA 0.01 3.50 3.96 NA NA XXX
95251 A Gluc monitor, cont, phys ir 0.85 0.27 0.21 0.27 0.21 0.02 1.14 1.08 1.14 1.08 XXX
95805 A Multiple sleep latency test 1.88 6.99 14.70 NA NA 0.43 9.30 17.01 NA NA XXX
95805 TC A Multiple sleep latency test 0.00 6.50 14.08 NA NA 0.34 6.84 14.42 NA NA XXX
95805 26 A Multiple sleep latency test 1.88 0.49 0.62 0.49 0.62 0.09 2.46 2.59 2.46 2.59 XXX
95806 A Sleep study, unattended 1.66 3.84 3.46 NA NA 0.39 5.89 5.51 NA NA XXX
95806 TC A Sleep study, unattended 0.00 3.36 2.93 NA NA 0.31 3.67 3.24 NA NA XXX
95806 26 A Sleep study, unattended 1.66 0.48 0.53 0.48 0.53 0.08 2.22 2.27 2.22 2.27 XXX
95807 A Sleep study, attended 1.66 11.72 11.82 NA NA 0.50 13.88 13.98 NA NA XXX
95807 TC A Sleep study, attended 0.00 11.29 11.31 NA NA 0.42 11.71 11.73 NA NA XXX
95807 26 A Sleep study, attended 1.66 0.43 0.51 0.43 0.51 0.08 2.17 2.25 2.17 2.25 XXX
95808 A Polysomnography, 1-3 2.65 15.55 13.79 NA NA 0.55 18.75 16.99 NA NA XXX
95808 TC A Polysomnography, 1-3 0.00 14.85 12.92 NA NA 0.42 15.27 13.34 NA NA XXX
95808 26 A Polysomnography, 1-3 2.65 0.70 0.87 0.70 0.87 0.13 3.48 3.65 3.48 3.65 XXX
95810 A Polysomnography, 4 or more 3.52 17.67 17.54 NA NA 0.59 21.78 21.65 NA NA XXX
95810 TC A Polysomnography, 4 or more 0.00 16.75 16.42 NA NA 0.42 17.17 16.84 NA NA XXX
95810 26 A Polysomnography, 4 or more 3.52 0.92 1.12 0.92 1.12 0.17 4.61 4.81 4.61 4.81 XXX
95811 A Polysomnography w/cpap 3.79 19.70 19.32 NA NA 0.61 24.10 23.72 NA NA XXX
95811 TC A Polysomnography w/cpap 0.00 18.72 18.12 NA NA 0.43 19.15 18.55 NA NA XXX
95811 26 A Polysomnography w/cpap 3.79 0.98 1.20 0.98 1.20 0.18 4.95 5.17 4.95 5.17 XXX
95812 A Eeg, 41-60 minutes 1.08 5.85 4.49 NA NA 0.17 7.10 5.74 NA NA XXX
95812 TC A Eeg, 41-60 minutes 0.00 5.54 4.07 NA NA 0.11 5.65 4.18 NA NA XXX
95812 26 A Eeg, 41-60 minutes 1.08 0.31 0.42 0.31 0.42 0.06 1.45 1.56 1.45 1.56 XXX
95813 A Eeg, over 1 hour 1.73 6.53 5.40 NA NA 0.20 8.46 7.33 NA NA XXX
95813 TC A Eeg, over 1 hour 0.00 6.03 4.75 NA NA 0.11 6.14 4.86 NA NA XXX
95813 26 A Eeg, over 1 hour 1.73 0.50 0.65 0.50 0.65 0.09 2.32 2.47 2.32 2.47 XXX
95816 A Eeg, awake and drowsy 1.08 5.26 4.10 NA NA 0.16 6.50 5.34 NA NA XXX
95816 TC A Eeg, awake and drowsy 0.00 4.95 3.68 NA NA 0.10 5.05 3.78 NA NA XXX
95816 26 A Eeg, awake and drowsy 1.08 0.31 0.42 0.31 0.42 0.06 1.45 1.56 1.45 1.56 XXX
95819 A Eeg, awake and asleep 1.08 6.10 3.76 NA NA 0.16 7.34 5.00 NA NA XXX
95819 TC A Eeg, awake and asleep 0.00 5.79 3.34 NA NA 0.10 5.89 3.44 NA NA XXX
95819 26 A Eeg, awake and asleep 1.08 0.31 0.42 0.31 0.42 0.06 1.45 1.56 1.45 1.56 XXX
95822 A Eeg, coma or sleep only 1.08 5.49 4.82 NA NA 0.19 6.76 6.09 NA NA XXX
95822 TC A Eeg, coma or sleep only 0.00 5.18 4.40 NA NA 0.13 5.31 4.53 NA NA XXX
95822 26 A Eeg, coma or sleep only 1.08 0.31 0.42 0.31 0.42 0.06 1.45 1.56 1.45 1.56 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
95824 C Eeg, cerebral death only 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95824 TC C Eeg, cerebral death only 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95824 26 A Eeg, cerebral death only 0.74 0.22 0.29 0.22 0.29 0.04 1.00 1.07 1.00 1.07 XXX
95827 A Eeg, all night recording 1.08 11.46 4.89 NA NA 0.19 12.73 6.16 NA NA XXX
95827 TC A Eeg, all night recording 0.00 11.17 4.51 NA NA 0.14 11.31 4.65 NA NA XXX
95827 26 A Eeg, all night recording 1.08 0.29 0.38 0.29 0.38 0.05 1.42 1.51 1.42 1.51 XXX
95829 A Surgery electrocorticogram 6.20 25.25 29.56 NA NA 0.50 31.95 36.26 NA NA XXX
95829 TC A Surgery electrocorticogram 0.00 23.42 27.37 NA NA 0.02 23.44 27.39 NA NA XXX
95829 26 A Surgery electrocorticogram 6.20 1.83 2.19 1.83 2.19 0.48 8.51 8.87 8.51 8.87 XXX
95830 A Insert electrodes for EEG 1.70 2.98 3.21 0.43 0.66 0.11 4.79 5.02 2.24 2.47 XXX
95831 A Limb muscle testing, manual 0.28 0.38 0.44 0.09 0.12 0.01 0.67 0.73 0.38 0.41 XXX
95832 A Hand muscle testing, manual 0.29 0.36 0.34 0.10 0.12 0.02 0.67 0.65 0.41 0.43 XXX
95833 A Body muscle testing, manual 0.47 0.47 0.55 0.13 0.21 0.02 0.96 1.04 0.62 0.70 XXX
95834 A Body muscle testing, manual 0.60 0.54 0.61 0.18 0.26 0.03 1.17 1.24 0.81 0.89 XXX
95851 A Range of motion measurements 0.16 0.26 0.34 0.04 0.07 0.01 0.43 0.51 0.21 0.24 XXX
95852 A Range of motion measurements 0.11 0.21 0.25 0.03 0.05 0.01 0.33 0.37 0.15 0.17 XXX
95857 A Tensilon test 0.53 0.59 0.60 0.17 0.22 0.02 1.14 1.15 0.72 0.77 XXX
95860 A Muscle test, one limb 0.96 1.15 1.36 NA NA 0.07 2.18 2.39 NA NA XXX
95860 TC A Muscle test, one limb 0.00 0.83 0.96 NA NA 0.02 0.85 0.98 NA NA XXX
95860 26 A Muscle test, one limb 0.96 0.32 0.40 0.32 0.40 0.05 1.33 1.41 1.33 1.41 XXX
95861 A Muscle test, 2 limbs 1.54 1.67 1.48 NA NA 0.13 3.34 3.15 NA NA XXX
95861 TC A Muscle test, 2 limbs 0.00 1.15 0.84 NA NA 0.06 1.21 0.90 NA NA XXX
95861 26 A Muscle test, 2 limbs 1.54 0.52 0.64 0.52 0.64 0.07 2.13 2.25 2.13 2.25 XXX
95863 A Muscle test, 3 limbs 1.87 1.94 1.79 NA NA 0.15 3.96 3.81 NA NA XXX
95863 TC A Muscle test, 3 limbs 0.00 1.35 1.04 NA NA 0.06 1.41 1.10 NA NA XXX
95863 26 A Muscle test, 3 limbs 1.87 0.59 0.75 0.59 0.75 0.09 2.55 2.71 2.55 2.71 XXX
95864 A Muscle test, 4 limbs 1.99 2.19 2.53 NA NA 0.21 4.39 4.73 NA NA XXX
95864 TC A Muscle test, 4 limbs 0.00 1.55 1.72 NA NA 0.12 1.67 1.84 NA NA XXX
95864 26 A Muscle test, 4 limbs 1.99 0.64 0.81 0.64 0.81 0.09 2.72 2.89 2.72 2.89 XXX
95865 A Muscle test, larynx 1.57 1.35 1.43 NA NA 0.11 3.03 3.11 NA NA XXX
95865 TC A Muscle test, larynx 0.00 0.88 0.73 NA NA 0.03 0.91 0.76 NA NA XXX
95865 26 A Muscle test, larynx 1.57 0.47 0.70 0.47 0.70 0.08 2.12 2.35 2.12 2.35 XXX
95866 A Muscle test, hemidiaphragm 1.25 1.33 0.90 NA NA 0.10 2.68 2.25 NA NA XXX
95866 TC A Muscle test, hemidiaphragm 0.00 0.93 0.38 NA NA 0.03 0.96 0.41 NA NA XXX
95866 26 A Muscle test, hemidiaphragm 1.25 0.40 0.52 0.40 0.52 0.07 1.72 1.84 1.72 1.84 XXX
95867 A Muscle test cran nerv unilat 0.79 1.12 0.98 NA NA 0.07 1.98 1.84 NA NA XXX
95867 TC A Muscle test cran nerv unilat 0.00 0.88 0.66 NA NA 0.04 0.92 0.70 NA NA XXX
95867 26 A Muscle test cran nerv unilat 0.79 0.24 0.32 0.24 0.32 0.03 1.06 1.14 1.06 1.14 XXX
95868 A Muscle test cran nerve bilat 1.18 1.43 1.26 NA NA 0.10 2.71 2.54 NA NA XXX
95868 TC A Muscle test cran nerve bilat 0.00 1.07 0.79 NA NA 0.05 1.12 0.84 NA NA XXX
95868 26 A Muscle test cran nerve bilat 1.18 0.36 0.47 0.36 0.47 0.05 1.59 1.70 1.59 1.70 XXX
95869 A Muscle test, thor paraspinal 0.37 1.02 0.53 NA NA 0.04 1.43 0.94 NA NA XXX
95869 TC A Muscle test, thor paraspinal 0.00 0.90 0.38 NA NA 0.02 0.92 0.40 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
95869 26 A Muscle test, thor paraspinal 0.37 0.12 0.15 0.12 0.15 0.02 0.51 0.54 0.51 0.54 XXX
95870 A Muscle test, nonparaspinal 0.37 0.99 0.53 NA NA 0.04 1.40 0.94 NA NA XXX
95870 TC A Muscle test, nonparaspinal 0.00 0.87 0.38 NA NA 0.02 0.89 0.40 NA NA XXX
95870 26 A Muscle test, nonparaspinal 0.37 0.12 0.15 0.12 0.15 0.02 0.51 0.54 0.51 0.54 XXX
95872 A Muscle test, one fiber 2.88 1.72 1.35 NA NA 0.13 4.73 4.36 NA NA XXX
95872 TC A Muscle test, one fiber 0.00 0.77 0.64 NA NA 0.05 0.82 0.69 NA NA XXX
95872 26 A Muscle test, one fiber 2.88 0.95 0.71 0.95 0.71 0.08 3.91 3.67 3.91 3.67 XXX
95873 A Guide nerv destr, elec stim 0.37 0.94 0.51 0.94 0.51 0.04 1.35 0.92 1.35 0.92 ZZZ
95873 TC A Guide nerv destr, elec stim 0.00 0.82 0.36 0.82 0.36 0.02 0.84 0.38 0.84 0.38 ZZZ
95873 26 A Guide nerv destr, elec stim 0.37 0.12 0.15 0.12 0.15 0.02 0.51 0.54 0.51 0.54 ZZZ
95874 A Guide nerv destr, needle emg 0.37 0.95 0.52 0.95 0.52 0.04 1.36 0.93 1.36 0.93 ZZZ
95874 TC A Guide nerv destr, needle emg 0.00 0.83 0.36 0.83 0.36 0.02 0.85 0.38 0.85 0.38 ZZZ
95874 26 A Guide nerv destr, needle emg 0.37 0.12 0.16 0.12 0.16 0.02 0.51 0.55 0.51 0.55 ZZZ
95875 A Limb exercise test 1.10 1.31 1.41 NA NA 0.11 2.52 2.62 NA NA XXX
95875 TC A Limb exercise test 0.00 0.99 0.98 NA NA 0.06 1.05 1.04 NA NA XXX
95875 26 A Limb exercise test 1.10 0.32 0.43 0.32 0.43 0.05 1.47 1.58 1.47 1.58 XXX
95900 A Motor nerve conduction test 0.42 0.93 1.18 NA NA 0.04 1.39 1.64 NA NA XXX
95900 TC A Motor nerve conduction test 0.00 0.79 1.01 NA NA 0.02 0.81 1.03 NA NA XXX
95900 26 A Motor nerve conduction test 0.42 0.14 0.17 0.14 0.17 0.02 0.58 0.61 0.58 0.61 XXX
95903 A Motor nerve conduction test 0.60 1.02 1.15 NA NA 0.05 1.67 1.80 NA NA XXX
95903 TC A Motor nerve conduction test 0.00 0.84 0.91 NA NA 0.02 0.86 0.93 NA NA XXX
95903 26 A Motor nerve conduction test 0.60 0.18 0.24 0.18 0.24 0.03 0.81 0.87 0.81 0.87 XXX
95904 A Sense nerve conduction test 0.34 0.86 1.03 NA NA 0.04 1.24 1.41 NA NA XXX
95904 TC A Sense nerve conduction test 0.00 0.75 0.89 NA NA 0.02 0.77 0.91 NA NA XXX
95904 26 A Sense nerve conduction test 0.34 0.11 0.14 0.11 0.14 0.02 0.47 0.50 0.47 0.50 XXX
95920 A Intraop nerve test add-on 2.11 1.79 2.13 1.79 2.13 0.23 4.13 4.47 4.13 4.47 ZZZ
95920 TC A Intraop nerve test add-on 0.00 1.12 1.26 1.12 1.26 0.07 1.19 1.33 1.19 1.33 ZZZ
95920 26 A Intraop nerve test add-on 2.11 0.67 0.87 0.67 0.87 0.16 2.94 3.14 2.94 3.14 ZZZ
95921 A Autonomic nerv function test 0.90 1.12 0.82 NA NA 0.06 2.08 1.78 NA NA XXX
95921 TC A Autonomic nerv function test 0.00 0.88 0.51 NA NA 0.02 0.90 0.53 NA NA XXX
95921 26 A Autonomic nerv function test 0.90 0.24 0.31 0.24 0.31 0.04 1.18 1.25 1.18 1.25 XXX
95922 A Autonomic nerv function test 0.96 1.64 1.00 NA NA 0.07 2.67 2.03 NA NA XXX
95922 TC A Autonomic nerv function test 0.00 1.36 0.63 NA NA 0.02 1.38 0.65 NA NA XXX
95922 26 A Autonomic nerv function test 0.96 0.28 0.37 0.28 0.37 0.05 1.29 1.38 1.29 1.38 XXX
95923 A Autonomic nerv function test 0.90 2.11 1.99 NA NA 0.07 3.08 2.96 NA NA XXX
95923 TC A Autonomic nerv function test 0.00 1.87 1.64 NA NA 0.02 1.89 1.66 NA NA XXX
95923 26 A Autonomic nerv function test 0.90 0.24 0.35 0.24 0.35 0.05 1.19 1.30 1.19 1.30 XXX
95925 A Somatosensory testing 0.54 3.12 1.63 NA NA 0.10 3.76 2.27 NA NA XXX
95925 TC A Somatosensory testing 0.00 2.95 1.42 NA NA 0.06 3.01 1.48 NA NA XXX
95925 26 A Somatosensory testing 0.54 0.17 0.21 0.17 0.21 0.04 0.75 0.79 0.75 0.79 XXX
95926 A Somatosensory testing 0.54 2.95 1.59 NA NA 0.09 3.58 2.22 NA NA XXX
95926 TC A Somatosensory testing 0.00 2.79 1.38 NA NA 0.06 2.85 1.44 NA NA XXX
95926 26 A Somatosensory testing 0.54 0.16 0.21 0.16 0.21 0.03 0.73 0.78 0.73 0.78 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
95927 A Somatosensory testing 0.54 3.01 1.63 NA NA 0.10 3.65 2.27 NA NA XXX
95927 TC A Somatosensory testing 0.00 2.85 1.40 NA NA 0.06 2.91 1.46 NA NA XXX
95927 26 A Somatosensory testing 0.54 0.16 0.23 0.16 0.23 0.04 0.74 0.81 0.74 0.81 XXX
95928 A C motor evoked, uppr limbs 1.50 3.96 3.25 NA NA 0.09 5.55 4.84 NA NA XXX
95928 TC A C motor evoked, uppr limbs 0.00 3.50 2.65 NA NA 0.03 3.53 2.68 NA NA XXX
95928 26 A C motor evoked, uppr limbs 1.50 0.46 0.60 0.46 0.60 0.06 2.02 2.16 2.02 2.16 XXX
95929 A C motor evoked, lwr limbs 1.50 4.28 3.48 NA NA 0.09 5.87 5.07 NA NA XXX
95929 TC A C motor evoked, lwr limbs 0.00 3.81 2.87 NA NA 0.03 3.84 2.90 NA NA XXX
95929 26 A C motor evoked, lwr limbs 1.50 0.47 0.61 0.47 0.61 0.06 2.03 2.17 2.03 2.17 XXX
95930 A Visual evoked potential test 0.35 2.62 2.34 NA NA 0.03 3.00 2.72 NA NA XXX
95930 TC A Visual evoked potential test 0.00 2.52 2.20 NA NA 0.01 2.53 2.21 NA NA XXX
95930 26 A Visual evoked potential test 0.35 0.10 0.14 0.10 0.14 0.02 0.47 0.51 0.47 0.51 XXX
95933 A Blink reflex test 0.59 1.09 1.04 NA NA 0.10 1.78 1.73 NA NA XXX
95933 TC A Blink reflex test 0.00 0.92 0.82 NA NA 0.06 0.98 0.88 NA NA XXX
95933 26 A Blink reflex test 0.59 0.17 0.22 0.17 0.22 0.04 0.80 0.85 0.80 0.85 XXX
95934 A H-reflex test 0.51 0.88 0.55 NA NA 0.04 1.43 1.10 NA NA XXX
95934 TC A H-reflex test 0.00 0.72 0.34 NA NA 0.02 0.74 0.36 NA NA XXX
95934 26 A H-reflex test 0.51 0.16 0.21 0.16 0.21 0.02 0.69 0.74 0.69 0.74 XXX
95936 A H-reflex test 0.55 0.60 0.49 NA NA 0.05 1.20 1.09 NA NA XXX
95936 TC A H-reflex test 0.00 0.43 0.27 NA NA 0.02 0.45 0.29 NA NA XXX
95936 26 A H-reflex test 0.55 0.17 0.22 0.17 0.22 0.03 0.75 0.80 0.75 0.80 XXX
95937 A Neuromuscular junction test 0.65 0.91 0.68 NA NA 0.10 1.66 1.43 NA NA XXX
95937 TC A Neuromuscular junction test 0.00 0.71 0.43 NA NA 0.02 0.73 0.45 NA NA XXX
95937 26 A Neuromuscular junction test 0.65 0.20 0.25 0.20 0.25 0.08 0.93 0.98 0.93 0.98 XXX
95950 A Ambulatory eeg monitoring 1.51 4.91 4.18 NA NA 0.51 6.93 6.20 NA NA XXX
95950 TC A Ambulatory eeg monitoring 0.00 4.48 3.59 NA NA 0.43 4.91 4.02 NA NA XXX
95950 26 A Ambulatory eeg monitoring 1.51 0.43 0.59 0.43 0.59 0.08 2.02 2.18 2.02 2.18 XXX
95951 C EEG monitoring/videorecord 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95951 TC C EEG monitoring/videorecord 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95951 26 A EEG monitoring/videorecord 5.99 1.72 2.34 1.72 2.34 0.32 8.03 8.65 8.03 8.65 XXX
95953 A EEG monitoring/computer 3.30 7.18 7.52 NA NA 0.60 11.08 11.42 NA NA XXX
95953 TC A EEG monitoring/computer 0.00 6.23 6.31 NA NA 0.43 6.66 6.74 NA NA XXX
95953 26 A EEG monitoring/computer 3.30 0.95 1.21 0.95 1.21 0.17 4.42 4.68 4.42 4.68 XXX
95954 A EEG monitoring/giving drugs 2.45 4.86 4.38 NA NA 0.19 7.50 7.02 NA NA XXX
95954 TC A EEG monitoring/giving drugs 0.00 4.34 3.47 NA NA 0.06 4.40 3.53 NA NA XXX
95954 26 A EEG monitoring/giving drugs 2.45 0.52 0.91 0.52 0.91 0.13 3.10 3.49 3.10 3.49 XXX
95955 A EEG during surgery 1.01 2.78 2.43 2.78 2.43 0.22 4.01 3.66 4.01 3.66 XXX
95955 TC A EEG during surgery 0.00 2.49 2.09 2.49 2.09 0.17 2.66 2.26 2.66 2.26 XXX
95955 26 A EEG during surgery 1.01 0.29 0.34 0.29 0.34 0.05 1.35 1.40 1.35 1.40 XXX
95956 A Eeg monitoring, cable/radio 3.08 15.61 15.47 NA NA 0.59 19.28 19.14 NA NA XXX
95956 TC A Eeg monitoring, cable/radio 0.00 14.73 14.27 NA NA 0.43 15.16 14.70 NA NA XXX
95956 26 A Eeg monitoring, cable/radio 3.08 0.88 1.20 0.88 1.20 0.16 4.12 4.44 4.12 4.44 XXX
95957 A EEG digital analysis 1.98 5.82 3.37 NA NA 0.23 8.03 5.58 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
95957 TC A EEG digital analysis 0.00 5.26 2.59 NA NA 0.12 5.38 2.71 NA NA XXX
95957 26 A EEG digital analysis 1.98 0.56 0.78 0.56 0.78 0.11 2.65 2.87 2.65 2.87 XXX
95958 A EEG monitoring/function test 4.24 6.54 4.25 NA NA 0.34 11.12 8.83 NA NA XXX
95958 TC A EEG monitoring/function test 0.00 5.34 2.64 NA NA 0.13 5.47 2.77 NA NA XXX
95958 26 A EEG monitoring/function test 4.24 1.20 1.61 1.20 1.61 0.21 5.65 6.06 5.65 6.06 XXX
95961 A Electrode stimulation, brain 2.97 3.12 2.75 NA NA 0.55 6.64 6.27 NA NA XXX
95961 TC A Electrode stimulation, brain 0.00 2.20 1.53 NA NA 0.07 2.27 1.60 NA NA XXX
95961 26 A Electrode stimulation, brain 2.97 0.92 1.22 0.92 1.22 0.48 4.37 4.67 4.37 4.67 XXX
95962 A Electrode stim, brain add-on 3.21 2.22 2.59 2.22 2.59 0.39 5.82 6.19 5.82 6.19 ZZZ
95962 TC A Electrode stim, brain add-on 0.00 1.29 1.31 1.29 1.31 0.07 1.36 1.38 1.36 1.38 ZZZ
95962 26 A Electrode stim, brain add-on 3.21 0.93 1.28 0.93 1.28 0.32 4.46 4.81 4.46 4.81 ZZZ
95965 C Meg, spontaneous 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95965 TC C Meg, spontaneous 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95965 26 A Meg, spontaneous 7.99 2.30 3.14 2.30 3.14 0.46 10.75 11.59 10.75 11.59 XXX
95966 C Meg, evoked, single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95966 TC C Meg, evoked, single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
95966 26 A Meg, evoked, single 3.99 1.15 1.57 1.15 1.57 0.19 5.33 5.75 5.33 5.75 XXX
95967 C Meg, evoked, each addÆl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
95967 TC C Meg, evoked, each addÆl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
95967 26 A Meg, evoked, each addÆl 3.49 0.99 1.13 0.99 1.13 0.16 4.64 4.78 4.64 4.78 ZZZ
95970 A Analyze neurostim, no prog 0.45 0.88 0.86 0.13 0.14 0.03 1.36 1.34 0.61 0.62 XXX
95971 A Analyze neurostim, simple 0.78 0.61 0.66 0.20 0.22 0.07 1.46 1.51 1.05 1.07 XXX
95972 A Analyze neurostim, complex 1.50 1.19 1.21 0.46 0.48 0.14 2.83 2.85 2.10 2.12 XXX
95973 A Analyze neurostim, complex 0.92 0.56 0.61 0.25 0.32 0.07 1.55 1.60 1.24 1.31 ZZZ
95974 A Cranial neurostim, complex 3.00 1.49 1.65 0.87 1.19 0.16 4.65 4.81 4.03 4.35 XXX
95975 A Cranial neurostim, complex 1.70 0.75 0.86 0.49 0.67 0.12 2.57 2.68 2.31 2.49 ZZZ
95978 A Analyze neurostim brain/1h 3.50 1.85 1.91 1.06 1.24 0.18 5.53 5.59 4.74 4.92 XXX
95979 A Analyz neurostim brain addon 1.64 0.74 0.84 0.48 0.64 0.08 2.46 2.56 2.20 2.36 ZZZ
95990 A Spin/brain pump refil main 0.00 1.62 1.53 NA NA 0.06 1.68 1.59 NA NA XXX
95991 A Spin/brain pump refil main 0.77 1.63 1.53 NA NA 0.06 2.46 2.36 NA NA XXX
95999 C Neurological procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
96000 A Motion analysis, video/3d 1.80 NA NA 0.58 0.54 0.11 NA NA 2.49 2.45 XXX
96001 A Motion test w/ft press meas 2.15 NA NA 0.54 0.63 0.10 NA NA 2.79 2.88 XXX
96002 A Dynamic surface emg 0.41 NA NA 0.11 0.14 0.02 NA NA 0.54 0.57 XXX
96003 A Dynamic fine wire emg 0.37 NA NA 0.14 0.13 0.02 NA NA 0.53 0.52 XXX
96004 A Phys review of motion tests 2.14 0.55 0.84 0.55 0.84 0.11 2.80 3.09 2.80 3.09 XXX
96020 C Functional brain mapping 0.00 NA NA NA NA 0.00 NA NA NA NA XXX
96020 TC C Functional brain mapping 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
96020 26 A Functional brain mapping 3.43 0.86 0.86 0.86 0.86 0.17 4.46 4.46 4.46 4.46 XXX
96040 B Genetic counseling, 30 min 0.00 0.97 0.97 NA NA 0.01 0.98 0.98 NA NA XXX
96101 A Psycho testing by psych/phys 1.86 0.35 0.58 0.33 0.56 0.05 2.26 2.49 2.24 2.47 XXX
96102 A Psycho testing by technician 0.50 1.20 0.80 0.09 0.15 0.01 1.71 1.31 0.60 0.66 XXX
96103 A Psycho testing admin by comp 0.51 1.31 0.49 0.09 0.15 0.02 1.84 1.02 0.62 0.68 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
96105 A Assessment of aphasia 0.00 2.05 1.83 NA NA 0.18 2.23 2.01 NA NA XXX
96110 A Developmental test, lim 0.00 0.18 0.18 NA NA 0.18 0.36 0.36 NA NA XXX
96111 A Developmental test, extend 2.60 0.67 0.96 0.54 0.92 0.18 3.45 3.74 3.32 3.70 XXX
96116 A Neurobehavioral status exam 1.86 0.54 0.76 0.43 0.59 0.18 2.58 2.80 2.47 2.63 XXX
96118 A Neuropsych tst by psych/phys 1.86 0.82 1.25 0.33 0.56 0.18 2.86 3.29 2.37 2.60 XXX
96119 A Neuropsych testing by tec 0.55 1.53 1.15 0.10 0.17 0.18 2.26 1.88 0.83 0.90 XXX
96120 A Neuropsych tst admin w/comp 0.51 1.92 1.04 0.09 0.15 0.02 2.45 1.57 0.62 0.68 XXX
96150 A Assess hlth/behave, init 0.50 0.10 0.16 0.09 0.16 0.01 0.61 0.67 0.60 0.67 XXX
96151 A Assess hlth/behave, subseq 0.48 0.10 0.16 0.09 0.15 0.01 0.59 0.65 0.58 0.64 XXX
96152 A Intervene hlth/behave, indiv 0.46 0.09 0.15 0.08 0.14 0.01 0.56 0.62 0.55 0.61 XXX
96153 A Intervene hlth/behave, group 0.10 0.02 0.04 0.02 0.03 0.01 0.13 0.15 0.13 0.14 XXX
96154 A Interv hlth/behav, fam w/pt 0.45 0.09 0.15 0.08 0.14 0.01 0.55 0.61 0.54 0.60 XXX
96155 N Interv hlth/behav fam no pt 0.44 0.10 0.16 0.10 0.15 0.02 0.56 0.62 0.56 0.61 XXX
96401 A Chemo, anti-neopl, sq/im 0.21 1.86 1.34 NA NA 0.01 2.08 1.56 NA NA XXX
96402 A Chemo hormon antineopl sq/im 0.19 0.71 0.94 NA NA 0.01 0.91 1.14 NA NA XXX
96405 A Chemo intralesional, up to 7 0.52 3.55 2.71 0.23 0.24 0.03 4.10 3.26 0.78 0.79 000
96406 A Chemo intralesional over 7 0.80 3.29 3.08 0.28 0.29 0.03 4.12 3.91 1.11 1.12 000
96409 A Chemo, iv push, sngl drug 0.24 2.77 2.88 NA NA 0.06 3.07 3.18 NA NA XXX
96411 A Chemo, iv push, addl drug 0.20 1.49 1.58 NA NA 0.06 1.75 1.84 NA NA ZZZ
96413 A Chemo, iv infusion, 1 hr 0.28 3.61 4.05 NA NA 0.08 3.97 4.41 NA NA XXX
96415 A Chemo, iv infusion, addl hr 0.19 0.65 0.74 NA NA 0.07 0.91 1.00 NA NA ZZZ
96416 A Chemo prolong infuse w/pump 0.21 4.06 4.47 NA NA 0.08 4.35 4.76 NA NA XXX
96417 A Chemo iv infus each addl seq 0.21 1.72 1.89 NA NA 0.07 2.00 2.17 NA NA ZZZ
96420 A Chemo, ia, push tecnique 0.17 2.69 2.67 NA NA 0.08 2.94 2.92 NA NA XXX
96422 A Chemo ia infusion up to 1 hr 0.17 3.80 4.57 NA NA 0.08 4.05 4.82 NA NA XXX
96423 A Chemo ia infuse each addl hr 0.17 1.91 1.89 NA NA 0.02 2.10 2.08 NA NA ZZZ
96425 A Chemotherapy,infusion method 0.17 4.52 4.48 NA NA 0.08 4.77 4.73 NA NA XXX
96440 A Chemotherapy, intracavitary 2.37 5.51 7.48 1.00 1.17 0.17 8.05 10.02 3.54 3.71 000
96445 A Chemotherapy, intracavitary 2.20 5.41 7.38 0.95 1.12 0.14 7.75 9.72 3.29 3.46 000
96450 A Chemotherapy, into CNS 1.53 4.93 6.45 0.83 1.18 0.09 6.55 8.07 2.45 2.80 000
96521 A Refill/maint, portable pump 0.21 3.13 3.60 NA NA 0.06 3.40 3.87 NA NA XXX
96522 A Refill/maint pump/resvr syst 0.21 2.72 2.66 NA NA 0.06 2.99 2.93 NA NA XXX
96523 T Irrig drug delivery device 0.04 0.64 0.68 NA NA 0.01 0.69 0.73 NA NA XXX
96542 A Chemotherapy injection 0.75 3.54 4.07 0.33 0.58 0.07 4.36 4.89 1.15 1.40 XXX
96549 C Chemotherapy, unspecified 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
96567 A Photodynamic tx, skin 0.00 3.74 2.40 NA NA 0.04 3.78 2.44 NA NA XXX
96570 A Photodynamic tx, 30 min 1.10 0.41 0.38 0.41 0.38 0.11 1.62 1.59 1.62 1.59 ZZZ
96571 A Photodynamic tx, addl 15 min 0.55 0.20 0.19 0.20 0.19 0.03 0.78 0.77 0.78 0.77 ZZZ
96900 A Ultraviolet light therapy 0.00 0.56 0.47 NA NA 0.02 0.58 0.49 NA NA XXX
96902 B Trichogram 0.41 0.11 0.16 0.10 0.15 0.01 0.53 0.58 0.52 0.57 XXX
96904 R Whole body photography 0.00 1.84 1.84 NA NA 0.01 1.85 1.85 NA NA XXX
96910 A Photochemotherapy with UV-B 0.00 2.00 1.24 NA NA 0.04 2.04 1.28 NA NA XXX
96912 A Photochemotherapy with UV-A 0.00 2.58 1.59 NA NA 0.05 2.63 1.64 NA NA XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
96913 A Photochemotherapy, UV-A or B 0.00 3.65 2.17 NA NA 0.10 3.75 2.27 NA NA XXX
96920 A Laser tx, skin 250 sq cm 1.15 3.59 2.80 0.58 0.57 0.02 4.76 3.97 1.75 1.74 000
96921 A Laser tx, skin 250-500 sq cm 1.17 3.49 2.82 0.55 0.57 0.03 4.69 4.02 1.75 1.77 000
96922 A Laser tx, skin 500 sq cm 2.10 4.63 3.77 1.06 0.73 0.04 6.77 5.91 3.20 2.87 000
96999 C Dermatological procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97001 A Pt evaluation 1.20 0.67 0.73 NA NA 0.05 1.92 1.98 NA NA XXX
97002 A Pt re-evaluation 0.60 0.41 0.43 NA NA 0.02 1.03 1.05 NA NA XXX
97003 A Ot evaluation 1.20 0.78 0.86 NA NA 0.06 2.04 2.12 NA NA XXX
97004 A Ot re-evaluation 0.60 0.55 0.64 NA NA 0.02 1.17 1.26 NA NA XXX
97005 I Athletic train eval 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97006 I Athletic train reeval 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97010 B Hot or cold packs therapy 0.06 0.07 0.06 NA NA 0.01 0.14 0.13 NA NA XXX
97012 A Mechanical traction therapy 0.25 0.14 0.13 NA NA 0.01 0.40 0.39 NA NA XXX
97014 I Electric stimulation therapy 0.18 0.18 0.19 NA NA 0.01 0.37 0.38 NA NA XXX
97016 A Vasopneumatic device therapy 0.18 0.24 0.20 NA NA 0.01 0.43 0.39 NA NA XXX
97018 A Paraffin bath therapy 0.06 0.17 0.12 NA NA 0.01 0.24 0.19 NA NA XXX
97022 A Whirlpool therapy 0.17 0.33 0.24 NA NA 0.01 0.51 0.42 NA NA XXX
97024 A Diathermy eg, microwave 0.06 0.08 0.07 NA NA 0.01 0.15 0.14 NA NA XXX
97026 A Infrared therapy 0.06 0.07 0.06 NA NA 0.01 0.14 0.13 NA NA XXX
97028 A Ultraviolet therapy 0.08 0.08 0.07 NA NA 0.01 0.17 0.16 NA NA XXX
97032 A Electrical stimulation 0.25 0.20 0.17 NA NA 0.01 0.46 0.43 NA NA XXX
97033 A Electric current therapy 0.26 0.44 0.31 NA NA 0.01 0.71 0.58 NA NA XXX
97034 A Contrast bath therapy 0.21 0.20 0.16 NA NA 0.01 0.42 0.38 NA NA XXX
97035 A Ultrasound therapy 0.21 0.10 0.10 NA NA 0.01 0.32 0.32 NA NA XXX
97036 A Hydrotherapy 0.28 0.44 0.35 NA NA 0.01 0.73 0.64 NA NA XXX
97039 C Physical therapy treatment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97110 A Therapeutic exercises 0.45 0.32 0.28 NA NA 0.02 0.79 0.75 NA NA XXX
97112 A Neuromuscular reeducation 0.45 0.34 0.32 NA NA 0.01 0.80 0.78 NA NA XXX
97113 A Aquatic therapy/exercises 0.44 0.53 0.43 NA NA 0.01 0.98 0.88 NA NA XXX
97116 A Gait training therapy 0.40 0.28 0.25 NA NA 0.01 0.69 0.66 NA NA XXX
97124 A Massage therapy 0.35 0.27 0.24 NA NA 0.01 0.63 0.60 NA NA XXX
97139 C Physical medicine procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97140 A Manual therapy 0.43 0.29 0.26 NA NA 0.01 0.73 0.70 NA NA XXX
97150 A Group therapeutic procedures 0.27 0.22 0.19 NA NA 0.01 0.50 0.47 NA NA XXX
97530 A Therapeutic activities 0.44 0.38 0.34 NA NA 0.01 0.83 0.79 NA NA XXX
97532 A Cognitive skills development 0.44 0.22 0.21 NA NA 0.01 0.67 0.66 NA NA XXX
97533 A Sensory integration 0.44 0.27 0.25 NA NA 0.01 0.72 0.70 NA NA XXX
97535 A Self care mngment training 0.45 0.37 0.34 NA NA 0.01 0.83 0.80 NA NA XXX
97537 A Community/work reintegration 0.45 0.28 0.27 NA NA 0.01 0.74 0.73 NA NA XXX
97542 A Wheelchair mngment training 0.45 0.29 0.28 NA NA 0.01 0.75 0.74 NA NA XXX
97545 R Work hardening 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97546 R Work hardening add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
97597 A Active wound care/20 cm or 0.58 1.10 0.77 0.12 0.53 0.05 1.73 1.40 0.75 1.16 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
97598 A Active wound care 20 cm 0.80 1.27 0.91 0.17 0.64 0.05 2.12 1.76 1.02 1.49 XXX
97602 B Wound(s) care non-selective 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97605 A Neg press wound tx, 50 cm 0.55 0.41 0.36 0.12 0.20 0.02 0.98 0.93 0.69 0.77 XXX
97606 A Neg press wound tx, 50 cm 0.60 0.42 0.37 0.13 0.21 0.03 1.05 1.00 0.76 0.84 XXX
97750 A Physical performance test 0.45 0.33 0.32 NA NA 0.02 0.80 0.79 NA NA XXX
97755 A Assistive technology assess 0.62 0.28 0.28 NA NA 0.02 0.92 0.92 NA NA XXX
97760 A Orthotic mgmt and training 0.45 0.42 0.36 NA NA 0.03 0.90 0.84 NA NA XXX
97761 A Prosthetic training 0.45 0.33 0.29 NA NA 0.02 0.80 0.76 NA NA XXX
97762 A C/o for orthotic/prosth use 0.25 0.73 0.50 NA NA 0.02 1.00 0.77 NA NA XXX
97799 C Physical medicine procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
97802 A Medical nutrition, indiv, in 0.45 0.14 0.39 0.11 0.38 0.01 0.60 0.85 0.57 0.84 XXX
97803 A Med nutrition, indiv, subseq 0.37 0.12 0.38 0.09 0.38 0.01 0.50 0.76 0.47 0.76 XXX
97804 A Medical nutrition, group 0.25 0.07 0.15 0.06 0.15 0.01 0.33 0.41 0.32 0.41 XXX
97810 N Acupunct w/o stimul 15 min 0.60 0.26 0.35 0.14 0.21 0.03 0.89 0.98 0.77 0.84 XXX
97811 N Acupunct w/o stimul addl 15m 0.50 0.15 0.23 0.12 0.17 0.03 0.68 0.76 0.65 0.70 ZZZ
97813 N Acupunct w/stimul 15 min 0.65 0.27 0.37 0.15 0.23 0.03 0.95 1.05 0.83 0.91 XXX
97814 N Acupunct w/stimul addl 15m 0.55 0.19 0.27 0.13 0.19 0.03 0.77 0.85 0.71 0.77 ZZZ
98925 A Osteopathic manipulation 0.45 0.28 0.31 0.12 0.14 0.02 0.75 0.78 0.59 0.61 000
98926 A Osteopathic manipulation 0.65 0.36 0.40 0.17 0.23 0.03 1.04 1.08 0.85 0.91 000
98927 A Osteopathic manipulation 0.87 0.45 0.49 0.23 0.28 0.03 1.35 1.39 1.13 1.18 000
98928 A Osteopathic manipulation 1.03 0.51 0.57 0.26 0.32 0.04 1.58 1.64 1.33 1.39 000
98929 A Osteopathic manipulation 1.19 0.57 0.65 0.30 0.35 0.05 1.81 1.89 1.54 1.59 000
98940 A Chiropractic manipulation 0.45 0.21 0.23 0.12 0.12 0.01 0.67 0.69 0.58 0.58 000
98941 A Chiropractic manipulation 0.65 0.27 0.29 0.18 0.17 0.01 0.93 0.95 0.84 0.83 000
98942 A Chiropractic manipulation 0.87 0.34 0.36 0.24 0.23 0.02 1.23 1.25 1.13 1.12 000
98943 N Chiropractic manipulation 0.40 0.17 0.22 0.09 0.14 0.01 0.58 0.63 0.50 0.55 XXX
98960 B Self-mgmt educ train, 1 pt 0.00 0.48 0.48 0.00 0.00 0.01 0.49 0.49 0.01 0.01 XXX
98961 B Self-mgmt educ/train, 2-4 pt 0.00 0.23 0.23 0.00 0.00 0.01 0.24 0.24 0.01 0.01 XXX
98962 B Self-mgmt educ/train, 5-8 pt 0.00 0.17 0.17 0.00 0.00 0.01 0.18 0.18 0.01 0.01 XXX
99000 B Specimen handling 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99001 B Specimen handling 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99002 B Device handling 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99024 B Postop follow-up visit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99026 N In-hospital on call service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99027 N Out-of-hosp on call service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99050 B Medical services after hrs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99051 B Med serv, eve/wkend/holiday 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99053 B Med serv 10pm-8am, 24 hr fac 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99056 B Med service out of office 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99058 B Office emergency care 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99060 B Out of office emerg med serv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99070 B Special supplies 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99071 B Patient education materials 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
99075 N Medical testimony 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99078 B Group health education 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99080 B Special reports or forms 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99082 C Unusual physician travel 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99090 B Computer data analysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99091 B Collect/review data from pt 1.10 0.25 0.25 NA NA 0.04 1.39 1.39 NA NA XXX
99100 B Special anesthesia service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99116 B Anesthesia with hypothermia 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99135 B Special anesthesia procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99140 B Emergency anesthesia 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99143 C Mod cs by same phys, 5 yrs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99144 C Mod cs by same phys, 5 yrs + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99145 C Mod cs by same phys add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99148 C Mod cs diff phys 5 yrs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99149 C Mod cs diff phys 5 yrs + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99150 C Mod cs diff phys add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ZZZ
99170 A Anogenital exam, child 1.75 1.50 1.70 0.50 0.54 0.08 3.33 3.53 2.33 2.37 000
99172 N Ocular function screen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99173 N Visual acuity screen 0.00 0.06 0.06 NA NA 0.01 0.07 0.07 NA NA XXX
99175 A Induction of vomiting 0.00 0.33 1.13 NA NA 0.10 0.43 1.23 NA NA XXX
99183 A Hyperbaric oxygen therapy 2.34 2.60 3.08 0.59 0.69 0.16 5.10 5.58 3.09 3.19 XXX
99185 A Regional hypothermia 0.00 1.65 0.89 NA NA 0.04 1.69 0.93 NA NA XXX
99186 A Total body hypothermia 0.00 1.38 1.68 NA NA 0.45 1.83 2.13 NA NA XXX
99190 X Special pump services 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99191 X Special pump services 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99192 X Special pump services 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99195 A Phlebotomy 0.00 2.59 0.98 NA NA 0.02 2.61 1.00 NA NA XXX
99199 C Special service/proc/report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99201 A Office/outpatient visit, new 0.45 0.55 0.51 0.16 0.15 0.03 1.03 0.99 0.64 0.63 XXX
99202 A Office/outpatient visit, new 0.88 0.84 0.80 0.30 0.31 0.05 1.77 1.73 1.23 1.24 XXX
99203 A Office/outpatient visit, new 1.34 1.11 1.13 0.43 0.47 0.09 2.54 2.56 1.86 1.90 XXX
99204 A Office/outpatient visit, new 2.30 1.50 1.50 0.72 0.71 0.12 3.92 3.92 3.14 3.13 XXX
99205 A Office/outpatient visit, new 3.00 1.80 1.78 0.93 0.95 0.15 4.95 4.93 4.08 4.10 XXX
99211 A Office/outpatient visit, est 0.17 0.32 0.37 0.06 0.06 0.01 0.50 0.55 0.24 0.24 XXX
99212 A Office/outpatient visit, est 0.45 0.55 0.54 0.15 0.16 0.03 1.03 1.02 0.63 0.64 XXX
99213 A Office/outpatient visit, est 0.92 0.76 0.71 0.29 0.25 0.03 1.71 1.66 1.24 1.20 XXX
99214 A Office/outpatient visit, est 1.42 1.11 1.05 0.45 0.42 0.05 2.58 2.52 1.92 1.89 XXX
99215 A Office/outpatient visit, est 2.00 1.39 1.34 0.62 0.64 0.08 3.47 3.42 2.70 2.72 XXX
99217 A Observation care discharge 1.28 NA NA 0.51 0.53 0.06 NA NA 1.85 1.87 XXX
99218 A Observation care 1.28 NA NA 0.39 0.43 0.06 NA NA 1.73 1.77 XXX
99219 A Observation care 2.14 NA NA 0.61 0.69 0.10 NA NA 2.85 2.93 XXX
99220 A Observation care 2.99 NA NA 0.87 0.99 0.14 NA NA 4.00 4.12 XXX
99221 A Initial hospital care 1.88 NA NA 0.56 0.48 0.07 NA NA 2.51 2.43 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
99222 A Initial hospital care 2.56 NA NA 0.73 0.74 0.10 NA NA 3.39 3.40 XXX
99223 A Initial hospital care 3.78 NA NA 1.11 1.05 0.13 NA NA 5.02 4.96 XXX
99231 A Subsequent hospital care 0.76 NA NA 0.24 0.23 0.03 NA NA 1.03 1.02 XXX
99232 A Subsequent hospital care 1.39 NA NA 0.44 0.39 0.04 NA NA 1.87 1.82 XXX
99233 A Subsequent hospital care 2.00 NA NA 0.61 0.54 0.06 NA NA 2.67 2.60 XXX
99234 A Observ/hosp same date 2.56 NA NA 0.80 0.87 0.13 NA NA 3.49 3.56 XXX
99235 A Observ/hosp same date 3.41 NA NA 1.02 1.12 0.16 NA NA 4.59 4.69 XXX
99236 A Observ/hosp same date 4.26 NA NA 1.28 1.40 0.19 NA NA 5.73 5.85 XXX
99238 A Hospital discharge day 1.28 NA NA 0.50 0.53 0.05 NA NA 1.83 1.86 XXX
99239 A Hospital discharge day 1.90 NA NA 0.69 0.72 0.07 NA NA 2.66 2.69 XXX
99241 A Office consultation 0.64 0.66 0.65 0.23 0.22 0.05 1.35 1.34 0.92 0.91 XXX
99242 A Office consultation 1.34 1.09 1.05 0.49 0.47 0.10 2.53 2.49 1.93 1.91 XXX
99243 A Office consultation 1.88 1.45 1.41 0.68 0.64 0.13 3.46 3.42 2.69 2.65 XXX
99244 A Office consultation 3.02 1.96 1.86 1.12 0.97 0.16 5.14 5.04 4.30 4.15 XXX
99245 A Office consultation 3.77 2.30 2.28 1.35 1.27 0.21 6.28 6.26 5.33 5.25 XXX
99251 A Inpatient consultation 1.00 NA NA 0.32 0.26 0.05 NA NA 1.37 1.31 XXX
99252 A Inpatient consultation 1.50 NA NA 0.51 0.50 0.09 NA NA 2.10 2.09 XXX
99253 A Inpatient consultation 2.27 NA NA 0.82 0.72 0.11 NA NA 3.20 3.10 XXX
99254 A Inpatient consultation 3.29 NA NA 1.22 1.04 0.13 NA NA 4.64 4.46 XXX
99255 A Inpatient consultation 4.00 NA NA 1.43 1.37 0.18 NA NA 5.61 5.55 XXX
99281 A Emergency dept visit 0.45 NA NA 0.09 0.09 0.02 NA NA 0.56 0.56 XXX
99282 A Emergency dept visit 0.88 NA NA 0.17 0.15 0.04 NA NA 1.09 1.07 XXX
99283 A Emergency dept visit 1.34 NA NA 0.25 0.30 0.09 NA NA 1.68 1.73 XXX
99284 A Emergency dept visit 2.56 NA NA 0.48 0.47 0.14 NA NA 3.18 3.17 XXX
99285 A Emergency dept visit 3.80 NA NA 0.69 0.71 0.23 NA NA 4.72 4.74 XXX
99288 B Direct advanced life support 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99289 A Ped crit care transport 4.79 NA NA 1.14 1.37 0.24 NA NA 6.17 6.40 XXX
99290 A Ped crit care transport addl 2.40 NA NA 0.62 0.76 0.12 NA NA 3.14 3.28 ZZZ
99291 A Critical care, first hour 4.50 2.30 2.50 1.15 1.25 0.21 7.01 7.21 5.86 5.96 XXX
99292 A Critical care, addÆl 30 min 2.25 0.84 0.89 0.60 0.63 0.11 3.20 3.25 2.96 2.99 ZZZ
99293 A Ped critical care, initial 15.98 NA NA 3.67 4.48 1.12 NA NA 20.77 21.58 XXX
99294 A Ped critical care, subseq 7.99 NA NA 1.76 2.24 0.45 NA NA 10.20 10.68 XXX
99295 A Neonate crit care, initial 18.46 NA NA 4.44 5.14 1.16 NA NA 24.06 24.76 XXX
99296 A Neonate critical care subseq 7.99 NA NA 1.81 2.36 0.32 NA NA 10.12 10.67 XXX
99298 A Ic for lbw infant 1500 gm 2.75 NA NA 0.68 0.87 0.17 NA NA 3.60 3.79 XXX
99299 A Ic, lbw infant 1500-2500 gm 2.50 NA NA 0.77 0.84 0.16 NA NA 3.43 3.50 XXX
99300 A Ic, infant pbw 2501-5000 gm 2.40 NA NA 0.74 0.82 0.15 NA NA 3.29 3.37 XXX
99304 A Nursing facility care, init 1.20 0.45 0.48 0.45 0.48 0.05 1.70 1.73 1.70 1.73 XXX
99305 A Nursing facility care, init 1.61 0.57 0.62 0.57 0.62 0.07 2.25 2.30 2.25 2.30 XXX
99306 A Nursing facility care, init 2.01 0.67 0.73 0.67 0.73 0.09 2.77 2.83 2.77 2.83 XXX
99307 A Nursing fac care, subseq 0.60 0.27 0.27 0.27 0.27 0.03 0.90 0.90 0.90 0.90 XXX
99308 A Nursing fac care, subseq 1.00 0.44 0.45 0.44 0.45 0.04 1.48 1.49 1.48 1.49 XXX
99309 A Nursing fac care, subseq 1.42 0.59 0.61 0.59 0.61 0.06 2.07 2.09 2.07 2.09 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
99310 A Nursing fac care, subseq 1.77 0.74 0.77 0.74 0.77 0.08 2.59 2.62 2.59 2.62 XXX
99315 A Nursing fac discharge day 1.13 0.41 0.44 0.41 0.44 0.05 1.59 1.62 1.59 1.62 XXX
99316 A Nursing fac discharge day 1.50 0.52 0.57 0.52 0.57 0.06 2.08 2.13 2.08 2.13 XXX
99318 A Annual nursing fac assessmnt 1.20 0.45 0.48 0.45 0.48 0.05 1.70 1.73 1.70 1.73 XXX
99324 A Domicil/r-home visit new pat 1.01 0.44 0.48 NA NA 0.05 1.50 1.54 NA NA XXX
99325 A Domicil/r-home visit new pat 1.52 0.58 0.66 NA NA 0.07 2.17 2.25 NA NA XXX
99326 A Domicil/r-home visit new pat 2.27 0.74 0.88 NA NA 0.10 3.11 3.25 NA NA XXX
99327 A Domicil/r-home visit new pat 3.03 0.94 1.11 NA NA 0.13 4.10 4.27 NA NA XXX
99328 A Domicil/r-home visit new pat 3.78 1.13 1.35 NA NA 0.16 5.07 5.29 NA NA XXX
99334 A Domicil/r-home visit est pat 0.76 0.36 0.39 NA NA 0.04 1.16 1.19 NA NA XXX
99335 A Domicil/r-home visit est pat 1.26 0.48 0.56 NA NA 0.06 1.80 1.88 NA NA XXX
99336 A Domicil/r-home visit est pat 2.02 0.67 0.78 NA NA 0.09 2.78 2.89 NA NA XXX
99337 A Domicil/r-home visit est pat 3.03 0.92 1.09 NA NA 0.13 4.08 4.25 NA NA XXX
99339 B Domicil/r-home care supervis 1.25 0.58 0.58 NA NA 0.06 1.89 1.89 NA NA XXX
99340 B Domicil/r-home care supervis 1.80 0.76 0.76 NA NA 0.07 2.63 2.63 NA NA XXX
99341 A Home visit, new patient 1.01 0.44 0.47 NA NA 0.05 1.50 1.53 NA NA XXX
99342 A Home visit, new patient 1.52 0.58 0.66 NA NA 0.07 2.17 2.25 NA NA XXX
99343 A Home visit, new patient 2.27 0.77 0.90 NA NA 0.10 3.14 3.27 NA NA XXX
99344 A Home visit, new patient 3.03 0.93 1.12 NA NA 0.13 4.09 4.28 NA NA XXX
99345 A Home visit, new patient 3.78 1.10 1.35 NA NA 0.16 5.04 5.29 NA NA XXX
99347 A Home visit, est patient 0.76 0.37 0.39 NA NA 0.04 1.17 1.19 NA NA XXX
99348 A Home visit, est patient 1.26 0.49 0.56 NA NA 0.06 1.81 1.88 NA NA XXX
99349 A Home visit, est patient 2.02 0.67 0.79 NA NA 0.09 2.78 2.90 NA NA XXX
99350 A Home visit, est patient 3.03 0.92 1.12 NA NA 0.13 4.08 4.28 NA NA XXX
99354 A Prolonged service, office 1.77 0.66 0.74 0.51 0.62 0.08 2.51 2.59 2.36 2.47 ZZZ
99355 A Prolonged service, office 1.77 0.68 0.73 0.53 0.60 0.07 2.52 2.57 2.37 2.44 ZZZ
99356 A Prolonged service, inpatient 1.71 NA NA 0.52 0.60 0.07 NA NA 2.30 2.38 ZZZ
99357 A Prolonged service, inpatient 1.71 NA NA 0.51 0.60 0.08 NA NA 2.30 2.39 ZZZ
99358 B Prolonged serv, w/o contact 2.10 0.51 0.51 0.51 0.51 0.09 2.70 2.70 2.70 2.70 ZZZ
99359 B Prolonged serv, w/o contact 1.00 0.26 0.26 0.26 0.26 0.04 1.30 1.30 1.30 1.30 ZZZ
99360 X Physician standby services 1.20 0.00 0.00 0.00 0.00 0.05 1.25 1.25 1.25 1.25 XXX
99361 B Physician/team conference 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99362 B Physician/team conference 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99363 B Anticoag mgmt, init 1.65 1.29 1.29 0.38 0.38 0.07 3.01 3.01 2.10 2.10 XXX
99364 B Anticoag mgmt, subseq 0.63 0.38 0.38 0.15 0.15 0.04 1.05 1.05 0.82 0.82 XXX
99371 B Physician phone consultation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99372 B Physician phone consultation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99373 B Physician phone consultation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99374 B Home health care supervision 1.10 0.54 0.66 0.25 0.38 0.05 1.69 1.81 1.40 1.53 XXX
99375 I Home health care supervision 1.73 0.75 1.35 0.40 1.26 0.07 2.55 3.15 2.20 3.06 XXX
99377 B Hospice care supervision 1.10 0.54 0.66 0.25 0.38 0.05 1.69 1.81 1.40 1.53 XXX
99378 I Hospice care supervision 1.73 0.75 1.64 0.40 1.56 0.07 2.55 3.44 2.20 3.36 XXX
99379 B Nursing fac care supervision 1.10 0.54 0.66 0.25 0.38 0.04 1.68 1.80 1.39 1.52 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
99380 B Nursing fac care supervision 1.73 0.75 0.93 0.40 0.60 0.06 2.54 2.72 2.19 2.39 XXX
99381 N Init pm e/m, new pat, inf 1.19 0.99 1.37 0.27 0.41 0.05 2.23 2.61 1.51 1.65 XXX
99382 N Init pm e/m, new pat 1-4 yrs 1.36 1.03 1.41 0.31 0.47 0.05 2.44 2.82 1.72 1.88 XXX
99383 N Prev visit, new, age 5-11 1.36 1.02 1.37 0.31 0.47 0.05 2.43 2.78 1.72 1.88 XXX
99384 N Prev visit, new, age 12-17 1.53 1.06 1.43 0.35 0.53 0.06 2.65 3.02 1.94 2.12 XXX
99385 N Prev visit, new, age 18-39 1.53 1.06 1.43 0.35 0.53 0.06 2.65 3.02 1.94 2.12 XXX
99386 N Prev visit, new, age 40-64 1.88 1.14 1.59 0.43 0.65 0.07 3.09 3.54 2.38 2.60 XXX
99387 N Init pm e/m, new pat 65+ yrs 2.06 1.27 1.72 0.48 0.71 0.07 3.40 3.85 2.61 2.84 XXX
99391 N Per pm reeval, est pat, inf 1.02 0.86 0.98 0.24 0.35 0.04 1.92 2.04 1.30 1.41 XXX
99392 N Prev visit, est, age 1-4 1.19 0.89 1.04 0.27 0.41 0.05 2.13 2.28 1.51 1.65 XXX
99393 N Prev visit, est, age 5-11 1.19 0.89 1.02 0.27 0.41 0.05 2.13 2.26 1.51 1.65 XXX
99394 N Prev visit, est, age 12-17 1.36 0.93 1.08 0.31 0.47 0.05 2.34 2.49 1.72 1.88 XXX
99395 N Prev visit, est, age 18-39 1.36 0.93 1.10 0.31 0.47 0.05 2.34 2.51 1.72 1.88 XXX
99396 N Prev visit, est, age 40-64 1.53 0.97 1.18 0.35 0.53 0.06 2.56 2.77 1.94 2.12 XXX
99397 N Per pm reeval est pat 65+ yr 1.71 1.11 1.30 0.40 0.60 0.06 2.88 3.07 2.17 2.37 XXX
99401 N Preventive counseling, indiv 0.48 0.36 0.56 0.11 0.17 0.01 0.85 1.05 0.60 0.66 XXX
99402 N Preventive counseling, indiv 0.98 0.47 0.77 0.23 0.34 0.02 1.47 1.77 1.23 1.34 XXX
99403 N Preventive counseling, indiv 1.46 0.58 0.96 0.34 0.51 0.04 2.08 2.46 1.84 2.01 XXX
99404 N Preventive counseling, indiv 1.95 0.70 1.17 0.45 0.68 0.05 2.70 3.17 2.45 2.68 XXX
99411 N Preventive counseling, group 0.15 0.22 0.19 0.03 0.05 0.01 0.38 0.35 0.19 0.21 XXX
99412 N Preventive counseling, group 0.25 0.24 0.25 0.06 0.09 0.01 0.50 0.51 0.32 0.35 XXX
99420 N Health risk assessment test 0.00 0.22 0.22 NA NA 0.01 0.23 0.23 NA NA XXX
99429 N Unlisted preventive service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99431 A Initial care, normal newborn 1.17 NA NA 0.27 0.35 0.05 NA NA 1.49 1.57 XXX
99432 A Newborn care, not in hosp 1.26 1.00 0.95 0.29 0.37 0.07 2.33 2.28 1.62 1.70 XXX
99433 A Normal newborn care/hospital 0.62 NA NA 0.15 0.19 0.02 NA NA 0.79 0.83 XXX
99435 A Newborn discharge day hosp 1.50 NA NA 0.46 0.56 0.06 NA NA 2.02 2.12 XXX
99436 A Attendance, birth 1.50 NA NA 0.35 0.44 0.06 NA NA 1.91 2.00 XXX
99440 A Newborn resuscitation 2.93 NA NA 0.68 0.87 0.12 NA NA 3.73 3.92 XXX
99450 N Basic life disability exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99455 R Work related disability exam 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99456 R Disability examination 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99499 C Unlisted em service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99500 I Home visit, prenatal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99501 I Home visit, postnatal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99502 I Home visit, nb care 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99503 I Home visit, resp therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99504 I Home visit mech ventilator 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99505 I Home visit, stoma care 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99506 I Home visit, im injection 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99507 I Home visit, cath maintain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99509 I Home visit day life activity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99510 I Home visit, sing/m/fam couns 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
99511 I Home visit, fecal/enema mgmt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99512 I Home visit for hemodialysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99600 I Home visit nos 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99601 I Home infusion/visit, 2 hrs 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
99602 I Home infusion, each addtl hr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
A4890 R Repair/maint cont hemo equip 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0150 R Comprehensve oral evaluation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0240 R Intraoral occlusal film 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0250 R Extraoral first film 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0260 R Extraoral ea additional film 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0270 R Dental bitewing single film 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0272 R Dental bitewings two films 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0274 R Dental bitewings four films 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0277 R Vert bitewings-sev to eight 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0416 R Viral culture 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0421 R Gen tst suscept oral disease 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0431 R Diag tst detect mucos abnorm 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0460 R Pulp vitality test 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0472 R Gross exam, prep report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0473 R Micro exam, prep report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0474 R Micro w exam of surg margins 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0475 R Decalcification procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0476 R Spec stains for microorganis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0477 R Spec stains not for microorg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0478 R Immunohistochemical stains 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0479 R Tissue in-situ hybridization 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0480 R Cytopath smear prep report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0481 R Electron microscopy diagnost 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0482 R Direct immunofluorescence 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0483 R Indirect immunofluorescence 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0484 R Consult slides prep elsewher 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0485 R Consult inc prep of slides 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D0502 R Other oral pathology procedu 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D0999 R Unspecified diagnostic proce 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D1510 R Space maintainer fxd unilat 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D1515 R Fixed bilat space maintainer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D1520 R Remove unilat space maintain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D1525 R Remove bilat space maintain 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D1550 R Recement space maintainer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D2999 R Dental unspec restorative pr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D3460 R Endodontic endosseous implan 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D3999 R Endodontic procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4260 R Osseous surgery per quadrant 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
D4263 R Bone replce graft first site 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4264 R Bone replce graft each add 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4268 R Surgical revision procedure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D4270 R Pedicle soft tissue graft pr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4271 R Free soft tissue graft proc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4273 R Subepithelial tissue graft 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4355 R Full mouth debridement 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D4381 R Localized delivery antimicro 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5911 R Facial moulage sectional 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5912 R Facial moulage complete 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5951 R Feeding aid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5983 R Radiation applicator 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5984 R Radiation shield 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5985 R Radiation cone locator 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D5987 R Commissure splint 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D6920 R Dental connector bar 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7111 R Extraction coronal remnants 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7140 R Extraction erupted tooth/exr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7210 R Rem imp tooth w mucoper flp 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7220 R Impact tooth remov soft tiss 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7230 R Impact tooth remov part bony 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7240 R Impact tooth remov comp bony 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7241 R Impact tooth rem bony w/comp 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7250 R Tooth root removal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7260 R Oral antral fistula closure 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7261 R Primary closure sinus perf 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7283 R Place device impacted tooth 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7288 R Brush biopsy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7291 R Transseptal fiberotomy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D7321 R Alveoloplasty not w/extracts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7511 R Incision/drain abscess intra 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7521 R Incision/drain abscess extra 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D7940 R Reshaping bone orthognathic 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9110 R Tx dental pain minor proc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9230 R Analgesia 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9248 R Sedation (non-iv) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
D9630 R Other drugs/medicaments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9930 R Treatment of complications 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9940 R Dental occlusal guard 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9950 R Occlusion analysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9951 R Limited occlusal adjustment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
D9952 R Complete occlusal adjustment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
G0008 X Admin influenza virus vac 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
G0009 X Admin pneumococcal vaccine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0010 X Admin hepatitis b vaccine 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0027 X Semen analysis 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0101 A CA screen;pelvic/breast exam 0.45 0.48 0.51 NA NA 0.02 0.95 0.98 NA NA XXX
G0102 A Prostate ca screening; dre 0.17 0.32 0.37 0.06 0.06 0.01 0.50 0.55 0.24 0.24 XXX
G0103 X Psa, total screening 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0104 A CA screen;flexi sigmoidscope 0.96 2.49 2.33 0.62 0.53 0.08 3.53 3.37 1.66 1.57 000
G0105 A Colorectal scrn; hi risk ind 3.69 6.37 6.20 1.85 1.57 0.30 10.36 10.19 5.84 5.56 000
G0105 53 A Colorectal scrn; hi risk ind 0.96 2.49 2.33 0.62 0.53 0.08 3.53 3.37 1.66 1.57 000
G0106 A Colon CA screen;barium enema 0.99 4.64 3.07 NA NA 0.17 5.80 4.23 NA NA XXX
G0106 TC A Colon CA screen;barium enema 0.00 4.36 2.76 NA NA 0.13 4.49 2.89 NA NA XXX
G0106 26 A Colon CA screen;barium enema 0.99 0.28 0.31 0.28 0.31 0.04 1.31 1.34 1.31 1.34 XXX
G0108 A Diab manage trn per indiv 0.00 0.59 0.77 NA NA 0.01 0.60 0.78 NA NA XXX
G0109 A Diab manage trn ind/group 0.00 0.31 0.44 NA NA 0.01 0.32 0.45 NA NA XXX
G0117 T Glaucoma scrn hgh risk direc 0.45 0.79 0.74 NA NA 0.01 1.25 1.20 NA NA XXX
G0118 T Glaucoma scrn hgh risk direc 0.17 0.79 0.60 NA NA 0.01 0.97 0.78 NA NA XXX
G0120 A Colon ca scrn; barium enema 0.99 4.64 3.07 NA NA 0.17 5.80 4.23 NA NA XXX
G0120 TC A Colon ca scrn; barium enema 0.00 4.36 2.76 NA NA 0.13 4.49 2.89 NA NA XXX
G0120 26 A Colon ca scrn; barium enema 0.99 0.28 0.31 0.28 0.31 0.04 1.31 1.34 1.31 1.34 XXX
G0121 A Colon ca scrn not hi rsk ind 3.69 6.37 6.20 1.85 1.57 0.30 10.36 10.19 5.84 5.56 000
G0121 53 A Colon ca scrn not hi rsk ind 0.96 2.49 2.33 0.62 0.53 0.08 3.53 3.37 1.66 1.57 000
G0122 N Colon ca scrn; barium enema 0.99 5.58 3.32 NA NA 0.18 6.75 4.49 NA NA XXX
G0122 TC N Colon ca scrn; barium enema 0.00 5.35 2.98 NA NA 0.13 5.48 3.11 NA NA XXX
G0122 26 N Colon ca scrn; barium enema 0.99 0.23 0.34 0.23 0.34 0.05 1.27 1.38 1.27 1.38 XXX
G0123 X Screen cerv/vag thin layer 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0124 A Screen c/v thin layer by MD 0.42 0.37 0.21 0.37 0.21 0.02 0.81 0.65 0.81 0.65 XXX
G0127 R Trim nail(s) 0.17 0.38 0.28 0.05 0.07 0.01 0.56 0.46 0.23 0.25 000
G0128 R CORF skilled nursing service 0.08 0.02 0.03 0.02 0.03 0.01 0.11 0.12 0.11 0.12 XXX
G0130 A Single energy x-ray study 0.22 0.54 0.79 NA NA 0.06 0.82 1.07 NA NA XXX
G0130 TC A Single energy x-ray study 0.00 0.48 0.72 NA NA 0.05 0.53 0.77 NA NA XXX
G0130 26 A Single energy x-ray study 0.22 0.06 0.07 0.06 0.07 0.01 0.29 0.30 0.29 0.30 XXX
G0141 A Scr c/v cyto,autosys and md 0.42 0.37 0.21 0.37 0.21 0.02 0.81 0.65 0.81 0.65 XXX
G0143 X Scr c/v cyto,thinlayer,rescr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0144 X Scr c/v cyto,thinlayer,rescr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0145 X Scr c/v cyto,thinlayer,rescr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0147 X Scr c/v cyto, automated sys 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0148 X Scr c/v cyto, autosys, rescr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0166 A Extrnl counterpulse, per tx 0.07 4.51 3.81 NA NA 0.01 4.59 3.89 NA NA XXX
G0168 A Wound closure by adhesive 0.45 1.56 1.84 0.21 0.22 0.03 2.04 2.32 0.69 0.70 000
G0173 X Linear acc stereo radsur com 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0175 X OPPS Service,sched team conf 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0176 X OPPS/PHP;activity therapy 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0177 X OPPS/PHP; train educ serv 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
G0179 A MD recertification HHA PT 0.45 0.48 0.89 NA NA 0.02 0.95 1.36 NA NA XXX
G0180 A MD certification HHA patient 0.67 0.56 1.09 NA NA 0.03 1.26 1.79 NA NA XXX
G0181 A Home health care supervision 1.73 0.82 1.32 NA NA 0.07 2.62 3.12 NA NA XXX
G0182 A Hospice care supervision 1.73 0.84 1.46 NA NA 0.07 2.64 3.26 NA NA XXX
G0186 C Dstry eye lesn,fdr vssl tech 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
G0202 A Screeningmammographydigital 0.70 2.66 2.74 NA NA 0.10 3.46 3.54 NA NA XXX
G0202 TC A Screeningmammographydigital 0.00 2.46 2.52 NA NA 0.07 2.53 2.59 NA NA XXX
G0202 26 A Screeningmammographydigital 0.70 0.20 0.22 0.20 0.22 0.03 0.93 0.95 0.93 0.95 XXX
G0204 A Diagnosticmammographydigital 0.87 3.14 2.87 NA NA 0.11 4.12 3.85 NA NA XXX
G0204 TC A Diagnosticmammographydigital 0.00 2.90 2.60 NA NA 0.07 2.97 2.67 NA NA XXX
G0204 26 A Diagnosticmammographydigital 0.87 0.24 0.27 0.24 0.27 0.04 1.15 1.18 1.15 1.18 XXX
G0206 A Diagnosticmammographydigital 0.70 2.50 2.31 NA NA 0.09 3.29 3.10 NA NA XXX
G0206 TC A Diagnosticmammographydigital 0.00 2.30 2.09 NA NA 0.06 2.36 2.15 NA NA XXX
G0206 26 A Diagnosticmammographydigital 0.70 0.20 0.22 0.20 0.22 0.03 0.93 0.95 0.93 0.95 XXX
G0219 N PET img wholbod melano nonco 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0219 TC N PET img wholbod melano nonco 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0219 26 N PET img wholbod melano nonco 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0235 N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0235 TC N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0235 26 N PET not otherwise specified 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0237 A Therapeutic procd strg endur 0.00 0.21 0.41 NA NA 0.02 0.23 0.43 NA NA XXX
G0238 A Oth resp proc, indiv 0.00 0.23 0.43 NA NA 0.02 0.25 0.45 NA NA XXX
G0239 A Oth resp proc, group 0.00 0.31 0.33 NA NA 0.02 0.33 0.35 NA NA XXX
G0245 R Initial foot exam pt lops 0.88 0.84 0.80 0.30 0.31 0.04 1.76 1.72 1.22 1.23 XXX
G0246 R Followup eval of foot pt lop 0.45 0.55 0.54 0.15 0.16 0.02 1.02 1.01 0.62 0.63 XXX
G0247 R Routine footcare pt w lops 0.50 0.68 0.56 0.17 0.20 0.02 1.20 1.08 0.69 0.72 ZZZ
G0248 R Demonstrate use home inr mon 0.00 3.36 5.80 NA NA 0.01 3.37 5.81 NA NA XXX
G0249 R Provide test material,equipm 0.00 2.41 3.57 NA NA 0.01 2.42 3.58 NA NA XXX
G0250 R MD review interpret of test 0.18 0.08 0.07 NA NA 0.01 0.27 0.26 NA NA XXX
G0251 E Linear acc based stero radio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0252 N PET imaging initial dx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0252 TC N PET imaging initial dx 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0252 26 N PET imaging initial dx 1.50 0.00 0.60 0.00 0.60 0.04 1.54 2.14 1.54 2.14 XXX
G0255 N Current percep threshold tst 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0255 TC N Current percep threshold tst 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0255 26 N Current percep threshold tst 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0257 E Unsched dialysis ESRD pt hos 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0259 E Inject for sacroiliac joint 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0260 E Inj for sacroiliac jt anesth 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0265 X Cryopresevation Freeze+stora 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0266 X Thawing + expansion froz cel 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0267 X Bone marrow or psc harvest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0268 A Removal of impacted wax md 0.61 0.61 0.63 0.18 0.23 0.02 1.24 1.26 0.81 0.86 000
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
G0269 B Occlusive device in vein art 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0270 A MNT subs tx for change dx 0.37 0.12 0.38 0.09 0.38 0.01 0.50 0.76 0.47 0.76 XXX
G0271 A Group MNT 2 or more 30 mins 0.25 0.07 0.15 0.06 0.15 0.01 0.33 0.41 0.32 0.41 XXX
G0275 A Renal angio, cardiac cath 0.25 NA NA 0.14 0.11 0.01 NA NA 0.40 0.37 ZZZ
G0278 A Iliac art angio,cardiac cath 0.25 NA NA 0.14 0.11 0.01 NA NA 0.40 0.37 ZZZ
G0281 A Elec stim unattend for press 0.18 0.14 0.12 NA NA 0.01 0.33 0.31 NA NA XXX
G0282 N Elect stim wound care not pd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0283 A Elec stim other than wound 0.18 0.14 0.12 NA NA 0.01 0.33 0.31 NA NA XXX
G0288 A Recon, CTA for surg plan 0.00 1.00 8.21 NA NA 0.18 1.18 8.39 NA NA XXX
G0289 A Arthro, loose body + chondro 1.48 NA NA 0.60 0.75 0.26 NA NA 2.34 2.49 ZZZ
G0290 E Drug-eluting stents, single 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0291 E Drug-eluting stents,each add 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0293 E Non-cov surg proc,clin trial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0294 E Non-cov proc, clinical trial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0295 N Electromagnetic therapy onc 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0297 X Insert single chamber/cd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0298 X Insert dual chamber/cd 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0299 X Inser/repos single icd+leads 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0300 X Insert reposit lead dual+gen 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0302 X Pre-op service LVRS complete 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0303 X Pre-op service LVRS 10-15dos 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0304 X Pre-op service LVRS 1-9 dos 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0305 X Post op service LVRS min 6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0306 X CBC/diffwbc w/o platelet 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0307 X CBC without platelet 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0308 A ESRD related svc 4+mo 2yrs 12.74 5.57 7.80 5.57 7.80 0.42 18.73 20.96 18.73 20.96 XXX
G0309 A ESRD related svc 2-3mo 2yrs 10.61 4.85 6.54 4.85 6.54 0.36 15.82 17.51 15.82 17.51 XXX
G0310 A ESRD related svc 1 vst 2yrs 8.49 2.91 4.99 2.91 4.99 0.28 11.68 13.76 11.68 13.76 XXX
G0311 A ESRD related svs 4+mo 2-11yr 9.73 3.62 4.45 3.62 4.45 0.34 13.69 14.52 13.69 14.52 XXX
G0312 A ESRD relate svs 2-3 mo 2-11y 8.11 2.70 3.62 2.70 3.62 0.29 11.10 12.02 11.10 12.02 XXX
G0313 A ESRD related svs 1 mon 2-11y 6.49 1.89 2.83 1.89 2.83 0.22 8.60 9.54 8.60 9.54 XXX
G0314 A ESRD related svs 4+ mo 12-19 8.28 3.46 4.18 3.46 4.18 0.27 12.01 12.73 12.01 12.73 XXX
G0315 A ESRD related svs 2-3mo/12-19 6.90 2.64 3.41 2.64 3.41 0.23 9.77 10.54 9.77 10.54 XXX
G0316 A ESRD related svs 1vis/12-19y 5.52 1.71 2.63 1.71 2.63 0.17 7.40 8.32 7.40 8.32 XXX
G0317 A ESRD related svs 4+mo 20+yrs 5.09 2.29 2.72 2.29 2.72 0.17 7.55 7.98 7.55 7.98 XXX
G0318 A ESRD related svs 2-3 mo 20+y 4.24 1.73 2.22 1.73 2.22 0.14 6.11 6.60 6.11 6.60 XXX
G0319 A ESRD related svs 1visit 20+y 3.39 1.16 1.72 1.16 1.72 0.11 4.66 5.22 4.66 5.22 XXX
G0320 A ESD related svs home undr 2 10.61 2.73 6.01 2.73 6.01 0.36 13.70 16.98 13.70 16.98 XXX
G0321 A ESRDrelatedsvs home mo 2-11y 8.11 2.02 3.45 2.02 3.45 0.29 10.42 11.85 10.42 11.85 XXX
G0322 A ESRD related svs hom mo12-19 6.90 1.76 3.19 1.76 3.19 0.23 8.89 10.32 8.89 10.32 XXX
G0323 A ESRD related svs home mo 20+ 4.24 1.18 2.08 1.18 2.08 0.14 5.56 6.46 5.56 6.46 XXX
G0324 A ESRD relate svs home/dy 2yr 0.35 0.16 0.22 0.16 0.22 0.01 0.52 0.58 0.52 0.58 XXX
G0325 A ESRD relate home/day/ 2-11yr 0.23 0.09 0.11 0.09 0.11 0.01 0.33 0.35 0.33 0.35 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
G0326 A ESRD relate home/dy 12-19yr 0.27 0.10 0.12 0.10 0.12 0.01 0.38 0.40 0.38 0.40 XXX
G0327 A ESRD relate home/dy 20+yrs 0.14 0.06 0.08 0.06 0.08 0.01 0.21 0.23 0.21 0.23 XXX
G0328 X Fecal blood scrn immunoassay 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0329 A Electromagntic tx for ulcers 0.06 0.15 0.14 NA NA 0.01 0.22 0.21 NA NA XXX
G0332 A Preadmin IV immunoglobulin 0.00 NA 1.97 NA NA 0.00 NA 1.97 NA NA XXX
G0333 X Dispense fee initial 30 day 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0337 X Hospice evaluation preelecti 1.34 0.31 0.46 0.31 0.46 0.09 1.74 1.89 1.74 1.89 XXX
G0339 C Robot lin-radsurg com, first 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0340 C Robt lin-radsurg fractx 2-5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0341 A Percutaneous islet celltrans 6.98 NA NA 2.08 2.46 0.48 NA NA 9.54 9.92 000
G0342 A Laparoscopy islet cell trans 11.92 NA NA 5.09 5.24 1.46 NA NA 18.47 18.62 090
G0343 A Laparotomy islet cell transp 19.85 NA NA 8.63 8.72 2.07 NA NA 30.55 30.64 090
G0344 A Initial preventive exam 1.34 1.11 1.13 0.43 0.47 0.10 2.55 2.57 1.87 1.91 XXX
G0364 A Bone marrow aspirate biopsy 0.16 0.16 0.15 0.07 0.06 0.04 0.36 0.35 0.27 0.26 ZZZ
G0365 A Vessel mapping hemo access 0.25 5.16 4.28 NA NA 0.25 5.66 4.78 NA NA XXX
G0365 TC A Vessel mapping hemo access 0.00 5.10 4.20 NA NA 0.23 5.33 4.43 NA NA XXX
G0365 26 A Vessel mapping hemo access 0.25 0.06 0.08 0.06 0.08 0.02 0.33 0.35 0.33 0.35 XXX
G0366 A EKG for initial prevent exam 0.17 0.34 0.47 NA NA 0.03 0.54 0.67 NA NA XXX
G0367 A EKG tracing for initial prev 0.00 0.27 0.41 NA NA 0.02 0.29 0.43 NA NA XXX
G0368 A EKG interpret report preve 0.17 0.07 0.06 0.07 0.06 0.01 0.25 0.24 0.25 0.24 XXX
G0372 A MD service required for PMD 0.17 0.04 0.30 0.04 0.06 0.01 0.22 0.48 0.22 0.24 XXX
G0375 A Smoke/tobacco counselng 3-10 0.24 0.07 0.09 0.07 0.09 0.01 0.32 0.34 0.32 0.34 XXX
G0376 A Smoke/tobacco counseling 10 0.48 0.13 0.17 0.13 0.16 0.01 0.62 0.66 0.62 0.65 XXX
G0378 X Hospital observation per hr 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0379 X Direct admit hospital observ 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G0389 A Ultrasound exam AAA screen 0.58 2.29 2.29 NA NA 0.11 2.98 2.98 NA NA XXX
G0389 TC A Ultrasound exam AAA screen 0.00 2.12 2.12 NA NA 0.08 2.20 2.20 NA NA XXX
G0389 26 A Ultrasound exam AAA screen 0.58 0.17 0.17 0.17 0.17 0.03 0.78 0.78 0.78 0.78 XXX
G0392 A AV fistula or graft arterial 9.48 46.08 46.08 2.47 2.47 0.62 56.18 56.18 12.57 12.57 000
G0393 A AV fistula or graft venous 6.03 59.59 59.59 2.93 2.93 0.34 65.96 65.96 9.30 9.30 000
G0394 X Blood occult test,colorectal 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G3001 X Admin + supply, tositumomab 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9001 X MCCD, initial rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9002 X MCCD,maintenance rate 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9003 X MCCD, risk adj hi, initial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9004 X MCCD, risk adj lo, initial 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9005 X MCCD, risk adj, maintenance 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9006 X MCCD, Home monitoring 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9007 X MCCD, sch team conf 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9008 X Mccd,phys coor-care ovrsght 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9009 X MCCD, risk adj, level 3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9010 X MCCD, risk adj, level 4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9011 X MCCD, risk adj, level 5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
G9012 X Other Specified Case Mgmt 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9013 N ESRD demo bundle level I 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9014 N ESRD demo bundle-level II 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9016 N Demo-smoking cessation coun 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9017 X Amantadine HCL 100mg oral 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9018 X Zanamivir,inhalation pwd 10m 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9019 X Oseltamivir phosphate 75mg 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9020 X Rimantadine HCL 100mg oral 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9033 X Amantadine HCL oral brand 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9034 X Zanamivir, inh pwdr, brand 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9035 X Oseltamivir phosp, brand 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9036 X Rimantadine HCL, brand 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
G9041 A Low vision rehab occupationa 0.44 0.10 0.24 0.10 0.24 0.01 0.55 0.69 0.55 0.69 XXX
G9042 A Low vision rehab orient/mobi 0.10 0.02 0.22 0.02 0.22 0.01 0.13 0.33 0.13 0.33 XXX
G9043 A Low vision lowvision therapi 0.10 0.02 0.22 0.02 0.22 0.01 0.13 0.33 0.13 0.33 XXX
G9044 A Low vision rehabilate teache 0.10 0.02 0.18 0.02 0.18 0.01 0.13 0.29 0.13 0.29 XXX
M0064 A Visit for drug monitoring 0.37 0.89 0.48 0.07 0.11 0.01 1.27 0.86 0.45 0.49 XXX
P3001 A Screening pap smear by phys 0.42 0.37 0.21 0.37 0.21 0.02 0.81 0.65 0.81 0.65 XXX
Q0035 A Cardiokymography 0.17 0.30 0.42 NA NA 0.03 0.50 0.62 NA NA XXX
Q0035 TC A Cardiokymography 0.00 0.25 0.36 NA NA 0.02 0.27 0.38 NA NA XXX
Q0035 26 A Cardiokymography 0.17 0.05 0.06 0.05 0.06 0.01 0.23 0.24 0.23 0.24 XXX
Q0091 A Obtaining screen pap smear 0.37 0.75 0.69 0.10 0.13 0.02 1.14 1.08 0.49 0.52 XXX
Q0092 A Set up port xray equipment 0.00 0.45 0.35 0.45 0.35 0.01 0.46 0.36 0.46 0.36 XXX
Q3001 C Brachytherapy Radioelements 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
Q3014 X Telehealth facility fee 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
R0070 C Transport portable x-ray 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
R0075 C Transport port x-ray multipl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
R0076 B Transport portable EKG 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
V5299 R Hearing service 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
15002 A Wnd prep, ch/inf, trk/arm/lg 3.65 4.12 4.12 1.65 1.65 0.49 8.26 8.26 5.79 5.79 000
15003 A Wnd prep, ch/inf addl 100 cm 0.80 0.92 0.92 0.28 0.28 0.11 1.83 1.83 1.19 1.19 ZZZ
15004 A Wnd prep ch/inf, f/n/hf/g 4.58 4.77 4.77 1.97 1.97 0.62 9.97 9.97 7.17 7.17 000
15005 A Wnd prep, f/n/hf/g, addl cm 1.60 1.28 1.28 0.56 0.56 0.22 3.10 3.10 2.38 2.38 ZZZ
15731 A Forehead flap w/vasc pedicle 14.12 12.13 12.13 9.56 9.56 1.28 27.53 27.53 24.96 24.96 090
15830 R Exc skin abd 16.90 NA NA 10.15 10.15 2.93 NA NA 29.98 29.98 090
15847 C Exc skin abd add-on 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
17003 A Destruct premalg les, 2-14 0.07 0.11 0.11 0.06 0.06 0.01 0.19 0.19 0.14 0.14 ZZZ
17004 A Destroy premlg lesions 15+ 1.82 2.33 2.33 1.54 1.54 0.11 4.26 4.26 3.47 3.47 010
17311 A Mohs, 1 stage, h/n/hf/g 6.20 10.79 10.79 3.16 3.16 0.24 17.23 17.23 9.60 9.60 000
17312 A Mohs addl stage 3.30 6.92 6.92 1.68 1.68 0.13 10.35 10.35 5.11 5.11 ZZZ
17313 A Mohs, 1 stage, t/a/l 5.56 9.95 9.95 2.83 2.83 0.22 15.73 15.73 8.61 8.61 000
17314 A Mohs, addl stage, t/a/l 3.06 6.41 6.41 1.55 1.55 0.12 9.59 9.59 4.73 4.73 ZZZ
17315 A Mohs surg, addl block 0.87 1.15 1.15 0.44 0.44 0.03 2.05 2.05 1.34 1.34 ZZZ
19105 A Cryosurg ablate fa, each 3.69 45.93 45.93 1.00 1.00 0.30 49.92 49.92 4.99 4.99 000
19361 A Breast reconstr w/lat flap 23.17 NA NA 13.65 13.65 2.93 NA NA 39.75 39.75 090
22526 A Idet, single level 6.07 46.51 46.51 2.08 2.08 1.16 53.74 53.74 9.31 9.31 010
22527 A Idet, 1 or more levels 3.03 39.89 39.89 0.70 0.70 0.58 43.50 43.50 4.31 4.31 ZZZ
22857 R Lumbar artif diskectomy 26.93 NA NA 8.80 8.80 3.56 NA NA 39.29 39.29 090
22862 R Revise lumbar artif disc 32.43 NA NA 10.07 10.07 5.36 NA NA 47.86 47.86 090
22865 R Remove lumb artif disc 31.55 NA NA 9.87 9.87 5.18 NA NA 46.60 46.60 090
25109 A Excise tendon forearm/wrist 6.81 NA NA 5.32 5.32 0.96 NA NA 13.09 13.09 090
25606 A Treat fx distal radial 8.10 NA NA 8.41 8.41 1.26 NA NA 17.77 17.77 090
25607 A Treat fx rad extra-articul 9.35 NA NA 7.26 7.26 1.36 NA NA 17.97 17.97 090
25608 A Treat fx rad intra-articul 10.86 NA NA 7.88 7.88 1.84 NA NA 20.58 20.58 090
25609 A Treat fx radial 3+ frag 14.12 NA NA 9.77 9.77 2.38 NA NA 26.27 26.27 090
32998 A Perq rf ablate tx, pul tumor 5.68 68.64 68.64 1.77 1.77 0.36 74.68 74.68 7.81 7.81 000
33202 A Insert epicard eltrd, open 13.15 NA NA 6.22 6.22 1.71 NA NA 21.08 21.08 090
33203 A Insert epicard eltrd, endo 13.92 NA NA 6.29 6.29 1.39 NA NA 21.60 21.60 090
33254 A Ablate atria, lmtd 23.58 NA NA 9.94 9.94 3.35 NA NA 36.87 36.87 090
33255 A Ablate atria w/o bypass, ext 28.91 NA NA 11.57 11.57 3.94 NA NA 44.42 44.42 090
33256 A Ablate atria w/bypass, exten 34.77 NA NA 13.37 13.37 4.95 NA NA 53.09 53.09 090
33265 A Ablate atria w/bypass, endo 23.58 NA NA 9.94 9.94 3.35 NA NA 36.87 36.87 090
33266 A Ablate atria w/o bypass endo 32.91 NA NA 12.80 12.80 4.80 NA NA 50.51 50.51 090
33675 A Close mult vsd 35.87 NA NA 17.82 17.82 4.95 NA NA 58.64 58.64 090
33676 A Close mult vsd w/resection 36.87 NA NA 18.17 18.17 5.44 NA NA 60.48 60.48 090
33677 A Cl mult vsd w/rem pul band 38.37 NA NA 18.82 18.82 5.68 NA NA 62.87 62.87 090
33684 A Repair heart septum defect 34.29 NA NA 15.13 15.13 3.39 NA NA 52.81 52.81 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
33688 A Repair heart septum defect 34.67 NA NA 10.21 10.21 4.73 NA NA 49.61 49.61 090
33724 A Repair venous anomaly 27.55 NA NA 10.56 10.56 4.00 NA NA 42.11 42.11 090
33726 A Repair pul venous stenosis 37.04 NA NA 13.46 13.46 5.03 NA NA 55.53 55.53 090
35302 A Rechanneling of artery 21.27 NA NA 7.14 7.14 2.98 NA NA 31.39 31.39 090
35303 A Rechanneling of artery 23.52 NA NA 7.72 7.72 3.26 NA NA 34.50 34.50 090
35304 A Rechanneling of artery 24.52 NA NA 7.97 7.97 3.41 NA NA 35.90 35.90 090
35305 A Rechanneling of artery 23.52 NA NA 7.72 7.72 3.26 NA NA 34.50 34.50 090
35306 A Rechanneling of artery 9.25 NA NA 2.38 2.38 1.34 NA NA 12.97 12.97 ZZZ
35501 A Artery bypass graft 28.99 NA NA 9.22 9.22 4.10 NA NA 42.31 42.31 090
35509 A Artery bypass graft 27.99 NA NA 9.24 9.24 3.92 NA NA 41.15 41.15 090
35537 A Artery bypass graft 41.75 NA NA 13.22 13.22 5.72 NA NA 60.69 60.69 090
35538 A Artery bypass graft 46.82 NA NA 14.60 14.60 6.39 NA NA 67.81 67.81 090
35539 A Artery bypass graft 43.98 NA NA 13.73 13.73 6.02 NA NA 63.73 63.73 090
35540 A Artery bypass graft 49.20 NA NA 15.10 15.10 6.76 NA NA 71.06 71.06 090
35601 A Artery bypass graft 26.99 NA NA 9.09 9.09 3.72 NA NA 39.80 39.80 090
35637 A Artery bypass graft 32.92 NA NA 10.92 10.92 4.44 NA NA 48.28 48.28 090
35638 A Artery bypass graft 33.47 NA NA 11.06 11.06 4.52 NA NA 49.05 49.05 090
35883 A Revise graft w/nonauto graft 23.07 NA NA 8.96 8.96 3.19 NA NA 35.22 35.22 090
35884 A Revise graft w/vein 24.57 NA NA 9.43 9.43 3.41 NA NA 37.41 37.41 090
37210 A Embolization uterine fibroid 10.60 46.03 46.03 3.13 3.13 0.60 57.23 57.23 14.33 14.33 000
43647 C Lap impl electrode, antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43648 C Lap revise/remv eltrd antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43881 C Impl/redo electrd, antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
43882 C Revise/remove electrd antrum 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
44157 A Colectomy w/ileoanal anast 35.49 NA NA 15.67 15.67 3.93 NA NA 55.09 55.09 090
44158 A Colectomy w/neo-rectum pouch 36.49 NA NA 15.97 15.97 4.06 NA NA 56.52 56.52 090
49324 A Lap insertion perm ip cath 6.27 NA NA 2.80 2.80 0.73 NA NA 9.80 9.80 010
49325 A Lap revision perm ip cath 6.77 NA NA 2.93 2.93 0.86 NA NA 10.56 10.56 010
49326 A Lap w/omentopexy add-on 3.50 NA NA 0.92 0.92 0.44 NA NA 4.86 4.86 ZZZ
49435 A Insert subq exten to ip cath 2.25 NA NA 0.60 0.60 0.28 NA NA 3.13 3.13 ZZZ
49436 A Embedded ip cath exit-site 2.69 NA NA 1.63 1.63 0.28 NA NA 4.60 4.60 010
54150 A Circumcision w/regionl block 1.90 1.50 1.50 1.09 1.09 0.16 3.56 3.56 3.15 3.15 000
55876 A Place rt device/marker, pros 1.73 2.04 2.04 1.03 1.03 0.28 4.05 4.05 3.04 3.04 000
57296 A Revise vag graft, open abd 16.46 NA NA 6.75 6.75 1.68 NA NA 24.89 24.89 090
58240 A Removal of pelvis contents 49.02 NA NA 17.65 17.65 4.23 NA NA 70.90 70.90 090
58541 A Lsh, uterus 250 g or less 14.57 NA NA 6.14 6.14 1.68 NA NA 22.39 22.39 090
58542 A Lsh w/t/o ut 250 g or less 16.43 NA NA 6.66 6.66 1.69 NA NA 24.78 24.78 090
58543 A Lsh uterus above 250 g 16.74 NA NA 6.73 6.73 1.73 NA NA 25.20 25.20 090
58544 A Lsh w/t/o uterus above 250 g 18.24 NA NA 7.16 7.16 1.89 NA NA 27.29 27.29 090
58548 A Lap radical hyst 31.45 NA NA 12.74 12.74 3.52 NA NA 47.71 47.71 090
58957 A Resect recurrent gyn mal 26.06 NA NA 9.63 9.63 2.95 NA NA 38.64 38.64 090
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

CPT1 /HCPCS2 Mod Status Description Physician Work RVUs3 Fully Implemented Non-Facility PE RVUs Year 2007 Transitional Non-Facility PE RVUs Fully Implemented Facility PE RVUs Year 2007 Transitional Facility PE RVUs Mal-Practice RVUs Fully Implemented Non-Facility Total Year 2007 Transitional Non-Facility Total Fully Implemented Facility Total Year 2007 Transitional Facility Total Global
58958 A Resect recur gyn mal w/lym 29.06 NA NA 10.44 10.44 3.29 NA NA 42.79 42.79 090
64910 A Nerve repair w/allograft 11.21 NA NA 5.21 5.21 1.74 NA NA 18.16 18.16 090
64911 A Neurorraphy w/vein autograft 14.21 NA NA 5.97 5.97 1.91 NA NA 22.09 22.09 090
70554 26 A Fmri brain by tech 2.11 0.60 0.60 0.60 0.60 0.10 2.81 2.81 2.81 2.81 XXX
70555 26 A Fmri brain by phys/psych 2.54 0.72 0.72 0.72 0.72 0.11 3.37 3.37 3.37 3.37 XXX
76776 26 A Us exam k transpl w/doppler 0.76 0.23 0.23 0.23 0.23 0.03 1.02 1.02 1.02 1.02 XXX
76813 26 A Ob us nuchal meas, 1 gest 1.18 0.33 0.33 0.33 0.33 0.05 1.56 1.56 1.56 1.56 XXX
76814 26 A Ob us nuchal meas, add-on 0.99 0.27 0.27 0.27 0.27 0.05 1.31 1.31 1.31 1.31 XXX
77371 A Srs, multisource 0.00 30.25 30.25 NA NA 0.13 30.38 30.38 NA NA XXX
77372 A Srs, linear based 0.00 22.93 22.93 NA NA 0.13 23.06 23.06 NA NA XXX
77373 A Sbrt delivery 0.00 42.87 42.87 NA NA 0.13 43.00 43.00 NA NA XXX
77435 A Sbrt management 13.00 4.63 4.63 NA NA 0.67 18.30 18.30 NA NA XXX
78730 26 A Urinary bladder retention 0.15 0.11 0.11 0.11 0.11 0.02 0.28 0.28 0.28 0.28 ZZZ
91111 26 A Esophageal capsule endoscopy 1.00 0.46 0.46 0.46 0.46 0.03 1.49 1.49 1.49 1.49 XXX
92025 26 A Corneal topography 0.35 0.12 0.12 0.12 0.12 0.01 0.48 0.48 0.48 0.48 XXX
92640 A Aud brainstem implt programg 0.00 1.40 1.40 1.40 1.40 0.01 1.41 1.41 1.41 1.41 XXX
94002 A Vent mgmt inpat, init day 1.99 NA NA 0.34 0.34 0.09 NA NA 2.42 2.42 XXX
94003 A Vent mgmt inpat, subq day 1.37 NA NA 0.33 0.33 0.06 NA NA 1.76 1.76 XXX
94004 A Vent mgmt nf per day 1.00 NA NA 0.24 0.24 0.04 NA NA 1.28 1.28 XXX
94005 B Home vent mgmt supervision 1.50 0.69 0.69 NA NA 0.06 2.25 2.25 NA NA XXX
94610 A Surfactant admin thru tube 1.16 0.35 0.35 0.35 0.35 0.26 1.77 1.77 1.77 1.77 XXX
94644 A Cbt, 1st hour 0.00 0.92 0.92 NA NA 0.02 0.94 0.94 NA NA XXX
94645 A Cbt, each addl hour 0.00 0.34 0.34 NA NA 0.02 0.36 0.36 NA NA XXX
94774 C Ped home apnea rec, compl 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94775 C Ped home apnea rec, hk-up 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94776 C Ped home apnea rec, downld 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
94777 C Ped home apnea rec, report 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 YYY
95012 A Exhaled nitric oxide meas 0.00 0.48 0.48 NA NA 0.01 0.49 0.49 NA NA XXX
96020 26 A Functional brain mapping 3.43 0.86 0.86 0.86 0.86 0.17 4.46 4.46 4.46 4.46 XXX
96040 B Genetic counseling, 30 min 0.00 0.97 0.97 NA NA 0.01 0.98 0.98 NA NA XXX
96904 R Whole body photography 0.00 1.84 1.84 NA NA 0.01 1.85 1.85 NA NA XXX
99251 A Inpatient consultation 1.00 NA NA 0.26 0.26 0.05 NA NA 1.31 1.31 XXX
99252 A Inpatient consultation 1.50 NA NA 0.50 0.50 0.09 NA NA 2.09 2.09 XXX
99253 A Inpatient consultation 2.27 NA NA 0.72 0.72 0.11 NA NA 3.10 3.10 XXX
99254 A Inpatient consultation 3.29 NA NA 1.04 1.04 0.13 NA NA 4.46 4.46 XXX
99255 A Inpatient consultation 4.00 NA NA 1.37 1.37 0.18 NA NA 5.55 5.55 XXX
99363 B Anticoag mgmt, init 1.65 1.29 1.29 0.38 0.38 0.07 3.01 3.01 2.10 2.10 XXX
99364 B Anticoag mgmt, subseq 0.63 0.38 0.38 0.15 0.15 0.04 1.05 1.05 0.82 0.82 XXX
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Apply.
2 Copyright 2006 American Dental Association. All rights reserved.
3 + Indicates RVUs are not used for Medicare payment.

Carrier Locality Locality name Work GPCI PE GPCI MP GPCI
00510 00 Alabama 0.982 0.847 0.740
00831 01 Alaska 1.017 1.105 1.013
00312 00 Arizona 0.987 0.994 1.052
00520 13 Arkansas 0.961 0.832 0.431
31140 03 Marin/Napa/Solano, CA 1.035 1.342 0.640
31140 05 San Francisco, CA 1.060 1.546 0.640
31140 06 San Mateo, CA 1.073 1.539 0.629
31140 07 Oakland/Berkley, CA 1.054 1.373 0.640
31140 09 Santa Clara, CA 1.083 1.543 0.595
31146 17 Ventura, CA 1.028 1.181 0.732
31146 18 Los Angeles, CA 1.041 1.158 0.939
31146 26 Anaheim/Santa Ana, CA 1.034 1.238 0.939
31140 99 Rest of California * 1.007 1.054 0.721
31146 99 Rest of California * 1.007 1.054 0.721
00824 01 Colorado 0.986 1.015 0.790
00591 00 Connecticut 1.038 1.172 0.886
00903 01 DC + MD/VA Suburbs 1.048 1.252 0.911
00902 01 Delaware 1.012 1.020 0.877
00590 03 Fort Lauderdale, FL 0.988 0.990 1.675
00590 04 Miami, FL 1.000 1.048 2.233
00590 99 Rest of Florida 0.973 0.936 1.251
00511 01 Atlanta, GA 1.010 1.091 0.950
00511 99 Rest of Georgia 0.979 0.874 0.950
00833 01 Hawaii/Guam 1.005 1.113 0.787
05130 00 Idaho 0.968 0.869 0.452
00952 12 East St. Louis, IL 0.988 0.940 1.722
00952 15 Suburban Chicago, IL 1.018 1.117 1.626
00952 16 Chicago, IL 1.025 1.128 1.837
00952 99 Rest of Illinois 0.974 0.874 1.174
00630 00 Indiana 0.985 0.908 0.429
00826 00 Iowa 0.967 0.869 0.579
00650 00 Kansas * 0.968 0.880 0.709
00740 04 Kansas * 0.968 0.880 0.709
00660 00 Kentucky 0.970 0.855 0.859
00528 01 New Orleans, LA 0.986 0.947 1.178
00528 99 Rest of Louisiana 0.970 0.848 1.041
31142 03 Southern Maine 0.980 1.014 0.626
31142 99 Rest of Maine 0.962 0.887 0.626
00901 01 Baltimore/Surr. Cntys, MD 1.012 1.080 0.932
00901 99 Rest of Maryland 0.993 0.981 0.748
31143 01 Metropolitan Boston 1.030 1.331 0.810
31143 99 Rest of Massachusetts 1.007 1.105 0.810
00953 01 Detroit, MI 1.037 1.056 2.700
00953 99 Rest of Michigan 0.997 0.922 1.494
00954 00 Minnesota 0.991 1.006 0.404
00512 00 Mississippi 0.960 0.841 0.711
00523 01 Metropolitan St. Louis, MO 0.992 0.956 0.926
00740 02 Metropolitan Kansas City, MO 0.989 0.977 0.931
00523 99 Rest of Missouri * 0.950 0.803 0.878
00740 99 Rest of Missouri * 0.950 0.803 0.878
03202 01 Montana 0.950 0.845 0.889
00655 00 Nebraska 0.959 0.876 0.447
00834 00 Nevada 1.003 1.045 1.050
31144 40 New Hampshire 0.981 1.029 0.927
00805 01 Northern NJ 1.058 1.222 0.958
00805 99 Rest of New Jersey 1.043 1.121 0.958
00521 05 New Mexico 0.972 0.888 0.880
00801 99 Rest of New York 0.997 0.919 0.666
00803 01 Manhattan, NY 1.065 1.300 1.480
00803 02 NYC Suburbs/Long I., NY 1.052 1.283 1.756
00803 03 Poughkpsie/N NYC Suburbs, NY 1.014 1.076 1.148
14330 04 Queens, NY 1.032 1.230 1.682
05535 00 North Carolina 0.971 0.922 0.630
03302 01 North Dakota 0.946 0.861 0.593
00883 00 Ohio 0.992 0.934 0.960
00522 00 Oklahoma 0.964 0.856 0.376
00835 01 Portland, OR 1.002 1.059 0.434
00835 99 Rest of Oregon 0.968 0.927 0.434
00865 01 Metropolitan Philadelphia, PA 1.016 1.106 1.364
00865 99 Rest of Pennsylvania 0.992 0.904 0.793
00973 20 Puerto Rico 0.906 0.699 0.257
00524 01 Rhode Island 1.045 0.991 0.895
00880 01 South Carolina 0.975 0.894 0.388
03402 02 South Dakota 0.943 0.877 0.359
05440 35 Tennessee 0.977 0.881 0.621
00900 09 Brazoria, TX 1.020 0.963 1.277
00900 11 Dallas, TX 1.009 1.064 1.044
00900 15 Galveston, TX 0.990 0.954 1.277
00900 18 Houston, TX 1.016 1.016 1.276
00900 20 Beaumont, TX 0.983 0.862 1.277
00900 28 Fort Worth, TX 0.997 0.991 1.044
00900 31 Austin, TX 0.991 1.048 0.970
00900 99 Rest of Texas 0.968 0.866 1.120
03502 09 Utah 0.977 0.938 0.651
31145 50 Vermont 0.968 0.970 0.505
00973 50 Virgin Islands 0.967 1.015 0.987
00904 00 Virginia 0.981 0.942 0.569
00836 02 Seattle (King Cnty), WA 1.014 1.133 0.805
00836 99 Rest of Washington 0.987 0.980 0.805
00884 16 West Virginia 0.973 0.820 1.522
00951 00 Wisconsin 0.987 0.920 0.777
03602 21 Wyoming 0.956 0.855 0.920
* States are served by more than one carrier.

Carrier Locality Locality name GAF
31140 09 Santa Clara, CA 1.265
31140 06 San Mateo, CA 1.259
31140 05 San Francisco, CA 1.256
00803 01 Manhattan, NY 1.184
00803 02 NYC Suburbs/Long I., NY 1.180
31140 07 Oakland/Berkley, CA 1.177
31140 03 Marin/Napa/Solano, CA 1.154
31143 01 Metropolitan Boston 1.153
14330 04 Queens, NY 1.144
00903 01 DC + MD/VA Suburbs 1.132
00805 01 Northern NJ 1.126
31146 26 Anaheim/Santa Ana, CA 1.120
00953 01 Detroit, MI 1.110
00952 16 Chicago, IL 1.102
00591 00 Connecticut 1.091
31146 18 Los Angeles, CA 1.088
00952 15 Suburban Chicago, IL 1.085
31146 17 Ventura, CA 1.084
00805 99 Rest of New Jersey 1.074
00865 01 Metropolitan Philadelphia, PA 1.069
00590 04 Miami, FL 1.069
00836 02 Seattle (King Cnty), WA 1.058
00831 01 Alaska 1.055
00803 03 Poughkpsie/N NYC Suburbs, NY 1.046
00833 01 Hawaii/Guam 1.044
00511 01 Atlanta, GA 1.043
31143 99 Rest of Massachusetts 1.042
00901 01 Baltimore/Surr. Cntys, MD 1.039
00900 11 Dallas, TX 1.035
00900 18 Houston, TX 1.026
00834 00 Nevada 1.023
31140 99 Rest of California * 1.017
31146 99 Rest of California * 1.017
00524 01 Rhode Island 1.016
00590 03 Fort Lauderdale, FL 1.015
00900 31 Austin, TX 1.015
00902 01 Delaware 1.011
00900 09 Brazoria, TX 1.005
00835 01 Portland, OR 1.005
31144 40 New Hampshire 1.000
00900 28 Fort Worth, TX 0.996
00952 12 East St. Louis, IL 0.995
00832 00 Arizona 0.993
00824 01 Colorado 0.991
00973 50 Virgin Islands 0.989
00900 15 Galveston, TX 0.985
00953 99 Rest of Michigan 0.984
00740 02 Metropolitan Kansas City, MO 0.982
31142 03 Southern Maine 0.981
00901 99 Rest of Maryland 0.978
00836 99 Rest of Washington 0.977
00528 01 New Orleans, LA 0.976
00954 00 Minnesota 0.975
00523 01 Metropolitan St. Louis, MO 0.974
00590 99 Rest of Florida 0.968
00883 00 Ohio 0.965
31145 50 Vermont 0.951
00801 99 Rest of New York 0.950
00951 00 Wisconsin 0.950
00904 00 Virginia 0.948
00910 09 Utah 0.947
00865 99 Rest of Pennsylvania 0.946
00900 20 Beaumont, TX 0.942
00952 99 Rest of Illinois 0.938
05535 00 North Carolina 0.936
00511 99 Rest of Georgia 0.932
00521 05 New Mexico 0.932
00630 00 Indiana 0.930
00835 99 Rest of Oregon 0.929
00900 99 Rest of Texas 0.929
00884 16 West Virginia 0.927
05440 35 Tennessee 0.921
00650 00 Kansas * 0.919
00740 04 Kansas * 0.919
00528 99 Rest of Louisiana 0.919
00880 01 South Carolina 0.917
31142 99 Rest of Maine 0.916
00660 00 Kentucky 0.915
00510 00 Alabama 0.914
00825 21 Wyoming 0.910
00826 00 Iowa 0.909
05130 00 Idaho 0.905
00655 00 Nebraska 0.903
00751 01 Montana 0.902
00512 00 Mississippi 0.898
00820 01 North Dakota 0.895
00522 00 Oklahoma 0.894
00820 02 South Dakota 0.891
00520 13 Arkansas 0.884
00523 99 Rest of Missouri * 0.883
00740 99 Rest of Missouri * 0.883
00973 20 Puerto Rico 0.790
* States are served by more than one carrier.

HCPCS/CPT* Short descriptor
31620 Endobronchial us add-on
37250 Iv us first vessel add-on
37251 Iv us each add vessel add-on
51798 Us urine capacity measure
70010 Contrast x-ray of brain
70015 Contrast x-ray of brain
70030 X-ray eye for foreign body
70100 X-ray exam of jaw
70110 X-ray exam of jaw
70120 X-ray exam of mastoids
70130 X-ray exam of mastoids
70134 X-ray exam of middle ear
70140 X-ray exam of facial bones
70150 X-ray exam of facial bones
70160 X-ray exam of nasal bones
70170 X-ray exam of tear duct
70190 X-ray exam of eye sockets
70200 X-ray exam of eye sockets
70210 X-ray exam of sinuses
70220 X-ray exam of sinuses
70240 X-ray exam, pituitary saddle
70250 X-ray exam of skull
70260 X-ray exam of skull
70300 X-ray exam of teeth
70310 X-ray exam of teeth
70320 Full mouth x-ray of teeth
70328 X-ray exam of jaw joint
70330 X-ray exam of jaw joints
70332 X-ray exam of jaw joint
70336 Magnetic image, jaw joint
70350 X-ray head for orthodontia
70355 Panoramic x-ray of jaws
70360 X-ray exam of neck
70370 Throat x-ray fluoroscopy
70371 Speech evaluation, complex
70373 Contrast x-ray of larynx
70380 X-ray exam of salivary gland
70390 X-ray exam of salivary duct
70450 Ct head/brain w/o dye
70460 Ct head/brain w/dye
70470 Ct head/brain w/o w/dye
70480 Ct orbit/ear/fossa w/o dye
70481 Ct orbit/ear/fossa w/dye
70482 Ct orbit/ear/fossa w/ow/dye
70486 Ct maxillofacial w/o dye
70487 Ct maxillofacial w/dye
70488 Ct maxillofacial w/o w/dye
70490 Ct soft tissue neck w/o dye
70491 Ct soft tissue neck w/dye
70492 Ct sft tsue nck w/o w/dye
70496 Ct angiography, head
70498 Ct angiography, neck
70540 Mri orbit/face/neck w/o dye
70542 Mri orbit/face/neck w/dye
70543 Mri orbt/fac/nck w/o w/dye
70544 Mr angiography head w/o dye
70545 Mr angiography head w/dye
70546 Mr angiograph head w/ow/dye
70547 Mr angiography neck w/o dye
70548 Mr angiography neck w/dye
70549 Mr angiograph neck w/ow/dye
70551 Mri brain w/o dye
70552 Mri brain w/dye
70553 Mri brain w/o w/dye
70557 Mri brain w/o dye
70558 Mri brain w/dye
70559 Mri brain w/o w/dye
71010 Chest x-ray
71015 Chest x-ray
71020 Chest x-ray
71021 Chest x-ray
71022 Chest x-ray
71023 Chest x-ray and fluoroscopy
71030 Chest x-ray
71034 Chest x-ray and fluoroscopy
71035 Chest x-ray
71040 Contrast x-ray of bronchi
71060 Contrast x-ray of bronchi
71090 X-ray pacemaker insertion
71100 X-ray exam of ribs
71101 X-ray exam of ribs/chest
71110 X-ray exam of ribs
71111 X-ray exam of ribs/chest
71120 X-ray exam of breastbone
71130 X-ray exam of breastbone
71250 Ct thorax w/o dye
71260 Ct thorax w/dye
71270 Ct thorax w/o w/dye
71275 Ct angiography, chest
71550 Mri chest w/o dye
71551 Mri chest w/dye
71552 Mri chest w/o w/dye
71555 Mri angio chest w or w/o dye
72010 X-ray exam of spine
72020 X-ray exam of spine
72040 X-ray exam of neck spine
72050 X-ray exam of neck spine
72052 X-ray exam of neck spine
72069 X-ray exam of trunk spine
72070 X-ray exam of thoracic spine
72072 X-ray exam of thoracic spine
72074 X-ray exam of thoracic spine
72080 X-ray exam of trunk spine
72090 X-ray exam of trunk spine
72100 X-ray exam of lower spine
72110 X-ray exam of lower spine
72114 X-ray exam of lower spine
72120 X-ray exam of lower spine
72125 Ct neck spine w/o dye
72126 Ct neck spine w/dye
72127 Ct neck spine w/o w/dye
72128 Ct chest spine w/o dye
72129 Ct chest spine w/dye
72130 Ct chest spine w/o w/dye
72131 Ct lumbar spine w/o dye
72132 Ct lumbar spine w/dye
72133 Ct lumbar spine w/o w/dye
72141 Mri neck spine w/o dye
72142 Mri neck spine w/dye
72146 Mri chest spine w/o dye
72147 Mri chest spine w/dye
72148 Mri lumbar spine w/o dye
72149 Mri lumbar spine w/dye
72156 Mri neck spine w/o w/dye
72157 Mri chest spine w/o w/dye
72158 Mri lumbar spine w/o w/dye
72159 Mr angio spine w/ow/dye
72170 X-ray exam of pelvis
72190 X-ray exam of pelvis
72191 Ct angiograph pelv w/ow/dye
72192 Ct pelvis w/o dye
72193 Ct pelvis w/dye
72194 Ct pelvis w/o w/dye
72195 Mri pelvis w/o dye
72196 Mri pelvis w/dye
72197 Mri pelvis w/o w/dye
72198 Mr angio pelvis w/o w/dye
72200 X-ray exam sacroiliac joints
72202 X-ray exam sacroiliac joints
72220 X-ray exam of tailbone
72240 Contrast x-ray of neck spine
72255 Contrast x-ray, thorax spine
72265 Contrast x-ray, lower spine
72270 Contrast x-ray, spine
72275 Epidurography
72285 X-ray c/t spine disk
72291 Percut vertebroplasty fluor
72293 Percut vertebroplasty, ct
72295 X-ray of lower spine disk
73000 X-ray exam of collar bone
73010 X-ray exam of shoulder blade
73020 X-ray exam of shoulder
73030 X-ray exam of shoulder
73040 Contrast x-ray of shoulder
73050 X-ray exam of shoulders
73060 X-ray exam of humerus
73070 X-ray exam of elbow
73080 X-ray exam of elbow
73085 Contrast x-ray of elbow
73090 X-ray exam of forearm
73092 X-ray exam of arm, infant
73100 X-ray exam of wrist
73110 X-ray exam of wrist
73115 Contrast x-ray of wrist
73120 X-ray exam of hand
73130 X-ray exam of hand
73140 X-ray exam of finger(s)
73200 Ct upper extremity w/o dye
73201 Ct upper extremity w/dye
73202 Ct uppr extremity w/ow/dye
73206 Ct angio upr extrm w/ow/dye
73218 Mri upper extremity w/o dye
73219 Mri upper extremity w/dye
73220 Mri uppr extremity w/ow/dye
73221 Mri joint upr extrem w/o dye
73222 Mri joint upr extrem w/dye
73223 Mri joint upr extr w/ow/dye
73225 Mr angio upr extr w/ow/dye
73500 X-ray exam of hip
73510 X-ray exam of hip
73520 X-ray exam of hips
73525 Contrast x-ray of hip
73530 X-ray exam of hip
73540 X-ray exam of pelvis hips
73542 X-ray exam, sacroiliac joint
73550 X-ray exam of thigh
73560 X-ray exam of knee, 1 or 2
73562 X-ray exam of knee, 3
73564 X-ray exam, knee, 4 or more
73565 X-ray exam of knees
73580 Contrast x-ray of knee joint
73590 X-ray exam of lower leg
73592 X-ray exam of leg, infant
73600 X-ray exam of ankle
73610 X-ray exam of ankle
73615 Contrast x-ray of ankle
73620 X-ray exam of foot
73630 X-ray exam of foot
73650 X-ray exam of heel
73660 X-ray exam of toe(s)
73700 Ct lower extremity w/o dye
73701 Ct lower extremity w/dye
73702 Ct lwr extremity w/ow/dye
73706 Ct angio lwr extr w/ow/dye
73718 Mri lower extremity w/o dye
73719 Mri lower extremity w/dye
73720 Mri lwr extremity w/ow/dye
73721 Mri jnt of lwr extre w/o dye
73722 Mri joint of lwr extr w/dye
73723 Mri joint lwr extr w/ow/dye
73725 Mr ang lwr ext w or w/o dye
74000 X-ray exam of abdomen
74010 X-ray exam of abdomen
74020 X-ray exam of abdomen
74022 X-ray exam series, abdomen
74150 Ct abdomen w/o dye
74160 Ct abdomen w/dye
74170 Ct abdomen w/o w/dye
74175 Ct angio abdom w/o w/dye
74181 Mri abdomen w/o dye
74182 Mri abdomen w/dye
74183 Mri abdomen w/o w/dye
74185 Mri angio, abdom w orw/o dye
74190 X-ray exam of peritoneum
74210 Contrst x-ray exam of throat
74220 Contrast x-ray, esophagus
74230 Cine/vid x-ray, throat/esoph
74235 Remove esophagus obstruction
74240 X-ray exam, upper gi tract
74241 X-ray exam, upper gi tract
74245 X-ray exam, upper gi tract
74246 Contrst x-ray uppr gi tract
74247 Contrst x-ray uppr gi tract
74249 Contrst x-ray uppr gi tract
74250 X-ray exam of small bowel
74251 X-ray exam of small bowel
74260 X-ray exam of small bowel
74270 Contrast x-ray exam of colon
74280 Contrast x-ray exam of colon
74283 Contrast x-ray exam of colon
74290 Contrast x-ray, gallbladder
74291 Contrast x-rays, gallbladder
74300 X-ray bile ducts/pancreas
74301 X-rays at surgery add-on
74305 X-ray bile ducts/pancreas
74320 Contrast x-ray of bile ducts
74327 X-ray bile stone removal
74328 X-ray bile duct endoscopy
74329 X-ray for pancreas endoscopy
74330 X-ray bile/panc endoscopy
74340 X-ray guide for GI tube
74350 X-ray guide, stomach tube
74355 X-ray guide, intestinal tube
74360 X-ray guide, GI dilation
74363 X-ray, bile duct dilation
74400 Contrst x-ray, urinary tract
74410 Contrst x-ray, urinary tract
74415 Contrst x-ray, urinary tract
74420 Contrst x-ray, urinary tract
74425 Contrst x-ray, urinary tract
74430 Contrast x-ray, bladder
74440 X-ray, male genital tract
74445 X-ray exam of penis
74450 X-ray, urethra/bladder
74455 X-ray, urethra/bladder
74470 X-ray exam of kidney lesion
74475 X-ray control, cath insert
74480 X-ray control, cath insert
74485 X-ray guide, GU dilation
74710 X-ray measurement of pelvis
74740 X-ray, female genital tract
74742 X-ray, fallopian tube
74775 X-ray exam of perineum
75552 Heart mri for morph w/o dye
75553 Heart mri for morph w/dye
75554 Cardiac MRI/function
75555 Cardiac MRI/limited study
75556 Cardiac MRI/flow mapping
75600 Contrast x-ray exam of aorta
75605 Contrast x-ray exam of aorta
75625 Contrast x-ray exam of aorta
75630 X-ray aorta, leg arteries
75635 Ct angio abdominal arteries
75650 Artery x-rays, head neck
75658 Artery x-rays, arm
75660 Artery x-rays, head neck
75662 Artery x-rays, head neck
75665 Artery x-rays, head neck
75671 Artery x-rays, head neck
75676 Artery x-rays, neck
75680 Artery x-rays, neck
75685 Artery x-rays, spine
75705 Artery x-rays, spine
75710 Artery x-rays, arm/leg
75716 Artery x-rays, arms/legs
75722 Artery x-rays, kidney
75724 Artery x-rays, kidneys
75726 Artery x-rays, abdomen
75731 Artery x-rays, adrenal gland
75733 Artery x-rays, adrenals
75736 Artery x-rays, pelvis
75741 Artery x-rays, lung
75743 Artery x-rays, lungs
75746 Artery x-rays, lung
75756 Artery x-rays, chest
75774 Artery x-ray, each vessel
75790 Visualize A-V shunt
75801 Lymph vessel x-ray, arm/leg
75803 Lymph vessel x-ray,arms/legs
75805 Lymph vessel x-ray, trunk
75807 Lymph vessel x-ray, trunk
75809 Nonvascular shunt, x-ray
75810 Vein x-ray, spleen/liver
75820 Vein x-ray, arm/leg
75822 Vein x-ray, arms/legs
75825 Vein x-ray, trunk
75827 Vein x-ray, chest
75831 Vein x-ray, kidney
75833 Vein x-ray, kidneys
75840 Vein x-ray, adrenal gland
75842 Vein x-ray, adrenal glands
75860 Vein x-ray, neck
75870 Vein x-ray, skull
75872 Vein x-ray, skull
75880 Vein x-ray, eye socket
75885 Vein x-ray, liver
75887 Vein x-ray, liver
75889 Vein x-ray, liver
75891 Vein x-ray, liver
75893 Venous sampling by catheter
75894 X-rays, transcath therapy
75896 X-rays, transcath therapy
75898 Follow-up angiography
75900 Intravascular cath exchange
75901 Remove cva device obstruct
75902 Remove cva lumen obstruct
75940 X-ray placement, vein filter
75945 Intravascular us
75946 Intravascular us add-on
75953 Abdom aneurysm endovas rpr
75956 Xray, endovasc thor ao repr
75957 Xray, endovasc thor ao repr
75958 Xray, place prox ext thor ao
75959 Xray, place dist ext thor ao
75960 Transcath iv stent rsi
75961 Retrieval, broken catheter
75962 Repair arterial blockage
75964 Repair artery blockage, each
75966 Repair arterial blockage
75968 Repair artery blockage, each
75970 Vascular biopsy
75978 Repair venous blockage
75980 Contrast xray exam bile duct
75982 Contrast xray exam bile duct
75984 Xray control catheter change
75989 Abscess drainage under x-ray
75992 Atherectomy, x-ray exam
76000 Fluoroscope examination
76001 Fluoroscope exam, extensive
76010 X-ray, nose to rectum
76080 X-ray exam of fistula
76098 X-ray exam, breast specimen
76100 X-ray exam of body section
76101 Complex body section x-ray
76102 Complex body section x-rays
76120 Cine/video x-rays
76125 Cine/video x-rays add-on
76140 X-ray consultation
76150 X-ray exam, dry process
76350 Special x-ray contrast study
76376 3d render w/o postprocess
76377 3d rendering w/postprocess
76380 CAT scan follow-up study
76390 Mr spectroscopy
76496 Fluoroscopic procedure
76497 Ct procedure
76498 Mri procedure
76506 Echo exam of head
76510 Ophth us, b quant a
76511 Ophth us, quant a only
76512 Ophth us, b w/non-quant a
76513 Echo exam of eye, water bath
76514 Echo exam of eye, thickness
76516 Echo exam of eye
76519 Echo exam of eye
76529 Echo exam of eye
76536 Us exam of head and neck
76604 Us exam, chest, b-scan
76645 Us exam, breast(s)
76700 Us exam, abdom, complete
76705 Echo exam of abdomen
76770 Us exam abdo back wall, comp
76775 Us exam abdo back wall, lim
76778 Us exam kidney transplant
76800 Us exam, spinal canal
76801 Ob us 14 wks, single fetus
76802 Ob us 14 wks, add?l fetus
76805 Ob us /= 14 wks, sngl fetus
76810 Ob us /= 14 wks, addl fetus
76811 Ob us, detailed, sngl fetus
76812 Ob us, detailed, addl fetus
76815 Ob us, limited, fetus(s)
76816 Ob us, follow-up, per fetus
76817 Transvaginal us, obstetric
76818 Fetal biophys profile w/nst
76819 Fetal biophys profil w/o nst
76820 Umbilical artery echo
76821 Middle cerebral artery echo
76825 Echo exam of fetal heart
76826 Echo exam of fetal heart
76827 Echo exam of fetal heart
76828 Echo exam of fetal heart
76830 Transvaginal us, non-ob
76831 Echo exam, uterus
76856 Us exam, pelvic, complete
76857 Us exam, pelvic, limited
76870 Us exam, scrotum
76872 Us, transrectal
76873 Echograp trans r, pros study
76880 Us exam, extremity
76885 Us exam infant hips, dynamic
76886 Us exam infant hips, static
76930 Echo guide, cardiocentesis
76932 Echo guide for heart biopsy
76936 Echo guide for artery repair
76937 Us guide, vascular access
76940 Us guide, tissue ablation
76941 Echo guide for transfusion
76942 Echo guide for biopsy
76945 Echo guide, villus sampling
76946 Echo guide for amniocentesis
76948 Echo guide, ova aspiration
76950 Echo guidance radiotherapy
76965 Echo guidance radiotherapy
76970 Ultrasound exam follow-up
76975 GI endoscopic ultrasound
76977 Us bone density measure
76998 Ultrasound guide intraoper
77001 Fluoroguide for vein device
77002 Needle localization by x-ray
77003 Fluoroguide for spine inject
77011 Ct scan for localization
77012 Ct scan for needle biopsy
77013 Ct guide for tissue ablation
77014 Ct scan for therapy guide
77021 Mr guidance for needle place
77022 Mri for tissue ablation
77031 Stereotactic breast biopsy
77032 X-ray of needle wire, breast
77053 X-ray of mammary duct
77054 X-ray of mammary ducts
77058 Magnetic image, breast
77059 Magnetic image, both breasts
77071 X-ray stress view
77072 X-rays for bone age
77073 X-rays, bone evaluation
77074 X-rays, bone survey
77075 X-rays, bone survey
77076 X-rays, bone evaluation
77077 Joint survey, single view
77078 Ct bone density, axial
77079 Ct bone density, peripheral
77080 Dxa bone density, axial
77081 Dxa bone density/peripheral
77082 Dxa bone density/v-fracture
77083 Radiographic absorptiometry
77084 Magnetic image, bone marrow
77417 Radiology port film(s)
77421 Stereoscopic x-ray guidance
78006 Thyroid imaging with uptake
78007 Thyroid image, mult uptakes
78010 Thyroid imaging
78011 Thyroid imaging with flow
78015 Thyroid met imaging
78016 Thyroid met imaging/studies
78018 Thyroid met imaging, body
78020 Thyroid met uptake
78070 Parathyroid nuclear imaging
78075 Adrenal nuclear imaging
78102 Bone marrow imaging, ltd
78103 Bone marrow imaging, mult
78104 Bone marrow imaging, body
78135 Red cell survival kinetics
78140 Red cell sequestration
78185 Spleen imaging
78190 Platelet survival, kinetics
78195 Lymph system imaging
78201 Liver imaging
78202 Liver imaging with flow
78205 Liver imaging (3D)
78206 Liver image (3d) with flow
78215 Liver and spleen imaging
78216 Liver spleen image/flow
78220 Liver function study
78223 Hepatobiliary imaging
78230 Salivary gland imaging
78231 Serial salivary imaging
78232 Salivary gland function exam
78258 Esophageal motility study
78261 Gastric mucosa imaging
78262 Gastroesophageal reflux exam
78264 Gastric emptying study
78278 Acute GI blood loss imaging
78282 GI protein loss exam
78290 Meckel's divert exam
78291 Leveen/shunt patency exam
78300 Bone imaging, limited area
78305 Bone imaging, multiple areas
78306 Bone imaging, whole body
78315 Bone imaging, 3 phase
78320 Bone imaging (3D)
78350 Bone mineral, single photon
78351 Bone mineral, dual photon
78428 Cardiac shunt imaging
78445 Vascular flow imaging
78456 Acute venous thrombus image
78457 Venous thrombosis imaging
78458 Ven thrombosis images, bilat
78459 Heart muscle imaging (PET)
78460 Heart muscle blood, single
78461 Heart muscle blood, multiple
78464 Heart image (3d), single
78465 Heart image (3d), multiple
78466 Heart infarct image
78468 Heart infarct image (ef)
78469 Heart infarct image (3D)
78472 Gated heart, planar, single
78473 Gated heart, multiple
78478 Heart wall motion add-on
78480 Heart function add-on
78481 Heart first pass, single
78483 Heart first pass, multiple
78491 Heart image (pet), single
78492 Heart image (pet), multiple
78494 Heart image, spect
78496 Heart first pass add-on
78580 Lung perfusion imaging
78584 Lung V/Q image single breath
78585 Lung V/Q imaging
78586 Aerosol lung image, single
78587 Aerosol lung image, multiple
78588 Perfusion lung image
78591 Vent image, 1 breath, 1 proj
78593 Vent image, 1 proj, gas
78594 Vent image, mult proj, gas
78596 Lung differential function
78600 Brain imaging, ltd static
78601 Brain imaging, ltd w/flow
78605 Brain imaging, complete
78606 Brain imaging, compl w/flow
78607 Brain imaging (3D)
78608 Brain imaging (PET)
78609 Brain imaging (PET)
78610 Brain flow imaging only
78615 Cerebral vascular flow image
78630 Cerebrospinal fluid scan
78635 CSF ventriculography
78645 CSF shunt evaluation
78647 Cerebrospinal fluid scan
78650 CSF leakage imaging
78660 Nuclear exam of tear flow
78700 Kidney imaging, static
78701 Kidney imaging with flow
78704 Imaging renogram
78707 Kidney flow/function image
78708 Kidney flow/function image
78709 Kidney flow/function image
78710 Kidney imaging (3D)
78715 Renal vascular flow exam
78730 Urinary bladder retention
78740 Ureteral reflux study
78760 Testicular imaging
78761 Testicular imaging/flow
78800 Tumor imaging, limited area
78801 Tumor imaging, mult areas
78802 Tumor imaging, whole body
78803 Tumor imaging (3D)
78804 Tumor imaging, whole body
78805 Abscess imaging, ltd area
78806 Abscess imaging, whole body
78807 Nuclear localization/abscess
78811 Tumor imaging (pet), limited
78812 Tumor image (pet)/skul-thigh
78813 Tumor image (pet) full body
78814 Tumor image pet/ct, limited
78815 Tumorimage pet/ct skul-thigh
78816 Tumor image pet/ct full body
78890 Nuclear medicine data proc
78891 Nuclear med data proc
93303 Echo transthoracic
93304 Echo transthoracic
93307 Echo exam of heart
93308 Echo exam of heart
93312 Echo transesophageal
93313 Echo transesophageal
93314 Echo transesophageal
93315 Echo transesophageal
93316 Echo transesophageal
93317 Echo transesophageal
93318 Echo transesophageal intraop
93320 Doppler echo exam, heart
93321 Doppler echo exam, heart
93325 Doppler color flow add-on
93350 Echo transthoracic
93555 Imaging, cardiac cath
93556 Imaging, cardiac cath
93571 Heart flow reserve measure
93572 Heart flow reserve measure
93880 Extracranial study
93882 Extracranial study
93886 Intracranial study
93888 Intracranial study
93890 Tcd, vasoreactivity study
93892 Tcd, emboli detect w/o inj
93893 Tcd, emboli detect w/inj
93925 Lower extremity study
93926 Lower extremity study
93930 Upper extremity study
93931 Upper extremity study
93970 Extremity study
93971 Extremity study
93975 Vascular study
93976 Vascular study
93978 Vascular study
93979 Vascular study
93980 Penile vascular study
93981 Penile vascular study
93990 Doppler flow testing
0028T Dexa body composition study
0042T Ct perfusion w/contrast, cbf
0066T Ct colonography;screen
0067T Ct colonography;dx
0080T Endovasc aort repr rad si
0081T Endovasc visc extnsn si
0144T CT heart wo dye; qual calc
0145T CT heart w/wo dye funct
0146T CCTA w/wo dye
0147T CCTA w/wo, quan calcium
0148T CCTA w/wo, strxr
0149T CCTA w/wo, strxr quan calc
0150T CCTA w/wo, disease strxr
0151T CT heart funct add-on
0152T Computer chest add-on
G0120 Colon ca scrn; barium enema
G0122 Colon ca scrn; barium enema
G0130 Single energy x-ray study
G0219 PET img wholbod melano nonco
G0235 PET not otherwise specified
G0275 Renal angio, cardiac cath
G0278 Iliac art angio,cardiac cath
G0288 Recon, CTA for surg plan
G0365 Vessel mapping hemo access
* CPT codes are descriptors only are copyright 2006 American Medical Association. All rights reserved. Applicable FARS/DFARS apply.

CBSA code Urban area (constituent counties) Wage index
10180 Abilene, TX 0.8423
Callahan County, TX
Jones County, TX
Taylor County, TX
10380 Aguadilla-Isabela-San Sebastián, PR 0.8423
Aguada Municipio, PR
Aguadilla Municipio, PR
Añasco Municipio, PR
Isabela Municipio, PR
Lares Municipio, PR
Moca Municipio, PR
Rincón Municipio, PR
San Sebastián Municipio, PR
10420 Akron, OH 0.9111
Portage County, OH
Summit County, OH
10500 Albany, GA 0.9466
Baker County, GA
Dougherty County, GA
Lee County, GA
Terrell County, GA
Worth County, GA
10580 Albany-Schenectady-Troy, NY 0.9181
Albany County, NY
Rensselaer County, NY
Saratoga County, NY
Schenectady County, NY
Schoharie County, NY
10740 Albuquerque, NM 0.9958
Bernalillo County, NM
Sandoval County, NM
Torrance County, NM
Valencia County, NM
10780 Alexandria, LA 0.8429
Grant Parish, LA
Rapides Parish, LA
10900 Allentown-Bethlehem-Easton, PA-NJ 1.0472
Warren County, NJ
Carbon County, PA
Lehigh County, PA
Northampton County, PA
11020 Altoona, PA 0.9277
Blair County, PA
11100 Amarillo, TX 0.9653
Armstrong County, TX
Carson County, TX
Potter County, TX
Randall County, TX
11180 Ames, IA 1.0276
Story County, IA
11260 Anchorage, AK 1.2658
Anchorage Municipality, AK
Matanuska-Susitna Borough, AK
11300 Anderson, IN 0.9140
Madison County, IN
11340 Anderson, SC 0.9493
Anderson County, SC
11460 Ann Arbor, MI 1.1398
Washtenaw County, MI
11500 Anniston-Oxford, AL 0.8423
Calhoun County, AL
11540 Appleton, WI 0.9954
Calumet County, WI
Outagamie County, WI
11700 Asheville, NC 0.9703
Buncombe County, NC
Haywood County, NC
Henderson County, NC
Madison County, NC
12020 Athens-Clarke County, GA 1.0377
Clarke County, GA
Madison County, GA
Oconee County, GA
Oglethorpe County, GA
12060 Atlanta-Sandy Springs-Marietta, GA 1.0278
Barrow County, GA
Bartow County, GA
Butts County, GA
Carroll County, GA
Cherokee County, GA
Clayton County, GA
Cobb County, GA
Coweta County, GA
Dawson County, GA
DeKalb County, GA
Douglas County, GA
Fayette County, GA
Forsyth County, GA
Fulton County, GA
Gwinnett County, GA
Haralson County, GA
Heard County, GA
Henry County, GA
Jasper County, GA
Lamar County, GA
Meriwether County, GA
Newton County, GA
Paulding County, GA
Pickens County, GA
Pike County, GA
Rockdale County, GA
Spalding County, GA
Walton County, GA
12100 Atlantic City, NJ 1.2456
Atlantic County, NJ
12220 Auburn-Opelika, AL 0.8524
Lee County, AL
12260 Augusta-Richmond County, GA-SC 1.0178
Burke County, GA
Columbia County, GA
McDuffie County, GA
Richmond County, GA
Aiken County, SC
Edgefield County, SC
12420 Austin-Round Rock, TX 0.9838
Bastrop County, TX
Caldwell County, TX
Hays County, TX
Travis County, TX
Williamson County, TX
12540 Bakersfield, CA 1.1291
Kern County, CA
12580 Baltimore-Towson, MD 1.0621
Anne Arundel County, MD
Baltimore County, MD
Carroll County, MD
Harford County, MD
Howard County, MD
Queen Anne's County, MD
Baltimore City, MD
12620 Bangor, ME 1.0224
Penobscot County, ME
12700 Barnstable Town, MA 1.3201
Barnstable County, MA
12940 Baton Rouge, LA 0.8511
Ascension Parish, LA
East Baton Rouge Parish, LA
East Feliciana Parish, LA
Iberville Parish, LA
Livingston Parish, LA
Pointe Coupee Parish, LA
St. Helena Parish, LA
West Baton Rouge Parish, LA
West Feliciana Parish, LA
12980 Battle Creek, MI 1.0278
Calhoun County, MI
13020 Bay City, MI 0.9740
Bay County, MI
13140 Beaumont-Port Arthur, TX 0.9049
Hardin County, TX
Jefferson County, TX
Orange County, TX
13380 Bellingham, WA 1.1690
Whatcom County, WA
13460 Bend, OR 1.1310
Deschutes County, OR
13644 Bethesda-Gaithersburg-Frederick, MD 1.1479
Frederick County, MD
Montgomery County, MD
13740 Billings, MT 0.9172
Carbon County, MT
Yellowstone County, MT
13780 Binghamton, NY 0.9250
Broome County, NY
Tioga County, NY
13820 Birmingham-Hoover, AL 0.9364
Bibb County, AL
Blount County, AL
Chilton County, AL
Jefferson County, AL
St. Clair County, AL
Shelby County, AL
Walker County, AL
13900 Bismarck, ND 0.8423
Burleigh County, ND
Morton County, ND
13980 Blacksburg-Christiansburg-Radford, VA 0.8647
Giles County, VA
Montgomery County, VA
Pulaski County, VA
Radford City, VA
14020 Bloomington, IN 0.8984
Greene County, IN
Monroe County, IN
Owen County, IN
14060 Bloomington-Normal, IL 0.9416
McLean County, IL
14260 Boise City-Nampa, ID 0.9898
Ada County, ID
Boise County, ID
Canyon County, ID
Gem County, ID
Owyhee County, ID
14484 Boston-Quincy, MA 1.2296
Norfolk County, MA
Plymouth County, MA
Suffolk County, MA
14500 Boulder, CO 1.0897
Boulder County, CO
14540 Bowling Green, KY 0.8578
Edmonson County, KY
Warren County, KY
14740 Bremerton-Silverdale, WA 1.1489
Kitsap County, WA
14860 Bridgeport-Stamford-Norwalk, CT 1.3328
Fairfield County, CT
15180 Brownsville-Harlingen, TX 0.9928
Cameron County, TX
15260 Brunswick, GA 1.0701
Brantley County, GA
Glynn County, GA
McIntosh County, GA
15380 Buffalo-Niagara Falls, NY 0.9922
Erie County, NY
Niagara County, NY
15500 Burlington, NC 0.9132
Alamance County, NC
15540 Burlington-South Burlington, VT 0.9974
Chittenden County, VT
Franklin County, VT
Grand Isle County, VT
15764 Cambridge-Newton-Framingham, MA 1.1549
Middlesex County, MA
15804 Camden, NJ 1.0941
Burlington County, NJ
Camden County, NJ
Gloucester County, NJ
15940 Canton-Massillon, OH 0.9508
Carroll County, OH
Stark County, OH
15980 Cape Coral-Fort Myers, FL 0.9835
Lee County, FL
16180 Carson City, NV 1.0555
Carson City, NV
16220 Casper, WY 0.9628
Natrona County, WY
16300 Cedar Rapids, IA 0.9357
Benton County, IA
Jones County, IA
Linn County, IA
16580 Champaign-Urbana, IL 1.0153
Champaign County, IL
Ford County, IL
Piatt County, IL
16620 Charleston, WV 0.8993
Boone County, WV
Clay County, WV
Kanawha County, WV
Lincoln County, WV
Putnam County, WV
16700 Charleston-North Charleston, SC 0.9628
Berkeley County, SC
Charleston County, SC
Dorchester County, SC
16740 Charlotte-Gastonia-Concord, NC-SC 1.0059
Anson County, NC
Cabarrus County, NC
Gaston County, NC
Mecklenburg County, NC
Union County, NC
York County, SC
16820 Charlottesville, VA 1.0660
Albemarle County, VA
Fluvanna County, VA
Greene County, VA
Nelson County, VA
Charlottesville City, VA
16860 Chattanooga, TN-GA 0.9421
Catoosa County, GA
Dade County, GA
Walker County, GA
Hamilton County, TN
Marion County, TN
Sequatchie County, TN
16940 Cheyenne, WY 0.9539
Laramie County, WY
16974 Chicago-Naperville-Joliet, IL 1.1319
Cook County, IL
DeKalb County, IL
DuPage County, IL
Grundy County, IL
Kane County, IL
Kendall County, IL
McHenry County, IL
Will County, IL
17020 Chico, CA 1.1637
Butte County, CA
17140 Cincinnati-Middletown, OH-KY-IN 1.0108
Dearborn County, IN
Franklin County, IN
Ohio County, IN
Boone County, KY
Bracken County, KY
Campbell County, KY
Gallatin County, KY
Grant County, KY
Kenton County, KY
Pendleton County, KY
Brown County, OH
Butler County, OH
Clermont County, OH
Hamilton County, OH
Warren County, OH
17300 Clarksville, TN-KY 0.8882
Christian County, KY
Trigg County, KY
Montgomery County, TN
Stewart County, TN
17420 Cleveland, TN 0.8537
Bradley County, TN
Polk County, TN
17460 Cleveland-Elyria-Mentor, OH 0.9896
Cuyahoga County, OH
Geauga County, OH
Lake County, OH
Lorain County, OH
Medina County, OH
17660 Coeur d'Alene, ID 0.9838
Kootenai County, ID
17780 College Station-Bryan, TX 0.9523
Brazos County, TX
Burleson County, TX
Robertson County, TX
17820 Colorado Springs, CO 1.0213
El Paso County, CO
Teller County, CO
17860 Columbia, MO 0.8993
Boone County, MO
Howard County, MO
17900 Columbia, SC 0.9405
Calhoun County, SC
Fairfield County, SC
Kershaw County, SC
Lexington County, SC
Richland County, SC
Saluda County, SC
17980 Columbus, GA-AL 0.8674
Russell County, AL
Chattahoochee County, GA
Harris County, GA
Marion County, GA
Muscogee County, GA
18020 Columbus, IN 0.9810
Bartholomew County, IN
18140 Columbus, OH 1.0641
Delaware County, OH
Fairfield County, OH
Franklin County, OH
Licking County, OH
Madison County, OH
Morrow County, OH
Pickaway County, OH
Union County, OH
18580 Corpus Christi, TX 0.9016
Aransas County, TX
Nueces County, TX
San Patricio County, TX
18700 Corvallis, OR 1.2156
Benton County, OR
19060 Cumberland, MD-WV 0.8892
Allegany County, MD
Mineral County, WV
19124 Dallas-Plano-Irving, TX 1.0607
Collin County, TX
Dallas County, TX
Delta County, TX
Denton County, TX
Ellis County, TX
Hunt County, TX
Kaufman County, TX
Rockwall County, TX
19140 Dalton, GA 0.9573
Murray County, GA
Whitfield County, GA
19180 Danville, IL 0.9755
Vermilion County, IL
19260 Danville, VA 0.8897
Pittsylvania County, VA
Danville City, VA
19340 Davenport-Moline-Rock Island, IA-IL 0.9313
Henry County, IL
Mercer County, IL
Rock Island County, IL
Scott County, IA
19380 Dayton, OH 0.9514
Greene County, OH
Miami County, OH
Montgomery County, OH
Preble County, OH
19460 Decatur, AL 0.8590
Lawrence County, AL
Morgan County, AL
19500 Decatur, IL 0.8604
Macon County, IL
19660 Deltona-Daytona Beach-Ormond Beach, FL 0.9752
Volusia County, FL
19740 Denver-Aurora, CO 1.1507
Adams County, CO
Arapahoe County, CO
Broomfield County, CO
Clear Creek County, CO
Denver County, CO
Douglas County, CO
Elbert County, CO
Gilpin County, CO
Jefferson County, CO
Park County, CO
19780 Des Moines-West Des Moines, IA 0.9701
Dallas County, IA
Guthrie County, IA
Madison County, IA
Polk County, IA
Warren County, IA
19804 Detroit-Livonia-Dearborn, MI 1.0824
Wayne County, MI
20020 Dothan, AL 0.8423
Geneva County, AL
Henry County, AL
Houston County, AL
20100 Dover, DE 1.0367
Kent County, DE
20220 Dubuque, IA 0.9615
Dubuque County, IA
20260 Duluth, MN-WI 1.0572
Carlton County, MN
St. Louis County, MN
Douglas County, WI
20500 Durham, NC 1.0345
Chatham County, NC
Durham County, NC
Orange County, NC
Person County, NC
20740 Eau Claire, WI 1.0139
Chippewa County, WI
Eau Claire County, WI
20764 Edison, NJ 1.1781
Middlesex County, NJ
Monmouth County, NJ
Ocean County, NJ
Somerset County, NJ
20940 El Centro, CA 0.9555
Imperial County, CA
21060 Elizabethtown, KY 0.9156
Hardin County, KY
Larue County, KY
21140 Elkhart-Goshen, IN 0.9924
Elkhart County, IN
21300 Elmira, NY 0.8675
Chemung County, NY
21340 El Paso, TX 0.9531
El Paso County, TX
21500 Erie, PA 0.9293
Erie County, PA
21604 Essex County, MA 1.0968
Essex County, MA
21660 Eugene-Springfield, OR 1.1450
Lane County, OR
21780 Evansville, IN-KY 0.9550
Gibson County, IN
Posey County, IN
Vanderburgh County, IN
Warrick County, IN
Henderson County, KY
Webster County, KY
21820 Fairbanks, AK 1.1643
Fairbanks North Star Borough, AK
21940 Fajardo, PR 0.8423
Ceiba Municipio, PR
Fajardo Municipio, PR
Luquillo Municipio, PR
22020 Fargo, ND-MN 0.8686
Cass County, ND
Clay County, MN
22140 Farmington, NM 0.9043
San Juan County, NM
22180 Fayetteville, NC 0.9417
Cumberland County, NC
Hoke County, NC
22220 Fayetteville-Springdale-Rogers, AR-MO 0.9333
Benton County, AR
Madison County, AR
Washington County, AR
McDonald County, MO
22380 Flagstaff, AZ 1.2214
Coconino County, AZ
22420 Flint, MI 1.1548
Genesee County, MI
22500 Florence, SC 0.8831
Darlington County, SC
Florence County, SC
22520 Florence-Muscle Shoals, AL 0.8423
Colbert County, AL
Lauderdale County, AL
22540 Fond du Lac, WI 1.0595
Fond du Lac County, WI
22660 Fort Collins-Loveland, CO 1.0048
Larimer County, CO
22744 Fort Lauderdale-Pompano Beach-Deerfield Beach, FL 1.0668
Broward County, FL
22900 Fort Smith, AR-OK 0.8423
Crawford County, AR
Franklin County, AR
Sebastian County, AR
Le Flore County, OK
Sequoyah County, OK
23020 Fort Walton Beach-Crestview-Destin, FL 0.9100
Okaloosa County, FL
23060 Fort Wayne, IN 1.0020
Allen County, IN
Wells County, IN
Whitley County, IN
23104 Fort Worth-Arlington, TX 1.0074
Johnson County, TX
Parker County, TX
Tarrant County, TX
Wise County, TX
23420 Fresno, CA 1.1521
Fresno County, CA
23460 Gadsden, AL 0.8492
Etowah County, AL
23540 Gainesville, FL 0.9767
Alachua County, FL
Gilchrist County, FL
23580 Gainesville, GA 0.9431
Hall County, GA
23844 Gary, IN 0.9827
Jasper County, IN
Lake County, IN
Newton County, IN
Porter County, IN
24020 Glens Falls, NY 0.8764
Warren County, NY
Washington County, NY
24140 Goldsboro, NC 0.9655
Wayne County, NC
24220 Grand Forks, ND-MN 0.8423
Polk County, MN
Grand Forks County, ND
24300 Grand Junction, CO 1.0179
Mesa County, CO
24340 Grand Rapids-Wyoming, MI 0.9954
Barry County, MI
Ionia County, MI
Kent County, MI
Newaygo County, MI
24500 Great Falls, MT 0.9052
Cascade County, MT
24540 Greeley, CO 1.0109
Weld County, CO
24580 Green Bay, WI 1.0304
Brown County, WI
Kewaunee County, WI
Oconto County, WI
24660 Greensboro-High Point, NC 0.9334
Guilford County, NC
Randolph County, NC
Rockingham County, NC
24780 Greenville, NC 0.9930
Greene County, NC
Pitt County, NC
24860 Greenville, SC 1.0322
Greenville County, SC
Laurens County, SC
Pickens County, SC
25020 Guayama, PR 0.8423
Arroyo Municipio, PR
Guayama Municipio, PR
Patillas Municipio, PR
25060 Gulfport-Biloxi, MS 0.9386
Hancock County, MS
Harrison County, MS
Stone County, MS
25180 Hagerstown-Martinsburg, MD-WV 0.9515
Washington County, MD
Berkeley County, WV
Morgan County, WV
25260 Hanford-Corcoran, CA 1.0825
Kings County, CA
25420 Harrisburg-Carlisle, PA 0.9899
Cumberland County, PA
Dauphin County, PA
Perry County, PA
25500 Harrisonburg, VA 0.9552
Rockingham County, VA
Harrisonburg City, VA
25540 Hartford-West Hartford-East Hartford, CT 1.1469
Hartford County, CT
Litchfield County, CT
Middlesex County, CT
Tolland County, CT
25620 Hattiesburg, MS 0.8423
Forrest County, MS
Lamar County, MS
Perry County, MS
25860 Hickory-Lenoir-Morganton, NC 0.9486
Alexander County, NC
Burke County, NC
Caldwell County, NC
Catawba County, NC
25980 Hinesville-Fort Stewart, GA 0.9663
Liberty County, GA
Long County, GA
26100 Holland-Grand Haven, MI 0.9647
Ottawa County, MI
26180 Honolulu, HI 1.1682
Honolulu County, HI
26300 Hot Springs, AR 0.9246
Garland County, AR
26380 Houma-Bayou Cane-Thibodaux, LA 0.8509
Lafourche Parish, LA
Terrebonne Parish, LA
26420 Houston-Sugar Land-Baytown, TX 1.0537
Austin County, TX
Brazoria County, TX
Chambers County, TX
Fort Bend County, TX
Galveston County, TX
Harris County, TX
Liberty County, TX
Montgomery County, TX
San Jacinto County, TX
Waller County, TX
26580 Huntington-Ashland, WV-KY-OH 0.9472
Boyd County, KY
Greenup County, KY
Lawrence County, OH
Cabell County, WV
Wayne County, WV
26620 Huntsville, AL 0.9483
Limestone County, AL
Madison County, AL
26820 Idaho Falls, ID 0.9568
Bonneville County, ID
Jefferson County, ID
26900 Indianapolis-Carmel, IN 1.0418
Boone County, IN
Brown County, IN
Hamilton County, IN
Hancock County, IN
Hendricks County, IN
Johnson County, IN
Marion County, IN
Morgan County, IN
Putnam County, IN
Shelby County, IN
26980 Iowa City, IA 1.0227
Johnson County, IA
Washington County, IA
27060 Ithaca, NY 1.0452
Tompkins County, NY
27100 Jackson, MI 1.0065
Jackson County, MI
27140 Jackson, MS 0.8708
Copiah County, MS
Hinds County, MS
Madison County, MS
Rankin County, MS
Simpson County, MS
27180 Jackson, TN 0.9321
Chester County, TN
Madison County, TN
27260 Jacksonville, FL 0.9649
Baker County, FL
Clay County, FL
Duval County, FL
Nassau County, FL
St. Johns County, FL
27340 Jacksonville, NC 0.8666
Onslow County, NC
27500 Janesville, WI 1.0165
Rock County, WI
27620 Jefferson City, MO 0.8772
Callaway County, MO
Cole County, MO
Moniteau County, MO
Osage County, MO
27740 Johnson City, TN 0.8468
Carter County, TN
Unicoi County, TN
Washington County, TN
27780 Johnstown, PA 0.9075
Cambria County, PA
27860 Jonesboro, AR 0.8423
Craighead County, AR
Poinsett County, AR
27900 Joplin, MO 0.9059
Jasper County, MO
Newton County, MO
28020 Kalamazoo-Portage, MI 1.1269
Kalamazoo County, MI
Van Buren County, MI
28100 Kankakee-Bradley, IL 1.0616
Kankakee County, IL
28140 Kansas City, MO-KS 0.9997
Franklin County, KS
Johnson County, KS
Leavenworth County, KS
Linn County, KS
Miami County, KS
Wyandotte County, KS
Bates County, MO
Caldwell County, MO
Cass County, MO
Clay County, MO
Clinton County, MO
Jackson County, MO
Lafayette County, MO
Platte County, MO
Ray County, MO
28420 Kennewick-Richland-Pasco, WA 1.0889
Benton County, WA
Franklin County, WA
28660 Killeen-Temple-Fort Hood, TX 0.9371
Bell County, TX
Coryell County, TX
Lampasas County, TX
28700 Kingsport-Bristol-Bristol, TN-VA 0.8423
Hawkins County, TN
Sullivan County, TN
Bristol City, VA
Scott County, VA
Washington County, VA
28740 Kingston, NY 0.9862
Ulster County, NY
28940 Knoxville, TN 0.8685
Anderson County, TN
Blount County, TN
Knox County, TN
Loudon County, TN
Union County, TN
29020 Kokomo, IN 1.0180
Howard County, IN
Tipton County, IN
29100 La Crosse, WI-MN 0.9924
Houston County, MN
La Crosse County, WI
29140 Lafayette, IN 0.9403
Benton County, IN
Carroll County, IN
Tippecanoe County, IN
29180 Lafayette, LA 0.8727
Lafayette Parish, LA
St. Martin Parish, LA
29340 Lake Charles, LA 0.8423
Calcasieu Parish, LA
Cameron Parish, LA
29404 Lake County-Kenosha County, IL-WI 1.1128
Lake County, IL
Kenosha County, WI
29460 Lakeland, FL 0.9348
Polk County, FL
29540 Lancaster, PA 1.0095
Lancaster County, PA
29620 Lansing-East Lansing, MI 1.0621
Clinton County, MI
Eaton County, MI
Ingham County, MI
29700 Laredo, TX 0.8423
Webb County, TX
29740 Las Cruces, NM 0.9763
Dona Ana County, NM
29820 Las Vegas-Paradise, NV 1.2034
Clark County, NV
29940 Lawrence, KS 0.8807
Douglas County, KS
30020 Lawton, OK 0.8491
Comanche County, OK
30140 Lebanon, PA 0.9137
Lebanon County, PA
30300 Lewiston, ID-WA 1.0373
Nez Perce County, ID
Asotin County, WA
30340 Lewiston-Auburn, ME 0.9608
Androscoggin County, ME
30460 Lexington-Fayette, KY 0.9666
Bourbon County, KY
Clark County, KY
Fayette County, KY
Jessamine County, KY
Scott County, KY
Woodford County, KY
30620 Lima, OH 0.9520
Allen County, OH
30700 Lincoln, NE 1.0625
Lancaster County, NE
Seward County, NE
30780 Little Rock-North Little Rock, AR 0.9360
Faulkner County, AR
Grant County, AR
Lonoke County, AR
Perry County, AR
Pulaski County, AR
Saline County, AR
30860 Logan, UT-ID 0.9499
Franklin County, ID
Cache County, UT
30980 Longview, TX 0.9252
Gregg County, TX
Rusk County, TX
Upshur County, TX
31020 Longview, WA 1.0540
Cowlitz County, WA
31084 Los Angeles-Long Beach-Glendale, CA 1.2381
Los Angeles County, CA
31140 Louisville-Jefferson County, KY-IN 0.9600
Clark County, IN
Floyd County, IN
Harrison County, IN
Washington County, IN
Bullitt County, KY
Henry County, KY
Jefferson County, KY
Meade County, KY
Nelson County, KY
Oldham County, KY
Shelby County, KY
Spencer County, KY
Trimble County, KY
31180 Lubbock, TX 0.9068
Crosby County, TX
Lubbock County, TX
31340 Lynchburg, VA 0.9153
Amherst County, VA
Appomattox County, VA
Bedford County, VA
Campbell County, VA
Bedford City, VA
Lynchburg City, VA
31420 Macon, GA 1.0022
Bibb County, GA
Crawford County, GA
Jones County, GA
Monroe County, GA
Twiggs County, GA
31460 Madera, CA 0.8585
Madera County, CA
31540 Madison, WI 1.1413
Columbia County, WI
Dane County, WI
Iowa County, WI
31700 Manchester-Nashua, NH 1.0784
Hillsborough County, NH
Merrimack County, NH
31900 Mansfield, OH 0.9761
Richland County, OH
32420 Mayagüez, PR 0.8423
Hormigueros Municipio, PR
Mayagüez Municipio, PR
32580 McAllen-Edinburg-Mission, TX 0.9236
Hidalgo County, TX
32780 Medford, OR 1.1389
Jackson County, OR
32820 Memphis, TN-MS-AR 0.9868
Crittenden County, AR
DeSoto County, MS
Marshall County, MS
Tate County, MS
Tunica County, MS
Fayette County, TN
Shelby County, TN
Tipton County, TN
32900 Merced, CA 1.2077
Merced County, CA
33124 Miami-Miami Beach-Kendall, FL 1.0330
Miami-Dade County, FL
33140 Michigan City-La Porte, IN 0.9600
LaPorte County, IN
33260 Midland, TX 1.0303
Midland County, TX
33340 Milwaukee-Waukesha-West Allis, WI 1.0758
Milwaukee County, WI
Ozaukee County, WI
Washington County, WI
Waukesha County, WI
33460 Minneapolis-St. Paul-Bloomington, MN-WI 1.1524
Anoka County, MN
Carver County, MN
Chisago County, MN
Dakota County, MN
Hennepin County, MN
Isanti County, MN
Ramsey County, MN
Scott County, MN
Sherburne County, MN
Washington County, MN
Wright County, MN
Pierce County, WI
St. Croix County, WI
33540 Missoula, MT 0.9400
Missoula County, MT
33660 Mobile, AL 0.8423
Mobile County, AL
33700 Modesto, CA 1.2349
Stanislaus County, CA
33740 Monroe, LA 0.8423
Ouachita Parish, LA
Union Parish, LA
33780 Monroe, MI 1.0220
Monroe County, MI
33860 Montgomery, AL 0.8432
Autauga County, AL
Elmore County, AL
Lowndes County, AL
Montgomery County, AL
34060 Morgantown, WV 0.8868
Monongalia County, WV
Preston County, WV
34100 Morristown, TN 0.8423
Grainger County, TN
Hamblen County, TN
Jefferson County, TN
34580 Mount Vernon-Anacortes, WA 1.1072
Skagit County, WA
34620 Muncie, IN 0.9014
Delaware County, IN
34740 Muskegon-Norton Shores, MI 1.0466
Muskegon County, MI
34820 Myrtle Beach-Conway-North Myrtle Beach, SC 0.9275
Horry County, SC
34900 Napa, CA 1.4080
Napa County, CA
34940 Naples-Marco Island, FL 1.0466
Collier County, FL
34980 Nashville-Davidson--Murfreesboro, TN 1.0367
Cannon County, TN
Cheatham County, TN
Davidson County, TN
Dickson County, TN
Hickman County, TN
Macon County, TN
Robertson County, TN
Rutherford County, TN
Smith County, TN
Sumner County, TN
Trousdale County, TN
Williamson County, TN
Wilson County, TN
35004 Nassau-Suffolk, NY 1.3331
Nassau County, NY
Suffolk County, NY
35084 Newark-Union, NJ-PA 1.2520
Essex County, NJ
Hunterdon County, NJ
Morris County, NJ
Sussex County, NJ
Union County, NJ
Pike County, PA
35300 New Haven-Milford, CT 1.2584
New Haven County, CT
35380 New Orleans-Metairie-Kenner, LA 0.9297
Jefferson Parish, LA
Orleans Parish, LA
Plaquemines Parish, LA
St. Bernard Parish, LA
St. Charles Parish, LA
St. John the Baptist Parish, LA
St. Tammany Parish, LA
35644 New York-White Plains-Wayne, NY-NJ 1.3873
Bergen County, NJ
Hudson County, NJ
Passaic County, NJ
Bronx County, NY
Kings County, NY
New York County, NY
Putnam County, NY
Queens County, NY
Richmond County, NY
Rockland County, NY
Westchester County, NY
35660 Niles-Benton Harbor, MI 0.9386
Berrien County, MI
35980 Norwich-New London, CT 1.2562
New London County, CT
36084 Oakland-Fremont-Hayward, CA 1.6655
Alameda County, CA
Contra Costa County, CA
36100 Ocala, FL 0.9335
Marion County, FL
36140 Ocean City, NJ 1.1025
Cape May County, NJ
36220 Odessa, TX 1.0605
Ector County, TX
36260 Ogden-Clearfield, UT 0.9470
Davis County, UT
Morgan County, UT
Weber County, UT
36420 Oklahoma City, OK 0.9310
Canadian County, OK
Cleveland County, OK
Grady County, OK
Lincoln County, OK
Logan County, OK
McClain County, OK
Oklahoma County, OK
36500 Olympia, WA 1.1666
Thurston County, WA
36540 Omaha-Council Bluffs, NE-IA 0.9949
Harrison County, IA
Mills County, IA
Pottawattamie County, IA
Cass County, NE
Douglas County, NE
Sarpy County, NE
Saunders County, NE
Washington County, NE
36740 Orlando-Kissimmee, FL 0.9951
Lake County, FL
Orange County, FL
Osceola County, FL
Seminole County, FL
36780 Oshkosh-Neenah, WI 0.9807
Winnebago County, WI
36980 Owensboro, KY 0.9210
Daviess County, KY
Hancock County, KY
McLean County, KY
37100 Oxnard-Thousand Oaks-Ventura, CA 1.2156
Ventura County, CA
37340 Palm Bay-Melbourne-Titusville, FL 0.9942
Brevard County, FL
37460 Panama City-Lynn Haven, FL 0.8451
Bay County, FL
37620 Parkersburg-Marietta-Vienna, WV-OH 0.8423
Washington County, OH
Pleasants County, WV
Wirt County, WV
Wood County, WV
37700 Pascagoula, MS 0.8649
George County, MS
Jackson County, MS
37860 Pensacola-Ferry Pass-Brent, FL 0.8423
Escambia County, FL
Santa Rosa County, FL
37900 Peoria, IL 0.9456
Marshall County, IL
Peoria County, IL
Stark County, IL
Tazewell County, IL
Woodford County, IL
37964 Philadelphia, PA 1.1577
Bucks County, PA
Chester County, PA
Delaware County, PA
Montgomery County, PA
Philadelphia County, PA
38060 Phoenix-Mesa-Scottsdale, AZ 1.0830
Maricopa County, AZ
Pinal County, AZ
38220 Pine Bluff, AR 0.8826
Cleveland County, AR
Jefferson County, AR
Lincoln County, AR
38300 Pittsburgh, PA 0.9132
Allegheny County, PA
Armstrong County, PA
Beaver County, PA
Butler County, PA
Fayette County, PA
Washington County, PA
Westmoreland County, PA
38340 Pittsfield, MA 1.0808
Berkshire County, MA
38540 Pocatello, ID 0.9896
Bannock County, ID
Power County, ID
38660 Ponce, PR 0.8423
Juana Díaz Municipio, PR
Ponce Municipio, PR
Villalba Municipio, PR
38860 Portland-South Portland-Biddeford, ME 1.0431
Cumberland County, ME
Sagadahoc County, ME
York County, ME
38900 Portland-Vancouver-Beaverton, OR-WA 1.2019
Clackamas County, OR
Columbia County, OR
Multnomah County, OR
Washington County, OR
Yamhill County, OR
Clark County, WA
Skamania County, WA
38940 Port St. Lucie-Fort Pierce, FL 1.0352
Martin County, FL
St. Lucie County, FL
39100 Poughkeepsie-Newburgh-Middletown, NY 1.1487
Dutchess County, NY
Orange County, NY
39140 Prescott, AZ 1.0356
Yavapai County, AZ
39300 Providence-New Bedford-Fall River, RI-MA 1.1353
Bristol County, MA
Bristol County, RI
Kent County, RI
Newport County, RI
Providence County, RI
Washington County, RI
39340 Provo-Orem, UT 1.0041
Juab County, UT
Utah County, UT
39380 Pueblo, CO 0.9215
Pueblo County, CO
39460 Punta Gorda, FL 0.9902
Charlotte County, FL
39540 Racine, WI 0.9850
Racine County, WI
39580 Raleigh-Cary, NC 1.0385
Franklin County, NC
Johnston County, NC
Wake County, NC
39660 Rapid City, SD 0.9300
Meade County, SD
Pennington County, SD
39740 Reading, PA 1.0130
Berks County, PA
39820 Redding, CA 1.3985
Shasta County, CA
39900 Reno-Sparks, NV 1.2595
Storey County, NV
Washoe County, NV
40060 Richmond, VA 0.9662
Amelia County, VA
Caroline County, VA
Charles City County, VA
Chesterfield County, VA
Cumberland County, VA
Dinwiddie County, VA
Goochland County, VA
Hanover County, VA
Henrico County, VA
King and Queen County, VA
King William County, VA
Louisa County, VA
New Kent County, VA
Powhatan County, VA
Prince George County, VA
Sussex County, VA
Colonial Heights City, VA
Hopewell City, VA
Petersburg City, VA
Richmond City, VA
40140 Riverside-San Bernardino-Ontario, CA 1.1480
Riverside County, CA
San Bernardino County, CA
40220 Roanoke, VA 0.9104
Botetourt County, VA
Craig County, VA
Franklin County, VA
Roanoke County, VA
Roanoke City, VA
Salem City, VA
40340 Rochester, MN 1.2011
Dodge County, MN
Olmsted County, MN
Wabasha County, MN
40380 Rochester, NY 0.9469
Livingston County, NY
Monroe County, NY
Ontario County, NY
Orleans County, NY
Wayne County, NY
40420 Rockford, IL 1.0517
Boone County, IL
Winnebago County, IL
40484 Rockingham County-Strafford County, NH 1.0696
Rockingham County, NH
Strafford County, NH
40580 Rocky Mount, NC 0.9322
Edgecombe County, NC
Nash County, NC
40660 Rome, GA 0.9679
Floyd County, GA
40900 Sacramento-Arden-Arcade-Roseville, CA 1.4078
El Dorado County, CA
Placer County, CA
Sacramento County, CA
Yolo County, CA
40980 Saginaw-Saginaw Township North, MI 0.9343
Saginaw County, MI
41060 St. Cloud, MN 1.0909
Benton County, MN
Stearns County, MN
41100 St. George, UT 0.9754
Washington County, UT
41140 St. Joseph, MO-KS 1.0652
Doniphan County, KS
Andrew County, MO
Buchanan County, MO
DeKalb County, MO
41180 St. Louis, MO-IL 0.9481
Bond County, IL
Calhoun County, IL
Clinton County, IL
Jersey County, IL
Macoupin County, IL
Madison County, IL
Monroe County, IL
St. Clair County, IL
Crawford County, MO
Franklin County, MO
Jefferson County, MO
Lincoln County, MO
St. Charles County, MO
St. Louis County, MO
Warren County, MO
Washington County, MO
St. Louis City, MO
41420 Salem, OR 1.0989
Marion County, OR
Polk County, OR
41500 Salinas, CA 1.5094
Monterey County, CA
41540 Salisbury, MD 0.9426
Somerset County, MD
Wicomico County, MD
41620 Salt Lake City, UT 0.9899
Salt Lake County, UT
Summit County, UT
Tooele County, UT
41660 San Angelo, TX 0.8804
Irion County, TX
Tom Green County, TX
41700 San Antonio, TX 0.9311
Atascosa County, TX
Bandera County, TX
Bexar County, TX
Comal County, TX
Guadalupe County, TX
Kendall County, TX
Medina County, TX
Wilson County, TX
41740 San Diego-Carlsbad-San Marcos, CA 1.1954
San Diego County, CA
41780 Sandusky, OH 0.9793
Erie County, OH
41884 San Francisco-San Mateo-Redwood City, CA 1.5966
Marin County, CA
San Francisco County, CA
San Mateo County, CA
41900 San Germán-Cabo Rojo, PR 0.8423
Cabo Rojo Municipio, PR
Lajas Municipio, PR
Sabana Grande Municipio, PR
San Germán Municipio, PR
41940 San Jose-Sunnyvale-Santa Clara, CA 1.6364
San Benito County, CA
Santa Clara County, CA
41980 San Juan-Caguas-Guaynabo, PR 0.8423
Aguas Buenas Municipio, PR
Aibonito Municipio, PR
Arecibo Municipio, PR
Barceloneta Municipio, PR
Barranquitas Municipio, PR
Bayamón Municipio, PR
Caguas Municipio, PR
Camuy Municipio, PR
Canóvanas Municipio, PR
Carolina Municipio, PR
Cataño Municipio, PR
Cayey Municipio, PR
Ciales Municipio, PR
Cidra Municipio, PR
Comerío Municipio, PR
Corozal Municipio, PR
Dorado Municipio, PR
Florida Municipio, PR
Guaynabo Municipio, PR
Gurabo Municipio, PR
Hatillo Municipio, PR
Humacao Municipio, PR
Juncos Municipio, PR
Las Piedras Municipio, PR
Loíza Municipio, PR
Manatí Municipio, PR
Maunabo Municipio, PR
Morovis Municipio, PR
Naguabo Municipio, PR
Naranjito Municipio, PR
Orocovis Municipio, PR
Quebradillas Municipio, PR
Río Grande Municipio, PR
San Juan Municipio, PR
San Lorenzo Municipio, PR
Toa Alta Municipio, PR
Toa Baja Municipio, PR
Trujillo Alto Municipio, PR
Vega Alta Municipio, PR
Vega Baja Municipio, PR
Yabucoa Municipio, PR
42020 San Luis Obispo-Paso Robles, CA 1.2211
San Luis Obispo County, CA
42044 Santa Ana-Anaheim-Irvine, CA 1.2079
Orange County, CA
42060 Santa Barbara-Santa Maria, CA 1.1677
Santa Barbara County, CA
42100 Santa Cruz-Watsonville, CA 1.6273
Santa Cruz County, CA
42140 Santa Fe, NM 1.1396
Santa Fe County, NM
42220 Santa Rosa-Petaluma, CA 1.5228
Sonoma County, CA
42260 Sarasota-Bradenton-Venice, FL 1.0389
Manatee County, FL
Sarasota County, FL
42340 Savannah, GA 0.9845
Bryan County, GA
Chatham County, GA
Effingham County, GA
42540 Scranton-Wilkes-Barre, PA 0.8788
Lackawanna County, PA
Luzerne County, PA
Wyoming County, PA
42644 Seattle-Bellevue-Everett, WA 1.2038
42680 Sebastian-Vero Beach, FL 1.0079
Indian River County, FL
43100 Sheboygan, WI 0.9503
Sheboygan County, WI
43300 Sherman-Denison, TX 0.8951
Grayson County, TX
43340 Shreveport-Bossier City, LA 0.9333
Bossier Parish, LA
Caddo Parish, LA
De Soto Parish, LA
43580 Sioux City, IA-NE-SD 0.9686
Woodbury County, IA
Dakota County, NE
Dixon County, NE
Union County, SD
43620 Sioux Falls, SD 1.0064
Lincoln County, SD
McCook County, SD
Minnehaha County, SD
Turner County, SD
43780 South Bend-Mishawaka, IN-MI 1.0362
St. Joseph County, IN
Cass County, MI
43900 Spartanburg, SC 0.9659
Spartanburg County, SC
44060 Spokane, WA 1.0999
Spokane County, WA
44100 Springfield, IL 0.9360
Menard County, IL
Sangamon County, IL
44140 Springfield, MA 1.0611
Franklin County, MA
Hampden County, MA
Hampshire County, MA
44180 Springfield, MO 0.8916
Christian County, MO
Dallas County, MO
Greene County, MO
Polk County, MO
Webster County, MO
44220 Springfield, OH 0.9047
Clark County, OH
44300 State College, PA 0.9248
Centre County, PA
44700 Stockton, CA 1.2046
San Joaquin County, CA
44940 Sumter, SC 0.8510
Sumter County, SC
45060 Syracuse, NY 1.0203
Madison County, NY
Onondaga County, NY
Oswego County, NY
45104 Tacoma, WA 1.1359
Pierce County, WA
45220 Tallahassee, FL 0.9414
Gadsden County, FL
Jefferson County, FL
Leon County, FL
Wakulla County, FL
45300 Tampa-St. Petersburg-Clearwater, FL 0.9627
Hernando County, FL
Hillsborough County, FL
Pasco County, FL
Pinellas County, FL
45460 Terre Haute, IN 0.9228
Clay County, IN
Sullivan County, IN
Vermillion County, IN
Vigo County, IN
45500 Texarkana, TX-Texarkana, AR 0.8532
Miller County, AR
Bowie County, TX
45780 Toledo, OH 1.0092
Fulton County, OH
Lucas County, OH
Ottawa County, OH
Wood County, OH
45820 Topeka, KS 0.9191
Jackson County, KS
Jefferson County, KS
Osage County, KS
Shawnee County, KS
Wabaunsee County, KS
45940 Trenton-Ewing, NJ 1.1407
Mercer County, NJ
46060 Tucson, AZ 0.9688
Pima County, AZ
46140 Tulsa, OK 0.8531
Creek County, OK
Okmulgee County, OK
Osage County, OK
Pawnee County, OK
Rogers County, OK
Tulsa County, OK
Wagoner County, OK
46220 Tuscaloosa, AL 0.8993
Greene County, AL
Hale County, AL
Tuscaloosa County, AL
46340 Tyler, TX 0.9276
Smith County, TX
46540 Utica-Rome, NY 0.8839
Herkimer County, NY
Oneida County, NY
46660 Valdosta, GA 0.8811
Brooks County, GA
Echols County, GA
Lanier County, GA
Lowndes County, GA
46700 Vallejo-Fairfield, CA 1.5937
Solano County, CA
47020 Victoria, TX 0.9012
Calhoun County, TX
Goliad County, TX
Victoria County, TX
47220 Vineland-Millville-Bridgeton, NJ 1.0351
Cumberland County, NJ
47260 Virginia Beach-Norfolk-Newport News, VA-NC 0.9254
Currituck County, NC
Gloucester County, VA
Isle of Wight County, VA
James City County, VA
Mathews County, VA
Surry County, VA
York County, VA
Chesapeake City, VA
Hampton City, VA
Newport News City, VA
Norfolk City, VA
Poquoson City, VA
Portsmouth City, VA
Suffolk City, VA
Virginia Beach City, VA
Williamsburg City, VA
47300 Visalia-Porterville, CA 1.0494
Tulare County, CA
47380 Waco, TX 0.9089
McLennan County, TX
47580 Warner Robins, GA 0.8823
Houston County, GA
47644 Warren-Troy-Farmington Hills, MI 1.0585
Lapeer County, MI
Livingston County, MI
Macomb County, MI
Oakland County, MI
St. Clair County, MI
47894 Washington-Arlington-Alexandria, DC-VA-MD-WV 1.1638
District of Columbia, DC
Calvert County, MD
Charles County, MD
Prince George's County, MD
Arlington County, VA
Clarke County, VA
Fairfax County, VA
Fauquier County, VA
Loudoun County, VA
Prince William County, VA
Spotsylvania County, VA
Stafford County, VA
Warren County, VA
Alexandria City, VA
Fairfax City, VA
Falls Church City, VA
Fredericksburg City, VA
Manassas City, VA
Manassas Park City, VA
Jefferson County, WV
47940 Waterloo-Cedar Falls, IA 0.8852
Black Hawk County, IA
Bremer County, IA
Grundy County, IA
48140 Wausau, WI 1.0235
Marathon County, WI
48260 Weirton-Steubenville, WV-OH 0.8489
Jefferson County, OH
Brooke County, WV
Hancock County, WV
48300 Wenatchee, WA 1.0892
Chelan County, WA
Douglas County, WA
48424 West Palm Beach-Boca Raton-Boynton Beach, FL 1.0159
Palm Beach County, FL
48540 Wheeling, WV-OH 0.8423
Belmont County, OH
Marshall County, WV
Ohio County, WV
48620 Wichita, KS 0.9542
Butler County, KS
Harvey County, KS
Sedgwick County, KS
Sumner County, KS
48660 Wichita Falls, TX 0.8750
Archer County, TX
Clay County, TX
Wichita County, TX
48700 Williamsport, PA 0.8569
Lycoming County, PA
48864 Wilmington, DE-MD-NJ 1.1248
New Castle County, DE
Cecil County, MD
Salem County, NJ
48900 Wilmington, NC 1.0354
Brunswick County, NC
New Hanover County, NC
Pender County, NC
49020 Winchester, VA-WV 1.0624
Frederick County, VA
Winchester City, VA
Hampshire County, WV
49180 Winston-Salem, NC 0.9766
Davie County, NC
Forsyth County, NC
Stokes County, NC
Yadkin County, NC
49340 Worcester, MA 1.1288
Worcester County, MA
49420 Yakima, WA 1.0367
Yakima County, WA
49500 Yauco, PR 0.8423
Guánica Municipio, PR
Guayanilla Municipio, PR
Peñuelas Municipio, PR
Yauco Municipio, PR
49620 York-Hanover, PA 0.9893
York County, PA
49660 Youngstown-Warren-Boardman, OH-PA 0.9267
Mahoning County, OH
Trumbull County, OH
Mercer County, PA
49700 Yuba City, CA 1.1297
Sutter County, CA
Yuba County, CA
49740 Yuma, AZ 0.9590
Yuma County, AZ

CBSA code Nonurban area Wage index
1 Alabama 0.8423
2 Alaska 1.1224
3 Arizona 0.9379
4 Arkansas 0.8423
5 California 1.2059
6 Colorado 0.9818
7 Connecticut 1.2327
8 Delaware 1.0218
10 Florida 0.9048
11 Georgia 0.8423
12 Hawaii 1.1000
13 Idaho 0.8549
14 Illinois 0.8759
15 Indiana 0.8989
16 Iowa 0.9140
17 Kansas 0.8423
18 Kentucky 0.8423
19 Louisiana 0.8423
20 Maine 0.8889
21 Maryland 0.9397
22 Massachusetts 1.0756
23 Michigan 0.9541
24 Minnesota 0.9636
25 Mississippi 0.8423
26 Missouri 0.8423
27 Montana 0.9044
28 Nebraska 0.9135
29 Nevada 0.9416
30 New Hampshire 1.1426
31 New Jersey1
32 New Mexico 0.8772
33 New York 0.8667
34 North Carolina 0.9042
35 North Dakota 0.8423
36 Ohio 0.9115
37 Oklahoma 0.8423
38 Oregon 1.0268
39 Pennsylvania 0.8759
40 Puerto Rico 0.8423
41 Rhode Island1
42 South Carolina 0.9018
43 South Dakota 0.8928
44 Tennessee 0.8423
45 Texas 0.8423
46 Utah 0.8570
47 Vermont 1.0259
48 Virgin Islands 0.8914
49 Virginia 0.8423
50 Washington 1.0805
51 West Virginia 0.8423
52 Wisconsin 1.0058
53 Wyoming 0.9786
1 All counties in the States of New Jersey and Rhode Island are urban.

State Zip code RUCA level
AK 99501 1.0
AK 99502 1.0
AK 99503 1.0
AK 99504 1.0
AK 99505 1.0
AK 99506 1.0
AK 99507 1.0
AK 99508 1.0
AK 99509 1.0
AK 99510 1.0
AK 99511 1.0
AK 99512 1.0
AK 99513 1.0
AK 99514 1.0
AK 99515 1.0
AK 99516 1.0
AK 99517 1.0
AK 99518 1.0
AK 99519 1.0
AK 99520 1.0
AK 99521 1.0
AK 99522 1.0
AK 99523 1.0
AK 99524 1.0
AK 99529 1.0
AK 99530 1.0
AK 99540 2.0
AK 99546 10.5
AK 99547 10.5
AK 99548 10.0
AK 99549 10.0
AK 99550 4.0
AK 99551 10.0
AK 99552 10.0
AK 99553 10.0
AK 99554 10.0
AK 99555 10.0
AK 99556 10.0
AK 99557 10.0
AK 99558 10.0
AK 99559 7.0
AK 99561 10.0
AK 99563 10.0
AK 99564 10.0
AK 99565 10.0
AK 99566 10.0
AK 99567 2.0
AK 99568 8.0
AK 99569 10.0
AK 99571 10.0
AK 99572 10.0
AK 99573 10.0
AK 99574 10.0
AK 99575 10.0
AK 99576 10.0
AK 99577 2.0
AK 99578 10.0
AK 99579 10.0
AK 99580 10.0
AK 99581 1.0
AK 99583 10.0
AK 99584 10.0
AK 99585 10.0
AK 99586 10.0
AK 99587 2.0
AK 99588 10.0
AK 99589 10.0
AK 99590 10.0
AK 99591 10.5
AK 99599 1.0
AK 99602 10.0
AK 99603 10.0
AK 99604 10.0
AK 99605 10.0
AK 99606 10.0
AK 99607 10.0
AK 99608 4.0
AK 99609 7.0
AK 99610 8.0
AK 99611 7.0
AK 99612 10.0
AK 99613 10.0
AK 99614 10.0
AK 99615 4.0
AK 99619 4.0
AK 99620 10.0
AK 99621 10.0
AK 99622 10.0
AK 99624 4.0
AK 99625 10.0
AK 99626 10.0
AK 99627 10.0
AK 99628 10.0
AK 99629 4.1
AK 99630 10.0
AK 99631 10.0
AK 99632 10.0
AK 99633 10.0
AK 99634 10.0
AK 99635 7.0
AK 99636 10.0
AK 99637 10.0
AK 99638 10.5
AK 99639 10.0
AK 99640 10.0
AK 99641 7.0
AK 99643 4.0
AK 99644 4.0
AK 99645 2.0
AK 99647 10.0
AK 99648 10.0
AK 99649 10.0
AK 99650 10.0
AK 99651 10.0
AK 99652 5.2
AK 99653 10.0
AK 99654 4.1
AK 99655 10.0
AK 99656 10.0
AK 99657 10.0
AK 99658 10.0
AK 99659 10.0
AK 99660 10.5
AK 99661 10.0
AK 99662 10.0
AK 99663 10.0
AK 99664 10.0
AK 99665 10.0
AK 99666 10.0
AK 99667 10.0
AK 99668 10.0
AK 99669 8.0
AK 99670 10.0
AK 99671 10.0
AK 99672 8.0
AK 99674 2.0
AK 99675 10.0
AK 99676 10.0
AK 99677 10.0
AK 99678 10.0
AK 99679 10.0
AK 99680 7.0
AK 99681 10.0
AK 99682 10.0
AK 99683 5.2
AK 99684 10.0
AK 99685 7.3
AK 99686 10.0
AK 99687 5.2
AK 99688 5.0
AK 99689 10.1
AK 99690 7.0
AK 99691 10.0
AK 99692 7.3
AK 99693 10.0
AK 99694 5.0
AK 99695 1.0
AK 99697 4.0
AK 99701 1.0
AK 99702 7.3
AK 99703 1.0
AK 99704 10.4
AK 99705 1.0
AK 99706 1.0
AK 99707 1.0
AK 99708 1.0
AK 99709 1.0
AK 99710 1.0
AK 99711 1.0
AK 99712 1.0
AK 99714 2.0
AK 99716 1.0
AK 99720 10.0
AK 99721 10.0
AK 99722 10.0
AK 99723 7.0
AK 99724 10.0
AK 99725 1.0
AK 99726 10.4
AK 99727 10.6
AK 99729 10.0
AK 99730 10.0
AK 99731 10.0
AK 99732 10.0
AK 99733 10.0
AK 99734 10.0
AK 99736 10.6
AK 99737 10.0
AK 99738 10.0
AK 99739 10.0
AK 99740 10.0
AK 99741 10.0
AK 99742 10.0
AK 99743 10.0
AK 99744 10.0
AK 99745 10.0
AK 99746 10.0
AK 99747 10.0
AK 99748 10.0
AK 99749 10.6
AK 99750 10.6
AK 99751 10.6
AK 99752 7.0
AK 99753 10.0
AK 99754 10.0
AK 99755 10.0
AK 99756 10.4
AK 99757 10.0
AK 99758 10.4
AK 99759 10.0
AK 99760 10.4
AK 99761 10.6
AK 99762 7.0
AK 99763 10.6
AK 99764 10.0
AK 99765 10.0
AK 99766 10.0
AK 99767 10.4
AK 99768 10.0
AK 99769 10.0
AK 99770 10.6
AK 99771 10.0
AK 99772 10.0
AK 99773 10.6
AK 99774 10.4
AK 99775 1.0
AK 99776 10.0
AK 99777 10.4
AK 99778 10.0
AK 99779 10.0
AK 99780 10.0
AK 99781 10.0
AK 99782 10.0
AK 99783 10.0
AK 99784 10.0
AK 99785 10.0
AK 99786 10.6
AK 99788 10.0
AK 99789 10.0
AK 99790 1.0
AK 99791 7.0
AK 99801 4.0
AK 99802 4.0
AK 99803 4.0
AK 99811 4.0
AK 99820 10.0
AK 99821 4.0
AK 99824 7.2
AK 99825 10.0
AK 99826 10.0
AK 99827 10.0
AK 99829 10.0
AK 99830 7.0
AK 99832 10.0
AK 99833 7.0
AK 99835 7.0
AK 99836 7.0
AK 99840 10.0
AK 99841 10.0
AK 99850 4.0
AK 99901 4.0
AK 99903 5.0
AK 99918 4.0
AK 99919 10.0
AK 99921 10.0
AK 99922 10.0
AK 99923 5.0
AK 99925 10.0
AK 99926 10.0
AK 99927 10.0
AK 99928 4.0
AK 99929 10.0
AK 99950 10.0
AL 35004 2.0
AL 35005 1.0
AL 35006 2.0
AL 35007 1.0
AL 35010 7.0
AL 35011 7.0
AL 35013 7.1
AL 35014 6.1
AL 35015 1.0
AL 35016 7.3
AL 35019 9.2
AL 35020 1.0
AL 35021 1.0
AL 35022 1.0
AL 35023 1.0
AL 35031 2.0
AL 35032 9.2
AL 35033 5.2
AL 35034 7.3
AL 35035 10.4
AL 35036 1.0
AL 35038 2.0
AL 35040 2.0
AL 35041 1.0
AL 35042 7.0
AL 35043 2.0
AL 35044 9.2
AL 35045 7.3
AL 35046 8.3
AL 35048 1.0
AL 35049 2.0
AL 35051 2.0
AL 35052 7.1
AL 35053 5.2
AL 35054 10.4
AL 35055 4.0
AL 35056 4.0
AL 35057 5.0
AL 35058 5.0
AL 35060 1.0
AL 35061 1.0
AL 35062 2.0
AL 35063 2.0
AL 35064 1.0
AL 35068 1.0
AL 35070 5.0
AL 35071 1.0
AL 35072 8.0
AL 35073 1.0
AL 35074 2.0
AL 35077 5.0
AL 35078 2.0
AL 35079 2.0
AL 35080 1.0
AL 35082 8.0
AL 35083 5.0
AL 35085 2.0
AL 35087 3.0
AL 35089 8.0
AL 35091 2.0
AL 35094 2.0
AL 35096 3.0
AL 35097 2.0
AL 35098 5.0
AL 35111 2.0
AL 35112 2.0
AL 35114 1.0
AL 35115 2.0
AL 35116 2.0
AL 35117 1.0
AL 35118 2.0
AL 35119 1.0
AL 35120 2.0
AL 35121 7.1
AL 35123 1.0
AL 35124 1.0
AL 35125 3.0
AL 35126 1.0
AL 35127 1.0
AL 35128 7.1
AL 35130 2.0
AL 35131 3.0
AL 35133 2.0
AL 35135 3.0
AL 35136 8.0
AL 35137 1.0
AL 35139 1.0
AL 35142 1.0
AL 35143 2.0
AL 35144 1.0
AL 35146 2.0
AL 35147 2.0
AL 35148 2.0
AL 35149 4.0
AL 35150 4.0
AL 35151 5.2
AL 35160 4.0
AL 35161 4.0
AL 35171 2.0
AL 35172 2.0
AL 35173 1.0
AL 35175 2.0
AL 35176 2.0
AL 35178 2.0
AL 35179 5.0
AL 35180 2.0
AL 35181 1.0
AL 35182 3.0
AL 35183 5.0
AL 35184 2.0
AL 35185 2.0
AL 35186 2.0
AL 35187 10.4
AL 35188 2.0
AL 35201 1.0
AL 35202 1.0
AL 35203 1.0
AL 35204 1.0
AL 35205 1.0
AL 35206 1.0
AL 35207 1.0
AL 35208 1.0
AL 35209 1.0
AL 35210 1.0
AL 35211 1.0
AL 35212 1.0
AL 35213 1.0
AL 35214 1.0
AL 35215 1.0
AL 35216 1.0
AL 35217 1.0
AL 35218 1.0
AL 35219 1.0
AL 35220 1.0
AL 35221 1.0
AL 35222 1.0
AL 35223 1.0
AL 35224 1.0
AL 35225 1.0
AL 35226 1.0
AL 35228 1.0
AL 35229 1.0
AL 35230 1.0
AL 35231 1.0
AL 35232 1.0
AL 35233 1.0
AL 35234 1.0
AL 35235 1.0
AL 35236 1.0
AL 35237 1.0
AL 35238 1.0
AL 35240 1.0
AL 35242 1.0
AL 35243 1.0
AL 35244 1.0
AL 35245 1.0
AL 35246 1.0
AL 35249 1.0
AL 35253 1.0
AL 35254 1.0
AL 35255 1.0
AL 35259 1.0
AL 35260 1.0
AL 35261 1.0
AL 35263 1.0
AL 35266 1.0
AL 35277 1.0
AL 35278 1.0
AL 35279 1.0
AL 35280 1.0
AL 35281 1.0
AL 35282 1.0
AL 35283 1.0
AL 35285 1.0
AL 35286 1.0
AL 35287 1.0
AL 35288 1.0
AL 35289 1.0
AL 35290 1.0
AL 35291 1.0
AL 35292 1.0
AL 35293 1.0
AL 35294 1.0
AL 35295 1.0
AL 35296 1.0
AL 35297 1.0
AL 35298 1.0
AL 35299 1.0
AL 35401 1.0
AL 35402 1.0
AL 35403 1.0
AL 35404 1.0
AL 35405 1.0
AL 35406 1.0
AL 35407 1.0
AL 35440 2.1
AL 35441 2.0
AL 35442 10.4
AL 35443 9.0
AL 35444 2.0
AL 35446 1.0
AL 35447 10.0
AL 35448 10.4
AL 35449 2.0
AL 35452 1.0
AL 35453 2.0
AL 35456 2.0
AL 35457 2.0
AL 35458 2.0
AL 35459 10.0
AL 35460 10.0
AL 35461 5.0
AL 35462 10.4
AL 35463 2.0
AL 35464 10.0
AL 35466 2.0
AL 35468 2.1
AL 35469 10.4
AL 35470 10.0
AL 35471 5.0
AL 35473 1.0
AL 35474 2.0
AL 35475 2.0
AL 35476 1.0
AL 35477 10.0
AL 35478 2.1
AL 35480 2.0
AL 35481 3.0
AL 35482 2.0
AL 35485 1.0
AL 35486 1.0
AL 35487 1.0
AL 35490 2.1
AL 35491 10.4
AL 35501 4.2
AL 35502 4.2
AL 35503 5.0
AL 35504 5.2
AL 35540 10.0
AL 35541 10.0
AL 35542 8.3
AL 35543 9.0
AL 35544 10.0
AL 35545 7.0
AL 35546 8.3
AL 35548 10.0
AL 35549 10.5
AL 35550 5.2
AL 35551 7.0
AL 35552 10.0
AL 35553 10.0
AL 35554 8.0
AL 35555 7.0
AL 35559 10.0
AL 35560 5.0
AL 35563 10.0
AL 35564 10.0
AL 35565 7.0
AL 35570 10.0
AL 35571 10.0
AL 35572 10.0
AL 35573 10.5
AL 35574 10.5
AL 35575 10.6
AL 35576 10.5
AL 35577 10.6
AL 35578 5.2
AL 35579 5.2
AL 35580 5.0
AL 35581 10.6
AL 35582 10.0
AL 35584 2.0
AL 35585 8.0
AL 35586 10.0
AL 35587 5.2
AL 35592 10.0
AL 35593 10.0
AL 35594 10.0
AL 35601 1.0
AL 35602 1.0
AL 35603 1.0
AL 35609 1.0
AL 35610 2.0
AL 35611 4.2
AL 35612 4.2
AL 35613 2.0
AL 35614 5.2
AL 35615 5.2
AL 35616 2.0
AL 35617 2.0
AL 35618 2.0
AL 35619 2.0
AL 35620 5.2
AL 35621 3.0
AL 35622 2.0
AL 35630 1.0
AL 35631 1.0
AL 35632 1.0
AL 35633 2.0
AL 35634 2.0
AL 35640 2.0
AL 35643 2.0
AL 35645 2.0
AL 35646 2.0
AL 35647 5.2
AL 35648 2.0
AL 35649 1.0
AL 35650 2.0
AL 35651 3.0
AL 35652 2.0
AL 35653 7.3
AL 35654 9.2
AL 35660 1.0
AL 35661 1.0
AL 35662 1.0
AL 35670 2.1
AL 35671 5.2
AL 35672 3.0
AL 35673 2.0
AL 35674 1.0
AL 35677 2.0
AL 35699 1.0
AL 35739 2.0
AL 35740 7.3
AL 35741 1.0
AL 35742 2.0
AL 35744 6.0
AL 35745 5.2
AL 35746 10.6
AL 35747 2.0
AL 35748 2.0
AL 35749 2.0
AL 35750 2.0
AL 35751 5.2
AL 35752 5.0
AL 35754 2.0
AL 35755 5.0
AL 35756 2.0
AL 35757 1.0
AL 35758 1.0
AL 35759 2.0
AL 35760 2.0
AL 35761 2.0
AL 35762 1.0
AL 35763 1.0
AL 35764 2.0
AL 35765 10.5
AL 35766 5.2
AL 35767 1.0
AL 35768 4.0
AL 35769 4.0
AL 35771 6.0
AL 35772 10.6
AL 35773 2.0
AL 35774 5.2
AL 35775 2.0
AL 35776 2.0
AL 35801 1.0
AL 35802 1.0
AL 35803 1.0
AL 35804 1.0
AL 35805 1.0
AL 35806 1.0
AL 35807 1.0
AL 35808 1.0
AL 35809 1.0
AL 35810 1.0
AL 35811 1.0
AL 35812 1.0
AL 35813 1.0
AL 35814 1.0
AL 35815 1.0
AL 35816 1.0
AL 35824 1.0
AL 35893 1.0
AL 35894 1.0
AL 35895 1.0
AL 35896 1.0
AL 35897 1.0
AL 35898 1.0
AL 35899 1.0
AL 35901 1.0
AL 35902 1.0
AL 35903 1.0
AL 35904 1.0
AL 35905 1.0
AL 35906 1.0
AL 35907 1.0
AL 35950 4.0
AL 35951 4.0
AL 35952 2.0
AL 35953 3.0
AL 35954 1.0
AL 35956 5.2
AL 35957 4.0
AL 35958 2.0
AL 35959 3.0
AL 35960 10.0
AL 35961 10.6
AL 35962 5.0
AL 35963 5.0
AL 35964 5.0
AL 35966 2.0
AL 35967 8.0
AL 35968 9.0
AL 35971 10.6
AL 35972 2.0
AL 35973 3.0
AL 35974 5.0
AL 35975 10.6
AL 35976 4.0
AL 35978 9.0
AL 35979 2.0
AL 35980 5.0
AL 35981 2.0
AL 35983 10.0
AL 35984 10.6
AL 35986 10.6
AL 35987 3.0
AL 35988 10.6
AL 35989 10.6
AL 35990 2.0
AL 36003 5.2
AL 36005 5.0
AL 36006 6.1
AL 36008 2.0
AL 36009 10.0
AL 36010 5.0
AL 36013 2.0
AL 36015 10.6
AL 36016 10.3
AL 36017 10.0
AL 36020 2.0
AL 36022 2.0
AL 36023 2.0
AL 36024 2.0
AL 36025 2.0
AL 36026 8.0
AL 36027 7.0
AL 36028 10.6
AL 36029 2.0
AL 36030 10.6
AL 36031 5.2
AL 36032 2.0
AL 36033 10.6
AL 36034 6.0
AL 36035 5.0
AL 36036 2.0
AL 36037 10.6
AL 36038 8.0
AL 36039 2.0
AL 36040 2.0
AL 36041 3.0
AL 36042 2.0
AL 36043 2.0
AL 36045 2.0
AL 36046 2.0
AL 36047 2.0
AL 36048 10.0
AL 36049 10.0
AL 36051 2.0
AL 36052 2.0
AL 36053 8.0
AL 36054 2.0
AL 36057 2.0
AL 36061 8.0
AL 36062 10.0
AL 36064 2.0
AL 36065 2.0
AL 36066 2.0
AL 36067 2.0
AL 36068 2.0
AL 36069 2.0
AL 36071 10.4
AL 36072 7.0
AL 36075 2.0
AL 36078 2.0
AL 36079 5.0
AL 36080 2.0
AL 36081 4.0
AL 36082 4.0
AL 36083 4.2
AL 36087 4.2
AL 36088 4.2
AL 36089 7.0
AL 36091 8.3
AL 36092 2.0
AL 36093 2.0
AL 36101 1.0
AL 36102 1.0
AL 36103 1.0
AL 36104 1.0
AL 36105 1.0
AL 36106 1.0
AL 36107 1.0
AL 36108 1.0
AL 36109 1.0
AL 36110 1.0
AL 36111 1.0
AL 36112 1.0
AL 36113 1.0
AL 36114 1.0
AL 36115 1.0
AL 36116 1.0
AL 36117 1.0
AL 36118 1.0
AL 36119 1.0
AL 36120 1.0
AL 36121 1.0
AL 36123 1.0
AL 36124 1.0
AL 36125 1.0
AL 36130 1.0
AL 36131 1.0
AL 36132 1.0
AL 36133 1.0
AL 36134 1.0
AL 36135 1.0
AL 36140 1.0
AL 36141 1.0
AL 36142 1.0
AL 36177 1.0
AL 36191 1.0
AL 36201 1.0
AL 36202 1.0
AL 36203 1.0
AL 36204 1.0
AL 36205 2.0
AL 36206 1.0
AL 36207 1.0
AL 36250 1.0
AL 36251 10.0
AL 36253 1.0
AL 36254 1.0
AL 36255 10.0
AL 36256 8.0
AL 36257 1.0
AL 36258 10.0
AL 36260 1.0
AL 36261 5.1
AL 36262 10.0
AL 36263 10.0
AL 36264 5.1
AL 36265 1.0
AL 36266 10.0
AL 36267 10.0
AL 36268 2.0
AL 36269 10.0
AL 36271 2.0
AL 36272 7.3
AL 36273 6.0
AL 36274 7.4
AL 36275 10.0
AL 36276 8.0
AL 36277 1.0
AL 36278 10.6
AL 36279 2.0
AL 36280 10.0
AL 36301 1.0
AL 36302 1.0
AL 36303 1.0
AL 36304 1.0
AL 36305 1.0
AL 36310 10.4
AL 36311 5.0
AL 36312 2.0
AL 36313 5.0
AL 36314 10.4
AL 36316 5.0
AL 36317 10.6
AL 36318 5.0
AL 36319 2.0
AL 36320 2.0
AL 36321 2.0
AL 36322 5.0
AL 36323 10.5
AL 36330 4.2
AL 36331 4.2
AL 36340 7.0
AL 36343 2.0
AL 36344 10.4
AL 36345 2.0
AL 36346 10.5
AL 36349 2.0
AL 36350 1.0
AL 36351 5.0
AL 36352 2.0
AL 36353 2.0
AL 36360 4.2
AL 36361 4.2
AL 36362 4.2
AL 36370 2.0
AL 36371 1.0
AL 36373 10.4
AL 36374 5.0
AL 36375 2.0
AL 36376 2.0
AL 36401 10.0
AL 36420 7.0
AL 36421 7.0
AL 36425 8.0
AL 36426 7.0
AL 36427 7.0
AL 36429 10.0
AL 36432 10.6
AL 36435 10.6
AL 36436 8.0
AL 36439 7.0
AL 36441 10.6
AL 36442 10.6
AL 36444 8.0
AL 36445 8.0
AL 36446 8.0
AL 36449 8.0
AL 36451 10.6
AL 36453 9.0
AL 36454 8.0
AL 36455 10.6
AL 36456 10.0
AL 36457 8.0
AL 36458 8.0
AL 36460 7.0
AL 36461 7.0
AL 36462 7.0
AL 36467 7.0
AL 36470 7.0
AL 36471 8.0
AL 36473 8.0
AL 36474 8.0
AL 36475 8.0
AL 36476 7.0
AL 36477 10.6
AL 36480 10.3
AL 36481 8.0
AL 36482 10.6
AL 36483 8.0
AL 36501 8.0
AL 36502 8.0
AL 36503 8.0
AL 36504 8.0
AL 36505 2.0
AL 36507 7.3
AL 36509 1.0
AL 36511 8.4
AL 36512 2.0
AL 36513 2.0
AL 36515 8.0
AL 36518 10.0
AL 36521 2.0
AL 36522 2.0
AL 36523 1.0
AL 36524 10.6
AL 36525 1.0
AL 36526 4.1
AL 36527 4.1
AL 36528 2.0
AL 36529 3.0
AL 36530 9.0
AL 36532 4.1
AL 36533 4.1
AL 36535 7.0
AL 36536 7.0
AL 36538 10.0
AL 36539 3.0
AL 36540 8.0
AL 36541 2.0
AL 36542 7.0
AL 36543 8.0
AL 36544 1.0
AL 36545 8.0
AL 36547 7.0
AL 36548 8.0
AL 36549 9.0
AL 36550 9.1
AL 36551 10.4
AL 36553 2.0
AL 36555 8.4
AL 36556 2.0
AL 36558 10.6
AL 36559 4.1
AL 36560 2.0
AL 36561 7.0
AL 36562 8.3
AL 36564 4.1
AL 36567 9.2
AL 36568 1.0
AL 36569 8.0
AL 36570 8.0
AL 36571 1.0
AL 36572 1.0
AL 36574 10.4
AL 36575 1.0
AL 36576 9.2
AL 36577 4.1
AL 36578 9.2
AL 36579 9.1
AL 36580 9.2
AL 36581 8.0
AL 36582 1.0
AL 36583 3.0
AL 36584 3.0
AL 36585 8.0
AL 36587 2.0
AL 36590 1.0
AL 36601 1.0
AL 36602 1.0
AL 36603 1.0
AL 36604 1.0
AL 36605 1.0
AL 36606 1.0
AL 36607 1.0
AL 36608 1.0
AL 36609 1.0
AL 36610 1.0
AL 36611 1.0
AL 36612 1.0
AL 36613 1.0
AL 36614 1.0
AL 36615 1.0
AL 36616 1.0
AL 36617 1.0
AL 36618 1.0
AL 36619 1.0
AL 36621 1.0
AL 36622 1.0
AL 36623 1.0
AL 36625 1.0
AL 36626 1.0
AL 36628 1.0
AL 36630 1.0
AL 36631 1.0
AL 36633 1.0
AL 36640 1.0
AL 36641 1.0
AL 36644 1.0
AL 36652 1.0
AL 36660 1.0
AL 36663 1.0
AL 36670 1.0
AL 36671 1.0
AL 36675 1.0
AL 36685 1.0
AL 36688 1.0
AL 36689 1.0
AL 36690 1.0
AL 36691 1.0
AL 36693 1.0
AL 36695 1.0
AL 36701 4.0
AL 36702 4.0
AL 36703 4.0
AL 36720 10.5
AL 36721 10.6
AL 36722 10.6
AL 36723 10.5
AL 36726 10.0
AL 36727 10.6
AL 36728 10.5
AL 36732 7.0
AL 36736 10.6
AL 36738 10.6
AL 36740 9.0
AL 36741 10.0
AL 36742 7.0
AL 36744 7.3
AL 36745 7.0
AL 36748 10.6
AL 36749 5.0
AL 36750 10.6
AL 36751 10.6
AL 36752 2.0
AL 36753 10.0
AL 36754 10.6
AL 36756 10.0
AL 36758 5.0
AL 36759 5.0
AL 36761 2.0
AL 36762 7.0
AL 36763 10.6
AL 36764 9.0
AL 36765 9.0
AL 36766 10.0
AL 36767 5.0
AL 36768 10.0
AL 36769 10.6
AL 36773 5.0
AL 36775 5.0
AL 36776 8.1
AL 36782 9.0
AL 36783 10.6
AL 36784 7.0
AL 36785 2.0
AL 36786 10.5
AL 36790 10.6
AL 36792 10.4
AL 36793 10.4
AL 36801 1.0
AL 36802 1.0
AL 36803 1.0
AL 36804 1.0
AL 36830 1.0
AL 36831 1.0
AL 36832 1.0
AL 36849 1.0
AL 36850 3.0
AL 36851 2.0
AL 36852 2.0
AL 36853 10.6
AL 36854 4.0
AL 36855 6.0
AL 36856 2.0
AL 36858 2.0
AL 36859 2.0
AL 36860 2.0
AL 36861 9.0
AL 36862 10.5
AL 36863 4.0
AL 36865 1.0
AL 36866 2.0
AL 36867 1.0
AL 36868 1.0
AL 36869 1.0
AL 36870 1.0
AL 36871 2.0
AL 36872 4.0
AL 36874 2.0
AL 36875 2.0
AL 36877 1.0
AL 36879 10.5
AL 36901 10.0
AL 36904 10.0
AL 36906 10.0
AL 36907 10.0
AL 36908 10.0
AL 36910 10.0
AL 36912 10.0
AL 36913 10.0
AL 36915 10.0
AL 36916 10.0
AL 36919 10.0
AL 36921 10.0
AL 36922 10.0
AL 36925 10.0
AR 71601 1.0
AR 71602 1.0
AR 71603 1.0
AR 71611 1.0
AR 71612 1.0
AR 71613 1.0
AR 71630 10.6
AR 71631 8.0
AR 71635 7.0
AR 71638 7.0
AR 71639 7.0
AR 71640 7.0
AR 71642 8.0
AR 71643 10.4
AR 71644 10.4
AR 71646 7.0
AR 71647 8.0
AR 71651 8.0
AR 71652 10.4
AR 71653 7.4
AR 71654 7.0
AR 71655 7.0
AR 71656 7.0
AR 71657 7.0
AR 71658 10.6
AR 71659 10.4
AR 71660 10.4
AR 71661 10.6
AR 71662 7.0
AR 71663 10.6
AR 71665 2.0
AR 71666 10.6
AR 71667 10.2
AR 71670 8.0
AR 71671 7.0
AR 71674 10.6
AR 71675 8.0
AR 71676 8.0
AR 71677 8.0
AR 71678 10.0
AR 71701 4.0
AR 71711 4.0
AR 71720 5.0
AR 71721 10.2
AR 71722 6.0
AR 71724 4.0
AR 71725 9.0
AR 71726 5.0
AR 71728 10.2
AR 71730 4.0
AR 71731 4.0
AR 71740 5.0
AR 71742 7.0
AR 71743 10.2
AR 71744 10.6
AR 71745 10.0
AR 71747 5.0
AR 71748 9.0
AR 71749 5.0
AR 71750 4.0
AR 71751 5.0
AR 71752 5.0
AR 71753 4.0
AR 71754 4.0
AR 71758 5.0
AR 71759 4.0
AR 71762 5.0
AR 71763 10.5
AR 71764 5.0
AR 71765 5.0
AR 71766 10.6
AR 71768 4.0
AR 71770 5.0
AR 71772 10.2
AR 71801 4.0
AR 71802 4.0
AR 71820 7.3
AR 71822 7.3
AR 71823 10.6
AR 71825 5.0
AR 71826 10.0
AR 71827 10.5
AR 71828 6.0
AR 71831 6.0
AR 71832 7.0
AR 71833 10.6
AR 71834 2.0
AR 71835 6.0
AR 71836 10.6
AR 71837 2.0
AR 71838 6.0
AR 71839 2.0
AR 71840 2.0
AR 71841 8.0
AR 71842 8.0
AR 71844 6.0
AR 71845 10.5
AR 71846 10.6
AR 71847 5.0
AR 71851 8.0
AR 71852 7.0
AR 71853 7.3
AR 71854 1.0
AR 71855 5.0
AR 71857 7.4
AR 71858 6.0
AR 71859 6.0
AR 71860 10.5
AR 71861 5.0
AR 71862 6.0
AR 71864 6.0
AR 71865 8.3
AR 71866 8.3
AR 71901 1.0
AR 71902 1.0
AR 71903 1.0
AR 71909 2.0
AR 71910 2.0
AR 71913 1.0
AR 71914 1.0
AR 71920 5.0
AR 71921 5.0
AR 71922 10.6
AR 71923 4.0
AR 71929 2.0
AR 71932 7.0
AR 71933 2.0
AR 71935 10.0
AR 71937 8.0
AR 71940 10.6
AR 71941 3.0
AR 71942 3.0
AR 71943 10.4
AR 71944 10.6
AR 71945 8.0
AR 71949 2.0
AR 71950 10.4
AR 71951 1.0
AR 71952 10.0
AR 71953 7.0
AR 71956 2.0
AR 71957 10.4
AR 71958 10.6
AR 71959 10.0
AR 71960 10.0
AR 71961 10.0
AR 71962 5.0
AR 71964 2.0
AR 71965 10.0
AR 71966 10.0
AR 71968 2.0
AR 71969 10.0
AR 71970 10.0
AR 71971 10.6
AR 71972 8.0
AR 71973 10.6
AR 71998 4.0
AR 71999 4.0
AR 72001 10.0
AR 72002 1.0
AR 72003 8.0
AR 72004 3.0
AR 72005 8.0
AR 72006 10.0
AR 72007 2.0
AR 72010 5.0
AR 72011 2.0
AR 72012 2.0
AR 72013 6.0
AR 72014 8.0
AR 72015 1.0
AR 72016 2.0
AR 72017 10.6
AR 72018 1.0
AR 72020 5.0
AR 72021 7.0
AR 72022 1.0
AR 72023 1.0
AR 72024 10.4
AR 72025 10.0
AR 72026 8.0
AR 72027 8.4
AR 72028 6.0
AR 72029 10.6
AR 72030 8.4
AR 72031 10.0
AR 72032 4.2
AR 72033 4.2
AR 72034 4.2
AR 72035 4.2
AR 72036 10.0
AR 72037 2.0
AR 72038 8.0
AR 72039 5.0
AR 72040 10.4
AR 72041 10.6
AR 72042 7.0
AR 72043 7.0
AR 72044 10.6
AR 72045 2.0
AR 72046 2.0
AR 72047 5.2
AR 72048 8.0
AR 72051 10.0
AR 72052 5.0
AR 72053 1.0
AR 72055 10.6
AR 72057 2.0
AR 72058 5.2
AR 72059 10.0
AR 72060 5.0
AR 72061 5.2
AR 72063 8.4
AR 72064 10.6
AR 72065 2.0
AR 72066 10.4
AR 72067 10.6
AR 72068 5.0
AR 72069 10.6
AR 72070 2.0
AR 72072 10.4
AR 72073 8.0
AR 72074 10.0
AR 72075 7.0
AR 72076 1.0
AR 72078 1.0
AR 72079 2.0
AR 72080 8.4
AR 72081 5.0
AR 72082 5.0
AR 72083 2.0
AR 72084 3.0
AR 72085 4.0
AR 72086 2.0
AR 72087 1.0
AR 72088 10.0
AR 72089 1.0
AR 72099 1.0
AR 72101 10.0
AR 72102 2.0
AR 72103 1.0
AR 72104 7.3
AR 72105 9.1
AR 72106 5.1
AR 72107 6.0
AR 72108 7.0
AR 72110 7.4
AR 72111 5.2
AR 72112 7.0
AR 72113 2.0
AR 72114 1.0
AR 72115 1.0
AR 72116 1.0
AR 72117 1.0
AR 72118 1.0
AR 72119 1.0
AR 72120 1.0
AR 72121 5.0
AR 72122 2.0
AR 72123 10.0
AR 72124 1.0
AR 72125 10.4
AR 72126 10.1
AR 72127 6.0
AR 72128 3.0
AR 72129 3.0
AR 72130 10.6
AR 72131 9.0
AR 72132 2.0
AR 72133 3.0
AR 72134 10.6
AR 72135 2.0
AR 72136 2.0
AR 72137 5.0
AR 72139 5.0
AR 72140 8.0
AR 72141 10.5
AR 72142 2.0
AR 72143 4.0
AR 72145 4.0
AR 72149 4.0
AR 72150 2.0
AR 72152 3.0
AR 72153 10.0
AR 72156 8.4
AR 72157 8.4
AR 72158 1.0
AR 72160 7.0
AR 72164 1.0
AR 72165 5.0
AR 72166 10.6
AR 72167 2.0
AR 72168 10.4
AR 72169 7.0
AR 72170 10.6
AR 72173 5.1
AR 72175 3.0
AR 72176 2.0
AR 72178 4.0
AR 72179 8.0
AR 72180 2.0
AR 72181 5.2
AR 72182 10.4
AR 72183 1.0
AR 72189 10.0
AR 72190 1.0
AR 72198 1.0
AR 72199 1.0
AR 72201 1.0
AR 72202 1.0
AR 72203 1.0
AR 72204 1.0
AR 72205 1.0
AR 72206 1.0
AR 72207 1.0
AR 72209 1.0
AR 72210 1.0
AR 72211 1.0
AR 72212 1.0
AR 72214 1.0
AR 72215 1.0
AR 72216 1.0
AR 72217 1.0
AR 72219 1.0
AR 72221 1.0
AR 72222 1.0
AR 72223 1.0
AR 72225 1.0
AR 72227 1.0
AR 72231 1.0
AR 72260 1.0
AR 72295 1.0
AR 72301 1.0
AR 72303 1.0
AR 72310 5.0
AR 72311 8.0
AR 72312 5.0
AR 72313 10.6
AR 72315 4.0
AR 72316 4.0
AR 72319 4.0
AR 72320 8.0
AR 72321 5.0
AR 72322 5.0
AR 72324 8.0
AR 72325 1.0
AR 72326 5.0
AR 72327 2.0
AR 72328 5.0
AR 72329 10.6
AR 72330 10.6
AR 72331 2.0
AR 72332 1.0
AR 72333 5.0
AR 72335 4.0
AR 72336 4.0
AR 72338 10.6
AR 72339 1.0
AR 72340 5.0
AR 72341 8.0
AR 72342 4.0
AR 72346 2.0
AR 72347 10.6
AR 72348 2.0
AR 72350 10.6
AR 72351 10.6
AR 72352 5.0
AR 72353 5.0
AR 72354 9.0
AR 72355 5.0
AR 72358 7.4
AR 72359 4.0
AR 72360 7.0
AR 72364 1.0
AR 72365 7.3
AR 72366 5.0
AR 72367 5.0
AR 72368 9.0
AR 72369 5.0
AR 72370 7.4
AR 72372 5.0
AR 72373 2.0
AR 72374 5.0
AR 72376 1.0
AR 72377 7.3
AR 72379 10.6
AR 72383 5.0
AR 72384 1.0
AR 72386 9.0
AR 72387 7.4
AR 72389 5.0
AR 72390 4.0
AR 72391 7.4
AR 72392 5.0
AR 72394 2.0
AR 72395 10.6
AR 72396 7.4
AR 72401 1.0
AR 72402 1.0
AR 72403 1.0
AR 72404 1.0
AR 72410 3.0
AR 72411 2.0
AR 72412 5.0
AR 72413 8.0
AR 72414 2.0
AR 72415 9.0
AR 72416 2.0
AR 72417 2.0
AR 72419 2.0
AR 72421 2.0
AR 72422 7.0
AR 72424 8.0
AR 72425 5.0
AR 72426 5.0
AR 72427 2.0
AR 72428 7.4
AR 72429 10.4
AR 72430 8.0
AR 72431 7.0
AR 72432 2.0
AR 72433 7.3
AR 72434 9.0
AR 72435 8.0
AR 72436 5.0
AR 72437 2.0
AR 72438 7.4
AR 72439 1.0
AR 72440 10.6
AR 72441 9.2
AR 72442 7.4
AR 72443 5.0
AR 72444 8.0
AR 72445 3.0
AR 72447 2.0
AR 72449 8.0
AR 72450 4.0
AR 72451 4.0
AR 72453 8.0
AR 72454 7.0
AR 72455 7.0
AR 72456 9.2
AR 72457 10.3
AR 72458 9.0
AR 72459 9.0
AR 72460 8.0
AR 72461 10.5
AR 72462 8.0
AR 72464 8.0
AR 72465 3.0
AR 72466 10.6
AR 72467 2.0
AR 72469 10.6
AR 72470 8.0
AR 72471 8.0
AR 72472 7.3
AR 72473 8.0
AR 72474 4.0
AR 72475 10.4
AR 72476 7.3
AR 72478 8.0
AR 72479 10.4
AR 72482 9.0
AR 72501 4.0
AR 72503 4.0
AR 72512 10.0
AR 72513 10.6
AR 72515 10.5
AR 72517 10.0
AR 72519 10.5
AR 72520 10.0
AR 72521 10.2
AR 72522 5.0
AR 72523 8.0
AR 72524 5.0
AR 72525 7.0
AR 72526 5.0
AR 72527 5.0
AR 72528 10.5
AR 72529 7.0
AR 72530 10.6
AR 72531 10.5
AR 72532 10.2
AR 72533 10.0
AR 72534 5.0
AR 72536 10.0
AR 72537 5.0
AR 72538 10.5
AR 72539 10.0
AR 72540 10.0
AR 72542 7.0
AR 72543 7.0
AR 72544 5.0
AR 72545 7.0
AR 72546 8.0
AR 72550 5.0
AR 72553 5.0
AR 72554 10.0
AR 72555 10.0
AR 72556 10.0
AR 72560 10.0
AR 72561 10.0
AR 72562 5.0
AR 72564 5.0
AR 72565 10.0
AR 72566 10.5
AR 72567 10.0
AR 72568 5.0
AR 72569 10.2
AR 72571 5.0
AR 72572 10.6
AR 72573 10.0
AR 72575 4.0
AR 72576 10.5
AR 72577 10.2
AR 72578 10.5
AR 72579 5.0
AR 72581 10.6
AR 72583 10.5
AR 72584 10.0
AR 72585 10.0
AR 72587 10.0
AR 72601 5.0
AR 72602 5.0
AR 72611 5.0
AR 72613 10.0
AR 72615 5.0
AR 72616 7.0
AR 72617 5.0
AR 72619 10.5
AR 72623 5.0
AR 72624 5.0
AR 72626 5.0
AR 72628 10.5
AR 72629 10.0
AR 72630 5.0
AR 72631 10.0
AR 72632 10.0
AR 72633 5.0
AR 72634 10.5
AR 72635 5.0
AR 72636 6.0
AR 72638 7.0
AR 72639 10.0
AR 72640 5.0
AR 72641 5.0
AR 72642 5.0
AR 72644 5.0
AR 72645 10.0
AR 72648 5.0
AR 72650 10.0
AR 72651 5.0
AR 72653 4.0
AR 72654 4.0
AR 72655 10.5
AR 72657 10.0
AR 72658 5.0
AR 72659 5.0
AR 72660 8.0
AR 72661 10.5
AR 72662 5.0
AR 72663 10.0
AR 72666 10.5
AR 72668 10.5
AR 72669 6.0
AR 72670 5.0
AR 72672 10.5
AR 72675 6.0
AR 72677 10.5
AR 72679 5.0
AR 72680 10.0
AR 72682 10.0
AR 72683 10.5
AR 72685 5.0
AR 72686 6.0
AR 72687 10.5
AR 72701 1.0
AR 72702 1.0
AR 72703 1.0
AR 72704 1.0
AR 72711 1.0
AR 72712 1.0
AR 72714 2.0
AR 72715 2.0
AR 72716 1.0
AR 72717 2.0
AR 72718 1.0
AR 72719 2.0
AR 72721 2.0
AR 72722 2.0
AR 72727 1.0
AR 72728 1.0
AR 72729 2.0
AR 72730 1.0
AR 72732 2.0
AR 72733 2.0
AR 72734 4.2
AR 72735 1.0
AR 72736 2.0
AR 72737 1.0
AR 72738 2.0
AR 72739 2.0
AR 72740 10.2
AR 72741 1.0
AR 72742 10.0
AR 72744 2.0
AR 72745 1.0
AR 72747 2.0
AR 72749 2.0
AR 72751 2.0
AR 72752 10.0
AR 72753 2.0
AR 72756 1.0
AR 72757 1.0
AR 72758 1.0
AR 72760 10.0
AR 72761 4.2
AR 72762 1.0
AR 72764 1.0
AR 72765 1.0
AR 72766 1.0
AR 72768 2.0
AR 72769 2.0
AR 72770 1.0
AR 72773 2.0
AR 72774 2.0
AR 72776 10.0
AR 72801 4.0
AR 72802 4.0
AR 72811 4.0
AR 72812 4.0
AR 72820 7.3
AR 72821 7.3
AR 72823 5.0
AR 72824 5.0
AR 72826 9.1
AR 72827 10.5
AR 72828 10.5
AR 72829 4.0
AR 72830 7.0
AR 72832 8.0
AR 72833 10.5
AR 72834 4.0
AR 72835 10.6
AR 72837 5.0
AR 72838 10.5
AR 72839 8.0
AR 72840 8.0
AR 72841 8.0
AR 72842 5.0
AR 72843 5.0
AR 72845 8.0
AR 72846 8.0
AR 72847 5.0
AR 72851 10.6
AR 72852 8.0
AR 72853 10.5
AR 72854 8.0
AR 72855 7.0
AR 72856 5.0
AR 72857 10.5
AR 72858 5.0
AR 72860 10.5
AR 72863 10.6
AR 72865 8.0
AR 72901 1.0
AR 72902 1.0
AR 72903 1.0
AR 72904 1.0
AR 72905 2.0
AR 72906 1.0
AR 72908 1.0
AR 72913 1.0
AR 72914 1.0
AR 72916 2.0
AR 72917 1.0
AR 72918 1.0
AR 72919 1.0
AR 72921 2.0
AR 72923 1.0
AR 72924 8.0
AR 72926 8.0
AR 72927 7.0
AR 72928 2.0
AR 72930 2.0
AR 72932 2.0
AR 72933 2.0
AR 72934 2.0
AR 72935 2.0
AR 72936 2.0
AR 72937 2.0
AR 72938 2.0
AR 72940 2.0
AR 72941 2.0
AR 72943 8.0
AR 72944 8.0
AR 72945 2.0
AR 72946 2.0
AR 72947 2.0
AR 72948 2.0
AR 72949 7.3
AR 72950 8.0
AR 72951 8.0
AR 72952 2.0
AR 72955 2.0
AR 72956 1.0
AR 72957 1.0
AR 72958 7.0
AR 72959 2.0
AZ 85001 1.0
AZ 85002 1.0
AZ 85003 1.0
AZ 85004 1.0
AZ 85005 1.0
AZ 85006 1.0
AZ 85007 1.0
AZ 85008 1.0
AZ 85009 1.0
AZ 85010 1.0
AZ 85011 1.0
AZ 85012 1.0
AZ 85013 1.0
AZ 85014 1.0
AZ 85015 1.0
AZ 85016 1.0
AZ 85017 1.0
AZ 85018 1.0
AZ 85019 1.0
AZ 85020 1.0
AZ 85021 1.0
AZ 85022 1.0
AZ 85023 1.0
AZ 85024 1.0
AZ 85025 1.0
AZ 85026 1.0
AZ 85027 1.0
AZ 85028 1.0
AZ 85029 1.0
AZ 85030 1.0
AZ 85031 1.0
AZ 85032 1.0
AZ 85033 1.0
AZ 85034 1.0
AZ 85035 1.0
AZ 85036 1.0
AZ 85037 1.0
AZ 85038 1.0
AZ 85039 1.0
AZ 85040 1.0
AZ 85041 1.0
AZ 85042 1.0
AZ 85043 1.0
AZ 85044 1.0
AZ 85045 1.0
AZ 85046 1.0
AZ 85048 1.0
AZ 85050 1.0
AZ 85051 1.0
AZ 85053 1.0
AZ 85054 1.0
AZ 85055 1.0
AZ 85060 1.0
AZ 85061 1.0
AZ 85062 1.0
AZ 85063 1.0
AZ 85064 1.0
AZ 85065 1.0
AZ 85066 1.0
AZ 85067 1.0
AZ 85068 1.0
AZ 85069 1.0
AZ 85070 10.4
AZ 85071 1.0
AZ 85072 1.0
AZ 85073 1.0
AZ 85074 1.0
AZ 85075 1.0
AZ 85076 1.0
AZ 85077 1.0
AZ 85078 1.0
AZ 85079 1.0
AZ 85080 1.0
AZ 85082 1.0
AZ 85085 1.0
AZ 85086 2.0
AZ 85087 2.0
AZ 85098 1.0
AZ 85099 1.0
AZ 85201 1.0
AZ 85202 1.0
AZ 85203 1.0
AZ 85204 1.0
AZ 85205 1.0
AZ 85206 1.0
AZ 85207 1.0
AZ 85208 1.0
AZ 85209 1.0
AZ 85210 1.0
AZ 85211 1.0
AZ 85212 1.0
AZ 85213 1.0
AZ 85214 1.0
AZ 85215 1.0
AZ 85216 1.0
AZ 85217 1.0
AZ 85218 1.0
AZ 85219 1.0
AZ 85220 1.0
AZ 85221 4.2
AZ 85222 4.2
AZ 85223 4.2
AZ 85224 1.0
AZ 85225 1.0
AZ 85226 1.0
AZ 85227 2.0
AZ 85228 7.4
AZ 85230 4.2
AZ 85231 7.4
AZ 85232 4.0
AZ 85233 1.0
AZ 85234 1.0
AZ 85235 10.0
AZ 85236 1.0
AZ 85237 10.0
AZ 85239 10.1
AZ 85241 7.4
AZ 85242 2.0
AZ 85243 2.0
AZ 85244 1.0
AZ 85245 2.0
AZ 85246 1.0
AZ 85247 10.4
AZ 85248 1.0
AZ 85249 1.0
AZ 85250 1.0
AZ 85251 1.0
AZ 85252 1.0
AZ 85253 1.0
AZ 85254 1.0
AZ 85255 1.0
AZ 85256 1.0
AZ 85257 1.0
AZ 85258 1.0
AZ 85259 1.0
AZ 85260 1.0
AZ 85261 1.0
AZ 85262 1.0
AZ 85263 2.0
AZ 85264 10.1
AZ 85266 1.0
AZ 85267 1.0
AZ 85268 2.0
AZ 85269 2.0
AZ 85271 1.0
AZ 85272 10.1
AZ 85273 7.1
AZ 85274 1.0
AZ 85275 1.0
AZ 85277 1.0
AZ 85278 1.0
AZ 85279 4.0
AZ 85280 1.0
AZ 85281 1.0
AZ 85282 1.0
AZ 85283 1.0
AZ 85284 1.0
AZ 85285 1.0
AZ 85287 1.0
AZ 85289 1.0
AZ 85290 10.1
AZ 85291 7.4
AZ 85292 10.0
AZ 85296 1.0
AZ 85297 1.0
AZ 85299 1.0
AZ 85301 1.0
AZ 85302 1.0
AZ 85303 1.0
AZ 85304 1.0
AZ 85305 1.0
AZ 85306 1.0
AZ 85307 2.0
AZ 85308 1.0
AZ 85309 2.0
AZ 85310 1.0
AZ 85311 1.0
AZ 85312 1.0
AZ 85313 1.0
AZ 85318 1.0
AZ 85320 1.0
AZ 85321 7.3
AZ 85322 2.0
AZ 85323 2.0
AZ 85324 2.0
AZ 85325 7.0
AZ 85326 2.0
AZ 85327 1.0
AZ 85328 4.0
AZ 85329 2.0
AZ 85331 1.0
AZ 85332 2.0
AZ 85333 10.4
AZ 85334 4.0
AZ 85335 1.0
AZ 85336 2.0
AZ 85337 2.0
AZ 85338 2.0
AZ 85339 1.0
AZ 85340 2.0
AZ 85341 2.0
AZ 85342 1.0
AZ 85343 2.0
AZ 85344 7.0
AZ 85345 1.0
AZ 85346 7.0
AZ 85347 10.4
AZ 85348 10.3
AZ 85349 2.0
AZ 85350 2.0
AZ 85351 1.0
AZ 85352 10.1
AZ 85353 1.0
AZ 85354 2.0
AZ 85355 2.0
AZ 85356 10.1
AZ 85357 10.3
AZ 85358 1.0
AZ 85359 7.0
AZ 85360 4.0
AZ 85361 1.0
AZ 85362 2.0
AZ 85363 1.0
AZ 85364 1.0
AZ 85365 1.0
AZ 85366 1.0
AZ 85367 2.0
AZ 85369 1.0
AZ 85371 7.0
AZ 85372 1.0
AZ 85373 1.0
AZ 85374 1.0
AZ 85375 1.0
AZ 85376 1.0
AZ 85377 1.0
AZ 85378 1.0
AZ 85379 1.0
AZ 85380 1.0
AZ 85381 1.0
AZ 85382 1.0
AZ 85383 1.0
AZ 85385 1.0
AZ 85387 1.0
AZ 85388 1.0
AZ 85390 1.0
AZ 85396 1.0
AZ 85501 4.0
AZ 85502 4.0
AZ 85530 8.0
AZ 85531 4.0
AZ 85532 4.0
AZ 85533 7.0
AZ 85534 10.3
AZ 85535 5.0
AZ 85536 5.0
AZ 85539 4.0
AZ 85540 7.0
AZ 85541 4.0
AZ 85542 7.4
AZ 85543 5.0
AZ 85544 5.0
AZ 85545 10.5
AZ 85546 4.0
AZ 85547 4.0
AZ 85548 4.0
AZ 85550 8.0
AZ 85551 4.0
AZ 85552 4.0
AZ 85553 4.0
AZ 85554 4.0
AZ 85601 2.0
AZ 85602 7.3
AZ 85603 7.4
AZ 85605 10.6
AZ 85606 7.0
AZ 85607 4.0
AZ 85608 4.0
AZ 85609 7.0
AZ 85610 10.5
AZ 85611 10.4
AZ 85613 4.0
AZ 85614 4.1
AZ 85615 5.0
AZ 85616 4.0
AZ 85617 10.5
AZ 85618 2.0
AZ 85619 1.0
AZ 85620 7.4
AZ 85621 4.0
AZ 85622 4.1
AZ 85623 2.0
AZ 85624 10.4
AZ 85625 7.0
AZ 85626 4.0
AZ 85627 7.3
AZ 85628 4.0
AZ 85629 2.0
AZ 85630 7.3
AZ 85631 7.3
AZ 85632 10.6
AZ 85633 2.0
AZ 85634 10.4
AZ 85635 4.0
AZ 85636 4.0
AZ 85637 10.4
AZ 85638 10.5
AZ 85639 10.4
AZ 85640 10.5
AZ 85641 2.0
AZ 85643 7.0
AZ 85644 7.0
AZ 85645 5.1
AZ 85646 10.5
AZ 85648 4.0
AZ 85650 4.0
AZ 85652 1.0
AZ 85653 2.0
AZ 85654 2.0
AZ 85655 4.0
AZ 85662 4.0
AZ 85670 4.0
AZ 85671 4.0
AZ 85701 1.0
AZ 85702 1.0
AZ 85703 1.0
AZ 85704 1.0
AZ 85705 1.0
AZ 85706 1.0
AZ 85707 1.0
AZ 85708 1.0
AZ 85709 1.0
AZ 85710 1.0
AZ 85711 1.0
AZ 85712 1.0
AZ 85713 1.0
AZ 85714 1.0
AZ 85715 1.0
AZ 85716 1.0
AZ 85717 1.0
AZ 85718 1.0
AZ 85719 1.0
AZ 85720 1.0
AZ 85721 1.0
AZ 85722 1.0
AZ 85723 1.0
AZ 85724 1.0
AZ 85725 1.0
AZ 85726 1.0
AZ 85728 1.0
AZ 85730 1.0
AZ 85731 1.0
AZ 85732 1.0
AZ 85733 1.0
AZ 85734 1.0
AZ 85735 1.0
AZ 85736 2.0
AZ 85737 1.0
AZ 85738 1.0
AZ 85739 2.0
AZ 85740 1.0
AZ 85741 1.0
AZ 85742 1.0
AZ 85743 1.0
AZ 85744 2.0
AZ 85745 1.0
AZ 85746 1.0
AZ 85747 2.0
AZ 85748 1.0
AZ 85749 1.0
AZ 85750 1.0
AZ 85751 1.0
AZ 85752 1.0
AZ 85754 1.0
AZ 85755 1.0
AZ 85757 1.0
AZ 85775 1.0
AZ 85777 1.0
AZ 85901 7.0
AZ 85902 7.0
AZ 85911 7.0
AZ 85912 7.0
AZ 85920 7.0
AZ 85922 7.0
AZ 85923 7.0
AZ 85924 10.6
AZ 85925 7.0
AZ 85926 7.0
AZ 85927 7.0
AZ 85928 10.6
AZ 85929 7.0
AZ 85930 7.0
AZ 85931 7.0
AZ 85932 7.0
AZ 85933 10.6
AZ 85934 7.0
AZ 85935 7.0
AZ 85936 7.0
AZ 85937 7.0
AZ 85938 7.0
AZ 85939 7.0
AZ 85940 7.0
AZ 85941 7.0
AZ 85942 7.0
AZ 86001 1.0
AZ 86002 1.0
AZ 86003 1.0
AZ 86004 1.0
AZ 86011 1.0
AZ 86015 1.0
AZ 86016 1.0
AZ 86017 7.0
AZ 86018 10.4
AZ 86020 7.3
AZ 86021 9.0
AZ 86022 10.6
AZ 86023 10.4
AZ 86024 2.1
AZ 86025 7.0
AZ 86028 7.0
AZ 86029 7.0
AZ 86030 10.0
AZ 86031 7.0
AZ 86032 7.0
AZ 86033 7.0
AZ 86034 10.0
AZ 86035 2.0
AZ 86036 10.6
AZ 86038 2.1
AZ 86039 10.0
AZ 86040 7.0
AZ 86042 10.0
AZ 86043 10.0
AZ 86044 8.0
AZ 86045 7.3
AZ 86046 10.4
AZ 86047 7.0
AZ 86052 10.6
AZ 86053 8.0
AZ 86054 9.0
AZ 86301 1.0
AZ 86302 1.0
AZ 86303 1.0
AZ 86304 1.0
AZ 86305 1.0
AZ 86312 1.0
AZ 86313 1.0
AZ 86314 1.0
AZ 86320 10.4
AZ 86321 10.4
AZ 86322 10.5
AZ 86323 2.0
AZ 86324 4.0
AZ 86325 9.0
AZ 86326 4.0
AZ 86327 2.0
AZ 86329 2.0
AZ 86330 1.0
AZ 86331 4.0
AZ 86332 2.0
AZ 86333 2.0
AZ 86334 2.0
AZ 86335 10.5
AZ 86336 7.0
AZ 86337 10.4
AZ 86338 1.0
AZ 86339 7.0
AZ 86340 7.0
AZ 86341 9.0
AZ 86342 10.5
AZ 86343 2.0
AZ 86351 9.0
AZ 86401 4.0
AZ 86402 4.0
AZ 86403 4.0
AZ 86404 4.0
AZ 86405 4.0
AZ 86406 4.0
AZ 86409 4.0
AZ 86411 4.0
AZ 86412 4.0
AZ 86413 5.0
AZ 86426 8.2
AZ 86427 8.2
AZ 86429 8.4
AZ 86430 8.4
AZ 86431 4.0
AZ 86432 9.0
AZ 86433 8.2
AZ 86434 5.0
AZ 86435 10.4
AZ 86436 8.2
AZ 86437 4.0
AZ 86438 8.2
AZ 86439 8.2
AZ 86440 9.2
AZ 86441 5.0
AZ 86442 8.2
AZ 86443 5.0
AZ 86444 5.0
AZ 86445 5.0
AZ 86446 8.2
AZ 86502 10.5
AZ 86503 7.0
AZ 86504 7.4
AZ 86505 7.4
AZ 86506 7.4
AZ 86507 10.6
AZ 86508 7.4
AZ 86510 10.0
AZ 86511 7.4
AZ 86512 10.5
AZ 86514 10.4
AZ 86515 7.4
AZ 86520 10.0
AZ 86535 8.0
AZ 86538 8.0
AZ 86540 7.0
AZ 86544 10.4
AZ 86545 10.4
AZ 86547 8.0
AZ 86556 10.6
CA 90001 1.0
CA 90002 1.0
CA 90003 1.0
CA 90004 1.0
CA 90005 1.0
CA 90006 1.0
CA 90007 1.0
CA 90008 1.0
CA 90009 1.0
CA 90010 1.0
CA 90011 1.0
CA 90012 1.0
CA 90013 1.0
CA 90014 1.0
CA 90015 1.0
CA 90016 1.0
CA 90017 1.0
CA 90018 1.0
CA 90019 1.0
CA 90020 1.0
CA 90021 1.0
CA 90022 1.0
CA 90023 1.0
CA 90024 1.0
CA 90025 1.0
CA 90026 1.0
CA 90027 1.0
CA 90028 1.0
CA 90029 1.0
CA 90030 1.0
CA 90031 1.0
CA 90032 1.0
CA 90033 1.0
CA 90034 1.0
CA 90035 1.0
CA 90036 1.0
CA 90037 1.0
CA 90038 1.0
CA 90039 1.0
CA 90040 1.0
CA 90041 1.0
CA 90042 1.0
CA 90043 1.0
CA 90044 1.0
CA 90045 1.0
CA 90046 1.0
CA 90047 1.0
CA 90048 1.0
CA 90049 1.0
CA 90050 1.0
CA 90051 1.0
CA 90052 1.0
CA 90053 1.0
CA 90054 1.0
CA 90055 1.0
CA 90056 1.0
CA 90057 1.0
CA 90058 1.0
CA 90059 1.0
CA 90060 1.0
CA 90061 1.0
CA 90062 1.0
CA 90063 1.0
CA 90064 1.0
CA 90065 1.0
CA 90066 1.0
CA 90067 1.0
CA 90068 1.0
CA 90069 1.0
CA 90070 1.0
CA 90071 1.0
CA 90072 1.0
CA 90073 1.0
CA 90074 1.0
CA 90075 1.0
CA 90076 1.0
CA 90077 1.0
CA 90078 1.0
CA 90079 1.0
CA 90080 1.0
CA 90081 1.0
CA 90082 1.0
CA 90083 1.0
CA 90084 1.0
CA 90086 1.0
CA 90087 1.0
CA 90088 1.0
CA 90089 1.0
CA 90091 1.0
CA 90093 1.0
CA 90094 1.0
CA 90095 1.0
CA 90096 1.0
CA 90097 1.0
CA 90099 1.0
CA 90101 1.0
CA 90102 1.0
CA 90103 1.0
CA 90174 1.0
CA 90185 1.0
CA 90189 1.0
CA 90201 1.0
CA 90202 1.0
CA 90209 1.0
CA 90210 1.0
CA 90211 1.0
CA 90212 1.0
CA 90213 1.0
CA 90220 1.0
CA 90221 1.0
CA 90222 1.0
CA 90223 1.0
CA 90224 1.0
CA 90230 1.0
CA 90231 1.0
CA 90232 1.0
CA 90233 1.0
CA 90239 1.0
CA 90240 1.0
CA 90241 1.0
CA 90242 1.0
CA 90245 1.0
CA 90247 1.0
CA 90248 1.0
CA 90249 1.0
CA 90250 1.0
CA 90251 1.0
CA 90254 1.0
CA 90255 1.0
CA 90260 1.0
CA 90261 1.0
CA 90262 1.0
CA 90263 1.0
CA 90264 1.0
CA 90265 1.0
CA 90266 1.0
CA 90267 1.0
CA 90270 1.0
CA 90272 1.0
CA 90274 1.0
CA 90275 1.0
CA 90277 1.0
CA 90278 1.0
CA 90280 1.0
CA 90290 1.0
CA 90291 1.0
CA 90292 1.0
CA 90293 1.0
CA 90294 1.0
CA 90295 1.0
CA 90296 1.0
CA 90301 1.0
CA 90302 1.0
CA 90303 1.0
CA 90304 1.0
CA 90305 1.0
CA 90306 1.0
CA 90307 1.0
CA 90308 1.0
CA 90309 1.0
CA 90310 1.0
CA 90311 1.0
CA 90312 1.0
CA 90313 1.0
CA 90397 1.0
CA 90398 1.0
CA 90401 1.0
CA 90402 1.0
CA 90403 1.0
CA 90404 1.0
CA 90405 1.0
CA 90406 1.0
CA 90407 1.0
CA 90408 1.0
CA 90409 1.0
CA 90410 1.0
CA 90411 1.0
CA 90501 1.0
CA 90502 1.0
CA 90503 1.0
CA 90504 1.0
CA 90505 1.0
CA 90506 1.0
CA 90507 1.0
CA 90508 1.0
CA 90509 1.0
CA 90510 1.0
CA 90601 1.0
CA 90602 1.0
CA 90603 1.0
CA 90604 1.0
CA 90605 1.0
CA 90606 1.0
CA 90607 1.0
CA 90608 1.0
CA 90609 1.0
CA 90610 1.0
CA 90612 1.0
CA 90620 1.0
CA 90621 1.0
CA 90622 1.0
CA 90623 1.0
CA 90624 1.0
CA 90630 1.0
CA 90631 1.0
CA 90632 1.0
CA 90633 1.0
CA 90637 1.0
CA 90638 1.0
CA 90639 1.0
CA 90640 1.0
CA 90650 1.0
CA 90651 1.0
CA 90652 1.0
CA 90659 1.0
CA 90660 1.0
CA 90661 1.0
CA 90662 1.0
CA 90665 1.0
CA 90670 1.0
CA 90671 1.0
CA 90680 1.0
CA 90701 1.0
CA 90702 1.0
CA 90703 1.0
CA 90704 7.3
CA 90706 1.0
CA 90707 1.0
CA 90710 1.0
CA 90711 1.0
CA 90712 1.0
CA 90713 1.0
CA 90714 1.0
CA 90715 1.0
CA 90716 1.0
CA 90717 1.0
CA 90720 1.0
CA 90721 1.0
CA 90723 1.0
CA 90731 1.0
CA 90732 1.0
CA 90733 1.0
CA 90734 1.0
CA 90740 1.0
CA 90742 1.0
CA 90743 1.0
CA 90744 1.0
CA 90745 1.0
CA 90746 1.0
CA 90747 1.0
CA 90748 1.0
CA 90749 1.0
CA 90755 1.0
CA 90801 1.0
CA 90802 1.0
CA 90803 1.0
CA 90804 1.0
CA 90805 1.0
CA 90806 1.0
CA 90807 1.0
CA 90808 1.0
CA 90809 1.0
CA 90810 1.0
CA 90813 1.0
CA 90814 1.0
CA 90815 1.0
CA 90822 1.0
CA 90831 1.0
CA 90832 1.0
CA 90833 1.0
CA 90834 1.0
CA 90835 1.0
CA 90840 1.0
CA 90842 1.0
CA 90844 1.0
CA 90845 1.0
CA 90846 1.0
CA 90847 1.0
CA 90848 1.0
CA 90853 1.0
CA 90888 1.0
CA 90895 1.0
CA 90899 1.0
CA 91001 1.0
CA 91003 1.0
CA 91006 1.0
CA 91007 1.0
CA 91009 1.0
CA 91010 1.0
CA 91011 1.0
CA 91012 1.0
CA 91016 1.0
CA 91017 1.0
CA 91020 1.0
CA 91021 1.0
CA 91023 1.0
CA 91024 1.0
CA 91025 1.0
CA 91030 1.0
CA 91031 1.0
CA 91040 1.0
CA 91041 1.0
CA 91042 1.0
CA 91043 1.0
CA 91046 1.0
CA 91066 1.0
CA 91077 1.0
CA 91101 1.0
CA 91102 1.0
CA 91103 1.0
CA 91104 1.0
CA 91105 1.0
CA 91106 1.0
CA 91107 1.0
CA 91108 1.0
CA 91109 1.0
CA 91110 1.0
CA 91114 1.0
CA 91115 1.0
CA 91116 1.0
CA 91117 1.0
CA 91118 1.0
CA 91121 1.0
CA 91123 1.0
CA 91124 1.0
CA 91125 1.0
CA 91126 1.0
CA 91129 1.0
CA 91131 1.0
CA 91175 1.0
CA 91182 1.0
CA 91184 1.0
CA 91185 1.0
CA 91186 1.0
CA 91187 1.0
CA 91188 1.0
CA 91189 1.0
CA 91191 1.0
CA 91201 1.0
CA 91202 1.0
CA 91203 1.0
CA 91204 1.0
CA 91205 1.0
CA 91206 1.0
CA 91207 1.0
CA 91208 1.0
CA 91209 1.0
CA 91210 1.0
CA 91214 1.0
CA 91221 1.0
CA 91222 1.0
CA 91224 1.0
CA 91225 1.0
CA 91226 1.0
CA 91301 1.1
CA 91302 1.0
CA 91303 1.0
CA 91304 1.0
CA 91305 1.0
CA 91306 1.0
CA 91307 1.0
CA 91308 1.0
CA 91309 1.0
CA 91310 2.0
CA 91311 1.0
CA 91312 1.0
CA 91313 1.0
CA 91316 1.0
CA 91319 1.1
CA 91320 1.1
CA 91321 2.0
CA 91322 2.0
CA 91324 1.0
CA 91325 1.0
CA 91326 1.0
CA 91327 1.0
CA 91328 1.0
CA 91329 1.0
CA 91330 1.0
CA 91331 1.0
CA 91333 1.0
CA 91334 1.0
CA 91335 1.0
CA 91337 1.0
CA 91340 1.0
CA 91341 1.0
CA 91342 1.0
CA 91343 1.0
CA 91344 1.0
CA 91345 1.0
CA 91346 1.0
CA 91350 2.0
CA 91351 2.0
CA 91352 1.0
CA 91353 1.0
CA 91354 2.0
CA 91355 2.0
CA 91356 1.0
CA 91357 1.0
CA 91358 1.1
CA 91359 1.1
CA 91360 1.1
CA 91361 1.1
CA 91362 1.1
CA 91363 1.1
CA 91364 1.0
CA 91365 1.0
CA 91367 1.0
CA 91371 1.0
CA 91372 1.0
CA 91376 1.1
CA 91377 1.1
CA 91380 2.0
CA 91381 2.0
CA 91382 2.0
CA 91383 2.0
CA 91384 2.0
CA 91385 2.0
CA 91386 2.0
CA 91387 2.0
CA 91388 1.0
CA 91390 2.0
CA 91392 1.0
CA 91393 1.0
CA 91394 1.0
CA 91395 1.0
CA 91396 1.0
CA 91399 1.0
CA 91401 1.0
CA 91402 1.0
CA 91403 1.0
CA 91404 1.0
CA 91405 1.0
CA 91406 1.0
CA 91407 1.0
CA 91408 1.0
CA 91409 1.0
CA 91410 1.0
CA 91411 1.0
CA 91412 1.0
CA 91413 1.0
CA 91416 1.0
CA 91423 1.0
CA 91426 1.0
CA 91436 1.0
CA 91470 1.0
CA 91482 1.0
CA 91495 1.0
CA 91496 1.0
CA 91497 1.0
CA 91499 1.0
CA 91501 1.0
CA 91502 1.0
CA 91503 1.0
CA 91504 1.0
CA 91505 1.0
CA 91506 1.0
CA 91507 1.0
CA 91508 1.0
CA 91510 1.0
CA 91521 1.0
CA 91522 1.0
CA 91523 1.0
CA 91526 1.0
CA 91601 1.0
CA 91602 1.0
CA 91603 1.0
CA 91604 1.0
CA 91605 1.0
CA 91606 1.0
CA 91607 1.0
CA 91608 1.0
CA 91609 1.0
CA 91610 1.0
CA 91611 1.0
CA 91612 1.0
CA 91614 1.0
CA 91615 1.0
CA 91616 1.0
CA 91617 1.0
CA 91618 1.0
CA 91701 1.0
CA 91702 1.0
CA 91706 1.0
CA 91708 1.0
CA 91709 1.0
CA 91710 1.0
CA 91711 1.0
CA 91714 1.0
CA 91715 1.0
CA 91716 1.0
CA 91722 1.0
CA 91723 1.0
CA 91724 1.0
CA 91729 1.0
CA 91730 1.0
CA 91731 1.0
CA 91732 1.0
CA 91733 1.0
CA 91734 1.0
CA 91735 1.0
CA 91737 1.0
CA 91739 1.0
CA 91740 1.0
CA 91741 1.0
CA 91743 1.0
CA 91744 1.0
CA 91745 1.0
CA 91746 1.0
CA 91747 1.0
CA 91748 1.0
CA 91749 1.0
CA 91750 1.0
CA 91752 1.0
CA 91754 1.0
CA 91755 1.0
CA 91756 1.0
CA 91758 1.0
CA 91759 2.0
CA 91761 1.0
CA 91762 1.0
CA 91763 1.0
CA 91764 1.0
CA 91765 1.0
CA 91766 1.0
CA 91767 1.0
CA 91768 1.0
CA 91769 1.0
CA 91770 1.0
CA 91771 1.0
CA 91772 1.0
CA 91773 1.0
CA 91775 1.0
CA 91776 1.0
CA 91778 1.0
CA 91780 1.0
CA 91784 1.0
CA 91785 1.0
CA 91786 1.0
CA 91788 1.0
CA 91789 1.0
CA 91790 1.0
CA 91791 1.0
CA 91792 1.0
CA 91793 1.0
CA 91795 1.0
CA 91797 1.0
CA 91798 1.0
CA 91799 1.0
CA 91801 1.0
CA 91802 1.0
CA 91803 1.0
CA 91804 1.0
CA 91841 1.0
CA 91896 1.0
CA 91899 1.0
CA 91901 1.0
CA 91902 1.0
CA 91903 1.0
CA 91905 2.0
CA 91906 2.0
CA 91908 1.0
CA 91909 1.0
CA 91910 1.0
CA 91911 1.0
CA 91912 1.0
CA 91913 1.0
CA 91914 1.0
CA 91915 1.0
CA 91916 2.0
CA 91917 2.0
CA 91921 1.0
CA 91931 2.0
CA 91932 1.0
CA 91933 1.0
CA 91934 2.0
CA 91935 1.0
CA 91941 1.0
CA 91942 1.0
CA 91943 1.0
CA 91944 1.0
CA 91945 1.0
CA 91946 1.0
CA 91947 1.0
CA 91948 2.0
CA 91950 1.0
CA 91951 1.0
CA 91962 2.0
CA 91963 2.0
CA 91976 1.0
CA 91977 1.0
CA 91978 1.0
CA 91979 1.0
CA 91980 2.0
CA 91987 2.0
CA 91990 2.0
CA 92003 1.0
CA 92004 10.4
CA 92007 1.0
CA 92008 1.0
CA 92009 1.0
CA 92010 1.0
CA 92011 1.0
CA 92013 1.0
CA 92014 1.0
CA 92018 1.0
CA 92019 1.0
CA 92020 1.0
CA 92021 1.0
CA 92022 1.0
CA 92023 1.0
CA 92024 1.0
CA 92025 1.0
CA 92026 1.0
CA 92027 1.0
CA 92028 1.0
CA 92029 1.0
CA 92030 1.0
CA 92033 1.0
CA 92036 10.1
CA 92037 1.0
CA 92038 1.0
CA 92039 1.0
CA 92040 1.0
CA 92046 1.0
CA 92049 1.0
CA 92051 1.0
CA 92052 1.0
CA 92054 1.0
CA 92055 1.0
CA 92056 1.0
CA 92057 1.0
CA 92058 1.0
CA 92059 2.0
CA 92060 2.0
CA 92061 2.0
CA 92064 1.0
CA 92065 2.0
CA 92066 10.1
CA 92067 1.0
CA 92068 1.0
CA 92069 1.0
CA 92070 10.1
CA 92071 1.0
CA 92072 1.0
CA 92074 1.0
CA 92075 1.0
CA 92078 1.0
CA 92079 1.0
CA 92081 1.0
CA 92082 2.0
CA 92083 1.0
CA 92084 1.0
CA 92085 1.0
CA 92086 10.1
CA 92088 1.0
CA 92090 1.0
CA 92091 1.0
CA 92092 1.0
CA 92093 1.0
CA 92096 1.0
CA 92101 1.0
CA 92102 1.0
CA 92103 1.0
CA 92104 1.0
CA 92105 1.0
CA 92106 1.0
CA 92107 1.0
CA 92108 1.0
CA 92109 1.0
CA 92110 1.0
CA 92111 1.0
CA 92112 1.0
CA 92113 1.0
CA 92114 1.0
CA 92115 1.0
CA 92116 1.0
CA 92117 1.0
CA 92118 1.0
CA 92119 1.0
CA 92120 1.0
CA 92121 1.0
CA 92122 1.0
CA 92123 1.0
CA 92124 1.0
CA 92126 1.0
CA 92127 1.0
CA 92128 1.0
CA 92129 1.0
CA 92130 1.0
CA 92131 1.0
CA 92132 1.0
CA 92133 1.0
CA 92134 1.0
CA 92135 1.0
CA 92136 1.0
CA 92137 1.0
CA 92138 1.0
CA 92139 1.0
CA 92140 1.0
CA 92142 1.0
CA 92143 1.0
CA 92145 1.0
CA 92147 1.0
CA 92149 1.0
CA 92150 1.0
CA 92152 1.0
CA 92153 1.0
CA 92154 1.0
CA 92155 1.0
CA 92158 1.0
CA 92159 1.0
CA 92160 1.0
CA 92161 1.0
CA 92162 1.0
CA 92163 1.0
CA 92164 1.0
CA 92165 1.0
CA 92166 1.0
CA 92167 1.0
CA 92168 1.0
CA 92169 1.0
CA 92170 1.0
CA 92171 1.0
CA 92172 1.0
CA 92173 1.0
CA 92174 1.0
CA 92175 1.0
CA 92176 1.0
CA 92177 1.0
CA 92178 1.0
CA 92179 1.0
CA 92182 1.0
CA 92184 1.0
CA 92186 1.0
CA 92187 1.0
CA 92190 1.0
CA 92191 1.0
CA 92192 1.0
CA 92193 1.0
CA 92194 1.0
CA 92195 1.0
CA 92196 1.0
CA 92197 1.0
CA 92198 1.0
CA 92199 1.0
CA 92201 1.0
CA 92202 1.0
CA 92203 1.0
CA 92210 1.0
CA 92211 1.0
CA 92220 1.0
CA 92222 1.0
CA 92223 1.0
CA 92225 4.0
CA 92226 4.0
CA 92227 4.2
CA 92230 1.0
CA 92231 4.2
CA 92232 4.2
CA 92233 7.3
CA 92234 1.0
CA 92235 1.0
CA 92236 1.0
CA 92239 9.2
CA 92240 2.0
CA 92241 2.0
CA 92242 8.0
CA 92243 1.0
CA 92244 1.0
CA 92247 1.0
CA 92248 1.0
CA 92249 1.0
CA 92250 7.1
CA 92251 1.0
CA 92252 4.2
CA 92253 1.0
CA 92254 2.0
CA 92255 1.0
CA 92256 2.0
CA 92257 10.6
CA 92258 2.0
CA 92259 9.1
CA 92260 1.0
CA 92261 1.0
CA 92262 1.0
CA 92263 1.0
CA 92264 1.0
CA 92266 1.0
CA 92267 10.6
CA 92268 4.2
CA 92270 1.0
CA 92273 1.0
CA 92274 2.0
CA 92275 2.0
CA 92276 1.0
CA 92277 5.0
CA 92278 4.0
CA 92280 10.6
CA 92281 10.5
CA 92282 2.0
CA 92283 1.0
CA 92284 4.2
CA 92285 2.0
CA 92286 4.2
CA 92292 1.0
CA 92301 1.0
CA 92304 7.0
CA 92305 2.0
CA 92307 1.0
CA 92308 1.0
CA 92309 7.0
CA 92310 7.0
CA 92311 4.0
CA 92312 4.0
CA 92313 1.0
CA 92314 4.0
CA 92315 4.0
CA 92316 1.0
CA 92317 4.1
CA 92318 1.0
CA 92320 1.0
CA 92321 4.1
CA 92322 4.1
CA 92323 7.0
CA 92324 1.0
CA 92325 4.1
CA 92326 1.0
CA 92327 1.0
CA 92328 5.0
CA 92329 3.0
CA 92332 7.0
CA 92333 4.0
CA 92334 1.0
CA 92335 1.0
CA 92336 1.0
CA 92337 1.0
CA 92338 7.0
CA 92339 2.0
CA 92340 1.0
CA 92341 4.0
CA 92342 6.1
CA 92344 1.0
CA 92345 1.0
CA 92346 1.0
CA 92347 5.0
CA 92350 1.0
CA 92352 4.1
CA 92354 1.0
CA 92356 1.0
CA 92357 1.0
CA 92358 2.0
CA 92359 1.0
CA 92363 7.0
CA 92364 7.0
CA 92365 7.0
CA 92366 7.0
CA 92368 2.0
CA 92369 1.0
CA 92371 3.0
CA 92372 3.0
CA 92373 1.0
CA 92374 1.0
CA 92375 1.0
CA 92376 1.0
CA 92377 1.0
CA 92378 1.0
CA 92382 2.0
CA 92384 5.0
CA 92385 2.0
CA 92386 4.0
CA 92389 5.0
CA 92391 1.0
CA 92392 1.0
CA 92393 1.0
CA 92394 1.0
CA 92395 1.0
CA 92397 2.0
CA 92398 7.0
CA 92399 1.0
CA 92401 1.0
CA 92402 1.0
CA 92403 1.0
CA 92404 1.0
CA 92405 1.0
CA 92406 1.0
CA 92407 1.0
CA 92408 1.0
CA 92410 1.0
CA 92411 1.0
CA 92412 1.0
CA 92413 1.0
CA 92414 1.0
CA 92415 1.0
CA 92418 1.0
CA 92420 1.0
CA 92423 1.0
CA 92424 1.0
CA 92427 1.0
CA 92501 1.0
CA 92502 1.0
CA 92503 1.0
CA 92504 1.0
CA 92505 1.0
CA 92506 1.0
CA 92507 1.0
CA 92508 1.0
CA 92509 1.0
CA 92513 1.0
CA 92514 1.0
CA 92515 1.0
CA 92516 1.0
CA 92517 1.0
CA 92518 2.0
CA 92519 1.0
CA 92521 1.0
CA 92522 1.0
CA 92530 1.0
CA 92531 1.0
CA 92532 1.0
CA 92536 3.0
CA 92539 10.4
CA 92543 1.0
CA 92544 1.0
CA 92545 1.0
CA 92546 1.0
CA 92548 1.0
CA 92549 10.4
CA 92551 1.0
CA 92552 1.0
CA 92553 1.0
CA 92554 1.0
CA 92555 1.0
CA 92556 1.0
CA 92557 1.0
CA 92561 3.0
CA 92562 1.0
CA 92563 1.0
CA 92564 1.0
CA 92567 1.0
CA 92570 1.0
CA 92571 1.0
CA 92572 1.0
CA 92581 1.0
CA 92582 1.0
CA 92583 1.0
CA 92584 1.0
CA 92585 1.0
CA 92586 1.0
CA 92587 1.0
CA 92589 1.0
CA 92590 1.0
CA 92591 1.0
CA 92592 1.0
CA 92593 1.0
CA 92595 1.0
CA 92596 1.0
CA 92599 1.0
CA 92602 1.0
CA 92603 1.0
CA 92604 1.0
CA 92605 1.0
CA 92606 1.0
CA 92607 1.1
CA 92609 1.1
CA 92610 1.1
CA 92612 1.0
CA 92614 1.0
CA 92615 1.0
CA 92616 1.0
CA 92617 1.0
CA 92618 1.0
CA 92619 1.0
CA 92620 1.0
CA 92623 1.0
CA 92624 1.1
CA 92625 1.0
CA 92626 1.0
CA 92627 1.0
CA 92628 1.0
CA 92629 1.1
CA 92630 1.1
CA 92637 1.1
CA 92646 1.0
CA 92647 1.0
CA 92648 1.0
CA 92649 1.0
CA 92650 1.0
CA 92651 1.1
CA 92652 1.1
CA 92653 1.1
CA 92654 1.1
CA 92655 1.0
CA 92656 1.1
CA 92657 1.0
CA 92658 1.0
CA 92659 1.0
CA 92660 1.0
CA 92661 1.0
CA 92662 1.0
CA 92663 1.0
CA 92672 1.1
CA 92673 1.1
CA 92674 1.1
CA 92675 1.1
CA 92676 2.0
CA 92677 1.1
CA 92678 1.1
CA 92679 1.1
CA 92683 1.0
CA 92684 1.0
CA 92685 1.0
CA 92688 1.1
CA 92690 1.1
CA 92691 1.1
CA 92692 1.1
CA 92693 1.1
CA 92694 1.1
CA 92697 1.0
CA 92698 1.0
CA 92701 1.0
CA 92702 1.0
CA 92703 1.0
CA 92704 1.0
CA 92705 1.0
CA 92706 1.0
CA 92707 1.0
CA 92708 1.0
CA 92709 1.0
CA 92710 1.0
CA 92711 1.0
CA 92712 1.0
CA 92725 1.0
CA 92728 1.0
CA 92735 1.0
CA 92780 1.0
CA 92781 1.0
CA 92782 1.0
CA 92799 1.0
CA 92801 1.0
CA 92802 1.0
CA 92803 1.0
CA 92804 1.0
CA 92805 1.0
CA 92806 1.0
CA 92807 1.0
CA 92808 1.0
CA 92809 1.0
CA 92811 1.0
CA 92812 1.0
CA 92814 1.0
CA 92815 1.0
CA 92816 1.0
CA 92817 1.0
CA 92821 1.0
CA 92822 1.0
CA 92823 1.0
CA 92825 1.0
CA 92831 1.0
CA 92832 1.0
CA 92833 1.0
CA 92834 1.0
CA 92835 1.0
CA 92836 1.0
CA 92837 1.0
CA 92838 1.0
CA 92840 1.0
CA 92841 1.0
CA 92842 1.0
CA 92843 1.0
CA 92844 1.0
CA 92845 1.0
CA 92846 1.0
CA 92850 1.0
CA 92856 1.0
CA 92857 1.0
CA 92859 1.0
CA 92860 1.0
CA 92861 1.0
CA 92862 1.0
CA 92863 1.0
CA 92864 1.0
CA 92865 1.0
CA 92866 1.0
CA 92867 1.0
CA 92868 1.0
CA 92869 1.0
CA 92870 1.0
CA 92871 1.0
CA 92877 1.0
CA 92878 1.0
CA 92879 1.0
CA 92880 1.0
CA 92881 1.0
CA 92882 1.0
CA 92883 1.0
CA 92885 1.0
CA 92886 1.0
CA 92887 1.0
CA 92899 1.0
CA 93001 1.0
CA 93002 1.0
CA 93003 1.0
CA 93004 1.0
CA 93005 1.0
CA 93006 1.0
CA 93007 1.0
CA 93009 1.0
CA 93010 1.0
CA 93011 1.0
CA 93012 1.0
CA 93013 1.0
CA 93014 1.0
CA 93015 4.2
CA 93016 4.2
CA 93020 1.1
CA 93021 1.1
CA 93022 1.0
CA 93023 1.0
CA 93024 1.0
CA 93030 1.0
CA 93031 1.0
CA 93032 1.0
CA 93033 1.0
CA 93034 1.0
CA 93035 1.0
CA 93036 1.0
CA 93040 4.2
CA 93041 1.0
CA 93042 1.0
CA 93043 1.0
CA 93044 1.0
CA 93060 2.0
CA 93061 2.0
CA 93062 2.0
CA 93063 2.0
CA 93064 2.0
CA 93065 2.0
CA 93066 1.0
CA 93067 1.0
CA 93093 2.0
CA 93094 2.0
CA 93099 2.0
CA 93101 1.0
CA 93102 1.0
CA 93103 1.0
CA 93105 1.0
CA 93106 1.0
CA 93107 1.0
CA 93108 1.0
CA 93109 1.0
CA 93110 1.0
CA 93111 1.0
CA 93116 1.0
CA 93117 1.0
CA 93118 1.0
CA 93120 1.0
CA 93121 1.0
CA 93130 1.0
CA 93140 1.0
CA 93150 1.0
CA 93160 1.0
CA 93190 1.0
CA 93199 1.0
CA 93201 6.0
CA 93202 4.0
CA 93203 2.0
CA 93204 4.0
CA 93205 7.3
CA 93206 10.1
CA 93207 2.0
CA 93208 2.0
CA 93210 4.2
CA 93212 4.0
CA 93215 4.2
CA 93216 4.2
CA 93218 2.0
CA 93219 6.0
CA 93220 1.0
CA 93221 1.0
CA 93222 3.0
CA 93223 1.0
CA 93224 2.0
CA 93225 3.0
CA 93226 2.0
CA 93227 1.0
CA 93230 4.0
CA 93232 4.0
CA 93234 7.3
CA 93235 2.0
CA 93237 10.1
CA 93238 2.0
CA 93239 10.5
CA 93240 7.3
CA 93241 1.0
CA 93242 10.4
CA 93243 2.0
CA 93244 10.1
CA 93245 4.0
CA 93246 4.0
CA 93247 4.2
CA 93249 10.4
CA 93250 5.0
CA 93251 2.0
CA 93252 2.0
CA 93254 10.4
CA 93255 2.0
CA 93256 9.1
CA 93257 1.0
CA 93258 1.0
CA 93260 2.0
CA 93261 6.0
CA 93262 10.1
CA 93263 2.0
CA 93265 2.0
CA 93266 10.5
CA 93267 1.0
CA 93268 4.2
CA 93270 2.0
CA 93271 10.1
CA 93272 10.4
CA 93274 4.2
CA 93275 4.2
CA 93276 2.0
CA 93277 1.0
CA 93278 1.0
CA 93279 1.0
CA 93280 4.2
CA 93282 4.0
CA 93283 7.3
CA 93285 2.0
CA 93286 9.1
CA 93287 2.0
CA 93290 1.0
CA 93291 1.0
CA 93292 1.0
CA 93301 1.0
CA 93302 1.0
CA 93303 1.0
CA 93304 1.0
CA 93305 1.0
CA 93306 1.0
CA 93307 1.0
CA 93308 1.0
CA 93309 1.0
CA 93311 1.0
CA 93312 1.0
CA 93313 1.0
CA 93314 1.0
CA 93380 1.0
CA 93381 1.0
CA 93382 1.0
CA 93383 1.0
CA 93384 1.0
CA 93385 1.0
CA 93386 1.0
CA 93387 1.0
CA 93388 1.0
CA 93389 1.0
CA 93390 1.0
CA 93401 1.0
CA 93402 2.0
CA 93403 1.0
CA 93405 1.0
CA 93406 1.0
CA 93407 1.0
CA 93408 1.0
CA 93409 1.0
CA 93410 1.0
CA 93412 2.0
CA 93420 4.2
CA 93421 4.2
CA 93422 1.0
CA 93423 1.0
CA 93424 1.0
CA 93426 6.0
CA 93427 4.2
CA 93428 7.0
CA 93429 1.0
CA 93430 2.0
CA 93432 1.0
CA 93433 4.2
CA 93434 2.0
CA 93435 2.0
CA 93436 1.0
CA 93437 1.0
CA 93438 1.0
CA 93440 1.0
CA 93441 4.2
CA 93442 2.0
CA 93443 2.0
CA 93444 1.0
CA 93445 4.2
CA 93446 1.0
CA 93447 1.0
CA 93448 4.2
CA 93449 4.2
CA 93450 6.0
CA 93451 2.0
CA 93452 10.4
CA 93453 1.0
CA 93454 1.0
CA 93455 1.0
CA 93456 1.0
CA 93457 1.0
CA 93458 1.0
CA 93460 4.2
CA 93461 2.0
CA 93463 4.2
CA 93464 4.2
CA 93465 1.0
CA 93475 1.0
CA 93483 4.2
CA 93501 10.4
CA 93502 10.4
CA 93504 9.0
CA 93505 9.0
CA 93510 2.0
CA 93512 10.6
CA 93513 5.0
CA 93514 4.0
CA 93515 4.0
CA 93516 10.6
CA 93517 10.6
CA 93518 7.3
CA 93519 9.0
CA 93522 4.0
CA 93523 7.0
CA 93524 6.1
CA 93526 5.0
CA 93527 4.0
CA 93528 9.0
CA 93529 10.6
CA 93530 10.5
CA 93531 10.4
CA 93532 2.0
CA 93534 1.1
CA 93535 1.1
CA 93536 1.1
CA 93539 1.1
CA 93541 10.6
CA 93542 4.0
CA 93543 1.1
CA 93544 3.0
CA 93545 10.5
CA 93546 7.0
CA 93549 4.0
CA 93550 1.1
CA 93551 1.1
CA 93552 1.1
CA 93553 2.1
CA 93554 9.0
CA 93555 4.0
CA 93556 4.0
CA 93558 4.0
CA 93560 3.0
CA 93561 4.0
CA 93562 10.5
CA 93563 2.0
CA 93581 4.0
CA 93584 1.1
CA 93586 1.1
CA 93590 1.1
CA 93591 2.1
CA 93592 10.5
CA 93596 10.6
CA 93599 1.1
CA 93601 10.6
CA 93602 2.0
CA 93603 2.0
CA 93604 10.4
CA 93605 2.0
CA 93606 1.0
CA 93607 10.4
CA 93608 7.3
CA 93609 2.0
CA 93610 7.0
CA 93611 1.0
CA 93612 1.0
CA 93613 1.0
CA 93614 3.0
CA 93615 4.2
CA 93616 2.0
CA 93618 4.2
CA 93619 4.2
CA 93620 9.2
CA 93621 2.0
CA 93622 7.3
CA 93623 10.0
CA 93624 7.3
CA 93625 4.1
CA 93626 2.0
CA 93627 7.3
CA 93628 2.0
CA 93630 2.0
CA 93631 4.1
CA 93633 2.0
CA 93634 2.0
CA 93635 4.2
CA 93637 1.0
CA 93638 1.0
CA 93639 1.0
CA 93640 7.3
CA 93641 2.0
CA 93642 2.0
CA 93643 10.4
CA 93644 7.0
CA 93645 3.0
CA 93646 7.4
CA 93647 4.2
CA 93648 3.0
CA 93649 4.2
CA 93650 1.0
CA 93651 2.0
CA 93652 2.0
CA 93653 3.0
CA 93654 4.2
CA 93656 10.4
CA 93657 2.0
CA 93660 7.3
CA 93661 9.2
CA 93662 4.1
CA 93664 2.0
CA 93665 9.2
CA 93666 4.2
CA 93667 2.0
CA 93668 7.3
CA 93669 10.4
CA 93670 4.2
CA 93673 4.1
CA 93675 2.0
CA 93701 1.0
CA 93702 1.0
CA 93703 1.0
CA 93704 1.0
CA 93705 1.0
CA 93706 1.0
CA 93707 1.0
CA 93708 1.0
CA 93709 1.0
CA 93710 1.0
CA 93711 1.0
CA 93712 1.0
CA 93714 1.0
CA 93715 1.0
CA 93716 1.0
CA 93717 1.0
CA 93718 1.0
CA 93720 1.0
CA 93721 1.0
CA 93722 1.0
CA 93724 1.0
CA 93725 1.0
CA 93726 1.0
CA 93727 1.0
CA 93728 1.0
CA 93729 1.0
CA 93740 1.0
CA 93741 1.0
CA 93744 1.0
CA 93745 1.0
CA 93747 1.0
CA 93750 1.0
CA 93755 1.0
CA 93760 1.0
CA 93761 1.0
CA 93762 1.0
CA 93764 1.0
CA 93765 1.0
CA 93771 1.0
CA 93772 1.0
CA 93773 1.0
CA 93774 1.0
CA 93775 1.0
CA 93776 1.0
CA 93777 1.0
CA 93778 1.0
CA 93779 1.0
CA 93780 1.0
CA 93784 1.0
CA 93786 1.0
CA 93790 1.0
CA 93791 1.0
CA 93792 1.0
CA 93793 1.0
CA 93794 1.0
CA 93844 1.0
CA 93888 1.0
CA 93901 1.0
CA 93902 1.0
CA 93905 1.0
CA 93906 1.0
CA 93907 1.0
CA 93908 1.0
CA 93912 1.0
CA 93915 1.0
CA 93920 10.1
CA 93921 1.0
CA 93922 1.0
CA 93923 1.0
CA 93924 1.0
CA 93925 2.0
CA 93926 2.0
CA 93927 4.2
CA 93928 6.0
CA 93930 4.2
CA 93932 6.0
CA 93933 1.0
CA 93940 1.0
CA 93942 1.0
CA 93943 1.0
CA 93944 1.0
CA 93950 1.0
CA 93953 1.0
CA 93954 4.2
CA 93955 1.0
CA 93960 2.0
CA 93962 1.0
CA 94002 1.0
CA 94003 1.0
CA 94005 1.0
CA 94010 1.0
CA 94011 1.0
CA 94012 1.0
CA 94013 1.0
CA 94014 1.0
CA 94015 1.0
CA 94016 1.0
CA 94017 1.0
CA 94018 2.0
CA 94019 2.0
CA 94020 2.0
CA 94021 2.0
CA 94022 1.0
CA 94023 1.0
CA 94024 1.0
CA 94025 1.0
CA 94026 1.0
CA 94027 1.0
CA 94028 1.0
CA 94029 1.0
CA 94030 1.0
CA 94031 1.0
CA 94035 1.0
CA 94037 2.0
CA 94038 2.0
CA 94039 1.0
CA 94040 1.0
CA 94041 1.0
CA 94042 1.0
CA 94043 1.0
CA 94044 1.0
CA 94045 1.0
CA 94059 1.0
CA 94060 2.0
CA 94061 1.0
CA 94062 1.0
CA 94063 1.0
CA 94064 1.0
CA 94065 1.0
CA 94066 1.0
CA 94067 1.0
CA 94070 1.0
CA 94071 1.0
CA 94074 2.0
CA 94080 1.0
CA 94083 1.0
CA 94085 1.0
CA 94086 1.0
CA 94087 1.0
CA 94088 1.0
CA 94089 1.0
CA 94090 1.0
CA 94096 1.0
CA 94098 1.0
CA 94099 1.0
CA 94101 1.0
CA 94102 1.0
CA 94103 1.0
CA 94104 1.0
CA 94105 1.0
CA 94106 1.0
CA 94107 1.0
CA 94108 1.0
CA 94109 1.0
CA 94110 1.0
CA 94111 1.0
CA 94112 1.0
CA 94114 1.0
CA 94115 1.0
CA 94116 1.0
CA 94117 1.0
CA 94118 1.0
CA 94119 1.0
CA 94120 1.0
CA 94121 1.0
CA 94122 1.0
CA 94123 1.0
CA 94124 1.0
CA 94125 1.0
CA 94126 1.0
CA 94127 1.0
CA 94128 1.0
CA 94129 1.0
CA 94130 1.0
CA 94131 1.0
CA 94132 1.0
CA 94133 1.0
CA 94134 1.0
CA 94135 1.0
CA 94136 1.0
CA 94137 1.0
CA 94138 1.0
CA 94139 1.0
CA 94140 1.0
CA 94141 1.0
CA 94142 1.0
CA 94143 1.0
CA 94144 1.0
CA 94145 1.0
CA 94146 1.0
CA 94147 1.0
CA 94150 1.0
CA 94151 1.0
CA 94152 1.0
CA 94153 1.0
CA 94154 1.0
CA 94155 1.0
CA 94156 1.0
CA 94157 1.0
CA 94158 1.0
CA 94159 1.0
CA 94160 1.0
CA 94161 1.0
CA 94162 1.0
CA 94163 1.0
CA 94164 1.0
CA 94165 1.0
CA 94166 1.0
CA 94167 1.0
CA 94168 1.0
CA 94169 1.0
CA 94170 1.0
CA 94171 1.0
CA 94172 1.0
CA 94175 1.0
CA 94177 1.0
CA 94188 1.0
CA 94199 1.0
CA 94203 1.0
CA 94204 1.0
CA 94205 1.0
CA 94206 1.0
CA 94207 1.0
CA 94208 1.0
CA 94209 1.0
CA 94211 1.0
CA 94229 1.0
CA 94230 1.0
CA 94232 1.0
CA 94234 1.0
CA 94235 1.0
CA 94236 1.0
CA 94237 1.0
CA 94239 1.0
CA 94240 1.0
CA 94243 1.0
CA 94244 1.0
CA 94245 1.0
CA 94246 1.0
CA 94247 1.0
CA 94248 1.0
CA 94249 1.0
CA 94250 1.0
CA 94252 1.0
CA 94253 1.0
CA 94254 1.0
CA 94256 1.0
CA 94257 1.0
CA 94258 1.0
CA 94259 1.0
CA 94261 1.0
CA 94262 1.0
CA 94263 1.0
CA 94267 1.0
CA 94268 1.0
CA 94269 1.0
CA 94271 1.0
CA 94273 1.0
CA 94274 1.0
CA 94277 1.0
CA 94278 1.0
CA 94279 1.0
CA 94280 1.0
CA 94282 1.0
CA 94283 1.0
CA 94284 1.0
CA 94285 1.0
CA 94286 1.0
CA 94287 1.0
CA 94288 1.0
CA 94289 1.0
CA 94290 1.0
CA 94291 1.0
CA 94293 1.0
CA 94294 1.0
CA 94295 1.0
CA 94296 1.0
CA 94297 1.0
CA 94298 1.0
CA 94299 1.0
CA 94301 1.0
CA 94302 1.0
CA 94303 1.0
CA 94304 1.0
CA 94305 1.0
CA 94306 1.0
CA 94307 1.0
CA 94308 1.0
CA 94309 1.0
CA 94310 1.0
CA 94401 1.0
CA 94402 1.0
CA 94403 1.0
CA 94404 1.0
CA 94405 1.0
CA 94406 1.0
CA 94407 1.0
CA 94408 1.0
CA 94409 1.0
CA 94497 1.0
CA 94501 1.0
CA 94502 1.0
CA 94503 1.0
CA 94506 1.0
CA 94507 1.0
CA 94508 10.6
CA 94509 1.1
CA 94510 1.0
CA 94511 1.1
CA 94512 7.0
CA 94513 1.1
CA 94514 3.0
CA 94515 7.0
CA 94516 1.0
CA 94517 1.0
CA 94518 1.0
CA 94519 1.0
CA 94520 1.0
CA 94521 1.0
CA 94522 1.0
CA 94523 1.0
CA 94524 1.0
CA 94525 1.0
CA 94526 1.0
CA 94527 1.0
CA 94528 1.0
CA 94529 1.0
CA 94530 1.0
CA 94531 1.1
CA 94533 1.0
CA 94534 1.0
CA 94535 1.0
CA 94536 1.0
CA 94537 1.0
CA 94538 1.0
CA 94539 1.0
CA 94540 1.0
CA 94541 1.0
CA 94542 1.0
CA 94543 1.0
CA 94544 1.0
CA 94545 1.0
CA 94546 1.0
CA 94547 1.0
CA 94548 1.1
CA 94549 1.0
CA 94550 1.0
CA 94551 1.0
CA 94552 1.0
CA 94553 1.0
CA 94555 1.0
CA 94556 1.0
CA 94557 1.0
CA 94558 1.0
CA 94559 1.0
CA 94560 1.0
CA 94561 1.1
CA 94562 7.3
CA 94563 1.0
CA 94564 1.0
CA 94565 1.1
CA 94566 1.0
CA 94567 10.4
CA 94568 1.0
CA 94569 1.0
CA 94570 1.0
CA 94571 7.0
CA 94572 1.0
CA 94573 7.3
CA 94574 7.3
CA 94575 1.0
CA 94576 10.6
CA 94577 1.0
CA 94578 1.0
CA 94579 1.0
CA 94580 1.0
CA 94581 1.0
CA 94582 1.0
CA 94583 1.0
CA 94585 1.0
CA 94586 1.0
CA 94587 1.0
CA 94588 1.0
CA 94589 1.0
CA 94590 1.0
CA 94591 1.0
CA 94592 10.4
CA 94595 1.0
CA 94596 1.0
CA 94597 1.0
CA 94598 1.0
CA 94599 9.1
CA 94601 1.0
CA 94602 1.0
CA 94603 1.0
CA 94604 1.0
CA 94605 1.0
CA 94606 1.0
CA 94607 1.0
CA 94608 1.0
CA 94609 1.0
CA 94610 1.0
CA 94611 1.0
CA 94612 1.0
CA 94613 1.0
CA 94614 1.0
CA 94615 1.0
CA 94617 1.0
CA 94618 1.0
CA 94619 1.0
CA 94620 1.0
CA 94621 1.0
CA 94622 1.0
CA 94623 1.0
CA 94624 1.0
CA 94625 1.0
CA 94626 1.0
CA 94627 1.0
CA 94643 1.0
CA 94649 1.0
CA 94659 1.0
CA 94660 1.0
CA 94661 1.0
CA 94662 1.0
CA 94666 1.0
CA 94701 1.0
CA 94702 1.0
CA 94703 1.0
CA 94704 1.0
CA 94705 1.0
CA 94706 1.0
CA 94707 1.0
CA 94708 1.0
CA 94709 1.0
CA 94710 1.0
CA 94712 1.0
CA 94720 1.0
CA 94801 1.0
CA 94802 1.0
CA 94803 1.0
CA 94804 1.0
CA 94805 1.0
CA 94806 1.0
CA 94807 1.0
CA 94808 1.0
CA 94820 1.0
CA 94850 1.0
CA 94875 1.0
CA 94901 1.1
CA 94903 1.1
CA 94904 1.1
CA 94912 1.1
CA 94913 1.1
CA 94914 1.1
CA 94915 1.1
CA 94920 1.1
CA 94922 2.0
CA 94923 2.0
CA 94924 10.4
CA 94925 1.1
CA 94926 1.0
CA 94927 1.0
CA 94928 1.0
CA 94929 10.4
CA 94930 1.1
CA 94931 1.0
CA 94933 1.1
CA 94937 10.1
CA 94938 1.1
CA 94939 1.1
CA 94940 10.4
CA 94941 1.1
CA 94942 1.1
CA 94945 1.1
CA 94946 10.4
CA 94947 1.1
CA 94948 1.1
CA 94949 1.1
CA 94950 10.4
CA 94951 1.0
CA 94952 1.0
CA 94953 1.0
CA 94954 1.0
CA 94955 1.0
CA 94956 10.1
CA 94957 1.1
CA 94960 1.1
CA 94963 1.1
CA 94964 1.1
CA 94965 1.1
CA 94966 1.1
CA 94970 10.4
CA 94971 10.4
CA 94972 2.0
CA 94973 1.1
CA 94974 1.1
CA 94975 1.0
CA 94976 1.1
CA 94977 1.1
CA 94978 1.1
CA 94979 1.1
CA 94998 1.1
CA 94999 1.0
CA 95001 1.0
CA 95002 1.0
CA 95003 1.0
CA 95004 3.0
CA 95005 1.0
CA 95006 1.0
CA 95007 1.0
CA 95008 1.0
CA 95009 1.0
CA 95010 1.0
CA 95011 1.0
CA 95012 1.0
CA 95013 2.0
CA 95014 1.0
CA 95015 1.0
CA 95017 2.0
CA 95018 1.0
CA 95019 1.1
CA 95020 2.0
CA 95021 2.0
CA 95023 4.2
CA 95024 4.2
CA 95026 2.0
CA 95030 1.0
CA 95031 1.0
CA 95032 1.0
CA 95033 2.0
CA 95035 1.0
CA 95036 1.0
CA 95037 2.0
CA 95038 2.0
CA 95039 1.1
CA 95041 1.0
CA 95042 1.0
CA 95043 4.2
CA 95044 2.0
CA 95045 10.4
CA 95046 2.0
CA 95050 1.0
CA 95051 1.0
CA 95052 1.0
CA 95053 1.0
CA 95054 1.0
CA 95055 1.0
CA 95056 1.0
CA 95060 1.0
CA 95061 1.0
CA 95062 1.0
CA 95063 1.0
CA 95064 1.0
CA 95065 1.0
CA 95066 1.0
CA 95067 1.0
CA 95070 1.0
CA 95071 1.0
CA 95073 1.0
CA 95075 4.2
CA 95076 1.1
CA 95077 1.1
CA 95101 1.0
CA 95102 1.0
CA 95103 1.0
CA 95106 1.0
CA 95108 1.0
CA 95109 1.0
CA 95110 1.0
CA 95111 1.0
CA 95112 1.0
CA 95113 1.0
CA 95114 1.0
CA 95115 1.0
CA 95116 1.0
CA 95117 1.0
CA 95118 1.0
CA 95119 1.0
CA 95120 1.0
CA 95121 1.0
CA 95122 1.0
CA 95123 1.0
CA 95124 1.0
CA 95125 1.0
CA 95126 1.0
CA 95127 1.0
CA 95128 1.0
CA 95129 1.0
CA 95130 1.0
CA 95131 1.0
CA 95132 1.0
CA 95133 1.0
CA 95134 1.0
CA 95135 1.0
CA 95136 1.0
CA 95137 1.0
CA 95138 1.0
CA 95139 1.0
CA 95140 1.0
CA 95141 1.0
CA 95142 1.0
CA 95148 1.0
CA 95150 1.0
CA 95151 1.0
CA 95152 1.0
CA 95153 1.0
CA 95154 1.0
CA 95155 1.0
CA 95156 1.0
CA 95157 1.0
CA 95158 1.0
CA 95159 1.0
CA 95160 1.0
CA 95161 1.0
CA 95164 1.0
CA 95170 1.0
CA 95171 1.0
CA 95172 1.0
CA 95173 1.0
CA 95190 1.0
CA 95191 1.0
CA 95192 1.0
CA 95193 1.0
CA 95194 1.0
CA 95196 1.0
CA 95201 1.0
CA 95202 1.0
CA 95203 1.0
CA 95204 1.0
CA 95205 1.0
CA 95206 1.0
CA 95207 1.0
CA 95208 1.0
CA 95209 1.0
CA 95210 1.0
CA 95211 1.0
CA 95212 1.0
CA 95213 1.0
CA 95215 1.0
CA 95219 1.0
CA 95220 3.0
CA 95221 7.0
CA 95222 7.0
CA 95223 10.6
CA 95224 10.6
CA 95225 10.4
CA 95226 10.4
CA 95227 3.0
CA 95228 10.5
CA 95229 7.0
CA 95230 2.0
CA 95231 1.0
CA 95232 10.0
CA 95233 10.6
CA 95234 1.0
CA 95236 2.0
CA 95237 2.0
CA 95240 1.0
CA 95241 1.0
CA 95242 1.0
CA 95245 10.6
CA 95246 10.6
CA 95247 7.0
CA 95248 10.6
CA 95249 10.6
CA 95250 10.6
CA 95251 7.0
CA 95252 10.4
CA 95253 1.0
CA 95254 10.4
CA 95255 10.0
CA 95257 10.0
CA 95258 1.0
CA 95267 1.0
CA 95269 1.0
CA 95290 1.0
CA 95296 1.0
CA 95297 1.0
CA 95298 1.0
CA 95301 1.0
CA 95303 1.0
CA 95304 9.1
CA 95305 10.5
CA 95306 10.0
CA 95307 1.0
CA 95309 4.0
CA 95310 4.0
CA 95311 10.4
CA 95312 1.0
CA 95313 10.6
CA 95314 5.0
CA 95315 1.0
CA 95316 1.0
CA 95317 10.1
CA 95318 10.0
CA 95319 1.0
CA 95320 3.0
CA 95321 10.5
CA 95322 7.3
CA 95323 2.0
CA 95324 7.3
CA 95325 10.0
CA 95326 1.0
CA 95327 9.1
CA 95328 1.0
CA 95329 9.1
CA 95330 1.0
CA 95333 10.4
CA 95334 4.2
CA 95335 5.0
CA 95336 1.0
CA 95337 1.0
CA 95338 10.0
CA 95340 1.0
CA 95341 1.0
CA 95342 1.0
CA 95343 1.0
CA 95344 1.0
CA 95345 10.0
CA 95346 5.0
CA 95347 10.5
CA 95348 1.0
CA 95350 1.0
CA 95351 1.0
CA 95352 1.0
CA 95353 1.0
CA 95354 1.0
CA 95355 1.0
CA 95356 1.0
CA 95357 1.0
CA 95358 1.0
CA 95360 9.1
CA 95361 4.1
CA 95363 4.2
CA 95364 5.0
CA 95365 1.0
CA 95366 1.0
CA 95367 1.0
CA 95368 1.0
CA 95369 10.4
CA 95370 4.0
CA 95372 5.0
CA 95373 4.0
CA 95374 7.3
CA 95375 5.0
CA 95376 1.0
CA 95377 1.0
CA 95378 1.0
CA 95379 5.0
CA 95380 1.0
CA 95381 1.0
CA 95382 1.0
CA 95383 5.0
CA 95385 10.4
CA 95386 2.0
CA 95387 4.2
CA 95388 1.0
CA 95389 10.0
CA 95391 1.0
CA 95397 1.0
CA 95401 1.0
CA 95402 1.0
CA 95403 1.0
CA 95404 1.0
CA 95405 1.0
CA 95406 1.0
CA 95407 1.0
CA 95408 1.0
CA 95409 1.0
CA 95410 10.3
CA 95412 10.4
CA 95415 10.5
CA 95416 4.2
CA 95417 10.0
CA 95418 4.0
CA 95419 1.0
CA 95420 10.3
CA 95421 10.4
CA 95422 4.0
CA 95423 7.4
CA 95424 4.0
CA 95425 2.0
CA 95426 10.4
CA 95427 10.5
CA 95428 10.0
CA 95429 10.0
CA 95430 1.0
CA 95431 4.2
CA 95432 10.3
CA 95433 4.2
CA 95435 4.0
CA 95436 2.0
CA 95437 7.0
CA 95439 1.0
CA 95441 2.0
CA 95442 4.2
CA 95443 4.0
CA 95444 1.0
CA 95445 10.0
CA 95446 2.0
CA 95448 1.0
CA 95449 10.2
CA 95450 10.4
CA 95451 6.0
CA 95452 4.2
CA 95453 4.0
CA 95454 10.0
CA 95456 10.3
CA 95457 4.0
CA 95458 4.0
CA 95459 10.0
CA 95460 10.3
CA 95461 10.4
CA 95462 2.0
CA 95463 10.5
CA 95464 4.0
CA 95465 2.0
CA 95466 10.5
CA 95467 10.0
CA 95468 10.0
CA 95469 5.0
CA 95470 4.0
CA 95471 2.0
CA 95472 1.0
CA 95473 1.0
CA 95476 4.2
CA 95480 10.4
CA 95481 4.0
CA 95482 4.0
CA 95485 10.5
CA 95486 10.4
CA 95487 4.2
CA 95488 10.0
CA 95490 7.4
CA 95492 1.0
CA 95493 10.5
CA 95494 10.5
CA 95497 10.4
CA 95501 4.0
CA 95502 4.0
CA 95503 4.0
CA 95511 10.0
CA 95514 10.0
CA 95518 4.0
CA 95519 4.0
CA 95521 4.0
CA 95524 4.0
CA 95525 5.0
CA 95526 4.0
CA 95527 10.0
CA 95528 4.0
CA 95531 4.0
CA 95532 4.0
CA 95534 4.0
CA 95536 10.5
CA 95537 4.0
CA 95538 4.0
CA 95540 4.0
CA 95542 10.0
CA 95543 5.0
CA 95545 10.0
CA 95546 10.5
CA 95547 4.0
CA 95548 10.5
CA 95549 4.0
CA 95550 5.0
CA 95551 4.0
CA 95552 10.6
CA 95553 10.0
CA 95554 10.0
CA 95555 10.2
CA 95556 10.5
CA 95558 10.5
CA 95559 10.0
CA 95560 10.0
CA 95562 7.4
CA 95563 10.0
CA 95564 4.0
CA 95565 7.4
CA 95567 5.0
CA 95568 10.0
CA 95569 10.0
CA 95570 10.2
CA 95571 10.0
CA 95573 10.5
CA 95585 10.0
CA 95587 10.0
CA 95589 10.0
CA 95595 10.6
CA 95601 7.0
CA 95602 2.0
CA 95603 1.0
CA 95604 1.0
CA 95605 1.0
CA 95606 10.5
CA 95607 10.5
CA 95608 1.0
CA 95609 1.0
CA 95610 1.0
CA 95611 1.0
CA 95612 10.1
CA 95613 4.2
CA 95614 2.0
CA 95615 10.4
CA 95616 1.0
CA 95617 1.0
CA 95618 1.0
CA 95619 4.2
CA 95620 4.2
CA 95621 1.0
CA 95623 2.0
CA 95624 1.0
CA 95625 1.0
CA 95626 1.0
CA 95627 10.5
CA 95628 1.0
CA 95629 10.4
CA 95630 1.0
CA 95631 2.0
CA 95632 1.0
CA 95633 2.0
CA 95634 2.0
CA 95635 2.0
CA 95636 5.2
CA 95637 10.5
CA 95638 2.0
CA 95639 1.0
CA 95640 7.0
CA 95641 10.6
CA 95642 7.0
CA 95644 9.0
CA 95645 6.0
CA 95646 9.0
CA 95648 2.0
CA 95650 1.0
CA 95651 2.0
CA 95652 1.0
CA 95653 10.5
CA 95654 7.0
CA 95655 2.0
CA 95656 5.2
CA 95658 1.0
CA 95659 2.0
CA 95660 1.0
CA 95661 1.0
CA 95662 1.0
CA 95663 1.0
CA 95664 2.0
CA 95665 10.6
CA 95666 9.0
CA 95667 4.2
CA 95668 2.0
CA 95669 7.0
CA 95670 1.0
CA 95671 1.0
CA 95672 2.0
CA 95673 1.0
CA 95674 2.0
CA 95675 7.0
CA 95676 6.0
CA 95677 1.0
CA 95678 1.0
CA 95679 10.5
CA 95680 10.4
CA 95681 2.0
CA 95682 2.0
CA 95683 2.0
CA 95684 5.2
CA 95685 7.0
CA 95686 1.0
CA 95687 1.0
CA 95688 1.0
CA 95689 10.4
CA 95690 10.4
CA 95691 1.0
CA 95692 3.0
CA 95693 2.0
CA 95694 7.3
CA 95695 4.2
CA 95696 1.0
CA 95697 4.2
CA 95698 6.0
CA 95699 7.0
CA 95701 2.0
CA 95703 2.0
CA 95709 4.2
CA 95712 4.2
CA 95713 2.0
CA 95714 2.0
CA 95715 2.0
CA 95717 2.0
CA 95720 2.0
CA 95721 5.0
CA 95722 2.0
CA 95724 2.0
CA 95726 4.2
CA 95728 5.0
CA 95735 2.0
CA 95736 2.0
CA 95741 1.0
CA 95742 1.0
CA 95743 1.0
CA 95746 1.0
CA 95747 1.0
CA 95757 1.0
CA 95758 1.0
CA 95759 1.0
CA 95762 1.0
CA 95763 1.0
CA 95765 1.0
CA 95776 4.2
CA 95798 1.0
CA 95799 1.0
CA 95812 1.0
CA 95813 1.0
CA 95814 1.0
CA 95815 1.0
CA 95816 1.0
CA 95817 1.0
CA 95818 1.0
CA 95819 1.0
CA 95820 1.0
CA 95821 1.0
CA 95822 1.0
CA 95823 1.0
CA 95824 1.0
CA 95825 1.0
CA 95826 1.0
CA 95827 1.0
CA 95828 1.0
CA 95829 1.0
CA 95830 1.0
CA 95831 1.0
CA 95832 1.0
CA 95833 1.0
CA 95834 1.0
CA 95835 2.0
CA 95836 2.0
CA 95837 2.0
CA 95838 1.0
CA 95840 1.0
CA 95841 1.0
CA 95842 1.0
CA 95843 1.0
CA 95851 1.0
CA 95852 1.0
CA 95853 1.0
CA 95857 1.0
CA 95860 1.0
CA 95864 1.0
CA 95865 1.0
CA 95866 1.0
CA 95867 1.0
CA 95873 1.0
CA 95887 1.0
CA 95894 1.0
CA 95899 1.0
CA 95901 1.0
CA 95903 7.0
CA 95910 10.4
CA 95912 10.6
CA 95913 7.3
CA 95914 5.0
CA 95915 10.0
CA 95916 5.2
CA 95917 10.6
CA 95918 2.0
CA 95919 10.4
CA 95920 10.4
CA 95922 10.4
CA 95923 10.0
CA 95924 4.2
CA 95925 10.4
CA 95926 1.0
CA 95927 1.0
CA 95928 1.0
CA 95929 1.0
CA 95930 5.2
CA 95932 7.0
CA 95934 10.0
CA 95935 10.4
CA 95936 10.4
CA 95937 6.0
CA 95938 1.0
CA 95939 10.6
CA 95940 4.2
CA 95941 5.2
CA 95942 2.0
CA 95943 10.4
CA 95944 10.4
CA 95945 4.2
CA 95946 5.0
CA 95947 10.0
CA 95948 7.3
CA 95949 4.2
CA 95950 10.6
CA 95951 2.0
CA 95953 2.0
CA 95954 4.1
CA 95955 10.6
CA 95956 10.0
CA 95957 10.4
CA 95958 4.2
CA 95959 4.2
CA 95960 5.0
CA 95961 1.0
CA 95962 2.0
CA 95963 7.3
CA 95965 4.2
CA 95966 4.2
CA 95967 4.1
CA 95968 4.2
CA 95969 4.1
CA 95970 10.6
CA 95971 10.0
CA 95972 10.4
CA 95973 1.0
CA 95974 4.2
CA 95975 5.0
CA 95976 1.0
CA 95977 5.0
CA 95978 4.1
CA 95979 10.6
CA 95980 10.0
CA 95981 10.4
CA 95982 1.0
CA 95983 10.0
CA 95984 10.0
CA 95986 4.2
CA 95987 7.0
CA 95988 7.0
CA 95991 1.0
CA 95992 1.0
CA 95993 1.0
CA 96001 1.0
CA 96002 1.0
CA 96003 1.0
CA 96006 10.0
CA 96007 1.0
CA 96008 2.0
CA 96009 10.0
CA 96010 10.0
CA 96011 2.0
CA 96013 7.3
CA 96014 10.6
CA 96015 10.3
CA 96016 10.3
CA 96017 2.0
CA 96019 1.0
CA 96020 10.0
CA 96021 7.4
CA 96022 2.0
CA 96023 10.5
CA 96024 10.0
CA 96025 10.6
CA 96027 10.6
CA 96028 10.3
CA 96029 7.4
CA 96031 10.6
CA 96032 10.6
CA 96033 2.0
CA 96034 8.0
CA 96035 7.2
CA 96037 10.6
CA 96038 8.0
CA 96039 10.0
CA 96040 10.3
CA 96041 10.0
CA 96044 8.0
CA 96046 10.0
CA 96047 2.0
CA 96048 10.0
CA 96049 1.0
CA 96050 10.0
CA 96051 2.0
CA 96052 10.0
CA 96054 10.0
CA 96055 7.2
CA 96056 10.0
CA 96057 10.6
CA 96058 10.5
CA 96059 5.0
CA 96061 5.0
CA 96062 2.0
CA 96063 5.0
CA 96064 8.0
CA 96065 2.0
CA 96067 7.0
CA 96068 10.0
CA 96069 2.0
CA 96070 2.0
CA 96071 7.3
CA 96073 2.0
CA 96074 7.4
CA 96075 5.0
CA 96076 2.0
CA 96078 7.2
CA 96079 1.0
CA 96080 4.0
CA 96084 2.0
CA 96085 10.6
CA 96086 10.0
CA 96087 2.0
CA 96088 2.0
CA 96089 1.0
CA 96090 7.2
CA 96091 10.0
CA 96092 7.4
CA 96093 10.0
CA 96094 7.0
CA 96095 2.0
CA 96096 2.0
CA 96097 7.0
CA 96099 1.0
CA 96101 7.0
CA 96103 10.0
CA 96104 10.6
CA 96105 7.0
CA 96106 10.0
CA 96107 10.6
CA 96108 10.3
CA 96109 10.4
CA 96110 10.6
CA 96111 5.0
CA 96112 10.6
CA 96113 10.4
CA 96114 8.0
CA 96115 10.6
CA 96116 10.3
CA 96117 8.0
CA 96118 10.4
CA 96119 10.0
CA 96120 10.5
CA 96121 10.4
CA 96122 7.0
CA 96123 10.0
CA 96124 10.4
CA 96125 10.4
CA 96126 10.4
CA 96127 8.0
CA 96128 8.0
CA 96129 7.0
CA 96130 8.0
CA 96132 10.0
CA 96133 10.6
CA 96134 10.5
CA 96135 7.0
CA 96136 8.0
CA 96137 10.0
CA 96140 4.2
CA 96141 5.0
CA 96142 5.0
CA 96143 4.2
CA 96145 4.2
CA 96146 2.0
CA 96148 4.2
CA 96150 4.0
CA 96151 4.0
CA 96152 4.0
CA 96154 4.0
CA 96155 4.0
CA 96156 4.0
CA 96157 4.0
CA 96158 4.0
CA 96160 7.3
CA 96161 7.3
CA 96162 5.0
CO 80001 1.0
CO 80002 1.0
CO 80003 1.0
CO 80004 1.0
CO 80005 1.0
CO 80006 1.0
CO 80007 1.0
CO 80010 1.0
CO 80011 1.0
CO 80012 1.0
CO 80013 1.0
CO 80014 1.0
CO 80015 1.0
CO 80016 1.0
CO 80017 1.0
CO 80018 1.0
CO 80019 1.0
CO 80020 1.0
CO 80021 1.0
CO 80022 1.0
CO 80024 1.0
CO 80025 1.0
CO 80026 2.1
CO 80027 2.1
CO 80028 2.1
CO 80030 1.0
CO 80031 1.0
CO 80033 1.0
CO 80034 1.0
CO 80035 1.0
CO 80036 1.0
CO 80037 1.0
CO 80038 1.0
CO 80040 1.0
CO 80041 1.0
CO 80042 1.0
CO 80044 1.0
CO 80045 1.0
CO 80046 1.0
CO 80047 1.0
CO 80101 10.4
CO 80102 2.0
CO 80103 2.0
CO 80104 2.0
CO 80105 2.0
CO 80106 2.0
CO 80107 2.0
CO 80108 2.0
CO 80109 2.0
CO 80110 1.0
CO 80111 1.0
CO 80112 1.0
CO 80113 1.0
CO 80116 2.0
CO 80117 2.0
CO 80118 2.0
CO 80120 1.0
CO 80121 1.0
CO 80122 1.0
CO 80123 1.0
CO 80124 1.0
CO 80125 2.0
CO 80126 1.0
CO 80127 1.0
CO 80128 1.0
CO 80129 1.0
CO 80130 1.0
CO 80131 2.0
CO 80132 1.0
CO 80133 1.0
CO 80134 1.0
CO 80135 2.0
CO 80136 2.0
CO 80137 2.0
CO 80138 1.0
CO 80150 1.0
CO 80151 1.0
CO 80154 1.0
CO 80155 1.0
CO 80160 1.0
CO 80161 1.0
CO 80162 1.0
CO 80163 1.0
CO 80165 1.0
CO 80166 1.0
CO 80201 1.0
CO 80202 1.0
CO 80203 1.0
CO 80204 1.0
CO 80205 1.0
CO 80206 1.0
CO 80207 1.0
CO 80208 1.0
CO 80209 1.0
CO 80210 1.0
CO 80211 1.0
CO 80212 1.0
CO 80214 1.0
CO 80215 1.0
CO 80216 1.0
CO 80217 1.0
CO 80218 1.0
CO 80219 1.0
CO 80220 1.0
CO 80221 1.0
CO 80222 1.0
CO 80223 1.0
CO 80224 1.0
CO 80225 1.0
CO 80226 1.0
CO 80227 1.0
CO 80228 1.0
CO 80229 1.0
CO 80230 1.0
CO 80231 1.0
CO 80232 1.0
CO 80233 1.0
CO 80234 1.0
CO 80235 1.0
CO 80236 1.0
CO 80237 1.0
CO 80238 1.0
CO 80239 1.0
CO 80241 1.0
CO 80243 1.0
CO 80244 1.0
CO 80246 1.0
CO 80247 1.0
CO 80248 1.0
CO 80249 1.0
CO 80250 1.0
CO 80251 1.0
CO 80252 1.0
CO 80255 1.0
CO 80256 1.0
CO 80257 1.0
CO 80259 1.0
CO 80260 1.0
CO 80261 1.0
CO 80262 1.0
CO 80263 1.0
CO 80264 1.0
CO 80265 1.0
CO 80266 1.0
CO 80270 1.0
CO 80271 1.0
CO 80273 1.0
CO 80274 1.0
CO 80275 1.0
CO 80279 1.0
CO 80280 1.0
CO 80281 1.0
CO 80285 1.0
CO 80290 1.0
CO 80291 1.0
CO 80292 1.0
CO 80293 1.0
CO 80294 1.0
CO 80295 1.0
CO 80299 1.0
CO 80301 1.0
CO 80302 1.0
CO 80303 1.0
CO 80304 1.0
CO 80305 1.0
CO 80306 1.0
CO 80307 1.0
CO 80308 1.0
CO 80309 1.0
CO 80310 1.0
CO 80314 1.0
CO 80321 1.0
CO 80322 1.0
CO 80323 1.0
CO 80328 1.0
CO 80329 1.0
CO 80401 1.0
CO 80402 1.0
CO 80403 1.0
CO 80419 1.0
CO 80420 10.3
CO 80421 2.0
CO 80422 10.1
CO 80423 5.0
CO 80424 7.4
CO 80425 2.0
CO 80426 5.0
CO 80427 10.1
CO 80428 8.0
CO 80429 7.4
CO 80430 10.0
CO 80432 10.3
CO 80433 2.0
CO 80434 10.0
CO 80435 4.0
CO 80436 10.4
CO 80437 2.0
CO 80438 10.4
CO 80439 2.0
CO 80440 10.3
CO 80442 10.0
CO 80443 4.0
CO 80444 10.4
CO 80446 10.0
CO 80447 10.0
CO 80448 2.0
CO 80449 10.0
CO 80451 10.0
CO 80452 10.4
CO 80453 1.0
CO 80454 1.0
CO 80455 2.0
CO 80456 10.0
CO 80457 2.0
CO 80459 10.5
CO 80461 7.4
CO 80463 5.0
CO 80465 1.0
CO 80466 2.1
CO 80467 8.0
CO 80468 10.5
CO 80469 8.0
CO 80470 2.0
CO 80471 1.0
CO 80473 10.0
CO 80474 1.0
CO 80475 2.0
CO 80476 10.4
CO 80477 7.0
CO 80478 10.0
CO 80479 8.0
CO 80480 10.0
CO 80481 2.0
CO 80482 10.0
CO 80483 8.0
CO 80487 7.0
CO 80488 7.0
CO 80497 4.0
CO 80498 4.0
CO 80501 1.0
CO 80502 1.0
CO 80503 1.0
CO 80504 1.0
CO 80510 2.0
CO 80511 7.3
CO 80512 2.0
CO 80513 1.0
CO 80514 3.0
CO 80515 9.1
CO 80516 2.1
CO 80517 7.3
CO 80520 2.0
CO 80521 1.0
CO 80522 1.0
CO 80523 1.0
CO 80524 1.0
CO 80525 1.0
CO 80526 1.0
CO 80527 1.0
CO 80528 1.0
CO 80530 3.0
CO 80532 9.1
CO 80533 1.0
CO 80534 9.1
CO 80535 1.0
CO 80536 2.0
CO 80537 1.0
CO 80538 1.0
CO 80539 1.0
CO 80540 2.0
CO 80541 1.0
CO 80542 9.1
CO 80543 9.1
CO 80544 1.0
CO 80545 2.0
CO 80546 2.0
CO 80547 1.0
CO 80549 2.0
CO 80550 2.0
CO 80551 2.0
CO 80553 1.0
CO 80601 2.0
CO 80602 1.0
CO 80603 2.0
CO 80610 2.1
CO 80611 10.4
CO 80612 10.4
CO 80614 1.0
CO 80615 2.0
CO 80620 1.0
CO 80621 2.0
CO 80622 2.0
CO 80623 3.0
CO 80624 2.0
CO 80631 1.0
CO 80632 1.0
CO 80633 1.0
CO 80634 1.0
CO 80638 1.0
CO 80639 1.0
CO 80640 2.0
CO 80642 2.0
CO 80643 2.0
CO 80644 2.0
CO 80645 1.0
CO 80646 1.0
CO 80648 10.4
CO 80649 5.0
CO 80650 2.1
CO 80651 3.0
CO 80652 2.0
CO 80653 5.0
CO 80654 10.5
CO 80701 4.0
CO 80705 4.0
CO 80720 10.0
CO 80721 10.0
CO 80722 5.0
CO 80723 7.2
CO 80726 10.5
CO 80727 7.0
CO 80728 10.2
CO 80729 10.4
CO 80731 10.0
CO 80732 10.4
CO 80733 10.3
CO 80734 10.0
CO 80735 10.0
CO 80736 5.0
CO 80737 10.0
CO 80740 10.6
CO 80741 5.0
CO 80742 10.4
CO 80743 10.6
CO 80744 10.0
CO 80745 10.5
CO 80746 10.0
CO 80747 10.5
CO 80749 10.0
CO 80750 5.0
CO 80751 4.0
CO 80754 10.4
CO 80755 10.0
CO 80757 10.6
CO 80758 10.0
CO 80759 7.0
CO 80801 10.6
CO 80802 10.0
CO 80804 10.0
CO 80805 7.0
CO 80807 7.0
CO 80808 2.0
CO 80809 2.0
CO 80810 10.0
CO 80812 10.6
CO 80813 10.0
CO 80814 2.0
CO 80815 10.0
CO 80816 2.0
CO 80817 1.0
CO 80818 10.0
CO 80819 2.0
CO 80820 10.0
CO 80821 10.0
CO 80822 7.0
CO 80823 10.0
CO 80824 7.0
CO 80825 10.0
CO 80826 10.0
CO 80827 10.0
CO 80828 10.0
CO 80829 1.0
CO 80830 10.4
CO 80831 2.0
CO 80832 2.0
CO 80833 2.0
CO 80834 10.0
CO 80835 10.4
CO 80836 10.6
CO 80840 1.0
CO 80841 1.0
CO 80860 2.0
CO 80861 10.6
CO 80862 10.0
CO 80863 2.0
CO 80864 2.0
CO 80866 2.0
CO 80901 1.0
CO 80903 1.0
CO 80904 1.0
CO 80905 1.0
CO 80906 1.0
CO 80907 1.0
CO 80908 2.0
CO 80909 1.0
CO 80910 1.0
CO 80911 1.0
CO 80912 2.0
CO 80913 1.0
CO 80914 1.0
CO 80915 1.0
CO 80916 1.0
CO 80917 1.0
CO 80918 1.0
CO 80919 1.0
CO 80920 1.0
CO 80921 1.0
CO 80922 1.0
CO 80925 2.0
CO 80926 1.0
CO 80928 2.0
CO 80929 2.0
CO 80930 2.0
CO 80931 1.0
CO 80932 1.0
CO 80933 1.0
CO 80934 1.0
CO 80935 1.0
CO 80936 1.0
CO 80937 1.0
CO 80940 1.0
CO 80941 1.0
CO 80942 1.0
CO 80943 1.0
CO 80944 1.0
CO 80945 1.0
CO 80946 1.0
CO 80947 1.0
CO 80949 1.0
CO 80950 1.0
CO 80960 1.0
CO 80962 1.0
CO 80970 1.0
CO 80977 2.0
CO 80995 1.0
CO 80997 1.0
CO 81001 1.0
CO 81002 1.0
CO 81003 1.0
CO 81004 1.0
CO 81005 1.0
CO 81006 1.0
CO 81007 1.0
CO 81008 1.0
CO 81009 1.0
CO 81010 1.0
CO 81011 1.0
CO 81012 1.0
CO 81019 2.0
CO 81020 7.0
CO 81021 10.0
CO 81022 2.0
CO 81023 2.0
CO 81024 7.0
CO 81025 2.0
CO 81027 10.6
CO 81029 10.0
CO 81030 7.0
CO 81033 10.6
CO 81034 10.6
CO 81036 10.0
CO 81038 7.0
CO 81039 10.4
CO 81040 10.3
CO 81041 10.3
CO 81043 10.6
CO 81044 7.0
CO 81045 10.0
CO 81046 7.0
CO 81047 10.6
CO 81049 10.6
CO 81050 7.0
CO 81052 7.0
CO 81054 7.0
CO 81055 10.6
CO 81057 7.0
CO 81058 10.6
CO 81059 10.6
CO 81062 10.6
CO 81063 10.6
CO 81064 10.0
CO 81067 7.0
CO 81069 2.0
CO 81071 10.0
CO 81073 10.0
CO 81076 10.6
CO 81077 7.0
CO 81081 10.6
CO 81082 7.0
CO 81084 10.0
CO 81087 10.0
CO 81089 7.0
CO 81090 10.0
CO 81091 8.0
CO 81092 8.0
CO 81101 7.0
CO 81102 7.0
CO 81120 10.6
CO 81121 10.0
CO 81122 5.0
CO 81123 10.6
CO 81124 10.3
CO 81125 10.0
CO 81126 10.0
CO 81127 10.0
CO 81128 10.0
CO 81129 10.6
CO 81130 10.0
CO 81131 10.0
CO 81132 10.6
CO 81133 10.6
CO 81134 10.0
CO 81135 7.0
CO 81136 8.0
CO 81137 10.5
CO 81138 10.0
CO 81140 10.3
CO 81141 10.6
CO 81143 10.0
CO 81144 7.0
CO 81146 8.0
CO 81147 10.0
CO 81148 10.6
CO 81149 10.0
CO 81151 10.6
CO 81152 10.0
CO 81153 10.0
CO 81154 10.0
CO 81155 10.0
CO 81157 10.0
CO 81201 7.0
CO 81210 8.0
CO 81211 7.0
CO 81212 4.0
CO 81215 4.0
CO 81220 10.6
CO 81221 5.0
CO 81222 10.6
CO 81223 10.6
CO 81224 10.0
CO 81225 10.0
CO 81226 5.0
CO 81227 7.0
CO 81228 7.4
CO 81230 7.0
CO 81231 8.0
CO 81232 10.6
CO 81233 10.6
CO 81235 10.0
CO 81236 8.0
CO 81237 8.0
CO 81239 8.0
CO 81240 3.0
CO 81241 8.0
CO 81242 7.0
CO 81243 10.6
CO 81244 5.0
CO 81246 4.0
CO 81247 8.0
CO 81248 10.0
CO 81251 7.4
CO 81252 10.0
CO 81253 10.0
CO 81290 5.0
CO 81301 4.0
CO 81302 4.0
CO 81303 5.0
CO 81320 10.6
CO 81321 7.0
CO 81323 10.3
CO 81324 10.6
CO 81325 10.0
CO 81326 5.0
CO 81327 8.0
CO 81328 10.6
CO 81329 5.0
CO 81330 10.6
CO 81331 8.0
CO 81332 10.6
CO 81334 10.3
CO 81335 8.0
CO 81401 4.0
CO 81402 4.0
CO 81410 10.6
CO 81411 10.0
CO 81413 10.6
CO 81414 10.6
CO 81415 10.6
CO 81416 7.4
CO 81418 10.6
CO 81419 10.6
CO 81420 10.6
CO 81422 10.0
CO 81423 10.0
CO 81424 10.0
CO 81425 5.0
CO 81426 10.0
CO 81427 10.0
CO 81428 10.0
CO 81429 10.0
CO 81430 10.0
CO 81431 10.0
CO 81432 10.0
CO 81433 10.0
CO 81434 10.6
CO 81435 10.0
CO 81501 1.0
CO 81502 1.0
CO 81503 1.0
CO 81504 1.0
CO 81505 1.0
CO 81506 1.0
CO 81520 1.0
CO 81521 2.0
CO 81522 2.0
CO 81523 2.0
CO 81524 2.0
CO 81525 2.0
CO 81526 1.0
CO 81527 2.0
CO 81601 7.0
CO 81602 7.0
CO 81610 10.0
CO 81611 7.0
CO 81612 7.0
CO 81615 10.3
CO 81620 4.0
CO 81621 8.0
CO 81623 7.0
CO 81624 2.0
CO 81625 7.0
CO 81626 7.0
CO 81630 2.0
CO 81631 4.0
CO 81632 4.0
CO 81633 10.0
CO 81635 7.0
CO 81636 7.0
CO 81637 5.0
CO 81638 8.0
CO 81639 8.0
CO 81640 10.0
CO 81641 10.0
CO 81642 8.0
CO 81643 2.0
CO 81645 4.0
CO 81646 2.0
CO 81647 8.0
CO 81648 10.0
CO 81649 4.0
CO 81650 7.0
CO 81652 8.0
CO 81653 8.0
CO 81654 10.3
CO 81655 4.0
CO 81656 8.0
CO 81657 4.0
CO 81658 4.0
CT 06001 1.0
CT 06002 1.0
CT 06006 1.0
CT 06010 1.0
CT 06011 1.0
CT 06013 1.0
CT 06016 1.0
CT 06018 10.0
CT 06019 2.0
CT 06020 2.0
CT 06021 3.0
CT 06022 1.0
CT 06023 1.0
CT 06024 10.0
CT 06025 1.0
CT 06026 1.0
CT 06027 2.0
CT 06028 1.0
CT 06029 1.0
CT 06030 1.0
CT 06031 10.0
CT 06032 1.0
CT 06033 1.0
CT 06034 1.0
CT 06035 1.0
CT 06037 1.0
CT 06039 10.0
CT 06040 1.0
CT 06041 1.0
CT 06042 1.0
CT 06043 1.0
CT 06045 1.0
CT 06050 1.0
CT 06051 1.0
CT 06052 1.0
CT 06053 1.0
CT 06057 2.0
CT 06058 10.5
CT 06059 2.0
CT 06060 1.0
CT 06061 2.0
CT 06062 1.0
CT 06063 2.0
CT 06064 1.0
CT 06065 2.0
CT 06066 1.0
CT 06067 1.0
CT 06068 10.0
CT 06069 10.0
CT 06070 1.0
CT 06071 1.0
CT 06072 1.0
CT 06073 1.0
CT 06074 1.0
CT 06075 2.0
CT 06076 2.0
CT 06077 2.0
CT 06078 1.0
CT 06079 10.0
CT 06080 1.0
CT 06081 1.0
CT 06082 1.0
CT 06083 1.0
CT 06084 1.0
CT 06085 1.0
CT 06087 1.0
CT 06088 1.0
CT 06089 1.0
CT 06090 1.0
CT 06091 2.0
CT 06092 1.0
CT 06093 1.0
CT 06094 9.1
CT 06095 1.0
CT 06096 1.0
CT 06098 9.1
CT 06101 1.0
CT 06102 1.0
CT 06103 1.0
CT 06104 1.0
CT 06105 1.0
CT 06106 1.0
CT 06107 1.0
CT 06108 1.0
CT 06109 1.0
CT 06110 1.0
CT 06111 1.0
CT 06112 1.0
CT 06114 1.0
CT 06115 1.0
CT 06117 1.0
CT 06118 1.0
CT 06119 1.0
CT 06120 1.0
CT 06123 1.0
CT 06126 1.0
CT 06127 1.0
CT 06128 1.0
CT 06129 1.0
CT 06131 1.0
CT 06132 1.0
CT 06133 1.0
CT 06134 1.0
CT 06137 1.0
CT 06138 1.0
CT 06140 1.0
CT 06141 1.0
CT 06142 1.0
CT 06143 1.0
CT 06144 1.0
CT 06145 1.0
CT 06146 1.0
CT 06147 1.0
CT 06150 1.0
CT 06151 1.0
CT 06152 1.0
CT 06153 1.0
CT 06154 1.0
CT 06155 1.0
CT 06156 1.0
CT 06160 1.0
CT 06161 1.0
CT 06167 1.0
CT 06176 1.0
CT 06180 1.0
CT 06183 1.0
CT 06199 1.0
CT 06226 4.0
CT 06230 10.5
CT 06231 2.0
CT 06232 2.0
CT 06233 6.1
CT 06234 4.2
CT 06235 6.1
CT 06237 2.0
CT 06238 4.1
CT 06239 4.2
CT 06241 6.1
CT 06242 3.0
CT 06243 6.1
CT 06244 3.0
CT 06245 1.0
CT 06246 1.0
CT 06247 6.1
CT 06248 2.0
CT 06249 3.0
CT 06250 4.0
CT 06251 4.1
CT 06254 2.0
CT 06255 1.0
CT 06256 4.0
CT 06258 10.5
CT 06259 10.5
CT 06260 1.0
CT 06262 1.0
CT 06263 6.1
CT 06264 6.1
CT 06265 4.1
CT 06266 4.0
CT 06267 10.5
CT 06268 4.1
CT 06269 4.1
CT 06277 2.0
CT 06278 3.0
CT 06279 4.1
CT 06280 4.0
CT 06281 3.0
CT 06282 3.0
CT 06320 1.0
CT 06330 1.0
CT 06331 2.0
CT 06332 2.0
CT 06333 1.0
CT 06334 2.0
CT 06335 1.0
CT 06336 2.0
CT 06338 1.0
CT 06339 1.0
CT 06340 1.0
CT 06349 1.0
CT 06350 1.0
CT 06351 1.0
CT 06353 1.0
CT 06354 4.2
CT 06355 1.0
CT 06357 1.0
CT 06359 2.0
CT 06360 1.0
CT 06365 2.0
CT 06370 1.0
CT 06371 1.0
CT 06372 1.0
CT 06373 6.1
CT 06374 2.0
CT 06375 1.0
CT 06376 1.0
CT 06377 6.1
CT 06378 1.0
CT 06379 4.1
CT 06380 1.0
CT 06382 1.0
CT 06383 1.0
CT 06384 2.0
CT 06385 1.0
CT 06386 1.0
CT 06387 2.0
CT 06388 1.0
CT 06389 2.0
CT 06401 1.0
CT 06403 1.0
CT 06404 1.0
CT 06405 1.0
CT 06408 1.0
CT 06409 1.0
CT 06410 1.0
CT 06411 1.0
CT 06412 1.0
CT 06413 1.0
CT 06414 2.0
CT 06415 2.0
CT 06416 1.0
CT 06417 1.0
CT 06418 1.0
CT 06419 2.1
CT 06420 2.1
CT 06422 1.0
CT 06423 2.0
CT 06424 2.0
CT 06426 1.0
CT 06430 1.0
CT 06431 1.0
CT 06432 1.0
CT 06436 1.0
CT 06437 1.0
CT 06438 2.0
CT 06439 1.0
CT 06440 1.0
CT 06441 2.0
CT 06442 1.0
CT 06443 1.0
CT 06444 1.0
CT 06447 1.0
CT 06450 1.0
CT 06451 1.0
CT 06454 1.0
CT 06455 1.0
CT 06456 2.0
CT 06457 1.0
CT 06459 1.0
CT 06460 1.0
CT 06461 1.0
CT 06467 1.0
CT 06468 1.0
CT 06469 2.0
CT 06470 1.0
CT 06471 1.0
CT 06472 1.0
CT 06473 1.0
CT 06474 2.0
CT 06475 1.0
CT 06477 1.0
CT 06478 1.0
CT 06479 1.0
CT 06480 1.0
CT 06481 1.0
CT 06482 1.0
CT 06483 1.0
CT 06484 1.0
CT 06487 1.0
CT 06488 1.0
CT 06489 1.0
CT 06490 1.0
CT 06491 1.0
CT 06492 1.0
CT 06493 1.0
CT 06494 1.0
CT 06495 1.0
CT 06497 1.0
CT 06498 1.0
CT 06501 1.0
CT 06502 1.0
CT 06503 1.0
CT 06504 1.0
CT 06505 1.0
CT 06506 1.0
CT 06507 1.0
CT 06508 1.0
CT 06509 1.0
CT 06510 1.0
CT 06511 1.0
CT 06512 1.0
CT 06513 1.0
CT 06514 1.0
CT 06515 1.0
CT 06516 1.0
CT 06517 1.0
CT 06518 1.0
CT 06519 1.0
CT 06520 1.0
CT 06521 1.0
CT 06524 1.0
CT 06525 1.0
CT 06530 1.0
CT 06531 1.0
CT 06532 1.0
CT 06533 1.0
CT 06534 1.0
CT 06535 1.0
CT 06536 1.0
CT 06537 1.0
CT 06538 1.0
CT 06540 1.0
CT 06601 1.0
CT 06602 1.0
CT 06604 1.0
CT 06605 1.0
CT 06606 1.0
CT 06607 1.0
CT 06608 1.0
CT 06610 1.0
CT 06611 1.0
CT 06612 1.0
CT 06614 1.0
CT 06615 1.0
CT 06650 1.0
CT 06673 1.0
CT 06699 1.0
CT 06701 1.0
CT 06702 1.0
CT 06703 1.0
CT 06704 1.0
CT 06705 1.0
CT 06706 1.0
CT 06708 1.0
CT 06710 1.0
CT 06712 1.0
CT 06716 1.0
CT 06720 1.0
CT 06721 1.0
CT 06722 1.0
CT 06723 1.0
CT 06724 1.0
CT 06725 1.0
CT 06726 1.0
CT 06749 1.0
CT 06750 6.0
CT 06751 3.0
CT 06752 2.1
CT 06753 3.0
CT 06754 3.0
CT 06755 1.0
CT 06756 6.0
CT 06757 10.4
CT 06758 3.0
CT 06759 4.2
CT 06762 1.0
CT 06763 3.0
CT 06770 1.0
CT 06776 1.0
CT 06777 10.4
CT 06778 4.2
CT 06779 1.0
CT 06781 1.0
CT 06782 1.0
CT 06783 3.0
CT 06784 2.1
CT 06785 10.4
CT 06786 1.0
CT 06787 1.0
CT 06790 4.2
CT 06791 4.2
CT 06792 4.2
CT 06793 10.4
CT 06794 10.4
CT 06795 1.0
CT 06796 10.4
CT 06798 2.0
CT 06801 1.0
CT 06804 1.0
CT 06807 1.0
CT 06810 1.0
CT 06811 1.0
CT 06812 1.0
CT 06813 1.0
CT 06814 1.0
CT 06816 1.0
CT 06817 1.0
CT 06820 1.0
CT 06824 1.0
CT 06825 1.0
CT 06828 1.0
CT 06829 1.0
CT 06830 1.0
CT 06831 1.0
CT 06832 1.0
CT 06836 1.0
CT 06838 1.0
CT 06840 1.0
CT 06842 1.0
CT 06850 1.0
CT 06851 1.0
CT 06852 1.0
CT 06853 1.0
CT 06854 1.0
CT 06855 1.0
CT 06856 1.0
CT 06857 1.0
CT 06858 1.0
CT 06859 1.0
CT 06860 1.0
CT 06870 1.0
CT 06875 2.0
CT 06876 2.0
CT 06877 1.0
CT 06878 1.0
CT 06879 1.0
CT 06880 1.0
CT 06881 1.0
CT 06883 1.0
CT 06888 1.0
CT 06889 1.0
CT 06890 1.0
CT 06896 2.0
CT 06897 1.0
CT 06901 1.0
CT 06902 1.0
CT 06903 1.0
CT 06904 1.0
CT 06905 1.0
CT 06906 1.0
CT 06907 1.0
CT 06910 1.0
CT 06911 1.0
CT 06912 1.0
CT 06913 1.0
CT 06914 1.0
CT 06920 1.0
CT 06921 1.0
CT 06922 1.0
CT 06925 1.0
CT 06926 1.0
CT 06927 1.0
CT 06928 1.0
DC 20001 1.0
DC 20002 1.0
DC 20003 1.0
DC 20004 1.0
DC 20005 1.0
DC 20006 1.0
DC 20007 1.0
DC 20008 1.0
DC 20009 1.0
DC 20010 1.0
DC 20011 1.0
DC 20012 1.0
DC 20013 1.0
DC 20015 1.0
DC 20016 1.0
DC 20017 1.0
DC 20018 1.0
DC 20019 1.0
DC 20020 1.0
DC 20022 1.0
DC 20023 1.0
DC 20024 1.0
DC 20026 1.0
DC 20027 1.0
DC 20029 1.0
DC 20030 1.0
DC 20032 1.0
DC 20033 1.0
DC 20035 1.0
DC 20036 1.0
DC 20037 1.0
DC 20038 1.0
DC 20039 1.0
DC 20040 1.0
DC 20041 1.0
DC 20042 1.0
DC 20043 1.0
DC 20044 1.0
DC 20045 1.0
DC 20046 1.0
DC 20047 1.0
DC 20049 1.0
DC 20050 1.0
DC 20051 1.0
DC 20052 1.0
DC 20053 1.0
DC 20055 1.0
DC 20056 1.0
DC 20057 1.0
DC 20058 1.0
DC 20059 1.0
DC 20060 1.0
DC 20061 1.0
DC 20062 1.0
DC 20063 1.0
DC 20064 1.0
DC 20065 1.0
DC 20066 1.0
DC 20067 1.0
DC 20068 1.0
DC 20069 1.0
DC 20070 1.0
DC 20071 1.0
DC 20073 1.0
DC 20074 1.0
DC 20075 1.0
DC 20076 1.0
DC 20077 1.0
DC 20078 1.0
DC 20080 1.0
DC 20081 1.0
DC 20082 1.0
DC 20088 1.0
DC 20090 1.0
DC 20091 1.0
DC 20097 1.0
DC 20098 1.0
DC 20099 1.0
DC 20201 1.0
DC 20202 1.0
DC 20203 1.0
DC 20204 1.0
DC 20206 1.0
DC 20207 1.0
DC 20208 1.0
DC 20210 1.0
DC 20211 1.0
DC 20212 1.0
DC 20213 1.0
DC 20214 1.0
DC 20215 1.0
DC 20216 1.0
DC 20217 1.0
DC 20218 1.0
DC 20219 1.0
DC 20220 1.0
DC 20221 1.0
DC 20222 1.0
DC 20223 1.0
DC 20224 1.0
DC 20226 1.0
DC 20227 1.0
DC 20228 1.0
DC 20229 1.0
DC 20230 1.0
DC 20231 1.0
DC 20232 1.0
DC 20233 1.0
DC 20235 1.0
DC 20237 1.0
DC 20238 1.0
DC 20239 1.0
DC 20240 1.0
DC 20241 1.0
DC 20242 1.0
DC 20244 1.0
DC 20245 1.0
DC 20250 1.0
DC 20251 1.0
DC 20254 1.0
DC 20260 1.0
DC 20261 1.0
DC 20262 1.0
DC 20265 1.0
DC 20266 1.0
DC 20268 1.0
DC 20270 1.0
DC 20277 1.0
DC 20289 1.0
DC 20299 1.0
DC 20301 1.0
DC 20303 1.0
DC 20306 1.0
DC 20307 1.0
DC 20310 1.0
DC 20314 1.0
DC 20315 1.0
DC 20317 1.0
DC 20318 1.0
DC 20319 1.0
DC 20330 1.0
DC 20332 1.0
DC 20336 1.0
DC 20337 1.0
DC 20338 1.0
DC 20340 1.0
DC 20350 1.0
DC 20355 1.0
DC 20370 1.0
DC 20372 1.0
DC 20373 1.0
DC 20374 1.0
DC 20375 1.0
DC 20376 1.0
DC 20380 1.0
DC 20388 1.0
DC 20389 1.0
DC 20390 1.0
DC 20391 1.0
DC 20392 1.0
DC 20393 1.0
DC 20394 1.0
DC 20395 1.0
DC 20398 1.0
DC 20401 1.0
DC 20402 1.0
DC 20403 1.0
DC 20404 1.0
DC 20405 1.0
DC 20406 1.0
DC 20407 1.0
DC 20408 1.0
DC 20409 1.0
DC 20410 1.0
DC 20411 1.0
DC 20412 1.0
DC 20413 1.0
DC 20414 1.0
DC 20415 1.0
DC 20416 1.0
DC 20418 1.0
DC 20419 1.0
DC 20420 1.0
DC 20421 1.0
DC 20422 1.0
DC 20423 1.0
DC 20424 1.0
DC 20425 1.0
DC 20426 1.0
DC 20427 1.0
DC 20428 1.0
DC 20429 1.0
DC 20431 1.0
DC 20433 1.0
DC 20434 1.0
DC 20435 1.0
DC 20436 1.0
DC 20437 1.0
DC 20439 1.0
DC 20440 1.0
DC 20441 1.0
DC 20442 1.0
DC 20444 1.0
DC 20447 1.0
DC 20451 1.0
DC 20453 1.0
DC 20456 1.0
DC 20460 1.0
DC 20463 1.0
DC 20468 1.0
DC 20469 1.0
DC 20470 1.0
DC 20472 1.0
DC 20500 1.0
DC 20501 1.0
DC 20502 1.0
DC 20503 1.0
DC 20504 1.0
DC 20505 1.0
DC 20506 1.0
DC 20507 1.0
DC 20508 1.0
DC 20509 1.0
DC 20510 1.0
DC 20511 1.0
DC 20515 1.0
DC 20520 1.0
DC 20521 1.0
DC 20522 1.0
DC 20523 1.0
DC 20524 1.0
DC 20525 1.0
DC 20526 1.0
DC 20527 1.0
DC 20528 1.0
DC 20529 1.0
DC 20530 1.0
DC 20531 1.0
DC 20532 1.0
DC 20533 1.0
DC 20534 1.0
DC 20535 1.0
DC 20536 1.0
DC 20537 1.0
DC 20538 1.0
DC 20539 1.0
DC 20540 1.0
DC 20541 1.0
DC 20542 1.0
DC 20543 1.0
DC 20544 1.0
DC 20546 1.0
DC 20547 1.0
DC 20548 1.0
DC 20549 1.0
DC 20550 1.0
DC 20551 1.0
DC 20552 1.0
DC 20553 1.0
DC 20554 1.0
DC 20555 1.0
DC 20557 1.0
DC 20558 1.0
DC 20559 1.0
DC 20560 1.0
DC 20565 1.0
DC 20566 1.0
DC 20570 1.0
DC 20571 1.0
DC 20572 1.0
DC 20573 1.0
DC 20575 1.0
DC 20576 1.0
DC 20577 1.0
DC 20578 1.0
DC 20579 1.0
DC 20580 1.0
DC 20581 1.0
DC 20585 1.0
DC 20586 1.0
DC 20590 1.0
DC 20591 1.0
DC 20593 1.0
DC 20594 1.0
DC 20597 1.0
DC 20599 1.0
DC 56901 1.0
DC 56915 1.0
DC 56920 1.0
DE 19701 1.0
DE 19702 1.0
DE 19703 1.0
DE 19706 1.0
DE 19707 1.0
DE 19708 1.0
DE 19709 2.0
DE 19710 1.0
DE 19711 1.0
DE 19712 1.0
DE 19713 1.0
DE 19714 1.0
DE 19715 1.0
DE 19716 1.0
DE 19717 1.0
DE 19718 1.0
DE 19720 1.0
DE 19721 1.0
DE 19725 1.0
DE 19726 1.0
DE 19730 2.0
DE 19731 2.0
DE 19732 1.0
DE 19733 1.0
DE 19734 2.0
DE 19735 1.0
DE 19736 1.0
DE 19801 1.0
DE 19802 1.0
DE 19803 1.0
DE 19804 1.0
DE 19805 1.0
DE 19806 1.0
DE 19807 1.0
DE 19808 1.0
DE 19809 1.0
DE 19810 1.0
DE 19850 1.0
DE 19880 1.0
DE 19884 1.0
DE 19885 1.0
DE 19886 1.0
DE 19887 1.0
DE 19889 1.0
DE 19890 1.0
DE 19891 1.0
DE 19892 1.0
DE 19893 1.0
DE 19894 1.0
DE 19895 1.0
DE 19896 1.0
DE 19897 1.0
DE 19898 1.0
DE 19899 1.0
DE 19901 1.0
DE 19902 1.0
DE 19903 1.0
DE 19904 1.0
DE 19905 1.0
DE 19906 1.0
DE 19930 7.4
DE 19931 4.0
DE 19933 10.5
DE 19934 1.0
DE 19936 1.0
DE 19938 2.1
DE 19939 7.4
DE 19940 1.0
DE 19941 6.0
DE 19943 2.0
DE 19944 7.4
DE 19945 7.2
DE 19946 2.0
DE 19947 7.4
DE 19950 10.5
DE 19951 5.0
DE 19952 2.0
DE 19953 2.0
DE 19954 2.0
DE 19955 2.1
DE 19956 4.0
DE 19958 4.0
DE 19960 4.2
DE 19961 1.0
DE 19962 1.0
DE 19963 4.2
DE 19964 2.0
DE 19966 5.0
DE 19967 7.4
DE 19968 5.0
DE 19969 4.0
DE 19970 7.4
DE 19971 4.0
DE 19973 4.0
DE 19975 4.2
DE 19977 2.1
DE 19979 1.0
DE 19980 2.0
FL 32003 1.0
FL 32004 1.0
FL 32006 1.0
FL 32007 4.0
FL 32008 10.5
FL 32009 2.0
FL 32011 2.0
FL 32013 10.0
FL 32024 5.0
FL 32025 4.0
FL 32026 9.0
FL 32030 1.0
FL 32033 2.1
FL 32034 4.2
FL 32035 4.2
FL 32038 5.2
FL 32040 7.1
FL 32041 2.0
FL 32042 2.0
FL 32043 1.0
FL 32044 2.0
FL 32046 2.0
FL 32050 1.0
FL 32052 7.0
FL 32053 10.4
FL 32054 7.3
FL 32055 4.0
FL 32056 4.0
FL 32058 8.3
FL 32059 10.6
FL 32060 7.4
FL 32061 4.0
FL 32062 6.0
FL 32063 7.1
FL 32064 7.0
FL 32065 1.0
FL 32066 10.0
FL 32067 1.0
FL 32068 1.0
FL 32071 10.5
FL 32072 8.1
FL 32073 1.0
FL 32079 1.0
FL 32080 1.0
FL 32082 1.0
FL 32083 9.0
FL 32084 1.0
FL 32085 1.0
FL 32086 1.0
FL 32087 8.1
FL 32091 7.3
FL 32092 1.0
FL 32094 6.0
FL 32095 1.0
FL 32096 5.0
FL 32097 2.0
FL 32099 1.0
FL 32102 3.0
FL 32105 2.0
FL 32110 4.1
FL 32111 1.0
FL 32112 7.4
FL 32113 2.1
FL 32114 1.0
FL 32115 1.0
FL 32116 1.0
FL 32117 1.0
FL 32118 1.0
FL 32119 1.0
FL 32120 1.0
FL 32121 1.0
FL 32122 1.0
FL 32123 1.0
FL 32124 1.0
FL 32125 1.0
FL 32126 1.0
FL 32127 1.0
FL 32128 1.0
FL 32129 1.0
FL 32130 1.1
FL 32131 4.0
FL 32132 1.0
FL 32133 2.0
FL 32134 2.0
FL 32135 1.0
FL 32136 1.0
FL 32137 4.1
FL 32138 5.0
FL 32139 7.4
FL 32140 5.0
FL 32141 1.0
FL 32142 1.0
FL 32145 2.1
FL 32147 5.0
FL 32148 5.0
FL 32149 5.0
FL 32151 4.1
FL 32157 6.0
FL 32158 2.0
FL 32159 2.0
FL 32160 2.0
FL 32162 2.0
FL 32164 4.1
FL 32168 1.0
FL 32169 1.0
FL 32170 1.0
FL 32173 1.0
FL 32174 1.0
FL 32175 1.0
FL 32176 1.0
FL 32177 4.0
FL 32178 4.0
FL 32179 2.0
FL 32180 2.0
FL 32181 6.0
FL 32182 2.0
FL 32183 2.0
FL 32185 5.0
FL 32187 4.0
FL 32189 5.0
FL 32190 3.0
FL 32192 2.0
FL 32193 7.4
FL 32195 2.0
FL 32198 1.0
FL 32201 1.0
FL 32202 1.0
FL 32203 1.0
FL 32204 1.0
FL 32205 1.0
FL 32206 1.0
FL 32207 1.0
FL 32208 1.0
FL 32209 1.0
FL 32210 1.0
FL 32211 1.0
FL 32212 1.0
FL 32214 1.0
FL 32215 2.0
FL 32216 1.0
FL 32217 1.0
FL 32218 1.0
FL 32219 1.0
FL 32220 1.0
FL 32221 1.0
FL 32222 1.0
FL 32223 1.0
FL 32224 1.0
FL 32225 1.0
FL 32226 2.0
FL 32227 1.0
FL 32228 1.0
FL 32229 1.0
FL 32230 1.0
FL 32231 1.0
FL 32232 1.0
FL 32233 1.0
FL 32234 2.0
FL 32235 1.0
FL 32236 1.0
FL 32237 1.0
FL 32238 1.0
FL 32239 1.0
FL 32240 1.0
FL 32241 1.0
FL 32244 1.0
FL 32245 1.0
FL 32246 1.0
FL 32247 1.0
FL 32250 1.0
FL 32254 1.0
FL 32255 1.0
FL 32256 1.0
FL 32257 1.0
FL 32258 1.0
FL 32259 1.0
FL 32260 1.0
FL 32266 1.0
FL 32267 1.0
FL 32276 1.0
FL 32277 1.0
FL 32290 1.0
FL 32301 1.0
FL 32302 1.0
FL 32303 1.0
FL 32304 1.0
FL 32305 1.0
FL 32306 1.0
FL 32307 1.0
FL 32308 1.0
FL 32309 1.0
FL 32310 1.0
FL 32311 1.0
FL 32312 1.0
FL 32313 1.0
FL 32314 1.0
FL 32315 1.0
FL 32316 1.0
FL 32317 1.0
FL 32318 1.0
FL 32320 7.0
FL 32321 10.4
FL 32322 10.6
FL 32323 10.6
FL 32324 7.3
FL 32326 2.0
FL 32327 2.0
FL 32328 10.3
FL 32329 7.0
FL 32330 4.1
FL 32331 10.0
FL 32332 2.0
FL 32333 2.0
FL 32334 10.1
FL 32335 10.1
FL 32336 2.0
FL 32337 1.0
FL 32340 7.0
FL 32341 7.0
FL 32343 2.0
FL 32344 10.1
FL 32345 10.1
FL 32346 2.0
FL 32347 7.0
FL 32348 7.0
FL 32350 10.4
FL 32351 4.1
FL 32352 2.0
FL 32353 4.1
FL 32355 2.0
FL 32356 8.0
FL 32357 10.0
FL 32358 2.0
FL 32359 8.0
FL 32360 10.1
FL 32361 2.0
FL 32362 1.0
FL 32395 1.0
FL 32399 1.0
FL 32401 1.0
FL 32402 1.0
FL 32403 1.0
FL 32404 1.0
FL 32405 1.0
FL 32406 1.0
FL 32407 1.0
FL 32408 1.0
FL 32409 1.0
FL 32410 1.0
FL 32411 1.0
FL 32412 1.0
FL 32413 1.0
FL 32417 1.0
FL 32420 8.0
FL 32421 10.6
FL 32422 8.0
FL 32423 9.0
FL 32424 7.0
FL 32425 9.0
FL 32426 9.0
FL 32427 9.0
FL 32428 7.0
FL 32430 10.6
FL 32431 10.6
FL 32432 8.0
FL 32433 8.0
FL 32434 8.0
FL 32435 7.0
FL 32437 2.0
FL 32438 2.0
FL 32439 2.0
FL 32440 10.6
FL 32442 8.0
FL 32443 8.0
FL 32444 1.0
FL 32445 9.0
FL 32446 8.0
FL 32447 8.0
FL 32448 7.0
FL 32449 10.6
FL 32452 9.0
FL 32454 10.4
FL 32455 10.5
FL 32456 7.3
FL 32457 7.3
FL 32459 10.4
FL 32460 10.6
FL 32461 1.0
FL 32462 2.0
FL 32463 7.0
FL 32464 10.0
FL 32465 10.4
FL 32466 1.0
FL 32501 1.0
FL 32502 1.0
FL 32503 1.0
FL 32504 1.0
FL 32505 1.0
FL 32506 1.0
FL 32507 1.0
FL 32508 1.0
FL 32509 1.0
FL 32511 1.0
FL 32512 1.0
FL 32513 1.0
FL 32514 1.0
FL 32516 1.0
FL 32520 1.0
FL 32521 1.0
FL 32522 1.0
FL 32523 1.0
FL 32524 1.0
FL 32526 1.0
FL 32530 2.0
FL 32531 5.1
FL 32533 1.0
FL 32534 1.0
FL 32535 9.1
FL 32536 2.0
FL 32537 2.0
FL 32538 2.0
FL 32539 2.0
FL 32540 1.0
FL 32541 1.0
FL 32542 1.0
FL 32544 1.0
FL 32547 1.0
FL 32548 1.0
FL 32549 1.0
FL 32550 10.4
FL 32559 1.0
FL 32560 1.0
FL 32561 1.0
FL 32562 1.0
FL 32563 1.0
FL 32564 5.1
FL 32565 2.0
FL 32566 1.0
FL 32567 2.0
FL 32568 2.0
FL 32569 1.0
FL 32570 1.0
FL 32571 1.0
FL 32572 1.0
FL 32573 1.0
FL 32574 1.0
FL 32575 1.0
FL 32576 1.0
FL 32577 2.0
FL 32578 1.0
FL 32579 1.0
FL 32580 1.0
FL 32581 1.0
FL 32582 1.0
FL 32583 2.0
FL 32588 1.0
FL 32589 1.0
FL 32590 1.0
FL 32591 1.0
FL 32592 1.0
FL 32593 1.0
FL 32594 1.0
FL 32595 1.0
FL 32596 1.0
FL 32597 1.0
FL 32598 1.0
FL 32601 1.0
FL 32602 1.0
FL 32603 1.0
FL 32604 1.0
FL 32605 1.0
FL 32606 1.0
FL 32607 1.0
FL 32608 1.0
FL 32609 1.0
FL 32610 1.0
FL 32611 1.0
FL 32612 1.0
FL 32613 1.0
FL 32614 1.0
FL 32615 2.0
FL 32616 2.0
FL 32617 2.0
FL 32618 2.0
FL 32619 10.4
FL 32621 2.0
FL 32622 2.0
FL 32625 10.0
FL 32626 10.0
FL 32627 1.0
FL 32628 7.0
FL 32631 2.0
FL 32633 2.0
FL 32634 2.0
FL 32635 1.0
FL 32639 10.0
FL 32640 2.0
FL 32641 1.0
FL 32643 2.0
FL 32644 10.0
FL 32648 10.6
FL 32653 1.0
FL 32654 2.0
FL 32655 2.0
FL 32656 2.0
FL 32658 2.0
FL 32662 2.0
FL 32663 2.0
FL 32664 2.0
FL 32666 2.0
FL 32667 2.0
FL 32668 3.0
FL 32669 2.0
FL 32680 7.0
FL 32681 2.0
FL 32683 10.0
FL 32686 2.0
FL 32692 7.0
FL 32693 10.4
FL 32694 2.0
FL 32696 2.0
FL 32697 7.3
FL 32701 1.0
FL 32702 1.0
FL 32703 1.0
FL 32704 1.0
FL 32706 1.1
FL 32707 1.0
FL 32708 1.0
FL 32709 1.0
FL 32710 1.0
FL 32712 1.0
FL 32713 1.1
FL 32714 1.0
FL 32715 1.0
FL 32716 1.0
FL 32718 1.0
FL 32719 1.0
FL 32720 1.1
FL 32721 1.1
FL 32722 1.1
FL 32723 1.1
FL 32724 1.1
FL 32725 1.1
FL 32726 1.0
FL 32727 1.0
FL 32728 1.1
FL 32730 1.0
FL 32732 2.0
FL 32733 1.0
FL 32735 1.0
FL 32736 3.0
FL 32738 1.1
FL 32739 1.1
FL 32744 1.1
FL 32745 1.0
FL 32746 1.0
FL 32747 1.0
FL 32750 1.0
FL 32751 1.0
FL 32752 1.0
FL 32753 1.1
FL 32754 1.0
FL 32756 1.0
FL 32757 1.0
FL 32759 1.0
FL 32762 1.0
FL 32763 1.1
FL 32764 2.0
FL 32765 1.0
FL 32766 1.0
FL 32767 3.0
FL 32768 1.0
FL 32771 1.0
FL 32772 1.0
FL 32773 1.0
FL 32774 1.1
FL 32775 1.0
FL 32776 2.0
FL 32777 1.0
FL 32778 1.0
FL 32779 1.0
FL 32780 1.0
FL 32781 1.0
FL 32782 1.0
FL 32783 1.0
FL 32784 1.0
FL 32789 1.0
FL 32790 1.0
FL 32791 1.0
FL 32792 1.0
FL 32793 1.0
FL 32794 1.0
FL 32795 1.0
FL 32796 1.0
FL 32798 1.0
FL 32799 1.0
FL 32801 1.0
FL 32802 1.0
FL 32803 1.0
FL 32804 1.0
FL 32805 1.0
FL 32806 1.0
FL 32807 1.0
FL 32808 1.0
FL 32809 1.0
FL 32810 1.0
FL 32811 1.0
FL 32812 1.0
FL 32814 1.0
FL 32815 1.0
FL 32816 1.0
FL 32817 1.0
FL 32818 1.0
FL 32819 1.0
FL 32820 1.0
FL 32821 2.0
FL 32822 1.0
FL 32824 2.0
FL 32825 1.0
FL 32826 1.0
FL 32827 1.0
FL 32828 1.0
FL 32829 1.0
FL 32830 1.0
FL 32831 2.0
FL 32832 2.0
FL 32833 2.0
FL 32834 1.0
FL 32835 1.0
FL 32836 1.0
FL 32837 2.0
FL 32839 1.0
FL 32853 1.0
FL 32854 1.0
FL 32855 1.0
FL 32856 1.0
FL 32857 1.0
FL 32858 1.0
FL 32859 1.0
FL 32860 1.0
FL 32861 1.0
FL 32862 1.0
FL 32867 1.0
FL 32868 1.0
FL 32869 1.0
FL 32872 1.0
FL 32877 2.0
FL 32878 1.0
FL 32885 1.0
FL 32886 1.0
FL 32887 2.0
FL 32890 1.0
FL 32891 1.0
FL 32893 1.0
FL 32896 1.0
FL 32897 1.0
FL 32898 1.0
FL 32899 1.0
FL 32901 1.0
FL 32902 1.0
FL 32903 1.0
FL 32904 1.0
FL 32905 1.0
FL 32906 1.0
FL 32907 1.0
FL 32908 1.0
FL 32909 1.0
FL 32910 1.0
FL 32911 1.0
FL 32912 1.0
FL 32919 1.0
FL 32920 1.0
FL 32922 1.0
FL 32923 1.0
FL 32924 1.0
FL 32925 1.0
FL 32926 1.0
FL 32927 1.0
FL 32931 1.0
FL 32932 1.0
FL 32934 1.0
FL 32935 1.0
FL 32936 1.0
FL 32937 1.0
FL 32940 1.0
FL 32941 1.0
FL 32948 2.0
FL 32949 1.0
FL 32950 2.0
FL 32951 1.0
FL 32952 1.0
FL 32953 1.0
FL 32954 1.0
FL 32955 1.0
FL 32956 1.0
FL 32957 1.0
FL 32958 1.0
FL 32959 1.0
FL 32960 1.0
FL 32961 1.0
FL 32962 1.0
FL 32963 1.0
FL 32964 1.0
FL 32965 1.0
FL 32966 1.0
FL 32967 1.0
FL 32968 1.0
FL 32969 1.0
FL 32970 1.0
FL 32971 1.0
FL 32976 1.0
FL 32978 1.0
FL 33001 7.0
FL 33002 1.0
FL 33004 1.0
FL 33008 1.0
FL 33009 1.0
FL 33010 1.0
FL 33011 1.0
FL 33012 1.0
FL 33013 1.0
FL 33014 1.0
FL 33015 1.0
FL 33016 1.0
FL 33017 1.0
FL 33018 1.0
FL 33019 1.0
FL 33020 1.0
FL 33021 1.0
FL 33022 1.0
FL 33023 1.0
FL 33024 1.0
FL 33025 1.0
FL 33026 1.0
FL 33027 1.0
FL 33028 1.0
FL 33029 1.0
FL 33030 1.0
FL 33031 2.0
FL 33032 1.0
FL 33033 1.0
FL 33034 1.0
FL 33035 1.0
FL 33036 4.0
FL 33037 4.0
FL 33039 2.0
FL 33040 4.0
FL 33041 4.0
FL 33042 7.2
FL 33043 7.2
FL 33044 7.2
FL 33045 4.0
FL 33050 7.0
FL 33051 7.0
FL 33052 7.0
FL 33054 1.0
FL 33055 1.0
FL 33056 1.0
FL 33060 1.0
FL 33061 1.0
FL 33062 1.0
FL 33063 1.0
FL 33064 1.0
FL 33065 1.0
FL 33066 1.0
FL 33067 1.0
FL 33068 1.0
FL 33069 1.0
FL 33070 4.0
FL 33071 1.0
FL 33072 1.0
FL 33073 1.0
FL 33074 1.0
FL 33075 1.0
FL 33076 1.0
FL 33077 1.0
FL 33081 1.0
FL 33082 1.0
FL 33083 1.0
FL 33084 1.0
FL 33090 1.0
FL 33092 1.0
FL 33093 1.0
FL 33097 1.0
FL 33101 1.0
FL 33102 1.0
FL 33107 1.0
FL 33109 1.0
FL 33110 1.0
FL 33111 1.0
FL 33112 1.0
FL 33114 1.0
FL 33116 1.0
FL 33119 1.0
FL 33121 1.0
FL 33122 1.0
FL 33124 1.0
FL 33125 1.0
FL 33126 1.0
FL 33127 1.0
FL 33128 1.0
FL 33129 1.0
FL 33130 1.0
FL 33131 1.0
FL 33132 1.0
FL 33133 1.0
FL 33134 1.0
FL 33135 1.0
FL 33136 1.0
FL 33137 1.0
FL 33138 1.0
FL 33139 1.0
FL 33140 1.0
FL 33141 1.0
FL 33142 1.0
FL 33143 1.0
FL 33144 1.0
FL 33145 1.0
FL 33146 1.0
FL 33147 1.0
FL 33148 1.0
FL 33149 2.0
FL 33150 1.0
FL 33151 1.0
FL 33152 1.0
FL 33153 1.0
FL 33154 1.0
FL 33155 1.0
FL 33156 1.0
FL 33157 1.0
FL 33158 1.0
FL 33159 1.0
FL 33160 1.0
FL 33161 1.0
FL 33162 1.0
FL 33163 1.0
FL 33164 1.0
FL 33165 1.0
FL 33166 1.0
FL 33167 1.0
FL 33168 1.0
FL 33169 1.0
FL 33170 1.0
FL 33172 1.0
FL 33173 1.0
FL 33174 1.0
FL 33175 1.0
FL 33176 1.0
FL 33177 1.0
FL 33178 1.0
FL 33179 1.0
FL 33180 1.0
FL 33181 1.0
FL 33182 1.0
FL 33183 1.0
FL 33184 1.0
FL 33185 1.0
FL 33186 1.0
FL 33187 1.0
FL 33188 1.0
FL 33189 1.0
FL 33190 1.0
FL 33192 1.0
FL 33193 1.0
FL 33194 1.0
FL 33195 1.0
FL 33196 1.0
FL 33197 1.0
FL 33199 1.0
FL 33231 1.0
FL 33233 1.0
FL 33234 1.0
FL 33238 1.0
FL 33239 1.0
FL 33242 1.0
FL 33243 1.0
FL 33245 1.0
FL 33247 1.0
FL 33255 1.0
FL 33256 1.0
FL 33257 1.0
FL 33261 1.0
FL 33265 1.0
FL 33266 1.0
FL 33269 1.0
FL 33280 1.0
FL 33283 1.0
FL 33296 1.0
FL 33299 1.0
FL 33301 1.0
FL 33302 1.0
FL 33303 1.0
FL 33304 1.0
FL 33305 1.0
FL 33306 1.0
FL 33307 1.0
FL 33308 1.0
FL 33309 1.0
FL 33310 1.0
FL 33311 1.0
FL 33312 1.0
FL 33313 1.0
FL 33314 1.0
FL 33315 1.0
FL 33316 1.0
FL 33317 1.0
FL 33318 1.0
FL 33319 1.0
FL 33320 1.0
FL 33321 1.0
FL 33322 1.0
FL 33323 1.0
FL 33324 1.0
FL 33325 1.0
FL 33326 1.0
FL 33327 1.0
FL 33328 1.0
FL 33329 1.0
FL 33330 1.0
FL 33331 1.0
FL 33332 1.0
FL 33334 1.0
FL 33335 1.0
FL 33336 1.0
FL 33337 1.0
FL 33338 1.0
FL 33339 1.0
FL 33340 1.0
FL 33345 1.0
FL 33346 1.0
FL 33348 1.0
FL 33349 1.0
FL 33351 1.0
FL 33355 1.0
FL 33359 1.0
FL 33388 1.0
FL 33394 1.0
FL 33401 1.0
FL 33402 1.0
FL 33403 1.0
FL 33404 1.0
FL 33405 1.0
FL 33406 1.0
FL 33407 1.0
FL 33408 1.0
FL 33409 1.0
FL 33410 1.0
FL 33411 1.0
FL 33412 1.0
FL 33413 1.0
FL 33414 1.0
FL 33415 1.0
FL 33416 1.0
FL 33417 1.0
FL 33418 1.0
FL 33419 1.0
FL 33420 1.0
FL 33421 1.0
FL 33422 1.0
FL 33424 1.0
FL 33425 1.0
FL 33426 1.0
FL 33427 1.0
FL 33428 1.0
FL 33429 1.0
FL 33430 4.1
FL 33431 1.0
FL 33432 1.0
FL 33433 1.0
FL 33434 1.0
FL 33435 1.0
FL 33436 1.0
FL 33437 1.0
FL 33438 2.0
FL 33439 2.0
FL 33440 4.2
FL 33441 1.0
FL 33442 1.0
FL 33443 1.0
FL 33444 1.0
FL 33445 1.0
FL 33446 1.0
FL 33447 1.0
FL 33448 1.0
FL 33454 1.0
FL 33455 1.0
FL 33458 1.0
FL 33459 4.1
FL 33460 1.0
FL 33461 1.0
FL 33462 1.0
FL 33463 1.0
FL 33464 1.0
FL 33465 1.0
FL 33466 1.0
FL 33467 1.0
FL 33468 1.0
FL 33469 1.0
FL 33470 1.0
FL 33471 7.4
FL 33474 1.0
FL 33475 1.0
FL 33476 2.0
FL 33477 1.0
FL 33478 2.0
FL 33480 1.0
FL 33481 1.0
FL 33482 1.0
FL 33483 1.0
FL 33484 1.0
FL 33486 1.0
FL 33487 1.0
FL 33488 1.0
FL 33493 4.1
FL 33496 1.0
FL 33497 1.0
FL 33498 1.0
FL 33499 1.0
FL 33503 2.0
FL 33508 1.0
FL 33509 1.0
FL 33510 1.0
FL 33511 1.0
FL 33513 9.0
FL 33514 10.4
FL 33521 7.3
FL 33523 2.1
FL 33524 1.1
FL 33525 1.1
FL 33526 1.1
FL 33527 1.0
FL 33530 1.0
FL 33534 1.0
FL 33537 2.1
FL 33538 9.0
FL 33539 1.1
FL 33540 1.1
FL 33541 1.1
FL 33542 1.1
FL 33543 1.0
FL 33544 2.0
FL 33547 2.0
FL 33548 1.0
FL 33549 1.0
FL 33550 1.0
FL 33556 1.0
FL 33558 1.0
FL 33559 1.0
FL 33563 1.0
FL 33564 1.0
FL 33565 1.0
FL 33566 1.0
FL 33567 1.0
FL 33568 1.0
FL 33569 1.0
FL 33570 2.0
FL 33571 2.0
FL 33572 1.0
FL 33573 2.0
FL 33574 2.0
FL 33575 2.0
FL 33576 2.0
FL 33583 1.0
FL 33584 1.0
FL 33585 10.4
FL 33586 2.0
FL 33587 1.0
FL 33592 1.0
FL 33593 2.1
FL 33594 1.0
FL 33595 1.0
FL 33597 10.4
FL 33598 2.0
FL 33601 1.0
FL 33602 1.0
FL 33603 1.0
FL 33604 1.0
FL 33605 1.0
FL 33606 1.0
FL 33607 1.0
FL 33608 1.0
FL 33609 1.0
FL 33610 1.0
FL 33611 1.0
FL 33612 1.0
FL 33613 1.0
FL 33614 1.0
FL 33615 1.0
FL 33616 1.0
FL 33617 1.0
FL 33618 1.0
FL 33619 1.0
FL 33620 1.0
FL 33621 1.0
FL 33622 1.0
FL 33623 1.0
FL 33624 1.0
FL 33625 1.0
FL 33626 1.0
FL 33629 1.0
FL 33630 1.0
FL 33631 1.0
FL 33633 1.0
FL 33634 1.0
FL 33635 1.0
FL 33637 1.0
FL 33647 1.0
FL 33650 1.0
FL 33651 1.0
FL 33655 1.0
FL 33660 1.0
FL 33661 1.0
FL 33662 1.0
FL 33663 1.0
FL 33664 1.0
FL 33672 1.0
FL 33673 1.0
FL 33674 1.0
FL 33675 1.0
FL 33677 1.0
FL 33679 1.0
FL 33680 1.0
FL 33681 1.0
FL 33682 1.0
FL 33684 1.0
FL 33685 1.0
FL 33686 1.0
FL 33687 1.0
FL 33688 1.0
FL 33689 1.0
FL 33690 1.0
FL 33694 1.0
FL 33697 1.0
FL 33701 1.0
FL 33702 1.0
FL 33703 1.0
FL 33704 1.0
FL 33705 1.0
FL 33706 1.0
FL 33707 1.0
FL 33708 1.0
FL 33709 1.0
FL 33710 1.0
FL 33711 1.0
FL 33712 1.0
FL 33713 1.0
FL 33714 1.0
FL 33715 1.0
FL 33716 1.0
FL 33728 1.0
FL 33729 1.0
FL 33730 1.0
FL 33731 1.0
FL 33732 1.0
FL 33733 1.0
FL 33734 1.0
FL 33736 1.0
FL 33737 1.0
FL 33738 1.0
FL 33740 1.0
FL 33741 1.0
FL 33742 1.0
FL 33743 1.0
FL 33744 1.0
FL 33747 1.0
FL 33755 1.0
FL 33756 1.0
FL 33757 1.0
FL 33758 1.0
FL 33759 1.0
FL 33760 1.0
FL 33761 1.0
FL 33762 1.0
FL 33763 1.0
FL 33764 1.0
FL 33765 1.0
FL 33766 1.0
FL 33767 1.0
FL 33769 1.0
FL 33770 1.0
FL 33771 1.0
FL 33772 1.0
FL 33773 1.0
FL 33774 1.0
FL 33775 1.0
FL 33776 1.0
FL 33777 1.0
FL 33778 1.0
FL 33779 1.0
FL 33780 1.0
FL 33781 1.0
FL 33782 1.0
FL 33784 1.0
FL 33785 1.0
FL 33786 1.0
FL 33801 1.0
FL 33802 1.0
FL 33803 1.0
FL 33804 1.0
FL 33805 1.0
FL 33806 1.0
FL 33807 1.0
FL 33809 1.0
FL 33810 1.0
FL 33811 1.0
FL 33813 1.0
FL 33815 1.0
FL 33820 4.2
FL 33823 1.0
FL 33825 4.0
FL 33826 4.0
FL 33827 2.0
FL 33830 4.2
FL 33831 4.2
FL 33834 4.0
FL 33835 1.0
FL 33836 2.0
FL 33837 2.0
FL 33838 1.0
FL 33839 1.0
FL 33840 1.0
FL 33841 9.2
FL 33843 7.3
FL 33844 1.0
FL 33845 1.0
FL 33846 1.0
FL 33847 4.2
FL 33848 2.1
FL 33849 1.0
FL 33850 1.0
FL 33851 1.0
FL 33852 4.0
FL 33853 1.0
FL 33854 1.0
FL 33855 1.0
FL 33856 1.0
FL 33857 5.0
FL 33858 2.0
FL 33859 2.1
FL 33860 1.0
FL 33862 4.0
FL 33863 1.0
FL 33865 4.0
FL 33867 1.0
FL 33868 2.0
FL 33870 4.0
FL 33871 4.0
FL 33872 4.0
FL 33873 4.0
FL 33875 4.0
FL 33876 5.0
FL 33877 2.1
FL 33880 1.0
FL 33881 1.0
FL 33882 1.0
FL 33883 1.0
FL 33884 1.0
FL 33885 1.0
FL 33888 1.0
FL 33890 10.2
FL 33896 2.0
FL 33897 2.0
FL 33898 2.0
FL 33901 1.0
FL 33902 1.0
FL 33903 1.0
FL 33904 1.0
FL 33905 1.0
FL 33906 1.0
FL 33907 1.0
FL 33908 1.0
FL 33909 1.0
FL 33910 1.0
FL 33911 1.0
FL 33912 1.0
FL 33913 2.0
FL 33914 1.0
FL 33915 1.0
FL 33916 1.0
FL 33917 1.0
FL 33918 1.0
FL 33919 1.0
FL 33920 2.0
FL 33921 1.0
FL 33922 2.0
FL 33924 2.0
FL 33927 1.0
FL 33928 1.0
FL 33930 4.2
FL 33931 1.0
FL 33932 1.0
FL 33935 4.2
FL 33936 2.0
FL 33938 1.0
FL 33944 7.4
FL 33945 2.0
FL 33946 1.0
FL 33947 1.0
FL 33948 1.0
FL 33949 1.0
FL 33950 1.0
FL 33951 1.0
FL 33952 1.0
FL 33953 1.0
FL 33954 1.0
FL 33955 1.0
FL 33956 2.0
FL 33957 1.0
FL 33960 4.0
FL 33965 1.0
FL 33970 2.0
FL 33971 2.0
FL 33972 2.0
FL 33975 4.2
FL 33980 1.0
FL 33981 1.0
FL 33982 1.0
FL 33983 1.0
FL 33990 1.0
FL 33991 1.0
FL 33993 2.0
FL 33994 1.0
FL 34101 1.0
FL 34102 1.0
FL 34103 1.0
FL 34104 1.0
FL 34105 1.0
FL 34106 1.0
FL 34107 1.0
FL 34108 1.0
FL 34109 1.0
FL 34110 1.0
FL 34112 1.0
FL 34113 1.0
FL 34114 1.0
FL 34116 1.0
FL 34117 1.0
FL 34119 1.0
FL 34120 1.0
FL 34133 1.0
FL 34134 1.0
FL 34135 1.0
FL 34136 1.0
FL 34137 1.0
FL 34138 2.0
FL 34139 2.0
FL 34140 1.0
FL 34141 2.0
FL 34142 4.1
FL 34143 4.1
FL 34145 4.1
FL 34146 4.1
FL 34201 1.0
FL 34202 1.0
FL 34203 1.0
FL 34204 1.0
FL 34205 1.0
FL 34206 1.0
FL 34207 1.0
FL 34208 1.0
FL 34209 1.0
FL 34210 1.0
FL 34211 2.0
FL 34212 2.0
FL 34215 1.0
FL 34216 1.0
FL 34217 1.0
FL 34218 1.0
FL 34219 1.0
FL 34220 1.0
FL 34221 1.0
FL 34222 1.0
FL 34223 1.0
FL 34224 1.0
FL 34228 1.0
FL 34229 1.0
FL 34230 1.0
FL 34231 1.0
FL 34232 1.0
FL 34233 1.0
FL 34234 1.0
FL 34235 1.0
FL 34236 1.0
FL 34237 1.0
FL 34238 1.0
FL 34239 1.0
FL 34240 1.0
FL 34241 1.0
FL 34242 1.0
FL 34243 1.0
FL 34250 1.0
FL 34251 2.0
FL 34260 1.0
FL 34264 1.0
FL 34265 4.0
FL 34266 4.0
FL 34267 4.0
FL 34268 4.0
FL 34269 5.2
FL 34270 1.0
FL 34272 1.0
FL 34274 1.0
FL 34275 1.0
FL 34276 1.0
FL 34277 1.0
FL 34278 1.0
FL 34280 1.0
FL 34281 1.0
FL 34282 1.0
FL 34284 1.0
FL 34285 1.0
FL 34286 1.0
FL 34287 1.0
FL 34288 1.0
FL 34289 1.0
FL 34292 1.0
FL 34293 1.0
FL 34295 1.0
FL 34420 2.0
FL 34421 2.0
FL 34423 4.0
FL 34428 10.5
FL 34429 4.0
FL 34430 2.0
FL 34431 2.0
FL 34432 2.0
FL 34433 10.6
FL 34434 6.1
FL 34436 5.0
FL 34442 4.0
FL 34445 4.0
FL 34446 4.0
FL 34447 4.0
FL 34448 4.0
FL 34449 10.0
FL 34450 4.0
FL 34451 4.0
FL 34452 4.0
FL 34453 4.0
FL 34460 4.0
FL 34461 4.0
FL 34464 4.0
FL 34465 4.0
FL 34470 1.0
FL 34471 1.0
FL 34472 1.0
FL 34473 2.0
FL 34474 1.0
FL 34475 1.0
FL 34476 2.0
FL 34477 1.0
FL 34478 1.0
FL 34479 1.0
FL 34480 1.0
FL 34481 2.0
FL 34482 1.0
FL 34483 1.0
FL 34484 9.0
FL 34487 4.0
FL 34488 2.0
FL 34489 2.0
FL 34491 2.0
FL 34492 2.0
FL 34498 10.0
FL 34601 1.0
FL 34602 2.1
FL 34603 1.0
FL 34604 1.0
FL 34605 1.0
FL 34606 1.0
FL 34607 1.0
FL 34608 1.0
FL 34609 1.0
FL 34610 1.0
FL 34611 1.0
FL 34613 1.0
FL 34614 2.1
FL 34636 1.0
FL 34637 1.0
FL 34638 1.0
FL 34639 1.0
FL 34652 1.0
FL 34653 1.0
FL 34654 1.0
FL 34655 1.0
FL 34656 1.0
FL 34660 1.0
FL 34661 1.0
FL 34667 1.0
FL 34668 1.0
FL 34669 1.0
FL 34673 1.0
FL 34674 1.0
FL 34677 1.0
FL 34679 1.0
FL 34680 1.0
FL 34681 1.0
FL 34682 1.0
FL 34683 1.0
FL 34684 1.0
FL 34685 1.0
FL 34688 1.0
FL 34689 1.0
FL 34690 1.0
FL 34691 1.0
FL 34692 1.0
FL 34695 1.0
FL 34697 1.0
FL 34698 1.0
FL 34705 1.0
FL 34711 2.0
FL 34712 2.0
FL 34713 2.0
FL 34714 2.0
FL 34715 2.0
FL 34729 2.0
FL 34731 1.0
FL 34734 1.0
FL 34736 2.0
FL 34737 1.0
FL 34739 2.1
FL 34740 1.0
FL 34741 2.0
FL 34742 2.0
FL 34743 2.0
FL 34744 2.0
FL 34745 2.0
FL 34746 2.0
FL 34747 2.0
FL 34748 1.0
FL 34749 1.0
FL 34753 2.0
FL 34755 2.0
FL 34756 2.0
FL 34758 2.1
FL 34759 2.1
FL 34760 1.0
FL 34761 1.0
FL 34762 1.0
FL 34769 2.0
FL 34770 2.0
FL 34771 2.1
FL 34772 2.0
FL 34773 2.1
FL 34777 1.0
FL 34778 1.0
FL 34785 7.3
FL 34786 1.0
FL 34787 1.0
FL 34788 1.0
FL 34789 1.0
FL 34797 1.0
FL 34945 2.0
FL 34946 1.0
FL 34947 1.0
FL 34948 1.0
FL 34949 1.0
FL 34950 1.0
FL 34951 1.0
FL 34952 1.0
FL 34953 1.0
FL 34954 1.0
FL 34956 2.0
FL 34957 1.0
FL 34958 1.0
FL 34972 4.0
FL 34973 4.0
FL 34974 4.0
FL 34979 1.0
FL 34981 1.0
FL 34982 1.0
FL 34983 1.0
FL 34984 1.0
FL 34985 1.0
FL 34986 1.0
FL 34987 2.0
FL 34988 2.0
FL 34990 1.0
FL 34991 1.0
FL 34992 1.0
FL 34994 1.0
FL 34995 1.0
FL 34996 1.0
FL 34997 1.0
FM 96941 R
FM 96942 R
FM 96943 R
FM 96944 R
GA 30002 1.0
GA 30003 1.0
GA 30004 1.0
GA 30005 1.0
GA 30006 1.0
GA 30007 1.0
GA 30008 1.0
GA 30009 1.0
GA 30010 1.0
GA 30011 1.0
GA 30012 1.0
GA 30013 1.0
GA 30014 1.0
GA 30015 1.0
GA 30016 1.0
GA 30017 1.0
GA 30018 1.0
GA 30019 1.0
GA 30021 1.0
GA 30022 1.0
GA 30023 1.0
GA 30024 1.0
GA 30025 2.0
GA 30026 1.0
GA 30028 1.0
GA 30029 1.0
GA 30030 1.0
GA 30031 1.0
GA 30032 1.0
GA 30033 1.0
GA 30034 1.0
GA 30035 1.0
GA 30036 1.0
GA 30037 1.0
GA 30038 1.0
GA 30039 1.0
GA 30040 1.0
GA 30041 1.0
GA 30042 1.0
GA 30043 1.0
GA 30044 1.0
GA 30045 1.0
GA 30046 1.0
GA 30047 1.0
GA 30048 1.0
GA 30049 1.0
GA 30052 1.0
GA 30054 2.0
GA 30055 2.0
GA 30056 2.0
GA 30058 1.0
GA 30060 1.0
GA 30061 1.0
GA 30062 1.0
GA 30063 1.0
GA 30064 1.0
GA 30065 1.0
GA 30066 1.0
GA 30067 1.0
GA 30068 1.0
GA 30069 1.0
GA 30070 1.0
GA 30071 1.0
GA 30072 1.0
GA 30074 1.0
GA 30075 1.0
GA 30076 1.0
GA 30077 1.0
GA 30078 1.0
GA 30079 1.0
GA 30080 1.0
GA 30081 1.0
GA 30082 1.0
GA 30083 1.0
GA 30084 1.0
GA 30085 1.0
GA 30086 1.0
GA 30087 1.0
GA 30088 1.0
GA 30090 1.0
GA 30091 1.0
GA 30092 1.0
GA 30093 1.0
GA 30094 1.0
GA 30095 1.0
GA 30096 1.0
GA 30097 1.0
GA 30098 1.0
GA 30099 1.0
GA 30101 1.0
GA 30102 1.0
GA 30103 5.0
GA 30104 9.2
GA 30105 1.0
GA 30106 1.0
GA 30107 2.0
GA 30108 5.0
GA 30109 4.2
GA 30110 3.0
GA 30111 1.0
GA 30112 4.2
GA 30113 3.0
GA 30114 1.0
GA 30115 1.0
GA 30116 4.2
GA 30117 4.2
GA 30118 4.2
GA 30119 4.2
GA 30120 4.1
GA 30121 4.1
GA 30122 1.0
GA 30123 4.1
GA 30124 2.0
GA 30125 4.2
GA 30126 1.0
GA 30127 1.0
GA 30129 1.0
GA 30132 2.0
GA 30133 1.0
GA 30134 1.0
GA 30135 1.0
GA 30137 1.0
GA 30138 4.2
GA 30139 5.0
GA 30140 3.0
GA 30141 1.0
GA 30142 1.0
GA 30143 2.0
GA 30144 1.0
GA 30145 4.1
GA 30146 1.0
GA 30147 1.0
GA 30148 2.0
GA 30149 1.0
GA 30150 4.2
GA 30151 2.0
GA 30152 1.0
GA 30153 7.3
GA 30154 1.0
GA 30156 1.0
GA 30157 1.0
GA 30160 1.0
GA 30161 1.0
GA 30162 1.0
GA 30163 1.0
GA 30164 1.0
GA 30165 1.0
GA 30168 1.0
GA 30169 1.0
GA 30170 5.2
GA 30171 5.1
GA 30172 1.0
GA 30173 1.0
GA 30175 2.0
GA 30176 10.0
GA 30177 2.0
GA 30178 4.1
GA 30179 2.0
GA 30180 2.0
GA 30182 10.4
GA 30183 2.0
GA 30184 5.1
GA 30185 2.0
GA 30187 2.0
GA 30188 1.0
GA 30189 1.0
GA 30204 7.1
GA 30205 2.0
GA 30206 2.0
GA 30212 1.0
GA 30213 1.0
GA 30214 1.0
GA 30215 1.0
GA 30216 2.0
GA 30217 6.0
GA 30218 2.0
GA 30219 6.0
GA 30220 5.1
GA 30222 10.5
GA 30223 1.0
GA 30224 1.0
GA 30228 1.0
GA 30229 2.0
GA 30230 5.0
GA 30232 1.0
GA 30233 2.0
GA 30234 2.0
GA 30236 1.0
GA 30237 1.0
GA 30238 1.0
GA 30240 4.0
GA 30241 4.0
GA 30248 2.0
GA 30250 1.0
GA 30251 5.2
GA 30252 1.0
GA 30253 1.0
GA 30256 2.0
GA 30257 2.0
GA 30258 2.0
GA 30259 5.1
GA 30260 1.0
GA 30261 4.0
GA 30263 4.1
GA 30264 4.1
GA 30265 1.0
GA 30266 1.0
GA 30268 2.0
GA 30269 1.0
GA 30270 1.0
GA 30271 4.1
GA 30272 1.0
GA 30273 1.0
GA 30274 1.0
GA 30275 4.1
GA 30276 2.0
GA 30277 1.0
GA 30281 1.0
GA 30284 1.0
GA 30285 5.2
GA 30286 4.2
GA 30287 1.0
GA 30288 1.0
GA 30289 2.0
GA 30290 1.0
GA 30291 1.0
GA 30292 2.0
GA 30293 10.4
GA 30294 1.0
GA 30295 2.0
GA 30296 1.0
GA 30297 1.0
GA 30298 1.0
GA 30301 1.0
GA 30302 1.0
GA 30303 1.0
GA 30304 1.0
GA 30305 1.0
GA 30306 1.0
GA 30307 1.0
GA 30308 1.0
GA 30309 1.0
GA 30310 1.0
GA 30311 1.0
GA 30312 1.0
GA 30313 1.0
GA 30314 1.0
GA 30315 1.0
GA 30316 1.0
GA 30317 1.0
GA 30318 1.0
GA 30319 1.0
GA 30320 1.0
GA 30321 1.0
GA 30322 1.0
GA 30324 1.0
GA 30325 1.0
GA 30326 1.0
GA 30327 1.0
GA 30328 1.0
GA 30329 1.0
GA 30330 1.0
GA 30331 1.0
GA 30332 1.0
GA 30333 1.0
GA 30334 1.0
GA 30336 1.0
GA 30337 1.0
GA 30338 1.0
GA 30339 1.0
GA 30340 1.0
GA 30341 1.0
GA 30342 1.0
GA 30343 1.0
GA 30344 1.0
GA 30345 1.0
GA 30346 1.0
GA 30347 1.0
GA 30348 1.0
GA 30349 1.0
GA 30350 1.0
GA 30353 1.0
GA 30354 1.0
GA 30355 1.0
GA 30356 1.0
GA 30357 1.0
GA 30358 1.0
GA 30359 1.0
GA 30360 1.0
GA 30361 1.0
GA 30362 1.0
GA 30363 1.0
GA 30364 1.0
GA 30366 1.0
GA 30368 1.0
GA 30369 1.0
GA 30370 1.0
GA 30371 1.0
GA 30374 1.0
GA 30375 1.0
GA 30376 1.0
GA 30377 1.0
GA 30378 1.0
GA 30379 1.0
GA 30380 1.0
GA 30384 1.0
GA 30385 1.0
GA 30386 1.0
GA 30387 1.0
GA 30388 1.0
GA 30389 1.0
GA 30390 1.0
GA 30392 1.0
GA 30394 1.0
GA 30396 1.0
GA 30398 1.0
GA 30399 1.0
GA 30401 7.0
GA 30410 10.6
GA 30411 10.6
GA 30412 9.0
GA 30413 7.0
GA 30414 7.0
GA 30415 5.0
GA 30417 7.0
GA 30420 10.6
GA 30421 10.6
GA 30423 7.0
GA 30424 8.0
GA 30425 10.6
GA 30426 10.6
GA 30427 7.3
GA 30428 10.6
GA 30429 7.0
GA 30434 7.0
GA 30436 8.0
GA 30438 10.0
GA 30439 7.0
GA 30441 9.0
GA 30442 7.0
GA 30445 10.6
GA 30446 9.2
GA 30447 5.0
GA 30448 7.0
GA 30449 9.2
GA 30450 5.0
GA 30451 7.0
GA 30452 5.0
GA 30453 10.0
GA 30454 4.0
GA 30455 9.2
GA 30456 10.6
GA 30457 7.4
GA 30458 4.0
GA 30459 4.0
GA 30460 4.0
GA 30461 4.0
GA 30464 10.6
GA 30467 8.0
GA 30470 8.0
GA 30471 10.6
GA 30473 9.0
GA 30474 7.0
GA 30475 7.0
GA 30477 10.6
GA 30499 10.0
GA 30501 1.0
GA 30502 1.0
GA 30503 1.0
GA 30504 1.0
GA 30506 1.0
GA 30507 1.0
GA 30510 4.2
GA 30511 5.2
GA 30512 10.0
GA 30513 10.4
GA 30514 10.0
GA 30515 1.0
GA 30516 10.6
GA 30517 2.0
GA 30518 1.0
GA 30519 1.0
GA 30520 7.0
GA 30521 10.5
GA 30522 8.0
GA 30523 6.0
GA 30525 10.0
GA 30527 2.1
GA 30528 10.4
GA 30529 7.3
GA 30530 7.1
GA 30531 4.2
GA 30533 9.1
GA 30534 2.0
GA 30535 4.2
GA 30536 4.2
GA 30537 10.0
GA 30538 5.0
GA 30539 7.3
GA 30540 8.0
GA 30541 10.0
GA 30542 1.0
GA 30543 1.0
GA 30544 4.2
GA 30545 10.0
GA 30546 10.0
GA 30547 10.4
GA 30548 2.0
GA 30549 10.4
GA 30552 10.0
GA 30553 10.5
GA 30554 2.1
GA 30555 10.0
GA 30557 5.0
GA 30558 3.0
GA 30559 10.0
GA 30560 10.0
GA 30562 10.0
GA 30563 4.2
GA 30564 2.0
GA 30565 2.0
GA 30566 1.0
GA 30567 2.0
GA 30568 10.0
GA 30571 10.0
GA 30572 10.0
GA 30573 10.0
GA 30575 2.0
GA 30576 10.0
GA 30577 4.0
GA 30580 6.0
GA 30581 10.0
GA 30582 10.0
GA 30596 4.2
GA 30597 9.1
GA 30598 4.0
GA 30599 7.3
GA 30601 1.0
GA 30602 1.0
GA 30603 1.0
GA 30604 1.0
GA 30605 1.0
GA 30606 1.0
GA 30607 1.0
GA 30608 1.0
GA 30609 1.0
GA 30612 1.0
GA 30619 2.0
GA 30620 2.0
GA 30621 2.0
GA 30622 1.0
GA 30623 2.0
GA 30624 10.6
GA 30625 8.0
GA 30627 2.0
GA 30628 2.0
GA 30629 2.0
GA 30630 2.0
GA 30631 10.6
GA 30633 2.0
GA 30634 7.0
GA 30635 8.0
GA 30638 1.0
GA 30639 7.0
GA 30641 2.0
GA 30642 7.0
GA 30643 7.0
GA 30645 2.0
GA 30646 2.0
GA 30647 2.0
GA 30648 2.0
GA 30650 7.3
GA 30655 4.1
GA 30656 2.0
GA 30660 8.0
GA 30662 7.0
GA 30663 2.0
GA 30664 10.6
GA 30665 10.6
GA 30666 2.0
GA 30667 2.0
GA 30668 8.0
GA 30669 8.0
GA 30671 2.0
GA 30673 7.0
GA 30677 1.0
GA 30678 10.6
GA 30680 2.0
GA 30683 1.0
GA 30701 4.2
GA 30703 4.2
GA 30705 2.0
GA 30707 1.0
GA 30708 2.0
GA 30710 1.0
GA 30711 2.0
GA 30719 1.0
GA 30720 1.0
GA 30721 1.0
GA 30722 1.0
GA 30724 2.0
GA 30725 1.0
GA 30726 1.0
GA 30728 8.3
GA 30730 5.0
GA 30731 10.5
GA 30732 5.2
GA 30733 5.0
GA 30734 5.2
GA 30735 5.2
GA 30736 1.0
GA 30738 2.0
GA 30739 2.0
GA 30740 1.0
GA 30741 1.0
GA 30742 1.0
GA 30746 5.2
GA 30747 4.0
GA 30750 1.0
GA 30751 2.0
GA 30752 2.0
GA 30753 4.0
GA 30755 1.0
GA 30756 1.0
GA 30757 2.0
GA 30802 2.0
GA 30803 10.0
GA 30805 2.0
GA 30806 8.1
GA 30807 10.6
GA 30808 8.1
GA 30809 1.0
GA 30810 10.4
GA 30811 2.0
GA 30812 1.0
GA 30813 1.0
GA 30814 2.0
GA 30815 1.0
GA 30816 2.0
GA 30817 3.0
GA 30818 10.4
GA 30819 7.3
GA 30820 10.4
GA 30821 9.0
GA 30822 7.0
GA 30823 10.0
GA 30824 7.3
GA 30828 10.6
GA 30830 7.3
GA 30833 10.4
GA 30901 1.0
GA 30903 1.0
GA 30904 1.0
GA 30905 1.0
GA 30906 1.0
GA 30907 1.0
GA 30909 1.0
GA 30910 1.0
GA 30911 1.0
GA 30912 1.0
GA 30913 1.0
GA 30914 1.0
GA 30916 1.0
GA 30917 1.0
GA 30919 1.0
GA 30999 1.0
GA 31001 10.5
GA 31002 5.0
GA 31003 10.0
GA 31004 1.0
GA 31005 1.0
GA 31006 10.0
GA 31007 10.6
GA 31008 1.0
GA 31009 5.0
GA 31010 4.0
GA 31011 9.0
GA 31012 10.5
GA 31013 7.1
GA 31014 7.0
GA 31015 4.0
GA 31016 2.0
GA 31017 2.0
GA 31018 8.0
GA 31019 5.0
GA 31020 2.0
GA 31021 4.0
GA 31022 5.0
GA 31023 7.0
GA 31024 7.0
GA 31025 2.0
GA 31026 7.0
GA 31027 4.0
GA 31028 1.0
GA 31029 9.1
GA 31030 4.2
GA 31031 10.5
GA 31032 2.0
GA 31033 2.0
GA 31034 4.0
GA 31035 8.0
GA 31036 7.0
GA 31037 7.0
GA 31038 10.0
GA 31039 10.0
GA 31040 4.0
GA 31041 10.6
GA 31042 10.5
GA 31044 2.0
GA 31045 10.0
GA 31046 2.0
GA 31047 7.1
GA 31049 5.0
GA 31050 2.0
GA 31051 7.4
GA 31052 2.0
GA 31054 10.5
GA 31055 7.0
GA 31057 6.0
GA 31058 2.0
GA 31059 4.0
GA 31060 10.6
GA 31061 4.0
GA 31062 4.0
GA 31063 7.0
GA 31064 10.1
GA 31065 5.0
GA 31066 10.1
GA 31067 7.0
GA 31068 7.0
GA 31069 7.1
GA 31070 10.6
GA 31071 10.5
GA 31072 5.0
GA 31075 5.0
GA 31076 10.0
GA 31077 10.6
GA 31078 10.1
GA 31079 10.5
GA 31081 10.0
GA 31082 7.0
GA 31083 7.0
GA 31084 5.0
GA 31085 2.0
GA 31086 9.1
GA 31087 7.4
GA 31088 1.0
GA 31089 7.0
GA 31090 10.0
GA 31091 10.6
GA 31092 7.4
GA 31093 1.0
GA 31094 8.4
GA 31095 1.0
GA 31096 10.5
GA 31097 5.2
GA 31098 1.0
GA 31099 1.0
GA 31106 1.0
GA 31107 1.0
GA 31119 1.0
GA 31126 1.0
GA 31131 1.0
GA 31132 1.0
GA 31139 1.0
GA 31141 1.0
GA 31145 1.0
GA 31146 1.0
GA 31150 1.0
GA 31156 1.0
GA 31191 1.0
GA 31192 1.0
GA 31193 1.0
GA 31195 1.0
GA 31196 1.0
GA 31197 1.0
GA 31198 1.0
GA 31199 1.0
GA 31201 1.0
GA 31202 1.0
GA 31203 1.0
GA 31204 1.0
GA 31205 1.0
GA 31206 1.0
GA 31207 1.0
GA 31208 1.0
GA 31209 1.0
GA 31210 1.0
GA 31211 1.0
GA 31212 1.0
GA 31213 1.0
GA 31216 1.0
GA 31217 1.0
GA 31220 1.0
GA 31221 1.0
GA 31294 1.0
GA 31295 1.0
GA 31296 1.0
GA 31297 1.0
GA 31298 1.0
GA 31299 1.0
GA 31301 1.0
GA 31302 2.0
GA 31303 2.0
GA 31304 2.0
GA 31305 7.1
GA 31307 2.0
GA 31308 2.0
GA 31309 2.0
GA 31310 1.0
GA 31312 2.0
GA 31313 1.0
GA 31314 1.0
GA 31315 1.0
GA 31316 2.0
GA 31318 2.0
GA 31319 2.0
GA 31320 2.0
GA 31321 2.0
GA 31322 2.0
GA 31323 10.4
GA 31324 2.0
GA 31326 2.0
GA 31327 2.0
GA 31328 2.0
GA 31329 2.0
GA 31331 10.4
GA 31333 1.0
GA 31401 1.0
GA 31402 1.0
GA 31403 1.0
GA 31404 1.0
GA 31405 1.0
GA 31406 1.0
GA 31407 1.0
GA 31408 1.0
GA 31409 1.0
GA 31410 1.0
GA 31411 1.0
GA 31412 1.0
GA 31414 1.0
GA 31415 1.0
GA 31416 1.0
GA 31418 1.0
GA 31419 1.0
GA 31420 1.0
GA 31421 1.0
GA 31422 1.0
GA 31498 1.0
GA 31499 1.0
GA 31501 4.0
GA 31502 4.0
GA 31503 4.0
GA 31510 7.0
GA 31512 5.0
GA 31513 7.0
GA 31515 7.0
GA 31516 5.0
GA 31518 10.3
GA 31519 5.0
GA 31520 1.0
GA 31521 1.0
GA 31522 1.0
GA 31523 2.0
GA 31524 1.0
GA 31525 1.0
GA 31527 2.0
GA 31532 8.0
GA 31533 4.0
GA 31534 4.0
GA 31535 5.0
GA 31537 7.4
GA 31539 7.0
GA 31542 5.0
GA 31543 10.4
GA 31544 8.0
GA 31545 4.0
GA 31546 4.0
GA 31547 4.0
GA 31548 4.0
GA 31549 10.6
GA 31550 4.0
GA 31551 6.0
GA 31552 4.0
GA 31553 10.4
GA 31554 5.0
GA 31555 5.0
GA 31556 10.5
GA 31557 10.5
GA 31558 4.0
GA 31560 5.0
GA 31561 1.0
GA 31562 3.0
GA 31563 10.3
GA 31564 4.0
GA 31565 2.0
GA 31566 2.0
GA 31567 5.0
GA 31568 2.0
GA 31569 5.0
GA 31598 4.0
GA 31599 4.0
GA 31601 1.0
GA 31602 1.0
GA 31603 1.0
GA 31604 1.0
GA 31605 2.0
GA 31606 2.0
GA 31620 7.3
GA 31622 10.6
GA 31623 7.0
GA 31624 10.0
GA 31625 2.0
GA 31626 5.0
GA 31627 7.3
GA 31629 8.0
GA 31630 7.0
GA 31631 7.0
GA 31632 2.0
GA 31634 7.0
GA 31635 10.4
GA 31636 2.0
GA 31637 5.0
GA 31638 2.0
GA 31639 7.0
GA 31641 2.0
GA 31642 10.5
GA 31643 7.3
GA 31645 9.1
GA 31647 7.3
GA 31648 2.0
GA 31649 2.0
GA 31650 10.0
GA 31698 1.0
GA 31699 2.0
GA 31701 1.0
GA 31702 1.0
GA 31703 1.0
GA 31704 10.4
GA 31705 1.0
GA 31706 1.0
GA 31707 1.0
GA 31708 1.0
GA 31709 4.0
GA 31710 4.0
GA 31711 5.0
GA 31712 5.0
GA 31714 7.4
GA 31716 2.0
GA 31719 4.0
GA 31720 5.0
GA 31721 1.0
GA 31722 5.0
GA 31727 4.0
GA 31730 7.3
GA 31733 5.0
GA 31735 5.0
GA 31738 5.0
GA 31739 7.0
GA 31743 5.0
GA 31744 5.0
GA 31747 5.0
GA 31749 5.0
GA 31750 4.0
GA 31753 4.0
GA 31756 5.0
GA 31757 4.0
GA 31758 4.0
GA 31760 5.0
GA 31763 1.0
GA 31764 5.0
GA 31765 5.0
GA 31768 4.0
GA 31769 7.4
GA 31771 5.0
GA 31772 2.0
GA 31773 5.0
GA 31774 7.4
GA 31775 5.0
GA 31776 4.0
GA 31778 5.0
GA 31779 7.0
GA 31780 5.0
GA 31781 9.1
GA 31782 1.0
GA 31783 9.0
GA 31784 10.6
GA 31787 2.0
GA 31788 5.0
GA 31789 9.1
GA 31790 9.0
GA 31791 7.1
GA 31792 4.0
GA 31793 5.0
GA 31794 4.0
GA 31795 5.0
GA 31796 2.0
GA 31798 7.4
GA 31799 4.0
GA 31801 2.0
GA 31803 10.4
GA 31804 2.0
GA 31805 2.0
GA 31806 10.5
GA 31807 2.0
GA 31808 2.0
GA 31810 2.0
GA 31811 2.0
GA 31812 2.0
GA 31814 3.0
GA 31815 10.4
GA 31816 7.0
GA 31820 2.0
GA 31821 3.0
GA 31822 6.0
GA 31823 3.0
GA 31824 10.5
GA 31825 10.4
GA 31826 3.0
GA 31827 10.4
GA 31829 2.0
GA 31830 10.6
GA 31831 2.0
GA 31832 10.0
GA 31833 4.0
GA 31836 8.3
GA 31901 1.0
GA 31902 1.0
GA 31903 1.0
GA 31904 1.0
GA 31905 1.0
GA 31906 1.0
GA 31907 1.0
GA 31908 1.0
GA 31909 1.0
GA 31914 1.0
GA 31917 1.0
GA 31993 1.0
GA 31994 1.0
GA 31995 1.0
GA 31997 1.0
GA 31998 1.0
GA 31999 1.0
GA 39813 10.4
GA 39815 5.0
GA 39817 4.0
GA 39818 4.0
GA 39819 4.0
GA 39823 7.0
GA 39824 10.6
GA 39825 5.0
GA 39826 2.0
GA 39827 7.4
GA 39828 7.4
GA 39829 7.4
GA 39832 10.6
GA 39834 5.0
GA 39836 7.0
GA 39837 10.0
GA 39840 7.0
GA 39841 10.6
GA 39842 7.3
GA 39845 7.4
GA 39846 10.4
GA 39851 10.0
GA 39852 4.0
GA 39854 7.0
GA 39859 5.0
GA 39861 10.6
GA 39862 2.0
GA 39866 2.0
GA 39867 8.0
GA 39870 2.0
GA 39877 2.0
GA 39885 10.6
GA 39886 10.6
GA 39897 8.0
GA 39901 1.0
GU 96911 R
GU 96912 R
GU 96913 R
GU 96914 R
GU 96915 R
GU 96916 R
GU 96917 R
GU 96918 R
GU 96919 R
GU 96921 R
GU 96922 R
GU 96923 R
GU 96925 R
GU 96926 R
GU 96927 R
GU 96928 R
GU 96929 R
GU 96930 R
GU 96931 R
GU 96932 R
HI 96701 1.0
HI 96703 5.0
HI 96704 10.2
HI 96705 4.0
HI 96706 1.0
HI 96707 1.0
HI 96708 4.0
HI 96709 1.0
HI 96710 4.0
HI 96712 2.0
HI 96713 10.0
HI 96714 10.5
HI 96715 4.0
HI 96716 4.0
HI 96717 4.1
HI 96718 10.5
HI 96719 7.0
HI 96720 4.0
HI 96721 4.0
HI 96722 10.5
HI 96725 7.2
HI 96726 10.2
HI 96727 7.0
HI 96728 4.0
HI 96729 10.6
HI 96730 4.1
HI 96731 2.0
HI 96732 4.0
HI 96733 4.0
HI 96734 2.0
HI 96737 10.2
HI 96738 7.0
HI 96739 4.0
HI 96740 4.0
HI 96741 4.0
HI 96742 10.0
HI 96743 8.0
HI 96744 2.0
HI 96745 4.0
HI 96746 5.0
HI 96747 4.0
HI 96748 7.0
HI 96749 4.0
HI 96750 4.0
HI 96751 5.0
HI 96752 7.2
HI 96753 4.0
HI 96754 10.5
HI 96755 7.0
HI 96756 4.0
HI 96757 10.6
HI 96759 1.0
HI 96760 4.0
HI 96761 4.0
HI 96762 4.1
HI 96763 7.0
HI 96764 5.0
HI 96765 4.0
HI 96766 4.0
HI 96767 4.0
HI 96768 4.0
HI 96769 4.0
HI 96770 10.6
HI 96771 5.0
HI 96772 10.5
HI 96773 5.0
HI 96774 5.0
HI 96776 10.6
HI 96777 10.5
HI 96778 5.0
HI 96779 5.0
HI 96780 5.0
HI 96781 4.0
HI 96782 1.0
HI 96783 4.0
HI 96784 4.0
HI 96785 5.0
HI 96786 1.0
HI 96788 4.0
HI 96789 1.0
HI 96790 4.0
HI 96791 2.0
HI 96792 1.0
HI 96793 4.0
HI 96795 2.0
HI 96796 7.2
HI 96797 1.0
HI 96801 1.0
HI 96802 1.0
HI 96803 1.0
HI 96804 1.0
HI 96805 1.0
HI 96806 1.0
HI 96807 1.0
HI 96808 1.0
HI 96809 1.0
HI 96810 1.0
HI 96811 1.0
HI 96812 1.0
HI 96813 1.0
HI 96814 1.0
HI 96815 1.0
HI 96816 1.0
HI 96817 1.0
HI 96818 1.0
HI 96819 1.0
HI 96820 1.0
HI 96821 1.0
HI 96822 1.0
HI 96823 1.0
HI 96824 1.0
HI 96825 1.0
HI 96826 1.0
HI 96827 1.0
HI 96828 1.0
HI 96830 1.0
HI 96835 1.0
HI 96836 1.0
HI 96837 1.0
HI 96838 1.0
HI 96839 1.0
HI 96840 1.0
HI 96841 1.0
HI 96842 1.0
HI 96843 1.0
HI 96844 1.0
HI 96846 1.0
HI 96847 1.0
HI 96848 1.0
HI 96849 1.0
HI 96850 1.0
HI 96853 1.0
HI 96854 1.0
HI 96857 1.0
HI 96858 1.0
HI 96859 1.0
HI 96860 1.0
HI 96861 1.0
HI 96862 2.0
HI 96863 2.0
HI 96898 1.0
IA 50001 2.0
IA 50002 10.4
IA 50003 2.0
IA 50005 5.0
IA 50006 10.6
IA 50007 2.0
IA 50008 10.0
IA 50009 1.0
IA 50010 1.0
IA 50011 1.0
IA 50012 1.0
IA 50013 1.0
IA 50014 1.0
IA 50015 1.0
IA 50020 8.0
IA 50021 1.0
IA 50022 7.0
IA 50023 7.0
IA 50025 10.0
IA 50026 10.4
IA 50027 5.0
IA 50028 2.0
IA 50029 10.0
IA 50031 10.5
IA 50032 1.0
IA 50033 2.0
IA 50034 8.0
IA 50035 1.0
IA 50036 4.2
IA 50037 4.2
IA 50038 1.0
IA 50039 2.0
IA 50040 10.5
IA 50041 10.6
IA 50042 10.6
IA 50043 10.6
IA 50044 9.0
IA 50046 2.1
IA 50047 2.0
IA 50048 10.0
IA 50049 7.0
IA 50050 10.6
IA 50051 10.5
IA 50052 10.0
IA 50054 2.0
IA 50055 3.0
IA 50056 3.0
IA 50057 3.0
IA 50058 10.6
IA 50059 7.0
IA 50060 10.0
IA 50061 1.0
IA 50062 3.0
IA 50063 2.0
IA 50064 10.6
IA 50065 10.6
IA 50066 2.0
IA 50067 10.0
IA 50068 8.0
IA 50069 1.0
IA 50070 2.0
IA 50071 10.6
IA 50072 2.0
IA 50073 2.0
IA 50074 10.0
IA 50075 10.4
IA 50076 10.6
IA 50078 4.0
IA 50101 10.6
IA 50102 10.6
IA 50103 10.6
IA 50104 10.0
IA 50105 1.0
IA 50106 5.0
IA 50107 10.6
IA 50108 10.0
IA 50109 2.0
IA 50110 10.0
IA 50111 1.0
IA 50112 7.0
IA 50115 10.4
IA 50116 9.0
IA 50117 10.0
IA 50118 2.0
IA 50119 9.0
IA 50120 5.0
IA 50122 10.0
IA 50123 10.0
IA 50124 2.1
IA 50125 4.1
IA 50126 7.0
IA 50127 2.0
IA 50128 10.4
IA 50129 7.0
IA 50130 10.4
IA 50131 1.0
IA 50132 8.0
IA 50133 10.0
IA 50134 2.1
IA 50135 5.0
IA 50136 10.0
IA 50137 10.5
IA 50138 7.3
IA 50139 2.0
IA 50140 10.0
IA 50141 5.0
IA 50142 4.0
IA 50143 10.5
IA 50144 10.6
IA 50145 2.0
IA 50146 2.0
IA 50147 10.0
IA 50148 5.0
IA 50149 8.0
IA 50150 9.0
IA 50151 8.0
IA 50152 2.0
IA 50153 10.5
IA 50154 2.0
IA 50155 2.0
IA 50156 2.0
IA 50157 10.6
IA 50158 4.0
IA 50160 2.0
IA 50161 3.0
IA 50162 5.0
IA 50163 3.0
IA 50164 10.4
IA 50165 10.0
IA 50166 2.0
IA 50167 2.0
IA 50168 2.0
IA 50169 2.0
IA 50170 6.1
IA 50171 10.6
IA 50173 10.6
IA 50174 8.0
IA 50177 7.0
IA 50197 7.3
IA 50198 7.3
IA 50201 2.0
IA 50206 10.0
IA 50207 10.5
IA 50208 4.0
IA 50210 2.0
IA 50211 1.0
IA 50212 10.5
IA 50213 7.3
IA 50214 10.4
IA 50216 10.4
IA 50217 10.6
IA 50218 2.0
IA 50219 7.0
IA 50220 7.3
IA 50222 2.0
IA 50223 10.5
IA 50225 10.4
IA 50226 2.0
IA 50227 10.6
IA 50228 2.0
IA 50229 2.0
IA 50230 10.6
IA 50231 10.4
IA 50232 6.1
IA 50233 2.0
IA 50234 5.0
IA 50235 10.6
IA 50236 2.0
IA 50237 2.0
IA 50238 8.0
IA 50239 10.5
IA 50240 2.0
IA 50241 2.0
IA 50242 8.0
IA 50243 2.0
IA 50244 2.1
IA 50246 10.6
IA 50247 10.5
IA 50248 2.0
IA 50249 10.6
IA 50250 10.4
IA 50251 10.5
IA 50252 10.4
IA 50254 8.0
IA 50255 10.0
IA 50256 9.0
IA 50257 2.0
IA 50258 10.0
IA 50259 10.0
IA 50261 1.0
IA 50262 10.6
IA 50263 1.0
IA 50264 10.6
IA 50265 1.0
IA 50266 1.0
IA 50268 10.0
IA 50269 10.0
IA 50271 8.0
IA 50272 8.0
IA 50273 7.1
IA 50274 8.0
IA 50275 8.0
IA 50276 2.0
IA 50277 10.4
IA 50278 2.0
IA 50301 1.0
IA 50302 1.0
IA 50303 1.0
IA 50304 1.0
IA 50305 1.0
IA 50306 1.0
IA 50307 1.0
IA 50308 1.0
IA 50309 1.0
IA 50310 1.0
IA 50311 1.0
IA 50312 1.0
IA 50313 1.0
IA 50314 1.0
IA 50315 1.0
IA 50316 1.0
IA 50317 1.0
IA 50318 1.0
IA 50319 1.0
IA 50320 1.0
IA 50321 1.0
IA 50322 1.0
IA 50323 1.0
IA 50325 1.0
IA 50327 1.0
IA 50328 1.0
IA 50329 1.0
IA 50330 1.0
IA 50331 1.0
IA 50332 1.0
IA 50333 1.0
IA 50334 1.0
IA 50335 1.0
IA 50336 1.0
IA 50338 1.0
IA 50339 1.0
IA 50340 1.0
IA 50347 1.0
IA 50350 1.0
IA 50359 1.0
IA 50360 1.0
IA 50361 1.0
IA 50362 1.0
IA 50363 1.0
IA 50364 1.0
IA 50367 1.0
IA 50368 1.0
IA 50369 1.0
IA 50380 1.0
IA 50381 1.0
IA 50391 1.0
IA 50392 1.0
IA 50393 1.0
IA 50394 1.0
IA 50395 1.0
IA 50396 1.0
IA 50397 1.0
IA 50398 1.0
IA 50401 4.0
IA 50402 4.0
IA 50420 10.6
IA 50421 10.0
IA 50423 10.6
IA 50424 10.6
IA 50426 10.6
IA 50427 10.6
IA 50428 7.2
IA 50430 10.0
IA 50431 10.6
IA 50432 10.6
IA 50433 5.0
IA 50434 10.0
IA 50435 8.0
IA 50436 7.0
IA 50438 7.4
IA 50439 10.6
IA 50440 5.0
IA 50441 7.0
IA 50444 10.0
IA 50446 10.0
IA 50447 10.0
IA 50448 5.0
IA 50449 10.6
IA 50450 10.6
IA 50451 10.0
IA 50452 10.6
IA 50453 10.6
IA 50454 10.6
IA 50455 10.6
IA 50456 5.0
IA 50457 5.0
IA 50458 5.0
IA 50459 10.5
IA 50460 10.6
IA 50461 7.4
IA 50464 5.0
IA 50465 10.6
IA 50466 10.6
IA 50467 5.0
IA 50468 10.5
IA 50469 5.0
IA 50470 10.6
IA 50471 5.0
IA 50472 10.6
IA 50473 10.6
IA 50475 10.6
IA 50476 10.6
IA 50477 5.0
IA 50478 10.6
IA 50479 5.0
IA 50480 10.6
IA 50481 10.6
IA 50482 7.2
IA 50483 10.6
IA 50484 10.0
IA 50501 4.0
IA 50510 10.5
IA 50511 7.0
IA 50514 10.0
IA 50515 10.5
IA 50516 5.0
IA 50517 10.6
IA 50518 5.0
IA 50519 8.0
IA 50520 8.0
IA 50521 5.0
IA 50522 10.6
IA 50523 5.0
IA 50524 5.0
IA 50525 7.0
IA 50526 7.0
IA 50527 10.6
IA 50528 10.6
IA 50529 7.4
IA 50530 5.0
IA 50531 8.0
IA 50532 5.0
IA 50533 7.0
IA 50535 10.5
IA 50536 7.0
IA 50538 10.5
IA 50539 10.6
IA 50540 10.0
IA 50541 8.0
IA 50542 10.6
IA 50543 5.0
IA 50544 5.0
IA 50545 10.6
IA 50546 10.0
IA 50548 7.4
IA 50551 10.5
IA 50552 10.5
IA 50554 10.0
IA 50556 10.0
IA 50557 5.0
IA 50558 10.6
IA 50559 10.6
IA 50560 10.6
IA 50561 10.5
IA 50562 10.6
IA 50563 10.5
IA 50565 10.5
IA 50566 5.0
IA 50567 10.5
IA 50568 5.0
IA 50569 5.0
IA 50570 8.0
IA 50571 10.0
IA 50573 10.0
IA 50574 10.0
IA 50575 10.5
IA 50576 10.5
IA 50577 10.6
IA 50578 10.0
IA 50579 10.5
IA 50581 10.0
IA 50582 8.0
IA 50583 10.0
IA 50585 10.5
IA 50586 10.5
IA 50588 4.0
IA 50590 10.0
IA 50591 10.6
IA 50592 4.0
IA 50593 10.0
IA 50594 5.0
IA 50595 7.0
IA 50597 10.6
IA 50598 8.0
IA 50599 10.6
IA 50601 10.6
IA 50602 10.0
IA 50603 10.6
IA 50604 10.1
IA 50605 10.0
IA 50606 10.0
IA 50607 10.6
IA 50608 10.0
IA 50609 10.5
IA 50611 10.0
IA 50612 10.4
IA 50613 1.0
IA 50614 1.0
IA 50616 7.0
IA 50619 10.6
IA 50620 7.0
IA 50621 10.5
IA 50622 2.0
IA 50623 1.0
IA 50624 2.0
IA 50625 10.0
IA 50626 2.0
IA 50627 10.0
IA 50628 10.6
IA 50629 10.4
IA 50630 10.6
IA 50631 10.0
IA 50632 10.2
IA 50633 10.6
IA 50634 1.0
IA 50635 10.2
IA 50636 10.0
IA 50638 10.4
IA 50641 10.4
IA 50642 10.4
IA 50643 2.0
IA 50644 7.3
IA 50645 10.6
IA 50647 2.0
IA 50648 2.0
IA 50649 10.6
IA 50650 10.6
IA 50651 2.0
IA 50652 10.4
IA 50653 10.5
IA 50654 8.0
IA 50655 10.6
IA 50657 2.0
IA 50658 10.6
IA 50659 7.0
IA 50660 2.0
IA 50661 7.0
IA 50662 7.0
IA 50664 10.4
IA 50665 10.1
IA 50666 10.6
IA 50667 1.0
IA 50668 10.1
IA 50669 2.0
IA 50670 2.0
IA 50671 10.6
IA 50672 10.6
IA 50673 10.1
IA 50674 10.0
IA 50675 10.4
IA 50676 9.0
IA 50677 7.3
IA 50680 10.4
IA 50681 10.6
IA 50682 10.6
IA 50701 1.0
IA 50702 1.0
IA 50703 1.0
IA 50704 1.0
IA 50706 2.0
IA 50707 1.0
IA 50799 1.0
IA 50801 7.0
IA 50830 8.0
IA 50831 8.0
IA 50833 10.6
IA 50835 10.0
IA 50836 10.6
IA 50837 10.0
IA 50839 10.0
IA 50840 10.6
IA 50841 10.0
IA 50842 7.0
IA 50843 10.6
IA 50845 10.0
IA 50846 10.0
IA 50847 8.0
IA 50848 8.0
IA 50849 10.0
IA 50851 10.6
IA 50853 10.6
IA 50854 10.0
IA 50857 10.0
IA 50858 10.0
IA 50859 10.0
IA 50860 10.0
IA 50861 8.0
IA 50862 10.6
IA 50863 10.0
IA 50864 10.3
IA 50936 1.0
IA 50940 1.0
IA 50947 1.0
IA 50950 1.0
IA 50980 1.0
IA 50981 1.0
IA 51001 10.6
IA 51002 5.0
IA 51003 7.0
IA 51004 10.1
IA 51005 10.6
IA 51006 10.0
IA 51007 2.0
IA 51008 7.3
IA 51009 10.0
IA 51010 10.4
IA 51011 10.6
IA 51012 7.0
IA 51014 10.6
IA 51015 2.0
IA 51016 10.1
IA 51018 10.1
IA 51019 10.1
IA 51020 10.0
IA 51022 7.0
IA 51023 10.6
IA 51024 2.0
IA 51025 10.0
IA 51026 2.0
IA 51027 7.0
IA 51028 10.4
IA 51029 10.3
IA 51030 2.0
IA 51031 7.3
IA 51033 10.5
IA 51034 10.4
IA 51035 10.3
IA 51036 7.0
IA 51037 10.6
IA 51038 2.0
IA 51039 2.0
IA 51040 7.3
IA 51041 7.0
IA 51044 2.0
IA 51045 7.3
IA 51046 10.0
IA 51047 5.0
IA 51048 10.1
IA 51049 10.6
IA 51050 10.3
IA 51051 10.4
IA 51052 2.0
IA 51053 10.5
IA 51054 1.0
IA 51055 2.0
IA 51056 2.0
IA 51058 10.0
IA 51060 10.6
IA 51061 10.6
IA 51062 2.0
IA 51063 10.4
IA 51101 1.0
IA 51102 1.0
IA 51103 1.0
IA 51104 1.0
IA 51105 1.0
IA 51106 1.0
IA 51108 1.0
IA 51109 1.0
IA 51111 1.0
IA 51201 7.0
IA 51230 10.4
IA 51231 10.6
IA 51232 10.6
IA 51234 10.6
IA 51235 10.4
IA 51237 10.0
IA 51238 10.6
IA 51239 10.6
IA 51240 10.4
IA 51241 10.4
IA 51242 10.4
IA 51243 10.0
IA 51244 7.0
IA 51245 10.6
IA 51246 10.4
IA 51247 7.0
IA 51248 10.6
IA 51249 7.0
IA 51250 7.0
IA 51301 4.0
IA 51331 4.0
IA 51333 5.0
IA 51334 7.4
IA 51338 5.0
IA 51340 4.0
IA 51341 5.0
IA 51342 10.6
IA 51343 5.0
IA 51344 7.4
IA 51345 10.6
IA 51346 10.5
IA 51347 5.0
IA 51349 10.6
IA 51350 10.6
IA 51351 4.0
IA 51354 10.6
IA 51355 4.0
IA 51357 5.0
IA 51358 10.5
IA 51360 4.0
IA 51363 4.0
IA 51364 4.0
IA 51365 8.0
IA 51366 5.0
IA 51401 7.0
IA 51430 8.0
IA 51431 10.0
IA 51432 10.3
IA 51433 10.0
IA 51436 8.0
IA 51439 8.0
IA 51440 10.6
IA 51441 8.0
IA 51442 7.0
IA 51443 8.0
IA 51444 8.0
IA 51445 10.0
IA 51446 10.6
IA 51447 10.6
IA 51448 8.0
IA 51449 10.6
IA 51450 10.0
IA 51451 8.0
IA 51452 8.0
IA 51453 10.5
IA 51454 10.3
IA 51455 10.6
IA 51458 10.0
IA 51459 8.0
IA 51460 8.0
IA 51461 8.0
IA 51462 10.6
IA 51463 10.6
IA 51465 8.0
IA 51466 10.0
IA 51467 8.0
IA 51501 1.0
IA 51502 1.0
IA 51503 1.0
IA 51510 1.0
IA 51520 8.0
IA 51521 10.1
IA 51523 10.4
IA 51525 2.0
IA 51526 2.0
IA 51527 10.6
IA 51528 8.0
IA 51529 10.4
IA 51530 10.6
IA 51531 10.6
IA 51532 8.0
IA 51533 2.0
IA 51534 7.1
IA 51535 10.6
IA 51536 2.0
IA 51537 7.0
IA 51540 2.0
IA 51541 2.0
IA 51542 2.0
IA 51543 10.0
IA 51544 10.6
IA 51545 10.4
IA 51546 10.1
IA 51548 2.0
IA 51549 2.0
IA 51550 10.1
IA 51551 2.0
IA 51552 8.0
IA 51553 2.0
IA 51554 7.1
IA 51555 7.1
IA 51556 10.1
IA 51557 10.4
IA 51558 10.6
IA 51559 2.0
IA 51560 2.0
IA 51561 2.0
IA 51562 10.6
IA 51563 2.0
IA 51564 10.4
IA 51565 10.6
IA 51566 7.0
IA 51570 10.6
IA 51571 2.0
IA 51572 10.6
IA 51573 10.3
IA 51575 2.0
IA 51576 2.0
IA 51577 10.1
IA 51578 10.6
IA 51579 10.4
IA 51591 7.0
IA 51593 7.0
IA 51601 7.0
IA 51602 7.0
IA 51603 7.0
IA 51630 8.0
IA 51631 8.0
IA 51632 7.0
IA 51636 8.0
IA 51637 8.0
IA 51638 10.6
IA 51639 10.6
IA 51640 10.4
IA 51645 10.6
IA 51646 8.0
IA 51647 8.0
IA 51648 10.4
IA 51649 10.6
IA 51650 10.6
IA 51651 8.0
IA 51652 10.4
IA 51653 10.4
IA 51654 10.4
IA 51656 10.6
IA 52001 1.0
IA 52002 1.0
IA 52003 1.0
IA 52004 1.0
IA 52030 3.0
IA 52031 7.3
IA 52032 10.1
IA 52033 9.0
IA 52035 10.6
IA 52036 10.6
IA 52037 10.6
IA 52038 8.0
IA 52039 2.0
IA 52040 7.3
IA 52041 10.6
IA 52042 8.0
IA 52043 10.0
IA 52044 10.0
IA 52045 2.0
IA 52046 2.0
IA 52047 10.6
IA 52048 10.0
IA 52049 10.0
IA 52050 10.6
IA 52052 10.0
IA 52053 2.0
IA 52054 3.0
IA 52056 10.0
IA 52057 7.0
IA 52060 7.0
IA 52064 10.5
IA 52065 10.4
IA 52066 10.0
IA 52068 2.0
IA 52069 10.5
IA 52070 10.5
IA 52071 3.0
IA 52072 10.0
IA 52073 2.0
IA 52074 10.5
IA 52075 7.3
IA 52076 10.6
IA 52077 10.6
IA 52078 10.4
IA 52079 8.3
IA 52099 1.0
IA 52101 7.0
IA 52132 10.3
IA 52133 8.0
IA 52134 10.6
IA 52135 10.0
IA 52136 7.0
IA 52140 10.6
IA 52141 10.0
IA 52142 10.0
IA 52144 10.3
IA 52146 10.6
IA 52147 10.0
IA 52149 7.0
IA 52151 10.4
IA 52154 10.6
IA 52155 10.3
IA 52156 10.0
IA 52157 10.6
IA 52158 10.6
IA 52159 10.0
IA 52160 10.6
IA 52161 8.0
IA 52162 10.0
IA 52163 10.3
IA 52164 10.0
IA 52165 8.0
IA 52166 10.0
IA 52168 10.3
IA 52169 10.0
IA 52170 10.6
IA 52171 10.0
IA 52172 7.0
IA 52175 10.0
IA 52201 10.6
IA 52202 2.0
IA 52203 10.4
IA 52204 10.4
IA 52205 7.1
IA 52206 2.0
IA 52207 8.3
IA 52208 7.3
IA 52209 2.0
IA 52210 10.4
IA 52211 10.6
IA 52212 10.4
IA 52213 2.0
IA 52214 2.0
IA 52215 10.6
IA 52216 10.6
IA 52217 10.4
IA 52218 2.0
IA 52219 2.0
IA 52220 10.4
IA 52221 10.6
IA 52222 10.6
IA 52223 10.6
IA 52224 10.4
IA 52225 10.6
IA 52226 10.6
IA 52227 2.0
IA 52228 2.0
IA 52229 10.4
IA 52231 10.4
IA 52232 10.6
IA 52233 1.0
IA 52235 2.0
IA 52236 10.4
IA 52237 10.6
IA 52240 1.0
IA 52241 1.0
IA 52242 1.0
IA 52243 1.0
IA 52244 1.0
IA 52245 1.0
IA 52246 1.0
IA 52247 2.0
IA 52248 10.4
IA 52249 2.0
IA 52251 10.4
IA 52252 7.3
IA 52253 7.1
IA 52254 10.6
IA 52255 10.6
IA 52257 2.0
IA 52301 10.4
IA 52302 1.0
IA 52305 2.0
IA 52306 3.0
IA 52307 10.4
IA 52308 10.0
IA 52309 8.3
IA 52310 7.3
IA 52312 7.1
IA 52313 10.4
IA 52314 7.1
IA 52315 2.0
IA 52316 10.0
IA 52317 1.0
IA 52318 2.0
IA 52319 1.0
IA 52320 2.0
IA 52321 10.4
IA 52322 1.0
IA 52323 10.4
IA 52324 1.0
IA 52325 10.4
IA 52326 10.4
IA 52327 2.0
IA 52328 1.0
IA 52329 10.4
IA 52330 10.6
IA 52332 2.0
IA 52333 2.1
IA 52334 10.4
IA 52335 10.0
IA 52336 2.0
IA 52337 3.0
IA 52338 2.0
IA 52339 7.0
IA 52340 1.0
IA 52341 1.0
IA 52342 7.0
IA 52344 2.0
IA 52345 2.0
IA 52346 10.4
IA 52347 10.0
IA 52348 10.6
IA 52349 7.3
IA 52350 2.0
IA 52351 2.0
IA 52352 2.0
IA 52353 7.3
IA 52354 2.0
IA 52355 10.0
IA 52356 10.6
IA 52358 2.0
IA 52359 10.6
IA 52361 10.4
IA 52362 10.4
IA 52401 1.0
IA 52402 1.0
IA 52403 1.0
IA 52404 1.0
IA 52405 1.0
IA 52406 1.0
IA 52407 1.0
IA 52408 1.0
IA 52409 1.0
IA 52410 1.0
IA 52411 1.0
IA 52497 1.0
IA 52498 1.0
IA 52499 1.0
IA 52501 4.0
IA 52530 5.0
IA 52531 7.0
IA 52533 8.0
IA 52534 5.0
IA 52535 10.6
IA 52536 5.0
IA 52537 10.5
IA 52538 10.5
IA 52540 10.6
IA 52542 10.0
IA 52543 5.0
IA 52544 7.0
IA 52548 5.0
IA 52549 8.0
IA 52550 10.0
IA 52551 10.6
IA 52552 10.5
IA 52553 5.0
IA 52554 5.0
IA 52555 8.0
IA 52556 7.0
IA 52557 7.0
IA 52560 10.5
IA 52561 5.0
IA 52562 10.0
IA 52563 10.6
IA 52565 10.6
IA 52566 5.0
IA 52567 8.0
IA 52568 10.6
IA 52569 9.0
IA 52570 10.0
IA 52571 10.6
IA 52572 10.6
IA 52573 10.0
IA 52574 8.0
IA 52576 10.6
IA 52577 4.0
IA 52580 8.0
IA 52581 8.0
IA 52583 10.0
IA 52584 10.5
IA 52585 10.6
IA 52586 5.0
IA 52588 10.6
IA 52590 10.0
IA 52591 10.0
IA 52593 10.6
IA 52594 10.6
IA 52595 4.0
IA 52601 4.0
IA 52619 5.0
IA 52620 10.6
IA 52621 10.6
IA 52623 5.0
IA 52624 5.0
IA 52625 5.0
IA 52626 10.0
IA 52627 4.0
IA 52630 8.0
IA 52631 10.5
IA 52632 4.0
IA 52635 8.0
IA 52637 5.0
IA 52638 5.0
IA 52639 5.0
IA 52640 10.5
IA 52641 7.0
IA 52642 7.0
IA 52644 8.0
IA 52645 8.0
IA 52646 10.5
IA 52647 10.3
IA 52648 10.5
IA 52649 8.0
IA 52650 5.0
IA 52651 10.6
IA 52652 7.0
IA 52653 10.5
IA 52654 10.3
IA 52655 4.0
IA 52656 10.5
IA 52657 10.5
IA 52658 5.0
IA 52659 10.3
IA 52660 5.0
IA 52701 5.0
IA 52720 5.0
IA 52721 10.4
IA 52722 1.0
IA 52726 2.0
IA 52727 5.0
IA 52728 1.0
IA 52729 3.0
IA 52730 4.0
IA 52731 5.0
IA 52732 4.0
IA 52733 4.0
IA 52736 4.0
IA 52737 10.4
IA 52738 10.4
IA 52739 5.0
IA 52742 7.3
IA 52745 2.0
IA 52746 2.0
IA 52747 10.4
IA 52748 2.0
IA 52749 4.0
IA 52750 5.0
IA 52751 3.0
IA 52752 10.5
IA 52753 1.0
IA 52754 5.0
IA 52755 1.0
IA 52756 2.0
IA 52757 7.3
IA 52758 2.0
IA 52759 4.0
IA 52760 5.0
IA 52761 4.0
IA 52765 2.0
IA 52766 7.3
IA 52767 1.0
IA 52768 2.0
IA 52769 5.2
IA 52771 4.0
IA 52772 7.3
IA 52773 2.0
IA 52774 3.0
IA 52776 7.3
IA 52777 3.0
IA 52778 5.0
IA 52801 1.0
IA 52802 1.0
IA 52803 1.0
IA 52804 1.0
IA 52805 1.0
IA 52806 1.0
IA 52807 1.0
IA 52808 1.0
IA 52809 1.0
ID 83201 1.0
ID 83202 1.0
ID 83203 2.0
ID 83204 1.0
ID 83205 1.0
ID 83206 1.0
ID 83209 1.0
ID 83210 10.5
ID 83211 7.3
ID 83212 10.1
ID 83213 10.4
ID 83214 2.0
ID 83215 4.2
ID 83217 10.6
ID 83218 2.0
ID 83220 8.0
ID 83221 4.2
ID 83223 8.0
ID 83226 10.0
ID 83227 10.0
ID 83228 10.6
ID 83229 7.0
ID 83230 7.0
ID 83232 10.6
ID 83233 7.0
ID 83234 2.0
ID 83235 10.3
ID 83236 10.4
ID 83237 7.3
ID 83238 7.0
ID 83239 7.0
ID 83241 10.6
ID 83243 10.0
ID 83244 10.4
ID 83245 2.0
ID 83246 2.0
ID 83250 2.0
ID 83251 10.0
ID 83252 10.0
ID 83253 10.3
ID 83254 7.0
ID 83255 10.4
ID 83256 4.2
ID 83261 8.0
ID 83262 5.0
ID 83263 7.3
ID 83271 10.1
ID 83272 8.0
ID 83274 2.0
ID 83276 7.0
ID 83277 5.0
ID 83278 10.0
ID 83281 2.0
ID 83283 10.6
ID 83285 2.0
ID 83286 10.6
ID 83287 8.0
ID 83301 4.0
ID 83302 5.0
ID 83303 4.0
ID 83311 10.5
ID 83312 10.5
ID 83313 7.0
ID 83314 7.0
ID 83316 10.6
ID 83318 4.0
ID 83320 7.0
ID 83321 10.6
ID 83322 10.6
ID 83323 5.0
ID 83324 10.6
ID 83325 10.5
ID 83327 10.6
ID 83328 5.0
ID 83330 7.0
ID 83332 10.6
ID 83333 7.0
ID 83334 5.0
ID 83335 10.5
ID 83336 4.0
ID 83337 10.6
ID 83338 7.4
ID 83340 7.0
ID 83341 5.0
ID 83342 10.5
ID 83343 10.6
ID 83344 10.5
ID 83346 10.2
ID 83347 10.2
ID 83348 7.0
ID 83349 10.6
ID 83350 7.2
ID 83352 10.6
ID 83353 7.0
ID 83354 7.0
ID 83355 10.6
ID 83401 1.0
ID 83402 1.0
ID 83403 1.0
ID 83404 1.0
ID 83405 1.0
ID 83406 1.0
ID 83415 1.0
ID 83420 10.5
ID 83421 10.5
ID 83422 10.5
ID 83423 10.0
ID 83424 10.5
ID 83425 10.4
ID 83427 2.0
ID 83428 2.0
ID 83429 10.0
ID 83431 2.0
ID 83433 10.0
ID 83434 2.0
ID 83435 10.4
ID 83436 10.5
ID 83438 7.4
ID 83440 4.0
ID 83441 4.0
ID 83442 2.0
ID 83443 2.0
ID 83444 10.4
ID 83445 7.4
ID 83446 10.0
ID 83447 10.5
ID 83448 5.0
ID 83449 2.0
ID 83450 10.4
ID 83451 10.5
ID 83452 10.5
ID 83454 1.0
ID 83455 10.5
ID 83460 4.0
ID 83462 7.0
ID 83463 7.0
ID 83464 10.3
ID 83465 10.3
ID 83466 7.0
ID 83467 7.0
ID 83468 10.3
ID 83469 7.0
ID 83501 1.0
ID 83520 7.0
ID 83522 10.6
ID 83523 10.4
ID 83524 2.0
ID 83525 10.0
ID 83526 10.6
ID 83530 7.0
ID 83531 7.0
ID 83533 10.0
ID 83535 10.5
ID 83536 10.0
ID 83537 10.5
ID 83539 10.0
ID 83540 2.0
ID 83541 2.0
ID 83542 10.0
ID 83543 10.4
ID 83544 7.0
ID 83545 2.0
ID 83546 10.3
ID 83547 10.0
ID 83548 2.0
ID 83549 10.0
ID 83552 10.0
ID 83553 10.3
ID 83554 7.0
ID 83555 10.4
ID 83601 10.5
ID 83602 2.0
ID 83604 10.5
ID 83605 1.1
ID 83606 1.1
ID 83607 1.1
ID 83610 10.6
ID 83611 10.4
ID 83612 10.0
ID 83615 10.0
ID 83616 1.0
ID 83617 7.1
ID 83619 4.0
ID 83622 2.0
ID 83623 10.5
ID 83624 10.5
ID 83626 1.1
ID 83627 10.5
ID 83628 7.1
ID 83629 2.0
ID 83630 1.1
ID 83631 2.0
ID 83632 10.0
ID 83633 10.5
ID 83634 2.0
ID 83635 10.0
ID 83636 7.1
ID 83637 2.0
ID 83638 10.0
ID 83639 2.0
ID 83641 2.0
ID 83642 1.0
ID 83643 10.0
ID 83644 2.1
ID 83645 10.6
ID 83647 4.2
ID 83648 7.2
ID 83650 10.5
ID 83651 1.1
ID 83652 1.1
ID 83653 1.1
ID 83654 10.0
ID 83655 5.0
ID 83656 1.1
ID 83657 10.3
ID 83660 10.1
ID 83661 4.0
ID 83666 2.0
ID 83669 2.0
ID 83670 10.3
ID 83671 10.0
ID 83672 7.4
ID 83676 2.0
ID 83677 10.4
ID 83680 1.0
ID 83686 1.1
ID 83687 1.1
ID 83701 1.0
ID 83702 1.0
ID 83703 1.0
ID 83704 1.0
ID 83705 1.0
ID 83706 1.0
ID 83707 1.0
ID 83708 1.0
ID 83709 1.0
ID 83711 1.0
ID 83712 1.0
ID 83713 1.0
ID 83714 1.0
ID 83715 1.0
ID 83716 1.0
ID 83717 1.0
ID 83719 1.0
ID 83720 1.0
ID 83721 1.0
ID 83722 1.0
ID 83723 1.0
ID 83724 1.0
ID 83725 1.0
ID 83726 1.0
ID 83727 1.0
ID 83728 1.0
ID 83729 1.0
ID 83730 1.0
ID 83731 1.0
ID 83732 1.0
ID 83733 1.0
ID 83735 1.0
ID 83744 1.0
ID 83756 1.0
ID 83757 1.0
ID 83799 1.0
ID 83801 2.0
ID 83802 10.6
ID 83803 2.0
ID 83804 10.4
ID 83805 7.0
ID 83806 5.0
ID 83808 10.6
ID 83809 9.0
ID 83810 2.0
ID 83811 10.3
ID 83812 10.6
ID 83813 9.0
ID 83814 1.0
ID 83815 1.0
ID 83816 1.0
ID 83821 10.0
ID 83822 10.4
ID 83823 5.0
ID 83824 10.3
ID 83825 7.0
ID 83826 10.0
ID 83827 10.3
ID 83830 7.0
ID 83832 10.5
ID 83833 2.0
ID 83834 10.5
ID 83835 1.0
ID 83836 10.3
ID 83837 7.0
ID 83839 10.6
ID 83840 7.0
ID 83841 7.0
ID 83842 2.0
ID 83843 4.0
ID 83844 4.0
ID 83845 10.0
ID 83846 10.6
ID 83847 7.0
ID 83848 10.0
ID 83849 10.6
ID 83850 10.6
ID 83851 10.3
ID 83852 7.0
ID 83853 10.0
ID 83854 1.0
ID 83855 10.5
ID 83856 10.6
ID 83857 10.5
ID 83858 2.1
ID 83860 8.0
ID 83861 7.0
ID 83864 7.0
ID 83865 7.0
ID 83866 7.0
ID 83867 10.6
ID 83868 10.6
ID 83869 2.1
ID 83870 10.3
ID 83871 5.0
ID 83872 10.5
ID 83873 10.6
ID 83874 7.0
ID 83876 10.4
ID 83877 1.0
ID 83888 7.0
IL 60001 7.3
IL 60002 2.0
IL 60004 1.0
IL 60005 1.0
IL 60006 1.0
IL 60007 1.0
IL 60008 1.0
IL 60009 1.0
IL 60010 1.0
IL 60011 1.0
IL 60012 1.0
IL 60013 1.0
IL 60014 1.0
IL 60015 1.0
IL 60016 1.0
IL 60017 1.0
IL 60018 1.0
IL 60019 1.0
IL 60020 2.0
IL 60021 1.0
IL 60022 1.0
IL 60025 1.0
IL 60026 1.0
IL 60029 1.0
IL 60030 2.0
IL 60031 2.0
IL 60033 7.3
IL 60034 2.0
IL 60035 1.0
IL 60037 1.0
IL 60038 1.0
IL 60039 1.0
IL 60040 1.0
IL 60041 2.0
IL 60042 1.0
IL 60043 1.0
IL 60044 1.0
IL 60045 1.0
IL 60046 2.0
IL 60047 1.0
IL 60048 1.0
IL 60049 1.0
IL 60050 2.0
IL 60051 2.0
IL 60053 1.0
IL 60055 1.0
IL 60056 1.0
IL 60060 1.0
IL 60061 1.0
IL 60062 1.0
IL 60064 1.0
IL 60065 1.0
IL 60067 1.0
IL 60068 1.0
IL 60069 1.0
IL 60070 1.0
IL 60071 2.0
IL 60072 2.0
IL 60073 2.0
IL 60074 1.0
IL 60075 1.0
IL 60076 1.0
IL 60077 1.0
IL 60078 1.0
IL 60079 1.0
IL 60081 2.0
IL 60082 1.0
IL 60083 1.0
IL 60084 1.0
IL 60085 1.0
IL 60086 1.0
IL 60087 1.0
IL 60088 1.0
IL 60089 1.0
IL 60090 1.0
IL 60091 1.0
IL 60092 1.0
IL 60093 1.0
IL 60094 1.0
IL 60095 1.0
IL 60096 1.0
IL 60097 2.0
IL 60098 2.0
IL 60099 1.0
IL 60101 1.0
IL 60102 1.0
IL 60103 1.0
IL 60104 1.0
IL 60105 1.0
IL 60106 1.0
IL 60107 1.0
IL 60108 1.0
IL 60109 2.0
IL 60110 1.0
IL 60111 2.1
IL 60112 1.0
IL 60113 4.2
IL 60115 1.0
IL 60116 1.0
IL 60117 1.0
IL 60118 1.0
IL 60119 1.0
IL 60120 1.0
IL 60121 1.0
IL 60122 1.0
IL 60123 1.0
IL 60125 1.0
IL 60126 1.0
IL 60128 1.0
IL 60129 2.1
IL 60130 1.0
IL 60131 1.0
IL 60132 1.0
IL 60133 1.0
IL 60134 1.0
IL 60135 2.0
IL 60136 1.0
IL 60137 1.0
IL 60138 1.0
IL 60139 1.0
IL 60140 2.0
IL 60141 1.0
IL 60142 1.0
IL 60143 1.0
IL 60144 1.0
IL 60145 2.0
IL 60146 2.0
IL 60147 1.0
IL 60148 1.0
IL 60150 2.1
IL 60151 2.0
IL 60152 2.0
IL 60153 1.0
IL 60154 1.0
IL 60155 1.0
IL 60156 1.0
IL 60157 1.0
IL 60159 1.0
IL 60160 1.0
IL 60161 1.0
IL 60162 1.0
IL 60163 1.0
IL 60164 1.0
IL 60165 1.0
IL 60168 1.0
IL 60170 1.0
IL 60171 1.0
IL 60172 1.0
IL 60173 1.0
IL 60174 1.0
IL 60175 1.0
IL 60176 1.0
IL 60177 1.0
IL 60178 1.0
IL 60179 1.0
IL 60180 2.0
IL 60181 1.0
IL 60183 1.0
IL 60184 1.0
IL 60185 1.0
IL 60186 1.0
IL 60187 1.0
IL 60188 1.0
IL 60189 1.0
IL 60190 1.0
IL 60191 1.0
IL 60192 1.0
IL 60193 1.0
IL 60194 1.0
IL 60195 1.0
IL 60196 1.0
IL 60197 1.0
IL 60199 1.0
IL 60201 1.0
IL 60202 1.0
IL 60203 1.0
IL 60204 1.0
IL 60208 1.0
IL 60209 1.0
IL 60296 1.0
IL 60297 1.0
IL 60301 1.0
IL 60302 1.0
IL 60303 1.0
IL 60304 1.0
IL 60305 1.0
IL 60398 1.0
IL 60399 1.0
IL 60401 1.0
IL 60402 1.0
IL 60406 1.0
IL 60407 2.0
IL 60408 2.0
IL 60409 1.0
IL 60410 1.0
IL 60411 1.0
IL 60412 1.0
IL 60415 1.0
IL 60416 2.0
IL 60417 1.0
IL 60419 1.0
IL 60420 7.3
IL 60421 2.0
IL 60422 1.0
IL 60423 1.0
IL 60424 2.0
IL 60425 1.0
IL 60426 1.0
IL 60428 1.0
IL 60429 1.0
IL 60430 1.0
IL 60431 1.0
IL 60432 1.0
IL 60433 1.0
IL 60434 1.0
IL 60435 1.0
IL 60436 1.0
IL 60437 3.0
IL 60438 1.0
IL 60439 1.0
IL 60440 1.0
IL 60441 1.0
IL 60442 1.0
IL 60443 1.0
IL 60444 3.0
IL 60445 1.0
IL 60446 1.0
IL 60447 1.0
IL 60448 1.0
IL 60449 2.0
IL 60450 4.1
IL 60451 1.0
IL 60452 1.0
IL 60453 1.0
IL 60454 1.0
IL 60455 1.0
IL 60456 1.0
IL 60457 1.0
IL 60458 1.0
IL 60459 1.0
IL 60460 10.5
IL 60461 1.0
IL 60462 1.0
IL 60463 1.0
IL 60464 1.0
IL 60465 1.0
IL 60466 1.0
IL 60467 1.0
IL 60468 2.0
IL 60469 1.0
IL 60470 9.1
IL 60471 1.0
IL 60472 1.0
IL 60473 1.0
IL 60474 2.0
IL 60475 1.0
IL 60476 1.0
IL 60477 1.0
IL 60478 1.0
IL 60479 3.0
IL 60480 1.0
IL 60481 2.0
IL 60482 1.0
IL 60490 1.0
IL 60491 1.0
IL 60499 1.0
IL 60501 1.0
IL 60502 1.0
IL 60503 1.0
IL 60504 1.0
IL 60505 1.0
IL 60506 1.0
IL 60507 1.0
IL 60510 1.0
IL 60511 2.0
IL 60512 1.0
IL 60513 1.0
IL 60514 1.0
IL 60515 1.0
IL 60516 1.0
IL 60517 1.0
IL 60518 3.0
IL 60519 1.0
IL 60520 2.0
IL 60521 1.0
IL 60522 1.0
IL 60523 1.0
IL 60525 1.0
IL 60526 1.0
IL 60527 1.0
IL 60530 10.4
IL 60531 2.0
IL 60532 1.0
IL 60534 1.0
IL 60536 2.0
IL 60537 2.0
IL 60538 1.0
IL 60539 1.0
IL 60540 1.0
IL 60541 2.0
IL 60542 1.0
IL 60543 1.0
IL 60544 1.0
IL 60545 2.0
IL 60546 1.0
IL 60548 2.0
IL 60549 2.0
IL 60550 2.0
IL 60551 2.0
IL 60552 2.0
IL 60553 10.4
IL 60554 1.0
IL 60555 1.0
IL 60556 2.0
IL 60557 4.0
IL 60558 1.0
IL 60559 1.0
IL 60560 1.0
IL 60561 1.0
IL 60563 1.0
IL 60564 1.0
IL 60565 1.0
IL 60566 1.0
IL 60567 1.0
IL 60568 1.0
IL 60570 1.0
IL 60572 1.0
IL 60585 1.0
IL 60586 1.0
IL 60597 1.0
IL 60598 1.0
IL 60599 1.0
IL 60601 1.0
IL 60602 1.0
IL 60603 1.0
IL 60604 1.0
IL 60605 1.0
IL 60606 1.0
IL 60607 1.0
IL 60608 1.0
IL 60609 1.0
IL 60610 1.0
IL 60611 1.0
IL 60612 1.0
IL 60613 1.0
IL 60614 1.0
IL 60615 1.0
IL 60616 1.0
IL 60617 1.0
IL 60618 1.0
IL 60619 1.0
IL 60620 1.0
IL 60621 1.0
IL 60622 1.0
IL 60623 1.0
IL 60624 1.0
IL 60625 1.0
IL 60626 1.0
IL 60628 1.0
IL 60629 1.0
IL 60630 1.0
IL 60631 1.0
IL 60632 1.0
IL 60633 1.0
IL 60634 1.0
IL 60636 1.0
IL 60637 1.0
IL 60638 1.0
IL 60639 1.0
IL 60640 1.0
IL 60641 1.0
IL 60643 1.0
IL 60644 1.0
IL 60645 1.0
IL 60646 1.0
IL 60647 1.0
IL 60649 1.0
IL 60651 1.0
IL 60652 1.0
IL 60653 1.0
IL 60654 1.0
IL 60655 1.0
IL 60656 1.0
IL 60657 1.0
IL 60659 1.0
IL 60660 1.0
IL 60661 1.0
IL 60663 1.0
IL 60664 1.0
IL 60665 1.0
IL 60666 1.0
IL 60667 1.0
IL 60668 1.0
IL 60669 1.0
IL 60670 1.0
IL 60671 1.0
IL 60672 1.0
IL 60673 1.0
IL 60674 1.0
IL 60675 1.0
IL 60677 1.0
IL 60678 1.0
IL 60679 1.0
IL 60680 1.0
IL 60681 1.0
IL 60682 1.0
IL 60683 1.0
IL 60684 1.0
IL 60685 1.0
IL 60686 1.0
IL 60687 1.0
IL 60688 1.0
IL 60689 1.0
IL 60690 1.0
IL 60691 1.0
IL 60693 1.0
IL 60694 1.0
IL 60695 1.0
IL 60696 1.0
IL 60697 1.0
IL 60699 1.0
IL 60701 1.0
IL 60706 1.0
IL 60707 1.0
IL 60712 1.0
IL 60714 1.0
IL 60803 1.0
IL 60804 1.0
IL 60805 1.0
IL 60827 1.0
IL 60901 1.0
IL 60902 1.0
IL 60910 2.0
IL 60911 3.0
IL 60912 3.0
IL 60913 2.1
IL 60914 1.0
IL 60915 1.0
IL 60917 2.1
IL 60918 10.6
IL 60919 10.4
IL 60920 7.3
IL 60921 10.6
IL 60922 2.0
IL 60924 10.6
IL 60926 10.6
IL 60927 2.0
IL 60928 3.0
IL 60929 10.5
IL 60930 3.0
IL 60931 3.0
IL 60932 3.0
IL 60933 7.3
IL 60934 10.5
IL 60935 2.1
IL 60936 7.3
IL 60938 7.0
IL 60939 10.6
IL 60940 2.0
IL 60941 2.0
IL 60942 7.3
IL 60944 2.0
IL 60945 7.0
IL 60946 10.4
IL 60948 10.6
IL 60949 4.1
IL 60950 2.0
IL 60951 3.0
IL 60952 9.0
IL 60953 10.6
IL 60954 7.1
IL 60955 7.0
IL 60956 2.0
IL 60957 7.3
IL 60959 10.4
IL 60960 3.0
IL 60961 2.1
IL 60962 10.6
IL 60963 3.0
IL 60964 2.0
IL 60966 7.0
IL 60967 10.6
IL 60968 10.6
IL 60969 2.0
IL 60970 7.0
IL 60973 10.6
IL 60974 7.0
IL 61001 10.6
IL 61006 10.4
IL 61007 10.5
IL 61008 1.0
IL 61010 2.0
IL 61011 1.0
IL 61012 1.0
IL 61013 4.0
IL 61014 10.5
IL 61015 2.0
IL 61016 1.0
IL 61018 5.2
IL 61019 5.2
IL 61020 2.0
IL 61021 4.0
IL 61024 2.0
IL 61025 1.0
IL 61027 7.4
IL 61028 10.6
IL 61030 10.5
IL 61031 5.0
IL 61032 4.0
IL 61036 7.3
IL 61037 4.0
IL 61038 2.1
IL 61039 5.0
IL 61041 10.6
IL 61042 6.0
IL 61043 2.0
IL 61044 5.0
IL 61046 10.5
IL 61047 2.0
IL 61048 7.4
IL 61049 2.0
IL 61050 5.0
IL 61051 10.5
IL 61052 2.0
IL 61053 10.0
IL 61054 7.0
IL 61057 4.0
IL 61058 4.0
IL 61059 10.6
IL 61060 5.0
IL 61061 7.0
IL 61062 5.0
IL 61063 2.0
IL 61064 7.4
IL 61065 1.0
IL 61067 5.0
IL 61068 4.2
IL 61070 5.2
IL 61071 4.0
IL 61072 1.0
IL 61073 1.0
IL 61074 7.0
IL 61075 10.6
IL 61077 2.0
IL 61078 10.5
IL 61079 1.0
IL 61080 1.0
IL 61081 4.0
IL 61084 2.0
IL 61085 10.5
IL 61087 10.6
IL 61088 1.0
IL 61089 7.4
IL 61091 7.4
IL 61101 1.0
IL 61102 1.0
IL 61103 1.0
IL 61104 1.0
IL 61105 1.0
IL 61106 1.0
IL 61107 1.0
IL 61108 1.0
IL 61109 1.0
IL 61110 1.0
IL 61111 1.0
IL 61112 1.0
IL 61114 1.0
IL 61115 1.0
IL 61125 1.0
IL 61126 1.0
IL 61130 1.0
IL 61131 1.0
IL 61132 1.0
IL 61201 1.0
IL 61204 1.0
IL 61230 5.0
IL 61231 7.3
IL 61232 1.0
IL 61233 10.1
IL 61234 10.5
IL 61235 9.1
IL 61236 1.0
IL 61237 2.0
IL 61238 10.1
IL 61239 1.0
IL 61240 1.0
IL 61241 1.0
IL 61242 2.0
IL 61243 5.0
IL 61244 1.0
IL 61250 3.0
IL 61251 3.0
IL 61252 4.0
IL 61254 7.3
IL 61256 1.0
IL 61257 2.0
IL 61258 10.5
IL 61259 2.0
IL 61260 9.0
IL 61261 3.0
IL 61262 2.0
IL 61263 2.0
IL 61264 1.0
IL 61265 1.0
IL 61266 1.0
IL 61270 7.4
IL 61272 9.0
IL 61273 2.0
IL 61274 10.1
IL 61275 2.0
IL 61276 2.0
IL 61277 10.5
IL 61278 2.0
IL 61279 2.0
IL 61281 2.0
IL 61282 1.0
IL 61283 5.0
IL 61284 1.0
IL 61285 10.5
IL 61299 1.0
IL 61301 4.0
IL 61310 7.4
IL 61311 4.0
IL 61312 10.5
IL 61313 4.0
IL 61314 10.6
IL 61315 7.0
IL 61316 4.0
IL 61317 10.5
IL 61318 3.0
IL 61319 10.2
IL 61320 4.0
IL 61321 6.0
IL 61322 7.0
IL 61323 7.0
IL 61324 4.0
IL 61325 6.0
IL 61326 5.0
IL 61327 10.5
IL 61328 10.5
IL 61329 4.0
IL 61330 10.5
IL 61331 7.4
IL 61332 6.0
IL 61333 10.2
IL 61334 6.0
IL 61335 10.5
IL 61336 10.5
IL 61337 7.0
IL 61338 10.6
IL 61340 5.0
IL 61341 9.1
IL 61342 7.4
IL 61344 10.6
IL 61345 10.6
IL 61346 10.6
IL 61348 4.0
IL 61349 10.5
IL 61350 4.0
IL 61353 3.0
IL 61354 4.0
IL 61356 7.0
IL 61358 6.0
IL 61359 7.0
IL 61360 9.1
IL 61361 10.6
IL 61362 4.0
IL 61363 5.0
IL 61364 4.0
IL 61367 3.0
IL 61368 8.0
IL 61369 10.4
IL 61370 6.0
IL 61371 7.4
IL 61372 7.4
IL 61373 6.0
IL 61374 10.5
IL 61375 10.4
IL 61376 10.6
IL 61377 10.4
IL 61378 3.0
IL 61379 8.0
IL 61401 4.0
IL 61402 4.0
IL 61410 5.0
IL 61411 5.0
IL 61412 5.0
IL 61413 3.0
IL 61414 5.0
IL 61415 10.5
IL 61416 4.0
IL 61417 10.5
IL 61418 5.0
IL 61419 7.4
IL 61420 5.0
IL 61421 10.4
IL 61422 7.4
IL 61423 5.0
IL 61424 10.4
IL 61425 5.0
IL 61426 10.4
IL 61427 6.0
IL 61428 5.0
IL 61430 4.0
IL 61431 10.5
IL 61432 2.0
IL 61433 2.0
IL 61434 7.4
IL 61435 5.0
IL 61436 2.0
IL 61437 5.0
IL 61438 5.0
IL 61439 4.0
IL 61440 5.0
IL 61441 10.5
IL 61442 9.0
IL 61443 4.0
IL 61447 6.0
IL 61448 4.0
IL 61449 10.4
IL 61450 10.6
IL 61451 2.0
IL 61452 10.6
IL 61453 6.0
IL 61454 10.2
IL 61455 4.0
IL 61458 2.0
IL 61459 10.5
IL 61460 10.2
IL 61462 4.0
IL 61465 2.0
IL 61466 2.0
IL 61467 5.0
IL 61468 2.0
IL 61469 5.0
IL 61470 7.4
IL 61471 10.2
IL 61472 5.0
IL 61473 10.5
IL 61474 5.0
IL 61475 5.0
IL 61476 9.0
IL 61477 10.5
IL 61478 10.5
IL 61479 10.4
IL 61480 10.2
IL 61482 10.5
IL 61483 10.4
IL 61484 10.5
IL 61485 5.0
IL 61486 2.0
IL 61488 5.0
IL 61489 2.0
IL 61490 3.0
IL 61491 10.4
IL 61501 10.5
IL 61516 10.4
IL 61517 2.0
IL 61519 3.0
IL 61520 4.2
IL 61523 2.0
IL 61524 3.0
IL 61525 1.0
IL 61526 2.0
IL 61528 1.0
IL 61529 2.0
IL 61530 7.1
IL 61531 2.0
IL 61532 2.0
IL 61533 2.0
IL 61534 2.0
IL 61535 1.0
IL 61536 2.0
IL 61537 7.3
IL 61539 2.0
IL 61540 10.1
IL 61541 10.4
IL 61542 10.5
IL 61543 3.0
IL 61544 10.5
IL 61545 2.0
IL 61546 2.0
IL 61547 2.0
IL 61548 2.0
IL 61550 1.0
IL 61552 1.0
IL 61553 2.0
IL 61554 1.0
IL 61555 1.0
IL 61558 1.0
IL 61559 2.0
IL 61560 10.5
IL 61561 10.4
IL 61562 2.0
IL 61563 6.0
IL 61564 1.0
IL 61565 2.0
IL 61567 8.3
IL 61568 2.0
IL 61569 2.0
IL 61570 2.0
IL 61571 1.0
IL 61572 2.0
IL 61601 1.0
IL 61602 1.0
IL 61603 1.0
IL 61604 1.0
IL 61605 1.0
IL 61606 1.0
IL 61607 1.0
IL 61610 1.0
IL 61611 1.0
IL 61612 1.0
IL 61613 1.0
IL 61614 1.0
IL 61615 1.0
IL 61616 1.0
IL 61625 1.0
IL 61628 1.0
IL 61629 1.0
IL 61630 1.0
IL 61632 1.0
IL 61633 1.0
IL 61634 1.0
IL 61635 1.0
IL 61636 1.0
IL 61637 1.0
IL 61638 1.0
IL 61639 1.0
IL 61640 1.0
IL 61641 1.0
IL 61643 1.0
IL 61644 1.0
IL 61650 1.0
IL 61651 1.0
IL 61652 1.0
IL 61653 1.0
IL 61654 1.0
IL 61655 1.0
IL 61656 1.0
IL 61701 1.0
IL 61702 1.0
IL 61704 1.0
IL 61709 1.0
IL 61710 1.0
IL 61720 2.0
IL 61721 3.0
IL 61722 2.0
IL 61723 5.2
IL 61724 2.0
IL 61725 2.0
IL 61726 2.0
IL 61727 7.3
IL 61728 2.0
IL 61729 2.1
IL 61730 2.0
IL 61731 2.0
IL 61732 2.0
IL 61733 2.0
IL 61734 2.0
IL 61735 10.4
IL 61736 2.0
IL 61737 2.0
IL 61738 7.1
IL 61739 7.4
IL 61740 10.2
IL 61741 10.5
IL 61742 2.1
IL 61743 10.2
IL 61744 1.0
IL 61745 2.0
IL 61747 3.0
IL 61748 1.0
IL 61749 8.3
IL 61750 7.3
IL 61751 4.2
IL 61752 2.0
IL 61753 2.0
IL 61754 2.0
IL 61755 2.0
IL 61756 2.0
IL 61758 1.0
IL 61759 3.0
IL 61760 10.4
IL 61761 1.0
IL 61764 4.0
IL 61769 10.5
IL 61770 2.0
IL 61771 7.1
IL 61772 2.0
IL 61773 9.0
IL 61774 2.0
IL 61775 10.6
IL 61776 1.0
IL 61777 10.4
IL 61778 8.3
IL 61790 1.0
IL 61791 1.0
IL 61799 1.0
IL 61801 1.0
IL 61802 1.0
IL 61803 1.0
IL 61810 2.1
IL 61811 2.0
IL 61812 2.0
IL 61813 10.4
IL 61814 2.0
IL 61815 1.0
IL 61816 2.0
IL 61817 1.0
IL 61818 2.0
IL 61820 1.0
IL 61821 1.0
IL 61822 1.0
IL 61824 1.0
IL 61825 1.0
IL 61826 1.0
IL 61830 2.0
IL 61831 2.0
IL 61832 1.0
IL 61833 1.0
IL 61834 1.0
IL 61839 2.0
IL 61840 2.0
IL 61841 2.1
IL 61842 10.4
IL 61843 2.0
IL 61844 2.1
IL 61845 2.0
IL 61846 1.0
IL 61847 4.1
IL 61848 3.0
IL 61849 2.0
IL 61850 2.1
IL 61851 2.0
IL 61852 2.0
IL 61853 2.0
IL 61854 2.0
IL 61855 2.0
IL 61856 7.1
IL 61857 2.1
IL 61858 2.1
IL 61859 2.0
IL 61862 4.1
IL 61863 2.0
IL 61864 2.0
IL 61865 2.0
IL 61866 4.1
IL 61870 2.0
IL 61871 2.0
IL 61872 2.0
IL 61873 2.0
IL 61874 1.0
IL 61875 2.0
IL 61876 2.1
IL 61877 2.0
IL 61878 4.1
IL 61880 2.0
IL 61882 10.4
IL 61883 1.0
IL 61884 2.0
IL 61910 7.0
IL 61911 10.0
IL 61912 5.0
IL 61913 10.0
IL 61914 8.3
IL 61917 10.6
IL 61919 2.0
IL 61920 4.0
IL 61924 10.6
IL 61925 2.0
IL 61928 10.5
IL 61929 10.4
IL 61930 10.4
IL 61931 10.5
IL 61932 10.6
IL 61933 8.0
IL 61936 2.0
IL 61937 2.0
IL 61938 4.0
IL 61940 10.6
IL 61941 2.0
IL 61942 10.4
IL 61943 10.5
IL 61944 7.0
IL 61949 7.0
IL 61951 7.3
IL 61953 7.3
IL 61955 7.0
IL 61956 2.0
IL 61957 10.5
IL 62001 2.0
IL 62002 1.1
IL 62006 2.0
IL 62009 7.3
IL 62010 1.1
IL 62011 8.0
IL 62012 2.1
IL 62013 2.0
IL 62014 3.0
IL 62015 8.0
IL 62016 10.6
IL 62017 9.0
IL 62018 1.1
IL 62019 9.0
IL 62021 2.0
IL 62022 2.0
IL 62023 10.4
IL 62024 1.1
IL 62025 1.0
IL 62026 1.0
IL 62027 10.6
IL 62028 2.0
IL 62030 7.3
IL 62031 7.3
IL 62032 9.0
IL 62033 7.3
IL 62034 1.0
IL 62035 1.1
IL 62036 2.0
IL 62037 2.0
IL 62040 1.0
IL 62044 10.5
IL 62045 10.4
IL 62046 1.0
IL 62047 10.4
IL 62048 1.0
IL 62049 7.0
IL 62050 10.6
IL 62051 9.0
IL 62052 7.3
IL 62053 10.4
IL 62054 10.5
IL 62056 7.0
IL 62058 2.0
IL 62059 1.0
IL 62060 1.0
IL 62061 2.0
IL 62062 1.0
IL 62063 10.6
IL 62065 10.4
IL 62067 2.0
IL 62069 10.4
IL 62070 10.4
IL 62071 1.0
IL 62074 2.0
IL 62075 7.3
IL 62076 7.3
IL 62077 9.0
IL 62078 10.6
IL 62079 2.1
IL 62080 8.0
IL 62081 10.5
IL 62082 7.4
IL 62083 4.2
IL 62084 1.1
IL 62085 7.3
IL 62086 9.1
IL 62087 1.0
IL 62088 9.1
IL 62089 7.0
IL 62090 1.0
IL 62091 8.0
IL 62092 7.4
IL 62093 7.3
IL 62094 9.0
IL 62095 1.1
IL 62097 2.0
IL 62098 7.4
IL 62201 1.0
IL 62202 1.0
IL 62203 1.0
IL 62204 1.0
IL 62205 1.0
IL 62206 1.0
IL 62207 1.0
IL 62208 1.0
IL 62214 2.0
IL 62215 2.0
IL 62216 2.0
IL 62217 3.0
IL 62218 2.0
IL 62219 7.4
IL 62220 1.0
IL 62221 1.0
IL 62222 1.0
IL 62223 1.0
IL 62224 1.0
IL 62225 1.0
IL 62226 1.0
IL 62230 7.3
IL 62231 7.4
IL 62232 1.0
IL 62233 7.0
IL 62234 1.0
IL 62236 1.0
IL 62237 9.0
IL 62238 10.6
IL 62239 1.0
IL 62240 1.0
IL 62241 8.0
IL 62242 3.0
IL 62243 2.0
IL 62244 2.0
IL 62245 2.0
IL 62246 7.0
IL 62247 8.3
IL 62248 2.0
IL 62249 7.1
IL 62250 4.0
IL 62252 7.4
IL 62253 3.0
IL 62254 1.0
IL 62255 2.0
IL 62256 2.0
IL 62257 2.0
IL 62258 1.0
IL 62259 7.0
IL 62260 2.0
IL 62261 3.0
IL 62262 8.3
IL 62263 7.0
IL 62264 2.0
IL 62265 2.0
IL 62266 2.0
IL 62268 9.0
IL 62269 1.0
IL 62271 2.0
IL 62272 7.0
IL 62273 3.0
IL 62274 7.0
IL 62275 3.0
IL 62277 3.0
IL 62278 7.3
IL 62279 3.0
IL 62280 8.0
IL 62281 2.0
IL 62282 1.0
IL 62284 8.3
IL 62285 2.0
IL 62286 7.3
IL 62288 7.0
IL 62289 1.0
IL 62292 7.3
IL 62293 2.0
IL 62294 1.0
IL 62295 2.0
IL 62297 3.0
IL 62298 2.0
IL 62301 4.0
IL 62305 4.0
IL 62306 4.0
IL 62310 10.6
IL 62311 10.6
IL 62312 10.5
IL 62313 10.6
IL 62314 10.6
IL 62316 10.6
IL 62319 10.6
IL 62320 5.0
IL 62321 7.0
IL 62323 10.6
IL 62324 5.0
IL 62325 5.0
IL 62326 5.0
IL 62329 10.5
IL 62330 10.6
IL 62334 10.5
IL 62336 7.0
IL 62338 5.0
IL 62339 5.0
IL 62340 10.6
IL 62341 4.0
IL 62343 10.5
IL 62344 10.6
IL 62345 10.5
IL 62346 5.0
IL 62347 5.0
IL 62348 5.0
IL 62349 5.0
IL 62351 5.0
IL 62352 9.0
IL 62353 7.0
IL 62354 10.5
IL 62355 9.0
IL 62356 10.6
IL 62357 10.6
IL 62358 10.5
IL 62359 5.0
IL 62360 5.0
IL 62361 9.0
IL 62362 10.6
IL 62363 7.0
IL 62365 5.0
IL 62366 10.6
IL 62367 10.6
IL 62370 10.6
IL 62373 5.0
IL 62374 5.0
IL 62375 8.0
IL 62376 5.0
IL 62378 8.0
IL 62379 5.0
IL 62380 10.6
IL 62401 4.0
IL 62410 8.0
IL 62411 10.2
IL 62413 8.0
IL 62414 5.0
IL 62415 8.0
IL 62417 7.4
IL 62418 8.0
IL 62419 8.0
IL 62420 7.0
IL 62421 8.0
IL 62422 9.0
IL 62423 3.0
IL 62424 5.0
IL 62425 8.0
IL 62426 5.0
IL 62427 8.0
IL 62428 10.6
IL 62431 9.0
IL 62432 9.0
IL 62433 8.0
IL 62434 6.0
IL 62435 5.0
IL 62436 10.5
IL 62438 9.0
IL 62439 7.4
IL 62440 5.0
IL 62441 7.3
IL 62442 7.0
IL 62443 5.0
IL 62444 5.0
IL 62445 4.0
IL 62446 8.0
IL 62447 6.0
IL 62448 7.4
IL 62449 8.0
IL 62450 7.0
IL 62451 7.0
IL 62452 8.0
IL 62454 7.0
IL 62458 5.0
IL 62459 8.0
IL 62460 10.6
IL 62461 5.0
IL 62462 5.0
IL 62463 5.0
IL 62464 7.0
IL 62465 10.5
IL 62466 10.6
IL 62467 4.0
IL 62468 10.5
IL 62469 5.0
IL 62471 7.0
IL 62473 5.0
IL 62474 9.0
IL 62475 8.0
IL 62476 10.0
IL 62477 3.0
IL 62478 8.0
IL 62479 8.0
IL 62480 8.0
IL 62481 9.0
IL 62501 2.0
IL 62510 4.2
IL 62512 5.2
IL 62513 2.0
IL 62514 2.0
IL 62515 2.0
IL 62517 2.0
IL 62518 10.5
IL 62519 4.2
IL 62520 2.0
IL 62521 1.0
IL 62522 1.0
IL 62523 1.0
IL 62524 1.0
IL 62525 1.0
IL 62526 1.0
IL 62530 2.0
IL 62531 2.0
IL 62532 1.0
IL 62533 3.0
IL 62534 2.0
IL 62535 1.0
IL 62536 1.0
IL 62537 1.0
IL 62538 3.0
IL 62539 2.0
IL 62540 4.2
IL 62541 10.5
IL 62543 10.5
IL 62544 2.0
IL 62545 2.0
IL 62546 5.0
IL 62547 2.0
IL 62548 10.5
IL 62549 1.0
IL 62550 2.0
IL 62551 2.0
IL 62553 9.0
IL 62554 1.0
IL 62555 4.2
IL 62556 5.0
IL 62557 7.4
IL 62558 2.0
IL 62560 3.0
IL 62561 1.0
IL 62563 1.0
IL 62565 7.0
IL 62567 3.0
IL 62568 4.2
IL 62570 4.2
IL 62571 8.0
IL 62572 3.0
IL 62573 2.0
IL 62601 2.0
IL 62610 5.0
IL 62611 10.5
IL 62612 2.0
IL 62613 2.0
IL 62615 2.0
IL 62617 9.0
IL 62618 7.0
IL 62621 5.0
IL 62622 7.0
IL 62624 8.0
IL 62625 1.0
IL 62626 7.0
IL 62627 2.0
IL 62628 5.0
IL 62629 1.0
IL 62630 10.6
IL 62631 5.0
IL 62633 10.4
IL 62634 4.2
IL 62635 5.0
IL 62638 2.0
IL 62639 8.0
IL 62640 2.0
IL 62642 2.0
IL 62643 5.0
IL 62644 7.0
IL 62649 10.4
IL 62650 4.2
IL 62651 4.2
IL 62655 9.0
IL 62656 4.2
IL 62659 2.0
IL 62660 4.2
IL 62661 2.0
IL 62662 2.0
IL 62663 5.0
IL 62664 3.0
IL 62665 5.0
IL 62666 4.2
IL 62667 10.4
IL 62668 5.2
IL 62670 2.0
IL 62671 5.0
IL 62672 10.6
IL 62673 2.0
IL 62674 10.4
IL 62675 2.0
IL 62677 2.0
IL 62681 7.0
IL 62682 10.4
IL 62683 10.4
IL 62684 1.0
IL 62685 2.1
IL 62688 2.0
IL 62689 2.0
IL 62690 2.0
IL 62691 10.5
IL 62692 2.0
IL 62693 1.0
IL 62694 5.0
IL 62695 4.2
IL 62701 1.0
IL 62702 1.0
IL 62703 1.0
IL 62704 1.0
IL 62705 1.0
IL 62706 1.0
IL 62707 1.0
IL 62708 1.0
IL 62711 1.0
IL 62712 1.0
IL 62713 1.0
IL 62715 1.0
IL 62716 1.0
IL 62719 1.0
IL 62721 1.0
IL 62722 1.0
IL 62723 1.0
IL 62726 1.0
IL 62736 1.0
IL 62739 1.0
IL 62746 1.0
IL 62756 1.0
IL 62757 1.0
IL 62761 1.0
IL 62762 1.0
IL 62763 1.0
IL 62764 1.0
IL 62765 1.0
IL 62766 1.0
IL 62767 1.0
IL 62769 1.0
IL 62776 1.0
IL 62777 1.0
IL 62781 1.0
IL 62786 1.0
IL 62791 1.0
IL 62794 1.0
IL 62796 1.0
IL 62801 4.0
IL 62803 10.5
IL 62805 9.0
IL 62806 10.0
IL 62807 8.0
IL 62808 9.0
IL 62809 8.0
IL 62810 5.0
IL 62811 7.0
IL 62812 7.0
IL 62814 5.0
IL 62815 10.0
IL 62816 5.0
IL 62817 8.0
IL 62818 10.0
IL 62819 9.0
IL 62820 9.0
IL 62821 7.0
IL 62822 9.0
IL 62823 10.6
IL 62824 8.0
IL 62825 7.0
IL 62827 10.6
IL 62828 5.0
IL 62829 8.0
IL 62830 5.0
IL 62831 9.0
IL 62832 7.0
IL 62833 10.0
IL 62834 7.0
IL 62835 9.0
IL 62836 9.0
IL 62837 7.0
IL 62838 10.6
IL 62839 7.0
IL 62840 7.0
IL 62841 4.0
IL 62842 10.6
IL 62843 8.0
IL 62844 10.6
IL 62845 10.6
IL 62846 5.0
IL 62847 6.0
IL 62848 10.5
IL 62849 8.0
IL 62850 10.6
IL 62851 10.6
IL 62852 7.0
IL 62853 8.0
IL 62854 8.0
IL 62855 8.0
IL 62856 7.0
IL 62857 10.6
IL 62858 6.0
IL 62859 7.4
IL 62860 8.0
IL 62861 7.0
IL 62862 9.0
IL 62863 7.0
IL 62864 4.0
IL 62865 9.0
IL 62866 5.0
IL 62867 10.4
IL 62868 8.0
IL 62869 10.6
IL 62870 7.4
IL 62871 10.4
IL 62872 5.0
IL 62874 7.0
IL 62875 9.0
IL 62876 9.0
IL 62877 10.5
IL 62878 10.6
IL 62879 6.0
IL 62880 10.6
IL 62881 7.4
IL 62882 5.0
IL 62883 5.0
IL 62884 9.0
IL 62885 8.0
IL 62886 10.6
IL 62887 8.4
IL 62888 9.0
IL 62889 5.0
IL 62890 9.0
IL 62891 9.0
IL 62892 9.0
IL 62893 5.0
IL 62894 5.0
IL 62895 10.6
IL 62896 7.0
IL 62897 7.0
IL 62898 5.0
IL 62899 8.0
IL 62901 4.0
IL 62902 5.0
IL 62903 4.0
IL 62905 9.2
IL 62906 7.0
IL 62907 10.5
IL 62908 10.0
IL 62909 10.0
IL 62910 5.0
IL 62912 10.5
IL 62914 7.0
IL 62915 4.0
IL 62916 10.5
IL 62917 4.0
IL 62918 4.0
IL 62919 10.0
IL 62920 8.0
IL 62921 4.0
IL 62922 5.0
IL 62923 10.0
IL 62924 5.0
IL 62926 8.0
IL 62927 5.0
IL 62928 10.0
IL 62930 7.4
IL 62931 10.0
IL 62932 5.0
IL 62933 4.0
IL 62934 10.0
IL 62935 10.5
IL 62938 10.5
IL 62939 10.5
IL 62940 6.0
IL 62941 10.0
IL 62942 6.0
IL 62943 9.0
IL 62944 10.5
IL 62946 4.0
IL 62947 10.0
IL 62948 4.0
IL 62949 4.0
IL 62950 6.0
IL 62951 6.0
IL 62952 7.0
IL 62953 8.0
IL 62954 10.0
IL 62955 10.5
IL 62956 10.0
IL 62957 5.0
IL 62958 5.0
IL 62959 4.0
IL 62960 7.4
IL 62961 8.0
IL 62962 5.0
IL 62963 10.0
IL 62964 10.6
IL 62965 4.0
IL 62966 5.0
IL 62967 9.0
IL 62969 5.0
IL 62970 10.0
IL 62971 5.0
IL 62972 9.0
IL 62973 10.6
IL 62974 5.0
IL 62975 6.0
IL 62976 10.6
IL 62977 8.4
IL 62979 10.4
IL 62982 10.5
IL 62983 10.5
IL 62984 10.0
IL 62985 9.0
IL 62987 5.0
IL 62988 5.0
IL 62990 5.0
IL 62992 10.6
IL 62993 5.0
IL 62994 10.5
IL 62995 10.0
IL 62996 10.6
IL 62997 10.6
IL 62998 9.2
IL 62999 10.5
IN 46001 1.0
IN 46011 1.0
IN 46012 1.0
IN 46013 1.0
IN 46014 1.0
IN 46015 1.0
IN 46016 1.0
IN 46017 1.0
IN 46018 1.0
IN 46030 1.0
IN 46031 1.0
IN 46032 1.0
IN 46033 1.0
IN 46034 1.0
IN 46035 10.5
IN 46036 4.2
IN 46037 1.0
IN 46038 1.0
IN 46039 3.0
IN 46040 1.0
IN 46041 4.0
IN 46044 2.1
IN 46045 7.3
IN 46047 7.3
IN 46048 1.0
IN 46049 9.1
IN 46050 3.0
IN 46051 2.0
IN 46052 4.1
IN 46055 1.0
IN 46056 2.1
IN 46057 6.0
IN 46058 2.0
IN 46060 1.0
IN 46061 1.0
IN 46062 1.0
IN 46063 1.0
IN 46064 1.0
IN 46065 2.0
IN 46067 4.0
IN 46068 2.0
IN 46069 2.0
IN 46070 2.0
IN 46071 2.0
IN 46072 7.3
IN 46074 1.0
IN 46075 2.0
IN 46076 9.1
IN 46077 1.0
IN 46082 1.0
IN 46102 2.0
IN 46103 2.0
IN 46104 3.0
IN 46105 2.0
IN 46106 1.0
IN 46107 1.0
IN 46110 2.0
IN 46111 1.0
IN 46112 1.0
IN 46113 1.0
IN 46115 3.0
IN 46117 2.0
IN 46118 2.0
IN 46120 2.0
IN 46121 2.0
IN 46122 1.0
IN 46123 1.0
IN 46124 1.0
IN 46125 4.1
IN 46126 2.0
IN 46127 9.0
IN 46128 2.0
IN 46129 2.0
IN 46130 2.0
IN 46131 1.0
IN 46133 9.0
IN 46135 7.3
IN 46140 2.0
IN 46142 1.0
IN 46143 1.0
IN 46144 2.0
IN 46146 9.0
IN 46147 2.0
IN 46148 2.0
IN 46149 2.0
IN 46150 9.0
IN 46151 4.1
IN 46154 2.0
IN 46155 7.4
IN 46156 9.0
IN 46157 2.0
IN 46158 1.0
IN 46160 2.0
IN 46161 2.0
IN 46162 2.0
IN 46163 1.0
IN 46164 2.0
IN 46165 2.0
IN 46166 2.0
IN 46167 1.0
IN 46168 1.0
IN 46170 7.3
IN 46171 8.3
IN 46172 2.0
IN 46173 7.4
IN 46175 2.0
IN 46176 4.2
IN 46180 2.0
IN 46181 2.0
IN 46182 5.2
IN 46183 1.0
IN 46184 1.0
IN 46186 2.0
IN 46201 1.0
IN 46202 1.0
IN 46203 1.0
IN 46204 1.0
IN 46205 1.0
IN 46206 1.0
IN 46207 1.0
IN 46208 1.0
IN 46209 1.0
IN 46211 1.0
IN 46214 1.0
IN 46216 1.0
IN 46217 1.0
IN 46218 1.0
IN 46219 1.0
IN 46220 1.0
IN 46221 1.0
IN 46222 1.0
IN 46223 1.0
IN 46224 1.0
IN 46225 1.0
IN 46226 1.0
IN 46227 1.0
IN 46228 1.0
IN 46229 1.0
IN 46230 1.0
IN 46231 1.0
IN 46234 1.0
IN 46235 1.0
IN 46236 1.0
IN 46237 1.0
IN 46239 1.0
IN 46240 1.0
IN 46241 1.0
IN 46242 1.0
IN 46244 1.0
IN 46247 1.0
IN 46249 1.0
IN 46250 1.0
IN 46251 1.0
IN 46253 1.0
IN 46254 1.0
IN 46255 1.0
IN 46256 1.0
IN 46259 1.0
IN 46260 1.0
IN 46266 1.0
IN 46268 1.0
IN 46274 1.0
IN 46275 1.0
IN 46277 1.0
IN 46278 1.0
IN 46280 1.0
IN 46282 1.0
IN 46283 1.0
IN 46285 1.0
IN 46290 1.0
IN 46291 1.0
IN 46295 1.0
IN 46296 1.0
IN 46298 1.0
IN 46301 1.0
IN 46302 1.0
IN 46303 1.0
IN 46304 1.0
IN 46307 1.0
IN 46308 1.0
IN 46310 2.0
IN 46311 1.0
IN 46312 1.0
IN 46319 1.0
IN 46320 1.0
IN 46321 1.0
IN 46322 1.0
IN 46323 1.0
IN 46324 1.0
IN 46325 1.0
IN 46327 1.0
IN 46340 2.0
IN 46341 2.0
IN 46342 1.0
IN 46345 1.0
IN 46346 1.0
IN 46347 2.0
IN 46348 2.0
IN 46349 2.0
IN 46350 1.0
IN 46352 1.0
IN 46355 1.0
IN 46356 2.0
IN 46360 1.0
IN 46361 1.0
IN 46365 2.1
IN 46366 7.3
IN 46368 1.0
IN 46371 2.0
IN 46372 2.0
IN 46373 1.0
IN 46374 7.3
IN 46375 1.0
IN 46376 2.0
IN 46377 2.0
IN 46379 2.0
IN 46380 2.0
IN 46381 10.4
IN 46382 2.0
IN 46383 1.0
IN 46384 1.0
IN 46385 1.0
IN 46390 2.0
IN 46391 2.0
IN 46392 2.0
IN 46393 1.0
IN 46394 1.0
IN 46401 1.0
IN 46402 1.0
IN 46403 1.0
IN 46404 1.0
IN 46405 1.0
IN 46406 1.0
IN 46407 1.0
IN 46408 1.0
IN 46409 1.0
IN 46410 1.0
IN 46411 1.0
IN 46501 10.5
IN 46502 4.0
IN 46504 10.5
IN 46506 7.3
IN 46507 1.0
IN 46508 5.0
IN 46510 5.0
IN 46511 10.5
IN 46513 4.0
IN 46514 1.0
IN 46515 1.0
IN 46516 1.0
IN 46517 1.0
IN 46524 5.0
IN 46526 1.0
IN 46527 1.0
IN 46528 1.0
IN 46530 1.0
IN 46531 9.0
IN 46532 9.0
IN 46534 9.0
IN 46536 2.0
IN 46537 4.0
IN 46538 5.0
IN 46539 5.0
IN 46540 10.1
IN 46542 10.4
IN 46543 2.0
IN 46544 1.0
IN 46545 1.0
IN 46546 1.0
IN 46550 9.0
IN 46552 2.0
IN 46553 1.0
IN 46554 2.0
IN 46555 6.0
IN 46556 1.0
IN 46561 1.0
IN 46562 5.0
IN 46563 4.0
IN 46565 10.0
IN 46566 5.0
IN 46567 7.3
IN 46570 10.5
IN 46571 10.4
IN 46572 4.0
IN 46573 2.0
IN 46574 7.3
IN 46580 4.0
IN 46581 4.0
IN 46582 4.0
IN 46590 4.0
IN 46595 7.3
IN 46601 1.0
IN 46604 1.0
IN 46612 1.0
IN 46613 1.0
IN 46614 1.0
IN 46615 1.0
IN 46616 1.0
IN 46617 1.0
IN 46619 1.0
IN 46620 1.0
IN 46624 1.0
IN 46626 1.0
IN 46628 1.0
IN 46629 1.0
IN 46634 1.0
IN 46635 1.0
IN 46637 1.0
IN 46660 1.0
IN 46680 1.0
IN 46699 1.0
IN 46701 10.5
IN 46702 5.0
IN 46703 4.0
IN 46704 1.0
IN 46705 6.0
IN 46706 4.2
IN 46710 3.0
IN 46711 7.0
IN 46713 4.2
IN 46714 7.3
IN 46720 9.2
IN 46721 7.4
IN 46723 2.0
IN 46725 7.3
IN 46730 6.0
IN 46731 8.3
IN 46732 9.0
IN 46733 4.2
IN 46737 5.2
IN 46738 4.2
IN 46740 10.6
IN 46741 1.0
IN 46742 6.0
IN 46743 2.0
IN 46745 2.0
IN 46746 10.6
IN 46747 5.0
IN 46748 1.0
IN 46750 4.2
IN 46755 4.0
IN 46759 8.0
IN 46760 9.0
IN 46761 7.0
IN 46763 3.0
IN 46764 10.6
IN 46765 1.0
IN 46766 8.0
IN 46767 7.3
IN 46769 7.0
IN 46770 2.0
IN 46771 10.6
IN 46772 10.5
IN 46773 2.0
IN 46774 1.0
IN 46776 5.0
IN 46777 2.0
IN 46778 8.0
IN 46779 6.0
IN 46780 4.2
IN 46781 8.0
IN 46782 4.2
IN 46783 2.0
IN 46784 6.0
IN 46785 5.2
IN 46786 9.0
IN 46787 10.6
IN 46788 2.0
IN 46789 9.0
IN 46791 2.0
IN 46792 10.5
IN 46793 4.2
IN 46794 9.2
IN 46795 9.0
IN 46796 9.0
IN 46797 2.0
IN 46798 2.0
IN 46799 2.0
IN 46801 1.0
IN 46802 1.0
IN 46803 1.0
IN 46804 1.0
IN 46805 1.0
IN 46806 1.0
IN 46807 1.0
IN 46808 1.0
IN 46809 1.0
IN 46814 1.0
IN 46815 1.0
IN 46816 1.0
IN 46818 1.0
IN 46819 1.0
IN 46825 1.0
IN 46835 1.0
IN 46845 1.0
IN 46850 1.0
IN 46851 1.0
IN 46852 1.0
IN 46853 1.0
IN 46854 1.0
IN 46855 1.0
IN 46856 1.0
IN 46857 1.0
IN 46858 1.0
IN 46859 1.0
IN 46860 1.0
IN 46861 1.0
IN 46862 1.0
IN 46863 1.0
IN 46864 1.0
IN 46865 1.0
IN 46866 1.0
IN 46867 1.0
IN 46868 1.0
IN 46869 1.0
IN 46885 1.0
IN 46895 1.0
IN 46896 1.0
IN 46897 1.0
IN 46898 1.0
IN 46899 1.0
IN 46901 1.0
IN 46902 1.0
IN 46903 1.0
IN 46904 1.0
IN 46910 9.0
IN 46911 3.0
IN 46912 7.0
IN 46913 2.0
IN 46914 2.0
IN 46915 2.0
IN 46916 10.4
IN 46917 10.4
IN 46919 3.0
IN 46920 2.0
IN 46921 10.5
IN 46922 7.0
IN 46923 7.3
IN 46926 10.5
IN 46928 5.0
IN 46929 10.4
IN 46930 4.0
IN 46931 7.0
IN 46932 2.0
IN 46933 4.0
IN 46935 10.6
IN 46936 2.0
IN 46937 1.0
IN 46938 4.0
IN 46939 10.6
IN 46940 6.0
IN 46941 5.0
IN 46942 4.0
IN 46943 7.0
IN 46945 7.0
IN 46946 7.0
IN 46947 4.0
IN 46950 5.0
IN 46951 10.5
IN 46952 4.0
IN 46953 4.0
IN 46957 7.4
IN 46958 4.2
IN 46959 2.0
IN 46960 8.0
IN 46961 4.0
IN 46962 7.0
IN 46965 1.0
IN 46967 5.0
IN 46968 8.0
IN 46970 4.2
IN 46971 4.2
IN 46974 5.0
IN 46975 7.0
IN 46977 7.3
IN 46978 5.0
IN 46979 2.0
IN 46980 7.0
IN 46982 5.0
IN 46984 6.0
IN 46985 8.0
IN 46986 5.0
IN 46987 4.0
IN 46988 5.0
IN 46989 7.4
IN 46990 5.0
IN 46991 5.0
IN 46992 4.0
IN 46994 5.0
IN 46995 2.0
IN 46996 7.0
IN 46998 2.0
IN 47001 2.0
IN 47003 6.0
IN 47006 7.0
IN 47010 2.0
IN 47011 10.0
IN 47012 2.0
IN 47016 2.0
IN 47017 10.4
IN 47018 5.1
IN 47019 10.5
IN 47020 10.4
IN 47021 10.6
IN 47022 2.0
IN 47023 10.0
IN 47024 9.2
IN 47025 4.1
IN 47030 3.0
IN 47031 10.4
IN 47032 2.0
IN 47033 7.0
IN 47034 10.5
IN 47035 2.0
IN 47036 7.0
IN 47037 10.5
IN 47038 10.4
IN 47039 10.4
IN 47040 10.5
IN 47041 9.0
IN 47042 10.6
IN 47043 10.4
IN 47060 2.0
IN 47102 4.0
IN 47104 2.0
IN 47106 2.0
IN 47107 2.0
IN 47108 8.0
IN 47110 2.0
IN 47111 2.0
IN 47112 2.0
IN 47114 2.0
IN 47115 2.0
IN 47116 10.5
IN 47117 2.0
IN 47118 10.5
IN 47119 1.0
IN 47120 2.0
IN 47122 1.0
IN 47123 10.5
IN 47124 2.0
IN 47125 10.6
IN 47126 2.0
IN 47129 1.0
IN 47130 1.0
IN 47131 1.0
IN 47132 1.0
IN 47133 1.0
IN 47134 1.0
IN 47135 2.0
IN 47136 2.0
IN 47137 10.4
IN 47138 5.0
IN 47139 4.0
IN 47140 2.0
IN 47141 2.0
IN 47142 2.0
IN 47143 2.0
IN 47144 1.0
IN 47145 2.0
IN 47146 1.0
IN 47147 2.0
IN 47150 1.0
IN 47151 1.0
IN 47160 2.0
IN 47161 2.0
IN 47162 2.0
IN 47163 2.0
IN 47164 2.0
IN 47165 2.0
IN 47166 2.0
IN 47167 7.3
IN 47170 4.0
IN 47172 1.0
IN 47174 10.4
IN 47175 10.5
IN 47177 2.0
IN 47190 1.0
IN 47199 1.0
IN 47201 1.0
IN 47202 1.0
IN 47203 1.0
IN 47220 5.0
IN 47223 5.0
IN 47224 5.0
IN 47225 7.4
IN 47226 1.0
IN 47227 5.0
IN 47228 4.0
IN 47229 5.0
IN 47230 5.0
IN 47231 5.0
IN 47232 2.0
IN 47234 5.2
IN 47235 5.0
IN 47236 2.0
IN 47240 4.0
IN 47243 7.2
IN 47244 2.0
IN 47245 4.2
IN 47246 2.0
IN 47247 1.0
IN 47249 5.0
IN 47250 4.0
IN 47260 5.0
IN 47261 4.0
IN 47263 4.0
IN 47264 5.0
IN 47265 4.2
IN 47270 5.0
IN 47272 5.0
IN 47273 4.2
IN 47274 4.0
IN 47280 1.0
IN 47281 5.0
IN 47282 5.0
IN 47283 5.2
IN 47302 1.0
IN 47303 1.0
IN 47304 1.0
IN 47305 1.0
IN 47306 1.0
IN 47307 1.0
IN 47308 1.0
IN 47320 2.0
IN 47322 4.0
IN 47324 4.0
IN 47325 10.5
IN 47326 8.0
IN 47327 5.0
IN 47330 4.0
IN 47331 4.0
IN 47334 1.0
IN 47335 5.0
IN 47336 7.3
IN 47337 5.0
IN 47338 2.0
IN 47339 5.0
IN 47340 2.0
IN 47341 5.0
IN 47342 2.0
IN 47344 2.0
IN 47345 5.0
IN 47346 5.0
IN 47348 7.0
IN 47351 6.1
IN 47352 5.0
IN 47353 10.5
IN 47354 3.0
IN 47355 6.0
IN 47356 2.0
IN 47357 5.0
IN 47358 3.0
IN 47359 10.6
IN 47360 5.2
IN 47361 4.0
IN 47362 4.0
IN 47366 5.0
IN 47367 1.0
IN 47368 2.0
IN 47369 8.0
IN 47370 5.0
IN 47371 7.0
IN 47373 9.1
IN 47374 4.0
IN 47375 4.0
IN 47380 2.0
IN 47381 8.0
IN 47382 8.0
IN 47383 1.0
IN 47384 6.1
IN 47385 5.0
IN 47386 5.2
IN 47387 5.0
IN 47388 2.0
IN 47390 7.4
IN 47392 5.0
IN 47393 5.0
IN 47394 7.3
IN 47396 1.0
IN 47401 1.0
IN 47402 1.0
IN 47403 1.0
IN 47404 1.0
IN 47405 1.0
IN 47406 1.0
IN 47407 2.0
IN 47408 1.0
IN 47420 6.1
IN 47421 4.2
IN 47424 7.1
IN 47426 1.0
IN 47427 10.0
IN 47429 1.0
IN 47430 4.2
IN 47431 2.0
IN 47432 7.0
IN 47433 3.0
IN 47434 1.0
IN 47435 10.0
IN 47436 5.0
IN 47437 5.0
IN 47438 9.1
IN 47439 2.0
IN 47441 7.0
IN 47443 10.6
IN 47445 7.0
IN 47446 5.0
IN 47448 10.0
IN 47449 10.6
IN 47451 6.1
IN 47452 10.5
IN 47453 2.0
IN 47454 9.0
IN 47455 10.0
IN 47456 2.0
IN 47457 7.1
IN 47458 1.0
IN 47459 2.0
IN 47460 3.0
IN 47462 6.1
IN 47463 1.0
IN 47464 1.0
IN 47465 10.6
IN 47467 4.2
IN 47468 2.0
IN 47469 10.0
IN 47470 5.0
IN 47471 10.4
IN 47490 1.0
IN 47501 4.0
IN 47512 5.0
IN 47513 5.0
IN 47514 10.6
IN 47515 10.6
IN 47516 5.0
IN 47519 10.5
IN 47520 7.0
IN 47521 5.0
IN 47522 10.6
IN 47523 10.5
IN 47524 4.0
IN 47525 10.6
IN 47527 5.0
IN 47528 5.0
IN 47529 10.0
IN 47531 10.0
IN 47532 10.5
IN 47535 5.0
IN 47536 10.5
IN 47537 10.4
IN 47541 10.5
IN 47542 7.2
IN 47545 4.0
IN 47546 4.0
IN 47547 4.0
IN 47549 4.0
IN 47550 10.0
IN 47551 10.6
IN 47552 10.5
IN 47553 7.4
IN 47556 10.5
IN 47557 5.0
IN 47558 10.5
IN 47561 5.0
IN 47562 10.0
IN 47564 5.0
IN 47567 7.0
IN 47568 5.0
IN 47573 5.0
IN 47574 8.0
IN 47575 5.0
IN 47576 10.6
IN 47577 10.5
IN 47578 5.0
IN 47579 10.5
IN 47580 5.0
IN 47581 10.5
IN 47584 9.1
IN 47585 5.0
IN 47586 7.0
IN 47588 8.0
IN 47590 5.0
IN 47591 4.0
IN 47596 5.0
IN 47597 5.0
IN 47598 3.0
IN 47601 2.0
IN 47610 1.0
IN 47611 10.4
IN 47612 2.0
IN 47613 2.0
IN 47614 2.0
IN 47615 10.0
IN 47616 2.0
IN 47617 2.0
IN 47618 2.0
IN 47619 2.0
IN 47620 7.1
IN 47629 1.0
IN 47630 1.0
IN 47631 3.0
IN 47633 2.0
IN 47634 2.0
IN 47635 10.4
IN 47637 2.0
IN 47638 2.0
IN 47639 2.0
IN 47640 8.0
IN 47647 9.1
IN 47648 2.0
IN 47649 8.0
IN 47654 2.0
IN 47660 9.1
IN 47665 3.0
IN 47666 8.0
IN 47670 7.3
IN 47683 2.0
IN 47701 1.0
IN 47702 1.0
IN 47703 1.0
IN 47704 1.0
IN 47705 1.0
IN 47706 1.0
IN 47708 1.0
IN 47710 1.0
IN 47711 1.0
IN 47712 1.0
IN 47713 1.0
IN 47714 1.0
IN 47715 1.0
IN 47716 1.0
IN 47719 1.0
IN 47720 2.0
IN 47721 1.0
IN 47722 1.0
IN 47724 1.0
IN 47725 2.0
IN 47727 1.0
IN 47728 1.0
IN 47730 1.0
IN 47731 1.0
IN 47732 1.0
IN 47733 1.0
IN 47734 1.0
IN 47735 1.0
IN 47736 1.0
IN 47737 1.0
IN 47739 1.0
IN 47740 1.0
IN 47741 1.0
IN 47744 1.0
IN 47747 1.0
IN 47750 1.0
IN 47801 1.0
IN 47802 1.0
IN 47803 1.0
IN 47804 1.0
IN 47805 1.0
IN 47807 1.0
IN 47808 1.0
IN 47809 1.0
IN 47811 1.0
IN 47812 1.0
IN 47813 1.0
IN 47814 1.0
IN 47830 7.1
IN 47831 7.1
IN 47832 10.6
IN 47833 10.0
IN 47834 4.2
IN 47836 3.0
IN 47837 5.2
IN 47838 9.0
IN 47840 3.0
IN 47841 3.0
IN 47842 7.1
IN 47845 9.1
IN 47846 3.0
IN 47847 10.4
IN 47848 9.0
IN 47849 2.0
IN 47850 2.0
IN 47851 4.2
IN 47852 7.3
IN 47853 4.2
IN 47854 10.4
IN 47855 2.0
IN 47856 7.1
IN 47857 4.2
IN 47858 2.0
IN 47859 10.6
IN 47860 7.1
IN 47861 2.0
IN 47862 2.0
IN 47863 1.0
IN 47864 7.3
IN 47865 9.0
IN 47866 2.0
IN 47868 2.0
IN 47869 1.0
IN 47870 1.0
IN 47871 1.0
IN 47872 7.1
IN 47874 2.0
IN 47875 7.1
IN 47876 1.0
IN 47878 1.0
IN 47879 2.0
IN 47880 7.1
IN 47881 4.2
IN 47882 7.3
IN 47884 7.1
IN 47885 1.0
IN 47901 1.0
IN 47902 1.0
IN 47903 1.0
IN 47904 1.0
IN 47905 1.0
IN 47906 1.0
IN 47907 1.0
IN 47909 1.0
IN 47916 4.0
IN 47917 10.4
IN 47918 7.3
IN 47920 2.0
IN 47921 10.4
IN 47922 10.0
IN 47923 2.0
IN 47924 1.0
IN 47925 7.3
IN 47926 8.0
IN 47928 2.0
IN 47929 3.0
IN 47930 2.0
IN 47932 7.3
IN 47933 4.0
IN 47934 4.0
IN 47935 4.0
IN 47936 4.0
IN 47937 4.0
IN 47938 4.0
IN 47939 4.0
IN 47940 5.2
IN 47941 1.0
IN 47942 10.4
IN 47943 3.0
IN 47944 10.4
IN 47946 10.6
IN 47948 10.0
IN 47949 10.5
IN 47950 8.0
IN 47951 10.0
IN 47952 10.5
IN 47954 5.2
IN 47955 6.1
IN 47957 10.6
IN 47958 10.5
IN 47959 10.6
IN 47960 7.3
IN 47962 1.0
IN 47963 10.4
IN 47964 10.4
IN 47965 4.0
IN 47966 2.0
IN 47967 6.1
IN 47968 5.2
IN 47969 7.3
IN 47970 2.0
IN 47971 2.0
IN 47974 2.0
IN 47975 2.0
IN 47977 10.6
IN 47978 7.0
IN 47980 3.0
IN 47981 2.0
IN 47982 7.3
IN 47983 1.0
IN 47984 10.4
IN 47986 10.4
IN 47987 10.5
IN 47988 10.5
IN 47989 5.0
IN 47990 5.0
IN 47991 3.0
IN 47992 2.0
IN 47993 2.0
IN 47994 6.1
IN 47995 10.4
IN 47996 1.0
IN 47997 7.3
KS 66002 4.0
KS 66006 7.3
KS 66007 2.0
KS 66008 10.4
KS 66010 10.4
KS 66012 1.0
KS 66013 2.0
KS 66014 10.1
KS 66015 10.6
KS 66016 5.0
KS 66017 10.0
KS 66018 2.0
KS 66019 2.0
KS 66020 5.0
KS 66021 2.0
KS 66023 5.0
KS 66024 2.0
KS 66025 2.1
KS 66026 2.0
KS 66027 4.2
KS 66030 2.0
KS 66031 2.0
KS 66032 7.0
KS 66033 7.0
KS 66035 10.0
KS 66036 7.1
KS 66039 10.6
KS 66040 10.1
KS 66041 5.0
KS 66042 5.2
KS 66043 4.2
KS 66044 1.0
KS 66045 1.0
KS 66046 1.0
KS 66047 1.0
KS 66048 4.2
KS 66049 1.0
KS 66050 2.0
KS 66051 1.0
KS 66052 2.0
KS 66053 2.0
KS 66054 3.0
KS 66056 10.4
KS 66058 5.0
KS 66060 10.4
KS 66061 1.0
KS 66062 1.0
KS 66063 1.0
KS 66064 7.1
KS 66066 3.0
KS 66067 4.2
KS 66070 2.0
KS 66071 7.1
KS 66072 10.1
KS 66073 2.0
KS 66075 10.4
KS 66076 3.0
KS 66077 4.0
KS 66078 5.2
KS 66079 5.2
KS 66080 5.2
KS 66083 2.0
KS 66085 2.0
KS 66086 2.0
KS 66087 10.4
KS 66088 10.4
KS 66090 2.0
KS 66091 10.6
KS 66092 3.0
KS 66093 10.6
KS 66094 10.0
KS 66095 5.2
KS 66097 10.4
KS 66101 1.0
KS 66102 1.0
KS 66103 1.0
KS 66104 1.0
KS 66105 1.0
KS 66106 1.0
KS 66109 1.0
KS 66110 1.0
KS 66111 1.0
KS 66112 1.0
KS 66113 1.0
KS 66115 1.0
KS 66117 1.0
KS 66118 1.0
KS 66119 1.0
KS 66160 1.0
KS 66201 1.0
KS 66202 1.0
KS 66203 1.0
KS 66204 1.0
KS 66205 1.0
KS 66206 1.0
KS 66207 1.0
KS 66208 1.0
KS 66209 1.0
KS 66210 1.0
KS 66211 1.0
KS 66212 1.0
KS 66213 1.0
KS 66214 1.0
KS 66215 1.0
KS 66216 1.0
KS 66217 1.0
KS 66218 1.0
KS 66219 1.0
KS 66220 1.0
KS 66221 1.0
KS 66222 1.0
KS 66223 1.0
KS 66224 1.0
KS 66225 1.0
KS 66226 1.0
KS 66227 1.0
KS 66250 1.0
KS 66251 1.0
KS 66276 1.0
KS 66279 1.0
KS 66282 1.0
KS 66283 1.0
KS 66285 1.0
KS 66286 1.0
KS 66401 10.4
KS 66402 2.0
KS 66403 10.3
KS 66404 10.0
KS 66406 10.3
KS 66407 10.4
KS 66408 10.0
KS 66409 2.0
KS 66411 10.6
KS 66412 10.3
KS 66413 2.0
KS 66414 2.0
KS 66415 10.0
KS 66416 2.0
KS 66417 10.0
KS 66418 2.0
KS 66419 2.0
KS 66420 1.0
KS 66422 10.4
KS 66423 2.0
KS 66424 10.6
KS 66425 10.0
KS 66426 10.5
KS 66427 10.6
KS 66428 10.0
KS 66429 2.0
KS 66431 2.0
KS 66432 10.5
KS 66434 7.0
KS 66436 7.3
KS 66438 10.3
KS 66439 10.6
KS 66440 2.0
KS 66441 4.0
KS 66442 4.0
KS 66449 4.0
KS 66451 2.0
KS 66501 10.4
KS 66502 4.0
KS 66503 4.0
KS 66505 4.0
KS 66506 4.0
KS 66507 10.4
KS 66508 7.0
KS 66509 2.0
KS 66510 10.4
KS 66512 2.0
KS 66514 5.0
KS 66515 10.0
KS 66516 2.0
KS 66517 4.0
KS 66518 10.3
KS 66520 10.5
KS 66521 10.5
KS 66522 10.0
KS 66523 10.4
KS 66524 2.0
KS 66526 10.4
KS 66527 10.0
KS 66528 2.0
KS 66531 4.0
KS 66532 10.6
KS 66533 2.0
KS 66534 10.0
KS 66535 5.0
KS 66536 10.4
KS 66537 2.0
KS 66538 10.0
KS 66539 2.0
KS 66540 2.0
KS 66541 10.3
KS 66542 1.0
KS 66543 2.0
KS 66544 10.6
KS 66546 2.0
KS 66547 7.4
KS 66548 10.6
KS 66549 10.5
KS 66550 10.0
KS 66552 2.0
KS 66554 4.0
KS 66555 7.0
KS 66601 1.0
KS 66603 1.0
KS 66604 1.0
KS 66605 1.0
KS 66606 1.0
KS 66607 1.0
KS 66608 1.0
KS 66609 1.0
KS 66610 1.0
KS 66611 1.0
KS 66612 1.0
KS 66614 1.0
KS 66615 2.0
KS 66616 1.0
KS 66617 1.0
KS 66618 1.0
KS 66619 1.0
KS 66620 1.0
KS 66621 1.0
KS 66622 1.0
KS 66624 1.0
KS 66625 1.0
KS 66626 1.0
KS 66628 1.0
KS 66629 1.0
KS 66634 1.0
KS 66636 1.0
KS 66637 1.0
KS 66638 1.0
KS 66642 1.0
KS 66647 1.0
KS 66652 1.0
KS 66653 1.0
KS 66658 1.0
KS 66667 1.0
KS 66675 1.0
KS 66683 1.0
KS 66686 1.0
KS 66692 1.0
KS 66699 1.0
KS 66701 7.0
KS 66710 9.0
KS 66711 5.0
KS 66712 5.0
KS 66713 7.3
KS 66714 9.0
KS 66716 8.0
KS 66717 9.0
KS 66720 7.0
KS 66724 5.0
KS 66725 7.3
KS 66728 2.0
KS 66732 10.6
KS 66733 10.6
KS 66734 5.0
KS 66735 5.0
KS 66736 10.6
KS 66738 8.0
KS 66739 2.0
KS 66740 9.0
KS 66741 5.0
KS 66742 7.0
KS 66743 7.2
KS 66746 5.0
KS 66748 10.6
KS 66749 7.0
KS 66751 8.0
KS 66753 5.0
KS 66754 8.0
KS 66755 10.6
KS 66756 5.0
KS 66757 7.4
KS 66758 10.0
KS 66759 10.0
KS 66760 4.0
KS 66761 10.0
KS 66762 4.0
KS 66763 4.0
KS 66767 10.4
KS 66769 8.0
KS 66770 2.0
KS 66771 10.6
KS 66772 10.6
KS 66773 5.0
KS 66775 10.6
KS 66776 9.0
KS 66777 10.0
KS 66778 9.0
KS 66779 8.0
KS 66780 5.0
KS 66781 5.0
KS 66782 5.0
KS 66783 10.6
KS 66801 4.0
KS 66830 5.0
KS 66833 5.0
KS 66834 10.4
KS 66835 5.0
KS 66838 10.0
KS 66839 7.0
KS 66840 10.5
KS 66842 3.0
KS 66843 10.5
KS 66845 10.5
KS 66846 10.0
KS 66849 10.0
KS 66850 10.5
KS 66851 10.5
KS 66852 10.6
KS 66853 10.6
KS 66854 5.0
KS 66855 10.6
KS 66856 10.6
KS 66857 10.6
KS 66858 10.0
KS 66859 10.0
KS 66860 10.6
KS 66861 10.6
KS 66862 10.5
KS 66863 10.6
KS 66864 5.0
KS 66865 5.0
KS 66866 10.5
KS 66868 5.0
KS 66869 10.5
KS 66870 10.6
KS 66871 10.6
KS 66872 10.0
KS 66873 10.0
KS 66901 7.0
KS 66930 10.0
KS 66932 10.0
KS 66933 10.0
KS 66935 10.0
KS 66936 10.0
KS 66937 10.0
KS 66938 10.3
KS 66939 10.0
KS 66940 10.0
KS 66941 10.0
KS 66942 10.0
KS 66943 10.0
KS 66944 10.0
KS 66945 10.0
KS 66946 10.0
KS 66948 10.3
KS 66949 10.6
KS 66951 10.0
KS 66952 10.0
KS 66953 10.0
KS 66955 10.0
KS 66956 10.6
KS 66958 10.0
KS 66959 10.0
KS 66960 10.0
KS 66961 10.0
KS 66962 10.0
KS 66963 10.6
KS 66964 10.0
KS 66966 10.0
KS 66967 10.0
KS 66968 10.0
KS 66970 10.0
KS 67001 2.0
KS 67002 1.0
KS 67003 10.0
KS 67004 2.0
KS 67005 4.0
KS 67008 10.5
KS 67009 10.0
KS 67010 2.0
KS 67012 3.0
KS 67013 2.0
KS 67016 2.0
KS 67017 2.0
KS 67018 10.0
KS 67019 10.5
KS 67020 2.0
KS 67021 10.3
KS 67022 10.6
KS 67023 10.5
KS 67024 10.0
KS 67025 2.0
KS 67026 1.0
KS 67028 10.3
KS 67029 10.0
KS 67030 2.0
KS 67031 2.0
KS 67035 10.6
KS 67036 10.4
KS 67037 1.0
KS 67038 10.5
KS 67039 2.0
KS 67041 4.2
KS 67042 4.2
KS 67045 7.0
KS 67047 10.6
KS 67049 10.4
KS 67050 2.0
KS 67051 10.4
KS 67052 2.0
KS 67053 10.5
KS 67054 10.0
KS 67055 1.0
KS 67056 2.0
KS 67057 10.0
KS 67058 10.4
KS 67059 10.0
KS 67060 1.0
KS 67061 10.0
KS 67062 7.4
KS 67063 7.0
KS 67065 10.0
KS 67066 10.3
KS 67067 1.0
KS 67068 7.3
KS 67070 10.0
KS 67071 10.0
KS 67072 3.0
KS 67073 7.0
KS 67074 3.0
KS 67101 1.0
KS 67102 10.5
KS 67103 2.0
KS 67104 10.0
KS 67105 2.0
KS 67106 2.0
KS 67107 10.5
KS 67108 2.0
KS 67109 10.0
KS 67110 1.0
KS 67111 2.0
KS 67112 10.6
KS 67114 4.2
KS 67117 4.2
KS 67118 2.0
KS 67119 10.4
KS 67120 2.0
KS 67122 10.6
KS 67123 2.0
KS 67124 7.0
KS 67127 10.0
KS 67128 10.6
KS 67131 2.0
KS 67132 3.0
KS 67133 2.0
KS 67134 10.3
KS 67135 2.0
KS 67137 10.6
KS 67138 10.0
KS 67140 10.6
KS 67142 10.6
KS 67143 10.0
KS 67144 2.0
KS 67146 2.0
KS 67147 1.0
KS 67149 2.0
KS 67150 10.0
KS 67151 7.4
KS 67152 7.3
KS 67154 2.0
KS 67155 10.0
KS 67156 4.0
KS 67159 10.6
KS 67201 1.0
KS 67202 1.0
KS 67203 1.0
KS 67204 1.0
KS 67205 1.0
KS 67206 1.0
KS 67207 1.0
KS 67208 1.0
KS 67209 1.0
KS 67210 1.0
KS 67211 1.0
KS 67212 1.0
KS 67213 1.0
KS 67214 1.0
KS 67215 1.0
KS 67216 1.0
KS 67217 1.0
KS 67218 1.0
KS 67219 1.0
KS 67220 1.0
KS 67221 1.0
KS 67223 1.0
KS 67226 1.0
KS 67227 1.0
KS 67228 1.0
KS 67230 1.0
KS 67231 1.0
KS 67232 2.0
KS 67233 2.0
KS 67235 1.0
KS 67236 1.0
KS 67251 1.0
KS 67256 1.0
KS 67257 1.0
KS 67259 1.0
KS 67260 1.0
KS 67275 1.0
KS 67276 1.0
KS 67277 1.0
KS 67278 1.0
KS 67301 4.0
KS 67330 5.0
KS 67332 10.5
KS 67333 10.5
KS 67334 10.0
KS 67335 5.0
KS 67336 10.5
KS 67337 4.0
KS 67340 4.0
KS 67341 5.0
KS 67342 10.5
KS 67344 5.0
KS 67345 10.4
KS 67346 10.4
KS 67347 5.0
KS 67349 10.4
KS 67351 5.0
KS 67352 10.4
KS 67353 10.4
KS 67354 5.0
KS 67355 10.0
KS 67356 10.5
KS 67357 4.0
KS 67360 10.0
KS 67361 10.0
KS 67363 4.0
KS 67364 10.5
KS 67401 4.0
KS 67402 4.0
KS 67410 7.0
KS 67416 5.0
KS 67417 10.3
KS 67418 10.0
KS 67420 7.0
KS 67422 5.0
KS 67423 10.0
KS 67425 5.0
KS 67427 10.6
KS 67428 5.0
KS 67430 10.3
KS 67431 10.6
KS 67432 7.0
KS 67436 10.5
KS 67437 10.0
KS 67438 10.0
KS 67439 7.0
KS 67441 10.6
KS 67442 5.0
KS 67443 5.0
KS 67444 10.6
KS 67445 10.3
KS 67446 10.3
KS 67447 10.6
KS 67448 5.0
KS 67449 10.5
KS 67450 10.3
KS 67451 10.6
KS 67452 10.3
KS 67454 10.3
KS 67455 10.0
KS 67456 7.4
KS 67457 10.6
KS 67458 10.6
KS 67459 10.3
KS 67460 4.0
KS 67464 10.5
KS 67466 10.3
KS 67467 10.5
KS 67468 10.6
KS 67470 5.0
KS 67473 10.0
KS 67474 10.0
KS 67475 10.0
KS 67476 5.0
KS 67478 7.0
KS 67480 10.5
KS 67481 10.0
KS 67482 10.6
KS 67483 10.0
KS 67484 10.5
KS 67485 10.3
KS 67487 10.6
KS 67490 7.0
KS 67491 10.5
KS 67492 10.6
KS 67501 4.0
KS 67502 4.0
KS 67504 4.0
KS 67505 4.0
KS 67510 5.0
KS 67511 5.0
KS 67512 7.0
KS 67513 10.0
KS 67514 5.0
KS 67515 10.0
KS 67516 10.0
KS 67518 10.0
KS 67519 10.0
KS 67520 10.5
KS 67521 10.0
KS 67522 5.0
KS 67523 10.6
KS 67524 10.6
KS 67525 10.2
KS 67526 10.2
KS 67529 10.6
KS 67530 4.0
KS 67543 5.0
KS 67544 5.0
KS 67545 10.0
KS 67546 10.5
KS 67547 10.0
KS 67548 10.5
KS 67550 7.0
KS 67552 10.0
KS 67553 10.0
KS 67554 7.0
KS 67556 10.0
KS 67557 10.0
KS 67559 10.0
KS 67560 10.0
KS 67561 5.0
KS 67563 10.0
KS 67564 5.0
KS 67565 10.5
KS 67566 5.0
KS 67567 5.0
KS 67568 5.0
KS 67570 6.0
KS 67572 10.0
KS 67573 7.0
KS 67574 10.6
KS 67575 10.0
KS 67576 10.0
KS 67578 10.0
KS 67579 7.0
KS 67581 5.0
KS 67583 5.0
KS 67584 10.0
KS 67585 5.0
KS 67601 4.0
KS 67621 10.3
KS 67622 7.0
KS 67623 10.0
KS 67625 10.0
KS 67626 10.6
KS 67627 5.0
KS 67628 10.0
KS 67629 7.0
KS 67631 10.0
KS 67632 10.5
KS 67634 10.6
KS 67635 10.0
KS 67637 5.0
KS 67638 10.0
KS 67639 10.3
KS 67640 10.6
KS 67642 10.0
KS 67643 10.0
KS 67644 10.3
KS 67645 7.0
KS 67646 10.6
KS 67647 10.6
KS 67648 10.6
KS 67649 10.6
KS 67650 10.0
KS 67651 10.0
KS 67653 10.0
KS 67654 7.0
KS 67656 10.0
KS 67657 10.5
KS 67658 10.6
KS 67659 10.0
KS 67660 5.0
KS 67661 7.0
KS 67663 10.5
KS 67664 10.6
KS 67665 7.0
KS 67667 4.0
KS 67669 10.0
KS 67671 5.0
KS 67672 10.0
KS 67673 10.6
KS 67674 5.0
KS 67675 10.0
KS 67701 7.0
KS 67730 10.0
KS 67731 10.0
KS 67732 10.3
KS 67733 8.0
KS 67734 10.3
KS 67735 7.0
KS 67736 10.0
KS 67737 10.0
KS 67738 10.0
KS 67739 10.0
KS 67740 10.0
KS 67741 8.0
KS 67743 10.3
KS 67744 10.0
KS 67745 10.0
KS 67747 10.0
KS 67748 10.0
KS 67749 10.0
KS 67751 10.0
KS 67752 10.0
KS 67753 10.3
KS 67756 10.0
KS 67757 10.0
KS 67758 10.0
KS 67761 10.0
KS 67762 10.0
KS 67764 10.0
KS 67801 4.0
KS 67831 10.5
KS 67834 5.0
KS 67835 10.5
KS 67836 10.0
KS 67837 10.5
KS 67838 10.5
KS 67839 10.0
KS 67840 10.5
KS 67841 10.5
KS 67842 5.0
KS 67843 4.0
KS 67844 10.5
KS 67846 4.0
KS 67849 10.5
KS 67850 10.0
KS 67851 5.0
KS 67853 10.5
KS 67854 10.5
KS 67855 10.0
KS 67857 10.0
KS 67859 5.0
KS 67860 10.5
KS 67861 10.0
KS 67862 10.0
KS 67863 7.0
KS 67864 10.0
KS 67865 10.5
KS 67867 10.5
KS 67868 5.0
KS 67869 10.5
KS 67870 10.0
KS 67871 7.0
KS 67876 5.0
KS 67877 10.0
KS 67878 10.0
KS 67879 10.0
KS 67880 7.0
KS 67882 5.0
KS 67901 4.0
KS 67905 4.0
KS 67950 10.0
KS 67951 7.0
KS 67952 10.6
KS 67953 10.0
KS 67954 10.0
KY 40003 5.0
KY 40004 4.2
KY 40006 3.0
KY 40007 10.0
KY 40008 6.1
KY 40009 8.0
KY 40010 2.0
KY 40011 3.0
KY 40012 6.1
KY 40013 5.1
KY 40014 1.0
KY 40018 1.0
KY 40019 2.0
KY 40020 5.1
KY 40022 2.0
KY 40023 1.0
KY 40025 1.0
KY 40026 1.0
KY 40027 1.0
KY 40031 2.0
KY 40032 2.0
KY 40033 7.0
KY 40036 10.0
KY 40037 10.5
KY 40040 10.0
KY 40041 1.0
KY 40045 6.0
KY 40046 2.0
KY 40047 1.0
KY 40048 4.2
KY 40049 10.5
KY 40050 10.4
KY 40051 5.0
KY 40052 5.0
KY 40055 2.0
KY 40056 1.0
KY 40057 10.0
KY 40058 3.0
KY 40059 1.0
KY 40060 8.0
KY 40061 10.5
KY 40062 8.0
KY 40063 7.0
KY 40065 4.2
KY 40066 4.2
KY 40067 2.0
KY 40068 2.0
KY 40069 10.5
KY 40070 10.4
KY 40071 2.0
KY 40075 3.0
KY 40076 5.0
KY 40077 2.0
KY 40078 10.0
KY 40104 3.0
KY 40107 5.2
KY 40108 10.1
KY 40109 1.0
KY 40110 1.0
KY 40111 10.0
KY 40115 3.0
KY 40117 2.0
KY 40118 1.0
KY 40119 10.0
KY 40121 1.0
KY 40129 1.0
KY 40140 10.4
KY 40142 10.1
KY 40143 10.0
KY 40144 10.0
KY 40145 3.0
KY 40146 10.4
KY 40150 2.0
KY 40152 3.0
KY 40153 10.0
KY 40155 1.0
KY 40157 3.0
KY 40159 1.0
KY 40160 1.0
KY 40161 3.0
KY 40162 2.1
KY 40164 3.0
KY 40165 1.0
KY 40170 10.0
KY 40171 10.4
KY 40175 2.0
KY 40176 3.0
KY 40177 1.0
KY 40178 3.0
KY 40201 1.0
KY 40202 1.0
KY 40203 1.0
KY 40204 1.0
KY 40205 1.0
KY 40206 1.0
KY 40207 1.0
KY 40208 1.0
KY 40209 1.0
KY 40210 1.0
KY 40211 1.0
KY 40212 1.0
KY 40213 1.0
KY 40214 1.0
KY 40215 1.0
KY 40216 1.0
KY 40217 1.0
KY 40218 1.0
KY 40219 1.0
KY 40220 1.0
KY 40221 1.0
KY 40222 1.0
KY 40223 1.0
KY 40224 1.0
KY 40225 1.0
KY 40228 1.0
KY 40229 1.0
KY 40231 1.0
KY 40232 1.0
KY 40233 1.0
KY 40241 1.0
KY 40242 1.0
KY 40243 1.0
KY 40245 1.0
KY 40250 1.0
KY 40251 1.0
KY 40252 1.0
KY 40253 1.0
KY 40255 1.0
KY 40256 1.0
KY 40257 1.0
KY 40258 1.0
KY 40259 1.0
KY 40261 1.0
KY 40266 1.0
KY 40268 1.0
KY 40269 1.0
KY 40270 1.0
KY 40272 1.0
KY 40280 1.0
KY 40281 1.0
KY 40282 1.0
KY 40283 1.0
KY 40285 1.0
KY 40287 1.0
KY 40289 1.0
KY 40290 1.0
KY 40291 1.0
KY 40292 1.0
KY 40293 1.0
KY 40294 1.0
KY 40295 1.0
KY 40296 1.0
KY 40297 1.0
KY 40298 1.0
KY 40299 1.0
KY 40310 7.4
KY 40311 10.5
KY 40312 9.0
KY 40313 7.0
KY 40316 10.5
KY 40317 8.0
KY 40319 8.0
KY 40320 4.2
KY 40322 10.5
KY 40324 4.2
KY 40328 8.0
KY 40329 8.0
KY 40330 7.4
KY 40334 5.0
KY 40336 7.3
KY 40337 5.0
KY 40339 4.1
KY 40340 2.0
KY 40342 7.4
KY 40346 6.0
KY 40347 3.0
KY 40348 4.2
KY 40350 10.5
KY 40351 8.0
KY 40353 4.2
KY 40355 10.4
KY 40356 2.0
KY 40357 4.2
KY 40358 10.6
KY 40359 10.5
KY 40360 10.5
KY 40361 4.2
KY 40362 4.2
KY 40363 10.5
KY 40366 10.5
KY 40370 5.2
KY 40371 10.6
KY 40372 9.1
KY 40374 10.5
KY 40376 7.4
KY 40379 5.2
KY 40380 7.4
KY 40383 4.1
KY 40384 4.1
KY 40385 5.2
KY 40386 4.1
KY 40387 10.5
KY 40390 7.3
KY 40391 4.2
KY 40392 4.2
KY 40402 10.5
KY 40403 4.0
KY 40404 4.0
KY 40405 4.0
KY 40409 7.4
KY 40410 7.4
KY 40419 10.5
KY 40421 10.0
KY 40422 4.0
KY 40423 4.0
KY 40434 10.0
KY 40437 5.0
KY 40440 4.0
KY 40442 10.5
KY 40444 7.4
KY 40445 7.4
KY 40446 7.4
KY 40447 10.0
KY 40448 7.2
KY 40452 4.0
KY 40456 7.4
KY 40460 10.6
KY 40461 6.0
KY 40464 4.0
KY 40467 10.5
KY 40468 5.0
KY 40472 7.3
KY 40473 7.4
KY 40475 4.2
KY 40476 4.2
KY 40481 10.0
KY 40484 7.2
KY 40486 10.5
KY 40488 10.0
KY 40489 10.5
KY 40492 7.4
KY 40495 7.3
KY 40502 1.0
KY 40503 1.0
KY 40504 1.0
KY 40505 1.0
KY 40506 1.0
KY 40507 1.0
KY 40508 1.0
KY 40509 1.0
KY 40510 1.0
KY 40511 1.0
KY 40512 1.0
KY 40513 1.0
KY 40514 1.0
KY 40515 1.0
KY 40516 2.0
KY 40517 1.0
KY 40522 1.0
KY 40523 1.0
KY 40524 1.0
KY 40526 1.0
KY 40533 1.0
KY 40536 1.0
KY 40544 1.0
KY 40546 1.0
KY 40550 1.0
KY 40555 1.0
KY 40574 1.0
KY 40575 1.0
KY 40576 1.0
KY 40577 1.0
KY 40578 1.0
KY 40579 1.0
KY 40580 1.0
KY 40581 1.0
KY 40582 1.0
KY 40583 1.0
KY 40584 1.0
KY 40585 1.0
KY 40586 1.0
KY 40587 1.0
KY 40588 1.0
KY 40589 1.0
KY 40590 1.0
KY 40591 1.0
KY 40592 1.0
KY 40593 1.0
KY 40594 1.0
KY 40595 1.0
KY 40596 1.0
KY 40598 1.0
KY 40601 4.0
KY 40602 4.0
KY 40603 4.0
KY 40604 4.0
KY 40618 4.0
KY 40619 4.0
KY 40620 4.0
KY 40621 4.0
KY 40622 4.0
KY 40701 4.0
KY 40702 4.0
KY 40724 5.0
KY 40729 5.0
KY 40730 7.4
KY 40734 10.2
KY 40737 5.0
KY 40740 4.0
KY 40741 5.0
KY 40742 5.0
KY 40743 5.0
KY 40744 5.0
KY 40745 5.0
KY 40751 5.0
KY 40754 8.0
KY 40755 5.0
KY 40759 10.6
KY 40763 8.0
KY 40769 7.4
KY 40771 4.0
KY 40801 8.0
KY 40803 10.0
KY 40806 7.0
KY 40807 7.0
KY 40808 9.0
KY 40810 9.0
KY 40813 10.2
KY 40815 8.0
KY 40816 10.0
KY 40818 8.0
KY 40819 7.0
KY 40820 8.0
KY 40823 7.0
KY 40824 7.0
KY 40826 10.0
KY 40827 10.0
KY 40828 8.0
KY 40829 7.0
KY 40830 7.0
KY 40831 7.0
KY 40840 10.0
KY 40843 8.0
KY 40844 10.0
KY 40845 10.5
KY 40847 8.0
KY 40849 8.0
KY 40854 7.0
KY 40855 7.0
KY 40856 10.5
KY 40858 10.0
KY 40862 10.0
KY 40863 8.0
KY 40865 8.0
KY 40868 10.0
KY 40870 8.0
KY 40873 7.0
KY 40874 10.0
KY 40902 6.0
KY 40903 10.3
KY 40906 7.4
KY 40913 6.0
KY 40914 8.0
KY 40915 10.3
KY 40921 10.6
KY 40923 9.0
KY 40927 8.0
KY 40930 8.4
KY 40931 8.0
KY 40932 7.0
KY 40935 10.3
KY 40939 10.5
KY 40940 10.5
KY 40941 7.0
KY 40943 9.0
KY 40944 8.0
KY 40946 9.0
KY 40949 10.3
KY 40951 7.0
KY 40953 10.3
KY 40955 10.5
KY 40958 6.0
KY 40962 7.0
KY 40964 7.0
KY 40965 4.0
KY 40972 10.6
KY 40977 10.5
KY 40979 10.0
KY 40981 10.6
KY 40982 8.4
KY 40983 9.0
KY 40988 6.0
KY 40995 10.6
KY 40997 8.4
KY 40999 9.0
KY 41001 1.0
KY 41002 10.4
KY 41003 8.0
KY 41004 2.0
KY 41005 1.0
KY 41006 2.0
KY 41007 2.0
KY 41008 7.0
KY 41010 2.0
KY 41011 1.0
KY 41012 1.0
KY 41014 1.0
KY 41015 1.0
KY 41016 1.0
KY 41017 1.0
KY 41018 1.0
KY 41019 1.0
KY 41022 1.0
KY 41030 2.0
KY 41031 7.3
KY 41033 2.0
KY 41034 5.0
KY 41035 2.0
KY 41037 8.0
KY 41039 8.0
KY 41040 10.1
KY 41041 7.0
KY 41042 1.0
KY 41043 2.0
KY 41044 2.0
KY 41045 8.0
KY 41046 2.0
KY 41048 1.0
KY 41049 10.6
KY 41051 1.0
KY 41052 2.0
KY 41053 2.0
KY 41054 2.0
KY 41055 10.2
KY 41056 4.0
KY 41059 1.0
KY 41061 2.0
KY 41062 4.0
KY 41063 2.0
KY 41064 10.6
KY 41065 10.6
KY 41071 1.0
KY 41072 1.0
KY 41073 1.0
KY 41074 1.0
KY 41075 1.0
KY 41076 1.0
KY 41080 2.0
KY 41081 10.6
KY 41083 8.0
KY 41085 1.0
KY 41086 2.0
KY 41091 1.0
KY 41092 2.0
KY 41093 10.6
KY 41094 1.0
KY 41095 2.0
KY 41096 4.0
KY 41097 2.0
KY 41098 8.0
KY 41099 1.0
KY 41101 1.0
KY 41102 1.0
KY 41105 1.0
KY 41114 1.0
KY 41121 1.0
KY 41124 10.6
KY 41128 10.6
KY 41129 2.0
KY 41132 8.3
KY 41135 10.0
KY 41137 10.0
KY 41139 1.0
KY 41141 10.0
KY 41142 10.6
KY 41143 7.3
KY 41144 2.0
KY 41146 8.3
KY 41149 10.6
KY 41156 2.0
KY 41159 10.6
KY 41160 10.6
KY 41164 10.6
KY 41166 10.0
KY 41168 2.0
KY 41169 1.0
KY 41171 10.6
KY 41173 10.6
KY 41174 4.0
KY 41175 4.0
KY 41179 10.5
KY 41180 9.1
KY 41181 7.3
KY 41183 1.0
KY 41189 10.0
KY 41201 8.0
KY 41203 10.0
KY 41204 8.0
KY 41214 10.0
KY 41216 10.6
KY 41219 8.0
KY 41222 8.0
KY 41224 10.0
KY 41226 8.0
KY 41230 7.3
KY 41231 10.6
KY 41232 8.0
KY 41234 7.0
KY 41238 8.0
KY 41240 7.0
KY 41250 10.6
KY 41254 10.0
KY 41255 8.0
KY 41256 7.0
KY 41257 8.0
KY 41260 8.0
KY 41262 10.0
KY 41263 8.0
KY 41264 8.0
KY 41265 7.0
KY 41267 10.0
KY 41268 8.0
KY 41271 8.0
KY 41274 7.0
KY 41301 10.0
KY 41307 8.0
KY 41310 8.0
KY 41311 10.0
KY 41313 10.0
KY 41314 10.0
KY 41317 8.0
KY 41332 8.0
KY 41333 10.0
KY 41338 10.0
KY 41339 8.0
KY 41342 10.0
KY 41344 10.0
KY 41347 10.0
KY 41348 8.0
KY 41351 10.0
KY 41352 8.0
KY 41360 10.0
KY 41362 10.0
KY 41364 10.0
KY 41365 10.0
KY 41366 8.0
KY 41367 8.0
KY 41368 10.0
KY 41385 8.0
KY 41386 10.0
KY 41390 8.0
KY 41397 10.0
KY 41408 8.0
KY 41410 10.0
KY 41413 7.0
KY 41419 10.0
KY 41421 7.0
KY 41422 10.0
KY 41425 8.0
KY 41426 10.0
KY 41433 10.0
KY 41451 7.0
KY 41459 7.0
KY 41464 10.0
KY 41465 10.0
KY 41472 7.0
KY 41477 7.0
KY 41501 9.0
KY 41502 9.0
KY 41503 10.6
KY 41512 9.0
KY 41513 10.6
KY 41514 10.6
KY 41517 10.0
KY 41519 10.0
KY 41520 10.0
KY 41522 9.0
KY 41524 10.0
KY 41526 9.0
KY 41527 10.6
KY 41528 10.0
KY 41531 10.0
KY 41534 9.0
KY 41535 10.0
KY 41537 10.0
KY 41538 10.0
KY 41539 9.0
KY 41540 10.0
KY 41542 9.0
KY 41543 10.0
KY 41544 10.0
KY 41546 10.0
KY 41547 10.0
KY 41548 10.0
KY 41549 10.0
KY 41553 10.0
KY 41554 10.0
KY 41555 10.0
KY 41557 9.0
KY 41558 10.0
KY 41559 10.6
KY 41560 9.0
KY 41561 9.0
KY 41562 10.3
KY 41563 9.0
KY 41564 10.0
KY 41566 10.0
KY 41567 10.0
KY 41568 10.0
KY 41571 10.0
KY 41572 8.0
KY 41601 10.6
KY 41602 10.6
KY 41603 10.0
KY 41604 10.0
KY 41605 10.0
KY 41606 10.0
KY 41607 10.6
KY 41612 10.0
KY 41615 10.0
KY 41616 10.6
KY 41619 10.6
KY 41621 10.6
KY 41622 10.6
KY 41630 10.6
KY 41631 10.6
KY 41632 10.0
KY 41635 10.6
KY 41636 10.6
KY 41640 10.6
KY 41642 10.0
KY 41643 10.6
KY 41645 10.6
KY 41647 10.6
KY 41649 10.6
KY 41650 10.0
KY 41651 10.6
KY 41653 10.6
KY 41655 10.6
KY 41659 10.0
KY 41660 10.6
KY 41663 10.0
KY 41666 10.6
KY 41667 10.0
KY 41669 10.0
KY 41701 8.0
KY 41702 8.0
KY 41712 8.0
KY 41713 8.0
KY 41714 10.0
KY 41719 8.0
KY 41721 10.6
KY 41722 8.0
KY 41723 8.0
KY 41725 9.0
KY 41727 8.0
KY 41729 8.0
KY 41730 10.0
KY 41731 10.3
KY 41735 10.3
KY 41736 8.0
KY 41739 8.0
KY 41740 9.0
KY 41743 8.0
KY 41745 10.6
KY 41746 8.0
KY 41747 8.0
KY 41749 10.0
KY 41751 8.0
KY 41754 8.0
KY 41759 10.6
KY 41760 8.0
KY 41762 10.0
KY 41763 10.3
KY 41764 10.0
KY 41766 10.0
KY 41772 9.0
KY 41773 8.0
KY 41774 8.0
KY 41775 10.0
KY 41776 10.0
KY 41777 10.0
KY 41778 8.0
KY 41804 10.0
KY 41810 10.0
KY 41812 10.0
KY 41815 10.0
KY 41817 10.0
KY 41819 10.0
KY 41821 10.0
KY 41822 10.6
KY 41824 10.0
KY 41825 10.0
KY 41826 10.0
KY 41828 10.0
KY 41831 10.6
KY 41832 10.0
KY 41833 10.0
KY 41834 10.6
KY 41835 10.0
KY 41836 10.6
KY 41837 10.0
KY 41838 10.0
KY 41839 10.0
KY 41840 10.0
KY 41843 10.6
KY 41844 10.0
KY 41845 10.0
KY 41847 10.6
KY 41848 10.0
KY 41849 10.0
KY 41855 10.0
KY 41858 10.0
KY 41859 10.0
KY 41861 10.0
KY 41862 10.0
KY 41901 1.0
KY 41902 1.0
KY 41903 1.0
KY 41904 1.0
KY 41905 1.0
KY 41906 1.0
KY 42001 4.0
KY 42002 4.0
KY 42003 4.0
KY 42020 5.0
KY 42021 10.5
KY 42022 10.2
KY 42023 10.5
KY 42024 10.5
KY 42025 7.4
KY 42027 5.0
KY 42028 10.5
KY 42029 10.5
KY 42031 10.6
KY 42032 10.6
KY 42033 7.0
KY 42035 5.0
KY 42036 5.0
KY 42037 7.0
KY 42038 10.6
KY 42039 5.0
KY 42040 5.0
KY 42041 7.4
KY 42044 10.0
KY 42045 5.0
KY 42047 10.5
KY 42048 9.0
KY 42049 5.0
KY 42050 10.5
KY 42051 5.0
KY 42053 5.0
KY 42054 5.0
KY 42055 10.6
KY 42056 10.2
KY 42058 5.0
KY 42060 5.0
KY 42061 5.0
KY 42063 5.0
KY 42064 7.0
KY 42066 4.0
KY 42069 5.0
KY 42070 10.5
KY 42071 4.0
KY 42076 5.0
KY 42078 10.5
KY 42079 5.0
KY 42081 5.0
KY 42082 5.0
KY 42083 5.0
KY 42084 7.0
KY 42085 5.0
KY 42086 5.0
KY 42087 10.5
KY 42088 5.0
KY 42101 1.0
KY 42102 1.0
KY 42103 1.0
KY 42104 1.0
KY 42120 8.3
KY 42122 2.0
KY 42123 5.0
KY 42124 5.0
KY 42127 7.4
KY 42128 2.0
KY 42129 10.5
KY 42130 5.0
KY 42131 5.0
KY 42133 10.0
KY 42134 7.3
KY 42135 7.3
KY 42140 10.0
KY 42141 4.0
KY 42142 4.0
KY 42150 7.3
KY 42151 10.0
KY 42152 4.0
KY 42153 8.3
KY 42154 6.0
KY 42156 5.0
KY 42157 10.0
KY 42159 2.0
KY 42160 5.0
KY 42163 2.0
KY 42164 7.3
KY 42166 5.0
KY 42167 10.0
KY 42170 2.0
KY 42171 2.0
KY 42201 10.4
KY 42202 10.4
KY 42203 10.0
KY 42204 10.4
KY 42206 10.6
KY 42207 2.0
KY 42209 10.4
KY 42210 2.0
KY 42211 7.4
KY 42214 6.0
KY 42215 5.0
KY 42216 10.5
KY 42217 5.0
KY 42219 10.4
KY 42220 10.5
KY 42221 1.0
KY 42223 1.0
KY 42232 5.2
KY 42234 10.4
KY 42235 1.0
KY 42236 5.0
KY 42240 4.2
KY 42241 4.2
KY 42251 10.4
KY 42252 10.4
KY 42254 5.0
KY 42256 8.0
KY 42257 2.0
KY 42259 10.4
KY 42261 10.4
KY 42262 1.0
KY 42265 7.0
KY 42266 1.0
KY 42267 10.4
KY 42270 1.0
KY 42273 10.4
KY 42274 2.0
KY 42275 10.4
KY 42276 7.0
KY 42280 10.0
KY 42283 10.6
KY 42285 2.0
KY 42286 10.4
KY 42287 10.4
KY 42288 10.4
KY 42301 1.0
KY 42302 1.0
KY 42303 1.0
KY 42304 1.0
KY 42320 7.3
KY 42321 6.0
KY 42322 10.4
KY 42323 6.0
KY 42324 9.0
KY 42325 6.0
KY 42326 6.0
KY 42327 10.4
KY 42328 8.0
KY 42330 4.0
KY 42332 4.0
KY 42333 7.3
KY 42334 1.0
KY 42337 6.0
KY 42338 7.3
KY 42339 9.0
KY 42343 2.0
KY 42344 10.5
KY 42345 10.5
KY 42347 7.3
KY 42348 7.0
KY 42349 8.0
KY 42350 3.0
KY 42351 10.4
KY 42352 2.0
KY 42354 8.0
KY 42355 2.0
KY 42356 1.0
KY 42361 8.0
KY 42364 7.0
KY 42366 2.0
KY 42367 10.5
KY 42368 10.4
KY 42369 8.0
KY 42370 8.0
KY 42371 10.4
KY 42372 3.0
KY 42374 4.0
KY 42375 1.0
KY 42376 2.0
KY 42377 1.0
KY 42378 2.0
KY 42402 1.0
KY 42403 10.5
KY 42404 10.5
KY 42406 2.0
KY 42408 7.2
KY 42409 10.4
KY 42410 4.0
KY 42411 8.0
KY 42413 5.0
KY 42419 1.0
KY 42420 1.0
KY 42431 4.0
KY 42436 5.0
KY 42437 7.0
KY 42440 4.0
KY 42441 5.0
KY 42442 5.0
KY 42444 10.4
KY 42445 7.0
KY 42450 7.4
KY 42451 2.0
KY 42452 2.0
KY 42453 5.0
KY 42455 10.4
KY 42456 10.4
KY 42457 2.0
KY 42458 2.0
KY 42459 10.6
KY 42460 10.6
KY 42461 8.0
KY 42462 7.0
KY 42463 10.5
KY 42464 5.0
KY 42501 4.0
KY 42502 4.0
KY 42503 4.0
KY 42516 10.0
KY 42518 5.0
KY 42519 5.0
KY 42528 10.5
KY 42533 4.0
KY 42539 10.5
KY 42541 10.0
KY 42544 5.0
KY 42553 5.0
KY 42558 5.0
KY 42564 4.0
KY 42565 10.5
KY 42566 10.0
KY 42567 5.0
KY 42602 10.0
KY 42603 8.0
KY 42629 10.0
KY 42631 10.5
KY 42633 7.0
KY 42634 6.0
KY 42635 10.0
KY 42638 10.5
KY 42642 10.0
KY 42647 10.5
KY 42649 10.0
KY 42653 10.5
KY 42701 1.0
KY 42702 1.0
KY 42711 10.0
KY 42712 8.3
KY 42713 10.0
KY 42715 8.0
KY 42716 3.0
KY 42717 10.0
KY 42718 4.0
KY 42719 4.0
KY 42720 7.0
KY 42721 8.0
KY 42722 10.6
KY 42724 2.0
KY 42726 8.0
KY 42728 7.0
KY 42729 10.6
KY 42731 10.5
KY 42732 2.0
KY 42733 5.0
KY 42735 7.0
KY 42740 2.0
KY 42741 8.0
KY 42742 8.0
KY 42743 10.5
KY 42746 10.6
KY 42748 7.3
KY 42749 7.4
KY 42753 9.2
KY 42754 7.0
KY 42755 7.0
KY 42757 10.0
KY 42758 4.0
KY 42759 10.0
KY 42762 7.0
KY 42764 3.0
KY 42765 10.6
KY 42776 2.0
KY 42782 10.0
KY 42783 2.0
KY 42784 2.0
KY 42786 10.0
KY 42788 2.0
LA 70001 1.0
LA 70002 1.0
LA 70003 1.0
LA 70004 1.0
LA 70005 1.0
LA 70006 1.0
LA 70009 1.0
LA 70010 1.0
LA 70011 1.0
LA 70030 5.1
LA 70031 2.0
LA 70032 1.0
LA 70033 1.0
LA 70036 2.0
LA 70037 1.0
LA 70038 7.3
LA 70039 2.0
LA 70040 2.0
LA 70041 7.3
LA 70043 1.0
LA 70044 1.0
LA 70047 2.0
LA 70049 2.0
LA 70050 7.3
LA 70051 4.1
LA 70052 7.4
LA 70053 1.0
LA 70054 1.0
LA 70055 1.0
LA 70056 1.0
LA 70057 2.0
LA 70058 1.0
LA 70059 1.0
LA 70060 1.0
LA 70062 1.0
LA 70063 1.0
LA 70064 1.0
LA 70065 1.0
LA 70067 2.0
LA 70068 4.1
LA 70069 4.1
LA 70070 2.0
LA 70071 7.4
LA 70072 1.0
LA 70073 1.0
LA 70075 1.0
LA 70076 4.1
LA 70078 2.0
LA 70079 2.0
LA 70080 5.1
LA 70081 2.0
LA 70082 2.0
LA 70083 7.3
LA 70084 4.1
LA 70085 1.0
LA 70086 10.4
LA 70087 1.0
LA 70090 9.2
LA 70091 7.3
LA 70092 1.0
LA 70094 1.0
LA 70096 1.0
LA 70112 1.0
LA 70113 1.0
LA 70114 1.0
LA 70115 1.0
LA 70116 1.0
LA 70117 1.0
LA 70118 1.0
LA 70119 1.0
LA 70121 1.0
LA 70122 1.0
LA 70123 1.0
LA 70124 1.0
LA 70125 1.0
LA 70126 1.0
LA 70127 1.0
LA 70128 1.0
LA 70129 1.0
LA 70130 1.0
LA 70131 1.0
LA 70139 1.0
LA 70140 1.0
LA 70141 1.0
LA 70142 1.0
LA 70143 1.0
LA 70145 1.0
LA 70146 1.0
LA 70148 1.0
LA 70149 1.0
LA 70150 1.0
LA 70151 1.0
LA 70152 1.0
LA 70153 1.0
LA 70154 1.0
LA 70156 1.0
LA 70157 1.0
LA 70158 1.0
LA 70159 1.0
LA 70160 1.0
LA 70161 1.0
LA 70162 1.0
LA 70163 1.0
LA 70164 1.0
LA 70165 1.0
LA 70166 1.0
LA 70167 1.0
LA 70170 1.0
LA 70172 1.0
LA 70174 1.0
LA 70175 1.0
LA 70176 1.0
LA 70177 1.0
LA 70178 1.0
LA 70179 1.0
LA 70181 1.0
LA 70182 1.0
LA 70183 1.0
LA 70184 1.0
LA 70185 1.0
LA 70186 1.0
LA 70187 1.0
LA 70189 1.0
LA 70190 1.0
LA 70195 1.0
LA 70301 1.0
LA 70302 1.0
LA 70310 1.0
LA 70339 7.3
LA 70340 4.0
LA 70341 4.2
LA 70342 4.0
LA 70343 1.0
LA 70344 1.0
LA 70345 4.2
LA 70346 4.2
LA 70352 1.0
LA 70353 2.0
LA 70354 4.2
LA 70355 2.0
LA 70356 2.0
LA 70357 4.2
LA 70358 2.0
LA 70359 1.0
LA 70360 1.0
LA 70361 1.0
LA 70363 1.0
LA 70364 1.0
LA 70371 1.0
LA 70372 1.0
LA 70373 4.2
LA 70374 1.0
LA 70375 2.0
LA 70377 1.0
LA 70380 4.0
LA 70381 4.0
LA 70390 4.2
LA 70391 4.2
LA 70392 4.0
LA 70393 4.2
LA 70394 1.0
LA 70395 1.0
LA 70397 2.0
LA 70401 4.0
LA 70402 4.0
LA 70403 4.0
LA 70404 4.0
LA 70420 2.1
LA 70421 4.0
LA 70422 7.2
LA 70426 5.0
LA 70427 4.2
LA 70429 4.2
LA 70431 2.1
LA 70433 1.1
LA 70434 1.1
LA 70435 2.1
LA 70436 7.2
LA 70437 2.0
LA 70438 6.0
LA 70441 10.4
LA 70442 10.5
LA 70443 5.0
LA 70444 10.5
LA 70445 1.1
LA 70446 5.0
LA 70447 2.1
LA 70448 1.1
LA 70449 2.0
LA 70450 10.0
LA 70451 4.0
LA 70452 1.1
LA 70453 3.0
LA 70454 4.0
LA 70455 5.0
LA 70456 7.2
LA 70457 2.1
LA 70458 1.1
LA 70459 1.1
LA 70460 1.1
LA 70461 1.1
LA 70462 2.0
LA 70463 4.2
LA 70464 2.1
LA 70465 10.5
LA 70466 4.0
LA 70467 5.0
LA 70469 1.1
LA 70470 1.1
LA 70471 1.1
LA 70501 1.0
LA 70502 1.0
LA 70503 1.0
LA 70504 1.0
LA 70505 1.0
LA 70506 1.0
LA 70507 1.0
LA 70508 1.0
LA 70509 1.0
LA 70510 4.2
LA 70511 4.2
LA 70512 2.0
LA 70513 4.2
LA 70514 4.0
LA 70515 10.5
LA 70516 6.1
LA 70517 2.0
LA 70518 1.0
LA 70519 7.1
LA 70520 1.0
LA 70521 2.0
LA 70522 4.0
LA 70523 9.2
LA 70524 4.0
LA 70525 7.3
LA 70526 4.2
LA 70527 4.2
LA 70528 4.2
LA 70529 1.0
LA 70531 6.1
LA 70532 10.5
LA 70533 4.2
LA 70534 6.0
LA 70535 4.0
LA 70537 6.1
LA 70538 4.0
LA 70540 4.0
LA 70541 4.2
LA 70542 10.6
LA 70543 6.1
LA 70544 9.2
LA 70546 4.0
LA 70548 7.4
LA 70549 9.2
LA 70550 4.2
LA 70551 4.2
LA 70552 5.0
LA 70554 7.0
LA 70555 2.0
LA 70556 6.0
LA 70558 1.0
LA 70559 6.0
LA 70560 4.2
LA 70562 4.2
LA 70563 4.2
LA 70569 4.2
LA 70570 4.2
LA 70571 4.2
LA 70575 4.2
LA 70576 7.0
LA 70577 5.0
LA 70578 7.1
LA 70580 7.0
LA 70581 7.3
LA 70582 7.1
LA 70583 1.0
LA 70584 2.0
LA 70585 7.0
LA 70586 7.0
LA 70589 5.0
LA 70591 7.3
LA 70592 1.0
LA 70593 1.0
LA 70596 1.0
LA 70598 1.0
LA 70601 1.0
LA 70602 1.0
LA 70605 1.0
LA 70606 1.0
LA 70607 1.0
LA 70609 1.0
LA 70611 1.0
LA 70612 1.0
LA 70615 1.0
LA 70616 1.0
LA 70629 1.0
LA 70630 2.0
LA 70631 10.4
LA 70632 2.0
LA 70633 2.0
LA 70634 4.0
LA 70637 10.5
LA 70638 7.0
LA 70639 8.0
LA 70640 10.4
LA 70643 2.0
LA 70644 10.4
LA 70645 10.4
LA 70646 2.0
LA 70647 2.0
LA 70648 10.4
LA 70650 2.0
LA 70651 10.4
LA 70652 2.0
LA 70653 6.0
LA 70654 10.4
LA 70655 10.0
LA 70656 10.5
LA 70657 2.0
LA 70658 10.4
LA 70659 7.3
LA 70660 2.0
LA 70661 2.0
LA 70662 10.5
LA 70663 1.0
LA 70664 1.0
LA 70665 1.0
LA 70668 2.0
LA 70669 1.0
LA 70704 1.0
LA 70706 1.0
LA 70707 1.0
LA 70710 4.1
LA 70711 2.0
LA 70712 10.0
LA 70714 1.0
LA 70715 10.6
LA 70718 1.0
LA 70719 4.1
LA 70721 2.0
LA 70722 2.0
LA 70723 10.6
LA 70725 1.0
LA 70726 1.0
LA 70727 1.0
LA 70728 1.0
LA 70729 2.0
LA 70730 2.0
LA 70732 2.0
LA 70733 2.0
LA 70734 1.0
LA 70736 8.3
LA 70737 1.0
LA 70738 1.0
LA 70739 1.0
LA 70740 4.1
LA 70743 7.4
LA 70744 2.0
LA 70747 10.6
LA 70748 2.0
LA 70749 7.1
LA 70750 10.4
LA 70752 8.3
LA 70753 10.6
LA 70754 2.0
LA 70755 2.0
LA 70756 2.0
LA 70757 2.0
LA 70759 8.3
LA 70760 7.1
LA 70761 3.0
LA 70762 8.3
LA 70763 7.4
LA 70764 4.1
LA 70765 4.1
LA 70767 1.0
LA 70769 1.0
LA 70770 1.0
LA 70772 2.0
LA 70773 7.1
LA 70774 1.0
LA 70775 10.1
LA 70776 7.0
LA 70777 2.0
LA 70778 1.0
LA 70780 2.0
LA 70782 10.1
LA 70783 7.1
LA 70784 10.1
LA 70785 1.0
LA 70786 1.0
LA 70787 10.1
LA 70788 5.2
LA 70789 3.0
LA 70791 1.0
LA 70792 10.6
LA 70801 1.0
LA 70802 1.0
LA 70803 1.0
LA 70804 1.0
LA 70805 1.0
LA 70806 1.0
LA 70807 1.0
LA 70808 1.0
LA 70809 1.0
LA 70810 1.0
LA 70811 1.0
LA 70812 1.0
LA 70813 1.0
LA 70814 1.0
LA 70815 1.0
LA 70816 1.0
LA 70817 1.0
LA 70818 1.0
LA 70819 1.0
LA 70820 1.0
LA 70821 1.0
LA 70822 1.0
LA 70823 1.0
LA 70825 1.0
LA 70826 1.0
LA 70827 1.0
LA 70831 1.0
LA 70833 1.0
LA 70835 1.0
LA 70836 1.0
LA 70837 1.0
LA 70874 1.0
LA 70879 1.0
LA 70883 1.0
LA 70884 1.0
LA 70892 1.0
LA 70893 1.0
LA 70894 1.0
LA 70895 1.0
LA 70896 1.0
LA 70898 1.0
LA 71001 7.4
LA 71002 3.0
LA 71003 9.0
LA 71004 2.0
LA 71006 2.0
LA 71007 2.0
LA 71008 10.5
LA 71009 1.0
LA 71016 3.0
LA 71018 9.0
LA 71019 8.0
LA 71021 9.0
LA 71023 2.0
LA 71024 5.2
LA 71025 8.0
LA 71027 2.0
LA 71028 9.0
LA 71029 2.0
LA 71030 2.0
LA 71031 5.0
LA 71032 2.0
LA 71033 2.0
LA 71034 8.0
LA 71036 8.0
LA 71037 1.0
LA 71038 8.0
LA 71039 5.2
LA 71040 7.0
LA 71043 2.0
LA 71044 2.0
LA 71045 3.0
LA 71046 2.0
LA 71047 2.0
LA 71048 9.0
LA 71049 2.0
LA 71050 2.0
LA 71051 1.0
LA 71052 7.3
LA 71055 4.2
LA 71058 4.2
LA 71060 2.0
LA 71061 2.0
LA 71063 8.3
LA 71064 2.0
LA 71065 9.0
LA 71066 4.0
LA 71067 2.0
LA 71068 2.0
LA 71069 2.0
LA 71070 10.5
LA 71071 9.0
LA 71072 9.2
LA 71073 5.2
LA 71075 7.0
LA 71078 2.0
LA 71079 9.0
LA 71080 9.0
LA 71082 7.1
LA 71101 1.0
LA 71102 1.0
LA 71103 1.0
LA 71104 1.0
LA 71105 1.0
LA 71106 1.0
LA 71107 1.0
LA 71108 1.0
LA 71109 1.0
LA 71110 1.0
LA 71111 1.0
LA 71112 1.0
LA 71113 1.0
LA 71115 1.0
LA 71118 1.0
LA 71119 1.0
LA 71120 1.0
LA 71129 1.0
LA 71130 1.0
LA 71133 1.0
LA 71134 1.0
LA 71135 1.0
LA 71136 1.0
LA 71137 1.0
LA 71138 1.0
LA 71148 1.0
LA 71149 1.0
LA 71151 1.0
LA 71152 1.0
LA 71153 1.0
LA 71154 1.0
LA 71156 1.0
LA 71161 1.0
LA 71162 1.0
LA 71163 1.0
LA 71164 1.0
LA 71165 1.0
LA 71166 1.0
LA 71171 1.0
LA 71172 1.0
LA 71201 1.0
LA 71202 1.0
LA 71203 1.0
LA 71207 1.0
LA 71208 1.0
LA 71209 1.0
LA 71210 1.0
LA 71211 1.0
LA 71212 1.0
LA 71213 1.0
LA 71218 2.0
LA 71219 9.0
LA 71220 4.2
LA 71221 4.2
LA 71222 10.5
LA 71223 5.0
LA 71225 2.0
LA 71226 3.0
LA 71227 5.2
LA 71229 5.2
LA 71230 8.0
LA 71232 7.0
LA 71233 4.0
LA 71234 2.0
LA 71235 5.0
LA 71237 10.6
LA 71238 2.0
LA 71240 1.0
LA 71241 2.0
LA 71242 10.0
LA 71243 8.0
LA 71245 4.0
LA 71247 7.0
LA 71249 8.0
LA 71250 5.0
LA 71251 7.0
LA 71253 10.0
LA 71254 7.0
LA 71256 10.5
LA 71259 2.0
LA 71260 10.6
LA 71261 5.2
LA 71263 10.0
LA 71264 5.2
LA 71266 10.6
LA 71268 6.0
LA 71269 7.1
LA 71270 4.0
LA 71272 4.0
LA 71273 4.0
LA 71275 5.0
LA 71276 10.3
LA 71277 10.5
LA 71279 7.1
LA 71280 2.0
LA 71281 1.0
LA 71282 4.0
LA 71284 4.0
LA 71286 10.3
LA 71291 1.0
LA 71292 2.0
LA 71294 1.0
LA 71295 8.0
LA 71301 1.0
LA 71302 1.0
LA 71303 1.0
LA 71306 1.0
LA 71307 1.0
LA 71309 1.0
LA 71315 1.0
LA 71316 10.5
LA 71320 9.0
LA 71322 7.3
LA 71323 2.0
LA 71324 8.0
LA 71325 2.0
LA 71326 10.0
LA 71327 9.0
LA 71328 2.0
LA 71329 9.0
LA 71330 7.0
LA 71331 2.0
LA 71333 9.0
LA 71334 7.4
LA 71336 8.0
LA 71339 10.6
LA 71340 10.0
LA 71341 9.0
LA 71342 7.0
LA 71343 10.0
LA 71345 5.0
LA 71346 2.0
LA 71348 1.0
LA 71350 9.0
LA 71351 7.0
LA 71353 6.0
LA 71354 10.5
LA 71355 9.0
LA 71356 6.0
LA 71357 10.0
LA 71358 5.0
LA 71359 1.0
LA 71360 1.0
LA 71361 1.0
LA 71362 9.0
LA 71363 10.0
LA 71365 1.0
LA 71366 10.0
LA 71367 10.6
LA 71368 10.0
LA 71369 10.6
LA 71371 8.0
LA 71373 4.0
LA 71375 10.0
LA 71377 10.0
LA 71378 10.6
LA 71401 10.0
LA 71403 9.0
LA 71404 8.0
LA 71405 1.0
LA 71406 8.0
LA 71407 2.0
LA 71409 2.0
LA 71410 7.0
LA 71411 5.0
LA 71414 4.0
LA 71415 10.0
LA 71416 5.0
LA 71417 10.1
LA 71418 2.0
LA 71419 9.0
LA 71422 8.0
LA 71423 2.0
LA 71424 2.0
LA 71425 10.0
LA 71426 9.0
LA 71427 2.0
LA 71428 5.0
LA 71429 9.0
LA 71430 10.1
LA 71431 2.0
LA 71432 10.4
LA 71433 10.1
LA 71434 5.0
LA 71435 10.0
LA 71438 2.0
LA 71439 9.0
LA 71440 7.0
LA 71441 10.0
LA 71443 7.3
LA 71446 7.3
LA 71447 2.0
LA 71448 10.1
LA 71449 8.0
LA 71450 5.0
LA 71452 5.0
LA 71454 10.4
LA 71455 2.0
LA 71456 5.0
LA 71457 4.0
LA 71458 4.0
LA 71459 4.0
LA 71460 9.0
LA 71461 7.4
LA 71462 9.0
LA 71463 7.0
LA 71465 10.6
LA 71466 2.0
LA 71467 2.0
LA 71468 5.0
LA 71469 5.0
LA 71471 4.0
LA 71472 2.0
LA 71473 8.0
LA 71474 7.3
LA 71475 7.3
LA 71477 1.0
LA 71479 10.6
LA 71480 10.6
LA 71483 7.0
LA 71485 2.0
LA 71486 9.0
LA 71496 7.3
LA 71497 4.0
MA 01001 1.0
MA 01002 4.1
MA 01003 4.1
MA 01004 4.1
MA 01005 2.0
MA 01007 4.1
MA 01008 2.0
MA 01009 1.0
MA 01010 2.1
MA 01011 2.0
MA 01012 2.0
MA 01013 1.0
MA 01014 1.0
MA 01020 1.0
MA 01021 1.0
MA 01022 1.0
MA 01026 2.0
MA 01027 1.0
MA 01028 1.0
MA 01029 10.4
MA 01030 1.0
MA 01031 2.1
MA 01032 2.0
MA 01033 1.0
MA 01034 2.0
MA 01035 1.0
MA 01036 1.0
MA 01037 2.0
MA 01038 1.0
MA 01039 2.0
MA 01040 1.0
MA 01041 1.0
MA 01050 2.0
MA 01053 1.0
MA 01054 6.1
MA 01056 1.0
MA 01057 2.0
MA 01059 4.1
MA 01060 1.0
MA 01061 1.0
MA 01062 1.0
MA 01063 1.0
MA 01066 1.0
MA 01068 1.0
MA 01069 1.0
MA 01070 2.0
MA 01071 2.0
MA 01072 6.1
MA 01073 2.0
MA 01074 2.0
MA 01075 1.0
MA 01077 1.0
MA 01079 1.0
MA 01080 1.0
MA 01081 2.1
MA 01082 2.0
MA 01083 2.0
MA 01084 2.0
MA 01085 1.0
MA 01086 1.0
MA 01088 1.0
MA 01089 1.0
MA 01090 1.0
MA 01092 2.0
MA 01093 3.0
MA 01094 2.1
MA 01095 1.0
MA 01096 2.0
MA 01097 1.0
MA 01098 2.0
MA 01101 1.0
MA 01102 1.0
MA 01103 1.0
MA 01104 1.0
MA 01105 1.0
MA 01106 1.0
MA 01107 1.0
MA 01108 1.0
MA 01109 1.0
MA 01111 1.0
MA 01114 1.0
MA 01115 1.0
MA 01116 1.0
MA 01118 1.0
MA 01119 1.0
MA 01128 1.0
MA 01129 1.0
MA 01133 1.0
MA 01138 1.0
MA 01139 1.0
MA 01144 1.0
MA 01151 1.0
MA 01152 1.0
MA 01195 1.0
MA 01199 1.0
MA 01201 1.0
MA 01202 1.0
MA 01203 1.0
MA 01220 4.2
MA 01222 10.6
MA 01223 2.0
MA 01224 1.0
MA 01225 2.0
MA 01226 1.0
MA 01227 1.0
MA 01229 3.0
MA 01230 7.3
MA 01235 2.0
MA 01236 7.3
MA 01237 1.0
MA 01238 7.3
MA 01240 7.3
MA 01242 7.3
MA 01243 2.0
MA 01244 7.3
MA 01245 10.6
MA 01247 4.2
MA 01252 7.3
MA 01253 10.4
MA 01254 2.0
MA 01255 10.4
MA 01256 5.2
MA 01257 10.6
MA 01258 9.0
MA 01259 9.0
MA 01260 7.3
MA 01262 9.0
MA 01263 9.0
MA 01264 7.3
MA 01266 3.0
MA 01267 4.2
MA 01270 2.0
MA 01301 4.2
MA 01302 4.2
MA 01330 10.5
MA 01331 4.2
MA 01337 5.0
MA 01338 10.5
MA 01339 6.0
MA 01340 6.0
MA 01341 10.5
MA 01342 3.0
MA 01343 5.2
MA 01344 6.0
MA 01346 6.0
MA 01347 4.2
MA 01349 4.2
MA 01350 6.0
MA 01351 4.2
MA 01354 5.0
MA 01355 6.1
MA 01360 5.0
MA 01364 4.2
MA 01366 3.0
MA 01367 6.0
MA 01368 2.1
MA 01370 10.5
MA 01373 3.0
MA 01375 4.1
MA 01376 4.2
MA 01378 6.0
MA 01379 6.0
MA 01380 6.0
MA 01420 1.0
MA 01430 2.1
MA 01431 2.1
MA 01432 1.0
MA 01434 1.0
MA 01436 1.0
MA 01438 1.0
MA 01440 1.0
MA 01441 1.0
MA 01450 1.0
MA 01451 2.0
MA 01452 2.1
MA 01453 1.0
MA 01460 1.0
MA 01462 1.0
MA 01463 2.0
MA 01464 1.0
MA 01467 2.0
MA 01468 1.0
MA 01469 1.0
MA 01470 1.0
MA 01471 1.0
MA 01472 1.0
MA 01473 1.0
MA 01474 1.0
MA 01475 2.0
MA 01477 2.0
MA 01501 1.0
MA 01503 2.0
MA 01504 1.0
MA 01505 1.0
MA 01506 2.0
MA 01507 2.0
MA 01508 2.0
MA 01509 2.0
MA 01510 1.0
MA 01515 2.0
MA 01516 1.0
MA 01517 2.1
MA 01518 1.0
MA 01519 1.0
MA 01520 1.0
MA 01521 2.1
MA 01522 1.0
MA 01523 1.0
MA 01524 1.0
MA 01525 1.0
MA 01526 1.0
MA 01527 1.0
MA 01529 1.0
MA 01531 2.1
MA 01532 1.0
MA 01534 1.0
MA 01535 2.0
MA 01536 1.0
MA 01537 1.0
MA 01538 1.0
MA 01540 1.0
MA 01541 2.1
MA 01542 1.0
MA 01543 1.0
MA 01545 1.0
MA 01546 1.0
MA 01550 1.0
MA 01560 1.0
MA 01561 1.0
MA 01562 1.0
MA 01564 1.0
MA 01566 1.0
MA 01568 1.0
MA 01569 1.0
MA 01570 1.0
MA 01571 1.0
MA 01580 1.0
MA 01581 1.0
MA 01582 1.0
MA 01583 1.0
MA 01585 2.0
MA 01586 1.0
MA 01588 1.0
MA 01590 1.0
MA 01601 1.0
MA 01602 1.0
MA 01603 1.0
MA 01604 1.0
MA 01605 1.0
MA 01606 1.0
MA 01607 1.0
MA 01608 1.0
MA 01609 1.0
MA 01610 1.0
MA 01611 1.0
MA 01612 1.0
MA 01613 1.0
MA 01614 1.0
MA 01615 1.0
MA 01653 1.0
MA 01654 1.0
MA 01655 1.0
MA 01701 1.0
MA 01702 1.0
MA 01703 1.0
MA 01704 1.0
MA 01705 1.0
MA 01718 1.0
MA 01719 1.0
MA 01720 1.0
MA 01721 1.0
MA 01730 1.0
MA 01731 1.0
MA 01740 2.0
MA 01741 2.0
MA 01742 1.0
MA 01745 1.0
MA 01746 1.0
MA 01747 1.0
MA 01748 1.0
MA 01749 1.0
MA 01752 1.0
MA 01754 1.0
MA 01756 1.0
MA 01757 1.0
MA 01760 1.0
MA 01770 1.0
MA 01772 1.0
MA 01773 1.0
MA 01775 1.0
MA 01776 1.0
MA 01778 1.0
MA 01784 1.0
MA 01801 1.0
MA 01803 1.0
MA 01805 1.0
MA 01806 1.0
MA 01807 1.0
MA 01808 1.0
MA 01810 1.0
MA 01812 1.0
MA 01813 1.0
MA 01815 1.0
MA 01821 1.0
MA 01822 1.0
MA 01824 1.0
MA 01826 1.0
MA 01827 2.0
MA 01830 1.0
MA 01831 1.0
MA 01832 1.0
MA 01833 1.0
MA 01834 1.0
MA 01835 1.0
MA 01840 1.0
MA 01841 1.0
MA 01842 1.0
MA 01843 1.0
MA 01844 1.0
MA 01845 1.0
MA 01850 1.0
MA 01851 1.0
MA 01852 1.0
MA 01853 1.0
MA 01854 1.0
MA 01860 1.0
MA 01862 1.0
MA 01863 1.0
MA 01864 1.0
MA 01865 1.0
MA 01866 1.0
MA 01867 1.0
MA 01876 1.0
MA 01879 1.0
MA 01880 1.0
MA 01885 1.0
MA 01886 1.0
MA 01887 1.0
MA 01888 1.0
MA 01889 1.0
MA 01890 1.0
MA 01899 1.0
MA 01901 1.0
MA 01902 1.0
MA 01903 1.0
MA 01904 1.0
MA 01905 1.0
MA 01906 1.0
MA 01907 1.0
MA 01908 1.0
MA 01910 1.0
MA 01913 1.0
MA 01915 1.0
MA 01921 1.0
MA 01922 1.0
MA 01923 1.0
MA 01929 1.0
MA 01930 1.0
MA 01931 1.0
MA 01936 1.0
MA 01937 1.0
MA 01938 1.0
MA 01940 1.0
MA 01944 1.0
MA 01945 1.0
MA 01949 1.0
MA 01950 1.0
MA 01951 1.0
MA 01952 1.0
MA 01960 1.0
MA 01961 1.0
MA 01965 1.0
MA 01966 1.0
MA 01969 1.0
MA 01970 1.0
MA 01971 1.0
MA 01982 1.0
MA 01983 1.0
MA 01984 1.0
MA 01985 1.0
MA 02018 1.0
MA 02019 1.0
MA 02020 1.0
MA 02021 1.0
MA 02025 1.0
MA 02026 1.0
MA 02027 1.0
MA 02030 1.0
MA 02031 1.0
MA 02032 1.0
MA 02035 1.0
MA 02038 1.0
MA 02040 1.0
MA 02041 1.0
MA 02043 1.0
MA 02044 1.0
MA 02045 1.0
MA 02047 1.0
MA 02048 1.0
MA 02050 1.0
MA 02051 1.0
MA 02052 1.0
MA 02053 1.0
MA 02054 1.0
MA 02055 1.0
MA 02056 1.0
MA 02059 1.0
MA 02060 1.0
MA 02061 1.0
MA 02062 1.0
MA 02065 1.0
MA 02066 1.0
MA 02067 1.0
MA 02070 1.0
MA 02071 1.0
MA 02072 1.0
MA 02081 1.0
MA 02090 1.0
MA 02093 1.0
MA 02101 1.0
MA 02102 1.0
MA 02103 1.0
MA 02104 1.0
MA 02105 1.0
MA 02106 1.0
MA 02107 1.0
MA 02108 1.0
MA 02109 1.0
MA 02110 1.0
MA 02111 1.0
MA 02112 1.0
MA 02113 1.0
MA 02114 1.0
MA 02115 1.0
MA 02116 1.0
MA 02117 1.0
MA 02118 1.0
MA 02119 1.0
MA 02120 1.0
MA 02121 1.0
MA 02122 1.0
MA 02123 1.0
MA 02124 1.0
MA 02125 1.0
MA 02126 1.0
MA 02127 1.0
MA 02128 1.0
MA 02129 1.0
MA 02130 1.0
MA 02131 1.0
MA 02132 1.0
MA 02133 1.0
MA 02134 1.0
MA 02135 1.0
MA 02136 1.0
MA 02137 1.0
MA 02138 1.0
MA 02139 1.0
MA 02140 1.0
MA 02141 1.0
MA 02142 1.0
MA 02143 1.0
MA 02144 1.0
MA 02145 1.0
MA 02148 1.0
MA 02149 1.0
MA 02150 1.0
MA 02151 1.0
MA 02152 1.0
MA 02153 1.0
MA 02155 1.0
MA 02156 1.0
MA 02163 1.0
MA 02169 1.0
MA 02170 1.0
MA 02171 1.0
MA 02176 1.0
MA 02180 1.0
MA 02184 1.0
MA 02185 1.0
MA 02186 1.0
MA 02187 1.0
MA 02188 1.0
MA 02189 1.0
MA 02190 1.0
MA 02191 1.0
MA 02196 1.0
MA 02199 1.0
MA 02201 1.0
MA 02203 1.0
MA 02204 1.0
MA 02205 1.0
MA 02206 1.0
MA 02207 1.0
MA 02208 1.0
MA 02209 1.0
MA 02210 1.0
MA 02211 1.0
MA 02212 1.0
MA 02215 1.0
MA 02216 1.0
MA 02217 1.0
MA 02222 1.0
MA 02228 1.0
MA 02238 1.0
MA 02239 1.0
MA 02241 1.0
MA 02266 1.0
MA 02269 1.0
MA 02283 1.0
MA 02284 1.0
MA 02293 1.0
MA 02295 1.0
MA 02297 1.0
MA 02301 1.0
MA 02302 1.0
MA 02303 1.0
MA 02304 1.0
MA 02305 1.0
MA 02322 1.0
MA 02324 1.0
MA 02325 1.0
MA 02327 1.0
MA 02330 1.0
MA 02331 1.0
MA 02332 1.0
MA 02333 1.0
MA 02334 1.0
MA 02337 1.0
MA 02338 1.0
MA 02339 1.0
MA 02340 1.0
MA 02341 1.0
MA 02343 1.0
MA 02344 1.0
MA 02345 1.0
MA 02346 1.0
MA 02347 1.0
MA 02348 1.0
MA 02349 1.0
MA 02350 1.0
MA 02351 1.0
MA 02355 1.0
MA 02356 1.0
MA 02357 1.0
MA 02358 1.0
MA 02359 1.0
MA 02360 1.0
MA 02361 1.0
MA 02362 1.0
MA 02364 1.0
MA 02366 1.0
MA 02367 2.0
MA 02368 1.0
MA 02370 1.0
MA 02375 1.0
MA 02379 1.0
MA 02381 1.0
MA 02382 1.0
MA 02420 1.0
MA 02421 1.0
MA 02445 1.0
MA 02446 1.0
MA 02447 1.0
MA 02451 1.0
MA 02452 1.0
MA 02453 1.0
MA 02454 1.0
MA 02455 1.0
MA 02456 1.0
MA 02457 1.0
MA 02458 1.0
MA 02459 1.0
MA 02460 1.0
MA 02461 1.0
MA 02462 1.0
MA 02464 1.0
MA 02465 1.0
MA 02466 1.0
MA 02467 1.0
MA 02468 1.0
MA 02471 1.0
MA 02472 1.0
MA 02474 1.0
MA 02475 1.0
MA 02476 1.0
MA 02477 1.0
MA 02478 1.0
MA 02479 1.0
MA 02481 1.0
MA 02482 1.0
MA 02492 1.0
MA 02493 1.0
MA 02494 1.0
MA 02495 1.0
MA 02532 1.0
MA 02534 1.0
MA 02535 10.6
MA 02536 1.0
MA 02537 1.0
MA 02538 1.0
MA 02539 10.6
MA 02540 1.0
MA 02541 1.0
MA 02542 1.0
MA 02543 1.0
MA 02552 10.6
MA 02553 1.0
MA 02554 7.0
MA 02556 1.0
MA 02557 7.0
MA 02558 1.0
MA 02559 1.0
MA 02561 1.0
MA 02562 1.0
MA 02563 1.0
MA 02564 7.0
MA 02565 1.0
MA 02568 7.0
MA 02571 1.0
MA 02573 7.0
MA 02574 1.0
MA 02575 10.6
MA 02576 1.0
MA 02584 7.0
MA 02601 1.0
MA 02630 1.0
MA 02631 1.0
MA 02632 1.0
MA 02633 1.0
MA 02634 1.0
MA 02635 1.0
MA 02636 1.0
MA 02637 1.0
MA 02638 1.0
MA 02639 1.0
MA 02641 1.0
MA 02642 1.0
MA 02643 1.0
MA 02644 1.0
MA 02645 1.0
MA 02646 1.0
MA 02647 1.0
MA 02648 1.0
MA 02649 1.0
MA 02650 1.0
MA 02651 1.0
MA 02652 2.0
MA 02653 1.0
MA 02655 1.0
MA 02657 7.3
MA 02659 1.0
MA 02660 1.0
MA 02661 1.0
MA 02662 1.0
MA 02663 2.0
MA 02664 1.0
MA 02666 2.0
MA 02667 2.0
MA 02668 1.0
MA 02669 1.0
MA 02670 1.0
MA 02671 1.0
MA 02672 1.0
MA 02673 1.0
MA 02675 1.0
MA 02702 1.0
MA 02703 1.0
MA 02712 1.0
MA 02713 10.6
MA 02714 1.0
MA 02715 1.0
MA 02717 1.0
MA 02718 1.0
MA 02719 1.0
MA 02720 1.0
MA 02721 1.0
MA 02722 1.0
MA 02723 1.0
MA 02724 1.0
MA 02725 1.0
MA 02726 1.0
MA 02738 1.0
MA 02739 1.0
MA 02740 1.0
MA 02741 1.0
MA 02742 1.0
MA 02743 1.0
MA 02744 1.0
MA 02745 1.0
MA 02746 1.0
MA 02747 1.0
MA 02748 1.0
MA 02760 1.0
MA 02761 1.0
MA 02762 1.0
MA 02763 1.0
MA 02764 1.0
MA 02766 1.0
MA 02767 1.0
MA 02768 1.0
MA 02769 2.1
MA 02770 2.1
MA 02771 1.0
MA 02777 1.0
MA 02779 1.0
MA 02780 1.0
MA 02783 1.0
MA 02790 1.0
MA 02791 1.0
MA 05501 1.0
MA 05544 1.0
MD 20601 2.0
MD 20602 2.0
MD 20603 2.0
MD 20604 2.0
MD 20606 6.0
MD 20607 1.0
MD 20608 2.0
MD 20609 6.0
MD 20610 2.0
MD 20611 3.0
MD 20612 2.0
MD 20613 1.0
MD 20615 3.0
MD 20616 2.0
MD 20617 2.0
MD 20618 6.0
MD 20619 4.2
MD 20620 5.0
MD 20621 3.0
MD 20622 2.0
MD 20623 1.0
MD 20624 3.0
MD 20625 2.0
MD 20626 6.0
MD 20627 5.0
MD 20628 5.0
MD 20629 4.2
MD 20630 5.0
MD 20632 3.0
MD 20634 4.2
MD 20635 2.0
MD 20636 5.0
MD 20637 2.0
MD 20639 2.0
MD 20640 2.0
MD 20643 2.0
MD 20645 2.0
MD 20646 2.0
MD 20650 5.0
MD 20653 4.2
MD 20656 5.0
MD 20657 4.2
MD 20658 2.0
MD 20659 2.0
MD 20660 2.0
MD 20661 2.0
MD 20662 2.1
MD 20664 2.0
MD 20667 4.2
MD 20670 4.2
MD 20674 5.0
MD 20675 2.0
MD 20676 3.0
MD 20677 2.0
MD 20678 2.0
MD 20680 5.0
MD 20682 6.0
MD 20684 5.0
MD 20685 3.0
MD 20686 4.2
MD 20687 5.0
MD 20688 4.2
MD 20689 2.0
MD 20690 5.0
MD 20692 5.0
MD 20693 2.0
MD 20695 2.0
MD 20697 1.0
MD 20701 1.0
MD 20703 1.0
MD 20704 1.0
MD 20705 1.0
MD 20706 1.0
MD 20707 1.0
MD 20708 1.0
MD 20709 1.0
MD 20710 1.0
MD 20711 2.0
MD 20712 1.0
MD 20714 2.0
MD 20715 1.0
MD 20716 1.0
MD 20717 1.0
MD 20718 1.0
MD 20719 1.0
MD 20720 1.0
MD 20721 1.0
MD 20722 1.0
MD 20723 1.0
MD 20724 1.0
MD 20725 1.0
MD 20726 1.0
MD 20731 1.0
MD 20732 2.0
MD 20733 2.1
MD 20735 1.0
MD 20736 2.0
MD 20737 1.0
MD 20738 1.0
MD 20740 1.0
MD 20741 1.0
MD 20742 1.0
MD 20743 1.0
MD 20744 1.0
MD 20745 1.0
MD 20746 1.0
MD 20747 1.0
MD 20748 1.0
MD 20749 1.0
MD 20750 1.0
MD 20751 2.1
MD 20752 1.0
MD 20753 1.0
MD 20754 2.0
MD 20755 1.0
MD 20757 1.0
MD 20758 2.0
MD 20759 1.0
MD 20762 1.0
MD 20763 1.0
MD 20764 2.1
MD 20765 2.0
MD 20768 1.0
MD 20769 1.0
MD 20770 1.0
MD 20771 1.0
MD 20772 1.0
MD 20773 1.0
MD 20774 1.0
MD 20775 1.0
MD 20776 2.0
MD 20777 2.1
MD 20778 2.1
MD 20779 2.0
MD 20781 1.0
MD 20782 1.0
MD 20783 1.0
MD 20784 1.0
MD 20785 1.0
MD 20787 1.0
MD 20788 1.0
MD 20790 1.0
MD 20791 1.0
MD 20792 1.0
MD 20794 1.0
MD 20797 1.0
MD 20799 1.0
MD 20810 1.0
MD 20811 1.0
MD 20812 1.0
MD 20813 1.0
MD 20814 1.0
MD 20815 1.0
MD 20816 1.0
MD 20817 1.0
MD 20818 1.0
MD 20824 1.0
MD 20825 1.0
MD 20827 1.0
MD 20830 1.0
MD 20832 1.0
MD 20833 1.0
MD 20837 2.0
MD 20838 2.0
MD 20839 2.0
MD 20841 1.0
MD 20842 2.0
MD 20847 1.0
MD 20848 1.0
MD 20849 1.0
MD 20850 1.0
MD 20851 1.0
MD 20852 1.0
MD 20853 1.0
MD 20854 1.0
MD 20855 1.0
MD 20857 1.0
MD 20859 1.0
MD 20860 1.0
MD 20861 1.0
MD 20862 1.0
MD 20866 1.0
MD 20868 1.0
MD 20871 2.0
MD 20872 1.0
MD 20874 1.0
MD 20875 1.0
MD 20876 1.0
MD 20877 1.0
MD 20878 1.0
MD 20879 1.0
MD 20880 1.0
MD 20882 1.0
MD 20883 1.0
MD 20884 1.0
MD 20885 1.0
MD 20886 1.0
MD 20889 1.0
MD 20891 1.0
MD 20892 1.0
MD 20894 1.0
MD 20895 1.0
MD 20896 1.0
MD 20897 1.0
MD 20898 1.0
MD 20899 1.0
MD 20901 1.0
MD 20902 1.0
MD 20903 1.0
MD 20904 1.0
MD 20905 1.0
MD 20906 1.0
MD 20907 1.0
MD 20908 1.0
MD 20910 1.0
MD 20911 1.0
MD 20912 1.0
MD 20913 1.0
MD 20914 1.0
MD 20915 1.0
MD 20916 1.0
MD 20918 1.0
MD 20993 1.0
MD 20997 1.0
MD 21001 1.1
MD 21005 1.1
MD 21009 1.1
MD 21010 2.0
MD 21012 1.0
MD 21013 1.0
MD 21014 1.1
MD 21015 1.1
MD 21017 1.1
MD 21018 1.1
MD 21020 2.0
MD 21022 1.0
MD 21023 1.0
MD 21027 1.0
MD 21028 1.1
MD 21029 1.0
MD 21030 1.0
MD 21031 10.1
MD 21032 1.0
MD 21034 2.1
MD 21035 2.0
MD 21036 2.1
MD 21037 1.0
MD 21040 1.1
MD 21041 1.0
MD 21042 1.0
MD 21043 1.0
MD 21044 1.0
MD 21045 1.0
MD 21046 1.0
MD 21047 1.1
MD 21048 2.0
MD 21050 1.1
MD 21051 1.0
MD 21052 1.0
MD 21053 2.0
MD 21054 1.0
MD 21055 1.0
MD 21056 1.0
MD 21057 2.0
MD 21060 1.0
MD 21061 1.0
MD 21062 1.0
MD 21065 10.1
MD 21071 1.0
MD 21074 2.0
MD 21075 1.0
MD 21076 1.0
MD 21077 1.0
MD 21078 1.1
MD 21082 1.0
MD 21084 1.0
MD 21085 1.1
MD 21087 1.1
MD 21088 2.0
MD 21090 1.0
MD 21092 2.0
MD 21093 1.0
MD 21094 1.0
MD 21098 1.0
MD 21102 2.0
MD 21104 2.0
MD 21105 2.0
MD 21106 1.0
MD 21108 1.0
MD 21111 2.0
MD 21113 1.0
MD 21114 1.0
MD 21117 1.0
MD 21120 2.0
MD 21122 1.0
MD 21123 1.0
MD 21128 1.0
MD 21130 1.1
MD 21131 2.0
MD 21132 2.1
MD 21133 1.0
MD 21136 1.0
MD 21139 1.0
MD 21140 1.0
MD 21144 1.0
MD 21146 1.0
MD 21150 1.0
MD 21152 1.0
MD 21153 1.0
MD 21154 2.1
MD 21155 2.0
MD 21156 1.1
MD 21157 2.0
MD 21158 2.0
MD 21160 2.1
MD 21161 2.0
MD 21162 1.0
MD 21163 1.0
MD 21201 1.0
MD 21202 1.0
MD 21203 1.0
MD 21204 1.0
MD 21205 1.0
MD 21206 1.0
MD 21207 1.0
MD 21208 1.0
MD 21209 1.0
MD 21210 1.0
MD 21211 1.0
MD 21212 1.0
MD 21213 1.0
MD 21214 1.0
MD 21215 1.0
MD 21216 1.0
MD 21217 1.0
MD 21218 1.0
MD 21219 1.0
MD 21220 1.0
MD 21221 1.0
MD 21222 1.0
MD 21223 1.0
MD 21224 1.0
MD 21225 1.0
MD 21226 1.0
MD 21227 1.0
MD 21228 1.0
MD 21229 1.0
MD 21230 1.0
MD 21231 1.0
MD 21233 1.0
MD 21234 1.0
MD 21235 1.0
MD 21236 1.0
MD 21237 1.0
MD 21239 1.0
MD 21240 1.0
MD 21241 1.0
MD 21244 1.0
MD 21250 1.0
MD 21251 1.0
MD 21252 1.0
MD 21263 1.0
MD 21264 1.0
MD 21265 1.0
MD 21268 1.0
MD 21270 1.0
MD 21273 1.0
MD 21274 1.0
MD 21275 1.0
MD 21278 1.0
MD 21279 1.0
MD 21280 1.0
MD 21281 1.0
MD 21282 1.0
MD 21283 1.0
MD 21284 1.0
MD 21285 1.0
MD 21286 1.0
MD 21287 1.0
MD 21288 1.0
MD 21289 1.0
MD 21290 1.0
MD 21297 1.0
MD 21298 1.0
MD 21401 1.0
MD 21402 1.0
MD 21403 1.0
MD 21404 1.0
MD 21405 1.0
MD 21409 1.0
MD 21411 1.0
MD 21412 1.0
MD 21501 4.0
MD 21502 4.0
MD 21503 4.0
MD 21504 4.0
MD 21505 4.0
MD 21520 10.6
MD 21521 5.0
MD 21522 10.5
MD 21523 8.4
MD 21524 4.0
MD 21528 5.0
MD 21529 4.0
MD 21530 5.0
MD 21531 10.6
MD 21532 5.0
MD 21536 10.5
MD 21538 8.4
MD 21539 5.0
MD 21540 4.0
MD 21541 8.0
MD 21542 5.0
MD 21543 5.0
MD 21545 5.0
MD 21550 7.0
MD 21555 5.0
MD 21556 4.0
MD 21557 4.0
MD 21560 4.0
MD 21561 8.0
MD 21562 4.0
MD 21601 4.0
MD 21606 4.0
MD 21607 10.6
MD 21609 5.0
MD 21610 8.0
MD 21612 10.2
MD 21613 4.0
MD 21617 10.4
MD 21619 2.0
MD 21620 7.0
MD 21622 5.0
MD 21623 7.0
MD 21624 10.2
MD 21625 5.0
MD 21626 5.0
MD 21627 5.0
MD 21628 8.0
MD 21629 7.4
MD 21631 5.0
MD 21632 7.4
MD 21634 5.0
MD 21635 9.1
MD 21636 10.5
MD 21638 9.1
MD 21639 10.5
MD 21640 3.0
MD 21641 7.4
MD 21643 6.0
MD 21644 10.6
MD 21645 8.0
MD 21647 5.0
MD 21648 5.0
MD 21649 3.0
MD 21650 9.1
MD 21651 8.0
MD 21652 10.2
MD 21653 10.2
MD 21654 5.0
MD 21655 5.0
MD 21656 7.0
MD 21657 10.0
MD 21658 2.0
MD 21659 6.0
MD 21660 10.4
MD 21661 10.6
MD 21662 5.0
MD 21663 10.2
MD 21664 5.0
MD 21665 5.0
MD 21666 2.1
MD 21667 8.0
MD 21668 10.6
MD 21669 5.0
MD 21670 3.0
MD 21671 5.0
MD 21672 5.0
MD 21673 5.0
MD 21675 5.0
MD 21676 5.0
MD 21677 5.0
MD 21678 8.0
MD 21679 5.0
MD 21681 10.4
MD 21682 10.4
MD 21683 10.4
MD 21684 10.4
MD 21685 10.4
MD 21686 10.4
MD 21687 10.4
MD 21688 10.4
MD 21690 7.0
MD 21701 1.1
MD 21702 1.1
MD 21703 1.1
MD 21704 1.1
MD 21705 1.1
MD 21709 1.1
MD 21710 1.1
MD 21711 2.0
MD 21713 2.0
MD 21714 1.1
MD 21715 2.1
MD 21716 2.1
MD 21717 1.1
MD 21718 1.1
MD 21719 4.2
MD 21720 1.0
MD 21721 1.0
MD 21722 2.0
MD 21723 2.1
MD 21727 9.1
MD 21733 1.0
MD 21734 1.0
MD 21737 2.1
MD 21738 2.1
MD 21740 1.0
MD 21741 1.0
MD 21742 1.0
MD 21746 1.0
MD 21747 1.0
MD 21748 1.0
MD 21749 1.0
MD 21750 2.0
MD 21754 1.1
MD 21755 1.1
MD 21756 3.0
MD 21757 2.1
MD 21758 2.1
MD 21759 2.1
MD 21762 1.1
MD 21765 2.1
MD 21766 5.0
MD 21767 1.0
MD 21769 1.1
MD 21770 1.1
MD 21771 2.0
MD 21773 2.1
MD 21774 1.1
MD 21775 2.1
MD 21776 2.1
MD 21777 1.1
MD 21778 2.0
MD 21779 3.0
MD 21780 2.0
MD 21781 1.0
MD 21782 2.0
MD 21783 1.0
MD 21784 2.0
MD 21787 3.0
MD 21788 2.0
MD 21790 1.1
MD 21791 2.1
MD 21792 2.1
MD 21793 1.1
MD 21794 2.1
MD 21795 1.0
MD 21797 2.0
MD 21798 2.0
MD 21801 1.0
MD 21802 1.0
MD 21803 1.0
MD 21804 1.0
MD 21810 2.0
MD 21811 4.2
MD 21813 5.0
MD 21814 2.0
MD 21817 7.0
MD 21821 2.0
MD 21822 2.0
MD 21824 2.0
MD 21826 1.0
MD 21829 3.0
MD 21830 1.0
MD 21835 5.0
MD 21836 7.3
MD 21837 2.0
MD 21838 10.6
MD 21840 2.0
MD 21841 10.4
MD 21842 4.2
MD 21843 4.2
MD 21849 1.0
MD 21850 2.0
MD 21851 7.3
MD 21852 2.0
MD 21853 7.3
MD 21856 2.0
MD 21857 7.3
MD 21861 2.0
MD 21862 4.2
MD 21863 10.5
MD 21864 3.0
MD 21865 2.0
MD 21866 2.0
MD 21867 7.3
MD 21869 6.0
MD 21870 2.0
MD 21871 7.3
MD 21872 5.0
MD 21874 2.0
MD 21875 1.0
MD 21890 7.3
MD 21901 2.0
MD 21902 1.1
MD 21903 1.1
MD 21904 1.1
MD 21911 2.0
MD 21912 2.0
MD 21913 2.0
MD 21914 2.0
MD 21915 2.0
MD 21916 1.0
MD 21917 2.0
MD 21918 2.1
MD 21919 2.0
MD 21920 1.0
MD 21921 1.0
MD 21922 1.0
MD 21930 2.0
ME 03901 1.0
ME 03902 3.0
ME 03903 1.0
ME 03904 1.0
ME 03905 1.0
ME 03906 10.4
ME 03907 10.4
ME 03908 1.0
ME 03909 3.0
ME 03910 3.0
ME 03911 3.0
ME 04001 6.1
ME 04002 2.0
ME 04003 5.2
ME 04004 2.0
ME 04005 1.0
ME 04006 1.0
ME 04007 1.0
ME 04008 5.2
ME 04009 10.4
ME 04010 10.0
ME 04011 4.2
ME 04013 1.0
ME 04014 7.1
ME 04015 2.0
ME 04016 10.6
ME 04017 1.0
ME 04019 2.0
ME 04020 2.0
ME 04021 1.0
ME 04022 10.0
ME 04024 2.0
ME 04027 2.0
ME 04028 2.0
ME 04029 2.0
ME 04030 2.0
ME 04032 1.0
ME 04033 1.0
ME 04034 1.0
ME 04037 10.0
ME 04038 1.0
ME 04039 2.0
ME 04040 3.0
ME 04041 2.0
ME 04042 2.0
ME 04043 7.1
ME 04046 7.1
ME 04047 2.0
ME 04048 2.0
ME 04049 2.0
ME 04050 2.0
ME 04051 10.6
ME 04053 4.2
ME 04054 3.0
ME 04055 2.0
ME 04056 6.1
ME 04057 3.0
ME 04061 2.0
ME 04062 1.0
ME 04063 1.0
ME 04064 1.0
ME 04066 5.2
ME 04068 2.0
ME 04069 2.0
ME 04070 1.0
ME 04071 2.0
ME 04072 1.0
ME 04073 4.2
ME 04074 1.0
ME 04075 2.0
ME 04076 6.1
ME 04077 2.0
ME 04078 1.0
ME 04079 5.2
ME 04082 1.0
ME 04083 4.2
ME 04084 2.0
ME 04085 2.0
ME 04086 4.2
ME 04087 2.0
ME 04088 10.6
ME 04090 3.0
ME 04091 2.0
ME 04092 1.0
ME 04093 2.0
ME 04094 7.1
ME 04095 6.1
ME 04096 1.0
ME 04097 2.0
ME 04098 1.0
ME 04101 1.0
ME 04102 1.0
ME 04103 1.0
ME 04104 1.0
ME 04105 1.0
ME 04106 1.0
ME 04107 1.0
ME 04108 2.0
ME 04109 2.0
ME 04110 1.0
ME 04112 1.0
ME 04116 1.0
ME 04122 1.0
ME 04123 1.0
ME 04124 1.0
ME 04210 1.0
ME 04211 1.0
ME 04212 1.0
ME 04216 10.0
ME 04217 10.6
ME 04219 10.0
ME 04220 2.0
ME 04221 10.6
ME 04222 2.0
ME 04223 1.0
ME 04224 10.6
ME 04225 10.0
ME 04226 10.0
ME 04227 10.3
ME 04228 9.1
ME 04230 2.1
ME 04231 10.6
ME 04234 10.3
ME 04236 2.0
ME 04237 10.6
ME 04238 2.0
ME 04239 10.6
ME 04240 1.0
ME 04241 1.0
ME 04243 1.0
ME 04250 2.0
ME 04252 2.0
ME 04253 3.0
ME 04254 9.1
ME 04255 10.0
ME 04256 2.0
ME 04257 7.0
ME 04258 2.0
ME 04259 6.1
ME 04260 2.0
ME 04261 10.0
ME 04262 10.6
ME 04263 2.0
ME 04265 6.1
ME 04266 2.0
ME 04267 10.6
ME 04268 7.0
ME 04270 10.6
ME 04271 7.0
ME 04274 2.1
ME 04275 7.0
ME 04276 7.0
ME 04278 10.0
ME 04280 1.0
ME 04281 7.0
ME 04282 2.0
ME 04283 2.0
ME 04284 6.1
ME 04285 10.0
ME 04286 10.6
ME 04287 5.2
ME 04288 2.0
ME 04289 10.6
ME 04290 9.1
ME 04291 2.1
ME 04292 9.1
ME 04294 10.3
ME 04330 4.0
ME 04332 4.0
ME 04333 4.0
ME 04336 4.0
ME 04338 4.0
ME 04341 5.0
ME 04342 10.5
ME 04343 5.0
ME 04344 4.0
ME 04345 4.0
ME 04346 5.0
ME 04347 4.0
ME 04348 5.0
ME 04349 6.1
ME 04350 6.1
ME 04351 5.0
ME 04352 5.0
ME 04353 5.0
ME 04354 10.5
ME 04355 5.0
ME 04357 5.0
ME 04358 5.0
ME 04359 4.0
ME 04360 5.0
ME 04363 5.0
ME 04364 5.0
ME 04401 1.0
ME 04402 1.0
ME 04406 10.0
ME 04408 10.0
ME 04410 2.0
ME 04411 1.0
ME 04412 1.0
ME 04413 10.0
ME 04414 10.0
ME 04415 10.0
ME 04416 10.4
ME 04417 2.0
ME 04418 2.0
ME 04419 2.0
ME 04420 10.0
ME 04421 10.0
ME 04422 2.0
ME 04423 1.0
ME 04424 10.0
ME 04426 10.4
ME 04427 2.0
ME 04428 2.0
ME 04429 2.0
ME 04430 10.6
ME 04431 10.0
ME 04434 2.0
ME 04435 2.0
ME 04438 10.6
ME 04441 10.0
ME 04442 10.0
ME 04443 10.0
ME 04444 1.0
ME 04448 2.0
ME 04449 2.0
ME 04450 2.0
ME 04451 9.1
ME 04453 2.0
ME 04454 10.0
ME 04455 2.0
ME 04456 2.0
ME 04457 10.4
ME 04459 9.1
ME 04460 10.6
ME 04461 1.0
ME 04462 7.0
ME 04463 10.4
ME 04464 10.0
ME 04467 2.0
ME 04468 1.0
ME 04469 1.0
ME 04471 8.0
ME 04472 10.0
ME 04473 1.0
ME 04474 2.0
ME 04475 2.0
ME 04476 10.0
ME 04478 10.0
ME 04479 10.0
ME 04481 10.4
ME 04485 10.0
ME 04487 9.1
ME 04488 2.0
ME 04489 1.0
ME 04490 10.0
ME 04491 10.0
ME 04492 10.0
ME 04493 2.0
ME 04495 2.0
ME 04496 2.0
ME 04497 8.0
ME 04530 4.2
ME 04535 10.0
ME 04536 10.0
ME 04537 10.0
ME 04538 10.0
ME 04539 10.0
ME 04541 10.0
ME 04543 10.0
ME 04544 10.0
ME 04547 10.2
ME 04548 5.0
ME 04549 10.0
ME 04551 10.0
ME 04553 10.0
ME 04554 10.0
ME 04555 10.0
ME 04556 10.0
ME 04558 10.0
ME 04562 5.0
ME 04563 10.2
ME 04564 10.0
ME 04565 5.0
ME 04567 5.0
ME 04568 10.0
ME 04570 10.0
ME 04571 10.0
ME 04572 10.5
ME 04573 10.0
ME 04574 10.5
ME 04575 10.0
ME 04576 10.0
ME 04578 10.5
ME 04579 5.0
ME 04605 10.0
ME 04606 10.0
ME 04607 10.0
ME 04609 7.0
ME 04611 10.0
ME 04612 10.0
ME 04613 10.0
ME 04614 10.0
ME 04615 10.0
ME 04616 10.0
ME 04617 10.0
ME 04619 7.0
ME 04622 10.0
ME 04623 10.0
ME 04624 10.0
ME 04625 10.6
ME 04626 10.0
ME 04627 10.0
ME 04628 10.6
ME 04629 10.0
ME 04630 10.0
ME 04631 10.0
ME 04634 10.0
ME 04635 10.0
ME 04637 10.6
ME 04640 10.0
ME 04642 10.0
ME 04643 10.0
ME 04644 7.0
ME 04645 10.0
ME 04646 10.6
ME 04648 10.0
ME 04649 10.0
ME 04650 10.0
ME 04652 10.0
ME 04653 10.0
ME 04654 10.0
ME 04655 10.0
ME 04656 10.6
ME 04657 10.6
ME 04658 10.0
ME 04660 10.6
ME 04662 7.0
ME 04664 10.0
ME 04666 10.6
ME 04667 10.6
ME 04668 10.6
ME 04669 10.0
ME 04671 10.6
ME 04672 7.0
ME 04673 10.0
ME 04674 10.6
ME 04675 7.0
ME 04676 10.0
ME 04677 10.0
ME 04679 10.6
ME 04680 10.0
ME 04681 10.0
ME 04683 10.0
ME 04684 10.0
ME 04685 10.0
ME 04686 10.0
ME 04691 10.0
ME 04693 10.0
ME 04694 10.6
ME 04730 7.0
ME 04732 10.6
ME 04733 8.0
ME 04734 8.0
ME 04735 8.0
ME 04736 7.0
ME 04737 10.0
ME 04738 8.0
ME 04739 10.0
ME 04740 10.3
ME 04741 10.0
ME 04742 10.3
ME 04743 10.0
ME 04744 10.0
ME 04745 10.3
ME 04746 10.6
ME 04747 10.6
ME 04750 10.6
ME 04751 10.6
ME 04756 7.0
ME 04757 8.0
ME 04758 8.0
ME 04759 10.6
ME 04760 8.0
ME 04761 8.0
ME 04762 9.0
ME 04763 8.0
ME 04764 8.0
ME 04765 9.0
ME 04766 8.0
ME 04768 10.6
ME 04769 7.0
ME 04770 10.0
ME 04772 10.3
ME 04773 7.0
ME 04774 10.0
ME 04775 10.6
ME 04776 10.6
ME 04777 9.0
ME 04779 9.0
ME 04780 10.6
ME 04781 10.0
ME 04783 9.0
ME 04785 10.6
ME 04786 8.0
ME 04787 8.0
ME 04788 10.0
ME 04841 4.0
ME 04843 7.4
ME 04846 4.0
ME 04847 10.5
ME 04848 10.6
ME 04849 10.6
ME 04850 10.6
ME 04851 10.0
ME 04852 10.0
ME 04853 10.0
ME 04854 5.0
ME 04855 10.5
ME 04856 10.5
ME 04857 10.5
ME 04858 5.0
ME 04859 10.5
ME 04860 10.5
ME 04861 4.0
ME 04862 10.5
ME 04863 10.0
ME 04864 4.0
ME 04865 10.5
ME 04901 4.0
ME 04903 4.0
ME 04910 5.0
ME 04911 10.6
ME 04912 10.6
ME 04915 7.0
ME 04917 5.0
ME 04918 5.0
ME 04920 10.6
ME 04921 8.0
ME 04922 10.5
ME 04923 10.0
ME 04924 9.0
ME 04925 10.0
ME 04926 5.0
ME 04927 5.0
ME 04928 3.0
ME 04929 10.6
ME 04930 10.4
ME 04932 2.0
ME 04933 2.0
ME 04935 5.0
ME 04936 10.0
ME 04937 4.0
ME 04938 7.0
ME 04939 2.0
ME 04940 7.0
ME 04941 9.0
ME 04942 10.6
ME 04943 10.6
ME 04944 4.0
ME 04945 10.0
ME 04947 10.0
ME 04949 9.0
ME 04950 7.0
ME 04951 8.0
ME 04952 9.0
ME 04953 2.0
ME 04954 10.0
ME 04955 10.6
ME 04956 10.3
ME 04957 10.6
ME 04958 10.6
ME 04961 10.0
ME 04962 5.0
ME 04963 4.0
ME 04964 10.0
ME 04965 10.6
ME 04966 10.0
ME 04967 7.0
ME 04969 2.0
ME 04970 10.0
ME 04971 10.0
ME 04972 10.6
ME 04973 9.0
ME 04974 10.6
ME 04975 4.0
ME 04976 7.4
ME 04978 10.5
ME 04979 10.6
ME 04981 10.6
ME 04982 10.0
ME 04983 10.3
ME 04984 10.3
ME 04985 10.0
ME 04986 10.5
ME 04987 10.5
ME 04988 10.5
ME 04989 5.0
ME 04992 7.0
MH 96960 R
MH 96970 R
MI 48001 1.0
MI 48002 2.0
MI 48003 2.0
MI 48004 1.0
MI 48005 2.0
MI 48006 2.1
MI 48007 1.0
MI 48009 1.0
MI 48012 1.0
MI 48014 2.0
MI 48015 1.0
MI 48017 1.0
MI 48021 1.0
MI 48022 2.0
MI 48023 1.0
MI 48025 1.0
MI 48026 1.0
MI 48027 2.0
MI 48028 2.0
MI 48030 1.0
MI 48032 2.1
MI 48034 1.0
MI 48035 1.0
MI 48036 1.0
MI 48037 1.0
MI 48038 1.0
MI 48039 1.0
MI 48040 1.0
MI 48041 2.0
MI 48042 1.0
MI 48043 1.0
MI 48044 1.0
MI 48045 1.0
MI 48046 1.0
MI 48047 1.0
MI 48048 1.0
MI 48049 1.0
MI 48050 2.0
MI 48051 1.0
MI 48054 1.0
MI 48059 1.0
MI 48060 1.0
MI 48061 1.0
MI 48062 2.0
MI 48063 2.0
MI 48064 1.0
MI 48065 1.0
MI 48066 1.0
MI 48067 1.0
MI 48068 1.0
MI 48069 1.0
MI 48070 1.0
MI 48071 1.0
MI 48072 1.0
MI 48073 1.0
MI 48074 1.0
MI 48075 1.0
MI 48076 1.0
MI 48079 1.0
MI 48080 1.0
MI 48081 1.0
MI 48082 1.0
MI 48083 1.0
MI 48084 1.0
MI 48085 1.0
MI 48086 1.0
MI 48088 1.0
MI 48089 1.0
MI 48090 1.0
MI 48091 1.0
MI 48092 1.0
MI 48093 1.0
MI 48094 1.0
MI 48095 1.0
MI 48096 2.0
MI 48097 2.0
MI 48098 1.0
MI 48099 1.0
MI 48101 1.0
MI 48102 1.0
MI 48103 1.0
MI 48104 1.0
MI 48105 1.0
MI 48106 1.0
MI 48107 1.0
MI 48108 1.0
MI 48109 1.0
MI 48110 2.0
MI 48111 1.0
MI 48112 1.0
MI 48113 1.0
MI 48114 2.0
MI 48115 1.0
MI 48116 2.0
MI 48117 2.0
MI 48118 2.0
MI 48120 1.0
MI 48121 1.0
MI 48122 1.0
MI 48123 1.0
MI 48124 1.0
MI 48125 1.0
MI 48126 1.0
MI 48127 1.0
MI 48128 1.0
MI 48130 2.1
MI 48131 3.0
MI 48133 1.0
MI 48134 1.0
MI 48135 1.0
MI 48136 1.0
MI 48137 2.0
MI 48138 1.0
MI 48139 2.0
MI 48140 2.0
MI 48141 1.0
MI 48143 2.0
MI 48144 1.0
MI 48145 1.0
MI 48146 1.0
MI 48150 1.0
MI 48151 1.0
MI 48152 1.0
MI 48153 1.0
MI 48154 1.0
MI 48157 2.0
MI 48158 2.0
MI 48159 2.0
MI 48160 2.0
MI 48161 1.0
MI 48162 1.0
MI 48164 1.0
MI 48165 2.0
MI 48166 1.0
MI 48167 1.0
MI 48168 1.0
MI 48169 2.0
MI 48170 1.0
MI 48173 1.0
MI 48174 1.0
MI 48175 1.0
MI 48176 1.0
MI 48177 1.0
MI 48178 2.0
MI 48179 1.0
MI 48180 1.0
MI 48182 1.0
MI 48183 1.0
MI 48184 1.0
MI 48185 1.0
MI 48186 1.0
MI 48187 1.0
MI 48188 1.0
MI 48189 2.0
MI 48190 2.0
MI 48191 2.1
MI 48192 1.0
MI 48193 1.0
MI 48195 1.0
MI 48197 1.0
MI 48198 1.0
MI 48201 1.0
MI 48202 1.0
MI 48203 1.0
MI 48204 1.0
MI 48205 1.0
MI 48206 1.0
MI 48207 1.0
MI 48208 1.0
MI 48209 1.0
MI 48210 1.0
MI 48211 1.0
MI 48212 1.0
MI 48213 1.0
MI 48214 1.0
MI 48215 1.0
MI 48216 1.0
MI 48217 1.0
MI 48218 1.0
MI 48219 1.0
MI 48220 1.0
MI 48221 1.0
MI 48222 1.0
MI 48223 1.0
MI 48224 1.0
MI 48225 1.0
MI 48226 1.0
MI 48227 1.0
MI 48228 1.0
MI 48229 1.0
MI 48230 1.0
MI 48231 1.0
MI 48232 1.0
MI 48233 1.0
MI 48234 1.0
MI 48235 1.0
MI 48236 1.0
MI 48237 1.0
MI 48238 1.0
MI 48239 1.0
MI 48240 1.0
MI 48242 1.0
MI 48243 1.0
MI 48244 1.0
MI 48255 1.0
MI 48260 1.0
MI 48264 1.0
MI 48265 1.0
MI 48266 1.0
MI 48267 1.0
MI 48268 1.0
MI 48269 1.0
MI 48272 1.0
MI 48275 1.0
MI 48277 1.0
MI 48278 1.0
MI 48279 1.0
MI 48288 1.0
MI 48301 1.0
MI 48302 1.0
MI 48303 1.0
MI 48304 1.0
MI 48306 1.0
MI 48307 1.0
MI 48308 1.0
MI 48309 1.0
MI 48310 1.0
MI 48311 1.0
MI 48312 1.0
MI 48313 1.0
MI 48314 1.0
MI 48315 1.0
MI 48316 1.0
MI 48317 1.0
MI 48318 1.0
MI 48320 1.0
MI 48321 1.0
MI 48322 1.0
MI 48323 1.0
MI 48324 1.0
MI 48325 1.0
MI 48326 1.0
MI 48327 1.0
MI 48328 1.0
MI 48329 1.0
MI 48330 1.0
MI 48331 1.0
MI 48332 1.0
MI 48333 1.0
MI 48334 1.0
MI 48335 1.0
MI 48336 1.0
MI 48340 1.0
MI 48341 1.0
MI 48342 1.0
MI 48343 1.0
MI 48346 1.0
MI 48347 1.0
MI 48348 1.0
MI 48350 1.0
MI 48353 1.0
MI 48356 1.0
MI 48357 1.0
MI 48359 1.0
MI 48360 1.0
MI 48361 1.0
MI 48362 1.0
MI 48363 2.0
MI 48366 2.0
MI 48367 2.0
MI 48370 2.0
MI 48371 1.0
MI 48374 1.0
MI 48375 1.0
MI 48376 1.0
MI 48377 1.0
MI 48380 2.0
MI 48381 1.0
MI 48382 1.0
MI 48383 1.0
MI 48386 1.0
MI 48387 1.0
MI 48390 1.0
MI 48391 1.0
MI 48393 1.0
MI 48397 1.0
MI 48398 1.0
MI 48401 3.0
MI 48410 9.0
MI 48411 1.0
MI 48412 2.0
MI 48413 7.0
MI 48414 3.0
MI 48415 3.0
MI 48416 10.4
MI 48417 2.1
MI 48418 3.0
MI 48419 10.6
MI 48420 1.0
MI 48421 3.0
MI 48422 2.0
MI 48423 1.0
MI 48426 9.0
MI 48427 10.6
MI 48428 2.0
MI 48429 2.0
MI 48430 1.0
MI 48432 10.6
MI 48433 1.0
MI 48434 10.0
MI 48435 3.0
MI 48436 2.1
MI 48437 1.0
MI 48438 2.1
MI 48439 1.0
MI 48440 2.0
MI 48441 10.6
MI 48442 2.0
MI 48444 2.0
MI 48445 9.0
MI 48446 4.1
MI 48449 2.0
MI 48450 1.0
MI 48451 2.1
MI 48453 10.6
MI 48454 3.0
MI 48455 2.0
MI 48456 10.0
MI 48457 2.0
MI 48458 1.0
MI 48460 2.0
MI 48461 3.0
MI 48462 2.0
MI 48463 2.1
MI 48464 3.0
MI 48465 10.0
MI 48466 3.0
MI 48467 10.6
MI 48468 10.6
MI 48469 3.0
MI 48470 10.6
MI 48471 7.0
MI 48472 9.0
MI 48473 1.0
MI 48475 10.6
MI 48476 2.0
MI 48480 2.0
MI 48501 1.0
MI 48502 1.0
MI 48503 1.0
MI 48504 1.0
MI 48505 1.0
MI 48506 1.0
MI 48507 1.0
MI 48509 1.0
MI 48519 1.0
MI 48529 1.0
MI 48531 1.0
MI 48532 1.0
MI 48550 1.0
MI 48551 1.0
MI 48552 1.0
MI 48553 1.0
MI 48554 1.0
MI 48555 1.0
MI 48556 1.0
MI 48557 1.0
MI 48559 1.0
MI 48601 1.0
MI 48602 1.0
MI 48603 1.0
MI 48604 1.0
MI 48605 1.0
MI 48606 1.0
MI 48607 1.0
MI 48608 1.0
MI 48609 1.0
MI 48610 10.0
MI 48611 4.0
MI 48612 6.0
MI 48613 3.0
MI 48614 6.1
MI 48615 6.0
MI 48616 10.4
MI 48617 7.4
MI 48618 6.0
MI 48619 10.0
MI 48620 4.0
MI 48621 10.0
MI 48622 9.2
MI 48623 1.0
MI 48624 9.0
MI 48625 7.0
MI 48626 2.0
MI 48627 9.0
MI 48628 5.0
MI 48629 7.0
MI 48630 7.0
MI 48631 2.1
MI 48632 6.0
MI 48633 6.0
MI 48634 2.1
MI 48635 10.0
MI 48636 10.0
MI 48637 2.0
MI 48638 2.0
MI 48640 4.0
MI 48641 4.0
MI 48642 4.0
MI 48647 10.0
MI 48649 6.1
MI 48650 10.4
MI 48651 7.0
MI 48652 5.0
MI 48653 9.0
MI 48654 10.0
MI 48655 2.0
MI 48656 9.0
MI 48657 4.0
MI 48658 10.4
MI 48659 10.0
MI 48661 10.0
MI 48662 6.0
MI 48663 1.0
MI 48667 4.0
MI 48670 4.0
MI 48674 4.0
MI 48686 4.0
MI 48701 10.4
MI 48703 10.0
MI 48705 10.0
MI 48706 1.0
MI 48707 1.0
MI 48708 1.0
MI 48710 2.1
MI 48720 10.0
MI 48721 10.0
MI 48722 2.0
MI 48723 9.0
MI 48724 1.0
MI 48725 10.0
MI 48726 7.0
MI 48727 3.0
MI 48728 10.0
MI 48729 9.0
MI 48730 7.0
MI 48731 10.6
MI 48732 1.0
MI 48733 10.4
MI 48734 7.1
MI 48735 7.0
MI 48736 10.4
MI 48737 10.0
MI 48738 8.0
MI 48739 10.6
MI 48740 10.0
MI 48741 3.0
MI 48742 10.0
MI 48743 8.0
MI 48744 10.4
MI 48745 10.0
MI 48746 2.0
MI 48747 1.0
MI 48748 8.0
MI 48749 10.0
MI 48750 7.0
MI 48754 10.0
MI 48755 10.0
MI 48756 10.0
MI 48757 2.0
MI 48758 9.1
MI 48759 10.0
MI 48760 3.0
MI 48761 10.0
MI 48762 6.0
MI 48763 7.0
MI 48764 7.0
MI 48765 10.0
MI 48766 10.0
MI 48767 10.4
MI 48768 9.1
MI 48769 9.1
MI 48770 10.6
MI 48787 7.1
MI 48801 4.0
MI 48802 4.0
MI 48804 4.0
MI 48805 1.0
MI 48806 3.0
MI 48807 3.0
MI 48808 2.0
MI 48809 3.0
MI 48811 7.0
MI 48812 6.0
MI 48813 2.0
MI 48815 2.0
MI 48816 2.1
MI 48817 4.2
MI 48818 9.0
MI 48819 2.0
MI 48820 1.0
MI 48821 1.0
MI 48822 2.0
MI 48823 1.0
MI 48824 1.0
MI 48825 1.0
MI 48826 1.0
MI 48827 2.0
MI 48829 10.0
MI 48830 5.0
MI 48831 10.4
MI 48832 5.0
MI 48833 2.0
MI 48834 7.0
MI 48835 2.0
MI 48836 2.1
MI 48837 1.0
MI 48838 7.3
MI 48840 1.0
MI 48841 5.2
MI 48842 1.0
MI 48843 2.0
MI 48844 2.0
MI 48845 6.1
MI 48846 4.2
MI 48847 7.4
MI 48848 2.0
MI 48849 9.1
MI 48850 10.6
MI 48851 6.1
MI 48852 10.0
MI 48853 2.0
MI 48854 2.0
MI 48855 2.1
MI 48856 10.4
MI 48857 2.0
MI 48858 4.0
MI 48859 4.0
MI 48860 6.1
MI 48861 2.0
MI 48862 7.4
MI 48863 2.1
MI 48864 1.0
MI 48865 2.0
MI 48866 3.0
MI 48867 4.2
MI 48870 7.0
MI 48871 10.4
MI 48872 2.0
MI 48873 6.1
MI 48874 10.4
MI 48875 2.0
MI 48876 2.0
MI 48877 5.0
MI 48878 5.0
MI 48879 2.0
MI 48880 4.0
MI 48881 2.0
MI 48882 2.0
MI 48883 5.0
MI 48884 9.0
MI 48885 8.3
MI 48886 9.0
MI 48887 3.0
MI 48888 9.0
MI 48889 5.0
MI 48890 2.0
MI 48891 6.0
MI 48892 2.0
MI 48893 5.0
MI 48894 2.0
MI 48895 2.0
MI 48896 4.0
MI 48897 9.0
MI 48901 1.0
MI 48906 1.0
MI 48907 1.0
MI 48908 1.0
MI 48909 1.0
MI 48910 1.0
MI 48911 1.0
MI 48912 1.0
MI 48913 1.0
MI 48915 1.0
MI 48916 1.0
MI 48917 1.0
MI 48918 1.0
MI 48919 1.0
MI 48921 1.0
MI 48922 1.0
MI 48924 1.0
MI 48929 1.0
MI 48930 1.0
MI 48933 1.0
MI 48937 1.0
MI 48950 1.0
MI 48951 1.0
MI 48956 1.0
MI 48980 1.0
MI 49001 1.0
MI 49002 1.0
MI 49003 1.0
MI 49004 1.0
MI 49005 1.0
MI 49006 1.0
MI 49007 1.0
MI 49008 1.0
MI 49009 1.0
MI 49010 8.0
MI 49011 2.0
MI 49012 2.0
MI 49013 9.0
MI 49014 1.0
MI 49015 1.0
MI 49016 1.0
MI 49017 1.0
MI 49018 1.0
MI 49019 1.0
MI 49020 1.0
MI 49021 3.0
MI 49022 1.0
MI 49023 1.0
MI 49024 1.0
MI 49026 2.0
MI 49027 9.0
MI 49028 5.0
MI 49029 2.0
MI 49030 5.0
MI 49031 3.0
MI 49032 10.5
MI 49033 2.0
MI 49034 2.0
MI 49035 3.0
MI 49036 4.0
MI 49038 2.0
MI 49039 2.0
MI 49040 10.5
MI 49041 1.0
MI 49042 9.0
MI 49043 3.0
MI 49045 3.0
MI 49046 3.0
MI 49047 7.3
MI 49048 1.0
MI 49050 2.0
MI 49051 2.0
MI 49052 2.0
MI 49053 1.0
MI 49055 2.0
MI 49056 9.0
MI 49057 3.0
MI 49058 7.3
MI 49060 2.0
MI 49061 10.4
MI 49062 2.0
MI 49063 9.0
MI 49064 10.5
MI 49065 2.0
MI 49066 10.4
MI 49067 3.0
MI 49068 7.3
MI 49069 7.3
MI 49070 3.0
MI 49071 2.0
MI 49072 10.4
MI 49073 9.0
MI 49074 1.0
MI 49075 4.0
MI 49076 3.0
MI 49077 1.0
MI 49078 4.2
MI 49079 2.0
MI 49080 4.2
MI 49081 1.0
MI 49082 5.0
MI 49083 2.0
MI 49084 2.0
MI 49085 1.0
MI 49087 1.0
MI 49088 2.0
MI 49089 10.5
MI 49090 7.0
MI 49091 4.0
MI 49092 9.1
MI 49093 7.3
MI 49094 10.5
MI 49095 3.0
MI 49096 2.0
MI 49097 2.0
MI 49098 2.0
MI 49099 9.0
MI 49101 2.0
MI 49102 3.0
MI 49103 7.3
MI 49104 7.3
MI 49106 1.0
MI 49107 1.0
MI 49111 2.0
MI 49112 2.1
MI 49113 2.0
MI 49115 3.0
MI 49116 2.0
MI 49117 7.3
MI 49119 2.0
MI 49120 1.0
MI 49121 1.0
MI 49125 2.0
MI 49126 1.0
MI 49127 1.0
MI 49128 3.0
MI 49129 7.3
MI 49130 2.0
MI 49201 1.0
MI 49202 1.0
MI 49203 1.0
MI 49204 1.0
MI 49220 6.0
MI 49221 4.2
MI 49224 7.3
MI 49227 10.0
MI 49228 9.2
MI 49229 2.0
MI 49230 2.0
MI 49232 10.0
MI 49233 2.0
MI 49234 2.0
MI 49235 5.0
MI 49236 2.0
MI 49237 2.0
MI 49238 6.1
MI 49239 7.0
MI 49240 2.0
MI 49241 2.0
MI 49242 7.0
MI 49245 10.0
MI 49246 2.0
MI 49247 5.0
MI 49248 5.2
MI 49249 2.0
MI 49250 10.6
MI 49251 2.0
MI 49252 10.0
MI 49253 6.0
MI 49254 1.0
MI 49255 5.0
MI 49256 5.0
MI 49257 10.6
MI 49258 10.6
MI 49259 2.0
MI 49261 1.0
MI 49262 10.6
MI 49263 2.0
MI 49264 2.0
MI 49265 6.1
MI 49266 9.0
MI 49267 2.0
MI 49268 5.0
MI 49269 2.0
MI 49270 3.0
MI 49271 9.0
MI 49272 2.1
MI 49274 10.0
MI 49275 2.0
MI 49276 6.1
MI 49277 2.0
MI 49278 5.0
MI 49279 5.2
MI 49280 5.0
MI 49281 2.0
MI 49282 2.0
MI 49283 1.0
MI 49284 2.0
MI 49285 3.0
MI 49286 4.2
MI 49287 6.1
MI 49288 10.0
MI 49289 4.2
MI 49301 2.0
MI 49302 1.0
MI 49303 2.0
MI 49304 10.0
MI 49305 10.5
MI 49306 1.0
MI 49307 4.0
MI 49309 6.1
MI 49310 4.0
MI 49311 2.0
MI 49312 6.1
MI 49314 2.0
MI 49315 1.0
MI 49316 2.0
MI 49317 1.0
MI 49318 2.0
MI 49319 2.0
MI 49320 5.0
MI 49321 1.0
MI 49322 2.0
MI 49323 2.0
MI 49325 2.0
MI 49326 2.0
MI 49327 2.0
MI 49328 2.0
MI 49329 2.0
MI 49330 2.0
MI 49331 2.0
MI 49332 6.0
MI 49333 2.0
MI 49335 2.0
MI 49336 3.0
MI 49337 2.0
MI 49338 5.0
MI 49339 2.0
MI 49340 6.0
MI 49341 1.0
MI 49342 5.0
MI 49343 2.0
MI 49344 2.0
MI 49345 2.0
MI 49346 5.1
MI 49347 2.0
MI 49348 2.0
MI 49349 10.4
MI 49351 1.0
MI 49355 2.0
MI 49356 2.0
MI 49357 2.0
MI 49401 1.0
MI 49402 8.0
MI 49403 2.0
MI 49404 2.0
MI 49405 8.0
MI 49406 2.0
MI 49408 2.0
MI 49409 1.0
MI 49410 9.0
MI 49411 9.0
MI 49412 7.0
MI 49413 7.0
MI 49415 1.0
MI 49416 2.0
MI 49417 1.0
MI 49418 1.0
MI 49419 2.0
MI 49420 10.0
MI 49421 10.4
MI 49422 1.0
MI 49423 1.0
MI 49424 1.0
MI 49425 2.0
MI 49426 1.0
MI 49427 1.0
MI 49428 1.0
MI 49429 1.0
MI 49430 2.0
MI 49431 7.0
MI 49434 1.0
MI 49435 2.0
MI 49436 10.0
MI 49437 7.1
MI 49440 1.0
MI 49441 1.0
MI 49442 1.0
MI 49443 1.0
MI 49444 1.0
MI 49445 1.0
MI 49446 10.6
MI 49448 2.1
MI 49449 10.0
MI 49450 3.0
MI 49451 2.1
MI 49452 10.6
MI 49453 2.0
MI 49454 8.0
MI 49455 10.6
MI 49456 1.0
MI 49457 2.0
MI 49458 8.0
MI 49459 10.4
MI 49460 2.0
MI 49461 7.1
MI 49463 7.1
MI 49464 1.0
MI 49468 1.0
MI 49501 1.0
MI 49502 1.0
MI 49503 1.0
MI 49504 1.0
MI 49505 1.0
MI 49506 1.0
MI 49507 1.0
MI 49508 1.0
MI 49509 1.0
MI 49510 1.0
MI 49512 1.0
MI 49514 1.0
MI 49515 1.0
MI 49516 1.0
MI 49518 1.0
MI 49519 1.0
MI 49523 1.0
MI 49525 1.0
MI 49528 1.0
MI 49530 1.0
MI 49534 1.0
MI 49544 1.0
MI 49546 1.0
MI 49548 1.0
MI 49550 1.0
MI 49555 1.0
MI 49560 1.0
MI 49588 1.0
MI 49599 1.0
MI 49601 5.0
MI 49610 4.0
MI 49611 10.0
MI 49612 10.5
MI 49613 10.6
MI 49614 10.6
MI 49615 10.0
MI 49616 10.0
MI 49617 6.0
MI 49618 5.0
MI 49619 8.0
MI 49620 5.0
MI 49621 5.0
MI 49622 10.0
MI 49623 9.0
MI 49625 10.5
MI 49626 7.0
MI 49627 10.0
MI 49628 10.0
MI 49629 5.0
MI 49630 10.5
MI 49631 10.6
MI 49632 10.5
MI 49633 5.0
MI 49634 7.0
MI 49635 10.0
MI 49636 10.5
MI 49637 4.0
MI 49638 5.0
MI 49639 10.0
MI 49640 6.0
MI 49642 9.0
MI 49643 5.0
MI 49644 9.0
MI 49645 10.5
MI 49646 9.2
MI 49648 5.0
MI 49649 5.0
MI 49650 5.0
MI 49651 5.0
MI 49653 10.5
MI 49654 10.5
MI 49655 5.0
MI 49656 9.0
MI 49657 5.0
MI 49659 10.0
MI 49660 7.0
MI 49663 5.0
MI 49664 5.0
MI 49665 10.5
MI 49666 5.0
MI 49667 10.5
MI 49668 5.0
MI 49670 10.5
MI 49673 4.0
MI 49674 10.2
MI 49675 10.6
MI 49676 9.2
MI 49677 7.4
MI 49679 10.0
MI 49680 5.0
MI 49682 10.2
MI 49683 5.0
MI 49684 4.0
MI 49685 4.0
MI 49686 4.0
MI 49688 5.0
MI 49689 10.6
MI 49690 4.0
MI 49696 4.0
MI 49701 9.0
MI 49705 10.6
MI 49706 8.0
MI 49707 4.0
MI 49709 10.0
MI 49710 5.0
MI 49711 9.0
MI 49712 7.0
MI 49713 10.6
MI 49715 5.0
MI 49716 8.0
MI 49717 8.0
MI 49718 9.0
MI 49719 10.0
MI 49720 9.0
MI 49721 7.0
MI 49722 8.0
MI 49723 10.3
MI 49724 5.0
MI 49725 10.0
MI 49726 10.0
MI 49727 9.0
MI 49728 10.6
MI 49729 10.0
MI 49730 8.0
MI 49733 9.0
MI 49734 8.0
MI 49735 8.0
MI 49736 5.0
MI 49737 10.3
MI 49738 7.0
MI 49739 7.0
MI 49740 10.3
MI 49743 10.6
MI 49744 5.0
MI 49745 10.0
MI 49746 10.5
MI 49747 5.0
MI 49748 10.6
MI 49749 9.0
MI 49751 8.0
MI 49752 5.0
MI 49753 5.0
MI 49755 8.0
MI 49756 10.0
MI 49757 10.6
MI 49759 10.6
MI 49760 10.6
MI 49761 7.0
MI 49762 10.0
MI 49764 8.0
MI 49765 10.0
MI 49766 4.0
MI 49768 10.6
MI 49769 8.0
MI 49770 8.0
MI 49774 5.0
MI 49775 7.0
MI 49776 6.0
MI 49777 5.0
MI 49778 5.0
MI 49779 7.0
MI 49780 5.0
MI 49781 7.0
MI 49782 10.0
MI 49783 4.0
MI 49784 4.0
MI 49785 5.0
MI 49786 5.0
MI 49788 5.0
MI 49790 5.0
MI 49791 9.0
MI 49792 10.6
MI 49793 5.0
MI 49795 8.0
MI 49796 7.0
MI 49797 8.0
MI 49799 10.6
MI 49801 4.0
MI 49802 4.0
MI 49805 7.2
MI 49806 10.0
MI 49807 5.0
MI 49808 4.0
MI 49812 10.5
MI 49814 6.0
MI 49815 5.0
MI 49816 10.0
MI 49817 8.0
MI 49818 5.0
MI 49819 5.0
MI 49820 10.6
MI 49821 5.0
MI 49822 10.0
MI 49825 10.0
MI 49826 10.0
MI 49827 10.6
MI 49829 4.0
MI 49831 5.0
MI 49833 5.0
MI 49834 5.0
MI 49835 10.5
MI 49836 10.3
MI 49837 4.0
MI 49838 10.6
MI 49839 10.0
MI 49840 10.3
MI 49841 5.0
MI 49845 10.5
MI 49847 10.0
MI 49848 5.0
MI 49849 4.0
MI 49852 5.0
MI 49853 8.0
MI 49854 7.0
MI 49855 4.0
MI 49858 4.0
MI 49861 4.0
MI 49862 10.0
MI 49863 10.5
MI 49864 5.0
MI 49865 4.0
MI 49866 4.0
MI 49868 7.0
MI 49870 5.0
MI 49871 4.0
MI 49872 5.0
MI 49873 10.0
MI 49874 10.0
MI 49876 5.0
MI 49877 5.0
MI 49878 5.0
MI 49879 6.0
MI 49880 5.0
MI 49881 5.0
MI 49883 10.3
MI 49884 10.0
MI 49885 5.0
MI 49886 10.0
MI 49887 5.0
MI 49891 10.0
MI 49892 5.0
MI 49893 5.0
MI 49894 4.0
MI 49895 10.0
MI 49896 10.5
MI 49901 7.2
MI 49902 10.6
MI 49903 10.6
MI 49905 5.0
MI 49908 10.0
MI 49910 10.0
MI 49911 10.6
MI 49912 10.0
MI 49913 7.2
MI 49915 7.0
MI 49916 5.0
MI 49917 7.2
MI 49918 10.5
MI 49919 10.0
MI 49920 10.6
MI 49921 4.0
MI 49922 4.0
MI 49925 10.0
MI 49927 7.0
MI 49929 10.0
MI 49930 4.0
MI 49931 4.0
MI 49934 5.0
MI 49935 7.0
MI 49938 7.0
MI 49942 7.2
MI 49945 5.0
MI 49946 10.0
MI 49947 10.0
MI 49948 10.0
MI 49950 10.5
MI 49952 5.0
MI 49953 10.0
MI 49955 5.0
MI 49958 10.0
MI 49959 10.6
MI 49960 10.0
MI 49961 10.0
MI 49962 10.0
MI 49963 5.0
MI 49964 7.0
MI 49965 5.0
MI 49967 10.0
MI 49968 10.6
MI 49969 10.0
MI 49970 10.0
MI 49971 10.0
MN 55001 2.0
MN 55002 2.0
MN 55003 2.0
MN 55005 2.0
MN 55006 2.0
MN 55007 10.4
MN 55008 7.3
MN 55009 7.1
MN 55010 2.0
MN 55011 2.0
MN 55012 2.0
MN 55013 2.0
MN 55014 1.0
MN 55016 1.0
MN 55017 2.0
MN 55018 2.0
MN 55019 4.2
MN 55020 2.0
MN 55021 4.2
MN 55024 1.0
MN 55025 2.0
MN 55026 5.0
MN 55027 5.0
MN 55029 7.3
MN 55030 8.3
MN 55031 2.0
MN 55032 2.0
MN 55033 2.0
MN 55036 3.0
MN 55037 10.4
MN 55038 1.0
MN 55040 2.0
MN 55041 7.4
MN 55042 1.0
MN 55043 2.0
MN 55044 1.0
MN 55045 2.0
MN 55046 2.0
MN 55047 2.0
MN 55049 5.0
MN 55051 8.3
MN 55052 5.2
MN 55053 5.0
MN 55054 2.0
MN 55055 1.0
MN 55056 2.0
MN 55057 4.2
MN 55060 4.0
MN 55063 3.0
MN 55065 2.0
MN 55066 4.0
MN 55067 3.0
MN 55068 1.0
MN 55069 2.0
MN 55070 2.0
MN 55071 1.0
MN 55072 10.0
MN 55073 2.0
MN 55074 2.0
MN 55075 1.0
MN 55076 1.0
MN 55077 1.0
MN 55078 2.0
MN 55079 2.0
MN 55080 2.0
MN 55082 2.0
MN 55083 2.0
MN 55084 2.0
MN 55085 2.0
MN 55087 5.0
MN 55088 2.0
MN 55089 5.0
MN 55090 1.0
MN 55092 2.0
MN 55101 1.0
MN 55102 1.0
MN 55103 1.0
MN 55104 1.0
MN 55105 1.0
MN 55106 1.0
MN 55107 1.0
MN 55108 1.0
MN 55109 1.0
MN 55110 1.0
MN 55111 1.0
MN 55112 1.0
MN 55113 1.0
MN 55114 1.0
MN 55115 1.0
MN 55116 1.0
MN 55117 1.0
MN 55118 1.0
MN 55119 1.0
MN 55120 1.0
MN 55121 1.0
MN 55122 1.0
MN 55123 1.0
MN 55124 1.0
MN 55125 1.0
MN 55126 1.0
MN 55127 1.0
MN 55128 1.0
MN 55129 1.0
MN 55133 1.0
MN 55144 1.0
MN 55145 1.0
MN 55146 1.0
MN 55150 1.0
MN 55155 1.0
MN 55161 1.0
MN 55164 1.0
MN 55165 1.0
MN 55166 1.0
MN 55168 1.0
MN 55169 1.0
MN 55170 1.0
MN 55171 1.0
MN 55172 1.0
MN 55175 1.0
MN 55177 1.0
MN 55182 1.0
MN 55187 1.0
MN 55188 1.0
MN 55190 1.0
MN 55191 1.0
MN 55199 1.0
MN 55301 2.0
MN 55302 3.0
MN 55303 1.0
MN 55304 1.0
MN 55305 1.0
MN 55306 1.0
MN 55307 10.4
MN 55308 2.0
MN 55309 2.0
MN 55310 10.0
MN 55311 1.0
MN 55312 6.0
MN 55313 2.0
MN 55314 10.5
MN 55315 2.0
MN 55316 1.0
MN 55317 1.0
MN 55318 1.0
MN 55319 2.1
MN 55320 3.0
MN 55321 7.3
MN 55322 2.0
MN 55323 1.0
MN 55324 9.0
MN 55325 10.5
MN 55327 1.0
MN 55328 2.0
MN 55329 9.0
MN 55330 2.0
MN 55331 1.0
MN 55332 10.6
MN 55333 10.6
MN 55334 10.0
MN 55335 10.0
MN 55336 7.3
MN 55337 1.0
MN 55338 2.0
MN 55339 2.0
MN 55340 2.0
MN 55341 2.0
MN 55342 10.5
MN 55343 1.0
MN 55344 1.0
MN 55345 1.0
MN 55346 1.0
MN 55347 1.0
MN 55348 1.0
MN 55349 2.0
MN 55350 4.0
MN 55352 2.0
MN 55353 2.0
MN 55354 3.0
MN 55355 7.0
MN 55356 1.0
MN 55357 2.0
MN 55358 2.0
MN 55359 1.0
MN 55360 2.0
MN 55361 1.0
MN 55362 2.0
MN 55363 2.0
MN 55364 1.0
MN 55365 2.0
MN 55366 2.0
MN 55367 2.0
MN 55368 2.0
MN 55369 1.0
MN 55370 3.0
MN 55371 2.0
MN 55372 1.0
MN 55373 2.0
MN 55374 2.0
MN 55375 1.0
MN 55376 2.0
MN 55377 2.1
MN 55378 1.0
MN 55379 1.0
MN 55380 2.0
MN 55381 10.4
MN 55382 2.0
MN 55383 2.0
MN 55384 1.0
MN 55385 6.0
MN 55386 1.0
MN 55387 2.0
MN 55388 2.0
MN 55389 9.0
MN 55390 2.0
MN 55391 1.0
MN 55392 1.0
MN 55393 1.0
MN 55394 2.0
MN 55395 10.4
MN 55396 10.0
MN 55397 2.0
MN 55398 2.0
MN 55399 2.0
MN 55401 1.0
MN 55402 1.0
MN 55403 1.0
MN 55404 1.0
MN 55405 1.0
MN 55406 1.0
MN 55407 1.0
MN 55408 1.0
MN 55409 1.0
MN 55410 1.0
MN 55411 1.0
MN 55412 1.0
MN 55413 1.0
MN 55414 1.0
MN 55415 1.0
MN 55416 1.0
MN 55417 1.0
MN 55418 1.0
MN 55419 1.0
MN 55420 1.0
MN 55421 1.0
MN 55422 1.0
MN 55423 1.0
MN 55424 1.0
MN 55425 1.0
MN 55426 1.0
MN 55427 1.0
MN 55428 1.0
MN 55429 1.0
MN 55430 1.0
MN 55431 1.0
MN 55432 1.0
MN 55433 1.0
MN 55434 1.0
MN 55435 1.0
MN 55436 1.0
MN 55437 1.0
MN 55438 1.0
MN 55439 1.0
MN 55440 1.0
MN 55441 1.0
MN 55442 1.0
MN 55443 1.0
MN 55444 1.0
MN 55445 1.0
MN 55446 1.0
MN 55447 1.0
MN 55448 1.0
MN 55449 1.0
MN 55450 1.0
MN 55454 1.0
MN 55455 1.0
MN 55458 1.0
MN 55459 1.0
MN 55460 1.0
MN 55467 1.0
MN 55468 1.0
MN 55470 1.0
MN 55472 1.0
MN 55473 2.0
MN 55474 1.0
MN 55478 1.0
MN 55479 1.0
MN 55480 1.0
MN 55483 1.0
MN 55484 1.0
MN 55485 1.0
MN 55486 1.0
MN 55487 1.0
MN 55488 1.0
MN 55550 2.0
MN 55551 2.0
MN 55552 2.0
MN 55553 2.0
MN 55554 2.0
MN 55555 2.0
MN 55556 2.0
MN 55557 2.0
MN 55558 2.0
MN 55559 2.0
MN 55560 2.0
MN 55561 2.0
MN 55562 2.0
MN 55563 2.0
MN 55564 2.0
MN 55565 2.0
MN 55566 2.0
MN 55567 2.0
MN 55568 2.0
MN 55569 1.0
MN 55570 1.0
MN 55571 1.0
MN 55572 1.0
MN 55573 2.0
MN 55574 1.0
MN 55575 2.0
MN 55576 1.0
MN 55577 1.0
MN 55578 1.0
MN 55579 1.0
MN 55580 2.0
MN 55581 2.0
MN 55582 2.0
MN 55583 2.0
MN 55584 2.0
MN 55585 2.0
MN 55586 2.0
MN 55587 2.0
MN 55588 2.0
MN 55589 2.0
MN 55590 2.0
MN 55591 2.0
MN 55592 1.0
MN 55593 1.0
MN 55594 2.0
MN 55595 2.0
MN 55596 2.0
MN 55597 2.0
MN 55598 2.0
MN 55599 2.0
MN 55601 10.6
MN 55602 3.0
MN 55603 8.3
MN 55604 10.0
MN 55605 10.0
MN 55606 10.0
MN 55607 8.3
MN 55609 7.3
MN 55612 10.0
MN 55613 10.0
MN 55614 10.6
MN 55615 10.0
MN 55616 7.3
MN 55701 1.0
MN 55702 3.0
MN 55703 6.0
MN 55704 10.0
MN 55705 10.5
MN 55706 10.6
MN 55707 10.5
MN 55708 5.0
MN 55709 8.0
MN 55710 5.0
MN 55711 3.0
MN 55712 10.0
MN 55713 7.4
MN 55716 8.0
MN 55717 3.0
MN 55718 4.2
MN 55719 7.4
MN 55720 4.2
MN 55721 8.0
MN 55722 8.0
MN 55723 6.0
MN 55724 3.0
MN 55725 10.5
MN 55726 6.0
MN 55730 7.0
MN 55731 7.0
MN 55732 5.0
MN 55733 2.0
MN 55734 4.0
MN 55735 10.0
MN 55736 3.0
MN 55738 6.1
MN 55741 5.0
MN 55742 8.0
MN 55744 7.0
MN 55745 7.0
MN 55746 4.0
MN 55747 4.0
MN 55748 10.6
MN 55749 4.2
MN 55750 5.0
MN 55751 5.0
MN 55752 10.0
MN 55753 10.5
MN 55756 10.0
MN 55757 6.0
MN 55758 7.4
MN 55760 10.4
MN 55763 3.0
MN 55764 8.0
MN 55765 6.1
MN 55766 3.0
MN 55767 10.5
MN 55768 4.0
MN 55769 10.5
MN 55771 10.5
MN 55772 10.5
MN 55775 8.0
MN 55777 4.0
MN 55779 2.0
MN 55780 5.0
MN 55781 6.0
MN 55782 9.0
MN 55783 10.0
MN 55784 8.0
MN 55785 10.6
MN 55786 8.0
MN 55787 10.4
MN 55790 9.0
MN 55791 2.0
MN 55792 4.0
MN 55793 8.0
MN 55795 10.0
MN 55796 7.0
MN 55797 4.2
MN 55798 6.0
MN 55801 2.0
MN 55802 1.0
MN 55803 1.0
MN 55804 1.0
MN 55805 1.0
MN 55806 1.0
MN 55807 1.0
MN 55808 1.0
MN 55810 1.0
MN 55811 1.0
MN 55812 1.0
MN 55814 1.0
MN 55815 1.0
MN 55816 1.0
MN 55901 1.0
MN 55902 1.0
MN 55903 1.0
MN 55904 1.0
MN 55905 1.0
MN 55906 1.0
MN 55909 10.5
MN 55910 5.0
MN 55912 4.0
MN 55917 10.2
MN 55918 5.0
MN 55919 2.0
MN 55920 2.0
MN 55921 7.3
MN 55922 10.4
MN 55923 2.0
MN 55924 10.4
MN 55925 5.2
MN 55926 10.4
MN 55927 10.4
MN 55929 2.0
MN 55931 7.3
MN 55932 2.0
MN 55933 10.5
MN 55934 2.0
MN 55935 2.0
MN 55936 2.0
MN 55939 10.4
MN 55940 2.0
MN 55941 2.0
MN 55942 4.0
MN 55943 10.5
MN 55944 2.0
MN 55945 10.0
MN 55946 10.4
MN 55947 1.0
MN 55949 10.0
MN 55950 4.0
MN 55951 10.5
MN 55952 10.5
MN 55953 10.5
MN 55954 10.0
MN 55955 2.0
MN 55956 2.0
MN 55957 2.0
MN 55959 5.0
MN 55960 2.0
MN 55961 10.1
MN 55962 10.5
MN 55963 2.0
MN 55964 7.1
MN 55965 10.4
MN 55967 2.0
MN 55968 10.0
MN 55969 5.0
MN 55970 5.0
MN 55971 10.5
MN 55972 2.0
MN 55973 10.4
MN 55974 10.6
MN 55975 10.1
MN 55976 2.0
MN 55977 10.5
MN 55979 10.5
MN 55981 10.0
MN 55982 10.4
MN 55983 7.3
MN 55985 10.4
MN 55987 4.0
MN 55988 4.0
MN 55990 2.0
MN 55991 2.0
MN 55992 7.3
MN 56001 4.0
MN 56002 4.0
MN 56003 4.0
MN 56006 4.0
MN 56007 4.0
MN 56009 5.0
MN 56010 10.2
MN 56011 2.0
MN 56013 7.0
MN 56014 10.6
MN 56016 5.0
MN 56017 5.0
MN 56019 10.0
MN 56020 5.0
MN 56021 5.0
MN 56022 10.5
MN 56023 10.6
MN 56024 4.0
MN 56025 10.0
MN 56026 10.2
MN 56027 8.0
MN 56028 10.6
MN 56029 5.0
MN 56030 4.0
MN 56031 4.0
MN 56032 5.0
MN 56033 10.6
MN 56034 5.0
MN 56035 6.0
MN 56036 5.0
MN 56037 10.2
MN 56039 5.0
MN 56041 5.0
MN 56042 5.0
MN 56043 5.0
MN 56044 2.0
MN 56045 6.0
MN 56046 5.0
MN 56047 8.0
MN 56048 6.0
MN 56050 5.0
MN 56051 10.6
MN 56052 7.3
MN 56054 5.0
MN 56055 5.0
MN 56056 7.0
MN 56057 10.5
MN 56058 7.3
MN 56060 10.6
MN 56062 10.5
MN 56063 4.0
MN 56065 10.2
MN 56068 10.0
MN 56069 7.3
MN 56071 2.0
MN 56072 10.6
MN 56073 4.0
MN 56074 5.0
MN 56075 5.0
MN 56078 10.2
MN 56080 5.0
MN 56081 7.0
MN 56082 4.0
MN 56083 10.0
MN 56084 4.0
MN 56085 7.4
MN 56087 10.0
MN 56088 10.5
MN 56089 5.0
MN 56090 10.2
MN 56091 10.6
MN 56093 7.4
MN 56096 10.6
MN 56097 10.0
MN 56098 10.6
MN 56101 7.0
MN 56110 10.5
MN 56111 8.0
MN 56113 10.5
MN 56114 10.0
MN 56115 5.0
MN 56116 10.4
MN 56117 10.2
MN 56118 7.0
MN 56119 5.0
MN 56120 10.6
MN 56121 5.0
MN 56122 10.0
MN 56123 10.0
MN 56125 10.0
MN 56127 5.0
MN 56128 10.6
MN 56129 10.2
MN 56131 10.0
MN 56132 5.0
MN 56134 10.4
MN 56136 10.5
MN 56137 10.5
MN 56138 10.4
MN 56139 8.0
MN 56140 8.0
MN 56141 10.0
MN 56142 10.5
MN 56143 7.0
MN 56144 8.0
MN 56145 10.6
MN 56146 10.4
MN 56147 10.4
MN 56149 10.5
MN 56150 10.6
MN 56151 10.0
MN 56152 10.0
MN 56153 10.5
MN 56155 10.5
MN 56156 7.0
MN 56157 5.0
MN 56158 10.4
MN 56159 10.6
MN 56160 10.6
MN 56161 10.5
MN 56162 10.6
MN 56164 7.0
MN 56165 5.0
MN 56166 10.0
MN 56167 10.2
MN 56168 5.0
MN 56169 5.0
MN 56170 8.0
MN 56171 10.2
MN 56172 10.0
MN 56173 10.4
MN 56174 10.6
MN 56175 10.5
MN 56176 10.5
MN 56177 7.0
MN 56178 10.5
MN 56180 10.5
MN 56181 5.0
MN 56183 10.6
MN 56185 10.5
MN 56186 10.6
MN 56187 4.0
MN 56201 4.0
MN 56207 8.0
MN 56208 7.0
MN 56209 5.0
MN 56210 10.0
MN 56211 10.0
MN 56212 10.0
MN 56214 10.6
MN 56215 7.0
MN 56216 5.0
MN 56218 10.6
MN 56219 10.0
MN 56220 10.0
MN 56221 8.0
MN 56222 10.5
MN 56223 10.5
MN 56224 10.6
MN 56225 10.0
MN 56226 10.3
MN 56227 10.0
MN 56228 10.6
MN 56229 10.2
MN 56230 10.0
MN 56231 10.3
MN 56232 10.6
MN 56235 8.0
MN 56236 10.0
MN 56237 10.6
MN 56239 5.0
MN 56240 10.0
MN 56241 7.0
MN 56243 10.6
MN 56244 7.0
MN 56245 10.6
MN 56248 10.0
MN 56249 7.0
MN 56251 5.0
MN 56252 10.2
MN 56253 5.0
MN 56255 10.5
MN 56256 10.0
MN 56257 10.0
MN 56258 4.0
MN 56260 7.0
MN 56262 10.6
MN 56263 10.5
MN 56264 10.2
MN 56265 7.0
MN 56266 10.6
MN 56267 7.0
MN 56270 10.6
MN 56271 10.2
MN 56273 5.0
MN 56274 10.0
MN 56276 10.0
MN 56277 10.0
MN 56278 10.6
MN 56279 4.0
MN 56280 10.5
MN 56281 5.0
MN 56282 5.0
MN 56283 7.0
MN 56284 10.6
MN 56285 10.0
MN 56287 10.6
MN 56288 5.0
MN 56289 5.0
MN 56291 10.2
MN 56292 10.5
MN 56293 10.6
MN 56294 10.6
MN 56295 10.6
MN 56296 10.0
MN 56297 10.6
MN 56301 1.0
MN 56302 1.0
MN 56303 1.0
MN 56304 1.0
MN 56307 10.1
MN 56308 4.0
MN 56309 10.5
MN 56310 2.0
MN 56311 10.0
MN 56312 10.0
MN 56313 10.4
MN 56314 10.4
MN 56315 5.0
MN 56316 10.0
MN 56317 10.4
MN 56318 9.0
MN 56319 4.0
MN 56320 2.0
MN 56321 1.0
MN 56323 10.6
MN 56324 5.0
MN 56325 10.0
MN 56326 5.0
MN 56327 5.0
MN 56328 8.0
MN 56329 2.0
MN 56330 10.4
MN 56331 10.6
MN 56332 5.0
MN 56333 2.0
MN 56334 10.5
MN 56335 7.3
MN 56336 10.6
MN 56338 10.6
MN 56339 10.0
MN 56340 2.0
MN 56341 5.0
MN 56342 10.4
MN 56343 5.0
MN 56344 10.4
MN 56345 7.3
MN 56347 7.0
MN 56349 10.0
MN 56350 10.0
MN 56352 7.3
MN 56353 10.4
MN 56354 5.0
MN 56355 4.0
MN 56356 7.3
MN 56357 2.0
MN 56358 9.1
MN 56359 10.0
MN 56360 5.0
MN 56361 10.5
MN 56362 10.4
MN 56363 10.4
MN 56364 10.4
MN 56367 1.0
MN 56368 3.0
MN 56369 1.0
MN 56371 3.0
MN 56372 1.0
MN 56373 8.3
MN 56374 1.0
MN 56375 2.0
MN 56376 10.4
MN 56377 1.0
MN 56378 7.0
MN 56379 1.0
MN 56381 10.0
MN 56382 10.4
MN 56384 10.4
MN 56385 10.0
MN 56386 10.4
MN 56387 1.0
MN 56388 1.0
MN 56389 10.6
MN 56393 1.0
MN 56395 1.0
MN 56396 1.0
MN 56397 1.0
MN 56398 1.0
MN 56399 1.0
MN 56401 4.0
MN 56425 4.0
MN 56430 10.0
MN 56431 10.0
MN 56433 8.0
MN 56434 10.6
MN 56435 10.0
MN 56436 5.0
MN 56437 10.6
MN 56438 10.6
MN 56440 10.6
MN 56441 7.4
MN 56442 10.5
MN 56443 10.5
MN 56444 5.0
MN 56446 10.6
MN 56447 10.5
MN 56448 10.5
MN 56449 5.0
MN 56450 10.0
MN 56452 10.0
MN 56453 10.6
MN 56455 5.0
MN 56456 10.5
MN 56458 8.0
MN 56459 5.0
MN 56461 5.0
MN 56464 10.6
MN 56465 5.0
MN 56466 10.5
MN 56467 8.0
MN 56468 5.0
MN 56469 10.6
MN 56470 8.0
MN 56472 5.0
MN 56473 5.0
MN 56474 10.5
MN 56475 8.0
MN 56477 10.6
MN 56478 10.6
MN 56479 7.0
MN 56481 10.6
MN 56482 7.0
MN 56484 10.0
MN 56501 7.0
MN 56502 7.0
MN 56510 10.4
MN 56511 8.0
MN 56514 2.0
MN 56515 6.0
MN 56516 10.0
MN 56517 8.0
MN 56518 10.0
MN 56519 10.4
MN 56520 4.0
MN 56521 10.6
MN 56522 5.0
MN 56523 8.3
MN 56524 10.5
MN 56525 2.0
MN 56527 10.6
MN 56528 6.0
MN 56529 1.0
MN 56531 10.5
MN 56533 5.0
MN 56534 6.0
MN 56535 10.6
MN 56536 2.0
MN 56537 4.0
MN 56538 4.0
MN 56540 8.0
MN 56541 10.0
MN 56542 10.0
MN 56543 5.0
MN 56544 8.0
MN 56545 10.0
MN 56546 2.0
MN 56547 2.0
MN 56548 10.4
MN 56549 2.0
MN 56550 10.4
MN 56551 10.6
MN 56552 2.0
MN 56553 5.0
MN 56554 3.0
MN 56556 10.6
MN 56557 10.0
MN 56560 1.0
MN 56561 1.0
MN 56562 1.0
MN 56563 1.0
MN 56565 5.0
MN 56566 10.0
MN 56567 10.0
MN 56568 8.3
MN 56569 10.6
MN 56570 8.0
MN 56571 10.0
MN 56572 10.0
MN 56573 10.0
MN 56574 10.4
MN 56575 10.6
MN 56576 10.0
MN 56577 8.0
MN 56578 8.0
MN 56579 5.0
MN 56580 2.0
MN 56581 10.4
MN 56583 10.0
MN 56584 10.0
MN 56585 2.0
MN 56586 10.2
MN 56587 10.0
MN 56588 10.5
MN 56589 10.0
MN 56590 10.5
MN 56591 10.6
MN 56592 10.6
MN 56593 8.0
MN 56594 5.0
MN 56601 4.0
MN 56619 4.0
MN 56621 10.5
MN 56623 10.0
MN 56626 10.0
MN 56627 8.0
MN 56628 10.6
MN 56629 8.0
MN 56630 10.2
MN 56631 8.0
MN 56633 10.0
MN 56634 10.0
MN 56636 8.0
MN 56637 10.6
MN 56639 10.6
MN 56641 10.0
MN 56644 10.0
MN 56646 10.0
MN 56647 10.2
MN 56649 7.0
MN 56650 10.0
MN 56651 10.0
MN 56652 10.0
MN 56653 8.0
MN 56654 8.0
MN 56655 10.0
MN 56657 9.0
MN 56658 8.0
MN 56659 10.0
MN 56660 8.0
MN 56661 8.0
MN 56662 10.6
MN 56663 10.2
MN 56666 10.0
MN 56667 10.2
MN 56668 8.0
MN 56669 8.0
MN 56670 10.0
MN 56671 10.0
MN 56672 10.6
MN 56673 10.3
MN 56676 10.5
MN 56678 5.0
MN 56679 7.0
MN 56680 10.6
MN 56681 10.0
MN 56682 10.3
MN 56683 5.0
MN 56684 10.0
MN 56685 10.0
MN 56686 10.0
MN 56687 4.0
MN 56688 10.6
MN 56701 7.0
MN 56710 10.4
MN 56711 10.0
MN 56713 10.4
MN 56714 8.0
MN 56715 10.6
MN 56716 7.0
MN 56720 10.0
MN 56721 1.0
MN 56722 2.0
MN 56723 8.3
MN 56724 10.3
MN 56725 8.0
MN 56726 10.3
MN 56727 10.3
MN 56728 10.0
MN 56729 10.0
MN 56731 10.0
MN 56732 10.0
MN 56733 10.0
MN 56734 10.0
MN 56735 10.0
MN 56736 10.6
MN 56737 10.3
MN 56738 8.0
MN 56740 10.0
MN 56741 10.0
MN 56742 10.6
MN 56744 10.4
MN 56748 10.6
MN 56750 10.6
MN 56751 7.0
MN 56754 8.0
MN 56755 10.0
MN 56756 10.3
MN 56757 10.4
MN 56758 8.0
MN 56759 10.3
MN 56760 8.0
MN 56761 10.3
MN 56762 10.4
MN 56763 10.6
MO 63001 2.0
MO 63005 1.0
MO 63006 1.0
MO 63010 1.0
MO 63011 1.0
MO 63012 1.0
MO 63013 6.1
MO 63014 10.5
MO 63015 2.0
MO 63016 2.0
MO 63017 1.0
MO 63019 1.0
MO 63020 2.0
MO 63021 1.0
MO 63022 1.0
MO 63023 2.0
MO 63024 1.0
MO 63025 2.0
MO 63026 1.0
MO 63028 1.0
MO 63030 2.0
MO 63031 1.0
MO 63032 1.0
MO 63033 1.0
MO 63034 1.0
MO 63036 3.0
MO 63037 3.0
MO 63038 2.0
MO 63039 2.0
MO 63040 1.0
MO 63041 2.0
MO 63042 1.0
MO 63043 1.0
MO 63044 1.0
MO 63045 1.0
MO 63047 1.0
MO 63048 1.0
MO 63049 1.0
MO 63050 2.0
MO 63051 1.0
MO 63052 1.0
MO 63053 1.0
MO 63055 2.0
MO 63056 6.1
MO 63057 1.0
MO 63060 2.0
MO 63061 2.0
MO 63065 2.0
MO 63066 2.0
MO 63068 10.5
MO 63069 2.0
MO 63070 1.0
MO 63071 3.0
MO 63072 2.0
MO 63073 2.0
MO 63074 1.0
MO 63077 2.0
MO 63079 7.3
MO 63080 7.3
MO 63084 7.3
MO 63087 3.0
MO 63088 1.0
MO 63089 2.0
MO 63090 4.2
MO 63091 8.0
MO 63099 1.0
MO 63101 1.0
MO 63102 1.0
MO 63103 1.0
MO 63104 1.0
MO 63105 1.0
MO 63106 1.0
MO 63107 1.0
MO 63108 1.0
MO 63109 1.0
MO 63110 1.0
MO 63111 1.0
MO 63112 1.0
MO 63113 1.0
MO 63114 1.0
MO 63115 1.0
MO 63116 1.0
MO 63117 1.0
MO 63118 1.0
MO 63119 1.0
MO 63120 1.0
MO 63121 1.0
MO 63122 1.0
MO 63123 1.0
MO 63124 1.0
MO 63125 1.0
MO 63126 1.0
MO 63127 1.0
MO 63128 1.0
MO 63129 1.0
MO 63130 1.0
MO 63131 1.0
MO 63132 1.0
MO 63133 1.0
MO 63134 1.0
MO 63135 1.0
MO 63136 1.0
MO 63137 1.0
MO 63138 1.0
MO 63139 1.0
MO 63140 1.0
MO 63141 1.0
MO 63143 1.0
MO 63144 1.0
MO 63145 1.0
MO 63146 1.0
MO 63147 1.0
MO 63150 1.0
MO 63151 1.0
MO 63155 1.0
MO 63156 1.0
MO 63157 1.0
MO 63158 1.0
MO 63160 1.0
MO 63163 1.0
MO 63164 1.0
MO 63166 1.0
MO 63167 1.0
MO 63169 1.0
MO 63171 1.0
MO 63177 1.0
MO 63178 1.0
MO 63179 1.0
MO 63180 1.0
MO 63182 1.0
MO 63188 1.0
MO 63190 1.0
MO 63195 1.0
MO 63196 1.0
MO 63197 1.0
MO 63198 1.0
MO 63199 1.0
MO 63301 1.0
MO 63302 1.0
MO 63303 1.0
MO 63304 1.0
MO 63330 10.4
MO 63332 2.0
MO 63333 10.4
MO 63334 7.0
MO 63336 10.4
MO 63338 1.0
MO 63339 7.0
MO 63341 2.0
MO 63342 2.0
MO 63343 2.0
MO 63344 10.4
MO 63345 5.0
MO 63346 1.0
MO 63347 2.0
MO 63348 2.0
MO 63349 2.0
MO 63350 10.4
MO 63351 10.4
MO 63352 5.0
MO 63353 7.0
MO 63357 2.0
MO 63359 10.0
MO 63361 10.0
MO 63362 2.0
MO 63363 10.6
MO 63365 1.0
MO 63366 1.0
MO 63367 1.0
MO 63368 1.0
MO 63369 2.0
MO 63370 2.0
MO 63373 2.0
MO 63376 1.0
MO 63377 2.0
MO 63378 2.0
MO 63379 2.0
MO 63381 7.1
MO 63382 7.4
MO 63383 7.1
MO 63384 10.0
MO 63385 1.0
MO 63386 2.0
MO 63387 2.0
MO 63388 5.0
MO 63389 2.0
MO 63390 2.0
MO 63401 4.0
MO 63430 5.0
MO 63431 8.0
MO 63432 10.0
MO 63433 10.6
MO 63434 10.0
MO 63435 10.5
MO 63436 5.0
MO 63437 10.6
MO 63438 10.2
MO 63439 10.0
MO 63440 10.2
MO 63441 10.6
MO 63442 10.0
MO 63443 10.0
MO 63445 10.5
MO 63446 10.0
MO 63447 10.5
MO 63448 5.0
MO 63450 10.6
MO 63451 10.6
MO 63452 10.5
MO 63453 10.0
MO 63454 5.0
MO 63456 10.0
MO 63457 10.2
MO 63458 10.0
MO 63459 5.0
MO 63460 10.0
MO 63461 7.4
MO 63462 10.0
MO 63463 10.0
MO 63464 10.0
MO 63465 5.0
MO 63466 5.0
MO 63467 4.0
MO 63468 10.0
MO 63469 10.0
MO 63471 5.0
MO 63472 5.0
MO 63473 10.5
MO 63474 10.0
MO 63501 4.0
MO 63530 10.5
MO 63531 10.5
MO 63532 8.0
MO 63533 5.0
MO 63534 10.6
MO 63535 5.0
MO 63536 10.5
MO 63537 10.5
MO 63538 10.6
MO 63539 10.6
MO 63540 5.0
MO 63541 5.0
MO 63543 10.0
MO 63544 10.0
MO 63545 10.0
MO 63546 5.0
MO 63547 10.5
MO 63548 10.5
MO 63549 10.5
MO 63551 10.0
MO 63552 7.0
MO 63555 10.0
MO 63556 10.0
MO 63557 8.0
MO 63558 10.6
MO 63559 5.0
MO 63560 10.0
MO 63561 5.0
MO 63563 10.0
MO 63565 10.0
MO 63566 8.0
MO 63567 10.0
MO 63601 4.0
MO 63620 10.0
MO 63621 9.0
MO 63622 10.6
MO 63623 10.0
MO 63624 6.0
MO 63625 10.0
MO 63626 2.0
MO 63627 2.0
MO 63628 3.0
MO 63629 10.0
MO 63630 2.0
MO 63631 10.6
MO 63632 10.0
MO 63633 10.0
MO 63636 10.0
MO 63637 5.0
MO 63638 10.0
MO 63640 4.0
MO 63645 8.0
MO 63648 9.0
MO 63650 7.4
MO 63651 4.0
MO 63653 4.0
MO 63654 10.0
MO 63655 8.0
MO 63656 10.0
MO 63660 9.0
MO 63661 7.3
MO 63662 5.0
MO 63663 7.4
MO 63664 7.1
MO 63665 10.0
MO 63666 10.0
MO 63670 7.3
MO 63673 8.0
MO 63674 2.0
MO 63675 10.0
MO 63701 4.0
MO 63702 4.0
MO 63703 4.0
MO 63705 4.0
MO 63730 10.5
MO 63732 8.0
MO 63735 10.5
MO 63736 5.0
MO 63737 8.0
MO 63738 10.5
MO 63739 5.0
MO 63740 5.0
MO 63742 5.0
MO 63743 5.0
MO 63744 5.0
MO 63745 4.0
MO 63746 8.0
MO 63747 5.0
MO 63748 8.0
MO 63750 6.0
MO 63751 10.2
MO 63752 4.0
MO 63755 4.0
MO 63758 5.0
MO 63760 10.2
MO 63763 6.0
MO 63764 10.2
MO 63766 5.0
MO 63767 5.0
MO 63769 5.0
MO 63770 5.0
MO 63771 10.5
MO 63772 10.5
MO 63774 10.5
MO 63775 8.0
MO 63776 8.0
MO 63779 4.0
MO 63780 5.0
MO 63781 5.0
MO 63782 6.0
MO 63783 8.0
MO 63784 4.0
MO 63785 5.0
MO 63787 6.0
MO 63801 4.0
MO 63820 7.4
MO 63821 10.5
MO 63822 10.6
MO 63823 6.0
MO 63824 4.0
MO 63825 8.0
MO 63826 7.4
MO 63827 10.6
MO 63828 5.0
MO 63829 10.5
MO 63830 7.0
MO 63833 10.6
MO 63834 7.4
MO 63837 6.0
MO 63839 7.4
MO 63840 10.6
MO 63841 7.0
MO 63845 7.4
MO 63846 9.0
MO 63847 6.0
MO 63848 10.6
MO 63849 10.6
MO 63850 9.0
MO 63851 7.0
MO 63852 6.0
MO 63853 7.4
MO 63855 10.5
MO 63857 4.0
MO 63860 7.0
MO 63862 10.0
MO 63863 7.0
MO 63866 10.6
MO 63867 5.0
MO 63868 5.0
MO 63869 7.0
MO 63870 10.6
MO 63873 7.0
MO 63874 10.6
MO 63875 10.5
MO 63876 10.5
MO 63877 7.4
MO 63878 7.0
MO 63879 10.6
MO 63880 6.0
MO 63881 7.4
MO 63882 7.4
MO 63901 4.0
MO 63902 4.0
MO 63931 10.0
MO 63932 5.0
MO 63933 10.6
MO 63934 6.0
MO 63935 10.5
MO 63936 10.6
MO 63937 10.2
MO 63938 5.0
MO 63939 5.0
MO 63940 5.0
MO 63941 10.0
MO 63942 10.0
MO 63943 10.2
MO 63944 10.0
MO 63945 5.0
MO 63950 6.0
MO 63951 6.0
MO 63952 5.0
MO 63953 10.0
MO 63954 5.0
MO 63955 10.0
MO 63956 10.0
MO 63957 10.0
MO 63960 10.6
MO 63961 5.0
MO 63962 5.0
MO 63963 6.0
MO 63964 10.0
MO 63965 10.0
MO 63966 6.0
MO 63967 5.0
MO 64001 7.3
MO 64011 2.0
MO 64012 1.0
MO 64013 1.0
MO 64014 1.0
MO 64015 1.0
MO 64016 2.0
MO 64017 2.0
MO 64018 2.0
MO 64019 4.2
MO 64020 10.4
MO 64021 7.3
MO 64022 9.1
MO 64024 2.0
MO 64028 2.0
MO 64029 1.0
MO 64030 1.0
MO 64034 1.0
MO 64035 2.0
MO 64036 2.0
MO 64037 7.3
MO 64040 2.0
MO 64048 2.0
MO 64050 1.0
MO 64051 1.0
MO 64052 1.0
MO 64053 1.0
MO 64054 1.0
MO 64055 1.0
MO 64056 1.0
MO 64057 1.0
MO 64058 1.0
MO 64060 2.0
MO 64061 2.0
MO 64062 2.0
MO 64063 2.0
MO 64064 1.0
MO 64065 1.0
MO 64066 2.0
MO 64067 9.1
MO 64068 1.0
MO 64069 1.0
MO 64070 2.0
MO 64071 7.3
MO 64072 1.0
MO 64073 1.0
MO 64074 2.0
MO 64075 2.0
MO 64076 2.0
MO 64077 2.0
MO 64078 2.0
MO 64079 2.0
MO 64080 2.0
MO 64081 2.0
MO 64082 1.0
MO 64083 1.0
MO 64084 2.0
MO 64085 7.1
MO 64086 2.0
MO 64087 1.0
MO 64088 2.0
MO 64089 2.0
MO 64090 2.0
MO 64092 1.0
MO 64093 4.2
MO 64096 10.4
MO 64097 2.0
MO 64098 2.0
MO 64101 1.0
MO 64102 1.0
MO 64105 1.0
MO 64106 1.0
MO 64108 1.0
MO 64109 1.0
MO 64110 1.0
MO 64111 1.0
MO 64112 1.0
MO 64113 1.0
MO 64114 1.0
MO 64116 1.0
MO 64117 1.0
MO 64118 1.0
MO 64119 1.0
MO 64120 1.0
MO 64121 1.0
MO 64123 1.0
MO 64124 1.0
MO 64125 1.0
MO 64126 1.0
MO 64127 1.0
MO 64128 1.0
MO 64129 1.0
MO 64130 1.0
MO 64131 1.0
MO 64132 1.0
MO 64133 1.0
MO 64134 1.0
MO 64136 1.0
MO 64137 1.0
MO 64138 1.0
MO 64139 1.0
MO 64141 1.0
MO 64142 1.0
MO 64144 1.0
MO 64145 1.0
MO 64146 1.0
MO 64147 1.0
MO 64148 1.0
MO 64149 1.0
MO 64150 1.0
MO 64151 1.0
MO 64152 1.0
MO 64153 1.0
MO 64154 1.0
MO 64155 1.0
MO 64156 1.0
MO 64157 2.0
MO 64158 1.0
MO 64160 1.0
MO 64161 1.0
MO 64163 2.0
MO 64164 2.0
MO 64165 2.0
MO 64166 2.0
MO 64167 2.0
MO 64168 1.0
MO 64170 1.0
MO 64171 1.0
MO 64172 1.0
MO 64173 1.0
MO 64179 1.0
MO 64180 1.0
MO 64183 1.0
MO 64184 1.0
MO 64185 1.0
MO 64187 1.0
MO 64188 1.0
MO 64189 1.0
MO 64190 1.0
MO 64191 1.0
MO 64192 1.0
MO 64193 1.0
MO 64194 1.0
MO 64195 1.0
MO 64196 1.0
MO 64197 1.0
MO 64198 1.0
MO 64199 1.0
MO 64401 2.1
MO 64402 10.0
MO 64420 10.5
MO 64421 2.0
MO 64422 2.0
MO 64423 5.0
MO 64424 7.0
MO 64426 10.6
MO 64427 2.0
MO 64428 5.0
MO 64429 7.3
MO 64430 2.0
MO 64431 5.0
MO 64432 5.0
MO 64433 5.0
MO 64434 5.0
MO 64436 1.0
MO 64437 10.4
MO 64438 10.0
MO 64439 2.0
MO 64440 2.0
MO 64441 10.5
MO 64442 10.6
MO 64443 2.0
MO 64444 2.0
MO 64445 5.0
MO 64446 10.0
MO 64447 7.3
MO 64448 2.1
MO 64449 2.0
MO 64451 10.4
MO 64453 10.4
MO 64454 3.0
MO 64455 5.0
MO 64456 10.5
MO 64457 5.0
MO 64458 8.0
MO 64459 2.0
MO 64461 5.0
MO 64463 10.4
MO 64465 2.0
MO 64466 10.4
MO 64467 8.0
MO 64468 4.0
MO 64469 7.3
MO 64470 10.4
MO 64471 8.0
MO 64473 10.4
MO 64474 2.0
MO 64475 5.0
MO 64476 5.0
MO 64477 2.0
MO 64478 5.0
MO 64479 5.0
MO 64480 2.0
MO 64481 10.6
MO 64482 10.0
MO 64483 2.0
MO 64484 2.0
MO 64485 2.0
MO 64486 10.5
MO 64487 5.0
MO 64489 10.4
MO 64490 2.0
MO 64491 10.0
MO 64492 3.0
MO 64493 2.0
MO 64494 2.0
MO 64496 10.0
MO 64497 7.3
MO 64498 10.0
MO 64499 10.5
MO 64501 1.0
MO 64502 1.0
MO 64503 1.0
MO 64504 1.0
MO 64505 1.0
MO 64506 1.0
MO 64507 1.0
MO 64508 1.0
MO 64601 7.0
MO 64620 10.4
MO 64622 10.6
MO 64623 10.6
MO 64624 10.4
MO 64625 10.4
MO 64628 7.0
MO 64630 10.6
MO 64631 8.0
MO 64632 10.6
MO 64633 7.0
MO 64635 8.0
MO 64636 10.4
MO 64637 10.4
MO 64638 8.0
MO 64639 10.6
MO 64640 10.4
MO 64641 8.0
MO 64642 10.6
MO 64643 10.6
MO 64644 10.4
MO 64645 10.0
MO 64646 10.0
MO 64647 10.4
MO 64648 10.4
MO 64649 10.4
MO 64650 10.4
MO 64651 7.0
MO 64652 8.0
MO 64653 10.6
MO 64654 10.4
MO 64655 10.0
MO 64656 8.0
MO 64657 10.0
MO 64658 10.6
MO 64659 10.6
MO 64660 10.6
MO 64661 10.0
MO 64664 8.0
MO 64667 10.0
MO 64668 10.6
MO 64670 10.4
MO 64671 10.4
MO 64672 10.0
MO 64673 10.6
MO 64674 10.6
MO 64676 10.6
MO 64679 8.0
MO 64680 10.6
MO 64681 10.6
MO 64682 10.6
MO 64683 7.0
MO 64686 8.0
MO 64688 8.0
MO 64689 10.4
MO 64701 7.1
MO 64720 3.0
MO 64722 3.0
MO 64723 3.0
MO 64724 10.6
MO 64725 2.0
MO 64726 8.3
MO 64728 8.0
MO 64730 7.3
MO 64733 6.1
MO 64734 2.0
MO 64735 7.0
MO 64738 10.6
MO 64739 2.0
MO 64740 8.0
MO 64741 8.0
MO 64742 2.0
MO 64743 7.1
MO 64744 7.0
MO 64745 3.0
MO 64746 2.0
MO 64747 2.0
MO 64748 8.0
MO 64750 8.0
MO 64752 3.0
MO 64755 2.0
MO 64756 10.0
MO 64759 7.0
MO 64761 6.1
MO 64762 10.6
MO 64763 10.6
MO 64765 8.0
MO 64766 7.0
MO 64767 8.0
MO 64769 10.6
MO 64770 8.0
MO 64771 8.0
MO 64772 7.0
MO 64776 10.6
MO 64777 7.3
MO 64778 8.0
MO 64779 10.6
MO 64780 10.6
MO 64781 10.6
MO 64783 8.0
MO 64784 8.0
MO 64788 8.3
MO 64789 10.6
MO 64790 8.0
MO 64801 1.0
MO 64802 1.0
MO 64803 1.0
MO 64804 1.0
MO 64830 2.0
MO 64831 10.4
MO 64832 2.0
MO 64833 5.2
MO 64834 1.0
MO 64835 1.0
MO 64836 4.2
MO 64840 2.0
MO 64841 1.0
MO 64842 10.0
MO 64843 10.0
MO 64844 6.1
MO 64847 10.4
MO 64848 2.0
MO 64849 2.0
MO 64850 4.0
MO 64853 10.0
MO 64854 10.4
MO 64855 2.0
MO 64856 10.4
MO 64857 2.0
MO 64858 4.0
MO 64859 5.2
MO 64861 2.0
MO 64862 5.2
MO 64863 10.4
MO 64864 1.0
MO 64865 3.0
MO 64866 10.0
MO 64867 2.0
MO 64868 10.0
MO 64869 2.0
MO 64870 1.0
MO 64873 2.0
MO 64874 8.0
MO 64944 1.0
MO 64999 1.0
MO 65001 2.0
MO 65010 2.0
MO 65011 10.0
MO 65013 10.4
MO 65014 8.0
MO 65016 2.0
MO 65017 10.0
MO 65018 7.1
MO 65020 10.0
MO 65022 2.0
MO 65023 2.0
MO 65024 2.0
MO 65025 3.0
MO 65026 7.0
MO 65031 7.0
MO 65032 2.0
MO 65034 10.0
MO 65035 10.1
MO 65036 7.0
MO 65037 10.0
MO 65038 10.0
MO 65039 2.0
MO 65040 2.0
MO 65041 7.0
MO 65042 3.0
MO 65043 2.0
MO 65046 2.0
MO 65047 10.0
MO 65048 2.0
MO 65049 10.0
MO 65050 3.0
MO 65051 10.1
MO 65052 10.0
MO 65053 2.0
MO 65054 2.0
MO 65055 7.1
MO 65058 10.1
MO 65059 2.0
MO 65061 8.0
MO 65062 8.0
MO 65063 2.0
MO 65064 9.1
MO 65065 10.0
MO 65066 7.0
MO 65067 5.0
MO 65068 9.1
MO 65069 10.6
MO 65072 10.0
MO 65074 2.0
MO 65075 10.4
MO 65076 2.0
MO 65077 5.0
MO 65078 10.0
MO 65079 10.0
MO 65080 2.0
MO 65081 7.0
MO 65082 10.0
MO 65083 10.0
MO 65084 10.0
MO 65085 2.0
MO 65101 1.0
MO 65102 1.0
MO 65103 1.0
MO 65104 1.0
MO 65105 1.0
MO 65106 1.0
MO 65107 1.0
MO 65108 1.0
MO 65109 1.0
MO 65110 1.0
MO 65111 1.0
MO 65201 1.0
MO 65202 1.0
MO 65203 1.0
MO 65205 1.0
MO 65211 1.0
MO 65212 1.0
MO 65215 1.0
MO 65216 1.0
MO 65217 1.0
MO 65218 1.0
MO 65230 10.4
MO 65231 3.0
MO 65232 5.0
MO 65233 7.3
MO 65236 10.0
MO 65237 10.6
MO 65239 5.0
MO 65240 7.1
MO 65243 5.2
MO 65244 5.0
MO 65246 10.0
MO 65247 8.0
MO 65248 7.3
MO 65250 7.3
MO 65251 4.0
MO 65254 10.4
MO 65255 2.0
MO 65256 2.0
MO 65257 5.2
MO 65258 10.5
MO 65259 5.0
MO 65260 5.0
MO 65261 10.0
MO 65262 3.0
MO 65263 10.5
MO 65264 5.0
MO 65265 4.0
MO 65270 4.2
MO 65274 7.3
MO 65275 10.0
MO 65276 10.6
MO 65278 5.2
MO 65279 2.0
MO 65280 5.0
MO 65281 10.5
MO 65282 10.0
MO 65283 10.0
MO 65284 2.0
MO 65285 10.5
MO 65286 10.0
MO 65287 9.1
MO 65299 1.0
MO 65301 4.0
MO 65302 4.0
MO 65305 7.4
MO 65320 5.0
MO 65321 10.5
MO 65322 10.6
MO 65323 8.0
MO 65324 10.6
MO 65325 10.5
MO 65326 10.0
MO 65327 10.5
MO 65329 10.0
MO 65330 10.2
MO 65332 5.0
MO 65333 5.0
MO 65334 5.0
MO 65335 10.5
MO 65336 7.4
MO 65337 5.0
MO 65338 10.5
MO 65339 5.0
MO 65340 4.0
MO 65344 5.0
MO 65345 4.0
MO 65347 5.0
MO 65348 10.6
MO 65349 10.2
MO 65350 4.0
MO 65351 10.5
MO 65354 10.0
MO 65355 10.0
MO 65360 7.0
MO 65401 4.0
MO 65402 4.0
MO 65409 4.0
MO 65436 6.0
MO 65438 10.0
MO 65439 10.0
MO 65440 8.0
MO 65441 10.6
MO 65443 6.0
MO 65444 10.0
MO 65446 9.0
MO 65449 10.6
MO 65452 10.5
MO 65453 7.0
MO 65456 9.0
MO 65457 4.0
MO 65459 10.5
MO 65461 6.0
MO 65462 6.0
MO 65463 5.0
MO 65464 10.0
MO 65466 10.0
MO 65468 10.0
MO 65470 5.0
MO 65473 4.0
MO 65479 10.0
MO 65483 10.0
MO 65484 10.0
MO 65486 10.4
MO 65501 8.0
MO 65529 6.0
MO 65532 4.0
MO 65534 5.0
MO 65535 9.0
MO 65536 5.0
MO 65541 10.3
MO 65542 10.5
MO 65543 5.0
MO 65546 10.0
MO 65548 10.5
MO 65550 5.0
MO 65552 10.5
MO 65555 10.0
MO 65556 5.0
MO 65557 10.5
MO 65559 7.4
MO 65560 7.0
MO 65564 10.0
MO 65565 10.6
MO 65566 10.0
MO 65567 10.5
MO 65570 10.5
MO 65571 10.0
MO 65572 5.0
MO 65580 6.0
MO 65582 10.1
MO 65583 4.0
MO 65584 4.0
MO 65586 10.6
MO 65588 10.0
MO 65589 10.0
MO 65590 2.0
MO 65591 10.5
MO 65601 7.1
MO 65603 10.0
MO 65604 2.0
MO 65605 7.0
MO 65606 10.5
MO 65607 10.0
MO 65608 7.3
MO 65609 10.0
MO 65610 2.0
MO 65611 5.0
MO 65612 2.0
MO 65613 7.1
MO 65614 5.0
MO 65615 4.0
MO 65616 4.0
MO 65617 7.1
MO 65618 10.0
MO 65619 1.0
MO 65620 2.0
MO 65622 2.0
MO 65623 10.6
MO 65624 10.4
MO 65625 7.0
MO 65626 5.0
MO 65627 5.0
MO 65629 2.0
MO 65630 2.0
MO 65631 2.0
MO 65632 5.0
MO 65633 2.0
MO 65634 10.0
MO 65635 10.4
MO 65636 2.0
MO 65637 10.0
MO 65638 10.6
MO 65640 8.0
MO 65641 9.0
MO 65644 2.0
MO 65645 2.0
MO 65646 10.4
MO 65647 10.6
MO 65648 2.0
MO 65649 8.0
MO 65650 7.1
MO 65652 2.0
MO 65653 5.0
MO 65654 8.0
MO 65655 10.5
MO 65656 10.4
MO 65657 2.0
MO 65658 10.0
MO 65660 10.5
MO 65661 10.4
MO 65662 10.5
MO 65663 7.1
MO 65664 2.0
MO 65666 10.0
MO 65667 10.4
MO 65668 10.4
MO 65669 2.0
MO 65672 4.0
MO 65673 4.0
MO 65674 8.0
MO 65675 2.0
MO 65676 10.5
MO 65679 5.0
MO 65680 5.0
MO 65681 5.0
MO 65682 10.0
MO 65685 7.3
MO 65686 10.5
MO 65688 5.0
MO 65689 10.6
MO 65690 10.6
MO 65692 7.4
MO 65701 5.0
MO 65702 10.4
MO 65704 10.4
MO 65705 3.0
MO 65706 7.1
MO 65707 2.0
MO 65708 7.0
MO 65710 7.1
MO 65711 7.0
MO 65712 7.3
MO 65713 2.0
MO 65714 1.0
MO 65715 10.5
MO 65717 10.4
MO 65720 2.0
MO 65721 1.0
MO 65722 5.0
MO 65723 7.0
MO 65724 10.6
MO 65725 7.1
MO 65726 4.0
MO 65727 7.1
MO 65728 2.0
MO 65729 10.5
MO 65730 2.0
MO 65731 5.0
MO 65732 10.0
MO 65733 5.0
MO 65734 8.0
MO 65735 10.0
MO 65737 10.5
MO 65738 2.0
MO 65739 4.0
MO 65740 5.0
MO 65741 10.0
MO 65742 2.0
MO 65744 5.0
MO 65745 10.6
MO 65746 2.0
MO 65747 9.2
MO 65752 10.0
MO 65753 2.0
MO 65754 2.0
MO 65755 8.0
MO 65756 8.0
MO 65757 2.0
MO 65759 5.0
MO 65760 10.0
MO 65761 10.5
MO 65762 10.5
MO 65764 10.6
MO 65765 1.0
MO 65766 10.0
MO 65767 10.6
MO 65768 10.6
MO 65769 8.0
MO 65770 2.0
MO 65771 5.0
MO 65772 10.6
MO 65773 10.0
MO 65774 10.6
MO 65775 5.0
MO 65776 5.0
MO 65777 5.0
MO 65778 10.6
MO 65779 10.6
MO 65781 2.0
MO 65783 10.6
MO 65784 10.0
MO 65785 10.0
MO 65786 10.0
MO 65787 10.6
MO 65788 5.0
MO 65789 5.0
MO 65790 5.0
MO 65791 7.4
MO 65793 10.5
MO 65801 1.0
MO 65802 1.0
MO 65803 1.0
MO 65804 1.0
MO 65805 1.0
MO 65806 1.0
MO 65807 1.0
MO 65808 1.0
MO 65809 1.0
MO 65810 1.0
MO 65814 1.0
MO 65817 1.0
MO 65890 1.0
MO 65898 1.0
MO 65899 1.0
MP 96950 R
MP 96951 R
MP 96952 R
MS 38601 5.0
MS 38602 9.1
MS 38603 10.4
MS 38606 7.0
MS 38609 7.0
MS 38610 10.6
MS 38611 2.0
MS 38614 4.0
MS 38617 6.0
MS 38618 9.1
MS 38619 10.6
MS 38620 8.0
MS 38621 10.6
MS 38622 7.0
MS 38623 10.6
MS 38625 10.6
MS 38626 10.3
MS 38627 8.0
MS 38628 10.6
MS 38629 10.0
MS 38630 4.0
MS 38631 4.0
MS 38632 2.0
MS 38633 10.6
MS 38634 7.3
MS 38635 7.3
MS 38637 1.0
MS 38638 7.3
MS 38639 6.0
MS 38641 1.0
MS 38642 2.0
MS 38643 7.0
MS 38644 6.0
MS 38645 4.0
MS 38646 7.0
MS 38647 10.4
MS 38649 7.3
MS 38650 8.4
MS 38651 2.0
MS 38652 7.0
MS 38654 1.0
MS 38655 5.0
MS 38658 8.0
MS 38659 9.1
MS 38661 2.0
MS 38663 10.6
MS 38664 10.3
MS 38665 9.1
MS 38666 7.0
MS 38668 7.3
MS 38669 4.0
MS 38670 10.6
MS 38671 1.0
MS 38672 2.0
MS 38673 5.0
MS 38674 10.0
MS 38675 5.0
MS 38676 10.3
MS 38677 5.0
MS 38679 2.0
MS 38680 1.0
MS 38683 10.0
MS 38685 9.1
MS 38686 1.0
MS 38701 4.0
MS 38702 4.0
MS 38703 4.0
MS 38704 4.0
MS 38720 5.0
MS 38721 10.0
MS 38722 4.0
MS 38723 7.4
MS 38725 5.0
MS 38726 5.0
MS 38730 4.0
MS 38731 5.0
MS 38732 4.0
MS 38733 4.0
MS 38736 10.2
MS 38737 7.4
MS 38738 7.4
MS 38739 4.0
MS 38740 9.2
MS 38744 5.0
MS 38745 10.0
MS 38746 9.2
MS 38748 7.4
MS 38749 4.0
MS 38751 4.0
MS 38753 4.0
MS 38754 7.0
MS 38756 5.0
MS 38758 4.0
MS 38759 5.0
MS 38760 4.0
MS 38761 7.2
MS 38762 5.0
MS 38764 4.0
MS 38765 10.0
MS 38767 4.0
MS 38768 7.4
MS 38769 5.0
MS 38771 7.4
MS 38772 5.0
MS 38773 5.0
MS 38774 9.2
MS 38776 4.0
MS 38778 5.0
MS 38780 5.0
MS 38781 5.0
MS 38782 4.0
MS 38801 4.0
MS 38802 4.0
MS 38803 4.0
MS 38804 4.0
MS 38820 7.4
MS 38821 7.4
MS 38824 6.0
MS 38825 7.4
MS 38826 4.0
MS 38827 10.0
MS 38828 9.2
MS 38829 8.0
MS 38833 6.0
MS 38834 4.0
MS 38835 4.0
MS 38838 10.0
MS 38839 7.0
MS 38841 5.0
MS 38843 7.4
MS 38844 9.0
MS 38846 5.0
MS 38847 9.2
MS 38848 9.0
MS 38849 5.0
MS 38850 8.0
MS 38851 7.0
MS 38852 6.0
MS 38854 7.0
MS 38855 5.0
MS 38856 9.2
MS 38857 5.0
MS 38858 5.0
MS 38859 9.2
MS 38860 5.0
MS 38862 5.0
MS 38863 7.4
MS 38864 8.0
MS 38865 5.0
MS 38866 5.0
MS 38868 5.0
MS 38869 5.0
MS 38870 8.0
MS 38871 9.0
MS 38873 10.0
MS 38874 9.0
MS 38875 7.0
MS 38876 8.4
MS 38877 7.0
MS 38878 10.6
MS 38879 4.0
MS 38880 8.0
MS 38901 4.0
MS 38902 4.0
MS 38912 5.0
MS 38913 10.0
MS 38914 9.0
MS 38915 10.0
MS 38916 7.0
MS 38917 5.0
MS 38920 8.0
MS 38921 7.4
MS 38922 10.6
MS 38923 5.0
MS 38924 9.2
MS 38925 5.0
MS 38926 4.0
MS 38927 8.0
MS 38928 10.2
MS 38929 5.0
MS 38930 4.0
MS 38935 4.0
MS 38940 5.0
MS 38941 7.2
MS 38943 5.0
MS 38944 10.2
MS 38945 4.0
MS 38946 7.2
MS 38947 5.0
MS 38948 9.2
MS 38949 5.0
MS 38950 6.0
MS 38951 9.0
MS 38952 10.2
MS 38953 9.2
MS 38954 4.0
MS 38955 7.0
MS 38957 10.5
MS 38958 7.4
MS 38959 7.2
MS 38960 4.0
MS 38961 9.2
MS 38962 7.4
MS 38963 10.5
MS 38964 7.0
MS 38965 7.0
MS 38966 10.5
MS 38967 7.0
MS 39038 7.0
MS 39039 4.2
MS 39040 5.2
MS 39041 2.0
MS 39042 1.0
MS 39043 1.0
MS 39044 2.0
MS 39045 2.0
MS 39046 2.0
MS 39047 2.0
MS 39051 8.0
MS 39054 10.0
MS 39056 1.0
MS 39057 9.0
MS 39058 1.0
MS 39059 2.0
MS 39060 1.0
MS 39061 10.0
MS 39062 10.1
MS 39063 7.0
MS 39066 2.0
MS 39067 8.0
MS 39069 9.0
MS 39071 2.0
MS 39072 2.0
MS 39073 2.0
MS 39074 8.0
MS 39077 2.0
MS 39078 2.0
MS 39079 9.1
MS 39080 8.0
MS 39081 9.0
MS 39082 2.0
MS 39083 7.3
MS 39086 9.0
MS 39087 3.0
MS 39088 5.0
MS 39090 7.0
MS 39092 8.0
MS 39094 9.1
MS 39095 7.0
MS 39096 9.0
MS 39097 8.0
MS 39098 3.0
MS 39107 8.0
MS 39108 8.0
MS 39109 8.0
MS 39110 1.0
MS 39111 7.3
MS 39112 10.1
MS 39113 10.0
MS 39114 10.1
MS 39115 8.0
MS 39116 10.0
MS 39117 3.0
MS 39119 10.0
MS 39120 4.0
MS 39121 4.0
MS 39122 4.0
MS 39130 1.0
MS 39140 10.0
MS 39144 10.6
MS 39145 2.0
MS 39146 9.1
MS 39148 2.0
MS 39149 9.0
MS 39150 10.6
MS 39151 1.0
MS 39152 8.0
MS 39153 10.0
MS 39154 2.0
MS 39156 5.0
MS 39157 1.0
MS 39158 1.0
MS 39159 10.0
MS 39160 8.0
MS 39161 2.0
MS 39162 5.0
MS 39163 2.0
MS 39165 4.0
MS 39166 8.0
MS 39167 2.0
MS 39168 10.5
MS 39169 9.2
MS 39170 2.0
MS 39171 8.0
MS 39173 4.2
MS 39174 1.0
MS 39175 2.0
MS 39176 5.0
MS 39177 10.0
MS 39179 4.2
MS 39180 4.0
MS 39181 4.0
MS 39182 4.0
MS 39183 4.0
MS 39189 9.0
MS 39190 4.0
MS 39191 6.0
MS 39192 8.0
MS 39193 1.0
MS 39194 4.2
MS 39201 1.0
MS 39202 1.0
MS 39203 1.0
MS 39204 1.0
MS 39205 1.0
MS 39206 1.0
MS 39207 1.0
MS 39208 1.0
MS 39209 1.0
MS 39210 1.0
MS 39211 1.0
MS 39212 1.0
MS 39213 1.0
MS 39215 1.0
MS 39216 1.0
MS 39217 1.0
MS 39218 2.0
MS 39225 1.0
MS 39232 1.0
MS 39235 1.0
MS 39236 1.0
MS 39250 1.0
MS 39269 1.0
MS 39271 1.0
MS 39272 1.0
MS 39282 1.0
MS 39283 1.0
MS 39284 1.0
MS 39286 1.0
MS 39288 1.0
MS 39289 1.0
MS 39296 1.0
MS 39298 1.0
MS 39301 4.0
MS 39302 4.0
MS 39303 4.0
MS 39304 4.0
MS 39305 4.0
MS 39307 4.0
MS 39309 5.0
MS 39320 5.0
MS 39322 8.0
MS 39323 9.0
MS 39324 8.0
MS 39325 5.0
MS 39326 5.0
MS 39327 9.0
MS 39328 6.0
MS 39330 10.5
MS 39332 9.0
MS 39335 5.0
MS 39336 9.0
MS 39337 6.0
MS 39338 10.0
MS 39339 8.0
MS 39341 10.6
MS 39342 5.0
MS 39345 7.0
MS 39346 8.0
MS 39347 10.0
MS 39348 5.0
MS 39350 8.0
MS 39352 10.5
MS 39354 6.0
MS 39355 10.5
MS 39356 10.0
MS 39358 10.5
MS 39359 8.0
MS 39360 10.0
MS 39361 10.6
MS 39362 10.0
MS 39363 10.5
MS 39364 5.0
MS 39365 10.6
MS 39366 5.0
MS 39367 8.0
MS 39401 1.0
MS 39402 1.0
MS 39403 1.0
MS 39404 1.0
MS 39406 1.0
MS 39407 1.0
MS 39421 10.4
MS 39422 10.5
MS 39423 10.4
MS 39425 2.0
MS 39426 6.1
MS 39427 10.4
MS 39428 10.0
MS 39429 8.0
MS 39436 2.0
MS 39437 4.0
MS 39439 5.0
MS 39440 4.0
MS 39441 4.0
MS 39442 4.0
MS 39443 5.0
MS 39451 10.0
MS 39452 10.4
MS 39455 3.0
MS 39456 10.0
MS 39457 6.1
MS 39459 3.0
MS 39460 5.0
MS 39461 10.0
MS 39462 10.4
MS 39463 4.2
MS 39464 5.2
MS 39465 2.0
MS 39466 4.2
MS 39470 10.0
MS 39474 10.0
MS 39475 2.0
MS 39476 10.1
MS 39477 5.0
MS 39478 10.0
MS 39479 3.0
MS 39480 5.0
MS 39481 10.5
MS 39482 2.0
MS 39483 8.0
MS 39501 1.0
MS 39502 1.0
MS 39503 1.0
MS 39505 1.0
MS 39506 1.0
MS 39507 1.0
MS 39520 1.0
MS 39521 1.0
MS 39522 2.0
MS 39525 2.0
MS 39529 2.0
MS 39530 1.0
MS 39531 1.0
MS 39532 1.0
MS 39533 1.0
MS 39534 1.0
MS 39535 1.0
MS 39540 1.0
MS 39552 1.0
MS 39553 1.0
MS 39555 1.0
MS 39556 2.0
MS 39558 1.0
MS 39560 1.0
MS 39561 9.1
MS 39562 1.0
MS 39563 1.0
MS 39564 1.0
MS 39565 2.1
MS 39566 1.0
MS 39567 1.0
MS 39568 1.0
MS 39569 1.0
MS 39571 2.0
MS 39572 2.1
MS 39573 9.1
MS 39574 2.0
MS 39576 1.0
MS 39577 9.1
MS 39581 1.0
MS 39595 1.0
MS 39601 5.0
MS 39602 5.0
MS 39603 5.0
MS 39629 5.0
MS 39630 10.5
MS 39631 10.0
MS 39632 5.0
MS 39633 10.0
MS 39635 4.0
MS 39638 10.0
MS 39641 10.0
MS 39643 8.0
MS 39645 10.5
MS 39647 10.5
MS 39648 4.0
MS 39649 4.0
MS 39652 5.0
MS 39653 10.5
MS 39654 10.5
MS 39656 10.0
MS 39657 5.0
MS 39661 10.5
MS 39662 5.0
MS 39663 10.0
MS 39664 10.5
MS 39665 10.5
MS 39666 5.0
MS 39667 10.0
MS 39668 9.0
MS 39669 10.0
MS 39701 4.0
MS 39702 4.0
MS 39703 4.0
MS 39704 4.0
MS 39705 4.0
MS 39710 5.0
MS 39730 7.4
MS 39735 10.0
MS 39736 4.0
MS 39737 10.0
MS 39739 10.6
MS 39740 5.0
MS 39741 8.0
MS 39743 5.0
MS 39744 10.0
MS 39745 10.0
MS 39746 9.0
MS 39747 8.0
MS 39750 5.0
MS 39751 6.0
MS 39752 6.0
MS 39753 4.0
MS 39754 8.0
MS 39755 8.0
MS 39756 9.2
MS 39759 4.0
MS 39760 4.0
MS 39762 4.0
MS 39766 5.0
MS 39767 10.0
MS 39769 5.0
MS 39771 10.0
MS 39772 10.0
MS 39773 8.0
MS 39776 8.4
MT 59001 10.0
MT 59002 2.0
MT 59003 10.0
MT 59004 10.0
MT 59006 2.0
MT 59007 10.0
MT 59008 10.0
MT 59010 10.0
MT 59011 10.0
MT 59012 10.0
MT 59013 2.0
MT 59014 10.4
MT 59015 2.0
MT 59016 10.0
MT 59018 10.3
MT 59019 10.0
MT 59020 10.0
MT 59022 10.6
MT 59024 2.0
MT 59025 10.5
MT 59026 2.0
MT 59027 8.0
MT 59028 10.0
MT 59029 10.4
MT 59030 10.0
MT 59031 10.6
MT 59032 10.6
MT 59033 10.0
MT 59034 7.0
MT 59035 10.0
MT 59036 10.0
MT 59037 2.0
MT 59038 10.0
MT 59039 10.0
MT 59041 2.0
MT 59043 10.0
MT 59044 2.0
MT 59046 10.4
MT 59047 7.0
MT 59050 10.0
MT 59052 10.0
MT 59053 10.0
MT 59054 10.0
MT 59055 10.0
MT 59057 2.0
MT 59058 10.0
MT 59059 10.0
MT 59061 10.0
MT 59062 10.0
MT 59063 2.0
MT 59064 2.0
MT 59065 8.0
MT 59066 10.0
MT 59067 10.4
MT 59068 10.0
MT 59069 10.4
MT 59070 10.0
MT 59071 10.0
MT 59072 10.4
MT 59073 10.4
MT 59074 10.4
MT 59075 10.4
MT 59076 10.0
MT 59077 10.0
MT 59078 10.0
MT 59079 2.0
MT 59081 10.0
MT 59082 7.0
MT 59083 10.0
MT 59084 10.0
MT 59085 10.0
MT 59086 10.3
MT 59087 10.0
MT 59088 2.0
MT 59089 10.0
MT 59101 1.0
MT 59102 1.0
MT 59103 1.0
MT 59104 1.0
MT 59105 1.0
MT 59106 2.0
MT 59107 1.0
MT 59108 1.0
MT 59111 1.0
MT 59112 1.0
MT 59114 1.0
MT 59115 1.0
MT 59116 1.0
MT 59117 1.0
MT 59201 7.0
MT 59211 10.0
MT 59212 10.0
MT 59213 10.6
MT 59214 10.6
MT 59215 10.6
MT 59217 10.6
MT 59218 10.0
MT 59219 10.0
MT 59221 10.6
MT 59222 10.0
MT 59223 10.6
MT 59225 10.6
MT 59226 10.0
MT 59230 7.0
MT 59231 7.0
MT 59240 10.6
MT 59241 10.6
MT 59242 10.0
MT 59243 10.6
MT 59244 10.6
MT 59247 10.0
MT 59248 10.6
MT 59250 10.6
MT 59252 10.0
MT 59253 10.0
MT 59254 10.0
MT 59255 7.0
MT 59256 10.0
MT 59257 10.0
MT 59258 10.0
MT 59259 10.6
MT 59260 10.6
MT 59261 10.0
MT 59262 10.6
MT 59263 10.0
MT 59270 7.0
MT 59273 10.6
MT 59274 10.6
MT 59275 10.0
MT 59276 10.0
MT 59301 7.0
MT 59311 10.0
MT 59312 10.0
MT 59313 10.0
MT 59314 10.0
MT 59315 10.6
MT 59316 10.0
MT 59317 10.0
MT 59318 10.0
MT 59319 10.0
MT 59322 10.0
MT 59323 10.0
MT 59324 10.0
MT 59326 10.6
MT 59327 10.0
MT 59330 7.0
MT 59332 10.0
MT 59333 10.0
MT 59336 8.0
MT 59337 10.0
MT 59338 8.0
MT 59339 10.6
MT 59341 10.6
MT 59343 10.0
MT 59344 10.0
MT 59345 10.0
MT 59347 10.0
MT 59349 10.6
MT 59351 8.0
MT 59353 10.0
MT 59354 10.0
MT 59401 1.0
MT 59402 1.0
MT 59403 1.0
MT 59404 1.0
MT 59405 1.0
MT 59406 1.0
MT 59410 10.2
MT 59411 8.0
MT 59412 2.0
MT 59414 2.0
MT 59416 7.0
MT 59417 7.0
MT 59418 10.6
MT 59419 10.0
MT 59420 10.4
MT 59421 2.0
MT 59422 10.0
MT 59424 10.6
MT 59425 7.0
MT 59427 7.0
MT 59430 10.6
MT 59432 10.6
MT 59433 10.4
MT 59434 8.0
MT 59435 7.0
MT 59436 10.4
MT 59440 2.0
MT 59441 10.6
MT 59442 10.4
MT 59443 2.0
MT 59444 7.0
MT 59445 10.6
MT 59446 10.0
MT 59447 10.6
MT 59448 10.6
MT 59450 10.0
MT 59451 10.6
MT 59452 10.6
MT 59453 10.0
MT 59454 10.6
MT 59456 7.0
MT 59457 7.0
MT 59460 10.0
MT 59461 10.0
MT 59462 10.6
MT 59463 2.0
MT 59464 10.6
MT 59465 2.0
MT 59466 10.6
MT 59467 10.4
MT 59468 10.4
MT 59469 10.6
MT 59471 10.6
MT 59472 2.0
MT 59474 7.0
MT 59477 2.0
MT 59479 10.6
MT 59480 2.0
MT 59482 10.6
MT 59483 2.0
MT 59484 10.6
MT 59485 2.0
MT 59486 10.6
MT 59487 2.0
MT 59489 10.6
MT 59501 4.0
MT 59520 10.0
MT 59521 5.0
MT 59522 10.0
MT 59523 10.5
MT 59524 10.0
MT 59525 10.5
MT 59526 10.0
MT 59527 10.0
MT 59528 10.5
MT 59529 10.0
MT 59530 10.5
MT 59531 10.0
MT 59532 10.5
MT 59535 10.5
MT 59537 10.0
MT 59538 10.0
MT 59540 10.5
MT 59542 10.0
MT 59544 10.0
MT 59545 10.0
MT 59546 10.0
MT 59547 10.5
MT 59601 4.0
MT 59602 4.0
MT 59604 4.0
MT 59620 4.0
MT 59623 4.0
MT 59624 4.0
MT 59625 4.0
MT 59626 4.0
MT 59631 5.0
MT 59632 5.0
MT 59633 5.0
MT 59634 5.0
MT 59635 4.0
MT 59636 4.0
MT 59638 5.0
MT 59639 10.2
MT 59640 5.0
MT 59641 10.0
MT 59642 10.0
MT 59643 10.0
MT 59644 10.0
MT 59645 10.0
MT 59647 10.0
MT 59648 5.0
MT 59701 4.0
MT 59702 4.0
MT 59703 4.0
MT 59707 4.0
MT 59710 10.0
MT 59711 7.4
MT 59713 10.5
MT 59714 5.0
MT 59715 4.0
MT 59716 10.5
MT 59717 4.0
MT 59718 5.0
MT 59719 5.0
MT 59720 10.0
MT 59721 10.0
MT 59722 7.0
MT 59724 10.0
MT 59725 7.0
MT 59727 5.0
MT 59728 10.5
MT 59729 10.0
MT 59730 10.5
MT 59731 10.5
MT 59732 7.0
MT 59733 10.5
MT 59735 10.0
MT 59736 10.0
MT 59739 10.0
MT 59740 10.0
MT 59741 10.2
MT 59743 5.0
MT 59745 10.0
MT 59746 7.0
MT 59747 10.0
MT 59748 5.0
MT 59749 10.0
MT 59750 5.0
MT 59751 10.0
MT 59752 10.5
MT 59754 10.0
MT 59755 10.0
MT 59756 8.0
MT 59758 10.5
MT 59759 10.5
MT 59760 10.5
MT 59761 10.0
MT 59762 10.0
MT 59771 4.0
MT 59772 4.0
MT 59773 5.0
MT 59801 1.0
MT 59802 1.0
MT 59803 1.0
MT 59804 1.0
MT 59806 1.0
MT 59807 1.0
MT 59808 1.0
MT 59812 1.0
MT 59820 2.0
MT 59821 10.4
MT 59823 2.0
MT 59824 10.0
MT 59825 1.0
MT 59826 2.0
MT 59827 10.6
MT 59828 10.3
MT 59829 10.3
MT 59830 10.0
MT 59831 10.0
MT 59832 10.0
MT 59833 2.0
MT 59834 2.0
MT 59835 7.0
MT 59837 10.0
MT 59840 7.0
MT 59841 7.0
MT 59842 10.0
MT 59843 10.5
MT 59844 10.0
MT 59845 10.0
MT 59846 2.0
MT 59847 2.0
MT 59848 10.0
MT 59851 1.0
MT 59853 10.0
MT 59854 10.5
MT 59855 10.0
MT 59856 10.0
MT 59858 10.0
MT 59859 10.0
MT 59860 7.0
MT 59863 10.4
MT 59864 10.0
MT 59865 10.0
MT 59866 10.0
MT 59867 10.0
MT 59868 2.0
MT 59870 10.1
MT 59871 10.6
MT 59872 10.4
MT 59873 10.0
MT 59874 10.0
MT 59875 10.6
MT 59901 4.0
MT 59902 4.0
MT 59903 4.0
MT 59904 4.0
MT 59910 8.0
MT 59911 10.2
MT 59912 7.4
MT 59913 4.0
MT 59914 8.0
MT 59915 8.0
MT 59916 6.0
MT 59917 10.0
MT 59918 10.0
MT 59919 4.0
MT 59920 5.0
MT 59921 6.0
MT 59922 5.0
MT 59923 7.0
MT 59925 5.0
MT 59926 4.0
MT 59927 7.4
MT 59928 6.0
MT 59929 6.0
MT 59930 10.0
MT 59931 6.0
MT 59932 5.0
MT 59933 10.0
MT 59934 10.0
MT 59935 10.6
MT 59936 4.0
MT 59937 7.4
NC 27006 1.0
NC 27007 3.0
NC 27009 1.0
NC 27010 1.0
NC 27011 9.1
NC 27012 1.0
NC 27013 5.0
NC 27014 7.3
NC 27016 2.0
NC 27017 10.5
NC 27018 2.0
NC 27019 2.0
NC 27020 9.1
NC 27021 1.0
NC 27022 2.0
NC 27023 1.0
NC 27024 6.0
NC 27025 2.0
NC 27027 7.3
NC 27028 7.3
NC 27030 4.2
NC 27031 4.2
NC 27040 1.0
NC 27041 2.0
NC 27042 10.4
NC 27043 2.0
NC 27045 1.0
NC 27046 10.4
NC 27047 3.0
NC 27048 6.0
NC 27049 4.2
NC 27050 1.0
NC 27051 1.0
NC 27052 2.0
NC 27053 2.0
NC 27054 5.0
NC 27055 7.1
NC 27094 1.0
NC 27098 1.0
NC 27099 1.0
NC 27101 1.0
NC 27102 1.0
NC 27103 1.0
NC 27104 1.0
NC 27105 1.0
NC 27106 1.0
NC 27107 1.0
NC 27108 1.0
NC 27109 1.0
NC 27110 1.0
NC 27111 1.0
NC 27113 1.0
NC 27114 1.0
NC 27115 1.0
NC 27116 1.0
NC 27117 1.0
NC 27120 1.0
NC 27127 1.0
NC 27130 1.0
NC 27150 1.0
NC 27151 1.0
NC 27152 1.0
NC 27155 1.0
NC 27156 1.0
NC 27157 1.0
NC 27198 1.0
NC 27199 1.0
NC 27201 1.0
NC 27202 1.0
NC 27203 4.0
NC 27204 4.0
NC 27205 5.0
NC 27207 8.0
NC 27208 8.0
NC 27209 10.6
NC 27212 10.4
NC 27213 8.0
NC 27214 2.0
NC 27215 1.0
NC 27216 1.0
NC 27217 1.0
NC 27220 1.0
NC 27228 2.0
NC 27229 10.0
NC 27230 5.0
NC 27231 2.0
NC 27233 2.0
NC 27235 2.1
NC 27237 4.0
NC 27239 3.0
NC 27242 5.0
NC 27243 1.0
NC 27244 1.0
NC 27247 10.6
NC 27248 5.0
NC 27249 1.0
NC 27252 6.0
NC 27253 1.0
NC 27256 6.0
NC 27258 1.0
NC 27259 10.0
NC 27260 1.0
NC 27261 1.0
NC 27262 1.0
NC 27263 1.0
NC 27264 1.0
NC 27265 1.0
NC 27278 1.0
NC 27281 5.0
NC 27282 1.0
NC 27283 2.0
NC 27284 1.0
NC 27285 1.0
NC 27288 4.0
NC 27289 4.0
NC 27291 2.0
NC 27292 4.2
NC 27293 4.2
NC 27294 4.2
NC 27295 5.2
NC 27298 10.4
NC 27299 5.2
NC 27301 1.0
NC 27302 1.0
NC 27305 3.0
NC 27306 10.6
NC 27310 2.1
NC 27311 2.0
NC 27312 2.0
NC 27313 2.0
NC 27314 2.0
NC 27315 2.0
NC 27316 6.0
NC 27317 4.1
NC 27320 4.1
NC 27321 4.1
NC 27322 4.1
NC 27323 4.1
NC 27325 10.0
NC 27326 6.1
NC 27330 4.0
NC 27331 4.0
NC 27332 5.0
NC 27340 1.0
NC 27341 5.0
NC 27342 1.0
NC 27343 8.3
NC 27344 7.0
NC 27349 2.0
NC 27350 1.0
NC 27351 4.2
NC 27355 6.0
NC 27356 10.6
NC 27357 2.0
NC 27358 2.0
NC 27359 1.0
NC 27360 1.0
NC 27361 1.0
NC 27370 1.0
NC 27371 7.0
NC 27373 1.0
NC 27374 5.2
NC 27375 4.1
NC 27376 5.0
NC 27377 2.0
NC 27379 10.4
NC 27395 1.0
NC 27401 1.0
NC 27402 1.0
NC 27403 1.0
NC 27404 1.0
NC 27405 1.0
NC 27406 1.0
NC 27407 1.0
NC 27408 1.0
NC 27409 1.0
NC 27410 1.0
NC 27411 1.0
NC 27412 1.0
NC 27413 1.0
NC 27415 1.0
NC 27416 1.0
NC 27417 1.0
NC 27419 1.0
NC 27420 1.0
NC 27425 1.0
NC 27427 1.0
NC 27429 1.0
NC 27435 1.0
NC 27438 1.0
NC 27455 1.0
NC 27480 1.0
NC 27495 1.0
NC 27497 1.0
NC 27498 1.0
NC 27499 1.0
NC 27501 2.0
NC 27502 1.0
NC 27503 2.0
NC 27504 2.0
NC 27505 6.0
NC 27506 7.3
NC 27507 8.3
NC 27508 2.0
NC 27509 2.0
NC 27510 1.0
NC 27511 1.0
NC 27512 1.0
NC 27513 1.0
NC 27514 1.0
NC 27515 1.0
NC 27516 1.0
NC 27517 1.0
NC 27518 1.0
NC 27519 1.0
NC 27520 2.0
NC 27521 3.0
NC 27522 2.1
NC 27523 1.0
NC 27524 4.2
NC 27525 2.0
NC 27526 1.0
NC 27527 1.0
NC 27528 1.0
NC 27529 1.0
NC 27530 1.0
NC 27531 1.0
NC 27532 1.0
NC 27533 1.0
NC 27534 1.0
NC 27536 4.0
NC 27537 5.0
NC 27539 1.0
NC 27540 1.0
NC 27541 2.0
NC 27542 6.0
NC 27543 1.0
NC 27544 5.2
NC 27545 1.0
NC 27546 7.3
NC 27549 7.1
NC 27551 10.0
NC 27552 7.3
NC 27553 10.5
NC 27555 4.2
NC 27556 5.0
NC 27557 2.0
NC 27559 2.1
NC 27560 1.0
NC 27562 2.1
NC 27563 10.5
NC 27564 2.1
NC 27565 7.0
NC 27568 5.2
NC 27569 5.2
NC 27570 10.5
NC 27571 1.0
NC 27572 2.0
NC 27573 7.3
NC 27574 9.1
NC 27576 4.2
NC 27577 4.2
NC 27581 2.0
NC 27582 7.0
NC 27583 2.0
NC 27584 5.0
NC 27586 10.0
NC 27587 1.0
NC 27588 1.0
NC 27589 10.5
NC 27591 2.0
NC 27592 2.0
NC 27593 4.2
NC 27594 10.5
NC 27596 2.0
NC 27597 2.0
NC 27599 1.0
NC 27601 1.0
NC 27602 1.0
NC 27603 1.0
NC 27604 1.0
NC 27605 1.0
NC 27606 1.0
NC 27607 1.0
NC 27608 1.0
NC 27609 1.0
NC 27610 1.0
NC 27611 1.0
NC 27612 1.0
NC 27613 1.0
NC 27614 1.0
NC 27615 1.0
NC 27616 1.0
NC 27617 1.0
NC 27619 1.0
NC 27620 1.0
NC 27621 1.0
NC 27622 1.0
NC 27623 1.0
NC 27624 1.0
NC 27625 1.0
NC 27626 1.0
NC 27627 1.0
NC 27628 1.0
NC 27629 1.0
NC 27634 1.0
NC 27635 1.0
NC 27636 1.0
NC 27640 1.0
NC 27650 1.0
NC 27656 1.0
NC 27658 1.0
NC 27661 1.0
NC 27668 1.0
NC 27675 1.0
NC 27676 1.0
NC 27690 1.0
NC 27695 1.0
NC 27697 1.0
NC 27698 1.0
NC 27699 1.0
NC 27701 1.0
NC 27702 1.0
NC 27703 1.0
NC 27704 1.0
NC 27705 1.0
NC 27706 1.0
NC 27707 1.0
NC 27708 1.0
NC 27709 1.0
NC 27710 1.0
NC 27711 1.0
NC 27712 1.0
NC 27713 1.0
NC 27715 1.0
NC 27717 1.0
NC 27722 1.0
NC 27801 1.0
NC 27802 1.0
NC 27803 1.0
NC 27804 1.0
NC 27805 9.0
NC 27806 10.5
NC 27807 6.1
NC 27808 10.2
NC 27809 2.0
NC 27810 10.5
NC 27811 1.0
NC 27812 2.0
NC 27813 4.0
NC 27814 6.0
NC 27816 2.0
NC 27817 5.0
NC 27818 7.0
NC 27819 10.5
NC 27820 10.0
NC 27821 6.0
NC 27822 5.2
NC 27823 3.0
NC 27824 10.0
NC 27825 7.0
NC 27826 10.0
NC 27827 1.0
NC 27828 2.0
NC 27829 2.0
NC 27830 2.0
NC 27831 10.5
NC 27832 5.0
NC 27833 1.0
NC 27834 1.0
NC 27835 1.0
NC 27836 1.0
NC 27837 2.0
NC 27839 6.0
NC 27840 9.0
NC 27841 9.0
NC 27842 5.0
NC 27843 5.0
NC 27844 2.0
NC 27845 10.5
NC 27846 10.6
NC 27847 10.0
NC 27849 10.0
NC 27850 5.0
NC 27851 5.0
NC 27852 10.5
NC 27853 10.0
NC 27854 10.0
NC 27855 7.0
NC 27856 1.0
NC 27857 9.0
NC 27858 1.0
NC 27860 10.5
NC 27861 3.0
NC 27862 10.0
NC 27863 2.0
NC 27864 10.4
NC 27865 5.0
NC 27866 10.5
NC 27867 10.0
NC 27868 2.0
NC 27869 10.0
NC 27870 4.0
NC 27871 3.0
NC 27872 10.0
NC 27873 5.0
NC 27874 7.3
NC 27875 10.0
NC 27876 10.5
NC 27877 10.0
NC 27878 1.0
NC 27879 1.0
NC 27880 5.0
NC 27881 5.0
NC 27882 3.0
NC 27883 5.0
NC 27884 2.0
NC 27885 10.0
NC 27886 4.2
NC 27887 6.0
NC 27888 3.0
NC 27889 4.2
NC 27890 4.0
NC 27891 2.0
NC 27892 7.0
NC 27893 4.0
NC 27894 4.0
NC 27895 4.0
NC 27896 4.0
NC 27897 10.0
NC 27906 4.0
NC 27907 4.0
NC 27909 4.0
NC 27910 7.0
NC 27915 10.5
NC 27916 5.0
NC 27917 2.0
NC 27919 6.0
NC 27920 10.5
NC 27921 6.0
NC 27922 9.0
NC 27923 5.0
NC 27924 10.0
NC 27925 10.6
NC 27926 10.4
NC 27927 10.4
NC 27928 10.6
NC 27929 2.0
NC 27930 10.5
NC 27932 7.0
NC 27935 10.6
NC 27936 10.5
NC 27937 10.4
NC 27938 10.4
NC 27939 5.0
NC 27941 5.0
NC 27942 9.0
NC 27943 10.5
NC 27944 10.5
NC 27946 10.4
NC 27947 5.0
NC 27948 4.0
NC 27949 4.0
NC 27950 2.0
NC 27953 10.5
NC 27954 7.4
NC 27956 2.0
NC 27957 10.0
NC 27958 2.0
NC 27959 10.5
NC 27960 10.0
NC 27962 7.0
NC 27964 5.0
NC 27965 5.0
NC 27966 5.0
NC 27967 7.0
NC 27968 10.5
NC 27969 10.6
NC 27970 10.6
NC 27972 10.5
NC 27973 6.0
NC 27974 6.0
NC 27976 6.0
NC 27978 10.5
NC 27979 10.4
NC 27980 8.0
NC 27981 7.4
NC 27982 10.5
NC 27983 10.0
NC 27985 10.5
NC 27986 9.0
NC 28001 4.0
NC 28002 4.0
NC 28006 2.1
NC 28007 7.3
NC 28009 4.0
NC 28010 4.0
NC 28012 1.0
NC 28016 1.0
NC 28017 5.0
NC 28018 5.0
NC 28019 4.0
NC 28020 5.2
NC 28021 9.1
NC 28023 1.0
NC 28024 5.0
NC 28025 1.0
NC 28026 1.0
NC 28027 1.0
NC 28031 1.0
NC 28032 1.0
NC 28033 4.0
NC 28034 2.1
NC 28035 1.0
NC 28036 1.0
NC 28037 2.0
NC 28038 3.0
NC 28039 4.2
NC 28040 5.0
NC 28041 4.2
NC 28042 5.0
NC 28043 4.0
NC 28052 1.0
NC 28053 1.0
NC 28054 1.0
NC 28055 1.0
NC 28056 1.0
NC 28070 1.0
NC 28071 5.0
NC 28072 4.2
NC 28073 3.0
NC 28074 5.0
NC 28075 1.0
NC 28076 5.0
NC 28077 2.1
NC 28078 1.0
NC 28079 1.0
NC 28080 2.0
NC 28081 1.0
NC 28082 1.0
NC 28083 1.0
NC 28086 2.0
NC 28088 1.0
NC 28089 4.0
NC 28090 5.0
NC 28091 8.3
NC 28092 4.0
NC 28093 4.0
NC 28097 2.0
NC 28098 1.0
NC 28101 1.0
NC 28102 9.1
NC 28103 2.0
NC 28104 1.0
NC 28105 1.0
NC 28106 1.0
NC 28107 2.0
NC 28108 1.0
NC 28109 5.0
NC 28110 1.0
NC 28111 1.0
NC 28112 1.0
NC 28114 5.0
NC 28115 2.0
NC 28117 2.0
NC 28119 9.1
NC 28120 1.0
NC 28123 2.0
NC 28124 2.1
NC 28125 5.2
NC 28126 1.0
NC 28127 5.0
NC 28128 6.0
NC 28129 3.0
NC 28130 1.0
NC 28133 2.0
NC 28134 1.0
NC 28135 2.0
NC 28136 4.0
NC 28137 5.0
NC 28138 4.2
NC 28139 5.0
NC 28144 4.2
NC 28145 4.2
NC 28146 4.2
NC 28147 4.2
NC 28150 4.0
NC 28151 4.0
NC 28152 5.0
NC 28159 4.2
NC 28160 4.0
NC 28163 2.0
NC 28164 1.0
NC 28166 6.1
NC 28167 5.0
NC 28168 2.0
NC 28169 9.1
NC 28170 7.3
NC 28173 2.0
NC 28174 2.0
NC 28201 1.0
NC 28202 1.0
NC 28203 1.0
NC 28204 1.0
NC 28205 1.0
NC 28206 1.0
NC 28207 1.0
NC 28208 1.0
NC 28209 1.0
NC 28210 1.0
NC 28211 1.0
NC 28212 1.0
NC 28213 1.0
NC 28214 1.0
NC 28215 1.0
NC 28216 1.0
NC 28217 1.0
NC 28218 1.0
NC 28219 1.0
NC 28220 1.0
NC 28221 1.0
NC 28222 1.0
NC 28223 1.0
NC 28224 1.0
NC 28225 1.0
NC 28226 1.0
NC 28227 1.0
NC 28228 1.0
NC 28229 1.0
NC 28230 1.0
NC 28231 1.0
NC 28232 1.0
NC 28233 1.0
NC 28234 1.0
NC 28235 1.0
NC 28236 1.0
NC 28237 1.0
NC 28240 1.0
NC 28241 1.0
NC 28242 1.0
NC 28243 1.0
NC 28244 1.0
NC 28246 1.0
NC 28247 1.0
NC 28250 1.0
NC 28253 1.0
NC 28254 1.0
NC 28255 1.0
NC 28256 1.0
NC 28258 1.0
NC 28260 1.0
NC 28261 1.0
NC 28262 1.0
NC 28265 1.0
NC 28266 1.0
NC 28269 1.0
NC 28270 1.0
NC 28271 1.0
NC 28272 1.0
NC 28273 1.0
NC 28274 1.0
NC 28275 1.0
NC 28277 1.0
NC 28278 1.0
NC 28280 1.0
NC 28281 1.0
NC 28282 1.0
NC 28283 1.0
NC 28284 1.0
NC 28285 1.0
NC 28286 1.0
NC 28287 1.0
NC 28288 1.0
NC 28289 1.0
NC 28290 1.0
NC 28296 1.0
NC 28297 1.0
NC 28299 1.0
NC 28301 1.0
NC 28302 1.0
NC 28303 1.0
NC 28304 1.0
NC 28305 1.0
NC 28306 1.0
NC 28307 1.0
NC 28308 1.0
NC 28309 1.0
NC 28310 1.0
NC 28311 1.0
NC 28312 2.0
NC 28314 1.0
NC 28315 4.0
NC 28318 6.1
NC 28319 5.0
NC 28320 10.6
NC 28323 2.0
NC 28325 2.0
NC 28326 3.0
NC 28327 5.0
NC 28328 7.0
NC 28329 7.0
NC 28330 4.0
NC 28331 1.0
NC 28332 10.6
NC 28333 1.0
NC 28334 4.2
NC 28335 4.2
NC 28337 7.0
NC 28338 6.0
NC 28339 4.2
NC 28340 5.0
NC 28341 8.0
NC 28342 6.1
NC 28343 5.0
NC 28344 6.1
NC 28345 4.0
NC 28347 6.1
NC 28348 1.0
NC 28349 10.6
NC 28350 4.0
NC 28351 5.0
NC 28352 4.0
NC 28353 4.0
NC 28355 5.0
NC 28356 2.0
NC 28357 2.0
NC 28358 4.0
NC 28359 4.0
NC 28360 4.0
NC 28361 1.0
NC 28362 5.0
NC 28363 6.1
NC 28364 6.0
NC 28365 2.0
NC 28366 9.0
NC 28367 6.0
NC 28368 5.0
NC 28369 5.0
NC 28370 4.0
NC 28371 2.0
NC 28372 7.4
NC 28373 4.0
NC 28374 4.0
NC 28375 5.0
NC 28376 1.0
NC 28377 7.4
NC 28378 7.3
NC 28379 4.0
NC 28380 4.0
NC 28382 9.1
NC 28383 5.0
NC 28384 7.3
NC 28385 8.3
NC 28386 2.0
NC 28387 4.0
NC 28388 4.0
NC 28390 1.0
NC 28391 2.0
NC 28392 10.6
NC 28393 8.0
NC 28394 4.0
NC 28395 2.0
NC 28396 5.0
NC 28398 7.0
NC 28399 8.0
NC 28401 1.0
NC 28402 1.0
NC 28403 1.0
NC 28404 1.0
NC 28405 1.0
NC 28406 1.0
NC 28407 1.0
NC 28408 1.0
NC 28409 1.0
NC 28410 1.0
NC 28411 1.0
NC 28412 1.0
NC 28420 10.6
NC 28421 2.0
NC 28422 2.0
NC 28423 10.4
NC 28424 7.0
NC 28425 2.0
NC 28428 1.0
NC 28429 1.0
NC 28430 10.6
NC 28431 8.0
NC 28432 8.0
NC 28433 10.6
NC 28434 10.6
NC 28435 2.0
NC 28436 2.0
NC 28438 8.0
NC 28439 10.6
NC 28441 8.0
NC 28442 8.0
NC 28443 2.0
NC 28444 8.0
NC 28445 2.0
NC 28446 7.0
NC 28447 8.0
NC 28448 9.0
NC 28449 1.0
NC 28450 8.0
NC 28451 1.0
NC 28452 10.6
NC 28453 10.0
NC 28454 2.0
NC 28455 8.0
NC 28456 2.0
NC 28457 2.0
NC 28458 10.0
NC 28459 10.6
NC 28460 2.0
NC 28461 10.0
NC 28462 10.0
NC 28463 10.4
NC 28464 7.0
NC 28465 10.6
NC 28466 7.0
NC 28467 7.3
NC 28468 7.3
NC 28469 7.3
NC 28470 10.6
NC 28472 7.0
NC 28478 3.0
NC 28479 2.0
NC 28480 1.0
NC 28501 4.0
NC 28502 4.0
NC 28503 4.0
NC 28504 4.0
NC 28508 10.4
NC 28509 10.2
NC 28510 10.5
NC 28511 5.0
NC 28512 4.0
NC 28513 1.0
NC 28515 10.2
NC 28516 4.0
NC 28518 10.0
NC 28519 4.0
NC 28520 5.0
NC 28521 10.6
NC 28522 5.0
NC 28523 5.0
NC 28524 4.0
NC 28525 5.0
NC 28526 5.0
NC 28527 5.0
NC 28528 5.0
NC 28529 10.2
NC 28530 2.0
NC 28531 5.0
NC 28532 4.0
NC 28533 4.0
NC 28537 10.2
NC 28538 3.0
NC 28539 2.0
NC 28540 1.0
NC 28541 1.0
NC 28542 1.0
NC 28543 1.0
NC 28544 1.0
NC 28545 1.0
NC 28546 1.0
NC 28547 1.0
NC 28551 6.1
NC 28552 10.2
NC 28553 5.0
NC 28554 3.0
NC 28555 2.0
NC 28556 10.5
NC 28557 4.0
NC 28560 4.0
NC 28561 4.0
NC 28562 4.0
NC 28563 4.0
NC 28564 4.0
NC 28570 5.0
NC 28571 10.5
NC 28572 10.0
NC 28573 5.0
NC 28574 2.0
NC 28575 4.0
NC 28577 5.0
NC 28578 2.0
NC 28579 5.0
NC 28580 10.5
NC 28581 5.0
NC 28582 7.3
NC 28583 10.5
NC 28584 7.3
NC 28585 5.0
NC 28586 5.0
NC 28587 10.2
NC 28589 5.0
NC 28590 1.0
NC 28594 7.3
NC 28601 1.0
NC 28602 1.0
NC 28603 1.0
NC 28604 5.0
NC 28605 10.2
NC 28606 5.0
NC 28607 4.0
NC 28608 4.0
NC 28609 2.1
NC 28610 1.0
NC 28611 2.0
NC 28612 1.0
NC 28613 1.0
NC 28615 10.5
NC 28616 10.0
NC 28617 10.0
NC 28618 4.0
NC 28619 1.0
NC 28621 7.0
NC 28622 10.0
NC 28623 10.0
NC 28624 5.0
NC 28625 4.0
NC 28626 6.0
NC 28627 10.0
NC 28628 1.0
NC 28629 10.0
NC 28630 1.0
NC 28631 10.0
NC 28633 1.0
NC 28634 5.0
NC 28635 5.0
NC 28636 10.6
NC 28637 1.0
NC 28638 1.0
NC 28640 10.0
NC 28641 10.0
NC 28642 7.0
NC 28643 10.0
NC 28644 10.0
NC 28645 1.0
NC 28646 10.0
NC 28647 7.0
NC 28649 5.0
NC 28650 2.0
NC 28651 4.0
NC 28652 10.0
NC 28653 10.0
NC 28654 5.0
NC 28655 1.0
NC 28656 4.0
NC 28657 10.0
NC 28658 1.0
NC 28659 4.0
NC 28660 5.0
NC 28661 1.0
NC 28662 10.0
NC 28663 10.0
NC 28664 10.0
NC 28665 5.0
NC 28666 1.0
NC 28667 1.0
NC 28668 10.0
NC 28669 8.4
NC 28670 8.4
NC 28671 1.0
NC 28672 10.0
NC 28673 3.0
NC 28674 4.0
NC 28675 10.0
NC 28676 7.0
NC 28677 4.0
NC 28678 10.6
NC 28679 5.0
NC 28680 1.0
NC 28681 2.0
NC 28682 3.0
NC 28683 8.0
NC 28684 6.0
NC 28685 8.0
NC 28687 4.0
NC 28688 4.0
NC 28689 5.0
NC 28690 1.0
NC 28691 10.0
NC 28692 5.0
NC 28693 10.0
NC 28694 10.0
NC 28697 5.0
NC 28698 5.0
NC 28699 4.0
NC 28701 2.0
NC 28702 10.0
NC 28704 1.0
NC 28705 10.0
NC 28707 7.0
NC 28708 5.0
NC 28709 2.0
NC 28710 2.0
NC 28711 1.0
NC 28712 4.2
NC 28713 10.0
NC 28714 10.0
NC 28715 1.0
NC 28716 1.0
NC 28717 10.0
NC 28718 5.0
NC 28719 10.0
NC 28720 10.5
NC 28721 1.0
NC 28722 10.0
NC 28723 7.0
NC 28724 1.0
NC 28725 7.0
NC 28726 1.0
NC 28727 1.0
NC 28728 1.0
NC 28729 2.0
NC 28730 2.0
NC 28731 2.0
NC 28732 1.0
NC 28733 10.0
NC 28734 8.0
NC 28735 2.0
NC 28736 10.0
NC 28737 7.0
NC 28738 1.0
NC 28739 1.0
NC 28740 10.0
NC 28741 10.0
NC 28742 2.0
NC 28743 10.4
NC 28744 8.0
NC 28745 1.0
NC 28746 10.5
NC 28747 5.0
NC 28748 2.0
NC 28749 7.0
NC 28750 10.4
NC 28751 2.0
NC 28752 7.0
NC 28753 2.0
NC 28754 2.0
NC 28755 10.0
NC 28756 10.0
NC 28757 1.0
NC 28758 1.0
NC 28760 1.0
NC 28761 8.3
NC 28762 9.0
NC 28763 8.0
NC 28765 10.0
NC 28766 5.0
NC 28768 4.2
NC 28770 1.0
NC 28771 10.0
NC 28772 5.0
NC 28773 10.4
NC 28774 5.0
NC 28775 8.0
NC 28776 1.0
NC 28777 10.0
NC 28778 1.0
NC 28779 7.0
NC 28781 8.0
NC 28782 10.4
NC 28783 8.0
NC 28784 2.0
NC 28785 2.0
NC 28786 1.0
NC 28787 1.0
NC 28788 7.0
NC 28789 10.0
NC 28790 2.0
NC 28791 1.0
NC 28792 1.0
NC 28793 1.0
NC 28801 1.0
NC 28802 1.0
NC 28803 1.0
NC 28804 1.0
NC 28805 1.0
NC 28806 1.0
NC 28810 1.0
NC 28813 1.0
NC 28814 1.0
NC 28815 1.0
NC 28816 1.0
NC 28901 10.0
NC 28902 10.0
NC 28903 10.0
NC 28904 10.0
NC 28905 10.0
NC 28906 10.0
NC 28909 10.0
ND 58001 4.0
ND 58002 10.1
ND 58004 2.0
ND 58005 2.0
ND 58006 2.0
ND 58007 10.1
ND 58008 10.2
ND 58009 10.0
ND 58011 10.1
ND 58012 2.0
ND 58013 10.0
ND 58015 2.0
ND 58016 10.0
ND 58017 10.0
ND 58018 2.0
ND 58021 2.0
ND 58027 10.0
ND 58029 2.0
ND 58030 5.0
ND 58031 8.0
ND 58032 10.0
ND 58033 10.0
ND 58035 10.0
ND 58036 2.0
ND 58038 2.0
ND 58040 10.0
ND 58041 10.5
ND 58042 2.0
ND 58043 10.0
ND 58045 10.0
ND 58046 10.0
ND 58047 1.0
ND 58048 2.0
ND 58049 8.0
ND 58051 2.0
ND 58052 2.0
ND 58053 10.5
ND 58054 10.0
ND 58056 10.0
ND 58057 10.0
ND 58058 10.5
ND 58059 2.0
ND 58060 10.0
ND 58061 10.2
ND 58062 8.0
ND 58063 8.0
ND 58064 10.1
ND 58065 10.0
ND 58067 10.0
ND 58068 10.0
ND 58069 10.0
ND 58071 10.1
ND 58072 7.0
ND 58074 4.0
ND 58075 4.0
ND 58076 4.0
ND 58077 2.0
ND 58078 1.0
ND 58079 2.0
ND 58081 10.2
ND 58102 1.0
ND 58103 1.0
ND 58104 1.0
ND 58105 1.0
ND 58106 1.0
ND 58107 1.0
ND 58108 1.0
ND 58109 1.0
ND 58121 1.0
ND 58122 1.0
ND 58123 1.0
ND 58124 1.0
ND 58125 1.0
ND 58126 1.0
ND 58201 1.0
ND 58202 1.0
ND 58203 1.0
ND 58204 7.3
ND 58205 7.3
ND 58206 1.0
ND 58207 7.3
ND 58208 1.0
ND 58210 10.6
ND 58212 10.0
ND 58214 2.0
ND 58216 10.0
ND 58218 10.4
ND 58219 10.0
ND 58220 10.0
ND 58222 10.0
ND 58223 10.4
ND 58224 10.0
ND 58225 10.6
ND 58227 10.6
ND 58228 2.0
ND 58229 10.6
ND 58230 10.0
ND 58231 10.6
ND 58233 10.6
ND 58235 2.0
ND 58236 10.6
ND 58237 7.0
ND 58238 10.0
ND 58239 10.0
ND 58240 10.4
ND 58241 10.0
ND 58243 10.6
ND 58244 2.0
ND 58249 10.0
ND 58250 10.6
ND 58251 2.0
ND 58254 10.0
ND 58255 10.0
ND 58256 2.0
ND 58257 10.0
ND 58258 2.0
ND 58259 10.0
ND 58260 10.0
ND 58261 8.0
ND 58262 10.0
ND 58265 10.0
ND 58266 2.0
ND 58267 10.4
ND 58269 10.0
ND 58270 10.6
ND 58271 10.0
ND 58272 10.0
ND 58273 10.6
ND 58274 10.0
ND 58275 2.0
ND 58276 10.6
ND 58277 10.0
ND 58278 2.0
ND 58281 10.0
ND 58282 10.0
ND 58301 7.0
ND 58310 10.0
ND 58311 10.0
ND 58313 7.0
ND 58316 10.0
ND 58317 10.0
ND 58318 10.0
ND 58319 10.0
ND 58321 10.3
ND 58323 10.0
ND 58324 10.0
ND 58325 8.0
ND 58327 10.3
ND 58329 10.0
ND 58330 10.3
ND 58331 10.0
ND 58332 10.0
ND 58335 10.6
ND 58337 10.0
ND 58338 10.3
ND 58339 10.0
ND 58341 10.0
ND 58343 10.6
ND 58344 10.0
ND 58345 10.3
ND 58346 10.6
ND 58348 10.0
ND 58351 10.6
ND 58352 10.0
ND 58353 10.0
ND 58355 10.0
ND 58356 10.0
ND 58357 10.6
ND 58359 7.0
ND 58361 10.0
ND 58362 8.0
ND 58363 10.0
ND 58365 10.0
ND 58366 10.0
ND 58367 10.0
ND 58368 7.0
ND 58369 10.0
ND 58370 10.6
ND 58372 10.0
ND 58374 10.0
ND 58377 8.0
ND 58379 10.6
ND 58380 10.0
ND 58381 10.6
ND 58382 8.0
ND 58384 10.0
ND 58385 7.0
ND 58386 10.6
ND 58401 4.0
ND 58402 4.0
ND 58405 4.0
ND 58413 10.0
ND 58415 10.0
ND 58416 10.0
ND 58418 10.0
ND 58420 5.0
ND 58421 10.0
ND 58422 10.0
ND 58423 10.0
ND 58424 5.0
ND 58425 10.0
ND 58426 5.0
ND 58428 10.4
ND 58429 8.0
ND 58430 10.0
ND 58431 10.0
ND 58433 10.0
ND 58436 10.0
ND 58438 10.0
ND 58439 10.0
ND 58440 10.0
ND 58441 10.0
ND 58442 10.0
ND 58443 10.0
ND 58444 10.0
ND 58445 10.0
ND 58448 10.0
ND 58451 10.0
ND 58452 10.0
ND 58454 10.0
ND 58455 5.0
ND 58456 10.0
ND 58458 10.0
ND 58460 10.0
ND 58461 8.0
ND 58463 10.0
ND 58464 10.0
ND 58466 10.0
ND 58467 5.0
ND 58472 5.0
ND 58474 10.0
ND 58475 10.0
ND 58476 5.0
ND 58477 2.0
ND 58478 10.0
ND 58479 8.0
ND 58480 8.0
ND 58481 8.0
ND 58482 10.4
ND 58483 5.0
ND 58484 10.0
ND 58486 10.0
ND 58487 10.4
ND 58488 10.0
ND 58490 10.0
ND 58492 8.0
ND 58494 2.0
ND 58495 10.0
ND 58496 5.0
ND 58497 5.0
ND 58501 1.0
ND 58502 1.0
ND 58503 1.0
ND 58504 1.0
ND 58505 1.0
ND 58506 1.0
ND 58507 1.0
ND 58520 10.4
ND 58521 2.0
ND 58523 7.0
ND 58524 10.0
ND 58528 2.0
ND 58529 10.0
ND 58530 10.4
ND 58531 10.0
ND 58532 2.0
ND 58533 10.0
ND 58535 2.0
ND 58538 10.0
ND 58540 10.0
ND 58541 10.6
ND 58542 10.0
ND 58544 10.0
ND 58545 10.0
ND 58549 10.0
ND 58552 10.0
ND 58554 1.0
ND 58558 2.0
ND 58559 10.4
ND 58560 2.0
ND 58561 10.0
ND 58562 10.0
ND 58563 10.4
ND 58564 10.0
ND 58565 10.4
ND 58566 2.0
ND 58568 10.0
ND 58569 10.0
ND 58570 10.0
ND 58571 10.0
ND 58572 2.0
ND 58573 10.0
ND 58575 10.0
ND 58576 10.4
ND 58577 10.4
ND 58579 10.4
ND 58580 10.6
ND 58581 10.0
ND 58601 4.0
ND 58602 4.0
ND 58620 10.0
ND 58621 10.0
ND 58622 10.2
ND 58623 10.0
ND 58625 10.5
ND 58626 10.5
ND 58627 10.0
ND 58630 5.0
ND 58631 10.4
ND 58632 10.0
ND 58634 10.0
ND 58636 10.5
ND 58638 10.4
ND 58639 10.0
ND 58640 10.5
ND 58641 5.0
ND 58642 10.5
ND 58643 10.0
ND 58644 10.5
ND 58645 10.0
ND 58646 10.0
ND 58647 10.5
ND 58649 10.0
ND 58650 10.5
ND 58651 10.0
ND 58652 10.5
ND 58653 10.0
ND 58654 10.0
ND 58655 10.2
ND 58656 10.5
ND 58701 4.0
ND 58702 4.0
ND 58703 4.0
ND 58704 7.4
ND 58705 7.4
ND 58707 4.0
ND 58710 10.0
ND 58711 10.5
ND 58712 10.0
ND 58713 10.5
ND 58716 10.0
ND 58718 5.0
ND 58721 10.0
ND 58722 5.0
ND 58723 10.0
ND 58725 10.5
ND 58727 10.0
ND 58730 10.0
ND 58731 10.5
ND 58733 5.0
ND 58734 10.5
ND 58735 5.0
ND 58736 10.0
ND 58737 10.0
ND 58740 7.4
ND 58741 10.5
ND 58744 10.0
ND 58746 10.5
ND 58747 10.0
ND 58748 10.0
ND 58750 10.5
ND 58752 10.0
ND 58755 10.5
ND 58756 5.0
ND 58757 10.0
ND 58758 10.0
ND 58759 10.0
ND 58760 10.5
ND 58761 10.5
ND 58762 10.5
ND 58763 10.0
ND 58765 10.0
ND 58768 5.0
ND 58769 10.0
ND 58770 10.0
ND 58771 10.0
ND 58772 10.0
ND 58773 10.0
ND 58775 10.0
ND 58776 10.0
ND 58778 10.0
ND 58779 5.0
ND 58781 5.0
ND 58782 10.5
ND 58783 10.0
ND 58784 10.0
ND 58785 5.0
ND 58787 10.5
ND 58788 10.5
ND 58789 10.5
ND 58790 10.5
ND 58792 10.5
ND 58793 10.5
ND 58794 10.0
ND 58795 10.5
ND 58801 4.0
ND 58802 4.0
ND 58830 10.5
ND 58831 10.6
ND 58833 10.0
ND 58835 10.0
ND 58838 10.6
ND 58843 5.0
ND 58844 10.0
ND 58845 5.0
ND 58847 10.0
ND 58849 5.0
ND 58852 10.5
ND 58853 5.0
ND 58854 10.0
ND 58856 5.0
NE 68001 5.0
NE 68002 2.0
NE 68003 2.0
NE 68004 10.6
NE 68005 1.0
NE 68007 2.0
NE 68008 7.3
NE 68009 7.3
NE 68010 1.0
NE 68014 5.0
NE 68015 5.2
NE 68016 2.0
NE 68017 2.0
NE 68018 5.2
NE 68019 10.4
NE 68020 10.0
NE 68022 1.0
NE 68023 2.0
NE 68025 4.2
NE 68026 4.2
NE 68028 2.0
NE 68029 2.0
NE 68030 2.0
NE 68031 10.5
NE 68033 2.0
NE 68034 2.0
NE 68036 5.0
NE 68037 2.0
NE 68038 10.0
NE 68039 10.0
NE 68040 2.0
NE 68041 2.0
NE 68042 2.0
NE 68044 10.5
NE 68045 10.4
NE 68046 1.0
NE 68047 10.0
NE 68048 2.0
NE 68050 2.0
NE 68055 10.0
NE 68056 1.0
NE 68057 10.5
NE 68058 2.0
NE 68059 2.0
NE 68061 10.4
NE 68062 10.4
NE 68063 10.5
NE 68064 2.0
NE 68065 2.0
NE 68066 7.3
NE 68067 10.0
NE 68068 2.0
NE 68069 1.0
NE 68070 2.0
NE 68071 10.4
NE 68072 10.5
NE 68073 2.0
NE 68101 1.0
NE 68102 1.0
NE 68103 1.0
NE 68104 1.0
NE 68105 1.0
NE 68106 1.0
NE 68107 1.0
NE 68108 1.0
NE 68109 1.0
NE 68110 1.0
NE 68111 1.0
NE 68112 1.0
NE 68113 1.0
NE 68114 1.0
NE 68116 1.0
NE 68117 1.0
NE 68118 1.0
NE 68119 1.0
NE 68120 1.0
NE 68122 1.0
NE 68123 1.0
NE 68124 1.0
NE 68127 1.0
NE 68128 1.0
NE 68130 1.0
NE 68131 1.0
NE 68132 1.0
NE 68133 1.0
NE 68134 1.0
NE 68135 1.0
NE 68136 1.0
NE 68137 1.0
NE 68138 1.0
NE 68139 1.0
NE 68142 1.0
NE 68144 1.0
NE 68145 1.0
NE 68147 1.0
NE 68152 1.0
NE 68154 1.0
NE 68155 1.0
NE 68157 1.0
NE 68164 1.0
NE 68172 1.0
NE 68175 1.0
NE 68176 1.0
NE 68178 1.0
NE 68179 1.0
NE 68180 1.0
NE 68181 1.0
NE 68182 1.0
NE 68183 1.0
NE 68197 1.0
NE 68198 1.0
NE 68301 6.0
NE 68303 10.0
NE 68304 2.1
NE 68305 7.0
NE 68307 2.0
NE 68309 5.0
NE 68310 4.0
NE 68313 2.0
NE 68314 2.0
NE 68315 10.0
NE 68316 8.0
NE 68317 2.0
NE 68318 5.0
NE 68319 8.0
NE 68320 10.6
NE 68321 10.6
NE 68322 10.0
NE 68323 10.0
NE 68324 2.0
NE 68325 10.0
NE 68326 10.0
NE 68327 10.0
NE 68328 5.0
NE 68329 10.4
NE 68330 2.0
NE 68331 5.0
NE 68332 10.4
NE 68333 7.3
NE 68335 10.0
NE 68336 2.0
NE 68337 10.6
NE 68338 10.6
NE 68339 2.0
NE 68340 10.0
NE 68341 10.6
NE 68342 10.6
NE 68343 10.4
NE 68344 2.0
NE 68345 10.0
NE 68346 8.0
NE 68347 2.0
NE 68348 10.0
NE 68349 2.0
NE 68350 10.6
NE 68351 10.0
NE 68352 7.0
NE 68354 10.0
NE 68355 7.0
NE 68357 6.0
NE 68358 2.0
NE 68359 10.4
NE 68360 2.0
NE 68361 10.0
NE 68362 10.0
NE 68364 2.0
NE 68365 10.0
NE 68366 2.1
NE 68367 8.0
NE 68368 2.0
NE 68370 10.0
NE 68371 10.3
NE 68372 2.0
NE 68375 10.0
NE 68376 10.6
NE 68377 10.6
NE 68378 10.6
NE 68380 10.0
NE 68381 5.0
NE 68382 8.0
NE 68401 10.3
NE 68402 2.0
NE 68403 2.0
NE 68404 2.0
NE 68405 2.0
NE 68406 10.0
NE 68407 2.1
NE 68409 2.0
NE 68410 7.0
NE 68413 2.0
NE 68414 10.6
NE 68415 5.0
NE 68416 10.0
NE 68417 10.4
NE 68418 2.0
NE 68419 2.0
NE 68420 10.0
NE 68421 10.6
NE 68422 5.0
NE 68423 2.0
NE 68424 10.6
NE 68428 2.0
NE 68429 10.6
NE 68430 2.0
NE 68431 8.0
NE 68433 10.6
NE 68434 7.3
NE 68436 10.0
NE 68437 8.0
NE 68438 2.0
NE 68439 2.0
NE 68440 10.6
NE 68441 10.0
NE 68442 8.0
NE 68443 10.4
NE 68444 10.0
NE 68445 10.0
NE 68446 10.4
NE 68447 10.0
NE 68448 8.0
NE 68450 10.0
NE 68452 10.5
NE 68453 10.0
NE 68454 2.0
NE 68455 2.0
NE 68456 2.0
NE 68457 8.0
NE 68458 6.0
NE 68460 8.0
NE 68461 2.0
NE 68462 2.0
NE 68463 2.0
NE 68464 10.0
NE 68465 10.6
NE 68466 5.0
NE 68467 7.0
NE 68501 1.0
NE 68502 1.0
NE 68503 1.0
NE 68504 1.0
NE 68505 1.0
NE 68506 1.0
NE 68507 1.0
NE 68508 1.0
NE 68509 1.0
NE 68510 1.0
NE 68512 1.0
NE 68514 2.0
NE 68516 1.0
NE 68517 2.0
NE 68520 1.0
NE 68521 1.0
NE 68522 1.0
NE 68523 2.0
NE 68524 1.0
NE 68526 1.0
NE 68527 2.0
NE 68528 1.0
NE 68529 1.0
NE 68531 2.0
NE 68532 2.0
NE 68542 1.0
NE 68583 1.0
NE 68588 1.0
NE 68601 4.0
NE 68602 4.0
NE 68620 10.0
NE 68621 4.2
NE 68622 10.0
NE 68623 10.5
NE 68624 5.0
NE 68626 10.4
NE 68627 10.0
NE 68628 10.6
NE 68629 10.0
NE 68631 10.5
NE 68632 7.0
NE 68633 10.5
NE 68634 4.0
NE 68635 10.4
NE 68636 10.0
NE 68637 10.0
NE 68638 10.5
NE 68640 10.5
NE 68641 10.0
NE 68642 10.5
NE 68643 10.0
NE 68644 10.5
NE 68647 5.0
NE 68648 2.0
NE 68649 10.2
NE 68651 10.5
NE 68652 10.0
NE 68653 5.0
NE 68654 10.6
NE 68655 10.0
NE 68658 5.0
NE 68659 10.5
NE 68660 10.0
NE 68661 7.4
NE 68662 10.6
NE 68663 10.6
NE 68664 10.5
NE 68665 10.0
NE 68666 10.6
NE 68667 10.4
NE 68669 10.4
NE 68701 4.0
NE 68702 4.0
NE 68710 10.4
NE 68711 10.6
NE 68713 10.6
NE 68714 10.0
NE 68715 5.0
NE 68716 10.6
NE 68717 10.6
NE 68718 10.0
NE 68719 10.0
NE 68720 10.0
NE 68722 10.0
NE 68723 10.6
NE 68724 10.0
NE 68725 10.6
NE 68726 10.0
NE 68727 10.6
NE 68728 10.4
NE 68729 10.0
NE 68730 10.2
NE 68731 1.0
NE 68732 10.4
NE 68733 2.0
NE 68734 10.6
NE 68735 10.6
NE 68736 10.5
NE 68738 4.0
NE 68739 10.5
NE 68740 10.6
NE 68741 2.0
NE 68742 10.6
NE 68743 2.0
NE 68745 10.6
NE 68746 10.0
NE 68747 5.0
NE 68748 10.5
NE 68749 10.6
NE 68751 10.1
NE 68752 5.0
NE 68753 10.0
NE 68755 10.0
NE 68756 10.0
NE 68757 10.1
NE 68758 10.5
NE 68759 10.0
NE 68760 10.0
NE 68761 10.0
NE 68763 7.0
NE 68764 10.0
NE 68765 10.5
NE 68766 10.6
NE 68767 5.0
NE 68768 10.5
NE 68769 10.5
NE 68770 10.1
NE 68771 10.6
NE 68773 10.0
NE 68774 10.5
NE 68776 1.0
NE 68777 10.0
NE 68778 10.0
NE 68779 4.0
NE 68780 10.6
NE 68781 5.0
NE 68783 10.0
NE 68784 10.4
NE 68785 10.4
NE 68786 10.0
NE 68787 7.0
NE 68788 7.0
NE 68789 10.0
NE 68790 10.6
NE 68791 10.6
NE 68792 10.5
NE 68801 4.0
NE 68802 4.0
NE 68803 4.0
NE 68810 5.0
NE 68812 5.0
NE 68813 10.6
NE 68814 10.3
NE 68815 10.0
NE 68816 10.6
NE 68817 10.5
NE 68818 7.4
NE 68819 10.3
NE 68820 10.2
NE 68821 10.0
NE 68822 7.0
NE 68823 10.0
NE 68824 5.0
NE 68825 10.6
NE 68826 7.4
NE 68827 5.0
NE 68828 10.6
NE 68831 10.2
NE 68832 5.0
NE 68833 10.0
NE 68834 5.0
NE 68835 10.2
NE 68836 5.0
NE 68837 10.0
NE 68838 10.2
NE 68840 5.0
NE 68841 5.0
NE 68842 10.0
NE 68843 10.6
NE 68844 10.5
NE 68845 4.0
NE 68846 10.6
NE 68847 4.0
NE 68848 4.0
NE 68849 4.0
NE 68850 4.0
NE 68852 10.5
NE 68853 10.5
NE 68854 5.0
NE 68855 10.3
NE 68856 10.6
NE 68858 10.2
NE 68859 10.0
NE 68860 10.6
NE 68861 5.0
NE 68862 10.0
NE 68863 5.0
NE 68864 5.0
NE 68865 5.0
NE 68866 10.2
NE 68869 10.2
NE 68870 5.0
NE 68871 10.5
NE 68872 5.0
NE 68873 10.2
NE 68874 10.6
NE 68875 10.0
NE 68876 5.0
NE 68878 5.0
NE 68879 10.0
NE 68881 10.6
NE 68882 10.0
NE 68883 5.0
NE 68901 4.0
NE 68902 4.0
NE 68920 10.6
NE 68922 10.0
NE 68923 10.3
NE 68924 5.0
NE 68925 5.0
NE 68926 10.0
NE 68927 10.3
NE 68928 10.2
NE 68929 10.0
NE 68930 10.2
NE 68932 10.5
NE 68933 10.5
NE 68934 10.5
NE 68935 10.5
NE 68936 10.0
NE 68937 10.5
NE 68938 10.5
NE 68939 10.0
NE 68940 10.3
NE 68941 10.5
NE 68942 10.5
NE 68943 10.0
NE 68944 10.5
NE 68945 5.0
NE 68946 10.0
NE 68947 10.5
NE 68948 10.0
NE 68949 7.0
NE 68950 5.0
NE 68952 10.5
NE 68954 10.5
NE 68955 5.0
NE 68956 5.0
NE 68957 10.0
NE 68958 10.3
NE 68959 7.4
NE 68960 10.0
NE 68961 10.0
NE 68964 10.0
NE 68966 10.6
NE 68967 10.0
NE 68969 10.6
NE 68970 10.5
NE 68971 10.6
NE 68972 10.0
NE 68973 5.0
NE 68974 10.0
NE 68975 10.5
NE 68976 10.5
NE 68977 10.6
NE 68978 10.0
NE 68979 10.5
NE 68980 10.5
NE 68981 10.5
NE 68982 5.0
NE 69001 7.0
NE 69020 8.0
NE 69021 10.0
NE 69022 10.0
NE 69023 10.0
NE 69024 10.6
NE 69025 10.0
NE 69026 8.0
NE 69027 10.0
NE 69028 10.0
NE 69029 6.0
NE 69030 10.0
NE 69032 10.0
NE 69033 10.0
NE 69034 8.0
NE 69036 8.0
NE 69037 10.0
NE 69038 10.0
NE 69039 10.0
NE 69040 10.6
NE 69041 10.0
NE 69042 10.0
NE 69043 10.6
NE 69044 10.6
NE 69045 10.0
NE 69046 10.0
NE 69101 4.0
NE 69103 4.0
NE 69120 10.6
NE 69121 10.0
NE 69122 10.0
NE 69123 5.0
NE 69125 10.5
NE 69127 10.3
NE 69128 7.0
NE 69129 10.0
NE 69130 7.4
NE 69131 10.3
NE 69132 5.0
NE 69133 7.0
NE 69134 10.0
NE 69135 10.6
NE 69138 7.0
NE 69140 10.0
NE 69141 10.3
NE 69142 10.0
NE 69143 5.0
NE 69144 10.3
NE 69145 7.0
NE 69146 10.3
NE 69147 10.0
NE 69148 10.0
NE 69149 10.3
NE 69150 10.0
NE 69151 5.0
NE 69152 10.0
NE 69153 7.0
NE 69154 10.0
NE 69155 10.3
NE 69156 10.3
NE 69157 10.0
NE 69160 7.0
NE 69161 10.0
NE 69162 7.0
NE 69163 10.5
NE 69165 5.0
NE 69166 10.0
NE 69167 10.5
NE 69168 10.0
NE 69169 5.0
NE 69170 5.0
NE 69171 7.4
NE 69190 10.0
NE 69201 7.0
NE 69210 10.0
NE 69211 7.0
NE 69212 7.0
NE 69214 10.0
NE 69216 7.0
NE 69217 10.0
NE 69218 7.0
NE 69219 7.0
NE 69220 7.0
NE 69221 10.6
NE 69301 7.0
NE 69331 10.5
NE 69333 10.0
NE 69334 10.5
NE 69335 10.0
NE 69336 10.5
NE 69337 7.0
NE 69339 10.6
NE 69340 10.0
NE 69341 4.0
NE 69343 10.0
NE 69345 10.2
NE 69346 10.5
NE 69347 10.0
NE 69348 10.3
NE 69350 10.0
NE 69351 10.0
NE 69352 10.2
NE 69353 4.0
NE 69354 10.6
NE 69355 4.0
NE 69356 5.0
NE 69357 5.0
NE 69358 10.2
NE 69360 10.0
NE 69361 4.0
NE 69363 4.0
NE 69365 10.0
NE 69366 10.0
NE 69367 10.6
NH 03031 1.0
NH 03032 1.0
NH 03033 2.1
NH 03034 2.1
NH 03036 2.0
NH 03037 3.0
NH 03038 1.0
NH 03040 2.1
NH 03041 1.0
NH 03042 2.0
NH 03043 3.0
NH 03044 2.0
NH 03045 1.0
NH 03046 2.0
NH 03047 3.0
NH 03048 2.1
NH 03049 2.1
NH 03051 1.0
NH 03052 1.0
NH 03053 1.0
NH 03054 1.0
NH 03055 1.0
NH 03057 2.1
NH 03060 1.0
NH 03061 1.0
NH 03062 1.0
NH 03063 1.0
NH 03064 1.0
NH 03070 2.1
NH 03071 10.4
NH 03073 1.0
NH 03076 1.0
NH 03077 2.0
NH 03079 1.0
NH 03082 2.1
NH 03084 10.4
NH 03086 2.0
NH 03087 1.0
NH 03101 1.0
NH 03102 1.0
NH 03103 1.0
NH 03104 1.0
NH 03105 1.0
NH 03106 1.0
NH 03107 1.0
NH 03108 1.0
NH 03109 1.0
NH 03110 1.0
NH 03111 1.0
NH 03215 9.0
NH 03216 6.0
NH 03217 10.6
NH 03218 6.0
NH 03220 5.0
NH 03221 10.5
NH 03222 10.5
NH 03223 9.0
NH 03224 5.0
NH 03225 6.0
NH 03226 6.0
NH 03227 10.0
NH 03229 5.0
NH 03230 10.5
NH 03231 6.0
NH 03233 10.0
NH 03234 5.2
NH 03235 4.0
NH 03237 6.0
NH 03238 10.6
NH 03240 6.0
NH 03241 5.0
NH 03242 10.5
NH 03243 10.5
NH 03244 7.4
NH 03245 7.0
NH 03246 4.0
NH 03247 4.0
NH 03249 4.0
NH 03251 10.6
NH 03252 4.0
NH 03253 10.5
NH 03254 10.5
NH 03255 10.5
NH 03256 6.0
NH 03257 10.0
NH 03258 5.2
NH 03259 10.0
NH 03260 5.0
NH 03261 6.0
NH 03262 10.6
NH 03263 5.0
NH 03264 7.0
NH 03266 9.0
NH 03268 6.0
NH 03269 6.0
NH 03272 10.5
NH 03273 5.0
NH 03274 9.0
NH 03275 4.2
NH 03276 4.0
NH 03278 5.0
NH 03279 10.6
NH 03280 9.0
NH 03281 2.1
NH 03282 6.0
NH 03284 5.0
NH 03287 10.5
NH 03289 5.0
NH 03290 3.0
NH 03291 3.0
NH 03293 10.6
NH 03298 10.5
NH 03299 10.5
NH 03301 4.2
NH 03302 4.2
NH 03303 4.2
NH 03304 4.2
NH 03305 4.2
NH 03307 5.0
NH 03431 4.0
NH 03435 4.0
NH 03440 10.6
NH 03441 5.0
NH 03442 3.0
NH 03443 5.0
NH 03444 5.0
NH 03445 5.0
NH 03446 5.0
NH 03447 6.0
NH 03448 5.0
NH 03449 8.0
NH 03450 5.0
NH 03451 8.0
NH 03452 7.0
NH 03455 5.0
NH 03456 5.0
NH 03457 5.0
NH 03458 7.0
NH 03461 10.6
NH 03462 5.0
NH 03464 5.0
NH 03465 5.0
NH 03466 5.0
NH 03467 5.0
NH 03468 7.0
NH 03469 5.0
NH 03470 5.0
NH 03561 7.0
NH 03570 4.0
NH 03574 10.3
NH 03575 10.6
NH 03576 10.5
NH 03579 5.0
NH 03580 10.3
NH 03581 4.0
NH 03582 10.0
NH 03583 10.5
NH 03584 10.6
NH 03585 10.6
NH 03586 10.6
NH 03587 10.5
NH 03588 5.0
NH 03589 10.5
NH 03590 10.0
NH 03592 10.0
NH 03593 10.5
NH 03595 10.6
NH 03597 10.5
NH 03598 10.6
NH 03601 9.0
NH 03602 5.0
NH 03603 7.0
NH 03604 5.0
NH 03605 9.0
NH 03607 9.0
NH 03608 10.5
NH 03609 10.5
NH 03740 10.6
NH 03741 5.0
NH 03743 7.0
NH 03745 5.0
NH 03746 5.0
NH 03748 4.0
NH 03749 4.0
NH 03750 5.0
NH 03751 9.0
NH 03752 9.0
NH 03753 5.0
NH 03754 7.0
NH 03755 4.0
NH 03756 4.0
NH 03765 10.0
NH 03766 4.0
NH 03768 5.0
NH 03769 5.0
NH 03770 5.0
NH 03771 10.6
NH 03773 7.0
NH 03774 10.0
NH 03777 6.0
NH 03779 6.0
NH 03780 10.0
NH 03781 5.0
NH 03782 9.0
NH 03784 4.0
NH 03785 10.0
NH 03801 1.0
NH 03802 1.0
NH 03803 1.0
NH 03804 1.0
NH 03805 1.0
NH 03809 10.5
NH 03810 10.5
NH 03811 1.0
NH 03812 10.0
NH 03813 10.0
NH 03814 10.0
NH 03815 2.0
NH 03816 10.0
NH 03817 10.0
NH 03818 10.0
NH 03819 1.0
NH 03820 1.0
NH 03821 1.0
NH 03822 1.0
NH 03823 1.0
NH 03824 1.0
NH 03825 2.0
NH 03826 1.0
NH 03827 2.0
NH 03830 3.0
NH 03832 10.0
NH 03833 1.0
NH 03835 2.0
NH 03836 10.0
NH 03837 6.0
NH 03838 10.0
NH 03839 1.0
NH 03840 1.0
NH 03841 1.0
NH 03842 1.0
NH 03843 1.0
NH 03844 2.0
NH 03845 10.0
NH 03846 10.0
NH 03847 10.0
NH 03848 1.0
NH 03849 10.0
NH 03850 10.0
NH 03851 1.0
NH 03852 1.0
NH 03853 10.0
NH 03854 1.0
NH 03855 3.0
NH 03856 3.0
NH 03857 3.0
NH 03858 1.0
NH 03859 1.0
NH 03860 10.0
NH 03862 1.0
NH 03864 10.0
NH 03865 1.0
NH 03866 1.0
NH 03867 1.0
NH 03868 1.0
NH 03869 1.0
NH 03870 1.0
NH 03871 1.0
NH 03872 3.0
NH 03873 1.0
NH 03874 1.0
NH 03875 10.0
NH 03878 1.0
NH 03882 10.0
NH 03883 10.0
NH 03884 2.0
NH 03885 3.0
NH 03886 10.0
NH 03887 3.0
NH 03890 10.0
NH 03894 10.0
NH 03896 10.0
NH 03897 10.0
NJ 07001 1.0
NJ 07002 1.0
NJ 07003 1.0
NJ 07004 1.0
NJ 07005 1.0
NJ 07006 1.0
NJ 07007 1.0
NJ 07008 1.0
NJ 07009 1.0
NJ 07010 1.0
NJ 07011 1.0
NJ 07012 1.0
NJ 07013 1.0
NJ 07014 1.0
NJ 07015 1.0
NJ 07016 1.0
NJ 07017 1.0
NJ 07018 1.0
NJ 07019 1.0
NJ 07020 1.0
NJ 07021 1.0
NJ 07022 1.0
NJ 07023 1.0
NJ 07024 1.0
NJ 07026 1.0
NJ 07027 1.0
NJ 07028 1.0
NJ 07029 1.0
NJ 07030 1.0
NJ 07031 1.0
NJ 07032 1.0
NJ 07033 1.0
NJ 07034 1.0
NJ 07035 1.0
NJ 07036 1.0
NJ 07039 1.0
NJ 07040 1.0
NJ 07041 1.0
NJ 07042 1.0
NJ 07043 1.0
NJ 07044 1.0
NJ 07045 1.0
NJ 07046 1.0
NJ 07047 1.0
NJ 07050 1.0
NJ 07051 1.0
NJ 07052 1.0
NJ 07054 1.0
NJ 07055 1.0
NJ 07057 1.0
NJ 07058 1.0
NJ 07059 1.0
NJ 07060 1.0
NJ 07061 1.0
NJ 07062 1.0
NJ 07063 1.0
NJ 07064 1.0
NJ 07065 1.0
NJ 07066 1.0
NJ 07067 1.0
NJ 07068 1.0
NJ 07069 1.0
NJ 07070 1.0
NJ 07071 1.0
NJ 07072 1.0
NJ 07073 1.0
NJ 07074 1.0
NJ 07075 1.0
NJ 07076 1.0
NJ 07077 1.0
NJ 07078 1.0
NJ 07079 1.0
NJ 07080 1.0
NJ 07081 1.0
NJ 07082 1.0
NJ 07083 1.0
NJ 07086 1.0
NJ 07087 1.0
NJ 07088 1.0
NJ 07090 1.0
NJ 07091 1.0
NJ 07092 1.0
NJ 07093 1.0
NJ 07094 1.0
NJ 07095 1.0
NJ 07096 1.0
NJ 07097 1.0
NJ 07099 1.0
NJ 07101 1.0
NJ 07102 1.0
NJ 07103 1.0
NJ 07104 1.0
NJ 07105 1.0
NJ 07106 1.0
NJ 07107 1.0
NJ 07108 1.0
NJ 07109 1.0
NJ 07110 1.0
NJ 07111 1.0
NJ 07112 1.0
NJ 07114 1.0
NJ 07175 1.0
NJ 07182 1.0
NJ 07184 1.0
NJ 07188 1.0
NJ 07189 1.0
NJ 07191 1.0
NJ 07192 1.0
NJ 07193 1.0
NJ 07194 1.0
NJ 07195 1.0
NJ 07197 1.0
NJ 07198 1.0
NJ 07199 1.0
NJ 07201 1.0
NJ 07202 1.0
NJ 07203 1.0
NJ 07204 1.0
NJ 07205 1.0
NJ 07206 1.0
NJ 07207 1.0
NJ 07208 1.0
NJ 07302 1.0
NJ 07303 1.0
NJ 07304 1.0
NJ 07305 1.0
NJ 07306 1.0
NJ 07307 1.0
NJ 07308 1.0
NJ 07309 1.0
NJ 07310 1.0
NJ 07311 1.0
NJ 07390 1.0
NJ 07395 1.0
NJ 07399 1.0
NJ 07401 1.0
NJ 07403 1.0
NJ 07405 1.0
NJ 07407 1.0
NJ 07410 1.0
NJ 07416 2.0
NJ 07417 1.0
NJ 07418 2.0
NJ 07419 2.0
NJ 07420 1.0
NJ 07421 2.0
NJ 07422 2.0
NJ 07423 1.0
NJ 07424 1.0
NJ 07428 2.0
NJ 07430 1.0
NJ 07432 1.0
NJ 07435 1.0
NJ 07436 1.0
NJ 07438 2.0
NJ 07439 2.0
NJ 07440 1.0
NJ 07442 1.0
NJ 07444 1.0
NJ 07446 1.0
NJ 07450 1.0
NJ 07451 1.0
NJ 07452 1.0
NJ 07456 1.0
NJ 07457 1.0
NJ 07458 1.0
NJ 07460 2.0
NJ 07461 2.0
NJ 07462 2.0
NJ 07463 1.0
NJ 07465 1.0
NJ 07470 1.0
NJ 07474 1.0
NJ 07477 1.0
NJ 07480 1.0
NJ 07481 1.0
NJ 07495 1.0
NJ 07498 1.0
NJ 07501 1.0
NJ 07502 1.0
NJ 07503 1.0
NJ 07504 1.0
NJ 07505 1.0
NJ 07506 1.0
NJ 07507 1.0
NJ 07508 1.0
NJ 07509 1.0
NJ 07510 1.0
NJ 07511 1.0
NJ 07512 1.0
NJ 07513 1.0
NJ 07514 1.0
NJ 07522 1.0
NJ 07524 1.0
NJ 07533 1.0
NJ 07538 1.0
NJ 07543 1.0
NJ 07544 1.0
NJ 07601 1.0
NJ 07602 1.0
NJ 07603 1.0
NJ 07604 1.0
NJ 07605 1.0
NJ 07606 1.0
NJ 07607 1.0
NJ 07608 1.0
NJ 07620 1.0
NJ 07621 1.0
NJ 07624 1.0
NJ 07626 1.0
NJ 07627 1.0
NJ 07628 1.0
NJ 07630 1.0
NJ 07631 1.0
NJ 07632 1.0
NJ 07640 1.0
NJ 07641 1.0
NJ 07642 1.0
NJ 07643 1.0
NJ 07644 1.0
NJ 07645 1.0
NJ 07646 1.0
NJ 07647 1.0
NJ 07648 1.0
NJ 07649 1.0
NJ 07650 1.0
NJ 07652 1.0
NJ 07653 1.0
NJ 07656 1.0
NJ 07657 1.0
NJ 07660 1.0
NJ 07661 1.0
NJ 07662 1.0
NJ 07663 1.0
NJ 07666 1.0
NJ 07670 1.0
NJ 07675 1.0
NJ 07676 1.0
NJ 07677 1.0
NJ 07699 1.0
NJ 07701 1.0
NJ 07702 1.0
NJ 07703 1.0
NJ 07704 1.0
NJ 07709 1.0
NJ 07710 1.0
NJ 07711 1.0
NJ 07712 1.0
NJ 07715 1.0
NJ 07716 1.0
NJ 07717 1.0
NJ 07718 1.0
NJ 07719 1.0
NJ 07720 1.0
NJ 07721 1.0
NJ 07722 1.0
NJ 07723 1.0
NJ 07724 1.0
NJ 07726 1.0
NJ 07727 1.0
NJ 07728 1.0
NJ 07730 1.0
NJ 07731 1.0
NJ 07732 1.0
NJ 07733 1.0
NJ 07734 1.0
NJ 07735 1.0
NJ 07737 1.0
NJ 07738 1.0
NJ 07739 1.0
NJ 07740 1.0
NJ 07746 1.0
NJ 07747 1.0
NJ 07748 1.0
NJ 07750 1.0
NJ 07751 1.0
NJ 07752 1.0
NJ 07753 1.0
NJ 07754 1.0
NJ 07755 1.0
NJ 07756 1.0
NJ 07757 1.0
NJ 07758 1.0
NJ 07760 1.0
NJ 07762 1.0
NJ 07763 1.0
NJ 07764 1.0
NJ 07765 1.0
NJ 07777 1.0
NJ 07799 1.0
NJ 07801 1.0
NJ 07802 1.0
NJ 07803 1.0
NJ 07806 1.0
NJ 07820 1.0
NJ 07821 1.0
NJ 07822 2.0
NJ 07823 2.0
NJ 07825 2.0
NJ 07826 2.0
NJ 07827 2.0
NJ 07828 1.0
NJ 07829 2.0
NJ 07830 2.0
NJ 07831 2.0
NJ 07832 2.0
NJ 07833 2.0
NJ 07834 1.0
NJ 07836 1.0
NJ 07837 1.0
NJ 07838 2.0
NJ 07839 1.0
NJ 07840 1.0
NJ 07842 1.0
NJ 07843 1.0
NJ 07844 2.0
NJ 07845 1.0
NJ 07846 2.0
NJ 07847 1.0
NJ 07848 2.0
NJ 07849 1.0
NJ 07850 1.0
NJ 07851 2.0
NJ 07852 1.0
NJ 07853 1.0
NJ 07855 2.0
NJ 07856 1.0
NJ 07857 1.0
NJ 07860 2.0
NJ 07863 2.0
NJ 07865 1.0
NJ 07866 1.0
NJ 07869 1.0
NJ 07870 1.0
NJ 07871 1.0
NJ 07874 1.0
NJ 07875 2.0
NJ 07876 1.0
NJ 07877 2.0
NJ 07878 1.0
NJ 07879 1.0
NJ 07880 1.0
NJ 07881 2.0
NJ 07882 2.0
NJ 07885 1.0
NJ 07890 2.0
NJ 07901 1.0
NJ 07902 1.0
NJ 07920 1.0
NJ 07921 1.0
NJ 07922 1.0
NJ 07924 1.0
NJ 07926 1.0
NJ 07927 1.0
NJ 07928 1.0
NJ 07930 1.0
NJ 07931 1.0
NJ 07932 1.0
NJ 07933 1.0
NJ 07934 1.0
NJ 07935 1.0
NJ 07936 1.0
NJ 07938 1.0
NJ 07939 1.0
NJ 07940 1.0
NJ 07945 1.0
NJ 07946 1.0
NJ 07950 1.0
NJ 07960 1.0
NJ 07961 1.0
NJ 07962 1.0
NJ 07963 1.0
NJ 07970 1.0
NJ 07974 1.0
NJ 07976 2.0
NJ 07977 1.0
NJ 07978 1.0
NJ 07979 2.0
NJ 07980 1.0
NJ 07981 1.0
NJ 07983 1.0
NJ 07999 1.0
NJ 08001 2.0
NJ 08002 1.0
NJ 08003 1.0
NJ 08004 1.0
NJ 08005 1.0
NJ 08006 1.0
NJ 08007 1.0
NJ 08008 1.0
NJ 08009 1.0
NJ 08010 1.0
NJ 08011 1.0
NJ 08012 1.0
NJ 08014 1.0
NJ 08015 4.2
NJ 08016 1.0
NJ 08018 1.0
NJ 08019 2.1
NJ 08020 1.0
NJ 08021 1.0
NJ 08022 2.1
NJ 08023 1.0
NJ 08025 1.0
NJ 08026 1.0
NJ 08027 1.0
NJ 08028 1.0
NJ 08029 1.0
NJ 08030 1.0
NJ 08031 1.0
NJ 08032 1.0
NJ 08033 1.0
NJ 08034 1.0
NJ 08035 1.0
NJ 08036 1.0
NJ 08037 4.2
NJ 08038 2.0
NJ 08039 1.0
NJ 08041 2.0
NJ 08042 1.0
NJ 08043 1.0
NJ 08045 1.0
NJ 08046 1.0
NJ 08048 1.0
NJ 08049 1.0
NJ 08050 1.0
NJ 08051 1.0
NJ 08052 1.0
NJ 08053 1.0
NJ 08054 1.0
NJ 08055 1.0
NJ 08056 1.0
NJ 08057 1.0
NJ 08059 1.0
NJ 08060 1.0
NJ 08061 1.0
NJ 08062 1.0
NJ 08063 1.0
NJ 08064 1.0
NJ 08065 1.0
NJ 08066 1.0
NJ 08067 2.0
NJ 08068 1.0
NJ 08069 1.0
NJ 08070 1.0
NJ 08071 1.0
NJ 08072 2.0
NJ 08073 1.0
NJ 08074 1.0
NJ 08075 1.0
NJ 08076 1.0
NJ 08077 1.0
NJ 08078 1.0
NJ 08079 2.0
NJ 08080 1.0
NJ 08081 1.0
NJ 08083 1.0
NJ 08084 1.0
NJ 08085 1.0
NJ 08086 1.0
NJ 08087 1.0
NJ 08088 1.0
NJ 08089 1.0
NJ 08090 1.0
NJ 08091 1.0
NJ 08092 1.0
NJ 08093 1.0
NJ 08094 1.0
NJ 08095 4.2
NJ 08096 1.0
NJ 08097 1.0
NJ 08098 2.0
NJ 08099 1.0
NJ 08101 1.0
NJ 08102 1.0
NJ 08103 1.0
NJ 08104 1.0
NJ 08105 1.0
NJ 08106 1.0
NJ 08107 1.0
NJ 08108 1.0
NJ 08109 1.0
NJ 08110 1.0
NJ 08201 1.0
NJ 08202 1.0
NJ 08203 1.0
NJ 08204 1.0
NJ 08205 1.0
NJ 08210 1.0
NJ 08212 1.0
NJ 08213 2.0
NJ 08214 1.0
NJ 08215 2.0
NJ 08217 4.2
NJ 08218 1.0
NJ 08219 1.0
NJ 08220 1.0
NJ 08221 1.0
NJ 08223 1.0
NJ 08224 1.0
NJ 08225 1.0
NJ 08226 1.0
NJ 08230 1.0
NJ 08231 1.0
NJ 08232 1.0
NJ 08234 1.0
NJ 08240 2.0
NJ 08241 1.0
NJ 08242 1.0
NJ 08243 1.0
NJ 08244 1.0
NJ 08245 1.0
NJ 08246 1.0
NJ 08247 1.0
NJ 08248 1.0
NJ 08250 1.0
NJ 08251 1.0
NJ 08252 1.0
NJ 08260 1.0
NJ 08270 1.0
NJ 08302 4.2
NJ 08310 3.0
NJ 08311 2.0
NJ 08312 1.0
NJ 08313 4.2
NJ 08314 2.1
NJ 08315 2.0
NJ 08316 1.0
NJ 08317 2.0
NJ 08318 1.0
NJ 08319 2.0
NJ 08320 4.2
NJ 08321 2.0
NJ 08322 2.0
NJ 08323 5.2
NJ 08324 2.1
NJ 08326 1.0
NJ 08327 2.1
NJ 08328 1.0
NJ 08329 2.0
NJ 08330 1.0
NJ 08332 1.0
NJ 08340 3.0
NJ 08341 1.0
NJ 08342 1.0
NJ 08343 2.0
NJ 08344 1.0
NJ 08345 2.0
NJ 08346 3.0
NJ 08347 1.0
NJ 08348 1.0
NJ 08349 2.0
NJ 08350 3.0
NJ 08352 4.2
NJ 08353 4.2
NJ 08360 1.0
NJ 08361 1.0
NJ 08362 1.0
NJ 08401 1.0
NJ 08402 1.0
NJ 08403 1.0
NJ 08404 1.0
NJ 08405 1.0
NJ 08406 1.0
NJ 08501 1.0
NJ 08502 1.0
NJ 08504 1.0
NJ 08505 1.0
NJ 08510 2.0
NJ 08511 4.2
NJ 08512 2.0
NJ 08514 2.0
NJ 08515 2.1
NJ 08518 1.0
NJ 08520 2.0
NJ 08525 2.0
NJ 08526 2.0
NJ 08527 1.0
NJ 08528 1.0
NJ 08530 3.0
NJ 08533 4.2
NJ 08534 1.0
NJ 08535 2.0
NJ 08536 2.0
NJ 08540 1.0
NJ 08541 1.0
NJ 08542 1.0
NJ 08543 1.0
NJ 08544 1.0
NJ 08550 2.0
NJ 08551 2.0
NJ 08553 1.0
NJ 08554 1.0
NJ 08555 2.0
NJ 08556 2.0
NJ 08557 2.0
NJ 08558 1.0
NJ 08559 2.0
NJ 08560 1.0
NJ 08561 2.0
NJ 08562 4.2
NJ 08570 2.0
NJ 08601 1.0
NJ 08602 1.0
NJ 08603 1.0
NJ 08604 1.0
NJ 08605 1.0
NJ 08606 1.0
NJ 08607 1.0
NJ 08608 1.0
NJ 08609 1.0
NJ 08610 1.0
NJ 08611 1.0
NJ 08618 1.0
NJ 08619 1.0
NJ 08620 1.0
NJ 08625 1.0
NJ 08628 1.0
NJ 08629 1.0
NJ 08638 1.0
NJ 08640 4.2
NJ 08641 4.2
NJ 08645 1.0
NJ 08646 1.0
NJ 08647 1.0
NJ 08648 1.0
NJ 08650 1.0
NJ 08666 1.0
NJ 08677 1.0
NJ 08690 1.0
NJ 08691 1.0
NJ 08695 1.0
NJ 08701 1.0
NJ 08720 1.0
NJ 08721 1.0
NJ 08722 1.0
NJ 08723 1.0
NJ 08724 1.0
NJ 08730 1.0
NJ 08731 1.0
NJ 08732 1.0
NJ 08733 1.0
NJ 08734 1.0
NJ 08735 1.0
NJ 08736 1.0
NJ 08738 1.0
NJ 08739 1.0
NJ 08740 1.0
NJ 08741 1.0
NJ 08742 1.0
NJ 08750 1.0
NJ 08751 1.0
NJ 08752 1.0
NJ 08753 1.0
NJ 08754 1.0
NJ 08755 1.0
NJ 08756 1.0
NJ 08757 1.0
NJ 08758 1.0
NJ 08759 1.0
NJ 08801 1.0
NJ 08802 2.0
NJ 08803 2.0
NJ 08804 2.0
NJ 08805 1.0
NJ 08807 1.0
NJ 08808 2.0
NJ 08809 1.0
NJ 08810 1.0
NJ 08812 1.0
NJ 08816 1.0
NJ 08817 1.0
NJ 08818 1.0
NJ 08820 1.0
NJ 08821 1.0
NJ 08822 1.0
NJ 08823 1.0
NJ 08824 1.0
NJ 08825 2.0
NJ 08826 2.0
NJ 08827 2.0
NJ 08828 1.0
NJ 08829 1.0
NJ 08830 1.0
NJ 08831 1.0
NJ 08832 1.0
NJ 08833 1.0
NJ 08834 2.0
NJ 08835 1.0
NJ 08836 1.0
NJ 08837 1.0
NJ 08840 1.0
NJ 08844 1.0
NJ 08846 1.0
NJ 08848 2.0
NJ 08850 1.0
NJ 08852 1.0
NJ 08853 1.0
NJ 08854 1.0
NJ 08855 1.0
NJ 08857 1.0
NJ 08858 1.0
NJ 08859 1.0
NJ 08861 1.0
NJ 08862 1.0
NJ 08863 1.0
NJ 08865 1.0
NJ 08867 2.0
NJ 08868 2.0
NJ 08869 1.0
NJ 08870 1.0
NJ 08871 1.0
NJ 08872 1.0
NJ 08873 1.0
NJ 08875 1.0
NJ 08876 1.0
NJ 08877 1.0
NJ 08878 1.0
NJ 08879 1.0
NJ 08880 1.0
NJ 08882 1.0
NJ 08884 1.0
NJ 08885 1.0
NJ 08886 1.0
NJ 08887 1.0
NJ 08888 1.0
NJ 08889 1.0
NJ 08890 1.0
NJ 08896 1.0
NJ 08899 1.0
NJ 08901 1.0
NJ 08902 1.0
NJ 08903 1.0
NJ 08904 1.0
NJ 08905 1.0
NJ 08906 1.0
NJ 08922 1.0
NJ 08933 1.0
NJ 08988 1.0
NJ 08989 1.0
NM 87001 2.0
NM 87002 4.2
NM 87004 1.0
NM 87005 5.0
NM 87006 10.6
NM 87007 10.1
NM 87008 2.0
NM 87009 10.4
NM 87010 2.0
NM 87011 7.0
NM 87012 10.0
NM 87013 10.4
NM 87014 4.0
NM 87015 2.0
NM 87016 2.0
NM 87017 10.5
NM 87018 10.4
NM 87020 4.0
NM 87021 4.0
NM 87022 2.0
NM 87023 2.0
NM 87024 2.0
NM 87025 2.0
NM 87026 2.0
NM 87027 10.4
NM 87028 10.6
NM 87029 10.0
NM 87031 2.0
NM 87032 2.0
NM 87034 4.0
NM 87035 2.0
NM 87036 10.4
NM 87037 2.0
NM 87038 10.1
NM 87040 4.0
NM 87041 2.0
NM 87042 2.0
NM 87043 2.0
NM 87044 2.0
NM 87045 10.5
NM 87046 10.0
NM 87047 2.0
NM 87048 1.0
NM 87049 4.0
NM 87051 4.0
NM 87052 2.0
NM 87053 2.0
NM 87056 2.0
NM 87059 2.0
NM 87060 2.0
NM 87061 2.0
NM 87062 10.6
NM 87063 10.4
NM 87064 10.5
NM 87068 2.0
NM 87070 2.0
NM 87072 2.0
NM 87083 2.0
NM 87101 1.0
NM 87102 1.0
NM 87103 1.0
NM 87104 1.0
NM 87105 1.0
NM 87106 1.0
NM 87107 1.0
NM 87108 1.0
NM 87109 1.0
NM 87110 1.0
NM 87111 1.0
NM 87112 1.0
NM 87113 1.0
NM 87114 1.0
NM 87115 2.0
NM 87116 1.0
NM 87117 1.0
NM 87118 1.0
NM 87119 1.0
NM 87120 1.0
NM 87121 1.0
NM 87122 1.0
NM 87123 1.0
NM 87124 1.0
NM 87125 1.0
NM 87131 1.0
NM 87144 1.0
NM 87151 1.0
NM 87153 1.0
NM 87154 1.0
NM 87158 1.0
NM 87174 1.0
NM 87176 1.0
NM 87181 1.0
NM 87184 1.0
NM 87185 1.0
NM 87187 1.0
NM 87190 1.0
NM 87191 1.0
NM 87192 1.0
NM 87193 1.0
NM 87194 1.0
NM 87195 1.0
NM 87196 1.0
NM 87197 1.0
NM 87198 1.0
NM 87199 1.0
NM 87301 4.0
NM 87302 4.0
NM 87305 4.0
NM 87310 5.0
NM 87311 4.0
NM 87312 5.0
NM 87313 10.5
NM 87315 5.0
NM 87316 4.0
NM 87317 4.0
NM 87319 4.0
NM 87320 9.2
NM 87321 10.2
NM 87322 4.0
NM 87323 10.5
NM 87325 5.0
NM 87326 4.0
NM 87327 5.0
NM 87328 9.2
NM 87347 5.0
NM 87357 4.0
NM 87364 7.3
NM 87365 10.5
NM 87375 4.0
NM 87401 1.0
NM 87402 1.0
NM 87410 1.0
NM 87412 2.0
NM 87413 2.0
NM 87415 1.0
NM 87416 1.0
NM 87417 1.0
NM 87418 1.0
NM 87419 10.1
NM 87420 7.3
NM 87421 1.0
NM 87455 7.3
NM 87461 7.3
NM 87499 1.0
NM 87500 1.0
NM 87501 1.0
NM 87502 1.0
NM 87503 1.0
NM 87504 1.0
NM 87505 1.0
NM 87506 2.0
NM 87507 1.0
NM 87508 2.0
NM 87509 1.0
NM 87510 10.5
NM 87511 4.0
NM 87512 10.2
NM 87513 10.2
NM 87514 10.2
NM 87515 10.0
NM 87516 10.5
NM 87517 5.0
NM 87518 10.0
NM 87519 10.2
NM 87520 10.0
NM 87521 4.0
NM 87522 4.0
NM 87523 4.0
NM 87524 10.2
NM 87525 4.0
NM 87527 4.0
NM 87528 10.0
NM 87529 4.0
NM 87530 10.5
NM 87531 4.0
NM 87532 4.0
NM 87533 4.0
NM 87535 2.0
NM 87537 4.0
NM 87538 1.0
NM 87539 10.5
NM 87540 2.0
NM 87543 10.5
NM 87544 4.0
NM 87545 4.0
NM 87548 10.5
NM 87549 5.0
NM 87551 10.0
NM 87552 2.0
NM 87553 10.5
NM 87554 10.5
NM 87556 10.2
NM 87557 4.0
NM 87558 10.2
NM 87560 2.0
NM 87562 2.0
NM 87564 10.2
NM 87565 2.0
NM 87566 4.0
NM 87567 4.0
NM 87569 2.0
NM 87571 4.0
NM 87573 2.0
NM 87574 2.0
NM 87575 10.0
NM 87576 4.0
NM 87577 5.0
NM 87578 4.0
NM 87579 10.5
NM 87580 10.2
NM 87581 10.5
NM 87582 4.0
NM 87583 4.0
NM 87592 1.0
NM 87594 1.0
NM 87701 4.0
NM 87710 10.0
NM 87711 7.0
NM 87712 10.5
NM 87713 10.5
NM 87714 10.0
NM 87715 10.5
NM 87718 10.0
NM 87722 10.5
NM 87723 10.5
NM 87724 7.0
NM 87728 10.0
NM 87729 10.0
NM 87730 10.0
NM 87731 5.0
NM 87732 10.5
NM 87733 10.0
NM 87734 10.5
NM 87735 10.5
NM 87736 10.5
NM 87740 7.0
NM 87742 5.0
NM 87743 10.0
NM 87745 5.0
NM 87746 10.0
NM 87747 10.0
NM 87749 10.0
NM 87750 10.5
NM 87752 10.5
NM 87753 10.5
NM 87801 7.0
NM 87820 10.0
NM 87821 10.0
NM 87823 10.6
NM 87824 10.0
NM 87825 10.6
NM 87827 10.0
NM 87828 10.6
NM 87829 10.0
NM 87830 10.0
NM 87831 10.6
NM 87832 7.0
NM 87901 7.0
NM 87930 10.3
NM 87931 10.3
NM 87933 10.3
NM 87935 7.0
NM 87936 10.4
NM 87937 10.4
NM 87939 7.0
NM 87940 10.4
NM 87941 10.4
NM 87942 10.3
NM 87943 10.3
NM 88001 1.0
NM 88002 10.4
NM 88003 1.0
NM 88004 1.0
NM 88005 1.0
NM 88006 1.0
NM 88007 1.0
NM 88008 1.0
NM 88009 7.0
NM 88011 1.0
NM 88012 1.0
NM 88020 10.6
NM 88021 1.0
NM 88022 7.2
NM 88023 7.2
NM 88024 2.0
NM 88025 10.2
NM 88026 7.2
NM 88027 2.1
NM 88028 10.2
NM 88029 4.0
NM 88030 4.0
NM 88031 4.0
NM 88032 1.0
NM 88033 1.0
NM 88034 7.2
NM 88036 4.0
NM 88038 4.0
NM 88039 10.0
NM 88040 5.0
NM 88041 5.0
NM 88042 10.3
NM 88043 5.0
NM 88044 2.1
NM 88045 7.0
NM 88046 1.0
NM 88047 2.1
NM 88048 2.1
NM 88049 5.0
NM 88051 10.2
NM 88052 1.0
NM 88053 4.0
NM 88054 10.4
NM 88055 10.2
NM 88056 10.6
NM 88058 2.1
NM 88061 4.0
NM 88062 4.0
NM 88063 1.0
NM 88065 4.0
NM 88072 2.1
NM 88081 2.0
NM 88101 4.0
NM 88102 4.0
NM 88103 4.0
NM 88112 5.0
NM 88113 10.2
NM 88114 10.6
NM 88115 4.0
NM 88116 10.2
NM 88118 10.2
NM 88119 10.0
NM 88120 5.0
NM 88121 10.3
NM 88122 10.2
NM 88123 10.2
NM 88124 5.0
NM 88125 10.2
NM 88126 10.2
NM 88130 4.0
NM 88132 10.2
NM 88133 5.0
NM 88134 10.0
NM 88135 5.0
NM 88136 10.0
NM 88201 4.0
NM 88202 4.0
NM 88203 4.0
NM 88210 4.0
NM 88211 4.0
NM 88213 10.6
NM 88220 4.0
NM 88221 4.0
NM 88230 10.2
NM 88231 7.2
NM 88232 10.5
NM 88240 4.0
NM 88241 4.0
NM 88242 4.0
NM 88244 4.0
NM 88250 5.0
NM 88252 10.5
NM 88253 10.5
NM 88254 4.0
NM 88255 4.0
NM 88256 5.0
NM 88260 7.4
NM 88262 7.4
NM 88263 5.0
NM 88264 10.6
NM 88265 4.0
NM 88267 10.6
NM 88268 4.0
NM 88301 10.6
NM 88310 4.0
NM 88311 4.0
NM 88312 7.0
NM 88314 5.0
NM 88316 10.3
NM 88317 2.0
NM 88318 10.6
NM 88321 10.4
NM 88323 10.3
NM 88324 7.0
NM 88325 2.0
NM 88330 10.5
NM 88336 7.0
NM 88337 4.0
NM 88338 10.3
NM 88339 2.0
NM 88340 10.6
NM 88341 10.3
NM 88342 2.0
NM 88343 7.0
NM 88344 2.0
NM 88345 7.0
NM 88346 7.0
NM 88347 2.0
NM 88348 7.0
NM 88349 2.0
NM 88350 2.0
NM 88351 7.0
NM 88352 5.0
NM 88353 7.0
NM 88354 2.0
NM 88355 7.0
NM 88401 7.0
NM 88410 10.0
NM 88411 10.6
NM 88414 10.0
NM 88415 10.0
NM 88416 5.0
NM 88417 7.0
NM 88418 10.0
NM 88419 10.0
NM 88421 5.0
NM 88422 10.0
NM 88424 10.0
NM 88426 10.6
NM 88427 10.3
NM 88430 10.6
NM 88431 5.0
NM 88433 7.0
NM 88434 10.6
NM 88435 7.0
NM 88436 10.0
NM 88437 10.0
NM 88439 5.0
NV 88901 1.0
NV 88905 1.0
NV 89001 10.0
NV 89003 10.0
NV 89004 2.0
NV 89005 2.0
NV 89006 2.0
NV 89007 2.0
NV 89008 10.0
NV 89009 1.0
NV 89010 10.0
NV 89011 1.0
NV 89012 1.0
NV 89013 10.0
NV 89014 1.0
NV 89015 1.0
NV 89016 1.0
NV 89017 10.0
NV 89018 2.0
NV 89019 2.0
NV 89020 10.0
NV 89021 2.0
NV 89022 10.0
NV 89023 10.0
NV 89024 7.3
NV 89025 2.0
NV 89026 2.0
NV 89027 7.3
NV 89028 7.3
NV 89029 7.3
NV 89030 1.0
NV 89031 1.0
NV 89032 1.0
NV 89033 1.0
NV 89036 1.0
NV 89039 10.4
NV 89040 2.0
NV 89041 10.4
NV 89042 10.0
NV 89043 10.0
NV 89044 10.0
NV 89045 10.0
NV 89046 10.4
NV 89047 10.0
NV 89048 4.2
NV 89049 10.0
NV 89052 1.0
NV 89053 2.0
NV 89060 4.2
NV 89061 4.2
NV 89070 2.0
NV 89074 1.0
NV 89077 1.0
NV 89081 1.0
NV 89084 1.0
NV 89085 1.0
NV 89086 1.0
NV 89087 1.0
NV 89101 1.0
NV 89102 1.0
NV 89103 1.0
NV 89104 1.0
NV 89105 1.0
NV 89106 1.0
NV 89107 1.0
NV 89108 1.0
NV 89109 1.0
NV 89110 1.0
NV 89111 1.0
NV 89112 1.0
NV 89113 1.0
NV 89114 1.0
NV 89115 1.0
NV 89116 1.0
NV 89117 1.0
NV 89118 1.0
NV 89119 1.0
NV 89120 1.0
NV 89121 1.0
NV 89122 1.0
NV 89123 1.0
NV 89124 2.0
NV 89125 1.0
NV 89126 1.0
NV 89127 1.0
NV 89128 1.0
NV 89129 1.0
NV 89130 1.0
NV 89131 1.0
NV 89132 1.0
NV 89133 1.0
NV 89134 1.0
NV 89135 1.0
NV 89136 1.0
NV 89137 1.0
NV 89138 1.0
NV 89139 1.0
NV 89140 1.0
NV 89141 2.0
NV 89142 1.0
NV 89143 1.0
NV 89144 1.0
NV 89145 1.0
NV 89146 1.0
NV 89147 1.0
NV 89148 1.0
NV 89149 1.0
NV 89150 1.0
NV 89151 1.0
NV 89152 1.0
NV 89153 1.0
NV 89154 1.0
NV 89155 1.0
NV 89156 1.0
NV 89157 1.0
NV 89159 1.0
NV 89160 1.0
NV 89161 1.0
NV 89162 1.0
NV 89163 1.0
NV 89164 1.0
NV 89165 1.0
NV 89166 1.0
NV 89170 1.0
NV 89173 1.0
NV 89177 1.0
NV 89178 1.0
NV 89179 1.0
NV 89180 1.0
NV 89185 1.0
NV 89191 1.0
NV 89193 1.0
NV 89195 1.0
NV 89199 1.0
NV 89301 7.0
NV 89310 10.3
NV 89311 8.0
NV 89314 7.0
NV 89315 7.0
NV 89316 10.0
NV 89317 7.0
NV 89318 7.0
NV 89319 7.0
NV 89402 4.2
NV 89403 2.0
NV 89404 7.0
NV 89405 2.0
NV 89406 4.0
NV 89407 4.0
NV 89408 2.0
NV 89409 10.0
NV 89410 4.2
NV 89411 4.0
NV 89412 2.0
NV 89413 4.0
NV 89414 8.0
NV 89415 7.0
NV 89418 10.6
NV 89419 10.6
NV 89420 8.0
NV 89421 7.0
NV 89422 8.0
NV 89423 1.0
NV 89424 2.0
NV 89425 7.0
NV 89426 7.0
NV 89427 6.0
NV 89428 1.0
NV 89429 10.4
NV 89430 10.3
NV 89431 1.0
NV 89432 1.0
NV 89433 1.0
NV 89434 1.0
NV 89435 1.0
NV 89436 1.0
NV 89438 8.0
NV 89439 1.0
NV 89440 2.0
NV 89442 2.0
NV 89444 10.5
NV 89445 7.0
NV 89446 7.0
NV 89447 7.0
NV 89448 4.0
NV 89449 4.0
NV 89450 4.2
NV 89451 4.2
NV 89452 4.2
NV 89460 4.2
NV 89496 4.0
NV 89501 1.0
NV 89502 1.0
NV 89503 1.0
NV 89504 1.0
NV 89505 1.0
NV 89506 1.0
NV 89507 1.0
NV 89509 1.0
NV 89510 2.0
NV 89511 1.0
NV 89512 1.0
NV 89513 1.0
NV 89515 1.0
NV 89520 1.0
NV 89521 1.0
NV 89523 1.0
NV 89533 1.0
NV 89555 1.0
NV 89557 1.0
NV 89570 1.0
NV 89595 1.0
NV 89599 1.0
NV 89701 1.0
NV 89702 1.0
NV 89703 1.0
NV 89704 1.0
NV 89705 1.0
NV 89706 1.0
NV 89711 1.0
NV 89712 1.0
NV 89713 1.0
NV 89714 1.0
NV 89721 1.0
NV 89801 4.0
NV 89802 4.0
NV 89803 4.0
NV 89815 5.0
NV 89820 7.0
NV 89821 10.0
NV 89822 10.5
NV 89823 4.0
NV 89824 4.0
NV 89825 10.0
NV 89826 10.0
NV 89828 5.0
NV 89830 7.0
NV 89831 10.5
NV 89832 10.5
NV 89833 10.5
NV 89834 10.0
NV 89835 7.0
NV 89883 7.0
NY 00501 1.0
NY 00544 1.0
NY 06390 7.3
NY 10001 1.0
NY 10002 1.0
NY 10003 1.0
NY 10004 1.0
NY 10005 1.0
NY 10006 1.0
NY 10007 1.0
NY 10008 1.0
NY 10009 1.0
NY 10010 1.0
NY 10011 1.0
NY 10012 1.0
NY 10013 1.0
NY 10014 1.0
NY 10015 1.0
NY 10016 1.0
NY 10017 1.0
NY 10018 1.0
NY 10019 1.0
NY 10020 1.0
NY 10021 1.0
NY 10022 1.0
NY 10023 1.0
NY 10024 1.0
NY 10025 1.0
NY 10026 1.0
NY 10027 1.0
NY 10028 1.0
NY 10029 1.0
NY 10030 1.0
NY 10031 1.0
NY 10032 1.0
NY 10033 1.0
NY 10034 1.0
NY 10035 1.0
NY 10036 1.0
NY 10037 1.0
NY 10038 1.0
NY 10039 1.0
NY 10040 1.0
NY 10041 1.0
NY 10043 1.0
NY 10044 1.0
NY 10045 1.0
NY 10046 1.0
NY 10047 1.0
NY 10048 1.0
NY 10055 1.0
NY 10060 1.0
NY 10069 1.0
NY 10072 1.0
NY 10079 1.0
NY 10080 1.0
NY 10081 1.0
NY 10082 1.0
NY 10087 1.0
NY 10090 1.0
NY 10094 1.0
NY 10095 1.0
NY 10096 1.0
NY 10098 1.0
NY 10099 1.0
NY 10101 1.0
NY 10102 1.0
NY 10103 1.0
NY 10104 1.0
NY 10105 1.0
NY 10106 1.0
NY 10107 1.0
NY 10108 1.0
NY 10109 1.0
NY 10110 1.0
NY 10111 1.0
NY 10112 1.0
NY 10113 1.0
NY 10114 1.0
NY 10115 1.0
NY 10116 1.0
NY 10117 1.0
NY 10118 1.0
NY 10119 1.0
NY 10120 1.0
NY 10121 1.0
NY 10122 1.0
NY 10123 1.0
NY 10124 1.0
NY 10125 1.0
NY 10126 1.0
NY 10128 1.0
NY 10129 1.0
NY 10130 1.0
NY 10131 1.0
NY 10132 1.0
NY 10133 1.0
NY 10138 1.0
NY 10149 1.0
NY 10150 1.0
NY 10151 1.0
NY 10152 1.0
NY 10153 1.0
NY 10154 1.0
NY 10155 1.0
NY 10156 1.0
NY 10157 1.0
NY 10158 1.0
NY 10159 1.0
NY 10160 1.0
NY 10161 1.0
NY 10162 1.0
NY 10163 1.0
NY 10164 1.0
NY 10165 1.0
NY 10166 1.0
NY 10167 1.0
NY 10168 1.0
NY 10169 1.0
NY 10170 1.0
NY 10171 1.0
NY 10172 1.0
NY 10173 1.0
NY 10174 1.0
NY 10175 1.0
NY 10176 1.0
NY 10177 1.0
NY 10178 1.0
NY 10179 1.0
NY 10184 1.0
NY 10185 1.0
NY 10196 1.0
NY 10197 1.0
NY 10199 1.0
NY 10203 1.0
NY 10211 1.0
NY 10212 1.0
NY 10213 1.0
NY 10242 1.0
NY 10249 1.0
NY 10256 1.0
NY 10257 1.0
NY 10258 1.0
NY 10259 1.0
NY 10260 1.0
NY 10261 1.0
NY 10265 1.0
NY 10268 1.0
NY 10269 1.0
NY 10270 1.0
NY 10271 1.0
NY 10272 1.0
NY 10273 1.0
NY 10274 1.0
NY 10275 1.0
NY 10276 1.0
NY 10277 1.0
NY 10278 1.0
NY 10279 1.0
NY 10280 1.0
NY 10281 1.0
NY 10282 1.0
NY 10285 1.0
NY 10286 1.0
NY 10292 1.0
NY 10301 1.0
NY 10302 1.0
NY 10303 1.0
NY 10304 1.0
NY 10305 1.0
NY 10306 1.0
NY 10307 1.0
NY 10308 1.0
NY 10309 1.0
NY 10310 1.0
NY 10311 1.0
NY 10312 1.0
NY 10313 1.0
NY 10314 1.0
NY 10451 1.0
NY 10452 1.0
NY 10453 1.0
NY 10454 1.0
NY 10455 1.0
NY 10456 1.0
NY 10457 1.0
NY 10458 1.0
NY 10459 1.0
NY 10460 1.0
NY 10461 1.0
NY 10462 1.0
NY 10463 1.0
NY 10464 1.0
NY 10465 1.0
NY 10466 1.0
NY 10467 1.0
NY 10468 1.0
NY 10469 1.0
NY 10470 1.0
NY 10471 1.0
NY 10472 1.0
NY 10473 1.0
NY 10474 1.0
NY 10475 1.0
NY 10499 1.0
NY 10501 1.0
NY 10502 1.0
NY 10503 1.0
NY 10504 1.0
NY 10505 1.0
NY 10506 2.0
NY 10507 1.0
NY 10509 1.0
NY 10510 1.0
NY 10511 1.0
NY 10512 1.0
NY 10514 1.0
NY 10516 2.0
NY 10517 1.0
NY 10518 1.0
NY 10519 1.0
NY 10520 1.0
NY 10521 1.0
NY 10522 1.0
NY 10523 1.0
NY 10524 1.0
NY 10526 1.0
NY 10527 1.0
NY 10528 1.0
NY 10530 1.0
NY 10532 1.0
NY 10533 1.0
NY 10535 1.0
NY 10536 1.0
NY 10537 1.0
NY 10538 1.0
NY 10540 1.0
NY 10541 1.0
NY 10542 1.0
NY 10543 1.0
NY 10545 1.0
NY 10546 1.0
NY 10547 1.0
NY 10548 1.0
NY 10549 1.0
NY 10550 1.0
NY 10551 1.0
NY 10552 1.0
NY 10553 1.0
NY 10557 1.0
NY 10558 1.0
NY 10560 1.0
NY 10562 1.0
NY 10566 1.0
NY 10567 1.0
NY 10570 1.0
NY 10571 1.0
NY 10572 1.0
NY 10573 1.0
NY 10576 2.0
NY 10577 1.0
NY 10578 1.0
NY 10579 1.0
NY 10580 1.0
NY 10583 1.0
NY 10587 1.0
NY 10588 1.0
NY 10589 1.0
NY 10590 1.0
NY 10591 1.0
NY 10594 1.0
NY 10595 1.0
NY 10596 1.0
NY 10597 1.0
NY 10598 1.0
NY 10601 1.0
NY 10602 1.0
NY 10603 1.0
NY 10604 1.0
NY 10605 1.0
NY 10606 1.0
NY 10607 1.0
NY 10610 1.0
NY 10650 1.0
NY 10701 1.0
NY 10702 1.0
NY 10703 1.0
NY 10704 1.0
NY 10705 1.0
NY 10706 1.0
NY 10707 1.0
NY 10708 1.0
NY 10709 1.0
NY 10710 1.0
NY 10801 1.0
NY 10802 1.0
NY 10803 1.0
NY 10804 1.0
NY 10805 1.0
NY 10901 1.0
NY 10910 2.0
NY 10911 1.0
NY 10912 2.0
NY 10913 1.0
NY 10914 1.0
NY 10915 1.0
NY 10916 3.0
NY 10917 2.0
NY 10918 2.0
NY 10919 3.0
NY 10920 1.0
NY 10921 2.0
NY 10922 1.0
NY 10923 1.0
NY 10924 2.0
NY 10925 1.0
NY 10926 1.0
NY 10927 1.0
NY 10928 1.0
NY 10930 2.0
NY 10931 1.0
NY 10932 1.0
NY 10933 3.0
NY 10940 1.0
NY 10941 1.0
NY 10943 1.0
NY 10949 1.0
NY 10950 1.0
NY 10952 1.0
NY 10953 1.0
NY 10954 1.0
NY 10956 1.0
NY 10958 3.0
NY 10959 2.0
NY 10960 1.0
NY 10962 1.0
NY 10963 1.0
NY 10964 1.0
NY 10965 1.0
NY 10968 1.0
NY 10969 2.0
NY 10970 1.0
NY 10973 3.0
NY 10974 1.0
NY 10975 2.0
NY 10976 1.0
NY 10977 1.0
NY 10979 1.0
NY 10980 1.0
NY 10981 2.0
NY 10982 1.0
NY 10983 1.0
NY 10984 1.0
NY 10985 3.0
NY 10986 1.0
NY 10987 2.0
NY 10988 3.0
NY 10989 1.0
NY 10990 2.0
NY 10992 1.0
NY 10993 1.0
NY 10994 1.0
NY 10996 1.0
NY 10997 1.0
NY 10998 3.0
NY 11001 1.0
NY 11002 1.0
NY 11003 1.0
NY 11004 1.0
NY 11005 1.0
NY 11010 1.0
NY 11020 1.0
NY 11021 1.0
NY 11022 1.0
NY 11023 1.0
NY 11024 1.0
NY 11025 1.0
NY 11026 1.0
NY 11027 1.0
NY 11030 1.0
NY 11040 1.0
NY 11041 1.0
NY 11042 1.0
NY 11043 1.0
NY 11044 1.0
NY 11050 1.0
NY 11051 1.0
NY 11052 1.0
NY 11053 1.0
NY 11054 1.0
NY 11055 1.0
NY 11096 1.0
NY 11099 1.0
NY 11101 1.0
NY 11102 1.0
NY 11103 1.0
NY 11104 1.0
NY 11105 1.0
NY 11106 1.0
NY 11109 1.0
NY 11120 1.0
NY 11201 1.0
NY 11202 1.0
NY 11203 1.0
NY 11204 1.0
NY 11205 1.0
NY 11206 1.0
NY 11207 1.0
NY 11208 1.0
NY 11209 1.0
NY 11210 1.0
NY 11211 1.0
NY 11212 1.0
NY 11213 1.0
NY 11214 1.0
NY 11215 1.0
NY 11216 1.0
NY 11217 1.0
NY 11218 1.0
NY 11219 1.0
NY 11220 1.0
NY 11221 1.0
NY 11222 1.0
NY 11223 1.0
NY 11224 1.0
NY 11225 1.0
NY 11226 1.0
NY 11228 1.0
NY 11229 1.0
NY 11230 1.0
NY 11231 1.0
NY 11232 1.0
NY 11233 1.0
NY 11234 1.0
NY 11235 1.0
NY 11236 1.0
NY 11237 1.0
NY 11238 1.0
NY 11239 1.0
NY 11240 1.0
NY 11241 1.0
NY 11242 1.0
NY 11243 1.0
NY 11244 1.0
NY 11245 1.0
NY 11247 1.0
NY 11248 1.0
NY 11249 1.0
NY 11251 1.0
NY 11252 1.0
NY 11254 1.0
NY 11255 1.0
NY 11256 1.0
NY 11351 1.0
NY 11352 1.0
NY 11354 1.0
NY 11355 1.0
NY 11356 1.0
NY 11357 1.0
NY 11358 1.0
NY 11359 1.0
NY 11360 1.0
NY 11361 1.0
NY 11362 1.0
NY 11363 1.0
NY 11364 1.0
NY 11365 1.0
NY 11366 1.0
NY 11367 1.0
NY 11368 1.0
NY 11369 1.0
NY 11370 1.0
NY 11371 1.0
NY 11372 1.0
NY 11373 1.0
NY 11374 1.0
NY 11375 1.0
NY 11377 1.0
NY 11378 1.0
NY 11379 1.0
NY 11380 1.0
NY 11381 1.0
NY 11385 1.0
NY 11386 1.0
NY 11390 1.0
NY 11405 1.0
NY 11411 1.0
NY 11412 1.0
NY 11413 1.0
NY 11414 1.0
NY 11415 1.0
NY 11416 1.0
NY 11417 1.0
NY 11418 1.0
NY 11419 1.0
NY 11420 1.0
NY 11421 1.0
NY 11422 1.0
NY 11423 1.0
NY 11424 1.0
NY 11425 1.0
NY 11426 1.0
NY 11427 1.0
NY 11428 1.0
NY 11429 1.0
NY 11430 1.0
NY 11431 1.0
NY 11432 1.0
NY 11433 1.0
NY 11434 1.0
NY 11435 1.0
NY 11436 1.0
NY 11439 1.0
NY 11451 1.0
NY 11484 1.0
NY 11499 1.0
NY 11501 1.0
NY 11507 1.0
NY 11509 1.0
NY 11510 1.0
NY 11514 1.0
NY 11516 1.0
NY 11518 1.0
NY 11520 1.0
NY 11530 1.0
NY 11531 1.0
NY 11535 1.0
NY 11536 1.0
NY 11542 1.0
NY 11545 1.0
NY 11547 1.0
NY 11548 1.0
NY 11549 1.0
NY 11550 1.0
NY 11551 1.0
NY 11552 1.0
NY 11553 1.0
NY 11554 1.0
NY 11555 1.0
NY 11556 1.0
NY 11557 1.0
NY 11558 1.0
NY 11559 1.0
NY 11560 1.0
NY 11561 1.0
NY 11563 1.0
NY 11564 1.0
NY 11565 1.0
NY 11566 1.0
NY 11568 1.0
NY 11569 1.0
NY 11570 1.0
NY 11571 1.0
NY 11572 1.0
NY 11575 1.0
NY 11576 1.0
NY 11577 1.0
NY 11579 1.0
NY 11580 1.0
NY 11581 1.0
NY 11582 1.0
NY 11583 1.0
NY 11588 1.0
NY 11590 1.0
NY 11592 1.0
NY 11593 1.0
NY 11594 1.0
NY 11595 1.0
NY 11596 1.0
NY 11597 1.0
NY 11598 1.0
NY 11599 1.0
NY 11690 1.0
NY 11691 1.0
NY 11692 1.0
NY 11693 1.0
NY 11694 1.0
NY 11695 1.0
NY 11697 1.0
NY 11701 1.0
NY 11702 1.0
NY 11703 1.0
NY 11704 1.0
NY 11705 1.0
NY 11706 1.0
NY 11707 1.0
NY 11708 1.0
NY 11709 1.0
NY 11710 1.0
NY 11713 1.0
NY 11714 1.0
NY 11715 1.0
NY 11716 1.0
NY 11717 1.0
NY 11718 1.0
NY 11719 1.0
NY 11720 1.0
NY 11721 1.0
NY 11722 1.0
NY 11724 1.0
NY 11725 1.0
NY 11726 1.0
NY 11727 1.0
NY 11729 1.0
NY 11730 1.0
NY 11731 1.0
NY 11732 1.0
NY 11733 1.0
NY 11735 1.0
NY 11736 1.0
NY 11737 1.0
NY 11738 1.0
NY 11739 1.0
NY 11740 1.0
NY 11741 1.0
NY 11742 1.0
NY 11743 1.0
NY 11745 1.0
NY 11746 1.0
NY 11747 1.0
NY 11749 1.0
NY 11750 1.0
NY 11751 1.0
NY 11752 1.0
NY 11753 1.0
NY 11754 1.0
NY 11755 1.0
NY 11756 1.0
NY 11757 1.0
NY 11758 1.0
NY 11760 1.0
NY 11762 1.0
NY 11763 1.0
NY 11764 1.0
NY 11765 1.0
NY 11766 1.0
NY 11767 1.0
NY 11768 1.0
NY 11769 1.0
NY 11770 1.0
NY 11771 1.0
NY 11772 1.0
NY 11773 1.0
NY 11774 1.0
NY 11775 1.0
NY 11776 1.0
NY 11777 1.0
NY 11778 1.0
NY 11779 1.0
NY 11780 1.0
NY 11782 1.0
NY 11783 1.0
NY 11784 1.0
NY 11786 1.0
NY 11787 1.0
NY 11788 1.0
NY 11789 1.0
NY 11790 1.0
NY 11791 1.0
NY 11792 1.0
NY 11793 1.0
NY 11794 1.0
NY 11795 1.0
NY 11796 1.0
NY 11797 1.0
NY 11798 1.0
NY 11801 1.0
NY 11802 1.0
NY 11803 1.0
NY 11804 1.0
NY 11805 1.0
NY 11815 1.0
NY 11819 1.0
NY 11853 1.0
NY 11854 1.0
NY 11855 1.0
NY 11901 2.0
NY 11930 7.3
NY 11931 2.0
NY 11932 2.0
NY 11933 2.0
NY 11934 1.0
NY 11935 2.0
NY 11937 7.3
NY 11939 7.3
NY 11940 1.0
NY 11941 1.0
NY 11942 1.0
NY 11944 7.3
NY 11946 1.0
NY 11947 2.0
NY 11948 2.0
NY 11949 1.0
NY 11950 1.0
NY 11951 1.0
NY 11952 2.0
NY 11953 1.0
NY 11954 10.1
NY 11955 1.0
NY 11956 2.0
NY 11957 7.3
NY 11958 2.0
NY 11959 1.0
NY 11960 1.0
NY 11961 1.0
NY 11962 2.0
NY 11963 2.0
NY 11964 10.4
NY 11965 10.4
NY 11967 1.0
NY 11968 1.0
NY 11969 1.0
NY 11970 2.0
NY 11971 7.3
NY 11972 1.0
NY 11973 1.0
NY 11975 7.3
NY 11976 2.0
NY 11977 1.0
NY 11978 1.0
NY 11980 1.0
NY 12007 2.0
NY 12008 1.0
NY 12009 2.0
NY 12010 4.2
NY 12015 7.3
NY 12016 4.2
NY 12017 10.4
NY 12018 1.0
NY 12019 1.0
NY 12020 1.1
NY 12022 2.0
NY 12023 2.0
NY 12024 10.4
NY 12025 3.0
NY 12027 1.0
NY 12028 2.0
NY 12029 10.4
NY 12031 10.6
NY 12032 5.0
NY 12033 1.0
NY 12035 2.0
NY 12036 10.6
NY 12037 10.4
NY 12040 2.0
NY 12041 2.0
NY 12042 7.3
NY 12043 7.0
NY 12045 2.0
NY 12046 2.0
NY 12047 1.0
NY 12050 2.0
NY 12051 7.3
NY 12052 2.0
NY 12053 2.0
NY 12054 1.0
NY 12055 2.0
NY 12056 2.0
NY 12057 10.4
NY 12058 7.3
NY 12059 2.0
NY 12060 10.4
NY 12061 1.0
NY 12062 2.0
NY 12063 2.0
NY 12064 10.2
NY 12065 1.0
NY 12066 2.0
NY 12067 2.0
NY 12068 4.0
NY 12069 4.0
NY 12070 4.2
NY 12071 10.4
NY 12072 10.4
NY 12073 2.0
NY 12074 2.0
NY 12075 10.5
NY 12076 10.4
NY 12077 1.0
NY 12078 4.0
NY 12082 2.0
NY 12083 10.4
NY 12084 1.0
NY 12085 2.0
NY 12086 4.2
NY 12087 2.0
NY 12089 7.4
NY 12090 7.4
NY 12092 2.0
NY 12093 10.4
NY 12094 2.0
NY 12095 4.0
NY 12106 2.0
NY 12107 2.0
NY 12108 10.0
NY 12110 1.0
NY 12111 1.0
NY 12115 10.4
NY 12116 5.0
NY 12117 4.0
NY 12118 2.0
NY 12120 2.0
NY 12121 2.0
NY 12122 2.0
NY 12123 2.0
NY 12124 2.0
NY 12125 10.4
NY 12128 1.0
NY 12130 2.0
NY 12131 10.4
NY 12132 2.0
NY 12133 10.4
NY 12134 10.5
NY 12136 10.4
NY 12137 2.0
NY 12138 2.0
NY 12139 10.0
NY 12140 2.0
NY 12141 2.0
NY 12143 2.0
NY 12144 1.0
NY 12147 2.0
NY 12148 1.0
NY 12149 10.6
NY 12150 1.0
NY 12151 1.0
NY 12153 1.0
NY 12154 2.0
NY 12155 10.2
NY 12156 1.0
NY 12157 2.0
NY 12158 1.0
NY 12159 1.0
NY 12160 10.6
NY 12161 1.0
NY 12164 10.0
NY 12165 10.4
NY 12166 10.4
NY 12167 10.0
NY 12168 2.0
NY 12169 2.0
NY 12170 2.0
NY 12172 4.0
NY 12173 2.0
NY 12174 2.0
NY 12175 10.6
NY 12176 10.4
NY 12177 4.0
NY 12179 1.0
NY 12180 1.0
NY 12181 1.0
NY 12182 1.0
NY 12183 1.0
NY 12184 2.0
NY 12185 2.0
NY 12186 1.0
NY 12187 10.6
NY 12188 1.0
NY 12189 1.0
NY 12190 10.5
NY 12192 2.0
NY 12193 2.0
NY 12194 10.4
NY 12195 10.4
NY 12196 1.0
NY 12197 10.2
NY 12198 1.0
NY 12201 1.0
NY 12202 1.0
NY 12203 1.0
NY 12204 1.0
NY 12205 1.0
NY 12206 1.0
NY 12207 1.0
NY 12208 1.0
NY 12209 1.0
NY 12210 1.0
NY 12211 1.0
NY 12212 1.0
NY 12214 1.0
NY 12220 1.0
NY 12222 1.0
NY 12223 1.0
NY 12224 1.0
NY 12225 1.0
NY 12226 1.0
NY 12227 1.0
NY 12228 1.0
NY 12229 1.0
NY 12230 1.0
NY 12231 1.0
NY 12232 1.0
NY 12233 1.0
NY 12234 1.0
NY 12235 1.0
NY 12236 1.0
NY 12237 1.0
NY 12238 1.0
NY 12239 1.0
NY 12240 1.0
NY 12241 1.0
NY 12242 1.0
NY 12243 1.0
NY 12244 1.0
NY 12245 1.0
NY 12246 1.0
NY 12247 1.0
NY 12248 1.0
NY 12249 1.0
NY 12250 1.0
NY 12252 1.0
NY 12255 1.0
NY 12256 1.0
NY 12257 1.0
NY 12260 1.0
NY 12261 1.0
NY 12262 1.0
NY 12288 1.0
NY 12301 1.0
NY 12302 1.0
NY 12303 1.0
NY 12304 1.0
NY 12305 1.0
NY 12306 1.0
NY 12307 1.0
NY 12308 1.0
NY 12309 1.0
NY 12325 1.0
NY 12345 1.0
NY 12401 1.0
NY 12402 1.0
NY 12404 3.0
NY 12405 10.6
NY 12406 10.0
NY 12407 10.0
NY 12409 3.0
NY 12410 3.0
NY 12411 1.0
NY 12412 2.0
NY 12413 10.6
NY 12414 7.3
NY 12416 3.0
NY 12417 1.0
NY 12418 10.4
NY 12419 1.0
NY 12420 3.0
NY 12421 10.0
NY 12422 10.4
NY 12423 10.4
NY 12424 10.4
NY 12427 10.4
NY 12428 7.3
NY 12429 1.0
NY 12430 10.0
NY 12431 10.4
NY 12432 2.0
NY 12433 2.0
NY 12434 10.0
NY 12435 8.0
NY 12436 10.4
NY 12438 10.0
NY 12439 10.4
NY 12440 2.0
NY 12441 10.4
NY 12442 10.4
NY 12443 1.0
NY 12444 10.4
NY 12446 3.0
NY 12448 3.0
NY 12449 1.0
NY 12450 10.4
NY 12451 10.6
NY 12452 10.4
NY 12453 2.0
NY 12454 10.4
NY 12455 10.0
NY 12456 2.0
NY 12457 3.0
NY 12458 7.3
NY 12459 10.0
NY 12460 10.4
NY 12461 2.0
NY 12463 9.0
NY 12464 3.0
NY 12465 10.4
NY 12466 1.0
NY 12468 10.4
NY 12469 2.0
NY 12470 10.6
NY 12471 2.1
NY 12472 1.0
NY 12473 10.6
NY 12474 10.0
NY 12475 1.0
NY 12477 2.0
NY 12480 10.0
NY 12481 2.0
NY 12482 10.6
NY 12483 7.3
NY 12484 2.0
NY 12485 10.4
NY 12486 1.0
NY 12487 2.1
NY 12489 3.0
NY 12490 2.0
NY 12491 2.0
NY 12492 10.4
NY 12493 1.0
NY 12494 2.0
NY 12495 3.0
NY 12496 10.4
NY 12498 2.0
NY 12501 2.0
NY 12502 10.4
NY 12503 10.4
NY 12504 7.3
NY 12506 2.0
NY 12507 7.3
NY 12508 1.0
NY 12510 2.1
NY 12511 1.0
NY 12512 1.0
NY 12513 5.0
NY 12514 2.0
NY 12515 2.0
NY 12516 10.0
NY 12517 10.0
NY 12518 1.0
NY 12520 1.0
NY 12521 5.0
NY 12522 3.0
NY 12523 6.0
NY 12524 1.0
NY 12525 2.0
NY 12526 10.5
NY 12527 1.0
NY 12528 1.0
NY 12529 10.4
NY 12530 5.0
NY 12531 2.0
NY 12533 1.0
NY 12534 4.0
NY 12537 1.0
NY 12538 1.0
NY 12540 2.1
NY 12541 10.4
NY 12542 1.0
NY 12543 2.1
NY 12544 10.5
NY 12545 2.0
NY 12546 3.0
NY 12547 1.0
NY 12548 2.0
NY 12549 2.1
NY 12550 1.0
NY 12551 1.0
NY 12552 1.0
NY 12553 1.0
NY 12555 1.0
NY 12561 2.0
NY 12563 1.0
NY 12564 2.0
NY 12565 4.0
NY 12566 3.0
NY 12567 3.0
NY 12568 1.0
NY 12569 1.0
NY 12570 1.0
NY 12571 7.3
NY 12572 3.0
NY 12574 3.0
NY 12575 1.0
NY 12577 1.0
NY 12578 2.0
NY 12580 2.0
NY 12581 2.0
NY 12582 1.0
NY 12583 7.3
NY 12584 1.0
NY 12585 2.1
NY 12586 1.0
NY 12588 3.0
NY 12589 1.0
NY 12590 1.0
NY 12592 2.0
NY 12593 10.0
NY 12594 2.0
NY 12601 1.0
NY 12602 1.0
NY 12603 1.0
NY 12604 1.0
NY 12701 7.0
NY 12719 10.5
NY 12720 10.6
NY 12721 3.0
NY 12722 3.0
NY 12723 10.0
NY 12724 10.6
NY 12725 10.4
NY 12726 10.4
NY 12727 10.4
NY 12729 4.2
NY 12732 10.5
NY 12733 7.0
NY 12734 9.0
NY 12736 10.0
NY 12737 10.5
NY 12738 9.0
NY 12740 10.6
NY 12741 10.0
NY 12742 8.3
NY 12743 10.5
NY 12745 10.0
NY 12746 4.2
NY 12747 10.6
NY 12748 10.6
NY 12749 10.6
NY 12750 10.0
NY 12751 8.3
NY 12752 10.4
NY 12754 7.0
NY 12758 10.6
NY 12759 10.6
NY 12760 10.0
NY 12762 10.6
NY 12763 7.0
NY 12764 10.4
NY 12765 10.6
NY 12766 10.6
NY 12767 10.6
NY 12768 7.0
NY 12769 3.0
NY 12770 10.5
NY 12771 4.2
NY 12775 9.0
NY 12776 10.6
NY 12777 9.0
NY 12778 7.0
NY 12779 7.0
NY 12780 4.2
NY 12781 3.0
NY 12782 10.4
NY 12783 10.6
NY 12784 7.0
NY 12785 4.2
NY 12786 10.6
NY 12787 9.0
NY 12788 10.6
NY 12789 7.0
NY 12790 3.0
NY 12791 10.6
NY 12792 10.5
NY 12801 1.0
NY 12803 1.0
NY 12804 1.0
NY 12808 3.0
NY 12809 2.0
NY 12810 2.0
NY 12811 10.4
NY 12812 10.0
NY 12814 10.4
NY 12815 3.0
NY 12816 10.4
NY 12817 3.0
NY 12819 10.4
NY 12820 2.0
NY 12821 2.0
NY 12822 7.1
NY 12823 9.1
NY 12824 10.4
NY 12827 2.0
NY 12828 1.0
NY 12831 1.1
NY 12832 7.3
NY 12833 2.1
NY 12834 9.1
NY 12835 3.0
NY 12836 3.0
NY 12837 10.4
NY 12838 2.0
NY 12839 1.0
NY 12841 10.4
NY 12842 10.0
NY 12843 10.4
NY 12844 2.0
NY 12845 2.0
NY 12846 2.0
NY 12847 10.0
NY 12848 9.1
NY 12849 7.3
NY 12850 2.0
NY 12851 10.6
NY 12852 10.6
NY 12853 10.4
NY 12854 10.4
NY 12855 10.6
NY 12856 10.4
NY 12857 10.6
NY 12858 10.6
NY 12859 2.1
NY 12860 3.0
NY 12861 10.4
NY 12862 3.0
NY 12863 1.1
NY 12864 10.0
NY 12865 10.4
NY 12866 1.1
NY 12870 10.6
NY 12871 2.1
NY 12872 10.6
NY 12873 10.4
NY 12874 3.0
NY 12878 2.0
NY 12879 10.6
NY 12883 7.0
NY 12884 2.1
NY 12885 2.0
NY 12886 10.4
NY 12887 10.4
NY 12901 4.0
NY 12903 4.0
NY 12910 5.0
NY 12911 5.0
NY 12912 5.0
NY 12913 8.0
NY 12914 10.5
NY 12915 10.2
NY 12916 5.0
NY 12917 10.2
NY 12918 5.0
NY 12919 10.5
NY 12920 10.2
NY 12921 5.0
NY 12922 10.6
NY 12923 5.0
NY 12924 5.0
NY 12926 10.2
NY 12927 8.0
NY 12928 9.0
NY 12929 5.0
NY 12930 10.5
NY 12932 10.0
NY 12933 5.0
NY 12934 5.0
NY 12935 5.0
NY 12936 10.0
NY 12937 10.5
NY 12939 7.0
NY 12941 10.6
NY 12942 10.0
NY 12943 10.0
NY 12944 5.0
NY 12945 7.0
NY 12946 7.0
NY 12949 10.6
NY 12950 10.0
NY 12952 5.0
NY 12953 4.0
NY 12955 5.0
NY 12956 10.6
NY 12957 5.0
NY 12958 5.0
NY 12959 5.0
NY 12960 10.6
NY 12961 10.6
NY 12962 5.0
NY 12964 10.0
NY 12965 10.6
NY 12966 5.0
NY 12967 10.6
NY 12969 5.0
NY 12970 8.0
NY 12972 5.0
NY 12973 10.6
NY 12974 10.6
NY 12975 5.0
NY 12976 8.0
NY 12977 7.0
NY 12978 5.0
NY 12979 10.5
NY 12980 10.5
NY 12981 5.0
NY 12983 7.0
NY 12985 5.0
NY 12986 7.0
NY 12987 8.0
NY 12989 8.0
NY 12992 5.0
NY 12993 10.0
NY 12995 4.0
NY 12996 10.0
NY 12997 8.0
NY 12998 10.6
NY 13020 2.0
NY 13021 4.2
NY 13022 4.2
NY 13024 4.2
NY 13026 10.4
NY 13027 1.0
NY 13028 2.0
NY 13029 1.0
NY 13030 1.0
NY 13031 1.0
NY 13032 4.2
NY 13033 2.0
NY 13034 5.0
NY 13035 2.0
NY 13036 2.0
NY 13037 2.0
NY 13039 1.0
NY 13040 5.0
NY 13041 1.0
NY 13042 2.0
NY 13043 4.2
NY 13044 2.0
NY 13045 4.0
NY 13051 2.0
NY 13052 3.0
NY 13053 2.0
NY 13054 5.0
NY 13056 4.0
NY 13057 1.0
NY 13060 2.0
NY 13061 10.4
NY 13062 1.0
NY 13063 2.0
NY 13064 3.0
NY 13065 4.0
NY 13066 1.0
NY 13068 2.0
NY 13069 4.2
NY 13071 10.4
NY 13072 3.0
NY 13073 2.0
NY 13074 6.1
NY 13076 2.0
NY 13077 4.0
NY 13078 1.0
NY 13080 2.0
NY 13081 10.4
NY 13082 1.0
NY 13083 3.0
NY 13084 2.0
NY 13087 5.2
NY 13088 1.0
NY 13089 1.0
NY 13090 1.0
NY 13092 6.1
NY 13093 4.2
NY 13101 4.0
NY 13102 2.0
NY 13103 2.0
NY 13104 1.0
NY 13107 2.0
NY 13108 1.0
NY 13110 2.0
NY 13111 3.0
NY 13112 2.0
NY 13113 2.0
NY 13114 2.0
NY 13115 4.2
NY 13116 1.0
NY 13117 3.0
NY 13118 7.4
NY 13119 2.0
NY 13120 1.0
NY 13121 2.0
NY 13122 2.0
NY 13123 2.0
NY 13124 10.6
NY 13126 4.2
NY 13129 3.0
NY 13131 2.0
NY 13132 2.0
NY 13134 10.4
NY 13135 1.0
NY 13136 10.6
NY 13137 1.0
NY 13138 2.0
NY 13139 5.2
NY 13140 3.0
NY 13141 5.2
NY 13142 10.4
NY 13143 10.4
NY 13144 3.0
NY 13145 3.0
NY 13146 10.5
NY 13147 5.2
NY 13148 4.0
NY 13152 2.0
NY 13153 2.0
NY 13154 10.5
NY 13155 10.6
NY 13156 3.0
NY 13157 3.0
NY 13158 5.2
NY 13159 2.0
NY 13160 5.0
NY 13162 3.0
NY 13163 4.2
NY 13164 2.0
NY 13165 4.0
NY 13166 3.0
NY 13167 2.0
NY 13201 1.0
NY 13202 1.0
NY 13203 1.0
NY 13204 1.0
NY 13205 1.0
NY 13206 1.0
NY 13207 1.0
NY 13208 1.0
NY 13209 1.0
NY 13210 1.0
NY 13211 1.0
NY 13212 1.0
NY 13214 1.0
NY 13215 1.0
NY 13217 1.0
NY 13218 1.0
NY 13219 1.0
NY 13220 1.0
NY 13221 1.0
NY 13224 1.0
NY 13225 1.0
NY 13235 1.0
NY 13244 1.0
NY 13250 1.0
NY 13251 1.0
NY 13252 1.0
NY 13260 1.0
NY 13261 1.0
NY 13290 1.0
NY 13301 10.4
NY 13302 2.0
NY 13303 5.2
NY 13304 2.0
NY 13305 10.6
NY 13308 3.0
NY 13309 10.4
NY 13310 10.4
NY 13312 10.6
NY 13313 2.0
NY 13314 3.0
NY 13315 10.5
NY 13316 10.5
NY 13317 7.0
NY 13318 2.0
NY 13319 1.0
NY 13320 10.0
NY 13321 1.0
NY 13322 1.0
NY 13323 1.0
NY 13324 2.0
NY 13325 10.0
NY 13326 10.5
NY 13327 10.6
NY 13328 2.0
NY 13329 10.5
NY 13331 2.0
NY 13332 8.0
NY 13333 10.0
NY 13334 10.4
NY 13335 10.5
NY 13337 10.5
NY 13338 2.0
NY 13339 7.0
NY 13340 4.1
NY 13341 1.0
NY 13342 10.5
NY 13343 8.0
NY 13345 10.6
NY 13346 7.0
NY 13348 10.5
NY 13350 4.2
NY 13352 2.0
NY 13353 10.0
NY 13354 2.0
NY 13355 8.0
NY 13357 4.2
NY 13360 10.0
NY 13361 10.1
NY 13362 2.0
NY 13363 5.2
NY 13364 3.0
NY 13365 7.4
NY 13367 7.4
NY 13368 10.0
NY 13401 3.0
NY 13402 8.0
NY 13403 1.0
NY 13404 7.4
NY 13406 2.0
NY 13407 4.2
NY 13408 10.4
NY 13409 6.1
NY 13410 7.0
NY 13411 10.6
NY 13413 1.0
NY 13415 10.5
NY 13416 2.0
NY 13417 1.0
NY 13418 3.0
NY 13420 2.0
NY 13421 4.2
NY 13424 2.0
NY 13425 2.0
NY 13426 3.0
NY 13428 7.0
NY 13431 2.0
NY 13433 10.6
NY 13435 2.0
NY 13436 10.0
NY 13437 3.0
NY 13438 2.0
NY 13439 10.4
NY 13440 4.2
NY 13441 4.2
NY 13442 4.2
NY 13449 4.2
NY 13450 10.0
NY 13452 10.0
NY 13454 9.0
NY 13455 2.0
NY 13456 1.0
NY 13457 10.5
NY 13459 10.6
NY 13460 10.6
NY 13461 4.2
NY 13464 10.6
NY 13465 8.0
NY 13468 10.0
NY 13469 1.0
NY 13470 6.0
NY 13471 5.2
NY 13472 2.0
NY 13473 10.0
NY 13475 10.5
NY 13476 4.2
NY 13477 4.2
NY 13478 5.0
NY 13479 1.0
NY 13480 2.0
NY 13482 10.5
NY 13483 5.2
NY 13484 10.4
NY 13485 3.0
NY 13486 5.2
NY 13488 10.0
NY 13489 10.0
NY 13490 2.0
NY 13491 2.0
NY 13492 1.0
NY 13493 2.0
NY 13494 2.0
NY 13495 1.0
NY 13501 1.0
NY 13502 1.0
NY 13503 1.0
NY 13504 1.0
NY 13505 1.0
NY 13599 1.0
NY 13601 4.0
NY 13602 4.0
NY 13603 4.0
NY 13605 5.0
NY 13606 5.0
NY 13607 10.2
NY 13608 5.0
NY 13611 10.5
NY 13612 4.0
NY 13613 6.0
NY 13614 10.5
NY 13615 4.0
NY 13616 5.0
NY 13617 7.0
NY 13618 5.0
NY 13619 5.0
NY 13620 10.6
NY 13621 5.0
NY 13622 5.0
NY 13623 10.6
NY 13624 10.2
NY 13625 8.0
NY 13626 7.4
NY 13627 5.0
NY 13628 5.0
NY 13630 10.6
NY 13631 5.0
NY 13632 5.0
NY 13633 10.6
NY 13634 5.0
NY 13635 10.6
NY 13636 10.5
NY 13637 4.0
NY 13638 4.0
NY 13639 10.6
NY 13640 10.2
NY 13641 10.2
NY 13642 7.4
NY 13643 5.0
NY 13645 7.4
NY 13646 10.6
NY 13647 7.0
NY 13648 10.6
NY 13649 6.0
NY 13650 5.0
NY 13651 5.0
NY 13652 10.6
NY 13654 5.0
NY 13655 6.0
NY 13656 10.2
NY 13657 5.0
NY 13658 10.5
NY 13659 10.5
NY 13660 10.5
NY 13661 10.5
NY 13662 4.0
NY 13664 4.0
NY 13665 5.0
NY 13666 10.6
NY 13667 5.0
NY 13668 8.0
NY 13669 4.0
NY 13670 10.6
NY 13671 5.0
NY 13672 8.0
NY 13673 4.0
NY 13674 5.0
NY 13675 10.2
NY 13676 7.0
NY 13677 10.6
NY 13678 5.0
NY 13679 10.2
NY 13680 7.0
NY 13681 10.6
NY 13682 5.0
NY 13683 6.0
NY 13684 10.6
NY 13685 5.0
NY 13687 8.0
NY 13690 10.6
NY 13691 5.0
NY 13692 10.2
NY 13693 5.0
NY 13694 10.5
NY 13695 10.6
NY 13696 6.0
NY 13697 6.0
NY 13699 7.0
NY 13730 10.4
NY 13731 10.0
NY 13732 1.0
NY 13733 10.4
NY 13734 2.0
NY 13736 2.0
NY 13737 1.0
NY 13738 4.0
NY 13739 10.0
NY 13740 10.0
NY 13743 2.1
NY 13744 2.0
NY 13745 1.0
NY 13746 2.0
NY 13747 5.0
NY 13748 1.0
NY 13749 1.0
NY 13750 5.0
NY 13751 5.0
NY 13752 10.0
NY 13753 10.0
NY 13754 3.0
NY 13755 10.0
NY 13756 10.0
NY 13757 10.0
NY 13758 10.6
NY 13760 1.0
NY 13761 1.0
NY 13762 1.0
NY 13763 1.0
NY 13774 10.0
NY 13775 10.5
NY 13776 10.5
NY 13777 2.0
NY 13778 10.4
NY 13780 9.0
NY 13782 10.0
NY 13783 10.0
NY 13784 2.0
NY 13786 5.0
NY 13787 2.0
NY 13788 10.0
NY 13790 1.0
NY 13794 2.0
NY 13795 1.0
NY 13796 5.0
NY 13797 2.0
NY 13801 10.6
NY 13802 2.0
NY 13803 5.0
NY 13804 10.6
NY 13806 10.0
NY 13807 5.0
NY 13808 10.5
NY 13809 9.0
NY 13810 10.5
NY 13811 2.0
NY 13812 2.0
NY 13813 2.0
NY 13814 7.0
NY 13815 7.0
NY 13820 4.0
NY 13825 5.0
NY 13826 2.0
NY 13827 2.0
NY 13830 9.0
NY 13832 10.6
NY 13833 2.0
NY 13834 5.0
NY 13835 2.0
NY 13837 10.0
NY 13838 7.0
NY 13839 7.0
NY 13840 2.0
NY 13841 10.4
NY 13842 10.0
NY 13843 10.6
NY 13844 10.6
NY 13845 2.0
NY 13846 10.5
NY 13847 7.0
NY 13848 2.0
NY 13849 9.2
NY 13850 1.0
NY 13851 1.0
NY 13856 7.0
NY 13859 9.2
NY 13860 4.0
NY 13861 4.0
NY 13862 2.0
NY 13863 5.0
NY 13864 2.1
NY 13865 2.0
NY 13901 1.0
NY 13902 1.0
NY 13903 1.0
NY 13904 1.0
NY 13905 1.0
NY 14001 2.0
NY 14004 1.0
NY 14005 3.0
NY 14006 1.0
NY 14008 5.2
NY 14009 7.3
NY 14010 1.0
NY 14011 7.4
NY 14012 10.5
NY 14013 2.0
NY 14020 4.2
NY 14021 4.2
NY 14024 10.4
NY 14025 1.0
NY 14026 1.0
NY 14027 2.0
NY 14028 5.0
NY 14029 8.3
NY 14030 2.0
NY 14031 1.0
NY 14032 2.0
NY 14033 2.0
NY 14034 7.1
NY 14035 7.1
NY 14036 2.0
NY 14037 2.0
NY 14038 1.0
NY 14039 10.4
NY 14040 3.0
NY 14041 10.4
NY 14042 7.3
NY 14043 1.0
NY 14047 1.0
NY 14048 4.0
NY 14051 1.0
NY 14052 2.0
NY 14054 6.1
NY 14055 2.0
NY 14056 4.2
NY 14057 1.0
NY 14058 6.0
NY 14059 1.0
NY 14060 10.5
NY 14061 2.0
NY 14062 5.0
NY 14063 4.0
NY 14065 8.3
NY 14066 10.6
NY 14067 5.1
NY 14068 1.0
NY 14069 2.0
NY 14070 7.1
NY 14072 1.0
NY 14075 1.0
NY 14080 2.0
NY 14081 2.0
NY 14082 2.0
NY 14083 2.0
NY 14085 1.0
NY 14086 1.0
NY 14091 2.0
NY 14092 1.0
NY 14094 4.1
NY 14095 4.1
NY 14098 10.4
NY 14101 7.3
NY 14102 2.0
NY 14103 7.0
NY 14105 6.0
NY 14107 1.0
NY 14108 5.2
NY 14109 1.0
NY 14110 1.0
NY 14111 2.0
NY 14112 1.0
NY 14113 2.0
NY 14120 1.0
NY 14125 6.0
NY 14126 5.0
NY 14127 1.0
NY 14129 7.1
NY 14130 10.6
NY 14131 2.0
NY 14132 1.0
NY 14133 8.3
NY 14134 2.0
NY 14135 2.0
NY 14136 2.0
NY 14138 10.4
NY 14139 2.0
NY 14140 1.0
NY 14141 7.1
NY 14143 2.0
NY 14144 1.0
NY 14145 3.0
NY 14150 1.0
NY 14151 1.0
NY 14166 4.0
NY 14167 3.0
NY 14168 7.1
NY 14169 2.0
NY 14170 2.0
NY 14171 3.0
NY 14172 2.0
NY 14173 7.3
NY 14174 1.0
NY 14201 1.0
NY 14202 1.0
NY 14203 1.0
NY 14204 1.0
NY 14205 1.0
NY 14206 1.0
NY 14207 1.0
NY 14208 1.0
NY 14209 1.0
NY 14210 1.0
NY 14211 1.0
NY 14212 1.0
NY 14213 1.0
NY 14214 1.0
NY 14215 1.0
NY 14216 1.0
NY 14217 1.0
NY 14218 1.0
NY 14219 1.0
NY 14220 1.0
NY 14221 1.0
NY 14222 1.0
NY 14223 1.0
NY 14224 1.0
NY 14225 1.0
NY 14226 1.0
NY 14227 1.0
NY 14228 1.0
NY 14231 1.0
NY 14233 1.0
NY 14240 1.0
NY 14241 1.0
NY 14260 1.0
NY 14261 1.0
NY 14263 1.0
NY 14264 1.0
NY 14265 1.0
NY 14267 1.0
NY 14269 1.0
NY 14270 1.0
NY 14272 1.0
NY 14273 1.0
NY 14276 1.0
NY 14280 1.0
NY 14301 1.0
NY 14302 1.0
NY 14303 1.0
NY 14304 1.0
NY 14305 1.0
NY 14410 1.0
NY 14411 7.3
NY 14413 10.4
NY 14414 2.0
NY 14415 7.0
NY 14416 2.0
NY 14418 3.0
NY 14420 1.0
NY 14422 2.0
NY 14423 2.0
NY 14424 2.0
NY 14425 1.0
NY 14427 10.6
NY 14428 2.0
NY 14429 2.0
NY 14430 1.0
NY 14432 4.1
NY 14433 10.6
NY 14435 2.0
NY 14437 3.0
NY 14441 10.6
NY 14443 2.0
NY 14445 1.0
NY 14449 2.0
NY 14450 1.0
NY 14452 2.0
NY 14453 1.0
NY 14454 7.3
NY 14456 4.0
NY 14461 6.0
NY 14462 3.0
NY 14463 4.0
NY 14464 2.0
NY 14466 2.0
NY 14467 1.0
NY 14468 1.0
NY 14469 2.0
NY 14470 2.0
NY 14471 2.0
NY 14472 2.0
NY 14475 2.0
NY 14476 2.0
NY 14477 2.0
NY 14478 7.0
NY 14479 7.3
NY 14480 2.0
NY 14481 3.0
NY 14482 2.0
NY 14485 2.0
NY 14486 3.0
NY 14487 2.0
NY 14488 2.0
NY 14489 7.3
NY 14502 1.0
NY 14504 4.1
NY 14505 2.0
NY 14506 2.0
NY 14507 3.0
NY 14508 2.0
NY 14510 9.1
NY 14511 2.0
NY 14512 10.4
NY 14513 4.1
NY 14514 1.0
NY 14515 1.0
NY 14516 10.4
NY 14517 10.4
NY 14518 4.0
NY 14519 2.0
NY 14520 2.0
NY 14521 3.0
NY 14522 4.1
NY 14525 6.1
NY 14526 1.0
NY 14527 7.0
NY 14529 10.4
NY 14530 9.0
NY 14532 10.5
NY 14533 3.0
NY 14534 1.0
NY 14536 10.4
NY 14537 4.1
NY 14538 2.0
NY 14539 3.0
NY 14541 5.0
NY 14542 7.3
NY 14543 2.0
NY 14544 3.0
NY 14545 3.0
NY 14546 2.0
NY 14547 6.0
NY 14548 4.1
NY 14549 10.6
NY 14550 10.6
NY 14551 2.0
NY 14555 2.0
NY 14556 9.1
NY 14557 2.0
NY 14558 2.0
NY 14559 1.0
NY 14560 2.0
NY 14561 6.0
NY 14563 2.0
NY 14564 1.0
NY 14568 2.0
NY 14569 7.0
NY 14571 2.0
NY 14572 10.4
NY 14580 1.0
NY 14585 2.0
NY 14586 1.0
NY 14588 3.0
NY 14589 2.0
NY 14590 10.4
NY 14591 10.4
NY 14592 3.0
NY 14602 1.0
NY 14603 1.0
NY 14604 1.0
NY 14605 1.0
NY 14606 1.0
NY 14607 1.0
NY 14608 1.0
NY 14609 1.0
NY 14610 1.0
NY 14611 1.0
NY 14612 1.0
NY 14613 1.0
NY 14614 1.0
NY 14615 1.0
NY 14616 1.0
NY 14617 1.0
NY 14618 1.0
NY 14619 1.0
NY 14620 1.0
NY 14621 1.0
NY 14622 1.0
NY 14623 1.0
NY 14624 1.0
NY 14625 1.0
NY 14626 1.0
NY 14627 1.0
NY 14638 1.0
NY 14639 1.0
NY 14642 1.0
NY 14643 1.0
NY 14644 1.0
NY 14645 1.0
NY 14646 1.0
NY 14647 1.0
NY 14649 1.0
NY 14650 1.0
NY 14651 1.0
NY 14652 1.0
NY 14653 1.0
NY 14664 1.0
NY 14673 1.0
NY 14683 1.0
NY 14692 1.0
NY 14694 1.0
NY 14701 4.0
NY 14702 4.0
NY 14703 4.0
NY 14704 4.0
NY 14706 4.0
NY 14707 7.0
NY 14708 7.0
NY 14709 10.0
NY 14710 5.0
NY 14711 10.5
NY 14712 5.0
NY 14714 10.5
NY 14715 5.0
NY 14716 5.0
NY 14717 10.5
NY 14718 5.0
NY 14719 10.4
NY 14720 4.0
NY 14721 5.0
NY 14722 10.5
NY 14723 6.0
NY 14724 10.5
NY 14726 10.4
NY 14727 10.5
NY 14728 10.5
NY 14729 3.0
NY 14730 10.2
NY 14731 10.6
NY 14732 5.0
NY 14733 4.0
NY 14735 10.0
NY 14736 3.0
NY 14737 10.4
NY 14738 5.0
NY 14739 10.6
NY 14740 5.0
NY 14741 5.0
NY 14742 4.0
NY 14743 4.0
NY 14744 10.0
NY 14745 10.0
NY 14747 5.0
NY 14748 4.0
NY 14750 4.0
NY 14751 10.4
NY 14752 10.5
NY 14753 4.0
NY 14754 5.0
NY 14755 10.6
NY 14756 5.0
NY 14757 10.5
NY 14758 5.0
NY 14760 4.0
NY 14766 10.4
NY 14767 5.0
NY 14769 5.0
NY 14770 4.0
NY 14772 10.2
NY 14774 5.0
NY 14775 3.0
NY 14777 10.5
NY 14778 4.0
NY 14779 7.4
NY 14781 10.5
NY 14782 5.0
NY 14783 10.2
NY 14784 10.5
NY 14785 5.0
NY 14786 10.5
NY 14787 7.4
NY 14788 4.0
NY 14801 6.0
NY 14802 7.0
NY 14803 7.0
NY 14804 7.0
NY 14805 10.4
NY 14806 8.0
NY 14807 6.0
NY 14808 10.0
NY 14809 10.6
NY 14810 7.4
NY 14812 5.1
NY 14813 10.6
NY 14814 2.0
NY 14815 6.0
NY 14816 1.0
NY 14817 2.0
NY 14818 2.0
NY 14819 6.0
NY 14820 6.0
NY 14821 5.0
NY 14822 6.0
NY 14823 5.0
NY 14824 10.4
NY 14825 2.0
NY 14826 10.0
NY 14827 4.2
NY 14830 4.2
NY 14831 4.2
NY 14836 10.4
NY 14837 10.6
NY 14838 2.0
NY 14839 10.5
NY 14840 10.6
NY 14841 2.0
NY 14842 10.6
NY 14843 4.0
NY 14844 1.0
NY 14845 1.0
NY 14846 10.4
NY 14847 2.0
NY 14850 1.0
NY 14851 1.0
NY 14852 1.0
NY 14853 1.0
NY 14854 2.0
NY 14855 10.5
NY 14856 7.4
NY 14857 10.6
NY 14858 5.2
NY 14859 5.0
NY 14860 3.0
NY 14861 2.0
NY 14863 2.0
NY 14864 2.0
NY 14865 10.4
NY 14867 2.0
NY 14869 10.4
NY 14870 4.2
NY 14871 1.0
NY 14872 2.0
NY 14873 10.6
NY 14874 10.6
NY 14876 7.3
NY 14877 10.5
NY 14878 9.1
NY 14879 8.4
NY 14880 7.0
NY 14881 2.0
NY 14882 2.0
NY 14883 2.0
NY 14884 6.0
NY 14885 10.5
NY 14886 2.0
NY 14887 10.6
NY 14889 2.0
NY 14891 7.3
NY 14892 4.0
NY 14893 10.6
NY 14894 1.0
NY 14895 7.0
NY 14897 7.0
NY 14898 6.0
NY 14901 1.0
NY 14902 1.0
NY 14903 1.0
NY 14904 1.0
NY 14905 1.0
NY 14925 1.0
OH 43001 2.0
OH 43002 1.0
OH 43003 2.0
OH 43004 1.0
OH 43005 2.1
OH 43006 9.0
OH 43007 2.0
OH 43008 1.0
OH 43009 6.0
OH 43010 6.1
OH 43011 2.0
OH 43013 2.0
OH 43014 5.0
OH 43015 2.0
OH 43016 1.0
OH 43017 1.0
OH 43018 2.0
OH 43019 5.0
OH 43021 2.0
OH 43022 4.0
OH 43023 1.0
OH 43025 1.0
OH 43026 1.0
OH 43027 2.1
OH 43028 5.0
OH 43029 2.0
OH 43030 2.0
OH 43031 2.0
OH 43032 2.0
OH 43033 2.0
OH 43035 1.0
OH 43036 2.0
OH 43037 5.2
OH 43040 2.0
OH 43041 2.0
OH 43044 6.1
OH 43045 2.0
OH 43046 1.0
OH 43047 6.0
OH 43048 2.0
OH 43050 4.0
OH 43054 1.0
OH 43055 1.0
OH 43056 1.0
OH 43058 1.0
OH 43060 6.0
OH 43061 2.0
OH 43062 2.0
OH 43064 2.0
OH 43065 1.0
OH 43066 2.0
OH 43067 2.0
OH 43068 1.0
OH 43070 10.5
OH 43071 2.1
OH 43072 3.0
OH 43073 2.0
OH 43074 2.0
OH 43076 2.0
OH 43077 2.0
OH 43078 4.2
OH 43080 2.1
OH 43081 1.0
OH 43082 1.0
OH 43083 4.2
OH 43084 6.0
OH 43085 1.0
OH 43086 1.0
OH 43093 1.0
OH 43098 1.0
OH 43101 3.0
OH 43102 2.0
OH 43103 2.0
OH 43105 2.0
OH 43106 5.2
OH 43107 5.2
OH 43109 1.0
OH 43110 1.0
OH 43111 7.4
OH 43112 2.0
OH 43113 4.2
OH 43115 5.0
OH 43116 2.0
OH 43117 2.0
OH 43119 1.0
OH 43123 1.0
OH 43125 1.0
OH 43126 2.0
OH 43127 7.4
OH 43128 6.0
OH 43130 4.2
OH 43135 3.0
OH 43136 1.0
OH 43137 1.0
OH 43138 7.4
OH 43140 7.1
OH 43142 4.0
OH 43143 2.0
OH 43144 5.0
OH 43145 3.0
OH 43146 2.0
OH 43147 1.0
OH 43148 2.0
OH 43149 3.0
OH 43150 5.2
OH 43151 7.1
OH 43152 8.3
OH 43153 9.1
OH 43154 2.0
OH 43155 5.2
OH 43156 3.0
OH 43157 2.0
OH 43158 7.4
OH 43160 4.0
OH 43162 2.0
OH 43163 4.2
OH 43164 3.0
OH 43195 1.0
OH 43196 1.0
OH 43198 1.0
OH 43199 1.0
OH 43201 1.0
OH 43202 1.0
OH 43203 1.0
OH 43204 1.0
OH 43205 1.0
OH 43206 1.0
OH 43207 1.0
OH 43209 1.0
OH 43210 1.0
OH 43211 1.0
OH 43212 1.0
OH 43213 1.0
OH 43214 1.0
OH 43215 1.0
OH 43216 1.0
OH 43217 1.0
OH 43218 1.0
OH 43219 1.0
OH 43220 1.0
OH 43221 1.0
OH 43222 1.0
OH 43223 1.0
OH 43224 1.0
OH 43226 1.0
OH 43227 1.0
OH 43228 1.0
OH 43229 1.0
OH 43230 1.0
OH 43231 1.0
OH 43232 1.0
OH 43234 1.0
OH 43235 1.0
OH 43236 1.0
OH 43240 1.0
OH 43251 1.0
OH 43260 1.0
OH 43265 1.0
OH 43266 1.0
OH 43268 1.0
OH 43270 1.0
OH 43271 1.0
OH 43272 1.0
OH 43279 1.0
OH 43287 1.0
OH 43291 1.0
OH 43299 1.0
OH 43301 4.0
OH 43302 4.0
OH 43306 4.0
OH 43307 4.0
OH 43310 6.0
OH 43311 4.0
OH 43314 5.0
OH 43315 3.0
OH 43316 7.4
OH 43317 5.0
OH 43318 10.5
OH 43319 6.0
OH 43320 9.1
OH 43321 3.0
OH 43322 4.0
OH 43323 8.4
OH 43324 6.0
OH 43325 4.2
OH 43326 7.0
OH 43330 7.0
OH 43331 9.2
OH 43332 5.0
OH 43333 10.5
OH 43334 2.0
OH 43335 5.0
OH 43336 6.0
OH 43337 4.0
OH 43338 7.3
OH 43340 8.0
OH 43341 5.0
OH 43342 5.2
OH 43343 10.5
OH 43344 10.0
OH 43345 8.0
OH 43346 9.0
OH 43347 6.0
OH 43348 9.2
OH 43349 2.0
OH 43350 2.0
OH 43351 7.0
OH 43356 5.2
OH 43357 6.0
OH 43358 6.0
OH 43359 8.4
OH 43360 6.0
OH 43402 4.2
OH 43403 4.2
OH 43406 3.0
OH 43407 5.0
OH 43408 2.0
OH 43410 7.4
OH 43412 2.0
OH 43413 6.0
OH 43414 4.2
OH 43416 2.0
OH 43420 4.0
OH 43430 2.0
OH 43431 10.5
OH 43432 2.0
OH 43433 4.0
OH 43434 1.0
OH 43435 5.0
OH 43436 10.0
OH 43437 6.0
OH 43438 1.0
OH 43439 4.0
OH 43440 6.0
OH 43441 2.0
OH 43442 5.2
OH 43443 2.0
OH 43445 2.0
OH 43446 4.0
OH 43447 1.0
OH 43449 6.0
OH 43450 2.0
OH 43451 5.2
OH 43452 4.0
OH 43456 10.0
OH 43457 3.0
OH 43458 6.0
OH 43460 1.0
OH 43462 5.2
OH 43463 1.0
OH 43464 3.0
OH 43465 1.0
OH 43466 3.0
OH 43467 3.0
OH 43468 2.0
OH 43469 2.0
OH 43501 10.6
OH 43502 7.0
OH 43504 2.0
OH 43505 10.6
OH 43506 7.0
OH 43510 9.1
OH 43511 5.2
OH 43512 4.0
OH 43515 2.0
OH 43516 10.6
OH 43517 10.6
OH 43518 10.6
OH 43519 4.0
OH 43520 7.0
OH 43521 8.0
OH 43522 2.0
OH 43523 8.0
OH 43524 10.6
OH 43525 2.0
OH 43526 7.3
OH 43527 8.4
OH 43528 1.0
OH 43529 10.6
OH 43530 4.0
OH 43531 10.6
OH 43532 9.1
OH 43533 9.1
OH 43534 8.0
OH 43535 8.0
OH 43536 6.0
OH 43537 1.0
OH 43540 2.0
OH 43541 5.2
OH 43542 1.0
OH 43543 7.0
OH 43545 7.0
OH 43547 2.0
OH 43548 8.4
OH 43549 9.2
OH 43550 7.0
OH 43551 1.0
OH 43552 1.0
OH 43553 7.0
OH 43554 10.6
OH 43555 7.0
OH 43556 6.0
OH 43557 9.0
OH 43558 2.0
OH 43560 1.0
OH 43565 4.2
OH 43566 1.0
OH 43567 7.0
OH 43569 5.2
OH 43570 10.6
OH 43571 2.0
OH 43601 1.0
OH 43602 1.0
OH 43603 1.0
OH 43604 1.0
OH 43605 1.0
OH 43606 1.0
OH 43607 1.0
OH 43608 1.0
OH 43609 1.0
OH 43610 1.0
OH 43611 1.0
OH 43612 1.0
OH 43613 1.0
OH 43614 1.0
OH 43615 1.0
OH 43616 1.0
OH 43617 1.0
OH 43618 2.0
OH 43619 1.0
OH 43620 1.0
OH 43623 1.0
OH 43624 1.0
OH 43635 1.0
OH 43652 1.0
OH 43654 1.0
OH 43656 1.0
OH 43657 1.0
OH 43659 1.0
OH 43660 1.0
OH 43661 1.0
OH 43666 1.0
OH 43667 1.0
OH 43681 1.0
OH 43682 1.0
OH 43697 1.0
OH 43699 1.0
OH 43701 4.0
OH 43702 4.0
OH 43711 5.0
OH 43713 7.3
OH 43716 10.0
OH 43717 7.4
OH 43718 2.0
OH 43719 2.0
OH 43720 5.0
OH 43721 2.0
OH 43722 5.0
OH 43723 4.0
OH 43724 7.4
OH 43725 4.0
OH 43727 5.0
OH 43728 9.0
OH 43730 9.1
OH 43731 9.2
OH 43732 5.0
OH 43733 5.0
OH 43734 5.0
OH 43735 5.0
OH 43736 6.0
OH 43738 2.0
OH 43739 2.0
OH 43740 1.0
OH 43746 5.2
OH 43747 10.0
OH 43748 9.1
OH 43749 5.0
OH 43750 4.0
OH 43752 10.0
OH 43754 10.0
OH 43755 5.0
OH 43756 7.0
OH 43757 10.0
OH 43758 7.0
OH 43759 2.0
OH 43760 2.0
OH 43761 9.1
OH 43762 7.4
OH 43764 7.4
OH 43766 9.1
OH 43767 7.4
OH 43768 5.0
OH 43771 5.0
OH 43772 5.0
OH 43773 6.0
OH 43777 5.0
OH 43778 6.0
OH 43779 6.0
OH 43780 5.0
OH 43782 9.1
OH 43783 3.0
OH 43786 10.0
OH 43787 9.0
OH 43788 6.0
OH 43789 10.0
OH 43791 4.0
OH 43793 10.0
OH 43802 5.0
OH 43803 7.4
OH 43804 10.0
OH 43805 6.0
OH 43811 5.0
OH 43812 4.0
OH 43821 10.2
OH 43822 5.0
OH 43824 5.0
OH 43828 4.0
OH 43830 5.0
OH 43832 7.4
OH 43836 4.0
OH 43837 5.0
OH 43840 5.0
OH 43842 10.2
OH 43843 6.0
OH 43844 6.0
OH 43845 5.0
OH 43901 2.0
OH 43902 2.0
OH 43903 2.0
OH 43905 1.0
OH 43906 2.0
OH 43907 7.4
OH 43908 2.0
OH 43909 1.0
OH 43910 2.0
OH 43912 1.0
OH 43913 1.0
OH 43914 10.0
OH 43915 10.6
OH 43916 1.0
OH 43917 2.1
OH 43920 4.0
OH 43925 2.0
OH 43926 1.0
OH 43927 1.0
OH 43928 1.0
OH 43930 2.0
OH 43931 10.6
OH 43932 2.0
OH 43933 2.0
OH 43934 1.0
OH 43935 1.0
OH 43937 1.0
OH 43938 1.0
OH 43939 2.1
OH 43940 2.0
OH 43941 2.1
OH 43942 2.0
OH 43943 2.0
OH 43944 2.0
OH 43945 6.0
OH 43946 10.6
OH 43947 1.0
OH 43948 2.1
OH 43950 1.0
OH 43951 2.0
OH 43952 1.0
OH 43953 1.0
OH 43961 1.0
OH 43962 6.0
OH 43963 1.0
OH 43964 1.0
OH 43967 2.0
OH 43968 4.0
OH 43970 2.0
OH 43971 1.0
OH 43972 1.0
OH 43973 5.0
OH 43974 7.4
OH 43976 3.0
OH 43977 2.0
OH 43981 7.4
OH 43983 2.0
OH 43984 3.0
OH 43985 2.0
OH 43986 3.0
OH 43988 6.0
OH 44001 1.0
OH 44003 10.5
OH 44004 4.2
OH 44005 4.2
OH 44010 2.0
OH 44011 1.0
OH 44012 1.0
OH 44017 1.0
OH 44021 7.1
OH 44022 1.0
OH 44023 1.0
OH 44024 2.0
OH 44026 1.0
OH 44028 2.0
OH 44030 4.0
OH 44032 10.5
OH 44033 2.0
OH 44035 1.0
OH 44036 1.0
OH 44039 1.0
OH 44040 2.0
OH 44041 4.2
OH 44044 1.0
OH 44045 1.0
OH 44046 3.0
OH 44047 7.2
OH 44048 5.0
OH 44049 7.1
OH 44050 2.1
OH 44052 1.0
OH 44053 1.0
OH 44054 1.0
OH 44055 1.0
OH 44056 1.0
OH 44057 1.0
OH 44060 1.0
OH 44061 1.0
OH 44062 7.1
OH 44064 2.0
OH 44065 2.0
OH 44067 1.0
OH 44068 4.0
OH 44070 1.0
OH 44072 1.0
OH 44073 1.0
OH 44074 1.0
OH 44076 10.4
OH 44077 1.0
OH 44080 7.1
OH 44081 1.0
OH 44082 5.0
OH 44084 2.0
OH 44085 2.0
OH 44086 2.0
OH 44087 1.0
OH 44088 4.2
OH 44089 1.0
OH 44090 7.1
OH 44092 1.0
OH 44093 10.5
OH 44094 1.0
OH 44095 1.0
OH 44096 1.0
OH 44097 1.0
OH 44099 10.4
OH 44101 1.0
OH 44102 1.0
OH 44103 1.0
OH 44104 1.0
OH 44105 1.0
OH 44106 1.0
OH 44107 1.0
OH 44108 1.0
OH 44109 1.0
OH 44110 1.0
OH 44111 1.0
OH 44112 1.0
OH 44113 1.0
OH 44114 1.0
OH 44115 1.0
OH 44116 1.0
OH 44117 1.0
OH 44118 1.0
OH 44119 1.0
OH 44120 1.0
OH 44121 1.0
OH 44122 1.0
OH 44123 1.0
OH 44124 1.0
OH 44125 1.0
OH 44126 1.0
OH 44127 1.0
OH 44128 1.0
OH 44129 1.0
OH 44130 1.0
OH 44131 1.0
OH 44132 1.0
OH 44133 1.0
OH 44134 1.0
OH 44135 1.0
OH 44136 1.0
OH 44137 1.0
OH 44138 1.0
OH 44139 1.0
OH 44140 1.0
OH 44141 1.0
OH 44142 1.0
OH 44143 1.0
OH 44144 1.0
OH 44145 1.0
OH 44146 1.0
OH 44147 1.0
OH 44149 1.0
OH 44178 1.0
OH 44181 1.0
OH 44185 1.0
OH 44188 1.0
OH 44189 1.0
OH 44190 1.0
OH 44191 1.0
OH 44192 1.0
OH 44193 1.0
OH 44194 1.0
OH 44195 1.0
OH 44197 1.0
OH 44198 1.0
OH 44199 1.0
OH 44201 2.1
OH 44202 1.0
OH 44203 1.0
OH 44210 1.0
OH 44211 1.0
OH 44212 1.0
OH 44214 6.0
OH 44215 4.1
OH 44216 1.0
OH 44217 3.0
OH 44221 1.0
OH 44222 1.0
OH 44223 1.0
OH 44224 1.0
OH 44230 1.0
OH 44231 2.0
OH 44232 1.0
OH 44233 2.0
OH 44234 2.0
OH 44235 3.0
OH 44236 1.0
OH 44237 1.0
OH 44240 1.0
OH 44241 1.0
OH 44242 1.0
OH 44243 1.0
OH 44250 1.0
OH 44251 3.0
OH 44253 2.0
OH 44254 5.0
OH 44255 2.0
OH 44256 4.1
OH 44258 4.1
OH 44260 1.0
OH 44262 1.0
OH 44264 1.0
OH 44265 2.1
OH 44266 1.0
OH 44270 2.0
OH 44272 2.1
OH 44273 3.0
OH 44274 1.0
OH 44275 3.0
OH 44276 10.5
OH 44278 1.0
OH 44280 2.0
OH 44281 1.0
OH 44282 1.0
OH 44285 1.0
OH 44286 1.0
OH 44287 6.0
OH 44288 2.0
OH 44301 1.0
OH 44302 1.0
OH 44303 1.0
OH 44304 1.0
OH 44305 1.0
OH 44306 1.0
OH 44307 1.0
OH 44308 1.0
OH 44309 1.0
OH 44310 1.0
OH 44311 1.0
OH 44312 1.0
OH 44313 1.0
OH 44314 1.0
OH 44315 1.0
OH 44316 1.0
OH 44317 1.0
OH 44319 1.0
OH 44320 1.0
OH 44321 1.0
OH 44322 1.0
OH 44325 1.0
OH 44326 1.0
OH 44328 1.0
OH 44333 1.0
OH 44334 1.0
OH 44372 1.0
OH 44393 1.0
OH 44396 1.0
OH 44398 1.0
OH 44399 1.0
OH 44401 2.0
OH 44402 2.0
OH 44403 2.0
OH 44404 2.0
OH 44405 1.0
OH 44406 1.0
OH 44408 3.0
OH 44410 1.0
OH 44411 2.1
OH 44412 2.1
OH 44413 9.1
OH 44415 9.1
OH 44416 2.0
OH 44417 2.0
OH 44418 2.0
OH 44420 1.0
OH 44422 1.0
OH 44423 10.6
OH 44424 2.0
OH 44425 1.0
OH 44427 10.1
OH 44428 2.0
OH 44429 2.1
OH 44430 1.0
OH 44431 3.0
OH 44432 9.1
OH 44436 2.0
OH 44437 1.0
OH 44438 1.0
OH 44439 7.1
OH 44440 1.0
OH 44441 6.0
OH 44442 1.0
OH 44443 1.0
OH 44444 1.0
OH 44445 3.0
OH 44446 1.0
OH 44449 2.1
OH 44450 2.0
OH 44451 2.0
OH 44452 2.0
OH 44453 2.0
OH 44454 1.0
OH 44455 9.1
OH 44460 4.2
OH 44470 2.0
OH 44471 1.0
OH 44473 2.0
OH 44481 2.0
OH 44482 2.0
OH 44483 1.0
OH 44484 1.0
OH 44485 1.0
OH 44486 2.0
OH 44487 2.0
OH 44488 2.0
OH 44490 3.0
OH 44491 9.1
OH 44492 9.1
OH 44493 10.6
OH 44501 1.0
OH 44502 1.0
OH 44503 1.0
OH 44504 1.0
OH 44505 1.0
OH 44506 1.0
OH 44507 1.0
OH 44509 1.0
OH 44510 1.0
OH 44511 1.0
OH 44512 1.0
OH 44513 1.0
OH 44514 1.0
OH 44515 1.0
OH 44555 1.0
OH 44598 1.0
OH 44599 1.0
OH 44601 4.2
OH 44606 5.0
OH 44607 10.1
OH 44608 2.0
OH 44609 4.2
OH 44610 10.5
OH 44611 6.0
OH 44612 2.0
OH 44613 2.0
OH 44614 1.0
OH 44615 7.1
OH 44617 10.0
OH 44618 10.4
OH 44619 4.2
OH 44620 2.0
OH 44621 4.0
OH 44622 4.0
OH 44624 10.0
OH 44625 10.6
OH 44626 2.0
OH 44627 10.5
OH 44628 9.0
OH 44629 5.0
OH 44630 1.0
OH 44631 7.1
OH 44632 1.0
OH 44633 10.6
OH 44634 5.0
OH 44636 10.4
OH 44637 9.0
OH 44638 6.0
OH 44639 4.0
OH 44640 4.2
OH 44641 1.0
OH 44643 2.0
OH 44644 2.0
OH 44645 2.0
OH 44646 1.0
OH 44647 1.0
OH 44648 1.0
OH 44650 4.2
OH 44651 3.0
OH 44652 1.0
OH 44653 4.0
OH 44654 10.5
OH 44656 5.2
OH 44657 7.1
OH 44659 10.0
OH 44660 10.5
OH 44661 6.0
OH 44662 2.0
OH 44663 4.0
OH 44665 4.2
OH 44666 2.1
OH 44667 7.4
OH 44669 2.0
OH 44670 2.0
OH 44671 5.2
OH 44672 4.2
OH 44675 2.0
OH 44676 5.0
OH 44677 4.0
OH 44678 5.2
OH 44679 4.0
OH 44680 4.0
OH 44681 10.5
OH 44682 5.0
OH 44683 4.0
OH 44685 1.0
OH 44687 10.5
OH 44688 2.0
OH 44689 10.0
OH 44690 10.0
OH 44691 4.0
OH 44693 5.0
OH 44695 6.0
OH 44697 2.0
OH 44699 5.0
OH 44701 1.0
OH 44702 1.0
OH 44703 1.0
OH 44704 1.0
OH 44705 1.0
OH 44706 1.0
OH 44707 1.0
OH 44708 1.0
OH 44709 1.0
OH 44710 1.0
OH 44711 1.0
OH 44712 1.0
OH 44714 1.0
OH 44718 1.0
OH 44720 1.0
OH 44721 1.0
OH 44730 1.0
OH 44735 1.0
OH 44750 1.0
OH 44760 1.0
OH 44767 1.0
OH 44798 1.0
OH 44799 1.0
OH 44802 6.0
OH 44804 4.0
OH 44805 4.0
OH 44807 6.0
OH 44809 4.0
OH 44811 7.3
OH 44813 2.0
OH 44814 2.0
OH 44815 6.0
OH 44816 2.0
OH 44817 6.0
OH 44818 6.0
OH 44820 4.0
OH 44822 2.0
OH 44824 1.0
OH 44825 6.0
OH 44826 6.1
OH 44827 4.2
OH 44828 7.3
OH 44830 4.0
OH 44833 4.2
OH 44836 6.0
OH 44837 6.0
OH 44838 4.0
OH 44839 1.0
OH 44840 5.0
OH 44841 6.0
OH 44842 7.0
OH 44843 2.0
OH 44844 8.0
OH 44845 8.0
OH 44846 2.0
OH 44847 4.2
OH 44848 4.0
OH 44849 8.4
OH 44850 3.0
OH 44851 10.5
OH 44853 6.0
OH 44854 10.5
OH 44855 5.0
OH 44856 4.2
OH 44857 4.2
OH 44859 5.0
OH 44860 8.4
OH 44861 4.0
OH 44862 1.0
OH 44864 6.0
OH 44865 3.0
OH 44866 6.0
OH 44867 5.0
OH 44870 1.0
OH 44871 1.0
OH 44874 4.0
OH 44875 4.1
OH 44878 2.0
OH 44880 6.0
OH 44881 4.0
OH 44882 8.0
OH 44883 4.0
OH 44887 10.5
OH 44888 4.0
OH 44889 2.0
OH 44890 4.0
OH 44901 1.0
OH 44902 1.0
OH 44903 1.0
OH 44904 1.0
OH 44905 1.0
OH 44906 1.0
OH 44907 1.0
OH 44999 1.0
OH 45001 1.0
OH 45002 1.0
OH 45003 6.0
OH 45004 1.0
OH 45005 1.0
OH 45011 1.0
OH 45012 1.0
OH 45013 1.0
OH 45014 1.0
OH 45015 1.0
OH 45018 1.0
OH 45025 1.0
OH 45026 1.0
OH 45030 1.0
OH 45032 2.0
OH 45033 1.0
OH 45034 1.0
OH 45036 2.0
OH 45039 1.0
OH 45040 1.0
OH 45041 1.0
OH 45042 1.0
OH 45043 1.0
OH 45044 1.0
OH 45050 1.0
OH 45051 1.0
OH 45052 1.0
OH 45053 2.0
OH 45054 2.0
OH 45055 1.0
OH 45056 4.2
OH 45061 1.0
OH 45062 1.0
OH 45063 1.0
OH 45064 2.0
OH 45065 1.0
OH 45066 1.0
OH 45067 1.0
OH 45068 2.0
OH 45069 1.0
OH 45070 9.1
OH 45071 1.0
OH 45073 1.0
OH 45099 1.0
OH 45101 4.0
OH 45102 1.0
OH 45103 1.0
OH 45105 10.4
OH 45106 2.0
OH 45107 2.0
OH 45110 2.0
OH 45111 1.0
OH 45112 2.0
OH 45113 5.2
OH 45114 2.0
OH 45115 2.0
OH 45118 2.0
OH 45119 2.0
OH 45120 2.0
OH 45121 7.1
OH 45122 2.0
OH 45123 7.4
OH 45130 2.0
OH 45131 7.1
OH 45132 6.0
OH 45133 8.0
OH 45135 6.0
OH 45138 5.0
OH 45140 1.0
OH 45142 6.0
OH 45144 10.4
OH 45145 2.0
OH 45146 5.2
OH 45147 1.0
OH 45148 5.2
OH 45150 1.0
OH 45152 2.0
OH 45153 2.0
OH 45154 2.0
OH 45155 8.0
OH 45156 2.0
OH 45157 1.0
OH 45158 2.0
OH 45159 5.0
OH 45160 2.0
OH 45162 2.0
OH 45164 4.0
OH 45165 7.4
OH 45166 5.0
OH 45167 10.4
OH 45168 2.0
OH 45169 5.0
OH 45171 2.0
OH 45172 8.0
OH 45174 1.0
OH 45176 2.0
OH 45177 4.0
OH 45201 1.0
OH 45202 1.0
OH 45203 1.0
OH 45204 1.0
OH 45205 1.0
OH 45206 1.0
OH 45207 1.0
OH 45208 1.0
OH 45209 1.0
OH 45210 1.0
OH 45211 1.0
OH 45212 1.0
OH 45213 1.0
OH 45214 1.0
OH 45215 1.0
OH 45216 1.0
OH 45217 1.0
OH 45218 1.0
OH 45219 1.0
OH 45220 1.0
OH 45221 1.0
OH 45222 1.0
OH 45223 1.0
OH 45224 1.0
OH 45225 1.0
OH 45226 1.0
OH 45227 1.0
OH 45228 1.0
OH 45229 1.0
OH 45230 1.0
OH 45231 1.0
OH 45232 1.0
OH 45233 1.0
OH 45234 1.0
OH 45235 1.0
OH 45236 1.0
OH 45237 1.0
OH 45238 1.0
OH 45239 1.0
OH 45240 1.0
OH 45241 1.0
OH 45242 1.0
OH 45243 1.0
OH 45244 1.0
OH 45245 1.0
OH 45246 1.0
OH 45247 1.0
OH 45248 1.0
OH 45249 1.0
OH 45250 1.0
OH 45251 1.0
OH 45252 1.0
OH 45253 1.0
OH 45254 1.0
OH 45255 1.0
OH 45258 1.0
OH 45262 1.0
OH 45263 1.0
OH 45264 1.0
OH 45267 1.0
OH 45268 1.0
OH 45269 1.0
OH 45270 1.0
OH 45271 1.0
OH 45273 1.0
OH 45274 1.0
OH 45275 1.0
OH 45277 1.0
OH 45280 1.0
OH 45296 1.0
OH 45298 1.0
OH 45299 1.0
OH 45301 1.0
OH 45302 6.0
OH 45303 5.0
OH 45304 2.0
OH 45305 1.0
OH 45306 6.0
OH 45307 2.0
OH 45308 3.0
OH 45309 2.0
OH 45310 10.5
OH 45311 9.1
OH 45312 2.0
OH 45314 7.1
OH 45315 1.0
OH 45316 2.0
OH 45317 2.0
OH 45318 2.0
OH 45319 2.0
OH 45320 7.3
OH 45321 3.0
OH 45322 1.0
OH 45323 1.0
OH 45324 1.0
OH 45325 2.0
OH 45326 2.0
OH 45327 1.0
OH 45328 3.0
OH 45330 2.0
OH 45331 4.2
OH 45332 5.0
OH 45333 5.0
OH 45334 6.0
OH 45335 2.0
OH 45336 6.0
OH 45337 2.0
OH 45338 2.0
OH 45339 2.0
OH 45340 6.0
OH 45341 1.0
OH 45342 1.0
OH 45343 1.0
OH 45344 2.0
OH 45345 2.0
OH 45346 5.0
OH 45347 5.2
OH 45348 10.5
OH 45349 1.0
OH 45350 10.5
OH 45351 10.5
OH 45352 4.2
OH 45353 4.0
OH 45354 2.0
OH 45356 4.2
OH 45358 2.0
OH 45359 2.0
OH 45360 4.0
OH 45361 2.0
OH 45362 10.5
OH 45363 5.0
OH 45365 4.0
OH 45367 4.0
OH 45368 2.0
OH 45369 2.0
OH 45370 2.0
OH 45371 1.0
OH 45372 1.0
OH 45373 1.0
OH 45374 1.0
OH 45377 1.0
OH 45378 2.0
OH 45380 7.4
OH 45381 2.0
OH 45382 3.0
OH 45383 1.0
OH 45384 1.0
OH 45385 1.0
OH 45387 2.0
OH 45388 10.5
OH 45389 2.0
OH 45390 7.4
OH 45401 1.0
OH 45402 1.0
OH 45403 1.0
OH 45404 1.0
OH 45405 1.0
OH 45406 1.0
OH 45407 1.0
OH 45408 1.0
OH 45409 1.0
OH 45410 1.0
OH 45412 1.0
OH 45413 1.0
OH 45414 1.0
OH 45415 1.0
OH 45416 1.0
OH 45417 1.0
OH 45418 1.0
OH 45419 1.0
OH 45420 1.0
OH 45422 1.0
OH 45423 1.0
OH 45424 1.0
OH 45426 1.0
OH 45427 1.0
OH 45428 1.0
OH 45429 1.0
OH 45430 1.0
OH 45431 1.0
OH 45432 1.0
OH 45433 1.0
OH 45434 1.0
OH 45435 1.0
OH 45437 1.0
OH 45439 1.0
OH 45440 1.0
OH 45441 1.0
OH 45448 1.0
OH 45449 1.0
OH 45454 1.0
OH 45458 1.0
OH 45459 1.0
OH 45463 1.0
OH 45469 1.0
OH 45470 1.0
OH 45475 1.0
OH 45479 1.0
OH 45481 1.0
OH 45482 1.0
OH 45490 1.0
OH 45501 1.0
OH 45502 1.0
OH 45503 1.0
OH 45504 1.0
OH 45505 1.0
OH 45506 1.0
OH 45601 4.0
OH 45612 5.0
OH 45613 8.0
OH 45614 5.0
OH 45616 9.0
OH 45617 4.0
OH 45618 8.1
OH 45619 1.0
OH 45620 5.0
OH 45621 7.0
OH 45622 10.5
OH 45623 5.0
OH 45624 5.0
OH 45628 5.0
OH 45629 5.2
OH 45630 5.0
OH 45631 5.0
OH 45633 5.2
OH 45634 10.0
OH 45636 5.2
OH 45638 1.0
OH 45640 7.0
OH 45642 8.0
OH 45643 5.0
OH 45644 5.2
OH 45645 2.0
OH 45646 8.0
OH 45647 5.0
OH 45648 5.0
OH 45650 9.0
OH 45651 10.0
OH 45652 5.0
OH 45653 5.0
OH 45654 10.5
OH 45656 9.0
OH 45657 5.0
OH 45658 5.0
OH 45659 2.0
OH 45660 10.4
OH 45661 8.0
OH 45662 4.0
OH 45663 5.0
OH 45669 1.0
OH 45671 5.0
OH 45672 9.2
OH 45673 5.0
OH 45674 5.0
OH 45675 1.0
OH 45677 4.0
OH 45678 2.0
OH 45679 10.4
OH 45680 1.0
OH 45681 6.0
OH 45682 5.0
OH 45683 8.0
OH 45684 5.0
OH 45685 5.0
OH 45686 6.0
OH 45687 5.0
OH 45688 2.0
OH 45690 7.4
OH 45692 7.0
OH 45693 7.3
OH 45694 4.0
OH 45695 10.5
OH 45696 2.0
OH 45697 8.1
OH 45698 10.0
OH 45699 5.0
OH 45701 4.0
OH 45710 5.0
OH 45711 5.0
OH 45712 2.0
OH 45713 2.0
OH 45714 1.0
OH 45715 2.0
OH 45716 7.4
OH 45717 7.4
OH 45719 4.0
OH 45720 3.0
OH 45721 2.0
OH 45723 2.0
OH 45724 2.0
OH 45727 8.3
OH 45729 2.0
OH 45732 5.0
OH 45734 10.0
OH 45735 5.0
OH 45739 2.0
OH 45740 5.0
OH 45741 6.0
OH 45742 2.0
OH 45743 3.0
OH 45744 2.0
OH 45745 2.0
OH 45746 2.0
OH 45750 1.0
OH 45760 7.4
OH 45761 4.0
OH 45764 7.4
OH 45766 5.0
OH 45767 2.0
OH 45768 2.0
OH 45769 9.2
OH 45770 10.6
OH 45771 10.6
OH 45772 3.0
OH 45773 2.0
OH 45775 6.0
OH 45776 9.2
OH 45777 5.0
OH 45778 5.0
OH 45779 10.6
OH 45780 4.0
OH 45782 5.0
OH 45783 2.0
OH 45784 2.0
OH 45786 10.1
OH 45787 10.1
OH 45788 2.0
OH 45789 2.0
OH 45801 1.0
OH 45802 1.0
OH 45804 1.0
OH 45805 1.0
OH 45806 1.0
OH 45807 1.0
OH 45808 1.0
OH 45809 1.0
OH 45810 7.3
OH 45812 9.0
OH 45813 10.4
OH 45814 5.0
OH 45815 10.6
OH 45816 4.0
OH 45817 7.3
OH 45819 4.2
OH 45820 1.0
OH 45821 10.4
OH 45822 4.0
OH 45826 4.0
OH 45827 9.0
OH 45828 4.0
OH 45830 3.0
OH 45831 9.0
OH 45832 5.0
OH 45833 7.1
OH 45835 9.0
OH 45836 9.0
OH 45837 9.0
OH 45838 5.0
OH 45839 4.0
OH 45840 4.0
OH 45841 5.0
OH 45843 9.0
OH 45844 10.4
OH 45845 6.0
OH 45846 10.5
OH 45848 7.3
OH 45849 10.5
OH 45850 2.0
OH 45851 10.4
OH 45853 10.4
OH 45854 1.0
OH 45855 7.0
OH 45856 10.6
OH 45858 5.0
OH 45859 9.0
OH 45860 10.5
OH 45861 10.5
OH 45862 10.5
OH 45863 5.0
OH 45864 10.6
OH 45865 7.0
OH 45866 4.0
OH 45867 5.0
OH 45868 5.0
OH 45869 7.0
OH 45870 4.2
OH 45871 10.0
OH 45872 9.2
OH 45873 10.5
OH 45874 5.0
OH 45875 7.3
OH 45876 10.4
OH 45877 10.6
OH 45879 7.0
OH 45880 10.4
OH 45881 5.0
OH 45882 10.5
OH 45883 10.5
OH 45884 4.2
OH 45885 7.0
OH 45886 5.0
OH 45887 2.0
OH 45888 4.2
OH 45889 5.0
OH 45890 5.0
OH 45891 4.0
OH 45893 3.0
OH 45894 5.0
OH 45895 4.2
OH 45896 2.0
OH 45897 9.0
OH 45898 5.0
OH 45899 5.0
OH 45944 1.0
OH 45950 1.0
OH 45999 1.0
OK 73001 10.6
OK 73002 10.5
OK 73003 1.0
OK 73004 2.0
OK 73005 7.0
OK 73006 10.1
OK 73007 2.0
OK 73008 1.0
OK 73009 10.4
OK 73010 2.0
OK 73011 10.5
OK 73013 1.0
OK 73014 2.0
OK 73015 10.0
OK 73016 2.0
OK 73017 10.4
OK 73018 4.0
OK 73019 1.1
OK 73020 1.0
OK 73021 10.6
OK 73022 4.1
OK 73023 4.0
OK 73024 10.6
OK 73026 2.1
OK 73027 2.0
OK 73028 2.0
OK 73029 10.4
OK 73030 10.6
OK 73031 2.0
OK 73032 10.6
OK 73033 10.6
OK 73034 1.0
OK 73036 4.1
OK 73038 10.6
OK 73039 10.6
OK 73040 10.4
OK 73041 10.0
OK 73042 8.0
OK 73043 10.6
OK 73044 2.0
OK 73045 2.0
OK 73047 10.4
OK 73048 10.6
OK 73049 2.0
OK 73050 2.0
OK 73051 2.1
OK 73052 7.0
OK 73053 10.4
OK 73054 2.0
OK 73055 7.4
OK 73056 2.0
OK 73057 10.6
OK 73058 2.0
OK 73059 2.0
OK 73061 10.5
OK 73062 10.0
OK 73063 2.0
OK 73064 1.0
OK 73065 2.0
OK 73066 1.0
OK 73067 10.5
OK 73068 1.1
OK 73069 1.1
OK 73070 1.1
OK 73071 1.1
OK 73072 1.1
OK 73073 2.0
OK 73074 8.0
OK 73075 7.0
OK 73077 7.0
OK 73078 2.0
OK 73079 2.0
OK 73080 7.3
OK 73082 10.5
OK 73083 1.0
OK 73084 1.0
OK 73085 1.0
OK 73086 7.0
OK 73089 2.0
OK 73090 4.1
OK 73092 5.0
OK 73093 3.0
OK 73094 7.0
OK 73095 3.0
OK 73096 7.0
OK 73097 1.0
OK 73098 10.6
OK 73099 1.0
OK 73101 1.0
OK 73102 1.0
OK 73103 1.0
OK 73104 1.0
OK 73105 1.0
OK 73106 1.0
OK 73107 1.0
OK 73108 1.0
OK 73109 1.0
OK 73110 1.0
OK 73111 1.0
OK 73112 1.0
OK 73113 1.0
OK 73114 1.0
OK 73115 1.0
OK 73116 1.0
OK 73117 1.0
OK 73118 1.0
OK 73119 1.0
OK 73120 1.0
OK 73121 1.0
OK 73122 1.0
OK 73123 1.0
OK 73124 1.0
OK 73125 1.0
OK 73126 1.0
OK 73127 1.0
OK 73128 1.0
OK 73129 1.0
OK 73130 1.0
OK 73131 1.0
OK 73132 1.0
OK 73134 1.0
OK 73135 1.0
OK 73136 1.0
OK 73137 1.0
OK 73139 1.0
OK 73140 1.0
OK 73141 1.0
OK 73142 1.0
OK 73143 1.0
OK 73144 1.0
OK 73145 1.0
OK 73146 1.0
OK 73147 1.0
OK 73148 1.0
OK 73149 1.0
OK 73150 1.0
OK 73151 2.0
OK 73152 1.0
OK 73153 1.0
OK 73154 1.0
OK 73155 1.0
OK 73156 1.0
OK 73157 1.0
OK 73159 1.0
OK 73160 1.0
OK 73162 1.0
OK 73163 1.0
OK 73164 1.0
OK 73165 2.0
OK 73167 1.0
OK 73169 1.0
OK 73170 1.0
OK 73172 1.0
OK 73173 2.0
OK 73178 1.0
OK 73179 1.0
OK 73184 1.0
OK 73185 1.0
OK 73189 1.0
OK 73190 1.0
OK 73193 1.0
OK 73194 1.0
OK 73195 1.0
OK 73196 1.0
OK 73197 1.0
OK 73198 1.0
OK 73199 1.0
OK 73401 4.0
OK 73402 4.0
OK 73403 4.0
OK 73425 4.0
OK 73430 10.0
OK 73432 9.0
OK 73433 10.6
OK 73434 10.6
OK 73435 10.5
OK 73436 5.0
OK 73437 10.5
OK 73438 10.5
OK 73439 10.6
OK 73440 10.6
OK 73441 10.0
OK 73442 5.0
OK 73443 5.0
OK 73444 5.0
OK 73446 7.0
OK 73447 9.2
OK 73448 10.5
OK 73449 5.0
OK 73450 9.0
OK 73453 10.0
OK 73455 9.2
OK 73456 10.5
OK 73458 5.0
OK 73459 10.0
OK 73460 7.0
OK 73461 9.0
OK 73463 10.5
OK 73476 10.6
OK 73481 10.5
OK 73487 5.0
OK 73488 10.5
OK 73491 4.0
OK 73501 1.0
OK 73502 1.0
OK 73503 1.0
OK 73505 1.0
OK 73506 1.0
OK 73507 1.0
OK 73520 10.5
OK 73521 4.0
OK 73522 4.0
OK 73523 4.0
OK 73526 5.0
OK 73527 2.0
OK 73528 2.0
OK 73529 5.0
OK 73530 10.6
OK 73531 10.4
OK 73532 5.0
OK 73533 4.0
OK 73534 4.0
OK 73536 4.0
OK 73537 5.0
OK 73538 2.0
OK 73539 5.0
OK 73540 2.0
OK 73541 2.0
OK 73542 7.0
OK 73543 2.0
OK 73544 10.0
OK 73546 10.4
OK 73547 10.5
OK 73548 10.5
OK 73549 5.0
OK 73550 10.0
OK 73551 10.6
OK 73552 2.0
OK 73553 10.4
OK 73554 7.4
OK 73555 7.0
OK 73556 4.0
OK 73557 2.0
OK 73558 1.0
OK 73559 10.5
OK 73560 5.0
OK 73561 10.0
OK 73562 10.4
OK 73564 10.5
OK 73565 10.0
OK 73566 10.5
OK 73567 2.0
OK 73568 10.4
OK 73569 10.0
OK 73570 10.5
OK 73571 10.0
OK 73572 7.1
OK 73573 10.5
OK 73601 7.0
OK 73620 7.0
OK 73622 10.6
OK 73624 10.6
OK 73625 10.6
OK 73626 10.6
OK 73627 7.0
OK 73628 10.6
OK 73632 7.0
OK 73638 10.6
OK 73639 10.6
OK 73641 10.6
OK 73642 10.6
OK 73644 7.0
OK 73645 10.6
OK 73646 10.0
OK 73647 10.6
OK 73648 7.0
OK 73650 10.6
OK 73651 7.0
OK 73654 10.0
OK 73655 10.5
OK 73658 10.0
OK 73659 10.0
OK 73660 10.6
OK 73661 10.6
OK 73662 7.0
OK 73663 10.0
OK 73664 10.6
OK 73666 10.6
OK 73667 10.0
OK 73668 10.6
OK 73669 10.6
OK 73673 10.5
OK 73701 4.0
OK 73702 4.0
OK 73703 4.0
OK 73705 4.0
OK 73706 4.0
OK 73716 10.5
OK 73717 7.0
OK 73718 10.2
OK 73719 10.0
OK 73720 5.0
OK 73722 10.0
OK 73724 10.6
OK 73726 10.5
OK 73727 5.0
OK 73728 10.0
OK 73729 10.2
OK 73730 5.0
OK 73731 10.6
OK 73733 5.0
OK 73734 8.0
OK 73735 5.0
OK 73736 4.0
OK 73737 10.0
OK 73738 5.0
OK 73739 10.5
OK 73741 10.5
OK 73742 10.5
OK 73743 5.0
OK 73744 10.6
OK 73746 10.6
OK 73747 10.0
OK 73749 10.0
OK 73750 7.0
OK 73753 5.0
OK 73754 4.0
OK 73755 10.6
OK 73756 8.0
OK 73757 8.0
OK 73758 10.0
OK 73759 10.0
OK 73760 10.2
OK 73761 10.5
OK 73762 2.0
OK 73763 10.0
OK 73764 8.0
OK 73766 10.5
OK 73768 10.2
OK 73770 10.0
OK 73771 10.0
OK 73772 7.0
OK 73773 5.0
OK 73801 4.0
OK 73802 4.0
OK 73832 10.0
OK 73834 10.0
OK 73835 10.5
OK 73838 10.0
OK 73840 10.5
OK 73841 5.0
OK 73842 7.0
OK 73843 10.5
OK 73844 5.0
OK 73847 5.0
OK 73848 10.0
OK 73851 10.0
OK 73852 10.2
OK 73853 5.0
OK 73855 10.0
OK 73857 5.0
OK 73858 10.5
OK 73859 10.5
OK 73860 10.6
OK 73901 10.2
OK 73931 10.0
OK 73932 10.0
OK 73933 10.0
OK 73937 10.0
OK 73938 5.0
OK 73939 10.2
OK 73942 4.0
OK 73944 10.2
OK 73945 10.2
OK 73946 10.0
OK 73947 10.0
OK 73949 10.5
OK 73950 5.0
OK 73951 10.2
OK 74001 3.0
OK 74002 3.0
OK 74003 4.0
OK 74004 4.0
OK 74005 4.0
OK 74006 4.0
OK 74008 1.0
OK 74009 7.0
OK 74010 7.1
OK 74011 1.0
OK 74012 1.0
OK 74013 1.0
OK 74014 1.0
OK 74015 1.0
OK 74016 2.0
OK 74017 4.1
OK 74018 4.1
OK 74019 4.1
OK 74020 2.0
OK 74021 2.0
OK 74022 5.0
OK 74023 7.4
OK 74026 9.0
OK 74027 10.5
OK 74028 2.0
OK 74029 4.0
OK 74030 2.0
OK 74031 4.1
OK 74032 5.0
OK 74033 2.0
OK 74034 2.0
OK 74035 7.3
OK 74036 2.0
OK 74037 1.0
OK 74038 2.0
OK 74039 2.0
OK 74041 2.0
OK 74042 10.5
OK 74043 1.0
OK 74044 2.0
OK 74045 10.0
OK 74046 2.0
OK 74047 2.0
OK 74048 7.4
OK 74050 1.0
OK 74051 2.0
OK 74052 2.0
OK 74053 2.0
OK 74054 7.3
OK 74055 2.0
OK 74056 7.0
OK 74058 10.5
OK 74059 5.0
OK 74060 2.0
OK 74061 2.0
OK 74062 7.4
OK 74063 1.0
OK 74066 1.0
OK 74067 1.0
OK 74068 2.0
OK 74070 2.0
OK 74071 7.1
OK 74072 4.0
OK 74073 1.0
OK 74074 4.0
OK 74075 4.0
OK 74076 4.0
OK 74077 4.0
OK 74078 4.0
OK 74079 10.6
OK 74080 2.0
OK 74081 2.0
OK 74082 2.0
OK 74083 4.0
OK 74084 7.3
OK 74085 6.0
OK 74101 1.0
OK 74102 1.0
OK 74103 1.0
OK 74104 1.0
OK 74105 1.0
OK 74106 1.0
OK 74107 1.0
OK 74108 1.0
OK 74110 1.0
OK 74112 1.0
OK 74114 1.0
OK 74115 1.0
OK 74116 1.0
OK 74117 2.0
OK 74119 1.0
OK 74120 1.0
OK 74121 1.0
OK 74126 1.0
OK 74127 1.0
OK 74128 1.0
OK 74129 1.0
OK 74130 1.0
OK 74131 1.0
OK 74132 1.0
OK 74133 1.0
OK 74134 1.0
OK 74135 1.0
OK 74136 1.0
OK 74137 1.0
OK 74141 1.0
OK 74145 1.0
OK 74146 1.0
OK 74147 1.0
OK 74148 1.0
OK 74149 1.0
OK 74150 1.0
OK 74152 1.0
OK 74153 1.0
OK 74155 1.0
OK 74156 1.0
OK 74157 1.0
OK 74158 1.0
OK 74159 1.0
OK 74169 1.0
OK 74170 1.0
OK 74171 1.0
OK 74172 1.0
OK 74182 1.0
OK 74183 1.0
OK 74184 1.0
OK 74186 1.0
OK 74187 1.0
OK 74189 1.0
OK 74192 1.0
OK 74193 1.0
OK 74194 1.0
OK 74301 7.0
OK 74330 10.3
OK 74331 6.0
OK 74332 8.0
OK 74333 10.6
OK 74335 4.0
OK 74337 10.6
OK 74338 5.0
OK 74339 4.0
OK 74340 10.6
OK 74342 10.0
OK 74343 10.5
OK 74344 7.0
OK 74345 7.0
OK 74346 10.6
OK 74347 6.0
OK 74349 7.0
OK 74350 10.6
OK 74352 10.6
OK 74354 4.0
OK 74355 4.0
OK 74358 4.0
OK 74359 6.0
OK 74360 5.0
OK 74361 7.0
OK 74362 7.0
OK 74363 5.0
OK 74364 6.0
OK 74365 10.6
OK 74366 10.6
OK 74367 10.6
OK 74368 6.0
OK 74369 10.6
OK 74370 10.5
OK 74401 4.0
OK 74402 4.0
OK 74403 4.0
OK 74421 2.0
OK 74422 2.0
OK 74423 5.0
OK 74425 5.0
OK 74426 7.0
OK 74427 5.0
OK 74428 10.6
OK 74429 1.0
OK 74430 5.0
OK 74431 7.4
OK 74432 10.5
OK 74434 5.0
OK 74435 10.6
OK 74436 2.0
OK 74437 7.4
OK 74438 10.6
OK 74440 10.6
OK 74441 10.5
OK 74442 5.0
OK 74444 4.0
OK 74445 2.0
OK 74446 7.3
OK 74447 4.2
OK 74450 5.0
OK 74451 5.0
OK 74452 6.0
OK 74454 2.0
OK 74455 5.0
OK 74456 4.2
OK 74457 5.0
OK 74458 2.0
OK 74459 7.0
OK 74460 7.4
OK 74461 10.0
OK 74462 7.0
OK 74463 5.0
OK 74464 4.0
OK 74465 4.0
OK 74467 7.3
OK 74468 5.0
OK 74469 5.0
OK 74470 5.0
OK 74471 5.0
OK 74472 10.6
OK 74477 7.3
OK 74501 4.0
OK 74502 4.0
OK 74521 9.0
OK 74522 4.0
OK 74523 10.0
OK 74525 8.0
OK 74528 5.0
OK 74529 6.0
OK 74530 9.0
OK 74531 10.5
OK 74533 8.0
OK 74534 5.0
OK 74535 5.0
OK 74536 10.0
OK 74538 10.6
OK 74540 9.0
OK 74542 8.0
OK 74543 10.0
OK 74545 7.0
OK 74546 5.0
OK 74547 5.0
OK 74549 10.0
OK 74552 10.6
OK 74553 5.0
OK 74554 4.0
OK 74555 8.0
OK 74556 10.6
OK 74557 10.0
OK 74558 10.0
OK 74559 7.0
OK 74560 5.0
OK 74561 6.0
OK 74562 10.0
OK 74563 8.0
OK 74565 4.0
OK 74567 10.0
OK 74569 9.0
OK 74570 10.5
OK 74571 10.0
OK 74572 5.0
OK 74574 9.0
OK 74576 9.0
OK 74577 10.0
OK 74578 7.0
OK 74601 4.0
OK 74602 4.0
OK 74603 4.0
OK 74604 4.0
OK 74630 8.0
OK 74631 7.4
OK 74632 10.6
OK 74633 10.5
OK 74636 10.0
OK 74637 5.0
OK 74640 5.0
OK 74641 5.0
OK 74643 10.0
OK 74644 10.5
OK 74646 7.4
OK 74647 10.2
OK 74650 10.0
OK 74651 10.5
OK 74652 10.5
OK 74653 7.4
OK 74701 4.0
OK 74702 4.0
OK 74720 2.0
OK 74721 5.0
OK 74722 10.6
OK 74723 5.0
OK 74724 10.6
OK 74726 5.0
OK 74727 10.6
OK 74728 7.0
OK 74729 5.0
OK 74730 5.0
OK 74731 2.0
OK 74733 2.0
OK 74734 10.6
OK 74735 10.6
OK 74736 7.0
OK 74737 7.0
OK 74738 8.0
OK 74740 10.6
OK 74741 2.0
OK 74743 7.0
OK 74745 7.0
OK 74747 2.0
OK 74748 9.0
OK 74750 10.6
OK 74752 10.6
OK 74753 5.0
OK 74754 10.6
OK 74755 10.6
OK 74756 10.6
OK 74759 10.6
OK 74760 10.6
OK 74761 10.6
OK 74764 10.6
OK 74766 10.6
OK 74801 4.2
OK 74802 4.2
OK 74804 4.2
OK 74818 7.0
OK 74820 4.0
OK 74821 4.0
OK 74824 6.1
OK 74825 5.0
OK 74826 3.0
OK 74827 10.5
OK 74829 10.4
OK 74830 9.0
OK 74831 10.5
OK 74832 6.1
OK 74833 8.0
OK 74834 7.3
OK 74836 7.0
OK 74837 7.0
OK 74839 10.0
OK 74840 4.2
OK 74842 5.0
OK 74843 5.0
OK 74844 5.0
OK 74845 10.6
OK 74848 7.0
OK 74849 10.5
OK 74850 8.0
OK 74851 2.0
OK 74852 4.2
OK 74854 9.0
OK 74855 2.0
OK 74856 9.2
OK 74857 2.0
OK 74859 7.0
OK 74860 10.4
OK 74864 10.4
OK 74865 5.0
OK 74866 9.0
OK 74867 10.6
OK 74868 7.0
OK 74869 9.0
OK 74871 5.0
OK 74872 10.5
OK 74873 4.2
OK 74875 6.1
OK 74878 3.0
OK 74880 10.6
OK 74881 2.0
OK 74883 10.0
OK 74884 7.0
OK 74901 1.0
OK 74902 2.0
OK 74930 3.0
OK 74931 8.0
OK 74932 3.0
OK 74935 8.0
OK 74936 2.0
OK 74937 7.0
OK 74939 7.0
OK 74940 7.0
OK 74941 3.0
OK 74942 8.0
OK 74943 8.0
OK 74944 8.0
OK 74945 7.3
OK 74946 2.0
OK 74947 7.3
OK 74948 2.0
OK 74949 10.0
OK 74951 3.0
OK 74953 7.3
OK 74954 2.0
OK 74955 7.3
OK 74956 3.0
OK 74957 10.6
OK 74959 2.0
OK 74960 8.0
OK 74962 10.6
OK 74963 10.6
OK 74964 5.0
OK 74965 10.5
OK 74966 8.0
OR 97001 10.5
OR 97002 2.0
OR 97004 2.0
OR 97005 1.0
OR 97006 1.0
OR 97007 1.0
OR 97008 1.0
OR 97009 1.0
OR 97010 2.0
OR 97011 2.0
OR 97013 2.0
OR 97014 10.2
OR 97015 1.0
OR 97016 10.4
OR 97017 2.0
OR 97018 4.1
OR 97019 2.0
OR 97020 2.0
OR 97021 10.5
OR 97022 2.0
OR 97023 2.0
OR 97024 1.0
OR 97026 2.0
OR 97027 1.0
OR 97028 2.0
OR 97029 10.5
OR 97030 1.0
OR 97031 4.0
OR 97032 2.0
OR 97033 10.5
OR 97034 1.0
OR 97035 1.0
OR 97036 1.0
OR 97037 10.5
OR 97038 2.0
OR 97039 10.5
OR 97040 5.0
OR 97041 10.2
OR 97042 2.0
OR 97044 5.0
OR 97045 1.0
OR 97048 1.0
OR 97049 2.0
OR 97050 10.5
OR 97051 4.1
OR 97053 4.1
OR 97054 2.0
OR 97055 2.0
OR 97056 4.1
OR 97057 10.5
OR 97058 4.0
OR 97060 1.0
OR 97062 1.0
OR 97063 10.5
OR 97064 2.0
OR 97065 10.5
OR 97067 2.0
OR 97068 1.0
OR 97070 1.0
OR 97071 2.0
OR 97075 1.0
OR 97076 1.0
OR 97077 1.0
OR 97078 1.0
OR 97080 1.0
OR 97101 5.2
OR 97102 7.4
OR 97103 4.0
OR 97106 2.0
OR 97107 8.0
OR 97108 8.0
OR 97109 2.0
OR 97110 7.4
OR 97111 2.0
OR 97112 10.6
OR 97113 1.0
OR 97114 4.2
OR 97115 2.0
OR 97116 1.0
OR 97117 2.0
OR 97118 10.3
OR 97119 2.0
OR 97121 4.0
OR 97122 10.6
OR 97123 1.0
OR 97124 1.0
OR 97125 2.0
OR 97127 2.0
OR 97128 4.2
OR 97130 10.6
OR 97131 10.6
OR 97132 2.0
OR 97133 2.0
OR 97134 7.0
OR 97135 10.6
OR 97136 10.3
OR 97137 10.4
OR 97138 7.4
OR 97140 1.0
OR 97141 7.0
OR 97143 7.0
OR 97144 2.0
OR 97145 7.4
OR 97146 4.0
OR 97147 10.3
OR 97148 2.0
OR 97149 10.6
OR 97201 1.0
OR 97202 1.0
OR 97203 1.0
OR 97204 1.0
OR 97205 1.0
OR 97206 1.0
OR 97207 1.0
OR 97208 1.0
OR 97209 1.0
OR 97210 1.0
OR 97211 1.0
OR 97212 1.0
OR 97213 1.0
OR 97214 1.0
OR 97215 1.0
OR 97216 1.0
OR 97217 1.0
OR 97218 1.0
OR 97219 1.0
OR 97220 1.0
OR 97221 1.0
OR 97222 1.0
OR 97223 1.0
OR 97224 1.0
OR 97225 1.0
OR 97227 1.0
OR 97228 1.0
OR 97229 1.0
OR 97230 1.0
OR 97231 2.0
OR 97232 1.0
OR 97233 1.0
OR 97236 1.0
OR 97238 1.0
OR 97239 1.0
OR 97240 1.0
OR 97242 1.0
OR 97251 1.0
OR 97253 1.0
OR 97254 1.0
OR 97255 1.0
OR 97256 1.0
OR 97258 1.0
OR 97259 1.0
OR 97266 1.0
OR 97267 1.0
OR 97268 1.0
OR 97269 1.0
OR 97271 1.0
OR 97272 1.0
OR 97280 1.0
OR 97281 1.0
OR 97282 1.0
OR 97283 1.0
OR 97286 1.0
OR 97290 1.0
OR 97291 1.0
OR 97292 1.0
OR 97293 1.0
OR 97294 1.0
OR 97296 1.0
OR 97298 1.0
OR 97299 1.0
OR 97301 1.0
OR 97302 1.0
OR 97303 1.0
OR 97304 1.0
OR 97305 1.0
OR 97306 1.0
OR 97307 1.0
OR 97308 1.0
OR 97309 1.0
OR 97310 1.0
OR 97311 1.0
OR 97312 1.0
OR 97313 1.0
OR 97314 1.0
OR 97321 4.2
OR 97322 4.2
OR 97324 2.0
OR 97325 2.0
OR 97326 8.0
OR 97327 10.5
OR 97329 10.5
OR 97330 1.0
OR 97331 1.0
OR 97333 1.0
OR 97335 5.0
OR 97336 7.4
OR 97338 4.1
OR 97339 1.0
OR 97341 7.0
OR 97342 2.0
OR 97343 8.0
OR 97344 10.4
OR 97345 7.4
OR 97346 2.0
OR 97347 10.4
OR 97348 2.0
OR 97350 2.0
OR 97351 4.2
OR 97352 2.0
OR 97355 4.0
OR 97357 8.0
OR 97358 3.0
OR 97359 2.0
OR 97360 3.0
OR 97361 4.2
OR 97362 4.2
OR 97364 7.0
OR 97365 7.0
OR 97366 8.0
OR 97367 7.0
OR 97368 8.0
OR 97369 7.0
OR 97370 1.0
OR 97371 10.4
OR 97372 7.0
OR 97373 4.2
OR 97374 5.0
OR 97375 6.1
OR 97376 7.0
OR 97377 2.0
OR 97378 7.4
OR 97380 8.0
OR 97381 4.2
OR 97383 2.0
OR 97384 2.0
OR 97385 2.0
OR 97386 7.4
OR 97388 7.0
OR 97389 2.0
OR 97390 7.0
OR 97391 8.0
OR 97392 2.0
OR 97394 7.0
OR 97396 7.4
OR 97401 1.0
OR 97402 1.0
OR 97403 1.0
OR 97404 1.0
OR 97405 1.0
OR 97406 10.0
OR 97407 4.0
OR 97408 1.0
OR 97409 2.0
OR 97410 10.0
OR 97411 7.4
OR 97412 10.4
OR 97413 2.0
OR 97414 10.5
OR 97415 4.0
OR 97416 5.0
OR 97417 10.5
OR 97419 2.0
OR 97420 4.0
OR 97423 7.2
OR 97424 2.0
OR 97425 10.4
OR 97426 2.0
OR 97427 2.0
OR 97428 2.0
OR 97429 10.0
OR 97430 10.4
OR 97431 2.0
OR 97432 4.0
OR 97434 2.0
OR 97435 10.4
OR 97436 10.4
OR 97437 2.0
OR 97438 2.0
OR 97439 7.0
OR 97440 1.0
OR 97441 7.4
OR 97442 10.0
OR 97443 10.2
OR 97444 10.0
OR 97446 2.0
OR 97447 10.2
OR 97448 2.0
OR 97449 5.0
OR 97450 10.0
OR 97451 2.0
OR 97452 2.0
OR 97453 10.4
OR 97454 2.0
OR 97455 2.0
OR 97456 2.0
OR 97457 5.0
OR 97458 10.5
OR 97459 4.0
OR 97461 2.0
OR 97462 5.0
OR 97463 7.3
OR 97464 10.0
OR 97465 10.0
OR 97466 10.5
OR 97467 7.4
OR 97469 10.5
OR 97470 4.0
OR 97472 2.0
OR 97473 7.4
OR 97476 10.0
OR 97477 1.0
OR 97478 1.0
OR 97479 5.0
OR 97480 10.4
OR 97481 5.0
OR 97482 1.0
OR 97484 10.0
OR 97486 5.0
OR 97487 2.0
OR 97488 2.0
OR 97489 2.0
OR 97490 2.0
OR 97491 10.0
OR 97492 7.3
OR 97493 8.0
OR 97494 4.0
OR 97495 4.0
OR 97496 4.0
OR 97497 5.0
OR 97498 10.6
OR 97499 10.5
OR 97501 1.0
OR 97502 1.0
OR 97503 1.0
OR 97504 1.0
OR 97520 1.0
OR 97522 2.0
OR 97523 10.5
OR 97524 2.0
OR 97525 2.0
OR 97526 4.2
OR 97527 4.2
OR 97528 4.2
OR 97530 2.0
OR 97531 10.5
OR 97532 5.0
OR 97533 4.2
OR 97534 10.5
OR 97535 1.0
OR 97536 2.0
OR 97537 4.2
OR 97538 5.0
OR 97539 2.0
OR 97540 1.0
OR 97541 2.0
OR 97543 5.0
OR 97544 10.2
OR 97601 4.0
OR 97602 4.0
OR 97603 4.0
OR 97604 10.4
OR 97620 10.0
OR 97621 10.5
OR 97622 10.2
OR 97623 10.2
OR 97624 10.5
OR 97625 5.0
OR 97626 10.5
OR 97627 5.0
OR 97630 7.0
OR 97632 10.5
OR 97633 5.0
OR 97634 4.0
OR 97635 7.0
OR 97636 10.0
OR 97637 10.0
OR 97638 10.0
OR 97639 10.5
OR 97640 10.0
OR 97641 10.0
OR 97701 1.0
OR 97702 1.0
OR 97707 1.0
OR 97708 1.0
OR 97709 1.0
OR 97710 10.3
OR 97711 10.6
OR 97712 2.0
OR 97720 7.0
OR 97721 10.3
OR 97722 10.3
OR 97730 10.6
OR 97731 10.4
OR 97732 7.0
OR 97733 10.4
OR 97734 10.6
OR 97735 10.0
OR 97736 10.3
OR 97737 10.4
OR 97738 7.0
OR 97739 2.0
OR 97741 7.0
OR 97750 10.0
OR 97751 5.0
OR 97752 5.0
OR 97753 4.0
OR 97754 4.0
OR 97756 4.1
OR 97758 7.0
OR 97759 10.4
OR 97760 10.6
OR 97761 10.0
OR 97801 4.0
OR 97810 10.5
OR 97812 10.0
OR 97813 10.5
OR 97814 7.0
OR 97817 10.0
OR 97818 7.4
OR 97819 8.0
OR 97820 10.0
OR 97823 10.0
OR 97824 5.0
OR 97825 10.0
OR 97826 5.0
OR 97827 10.2
OR 97828 10.0
OR 97830 10.0
OR 97833 8.0
OR 97834 10.6
OR 97835 4.0
OR 97836 10.0
OR 97837 8.0
OR 97838 4.0
OR 97839 10.0
OR 97840 10.6
OR 97841 5.0
OR 97842 10.0
OR 97843 10.0
OR 97844 7.4
OR 97845 10.0
OR 97846 10.0
OR 97848 10.0
OR 97850 4.0
OR 97856 10.0
OR 97857 10.0
OR 97859 4.0
OR 97861 10.0
OR 97862 7.4
OR 97864 10.0
OR 97865 10.0
OR 97867 5.0
OR 97868 5.0
OR 97869 10.0
OR 97870 10.6
OR 97873 10.0
OR 97874 10.0
OR 97875 5.0
OR 97876 10.2
OR 97877 8.0
OR 97880 5.0
OR 97882 4.0
OR 97883 5.0
OR 97884 8.0
OR 97885 10.0
OR 97886 5.0
OR 97901 10.5
OR 97902 10.0
OR 97903 5.0
OR 97904 10.3
OR 97905 7.0
OR 97906 5.0
OR 97907 7.0
OR 97908 5.0
OR 97909 10.5
OR 97910 10.0
OR 97911 5.0
OR 97913 7.2
OR 97914 4.0
OR 97917 10.0
OR 97918 10.5
OR 97920 5.0
PA 15001 1.0
PA 15003 1.0
PA 15004 2.0
PA 15005 1.0
PA 15006 1.0
PA 15007 1.0
PA 15009 1.0
PA 15010 1.0
PA 15012 1.1
PA 15014 1.0
PA 15015 1.0
PA 15017 1.0
PA 15018 1.0
PA 15019 2.0
PA 15020 1.1
PA 15021 2.0
PA 15022 1.1
PA 15024 1.0
PA 15025 1.0
PA 15026 2.0
PA 15027 1.0
PA 15028 1.0
PA 15030 1.0
PA 15031 1.0
PA 15032 1.0
PA 15033 1.1
PA 15034 1.0
PA 15035 1.0
PA 15036 2.0
PA 15037 1.0
PA 15038 1.0
PA 15042 1.0
PA 15043 2.0
PA 15044 1.0
PA 15045 1.0
PA 15046 1.0
PA 15047 1.0
PA 15049 1.0
PA 15050 2.0
PA 15051 1.0
PA 15052 2.0
PA 15053 2.0
PA 15054 2.0
PA 15055 1.0
PA 15056 1.0
PA 15057 1.0
PA 15059 4.0
PA 15060 2.0
PA 15061 1.0
PA 15062 1.1
PA 15063 1.1
PA 15064 1.0
PA 15065 1.0
PA 15066 1.0
PA 15067 1.1
PA 15068 1.0
PA 15069 2.0
PA 15071 1.0
PA 15072 1.1
PA 15074 1.0
PA 15075 1.0
PA 15076 1.0
PA 15077 2.0
PA 15078 2.0
PA 15081 1.0
PA 15082 1.0
PA 15083 1.0
PA 15084 1.0
PA 15085 1.0
PA 15086 1.0
PA 15087 1.1
PA 15088 1.0
PA 15089 1.0
PA 15090 1.0
PA 15091 1.0
PA 15095 1.0
PA 15096 1.0
PA 15101 1.0
PA 15102 1.0
PA 15104 1.0
PA 15106 1.0
PA 15108 1.0
PA 15110 1.0
PA 15112 1.0
PA 15116 1.0
PA 15120 1.0
PA 15122 1.0
PA 15123 1.0
PA 15126 1.0
PA 15127 1.0
PA 15129 1.0
PA 15130 1.0
PA 15131 1.0
PA 15132 1.0
PA 15133 1.0
PA 15134 1.0
PA 15135 1.0
PA 15136 1.0
PA 15137 1.0
PA 15139 1.0
PA 15140 1.0
PA 15142 1.0
PA 15143 1.0
PA 15144 1.0
PA 15145 1.0
PA 15146 1.0
PA 15147 1.0
PA 15148 1.0
PA 15189 1.0
PA 15201 1.0
PA 15202 1.0
PA 15203 1.0
PA 15204 1.0
PA 15205 1.0
PA 15206 1.0
PA 15207 1.0
PA 15208 1.0
PA 15209 1.0
PA 15210 1.0
PA 15211 1.0
PA 15212 1.0
PA 15213 1.0
PA 15214 1.0
PA 15215 1.0
PA 15216 1.0
PA 15217 1.0
PA 15218 1.0
PA 15219 1.0
PA 15220 1.0
PA 15221 1.0
PA 15222 1.0
PA 15223 1.0
PA 15224 1.0
PA 15225 1.0
PA 15226 1.0
PA 15227 1.0
PA 15228 1.0
PA 15229 1.0
PA 15230 1.0
PA 15231 1.0
PA 15232 1.0
PA 15233 1.0
PA 15234 1.0
PA 15235 1.0
PA 15236 1.0
PA 15237 1.0
PA 15238 1.0
PA 15239 1.0
PA 15240 1.0
PA 15241 1.0
PA 15242 1.0
PA 15243 1.0
PA 15244 1.0
PA 15250 1.0
PA 15251 1.0
PA 15252 1.0
PA 15253 1.0
PA 15254 1.0
PA 15255 1.0
PA 15257 1.0
PA 15258 1.0
PA 15259 1.0
PA 15260 1.0
PA 15261 1.0
PA 15262 1.0
PA 15263 1.0
PA 15264 1.0
PA 15265 1.0
PA 15267 1.0
PA 15268 1.0
PA 15270 1.0
PA 15272 1.0
PA 15274 1.0
PA 15275 1.0
PA 15276 1.0
PA 15277 1.0
PA 15278 1.0
PA 15279 1.0
PA 15281 1.0
PA 15282 1.0
PA 15283 1.0
PA 15285 1.0
PA 15286 1.0
PA 15289 1.0
PA 15290 1.0
PA 15295 1.0
PA 15301 1.0
PA 15310 8.3
PA 15311 2.0
PA 15312 2.0
PA 15313 2.0
PA 15314 1.1
PA 15315 3.0
PA 15316 8.1
PA 15317 1.0
PA 15320 7.0
PA 15321 1.0
PA 15322 2.0
PA 15323 2.0
PA 15324 2.0
PA 15325 7.0
PA 15327 3.0
PA 15329 2.0
PA 15330 2.0
PA 15331 1.1
PA 15332 1.0
PA 15333 2.0
PA 15334 7.0
PA 15336 1.0
PA 15337 8.3
PA 15338 3.0
PA 15339 1.0
PA 15340 2.0
PA 15341 8.3
PA 15342 1.0
PA 15344 8.3
PA 15345 2.0
PA 15346 8.1
PA 15347 1.0
PA 15348 7.0
PA 15349 8.1
PA 15350 1.0
PA 15351 7.0
PA 15352 8.3
PA 15353 8.1
PA 15354 8.1
PA 15357 7.0
PA 15358 2.0
PA 15359 8.3
PA 15360 2.0
PA 15361 1.0
PA 15362 8.1
PA 15363 1.0
PA 15364 8.1
PA 15365 2.0
PA 15366 1.1
PA 15367 1.0
PA 15368 2.0
PA 15370 7.3
PA 15376 2.0
PA 15377 2.0
PA 15378 2.0
PA 15379 2.0
PA 15380 8.3
PA 15401 1.0
PA 15410 2.1
PA 15411 10.5
PA 15412 1.1
PA 15413 3.0
PA 15415 3.0
PA 15416 1.0
PA 15417 3.0
PA 15419 3.0
PA 15420 3.0
PA 15421 2.0
PA 15422 3.0
PA 15423 1.1
PA 15424 10.5
PA 15425 1.0
PA 15427 2.0
PA 15428 1.0
PA 15429 3.0
PA 15430 1.0
PA 15431 1.0
PA 15432 1.1
PA 15433 3.0
PA 15434 1.1
PA 15435 2.1
PA 15436 1.0
PA 15437 2.0
PA 15438 2.0
PA 15439 3.0
PA 15440 2.0
PA 15442 3.0
PA 15443 2.1
PA 15444 3.0
PA 15445 1.0
PA 15446 2.0
PA 15447 3.0
PA 15448 2.0
PA 15449 2.1
PA 15450 3.0
PA 15451 3.0
PA 15454 2.1
PA 15455 1.0
PA 15456 1.0
PA 15458 2.1
PA 15459 2.0
PA 15460 2.1
PA 15461 2.0
PA 15462 2.0
PA 15463 3.0
PA 15464 2.0
PA 15465 1.0
PA 15466 2.0
PA 15467 2.1
PA 15468 2.1
PA 15469 2.0
PA 15470 2.0
PA 15472 1.0
PA 15473 2.0
PA 15474 3.0
PA 15475 3.0
PA 15476 2.0
PA 15477 1.1
PA 15478 2.1
PA 15479 2.0
PA 15480 2.1
PA 15482 2.0
PA 15483 1.1
PA 15484 1.0
PA 15485 10.5
PA 15486 1.0
PA 15488 2.1
PA 15489 1.0
PA 15490 2.0
PA 15492 1.1
PA 15501 4.0
PA 15502 4.0
PA 15510 4.0
PA 15520 4.0
PA 15521 9.0
PA 15522 7.0
PA 15530 10.5
PA 15531 10.5
PA 15532 7.4
PA 15533 10.6
PA 15534 10.6
PA 15535 10.6
PA 15536 10.0
PA 15537 7.0
PA 15538 6.0
PA 15539 9.0
PA 15540 10.5
PA 15541 4.0
PA 15542 10.6
PA 15544 10.5
PA 15545 5.0
PA 15546 10.5
PA 15547 10.5
PA 15548 10.5
PA 15549 4.0
PA 15550 10.6
PA 15551 10.5
PA 15552 7.4
PA 15553 10.5
PA 15554 9.0
PA 15555 4.0
PA 15557 5.0
PA 15558 10.0
PA 15559 10.6
PA 15560 4.0
PA 15561 4.0
PA 15562 10.0
PA 15563 10.5
PA 15564 5.0
PA 15565 10.0
PA 15601 1.0
PA 15605 1.0
PA 15606 1.0
PA 15610 2.0
PA 15611 1.0
PA 15612 1.0
PA 15613 2.0
PA 15615 1.0
PA 15616 1.0
PA 15617 1.0
PA 15618 2.0
PA 15619 1.0
PA 15620 2.0
PA 15621 1.0
PA 15622 2.0
PA 15623 1.0
PA 15624 1.0
PA 15625 1.0
PA 15626 1.0
PA 15627 1.0
PA 15628 2.0
PA 15629 2.0
PA 15631 1.0
PA 15632 1.0
PA 15633 1.0
PA 15634 1.0
PA 15635 1.0
PA 15636 1.0
PA 15637 1.0
PA 15638 1.0
PA 15639 1.0
PA 15640 1.0
PA 15641 2.0
PA 15642 1.0
PA 15644 1.0
PA 15646 2.0
PA 15647 1.0
PA 15650 1.0
PA 15655 2.0
PA 15656 2.0
PA 15658 2.0
PA 15660 1.0
PA 15661 1.0
PA 15662 1.0
PA 15663 1.0
PA 15664 1.0
PA 15665 1.0
PA 15666 1.0
PA 15668 1.0
PA 15670 2.0
PA 15671 1.0
PA 15672 1.0
PA 15673 2.0
PA 15674 1.0
PA 15675 1.0
PA 15676 1.0
PA 15677 2.0
PA 15678 1.0
PA 15679 1.0
PA 15680 2.0
PA 15681 2.0
PA 15682 2.0
PA 15683 1.0
PA 15684 2.0
PA 15685 1.0
PA 15686 2.0
PA 15687 2.0
PA 15688 1.0
PA 15689 1.0
PA 15690 2.0
PA 15691 1.0
PA 15692 1.0
PA 15693 1.0
PA 15695 1.0
PA 15696 1.0
PA 15697 1.0
PA 15698 2.0
PA 15701 4.0
PA 15705 4.0
PA 15710 9.0
PA 15711 10.5
PA 15712 5.0
PA 15713 4.0
PA 15714 9.0
PA 15715 7.0
PA 15716 7.2
PA 15717 7.2
PA 15720 5.2
PA 15721 10.5
PA 15722 9.0
PA 15723 4.0
PA 15724 5.0
PA 15725 2.0
PA 15727 4.0
PA 15728 5.0
PA 15729 5.0
PA 15730 8.0
PA 15731 4.0
PA 15732 5.0
PA 15733 7.0
PA 15734 5.0
PA 15736 6.0
PA 15737 9.0
PA 15738 9.0
PA 15739 5.0
PA 15740 7.0
PA 15741 9.0
PA 15742 9.0
PA 15744 9.0
PA 15745 5.0
PA 15746 5.0
PA 15747 5.0
PA 15748 4.0
PA 15750 7.2
PA 15752 4.0
PA 15753 10.5
PA 15754 4.0
PA 15756 6.0
PA 15757 5.0
PA 15758 9.0
PA 15759 5.0
PA 15760 9.1
PA 15761 9.0
PA 15762 9.1
PA 15763 5.0
PA 15764 9.0
PA 15765 5.0
PA 15767 7.0
PA 15770 9.0
PA 15771 9.0
PA 15772 9.0
PA 15773 9.0
PA 15774 6.0
PA 15775 9.0
PA 15776 9.0
PA 15777 5.0
PA 15778 9.0
PA 15779 1.0
PA 15780 9.0
PA 15781 7.0
PA 15783 2.0
PA 15784 9.0
PA 15801 4.0
PA 15821 5.0
PA 15822 5.0
PA 15823 5.0
PA 15824 10.5
PA 15825 7.0
PA 15827 5.0
PA 15828 10.0
PA 15829 8.0
PA 15831 5.0
PA 15832 8.0
PA 15834 8.0
PA 15840 6.0
PA 15841 5.0
PA 15845 7.2
PA 15846 5.0
PA 15847 7.0
PA 15848 5.0
PA 15849 5.0
PA 15851 5.0
PA 15853 7.4
PA 15856 5.0
PA 15857 4.0
PA 15860 10.4
PA 15861 8.0
PA 15863 5.0
PA 15864 8.0
PA 15865 5.0
PA 15866 5.0
PA 15868 5.0
PA 15870 6.0
PA 15901 1.0
PA 15902 1.0
PA 15904 1.0
PA 15905 1.0
PA 15906 1.0
PA 15907 1.0
PA 15909 1.0
PA 15915 1.0
PA 15920 6.1
PA 15921 2.0
PA 15922 7.3
PA 15923 2.0
PA 15924 3.0
PA 15925 2.0
PA 15926 3.0
PA 15927 7.3
PA 15928 2.0
PA 15929 4.0
PA 15930 1.0
PA 15931 7.3
PA 15934 1.0
PA 15935 2.0
PA 15936 10.5
PA 15937 2.0
PA 15938 2.0
PA 15940 2.0
PA 15942 2.0
PA 15943 2.0
PA 15944 2.0
PA 15945 1.0
PA 15946 3.0
PA 15948 7.3
PA 15949 5.2
PA 15951 1.0
PA 15952 1.0
PA 15953 2.0
PA 15954 6.1
PA 15955 2.0
PA 15956 2.0
PA 15957 5.2
PA 15958 2.0
PA 15959 1.0
PA 15960 3.0
PA 15961 3.0
PA 15962 3.0
PA 15963 1.0
PA 16001 4.2
PA 16002 2.0
PA 16003 4.2
PA 16016 5.2
PA 16017 5.2
PA 16018 6.0
PA 16020 6.0
PA 16021 9.2
PA 16022 6.0
PA 16023 2.0
PA 16024 2.0
PA 16025 5.2
PA 16027 2.0
PA 16028 10.6
PA 16029 4.2
PA 16030 6.0
PA 16033 2.0
PA 16034 5.2
PA 16035 9.2
PA 16036 10.0
PA 16037 2.0
PA 16038 9.2
PA 16039 4.2
PA 16040 6.0
PA 16041 6.0
PA 16045 4.2
PA 16046 1.0
PA 16048 6.0
PA 16049 6.0
PA 16050 6.0
PA 16051 6.1
PA 16052 6.1
PA 16053 2.0
PA 16054 10.0
PA 16055 1.0
PA 16056 2.0
PA 16057 9.2
PA 16058 10.0
PA 16059 2.0
PA 16061 5.2
PA 16063 2.0
PA 16066 1.0
PA 16101 4.0
PA 16102 4.0
PA 16103 4.0
PA 16105 4.0
PA 16107 4.0
PA 16108 4.0
PA 16110 5.0
PA 16111 5.0
PA 16112 5.2
PA 16113 7.3
PA 16114 9.0
PA 16115 2.0
PA 16116 5.2
PA 16117 1.0
PA 16120 5.2
PA 16121 1.0
PA 16123 1.0
PA 16124 2.0
PA 16125 7.3
PA 16127 4.0
PA 16130 9.0
PA 16131 5.0
PA 16132 5.2
PA 16133 3.0
PA 16134 6.0
PA 16136 1.0
PA 16137 7.1
PA 16140 5.2
PA 16141 2.0
PA 16142 5.2
PA 16143 5.2
PA 16145 10.0
PA 16146 1.0
PA 16148 1.0
PA 16150 1.0
PA 16151 9.0
PA 16153 10.0
PA 16154 2.0
PA 16155 5.2
PA 16156 5.2
PA 16157 2.0
PA 16159 2.0
PA 16160 2.0
PA 16161 1.0
PA 16172 7.3
PA 16201 4.2
PA 16210 5.2
PA 16211 5.0
PA 16212 2.0
PA 16213 10.0
PA 16214 7.0
PA 16215 4.2
PA 16217 10.0
PA 16218 6.0
PA 16220 10.0
PA 16221 10.6
PA 16222 10.0
PA 16223 10.6
PA 16224 10.6
PA 16225 10.0
PA 16226 4.2
PA 16228 4.2
PA 16229 1.0
PA 16230 10.6
PA 16232 10.6
PA 16233 10.0
PA 16234 10.6
PA 16235 10.6
PA 16236 4.2
PA 16238 4.2
PA 16239 10.0
PA 16240 10.0
PA 16242 10.6
PA 16244 5.0
PA 16245 10.6
PA 16246 5.0
PA 16248 10.6
PA 16249 5.0
PA 16250 5.0
PA 16253 10.6
PA 16254 10.6
PA 16255 10.0
PA 16256 5.0
PA 16257 10.6
PA 16258 10.0
PA 16259 5.2
PA 16260 10.0
PA 16261 5.2
PA 16262 4.2
PA 16263 5.0
PA 16301 4.0
PA 16311 9.0
PA 16312 6.0
PA 16313 4.0
PA 16314 5.0
PA 16316 5.0
PA 16317 9.0
PA 16319 4.0
PA 16321 10.0
PA 16322 10.0
PA 16323 7.0
PA 16326 10.6
PA 16327 5.0
PA 16328 7.0
PA 16329 5.0
PA 16331 10.6
PA 16332 10.6
PA 16333 7.0
PA 16334 10.6
PA 16335 4.0
PA 16340 5.0
PA 16341 9.0
PA 16342 10.6
PA 16343 4.0
PA 16344 4.0
PA 16345 5.0
PA 16346 4.0
PA 16347 5.0
PA 16350 6.0
PA 16351 5.0
PA 16352 4.0
PA 16353 10.0
PA 16354 7.0
PA 16360 10.5
PA 16361 10.0
PA 16362 10.6
PA 16364 4.0
PA 16365 4.0
PA 16366 4.0
PA 16367 4.0
PA 16368 4.0
PA 16369 4.0
PA 16370 10.0
PA 16371 5.0
PA 16372 10.6
PA 16373 10.5
PA 16374 10.5
PA 16375 10.6
PA 16388 4.0
PA 16401 2.0
PA 16402 6.0
PA 16403 10.4
PA 16404 10.5
PA 16405 6.0
PA 16406 10.5
PA 16407 7.3
PA 16410 2.0
PA 16411 2.0
PA 16412 7.1
PA 16413 7.3
PA 16415 1.0
PA 16416 5.0
PA 16417 1.0
PA 16420 5.0
PA 16421 1.0
PA 16422 5.0
PA 16423 1.0
PA 16424 10.5
PA 16426 2.0
PA 16427 2.0
PA 16428 2.0
PA 16430 2.0
PA 16432 2.0
PA 16433 4.0
PA 16434 10.4
PA 16435 10.5
PA 16436 5.0
PA 16438 2.0
PA 16440 10.4
PA 16441 2.0
PA 16442 2.0
PA 16443 2.0
PA 16444 7.1
PA 16475 2.0
PA 16501 1.0
PA 16502 1.0
PA 16503 1.0
PA 16504 1.0
PA 16505 1.0
PA 16506 1.0
PA 16507 1.0
PA 16508 1.0
PA 16509 1.0
PA 16510 1.0
PA 16511 1.0
PA 16512 1.0
PA 16514 1.0
PA 16515 1.0
PA 16522 1.0
PA 16530 1.0
PA 16531 1.0
PA 16532 1.0
PA 16533 1.0
PA 16534 1.0
PA 16538 1.0
PA 16541 1.0
PA 16544 1.0
PA 16546 1.0
PA 16550 1.0
PA 16553 1.0
PA 16554 1.0
PA 16563 1.0
PA 16565 1.0
PA 16601 1.0
PA 16602 1.0
PA 16603 1.0
PA 16611 4.0
PA 16613 2.0
PA 16616 10.4
PA 16617 1.0
PA 16619 2.0
PA 16620 9.2
PA 16621 10.5
PA 16622 6.0
PA 16623 6.0
PA 16624 3.0
PA 16625 2.0
PA 16627 10.4
PA 16629 2.0
PA 16630 2.0
PA 16631 2.0
PA 16633 10.6
PA 16634 10.5
PA 16635 1.0
PA 16636 3.0
PA 16637 2.0
PA 16638 5.0
PA 16639 2.0
PA 16640 2.0
PA 16641 2.0
PA 16644 2.0
PA 16645 5.0
PA 16646 3.0
PA 16647 5.0
PA 16648 1.0
PA 16650 10.4
PA 16651 9.2
PA 16652 4.0
PA 16654 4.0
PA 16655 3.0
PA 16656 10.4
PA 16657 5.0
PA 16659 10.4
PA 16660 4.0
PA 16661 5.0
PA 16662 2.0
PA 16663 9.2
PA 16664 10.4
PA 16665 1.0
PA 16666 7.3
PA 16667 9.0
PA 16668 3.0
PA 16669 4.0
PA 16670 3.0
PA 16671 9.2
PA 16672 10.6
PA 16673 2.0
PA 16674 10.5
PA 16675 3.0
PA 16677 7.3
PA 16678 10.4
PA 16679 10.6
PA 16680 9.2
PA 16681 5.0
PA 16682 2.0
PA 16683 2.0
PA 16684 1.0
PA 16685 6.0
PA 16686 2.0
PA 16689 10.0
PA 16691 10.0
PA 16692 10.5
PA 16693 2.0
PA 16694 10.6
PA 16695 10.4
PA 16698 9.2
PA 16699 2.0
PA 16701 4.0
PA 16720 10.0
PA 16724 10.5
PA 16725 4.0
PA 16726 10.5
PA 16727 5.0
PA 16728 10.5
PA 16729 6.0
PA 16730 10.5
PA 16731 6.0
PA 16732 5.0
PA 16733 10.5
PA 16734 10.5
PA 16735 7.0
PA 16738 5.0
PA 16740 10.5
PA 16743 10.0
PA 16744 6.0
PA 16745 6.0
PA 16746 10.0
PA 16748 10.0
PA 16749 10.5
PA 16750 10.0
PA 16801 1.0
PA 16802 1.0
PA 16803 1.0
PA 16804 1.0
PA 16805 1.0
PA 16820 2.0
PA 16821 6.1
PA 16822 4.2
PA 16823 2.0
PA 16825 5.0
PA 16826 2.0
PA 16827 1.0
PA 16828 2.0
PA 16829 2.0
PA 16830 4.0
PA 16832 2.0
PA 16833 4.0
PA 16834 6.1
PA 16835 2.0
PA 16836 5.0
PA 16837 4.0
PA 16838 4.0
PA 16839 6.1
PA 16840 6.1
PA 16841 2.0
PA 16843 4.0
PA 16844 2.0
PA 16845 5.0
PA 16847 6.1
PA 16848 5.2
PA 16849 6.1
PA 16850 5.0
PA 16851 1.0
PA 16852 2.0
PA 16853 2.0
PA 16854 2.0
PA 16855 5.0
PA 16856 2.0
PA 16858 6.1
PA 16859 2.0
PA 16860 6.1
PA 16861 5.0
PA 16863 5.0
PA 16864 2.0
PA 16865 1.0
PA 16866 7.3
PA 16868 1.0
PA 16870 2.0
PA 16871 10.5
PA 16872 2.0
PA 16873 4.0
PA 16874 2.0
PA 16875 2.0
PA 16876 5.0
PA 16877 2.0
PA 16878 5.0
PA 16879 6.1
PA 16881 5.0
PA 16882 2.0
PA 16901 8.0
PA 16910 10.0
PA 16911 8.0
PA 16912 8.0
PA 16914 10.0
PA 16915 10.0
PA 16917 9.0
PA 16918 10.6
PA 16920 10.5
PA 16921 8.0
PA 16922 10.0
PA 16923 10.0
PA 16925 2.0
PA 16926 10.6
PA 16927 10.0
PA 16928 10.6
PA 16929 3.0
PA 16930 10.0
PA 16932 9.0
PA 16933 7.0
PA 16935 9.0
PA 16936 3.0
PA 16937 10.0
PA 16938 10.0
PA 16939 9.0
PA 16940 10.5
PA 16941 10.0
PA 16942 10.5
PA 16943 9.0
PA 16945 10.0
PA 16946 9.0
PA 16947 10.0
PA 16948 10.0
PA 16950 10.6
PA 17001 1.0
PA 17002 10.5
PA 17003 1.0
PA 17004 10.5
PA 17005 2.0
PA 17006 10.1
PA 17007 4.1
PA 17008 1.0
PA 17009 4.0
PA 17010 1.0
PA 17011 1.0
PA 17012 1.0
PA 17013 4.1
PA 17014 3.0
PA 17016 1.0
PA 17017 10.4
PA 17018 2.0
PA 17019 1.0
PA 17020 2.0
PA 17021 10.0
PA 17022 4.1
PA 17023 2.0
PA 17024 2.0
PA 17025 1.0
PA 17026 2.1
PA 17027 1.0
PA 17028 2.0
PA 17029 5.0
PA 17030 2.0
PA 17032 2.0
PA 17033 1.0
PA 17034 1.0
PA 17035 10.0
PA 17036 1.0
PA 17037 2.0
PA 17038 1.0
PA 17039 2.0
PA 17040 2.0
PA 17041 1.0
PA 17042 1.0
PA 17043 1.0
PA 17044 4.0
PA 17045 2.0
PA 17046 1.0
PA 17047 10.1
PA 17048 3.0
PA 17049 10.4
PA 17050 1.0
PA 17051 5.0
PA 17052 6.0
PA 17053 1.0
PA 17054 5.0
PA 17055 1.0
PA 17056 10.4
PA 17057 1.0
PA 17058 10.0
PA 17059 10.4
PA 17060 5.0
PA 17061 7.1
PA 17062 2.0
PA 17063 4.0
PA 17064 1.0
PA 17065 4.1
PA 17066 5.0
PA 17067 2.0
PA 17068 2.0
PA 17069 2.0
PA 17070 1.0
PA 17071 10.1
PA 17072 1.0
PA 17073 2.0
PA 17074 2.0
PA 17075 5.0
PA 17076 10.4
PA 17077 1.0
PA 17078 1.0
PA 17080 2.0
PA 17081 4.1
PA 17082 10.0
PA 17083 1.0
PA 17084 4.0
PA 17085 1.0
PA 17086 6.0
PA 17087 2.0
PA 17088 2.0
PA 17089 1.0
PA 17090 2.0
PA 17091 1.0
PA 17093 1.0
PA 17094 10.4
PA 17097 3.0
PA 17098 3.0
PA 17099 4.0
PA 17101 1.0
PA 17102 1.0
PA 17103 1.0
PA 17104 1.0
PA 17105 1.0
PA 17106 1.0
PA 17107 1.0
PA 17108 1.0
PA 17109 1.0
PA 17110 1.0
PA 17111 1.0
PA 17112 1.0
PA 17113 1.0
PA 17120 1.0
PA 17121 1.0
PA 17122 1.0
PA 17123 1.0
PA 17124 1.0
PA 17125 1.0
PA 17126 1.0
PA 17127 1.0
PA 17128 1.0
PA 17129 1.0
PA 17130 1.0
PA 17140 1.0
PA 17177 1.0
PA 17201 4.0
PA 17210 10.5
PA 17211 10.6
PA 17212 10.0
PA 17213 10.0
PA 17214 4.2
PA 17215 10.0
PA 17217 10.5
PA 17219 10.5
PA 17220 10.5
PA 17221 10.5
PA 17222 4.0
PA 17223 10.0
PA 17224 10.5
PA 17225 2.0
PA 17228 10.0
PA 17229 10.0
PA 17231 10.5
PA 17232 5.0
PA 17233 10.0
PA 17235 4.0
PA 17236 10.5
PA 17237 4.2
PA 17238 3.0
PA 17239 10.0
PA 17240 6.1
PA 17241 5.2
PA 17243 10.0
PA 17244 5.0
PA 17246 5.0
PA 17247 4.2
PA 17249 10.0
PA 17250 4.2
PA 17251 10.5
PA 17252 4.0
PA 17253 10.0
PA 17254 4.0
PA 17255 10.0
PA 17256 2.0
PA 17257 4.0
PA 17260 6.0
PA 17261 4.0
PA 17262 10.5
PA 17263 4.2
PA 17264 10.0
PA 17265 5.0
PA 17266 5.2
PA 17267 3.0
PA 17268 4.2
PA 17270 2.0
PA 17271 10.5
PA 17272 4.2
PA 17301 5.2
PA 17302 2.0
PA 17303 6.0
PA 17304 6.0
PA 17306 6.0
PA 17307 6.0
PA 17309 2.0
PA 17310 5.0
PA 17311 2.0
PA 17312 1.0
PA 17313 1.0
PA 17314 3.0
PA 17315 1.0
PA 17316 5.2
PA 17317 1.0
PA 17318 1.0
PA 17319 1.0
PA 17320 6.1
PA 17321 3.0
PA 17322 2.0
PA 17323 1.0
PA 17324 5.2
PA 17325 4.0
PA 17326 4.0
PA 17327 2.0
PA 17329 5.2
PA 17331 4.2
PA 17332 4.2
PA 17333 4.2
PA 17334 4.2
PA 17337 5.2
PA 17339 1.0
PA 17340 6.0
PA 17342 1.0
PA 17343 6.0
PA 17344 4.2
PA 17345 1.0
PA 17347 1.0
PA 17349 2.0
PA 17350 4.2
PA 17352 3.0
PA 17353 5.0
PA 17354 2.0
PA 17355 2.0
PA 17356 1.0
PA 17358 1.0
PA 17360 1.0
PA 17361 2.0
PA 17362 2.0
PA 17363 2.0
PA 17364 2.0
PA 17365 2.0
PA 17366 1.0
PA 17368 1.0
PA 17370 1.0
PA 17371 1.0
PA 17372 10.4
PA 17375 5.2
PA 17401 1.0
PA 17402 1.0
PA 17403 1.0
PA 17404 1.0
PA 17405 1.0
PA 17406 1.0
PA 17407 1.0
PA 17415 1.0
PA 17501 1.0
PA 17502 2.0
PA 17503 1.0
PA 17504 1.0
PA 17505 1.0
PA 17506 1.0
PA 17507 1.0
PA 17508 1.0
PA 17509 10.4
PA 17512 1.0
PA 17516 1.0
PA 17517 1.0
PA 17518 2.0
PA 17519 1.0
PA 17520 1.0
PA 17521 1.0
PA 17522 1.0
PA 17527 2.0
PA 17528 1.0
PA 17529 10.1
PA 17532 2.0
PA 17533 1.0
PA 17534 10.1
PA 17535 2.0
PA 17536 3.0
PA 17537 1.0
PA 17538 1.0
PA 17540 1.0
PA 17543 1.0
PA 17545 1.0
PA 17547 1.0
PA 17549 1.0
PA 17550 1.0
PA 17551 1.0
PA 17552 1.0
PA 17554 1.0
PA 17555 2.0
PA 17557 1.0
PA 17560 1.0
PA 17562 1.0
PA 17563 2.0
PA 17564 1.0
PA 17565 2.0
PA 17566 2.0
PA 17567 1.0
PA 17568 1.0
PA 17569 1.0
PA 17570 4.1
PA 17572 1.0
PA 17573 1.0
PA 17575 1.0
PA 17576 1.0
PA 17577 10.1
PA 17578 1.0
PA 17579 1.0
PA 17580 1.0
PA 17581 1.0
PA 17582 2.0
PA 17583 1.0
PA 17584 1.0
PA 17585 1.0
PA 17601 1.0
PA 17602 1.0
PA 17603 1.0
PA 17604 1.0
PA 17605 1.0
PA 17606 1.0
PA 17607 1.0
PA 17608 1.0
PA 17699 1.0
PA 17701 1.0
PA 17702 1.0
PA 17703 1.0
PA 17705 1.0
PA 17720 1.0
PA 17721 4.2
PA 17722 2.0
PA 17723 5.1
PA 17724 10.0
PA 17726 4.2
PA 17727 5.1
PA 17728 2.0
PA 17729 10.5
PA 17730 4.0
PA 17731 10.0
PA 17735 10.0
PA 17737 2.0
PA 17738 10.5
PA 17739 5.1
PA 17740 4.2
PA 17742 9.1
PA 17744 1.0
PA 17745 4.2
PA 17747 10.5
PA 17748 4.2
PA 17749 4.0
PA 17750 5.2
PA 17751 5.2
PA 17752 5.2
PA 17754 1.0
PA 17756 2.0
PA 17758 10.0
PA 17759 1.0
PA 17760 10.5
PA 17762 2.0
PA 17763 2.0
PA 17764 10.5
PA 17765 10.0
PA 17767 5.2
PA 17768 10.0
PA 17769 4.2
PA 17771 2.0
PA 17772 5.0
PA 17773 10.5
PA 17774 9.1
PA 17776 2.0
PA 17777 4.0
PA 17778 10.5
PA 17779 4.2
PA 17801 4.0
PA 17810 5.2
PA 17812 10.5
PA 17813 6.0
PA 17814 5.0
PA 17815 4.0
PA 17820 5.0
PA 17821 4.0
PA 17822 4.0
PA 17823 6.0
PA 17824 6.0
PA 17827 5.0
PA 17829 5.0
PA 17830 10.4
PA 17831 4.0
PA 17832 7.4
PA 17833 10.5
PA 17834 4.0
PA 17835 5.0
PA 17836 10.4
PA 17837 4.0
PA 17839 4.0
PA 17840 7.4
PA 17841 5.0
PA 17842 10.5
PA 17843 5.0
PA 17844 5.0
PA 17845 5.0
PA 17846 5.0
PA 17847 4.0
PA 17850 4.0
PA 17851 7.4
PA 17853 6.0
PA 17855 5.0
PA 17856 5.2
PA 17857 4.0
PA 17858 5.0
PA 17859 4.0
PA 17860 6.0
PA 17861 10.5
PA 17862 10.5
PA 17864 5.0
PA 17865 4.0
PA 17866 4.0
PA 17867 10.4
PA 17868 4.0
PA 17870 4.0
PA 17872 4.0
PA 17876 4.0
PA 17877 6.0
PA 17878 5.0
PA 17880 5.0
PA 17881 6.0
PA 17882 6.0
PA 17883 5.0
PA 17884 4.0
PA 17885 5.0
PA 17886 4.0
PA 17887 5.2
PA 17888 5.0
PA 17889 5.0
PA 17901 4.0
PA 17920 5.0
PA 17921 4.0
PA 17922 6.1
PA 17923 6.0
PA 17925 6.0
PA 17929 4.0
PA 17930 4.0
PA 17931 4.0
PA 17932 4.0
PA 17933 4.0
PA 17934 4.0
PA 17935 4.0
PA 17936 4.0
PA 17938 10.5
PA 17941 10.5
PA 17942 6.1
PA 17943 4.0
PA 17944 4.0
PA 17945 4.0
PA 17946 4.0
PA 17948 6.0
PA 17949 4.0
PA 17951 4.0
PA 17952 6.0
PA 17953 4.0
PA 17954 4.0
PA 17957 3.0
PA 17959 4.0
PA 17960 3.0
PA 17961 5.0
PA 17963 6.0
PA 17964 10.5
PA 17965 4.0
PA 17966 6.0
PA 17967 2.0
PA 17968 10.5
PA 17970 4.0
PA 17972 4.0
PA 17974 4.0
PA 17976 4.0
PA 17978 10.5
PA 17979 6.1
PA 17980 3.0
PA 17981 6.0
PA 17982 6.0
PA 17983 10.5
PA 17985 2.0
PA 18001 1.0
PA 18002 1.0
PA 18003 1.0
PA 18010 1.0
PA 18011 1.0
PA 18012 1.0
PA 18013 1.0
PA 18014 1.0
PA 18015 1.0
PA 18016 1.0
PA 18017 1.0
PA 18018 1.0
PA 18020 1.0
PA 18025 1.0
PA 18030 1.0
PA 18031 1.0
PA 18032 1.0
PA 18034 1.0
PA 18035 1.0
PA 18036 1.0
PA 18037 1.0
PA 18038 1.0
PA 18039 2.0
PA 18040 1.0
PA 18041 1.0
PA 18042 1.0
PA 18043 1.0
PA 18044 1.0
PA 18045 1.0
PA 18046 1.0
PA 18049 1.0
PA 18050 1.0
PA 18051 1.0
PA 18052 1.0
PA 18053 2.0
PA 18054 1.0
PA 18055 1.0
PA 18056 2.0
PA 18058 10.5
PA 18059 1.0
PA 18060 1.0
PA 18062 1.0
PA 18063 1.0
PA 18064 1.0
PA 18065 1.0
PA 18066 2.0
PA 18067 1.0
PA 18068 1.0
PA 18069 1.0
PA 18070 2.0
PA 18071 1.0
PA 18072 1.0
PA 18073 1.0
PA 18074 1.0
PA 18076 1.0
PA 18077 2.1
PA 18078 1.0
PA 18079 1.0
PA 18080 1.0
PA 18081 1.0
PA 18083 1.0
PA 18084 1.0
PA 18085 1.0
PA 18086 1.0
PA 18087 1.0
PA 18088 1.0
PA 18091 1.0
PA 18092 1.0
PA 18098 1.0
PA 18099 1.0
PA 18101 1.0
PA 18102 1.0
PA 18103 1.0
PA 18104 1.0
PA 18105 1.0
PA 18106 1.0
PA 18109 1.0
PA 18175 1.0
PA 18195 1.0
PA 18201 1.0
PA 18202 1.0
PA 18210 3.0
PA 18211 3.0
PA 18212 1.0
PA 18214 6.0
PA 18216 1.0
PA 18218 4.2
PA 18219 1.0
PA 18220 4.2
PA 18221 1.0
PA 18222 1.0
PA 18223 1.0
PA 18224 1.0
PA 18225 1.0
PA 18229 2.0
PA 18230 1.0
PA 18231 1.0
PA 18232 4.2
PA 18234 1.0
PA 18235 1.0
PA 18237 1.0
PA 18239 1.0
PA 18240 4.2
PA 18241 2.0
PA 18242 2.0
PA 18244 1.0
PA 18245 4.2
PA 18246 2.1
PA 18247 1.0
PA 18248 2.0
PA 18249 1.0
PA 18250 4.2
PA 18251 1.0
PA 18252 4.2
PA 18254 1.0
PA 18255 1.0
PA 18256 2.1
PA 18301 4.2
PA 18320 4.2
PA 18321 4.2
PA 18322 4.2
PA 18323 10.5
PA 18324 2.0
PA 18325 10.5
PA 18326 10.5
PA 18327 4.2
PA 18328 2.0
PA 18330 4.2
PA 18331 10.5
PA 18332 6.0
PA 18333 10.5
PA 18334 4.2
PA 18335 4.2
PA 18336 4.2
PA 18337 2.0
PA 18340 4.2
PA 18341 4.2
PA 18342 10.5
PA 18343 2.1
PA 18344 10.5
PA 18346 10.4
PA 18347 10.4
PA 18348 10.4
PA 18349 4.2
PA 18350 10.4
PA 18351 2.1
PA 18352 10.5
PA 18353 2.0
PA 18354 4.2
PA 18355 6.0
PA 18356 4.2
PA 18357 10.5
PA 18360 4.2
PA 18370 6.0
PA 18371 2.0
PA 18372 4.2
PA 18373 2.0
PA 18401 1.0
PA 18403 1.0
PA 18405 10.6
PA 18407 1.0
PA 18410 1.0
PA 18411 1.0
PA 18413 1.0
PA 18414 2.0
PA 18415 10.6
PA 18416 2.0
PA 18417 10.6
PA 18419 2.0
PA 18420 2.0
PA 18421 1.0
PA 18424 2.0
PA 18425 10.4
PA 18426 10.0
PA 18427 2.0
PA 18428 10.6
PA 18430 2.0
PA 18431 8.0
PA 18433 1.0
PA 18434 1.0
PA 18435 10.4
PA 18436 10.4
PA 18437 10.6
PA 18438 10.4
PA 18439 10.4
PA 18440 2.0
PA 18441 2.0
PA 18443 10.6
PA 18444 2.0
PA 18445 10.4
PA 18446 2.0
PA 18447 1.0
PA 18448 1.0
PA 18449 10.4
PA 18451 10.4
PA 18452 1.0
PA 18453 10.4
PA 18454 10.4
PA 18455 10.4
PA 18456 2.0
PA 18457 10.4
PA 18458 4.2
PA 18459 10.4
PA 18460 10.4
PA 18461 10.6
PA 18462 10.4
PA 18463 10.4
PA 18464 3.0
PA 18465 2.0
PA 18466 10.4
PA 18469 10.6
PA 18470 2.0
PA 18471 1.0
PA 18472 10.4
PA 18473 8.0
PA 18501 1.0
PA 18502 1.0
PA 18503 1.0
PA 18504 1.0
PA 18505 1.0
PA 18507 1.0
PA 18508 1.0
PA 18509 1.0
PA 18510 1.0
PA 18512 1.0
PA 18514 1.0
PA 18515 1.0
PA 18517 1.0
PA 18518 1.0
PA 18519 1.0
PA 18522 1.0
PA 18540 1.0
PA 18577 1.0
PA 18601 4.0
PA 18602 1.0
PA 18603 4.0
PA 18610 4.2
PA 18611 5.0
PA 18612 1.0
PA 18614 10.0
PA 18615 2.0
PA 18616 10.0
PA 18617 1.0
PA 18618 1.0
PA 18619 10.0
PA 18621 2.0
PA 18622 2.0
PA 18623 10.0
PA 18624 3.0
PA 18625 2.0
PA 18626 10.0
PA 18627 1.0
PA 18628 10.0
PA 18629 10.6
PA 18630 10.6
PA 18631 4.0
PA 18632 10.0
PA 18634 1.0
PA 18635 5.2
PA 18636 2.0
PA 18640 1.0
PA 18641 1.0
PA 18642 1.0
PA 18643 1.0
PA 18644 1.0
PA 18651 1.0
PA 18653 1.0
PA 18654 1.0
PA 18655 2.0
PA 18656 2.0
PA 18657 7.2
PA 18660 5.2
PA 18661 2.0
PA 18690 1.0
PA 18701 1.0
PA 18702 1.0
PA 18703 1.0
PA 18704 1.0
PA 18705 1.0
PA 18706 1.0
PA 18707 1.0
PA 18708 1.0
PA 18709 1.0
PA 18710 1.0
PA 18711 1.0
PA 18761 1.0
PA 18762 1.0
PA 18763 1.0
PA 18764 1.0
PA 18765 1.0
PA 18766 1.0
PA 18767 1.0
PA 18768 1.0
PA 18769 1.0
PA 18773 1.0
PA 18774 1.0
PA 18801 10.4
PA 18810 4.0
PA 18812 2.0
PA 18813 10.4
PA 18814 10.6
PA 18815 10.0
PA 18816 10.4
PA 18817 10.5
PA 18818 2.0
PA 18820 2.0
PA 18821 1.0
PA 18822 1.0
PA 18823 2.0
PA 18824 10.4
PA 18825 2.0
PA 18826 10.4
PA 18827 7.1
PA 18828 10.0
PA 18829 10.6
PA 18830 2.0
PA 18831 10.5
PA 18832 10.6
PA 18833 10.6
PA 18834 2.0
PA 18837 10.6
PA 18840 4.0
PA 18842 2.0
PA 18843 10.4
PA 18844 10.4
PA 18845 10.6
PA 18846 10.6
PA 18847 7.1
PA 18848 10.6
PA 18850 6.0
PA 18851 10.6
PA 18853 10.0
PA 18854 10.6
PA 18901 1.0
PA 18910 1.0
PA 18911 1.0
PA 18912 1.0
PA 18913 1.0
PA 18914 1.0
PA 18915 1.0
PA 18916 1.0
PA 18917 2.0
PA 18918 1.0
PA 18920 2.0
PA 18921 2.0
PA 18922 1.0
PA 18923 1.0
PA 18924 1.0
PA 18925 1.0
PA 18926 1.0
PA 18927 1.0
PA 18928 1.0
PA 18929 1.0
PA 18930 2.0
PA 18931 1.0
PA 18932 1.0
PA 18933 1.0
PA 18934 1.0
PA 18935 1.0
PA 18936 1.0
PA 18938 1.0
PA 18940 1.0
PA 18942 2.0
PA 18943 1.0
PA 18944 1.0
PA 18946 1.0
PA 18947 1.0
PA 18949 1.0
PA 18950 1.0
PA 18951 1.0
PA 18953 2.0
PA 18954 1.0
PA 18955 2.0
PA 18956 1.0
PA 18957 1.0
PA 18958 1.0
PA 18960 1.0
PA 18962 1.0
PA 18963 1.0
PA 18964 1.0
PA 18966 1.0
PA 18968 1.0
PA 18969 1.0
PA 18970 1.0
PA 18971 1.0
PA 18972 2.0
PA 18974 1.0
PA 18976 1.0
PA 18977 1.0
PA 18979 1.0
PA 18980 1.0
PA 18981 1.0
PA 18991 1.0
PA 19001 1.0
PA 19002 1.0
PA 19003 1.0
PA 19004 1.0
PA 19006 1.0
PA 19007 1.0
PA 19008 1.0
PA 19009 1.0
PA 19010 1.0
PA 19012 1.0
PA 19013 1.0
PA 19014 1.0
PA 19015 1.0
PA 19016 1.0
PA 19017 1.0
PA 19018 1.0
PA 19019 1.0
PA 19020 1.0
PA 19021 1.0
PA 19022 1.0
PA 19023 1.0
PA 19025 1.0
PA 19026 1.0
PA 19027 1.0
PA 19028 1.0
PA 19029 1.0
PA 19030 1.0
PA 19031 1.0
PA 19032 1.0
PA 19033 1.0
PA 19034 1.0
PA 19035 1.0
PA 19036 1.0
PA 19037 1.0
PA 19038 1.0
PA 19039 1.0
PA 19040 1.0
PA 19041 1.0
PA 19043 1.0
PA 19044 1.0
PA 19046 1.0
PA 19047 1.0
PA 19048 1.0
PA 19049 1.0
PA 19050 1.0
PA 19052 1.0
PA 19053 1.0
PA 19054 1.0
PA 19055 1.0
PA 19056 1.0
PA 19057 1.0
PA 19058 1.0
PA 19059 1.0
PA 19061 1.0
PA 19063 1.0
PA 19064 1.0
PA 19065 1.0
PA 19066 1.0
PA 19067 1.0
PA 19070 1.0
PA 19072 1.0
PA 19073 1.0
PA 19074 1.0
PA 19075 1.0
PA 19076 1.0
PA 19078 1.0
PA 19079 1.0
PA 19080 1.0
PA 19081 1.0
PA 19082 1.0
PA 19083 1.0
PA 19085 1.0
PA 19086 1.0
PA 19087 1.0
PA 19088 1.0
PA 19089 1.0
PA 19090 1.0
PA 19091 1.0
PA 19092 1.0
PA 19093 1.0
PA 19094 1.0
PA 19095 1.0
PA 19096 1.0
PA 19098 1.0
PA 19099 1.0
PA 19101 1.0
PA 19102 1.0
PA 19103 1.0
PA 19104 1.0
PA 19105 1.0
PA 19106 1.0
PA 19107 1.0
PA 19108 1.0
PA 19109 1.0
PA 19110 1.0
PA 19111 1.0
PA 19112 1.0
PA 19113 1.0
PA 19114 1.0
PA 19115 1.0
PA 19116 1.0
PA 19118 1.0
PA 19119 1.0
PA 19120 1.0
PA 19121 1.0
PA 19122 1.0
PA 19123 1.0
PA 19124 1.0
PA 19125 1.0
PA 19126 1.0
PA 19127 1.0
PA 19128 1.0
PA 19129 1.0
PA 19130 1.0
PA 19131 1.0
PA 19132 1.0
PA 19133 1.0
PA 19134 1.0
PA 19135 1.0
PA 19136 1.0
PA 19137 1.0
PA 19138 1.0
PA 19139 1.0
PA 19140 1.0
PA 19141 1.0
PA 19142 1.0
PA 19143 1.0
PA 19144 1.0
PA 19145 1.0
PA 19146 1.0
PA 19147 1.0
PA 19148 1.0
PA 19149 1.0
PA 19150 1.0
PA 19151 1.0
PA 19152 1.0
PA 19153 1.0
PA 19154 1.0
PA 19155 1.0
PA 19160 1.0
PA 19161 1.0
PA 19162 1.0
PA 19170 1.0
PA 19171 1.0
PA 19172 1.0
PA 19173 1.0
PA 19175 1.0
PA 19176 1.0
PA 19177 1.0
PA 19178 1.0
PA 19179 1.0
PA 19181 1.0
PA 19182 1.0
PA 19183 1.0
PA 19184 1.0
PA 19185 1.0
PA 19187 1.0
PA 19188 1.0
PA 19191 1.0
PA 19192 1.0
PA 19193 1.0
PA 19194 1.0
PA 19195 1.0
PA 19196 1.0
PA 19197 1.0
PA 19244 1.0
PA 19255 1.0
PA 19301 1.0
PA 19310 2.0
PA 19311 1.0
PA 19312 1.0
PA 19316 1.0
PA 19317 1.0
PA 19318 1.0
PA 19319 1.0
PA 19320 1.0
PA 19330 2.0
PA 19331 1.0
PA 19333 1.0
PA 19335 1.0
PA 19339 1.0
PA 19340 1.0
PA 19341 1.0
PA 19342 1.0
PA 19343 2.0
PA 19344 2.0
PA 19345 1.0
PA 19346 1.0
PA 19347 1.0
PA 19348 1.0
PA 19350 1.0
PA 19351 1.0
PA 19352 2.0
PA 19353 1.0
PA 19354 1.0
PA 19355 1.0
PA 19357 1.0
PA 19358 1.0
PA 19360 2.0
PA 19362 2.0
PA 19363 2.0
PA 19365 1.0
PA 19366 1.0
PA 19367 1.0
PA 19369 1.0
PA 19371 2.0
PA 19372 1.0
PA 19373 1.0
PA 19374 1.0
PA 19375 1.0
PA 19376 1.0
PA 19380 1.0
PA 19381 1.0
PA 19382 1.0
PA 19383 1.0
PA 19390 1.0
PA 19395 1.0
PA 19397 1.0
PA 19398 1.0
PA 19399 1.0
PA 19401 1.0
PA 19403 1.0
PA 19404 1.0
PA 19405 1.0
PA 19406 1.0
PA 19407 1.0
PA 19408 1.0
PA 19409 1.0
PA 19415 1.0
PA 19420 1.0
PA 19421 1.0
PA 19422 1.0
PA 19423 1.0
PA 19424 1.0
PA 19425 1.0
PA 19426 1.0
PA 19428 1.0
PA 19429 1.0
PA 19430 1.0
PA 19432 1.0
PA 19435 2.0
PA 19436 1.0
PA 19437 1.0
PA 19438 1.0
PA 19440 1.0
PA 19441 1.0
PA 19442 1.0
PA 19443 1.0
PA 19444 1.0
PA 19446 1.0
PA 19450 1.0
PA 19451 1.0
PA 19453 1.0
PA 19454 1.0
PA 19455 1.0
PA 19456 1.0
PA 19457 1.0
PA 19460 1.0
PA 19462 1.0
PA 19464 2.0
PA 19465 2.0
PA 19468 1.0
PA 19470 2.0
PA 19472 2.0
PA 19473 1.0
PA 19474 1.0
PA 19475 1.0
PA 19477 1.0
PA 19478 1.0
PA 19480 1.0
PA 19481 1.0
PA 19482 1.0
PA 19483 1.0
PA 19484 1.0
PA 19485 1.0
PA 19486 1.0
PA 19487 1.0
PA 19488 1.0
PA 19489 1.0
PA 19490 1.0
PA 19492 1.0
PA 19493 1.0
PA 19494 1.0
PA 19495 1.0
PA 19496 1.0
PA 19501 1.0
PA 19503 2.0
PA 19504 2.0
PA 19505 2.0
PA 19506 2.0
PA 19507 2.0
PA 19508 1.0
PA 19510 1.0
PA 19511 2.0
PA 19512 2.0
PA 19516 2.0
PA 19518 1.0
PA 19519 1.0
PA 19520 2.0
PA 19522 2.0
PA 19523 1.0
PA 19525 2.0
PA 19526 2.0
PA 19529 3.0
PA 19530 7.3
PA 19533 1.0
PA 19534 3.0
PA 19535 2.0
PA 19536 2.0
PA 19538 7.3
PA 19539 2.0
PA 19540 2.1
PA 19541 2.0
PA 19542 1.0
PA 19543 2.1
PA 19544 2.0
PA 19545 2.0
PA 19547 2.0
PA 19548 2.0
PA 19549 5.0
PA 19550 2.0
PA 19551 1.0
PA 19554 2.0
PA 19555 2.0
PA 19557 3.0
PA 19559 2.0
PA 19560 1.0
PA 19562 2.0
PA 19564 7.3
PA 19565 1.0
PA 19567 1.0
PA 19601 1.0
PA 19602 1.0
PA 19603 1.0
PA 19604 1.0
PA 19605 1.0
PA 19606 1.0
PA 19607 1.0
PA 19608 1.0
PA 19609 1.0
PA 19610 1.0
PA 19611 1.0
PA 19612 1.0
PA 19640 1.0
PR 00601 R
PR 00602 U
PR 00603 U
PR 00604 U
PR 00605 U
PR 00606 R
PR 00610 U
PR 00611 R
PR 00612 U
PR 00613 U
PR 00614 U
PR 00616 U
PR 00617 U
PR 00622 U
PR 00623 U
PR 00624 U
PR 00627 U
PR 00631 R
PR 00636 U
PR 00637 U
PR 00638 R
PR 00641 R
PR 00646 U
PR 00647 R
PR 00650 U
PR 00652 U
PR 00653 R
PR 00656 U
PR 00659 U
PR 00660 U
PR 00662 R
PR 00664 R
PR 00667 R
PR 00669 R
PR 00670 R
PR 00674 U
PR 00676 U
PR 00677 R
PR 00678 R
PR 00680 U
PR 00681 U
PR 00682 U
PR 00683 U
PR 00685 R
PR 00687 U
PR 00688 U
PR 00690 U
PR 00692 U
PR 00693 U
PR 00694 U
PR 00698 U
PR 00703 U
PR 00704 R
PR 00705 R
PR 00707 R
PR 00714 R
PR 00715 U
PR 00716 U
PR 00717 U
PR 00718 U
PR 00719 U
PR 00720 R
PR 00721 U
PR 00723 R
PR 00725 U
PR 00726 U
PR 00727 U
PR 00728 U
PR 00729 U
PR 00730 U
PR 00731 U
PR 00732 U
PR 00733 U
PR 00734 U
PR 00735 U
PR 00736 U
PR 00737 U
PR 00738 U
PR 00739 U
PR 00740 U
PR 00741 U
PR 00742 U
PR 00744 U
PR 00745 U
PR 00751 R
PR 00754 U
PR 00757 R
PR 00765 R
PR 00766 U
PR 00767 U
PR 00769 R
PR 00771 U
PR 00772 U
PR 00773 U
PR 00775 R
PR 00777 U
PR 00778 U
PR 00780 U
PR 00782 U
PR 00783 U
PR 00784 R
PR 00785 R
PR 00786 R
PR 00791 U
PR 00792 U
PR 00794 R
PR 00795 U
PR 00901 U
PR 00902 U
PR 00906 U
PR 00907 U
PR 00908 U
PR 00909 U
PR 00910 U
PR 00911 U
PR 00912 U
PR 00913 U
PR 00914 U
PR 00915 U
PR 00916 U
PR 00917 U
PR 00918 U
PR 00919 U
PR 00920 U
PR 00921 U
PR 00922 U
PR 00923 U
PR 00924 U
PR 00925 U
PR 00926 U
PR 00927 U
PR 00928 U
PR 00929 U
PR 00930 U
PR 00931 U
PR 00933 U
PR 00934 U
PR 00935 U
PR 00936 U
PR 00937 U
PR 00938 U
PR 00939 U
PR 00940 U
PR 00949 U
PR 00950 U
PR 00951 U
PR 00952 U
PR 00953 U
PR 00954 U
PR 00955 U
PR 00956 U
PR 00957 U
PR 00958 U
PR 00959 U
PR 00960 U
PR 00961 U
PR 00962 U
PR 00963 U
PR 00965 U
PR 00966 U
PR 00968 U
PR 00969 U
PR 00970 U
PR 00971 U
PR 00975 U
PR 00976 U
PR 00977 U
PR 00978 U
PR 00979 U
PR 00981 U
PR 00982 U
PR 00983 U
PR 00984 U
PR 00985 U
PR 00986 U
PR 00987 U
PR 00988 U
PW 96940 R
RI 02801 2.0
RI 02802 1.0
RI 02804 3.0
RI 02806 1.0
RI 02807 2.0
RI 02808 4.1
RI 02809 1.0
RI 02812 2.0
RI 02813 2.0
RI 02814 2.0
RI 02815 2.0
RI 02816 1.0
RI 02817 2.0
RI 02818 1.0
RI 02822 2.0
RI 02823 1.0
RI 02824 1.0
RI 02825 2.0
RI 02826 1.0
RI 02827 2.0
RI 02828 1.0
RI 02829 2.0
RI 02830 1.0
RI 02831 1.0
RI 02832 3.0
RI 02833 3.0
RI 02835 1.0
RI 02836 2.0
RI 02837 2.0
RI 02838 1.0
RI 02839 1.0
RI 02840 1.0
RI 02841 1.0
RI 02842 1.0
RI 02852 1.0
RI 02854 1.0
RI 02857 2.0
RI 02858 1.0
RI 02859 1.0
RI 02860 1.0
RI 02861 1.0
RI 02862 1.0
RI 02863 1.0
RI 02864 1.0
RI 02865 1.0
RI 02871 1.0
RI 02872 1.0
RI 02873 3.0
RI 02874 1.0
RI 02875 2.0
RI 02876 1.0
RI 02877 2.0
RI 02878 1.0
RI 02879 1.0
RI 02880 1.0
RI 02881 1.0
RI 02882 1.0
RI 02883 1.0
RI 02885 1.0
RI 02886 1.0
RI 02887 1.0
RI 02888 1.0
RI 02889 1.0
RI 02891 4.1
RI 02892 2.0
RI 02893 1.0
RI 02894 2.0
RI 02895 1.0
RI 02896 1.0
RI 02898 2.0
RI 02901 1.0
RI 02902 1.0
RI 02903 1.0
RI 02904 1.0
RI 02905 1.0
RI 02906 1.0
RI 02907 1.0
RI 02908 1.0
RI 02909 1.0
RI 02910 1.0
RI 02911 1.0
RI 02912 1.0
RI 02914 1.0
RI 02915 1.0
RI 02916 1.0
RI 02917 1.0
RI 02918 1.0
RI 02919 1.0
RI 02920 1.0
RI 02921 1.0
RI 02940 1.0
SC 29001 9.1
SC 29002 1.0
SC 29003 7.4
SC 29006 2.0
SC 29009 5.0
SC 29010 7.4
SC 29014 10.5
SC 29015 6.1
SC 29016 2.0
SC 29018 5.0
SC 29020 4.2
SC 29030 6.1
SC 29031 5.0
SC 29032 5.0
SC 29033 1.0
SC 29036 2.0
SC 29037 6.0
SC 29038 5.0
SC 29039 5.0
SC 29040 2.0
SC 29041 10.6
SC 29042 7.0
SC 29044 2.0
SC 29045 2.0
SC 29046 7.4
SC 29047 6.0
SC 29048 3.0
SC 29051 10.0
SC 29052 2.0
SC 29053 2.0
SC 29054 2.0
SC 29055 10.5
SC 29056 9.0
SC 29058 5.0
SC 29059 10.4
SC 29061 2.0
SC 29062 6.1
SC 29063 1.0
SC 29065 6.1
SC 29067 6.0
SC 29069 2.0
SC 29070 2.0
SC 29071 1.0
SC 29072 1.0
SC 29073 1.0
SC 29074 5.0
SC 29075 2.0
SC 29078 4.2
SC 29079 4.2
SC 29080 10.6
SC 29081 10.6
SC 29082 10.5
SC 29101 10.5
SC 29102 10.6
SC 29104 2.0
SC 29105 3.0
SC 29106 6.1
SC 29107 5.2
SC 29108 4.2
SC 29111 10.4
SC 29112 5.2
SC 29113 6.0
SC 29114 2.0
SC 29115 4.0
SC 29116 4.0
SC 29117 4.0
SC 29118 4.0
SC 29122 2.0
SC 29123 2.0
SC 29125 2.0
SC 29126 5.2
SC 29127 2.0
SC 29128 6.1
SC 29129 10.4
SC 29130 2.0
SC 29132 7.1
SC 29133 4.0
SC 29135 10.5
SC 29137 3.0
SC 29138 7.0
SC 29142 10.5
SC 29143 10.0
SC 29145 5.0
SC 29146 6.0
SC 29147 1.0
SC 29148 10.4
SC 29150 1.0
SC 29151 1.0
SC 29152 1.0
SC 29153 2.0
SC 29154 1.0
SC 29160 2.0
SC 29161 2.0
SC 29162 10.4
SC 29163 10.5
SC 29164 2.1
SC 29166 10.4
SC 29168 2.0
SC 29169 1.0
SC 29170 1.0
SC 29171 1.0
SC 29172 1.0
SC 29175 6.1
SC 29176 7.1
SC 29177 2.0
SC 29178 10.5
SC 29180 7.1
SC 29201 1.0
SC 29202 1.0
SC 29203 1.0
SC 29204 1.0
SC 29205 1.0
SC 29206 1.0
SC 29207 1.0
SC 29208 1.0
SC 29209 1.0
SC 29210 1.0
SC 29211 1.0
SC 29212 1.0
SC 29214 1.0
SC 29215 1.0
SC 29216 1.0
SC 29217 1.0
SC 29218 1.0
SC 29219 1.0
SC 29220 1.0
SC 29221 1.0
SC 29222 1.0
SC 29223 1.0
SC 29224 1.0
SC 29225 1.0
SC 29226 1.0
SC 29227 1.0
SC 29228 1.0
SC 29229 1.0
SC 29230 1.0
SC 29240 1.0
SC 29250 1.0
SC 29260 1.0
SC 29290 1.0
SC 29292 1.0
SC 29301 1.0
SC 29302 1.0
SC 29303 1.0
SC 29304 1.0
SC 29305 1.0
SC 29306 1.0
SC 29307 1.0
SC 29316 1.0
SC 29318 1.0
SC 29319 1.0
SC 29320 1.0
SC 29321 4.2
SC 29322 2.0
SC 29323 2.0
SC 29324 1.0
SC 29325 4.0
SC 29329 1.0
SC 29330 2.0
SC 29331 2.0
SC 29332 6.0
SC 29333 1.0
SC 29334 1.0
SC 29335 2.0
SC 29336 1.0
SC 29338 1.0
SC 29340 4.0
SC 29341 4.0
SC 29342 4.0
SC 29346 1.0
SC 29348 1.0
SC 29349 1.0
SC 29351 5.0
SC 29353 2.0
SC 29355 10.5
SC 29356 2.0
SC 29360 4.0
SC 29364 4.2
SC 29365 1.0
SC 29368 2.0
SC 29369 1.0
SC 29370 6.0
SC 29372 2.0
SC 29373 2.0
SC 29374 2.0
SC 29375 2.1
SC 29376 2.0
SC 29377 1.0
SC 29378 1.0
SC 29379 4.2
SC 29384 6.0
SC 29385 1.0
SC 29386 1.0
SC 29388 2.1
SC 29390 1.0
SC 29391 1.0
SC 29395 2.0
SC 29401 1.0
SC 29402 1.0
SC 29403 1.0
SC 29404 1.0
SC 29405 1.0
SC 29406 1.0
SC 29407 1.0
SC 29409 1.0
SC 29410 1.0
SC 29412 1.0
SC 29413 1.0
SC 29414 1.0
SC 29415 1.0
SC 29416 1.0
SC 29417 1.0
SC 29418 1.0
SC 29419 1.0
SC 29420 1.0
SC 29422 1.0
SC 29423 1.0
SC 29424 1.0
SC 29425 1.0
SC 29426 2.0
SC 29429 2.0
SC 29430 2.0
SC 29431 2.0
SC 29432 5.0
SC 29433 2.0
SC 29434 2.0
SC 29435 2.0
SC 29436 2.0
SC 29437 2.0
SC 29438 2.0
SC 29439 1.0
SC 29440 4.2
SC 29442 4.2
SC 29445 1.0
SC 29446 10.4
SC 29447 10.4
SC 29448 2.0
SC 29449 2.0
SC 29450 2.0
SC 29451 1.0
SC 29452 10.4
SC 29453 2.0
SC 29455 2.0
SC 29456 1.0
SC 29457 2.0
SC 29458 2.0
SC 29461 7.1
SC 29464 1.0
SC 29465 1.0
SC 29466 1.0
SC 29468 2.0
SC 29469 7.1
SC 29470 2.0
SC 29471 2.0
SC 29472 2.0
SC 29474 2.0
SC 29475 5.0
SC 29476 2.0
SC 29477 10.4
SC 29479 2.0
SC 29481 10.0
SC 29482 1.0
SC 29483 1.0
SC 29484 1.0
SC 29485 1.0
SC 29487 2.0
SC 29488 5.0
SC 29492 2.0
SC 29493 5.0
SC 29501 1.0
SC 29502 1.0
SC 29503 1.0
SC 29504 1.0
SC 29505 1.0
SC 29506 1.0
SC 29510 7.2
SC 29511 2.0
SC 29512 4.0
SC 29516 5.0
SC 29518 10.6
SC 29519 7.0
SC 29520 7.0
SC 29525 5.0
SC 29526 1.0
SC 29527 2.0
SC 29528 1.0
SC 29530 2.0
SC 29532 4.1
SC 29536 4.0
SC 29540 1.0
SC 29541 2.0
SC 29542 4.0
SC 29543 6.0
SC 29544 2.0
SC 29545 2.0
SC 29546 2.0
SC 29547 5.0
SC 29550 4.2
SC 29551 4.2
SC 29554 10.0
SC 29555 10.4
SC 29556 7.0
SC 29560 7.3
SC 29563 6.0
SC 29564 9.0
SC 29565 6.0
SC 29566 1.0
SC 29567 5.0
SC 29568 2.0
SC 29569 2.0
SC 29570 6.0
SC 29571 7.0
SC 29572 1.0
SC 29573 4.0
SC 29574 7.0
SC 29575 1.0
SC 29576 1.0
SC 29577 1.0
SC 29578 1.0
SC 29579 1.0
SC 29580 9.0
SC 29581 2.0
SC 29582 1.0
SC 29583 2.0
SC 29584 9.2
SC 29585 7.3
SC 29587 1.0
SC 29588 1.0
SC 29589 7.0
SC 29590 9.0
SC 29591 2.0
SC 29592 6.0
SC 29593 6.1
SC 29594 6.0
SC 29596 8.0
SC 29597 1.0
SC 29598 1.0
SC 29601 1.0
SC 29602 1.0
SC 29603 1.0
SC 29604 1.0
SC 29605 1.0
SC 29606 1.0
SC 29607 1.0
SC 29608 1.0
SC 29609 1.0
SC 29610 1.0
SC 29611 1.0
SC 29612 1.0
SC 29613 1.0
SC 29614 1.0
SC 29615 1.0
SC 29616 1.0
SC 29617 1.0
SC 29620 7.4
SC 29621 1.0
SC 29622 1.0
SC 29623 1.0
SC 29624 1.0
SC 29625 1.0
SC 29626 1.0
SC 29627 2.0
SC 29628 10.6
SC 29630 4.2
SC 29631 4.2
SC 29632 4.2
SC 29633 4.2
SC 29634 4.2
SC 29635 2.0
SC 29636 1.0
SC 29638 6.1
SC 29639 10.4
SC 29640 1.0
SC 29641 1.0
SC 29642 1.0
SC 29643 5.0
SC 29644 2.1
SC 29645 2.1
SC 29646 4.0
SC 29647 5.0
SC 29648 4.0
SC 29649 4.0
SC 29650 1.0
SC 29651 1.0
SC 29652 1.0
SC 29653 5.0
SC 29654 2.0
SC 29655 2.0
SC 29656 4.2
SC 29657 1.0
SC 29658 5.0
SC 29659 2.0
SC 29661 2.0
SC 29662 2.0
SC 29664 5.0
SC 29665 4.2
SC 29666 5.0
SC 29667 4.2
SC 29669 2.0
SC 29670 4.2
SC 29671 1.0
SC 29672 4.2
SC 29673 1.0
SC 29675 5.0
SC 29676 5.0
SC 29677 4.2
SC 29678 4.2
SC 29679 4.2
SC 29680 2.0
SC 29681 2.0
SC 29682 2.0
SC 29683 2.0
SC 29684 2.0
SC 29685 2.0
SC 29686 5.0
SC 29687 1.0
SC 29688 2.0
SC 29689 2.0
SC 29690 2.0
SC 29691 5.0
SC 29692 5.0
SC 29693 5.0
SC 29695 5.0
SC 29696 5.0
SC 29697 2.0
SC 29698 1.0
SC 29702 5.0
SC 29703 2.0
SC 29704 2.1
SC 29706 4.0
SC 29708 1.0
SC 29709 8.0
SC 29710 2.0
SC 29712 3.0
SC 29714 3.0
SC 29715 1.0
SC 29716 1.0
SC 29717 3.0
SC 29718 9.0
SC 29720 4.0
SC 29721 4.0
SC 29722 4.0
SC 29724 3.0
SC 29726 2.1
SC 29727 9.0
SC 29728 7.3
SC 29729 3.0
SC 29730 1.1
SC 29731 1.1
SC 29732 1.1
SC 29733 1.1
SC 29734 1.1
SC 29741 9.0
SC 29742 3.0
SC 29743 3.0
SC 29744 4.0
SC 29745 2.1
SC 29801 1.0
SC 29802 1.0
SC 29803 1.0
SC 29804 1.0
SC 29805 2.0
SC 29808 9.0
SC 29809 2.0
SC 29810 7.0
SC 29812 8.0
SC 29813 8.0
SC 29816 1.0
SC 29817 10.6
SC 29819 5.0
SC 29821 2.0
SC 29822 2.0
SC 29824 7.3
SC 29826 10.4
SC 29827 8.0
SC 29828 1.0
SC 29829 1.0
SC 29831 2.0
SC 29832 10.6
SC 29834 1.0
SC 29835 10.5
SC 29836 7.0
SC 29838 2.0
SC 29839 1.0
SC 29840 10.0
SC 29841 1.0
SC 29842 2.0
SC 29843 10.6
SC 29844 2.0
SC 29845 2.0
SC 29846 8.0
SC 29847 2.0
SC 29848 5.0
SC 29849 8.0
SC 29850 1.0
SC 29851 1.0
SC 29853 10.4
SC 29856 2.0
SC 29860 2.0
SC 29861 1.0
SC 29899 10.5
SC 29901 4.0
SC 29902 4.0
SC 29903 4.0
SC 29904 4.0
SC 29905 4.0
SC 29906 4.0
SC 29907 4.0
SC 29909 5.0
SC 29910 5.0
SC 29911 8.0
SC 29912 7.4
SC 29913 7.0
SC 29914 5.0
SC 29915 4.0
SC 29916 10.5
SC 29918 7.0
SC 29920 5.0
SC 29921 7.0
SC 29922 10.6
SC 29923 7.0
SC 29924 7.0
SC 29925 4.0
SC 29926 4.0
SC 29927 10.5
SC 29928 4.0
SC 29929 10.5
SC 29931 5.0
SC 29932 7.0
SC 29933 7.0
SC 29934 8.4
SC 29935 4.0
SC 29936 7.4
SC 29938 4.0
SC 29939 7.0
SC 29940 5.0
SC 29941 5.0
SC 29943 8.4
SC 29944 7.0
SC 29945 5.0
SD 57001 10.4
SD 57002 5.0
SD 57003 2.0
SD 57004 10.4
SD 57005 2.0
SD 57006 4.0
SD 57007 4.0
SD 57010 5.0
SD 57012 10.4
SD 57013 7.1
SD 57014 10.4
SD 57015 10.1
SD 57016 8.3
SD 57017 10.4
SD 57018 2.0
SD 57020 2.0
SD 57021 10.4
SD 57022 2.0
SD 57024 10.4
SD 57025 2.0
SD 57026 5.0
SD 57027 3.0
SD 57028 10.4
SD 57029 10.0
SD 57030 2.0
SD 57031 5.0
SD 57032 1.0
SD 57033 2.0
SD 57034 3.0
SD 57035 2.0
SD 57036 10.4
SD 57037 5.0
SD 57038 1.0
SD 57039 2.0
SD 57040 5.0
SD 57041 2.0
SD 57042 7.0
SD 57043 10.1
SD 57044 5.0
SD 57045 10.0
SD 57046 5.0
SD 57047 10.1
SD 57048 10.4
SD 57049 1.0
SD 57050 8.0
SD 57051 10.5
SD 57052 10.0
SD 57053 10.1
SD 57054 8.0
SD 57055 2.0
SD 57056 2.0
SD 57057 8.0
SD 57058 10.4
SD 57059 10.5
SD 57061 4.0
SD 57062 10.0
SD 57063 10.5
SD 57064 1.0
SD 57065 10.4
SD 57066 10.5
SD 57067 5.0
SD 57068 2.0
SD 57069 4.0
SD 57070 10.4
SD 57071 5.0
SD 57072 5.0
SD 57073 5.0
SD 57075 8.3
SD 57076 8.0
SD 57077 2.0
SD 57078 4.0
SD 57079 4.0
SD 57101 1.0
SD 57103 1.0
SD 57104 1.0
SD 57105 1.0
SD 57106 1.0
SD 57107 1.0
SD 57108 1.0
SD 57109 1.0
SD 57110 1.0
SD 57117 1.0
SD 57118 1.0
SD 57186 1.0
SD 57188 1.0
SD 57189 1.0
SD 57192 1.0
SD 57193 1.0
SD 57194 1.0
SD 57195 1.0
SD 57196 1.0
SD 57197 1.0
SD 57198 2.0
SD 57201 4.0
SD 57212 10.5
SD 57213 10.0
SD 57214 10.5
SD 57216 7.0
SD 57217 10.5
SD 57218 10.0
SD 57219 10.0
SD 57220 5.0
SD 57221 10.5
SD 57223 10.5
SD 57224 10.0
SD 57225 10.5
SD 57226 10.0
SD 57227 10.6
SD 57231 10.0
SD 57232 10.0
SD 57233 10.5
SD 57234 10.5
SD 57235 5.0
SD 57236 10.5
SD 57237 10.0
SD 57238 10.0
SD 57239 10.0
SD 57241 10.5
SD 57242 10.5
SD 57243 5.0
SD 57245 5.0
SD 57246 8.0
SD 57247 10.0
SD 57248 10.5
SD 57249 10.5
SD 57251 7.0
SD 57252 7.0
SD 57253 7.0
SD 57255 10.0
SD 57256 10.0
SD 57257 10.0
SD 57258 10.5
SD 57259 8.0
SD 57260 10.0
SD 57261 10.0
SD 57262 10.0
SD 57263 5.0
SD 57264 8.0
SD 57265 8.0
SD 57266 10.0
SD 57268 10.0
SD 57269 8.0
SD 57270 10.0
SD 57271 10.0
SD 57272 5.0
SD 57273 10.0
SD 57274 10.0
SD 57276 5.0
SD 57278 10.0
SD 57279 10.6
SD 57301 4.0
SD 57311 5.0
SD 57312 10.0
SD 57313 10.0
SD 57314 10.5
SD 57315 10.0
SD 57317 10.0
SD 57319 10.4
SD 57321 10.0
SD 57322 5.0
SD 57323 10.0
SD 57324 5.0
SD 57325 10.0
SD 57326 10.0
SD 57328 10.0
SD 57329 10.0
SD 57330 10.0
SD 57331 10.5
SD 57332 5.0
SD 57334 5.0
SD 57335 10.0
SD 57337 10.0
SD 57339 10.0
SD 57340 5.0
SD 57341 10.0
SD 57342 10.0
SD 57344 10.0
SD 57345 10.0
SD 57346 10.0
SD 57348 5.0
SD 57349 10.0
SD 57350 4.0
SD 57353 10.0
SD 57354 10.0
SD 57355 10.0
SD 57356 10.0
SD 57358 10.0
SD 57359 10.5
SD 57361 10.0
SD 57362 10.0
SD 57363 5.0
SD 57364 10.0
SD 57365 10.0
SD 57366 10.5
SD 57367 10.0
SD 57368 10.5
SD 57369 10.0
SD 57370 10.0
SD 57371 10.0
SD 57373 10.0
SD 57374 10.4
SD 57375 10.5
SD 57376 10.0
SD 57379 5.0
SD 57380 10.0
SD 57381 5.0
SD 57382 10.0
SD 57383 10.5
SD 57384 5.0
SD 57385 10.5
SD 57386 5.0
SD 57399 4.0
SD 57401 4.0
SD 57402 4.0
SD 57420 10.6
SD 57421 10.0
SD 57422 10.0
SD 57424 10.3
SD 57426 5.0
SD 57427 5.0
SD 57428 10.0
SD 57429 10.6
SD 57430 10.0
SD 57432 10.5
SD 57433 10.5
SD 57434 10.6
SD 57435 10.0
SD 57436 10.6
SD 57437 10.0
SD 57438 10.0
SD 57439 10.6
SD 57440 10.6
SD 57441 5.0
SD 57442 10.0
SD 57445 5.0
SD 57446 10.5
SD 57448 10.0
SD 57449 10.5
SD 57450 10.0
SD 57451 10.2
SD 57452 10.6
SD 57454 10.0
SD 57455 10.0
SD 57456 10.0
SD 57457 10.0
SD 57460 5.0
SD 57461 10.3
SD 57465 10.3
SD 57466 10.0
SD 57467 10.0
SD 57468 10.0
SD 57469 7.0
SD 57470 10.0
SD 57471 10.0
SD 57472 10.6
SD 57473 10.0
SD 57474 5.0
SD 57475 10.0
SD 57476 10.3
SD 57477 10.6
SD 57479 5.0
SD 57481 5.0
SD 57501 4.0
SD 57520 10.5
SD 57521 10.0
SD 57522 5.0
SD 57523 10.0
SD 57528 10.3
SD 57529 10.0
SD 57531 10.0
SD 57532 4.0
SD 57533 10.0
SD 57534 10.3
SD 57536 5.0
SD 57537 4.0
SD 57538 10.0
SD 57540 10.0
SD 57541 10.3
SD 57542 10.0
SD 57543 10.0
SD 57544 10.0
SD 57547 10.0
SD 57548 10.0
SD 57551 10.0
SD 57552 10.0
SD 57553 10.0
SD 57555 10.0
SD 57559 10.0
SD 57560 10.0
SD 57562 10.0
SD 57563 10.0
SD 57564 10.5
SD 57566 10.0
SD 57567 10.0
SD 57568 10.0
SD 57569 10.0
SD 57570 10.0
SD 57571 10.0
SD 57572 10.0
SD 57574 10.0
SD 57576 10.0
SD 57577 10.0
SD 57579 10.0
SD 57580 7.0
SD 57584 10.3
SD 57585 10.0
SD 57601 7.0
SD 57620 10.0
SD 57621 10.0
SD 57622 10.0
SD 57623 10.0
SD 57625 10.0
SD 57626 10.4
SD 57630 10.0
SD 57631 10.6
SD 57632 10.0
SD 57633 10.0
SD 57634 10.0
SD 57636 10.0
SD 57638 10.0
SD 57639 10.0
SD 57640 10.0
SD 57641 10.0
SD 57642 10.0
SD 57644 10.0
SD 57645 10.0
SD 57646 10.0
SD 57648 10.0
SD 57649 10.0
SD 57650 10.0
SD 57651 10.0
SD 57652 10.0
SD 57656 10.0
SD 57657 10.0
SD 57658 10.6
SD 57659 10.0
SD 57660 10.0
SD 57661 10.0
SD 57701 1.0
SD 57702 1.0
SD 57703 1.0
SD 57706 7.3
SD 57709 1.0
SD 57714 10.6
SD 57716 8.0
SD 57717 7.4
SD 57718 1.0
SD 57719 1.0
SD 57720 10.0
SD 57722 10.4
SD 57724 10.0
SD 57725 2.0
SD 57730 10.0
SD 57732 10.5
SD 57735 10.3
SD 57736 10.4
SD 57737 10.4
SD 57738 10.4
SD 57741 2.0
SD 57744 10.4
SD 57745 2.0
SD 57747 7.0
SD 57748 10.4
SD 57750 10.0
SD 57751 2.0
SD 57752 8.0
SD 57754 10.3
SD 57755 10.0
SD 57756 8.0
SD 57758 10.4
SD 57759 10.0
SD 57760 10.6
SD 57761 2.0
SD 57762 10.6
SD 57763 10.3
SD 57764 7.0
SD 57766 10.3
SD 57767 2.0
SD 57769 2.0
SD 57770 7.0
SD 57772 8.0
SD 57773 10.0
SD 57775 2.0
SD 57776 10.0
SD 57777 10.4
SD 57779 10.5
SD 57780 2.0
SD 57782 10.3
SD 57783 4.0
SD 57785 7.3
SD 57787 10.4
SD 57788 10.6
SD 57790 2.0
SD 57791 2.0
SD 57792 10.4
SD 57793 10.5
SD 57794 10.3
SD 57799 4.0
TN 37010 1.0
TN 37011 1.0
TN 37012 10.6
TN 37013 1.0
TN 37014 2.0
TN 37015 2.0
TN 37016 2.0
TN 37018 9.1
TN 37019 8.0
TN 37020 5.2
TN 37022 2.0
TN 37023 2.0
TN 37024 1.0
TN 37025 2.0
TN 37026 2.0
TN 37027 1.0
TN 37028 2.0
TN 37029 4.2
TN 37030 7.0
TN 37031 2.0
TN 37032 2.0
TN 37033 10.4
TN 37034 2.0
TN 37035 2.0
TN 37036 5.2
TN 37037 2.1
TN 37040 1.0
TN 37041 1.0
TN 37042 1.0
TN 37043 1.0
TN 37044 1.0
TN 37046 2.0
TN 37047 8.0
TN 37048 2.0
TN 37049 2.0
TN 37050 2.0
TN 37051 5.2
TN 37052 2.0
TN 37055 4.2
TN 37056 4.2
TN 37057 7.3
TN 37058 10.4
TN 37059 10.6
TN 37060 2.1
TN 37061 10.5
TN 37062 2.0
TN 37063 5.2
TN 37064 1.0
TN 37065 1.0
TN 37066 1.0
TN 37067 1.0
TN 37068 1.0
TN 37069 1.0
TN 37070 1.0
TN 37071 1.0
TN 37072 1.0
TN 37073 1.0
TN 37074 2.0
TN 37075 1.0
TN 37076 1.0
TN 37077 1.0
TN 37078 8.0
TN 37079 2.0
TN 37080 2.0
TN 37082 2.0
TN 37083 7.3
TN 37085 2.1
TN 37086 1.1
TN 37087 4.1
TN 37088 4.1
TN 37089 1.1
TN 37090 2.0
TN 37091 7.0
TN 37095 10.6
TN 37096 10.0
TN 37097 10.0
TN 37098 2.0
TN 37101 6.0
TN 37110 4.0
TN 37111 4.0
TN 37115 1.0
TN 37116 1.0
TN 37118 2.1
TN 37119 7.1
TN 37121 1.0
TN 37122 1.0
TN 37127 1.1
TN 37128 1.1
TN 37129 1.1
TN 37130 1.1
TN 37131 1.1
TN 37132 1.1
TN 37133 1.1
TN 37134 10.6
TN 37135 2.0
TN 37136 5.2
TN 37137 3.0
TN 37138 1.0
TN 37140 3.0
TN 37141 2.0
TN 37142 2.0
TN 37143 2.0
TN 37144 8.0
TN 37145 8.0
TN 37146 2.0
TN 37148 7.1
TN 37149 2.1
TN 37150 10.6
TN 37151 8.0
TN 37152 1.0
TN 37153 2.1
TN 37155 1.0
TN 37160 4.0
TN 37161 4.0
TN 37162 4.0
TN 37165 5.2
TN 37166 7.0
TN 37167 1.1
TN 37171 2.0
TN 37172 1.0
TN 37174 2.0
TN 37175 10.0
TN 37178 10.0
TN 37179 2.0
TN 37180 5.2
TN 37181 5.2
TN 37183 5.0
TN 37184 5.2
TN 37185 7.0
TN 37186 2.0
TN 37187 2.0
TN 37188 2.0
TN 37189 1.0
TN 37190 2.0
TN 37191 2.0
TN 37201 1.0
TN 37202 1.0
TN 37203 1.0
TN 37204 1.0
TN 37205 1.0
TN 37206 1.0
TN 37207 1.0
TN 37208 1.0
TN 37209 1.0
TN 37210 1.0
TN 37211 1.0
TN 37212 1.0
TN 37213 1.0
TN 37214 1.0
TN 37215 1.0
TN 37216 1.0
TN 37217 1.0
TN 37218 1.0
TN 37219 1.0
TN 37220 1.0
TN 37221 1.0
TN 37222 1.0
TN 37224 1.0
TN 37227 1.0
TN 37228 1.0
TN 37229 1.0
TN 37230 1.0
TN 37232 1.0
TN 37234 1.0
TN 37235 1.0
TN 37236 1.0
TN 37237 1.0
TN 37238 1.0
TN 37239 1.0
TN 37240 1.0
TN 37241 1.0
TN 37242 1.0
TN 37243 1.0
TN 37244 1.0
TN 37245 1.0
TN 37246 1.0
TN 37247 1.0
TN 37248 1.0
TN 37249 1.0
TN 37250 1.0
TN 37301 10.5
TN 37302 1.0
TN 37303 4.0
TN 37304 2.0
TN 37305 10.5
TN 37306 5.0
TN 37307 2.0
TN 37308 2.1
TN 37309 5.2
TN 37310 1.0
TN 37311 1.0
TN 37312 1.0
TN 37313 10.4
TN 37314 10.5
TN 37315 1.0
TN 37316 2.0
TN 37317 10.0
TN 37318 4.0
TN 37320 1.0
TN 37321 7.3
TN 37322 10.5
TN 37323 1.0
TN 37324 5.0
TN 37325 2.0
TN 37326 10.0
TN 37327 10.4
TN 37328 8.3
TN 37329 5.0
TN 37330 5.0
TN 37331 7.2
TN 37332 8.3
TN 37333 10.0
TN 37334 7.3
TN 37335 8.3
TN 37336 2.1
TN 37337 10.3
TN 37338 8.3
TN 37339 10.4
TN 37340 2.0
TN 37341 1.0
TN 37342 8.4
TN 37343 1.0
TN 37345 6.0
TN 37347 2.0
TN 37348 8.3
TN 37349 7.4
TN 37350 1.0
TN 37351 1.0
TN 37352 5.0
TN 37353 2.1
TN 37354 7.0
TN 37355 7.4
TN 37356 10.6
TN 37357 5.0
TN 37359 8.3
TN 37360 5.0
TN 37361 2.0
TN 37362 2.0
TN 37363 1.0
TN 37364 1.0
TN 37365 10.4
TN 37366 10.6
TN 37367 10.0
TN 37369 2.0
TN 37370 5.2
TN 37371 4.0
TN 37373 2.0
TN 37374 2.0
TN 37375 10.0
TN 37376 10.0
TN 37377 1.0
TN 37378 4.0
TN 37379 1.0
TN 37380 7.3
TN 37381 8.0
TN 37382 5.0
TN 37383 10.0
TN 37384 1.0
TN 37385 10.5
TN 37387 10.6
TN 37388 4.0
TN 37389 7.4
TN 37391 10.0
TN 37394 5.0
TN 37396 2.0
TN 37397 2.0
TN 37398 4.0
TN 37401 1.0
TN 37402 1.0
TN 37403 1.0
TN 37404 1.0
TN 37405 1.0
TN 37406 1.0
TN 37407 1.0
TN 37408 1.0
TN 37409 1.0
TN 37410 1.0
TN 37411 1.0
TN 37412 1.0
TN 37414 1.0
TN 37415 1.0
TN 37416 1.0
TN 37419 1.0
TN 37421 1.0
TN 37422 1.0
TN 37424 1.0
TN 37450 1.0
TN 37501 1.0
TN 37544 1.0
TN 37601 1.0
TN 37602 1.0
TN 37604 1.0
TN 37605 1.0
TN 37614 1.0
TN 37615 1.0
TN 37616 5.0
TN 37617 1.0
TN 37618 1.0
TN 37620 1.0
TN 37621 1.0
TN 37625 1.0
TN 37640 8.1
TN 37641 5.2
TN 37642 1.0
TN 37643 1.0
TN 37644 1.0
TN 37645 1.0
TN 37650 7.3
TN 37656 2.0
TN 37657 8.0
TN 37658 1.0
TN 37659 2.0
TN 37660 1.0
TN 37662 1.0
TN 37663 1.0
TN 37664 1.0
TN 37665 1.0
TN 37669 1.0
TN 37680 9.0
TN 37681 2.0
TN 37682 1.0
TN 37683 7.4
TN 37684 1.0
TN 37686 2.0
TN 37687 10.0
TN 37688 8.0
TN 37690 2.0
TN 37691 9.0
TN 37692 2.0
TN 37694 2.0
TN 37699 2.0
TN 37701 1.0
TN 37705 2.0
TN 37707 6.0
TN 37708 2.0
TN 37709 2.0
TN 37710 5.2
TN 37711 10.4
TN 37713 5.2
TN 37714 4.0
TN 37715 6.0
TN 37716 4.2
TN 37717 4.2
TN 37719 4.2
TN 37721 1.0
TN 37722 5.0
TN 37723 5.0
TN 37724 6.0
TN 37725 6.1
TN 37726 10.6
TN 37727 5.0
TN 37729 5.0
TN 37730 6.0
TN 37731 8.0
TN 37732 10.6
TN 37733 10.6
TN 37737 2.0
TN 37738 10.5
TN 37742 2.0
TN 37743 4.0
TN 37744 4.0
TN 37745 4.0
TN 37748 4.0
TN 37752 5.0
TN 37753 5.0
TN 37754 2.0
TN 37755 10.6
TN 37756 10.0
TN 37757 4.0
TN 37760 1.0
TN 37762 10.5
TN 37763 4.1
TN 37764 6.1
TN 37765 10.0
TN 37766 4.0
TN 37769 4.0
TN 37770 9.0
TN 37771 1.0
TN 37772 1.0
TN 37773 8.0
TN 37774 2.0
TN 37777 1.0
TN 37778 2.0
TN 37779 2.0
TN 37801 1.0
TN 37802 1.0
TN 37803 1.0
TN 37804 1.0
TN 37806 2.0
TN 37807 2.0
TN 37809 5.0
TN 37810 5.0
TN 37811 2.0
TN 37813 1.0
TN 37814 1.0
TN 37815 1.0
TN 37816 1.0
TN 37818 5.0
TN 37819 10.5
TN 37820 2.1
TN 37821 4.0
TN 37822 4.0
TN 37824 8.0
TN 37825 8.0
TN 37826 5.0
TN 37828 2.0
TN 37829 5.0
TN 37830 4.2
TN 37831 4.2
TN 37840 4.2
TN 37841 7.0
TN 37843 5.0
TN 37845 4.2
TN 37846 3.0
TN 37847 10.6
TN 37848 10.4
TN 37849 1.0
TN 37851 6.0
TN 37852 10.6
TN 37853 1.0
TN 37854 4.0
TN 37857 7.0
TN 37860 2.0
TN 37861 10.4
TN 37862 4.0
TN 37863 4.0
TN 37864 4.0
TN 37865 1.0
TN 37866 3.0
TN 37867 5.0
TN 37868 4.0
TN 37869 10.0
TN 37870 6.0
TN 37871 2.0
TN 37872 10.6
TN 37873 2.0
TN 37874 7.3
TN 37876 5.0
TN 37877 1.0
TN 37878 2.0
TN 37879 7.0
TN 37880 6.0
TN 37881 10.4
TN 37882 2.0
TN 37885 10.4
TN 37886 2.0
TN 37887 7.4
TN 37888 10.4
TN 37890 1.0
TN 37891 2.0
TN 37892 10.3
TN 37901 1.0
TN 37902 1.0
TN 37909 1.0
TN 37912 1.0
TN 37914 1.0
TN 37915 1.0
TN 37916 1.0
TN 37917 1.0
TN 37918 1.0
TN 37919 1.0
TN 37920 1.0
TN 37921 1.0
TN 37922 1.0
TN 37923 1.0
TN 37924 1.0
TN 37927 1.0
TN 37928 1.0
TN 37929 1.0
TN 37930 1.0
TN 37931 1.0
TN 37932 1.0
TN 37933 1.0
TN 37934 1.0
TN 37938 1.0
TN 37939 1.0
TN 37940 1.0
TN 37950 1.0
TN 37955 1.0
TN 37990 1.0
TN 37995 1.0
TN 37996 1.0
TN 37997 1.0
TN 37998 1.0
TN 38001 10.4
TN 38002 1.0
TN 38004 2.0
TN 38006 10.4
TN 38007 4.0
TN 38008 7.0
TN 38010 2.0
TN 38011 2.0
TN 38012 4.0
TN 38014 1.0
TN 38015 2.0
TN 38016 1.0
TN 38017 1.0
TN 38018 1.0
TN 38019 7.3
TN 38021 10.5
TN 38023 2.0
TN 38024 4.0
TN 38025 4.0
TN 38027 1.0
TN 38028 2.0
TN 38029 1.0
TN 38030 5.0
TN 38034 10.5
TN 38036 2.0
TN 38037 8.0
TN 38039 2.0
TN 38040 8.0
TN 38041 8.0
TN 38042 7.0
TN 38044 9.0
TN 38045 2.0
TN 38046 2.0
TN 38047 4.0
TN 38048 2.0
TN 38049 2.0
TN 38050 10.5
TN 38052 10.6
TN 38053 1.0
TN 38054 1.0
TN 38055 1.0
TN 38057 2.0
TN 38058 2.0
TN 38059 4.0
TN 38060 2.0
TN 38061 10.6
TN 38063 7.0
TN 38066 2.0
TN 38067 2.0
TN 38068 2.0
TN 38069 6.1
TN 38070 4.0
TN 38071 2.0
TN 38074 7.0
TN 38075 7.0
TN 38076 2.0
TN 38077 10.5
TN 38079 10.5
TN 38080 10.5
TN 38083 1.0
TN 38088 1.0
TN 38101 1.0
TN 38103 1.0
TN 38104 1.0
TN 38105 1.0
TN 38106 1.0
TN 38107 1.0
TN 38108 1.0
TN 38109 1.0
TN 38110 1.0
TN 38111 1.0
TN 38112 1.0
TN 38113 1.0
TN 38114 1.0
TN 38115 1.0
TN 38116 1.0
TN 38117 1.0
TN 38118 1.0
TN 38119 1.0
TN 38120 1.0
TN 38122 1.0
TN 38124 1.0
TN 38125 1.0
TN 38126 1.0
TN 38127 1.0
TN 38128 1.0
TN 38129 1.0
TN 38130 1.0
TN 38131 1.0
TN 38132 1.0
TN 38133 1.0
TN 38134 1.0
TN 38135 1.0
TN 38136 1.0
TN 38137 1.0
TN 38138 1.0
TN 38139 1.0
TN 38140 1.0
TN 38141 1.0
TN 38142 1.0
TN 38143 1.0
TN 38145 1.0
TN 38146 1.0
TN 38147 1.0
TN 38148 1.0
TN 38150 1.0
TN 38151 1.0
TN 38152 1.0
TN 38157 1.0
TN 38159 1.0
TN 38161 1.0
TN 38163 1.0
TN 38165 1.0
TN 38166 1.0
TN 38167 1.0
TN 38168 1.0
TN 38173 1.0
TN 38174 1.0
TN 38175 1.0
TN 38177 1.0
TN 38181 1.0
TN 38182 1.0
TN 38183 1.0
TN 38184 1.0
TN 38186 1.0
TN 38187 1.0
TN 38188 1.0
TN 38190 1.0
TN 38193 1.0
TN 38194 1.0
TN 38195 1.0
TN 38197 1.0
TN 38201 7.0
TN 38220 9.0
TN 38221 10.5
TN 38222 5.0
TN 38223 4.0
TN 38224 5.0
TN 38225 10.6
TN 38226 9.0
TN 38229 10.6
TN 38230 10.0
TN 38231 5.0
TN 38232 6.0
TN 38233 6.0
TN 38235 9.0
TN 38236 5.0
TN 38237 7.0
TN 38238 7.0
TN 38240 5.0
TN 38241 10.6
TN 38242 4.0
TN 38251 5.0
TN 38253 5.0
TN 38254 6.0
TN 38255 8.0
TN 38256 5.0
TN 38257 7.4
TN 38258 9.0
TN 38259 4.0
TN 38260 5.0
TN 38261 4.0
TN 38271 4.0
TN 38281 4.0
TN 38301 1.0
TN 38302 1.0
TN 38303 1.0
TN 38305 1.0
TN 38308 1.0
TN 38310 10.6
TN 38311 10.0
TN 38313 2.0
TN 38314 1.0
TN 38315 8.0
TN 38316 8.0
TN 38317 10.0
TN 38318 10.0
TN 38320 8.0
TN 38321 2.0
TN 38324 10.6
TN 38326 10.6
TN 38327 9.0
TN 38328 8.0
TN 38329 10.0
TN 38330 7.0
TN 38331 7.3
TN 38332 3.0
TN 38333 8.0
TN 38334 3.0
TN 38336 10.4
TN 38337 3.0
TN 38338 7.3
TN 38339 5.0
TN 38340 7.1
TN 38341 9.0
TN 38342 10.0
TN 38343 7.3
TN 38344 10.6
TN 38345 8.3
TN 38346 8.0
TN 38347 3.0
TN 38348 2.0
TN 38351 7.3
TN 38352 3.0
TN 38355 2.0
TN 38356 2.0
TN 38357 5.0
TN 38358 7.3
TN 38359 10.6
TN 38361 9.0
TN 38362 2.0
TN 38363 10.6
TN 38365 10.6
TN 38366 2.0
TN 38367 8.4
TN 38368 8.0
TN 38369 7.0
TN 38370 9.0
TN 38371 8.0
TN 38372 7.0
TN 38374 8.0
TN 38375 7.0
TN 38376 10.6
TN 38377 7.1
TN 38378 1.0
TN 38379 9.0
TN 38380 10.6
TN 38381 9.0
TN 38382 7.3
TN 38387 10.6
TN 38388 8.3
TN 38389 4.0
TN 38390 10.6
TN 38391 2.0
TN 38392 2.0
TN 38393 8.4
TN 38401 4.2
TN 38402 4.2
TN 38425 10.0
TN 38449 9.0
TN 38450 10.0
TN 38451 5.0
TN 38452 10.4
TN 38453 8.0
TN 38454 10.4
TN 38455 9.0
TN 38456 5.0
TN 38457 5.0
TN 38459 8.0
TN 38460 8.0
TN 38461 5.0
TN 38462 7.4
TN 38463 6.0
TN 38464 4.0
TN 38468 5.0
TN 38469 5.0
TN 38471 10.4
TN 38472 9.2
TN 38473 8.0
TN 38474 5.0
TN 38475 8.0
TN 38476 2.0
TN 38477 8.0
TN 38478 7.0
TN 38481 5.0
TN 38482 5.1
TN 38483 5.0
TN 38485 10.0
TN 38486 5.0
TN 38487 5.1
TN 38488 2.0
TN 38501 4.0
TN 38502 4.0
TN 38503 4.0
TN 38504 10.0
TN 38505 4.0
TN 38506 4.0
TN 38541 8.0
TN 38542 5.0
TN 38543 8.0
TN 38544 5.0
TN 38545 5.0
TN 38547 10.4
TN 38548 5.0
TN 38549 10.6
TN 38550 5.0
TN 38551 10.5
TN 38552 10.6
TN 38553 10.0
TN 38554 5.0
TN 38555 4.0
TN 38556 10.0
TN 38557 4.0
TN 38558 5.0
TN 38559 8.0
TN 38560 10.6
TN 38562 5.0
TN 38563 10.4
TN 38564 5.0
TN 38565 10.0
TN 38567 10.4
TN 38568 8.4
TN 38569 10.4
TN 38570 7.4
TN 38571 5.0
TN 38572 5.0
TN 38573 8.0
TN 38574 7.2
TN 38575 10.0
TN 38577 10.6
TN 38578 5.0
TN 38579 8.0
TN 38580 5.0
TN 38581 5.0
TN 38582 5.0
TN 38583 8.0
TN 38585 10.6
TN 38587 8.0
TN 38588 6.0
TN 38589 10.0
TX 73301 1.0
TX 73344 1.0
TX 75001 1.0
TX 75002 1.0
TX 75006 1.0
TX 75007 1.0
TX 75008 1.0
TX 75009 2.0
TX 75010 1.0
TX 75011 1.0
TX 75013 1.0
TX 75014 1.0
TX 75015 1.0
TX 75016 1.0
TX 75017 1.0
TX 75019 2.0
TX 75020 1.0
TX 75021 1.0
TX 75022 2.0
TX 75023 1.0
TX 75024 1.0
TX 75025 1.0
TX 75026 1.0
TX 75027 2.0
TX 75028 2.0
TX 75029 2.0
TX 75030 1.0
TX 75032 1.0
TX 75034 1.0
TX 75035 1.0
TX 75037 1.0
TX 75038 1.0
TX 75039 1.0
TX 75040 1.0
TX 75041 1.0
TX 75042 1.0
TX 75043 1.0
TX 75044 1.0
TX 75045 1.0
TX 75046 1.0
TX 75047 1.0
TX 75048 1.0
TX 75049 1.0
TX 75050 1.0
TX 75051 1.0
TX 75052 1.0
TX 75053 1.0
TX 75054 1.0
TX 75056 1.0
TX 75057 2.0
TX 75058 3.0
TX 75060 1.0
TX 75061 1.0
TX 75062 1.0
TX 75063 2.0
TX 75065 2.0
TX 75067 2.0
TX 75068 2.0
TX 75069 2.0
TX 75070 2.0
TX 75071 2.0
TX 75074 1.0
TX 75075 1.0
TX 75076 2.0
TX 75077 2.0
TX 75078 2.0
TX 75080 1.0
TX 75081 1.0
TX 75082 1.0
TX 75083 1.0
TX 75085 1.0
TX 75086 1.0
TX 75087 1.0
TX 75088 1.0
TX 75089 1.0
TX 75090 1.0
TX 75091 1.0
TX 75092 1.0
TX 75093 1.0
TX 75094 1.0
TX 75097 2.0
TX 75098 1.0
TX 75099 2.0
TX 75101 4.2
TX 75102 4.0
TX 75103 3.0
TX 75104 1.0
TX 75105 6.1
TX 75106 1.0
TX 75109 4.0
TX 75110 4.0
TX 75114 2.0
TX 75115 1.0
TX 75116 1.0
TX 75117 2.0
TX 75118 2.0
TX 75119 4.2
TX 75120 4.2
TX 75121 2.0
TX 75123 1.0
TX 75124 6.1
TX 75125 2.0
TX 75126 2.0
TX 75127 10.6
TX 75132 2.0
TX 75134 1.0
TX 75135 2.0
TX 75137 1.0
TX 75138 1.0
TX 75140 7.0
TX 75141 1.0
TX 75142 2.0
TX 75143 2.0
TX 75144 5.0
TX 75146 1.0
TX 75147 2.0
TX 75148 6.0
TX 75149 1.0
TX 75150 1.0
TX 75151 4.0
TX 75152 2.0
TX 75153 5.0
TX 75154 1.0
TX 75155 6.1
TX 75156 2.0
TX 75157 2.0
TX 75158 2.0
TX 75159 1.0
TX 75160 4.2
TX 75161 2.0
TX 75163 2.0
TX 75164 2.0
TX 75165 4.1
TX 75166 2.0
TX 75167 2.0
TX 75168 4.1
TX 75169 2.0
TX 75172 2.0
TX 75173 2.0
TX 75180 1.0
TX 75181 1.0
TX 75182 1.0
TX 75185 1.0
TX 75187 1.0
TX 75189 2.0
TX 75201 1.0
TX 75202 1.0
TX 75203 1.0
TX 75204 1.0
TX 75205 1.0
TX 75206 1.0
TX 75207 1.0
TX 75208 1.0
TX 75209 1.0
TX 75210 1.0
TX 75211 1.0
TX 75212 1.0
TX 75214 1.0
TX 75215 1.0
TX 75216 1.0
TX 75217 1.0
TX 75218 1.0
TX 75219 1.0
TX 75220 1.0
TX 75221 1.0
TX 75222 1.0
TX 75223 1.0
TX 75224 1.0
TX 75225 1.0
TX 75226 1.0
TX 75227 1.0
TX 75228 1.0
TX 75229 1.0
TX 75230 1.0
TX 75231 1.0
TX 75232 1.0
TX 75233 1.0
TX 75234 1.0
TX 75235 1.0
TX 75236 1.0
TX 75237 1.0
TX 75238 1.0
TX 75239 1.0
TX 75240 1.0
TX 75241 1.0
TX 75242 1.0
TX 75243 1.0
TX 75244 1.0
TX 75245 1.0
TX 75246 1.0
TX 75247 1.0
TX 75248 1.0
TX 75249 1.0
TX 75250 1.0
TX 75251 1.0
TX 75252 1.0
TX 75253 1.0
TX 75254 1.0
TX 75258 1.0
TX 75260 1.0
TX 75261 1.0
TX 75262 1.0
TX 75263 1.0
TX 75264 1.0
TX 75265 1.0
TX 75266 1.0
TX 75267 1.0
TX 75270 1.0
TX 75275 1.0
TX 75277 1.0
TX 75283 1.0
TX 75284 1.0
TX 75285 1.0
TX 75286 1.0
TX 75287 1.0
TX 75295 1.0
TX 75301 1.0
TX 75303 1.0
TX 75310 1.0
TX 75312 1.0
TX 75313 1.0
TX 75315 1.0
TX 75320 1.0
TX 75323 1.0
TX 75326 1.0
TX 75336 1.0
TX 75339 1.0
TX 75342 1.0
TX 75346 1.0
TX 75353 1.0
TX 75354 1.0
TX 75355 1.0
TX 75356 1.0
TX 75357 1.0
TX 75358 1.0
TX 75359 1.0
TX 75360 1.0
TX 75363 1.0
TX 75364 1.0
TX 75367 1.0
TX 75368 2.0
TX 75369 1.0
TX 75370 1.0
TX 75371 1.0
TX 75372 1.0
TX 75373 1.0
TX 75374 1.0
TX 75376 1.0
TX 75378 1.0
TX 75379 1.0
TX 75380 1.0
TX 75381 1.0
TX 75382 1.0
TX 75386 1.0
TX 75387 1.0
TX 75388 1.0
TX 75389 1.0
TX 75390 1.0
TX 75391 1.0
TX 75392 1.0
TX 75393 1.0
TX 75394 1.0
TX 75395 1.0
TX 75396 1.0
TX 75397 1.0
TX 75398 1.0
TX 75401 4.0
TX 75402 4.0
TX 75403 4.0
TX 75404 4.0
TX 75407 2.0
TX 75409 2.0
TX 75410 10.0
TX 75411 5.0
TX 75412 6.0
TX 75413 3.0
TX 75414 2.0
TX 75415 9.0
TX 75416 5.0
TX 75417 10.5
TX 75418 7.0
TX 75420 10.5
TX 75421 5.0
TX 75422 6.1
TX 75423 2.0
TX 75424 2.0
TX 75425 5.0
TX 75426 7.4
TX 75428 7.4
TX 75429 7.4
TX 75431 10.2
TX 75432 10.6
TX 75433 10.5
TX 75434 5.0
TX 75435 5.0
TX 75436 5.0
TX 75437 5.0
TX 75438 9.0
TX 75439 3.0
TX 75440 10.4
TX 75441 10.6
TX 75442 2.0
TX 75443 3.0
TX 75444 10.0
TX 75446 10.6
TX 75447 8.0
TX 75448 9.0
TX 75449 9.0
TX 75450 9.0
TX 75451 8.0
TX 75452 3.0
TX 75453 6.1
TX 75454 2.0
TX 75455 10.2
TX 75456 10.2
TX 75457 10.0
TX 75458 2.0
TX 75459 2.0
TX 75460 4.0
TX 75461 4.0
TX 75462 4.0
TX 75468 5.0
TX 75469 9.0
TX 75470 5.0
TX 75471 10.2
TX 75472 3.0
TX 75473 5.0
TX 75474 2.0
TX 75475 7.0
TX 75476 8.0
TX 75477 5.0
TX 75478 10.2
TX 75479 3.0
TX 75480 10.6
TX 75481 5.0
TX 75482 4.0
TX 75483 4.0
TX 75485 2.0
TX 75486 5.0
TX 75487 10.0
TX 75488 8.0
TX 75489 1.0
TX 75490 2.0
TX 75491 2.1
TX 75492 9.0
TX 75493 5.0
TX 75494 8.0
TX 75495 2.0
TX 75496 10.5
TX 75497 10.0
TX 75501 1.0
TX 75503 1.0
TX 75504 1.0
TX 75505 1.0
TX 75507 1.0
TX 75550 8.0
TX 75551 7.3
TX 75554 8.0
TX 75555 8.3
TX 75556 8.1
TX 75558 5.0
TX 75559 2.0
TX 75560 3.0
TX 75561 2.0
TX 75562 10.6
TX 75563 10.6
TX 75564 10.5
TX 75565 8.3
TX 75566 3.0
TX 75567 2.0
TX 75568 10.5
TX 75569 1.0
TX 75570 2.0
TX 75571 10.5
TX 75572 8.1
TX 75573 2.0
TX 75574 2.0
TX 75599 1.0
TX 75601 1.0
TX 75602 1.0
TX 75603 2.0
TX 75604 1.0
TX 75605 1.0
TX 75606 1.0
TX 75607 1.0
TX 75608 1.0
TX 75615 1.0
TX 75630 10.5
TX 75631 10.6
TX 75633 7.0
TX 75636 10.6
TX 75637 7.0
TX 75638 10.6
TX 75639 8.3
TX 75640 2.0
TX 75641 2.0
TX 75642 4.0
TX 75643 8.0
TX 75644 10.6
TX 75645 2.0
TX 75647 2.0
TX 75650 2.0
TX 75651 5.2
TX 75652 5.0
TX 75653 4.0
TX 75654 4.0
TX 75656 10.0
TX 75657 10.5
TX 75658 5.0
TX 75659 2.0
TX 75660 1.0
TX 75661 2.0
TX 75662 4.2
TX 75663 4.2
TX 75666 4.2
TX 75667 6.0
TX 75668 10.6
TX 75669 8.0
TX 75670 4.0
TX 75671 4.0
TX 75672 4.0
TX 75680 4.0
TX 75681 10.5
TX 75682 10.4
TX 75683 2.0
TX 75684 10.4
TX 75685 8.3
TX 75686 8.0
TX 75687 5.0
TX 75688 4.0
TX 75689 5.0
TX 75691 2.0
TX 75692 2.0
TX 75693 1.0
TX 75694 4.0
TX 75701 1.0
TX 75702 1.0
TX 75703 1.0
TX 75704 2.0
TX 75705 2.0
TX 75706 2.0
TX 75707 2.0
TX 75708 1.0
TX 75709 2.0
TX 75710 1.0
TX 75711 1.0
TX 75712 1.0
TX 75713 1.0
TX 75750 2.0
TX 75751 4.0
TX 75752 5.0
TX 75754 2.0
TX 75755 3.0
TX 75756 2.0
TX 75757 2.0
TX 75758 2.0
TX 75759 4.0
TX 75760 5.0
TX 75762 2.0
TX 75763 10.5
TX 75764 9.2
TX 75765 10.4
TX 75766 4.0
TX 75770 3.0
TX 75771 2.0
TX 75772 9.2
TX 75773 7.3
TX 75778 2.0
TX 75779 4.0
TX 75780 2.0
TX 75782 10.5
TX 75783 10.0
TX 75784 10.5
TX 75785 9.2
TX 75788 5.0
TX 75789 2.0
TX 75790 10.4
TX 75791 1.0
TX 75792 2.0
TX 75797 3.0
TX 75798 1.0
TX 75799 1.0
TX 75801 4.0
TX 75802 4.0
TX 75803 4.0
TX 75831 10.0
TX 75832 10.0
TX 75833 10.0
TX 75834 5.0
TX 75835 7.0
TX 75838 10.6
TX 75839 5.0
TX 75840 10.6
TX 75844 10.6
TX 75845 10.0
TX 75846 10.0
TX 75847 10.6
TX 75848 10.5
TX 75849 7.0
TX 75850 10.0
TX 75851 10.0
TX 75852 8.0
TX 75853 5.0
TX 75855 10.0
TX 75856 10.0
TX 75858 10.6
TX 75859 10.6
TX 75860 7.0
TX 75861 10.0
TX 75862 6.0
TX 75865 10.0
TX 75880 10.0
TX 75882 4.0
TX 75884 10.0
TX 75886 10.0
TX 75901 4.0
TX 75902 4.0
TX 75903 4.0
TX 75904 4.0
TX 75915 4.0
TX 75925 10.0
TX 75926 5.0
TX 75928 10.0
TX 75929 10.5
TX 75930 10.0
TX 75931 8.0
TX 75932 10.6
TX 75933 10.0
TX 75934 10.5
TX 75935 8.0
TX 75936 10.6
TX 75937 5.0
TX 75938 10.6
TX 75939 10.5
TX 75941 5.0
TX 75942 8.0
TX 75943 5.0
TX 75944 5.0
TX 75946 5.0
TX 75947 10.0
TX 75948 10.0
TX 75949 5.0
TX 75951 8.0
TX 75954 10.6
TX 75956 9.0
TX 75958 4.0
TX 75959 10.0
TX 75960 10.5
TX 75961 4.0
TX 75962 4.0
TX 75963 4.0
TX 75964 4.0
TX 75965 4.0
TX 75966 10.6
TX 75968 10.0
TX 75969 5.0
TX 75972 10.0
TX 75973 8.0
TX 75974 10.6
TX 75975 10.5
TX 75976 5.0
TX 75977 10.6
TX 75978 4.0
TX 75979 8.0
TX 75980 5.0
TX 75990 8.0
TX 76001 1.0
TX 76002 1.0
TX 76003 1.0
TX 76004 1.0
TX 76005 1.0
TX 76006 1.0
TX 76007 1.0
TX 76008 2.0
TX 76009 2.0
TX 76010 1.0
TX 76011 1.0
TX 76012 1.0
TX 76013 1.0
TX 76014 1.0
TX 76015 1.0
TX 76016 1.0
TX 76017 1.0
TX 76018 1.0
TX 76019 1.0
TX 76020 1.0
TX 76021 1.0
TX 76022 1.0
TX 76023 2.0
TX 76028 1.0
TX 76031 4.1
TX 76033 4.1
TX 76034 1.0
TX 76035 4.2
TX 76036 1.0
TX 76039 1.0
TX 76040 1.0
TX 76041 2.0
TX 76043 10.0
TX 76044 2.0
TX 76048 4.2
TX 76049 4.2
TX 76050 2.0
TX 76051 1.0
TX 76052 2.0
TX 76053 1.0
TX 76054 1.0
TX 76055 3.0
TX 76058 4.1
TX 76059 4.1
TX 76060 1.0
TX 76061 2.0
TX 76063 1.0
TX 76064 2.0
TX 76065 2.0
TX 76066 2.0
TX 76067 4.0
TX 76068 4.0
TX 76070 10.0
TX 76071 2.0
TX 76073 2.0
TX 76077 10.0
TX 76078 2.0
TX 76082 2.0
TX 76084 2.0
TX 76085 2.0
TX 76086 2.0
TX 76087 2.0
TX 76088 2.0
TX 76092 1.0
TX 76093 5.1
TX 76094 1.0
TX 76095 1.0
TX 76096 1.0
TX 76097 1.0
TX 76098 1.0
TX 76099 1.0
TX 76101 1.0
TX 76102 1.0
TX 76103 1.0
TX 76104 1.0
TX 76105 1.0
TX 76106 1.0
TX 76107 1.0
TX 76108 1.0
TX 76109 1.0
TX 76110 1.0
TX 76111 1.0
TX 76112 1.0
TX 76113 1.0
TX 76114 1.0
TX 76115 1.0
TX 76116 1.0
TX 76117 1.0
TX 76118 1.0
TX 76119 1.0
TX 76120 1.0
TX 76121 1.0
TX 76122 1.0
TX 76123 1.0
TX 76124 1.0
TX 76126 1.0
TX 76127 1.0
TX 76129 1.0
TX 76130 1.0
TX 76131 1.0
TX 76132 1.0
TX 76133 1.0
TX 76134 1.0
TX 76135 1.0
TX 76136 1.0
TX 76137 1.0
TX 76140 1.0
TX 76147 1.0
TX 76148 1.0
TX 76150 1.0
TX 76155 1.0
TX 76161 1.0
TX 76162 1.0
TX 76163 1.0
TX 76164 1.0
TX 76177 1.0
TX 76178 1.0
TX 76179 1.0
TX 76180 1.0
TX 76181 1.0
TX 76182 1.0
TX 76185 1.0
TX 76191 1.0
TX 76192 1.0
TX 76193 1.0
TX 76195 1.0
TX 76196 1.0
TX 76197 1.0
TX 76198 1.0
TX 76199 1.0
TX 76201 2.0
TX 76202 2.0
TX 76203 2.0
TX 76204 2.0
TX 76205 2.0
TX 76206 2.0
TX 76207 2.0
TX 76208 2.0
TX 76209 2.0
TX 76210 2.0
TX 76225 10.4
TX 76226 2.0
TX 76227 2.1
TX 76228 2.0
TX 76230 7.0
TX 76233 3.0
TX 76234 3.0
TX 76238 3.0
TX 76239 10.4
TX 76240 4.2
TX 76241 4.2
TX 76244 1.0
TX 76245 2.0
TX 76246 3.0
TX 76247 2.0
TX 76248 1.0
TX 76249 2.0
TX 76250 10.2
TX 76251 10.4
TX 76252 10.2
TX 76253 10.2
TX 76255 7.0
TX 76258 2.1
TX 76259 2.0
TX 76261 8.0
TX 76262 1.0
TX 76263 3.0
TX 76264 2.0
TX 76265 10.5
TX 76266 2.1
TX 76267 3.0
TX 76268 1.0
TX 76270 8.0
TX 76271 3.0
TX 76272 3.0
TX 76273 7.1
TX 76299 1.0
TX 76301 1.0
TX 76302 1.0
TX 76305 2.0
TX 76306 1.0
TX 76307 1.0
TX 76308 1.0
TX 76309 1.0
TX 76310 1.0
TX 76311 1.0
TX 76351 10.4
TX 76352 7.1
TX 76354 2.0
TX 76357 2.0
TX 76360 7.3
TX 76363 10.0
TX 76364 5.0
TX 76365 7.1
TX 76366 2.0
TX 76367 2.0
TX 76369 2.0
TX 76370 2.0
TX 76371 10.0
TX 76372 8.0
TX 76373 5.0
TX 76374 7.0
TX 76377 2.0
TX 76379 10.4
TX 76380 7.0
TX 76384 4.0
TX 76385 4.0
TX 76388 10.6
TX 76389 10.4
TX 76401 4.0
TX 76402 4.0
TX 76424 7.0
TX 76426 7.0
TX 76427 10.6
TX 76429 8.0
TX 76430 10.4
TX 76431 10.6
TX 76432 5.0
TX 76433 5.0
TX 76435 10.6
TX 76436 10.5
TX 76437 7.0
TX 76439 2.0
TX 76442 7.0
TX 76443 10.4
TX 76444 10.5
TX 76445 10.6
TX 76446 7.4
TX 76448 7.0
TX 76449 10.5
TX 76450 7.0
TX 76452 10.6
TX 76453 10.4
TX 76454 10.6
TX 76455 10.6
TX 76457 10.5
TX 76458 7.0
TX 76459 10.6
TX 76460 7.0
TX 76461 4.0
TX 76462 4.2
TX 76463 10.4
TX 76464 10.4
TX 76465 5.0
TX 76466 7.0
TX 76467 5.0
TX 76468 7.4
TX 76469 10.4
TX 76470 10.6
TX 76471 10.5
TX 76472 10.5
TX 76474 8.0
TX 76475 10.4
TX 76476 4.2
TX 76481 7.0
TX 76483 10.0
TX 76484 10.5
TX 76485 2.0
TX 76486 10.4
TX 76487 2.0
TX 76490 2.0
TX 76491 10.0
TX 76501 1.0
TX 76502 1.0
TX 76503 1.0
TX 76504 1.0
TX 76505 1.0
TX 76508 1.0
TX 76511 2.0
TX 76513 1.0
TX 76518 10.4
TX 76519 10.4
TX 76520 7.3
TX 76522 1.0
TX 76523 10.6
TX 76524 2.0
TX 76525 2.0
TX 76526 2.0
TX 76527 2.0
TX 76528 4.0
TX 76530 2.0
TX 76531 7.0
TX 76533 1.0
TX 76534 2.0
TX 76537 2.0
TX 76538 2.0
TX 76539 2.0
TX 76540 1.0
TX 76541 1.0
TX 76542 1.0
TX 76543 1.0
TX 76544 1.0
TX 76545 1.0
TX 76546 1.0
TX 76547 1.0
TX 76548 1.0
TX 76549 1.0
TX 76550 7.3
TX 76554 2.0
TX 76556 10.4
TX 76557 2.0
TX 76558 4.0
TX 76559 1.0
TX 76561 2.0
TX 76564 2.0
TX 76565 10.6
TX 76566 2.0
TX 76567 7.3
TX 76569 2.0
TX 76570 10.4
TX 76571 2.0
TX 76573 2.0
TX 76574 2.0
TX 76577 2.0
TX 76578 2.0
TX 76579 2.0
TX 76596 2.0
TX 76597 4.0
TX 76598 4.0
TX 76599 4.0
TX 76621 9.0
TX 76622 10.6
TX 76623 4.1
TX 76624 2.0
TX 76626 5.0
TX 76627 3.0
TX 76628 8.0
TX 76629 10.0
TX 76630 2.0
TX 76631 8.0
TX 76632 2.0
TX 76633 2.0
TX 76634 8.4
TX 76635 10.1
TX 76636 3.0
TX 76637 10.6
TX 76638 2.0
TX 76639 5.0
TX 76640 2.0
TX 76641 5.0
TX 76642 7.0
TX 76643 1.0
TX 76644 8.4
TX 76645 7.0
TX 76648 10.4
TX 76649 10.4
TX 76650 8.0
TX 76651 2.0
TX 76652 10.4
TX 76653 8.0
TX 76654 2.0
TX 76655 2.0
TX 76656 10.4
TX 76657 2.0
TX 76660 3.0
TX 76661 7.3
TX 76664 2.0
TX 76665 10.4
TX 76666 8.0
TX 76667 7.0
TX 76670 2.0
TX 76671 3.0
TX 76673 10.4
TX 76675 2.0
TX 76676 3.0
TX 76678 10.1
TX 76679 5.0
TX 76680 10.6
TX 76681 5.0
TX 76682 2.0
TX 76684 2.0
TX 76685 2.0
TX 76686 7.0
TX 76687 8.0
TX 76689 2.0
TX 76690 10.4
TX 76691 2.0
TX 76692 10.6
TX 76693 10.5
TX 76701 1.0
TX 76702 1.0
TX 76703 1.0
TX 76704 1.0
TX 76705 1.0
TX 76706 1.0
TX 76707 1.0
TX 76708 1.0
TX 76710 1.0
TX 76711 1.0
TX 76712 1.0
TX 76714 1.0
TX 76715 1.0
TX 76716 1.0
TX 76795 1.0
TX 76797 1.0
TX 76798 1.0
TX 76799 1.0
TX 76801 4.0
TX 76802 4.0
TX 76803 4.0
TX 76804 4.0
TX 76820 10.0
TX 76821 7.0
TX 76823 5.0
TX 76824 7.0
TX 76825 7.0
TX 76827 5.0
TX 76828 8.0
TX 76831 10.6
TX 76832 10.6
TX 76834 7.0
TX 76836 10.3
TX 76837 10.0
TX 76841 10.0
TX 76842 10.0
TX 76844 10.0
TX 76845 10.6
TX 76848 10.0
TX 76849 7.0
TX 76852 10.3
TX 76853 10.6
TX 76854 10.3
TX 76855 10.4
TX 76856 10.0
TX 76857 5.0
TX 76858 10.3
TX 76859 10.0
TX 76861 10.1
TX 76862 10.4
TX 76864 10.0
TX 76865 10.3
TX 76866 10.4
TX 76867 10.3
TX 76869 10.0
TX 76870 10.0
TX 76871 10.6
TX 76872 10.3
TX 76873 10.6
TX 76874 10.3
TX 76875 10.1
TX 76877 7.0
TX 76878 10.6
TX 76880 10.0
TX 76882 10.6
TX 76883 10.3
TX 76884 10.6
TX 76885 8.0
TX 76886 1.0
TX 76887 8.0
TX 76888 10.6
TX 76890 5.0
TX 76901 1.0
TX 76902 1.0
TX 76903 1.0
TX 76904 1.0
TX 76905 1.0
TX 76906 1.0
TX 76908 1.0
TX 76909 1.0
TX 76930 10.4
TX 76932 7.0
TX 76933 10.4
TX 76934 2.0
TX 76935 2.0
TX 76936 10.4
TX 76937 10.4
TX 76939 1.0
TX 76940 2.0
TX 76941 10.4
TX 76943 7.0
TX 76945 10.4
TX 76949 10.4
TX 76950 7.0
TX 76951 10.0
TX 76953 10.4
TX 76955 2.0
TX 76957 2.0
TX 76958 2.0
TX 77001 1.0
TX 77002 1.0
TX 77003 1.0
TX 77004 1.0
TX 77005 1.0
TX 77006 1.0
TX 77007 1.0
TX 77008 1.0
TX 77009 1.0
TX 77010 1.0
TX 77011 1.0
TX 77012 1.0
TX 77013 1.0
TX 77014 1.0
TX 77015 1.0
TX 77016 1.0
TX 77017 1.0
TX 77018 1.0
TX 77019 1.0
TX 77020 1.0
TX 77021 1.0
TX 77022 1.0
TX 77023 1.0
TX 77024 1.0
TX 77025 1.0
TX 77026 1.0
TX 77027 1.0
TX 77028 1.0
TX 77029 1.0
TX 77030 1.0
TX 77031 1.0
TX 77032 1.0
TX 77033 1.0
TX 77034 1.0
TX 77035 1.0
TX 77036 1.0
TX 77037 1.0
TX 77038 1.0
TX 77039 1.0
TX 77040 1.0
TX 77041 1.0
TX 77042 1.0
TX 77043 1.0
TX 77044 1.0
TX 77045 1.0
TX 77046 1.0
TX 77047 1.0
TX 77048 1.0
TX 77049 1.0
TX 77050 1.0
TX 77051 1.0
TX 77052 1.0
TX 77053 1.0
TX 77054 1.0
TX 77055 1.0
TX 77056 1.0
TX 77057 1.0
TX 77058 1.0
TX 77059 1.0
TX 77060 1.0
TX 77061 1.0
TX 77062 1.0
TX 77063 1.0
TX 77064 1.0
TX 77065 1.0
TX 77066 1.0
TX 77067 1.0
TX 77068 1.0
TX 77069 1.0
TX 77070 1.0
TX 77071 1.0
TX 77072 1.0
TX 77073 1.0
TX 77074 1.0
TX 77075 1.0
TX 77076 1.0
TX 77077 1.0
TX 77078 1.0
TX 77079 1.0
TX 77080 1.0
TX 77081 1.0
TX 77082 1.0
TX 77083 1.0
TX 77084 1.0
TX 77085 1.0
TX 77086 1.0
TX 77087 1.0
TX 77088 1.0
TX 77089 1.0
TX 77090 1.0
TX 77091 1.0
TX 77092 1.0
TX 77093 1.0
TX 77094 1.0
TX 77095 1.0
TX 77096 1.0
TX 77097 1.0
TX 77098 1.0
TX 77099 1.0
TX 77201 1.0
TX 77202 1.0
TX 77203 1.0
TX 77204 1.0
TX 77205 1.0
TX 77206 1.0
TX 77207 1.0
TX 77208 1.0
TX 77209 1.0
TX 77210 1.0
TX 77212 1.0
TX 77213 1.0
TX 77215 1.0
TX 77216 1.0
TX 77217 1.0
TX 77218 1.0
TX 77219 1.0
TX 77220 1.0
TX 77221 1.0
TX 77222 1.0
TX 77223 1.0
TX 77224 1.0
TX 77225 1.0
TX 77226 1.0
TX 77227 1.0
TX 77228 1.0
TX 77229 1.0
TX 77230 1.0
TX 77231 1.0
TX 77233 1.0
TX 77234 1.0
TX 77235 1.0
TX 77236 1.0
TX 77237 1.0
TX 77238 1.0
TX 77240 1.0
TX 77241 1.0
TX 77242 1.0
TX 77243 1.0
TX 77244 1.0
TX 77245 1.0
TX 77248 1.0
TX 77249 1.0
TX 77250 1.0
TX 77251 1.0
TX 77252 1.0
TX 77253 1.0
TX 77254 1.0
TX 77255 1.0
TX 77256 1.0
TX 77257 1.0
TX 77258 1.0
TX 77259 1.0
TX 77261 1.0
TX 77262 1.0
TX 77263 1.0
TX 77265 1.0
TX 77266 1.0
TX 77267 1.0
TX 77268 1.0
TX 77269 1.0
TX 77270 1.0
TX 77271 1.0
TX 77272 1.0
TX 77273 1.0
TX 77274 1.0
TX 77275 1.0
TX 77277 1.0
TX 77279 1.0
TX 77280 1.0
TX 77281 1.0
TX 77282 1.0
TX 77284 1.0
TX 77287 1.0
TX 77288 1.0
TX 77289 1.0
TX 77290 1.0
TX 77291 1.0
TX 77292 1.0
TX 77293 1.0
TX 77297 1.0
TX 77298 1.0
TX 77299 1.0
TX 77301 4.2
TX 77302 2.0
TX 77303 5.2
TX 77304 4.2
TX 77305 4.2
TX 77306 5.2
TX 77315 1.0
TX 77316 2.0
TX 77318 2.0
TX 77320 4.0
TX 77325 1.0
TX 77326 10.6
TX 77327 7.1
TX 77328 2.0
TX 77331 10.4
TX 77332 10.6
TX 77333 2.0
TX 77334 4.0
TX 77335 10.6
TX 77336 1.0
TX 77337 2.0
TX 77338 1.0
TX 77339 1.0
TX 77340 4.0
TX 77341 4.0
TX 77342 4.0
TX 77343 4.0
TX 77344 4.0
TX 77345 1.0
TX 77346 1.0
TX 77347 1.0
TX 77348 4.0
TX 77349 4.0
TX 77350 10.6
TX 77351 10.6
TX 77353 2.0
TX 77354 2.0
TX 77355 2.0
TX 77356 2.0
TX 77357 1.0
TX 77358 5.0
TX 77359 6.1
TX 77360 10.6
TX 77362 2.0
TX 77363 2.0
TX 77364 6.1
TX 77365 1.0
TX 77367 4.0
TX 77368 7.1
TX 77369 7.1
TX 77371 10.4
TX 77372 2.0
TX 77373 1.0
TX 77374 3.0
TX 77375 2.0
TX 77376 3.0
TX 77377 1.0
TX 77378 5.0
TX 77379 1.0
TX 77380 2.0
TX 77381 2.0
TX 77382 2.0
TX 77383 1.0
TX 77384 2.0
TX 77385 2.0
TX 77386 2.0
TX 77387 2.0
TX 77388 1.0
TX 77389 1.0
TX 77391 1.0
TX 77393 2.0
TX 77396 1.0
TX 77399 10.6
TX 77401 1.0
TX 77402 1.0
TX 77404 4.0
TX 77406 1.0
TX 77410 1.0
TX 77411 1.0
TX 77412 10.6
TX 77413 1.0
TX 77414 4.0
TX 77415 4.0
TX 77417 2.0
TX 77418 7.3
TX 77419 10.2
TX 77420 10.6
TX 77422 2.0
TX 77423 2.0
TX 77426 5.2
TX 77428 7.4
TX 77429 1.0
TX 77430 2.0
TX 77431 2.0
TX 77432 4.0
TX 77433 2.0
TX 77434 7.3
TX 77435 10.4
TX 77436 10.4
TX 77437 4.0
TX 77440 10.2
TX 77441 2.0
TX 77442 10.6
TX 77443 10.4
TX 77444 2.0
TX 77445 7.1
TX 77446 2.0
TX 77447 2.0
TX 77448 10.4
TX 77449 1.0
TX 77450 1.0
TX 77451 2.0
TX 77452 7.3
TX 77453 7.3
TX 77454 10.4
TX 77455 5.0
TX 77456 10.2
TX 77457 10.5
TX 77458 10.2
TX 77459 1.0
TX 77460 10.6
TX 77461 2.0
TX 77463 2.0
TX 77464 1.0
TX 77465 7.4
TX 77466 2.0
TX 77467 4.0
TX 77468 4.0
TX 77469 1.0
TX 77470 10.6
TX 77471 1.0
TX 77473 7.1
TX 77474 7.1
TX 77475 10.6
TX 77476 2.0
TX 77477 1.0
TX 77478 1.0
TX 77479 1.0
TX 77480 2.0
TX 77481 1.0
TX 77482 4.0
TX 77483 10.5
TX 77484 2.0
TX 77485 2.0
TX 77486 2.0
TX 77487 1.0
TX 77488 7.3
TX 77489 1.0
TX 77491 1.0
TX 77492 1.0
TX 77493 1.0
TX 77494 1.0
TX 77496 1.0
TX 77497 1.0
TX 77501 1.0
TX 77502 1.0
TX 77503 1.0
TX 77504 1.0
TX 77505 1.0
TX 77506 1.0
TX 77507 1.0
TX 77508 1.0
TX 77510 1.1
TX 77511 1.0
TX 77512 1.0
TX 77514 10.1
TX 77515 1.0
TX 77516 1.0
TX 77517 1.1
TX 77518 1.0
TX 77519 3.0
TX 77520 1.0
TX 77521 1.0
TX 77522 1.0
TX 77530 1.0
TX 77531 1.0
TX 77532 1.0
TX 77533 3.0
TX 77534 1.0
TX 77535 2.0
TX 77536 1.0
TX 77538 7.3
TX 77539 1.1
TX 77541 1.0
TX 77542 1.0
TX 77545 1.0
TX 77546 1.0
TX 77547 1.0
TX 77549 1.0
TX 77550 1.0
TX 77551 1.0
TX 77552 1.0
TX 77553 1.0
TX 77554 2.1
TX 77555 1.0
TX 77560 2.0
TX 77561 7.3
TX 77562 1.0
TX 77563 1.1
TX 77564 3.0
TX 77565 1.0
TX 77566 1.0
TX 77568 1.1
TX 77571 1.0
TX 77572 1.0
TX 77573 1.0
TX 77574 1.0
TX 77575 7.3
TX 77577 2.0
TX 77578 1.0
TX 77580 1.0
TX 77581 1.0
TX 77582 7.3
TX 77583 2.0
TX 77584 1.0
TX 77585 3.0
TX 77586 1.0
TX 77587 1.0
TX 77588 1.0
TX 77590 1.1
TX 77591 1.1
TX 77592 1.1
TX 77597 2.0
TX 77598 1.0
TX 77611 4.2
TX 77612 3.0
TX 77613 2.0
TX 77614 5.0
TX 77615 3.0
TX 77616 10.4
TX 77617 3.0
TX 77619 1.0
TX 77622 2.0
TX 77623 3.0
TX 77624 8.0
TX 77625 2.0
TX 77626 5.2
TX 77627 1.0
TX 77629 2.0
TX 77630 4.2
TX 77631 4.2
TX 77632 5.2
TX 77639 4.2
TX 77640 1.0
TX 77641 1.0
TX 77642 1.0
TX 77643 1.0
TX 77650 3.0
TX 77651 1.0
TX 77655 1.0
TX 77656 7.1
TX 77657 1.0
TX 77659 2.0
TX 77660 10.4
TX 77661 7.3
TX 77662 1.0
TX 77663 2.0
TX 77664 10.4
TX 77665 7.3
TX 77670 1.0
TX 77701 1.0
TX 77702 1.0
TX 77703 1.0
TX 77704 1.0
TX 77705 1.0
TX 77706 1.0
TX 77707 1.0
TX 77708 1.0
TX 77709 1.0
TX 77710 1.0
TX 77713 2.0
TX 77720 1.0
TX 77725 1.0
TX 77726 1.0
TX 77801 1.0
TX 77802 1.0
TX 77803 1.0
TX 77805 1.0
TX 77806 1.0
TX 77807 2.0
TX 77808 1.0
TX 77830 10.4
TX 77831 9.0
TX 77833 4.0
TX 77834 4.0
TX 77835 5.0
TX 77836 7.1
TX 77837 10.4
TX 77838 7.1
TX 77840 1.0
TX 77841 1.0
TX 77842 1.0
TX 77843 1.0
TX 77844 1.0
TX 77845 1.0
TX 77850 10.4
TX 77852 7.1
TX 77853 8.0
TX 77855 10.4
TX 77856 10.4
TX 77857 10.4
TX 77859 7.1
TX 77861 10.4
TX 77862 1.0
TX 77863 10.4
TX 77864 7.0
TX 77865 10.4
TX 77866 1.0
TX 77867 7.1
TX 77868 7.3
TX 77869 7.3
TX 77870 10.4
TX 77871 10.4
TX 77872 10.4
TX 77873 9.0
TX 77875 10.4
TX 77876 10.4
TX 77878 10.4
TX 77879 10.4
TX 77880 5.2
TX 77881 1.0
TX 77882 10.4
TX 77901 1.0
TX 77902 1.0
TX 77903 1.0
TX 77904 1.0
TX 77905 2.0
TX 77950 10.4
TX 77951 2.0
TX 77954 7.0
TX 77957 7.0
TX 77960 2.0
TX 77961 10.5
TX 77962 10.5
TX 77963 2.0
TX 77964 10.0
TX 77967 7.0
TX 77968 1.0
TX 77969 7.0
TX 77970 10.5
TX 77971 10.5
TX 77973 2.0
TX 77974 8.0
TX 77975 10.6
TX 77976 1.0
TX 77977 2.0
TX 77978 10.5
TX 77979 4.0
TX 77982 4.0
TX 77983 10.5
TX 77984 10.0
TX 77986 10.0
TX 77987 7.0
TX 77988 2.0
TX 77989 7.0
TX 77990 10.4
TX 77991 7.0
TX 77993 2.0
TX 77994 7.0
TX 77995 7.0
TX 78001 7.0
TX 78002 1.0
TX 78003 10.4
TX 78004 2.0
TX 78005 7.3
TX 78006 2.0
TX 78007 10.0
TX 78008 4.1
TX 78009 2.0
TX 78010 5.0
TX 78011 10.5
TX 78012 4.1
TX 78013 7.3
TX 78014 7.0
TX 78015 2.0
TX 78016 7.1
TX 78017 7.0
TX 78019 10.1
TX 78021 7.0
TX 78022 7.0
TX 78023 1.0
TX 78024 4.0
TX 78025 4.0
TX 78026 4.1
TX 78027 7.3
TX 78028 4.0
TX 78029 4.0
TX 78039 2.0
TX 78040 1.0
TX 78041 1.0
TX 78042 1.0
TX 78043 1.0
TX 78044 1.0
TX 78045 1.0
TX 78046 1.0
TX 78049 1.0
TX 78050 4.1
TX 78052 2.0
TX 78054 1.0
TX 78055 10.0
TX 78056 2.0
TX 78057 7.3
TX 78058 4.0
TX 78059 2.0
TX 78060 10.0
TX 78061 7.3
TX 78062 4.1
TX 78063 2.0
TX 78064 4.1
TX 78065 2.0
TX 78066 2.0
TX 78067 10.4
TX 78069 2.0
TX 78070 2.0
TX 78071 10.0
TX 78072 10.0
TX 78073 2.0
TX 78074 7.3
TX 78075 10.0
TX 78076 7.0
TX 78101 2.0
TX 78102 5.0
TX 78104 5.0
TX 78107 2.0
TX 78108 1.0
TX 78109 1.0
TX 78111 10.4
TX 78112 2.0
TX 78113 10.4
TX 78114 2.0
TX 78115 4.2
TX 78116 10.4
TX 78117 10.4
TX 78118 7.0
TX 78119 7.0
TX 78121 2.0
TX 78122 10.5
TX 78123 4.2
TX 78124 2.0
TX 78125 5.0
TX 78130 4.2
TX 78131 4.2
TX 78132 2.0
TX 78133 2.0
TX 78135 4.2
TX 78140 10.5
TX 78141 10.0
TX 78142 5.0
TX 78143 10.4
TX 78144 10.4
TX 78145 5.0
TX 78146 5.0
TX 78147 2.0
TX 78148 1.0
TX 78150 1.0
TX 78151 10.6
TX 78152 2.0
TX 78154 1.0
TX 78155 4.2
TX 78156 4.2
TX 78159 10.6
TX 78160 10.4
TX 78161 2.0
TX 78162 5.0
TX 78163 2.0
TX 78164 10.0
TX 78201 1.0
TX 78202 1.0
TX 78203 1.0
TX 78204 1.0
TX 78205 1.0
TX 78206 1.0
TX 78207 1.0
TX 78208 1.0
TX 78209 1.0
TX 78210 1.0
TX 78211 1.0
TX 78212 1.0
TX 78213 1.0
TX 78214 1.0
TX 78215 1.0
TX 78216 1.0
TX 78217 1.0
TX 78218 1.0
TX 78219 1.0
TX 78220 1.0
TX 78221 1.0
TX 78222 1.0
TX 78223 1.0
TX 78224 1.0
TX 78225 1.0
TX 78226 1.0
TX 78227 1.0
TX 78228 1.0
TX 78229 1.0
TX 78230 1.0
TX 78231 1.0
TX 78232 1.0
TX 78233 1.0
TX 78234 1.0
TX 78235 10.4
TX 78236 1.0
TX 78237 1.0
TX 78238 1.0
TX 78239 1.0
TX 78240 1.0
TX 78241 1.0
TX 78242 1.0
TX 78243 1.0
TX 78244 1.0
TX 78245 1.0
TX 78246 1.0
TX 78247 1.0
TX 78248 1.0
TX 78249 1.0
TX 78250 1.0
TX 78251 1.0
TX 78252 1.0
TX 78253 1.0
TX 78254 1.0
TX 78255 1.0
TX 78256 1.0
TX 78257 1.0
TX 78258 1.0
TX 78259 1.0
TX 78260 1.0
TX 78261 2.0
TX 78262 2.0
TX 78263 2.0
TX 78264 2.0
TX 78265 1.0
TX 78266 1.0
TX 78268 1.0
TX 78269 1.0
TX 78270 1.0
TX 78275 1.0
TX 78278 1.0
TX 78279 1.0
TX 78280 1.0
TX 78283 1.0
TX 78284 1.0
TX 78285 1.0
TX 78286 1.0
TX 78287 1.0
TX 78288 1.0
TX 78289 1.0
TX 78291 1.0
TX 78292 1.0
TX 78293 1.0
TX 78294 1.0
TX 78295 1.0
TX 78296 1.0
TX 78297 1.0
TX 78298 1.0
TX 78299 1.0
TX 78330 2.0
TX 78332 4.0
TX 78333 4.0
TX 78335 4.2
TX 78336 4.2
TX 78338 10.0
TX 78339 2.0
TX 78340 10.6
TX 78341 10.0
TX 78342 4.0
TX 78343 5.2
TX 78344 1.0
TX 78347 1.0
TX 78349 10.0
TX 78350 7.0
TX 78351 2.0
TX 78352 2.0
TX 78353 8.0
TX 78355 7.0
TX 78357 7.0
TX 78358 4.0
TX 78359 1.0
TX 78360 7.3
TX 78361 7.3
TX 78362 4.2
TX 78363 4.0
TX 78364 4.0
TX 78368 2.0
TX 78369 1.0
TX 78370 2.0
TX 78371 1.0
TX 78372 2.0
TX 78373 7.3
TX 78374 1.0
TX 78375 7.0
TX 78376 10.6
TX 78377 7.0
TX 78379 5.0
TX 78380 2.0
TX 78381 4.0
TX 78382 4.0
TX 78383 2.0
TX 78384 7.4
TX 78385 10.0
TX 78387 7.3
TX 78389 10.5
TX 78390 2.0
TX 78391 10.5
TX 78393 10.6
TX 78401 1.0
TX 78402 1.0
TX 78403 1.0
TX 78404 1.0
TX 78405 1.0
TX 78406 1.0
TX 78407 1.0
TX 78408 1.0
TX 78409 1.0
TX 78410 1.0
TX 78411 1.0
TX 78412 1.0
TX 78413 1.0
TX 78414 1.0
TX 78415 1.0
TX 78416 1.0
TX 78417 1.0
TX 78418 1.0
TX 78419 1.0
TX 78426 1.0
TX 78427 1.0
TX 78460 1.0
TX 78461 1.0
TX 78463 1.0
TX 78465 1.0
TX 78466 1.0
TX 78467 1.0
TX 78468 1.0
TX 78469 1.0
TX 78470 1.0
TX 78471 1.0
TX 78472 1.0
TX 78473 1.0
TX 78474 1.0
TX 78475 1.0
TX 78476 1.0
TX 78477 1.0
TX 78478 1.0
TX 78480 1.0
TX 78501 1.0
TX 78502 1.0
TX 78503 1.0
TX 78504 1.0
TX 78505 1.0
TX 78516 1.0
TX 78520 1.0
TX 78521 1.0
TX 78522 1.0
TX 78523 1.0
TX 78526 1.0
TX 78535 1.0
TX 78536 10.4
TX 78537 1.0
TX 78538 1.0
TX 78539 1.0
TX 78540 1.0
TX 78541 1.0
TX 78543 1.0
TX 78545 4.0
TX 78547 5.2
TX 78548 5.2
TX 78549 2.0
TX 78550 1.0
TX 78551 1.0
TX 78552 1.0
TX 78553 1.0
TX 78557 1.0
TX 78558 1.0
TX 78559 1.0
TX 78560 1.0
TX 78561 4.2
TX 78562 1.0
TX 78563 2.0
TX 78564 7.0
TX 78565 2.0
TX 78566 1.0
TX 78567 1.0
TX 78568 2.0
TX 78569 10.4
TX 78570 1.0
TX 78572 1.0
TX 78573 1.0
TX 78574 1.0
TX 78575 1.0
TX 78576 1.0
TX 78577 1.0
TX 78578 4.2
TX 78579 1.0
TX 78580 4.2
TX 78582 4.2
TX 78583 2.0
TX 78584 4.0
TX 78585 4.0
TX 78586 1.0
TX 78588 10.4
TX 78589 1.0
TX 78590 10.5
TX 78591 10.4
TX 78592 1.0
TX 78593 1.0
TX 78594 2.0
TX 78595 2.0
TX 78596 1.0
TX 78597 4.2
TX 78598 10.5
TX 78599 1.0
TX 78602 2.0
TX 78604 7.0
TX 78605 2.0
TX 78606 10.4
TX 78607 8.0
TX 78608 2.0
TX 78609 10.4
TX 78610 1.0
TX 78611 9.0
TX 78612 2.0
TX 78613 1.0
TX 78614 10.6
TX 78615 2.0
TX 78616 2.0
TX 78617 2.0
TX 78618 10.5
TX 78619 2.0
TX 78620 2.0
TX 78621 2.0
TX 78622 5.2
TX 78623 2.0
TX 78624 7.0
TX 78626 2.0
TX 78627 2.0
TX 78628 2.0
TX 78629 7.0
TX 78630 1.0
TX 78631 10.5
TX 78632 10.6
TX 78634 2.0
TX 78635 10.4
TX 78636 10.4
TX 78638 4.2
TX 78639 9.0
TX 78640 4.2
TX 78641 1.0
TX 78642 2.0
TX 78643 7.0
TX 78644 2.0
TX 78645 2.0
TX 78646 1.0
TX 78648 7.3
TX 78650 2.0
TX 78651 1.0
TX 78652 1.0
TX 78653 2.0
TX 78654 7.0
TX 78655 5.2
TX 78656 5.2
TX 78657 10.6
TX 78658 7.0
TX 78659 2.0
TX 78660 1.0
TX 78661 5.2
TX 78662 2.0
TX 78663 10.4
TX 78664 1.0
TX 78666 4.2
TX 78667 4.2
TX 78669 2.0
TX 78670 4.2
TX 78671 8.0
TX 78672 8.0
TX 78673 2.0
TX 78674 2.0
TX 78675 8.0
TX 78676 3.0
TX 78677 10.6
TX 78680 1.0
TX 78681 1.0
TX 78682 1.0
TX 78683 1.0
TX 78691 1.0
TX 78701 1.0
TX 78702 1.0
TX 78703 1.0
TX 78704 1.0
TX 78705 1.0
TX 78708 1.0
TX 78709 1.0
TX 78710 1.0
TX 78711 1.0
TX 78712 1.0
TX 78713 1.0
TX 78714 1.0
TX 78715 1.0
TX 78716 1.0
TX 78717 1.0
TX 78718 1.0
TX 78719 2.0
TX 78720 1.0
TX 78721 1.0
TX 78722 1.0
TX 78723 1.0
TX 78724 1.0
TX 78725 2.0
TX 78726 1.0
TX 78727 1.0
TX 78728 1.0
TX 78729 1.0
TX 78730 2.0
TX 78731 1.0
TX 78732 2.0
TX 78733 1.0
TX 78734 2.0
TX 78735 1.0
TX 78736 1.0
TX 78737 1.0
TX 78738 2.0
TX 78739 1.0
TX 78741 1.0
TX 78742 1.0
TX 78744 1.0
TX 78745 1.0
TX 78746 1.0
TX 78747 1.0
TX 78748 1.0
TX 78749 1.0
TX 78750 1.0
TX 78751 1.0
TX 78752 1.0
TX 78753 1.0
TX 78754 1.0
TX 78755 1.0
TX 78756 1.0
TX 78757 1.0
TX 78758 1.0
TX 78759 1.0
TX 78760 1.0
TX 78761 1.0
TX 78762 1.0
TX 78763 1.0
TX 78764 1.0
TX 78765 1.0
TX 78766 1.0
TX 78767 1.0
TX 78768 1.0
TX 78769 1.0
TX 78772 1.0
TX 78773 1.0
TX 78774 1.0
TX 78778 1.0
TX 78779 1.0
TX 78780 1.0
TX 78781 1.0
TX 78783 1.0
TX 78785 1.0
TX 78786 1.0
TX 78788 1.0
TX 78789 1.0
TX 78799 1.0
TX 78801 4.0
TX 78802 4.0
TX 78827 8.0
TX 78828 10.0
TX 78829 10.5
TX 78830 10.6
TX 78832 10.5
TX 78833 10.0
TX 78834 7.0
TX 78836 8.0
TX 78837 10.2
TX 78838 10.5
TX 78839 7.0
TX 78840 4.0
TX 78841 4.0
TX 78842 4.0
TX 78843 4.0
TX 78847 4.0
TX 78850 8.0
TX 78851 10.0
TX 78852 4.0
TX 78853 4.0
TX 78860 4.0
TX 78861 7.3
TX 78870 4.0
TX 78871 10.2
TX 78872 10.2
TX 78873 10.0
TX 78877 10.2
TX 78879 10.0
TX 78880 10.0
TX 78881 10.5
TX 78883 10.4
TX 78884 10.5
TX 78885 10.0
TX 78886 7.3
TX 78931 6.0
TX 78932 10.5
TX 78933 7.4
TX 78934 7.0
TX 78935 8.0
TX 78938 10.6
TX 78940 10.6
TX 78941 10.6
TX 78942 7.3
TX 78943 7.0
TX 78944 6.0
TX 78945 7.0
TX 78946 8.0
TX 78947 2.0
TX 78948 8.0
TX 78949 10.6
TX 78950 6.0
TX 78951 10.6
TX 78952 7.0
TX 78953 2.0
TX 78954 10.5
TX 78956 7.0
TX 78957 2.0
TX 78959 10.6
TX 78960 7.0
TX 78961 10.5
TX 78962 10.6
TX 78963 8.0
TX 79001 10.4
TX 79002 10.2
TX 79003 10.0
TX 79005 10.6
TX 79007 4.0
TX 79008 4.0
TX 79009 10.0
TX 79010 10.4
TX 79011 10.0
TX 79012 1.0
TX 79013 4.0
TX 79014 10.0
TX 79015 2.0
TX 79016 2.0
TX 79018 7.0
TX 79019 2.0
TX 79021 2.0
TX 79022 7.0
TX 79024 10.0
TX 79025 4.0
TX 79027 7.0
TX 79029 4.0
TX 79031 10.0
TX 79032 4.0
TX 79033 7.0
TX 79034 10.0
TX 79035 7.0
TX 79036 5.0
TX 79039 10.4
TX 79040 10.6
TX 79041 5.0
TX 79042 10.6
TX 79043 10.6
TX 79044 7.0
TX 79045 4.0
TX 79046 10.0
TX 79051 7.0
TX 79052 5.0
TX 79053 10.0
TX 79054 4.0
TX 79056 10.0
TX 79057 10.2
TX 79058 7.2
TX 79059 10.5
TX 79061 10.0
TX 79062 7.0
TX 79063 10.6
TX 79064 10.5
TX 79065 4.0
TX 79066 4.0
TX 79068 10.1
TX 79070 7.0
TX 79072 4.0
TX 79073 4.0
TX 79077 10.0
TX 79078 5.0
TX 79079 10.0
TX 79080 10.4
TX 79081 7.0
TX 79082 10.0
TX 79083 5.0
TX 79084 10.0
TX 79085 10.6
TX 79086 10.6
TX 79087 10.6
TX 79088 7.0
TX 79091 2.0
TX 79092 10.4
TX 79093 7.0
TX 79094 2.0
TX 79095 10.0
TX 79096 10.0
TX 79097 10.4
TX 79098 10.4
TX 79101 1.0
TX 79102 1.0
TX 79103 1.0
TX 79104 1.0
TX 79105 1.0
TX 79106 1.0
TX 79107 1.0
TX 79108 1.0
TX 79109 1.0
TX 79110 1.0
TX 79111 1.0
TX 79114 1.0
TX 79116 1.0
TX 79117 1.0
TX 79118 2.0
TX 79119 1.0
TX 79120 1.0
TX 79121 1.0
TX 79123 1.0
TX 79124 1.0
TX 79159 1.0
TX 79163 1.0
TX 79165 1.0
TX 79166 1.0
TX 79167 1.0
TX 79168 1.0
TX 79170 1.0
TX 79171 1.0
TX 79172 1.0
TX 79174 1.0
TX 79175 1.0
TX 79178 1.0
TX 79180 1.0
TX 79181 1.0
TX 79182 1.0
TX 79184 1.0
TX 79185 1.0
TX 79186 1.0
TX 79187 1.0
TX 79189 1.0
TX 79201 7.0
TX 79220 10.0
TX 79221 10.5
TX 79223 10.0
TX 79225 7.4
TX 79226 10.0
TX 79227 10.5
TX 79229 10.0
TX 79230 10.0
TX 79231 7.4
TX 79232 10.0
TX 79233 10.0
TX 79234 10.0
TX 79235 7.4
TX 79236 10.0
TX 79237 10.0
TX 79239 10.0
TX 79240 10.0
TX 79241 10.5
TX 79243 10.0
TX 79244 10.0
TX 79245 10.0
TX 79247 5.0
TX 79248 10.0
TX 79250 2.0
TX 79251 10.0
TX 79252 7.4
TX 79255 10.0
TX 79256 10.0
TX 79257 10.0
TX 79258 10.5
TX 79259 8.0
TX 79261 10.0
TX 79311 2.0
TX 79312 10.6
TX 79313 2.0
TX 79314 10.5
TX 79316 7.0
TX 79320 7.0
TX 79322 10.4
TX 79323 7.0
TX 79324 7.0
TX 79325 10.0
TX 79326 10.5
TX 79329 2.0
TX 79330 7.3
TX 79331 4.0
TX 79336 4.2
TX 79338 4.2
TX 79339 7.3
TX 79342 10.6
TX 79343 2.0
TX 79344 7.0
TX 79345 10.6
TX 79346 10.5
TX 79347 7.0
TX 79350 1.0
TX 79351 10.6
TX 79353 5.2
TX 79355 10.6
TX 79356 7.3
TX 79357 10.4
TX 79358 2.0
TX 79359 10.6
TX 79360 10.3
TX 79363 2.0
TX 79364 2.0
TX 79366 2.0
TX 79367 4.2
TX 79369 7.3
TX 79370 10.0
TX 79371 10.6
TX 79372 4.2
TX 79373 7.3
TX 79376 10.6
TX 79377 10.2
TX 79378 7.0
TX 79379 10.5
TX 79380 4.2
TX 79381 2.0
TX 79382 1.0
TX 79383 7.3
TX 79401 1.0
TX 79402 1.0
TX 79403 1.0
TX 79404 1.0
TX 79405 1.0
TX 79406 1.0
TX 79407 1.0
TX 79408 1.0
TX 79409 1.0
TX 79410 1.0
TX 79411 1.0
TX 79412 1.0
TX 79413 1.0
TX 79414 1.0
TX 79415 1.0
TX 79416 1.0
TX 79423 1.0
TX 79424 1.0
TX 79430 1.0
TX 79452 1.0
TX 79453 1.0
TX 79457 1.0
TX 79464 1.0
TX 79490 1.0
TX 79491 1.0
TX 79493 1.0
TX 79499 1.0
TX 79501 10.4
TX 79502 10.0
TX 79503 7.0
TX 79504 10.4
TX 79505 7.0
TX 79506 10.5
TX 79508 2.0
TX 79510 2.0
TX 79511 5.0
TX 79512 7.0
TX 79516 4.0
TX 79517 5.0
TX 79518 10.0
TX 79519 8.0
TX 79520 10.0
TX 79521 7.0
TX 79525 2.0
TX 79526 4.0
TX 79527 5.0
TX 79528 10.0
TX 79529 10.0
TX 79530 2.0
TX 79532 10.3
TX 79533 2.0
TX 79534 10.0
TX 79535 10.5
TX 79536 2.0
TX 79537 10.5
TX 79538 8.0
TX 79539 10.6
TX 79540 10.0
TX 79541 2.0
TX 79543 10.5
TX 79544 10.6
TX 79545 10.5
TX 79546 10.0
TX 79547 10.6
TX 79548 10.6
TX 79549 4.0
TX 79550 4.0
TX 79553 7.0
TX 79556 4.0
TX 79560 10.5
TX 79561 2.0
TX 79562 2.0
TX 79563 2.0
TX 79565 10.6
TX 79566 10.3
TX 79567 7.0
TX 79601 1.0
TX 79602 1.0
TX 79603 1.0
TX 79604 1.0
TX 79605 1.0
TX 79606 1.0
TX 79607 1.0
TX 79608 1.0
TX 79697 1.0
TX 79698 1.0
TX 79699 1.0
TX 79701 1.0
TX 79702 1.0
TX 79703 1.0
TX 79704 1.0
TX 79705 1.0
TX 79706 2.0
TX 79707 1.0
TX 79708 1.0
TX 79710 1.0
TX 79711 2.0
TX 79712 1.0
TX 79713 10.2
TX 79714 4.0
TX 79718 5.0
TX 79719 10.3
TX 79720 4.0
TX 79721 4.0
TX 79730 10.0
TX 79731 7.3
TX 79733 4.0
TX 79734 10.6
TX 79735 7.0
TX 79738 10.5
TX 79739 10.5
TX 79740 7.0
TX 79741 2.0
TX 79742 10.3
TX 79743 10.0
TX 79744 10.0
TX 79745 7.0
TX 79748 5.0
TX 79749 10.6
TX 79752 10.0
TX 79754 10.2
TX 79755 10.0
TX 79756 7.0
TX 79758 2.0
TX 79759 2.0
TX 79760 1.0
TX 79761 1.0
TX 79762 1.0
TX 79763 1.0
TX 79764 1.0
TX 79765 1.0
TX 79766 2.0
TX 79768 1.0
TX 79769 1.0
TX 79770 4.0
TX 79772 4.0
TX 79776 2.0
TX 79777 10.3
TX 79778 10.0
TX 79780 5.0
TX 79781 10.0
TX 79782 7.3
TX 79783 10.6
TX 79785 4.0
TX 79786 5.0
TX 79788 7.0
TX 79789 8.0
TX 79821 1.0
TX 79830 7.0
TX 79831 7.0
TX 79832 7.0
TX 79834 8.0
TX 79835 1.0
TX 79836 2.0
TX 79837 10.4
TX 79838 2.0
TX 79839 10.4
TX 79842 10.6
TX 79843 10.0
TX 79845 7.0
TX 79846 7.0
TX 79847 10.0
TX 79848 10.0
TX 79849 1.0
TX 79851 10.0
TX 79852 8.0
TX 79853 2.0
TX 79854 10.6
TX 79855 10.0
TX 79901 1.0
TX 79902 1.0
TX 79903 1.0
TX 79904 1.0
TX 79905 1.0
TX 79906 1.0
TX 79907 1.0
TX 79908 1.0
TX 79910 1.0
TX 79911 1.0
TX 79912 1.0
TX 79913 1.0
TX 79914 1.0
TX 79915 1.0
TX 79916 1.0
TX 79917 1.0
TX 79918 1.0
TX 79920 1.0
TX 79922 1.0
TX 79923 1.0
TX 79924 1.0
TX 79925 1.0
TX 79926 1.0
TX 79927 1.0
TX 79928 1.0
TX 79929 1.0
TX 79930 1.0
TX 79931 1.0
TX 79932 1.0
TX 79934 1.0
TX 79935 1.0
TX 79936 1.0
TX 79937 1.0
TX 79938 1.0
TX 79940 1.0
TX 79941 1.0
TX 79942 1.0
TX 79943 1.0
TX 79944 1.0
TX 79945 1.0
TX 79946 1.0
TX 79947 1.0
TX 79948 1.0
TX 79949 1.0
TX 79950 1.0
TX 79951 1.0
TX 79952 1.0
TX 79953 1.0
TX 79954 1.0
TX 79955 1.0
TX 79958 1.0
TX 79960 1.0
TX 79961 1.0
TX 79966 1.0
TX 79968 1.0
TX 79973 1.0
TX 79974 1.0
TX 79975 1.0
TX 79976 1.0
TX 79977 1.0
TX 79978 1.0
TX 79980 1.0
TX 79982 1.0
TX 79983 1.0
TX 79984 1.0
TX 79985 1.0
TX 79986 1.0
TX 79987 1.0
TX 79988 1.0
TX 79989 1.0
TX 79990 1.0
TX 79991 1.0
TX 79992 1.0
TX 79993 1.0
TX 79994 1.0
TX 79995 1.0
TX 79996 1.0
TX 79997 1.0
TX 79998 1.0
TX 79999 1.0
TX 88510 1.0
TX 88511 1.0
TX 88512 1.0
TX 88513 1.0
TX 88514 1.0
TX 88515 1.0
TX 88516 1.0
TX 88517 1.0
TX 88518 1.0
TX 88519 1.0
TX 88520 1.0
TX 88521 1.0
TX 88523 1.0
TX 88524 1.0
TX 88525 1.0
TX 88526 1.0
TX 88527 1.0
TX 88528 1.0
TX 88529 1.0
TX 88530 1.0
TX 88531 1.0
TX 88532 1.0
TX 88533 1.0
TX 88534 1.0
TX 88535 1.0
TX 88536 1.0
TX 88538 1.0
TX 88539 1.0
TX 88540 1.0
TX 88541 1.0
TX 88542 1.0
TX 88543 1.0
TX 88544 1.0
TX 88545 1.0
TX 88546 1.0
TX 88547 1.0
TX 88548 1.0
TX 88549 1.0
TX 88550 1.0
TX 88553 1.0
TX 88554 1.0
TX 88555 1.0
TX 88556 1.0
TX 88557 1.0
TX 88558 1.0
TX 88559 1.0
TX 88560 1.0
TX 88561 1.0
TX 88562 1.0
TX 88563 1.0
TX 88565 1.0
TX 88566 1.0
TX 88567 1.0
TX 88568 1.0
TX 88569 1.0
TX 88570 1.0
TX 88571 1.0
TX 88572 1.0
TX 88573 1.0
TX 88574 1.0
TX 88575 1.0
TX 88576 1.0
TX 88577 1.0
TX 88578 1.0
TX 88579 1.0
TX 88580 1.0
TX 88581 1.0
TX 88582 1.0
TX 88583 1.0
TX 88584 1.0
TX 88585 1.0
TX 88586 1.0
TX 88587 1.0
TX 88588 1.0
TX 88589 1.0
TX 88590 1.0
TX 88595 1.0
UT 84001 10.3
UT 84002 10.3
UT 84003 1.0
UT 84004 1.0
UT 84006 1.0
UT 84007 10.3
UT 84008 4.0
UT 84010 1.0
UT 84011 1.0
UT 84013 2.0
UT 84014 1.0
UT 84015 1.0
UT 84016 1.0
UT 84017 10.6
UT 84018 2.0
UT 84020 1.0
UT 84021 10.0
UT 84022 7.0
UT 84023 10.0
UT 84024 10.6
UT 84025 1.0
UT 84026 10.6
UT 84027 10.0
UT 84028 10.0
UT 84029 3.0
UT 84030 10.6
UT 84031 10.0
UT 84032 7.0
UT 84033 10.6
UT 84034 7.0
UT 84035 5.0
UT 84036 10.6
UT 84037 1.0
UT 84038 10.0
UT 84039 10.6
UT 84040 1.0
UT 84041 1.0
UT 84042 1.0
UT 84043 1.0
UT 84044 1.0
UT 84046 10.0
UT 84047 1.0
UT 84049 7.0
UT 84050 2.0
UT 84051 10.0
UT 84052 10.6
UT 84053 10.3
UT 84054 1.0
UT 84055 10.6
UT 84056 1.0
UT 84057 1.0
UT 84058 1.0
UT 84059 1.0
UT 84060 7.3
UT 84061 10.6
UT 84062 1.0
UT 84063 10.0
UT 84064 10.0
UT 84065 1.0
UT 84066 7.0
UT 84067 1.0
UT 84068 7.3
UT 84069 2.0
UT 84070 1.0
UT 84071 2.0
UT 84072 10.0
UT 84073 10.0
UT 84074 4.1
UT 84075 1.0
UT 84076 10.6
UT 84078 4.0
UT 84079 4.0
UT 84080 2.0
UT 84082 7.0
UT 84083 7.0
UT 84084 1.0
UT 84085 10.6
UT 84086 10.0
UT 84087 1.0
UT 84088 1.0
UT 84089 1.0
UT 84090 1.0
UT 84091 1.0
UT 84092 1.0
UT 84093 1.0
UT 84094 1.0
UT 84095 1.0
UT 84097 1.0
UT 84098 2.0
UT 84101 1.0
UT 84102 1.0
UT 84103 1.0
UT 84104 1.0
UT 84105 1.0
UT 84106 1.0
UT 84107 1.0
UT 84108 1.0
UT 84109 1.0
UT 84110 1.0
UT 84111 1.0
UT 84112 1.0
UT 84113 1.0
UT 84114 1.0
UT 84115 1.0
UT 84116 1.0
UT 84117 1.0
UT 84118 1.0
UT 84119 1.0
UT 84120 1.0
UT 84121 1.0
UT 84122 1.0
UT 84123 1.0
UT 84124 1.0
UT 84125 1.0
UT 84126 1.0
UT 84127 1.0
UT 84128 1.0
UT 84130 1.0
UT 84131 1.0
UT 84132 1.0
UT 84133 1.0
UT 84134 1.0
UT 84136 1.0
UT 84138 1.0
UT 84139 1.0
UT 84141 1.0
UT 84143 1.0
UT 84144 1.0
UT 84145 1.0
UT 84147 1.0
UT 84148 1.0
UT 84150 1.0
UT 84151 1.0
UT 84152 1.0
UT 84153 1.0
UT 84157 1.0
UT 84158 1.0
UT 84165 1.0
UT 84170 1.0
UT 84171 1.0
UT 84180 1.0
UT 84184 1.0
UT 84189 1.0
UT 84190 1.0
UT 84199 1.0
UT 84201 1.0
UT 84244 1.0
UT 84301 10.5
UT 84302 4.2
UT 84304 7.4
UT 84305 2.0
UT 84306 7.4
UT 84307 10.5
UT 84308 2.0
UT 84309 7.4
UT 84310 2.0
UT 84311 7.4
UT 84312 7.4
UT 84313 10.6
UT 84314 10.5
UT 84315 1.0
UT 84316 10.6
UT 84317 2.0
UT 84318 1.0
UT 84319 1.0
UT 84320 2.0
UT 84321 1.0
UT 84322 1.0
UT 84323 1.0
UT 84324 4.2
UT 84325 1.0
UT 84326 1.0
UT 84327 1.0
UT 84328 2.0
UT 84329 10.6
UT 84330 10.6
UT 84331 10.6
UT 84332 1.0
UT 84333 2.0
UT 84334 7.4
UT 84335 1.0
UT 84336 10.6
UT 84337 7.4
UT 84338 2.0
UT 84339 1.0
UT 84340 4.2
UT 84341 1.0
UT 84401 1.0
UT 84402 1.0
UT 84403 1.0
UT 84404 1.0
UT 84405 1.0
UT 84407 1.0
UT 84408 1.0
UT 84409 1.0
UT 84412 1.0
UT 84414 1.0
UT 84415 1.0
UT 84501 4.0
UT 84510 8.0
UT 84511 7.0
UT 84512 7.0
UT 84513 10.5
UT 84515 7.0
UT 84516 10.0
UT 84518 10.5
UT 84520 5.0
UT 84521 10.5
UT 84522 10.0
UT 84523 10.0
UT 84525 10.6
UT 84526 4.0
UT 84527 4.0
UT 84528 10.5
UT 84529 4.0
UT 84530 10.6
UT 84531 10.0
UT 84532 7.0
UT 84533 7.0
UT 84534 8.0
UT 84535 10.6
UT 84536 10.0
UT 84537 10.5
UT 84539 5.0
UT 84540 7.0
UT 84542 4.0
UT 84601 1.0
UT 84602 1.0
UT 84603 1.0
UT 84604 1.0
UT 84605 1.0
UT 84606 1.0
UT 84620 10.6
UT 84621 7.0
UT 84622 7.0
UT 84623 10.6
UT 84624 7.0
UT 84626 2.0
UT 84627 7.0
UT 84628 3.0
UT 84629 10.6
UT 84630 7.0
UT 84631 10.6
UT 84632 10.6
UT 84633 2.0
UT 84634 7.0
UT 84635 8.0
UT 84636 10.6
UT 84637 10.6
UT 84638 7.0
UT 84639 7.3
UT 84640 7.0
UT 84642 7.0
UT 84643 7.0
UT 84644 10.6
UT 84645 3.0
UT 84646 10.6
UT 84647 10.6
UT 84648 7.3
UT 84649 7.0
UT 84650 8.0
UT 84651 2.0
UT 84652 10.6
UT 84653 2.0
UT 84654 10.6
UT 84655 2.0
UT 84656 10.6
UT 84657 7.0
UT 84660 2.0
UT 84662 10.6
UT 84663 1.0
UT 84664 1.0
UT 84665 7.0
UT 84667 10.6
UT 84701 7.0
UT 84710 10.6
UT 84711 7.0
UT 84712 10.0
UT 84713 10.0
UT 84714 5.0
UT 84715 10.0
UT 84716 10.0
UT 84717 10.0
UT 84718 10.0
UT 84719 10.2
UT 84720 4.0
UT 84721 4.0
UT 84722 2.0
UT 84723 10.6
UT 84724 8.0
UT 84725 2.0
UT 84726 10.0
UT 84728 8.0
UT 84729 10.6
UT 84730 7.0
UT 84731 10.0
UT 84732 10.6
UT 84733 1.0
UT 84734 10.0
UT 84735 10.0
UT 84736 10.0
UT 84737 7.1
UT 84738 1.0
UT 84739 8.0
UT 84740 10.6
UT 84741 7.0
UT 84742 4.0
UT 84743 10.6
UT 84744 7.0
UT 84745 7.1
UT 84746 7.1
UT 84747 10.0
UT 84749 10.0
UT 84750 10.6
UT 84751 10.0
UT 84752 10.0
UT 84753 5.0
UT 84754 8.0
UT 84755 10.6
UT 84756 5.0
UT 84757 10.1
UT 84758 10.6
UT 84759 10.0
UT 84760 10.2
UT 84761 10.2
UT 84762 10.6
UT 84763 7.1
UT 84764 10.0
UT 84765 1.0
UT 84766 8.0
UT 84767 7.1
UT 84770 1.0
UT 84771 1.0
UT 84772 10.2
UT 84773 10.0
UT 84774 7.1
UT 84775 10.0
UT 84776 10.0
UT 84779 7.1
UT 84780 1.0
UT 84781 2.0
UT 84782 1.0
UT 84783 1.0
UT 84784 7.0
UT 84790 1.0
UT 84791 1.0
VA 20101 1.0
VA 20102 1.0
VA 20103 1.0
VA 20104 1.0
VA 20105 2.0
VA 20106 2.0
VA 20107 1.0
VA 20108 1.0
VA 20109 1.0
VA 20110 1.0
VA 20111 1.0
VA 20112 1.0
VA 20113 1.0
VA 20115 2.0
VA 20116 2.0
VA 20117 2.0
VA 20118 2.0
VA 20119 2.0
VA 20120 1.0
VA 20121 1.0
VA 20122 1.0
VA 20124 1.0
VA 20128 2.0
VA 20129 2.0
VA 20130 2.0
VA 20131 2.0
VA 20132 2.0
VA 20134 2.0
VA 20135 2.0
VA 20136 1.0
VA 20137 2.0
VA 20138 2.0
VA 20139 2.0
VA 20140 2.0
VA 20141 2.0
VA 20142 2.0
VA 20143 2.0
VA 20144 2.0
VA 20146 1.0
VA 20147 1.0
VA 20148 1.0
VA 20149 1.0
VA 20151 1.0
VA 20152 1.0
VA 20153 1.0
VA 20155 2.0
VA 20156 2.0
VA 20158 2.0
VA 20159 2.0
VA 20160 2.0
VA 20163 1.0
VA 20164 1.0
VA 20165 1.0
VA 20166 1.0
VA 20167 1.0
VA 20168 2.0
VA 20169 2.0
VA 20170 1.0
VA 20171 1.0
VA 20172 1.0
VA 20175 1.0
VA 20176 1.0
VA 20177 1.0
VA 20178 1.0
VA 20180 2.0
VA 20181 2.0
VA 20182 2.0
VA 20184 2.0
VA 20185 2.0
VA 20186 2.0
VA 20187 2.0
VA 20188 2.0
VA 20189 1.0
VA 20190 1.0
VA 20191 1.0
VA 20192 1.0
VA 20193 1.0
VA 20194 1.0
VA 20195 1.0
VA 20196 1.0
VA 20197 2.0
VA 20198 2.0
VA 20199 1.0
VA 22003 1.0
VA 22009 1.0
VA 22015 1.0
VA 22025 1.0
VA 22026 1.0
VA 22027 1.0
VA 22030 1.0
VA 22031 1.0
VA 22032 1.0
VA 22033 1.0
VA 22034 1.0
VA 22035 1.0
VA 22036 1.0
VA 22037 1.0
VA 22038 1.0
VA 22039 1.0
VA 22040 1.0
VA 22041 1.0
VA 22042 1.0
VA 22043 1.0
VA 22044 1.0
VA 22046 1.0
VA 22047 1.0
VA 22060 1.0
VA 22066 1.0
VA 22067 2.0
VA 22079 1.0
VA 22081 1.0
VA 22082 1.0
VA 22092 1.0
VA 22093 1.0
VA 22095 1.0
VA 22096 1.0
VA 22101 1.0
VA 22102 1.0
VA 22103 1.0
VA 22106 1.0
VA 22107 1.0
VA 22108 1.0
VA 22109 1.0
VA 22116 1.0
VA 22118 1.0
VA 22119 1.0
VA 22120 1.0
VA 22121 1.0
VA 22122 1.0
VA 22124 1.0
VA 22125 1.0
VA 22134 1.0
VA 22135 1.0
VA 22150 1.0
VA 22151 1.0
VA 22152 1.0
VA 22153 1.0
VA 22156 1.0
VA 22158 1.0
VA 22159 1.0
VA 22160 1.0
VA 22161 1.0
VA 22172 1.0
VA 22180 1.0
VA 22181 1.0
VA 22182 1.0
VA 22183 1.0
VA 22184 1.0
VA 22185 1.0
VA 22191 1.0
VA 22192 1.0
VA 22193 1.0
VA 22194 1.0
VA 22195 1.0
VA 22199 1.0
VA 22201 1.0
VA 22202 1.0
VA 22203 1.0
VA 22204 1.0
VA 22205 1.0
VA 22206 1.0
VA 22207 1.0
VA 22209 1.0
VA 22210 1.0
VA 22211 1.0
VA 22212 1.0
VA 22213 1.0
VA 22214 1.0
VA 22215 1.0
VA 22216 1.0
VA 22217 1.0
VA 22218 1.0
VA 22219 1.0
VA 22222 1.0
VA 22223 1.0
VA 22225 1.0
VA 22226 1.0
VA 22227 1.0
VA 22229 1.0
VA 22230 1.0
VA 22234 1.0
VA 22240 1.0
VA 22241 1.0
VA 22242 1.0
VA 22243 1.0
VA 22244 1.0
VA 22245 1.0
VA 22246 1.0
VA 22301 1.0
VA 22302 1.0
VA 22303 1.0
VA 22304 1.0
VA 22305 1.0
VA 22306 1.0
VA 22307 1.0
VA 22308 1.0
VA 22309 1.0
VA 22310 1.0
VA 22311 1.0
VA 22312 1.0
VA 22313 1.0
VA 22314 1.0
VA 22315 1.0
VA 22320 1.0
VA 22321 1.0
VA 22331 1.0
VA 22332 1.0
VA 22333 1.0
VA 22334 1.0
VA 22336 1.0
VA 22401 1.0
VA 22402 1.0
VA 22403 1.0
VA 22404 1.0
VA 22405 1.0
VA 22406 2.0
VA 22407 1.0
VA 22408 1.0
VA 22412 2.0
VA 22427 10.4
VA 22428 10.4
VA 22430 1.0
VA 22432 10.0
VA 22433 9.0
VA 22435 10.0
VA 22436 8.0
VA 22437 8.1
VA 22438 8.0
VA 22442 10.0
VA 22443 7.0
VA 22446 2.1
VA 22448 10.4
VA 22451 10.4
VA 22454 8.1
VA 22456 10.0
VA 22460 10.0
VA 22463 1.0
VA 22469 10.0
VA 22471 2.0
VA 22472 10.6
VA 22473 10.0
VA 22476 8.0
VA 22480 10.0
VA 22481 10.4
VA 22482 10.0
VA 22485 10.4
VA 22488 10.0
VA 22501 3.0
VA 22503 10.0
VA 22504 8.1
VA 22507 10.0
VA 22508 3.0
VA 22509 8.0
VA 22511 10.0
VA 22513 10.0
VA 22514 3.0
VA 22517 10.0
VA 22520 10.0
VA 22523 10.0
VA 22524 10.0
VA 22526 10.4
VA 22528 10.0
VA 22529 10.0
VA 22530 10.0
VA 22534 2.1
VA 22535 2.0
VA 22538 2.0
VA 22539 10.0
VA 22542 9.0
VA 22544 10.4
VA 22545 1.0
VA 22546 3.0
VA 22547 10.4
VA 22548 10.6
VA 22552 3.0
VA 22553 1.0
VA 22554 1.0
VA 22555 1.0
VA 22556 1.0
VA 22558 10.0
VA 22560 7.3
VA 22565 1.0
VA 22567 9.0
VA 22570 10.0
VA 22572 10.6
VA 22576 10.0
VA 22577 10.0
VA 22578 10.0
VA 22579 10.0
VA 22580 2.1
VA 22581 10.0
VA 22601 1.0
VA 22602 1.0
VA 22603 2.0
VA 22604 1.0
VA 22610 5.2
VA 22611 7.3
VA 22620 10.4
VA 22622 2.0
VA 22623 4.2
VA 22624 2.0
VA 22625 2.0
VA 22626 7.3
VA 22627 10.4
VA 22630 4.2
VA 22637 2.0
VA 22638 1.0
VA 22639 2.0
VA 22640 10.4
VA 22641 9.0
VA 22642 2.0
VA 22643 2.0
VA 22644 9.0
VA 22645 2.0
VA 22646 10.4
VA 22649 6.1
VA 22650 7.0
VA 22652 10.6
VA 22654 2.0
VA 22655 1.0
VA 22656 2.0
VA 22657 7.3
VA 22660 9.0
VA 22663 1.0
VA 22664 7.0
VA 22701 7.3
VA 22709 10.6
VA 22711 10.4
VA 22712 2.0
VA 22713 8.3
VA 22714 10.6
VA 22715 10.6
VA 22716 10.4
VA 22718 10.6
VA 22719 10.4
VA 22720 2.0
VA 22721 10.4
VA 22722 10.6
VA 22723 10.4
VA 22724 2.0
VA 22725 10.6
VA 22726 10.6
VA 22727 10.4
VA 22728 2.0
VA 22729 7.3
VA 22730 10.6
VA 22731 10.4
VA 22732 10.6
VA 22733 7.3
VA 22734 2.0
VA 22735 8.3
VA 22736 10.6
VA 22737 2.0
VA 22738 10.6
VA 22739 2.0
VA 22740 10.4
VA 22741 10.6
VA 22742 2.0
VA 22743 10.4
VA 22746 2.0
VA 22747 10.4
VA 22748 10.4
VA 22749 10.4
VA 22801 1.0
VA 22802 1.0
VA 22803 1.0
VA 22807 1.0
VA 22810 9.0
VA 22811 2.0
VA 22812 1.0
VA 22815 2.0
VA 22820 2.0
VA 22821 2.0
VA 22824 8.0
VA 22827 2.0
VA 22830 2.0
VA 22831 2.0
VA 22832 2.0
VA 22833 1.0
VA 22834 2.0
VA 22835 7.0
VA 22840 2.0
VA 22841 1.0
VA 22842 10.6
VA 22843 2.0
VA 22844 10.4
VA 22845 9.0
VA 22846 1.0
VA 22847 10.6
VA 22848 1.0
VA 22849 3.0
VA 22850 2.0
VA 22851 10.6
VA 22853 2.0
VA 22901 1.0
VA 22902 1.0
VA 22903 1.0
VA 22904 1.0
VA 22905 1.0
VA 22906 1.0
VA 22907 1.0
VA 22908 1.0
VA 22909 1.0
VA 22910 1.0
VA 22911 1.0
VA 22920 10.1
VA 22922 2.0
VA 22923 2.0
VA 22924 1.0
VA 22931 2.0
VA 22932 2.0
VA 22935 2.0
VA 22936 2.0
VA 22937 2.0
VA 22938 2.0
VA 22939 6.0
VA 22940 2.0
VA 22942 3.0
VA 22943 2.0
VA 22945 1.0
VA 22946 2.0
VA 22947 2.0
VA 22948 10.6
VA 22949 10.4
VA 22952 4.0
VA 22954 10.4
VA 22957 7.0
VA 22958 10.1
VA 22959 2.0
VA 22960 7.0
VA 22963 2.0
VA 22964 10.4
VA 22965 2.0
VA 22967 10.4
VA 22968 2.0
VA 22969 2.0
VA 22971 2.0
VA 22972 3.0
VA 22973 2.0
VA 22974 2.0
VA 22976 10.4
VA 22980 4.0
VA 22987 2.0
VA 22989 10.6
VA 23001 1.0
VA 23002 2.0
VA 23003 2.0
VA 23004 10.4
VA 23005 1.0
VA 23009 2.0
VA 23011 3.0
VA 23014 2.0
VA 23015 2.0
VA 23017 2.0
VA 23018 1.0
VA 23021 10.4
VA 23022 10.1
VA 23023 2.0
VA 23024 2.0
VA 23025 10.4
VA 23027 2.0
VA 23030 2.0
VA 23031 10.4
VA 23032 10.0
VA 23035 10.4
VA 23038 2.0
VA 23039 2.0
VA 23040 2.0
VA 23043 10.4
VA 23045 10.4
VA 23047 2.0
VA 23050 10.4
VA 23055 10.1
VA 23056 10.4
VA 23058 1.0
VA 23059 1.0
VA 23060 1.0
VA 23061 2.0
VA 23062 1.0
VA 23063 2.0
VA 23064 10.4
VA 23065 2.0
VA 23066 10.4
VA 23067 3.0
VA 23068 10.4
VA 23069 2.0
VA 23070 10.4
VA 23071 10.4
VA 23072 1.0
VA 23075 1.0
VA 23076 10.4
VA 23079 10.0
VA 23081 1.0
VA 23083 2.0
VA 23084 10.1
VA 23085 2.0
VA 23086 2.0
VA 23089 3.0
VA 23090 1.0
VA 23091 2.0
VA 23092 10.4
VA 23093 3.0
VA 23101 2.0
VA 23102 2.0
VA 23103 2.0
VA 23105 2.0
VA 23106 2.0
VA 23107 1.0
VA 23108 3.0
VA 23109 10.4
VA 23110 3.0
VA 23111 1.0
VA 23112 1.0
VA 23113 1.0
VA 23114 1.0
VA 23115 7.3
VA 23116 1.0
VA 23117 2.0
VA 23119 10.4
VA 23120 2.0
VA 23123 10.4
VA 23124 2.0
VA 23125 10.4
VA 23126 2.0
VA 23127 1.0
VA 23128 10.4
VA 23129 2.0
VA 23130 10.4
VA 23131 1.0
VA 23138 10.4
VA 23139 2.0
VA 23140 2.0
VA 23141 2.0
VA 23146 2.0
VA 23147 2.0
VA 23148 2.0
VA 23149 10.4
VA 23150 1.0
VA 23153 2.0
VA 23154 2.0
VA 23155 2.0
VA 23156 3.0
VA 23160 2.0
VA 23161 2.0
VA 23162 1.0
VA 23163 10.4
VA 23168 2.0
VA 23169 10.4
VA 23170 3.0
VA 23173 1.0
VA 23175 10.4
VA 23176 10.4
VA 23177 2.0
VA 23178 2.0
VA 23180 10.0
VA 23181 7.3
VA 23183 2.0
VA 23184 1.0
VA 23185 1.0
VA 23186 1.0
VA 23187 1.0
VA 23188 1.0
VA 23190 2.0
VA 23191 2.0
VA 23192 2.0
VA 23218 1.0
VA 23219 1.0
VA 23220 1.0
VA 23221 1.0
VA 23222 1.0
VA 23223 1.0
VA 23224 1.0
VA 23225 1.0
VA 23226 1.0
VA 23227 1.0
VA 23228 1.0
VA 23229 1.0
VA 23230 1.0
VA 23231 1.0
VA 23232 1.0
VA 23233 1.0
VA 23234 1.0
VA 23235 1.0
VA 23236 1.0
VA 23237 1.0
VA 23238 1.0
VA 23240 1.0
VA 23241 1.0
VA 23242 1.0
VA 23249 1.0
VA 23250 1.0
VA 23255 1.0
VA 23260 1.0
VA 23261 1.0
VA 23269 1.0
VA 23270 1.0
VA 23272 1.0
VA 23273 1.0
VA 23274 1.0
VA 23275 1.0
VA 23276 1.0
VA 23278 1.0
VA 23279 1.0
VA 23280 1.0
VA 23282 1.0
VA 23284 1.0
VA 23285 1.0
VA 23286 1.0
VA 23288 1.0
VA 23289 1.0
VA 23290 1.0
VA 23291 1.0
VA 23292 1.0
VA 23293 1.0
VA 23294 1.0
VA 23295 1.0
VA 23297 1.0
VA 23298 1.0
VA 23301 10.0
VA 23302 9.0
VA 23303 9.0
VA 23304 2.0
VA 23306 10.0
VA 23307 10.0
VA 23308 10.0
VA 23310 10.0
VA 23313 10.0
VA 23314 1.0
VA 23315 3.0
VA 23316 10.0
VA 23320 1.0
VA 23321 1.0
VA 23322 1.0
VA 23323 1.0
VA 23324 1.0
VA 23325 1.0
VA 23326 1.0
VA 23327 1.0
VA 23328 1.0
VA 23336 7.0
VA 23337 9.0
VA 23341 10.0
VA 23345 10.0
VA 23347 10.0
VA 23350 10.0
VA 23354 10.0
VA 23356 9.0
VA 23357 10.0
VA 23358 10.0
VA 23359 10.0
VA 23389 10.0
VA 23395 9.0
VA 23396 9.0
VA 23397 2.0
VA 23398 10.0
VA 23399 10.0
VA 23401 10.0
VA 23404 10.0
VA 23405 10.0
VA 23407 10.0
VA 23408 10.0
VA 23409 10.0
VA 23410 10.0
VA 23412 10.0
VA 23413 10.0
VA 23414 10.0
VA 23415 9.0
VA 23416 9.0
VA 23417 10.0
VA 23418 10.0
VA 23419 10.0
VA 23420 10.0
VA 23421 10.0
VA 23422 10.0
VA 23423 10.0
VA 23424 1.0
VA 23426 10.0
VA 23427 10.0
VA 23429 10.0
VA 23430 2.0
VA 23431 2.0
VA 23432 1.0
VA 23433 1.0
VA 23434 4.1
VA 23435 1.0
VA 23436 1.0
VA 23437 5.1
VA 23438 5.1
VA 23439 4.1
VA 23440 10.0
VA 23441 10.0
VA 23442 9.0
VA 23443 10.0
VA 23450 1.0
VA 23451 1.0
VA 23452 1.0
VA 23453 1.0
VA 23454 1.0
VA 23455 1.0
VA 23456 1.0
VA 23457 2.0
VA 23458 1.0
VA 23459 1.0
VA 23460 1.0
VA 23461 1.0
VA 23462 1.0
VA 23463 1.0
VA 23464 1.0
VA 23465 1.0
VA 23466 1.0
VA 23467 1.0
VA 23468 1.0
VA 23471 1.0
VA 23479 1.0
VA 23480 10.0
VA 23482 10.0
VA 23483 9.0
VA 23486 10.0
VA 23487 2.0
VA 23488 9.0
VA 23501 1.0
VA 23502 1.0
VA 23503 1.0
VA 23504 1.0
VA 23505 1.0
VA 23506 1.0
VA 23507 1.0
VA 23508 1.0
VA 23509 1.0
VA 23510 1.0
VA 23511 1.0
VA 23512 1.0
VA 23513 1.0
VA 23514 1.0
VA 23515 1.0
VA 23517 1.0
VA 23518 1.0
VA 23519 1.0
VA 23520 1.0
VA 23521 1.0
VA 23523 1.0
VA 23529 1.0
VA 23530 1.0
VA 23541 1.0
VA 23551 1.0
VA 23601 1.0
VA 23602 1.0
VA 23603 1.0
VA 23604 1.0
VA 23605 1.0
VA 23606 1.0
VA 23607 1.0
VA 23608 1.0
VA 23609 1.0
VA 23612 1.0
VA 23628 1.0
VA 23630 1.0
VA 23631 1.0
VA 23651 1.0
VA 23653 1.0
VA 23661 1.0
VA 23662 1.0
VA 23663 1.0
VA 23664 1.0
VA 23665 1.0
VA 23666 1.0
VA 23667 1.0
VA 23668 1.0
VA 23669 1.0
VA 23670 1.0
VA 23681 1.0
VA 23690 1.0
VA 23691 1.0
VA 23692 1.0
VA 23693 1.0
VA 23694 1.0
VA 23696 1.0
VA 23701 1.0
VA 23702 1.0
VA 23703 1.0
VA 23704 1.0
VA 23705 1.0
VA 23707 1.0
VA 23708 1.0
VA 23709 1.0
VA 23801 1.0
VA 23803 1.0
VA 23804 1.0
VA 23805 1.0
VA 23806 1.0
VA 23821 10.6
VA 23822 2.0
VA 23824 7.3
VA 23827 10.6
VA 23828 10.6
VA 23829 10.0
VA 23830 2.0
VA 23831 1.0
VA 23832 1.0
VA 23833 2.0
VA 23834 1.0
VA 23836 1.0
VA 23837 10.6
VA 23838 2.0
VA 23839 3.0
VA 23840 2.0
VA 23841 2.0
VA 23842 2.0
VA 23843 10.6
VA 23844 9.0
VA 23845 9.0
VA 23846 3.0
VA 23847 7.0
VA 23850 2.0
VA 23851 7.0
VA 23856 7.0
VA 23857 9.0
VA 23860 1.0
VA 23866 3.0
VA 23867 3.0
VA 23868 7.0
VA 23870 7.0
VA 23872 2.0
VA 23873 9.0
VA 23874 10.6
VA 23875 1.0
VA 23876 10.6
VA 23878 3.0
VA 23879 8.0
VA 23881 2.0
VA 23882 3.0
VA 23883 2.0
VA 23884 3.0
VA 23885 2.0
VA 23887 9.0
VA 23888 10.4
VA 23889 10.6
VA 23890 3.0
VA 23891 3.0
VA 23893 9.0
VA 23894 2.0
VA 23897 2.0
VA 23898 3.0
VA 23899 2.0
VA 23901 7.2
VA 23909 7.0
VA 23915 8.0
VA 23917 10.0
VA 23919 8.0
VA 23920 9.0
VA 23921 10.0
VA 23922 7.3
VA 23923 10.0
VA 23924 7.0
VA 23927 10.0
VA 23930 7.3
VA 23934 10.0
VA 23936 10.0
VA 23937 10.0
VA 23938 10.0
VA 23939 10.1
VA 23941 10.0
VA 23942 10.6
VA 23943 7.2
VA 23944 10.6
VA 23947 10.0
VA 23950 8.0
VA 23952 10.6
VA 23954 10.6
VA 23955 7.3
VA 23958 7.1
VA 23959 10.0
VA 23960 7.0
VA 23962 10.0
VA 23963 10.0
VA 23964 10.0
VA 23966 10.3
VA 23967 10.0
VA 23968 10.0
VA 23970 7.0
VA 23974 10.6
VA 23976 10.0
VA 24001 1.0
VA 24002 1.0
VA 24003 1.0
VA 24004 1.0
VA 24005 1.0
VA 24006 1.0
VA 24007 1.0
VA 24008 1.0
VA 24009 1.0
VA 24010 1.0
VA 24011 1.0
VA 24012 1.0
VA 24013 1.0
VA 24014 1.0
VA 24015 1.0
VA 24016 1.0
VA 24017 1.0
VA 24018 1.0
VA 24019 1.0
VA 24020 1.0
VA 24022 1.0
VA 24023 1.0
VA 24024 1.0
VA 24025 1.0
VA 24026 1.0
VA 24027 1.0
VA 24028 1.0
VA 24029 1.0
VA 24030 1.0
VA 24031 1.0
VA 24032 1.0
VA 24033 1.0
VA 24034 1.0
VA 24035 1.0
VA 24036 1.0
VA 24037 1.0
VA 24038 1.0
VA 24040 1.0
VA 24042 1.0
VA 24043 1.0
VA 24044 1.0
VA 24045 1.0
VA 24048 1.0
VA 24050 1.0
VA 24053 10.5
VA 24054 5.0
VA 24055 5.0
VA 24058 4.2
VA 24059 2.0
VA 24060 1.0
VA 24061 1.0
VA 24062 1.0
VA 24063 1.0
VA 24064 1.0
VA 24065 2.0
VA 24066 2.0
VA 24067 2.0
VA 24068 1.0
VA 24069 2.0
VA 24070 2.0
VA 24072 10.4
VA 24073 1.0
VA 24076 10.5
VA 24077 1.0
VA 24078 4.0
VA 24079 10.4
VA 24082 10.2
VA 24083 2.0
VA 24084 4.2
VA 24085 2.0
VA 24086 2.0
VA 24087 2.0
VA 24088 10.6
VA 24089 5.0
VA 24090 2.0
VA 24091 10.4
VA 24092 8.3
VA 24093 10.6
VA 24094 2.0
VA 24095 2.0
VA 24101 2.0
VA 24102 8.4
VA 24104 2.0
VA 24105 10.4
VA 24111 1.0
VA 24112 4.0
VA 24113 4.0
VA 24114 4.0
VA 24115 4.0
VA 24120 10.5
VA 24121 2.0
VA 24122 2.0
VA 24124 10.6
VA 24126 4.2
VA 24127 2.0
VA 24128 2.0
VA 24129 4.2
VA 24130 2.0
VA 24131 2.0
VA 24132 4.2
VA 24133 10.2
VA 24134 10.6
VA 24136 2.0
VA 24137 8.4
VA 24138 2.0
VA 24139 9.0
VA 24141 4.2
VA 24142 4.2
VA 24143 4.2
VA 24146 7.3
VA 24147 10.6
VA 24148 4.0
VA 24149 2.0
VA 24150 2.0
VA 24151 7.3
VA 24153 1.0
VA 24155 1.0
VA 24156 1.0
VA 24157 1.0
VA 24161 9.0
VA 24162 2.0
VA 24165 5.0
VA 24167 10.6
VA 24168 4.0
VA 24171 10.5
VA 24174 8.3
VA 24175 1.0
VA 24176 3.0
VA 24177 10.5
VA 24178 1.0
VA 24179 1.0
VA 24184 3.0
VA 24185 10.5
VA 24201 1.0
VA 24202 2.0
VA 24203 1.0
VA 24209 1.0
VA 24210 4.2
VA 24211 5.2
VA 24212 4.2
VA 24215 7.0
VA 24216 7.0
VA 24217 10.6
VA 24218 10.0
VA 24219 7.0
VA 24220 10.0
VA 24221 10.0
VA 24224 10.0
VA 24225 10.0
VA 24226 10.6
VA 24228 10.6
VA 24230 8.0
VA 24236 6.1
VA 24237 10.6
VA 24239 10.0
VA 24243 8.0
VA 24244 2.0
VA 24245 2.0
VA 24246 7.0
VA 24248 10.5
VA 24250 2.0
VA 24251 2.0
VA 24256 10.0
VA 24258 2.0
VA 24260 10.0
VA 24263 10.0
VA 24265 10.0
VA 24266 10.0
VA 24269 10.6
VA 24270 2.0
VA 24271 2.0
VA 24272 10.6
VA 24273 7.0
VA 24277 10.0
VA 24279 8.0
VA 24280 10.0
VA 24281 10.5
VA 24282 10.0
VA 24283 10.6
VA 24290 1.0
VA 24292 10.0
VA 24293 7.0
VA 24301 7.4
VA 24311 10.6
VA 24312 10.6
VA 24313 8.0
VA 24314 10.6
VA 24315 10.5
VA 24316 10.6
VA 24317 5.0
VA 24318 10.6
VA 24319 10.6
VA 24322 10.3
VA 24323 10.3
VA 24324 7.4
VA 24325 10.0
VA 24326 10.6
VA 24327 5.0
VA 24328 6.0
VA 24330 8.0
VA 24333 7.0
VA 24340 6.1
VA 24343 10.0
VA 24347 8.4
VA 24348 10.6
VA 24350 8.0
VA 24351 5.0
VA 24352 10.0
VA 24354 7.0
VA 24360 8.0
VA 24361 5.0
VA 24363 10.0
VA 24366 10.6
VA 24368 10.3
VA 24370 10.0
VA 24374 10.3
VA 24375 10.6
VA 24377 10.6
VA 24378 10.0
VA 24380 10.4
VA 24381 10.6
VA 24382 7.0
VA 24401 4.0
VA 24402 4.0
VA 24407 4.0
VA 24411 10.5
VA 24412 10.0
VA 24413 10.0
VA 24415 10.6
VA 24416 7.0
VA 24421 10.2
VA 24422 7.0
VA 24426 7.0
VA 24430 10.5
VA 24431 10.5
VA 24432 10.5
VA 24433 10.0
VA 24435 10.6
VA 24437 10.5
VA 24438 2.0
VA 24439 10.6
VA 24440 10.5
VA 24441 2.0
VA 24442 10.0
VA 24445 10.0
VA 24448 7.0
VA 24450 10.6
VA 24457 7.0
VA 24458 10.0
VA 24459 10.5
VA 24460 10.0
VA 24463 4.0
VA 24464 10.4
VA 24465 10.0
VA 24467 2.0
VA 24468 10.0
VA 24469 10.5
VA 24471 1.0
VA 24472 10.5
VA 24473 10.6
VA 24474 7.0
VA 24476 10.6
VA 24477 7.4
VA 24479 10.2
VA 24482 4.0
VA 24483 10.6
VA 24484 10.0
VA 24485 10.5
VA 24486 2.0
VA 24487 10.0
VA 24501 1.0
VA 24502 1.0
VA 24503 1.0
VA 24504 1.0
VA 24505 1.0
VA 24506 1.0
VA 24512 1.0
VA 24513 1.0
VA 24514 1.0
VA 24515 1.0
VA 24517 7.3
VA 24520 9.0
VA 24521 10.1
VA 24522 10.1
VA 24523 8.3
VA 24526 2.0
VA 24527 2.0
VA 24528 10.4
VA 24529 10.0
VA 24530 2.0
VA 24531 10.4
VA 24533 10.1
VA 24534 8.0
VA 24535 9.0
VA 24536 2.0
VA 24538 2.0
VA 24539 8.0
VA 24540 1.0
VA 24541 1.0
VA 24543 1.0
VA 24544 1.0
VA 24549 2.0
VA 24550 2.0
VA 24551 1.0
VA 24553 2.0
VA 24554 2.0
VA 24555 10.6
VA 24556 2.0
VA 24557 9.0
VA 24558 8.0
VA 24562 2.0
VA 24563 8.0
VA 24565 10.4
VA 24566 2.0
VA 24569 8.0
VA 24570 8.3
VA 24571 8.3
VA 24572 1.0
VA 24574 2.0
VA 24576 10.4
VA 24577 8.0
VA 24578 10.6
VA 24579 10.6
VA 24580 10.0
VA 24581 2.0
VA 24585 8.0
VA 24586 2.0
VA 24588 2.0
VA 24589 8.0
VA 24590 2.0
VA 24592 7.0
VA 24593 10.1
VA 24594 2.0
VA 24595 10.1
VA 24597 8.0
VA 24598 8.0
VA 24599 2.0
VA 24601 10.6
VA 24602 10.6
VA 24603 10.0
VA 24604 10.6
VA 24605 4.0
VA 24606 4.0
VA 24607 10.0
VA 24608 7.4
VA 24609 7.0
VA 24612 7.0
VA 24613 4.0
VA 24614 10.0
VA 24618 10.0
VA 24619 10.6
VA 24620 10.0
VA 24622 10.6
VA 24624 10.0
VA 24627 10.0
VA 24628 10.0
VA 24630 10.6
VA 24631 10.0
VA 24634 10.6
VA 24635 4.0
VA 24637 10.6
VA 24639 7.0
VA 24640 7.0
VA 24641 7.0
VA 24646 10.0
VA 24647 7.0
VA 24649 10.0
VA 24651 7.4
VA 24656 10.0
VA 24657 10.6
VA 24658 10.0
VI 00801 R
VI 00802 R
VI 00803 R
VI 00804 R
VI 00805 R
VI 00820 R
VI 00821 R
VI 00822 R
VI 00823 R
VI 00824 R
VI 00830 R
VI 00831 R
VI 00840 R
VI 00841 R
VI 00850 R
VI 00851 R
VT 05001 5.0
VT 05009 5.0
VT 05030 7.4
VT 05031 10.5
VT 05032 10.0
VT 05033 10.5
VT 05034 10.0
VT 05035 10.0
VT 05036 10.0
VT 05037 10.0
VT 05038 10.5
VT 05039 10.5
VT 05040 10.5
VT 05041 10.0
VT 05042 10.0
VT 05043 5.0
VT 05045 5.0
VT 05046 10.0
VT 05047 5.0
VT 05048 5.0
VT 05049 7.4
VT 05050 10.6
VT 05051 10.5
VT 05052 5.0
VT 05053 10.5
VT 05054 5.0
VT 05055 5.0
VT 05056 10.0
VT 05058 5.0
VT 05059 5.0
VT 05060 10.0
VT 05061 10.0
VT 05062 10.0
VT 05065 10.5
VT 05067 10.5
VT 05068 10.5
VT 05069 10.0
VT 05070 10.5
VT 05071 10.5
VT 05072 10.5
VT 05073 10.5
VT 05074 5.0
VT 05075 5.0
VT 05076 10.5
VT 05077 10.5
VT 05079 10.5
VT 05081 10.5
VT 05083 5.0
VT 05084 10.5
VT 05085 10.5
VT 05086 10.5
VT 05088 5.0
VT 05089 7.4
VT 05091 10.5
VT 05101 7.0
VT 05141 10.6
VT 05142 9.0
VT 05143 10.6
VT 05144 10.6
VT 05146 10.6
VT 05148 10.0
VT 05149 10.6
VT 05150 7.0
VT 05151 8.0
VT 05152 10.0
VT 05153 9.0
VT 05154 10.6
VT 05155 10.0
VT 05156 7.0
VT 05158 10.6
VT 05159 10.6
VT 05161 10.6
VT 05201 4.0
VT 05250 10.0
VT 05251 10.0
VT 05252 10.5
VT 05253 10.0
VT 05254 10.0
VT 05255 10.0
VT 05257 4.0
VT 05260 5.0
VT 05261 5.0
VT 05262 5.0
VT 05301 7.0
VT 05302 7.0
VT 05303 7.0
VT 05304 7.0
VT 05340 10.0
VT 05341 10.0
VT 05342 10.0
VT 05343 10.6
VT 05344 7.0
VT 05345 10.3
VT 05346 8.0
VT 05350 10.5
VT 05351 10.3
VT 05352 10.5
VT 05353 10.6
VT 05354 8.0
VT 05355 10.6
VT 05356 10.0
VT 05357 7.0
VT 05358 10.6
VT 05359 10.6
VT 05360 10.6
VT 05361 10.0
VT 05362 10.3
VT 05363 10.0
VT 05401 1.0
VT 05402 1.0
VT 05403 1.0
VT 05404 1.0
VT 05405 1.0
VT 05406 1.0
VT 05407 1.0
VT 05439 1.0
VT 05440 10.1
VT 05441 8.3
VT 05442 10.0
VT 05443 10.4
VT 05444 2.0
VT 05445 2.0
VT 05446 1.0
VT 05447 10.6
VT 05448 8.3
VT 05449 1.0
VT 05450 10.6
VT 05451 1.0
VT 05452 1.0
VT 05453 1.0
VT 05454 2.0
VT 05455 8.3
VT 05456 2.0
VT 05457 8.3
VT 05458 2.0
VT 05459 8.3
VT 05460 8.0
VT 05461 2.0
VT 05462 2.0
VT 05463 10.1
VT 05464 2.0
VT 05465 1.0
VT 05466 2.0
VT 05468 1.0
VT 05469 10.4
VT 05470 10.6
VT 05471 10.6
VT 05472 10.6
VT 05473 2.0
VT 05474 10.1
VT 05476 10.6
VT 05477 2.0
VT 05478 7.1
VT 05479 7.1
VT 05481 7.1
VT 05482 1.0
VT 05483 8.3
VT 05485 8.3
VT 05486 2.0
VT 05487 2.0
VT 05488 8.0
VT 05489 2.0
VT 05490 2.0
VT 05491 7.2
VT 05492 10.0
VT 05494 2.0
VT 05495 1.0
VT 05601 4.0
VT 05602 4.0
VT 05603 4.0
VT 05604 4.0
VT 05609 4.0
VT 05620 4.0
VT 05633 4.0
VT 05640 5.0
VT 05641 4.0
VT 05647 5.0
VT 05648 5.0
VT 05649 4.0
VT 05650 5.0
VT 05651 5.0
VT 05652 10.0
VT 05653 10.0
VT 05654 4.0
VT 05655 10.0
VT 05656 10.0
VT 05657 10.0
VT 05658 5.0
VT 05660 3.0
VT 05661 10.0
VT 05662 10.4
VT 05663 7.4
VT 05664 7.4
VT 05665 10.0
VT 05666 5.0
VT 05667 5.0
VT 05669 7.4
VT 05670 4.0
VT 05671 9.1
VT 05672 10.4
VT 05673 10.0
VT 05674 10.0
VT 05675 10.5
VT 05676 9.1
VT 05677 9.1
VT 05678 4.0
VT 05679 5.0
VT 05680 10.0
VT 05681 5.0
VT 05682 5.0
VT 05701 4.0
VT 05702 4.0
VT 05730 5.0
VT 05731 7.2
VT 05732 7.2
VT 05733 10.5
VT 05734 10.6
VT 05735 7.2
VT 05736 5.0
VT 05737 5.0
VT 05738 10.5
VT 05739 10.0
VT 05740 7.0
VT 05741 10.5
VT 05742 5.0
VT 05743 7.2
VT 05744 5.0
VT 05745 10.5
VT 05746 10.5
VT 05747 10.6
VT 05748 10.6
VT 05750 10.5
VT 05751 10.5
VT 05753 7.0
VT 05757 10.2
VT 05758 5.0
VT 05759 5.0
VT 05760 10.6
VT 05761 10.0
VT 05762 5.0
VT 05763 5.0
VT 05764 10.5
VT 05765 5.0
VT 05766 10.6
VT 05767 10.0
VT 05768 10.0
VT 05769 10.6
VT 05770 10.6
VT 05772 10.5
VT 05773 5.0
VT 05774 10.5
VT 05775 10.0
VT 05776 10.0
VT 05777 4.0
VT 05778 10.6
VT 05819 7.0
VT 05820 10.0
VT 05821 10.6
VT 05822 10.6
VT 05823 7.0
VT 05824 9.0
VT 05825 10.6
VT 05826 10.0
VT 05827 10.0
VT 05828 10.6
VT 05829 10.3
VT 05830 10.3
VT 05832 8.0
VT 05833 10.6
VT 05836 10.0
VT 05837 10.0
VT 05838 7.0
VT 05839 10.0
VT 05840 10.0
VT 05841 10.0
VT 05842 10.0
VT 05843 10.0
VT 05845 10.0
VT 05846 10.0
VT 05847 10.0
VT 05848 7.0
VT 05849 7.0
VT 05850 7.0
VT 05851 7.0
VT 05853 10.6
VT 05855 7.0
VT 05857 10.6
VT 05858 10.0
VT 05859 10.6
VT 05860 10.6
VT 05861 7.0
VT 05862 10.0
VT 05863 7.0
VT 05866 10.6
VT 05867 10.6
VT 05868 10.6
VT 05871 8.0
VT 05872 10.6
VT 05873 10.6
VT 05874 10.6
VT 05875 10.0
VT 05901 10.0
VT 05902 10.0
VT 05903 10.0
VT 05904 10.0
VT 05905 10.0
VT 05906 10.0
VT 05907 10.0
WA 98001 1.0
WA 98002 1.0
WA 98003 1.0
WA 98004 1.0
WA 98005 1.0
WA 98006 1.0
WA 98007 1.0
WA 98008 1.0
WA 98009 1.0
WA 98010 1.0
WA 98011 1.0
WA 98012 1.0
WA 98013 2.0
WA 98014 2.0
WA 98015 1.0
WA 98019 1.0
WA 98020 1.0
WA 98021 1.0
WA 98022 1.0
WA 98023 1.0
WA 98024 2.0
WA 98025 1.0
WA 98026 1.0
WA 98027 1.0
WA 98028 1.0
WA 98029 1.0
WA 98030 1.0
WA 98031 1.0
WA 98032 1.0
WA 98033 1.0
WA 98034 1.0
WA 98035 1.0
WA 98036 1.0
WA 98037 1.0
WA 98038 1.0
WA 98039 1.0
WA 98040 1.0
WA 98041 1.0
WA 98042 1.0
WA 98043 1.0
WA 98045 2.0
WA 98046 1.0
WA 98047 1.0
WA 98050 1.0
WA 98051 2.0
WA 98052 1.0
WA 98053 1.0
WA 98054 1.0
WA 98055 1.0
WA 98056 1.0
WA 98057 1.0
WA 98058 1.0
WA 98059 1.0
WA 98061 1.0
WA 98062 1.0
WA 98063 1.0
WA 98064 1.0
WA 98065 2.0
WA 98068 7.3
WA 98070 2.0
WA 98071 1.0
WA 98072 1.0
WA 98073 1.0
WA 98074 1.0
WA 98075 1.0
WA 98077 1.0
WA 98082 1.0
WA 98083 1.0
WA 98087 1.0
WA 98089 1.0
WA 98092 1.0
WA 98093 1.0
WA 98101 1.0
WA 98102 1.0
WA 98103 1.0
WA 98104 1.0
WA 98105 1.0
WA 98106 1.0
WA 98107 1.0
WA 98108 1.0
WA 98109 1.0
WA 98110 1.0
WA 98111 1.0
WA 98112 1.0
WA 98113 1.0
WA 98114 1.0
WA 98115 1.0
WA 98116 1.0
WA 98117 1.0
WA 98118 1.0
WA 98119 1.0
WA 98121 1.0
WA 98122 1.0
WA 98124 1.0
WA 98125 1.0
WA 98126 1.0
WA 98127 1.0
WA 98129 1.0
WA 98131 1.0
WA 98132 1.0
WA 98133 1.0
WA 98134 1.0
WA 98136 1.0
WA 98138 1.0
WA 98139 1.0
WA 98141 1.0
WA 98144 1.0
WA 98145 1.0
WA 98146 1.0
WA 98148 1.0
WA 98151 1.0
WA 98154 1.0
WA 98155 1.0
WA 98158 1.0
WA 98160 1.0
WA 98161 1.0
WA 98164 1.0
WA 98165 1.0
WA 98166 1.0
WA 98168 1.0
WA 98170 1.0
WA 98171 1.0
WA 98174 1.0
WA 98175 1.0
WA 98177 1.0
WA 98178 1.0
WA 98181 1.0
WA 98184 1.0
WA 98185 1.0
WA 98188 1.0
WA 98190 1.0
WA 98191 1.0
WA 98194 1.0
WA 98195 1.0
WA 98198 1.0
WA 98199 1.0
WA 98201 1.0
WA 98203 1.0
WA 98204 1.0
WA 98205 2.0
WA 98206 1.0
WA 98207 1.0
WA 98208 1.0
WA 98213 1.0
WA 98220 2.0
WA 98221 4.2
WA 98222 4.2
WA 98223 2.0
WA 98224 2.0
WA 98225 1.0
WA 98226 1.0
WA 98227 1.0
WA 98228 1.0
WA 98229 1.0
WA 98230 2.0
WA 98231 2.0
WA 98232 2.0
WA 98233 1.0
WA 98235 1.0
WA 98236 2.0
WA 98237 2.0
WA 98238 1.0
WA 98239 5.0
WA 98240 7.3
WA 98241 2.0
WA 98243 10.0
WA 98244 2.0
WA 98245 10.0
WA 98247 2.0
WA 98248 2.0
WA 98249 2.0
WA 98250 10.0
WA 98251 2.0
WA 98252 2.0
WA 98253 2.0
WA 98255 1.0
WA 98256 2.0
WA 98257 2.0
WA 98258 2.0
WA 98259 2.0
WA 98260 2.0
WA 98261 10.0
WA 98262 10.1
WA 98263 1.0
WA 98264 7.1
WA 98266 2.0
WA 98267 2.0
WA 98270 2.0
WA 98271 2.0
WA 98272 1.0
WA 98273 1.0
WA 98274 1.0
WA 98275 1.0
WA 98276 2.0
WA 98277 4.0
WA 98278 4.0
WA 98279 10.0
WA 98280 10.0
WA 98281 10.0
WA 98282 2.0
WA 98283 2.0
WA 98284 1.0
WA 98286 10.0
WA 98287 2.0
WA 98288 2.0
WA 98290 2.0
WA 98291 2.0
WA 98292 2.0
WA 98293 2.0
WA 98294 2.0
WA 98295 2.0
WA 98296 1.0
WA 98297 10.0
WA 98303 2.0
WA 98304 2.0
WA 98305 10.3
WA 98310 1.0
WA 98311 1.0
WA 98312 1.0
WA 98314 1.0
WA 98315 1.0
WA 98320 10.4
WA 98321 1.0
WA 98322 1.0
WA 98323 1.0
WA 98324 7.4
WA 98325 8.0
WA 98326 10.0
WA 98327 1.0
WA 98328 2.0
WA 98329 1.0
WA 98330 2.0
WA 98331 7.0
WA 98332 1.0
WA 98333 1.0
WA 98335 1.0
WA 98336 10.5
WA 98337 1.0
WA 98338 1.0
WA 98339 8.0
WA 98340 2.1
WA 98342 2.1
WA 98343 4.0
WA 98344 1.0
WA 98345 1.0
WA 98346 2.1
WA 98348 2.0
WA 98349 2.0
WA 98350 7.0
WA 98351 2.0
WA 98352 1.0
WA 98353 1.0
WA 98354 1.0
WA 98355 5.0
WA 98356 10.5
WA 98357 10.0
WA 98358 8.0
WA 98359 1.0
WA 98360 1.0
WA 98361 10.0
WA 98362 4.0
WA 98363 4.0
WA 98364 1.0
WA 98365 10.4
WA 98366 1.0
WA 98367 1.0
WA 98368 7.0
WA 98370 1.0
WA 98371 1.0
WA 98372 1.0
WA 98373 1.0
WA 98374 1.0
WA 98375 1.0
WA 98376 10.4
WA 98377 10.0
WA 98378 1.0
WA 98380 2.1
WA 98381 10.0
WA 98382 7.4
WA 98383 1.0
WA 98384 1.0
WA 98385 1.0
WA 98386 1.0
WA 98387 1.0
WA 98388 1.0
WA 98390 1.0
WA 98391 1.0
WA 98392 1.0
WA 98393 1.0
WA 98394 2.0
WA 98395 1.0
WA 98396 1.0
WA 98397 1.0
WA 98398 10.0
WA 98401 1.0
WA 98402 1.0
WA 98403 1.0
WA 98404 1.0
WA 98405 1.0
WA 98406 1.0
WA 98407 1.0
WA 98408 1.0
WA 98409 1.0
WA 98411 1.0
WA 98412 1.0
WA 98413 1.0
WA 98415 1.0
WA 98416 1.0
WA 98418 1.0
WA 98421 1.0
WA 98422 1.0
WA 98424 1.0
WA 98430 1.0
WA 98431 1.0
WA 98433 1.0
WA 98438 1.0
WA 98439 1.0
WA 98442 1.0
WA 98443 1.0
WA 98444 1.0
WA 98445 1.0
WA 98446 1.0
WA 98447 1.0
WA 98450 1.0
WA 98455 1.0
WA 98460 1.0
WA 98464 1.0
WA 98465 1.0
WA 98466 1.0
WA 98467 1.0
WA 98471 1.0
WA 98477 1.0
WA 98481 1.0
WA 98492 1.0
WA 98493 1.0
WA 98497 1.0
WA 98498 1.0
WA 98499 1.0
WA 98501 1.0
WA 98502 1.0
WA 98503 1.0
WA 98504 1.0
WA 98505 1.0
WA 98506 1.0
WA 98507 1.0
WA 98508 1.0
WA 98509 1.0
WA 98511 1.0
WA 98512 1.0
WA 98513 1.0
WA 98516 1.0
WA 98520 4.0
WA 98522 5.0
WA 98524 2.0
WA 98526 10.5
WA 98527 7.0
WA 98528 2.0
WA 98530 2.0
WA 98531 4.2
WA 98532 5.0
WA 98533 5.0
WA 98535 7.4
WA 98536 7.4
WA 98537 4.0
WA 98538 5.0
WA 98539 5.0
WA 98540 1.0
WA 98541 7.4
WA 98542 5.0
WA 98544 4.2
WA 98546 5.2
WA 98547 10.5
WA 98548 5.2
WA 98550 4.0
WA 98552 5.0
WA 98554 7.0
WA 98555 5.2
WA 98556 1.0
WA 98557 3.0
WA 98558 2.0
WA 98559 7.4
WA 98560 10.5
WA 98561 7.0
WA 98562 7.4
WA 98563 5.0
WA 98564 10.5
WA 98565 5.0
WA 98566 5.0
WA 98568 10.4
WA 98569 7.4
WA 98570 5.0
WA 98571 7.4
WA 98572 5.0
WA 98575 5.0
WA 98576 2.0
WA 98577 7.0
WA 98579 4.2
WA 98580 2.0
WA 98581 2.0
WA 98582 5.0
WA 98583 5.0
WA 98584 4.2
WA 98585 5.0
WA 98586 7.0
WA 98587 10.5
WA 98588 2.0
WA 98589 2.0
WA 98590 7.0
WA 98591 10.5
WA 98592 6.1
WA 98593 10.5
WA 98595 10.5
WA 98596 5.0
WA 98597 2.0
WA 98599 1.0
WA 98601 2.0
WA 98602 6.0
WA 98603 7.1
WA 98604 1.0
WA 98605 5.0
WA 98606 2.0
WA 98607 1.0
WA 98609 1.0
WA 98610 10.0
WA 98611 2.0
WA 98612 10.4
WA 98613 6.0
WA 98614 10.6
WA 98616 7.1
WA 98617 6.0
WA 98619 7.0
WA 98620 7.0
WA 98621 10.4
WA 98622 1.0
WA 98623 4.0
WA 98624 7.0
WA 98625 2.0
WA 98626 1.0
WA 98628 6.0
WA 98629 2.0
WA 98631 7.0
WA 98632 1.0
WA 98635 6.0
WA 98637 8.0
WA 98638 10.6
WA 98639 5.1
WA 98640 8.0
WA 98641 8.0
WA 98642 2.0
WA 98643 10.4
WA 98644 7.0
WA 98645 2.0
WA 98647 10.4
WA 98648 5.1
WA 98649 2.0
WA 98650 4.0
WA 98651 5.0
WA 98660 1.0
WA 98661 1.0
WA 98662 1.0
WA 98663 1.0
WA 98664 1.0
WA 98665 1.0
WA 98666 1.0
WA 98667 1.0
WA 98668 1.0
WA 98670 6.0
WA 98671 1.0
WA 98672 4.0
WA 98673 6.0
WA 98674 7.1
WA 98675 2.0
WA 98682 1.0
WA 98683 1.0
WA 98684 1.0
WA 98685 1.0
WA 98686 1.0
WA 98687 1.0
WA 98801 1.0
WA 98802 1.0
WA 98807 1.0
WA 98811 10.1
WA 98812 10.0
WA 98813 10.0
WA 98814 10.0
WA 98815 2.0
WA 98816 7.3
WA 98817 7.3
WA 98819 8.0
WA 98821 2.0
WA 98822 10.1
WA 98823 7.4
WA 98824 7.0
WA 98826 10.4
WA 98827 10.0
WA 98828 2.0
WA 98829 7.0
WA 98830 10.0
WA 98831 10.6
WA 98832 5.0
WA 98833 10.0
WA 98834 10.0
WA 98836 1.0
WA 98837 4.0
WA 98840 7.0
WA 98841 7.0
WA 98843 10.0
WA 98844 10.0
WA 98845 10.4
WA 98846 10.0
WA 98847 2.0
WA 98848 7.0
WA 98849 8.0
WA 98850 1.0
WA 98851 8.0
WA 98852 10.1
WA 98853 5.0
WA 98855 10.6
WA 98856 10.0
WA 98857 10.5
WA 98858 10.4
WA 98859 10.0
WA 98860 5.0
WA 98862 10.0
WA 98901 1.0
WA 98902 1.0
WA 98903 1.0
WA 98904 1.0
WA 98907 1.0
WA 98908 1.0
WA 98909 1.0
WA 98920 2.0
WA 98921 4.2
WA 98922 7.3
WA 98923 2.0
WA 98925 7.3
WA 98926 4.0
WA 98929 2.0
WA 98930 7.4
WA 98932 6.0
WA 98933 2.0
WA 98934 4.0
WA 98935 10.5
WA 98936 2.0
WA 98937 2.0
WA 98938 6.0
WA 98939 2.0
WA 98940 7.3
WA 98941 7.3
WA 98942 1.0
WA 98943 7.3
WA 98944 4.2
WA 98946 5.0
WA 98947 2.0
WA 98948 4.2
WA 98950 4.0
WA 98951 2.0
WA 98952 10.4
WA 98953 4.2
WA 99001 1.0
WA 99003 2.0
WA 99004 7.1
WA 99005 2.0
WA 99006 2.0
WA 99008 10.4
WA 99009 2.0
WA 99011 4.1
WA 99012 2.0
WA 99013 2.0
WA 99014 7.1
WA 99015 2.0
WA 99016 1.0
WA 99017 10.4
WA 99018 2.0
WA 99019 1.0
WA 99020 7.1
WA 99021 1.0
WA 99022 4.1
WA 99023 2.0
WA 99025 1.0
WA 99026 2.0
WA 99027 1.0
WA 99029 10.4
WA 99030 2.0
WA 99031 2.0
WA 99032 10.4
WA 99033 10.4
WA 99034 2.0
WA 99036 2.0
WA 99037 1.0
WA 99039 2.0
WA 99040 10.0
WA 99101 8.0
WA 99102 4.0
WA 99103 10.0
WA 99104 10.2
WA 99105 10.0
WA 99107 10.0
WA 99109 10.0
WA 99110 2.0
WA 99111 7.4
WA 99113 10.5
WA 99114 8.0
WA 99115 10.0
WA 99116 10.0
WA 99117 10.0
WA 99118 10.0
WA 99119 10.0
WA 99121 10.0
WA 99122 10.4
WA 99123 10.0
WA 99124 10.0
WA 99125 10.4
WA 99126 10.3
WA 99127 10.4
WA 99128 10.2
WA 99129 10.0
WA 99130 10.2
WA 99131 10.6
WA 99133 10.0
WA 99134 10.4
WA 99135 10.0
WA 99136 10.5
WA 99137 10.6
WA 99138 10.0
WA 99139 10.0
WA 99140 10.0
WA 99141 10.3
WA 99143 10.5
WA 99144 10.4
WA 99146 10.3
WA 99147 10.0
WA 99148 2.0
WA 99149 10.4
WA 99150 10.0
WA 99151 10.3
WA 99152 10.0
WA 99153 10.0
WA 99154 10.4
WA 99155 10.0
WA 99156 2.0
WA 99157 10.3
WA 99158 10.2
WA 99159 10.4
WA 99160 10.0
WA 99161 10.2
WA 99163 4.0
WA 99164 4.0
WA 99165 4.0
WA 99166 10.0
WA 99167 10.3
WA 99169 10.0
WA 99170 10.4
WA 99171 10.4
WA 99173 10.4
WA 99174 7.4
WA 99176 10.2
WA 99179 10.5
WA 99180 10.0
WA 99181 10.4
WA 99185 10.0
WA 99201 1.0
WA 99202 1.0
WA 99203 1.0
WA 99204 1.0
WA 99205 1.0
WA 99206 1.0
WA 99207 1.0
WA 99208 1.0
WA 99209 1.0
WA 99210 1.0
WA 99211 1.0
WA 99212 1.0
WA 99213 1.0
WA 99214 1.0
WA 99215 1.0
WA 99216 1.0
WA 99217 1.0
WA 99218 1.0
WA 99219 1.0
WA 99220 1.0
WA 99223 1.0
WA 99224 1.0
WA 99228 1.0
WA 99251 1.0
WA 99252 1.0
WA 99256 1.0
WA 99258 1.0
WA 99260 1.0
WA 99299 1.0
WA 99301 1.0
WA 99302 1.0
WA 99320 2.0
WA 99321 10.0
WA 99322 7.0
WA 99323 2.0
WA 99324 4.0
WA 99326 7.3
WA 99327 7.0
WA 99328 7.4
WA 99329 5.0
WA 99330 2.0
WA 99332 7.0
WA 99333 10.5
WA 99335 1.0
WA 99336 1.0
WA 99337 1.0
WA 99338 1.0
WA 99341 10.0
WA 99343 7.3
WA 99344 7.0
WA 99345 7.3
WA 99346 1.0
WA 99347 10.4
WA 99348 2.0
WA 99349 10.0
WA 99350 7.3
WA 99352 1.0
WA 99353 1.0
WA 99354 1.0
WA 99356 7.0
WA 99357 10.0
WA 99359 5.0
WA 99360 5.0
WA 99361 5.0
WA 99362 4.0
WA 99363 5.0
WA 99371 10.0
WA 99401 1.0
WA 99402 1.0
WA 99403 1.0
WI 53001 3.0
WI 53002 3.0
WI 53003 1.0
WI 53004 2.0
WI 53005 1.0
WI 53006 10.4
WI 53007 1.0
WI 53008 1.0
WI 53010 10.5
WI 53011 2.0
WI 53012 1.0
WI 53013 2.0
WI 53014 7.0
WI 53015 2.0
WI 53016 10.5
WI 53017 2.0
WI 53018 1.0
WI 53019 2.0
WI 53020 2.0
WI 53021 2.0
WI 53022 1.0
WI 53023 9.1
WI 53024 1.0
WI 53026 9.1
WI 53027 2.0
WI 53029 1.0
WI 53031 1.0
WI 53032 7.0
WI 53033 2.0
WI 53034 2.0
WI 53035 3.0
WI 53036 2.0
WI 53037 2.0
WI 53038 3.0
WI 53039 10.5
WI 53040 6.1
WI 53042 7.3
WI 53044 1.0
WI 53045 1.0
WI 53046 1.0
WI 53047 4.2
WI 53048 10.4
WI 53049 2.0
WI 53050 7.0
WI 53051 1.0
WI 53052 1.0
WI 53056 1.0
WI 53057 2.0
WI 53058 1.0
WI 53059 2.0
WI 53060 4.1
WI 53061 7.3
WI 53062 7.3
WI 53063 2.0
WI 53064 1.0
WI 53065 2.0
WI 53066 1.0
WI 53069 1.0
WI 53070 2.0
WI 53072 1.0
WI 53073 7.1
WI 53074 2.0
WI 53075 2.0
WI 53076 2.0
WI 53078 2.0
WI 53079 2.0
WI 53080 1.0
WI 53081 1.0
WI 53082 1.0
WI 53083 1.0
WI 53085 1.0
WI 53086 2.0
WI 53088 7.0
WI 53089 1.0
WI 53090 4.1
WI 53091 10.4
WI 53092 1.0
WI 53093 2.0
WI 53094 4.2
WI 53095 4.1
WI 53097 1.0
WI 53098 4.2
WI 53099 3.0
WI 53101 4.2
WI 53102 2.0
WI 53103 1.0
WI 53104 2.0
WI 53105 4.2
WI 53108 2.1
WI 53109 2.0
WI 53110 1.0
WI 53114 4.0
WI 53115 4.0
WI 53118 1.0
WI 53119 2.0
WI 53120 2.0
WI 53121 7.0
WI 53122 1.0
WI 53125 9.1
WI 53126 2.0
WI 53127 1.0
WI 53128 4.2
WI 53129 1.0
WI 53130 1.0
WI 53132 1.0
WI 53137 5.2
WI 53138 4.2
WI 53139 9.1
WI 53140 1.0
WI 53141 1.0
WI 53142 1.0
WI 53143 1.0
WI 53144 1.0
WI 53146 1.0
WI 53147 4.2
WI 53148 4.2
WI 53149 2.0
WI 53150 1.0
WI 53151 1.0
WI 53152 4.2
WI 53153 1.0
WI 53154 1.0
WI 53156 2.0
WI 53157 4.2
WI 53158 1.0
WI 53159 4.2
WI 53167 2.0
WI 53168 2.0
WI 53170 2.0
WI 53171 1.0
WI 53172 1.0
WI 53176 7.0
WI 53177 1.0
WI 53178 2.0
WI 53179 2.0
WI 53181 2.0
WI 53182 9.1
WI 53183 1.0
WI 53184 9.1
WI 53185 2.0
WI 53186 1.0
WI 53187 1.0
WI 53188 1.0
WI 53189 1.0
WI 53190 4.0
WI 53191 9.1
WI 53192 2.0
WI 53194 2.0
WI 53195 4.2
WI 53201 1.0
WI 53202 1.0
WI 53203 1.0
WI 53204 1.0
WI 53205 1.0
WI 53206 1.0
WI 53207 1.0
WI 53208 1.0
WI 53209 1.0
WI 53210 1.0
WI 53211 1.0
WI 53212 1.0
WI 53213 1.0
WI 53214 1.0
WI 53215 1.0
WI 53216 1.0
WI 53217 1.0
WI 53218 1.0
WI 53219 1.0
WI 53220 1.0
WI 53221 1.0
WI 53222 1.0
WI 53223 1.0
WI 53224 1.0
WI 53225 1.0
WI 53226 1.0
WI 53227 1.0
WI 53228 1.0
WI 53233 1.0
WI 53234 1.0
WI 53235 1.0
WI 53237 1.0
WI 53259 1.0
WI 53263 1.0
WI 53267 1.0
WI 53268 1.0
WI 53270 1.0
WI 53274 1.0
WI 53277 1.0
WI 53278 1.0
WI 53280 1.0
WI 53281 1.0
WI 53284 1.0
WI 53285 1.0
WI 53288 1.0
WI 53290 1.0
WI 53293 1.0
WI 53295 1.0
WI 53401 1.0
WI 53402 1.0
WI 53403 1.0
WI 53404 1.0
WI 53405 1.0
WI 53406 1.0
WI 53407 1.0
WI 53408 1.0
WI 53490 1.0
WI 53501 1.0
WI 53502 6.0
WI 53503 2.0
WI 53504 10.4
WI 53505 2.0
WI 53506 10.6
WI 53507 2.0
WI 53508 2.0
WI 53510 10.5
WI 53511 1.0
WI 53512 1.0
WI 53515 2.0
WI 53516 10.4
WI 53517 2.0
WI 53518 9.0
WI 53520 7.3
WI 53521 2.0
WI 53522 5.0
WI 53523 2.0
WI 53525 10.4
WI 53526 10.6
WI 53527 1.0
WI 53528 2.0
WI 53529 2.0
WI 53530 10.0
WI 53531 2.0
WI 53532 2.0
WI 53533 7.3
WI 53534 2.0
WI 53535 7.3
WI 53536 7.1
WI 53537 1.0
WI 53538 4.0
WI 53540 9.0
WI 53541 10.5
WI 53542 1.0
WI 53543 10.6
WI 53544 2.0
WI 53545 1.0
WI 53546 1.0
WI 53547 1.0
WI 53548 1.0
WI 53549 4.0
WI 53550 5.0
WI 53551 7.3
WI 53553 10.6
WI 53554 10.5
WI 53555 2.0
WI 53556 9.0
WI 53557 10.4
WI 53558 1.0
WI 53559 2.0
WI 53560 2.0
WI 53561 3.0
WI 53562 1.0
WI 53563 1.0
WI 53565 10.6
WI 53566 4.0
WI 53569 10.6
WI 53570 2.0
WI 53571 2.0
WI 53572 2.0
WI 53573 10.6
WI 53574 2.0
WI 53575 2.0
WI 53576 2.0
WI 53577 10.6
WI 53578 7.3
WI 53579 10.4
WI 53580 10.6
WI 53581 7.0
WI 53582 2.0
WI 53583 7.3
WI 53584 9.0
WI 53585 4.0
WI 53586 10.4
WI 53587 10.5
WI 53588 10.4
WI 53589 1.0
WI 53590 1.0
WI 53591 1.0
WI 53593 1.0
WI 53594 7.3
WI 53595 7.3
WI 53596 1.0
WI 53597 1.0
WI 53598 2.0
WI 53599 10.4
WI 53701 1.0
WI 53702 1.0
WI 53703 1.0
WI 53704 1.0
WI 53705 1.0
WI 53706 1.0
WI 53707 1.0
WI 53708 1.0
WI 53711 1.0
WI 53713 1.0
WI 53714 1.0
WI 53715 1.0
WI 53716 1.0
WI 53717 1.0
WI 53718 1.0
WI 53719 1.0
WI 53725 1.0
WI 53726 1.0
WI 53744 1.0
WI 53774 1.0
WI 53777 1.0
WI 53778 1.0
WI 53779 1.0
WI 53782 1.0
WI 53783 1.0
WI 53784 1.0
WI 53785 1.0
WI 53786 1.0
WI 53788 1.0
WI 53789 1.0
WI 53790 1.0
WI 53791 1.0
WI 53792 1.0
WI 53793 1.0
WI 53794 1.0
WI 53801 10.6
WI 53802 10.6
WI 53803 10.4
WI 53804 10.6
WI 53805 7.0
WI 53806 10.6
WI 53807 10.4
WI 53808 10.4
WI 53809 10.6
WI 53810 10.6
WI 53811 2.0
WI 53812 10.4
WI 53813 7.0
WI 53816 10.6
WI 53817 7.0
WI 53818 4.0
WI 53820 6.1
WI 53821 7.0
WI 53824 2.0
WI 53825 10.5
WI 53826 8.0
WI 53827 10.6
WI 53901 7.3
WI 53910 10.0
WI 53911 2.0
WI 53913 4.0
WI 53916 4.0
WI 53917 4.0
WI 53919 10.4
WI 53920 9.0
WI 53922 9.0
WI 53923 10.4
WI 53924 10.6
WI 53925 7.3
WI 53926 10.0
WI 53927 10.0
WI 53928 2.0
WI 53929 10.6
WI 53930 9.0
WI 53931 10.4
WI 53932 2.0
WI 53933 10.5
WI 53934 10.0
WI 53935 10.4
WI 53936 10.6
WI 53937 10.6
WI 53939 10.0
WI 53940 4.0
WI 53941 8.0
WI 53942 8.0
WI 53943 10.6
WI 53944 9.0
WI 53946 10.6
WI 53947 10.0
WI 53948 7.0
WI 53949 10.6
WI 53950 10.6
WI 53951 7.3
WI 53952 10.6
WI 53953 10.6
WI 53954 3.0
WI 53955 2.0
WI 53956 6.0
WI 53957 6.0
WI 53958 7.4
WI 53959 7.4
WI 53960 2.0
WI 53961 6.0
WI 53962 10.6
WI 53963 4.0
WI 53964 10.6
WI 53965 7.4
WI 53968 10.6
WI 53969 3.0
WI 54001 7.3
WI 54002 7.3
WI 54003 3.0
WI 54004 10.6
WI 54005 10.6
WI 54006 10.0
WI 54007 9.1
WI 54009 10.4
WI 54010 10.4
WI 54011 10.4
WI 54013 10.4
WI 54014 5.2
WI 54015 2.0
WI 54016 2.0
WI 54017 7.3
WI 54020 10.4
WI 54021 2.0
WI 54022 4.2
WI 54023 2.0
WI 54024 10.4
WI 54025 2.0
WI 54026 3.0
WI 54027 10.4
WI 54028 7.3
WI 54082 2.0
WI 54101 2.0
WI 54102 10.5
WI 54103 10.0
WI 54104 10.5
WI 54106 2.0
WI 54107 3.0
WI 54110 7.3
WI 54111 3.0
WI 54112 10.5
WI 54113 1.0
WI 54114 10.5
WI 54115 1.0
WI 54119 10.5
WI 54120 5.0
WI 54121 10.2
WI 54123 7.3
WI 54124 10.4
WI 54125 10.5
WI 54126 2.0
WI 54127 7.3
WI 54128 10.6
WI 54129 3.0
WI 54130 1.0
WI 54131 1.0
WI 54135 10.0
WI 54136 1.0
WI 54137 3.0
WI 54138 10.0
WI 54139 10.4
WI 54140 1.0
WI 54141 2.0
WI 54143 4.0
WI 54149 10.0
WI 54150 10.0
WI 54151 4.0
WI 54152 7.3
WI 54153 7.3
WI 54154 7.3
WI 54155 1.0
WI 54156 10.5
WI 54157 5.0
WI 54159 5.0
WI 54160 7.0
WI 54161 10.5
WI 54162 2.0
WI 54165 7.3
WI 54166 7.0
WI 54169 1.0
WI 54170 2.0
WI 54171 2.0
WI 54173 1.0
WI 54174 10.4
WI 54175 10.0
WI 54177 10.5
WI 54180 2.1
WI 54182 3.0
WI 54201 7.3
WI 54202 10.6
WI 54204 8.3
WI 54205 2.0
WI 54207 10.5
WI 54208 2.0
WI 54209 10.6
WI 54210 10.0
WI 54211 10.0
WI 54212 10.0
WI 54213 8.0
WI 54214 4.0
WI 54215 5.0
WI 54216 10.4
WI 54217 2.0
WI 54220 4.0
WI 54221 4.0
WI 54226 7.0
WI 54227 5.2
WI 54228 5.0
WI 54229 2.0
WI 54230 10.5
WI 54232 7.3
WI 54234 10.0
WI 54235 7.0
WI 54240 2.0
WI 54241 4.0
WI 54245 5.0
WI 54246 10.0
WI 54247 5.0
WI 54301 1.0
WI 54302 1.0
WI 54303 1.0
WI 54304 1.0
WI 54305 1.0
WI 54306 1.0
WI 54307 1.0
WI 54308 1.0
WI 54311 1.0
WI 54313 1.0
WI 54324 1.0
WI 54344 1.0
WI 54401 1.0
WI 54402 1.0
WI 54403 1.0
WI 54404 4.0
WI 54405 7.0
WI 54406 5.0
WI 54407 5.0
WI 54408 2.0
WI 54409 7.0
WI 54410 10.2
WI 54411 2.0
WI 54412 10.2
WI 54413 6.0
WI 54414 10.1
WI 54415 10.2
WI 54416 10.0
WI 54417 1.0
WI 54418 8.0
WI 54420 10.5
WI 54421 10.6
WI 54422 10.6
WI 54423 5.0
WI 54424 8.0
WI 54425 7.0
WI 54426 2.0
WI 54427 2.0
WI 54428 10.6
WI 54429 10.1
WI 54430 8.0
WI 54432 10.1
WI 54433 10.6
WI 54434 10.6
WI 54435 5.2
WI 54436 10.5
WI 54437 10.0
WI 54439 10.6
WI 54440 2.0
WI 54441 4.0
WI 54442 5.2
WI 54443 5.0
WI 54446 10.5
WI 54447 10.6
WI 54448 2.0
WI 54449 4.0
WI 54450 7.0
WI 54451 7.0
WI 54452 4.2
WI 54454 10.2
WI 54455 1.0
WI 54456 10.0
WI 54457 5.0
WI 54458 5.0
WI 54459 10.0
WI 54460 10.6
WI 54462 10.6
WI 54463 8.0
WI 54464 7.0
WI 54465 10.6
WI 54466 6.0
WI 54467 4.0
WI 54469 4.0
WI 54470 8.0
WI 54471 2.0
WI 54472 4.0
WI 54473 5.0
WI 54474 1.0
WI 54475 4.0
WI 54476 1.0
WI 54479 5.0
WI 54480 8.0
WI 54481 4.0
WI 54484 5.0
WI 54485 10.6
WI 54486 10.0
WI 54487 7.4
WI 54488 10.5
WI 54489 5.0
WI 54490 8.0
WI 54491 10.6
WI 54492 4.0
WI 54493 10.0
WI 54494 4.0
WI 54495 4.0
WI 54498 10.6
WI 54499 10.1
WI 54501 8.0
WI 54511 10.0
WI 54512 10.0
WI 54513 10.0
WI 54514 10.0
WI 54515 10.0
WI 54517 8.0
WI 54519 10.0
WI 54520 10.0
WI 54521 10.0
WI 54524 10.0
WI 54525 7.0
WI 54526 8.0
WI 54527 10.0
WI 54529 10.0
WI 54530 8.0
WI 54531 10.0
WI 54532 7.4
WI 54534 7.0
WI 54536 8.0
WI 54537 10.0
WI 54538 10.0
WI 54539 10.0
WI 54540 10.0
WI 54541 10.0
WI 54542 10.0
WI 54543 8.0
WI 54545 10.0
WI 54546 10.6
WI 54547 10.0
WI 54548 10.0
WI 54550 7.0
WI 54552 10.0
WI 54554 10.0
WI 54555 10.0
WI 54556 10.0
WI 54557 10.0
WI 54558 10.0
WI 54559 8.0
WI 54560 10.0
WI 54561 10.0
WI 54562 8.0
WI 54563 8.0
WI 54564 10.0
WI 54565 8.0
WI 54566 10.0
WI 54568 10.0
WI 54601 1.0
WI 54602 1.0
WI 54603 1.0
WI 54610 10.0
WI 54611 8.0
WI 54612 10.0
WI 54613 10.0
WI 54614 2.0
WI 54615 7.0
WI 54616 10.0
WI 54618 10.6
WI 54619 10.6
WI 54620 7.3
WI 54621 2.0
WI 54622 6.0
WI 54623 2.0
WI 54624 2.0
WI 54625 3.0
WI 54626 10.6
WI 54627 10.4
WI 54628 10.6
WI 54629 5.0
WI 54630 10.4
WI 54631 10.0
WI 54632 2.0
WI 54634 10.0
WI 54635 9.0
WI 54636 1.0
WI 54637 10.6
WI 54638 8.0
WI 54639 10.0
WI 54640 10.6
WI 54641 10.6
WI 54642 8.0
WI 54643 7.0
WI 54644 2.0
WI 54645 10.0
WI 54646 10.6
WI 54648 10.6
WI 54649 7.0
WI 54650 1.0
WI 54651 10.0
WI 54652 10.6
WI 54653 2.0
WI 54654 10.0
WI 54655 10.0
WI 54656 7.3
WI 54657 10.6
WI 54658 2.0
WI 54659 9.0
WI 54660 7.0
WI 54661 3.0
WI 54662 7.0
WI 54664 10.6
WI 54665 7.0
WI 54666 8.0
WI 54667 10.4
WI 54669 2.0
WI 54670 10.6
WI 54701 1.0
WI 54702 1.0
WI 54703 1.0
WI 54720 1.0
WI 54721 10.0
WI 54722 10.4
WI 54723 5.2
WI 54724 7.1
WI 54725 6.0
WI 54726 2.0
WI 54727 2.0
WI 54728 10.6
WI 54729 1.0
WI 54730 5.0
WI 54731 8.0
WI 54732 2.0
WI 54733 10.6
WI 54734 6.0
WI 54735 4.0
WI 54736 10.4
WI 54737 5.0
WI 54738 2.0
WI 54739 2.0
WI 54740 10.4
WI 54741 10.4
WI 54742 2.0
WI 54743 10.4
WI 54745 3.0
WI 54746 10.0
WI 54747 10.0
WI 54748 2.0
WI 54749 6.0
WI 54750 10.5
WI 54751 4.0
WI 54754 8.0
WI 54755 10.4
WI 54756 10.0
WI 54757 3.0
WI 54758 10.4
WI 54759 10.0
WI 54760 10.4
WI 54761 10.5
WI 54762 10.6
WI 54763 10.5
WI 54764 10.4
WI 54765 10.5
WI 54766 8.0
WI 54767 10.4
WI 54768 10.4
WI 54769 10.0
WI 54770 10.4
WI 54771 10.0
WI 54772 10.5
WI 54773 10.0
WI 54774 1.0
WI 54801 7.0
WI 54805 10.6
WI 54806 7.0
WI 54810 3.0
WI 54812 7.0
WI 54813 10.0
WI 54814 10.0
WI 54816 10.3
WI 54817 10.0
WI 54818 7.0
WI 54819 10.6
WI 54820 2.0
WI 54821 10.0
WI 54822 8.0
WI 54824 10.4
WI 54826 10.0
WI 54827 10.0
WI 54828 10.0
WI 54829 10.0
WI 54830 10.0
WI 54832 10.3
WI 54834 10.0
WI 54835 10.0
WI 54836 2.0
WI 54837 10.0
WI 54838 2.0
WI 54839 10.3
WI 54840 10.4
WI 54841 7.0
WI 54842 2.0
WI 54843 10.0
WI 54844 10.4
WI 54845 10.0
WI 54846 8.0
WI 54847 10.3
WI 54848 7.0
WI 54849 2.0
WI 54850 10.3
WI 54853 10.0
WI 54854 2.0
WI 54855 8.0
WI 54856 10.3
WI 54857 10.0
WI 54858 10.4
WI 54859 10.0
WI 54861 7.0
WI 54862 10.0
WI 54864 2.0
WI 54865 10.4
WI 54867 10.0
WI 54868 7.0
WI 54870 7.0
WI 54871 10.6
WI 54872 10.0
WI 54873 2.0
WI 54874 2.0
WI 54875 10.0
WI 54876 10.0
WI 54880 1.0
WI 54888 8.0
WI 54889 10.6
WI 54890 10.0
WI 54891 10.3
WI 54893 10.0
WI 54895 10.6
WI 54896 10.0
WI 54901 1.0
WI 54902 1.0
WI 54903 1.0
WI 54904 1.0
WI 54906 1.0
WI 54909 5.0
WI 54911 1.0
WI 54912 1.0
WI 54913 1.0
WI 54914 1.0
WI 54915 1.0
WI 54919 1.0
WI 54921 5.0
WI 54922 2.0
WI 54923 7.3
WI 54926 10.0
WI 54927 2.0
WI 54928 9.0
WI 54929 7.0
WI 54930 10.0
WI 54931 2.0
WI 54932 2.0
WI 54933 7.0
WI 54934 7.3
WI 54935 1.0
WI 54936 1.0
WI 54937 1.0
WI 54940 2.0
WI 54941 10.6
WI 54942 1.0
WI 54943 10.0
WI 54944 2.0
WI 54945 10.0
WI 54946 7.0
WI 54947 2.0
WI 54948 10.6
WI 54949 10.0
WI 54950 10.6
WI 54952 1.0
WI 54956 1.0
WI 54957 1.0
WI 54960 10.0
WI 54961 7.1
WI 54962 10.0
WI 54963 2.0
WI 54964 2.0
WI 54965 3.0
WI 54966 10.5
WI 54967 3.0
WI 54968 10.6
WI 54969 2.0
WI 54970 3.0
WI 54971 7.0
WI 54974 2.0
WI 54975 7.1
WI 54976 10.0
WI 54977 10.0
WI 54978 10.6
WI 54979 2.0
WI 54980 2.0
WI 54981 7.0
WI 54982 10.0
WI 54983 10.6
WI 54984 10.0
WI 54985 1.0
WI 54986 2.0
WI 54990 10.0
WV 24701 4.0
WV 24712 4.0
WV 24714 5.0
WV 24715 5.0
WV 24716 10.5
WV 24719 10.5
WV 24724 5.0
WV 24726 10.5
WV 24729 5.0
WV 24731 5.0
WV 24732 4.0
WV 24733 5.0
WV 24736 5.0
WV 24737 4.0
WV 24738 4.0
WV 24739 4.0
WV 24740 4.0
WV 24747 5.0
WV 24751 4.0
WV 24801 7.0
WV 24808 7.0
WV 24811 10.0
WV 24813 10.0
WV 24815 10.0
WV 24816 10.6
WV 24817 10.0
WV 24818 7.4
WV 24820 7.0
WV 24821 10.0
WV 24822 10.0
WV 24823 10.0
WV 24824 10.0
WV 24825 6.0
WV 24826 10.0
WV 24827 10.0
WV 24828 10.6
WV 24829 7.0
WV 24830 7.0
WV 24831 6.0
WV 24834 10.0
WV 24836 7.0
WV 24839 10.0
WV 24842 7.0
WV 24843 10.6
WV 24844 10.0
WV 24845 10.0
WV 24846 10.0
WV 24847 10.5
WV 24848 7.0
WV 24849 10.0
WV 24850 10.0
WV 24851 10.0
WV 24852 7.0
WV 24853 7.0
WV 24854 7.4
WV 24855 6.0
WV 24856 7.0
WV 24857 7.4
WV 24859 10.0
WV 24860 7.4
WV 24861 6.0
WV 24862 10.0
WV 24866 10.0
WV 24867 10.0
WV 24868 6.0
WV 24869 10.0
WV 24870 7.4
WV 24871 7.0
WV 24872 10.0
WV 24873 10.0
WV 24874 10.0
WV 24878 7.0
WV 24879 10.0
WV 24880 10.0
WV 24881 10.6
WV 24882 10.0
WV 24884 10.0
WV 24887 5.0
WV 24888 7.0
WV 24892 10.0
WV 24894 10.0
WV 24895 7.0
WV 24896 10.0
WV 24897 6.0
WV 24898 10.0
WV 24899 10.0
WV 24901 7.0
WV 24902 7.0
WV 24910 10.6
WV 24915 10.0
WV 24916 8.0
WV 24917 7.0
WV 24918 10.6
WV 24920 10.0
WV 24924 10.0
WV 24925 10.3
WV 24927 10.0
WV 24931 10.6
WV 24934 10.0
WV 24935 10.0
WV 24936 10.3
WV 24938 10.6
WV 24941 10.0
WV 24943 8.0
WV 24944 10.0
WV 24945 10.6
WV 24946 10.0
WV 24950 10.0
WV 24951 10.6
WV 24954 10.0
WV 24957 10.6
WV 24961 7.0
WV 24962 10.0
WV 24963 10.6
WV 24966 10.0
WV 24970 10.3
WV 24974 10.0
WV 24976 10.0
WV 24977 10.6
WV 24981 10.0
WV 24983 10.6
WV 24984 10.0
WV 24985 10.0
WV 24986 7.0
WV 24991 10.6
WV 24993 10.6
WV 25002 1.0
WV 25003 1.0
WV 25004 5.0
WV 25005 2.0
WV 25007 5.0
WV 25008 5.0
WV 25009 2.0
WV 25010 10.0
WV 25011 1.0
WV 25015 1.0
WV 25019 10.4
WV 25021 10.0
WV 25022 10.6
WV 25024 2.0
WV 25025 1.0
WV 25026 2.0
WV 25028 10.0
WV 25030 10.4
WV 25031 1.0
WV 25033 2.0
WV 25035 1.0
WV 25036 1.0
WV 25039 1.0
WV 25040 1.0
WV 25043 10.4
WV 25044 5.0
WV 25045 2.0
WV 25046 2.0
WV 25047 7.0
WV 25048 5.0
WV 25049 2.0
WV 25051 2.0
WV 25053 7.1
WV 25054 1.0
WV 25057 1.0
WV 25059 10.4
WV 25060 5.0
WV 25061 1.0
WV 25062 5.0
WV 25063 3.0
WV 25064 1.0
WV 25067 1.0
WV 25070 2.0
WV 25071 2.0
WV 25075 1.0
WV 25076 10.6
WV 25079 2.0
WV 25081 10.1
WV 25082 2.0
WV 25083 1.0
WV 25085 1.0
WV 25086 1.0
WV 25088 10.4
WV 25090 1.0
WV 25093 10.1
WV 25102 1.0
WV 25103 1.0
WV 25106 10.5
WV 25107 1.0
WV 25108 3.0
WV 25109 2.0
WV 25110 1.0
WV 25111 10.4
WV 25112 1.0
WV 25113 10.4
WV 25114 10.0
WV 25115 4.0
WV 25118 2.0
WV 25119 2.0
WV 25121 9.0
WV 25123 5.0
WV 25124 1.0
WV 25125 10.4
WV 25126 1.0
WV 25130 7.0
WV 25132 1.0
WV 25133 3.0
WV 25134 1.0
WV 25136 1.0
WV 25139 2.0
WV 25140 5.0
WV 25141 3.0
WV 25142 2.0
WV 25143 1.0
WV 25147 1.0
WV 25148 2.0
WV 25149 10.0
WV 25150 3.0
WV 25152 1.0
WV 25154 2.0
WV 25156 2.0
WV 25159 1.0
WV 25160 1.0
WV 25161 2.0
WV 25162 1.0
WV 25164 10.4
WV 25165 2.0
WV 25168 2.0
WV 25169 2.0
WV 25173 2.0
WV 25174 5.0
WV 25177 1.0
WV 25180 5.0
WV 25181 10.1
WV 25183 10.6
WV 25185 1.0
WV 25186 1.0
WV 25187 10.5
WV 25193 10.1
WV 25201 1.0
WV 25202 1.0
WV 25203 7.1
WV 25204 10.0
WV 25205 7.0
WV 25206 10.0
WV 25208 10.0
WV 25209 5.0
WV 25211 10.4
WV 25213 2.0
WV 25214 1.0
WV 25231 2.0
WV 25234 10.6
WV 25235 10.6
WV 25239 10.6
WV 25241 10.6
WV 25243 8.3
WV 25244 2.0
WV 25245 2.0
WV 25247 10.5
WV 25248 2.0
WV 25251 2.0
WV 25252 10.6
WV 25253 10.5
WV 25259 2.0
WV 25260 10.5
WV 25261 10.6
WV 25262 10.6
WV 25264 10.6
WV 25265 10.5
WV 25266 2.0
WV 25267 10.0
WV 25268 10.6
WV 25270 8.0
WV 25271 7.3
WV 25275 10.6
WV 25276 7.0
WV 25279 2.0
WV 25281 2.0
WV 25285 3.0
WV 25286 8.3
WV 25287 5.0
WV 25301 1.0
WV 25302 1.0
WV 25303 1.0
WV 25304 1.0
WV 25305 1.0
WV 25306 1.0
WV 25309 1.0
WV 25311 1.0
WV 25312 1.0
WV 25313 1.0
WV 25314 1.0
WV 25315 1.0
WV 25317 1.0
WV 25320 2.0
WV 25321 1.0
WV 25322 1.0
WV 25323 1.0
WV 25324 1.0
WV 25325 1.0
WV 25326 1.0
WV 25327 1.0
WV 25328 1.0
WV 25329 1.0
WV 25330 1.0
WV 25331 1.0
WV 25332 1.0
WV 25333 1.0
WV 25334 1.0
WV 25335 1.0
WV 25336 1.0
WV 25337 1.0
WV 25338 1.0
WV 25339 1.0
WV 25350 1.0
WV 25356 1.0
WV 25357 1.0
WV 25358 1.0
WV 25360 1.0
WV 25361 1.0
WV 25362 2.0
WV 25364 1.0
WV 25365 1.0
WV 25375 1.0
WV 25387 1.0
WV 25389 1.0
WV 25392 1.0
WV 25396 1.0
WV 25401 1.0
WV 25402 1.0
WV 25410 2.0
WV 25411 10.0
WV 25413 2.0
WV 25414 4.2
WV 25419 1.0
WV 25420 2.0
WV 25421 2.0
WV 25422 3.0
WV 25423 2.0
WV 25425 2.0
WV 25427 2.0
WV 25428 2.0
WV 25429 6.0
WV 25430 6.0
WV 25431 10.4
WV 25432 2.0
WV 25434 2.0
WV 25437 2.0
WV 25438 4.2
WV 25440 2.0
WV 25441 4.2
WV 25442 6.0
WV 25443 7.3
WV 25444 2.0
WV 25446 3.0
WV 25501 3.0
WV 25502 10.5
WV 25503 10.5
WV 25504 1.0
WV 25505 10.6
WV 25506 2.0
WV 25507 1.0
WV 25508 8.0
WV 25510 1.0
WV 25511 2.0
WV 25512 2.0
WV 25514 3.0
WV 25515 10.5
WV 25517 3.0
WV 25520 10.5
WV 25521 2.0
WV 25523 10.4
WV 25524 10.0
WV 25526 1.0
WV 25529 3.0
WV 25530 1.0
WV 25534 10.4
WV 25535 2.0
WV 25537 2.1
WV 25540 3.0
WV 25541 1.0
WV 25544 10.4
WV 25545 2.1
WV 25547 9.0
WV 25550 4.0
WV 25555 2.0
WV 25557 2.0
WV 25559 2.0
WV 25560 1.0
WV 25562 1.0
WV 25564 2.0
WV 25565 3.0
WV 25567 2.0
WV 25569 1.0
WV 25570 2.0
WV 25571 2.0
WV 25572 2.0
WV 25573 2.0
WV 25601 7.0
WV 25606 10.6
WV 25607 10.6
WV 25608 10.0
WV 25611 10.6
WV 25612 10.6
WV 25614 7.0
WV 25617 10.6
WV 25621 10.0
WV 25624 7.0
WV 25625 7.0
WV 25628 10.6
WV 25630 10.6
WV 25632 10.6
WV 25634 10.6
WV 25635 10.6
WV 25636 7.0
WV 25637 7.0
WV 25638 10.6
WV 25639 7.0
WV 25644 10.6
WV 25646 7.0
WV 25647 7.0
WV 25649 8.0
WV 25650 10.0
WV 25651 10.0
WV 25652 7.0
WV 25653 7.0
WV 25654 10.6
WV 25661 7.0
WV 25665 7.0
WV 25666 10.0
WV 25667 7.0
WV 25669 10.4
WV 25670 10.6
WV 25671 10.0
WV 25672 10.0
WV 25674 10.0
WV 25676 10.0
WV 25678 10.6
WV 25682 10.0
WV 25685 10.0
WV 25686 10.0
WV 25687 7.0
WV 25688 10.6
WV 25690 10.6
WV 25691 7.0
WV 25692 10.6
WV 25694 10.0
WV 25696 10.6
WV 25697 10.0
WV 25699 10.4
WV 25701 1.0
WV 25702 1.0
WV 25703 1.0
WV 25704 1.0
WV 25705 1.0
WV 25706 1.0
WV 25707 1.0
WV 25708 1.0
WV 25709 1.0
WV 25710 1.0
WV 25711 1.0
WV 25712 1.0
WV 25713 1.0
WV 25714 1.0
WV 25715 1.0
WV 25716 1.0
WV 25717 1.0
WV 25718 1.0
WV 25719 1.0
WV 25720 1.0
WV 25721 1.0
WV 25722 1.0
WV 25723 1.0
WV 25724 1.0
WV 25725 1.0
WV 25726 1.0
WV 25727 1.0
WV 25728 1.0
WV 25729 1.0
WV 25755 1.0
WV 25770 1.0
WV 25771 1.0
WV 25772 1.0
WV 25773 1.0
WV 25774 1.0
WV 25775 1.0
WV 25776 1.0
WV 25777 1.0
WV 25778 1.0
WV 25779 1.0
WV 25801 4.0
WV 25802 4.0
WV 25810 10.5
WV 25811 10.5
WV 25812 10.5
WV 25813 4.0
WV 25816 4.0
WV 25817 5.0
WV 25818 4.0
WV 25820 5.0
WV 25823 5.0
WV 25825 5.0
WV 25826 10.5
WV 25827 4.0
WV 25831 6.0
WV 25832 4.0
WV 25833 5.0
WV 25836 4.0
WV 25837 10.5
WV 25839 5.0
WV 25840 4.0
WV 25841 5.0
WV 25843 5.0
WV 25844 5.0
WV 25845 10.0
WV 25846 4.0
WV 25847 4.0
WV 25848 10.5
WV 25849 4.0
WV 25851 4.0
WV 25853 5.0
WV 25854 10.5
WV 25855 4.0
WV 25856 5.0
WV 25857 5.0
WV 25859 4.0
WV 25860 4.0
WV 25862 10.5
WV 25864 4.0
WV 25865 5.0
WV 25866 4.0
WV 25868 10.5
WV 25870 10.5
WV 25871 4.0
WV 25873 4.0
WV 25875 10.5
WV 25876 10.5
WV 25878 4.0
WV 25879 4.0
WV 25880 4.0
WV 25882 10.5
WV 25901 4.0
WV 25902 5.0
WV 25904 4.0
WV 25906 4.0
WV 25907 6.0
WV 25908 5.0
WV 25909 4.0
WV 25911 4.0
WV 25913 10.5
WV 25914 4.0
WV 25915 5.0
WV 25916 10.5
WV 25917 5.0
WV 25918 4.0
WV 25919 4.0
WV 25920 5.0
WV 25921 4.0
WV 25922 5.0
WV 25926 4.0
WV 25927 4.0
WV 25928 10.5
WV 25931 4.0
WV 25932 5.0
WV 25934 4.0
WV 25936 6.0
WV 25938 10.5
WV 25942 4.0
WV 25943 10.5
WV 25951 10.6
WV 25958 10.0
WV 25961 10.0
WV 25962 10.6
WV 25965 10.6
WV 25966 10.6
WV 25967 10.6
WV 25969 10.5
WV 25971 4.0
WV 25972 10.0
WV 25976 6.0
WV 25977 10.6
WV 25978 10.5
WV 25979 10.5
WV 25981 10.0
WV 25984 10.0
WV 25985 10.6
WV 25986 6.0
WV 25989 5.0
WV 26003 1.0
WV 26030 2.1
WV 26031 1.0
WV 26032 2.0
WV 26033 2.0
WV 26034 4.0
WV 26035 1.0
WV 26036 2.0
WV 26037 1.0
WV 26038 1.0
WV 26039 2.0
WV 26040 1.0
WV 26041 1.0
WV 26047 2.0
WV 26050 4.0
WV 26055 2.0
WV 26056 4.0
WV 26058 2.1
WV 26059 2.0
WV 26060 2.0
WV 26062 1.0
WV 26070 2.1
WV 26074 1.0
WV 26075 2.1
WV 26101 1.0
WV 26102 1.0
WV 26103 1.0
WV 26104 1.0
WV 26105 1.0
WV 26106 1.0
WV 26120 1.0
WV 26121 1.0
WV 26133 2.0
WV 26134 2.0
WV 26136 10.6
WV 26137 10.0
WV 26138 2.0
WV 26141 10.6
WV 26142 1.0
WV 26143 2.0
WV 26146 10.6
WV 26147 10.6
WV 26148 2.0
WV 26149 10.6
WV 26150 1.0
WV 26151 10.6
WV 26152 2.0
WV 26155 8.0
WV 26159 7.0
WV 26160 2.0
WV 26161 2.0
WV 26162 10.6
WV 26164 7.0
WV 26167 10.6
WV 26169 2.0
WV 26170 9.0
WV 26173 10.6
WV 26175 7.0
WV 26178 2.0
WV 26180 2.0
WV 26181 1.0
WV 26184 2.0
WV 26186 10.0
WV 26187 1.0
WV 26201 7.0
WV 26202 8.0
WV 26203 10.0
WV 26205 10.6
WV 26206 10.0
WV 26208 10.6
WV 26209 10.0
WV 26210 8.0
WV 26215 8.0
WV 26217 10.0
WV 26218 8.0
WV 26219 8.0
WV 26222 10.0
WV 26224 8.0
WV 26228 8.0
WV 26229 7.0
WV 26230 8.0
WV 26234 8.0
WV 26236 8.0
WV 26237 8.0
WV 26238 9.0
WV 26241 7.0
WV 26250 10.6
WV 26253 8.0
WV 26254 8.0
WV 26257 8.0
WV 26259 8.0
WV 26260 10.0
WV 26261 7.0
WV 26263 8.0
WV 26264 10.0
WV 26266 10.0
WV 26267 8.0
WV 26268 8.0
WV 26269 10.6
WV 26270 8.0
WV 26271 10.0
WV 26273 10.6
WV 26275 10.6
WV 26276 8.0
WV 26278 8.0
WV 26280 10.6
WV 26282 10.6
WV 26283 8.0
WV 26285 8.0
WV 26287 10.6
WV 26288 10.0
WV 26289 10.0
WV 26291 10.0
WV 26292 10.0
WV 26293 8.0
WV 26294 10.6
WV 26296 8.0
WV 26298 10.0
WV 26301 4.0
WV 26302 4.0
WV 26306 4.0
WV 26320 10.0
WV 26321 8.0
WV 26323 4.0
WV 26325 10.4
WV 26327 10.4
WV 26330 4.0
WV 26332 5.0
WV 26334 7.4
WV 26335 10.0
WV 26337 2.0
WV 26338 8.0
WV 26339 5.0
WV 26342 10.0
WV 26343 10.6
WV 26346 10.4
WV 26347 7.4
WV 26348 10.6
WV 26349 9.0
WV 26351 10.0
WV 26354 7.4
WV 26361 5.0
WV 26362 10.4
WV 26366 4.0
WV 26369 4.0
WV 26372 10.6
WV 26374 2.0
WV 26376 10.6
WV 26377 10.6
WV 26378 10.6
WV 26384 10.0
WV 26385 5.0
WV 26386 5.0
WV 26404 5.0
WV 26405 9.0
WV 26408 5.0
WV 26410 10.4
WV 26411 5.0
WV 26412 10.6
WV 26415 10.4
WV 26416 9.0
WV 26419 10.6
WV 26421 10.4
WV 26422 4.0
WV 26424 7.4
WV 26425 10.6
WV 26426 5.0
WV 26430 10.0
WV 26431 5.0
WV 26434 10.0
WV 26435 7.4
WV 26436 10.5
WV 26437 10.6
WV 26438 4.0
WV 26440 9.0
WV 26443 10.0
WV 26444 10.6
WV 26447 10.6
WV 26448 5.0
WV 26451 5.0
WV 26452 7.0
WV 26456 10.5
WV 26461 4.0
WV 26463 5.0
WV 26501 1.0
WV 26502 1.0
WV 26504 1.0
WV 26505 1.0
WV 26506 1.0
WV 26507 1.0
WV 26508 1.0
WV 26519 2.0
WV 26520 2.0
WV 26521 2.0
WV 26524 2.0
WV 26525 2.0
WV 26527 1.0
WV 26529 2.0
WV 26531 1.0
WV 26534 1.0
WV 26537 7.3
WV 26541 2.0
WV 26542 2.0
WV 26543 1.0
WV 26544 1.0
WV 26546 2.0
WV 26547 2.0
WV 26554 4.0
WV 26555 4.0
WV 26559 4.0
WV 26560 4.0
WV 26561 10.6
WV 26562 10.0
WV 26563 4.0
WV 26566 4.0
WV 26568 5.0
WV 26570 5.0
WV 26571 4.0
WV 26572 4.0
WV 26574 4.0
WV 26575 10.0
WV 26576 4.0
WV 26578 4.0
WV 26581 10.0
WV 26582 5.0
WV 26585 5.0
WV 26586 4.0
WV 26587 5.0
WV 26588 4.0
WV 26590 2.0
WV 26591 4.0
WV 26601 10.0
WV 26610 8.0
WV 26611 10.0
WV 26615 10.0
WV 26617 10.4
WV 26619 10.0
WV 26621 10.0
WV 26623 10.0
WV 26624 10.0
WV 26627 10.0
WV 26629 10.0
WV 26631 10.0
WV 26636 10.0
WV 26638 10.0
WV 26639 10.0
WV 26641 10.0
WV 26651 7.0
WV 26656 10.4
WV 26660 10.6
WV 26662 8.0
WV 26667 10.4
WV 26671 7.0
WV 26674 10.5
WV 26675 7.0
WV 26676 8.0
WV 26678 9.0
WV 26679 9.0
WV 26680 10.5
WV 26681 8.0
WV 26684 9.0
WV 26690 10.4
WV 26691 8.0
WV 26704 2.0
WV 26705 10.6
WV 26707 10.6
WV 26710 5.0
WV 26711 2.0
WV 26714 2.0
WV 26716 10.6
WV 26717 4.0
WV 26719 5.0
WV 26720 10.6
WV 26722 10.4
WV 26726 4.0
WV 26731 10.6
WV 26739 10.6
WV 26743 4.0
WV 26750 4.0
WV 26753 5.0
WV 26755 10.0
WV 26757 10.0
WV 26761 10.0
WV 26763 10.4
WV 26764 10.6
WV 26767 4.0
WV 26801 10.0
WV 26802 10.4
WV 26804 10.0
WV 26807 10.4
WV 26808 2.0
WV 26810 10.0
WV 26812 10.0
WV 26814 10.0
WV 26815 10.4
WV 26817 2.0
WV 26818 10.0
WV 26823 2.0
WV 26824 10.0
WV 26833 8.0
WV 26836 10.0
WV 26838 10.0
WV 26845 10.0
WV 26847 7.0
WV 26851 10.0
WV 26852 10.0
WV 26855 8.0
WV 26865 2.0
WV 26866 10.4
WV 26884 10.0
WV 26886 10.0
WY 82001 1.0
WY 82002 1.0
WY 82003 1.0
WY 82005 1.0
WY 82006 1.0
WY 82007 1.0
WY 82008 1.0
WY 82009 1.0
WY 82010 1.0
WY 82050 2.0
WY 82051 5.0
WY 82052 5.0
WY 82053 2.0
WY 82054 2.0
WY 82055 5.0
WY 82058 5.0
WY 82059 1.0
WY 82060 2.0
WY 82061 1.0
WY 82063 5.0
WY 82070 4.0
WY 82071 4.0
WY 82072 4.0
WY 82073 4.0
WY 82081 2.0
WY 82082 2.0
WY 82083 5.0
WY 82084 5.0
WY 82190 8.0
WY 82201 7.0
WY 82210 7.0
WY 82212 10.3
WY 82213 10.6
WY 82214 10.6
WY 82215 10.6
WY 82217 10.6
WY 82218 7.0
WY 82219 10.3
WY 82221 10.6
WY 82222 10.0
WY 82223 10.3
WY 82224 10.0
WY 82225 10.0
WY 82227 10.0
WY 82229 10.6
WY 82240 7.0
WY 82242 10.0
WY 82243 10.6
WY 82244 10.6
WY 82301 7.0
WY 82310 10.3
WY 82321 7.0
WY 82322 10.5
WY 82323 7.0
WY 82324 10.6
WY 82325 10.6
WY 82327 10.6
WY 82329 10.6
WY 82331 10.6
WY 82332 7.0
WY 82334 7.0
WY 82335 10.6
WY 82336 10.5
WY 82401 7.0
WY 82410 10.0
WY 82411 10.0
WY 82412 10.0
WY 82414 7.0
WY 82420 10.0
WY 82421 10.0
WY 82422 10.0
WY 82423 10.0
WY 82426 10.0
WY 82428 10.0
WY 82430 7.0
WY 82431 10.0
WY 82432 10.0
WY 82433 8.0
WY 82434 10.0
WY 82435 7.0
WY 82440 7.0
WY 82441 10.0
WY 82442 8.0
WY 82443 7.0
WY 82450 7.0
WY 82501 4.0
WY 82510 5.0
WY 82512 10.0
WY 82513 10.0
WY 82514 10.0
WY 82515 7.0
WY 82516 10.0
WY 82520 7.0
WY 82523 5.0
WY 82524 4.0
WY 82601 1.0
WY 82602 1.0
WY 82604 1.0
WY 82605 1.0
WY 82609 1.0
WY 82615 1.0
WY 82620 2.0
WY 82630 1.0
WY 82633 7.0
WY 82635 2.0
WY 82636 1.0
WY 82637 10.4
WY 82638 10.3
WY 82639 10.3
WY 82640 10.3
WY 82642 10.3
WY 82643 2.0
WY 82644 1.0
WY 82646 1.0
WY 82648 1.0
WY 82649 10.3
WY 82701 7.0
WY 82710 10.5
WY 82711 10.5
WY 82712 10.0
WY 82713 10.5
WY 82714 10.5
WY 82715 10.3
WY 82716 4.0
WY 82717 4.0
WY 82718 4.0
WY 82720 10.5
WY 82721 10.5
WY 82723 10.3
WY 82725 4.0
WY 82727 5.0
WY 82729 10.0
WY 82730 10.3
WY 82731 4.0
WY 82732 5.0
WY 82801 4.0
WY 82831 5.0
WY 82832 5.0
WY 82833 4.0
WY 82834 7.0
WY 82835 5.0
WY 82836 5.0
WY 82837 5.0
WY 82838 5.0
WY 82839 5.0
WY 82840 7.0
WY 82842 5.0
WY 82844 5.0
WY 82845 4.0
WY 82901 4.0
WY 82902 4.0
WY 82922 10.0
WY 82923 10.0
WY 82925 10.0
WY 82929 4.0
WY 82930 4.0
WY 82931 4.0
WY 82932 4.0
WY 82933 10.5
WY 82934 4.0
WY 82935 4.0
WY 82936 10.5
WY 82937 10.5
WY 82938 4.0
WY 82939 10.5
WY 82941 10.0
WY 82942 4.0
WY 82943 4.0
WY 82944 10.5
WY 82945 4.0
WY 83001 4.0
WY 83002 4.0
WY 83011 10.2
WY 83012 10.2
WY 83013 10.2
WY 83014 4.0
WY 83025 4.0
WY 83101 7.0
WY 83110 10.0
WY 83111 10.0
WY 83112 10.2
WY 83113 10.0
WY 83114 10.6
WY 83115 10.0
WY 83116 7.0
WY 83118 10.2
WY 83119 10.0
WY 83120 10.2
WY 83121 7.0
WY 83122 10.2
WY 83123 10.6
WY 83124 7.0
WY 83126 10.0
WY 83127 10.2
WY 83128 10.2
WY 83414 10.2
R = Rural
U = Urban
The use of either "R or "U as an indicator in the "RUCA Level" column signifies that this area is either a military installation or located outside the 50 United States. Therefore, a RUCA level is not available for it.

CLINICAL LABORATORY SERVICES
INCLUDE CPT codes for all clinical laboratory services in the 80000 series, except EXCLUDE CPT codes for the following blood component collection services:
86890 Autologous blood process
86891 Autologous blood, op salvage
86927 Plasma, fresh frozen
86930 Frozen blood prep
86931 Frozen blood thaw
86932 Frozen blood freeze/thaw
86945 Blood product/irradiation
86950 Leukacyte transfusion
86960 Vol reduction of blood/prod
86965 Pooling blood platelets
86985 Split blood or products
INCLUDE the following CPT and HCPCS level 2 codes for other clinical laboratory services:
0026T Measure remnant lipoproteins
0030T Antiprothrombin antibody
0041T Detect ur infect agnt w/cpas
0043T Co expired gas analysis
0058T Cryopreservation, ovary tiss
0059T Cryopreservation, oocyte
0064T Spectroscop eval expired gas
0085T Breath test heart reject
0087T Sperm eval hyaluronan
0103T Holotranscobalamin
0104T At rest cardio gas rebreathe
0111T RBC membranes fatty acids
0140T Exhaled breath condensate ph
36415 Routine venipuncture
78110 Plasma volume, single
78111 Plasma volume, multiple
78120 Red cell mass, single
78121 Red cell mass, multiple
78122 Blood volume
78130 Red cell survival study
78191 Platelet survival
78270 Vit B-12 absorption exam
78271 Vit B-12 absrp exam, int fac
78272 Vit B-12 absorp, combined
78725 Kidney function study
78267 Breath tst attain/anal c-14
78268 Breath test analysis c-14
G0027 Semen analysis
G0103 Psa, total screening
G0123 Screen cerv/vag thin layer
G0124 Screen c/v thin layer by MD
G0141 Scr c/v cyto,autosys and md
G0143 Scr c/v cyto,thinlayer,rescr
G0144 Scr c/v cyto,thinlayer,rescr
G0145 Scr c/v cyto,thinlayer,rescr
G0147 Scr c/v cyto, automated sys
G0148 Scr c/v cyto, autosys, rescr
G0306 CBC/diffwbc w/o platelet
G0307 CBC without platelet
G0328 Fecal blood scrn immunoassay
G0394 Blood occult test colorectal
P2028 Cephalin floculation test
P2029 Congo red blood test
P2033 Blood thymol turbidity
P2038 Blood mucoprotein
P3000 Screen pap by tech w md supv
P3001 Screening pap smear by phys
P9612 Catheterize for urine spec
P9615 Urine specimen collect mult
Q0111 Wet mounts/w preparations
Q0112 Potassium hydroxide preps
Q0113 Pinworm examinations
Q0114 Fern test
Q0115 Post-coital mucous exam
PHYSICAL THERAPY, OCCUPATIONAL THERAPY, AND SPEECH-LANGUAGE PATHOLOGY
INCLUDE the following CPT and HCPCS codes for physical therapy/occupational therapy/speech-language pathology services:
0019T Extracorp shock wv tx,ms nos
0029T Magnetic tx for incontinence
64550 Apply neurostimulator
90901 Biofeedback train, any meth
90911 Biofeedback peri/uro/rectal
92506 Speech/hearing evaluation
92507 Speech/hearing therapy
92508 Speech/hearing therapy
92526 Oral function therapy
92597 Oral speech device eval
92607 Ex for speech device rx, 1hr
92608 Ex for speech device rx addl
92609 Use of speech device service
92610 Evaluate swallowing function
92611 Motion fluoroscopy/swallow
92612 Endoscopy swallow tst (fees)
92614 Laryngoscopic sensory test
92616 Fees w/laryngeal sense test
93797 Cardiac rehab
93798 Cardiac rehab/monitor
94667 Chest wall manipulation
94668 Chest wall manipulation
95831 Limb muscle testing, manual
95832 Hand muscle testing, manual
95833 Body muscle testing, manual
95834 Body muscle testing, manual
95851 Range of motion measurements
95852 Range of motion measurements
96000 Motion analysis, video/3d
96001 Motion test w/ft press meas
96002 Dynamic surface emg
96003 Dynamic fine wire emg
96105 Assessment of aphasia
96110 Developmental test, lim
96111 Developmental test, extend
97001 Pt evaluation
97002 Pt re-evaluation
97003 Ot evaluation
97004 Ot re-evaluation
97010 Hot or cold packs therapy
97012 Mechanical traction therapy
97016 Vasopneumatic device therapy
97018 Paraffin bath therapy
97022 Whirlpool therapy
97024 Diathermy eg, microwave
97026 Infrared therapy
97028 Ultraviolet therapy
97032 Electrical stimulation
97033 Electric current therapy
97034 Contrast bath therapy
97035 Ultrasound therapy
97036 Hydrotherapy
97039 Physical therapy treatment
97110 Therapeutic exercises
97112 Neuromuscular reeducation
97113 Aquatic therapy/exercises
97116 Gait training therapy
97124 Massage therapy
97139 Physical medicine procedure
97140 Manual therapy
97150 Group therapeutic procedures
97530 Therapeutic activities
97532 Cognitive skills development
97533 Sensory integration
97535 Self care mngment training
97537 Community/work reintegration
97542 Wheelchair mngment training
97545 Work hardening
97546 Work hardening add-on
97597 Active wound care/20cm or
97598 Active wound care 20cm
97602 Wound(s) care nonselective
97605 Neg press wound tx, 50 cm
97606 Neg press wound tx, 50 cm
97750 Physical performance test
97755 Assistive technology assess
97760 Orthotic mgmt and training
97761 Prosthetic training
97762 C/O for orthotic/prosth use
97799 Physical medicine procedure
G0281 Elec stim unattend for press
G0283 Elec stim other than wound
G0329 Electromagntic tx for ulcers
RADIOLOGY AND CERTAIN OTHER IMAGING SERVICES
INCLUDE the following CPT and HCPCS codes:
0028T Dexa body composition study
0042T Ct perfusion w/contrast, cbf
0067T Ct colonography;dx
0144T Ct heart wo dye; qual calc
0145T Ct heart w/wo dye funct
0146T Ccta w/wo dye
0147T Ccta w/wo, quan calcium
0148T Ccta w/wo, strxr
0149T Ccta w/wo, strxr quan calc
0150T Ccta w/wo, disease strxr
0151T Ct heart funct add-on
0159T Cad breast mri
0174T Cad crx with interp
0175T Cad crx remote
51798 Us urine capacity measure
70100 X-ray exam of jaw
70110 X-ray exam of jaw
70120 X-ray exam of mastoids
70130 X-ray exam of mastoids
70134 X-ray exam of middle ear
70140 X-ray exam of facial bones
70150 X-ray exam of facial bones
70160 X-ray exam of nasal bones
70190 X-ray exam of eye sockets
70200 X-ray exam of eye sockets
70210 X-ray exam of sinuses
70220 X-ray exam of sinuses
70240 X-ray exam, pituitary saddle
70250 X-ray exam of skull
70260 X-ray exam of skull
70300 X-ray exam of teeth
70310 X-ray exam of teeth
70320 Full mouth x-ray of teeth
70328 X-ray exam of jaw joint
70330 X-ray exam of jaw joints
70336 Magnetic image, jaw joint
70350 X-ray head for orthodontia
70355 Panoramic x-ray of jaws
70360 X-ray exam of neck
70370 Throat x-ray fluoroscopy
70371 Speech evaluation, complex
70380 X-ray exam of salivary gland
70450 Ct head/brain w/o dye
70460 Ct head/brain w/dye
70470 Ct head/brain w/o w/dye
70480 Ct orbit/ear/fossa w/o dye
70481 Ct orbit/ear/fossa w/dye
70482 Ct orbit/ear/fossa w/o w/dye
70486 Ct maxillofacial w/o dye
70487 Ct maxillofacial w/dye
70488 Ct maxillofacial w/o w/dye
70490 Ct soft tissue neck w/o dye
70491 Ct soft tissue neck w/dye
70492 Ct sft tsue nck w/o w/dye
70496 Ct angiography, head
70498 Ct angiography, neck
70540 Mri orbit/face/neck w/o dye
70542 Mri orbit/face/neck w/dye
70543 Mri orbt/fac/nck w/o w/dye
70544 Mr angiography head w/o dye
70545 Mr angiography head w/dye
70546 Mr angiograph head w/ow/dye
70547 Mr angiography neck w/o dye
70548 Mr angiography neck w/dye
70549 Mr angiograph neck w/ow/dye
70551 Mri brain w/o dye
70552 Mri brain w/dye
70553 Mri brain w/o w/dye
70554 Fmri brain by tech
70555 Fmri brain by phys/psych
71010 Chest x-ray
71015 Chest x-ray
71020 Chest x-ray
71021 Chest x-ray
71022 Chest x-ray
71023 Chest x-ray and fluoroscopy
71030 Chest x-ray
71034 Chest x-ray and fluoroscopy
71035 Chest x-ray
71100 X-ray exam of ribs
71101 X-ray exam of ribs/chest
71110 X-ray exam of ribs
71111 X-ray exam of ribs/chest
71120 X-ray exam of breastbone
71130 X-ray exam of breastbone
71250 Ct thorax w/o dye
71260 Ct thorax w/dye
71270 Ct thorax w/o w/dye
71275 Ct angiography, chest
71550 Mri chest w/o dye
71551 Mri chest w/dye
71552 Mri chest w/o w/dye
71555 Mri angio chest w or w/o dye
72010 X-ray exam of spine
72020 X-ray exam of spine
72040 X-ray exam of neck spine
72050 X-ray exam of neck spine
72052 X-ray exam of neck spine
72069 X-ray exam of trunk spine
72070 X-ray exam of thoracic spine
72072 X-ray exam of thoracic spine
72074 X-ray exam of thoracic spine
72080 X-ray exam of trunk spine
72090 X-ray exam of trunk spine
72100 X-ray exam of lower spine
72110 X-ray exam of lower spine
72114 X-ray exam of lower spine
72120 X-ray exam of lower spine
72125 Ct neck spine w/o dye
72126 Ct neck spine w/dye
72127 Ct neck spine w/o w/dye
72128 Ct chest spine w/o dye
72129 Ct chest spine w/dye
72130 Ct chest spine w/o w/dye
72131 Ct lumbar spine w/o dye
72132 Ct lumbar spine w/dye
72133 Ct lumbar spine w/o w/dye
72141 Mri neck spine w/o dye
72142 Mri neck spine w/dye
72146 Mri chest spine w/o dye
72147 Mri chest spine w/dye
72148 Mri lumbar spine w/o dye
72149 Mri lumbar spine w/dye
72156 Mri neck spine w/o w/dye
72157 Mri chest spine w/o w/dye
72158 Mri lumbar spine w/o w/dye
72170 X-ray exam of pelvis
72190 X-ray exam of pelvis
72191 Ct angiograph pelv w/o w/dye
72192 Ct pelvis w/o dye
72193 Ct pelvis w/dye
72194 Ct pelvis w/o w/dye
72195 Mri pelvis w/o dye
72196 Mri pelvis w/dye
72197 Mri pelvis w/o w/dye
72198 Mr angio pelvis w/o w/dye
72200 X-ray exam sacroiliac joints
72202 X-ray exam sacroiliac joints
72220 X-ray exam of tailbone
73000 X-ray exam of collar bone
73010 X-ray exam of shoulder blade
73020 X-ray exam of shoulder
73030 X-ray exam of shoulder
73050 X-ray exam of shoulders
73060 X-ray exam of humerus
73070 X-ray exam of elbow
73080 X-ray exam of elbow
73090 X-ray exam of forearm
73092 X-ray exam of arm, infant
73100 X-ray exam of wrist
73110 X-ray exam of wrist
73120 X-ray exam of hand
73130 X-ray exam of hand
73140 X-ray exam of finger(s)
73200 Ct upper extremity w/o dye
73201 Ct upper extremity w/dye
73202 Ct uppr extremity w/o amp; w/dye
73206 Ct angio upr extrm w/o w/dye
73218 Mri upper extremity w/o dye
73219 Mri upper extremity w/dye
73220 Mri uppr extremity w/o w/dye
73221 Mri joint upr extrem w/o dye
73222 Mri joint upr extrem w/dye
73223 Mri joint upr extr w/ow/dye
73500 X-ray exam of hip
73510 X-ray exam of hip
73520 X-ray exam of hips
73540 X-ray exam of pelvis hips
73550 X-ray exam of thigh
73560 X-ray exam of knee, 1 or 2
73562 X-ray exam of knee, 3
73564 X-ray exam, knee, 4 or more
73565 X-ray exam of knees
73590 X-ray exam of lower leg
73592 X-ray exam of leg, infant
73600 X-ray exam of ankle
73610 X-ray exam of ankle
73620 X-ray exam of foot
73630 X-ray exam of foot
73650 X-ray exam of heel
73660 X-ray exam of toe(s)
73700 Ct lower extremity w/o dye
73701 Ct lower extremity w/dye
73702 Ct lwr extremity w/ow/dye
73706 Ct angio lwr extr w/ow/dye
73718 Mri lower extremity w/o dye
73719 Mri lower extremity w/dye
73720 Mri lwr extremity w/ow/dye
73721 Mri jnt of lwr extre w/o dye
73722 Mri joint of lwr extr w/dye
73723 Mri joint lwr extr w/ow/dye
73725 Mr ang lwr ext w or w/o dye
74000 X-ray exam of abdomen
74010 X-ray exam of abdomen
74020 X-ray exam of abdomen
74022 X-ray exam series, abdomen
74150 Ct abdomen w/o dye
74160 Ct abdomen w/dye
74170 Ct abdomen w/o w/dye
74175 Ct angio abdom w/o w/dye
74181 Mri abdomen w/o dye
74182 Mri abdomen w/dye
74183 Mri abdomen w/o w/dye
74185 Mri angio, abdom w orw/o dye
74210 Contrst x-ray exam of throat
74220 Contrast x-ray, esophagus
74230 Cine/vid x-ray, throat/esoph
74240 X-ray exam, upper gi tract
74241 X-ray exam, upper gi tract
74245 X-ray exam, upper gi tract
74246 Contrst x-ray uppr gi tract
74247 Contrst x-ray uppr gi tract
74249 Contrst x-ray uppr gi tract
74250 X-ray exam of small bowel
74290 Contrast x-ray, gallbladder
74291 Contrast x-rays, gallbladder
74710 X-ray measurement of pelvis
75552 Heart mri for morph w/o dye
75553 Heart mri for morph w/dye
75554 Cardiac MRI/function
75555 Cardiac MRI/limited study
75635 Ct angio abdominal arteries
76000 Fluoroscope examination
76010 X-ray, nose to rectum
76100 X-ray exam of body section
76101 Complex body section x-ray
76102 Complex body section x-rays
76120 Cine/video x-rays
76125 Cine/video x-rays add-on
76150 X-ray exam, dry process
76376 3d render w/o postprocess
76377 3d rendering w/postprocess
76380 CAT scan follow-up study
76499 Radiographic procedure
76506 Echo exam of head
76510 Ophth us, b quant a
76511 Ophth us, quant a only
76512 Ophth us, b w/non-quant a
76513 Echo exam of eye, water bath
76514 Echo exam of eye, thickness
76516 Echo exam of eye
76519 Echo exam of eye
76536 Us exam of head and neck
76604 Us exam, chest
76645 Us exam, breast(s)
76700 Us exam, abdom, complete
76705 Echo exam of abdomen
76770 Us exam abdo back wall, comp
76775 Us exam abdo back wall, lim
76776 Us exam k transpl w/Doppler
76800 Us exam, spinal canal
76801 Ob us 14 wks, single fetus
76802 Ob us 14 wks, add?l fetus
76805 Ob us /= 14 wks, sngl fetus
76810 Ob us /= 14 wks, addl fetus
76811 Ob us, detailed, sngl fetus
76812 Ob us, detailed, addl fetus
76815 Ob us, limited, fetus(s)
76816 Ob us, follow-up, per fetus
76818 Fetal biophys profile w/nst
76819 Fetal biophys profil w/o nst
76820 Umbilical artery echo
76821 Middle cerebral artery echo
76825 Echo exam of fetal heart
76826 Echo exam of fetal heart
76827 Echo exam of fetal heart
76828 Echo exam of fetal heart
76856 Us exam, pelvic, complete
76857 Us exam, pelvic, limited
76870 Us exam, scrotum
76880 Us exam, extremity
76885 Us exam infant hips, dynamic
76886 Us exam infant hips, static
76970 Ultrasound exam follow-up
76977 Us bone density measure
76999 Echo examination procedure
77014 Ct scan for therapy guide
77051 Computer dx mammogram add-on
77052 Comp screen mammogram add-on
77055 Mammogram, one breast
77056 Mammogram, both breasts
77057 Mammogram, screening
77058 Mri, one breast
77059 Mri, both breasts
77071 X-ray stress view
77072 X-rays for bone age
77073 X-rays, bone length studies
77074 X-rays, bone survey, limited
77075 X-rays, bone survey complete
77076 X-rays, bone survey, infant
77077 Joint survey, single view
77078 Ct bone density, axial
77079 Ct bone density, peripheral
77080 Dxa bone density, axial
77081 Dxa bone density/peripheral
77082 Dxa bone density, vert fx
77083 Radiographic absorptiometry
77084 Magnetic image, bone marrow
78000 Thyroid, single uptake
78001 Thyroid, multiple uptakes
78003 Thyroid suppress/stimul
78006 Thyroid imaging with uptake
78007 Thyroid image, mult uptakes
78010 Thyroid imaging
78011 Thyroid imaging with flow
78015 Thyroid met imaging
78016 Thyroid met imaging/studies
78018 Thyroid met imaging, body
78020 Thyroid met uptake
78070 Parathyroid nuclear imaging
78075 Adrenal nuclear imaging
78099 Endocrine nuclear procedure
78102 Bone marrow imaging, ltd
78103 Bone marrow imaging, mult
78104 Bone marrow imaging, body
78135 Red cell survival kinetics
78140 Red cell sequestration
78185 Spleen imaging
78190 Platelet survival, kinetics
78195 Lymph system imaging
78199 Blood/lymph nuclear exam
78201 Liver imaging
78202 Liver imaging with flow
78205 Liver imaging (3D)
78206 Liver image (3d) with flow
78215 Liver and spleen imaging
78216 Liver spleen image/flow
78220 Liver function study
78223 Hepatobiliary imaging
78230 Salivary gland imaging
78231 Serial salivary imaging
78232 Salivary gland function exam
78258 Esophageal motility study
78261 Gastric mucosa imaging
78262 Gastroesophageal reflux exam
78264 Gastric emptying study
78278 Acute GI blood loss imaging
78282 GI protein loss exam
78290 Meckel?s divert exam
78291 Leveen/shunt patency exam
78299 GI nuclear procedure
78300 Bone imaging, limited area
78305 Bone imaging, multiple areas
78306 Bone imaging, whole body
78315 Bone imaging, 3 phase
78320 Bone imaging (3D)
78350 Bone mineral, single photon
78399 Musculoskeletal nuclear exam
78414 Non-imaging heart function
78428 Cardiac shunt imaging
78445 Vascular flow imaging
78456 Acute venous thrombus image
78457 Venous thrombosis imaging
78458 Ven thrombosis images, bilat
78459 Heart muscle imaging (PET)
78460 Heart muscle blood, single
78461 Heart muscle blood, multiple
78464 Heart image (3d), single
78465 Heart image (3d), multiple
78466 Heart infarct image
78468 Heart infarct image (ef)
78469 Heart infarct image (3D)
78472 Gated heart, planar, single
78473 Gated heart, multiple
78478 Heart wall motion add-on
78480 Heart function add-on
78481 Heart first pass, single
78483 Heart first pass, multiple
78491 Heart image (pet), single
78492 Heart image (pet), multiple
78494 Heart image, spect
78496 Heart first pass add-on
78499 Cardiovascular nuclear exam
78580 Lung perfusion imaging
78584 Lung V/Q image single breath
78585 Lung V/Q imaging
78586 Aerosol lung image, single
78587 Aerosol lung image, multiple
78588 Perfusion lung image
78591 Vent image, 1 breath, 1 proj
78593 Vent image, 1 proj, gas
78594 Vent image, mult proj, gas
78596 Lung differential function
78599 Respiratory nuclear exam
78600 Brain imaging, ltd static
78601 Brain imaging, ltd w/flow
78605 Brain imaging, complete
78606 Brain imaging, compl w/flow
78607 Brain imaging (3D)
78608 Brain imaging (PET)
78609 Brain imaging (PET)
78610 Brain flow imaging only
78615 Cerebral vascular flow image
78630 Cerebrospinal fluid scan
78635 CSF ventriculography
78645 CSF shunt evaluation
78647 Cerebrospinal fluid scan
78650 CSF leakage imaging
78660 Nuclear exam of tear flow
78699 Nervous system nuclear exam
78700 Kidney imaging, morphol
78701 Kidney imaging with flow
78707 K flow/funct image w/o drug
78708 K flow/funct image w/drug
78709 K flow/funct image, multiple
78710 Kidney imaging (3D)
78730 Urinary bladder retention
78740 Ureteral reflux study
78761 Testicular imaging w/flow
78799 Genitourinary nuclear exam
78800 Tumor imaging, limited area
78801 Tumor imaging, mult areas
78802 Tumor imaging, whole body
78803 Tumor imaging (3D)
78804 Tumor imaging, whole body
78805 Abscess imaging, ltd area
78806 Abscess imaging, whole body
78807 Nuclear localization/abscess
78811 Tumor imaging (pet), limited
78812 Tumor image (pet)/skull-thigh
78813 Tumor image (pet) full body
78814 Tumor image pet/ct, limited
78815 Tumorimage pet/ct skull-thigh
78816 Tumor image pet/ct full body
78890 Nuclear medicine data proc
78891 Nuclear med data proc
78999 Nuclear diagnostic exam
91110 Gi tract capsule endoscopy
91111 Esophageal capsule endoscopy
93303 Echo transthoracic
93304 Echo transthoracic
93307 Echo exam of heart
93308 Echo exam of heart
93320 Doppler echo exam, heart [if used in conjunction with 93303-93308]
93321 Doppler echo exam, heart [if used in conjunction with 93303-93308]
93325 Doppler color flow add-on [if used in conjunction with 93303-93308]
93875 Extracranial study
93880 Extracranial study
93882 Extracranial study
93886 Intracranial study
93888 Intracranial study
93890 Tcd, vasoreactivity study
93892 Tcd, emboli detect w/o inj
93922 Extremity study
93923 Extremity study
93924 Extremity study
93925 Lower extremity study
93926 Lower extremity study
93930 Upper extremity study
93931 Upper extremity study
93965 Extremity study
93970 Extremity study
93971 Extremity study
93975 Vascular study
93976 Vascular study
93978 Vascular study
93979 Vascular study
93980 Penile vascular study
93981 Penile vascular study
93990 Doppler flow testing
A4641 Radiopharm dx agent noc
A4642 In111 satumomab
A9500 Tc99m sestamibi
A9502 Tc99m tetrofosmin
A9503 Tc99m medronate
A9504 Tc99m apcitide
A9505 TL201 thallium
A9507 In111 capromab
A9508 I131 iodobenguate, dx
A9510 Tc99m disofenin
A9512 Tc99m pertechnetate
A9516 I123 iodide cap, dx
A9521 Tc99m exametazime
A9524 I131 serum albumin, dx
A9526 Nitrogen N-13 ammonia
A9528 Iodine I-131 iodide cap, dx
A9529 I131 iodide sol, dx
A9531 I131 max 100uCi
A9532 I125 serum albumin, dx
A9536 TC99m depreotide
A9537 Tc99m mebrofenin
A9538 Tc99m pyrophosphate
A9539 Tc99m pentetate
A9540 Tc99m MAA
A9541 Tc99m sulfur colloid
A9542 In111 ibritumomab, dx
A9544 I131 tositumomab, dx
A9546 CO57/58
A9547 In111 oxyquinoline
A9548 In111 pentetate
A9550 Tc99m gluceptate
A9551 Tc99m succimer
A9552 F18 fdg
A9553 Cr51 chromate
A9554 I125 iothalamate, dx
A9555 Rb82 rubidium
A9556 Ga67 gallium
A9557 Tc99m bicisate
A9558 Xe133 xenon 10mci
A9559 Co57 cyano
A9560 Tc99m labeled rbc
A9561 Tc99m oxidronate
A9562 Tc99m mertiatide
A9565 In111 pentetreotide
A9566 Tc99m fanolesomab
A9567 Technetium TC-99m
A9568 Tc99m arcitumomab
A9700 Echocardiography contrast
G0130 Single energy x-ray study
G0202 Screeningmammographydigital
G0204 Diagnosticmammographydigital
G0206 Diagnosticmammographydigital
G0288 Recon, CTA for surg plan
G0389 Ultrasound exam AAA screen
Q0092 Set up port xray equipment
Q9945 LOCM =149mg/ml iodine, 1 ml
Q9946 LOCM 150-199mg/ml iodine,1ml
Q9947 LOCM 200-249mg/ml iodine,1ml
Q9948 LOCM 250-299mg/ml/iodine,1ml
Q9949 LOCM 300-349mg/ml iodine,1ml
Q9950 LOCM 350-399mg/ml iodine,1ml
Q9951 LOCM=400 mg/ml iodine,1ml
Q9952 Inj Gad-base MR contrast, ml
Q9953 Inj Fe-base MR contrast, ml
Q9954 Oral MR contrast, 100ml
Q9955 Inj perflexane lip micros,ml
Q9956 Inj octafluoropropane mic,ml
Q9957 Inj perflutren lip micros,ml
Q9958 HOCM =149 mg/ml iodine, 1ml
Q9959 HOCM 150-199mg/ml iodine,1ml
Q9960 HOCM 200-249mg/ml iodine,1ml
Q9961 HOCM 250-299mg/ml iodine,1ml
Q9962 HOCM 300-349mg/ml iodine,1ml
Q9963 HOCM 350-399mg/ml iodine,1ml
Q9964 HOCM=400mg/ml iodine, 1ml
R0070 Transport portable x-ray
R0075 Transport port x-ray multipl
RADIATION THERAPY SERVICES AND SUPPLIES
INCLUDE the following CPT and HCPCS codes:
0073T Delivery, comp imrt
19296 Place po breast cath for rad
19297 Place breast cath for rad
19298 Place breast rad tube/caths
31643 Diag bronchoscope/catheter
55875 Transperi needle place, pros
55876 Place rt device/marker, pros
57155 Insert uteri tandems/ovoids
58346 Insert heyman uteri capsule
61770 Incise skull for treatment
61793 Focus radiation beam
77261 Radiation therapy planning
77262 Radiation therapy planning
77263 Radiation therapy planning
77280 Set radiation therapy field
77285 Set radiation therapy field
77290 Set radiation therapy field
77295 Set radiation therapy field
77299 Radiation therapy planning
77300 Radiation therapy dose plan
77301 Radiotherapy dose plan, imrt
77305 Teletx isodose plan simple
77310 Teletx isodose plan intermed
77315 Teletx isodose plan complex
77321 Special teletx port plan
77326 Brachytx isodose calc simp
77327 Brachytx isodose calc interm
77328 Brachytx isodose plan compl
77331 Special radiation dosimetry
77332 Radiation treatment aid(s)
77333 Radiation treatment aid(s)
77334 Radiation treatment aid(s)
77336 Radiation physics consult
77370 Radiation physics consult
77371 Srs, multisource
77372 Srs, linear based
77373 Sbrt delivery
77399 External radiation dosimetry
77401 Radiation treatment delivery
77402 Radiation treatment delivery
77403 Radiation treatment delivery
77404 Radiation treatment delivery
77406 Radiation treatment delivery
77407 Radiation treatment delivery
77408 Radiation treatment delivery
77409 Radiation treatment delivery
77411 Radiation treatment delivery
77412 Radiation treatment delivery
77413 Radiation treatment delivery
77414 Radiation treatment delivery
77416 Radiation treatment delivery
77417 Radiology port film(s)
77418 Radiation tx delivery, imrt
77421 Stereoscopic x-ray guidance
77422 Neutron beam tx, simple
77423 Neutron beam tx, complex
77427 Radiation tx management, x5
77431 Radiation therapy management
77432 Stereotactic radiation trmt
77435 Sbrt management
77470 Special radiation treatment
77499 Radiation therapy management
77520 Proton trmt, simple w/o comp
77522 Proton trmt, simple w/comp
77523 Proton trmt, intermediate
77525 Proton treatment, complex
77600 Hyperthermia treatment
77605 Hyperthermia treatment
77610 Hyperthermia treatment
77615 Hyperthermia treatment
77620 Hyperthermia treatment
77750 Infuse radioactive materials
77761 Apply intrcav radiat simple
77762 Apply intrcav radiat interm
77763 Apply intrcav radiat compl
77776 Apply interstit radiat simpl
77777 Apply interstit radiat inter
77778 Apply interstit radiat compl
77781 High intensity brachytherapy
77782 High intensity brachytherapy
77783 High intensity brachytherapy
77784 High intensity brachytherapy
77789 Apply surface radiation
77790 Radiation handling
77799 Radium/radioisotope therapy
79005 Nuclear rx, oral admin
79101 Nuclear rx, iv admin
79200 Nuclear rx, intracav admin
79300 Nuclr rx, interstit colloid
79403 Hematopoietic nuclear tx
79440 Nuclear rx, intra-articular
79445 Nuclear rx, intra-arterial
79999 Nuclear medicine therapy
92974 Cath place, cardio brachytx
A9517 I131 iodide cap, rx
A9527 Iodine I-125 sodium iodide
A9530 I131 iodide sol, rx
A9543 Y90 ibritumomab, rx
A9545 I131 tositumomab, rx
A9563 P32 Na phosphate
A9564 P32 chromic phosphate
A9600 Sr89 strontium
A9605 Sm 153 lexidronm
A9699 Radiopharm rx agent noc
G0173 Stereo radiosurgery,complete
G0243 Multisour photon stero treat
G0251 Linear acc based stero radio
G0339 Robot lin-radsurg com, first
G0340 Robt lin-radsurg fractx 2-5
Q3001 Brachytherapy Radioelements
EPO AND OTHER DIALYSIS-RELATED DRUGS
The physician self-referral prohibition does not apply to the following codes for EPO and other dialysis-related drugs furnished in or by an ESRD facility if the conditions in §411.355(g) are satisfied:
J0630 Calcitonin salmon injection
J0636 Inj calcitriol per 0.1 mcg
J0882 Darbepoetin alfa, esrd use
J0895 Deferoxamine mesylate inj
J1270 Injection, doxercalciferol
J1751 Iron dextran 165 injection
J1752 Iron dextran 267 injection
J1756 Iron sucrose injection
J1955 Inj levocarnitine per 1 gm
J2501 Paricalcitol
J2916 Na ferric gluconate complex
J2993 Reteplase injection
J2995 Inj streptokinase/250000 IU
J2997 Alteplase recombinant
J3364 Urokinase 5000 IU injection
P9041 Albumin (human),5%, 50ml
P9045 Albumin (human), 5%, 250ml
P9046 Albumin (human), 25%, 20ml
P9047 Albumin (human), 25%, 50ml
Q4081 Epoetin alfa, 100 units ESRD
PREVENTIVE SCREENING TESTS, IMMUNIZATIONS AND VACCINES
The physician self-referral prohibition does not apply to the following tests if they are performed for screening purposes and satisfy the conditions in §411.355(h):
77052 Comp screen mammogram add-on
77057 Mammogram, screening
80061 Lipid panel [only when billed with one of the following ICD-9-CM codes: V81.0, V81.1, or V.81.2]
82270 Occult blood, feces
82465 Assay, bld/serum cholesterol [only when billed with one of the following ICD-9-CM codes: V81.0, V81.1, or V.81.2]
82947 Assay, glucose, blood quant [only when billed with ICD-9-CM code V77.1]
82950 Glucose test [only when billed with ICD-9-CM code V77.1]
82951 Glucose tolerance test (GTT) [only when billed with ICD-9-CM code V77.1]
83718 Assay of lipoprotein [only when billed with one of the following ICD-9-CM codes: V81.0, V81.1, or V.81.2]
84478 Assay of triglycerides [only when billed with one of the following ICD-9-CM codes: V81.0, V81.1, or V.81.2]
G0103 Psa, total screening
G0123 Screen cerv/vag thin layer
G0124 Screen c/v thin layer by MD
G0141 Scr c/v cyto,autosys and md
G0143 Scr c/v cyto,thinlayer,rescr
G0144 Scr c/v cyto,thinlayer,rescr
G0145 Scr c/v cyto,thinlayer,rescr
G0147 Scr c/v cyto, automated sys
G0148 Scr c/v cyto, autosys, rescr
G0202 Screeningmammographydigital
G0328 Fecal blood scrn immunoassay
G0389 Ultrasound exam AAA screen
P3000 Screen pap by tech w md supv
P3001 Screening pap smear by phys
The physician self-referral prohibition does not apply to the following immunization and vaccine codes if they satisfy the conditions in §411.355(h):
90655 Flu vaccine no preserv 6-35m
90656 Flu vaccine no preserv 3
90657 Flu vaccine, 3 yrs, im
90658 Flu vaccine 3 yrs , im
90660 Flu vaccine, nasal
90732 Pneumococcal vaccine
90740 Hepb vacc, ill pat 3 dose im
90743 Hepb vacc, adol, 2 dose, im
90744 Hepb vacc ped/adol 3 dose im
90746 Hepb vaccine, adult, im
90747 Hepb vacc, ill pat 4 dose im
1 CPT codes and descriptions only are copyright 2006 American Medical Association. All rights are reserved and applicable FARS/DFARS clauses apply.
2 This list does not include codes for the following designated health service (DHS) categories: durable medical equipment and supplies; parenteral and enteral nutrients, equipment and supplies; prosthetics, orthotics, and prosthetic devices and supplies; home health services; outpatient prescription drugs; and inpatient and outpatient hospital services. For the definitions of these DHS categories, refer to §411.351. For more information, refer to http://cms.hhs.gov/medlearn/refphys.asp.

[FR Doc. 06-9086 Filed 11-1-06; 5:00 pm]

BILLING CODE 4120-01-P